data_2kfs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kfs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.275 0 N-CA-C 106.974 -1.491 . . . . 73.12 106.974 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.11 -109.77 0.83 Allowed Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.675 -1.25 . . . . 70.15 114.395 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.56 121.35 29.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 73.11 112.539 -168.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.03 120.22 9.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.489 -1.232 . . . . 71.21 110.993 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.84 -40.22 13.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.663 -0.699 . . . . 75.44 111.049 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.66 157.21 37.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.957 -0.697 . . . . 73.32 110.965 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.14 141.55 70.92 Favored Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 73.44 108.346 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.95 -21.73 16.47 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.111 2.541 . . . . 74.34 115.011 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.79 -13.41 59.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.984 0.421 . . . . 73.34 110.823 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.3 137.18 71.78 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 109.296 -0.631 . . . . 73.22 109.296 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.36 131.83 37.65 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 123.938 3.092 . . . . 73.04 113.841 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -137.87 158.83 43.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.595 -0.73 . . . . 72.14 111.832 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.465 ' CZ ' HD21 ' A' ' 38' ' ' LEU . 6.2 m-85 -109.5 160.15 16.47 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.339 1.855 . . . . 73.43 107.596 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -135.18 162.48 32.41 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.728 -1.953 . . . . 72.45 105.728 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.26 -54.34 39.43 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 113.239 0.829 . . . . 75.41 113.239 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.02 -36.7 96.15 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 121.807 1.671 . . . . 75.03 111.864 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -70.41 -37.61 74.47 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.373 -0.376 . . . . 73.45 111.856 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.35 -37.59 71.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 120.17 -0.612 . . . . 75.22 109.845 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.13 -41.7 84.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.662 -0.866 . . . . 63.42 108.662 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.12 -45.69 90.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.884 -1.053 . . . . 70.03 111.99 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.465 HD21 ' CZ ' ' A' ' 30' ' ' TYR . 60.2 tp -61.49 -50.19 73.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.617 0.767 . . . . 74.41 112.153 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.5 mt -89.09 -12.65 40.57 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.094 0.405 . . . . 71.33 112.094 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.17 27.75 65.57 Favored Glycine 0 C--N 1.316 -0.549 0 N-CA-C 111.212 -0.755 . . . . 75.44 111.212 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.7 m -118.63 160.78 38.78 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.531 -0.544 . . . . 65.44 109.531 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 37.5 Cg_endo -68.7 160.29 50.14 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.138 1.892 . . . . 74.41 111.723 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.51 -34.5 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.563 0.745 . . . . 65.34 110.492 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -61.27 -39.0 88.77 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.292 -0.867 . . . . 62.43 111.695 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD3' ' HD2' ' A' ' 42' ' ' PRO . 26.3 mtpp -69.82 -33.92 72.98 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.815 -0.354 . . . . 74.51 111.258 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -44.43 98.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.852 -0.795 . . . . 74.24 108.852 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.521 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -63.01 -36.41 83.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.239 -0.892 . . . . 72.13 110.433 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 15.4 mm100 -62.01 -40.77 96.8 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-N 117.002 -0.09 . . . . 71.22 111.064 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -58.73 -44.49 90.47 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.464 0.649 . . . . 73.23 109.815 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.5 -38.94 91.86 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.598 -1.183 . . . . 75.45 110.394 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 47' ' ' ALA . 20.0 mmm180 -71.32 -26.56 62.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.374 -0.375 . . . . 74.44 111.673 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 74.7 mm-40 -89.72 -2.64 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.596 -0.275 . . . . 74.12 111.119 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 35.86 54.14 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.776 -0.726 . . . . 63.24 111.907 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -99.81 -17.68 17.55 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 120.63 0.252 . . . . 74.2 111.01 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.9 tp -152.71 160.98 43.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.217 -1.031 . . . . 73.31 108.217 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.65 147.32 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.553 -0.906 . . . . 74.54 108.553 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.48 150.93 51.72 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.228 -0.656 . . . . 63.33 109.228 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -129.85 166.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.03 0.532 . . . . 73.22 110.034 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 37.2 ttt180 -114.61 123.11 48.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.879 -0.415 . . . . 74.3 109.879 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.485 ' C ' ' H ' ' A' ' 62' ' ' GLY . 8.8 ptm180 -116.64 114.07 23.56 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.723 -0.844 . . . . 72.25 108.723 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.03 -16.81 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.138 1.375 . . . . 73.51 113.369 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . 147.0 -18.93 1.58 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.713 -0.955 . . . . 72.44 110.713 -177.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -91.1 146.28 18.25 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 112.346 -0.302 . . . . 73.13 112.346 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.56 121.69 48.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.869 -0.789 . . . . 73.41 108.869 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.11 157.88 43.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.471 0.653 . . . . 74.32 111.659 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.52 122.22 23.7 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 107.144 -1.428 . . . . 75.23 107.144 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.54 132.36 50.04 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.152 1.901 . . . . 74.44 113.08 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -48.8 -38.52 22.27 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.818 0.847 . . . . 75.34 111.375 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 27.0 m -65.66 -11.1 11.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 114.592 1.33 . . . . 73.35 114.592 -174.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.583 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.6 m-85 -77.78 -12.87 60.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.699 0.761 . . . . 72.23 110.292 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.79 145.12 38.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 108.141 -1.059 . . . . 75.34 108.141 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.0 p -75.42 175.58 8.32 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.076 0.55 . . . . 73.33 110.421 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -65.85 -17.21 64.49 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 122.19 0.995 . . . . 71.14 109.863 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -90.15 -0.55 57.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.281 -0.872 . . . . 73.53 111.524 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 26.55 67.54 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.499 -0.382 . . . . 74.41 112.712 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -113.82 157.72 21.94 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.989 -1.115 . . . . 75.22 107.989 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.6 t -73.44 140.9 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.075 -1.083 . . . . 74.23 108.075 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 46.7 t -64.08 128.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.52 -0.919 . . . . 72.35 108.52 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -58.16 -43.9 87.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.342 0.867 . . . . 74.43 113.342 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 t -89.74 1.71 55.76 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 121.01 -0.276 . . . . 61.21 111.502 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 7.9 tt -65.99 -50.24 53.29 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 119.513 -0.279 . . . . 74.23 111.511 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.64 -24.58 75.92 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.464 1.443 . . . . 65.43 110.512 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.95 88.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.353 -0.84 . . . . 72.23 111.574 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -66.46 -39.78 89.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 108.021 -1.103 . . . . 72.53 108.021 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.52 -35.78 78.68 Favored 'General case' 0 C--O 1.202 -1.422 0 CA-C-N 115.44 -0.8 . . . . 72.31 110.652 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.4 m -59.46 -50.98 71.83 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.422 0.451 . . . . 72.12 111.263 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.97 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 116.268 -0.424 . . . . 74.03 111.36 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.72 -35.23 79.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.15 0.426 . . . . 64.15 112.15 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -64.37 -40.96 96.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.404 -0.591 . . . . 74.34 109.404 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.11 -30.14 68.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 75.34 110.067 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.88 -6.31 89.08 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.538 -0.755 . . . . 64.32 112.336 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.22 57.19 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 114.003 0.361 . . . . 74.42 114.003 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -90.87 129.11 36.95 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 122.168 -0.607 . . . . 75.44 112.099 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -78.02 171.8 14.46 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.159 -0.928 . . . . 75.21 110.802 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.26 -45.28 72.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.279 1.432 . . . . 63.0 111.848 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.9 m -61.8 -40.9 96.86 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.281 -0.872 . . . . 70.22 109.88 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.766 -0.652 . . . . 75.54 110.713 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.96 -48.63 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.367 0.603 . . . . 74.43 109.578 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -74.86 -21.33 59.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.346 -0.843 . . . . 73.35 111.941 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -55.59 -64.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.121 0.568 . . . . 75.51 110.954 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -68.89 -32.52 72.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.03 0.443 . . . . 73.01 112.102 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.441 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -67.39 -37.83 83.76 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.584 -0.734 . . . . 73.31 112.429 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -93.39 -1.4 55.88 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 112.779 0.659 . . . . 74.24 112.779 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -87.29 116.96 67.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.575 -0.528 . . . . 74.42 109.575 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.64 128.72 22.96 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.81 1.673 . . . . 72.4 109.383 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.597 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 33.4 t70 -100.43 125.81 38.03 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 120.271 -0.572 . . . . 74.32 111.04 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.56 -30.43 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.111 2.541 . . . . 72.31 113.164 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 p -92.0 5.49 49.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.289 0.566 . . . . 74.44 111.48 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.3 tp -102.79 126.07 49.78 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.205 -0.665 . . . . 73.54 109.205 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.3 m -131.72 110.53 10.95 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.542 -1.281 . . . . 75.43 107.542 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 C--N 1.286 -2.186 0 CA-C-N 115.292 -0.867 . . . . 73.34 109.922 -174.057 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 N--CA 1.431 -1.385 0 N-CA-C 108.918 -0.771 . . . . 65.14 108.918 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.6 t -86.51 139.04 31.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.441 -1.689 . . . . 73.14 106.441 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.6 t30 67.1 68.63 0.4 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.073 0.94 . . . . 74.0 109.146 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.77 162.81 21.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.648 -1.16 . . . . 73.0 109.581 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -75.4 130.83 78.9 Favored Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.592 0.557 . . . . 75.04 110.161 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 50.5 Cg_exo -55.49 -17.24 16.18 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 123.836 3.024 . . . . 74.21 113.351 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 65.8 t -59.73 -43.03 90.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.144 -0.48 . . . . 74.34 109.891 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -29.88 69.35 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 116.112 -0.495 . . . . 74.43 111.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.18 -52.64 57.95 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.943 -0.571 . . . . 72.21 109.541 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -68.02 -34.11 75.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 111.735 0.272 . . . . 74.03 111.735 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.61 -24.06 63.61 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.688 0.756 . . . . 70.44 109.196 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -104.45 16.47 26.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.965 -1.016 . . . . 74.42 110.833 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.5 m80 64.05 28.33 14.27 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.35 1.06 . . . . 74.03 113.344 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -99.73 23.11 10.04 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.796 -1.928 . . . . 70.05 105.796 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.31 -27.84 25.21 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 127.08 2.152 . . . . 72.42 114.658 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -56.49 -36.9 69.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.218 0.451 . . . . 75.14 112.218 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -67.76 -33.09 74.16 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.721 0.772 . . . . 72.43 109.664 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.1 t -72.01 -40.55 67.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.387 -0.824 . . . . 73.15 108.831 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.85 -44.22 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.086 -0.709 . . . . 73.33 109.086 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -57.87 -47.13 83.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.65 -0.705 . . . . 72.15 110.495 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -65.82 -34.29 77.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.726 -0.67 . . . . 73.03 109.787 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.29 76.5 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.474 -0.784 . . . . 73.14 109.61 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.78 -48.19 82.67 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.292 -0.867 . . . . 72.33 110.483 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.12 -29.8 71.08 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.286 0.366 . . . . 71.25 111.59 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.23 -34.07 70.45 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.286 -0.416 . . . . 72.54 110.925 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.9 -58.75 1.93 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.938 1.088 . . . . 75.11 113.938 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.314 -0.941 0 CA-C-O 119.072 -0.49 . . . . 65.25 110.743 -174.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.366 -0.605 . . . . 72.14 109.366 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.4 -120.93 4.62 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 115.998 -0.546 . . . . 61.3 112.847 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -119.91 142.2 48.92 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.8 0.333 . . . . 73.23 110.495 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.92 137.65 51.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.991 -0.549 . . . . 74.43 111.305 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 100' ' ' ARG . 21.8 t -115.45 -13.69 11.1 Favored 'Isoleucine or valine' 0 C--O 1.248 0.978 0 CA-C-O 122.195 0.997 . . . . 70.44 109.866 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.435 HD21 ' CZ ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -78.36 175.97 9.77 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.804 -1.184 . . . . 73.13 107.804 172.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.01 129.52 53.81 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 117.309 -1.756 . . . . 63.51 106.355 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.64 -21.19 7.51 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.215 2.61 . . . . 73.53 113.972 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.34 -21.19 46.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.032 0.382 . . . . 73.24 112.032 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.1 153.61 91.6 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 122.244 -0.285 . . . . 74.54 110.799 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.52 113.67 1.33 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.353 2.702 . . . . 62.54 113.666 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.7 p -126.4 -179.97 5.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 115.504 -0.771 . . . . 74.45 110.236 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CE2' HD23 ' A' ' 38' ' ' LEU . 40.8 m-85 -130.33 161.03 32.2 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.648 -1.612 . . . . 70.05 106.648 170.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 35' ' ' VAL . 4.7 m-20 -133.01 162.88 30.51 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 103.662 -2.718 . . . . 65.34 103.662 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -43.28 -56.04 7.23 Favored Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 114.501 1.297 . . . . 71.22 114.501 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.67 -36.54 51.93 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.381 1.387 . . . . 75.24 111.857 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -70.54 -34.4 72.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.053 -0.521 . . . . 71.4 110.951 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 31' ' ' ASP . 60.7 t -69.24 -41.75 81.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 108.867 -0.79 . . . . 73.13 108.867 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.31 83.19 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.661 -1.154 . . . . 70.41 109.385 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.09 -46.35 84.65 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.315 -0.857 . . . . 72.43 110.627 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.441 HD23 ' CE2' ' A' ' 30' ' ' TYR . 29.3 tp -65.33 -47.26 77.14 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.425 -0.807 . . . . 74.11 111.268 -175.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.6 mt -81.56 -17.46 48.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 72.24 111.688 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.16 29.47 60.39 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.873 -0.891 . . . . 73.22 110.873 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.68 164.14 26.65 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.541 -0.54 . . . . 73.55 109.541 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.27 165.47 27.72 Favored 'Trans proline' 0 C--O 1.264 1.821 0 C-N-CA 121.512 1.475 . . . . 75.41 110.875 172.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.49 -32.51 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.259 0.624 . . . . 73.23 110.408 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -57.06 -43.68 82.29 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.965 -0.561 . . . . 72.41 110.823 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.596 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 29.7 mtpp -69.49 -32.47 71.36 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 120.041 -0.664 . . . . 72.1 111.039 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.41 -42.05 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.31 -0.626 . . . . 75.34 109.31 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -62.63 -37.23 85.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.696 . . . . 54.23 109.787 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.7 -35.93 81.29 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.074 -0.512 . . . . 74.1 111.64 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.4 mm100 -58.42 -46.25 86.86 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 108.086 -1.079 . . . . 75.53 108.086 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.67 -38.92 92.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.135 -1.393 . . . . 74.51 110.979 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 97.9 mtt180 -71.05 -22.0 62.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.129 0.572 . . . . 74.01 112.289 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -85.11 -13.42 50.3 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.418 -0.513 . . . . 75.12 109.708 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.94 26.32 73.99 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.781 -1.328 . . . . 52.32 109.781 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -98.38 -9.13 25.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.551 0.691 . . . . 75.42 109.244 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.1 tp -158.21 152.55 24.4 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.932 -1.877 . . . . 73.12 105.932 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.27 158.03 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 120.213 -0.595 . . . . 75.21 109.49 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.0 162.04 29.59 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 122.71 0.404 . . . . 74.21 110.008 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 m -132.63 167.53 26.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 124.121 0.968 . . . . 74.2 109.141 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 75.4 mtm180 -109.9 139.27 45.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.683 -0.488 . . . . 75.43 109.683 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' NE ' HG13 ' A' ' 65' ' ' VAL . 36.7 ptt180 -128.41 120.05 26.17 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.509 -1.293 . . . . 72.34 107.509 173.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.1 16.9 8.66 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.864 0.866 . . . . 63.3 111.877 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.26 -7.31 54.2 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.991 -0.55 . . . . 73.42 112.55 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -95.61 151.83 20.13 Favored Glycine 0 CA--C 1.493 -1.31 0 N-CA-C 111.624 -0.591 . . . . 74.14 111.624 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.2 t -96.46 120.91 46.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.357 -0.979 . . . . 74.03 108.357 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.433 HG13 ' NE ' ' A' ' 60' ' ' ARG . 15.3 m -134.45 160.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.255 -0.884 . . . . 73.23 111.452 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.33 128.87 23.99 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 106.935 -1.505 . . . . 74.32 106.935 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.21 133.99 56.38 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.03 1.82 . . . . 62.24 111.622 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -63.05 -25.27 68.3 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 121.709 0.766 . . . . 62.4 111.312 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.31 -5.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.836 -1.075 . . . . 75.5 112.076 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.622 ' CD2' HD12 ' A' ' 81' ' ' LEU . 3.6 m-85 -87.7 -3.85 58.94 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.7 0.762 . . . . 73.15 110.211 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.16 148.54 43.51 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.395 -0.821 . . . . 75.2 109.179 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -83.64 174.98 10.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.884 -0.598 . . . . 74.14 109.602 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.66 -17.94 64.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.674 0.75 . . . . 71.41 109.171 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -79.52 -7.11 58.25 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.267 -0.879 . . . . 55.14 110.597 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.52 27.54 59.09 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.085 -0.578 . . . . 73.13 111.697 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -123.03 166.03 15.79 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.384 -0.599 . . . . 72.42 109.384 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.0 t -75.92 142.16 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.156 -1.053 . . . . 73.03 108.156 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 25.8 t -62.62 130.79 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 107.914 -1.143 . . . . 75.43 107.914 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -65.29 -24.5 67.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.066 1.135 . . . . 75.12 114.066 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 p -92.84 -2.05 56.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.206 0.526 . . . . 75.31 111.967 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.622 HD12 ' CD2' ' A' ' 70' ' ' PHE . 7.8 tt -65.42 -50.37 58.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-N 115.786 -0.643 . . . . 74.04 112.115 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.78 -29.52 86.17 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.34 1.36 . . . . 72.1 111.358 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.89 -44.33 94.77 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.954 -0.567 . . . . 63.03 111.946 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.01 -40.03 87.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.445 -0.576 . . . . 73.12 109.445 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.6 -37.9 89.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.933 -0.576 . . . . 74.03 110.527 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.8 m -67.39 -43.34 81.59 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 115.844 -0.616 . . . . 72.05 111.831 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -42.0 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.903 -0.319 . . . . 75.31 110.663 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.7 -34.57 78.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.167 0.432 . . . . 73.02 112.167 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -59.67 -35.15 73.86 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.021 -0.733 . . . . 72.33 109.021 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.04 -31.34 72.16 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.293 0.568 . . . . 74.23 110.371 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -9.26 75.91 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.623 -0.717 . . . . 74.25 112.34 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.17 35.24 34.72 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.296 -0.478 . . . . 72.34 112.401 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.16 132.8 42.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.928 0.394 . . . . 73.41 110.983 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -83.35 171.54 13.41 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.507 -0.77 . . . . 75.4 109.629 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 99' ' ' MET . 9.1 p-10 -53.95 -40.99 67.29 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.687 1.595 . . . . 71.13 112.107 -176.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -61.86 -41.25 97.61 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.238 0.615 . . . . 74.2 110.365 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 6.7 mm-40 -66.38 -36.5 83.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.152 -0.476 . . . . 74.51 109.897 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.7 mm -62.07 -47.77 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.842 -0.799 . . . . 71.15 108.842 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 23.9 mmt -69.15 -23.61 63.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.832 -1.077 . . . . 75.4 110.412 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 80.4 ttt180 -58.9 -63.43 1.3 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.618 -0.719 . . . . 72.31 110.773 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.501 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.5 p-90 -69.65 -35.34 75.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.069 0.766 . . . . 63.43 113.069 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.501 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.2 mt -57.77 -41.39 81.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.889 1.07 . . . . 70.52 113.889 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 96.8 m-85 -97.45 -6.04 34.75 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.311 0.856 . . . . 75.31 113.311 -174.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.8 m -87.29 121.24 71.41 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.208 0.317 . . . . 74.21 110.219 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 33.8 Cg_exo -63.99 128.91 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.737 1.625 . . . . 55.21 108.931 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 26.3 t70 -105.45 120.45 49.44 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 120.209 -0.596 . . . . 74.14 110.735 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.8 -22.72 74.6 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 123.332 2.688 . . . . 71.13 113.445 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 m -97.65 2.9 50.32 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.17 0.509 . . . . 72.13 110.109 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.4 tp -109.77 128.69 55.46 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.109 -0.7 . . . . 75.15 109.109 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.9 m -130.61 113.17 13.87 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.188 -1.041 . . . . 73.52 108.188 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.9 mm . . . . . 0 C--N 1.298 -1.656 0 CA-C-N 115.993 -0.549 . . . . 73.5 110.75 -172.437 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 50.0 t . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 108.418 -0.956 . . . . 74.31 108.418 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -82.27 154.82 25.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.755 -1.572 . . . . 72.45 106.755 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 16.2 m120 69.26 36.02 2.47 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.434 0.694 . . . . 64.33 110.354 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.11 152.12 29.45 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.211 -1.033 . . . . 74.13 108.211 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -87.71 142.14 32.41 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 105.34 -2.096 . . . . 74.44 105.34 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.431 ' HB2' HD22 ' A' ' 102' ' ' LEU . 92.8 Cg_exo -51.72 -27.35 26.21 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.273 1.982 . . . . 64.41 111.695 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.631 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 93.8 t -62.82 -43.06 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.814 -0.63 . . . . 75.44 110.73 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -60.04 -37.85 81.01 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.433 0.635 . . . . 75.42 109.461 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.78 82.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.285 -1.325 . . . . 74.1 112.194 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -69.23 -38.69 78.63 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.168 -0.613 . . . . 63.35 111.234 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.36 -23.41 63.75 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.614 0.721 . . . . 75.21 109.716 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.55 7.05 44.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.289 -0.869 . . . . 74.53 111.075 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.3 m80 59.51 28.81 18.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 122.144 0.973 . . . . 73.32 112.578 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.13 22.98 6.94 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.253 -1.388 . . . . 74.24 107.253 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.43 -28.81 32.04 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.738 1.615 . . . . 65.54 112.712 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -56.26 -43.14 78.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.373 -0.603 . . . . 74.24 109.373 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -73.67 -30.55 62.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.328 -0.851 . . . . 71.13 110.608 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -63.77 -45.25 97.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.838 -0.801 . . . . 75.51 108.838 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.1 t -62.99 -42.12 95.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 74.41 109.7 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.17 -45.6 83.53 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.023 -0.535 . . . . 74.25 110.025 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.2 mmt85 -68.86 -37.06 78.83 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.044 -0.525 . . . . 73.14 111.362 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.04 93.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.083 0.553 . . . . 73.41 109.903 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -64.7 -38.4 90.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 75.35 110.323 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.86 -17.77 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.0 -0.546 . . . . 74.42 111.664 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 94.1 mmm -87.6 -29.81 20.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.22 0.533 . . . . 74.4 110.253 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.96 -44.56 14.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.177 -0.465 . . . . 71.3 111.042 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 108.075 -1.083 . . . . 64.31 108.075 -178.745 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 109.958 -0.386 . . . . 43.31 109.958 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.38 -128.15 5.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.41 -0.9 . . . . 71.33 112.377 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 96' ' ' THR . 29.9 t70 -109.68 146.41 34.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.121 -0.696 . . . . 73.31 109.121 -174.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -86.06 125.37 33.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.449 0.642 . . . . 75.11 112.259 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.3 t -97.2 -31.17 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.33 -0.395 . . . . 75.53 111.457 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -69.77 171.72 8.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.011 0.745 . . . . 74.02 113.011 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 10.0 t70 -85.32 139.81 36.33 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 116.508 -0.314 . . . . 64.43 110.495 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.9 -24.6 14.02 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.066 3.177 . . . . 75.14 115.217 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.84 -25.18 28.24 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.134 -0.354 . . . . 74.41 111.568 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' HG3' ' HB3' ' A' ' 24' ' ' ASP . 45.9 mt-10 -62.78 132.81 94.87 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 116.523 -0.308 . . . . 74.13 110.994 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.485 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 38.3 Cg_endo -63.93 141.47 77.74 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 123.175 2.583 . . . . 75.11 113.137 -175.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -136.68 173.95 11.15 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.019 -0.991 . . . . 72.2 110.697 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -124.83 159.26 31.45 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.711 -1.589 . . . . 75.01 106.711 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.9 p-10 -137.04 173.84 11.26 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.334 -1.728 . . . . 74.23 106.334 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -37.32 -60.95 0.77 Allowed Pre-proline 0 CA--C 1.563 1.478 0 N-CA-C 115.45 1.648 . . . . 74.31 115.45 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.82 -33.81 32.77 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.216 1.277 . . . . 72.32 112.888 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.412 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 9.5 tpt180 -70.25 -35.12 73.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.627 0.251 . . . . 71.21 110.916 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 31' ' ' ASP . 62.0 t -69.2 -41.26 81.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.959 -0.756 . . . . 54.2 108.959 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.88 88.28 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 114.905 -1.043 . . . . 71.11 109.679 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.86 -45.49 92.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.131 1.372 . . . . 73.34 109.742 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.75 -50.1 39.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.608 -0.724 . . . . 72.15 112.382 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.04 -18.89 41.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.308 -0.406 . . . . 75.3 111.953 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.95 27.88 57.58 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.099 -0.801 . . . . 73.43 111.099 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -121.41 159.7 49.08 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 108.505 -0.924 . . . . 74.13 108.505 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.77 156.01 64.41 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 121.523 1.482 . . . . 74.41 112.819 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.42 -37.4 63.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.467 -0.788 . . . . 74.03 111.181 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.1 t -62.19 -35.92 80.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.509 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 53.7 tttp -65.75 -40.64 92.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.133 -1.062 . . . . 73.52 108.133 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.76 -41.26 87.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.404 -0.816 . . . . 75.52 110.333 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.86 88.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.902 -0.59 . . . . 63.31 110.243 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.498 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 1.4 mp0 -68.45 -41.61 79.99 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.764 -0.653 . . . . 73.13 112.051 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.2 mm100 -58.09 -46.06 86.12 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.848 -0.797 . . . . 74.02 108.848 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.9 mt -61.93 -44.23 97.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.99 -1.005 . . . . 74.3 111.447 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -70.95 -21.62 62.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.672 0.619 . . . . 75.24 112.672 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 52.5 mt-10 -87.64 -6.62 58.18 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.654 -0.418 . . . . 74.05 110.898 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.86 39.09 21.69 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.594 -0.812 . . . . 72.1 111.107 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -86.3 -30.0 22.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.862 -1.162 . . . . 74.32 107.862 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -160.82 167.62 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.667 -1.605 . . . . 75.21 106.667 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.42 161.46 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 118.758 0.708 . . . . 65.33 112.084 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.05 51.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.332 -0.849 . . . . 52.32 110.242 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.416 HG13 ' SD ' ' A' ' 99' ' ' MET . 18.0 m -130.79 162.55 38.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 O-C-N 123.528 0.517 . . . . 71.35 109.82 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -110.42 118.02 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.859 -0.423 . . . . 75.02 109.859 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -124.56 123.83 40.93 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.891 -0.411 . . . . 72.15 109.891 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.89 16.77 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.032 0.933 . . . . 64.05 110.656 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.43 -15.5 62.83 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.602 -0.726 . . . . 65.11 113.05 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.22 137.85 13.83 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.021 -0.831 . . . . 72.22 111.021 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.79 120.77 46.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.55 0.69 . . . . 75.24 109.169 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.06 159.32 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.069 -0.969 . . . . 73.4 112.172 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.3 mm -111.1 132.02 21.9 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 125.937 1.695 . . . . 74.42 106.803 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.69 119.31 6.33 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.981 1.787 . . . . 74.5 111.672 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' A' ' 28' ' ' PRO . 6.2 tt0 -62.95 -25.48 68.37 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.572 0.701 . . . . 74.33 111.556 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 m -70.81 -5.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.413 -0.812 . . . . 73.55 112.451 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.482 ' CD2' HD13 ' A' ' 81' ' ' LEU . 3.2 m-85 -86.13 -4.12 59.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.859 0.837 . . . . 65.41 109.653 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -111.12 160.14 17.18 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.037 -0.983 . . . . 74.33 108.397 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 p -84.06 166.27 17.85 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.247 -1.019 . . . . 74.43 108.247 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -67.53 -16.55 64.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.935 0.874 . . . . 75.1 109.609 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 m -78.76 -11.38 59.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.503 -0.771 . . . . 71.53 111.063 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.05 62.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.572 -0.823 . . . . 72.43 112.536 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -104.98 147.87 27.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.015 -0.365 . . . . 70.21 110.015 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.5 t -63.12 136.05 26.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.457 -0.942 . . . . 74.41 108.457 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.92 133.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.737 -0.468 . . . . 65.53 109.737 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -54.61 -26.29 31.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.393 1.257 . . . . 75.44 114.393 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.7 t -114.62 19.37 16.1 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.342 -0.543 . . . . 71.15 110.849 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 17.6 tp -63.95 -55.69 30.69 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 116.44 -0.346 . . . . 74.32 111.326 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.21 -28.55 87.14 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.887 1.725 . . . . 73.13 111.75 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.82 -44.81 94.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.889 -0.596 . . . . 71.53 112.2 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.18 -40.53 82.21 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 109.395 -0.594 . . . . 73.42 109.395 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.37 -44.51 97.03 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.718 -0.674 . . . . 74.24 110.634 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.7 m -61.41 -37.02 81.98 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.706 1.002 . . . . 64.14 113.706 -176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.41 HG21 HD23 ' A' ' 88' ' ' LEU 0.25 0.0 OUTLIER -68.17 -45.04 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 119.567 -0.853 . . . . 75.33 110.755 179.485 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 3.2 mm? -67.75 -35.56 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.008 0.433 . . . . 73.42 111.189 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -60.4 -39.54 87.7 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.744 0.818 . . . . 74.5 109.28 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.65 -30.6 70.19 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.728 0.775 . . . . 71.33 109.928 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.4 -3.05 89.9 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.065 -0.971 . . . . 54.13 112.053 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.89 22.46 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.895 -0.193 . . . . 73.44 113.155 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.418 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 93.7 m-85 -87.16 136.57 32.88 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 122.37 -0.488 . . . . 72.41 111.07 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.461 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 37.4 ptt180 -78.06 170.57 16.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.791 -0.641 . . . . 74.13 110.655 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -54.27 -41.01 68.36 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.946 1.298 . . . . 70.24 111.822 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 20' ' ' ASP . 23.4 m -61.74 -42.57 99.14 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.282 -0.872 . . . . 62.41 111.02 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 9.1 mm-40 -67.05 -33.49 75.63 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.141 -0.481 . . . . 75.13 110.965 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.2 mm -61.65 -49.05 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 108.211 -1.033 . . . . 70.33 108.211 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.498 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 10.9 ptp -74.84 -14.14 60.64 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.387 -0.824 . . . . 71.32 112.935 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 71.7 ttt180 -58.83 -65.62 0.63 Allowed 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.616 0.572 . . . . 72.21 109.944 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.54 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 46.0 p-90 -69.12 -32.92 72.65 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.236 0.458 . . . . 73.42 112.236 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.54 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.0 mt -58.93 -40.48 84.73 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.517 0.932 . . . . 75.02 113.517 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 73.0 m-85 -93.22 -2.5 55.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.406 0.521 . . . . 73.21 112.406 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -88.51 117.51 68.43 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 109.07 -0.715 . . . . 72.24 109.07 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 139.96 51.47 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.305 2.003 . . . . 75.41 113.208 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.559 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 17.5 t70 -98.26 119.9 60.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.645 -0.872 . . . . 61.14 108.645 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.08 -22.91 71.57 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.149 2.566 . . . . 74.21 114.016 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 p -104.0 5.63 35.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.036 0.384 . . . . 74.33 112.036 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.3 tp -105.12 135.28 46.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.053 -0.351 . . . . 72.33 110.053 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.6 m -118.53 116.9 27.62 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.41 108.286 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 109.128 -0.693 . . . . 71.34 109.128 -175.713 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 107.937 -1.135 . . . . 74.21 107.937 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.3 m -89.85 131.34 35.83 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.357 -1.72 . . . . 55.1 106.357 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.0 t30 75.46 69.06 0.08 Allowed 'General case' 0 C--N 1.321 -0.672 0 O-C-N 124.564 1.165 . . . . 73.41 108.235 -172.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.49 163.72 15.98 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.696 -1.138 . . . . 65.23 109.539 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 39.5 ptt180 -88.08 141.1 30.97 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.568 -0.742 . . . . 74.1 109.672 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' A' ' 102' ' ' LEU . 50.7 Cg_exo -55.17 -18.11 16.97 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.083 2.522 . . . . 75.22 114.228 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.603 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -61.03 -42.85 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.444 0.64 . . . . 73.13 109.493 173.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.61 -30.75 71.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.276 -0.874 . . . . 71.4 109.619 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.72 -50.34 65.18 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.734 -0.667 . . . . 73.12 110.556 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -63.99 -36.76 85.05 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 73.54 110.871 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -68.68 -24.7 64.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.38 -0.827 . . . . 74.31 109.54 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -102.53 12.78 35.96 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.406 -0.816 . . . . 75.35 112.85 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 70.02 27.87 4.26 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.638 1.209 . . . . 74.2 110.866 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -105.56 23.96 12.98 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.967 0.907 . . . . 70.22 109.028 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.12 -29.06 28.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.479 1.511 . . . . 71.54 113.817 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -56.7 -40.14 75.09 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.806 0.336 . . . . 71.45 110.752 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -73.12 -24.82 60.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.981 0.419 . . . . 74.42 110.967 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.84 -42.0 77.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 72.22 108.478 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.27 -42.23 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.44 -0.578 . . . . 74.35 109.44 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -59.5 -47.09 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.619 -0.719 . . . . 75.4 109.697 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.553 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.4 tpp180 -64.6 -39.65 94.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.371 -0.831 . . . . 73.02 110.005 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.62 87.36 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.564 0.746 . . . . 75.2 110.832 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.98 -39.02 93.19 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.238 -0.437 . . . . 75.23 110.281 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -21.25 66.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.18 -0.464 . . . . 70.54 111.333 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 85.4 mmm -92.71 -22.49 19.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.022 0.439 . . . . 64.42 110.986 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.83 -27.68 19.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.976 0.417 . . . . 70.01 111.062 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 108.022 -1.103 . . . . 73.11 108.022 178.024 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.992 0 N-CA-C 108.052 -1.092 . . . . 75.32 108.052 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.15 -110.27 3.45 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.684 -0.769 . . . . 71.11 113.411 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -110.76 133.56 53.24 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.043 0.386 . . . . 72.01 112.043 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.1 114.97 13.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.313 -0.995 . . . . 75.11 108.313 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.64 -8.61 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 112.409 0.522 . . . . 74.33 112.409 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 -173.11 2.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.772 -1.205 . . . . 74.31 113.936 -175.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -96.5 132.47 26.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.843 -1.169 . . . . 73.31 107.843 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.16 -20.73 32.34 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.452 2.768 . . . . 64.15 111.8 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.334 -0.848 . . . . 72.24 109.823 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -68.0 134.09 91.85 Favored Pre-proline 0 C--O 1.244 0.796 0 N-CA-C 109.365 -0.605 . . . . 75.13 109.365 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.22 128.1 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.57 2.18 . . . . 75.33 111.257 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.3 m -130.16 158.52 39.46 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.47 -0.567 . . . . 61.52 109.47 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -116.48 162.4 17.63 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.521 1.129 . . . . 72.0 109.965 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -134.06 167.25 20.97 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.381 -2.451 . . . . 72.25 104.381 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -48.45 -55.03 21.01 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 114.712 1.375 . . . . 74.43 114.712 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.44 -46.39 33.79 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.118 1.879 . . . . 74.42 112.11 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.456 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 28.0 tpt180 -65.29 -39.04 92.04 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 112.485 0.55 . . . . 75.24 112.485 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.12 -40.53 80.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.164 -0.614 . . . . 74.01 110.239 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.03 -39.52 92.6 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.206 -0.906 . . . . 70.53 108.978 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.59 -44.95 85.06 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.494 -1.23 . . . . 74.14 111.105 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 95.6 mt -62.25 -47.45 84.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.482 0.658 . . . . 73.54 111.572 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.77 -18.44 40.64 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.744 -0.662 . . . . 64.24 111.972 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 27.36 60.78 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 110.592 -1.003 . . . . 74.52 110.592 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 m -118.31 159.38 43.7 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 108.564 -0.902 . . . . 74.43 108.564 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.78 161.75 38.74 Favored 'Trans proline' 0 C--O 1.262 1.719 0 C-N-CA 121.149 1.232 . . . . 60.25 110.744 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.7 -33.85 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 115.88 -0.6 . . . . 73.51 109.92 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.6 m -57.66 -41.27 81.14 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.093 -0.958 . . . . 74.23 111.73 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 26.5 mtpp -69.77 -32.59 71.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.27 -0.572 . . . . 70.55 110.929 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.434 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 61.0 t -62.27 -42.27 94.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.68 . . . . 74.1 109.165 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.96 83.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.83 -0.623 . . . . 70.21 110.311 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -66.36 -37.32 85.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.24 -0.437 . . . . 72.04 110.67 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 46.2 mt-30 -63.19 -46.4 87.25 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.938 -0.393 . . . . 73.15 109.938 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 93.8 mt -61.67 -38.43 87.72 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.54 -1.209 . . . . 74.41 110.03 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -61.63 -44.41 97.04 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.164 0.986 . . . . 73.44 112.507 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.59 -11.8 33.38 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.419 -0.512 . . . . 72.43 112.364 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.92 35.53 18.41 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.34 -0.933 . . . . 44.33 111.049 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -92.5 -18.55 23.03 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.154 -1.054 . . . . 75.31 108.154 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -159.88 152.45 21.19 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.751 -1.944 . . . . 72.13 105.751 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.86 161.67 39.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.568 -0.53 . . . . 74.21 109.568 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.22 161.66 35.58 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.119 -0.697 . . . . 74.45 109.119 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.55 166.16 30.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.397 -0.594 . . . . 75.11 109.397 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -121.49 130.48 53.58 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.383 -0.527 . . . . 74.32 110.068 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -125.56 117.31 23.31 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.602 -0.888 . . . . 73.42 108.602 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 20.47 8.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.597 0.759 . . . . 74.32 112.748 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.73 -17.14 30.64 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.068 -0.587 . . . . 74.24 112.976 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.34 140.75 15.22 Favored Glycine 0 CA--C 1.488 -1.61 0 C-N-CA 121.23 -0.51 . . . . 61.43 111.829 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.24 120.91 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.254 -1.017 . . . . 74.54 108.254 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.3 154.6 40.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.826 -0.624 . . . . 75.53 110.916 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.3 mt -126.28 114.43 23.59 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.872 -1.158 . . . . 73.22 107.872 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.41 133.56 58.81 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.323 2.682 . . . . 75.24 113.102 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -57.12 -25.53 58.98 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 112.948 0.722 . . . . 73.33 112.948 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 21.9 m -60.28 -15.34 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 113.361 0.875 . . . . 72.11 113.361 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.415 ' CD2' HD11 ' A' ' 81' ' ' LEU . 13.9 m-85 -82.28 -6.15 59.04 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.519 0.676 . . . . 75.3 111.001 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -121.06 162.36 20.13 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.553 -0.748 . . . . 74.02 109.126 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.451 ' HG1' ' HB3' ' A' ' 76' ' ' GLN . 41.0 p -88.14 175.53 7.67 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.713 -0.476 . . . . 75.22 109.713 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -61.25 -16.98 50.99 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.239 0.616 . . . . 72.43 111.176 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.21 3.43 51.46 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.312 0.486 . . . . 73.03 112.312 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.76 57.87 Favored Glycine 0 C--O 1.235 0.166 0 C-N-CA 120.465 -0.874 . . . . 64.3 111.94 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.451 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 29.7 tt0 -112.55 146.23 38.9 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.634 -0.876 . . . . 75.54 108.634 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.9 130.39 32.24 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.546 -0.538 . . . . 71.3 109.546 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.14 130.55 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.798 -0.637 . . . . 73.25 109.459 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -57.32 -23.8 50.98 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.64 1.348 . . . . 75.1 114.64 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.2 t -105.31 10.63 33.48 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.987 -0.446 . . . . 73.03 110.91 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 36.2 tp -66.02 -57.68 12.84 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.39 0.885 . . . . 74.33 113.39 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.63 -33.86 97.26 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 121.864 1.709 . . . . 75.13 112.944 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 87' ' ' ILE . . . -61.94 -44.98 97.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.406 -0.426 . . . . 72.13 112.65 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.57 -40.32 80.64 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 121.289 0.566 . . . . 73.55 109.987 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.77 -42.25 95.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.51 -0.768 . . . . 74.53 111.144 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.1 m -64.41 -45.15 88.82 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.04 -0.527 . . . . 73.4 111.906 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -66.06 -43.85 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.973 0.416 . . . . 71.21 111.017 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.421 ' CD1' ' HZ2' ' A' ' 101' ' ' TRP . 38.1 mt -66.61 -38.33 86.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.286 -0.416 . . . . 75.54 111.77 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -63.27 -42.57 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.842 -0.429 . . . . 71.14 109.842 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.94 -28.63 65.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.12 -0.491 . . . . 74.25 110.737 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.89 -1.56 84.78 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.59 -0.732 . . . . 74.01 112.77 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.88 23.26 30.79 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.867 -0.682 . . . . 73.01 113.087 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -102.84 144.53 31.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.485 -0.42 . . . . 72.02 110.784 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.437 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 31.2 ptt180 -97.01 172.3 7.94 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.232 -0.894 . . . . 74.33 109.156 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.55 -43.18 68.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.791 1.636 . . . . 53.53 111.593 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 m -62.5 -41.04 98.55 Favored 'General case' 0 N--CA 1.415 -2.194 0 C-N-CA 123.854 0.862 . . . . 73.32 110.164 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 28.9 mm-40 -67.04 -33.36 75.36 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.43 -0.35 . . . . 75.44 110.649 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.3 -49.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.993 -1.114 . . . . 75.45 107.993 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 ptp -76.08 -17.89 59.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.289 -0.869 . . . . 65.12 112.8 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -56.47 -67.53 0.29 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.998 0.519 . . . . 72.11 110.66 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.521 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 52.5 p-90 -69.47 -32.13 70.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.277 0.473 . . . . 72.32 112.277 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.521 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 8.7 mt -60.09 -39.97 87.97 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.155 0.798 . . . . 74.11 113.155 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.08 -4.8 59.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.178 0.436 . . . . 74.31 112.178 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 m -87.17 120.2 71.28 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.193 -0.669 . . . . 72.43 109.193 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.83 129.62 31.39 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.251 1.968 . . . . 74.45 110.788 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 35.4 t70 -96.33 124.25 51.94 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.182 -0.463 . . . . 71.24 110.807 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.38 -35.43 96.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.324 2.683 . . . . 73.22 113.057 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 p -90.04 2.98 54.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.802 0.667 . . . . 72.11 112.802 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -102.69 129.51 49.33 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.291 0.567 . . . . 72.3 110.21 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.4 m -131.35 115.34 16.13 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.42 -1.696 . . . . 71.41 106.42 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.454 HG23 ' OE1' ' A' ' 133' ' ' GLN . 13.3 pt . . . . . 0 CA--C 1.493 -1.238 0 N-CA-C 112.812 0.671 . . . . 72.34 112.812 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.432 -1.349 0 N-CA-C 108.991 -0.744 . . . . 71.23 108.991 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.2 m -84.67 134.8 34.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.58 -1.267 . . . . 74.51 107.58 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.4 t30 66.71 64.72 0.47 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.534 1.159 . . . . 74.23 108.908 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.97 163.71 15.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.263 -1.335 . . . . 71.41 108.887 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -82.39 136.18 46.27 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.545 -0.539 . . . . 73.04 109.545 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.481 ' HB2' HD23 ' A' ' 102' ' ' LEU . 31.0 Cg_exo -56.78 -17.08 21.89 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.244 2.63 . . . . 72.14 114.07 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.1 t -59.9 -40.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.454 0.645 . . . . 73.32 109.9 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.2 -30.29 67.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.19 -0.459 . . . . 64.15 111.051 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.1 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.59 . . . . 61.41 111.375 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.45 -33.9 75.01 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.028 -0.269 . . . . 74.24 111.401 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -75.25 -24.68 57.68 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.781 0.8 . . . . 75.41 108.907 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.29 24.41 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.774 -1.103 . . . . 72.44 111.179 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.6 m80 64.39 28.22 13.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.528 1.131 . . . . 75.43 111.512 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.454 ' OE1' HG23 ' A' ' 111' ' ' ILE . 72.7 mt-30 -111.23 23.84 13.58 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.345 -1.354 . . . . 74.14 107.345 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.26 -27.87 24.68 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 113.306 -1.77 . . . . 73.02 113.111 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -56.16 -36.21 68.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.935 0.494 . . . . 73.1 109.926 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.33 -38.58 87.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.405 0.621 . . . . 73.42 109.737 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.7 -46.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.078 -0.964 . . . . 72.32 109.597 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 93.0 t -61.22 -47.8 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.506 -0.77 . . . . 74.13 110.484 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.52 -37.93 89.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.123 -0.631 . . . . 75.24 110.915 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -63.71 -41.64 98.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.229 -0.656 . . . . 72.43 109.229 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.921 -0.581 . . . . 71.43 110.072 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -63.98 -38.66 91.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.414 -0.812 . . . . 72.3 111.411 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.91 -33.03 70.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.147 0.499 . . . . 74.41 110.441 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 tpt -69.71 -32.01 70.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.342 -0.844 . . . . 74.31 110.719 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.27 -58.91 2.16 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.803 0.668 . . . . 71.31 112.803 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.31 -1.126 0 CA-C-O 118.303 -0.856 . . . . 74.2 110.624 -175.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.678 0 N-CA-C 109.922 -0.399 . . . . 74.35 109.922 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.67 -78.79 0.62 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.559 -0.829 . . . . 75.14 113.994 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.73 129.97 33.44 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 122.262 -0.552 . . . . 73.42 110.631 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.549 ' OD2' ' HD2' ' A' ' 60' ' ' ARG . 13.3 t0 -69.22 139.46 54.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.165 -0.471 . . . . 65.42 111.697 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.56 -18.52 7.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.661 -0.7 . . . . 72.34 110.991 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.285 1.0 OUTLIER -89.7 179.37 6.03 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.379 -1.328 . . . . 64.34 112.21 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -98.03 152.21 37.93 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.085 -0.709 . . . . 71.52 109.085 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.89 -22.92 32.01 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.005 2.47 . . . . 65.41 113.035 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.74 -24.98 56.17 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.295 -0.253 . . . . 72.45 111.582 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.34 137.21 81.18 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 109.973 -0.38 . . . . 75.53 109.973 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -63.02 136.72 58.1 Favored 'Trans proline' 0 C--O 1.256 1.408 0 C-N-CA 123.105 2.537 . . . . 75.02 112.774 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 p -130.6 169.81 15.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.283 0.563 . . . . 74.03 111.37 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.493 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 20.4 m-85 -130.33 160.2 34.68 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.808 1.243 . . . . 75.4 108.05 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.14 163.97 28.4 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 103.459 -2.793 . . . . 72.14 103.459 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.9 mt -49.93 -52.27 53.86 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 114.812 1.412 . . . . 75.25 114.812 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.91 -38.61 68.16 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 121.6 1.534 . . . . 71.14 111.762 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.8 tpt180 -70.05 -33.98 72.63 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.566 -0.288 . . . . 73.23 111.309 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.1 -42.06 84.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.951 -0.759 . . . . 70.42 108.951 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.07 84.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.406 -0.815 . . . . 74.51 109.597 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 7.5 tp10 -61.68 -44.94 95.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.672 -1.149 . . . . 64.21 109.552 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.443 HD21 ' CE2' ' A' ' 30' ' ' TYR . 27.0 tp -69.63 -46.33 66.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.195 -0.911 . . . . 72.23 111.724 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 75' ' ' GLY . 96.7 mt -81.36 -18.44 45.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.189 -0.46 . . . . 64.03 111.606 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.3 28.2 62.36 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.058 -0.817 . . . . 73.14 111.058 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.61 163.48 38.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 108.333 -0.988 . . . . 73.12 108.333 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.87 157.83 57.15 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 121.352 1.368 . . . . 72.23 111.232 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.9 -34.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.658 0.783 . . . . 74.15 109.786 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 47.1 m -57.66 -42.89 84.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.155 -0.929 . . . . 71.43 111.331 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.602 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.8 mtpt -69.27 -33.48 73.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.409 -0.516 . . . . 75.14 111.204 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.23 -44.94 99.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.164 -0.68 . . . . 73.33 109.164 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.39 -0.823 . . . . 72.22 110.427 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.0 mt-30 -63.49 -39.79 95.37 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.397 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 72.2 mt-30 -64.1 -42.4 96.93 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.418 0.628 . . . . 65.43 109.699 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.17 -40.77 97.14 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.892 -1.049 . . . . 71.04 109.281 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -68.83 -22.27 64.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.508 -0.769 . . . . 72.22 112.89 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 49.9 mt-10 -93.04 -12.87 29.53 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.313 -0.555 . . . . 74.21 111.337 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.38 28.96 31.62 Favored Glycine 0 C--N 1.319 -0.41 0 N-CA-C 111.222 -0.751 . . . . 74.35 111.222 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -87.72 -28.38 21.8 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.31 -0.996 . . . . 73.35 108.31 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -145.95 158.6 43.86 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.429 -1.323 . . . . 74.45 107.429 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.71 157.55 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.464 -0.939 . . . . 74.32 108.464 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.4 162.87 32.47 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.122 0.569 . . . . 71.14 110.004 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 m -125.91 166.09 22.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.277 0.56 . . . . 72.14 111.701 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -110.23 124.73 52.14 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.203 -0.908 . . . . 74.13 108.783 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.549 ' HD2' ' OD2' ' A' ' 21' ' ' ASP . 8.9 ptm180 -151.3 138.37 19.17 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-N 115.573 -0.739 . . . . 74.41 110.123 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.63 -59.16 0.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.205 1.802 . . . . 74.22 110.515 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.48 24.77 0.02 OUTLIER Glycine 0 C--N 1.28 -2.573 0 CA-C-N 114.766 -1.106 . . . . 51.33 110.825 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 160.81 27.81 Favored Glycine 0 N--CA 1.427 -1.907 0 C-N-CA 120.395 -0.907 . . . . 71.42 111.893 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.88 119.88 50.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.931 -1.507 . . . . 64.41 106.931 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.8 158.6 39.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 120.926 0.394 . . . . 74.45 110.867 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.07 126.92 27.07 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.497 -1.297 . . . . 65.53 107.497 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.31 132.29 51.38 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.384 2.056 . . . . 75.22 111.539 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.6 tt0 -62.17 -25.8 67.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.38 0.609 . . . . 70.1 112.353 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.408 ' HB ' HG12 ' A' ' 126' ' ' VAL . 31.2 m -71.81 -4.37 4.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.144 -0.934 . . . . 63.42 112.38 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.621 ' CD2' HD12 ' A' ' 81' ' ' LEU . 4.8 m-85 -82.85 -6.18 59.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.956 0.884 . . . . 74.33 110.239 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.65 160.87 20.59 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.579 -0.737 . . . . 75.14 110.52 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.3 p -92.84 168.53 11.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.065 -1.087 . . . . 75.54 108.065 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.93 -15.33 63.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.424 0.631 . . . . 74.24 111.661 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.0 m -78.64 -9.86 59.53 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.739 -0.664 . . . . 61.33 109.335 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.444 ' O ' HD23 ' A' ' 39' ' ' LEU . . . 81.16 25.8 54.2 Favored Glycine 0 C--O 1.212 -1.264 0 N-CA-C 111.0 -0.84 . . . . 74.23 111.0 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -114.52 147.34 39.54 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.092 -1.077 . . . . 75.02 108.092 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.58 137.73 23.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.847 -1.538 . . . . 71.14 106.847 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.8 t -60.87 127.28 20.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 108.666 -0.865 . . . . 74.14 108.666 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -55.3 -32.14 62.19 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 114.095 1.146 . . . . 74.4 114.095 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 m -85.16 -6.4 59.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.088 0.471 . . . . 70.11 111.457 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.621 HD12 ' CD2' ' A' ' 70' ' ' PHE . 7.0 tt -66.18 -50.09 52.13 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 112.616 0.598 . . . . 73.11 112.616 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.28 -31.39 84.28 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.552 1.502 . . . . 64.44 111.337 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.93 99.73 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 115.872 -0.604 . . . . 63.52 112.682 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -67.86 -39.81 83.72 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.32 -0.622 . . . . 74.45 109.32 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.63 -36.33 83.46 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.719 -0.673 . . . . 73.14 110.542 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.7 m -59.5 -50.26 74.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.022 -0.536 . . . . 73.13 110.372 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -44.16 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 116.143 -0.48 . . . . 73.35 111.485 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.36 -36.35 81.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.98 0.733 . . . . 74.24 112.98 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -70.64 -33.72 71.3 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 74.41 109.285 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.05 -31.7 72.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.674 -0.694 . . . . 74.23 109.389 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.17 -9.37 80.18 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.408 -0.814 . . . . 65.33 112.676 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.5 33.48 25.14 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 121.174 -0.536 . . . . 71.44 113.295 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -99.79 136.89 39.02 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.595 -0.356 . . . . 73.33 110.884 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -88.58 174.04 8.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.922 -0.581 . . . . 71.21 112.144 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.85 -42.59 65.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.355 1.862 . . . . 64.43 111.871 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -64.2 -41.73 96.94 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.782 -0.644 . . . . 65.11 110.142 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -66.61 -37.27 84.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.369 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.27 -48.97 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.777 0.799 . . . . 74.4 109.337 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.2 mtt -75.41 -19.28 59.61 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.036 -0.984 . . . . 65.41 112.215 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -56.88 -62.79 1.5 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.356 0.662 . . . . 72.15 111.05 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -69.05 -32.65 72.28 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.2 0.524 . . . . 75.25 111.829 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.412 HD12 ' HB2' ' A' ' 125' ' ' PRO . 19.2 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.13 0.972 . . . . 73.0 112.436 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -93.52 -2.6 54.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.261 0.837 . . . . 75.51 113.261 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.6 m -86.02 113.49 52.07 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.135 0.272 . . . . 72.12 111.224 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 38.4 Cg_endo -68.02 141.11 52.02 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.448 2.099 . . . . 64.43 110.856 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.9 t0 -112.53 126.94 27.52 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 120.371 -0.532 . . . . 73.02 109.693 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.55 -28.24 85.09 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.645 2.896 . . . . 74.43 112.961 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -96.13 7.18 47.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.05 -0.523 . . . . 74.31 110.504 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.402 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.8 tp -113.89 123.83 50.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.554 0.693 . . . . 74.14 109.891 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.8 m -120.26 120.57 36.49 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.547 -1.279 . . . . 73.2 107.547 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 C--N 1.297 -1.708 0 N-CA-C 107.896 -1.15 . . . . 75.22 107.896 -174.63 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 107.58 -1.267 . . . . 62.32 107.58 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.401 ' C ' HD21 ' A' ' 122' ' ' ASN . 19.3 m -83.46 154.0 24.17 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.262 -1.385 . . . . 74.43 107.262 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 106' ' ' ASP 0.393 0.1 OUTLIER 46.7 62.94 2.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.722 1.209 . . . . 73.01 113.244 -176.668 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 105' ' ' PRO . . . -104.51 172.62 6.7 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.37 -1.344 . . . . 74.21 107.37 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -103.89 151.43 38.88 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 109.137 -0.69 . . . . 74.32 109.137 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.412 ' HB2' HD12 ' A' ' 102' ' ' LEU . 71.1 Cg_exo -50.9 -22.08 9.56 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.06 2.507 . . . . 75.33 113.453 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.408 HG12 ' HB ' ' A' ' 69' ' ' VAL . 94.4 t -60.05 -41.62 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.082 -0.34 . . . . 70.24 110.082 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.07 -40.11 94.69 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.752 -0.658 . . . . 74.22 109.719 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.45 69.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 75.13 109.995 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.75 -44.18 93.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.576 0.751 . . . . 75.41 112.144 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -70.26 -23.58 62.92 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.441 0.638 . . . . 74.41 109.887 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -100.54 10.92 40.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.375 -0.83 . . . . 72.32 112.289 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 65.79 27.55 11.09 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.754 1.264 . . . . 74.41 111.018 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -102.86 24.76 10.18 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.3 -1.741 . . . . 73.41 106.3 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.23 -27.25 14.12 Favored 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 127.044 2.137 . . . . 61.44 115.381 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -56.5 -34.41 66.95 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.557 1.318 . . . . 75.51 114.557 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.417 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -67.39 -34.77 77.96 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.767 0.794 . . . . 61.24 109.338 175.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.62 -48.44 65.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.922 -1.035 . . . . 72.51 108.958 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.77 -43.94 99.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.529 -0.76 . . . . 74.25 109.55 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.417 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 26.1 ttt180 -57.74 -47.2 83.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.449 -0.341 . . . . 75.2 110.916 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -65.92 -33.7 76.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.684 0.278 . . . . 74.52 111.468 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.72 79.66 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.47 -0.567 . . . . 74.32 109.47 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.42 -48.01 81.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.106 -0.952 . . . . 75.44 110.509 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.75 -19.42 65.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.703 -0.681 . . . . 71.35 112.335 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 tpt -79.83 -45.84 17.99 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.209 0.528 . . . . 74.13 109.793 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.71 -44.26 17.33 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.539 0.57 . . . . 74.42 112.539 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 108.836 -0.802 . . . . 73.21 108.836 -178.303 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.294 0 N-CA-C 109.025 -0.731 . . . . 72.05 109.025 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.412 ' HA3' HH12 ' A' ' 94' ' ' ARG . . . -97.67 -87.12 1.85 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 116.17 -0.468 . . . . 72.32 113.717 -176.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.94 141.46 52.02 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.468 -0.493 . . . . 72.1 111.965 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -81.5 133.98 35.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.504 -0.771 . . . . 61.33 110.481 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.38 -15.75 9.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.602 -0.727 . . . . 71.0 111.025 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 103' ' ' PHE 0.279 0.9 OUTLIER -82.56 -176.88 6.47 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 118.751 -1.18 . . . . 73.32 112.566 -178.348 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -86.93 136.0 34.69 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 116.286 -0.415 . . . . 75.34 110.263 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.58 -25.44 33.02 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.616 2.877 . . . . 73.1 113.814 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.45 -30.18 70.47 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.102 0.477 . . . . 75.35 110.234 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 43.6 mt-10 -76.35 123.58 87.89 Favored Pre-proline 0 C--O 1.254 1.308 0 CA-C-N 115.457 -0.792 . . . . 74.44 109.935 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.2 Cg_exo -73.69 175.99 9.98 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.318 2.012 . . . . 74.45 110.019 177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.9 p -139.97 177.93 7.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.579 0.704 . . . . 73.41 112.062 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 43.0 m-85 -109.17 160.81 15.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 125.919 1.688 . . . . 74.12 107.905 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 13.3 t0 -135.66 166.86 22.25 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 104.091 -2.559 . . . . 53.3 104.091 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.21 -53.29 63.37 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 113.065 0.765 . . . . 72.03 113.065 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 14.8 Cg_endo -58.3 -35.71 98.43 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.11 1.873 . . . . 74.12 112.66 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -67.38 -38.44 84.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.345 0.658 . . . . 75.12 110.284 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.4 t -69.2 -40.37 80.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 109.406 -0.591 . . . . 75.34 109.406 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 41' ' ' VAL . . . -59.35 -39.49 83.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.822 -1.081 . . . . 75.33 109.646 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.18 -34.72 78.68 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.375 1.47 . . . . 73.53 110.469 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD13 ' CE1' ' A' ' 30' ' ' TYR . 97.1 mt -77.24 -47.5 19.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.284 0.564 . . . . 64.23 111.625 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -85.02 -18.5 34.22 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.315 0.857 . . . . 74.5 113.315 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.39 48.6 Favored Glycine 0 C--N 1.307 -1.038 0 C-N-CA 119.77 -1.205 . . . . 31.21 110.178 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 34.3 m -117.91 157.75 47.58 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.007 -1.108 . . . . 75.45 108.007 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD2' ' HD2' ' A' ' 45' ' ' LYS . 44.3 Cg_endo -72.04 164.53 35.38 Favored 'Trans proline' 0 C--O 1.259 1.558 0 C-N-CA 121.117 1.211 . . . . 64.41 110.958 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.89 -33.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.54 0.686 . . . . 75.15 109.269 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -57.45 -41.79 81.25 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.674 -1.148 . . . . 75.54 110.685 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 54.3 mttm -69.38 -36.93 77.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.625 -0.43 . . . . 74.3 111.658 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.64 -44.69 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.401 -0.592 . . . . 73.44 109.401 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.32 -36.92 79.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.439 -0.801 . . . . 55.44 110.157 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.497 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 96.2 mt-30 -67.38 -43.32 81.69 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.079 -0.51 . . . . 70.15 111.491 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 92.7 mt-30 -58.32 -46.1 86.81 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.486 0.66 . . . . 62.13 110.052 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.42 -45.7 93.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.352 -1.295 . . . . 51.11 110.16 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -70.85 -22.09 62.35 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.118 0.785 . . . . 74.24 113.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 57.5 mt-10 -94.48 -1.16 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.891 -0.505 . . . . 75.33 110.913 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.4 35.04 63.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.882 -0.675 . . . . 55.21 111.979 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -102.17 -16.94 16.2 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.808 -1.182 . . . . 72.33 107.808 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.9 tp -151.26 152.72 33.62 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.054 -1.832 . . . . 75.34 106.054 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.48 161.53 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 109.262 -0.644 . . . . 75.21 109.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.65 164.15 28.91 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.291 0.636 . . . . 75.41 110.902 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.8 m -125.24 165.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 123.826 0.85 . . . . 75.11 108.96 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -123.98 131.74 53.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.882 -0.784 . . . . 72.12 108.882 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -152.24 138.71 18.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.117 -0.697 . . . . 73.42 109.117 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.93 9.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.278 1.031 . . . . 74.41 112.335 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.21 9.7 67.01 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.181 -0.533 . . . . 74.24 112.843 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.47 142.0 15.55 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.596 -0.811 . . . . 55.33 111.168 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.78 120.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.084 -1.45 . . . . 74.51 107.084 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -137.16 164.37 29.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.25 -0.432 . . . . 74.12 111.312 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.81 130.61 24.68 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.67 -0.863 . . . . 75.43 108.67 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.71 141.82 83.67 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.086 2.524 . . . . 72.3 113.941 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -55.2 -39.82 70.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.786 1.234 . . . . 74.2 110.399 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.98 -4.91 4.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 114.129 1.159 . . . . 75.15 114.129 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CD2' HD12 ' A' ' 81' ' ' LEU . 4.7 m-85 -83.49 -5.46 59.17 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.856 0.836 . . . . 75.33 110.836 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -124.34 149.03 47.07 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.691 -1.14 . . . . 72.35 108.644 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.1 p -76.17 169.0 19.04 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.807 -0.812 . . . . 73.12 108.807 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -61.6 -19.15 61.9 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 70.13 110.953 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 m -80.08 -10.1 59.74 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 116.109 -0.496 . . . . 74.52 110.936 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.62 14.06 66.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.004 -0.617 . . . . 62.14 111.887 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -105.06 148.22 27.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.819 -0.224 . . . . 75.24 110.744 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.97 138.65 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 O-C-N 123.811 0.694 . . . . 72.35 109.627 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.94 127.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.264 -1.013 . . . . 71.3 108.264 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -24.02 67.7 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.454 0.645 . . . . 75.24 112.589 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -92.09 2.42 56.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.073 -0.512 . . . . 62.2 110.748 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.544 HD12 ' CD2' ' A' ' 70' ' ' PHE . 11.8 tp -65.05 -55.62 25.78 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.433 -0.349 . . . . 74.24 111.454 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.88 -28.46 86.41 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.815 1.677 . . . . 72.12 111.218 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.7 -45.46 65.78 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.489 -0.778 . . . . 44.3 111.967 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.22 -40.81 81.99 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 120.985 0.422 . . . . 74.32 110.118 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.43 -39.27 92.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.006 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.1 m -71.36 -41.23 70.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.899 -0.592 . . . . 73.43 112.224 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.84 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.32 -0.552 . . . . 73.13 109.535 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.417 HD21 ' O ' ' A' ' 84' ' ' LEU . 4.4 mm? -66.18 -35.67 81.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 122.257 -0.277 . . . . 74.21 111.399 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.34 -37.94 89.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.72 -0.474 . . . . 75.42 109.72 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.47 -24.94 65.66 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.741 0.781 . . . . 75.35 109.976 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -2.93 84.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.665 -0.698 . . . . 73.41 111.795 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 20.95 50.88 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.784 -0.246 . . . . 62.2 113.058 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -86.75 152.8 22.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.109 0.781 . . . . 72.4 113.109 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.436 ' O ' HG12 ' A' ' 98' ' ' ILE . 11.1 ptt180 -123.24 175.96 6.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.82 -1.082 . . . . 74.13 110.063 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 99' ' ' MET . 11.1 p-10 -52.18 -47.06 65.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.851 1.66 . . . . 74.33 113.49 -171.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.1 m -67.93 -40.0 83.41 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-O 121.471 0.653 . . . . 74.21 109.348 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 29.7 mm-40 -66.29 -34.62 78.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.338 -0.847 . . . . 75.24 111.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 94' ' ' ARG . 33.4 mm -61.49 -47.19 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.87 0.843 . . . . 72.04 108.819 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.429 ' SD ' ' HE2' ' A' ' 103' ' ' PHE . 23.0 mmt -70.41 -23.22 62.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.347 -1.297 . . . . 73.34 110.773 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 68.9 ttt180 -55.09 -67.23 0.29 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.474 0.71 . . . . 72.03 110.888 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.589 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 57.3 p-90 -68.93 -32.12 71.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.607 0.595 . . . . 72.35 112.607 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.589 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.2 mt -63.55 -40.6 97.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.328 0.862 . . . . 73.42 113.328 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 96.3 m-85 -98.33 -9.46 25.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.582 0.956 . . . . 70.33 113.582 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.4 m -88.35 110.97 40.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.815 -1.18 . . . . 61.44 107.815 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.26 129.9 37.27 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.65 2.233 . . . . 75.42 111.514 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.3 t70 -89.59 118.8 69.35 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 109.489 -0.559 . . . . 75.41 109.489 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -26.83 83.38 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.143 2.562 . . . . 75.01 112.213 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -94.84 10.05 36.77 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.685 -0.689 . . . . 65.23 111.431 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.9 tp -105.25 125.81 51.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.13 -0.693 . . . . 70.21 109.13 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 120' ' ' VAL . 52.1 m -132.04 110.68 10.89 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.352 -0.981 . . . . 62.31 108.352 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.6 pt . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 115.878 -0.601 . . . . 70.5 110.508 -175.66 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 110' ' ' THR . 44.4 t . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 110.177 -0.305 . . . . 72.21 110.177 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.7 m -83.17 139.35 33.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.07 -1.456 . . . . 75.34 107.07 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.5 t30 69.36 69.33 0.26 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.386 1.089 . . . . 73.52 108.779 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.43 159.94 21.98 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.698 -1.137 . . . . 75.3 109.931 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -75.46 125.23 88.99 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.796 -0.816 . . . . 74.31 108.796 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 72.3 Cg_exo -53.89 -23.92 29.46 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.269 2.646 . . . . 75.34 112.958 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.711 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 84.6 t -60.31 -42.16 89.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.642 -0.708 . . . . 75.22 111.553 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.18 -30.71 71.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.358 0.599 . . . . 74.32 110.471 -172.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.9 84.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.008 -0.996 . . . . 61.32 111.786 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -70.41 -36.82 74.26 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.82 -0.55 . . . . 65.11 111.671 -177.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -76.09 -22.62 55.39 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.588 -0.893 . . . . 75.34 108.588 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.16 43.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.715 -1.129 . . . . 62.45 111.413 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.8 m80 65.52 28.44 11.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.111 0.964 . . . . 75.44 112.127 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -108.64 25.23 11.97 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 125.146 1.378 . . . . 75.22 107.607 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.41 -26.37 7.82 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.89 2.076 . . . . 75.14 113.268 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 39.2 ttp180 -54.37 -41.26 68.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.933 -0.395 . . . . 75.43 109.933 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 56.6 mm-40 -67.35 -28.51 68.02 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.549 -0.296 . . . . 60.52 111.653 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.07 -45.5 54.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.4 -0.963 . . . . 71.15 108.4 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.66 -49.2 84.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.036 -0.529 . . . . 72.32 110.338 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 136' ' ' GLU 0.318 0.0 OUTLIER -63.64 -37.43 87.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.187 0.81 . . . . 74.22 113.187 178.379 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.433 ' O ' ' HG2' ' A' ' 144' ' ' MET . 1.6 mpt_? -63.6 -40.1 96.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.484 -0.561 . . . . 72.44 109.484 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.78 99.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 73.34 110.614 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -56.89 -49.52 75.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.339 0.656 . . . . 73.5 109.88 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.56 -33.12 74.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.172 -0.922 . . . . 73.33 111.892 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 92.6 mmm -77.01 -47.2 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.835 -0.346 . . . . 72.04 111.093 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.88 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.857 -0.61 . . . . 71.21 112.065 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 N--CA 1.427 -1.576 0 C-N-CA 120.655 -0.418 . . . . 74.23 110.47 -178.61 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.009 0 N-CA-C 109.758 -0.46 . . . . 71.34 109.758 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.35 -104.28 2.72 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 121.07 -0.586 . . . . 73.41 112.351 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.06 137.28 52.36 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.392 -0.523 . . . . 74.34 111.539 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.58 143.1 35.08 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.346 -0.843 . . . . 75.01 110.937 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.63 -15.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 116.055 -0.52 . . . . 75.34 110.932 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.266 1.0 OUTLIER -86.09 175.55 8.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 118.314 -1.354 . . . . 74.24 111.631 179.02 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.21 141.1 46.02 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.172 -0.677 . . . . 73.21 109.172 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.4 -32.06 32.59 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.003 2.469 . . . . 72.43 114.388 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.54 -10.02 59.55 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.942 1.09 . . . . 73.02 113.942 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -66.3 136.32 95.15 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 107.787 -1.19 . . . . 75.03 107.787 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.8 133.71 51.74 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.171 2.581 . . . . 72.43 112.629 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.7 p -132.84 168.55 18.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.057 -0.519 . . . . 72.44 111.092 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 24.6 m-85 -130.83 161.5 31.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 125.23 1.412 . . . . 73.35 108.464 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -134.67 166.57 22.62 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.343 -1.725 . . . . 74.4 106.343 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -43.37 -61.54 1.8 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 116.018 1.859 . . . . 63.12 116.018 -169.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.07 -29.37 74.86 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.448 1.432 . . . . 64.02 112.352 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.9 tpt180 -70.86 -36.22 72.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.081 0.467 . . . . 73.42 110.041 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.81 -37.9 74.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.628 -0.508 . . . . 74.43 109.628 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.15 81.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.458 -0.792 . . . . 74.13 109.393 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 35.9 tt0 -63.9 -45.78 87.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.716 -1.129 . . . . 73.4 110.724 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.457 HD22 ' CE2' ' A' ' 30' ' ' TYR . 39.6 tp -64.81 -46.93 79.94 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.194 -0.912 . . . . 74.45 111.534 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.65 -18.29 35.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.86 0.689 . . . . 70.43 112.86 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.81 53.07 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.07 -1.062 . . . . 71.34 111.448 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.05 158.71 74.39 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.131 -0.692 . . . . 63.31 109.131 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -65.78 159.84 46.66 Favored 'Trans proline' 0 C--O 1.25 1.089 0 C-N-CA 121.856 1.704 . . . . 74.32 112.192 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.2 -33.61 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.247 1.019 . . . . 72.32 111.252 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -57.87 -42.46 84.6 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.617 -0.72 . . . . 71.14 110.946 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HA ' ' HG3' ' A' ' 48' ' ' GLN . 68.2 mttm -70.06 -34.82 73.68 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.006 -0.543 . . . . 74.53 112.007 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.36 -41.63 90.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.287 -0.635 . . . . 72.42 109.287 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.37 96.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.203 -0.908 . . . . 72.5 110.589 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HG3' ' HA ' ' A' ' 45' ' ' LYS 0.308 0.0 OUTLIER -70.72 -35.03 72.52 Favored 'General case' 0 C--O 1.201 -1.483 0 C-N-CA 120.216 -0.594 . . . . 70.42 112.241 178.632 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 84.5 mm-40 -58.09 -43.14 86.93 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.482 0.658 . . . . 73.05 109.229 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.67 -46.09 91.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.687 -1.142 . . . . 75.22 108.933 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -70.68 -21.41 62.59 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.058 -0.974 . . . . 75.33 113.383 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -84.48 -7.39 59.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.904 0.383 . . . . 72.55 110.429 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.53 22.69 58.0 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.482 -0.647 . . . . 71.34 111.482 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 m170 -91.42 -17.95 24.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.058 0.456 . . . . 73.22 109.971 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 tp -151.42 155.37 38.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.43 -0.952 . . . . 72.12 108.43 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.5 t -137.47 147.11 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.028 -1.101 . . . . 70.34 108.028 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.14 156.15 44.36 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.3 -0.63 . . . . 64.21 109.3 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.3 m -127.48 166.03 25.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 O-C-N 123.595 0.559 . . . . 73.21 109.928 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -122.48 137.74 54.78 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.068 -0.716 . . . . 74.02 109.068 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -153.34 138.22 17.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.918 -1.142 . . . . 75.32 107.918 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.93 16.28 10.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.955 0.902 . . . . 74.32 110.875 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.06 78.42 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.614 -0.721 . . . . 71.41 112.133 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.76 143.61 15.68 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 111.312 -0.715 . . . . 64.35 111.312 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 p -97.73 123.27 50.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.777 0.799 . . . . 73.41 109.426 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.61 151.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.963 -1.017 . . . . 74.03 110.534 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 mp -105.35 126.67 30.33 Favored Pre-proline 0 C--N 1.28 -2.43 0 N-CA-C 107.517 -1.29 . . . . 64.12 107.517 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.36 118.03 4.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.091 1.86 . . . . 71.22 110.435 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.476 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 tt0 -60.95 -24.56 66.15 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.184 0.594 . . . . 75.34 111.667 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.83 -5.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 115.265 -0.88 . . . . 75.41 112.436 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -80.42 -14.39 58.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.009 0.909 . . . . 75.34 109.637 173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.3 151.39 26.05 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.127 -1.064 . . . . 75.22 108.127 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.4 p -76.23 175.24 9.21 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.574 -0.528 . . . . 75.15 109.574 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.82 -17.75 63.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.7 0.762 . . . . 74.35 109.994 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 m -83.3 -4.14 58.15 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.075 -0.511 . . . . 75.41 111.186 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.79 26.3 60.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.039 -0.601 . . . . 62.42 112.822 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.58 154.88 39.99 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.716 -0.846 . . . . 72.0 108.716 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.57 135.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.536 -0.542 . . . . 75.02 109.536 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.7 t -61.94 141.61 17.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.064 -1.458 . . . . 73.24 107.064 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -54.32 -44.94 72.47 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.459 1.281 . . . . 74.15 114.459 -169.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 64.6 m -109.31 21.72 16.73 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.543 -0.863 . . . . 73.02 112.246 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.441 ' HB3' ' HD3' ' A' ' 82' ' ' PRO . 17.7 tp -58.04 -48.65 96.71 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 115.041 -0.981 . . . . 72.15 110.799 174.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 50.1 Cg_exo -58.96 -27.47 84.88 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.907 1.738 . . . . 70.53 111.396 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 87' ' ' ILE . . . -62.81 -45.53 95.52 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.949 -0.569 . . . . 63.14 112.388 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.56 -39.9 80.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.699 0.762 . . . . 74.22 109.329 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.55 -44.52 90.51 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.906 -1.043 . . . . 71.53 110.492 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.7 m -67.14 -45.84 75.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.764 -0.653 . . . . 74.14 111.657 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -61.58 -45.27 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 120.542 0.211 . . . . 64.15 111.403 -178.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.23 -42.45 84.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.65 0.611 . . . . 70.11 112.65 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -64.56 -44.46 90.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.824 -0.436 . . . . 70.4 109.824 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -68.18 -26.77 65.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.852 -0.613 . . . . 72.52 109.51 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.48 -9.36 86.98 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.416 -0.811 . . . . 71.42 113.313 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.2 53.39 2.19 Favored Glycine 0 C--O 1.242 0.64 0 C-N-CA 121.03 -0.605 . . . . 71.02 113.009 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.529 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 84.1 m-85 -129.8 136.95 50.19 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.968 0.413 . . . . 71.43 111.46 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.496 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 24.1 ptt180 -81.23 169.97 16.68 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.114 -0.948 . . . . 75.04 110.807 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 99' ' ' MET . 12.3 p-10 -55.13 -45.2 75.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.217 1.407 . . . . 75.34 111.624 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -61.8 -40.38 95.04 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.596 -0.729 . . . . 74.1 111.084 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.496 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 45.1 mm-40 -66.13 -34.64 78.5 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.723 -0.391 . . . . 75.34 111.247 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 mm -63.17 -47.59 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.352 -0.981 . . . . 64.52 108.352 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 22.3 mmt -69.77 -22.1 63.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.201 -1.363 . . . . 74.24 110.543 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -58.2 -67.1 0.38 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.265 0.626 . . . . 74.52 109.734 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.482 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.5 p-90 -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.734 0.642 . . . . 74.23 112.734 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.482 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 mt -61.59 -39.93 92.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.828 0.677 . . . . 74.44 112.828 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 95.6 m-85 -98.69 -9.77 24.16 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 113.235 0.828 . . . . 72.5 113.235 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.9 m -86.0 116.04 64.18 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.552 -0.907 . . . . 72.14 108.552 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.99 154.68 73.86 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.753 2.302 . . . . 75.23 112.953 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.3 t70 -99.71 120.45 57.35 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.173 -1.047 . . . . 72.55 108.173 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.23 -27.32 84.64 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.267 2.645 . . . . 72.2 113.519 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.3 p -100.03 4.3 44.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.442 0.639 . . . . 63.24 112.215 -175.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.5 tp -102.16 139.33 37.92 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.408 -0.59 . . . . 75.55 109.408 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.2 m -129.82 118.49 21.85 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.278 -0.638 . . . . 74.24 109.278 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 C--N 1.309 -1.158 0 N-CA-C 108.262 -1.014 . . . . 71.22 108.262 -174.635 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.8 t . . . . . 0 N--CA 1.432 -1.368 0 N-CA-C 108.986 -0.746 . . . . 75.11 108.986 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.1 m -81.81 138.75 35.07 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.051 -1.092 . . . . 64.12 108.051 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 10.3 t30 72.4 69.33 0.14 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.293 1.044 . . . . 71.51 110.09 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.9 167.22 10.41 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.636 -1.165 . . . . 65.53 108.494 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.558 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 6.2 ptp180 -94.18 149.32 36.61 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.024 -0.732 . . . . 74.4 109.024 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.8 -27.54 20.6 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.168 2.579 . . . . 71.13 113.306 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 48.3 t -60.97 -36.78 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.242 0.544 . . . . 74.55 110.375 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 66.4 m-20 -69.04 -36.87 78.2 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.037 -0.727 . . . . 72.31 109.037 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.79 -40.16 79.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.269 -0.878 . . . . 75.23 111.589 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -66.73 -38.85 87.51 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.766 -0.374 . . . . 74.11 111.931 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.419 ' N ' HD12 ' A' ' 129' ' ' LEU . 47.6 t-80 -75.97 -17.17 59.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.91 0.862 . . . . 75.23 109.239 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.76 4.5 36.57 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.131 -0.941 . . . . 72.14 110.055 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 67.88 28.3 7.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.561 1.144 . . . . 75.24 111.763 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -103.93 24.11 11.83 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.581 1.152 . . . . 75.4 108.746 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.43 ' O ' HG21 ' A' ' 138' ' ' VAL . . . -52.49 -27.51 16.61 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 125.126 1.371 . . . . 73.42 112.72 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -55.53 -43.86 76.15 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.825 0.85 . . . . 74.05 110.974 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 2.3 tm-20 -73.2 -32.13 64.6 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.969 -0.752 . . . . 72.3 108.969 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.64 -42.5 89.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.015 -0.539 . . . . 73.12 110.013 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 134' ' ' ALA . 92.6 t -59.23 -41.65 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.956 -0.565 . . . . 71.21 109.523 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 136' ' ' GLU . 43.0 ttt180 -56.88 -47.12 81.2 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.01 -0.996 . . . . 73.03 110.016 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -68.96 -35.58 76.93 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.044 -0.526 . . . . 72.34 111.858 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.2 -43.44 98.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.841 0.353 . . . . 71.44 110.227 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -60.19 -45.86 91.69 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.803 -0.635 . . . . 71.42 110.178 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.4 84.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.196 -0.911 . . . . 54.14 112.075 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.57 -27.84 51.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.119 -0.492 . . . . 61.13 111.856 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -82.83 -63.6 1.33 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.182 0.808 . . . . 65.33 113.182 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 C--N 1.298 -1.665 0 CA-C-O 118.183 -0.913 . . . . 71.33 111.743 -170.863 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 106.924 -1.51 . . . . 70.44 106.924 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.24 -129.17 3.52 Favored Glycine 0 N--CA 1.422 -2.254 0 C-N-CA 120.556 -0.83 . . . . 62.44 111.849 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -109.97 146.75 34.72 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.614 -0.513 . . . . 55.34 109.614 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.599 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 19.1 t0 -78.44 125.24 29.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.349 0.595 . . . . 72.42 111.456 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.67 -15.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.922 -1.036 . . . . 75.4 109.059 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.58 HD21 ' CE1' ' A' ' 103' ' ' PHE . 24.0 mt -85.84 174.4 9.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 115.084 1.512 . . . . 74.14 115.084 -175.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -105.34 141.98 23.75 Favored Pre-proline 0 N--CA 1.423 -1.825 0 CA-C-N 112.379 -2.192 . . . . 74.51 106.636 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -55.38 -27.05 56.24 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.943 2.429 . . . . 65.22 114.412 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -91.55 -13.59 31.79 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.389 0.614 . . . . 73.33 110.755 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.53 ' OE2' ' HD2' ' A' ' 28' ' ' PRO . 9.0 tp10 -77.85 129.37 76.46 Favored Pre-proline 0 C--O 1.242 0.683 0 N-CA-C 105.562 -2.014 . . . . 73.2 105.562 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.53 ' HD2' ' OE2' ' A' ' 27' ' ' GLU . 17.7 Cg_exo -31.08 106.91 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 125.204 3.936 . . . . 73.32 115.381 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.88 155.85 48.27 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.689 -0.687 . . . . 74.53 112.385 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.485 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 22.6 m-85 -129.45 161.38 30.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 125.552 1.541 . . . . 74.43 108.077 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.596 ' OD1' ' HD3' ' A' ' 34' ' ' ARG . 5.5 p-10 -135.13 172.1 13.49 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.38 -1.711 . . . . 71.54 106.38 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -42.98 -61.13 1.89 Allowed Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 115.844 1.794 . . . . 65.22 115.844 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.1 -34.97 99.06 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.915 1.743 . . . . 62.13 112.764 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.596 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 5.2 mpt_? -70.15 -36.09 74.48 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.88 0.326 . . . . 73.42 111.88 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.407 HG23 HD13 ' A' ' 66' ' ' ILE . 79.8 t -69.69 -41.78 80.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.661 -0.496 . . . . 74.24 109.661 177.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.52 91.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.334 -0.848 . . . . 71.15 109.771 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -62.85 -46.11 89.41 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.838 1.255 . . . . 71.1 109.791 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.413 HD21 ' CE2' ' A' ' 30' ' ' TYR . 28.2 tp -70.52 -46.03 64.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.787 -1.097 . . . . 73.41 111.516 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.51 -18.97 34.06 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.42 0.526 . . . . 74.43 112.42 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.57 59.09 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 110.81 -0.916 . . . . 51.12 110.81 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.51 164.25 35.52 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.405 -0.591 . . . . 74.14 109.405 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.99 164.48 27.33 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 121.673 1.582 . . . . 73.33 111.446 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.54 -34.55 65.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.546 -0.752 . . . . 75.32 109.422 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 m -58.73 -38.9 79.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.59 -0.732 . . . . 61.21 111.851 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 24.3 ttmm -69.49 -37.5 77.27 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.481 -0.488 . . . . 73.24 110.285 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 59.7 t -63.84 -42.11 94.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.945 -0.761 . . . . 62.12 108.945 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.62 74.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 72.33 110.556 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.8 -46.38 75.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.26 -0.427 . . . . 72.53 110.577 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 68.3 mt-30 -59.08 -45.95 89.52 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.213 0.53 . . . . 74.41 110.131 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 96.9 mt -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.627 -1.17 . . . . 73.42 110.305 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -70.3 -31.24 68.49 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.811 1.041 . . . . 74.55 113.811 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.71 -11.76 35.94 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.165 -0.614 . . . . 73.35 112.234 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 36.44 6.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.318 -0.944 . . . . 73.2 111.965 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -99.11 -22.37 15.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.444 -0.947 . . . . 72.23 108.444 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.7 tp -157.13 155.26 30.72 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.773 -1.565 . . . . 75.23 106.773 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.83 161.64 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 118.159 0.436 . . . . 73.44 110.434 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.37 158.67 43.83 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.281 0.363 . . . . 60.01 110.21 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 m -127.83 165.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.343 0.657 . . . . 74.21 110.142 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -121.57 128.55 52.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.76 0.314 . . . . 75.5 111.161 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.599 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 20.9 ptt180 -136.2 124.2 22.84 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.394 -0.595 . . . . 74.1 109.394 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.72 14.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 74.43 111.729 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.93 -3.41 84.69 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.933 -0.576 . . . . 60.13 112.303 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.19 138.09 13.74 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 111.056 -0.818 . . . . 63.55 111.056 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.6 123.45 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.874 -1.158 . . . . 65.24 107.874 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.2 m -131.22 151.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.345 0.593 . . . . 73.05 110.936 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 35' ' ' VAL . 76.0 mt -124.45 125.5 25.6 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 107.437 -1.32 . . . . 75.32 107.437 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.87 128.98 32.17 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.769 2.313 . . . . 70.13 112.607 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.485 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -64.54 -24.79 67.72 Favored 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 123.421 0.688 . . . . 72.43 111.206 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.83 -3.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.569 -0.741 . . . . 74.04 112.425 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -87.15 -4.1 59.1 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.428 1.109 . . . . 74.43 108.752 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -117.35 150.43 38.85 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 113.979 -1.464 . . . . 75.54 107.398 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -83.01 173.03 12.14 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.629 -0.878 . . . . 70.11 108.629 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.28 -17.27 64.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.411 0.624 . . . . 74.12 110.62 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -81.27 -3.91 53.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.692 -0.686 . . . . 63.22 111.478 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 23.84 58.85 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.77 -0.729 . . . . 63.23 112.976 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.12 154.76 44.33 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.285 -1.005 . . . . 74.33 108.285 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.8 t -62.6 142.75 16.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 123.62 0.575 . . . . 74.34 109.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.31 135.08 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.974 0.796 . . . . 63.33 109.346 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -54.91 -43.66 73.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.852 -0.613 . . . . 71.11 112.295 -174.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -98.67 18.35 17.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.904 0.705 . . . . 62.44 112.904 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -60.6 -52.08 75.27 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-N 116.595 -0.275 . . . . 74.11 110.803 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 19.3 Cg_endo -59.85 -27.92 86.03 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 121.881 1.721 . . . . 70.13 111.796 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.58 92.93 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 116.098 -0.501 . . . . 64.42 112.084 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -68.22 -39.98 82.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.285 0.564 . . . . 65.13 109.482 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.29 -36.27 83.57 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.785 -0.643 . . . . 73.41 110.73 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.2 m -61.0 -47.8 84.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.358 -0.383 . . . . 73.04 111.999 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -42.56 86.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 120.67 -0.412 . . . . 71.25 110.607 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.04 -35.62 80.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.499 0.555 . . . . 75.21 112.499 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -63.9 -33.45 75.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.026 -0.361 . . . . 73.53 110.026 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.58 -31.18 71.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.075 -0.511 . . . . 73.4 110.222 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.97 -9.19 81.17 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.715 -0.675 . . . . 43.34 111.473 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.12 55.76 3.96 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 112.402 -0.279 . . . . 64.3 112.402 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 88.7 m-85 -113.77 137.83 51.1 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.236 0.458 . . . . 74.55 112.236 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.449 ' O ' HG12 ' A' ' 98' ' ' ILE . 15.4 ptp180 -88.03 172.23 9.7 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.462 -0.79 . . . . 72.34 111.176 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -53.59 -45.06 69.88 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.267 1.427 . . . . 71.43 112.425 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -60.13 -41.57 92.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.208 0.603 . . . . 75.32 110.059 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 5.7 mm-40 -63.21 -43.85 96.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.992 -0.549 . . . . 74.12 110.412 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.7 mm -61.15 -48.13 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.587 0.708 . . . . 72.23 109.3 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.44 ' O ' ' HD2' ' A' ' 103' ' ' PHE . 53.8 mtt -74.65 -20.97 59.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.138 -0.937 . . . . 74.52 111.638 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 64.3 ttt180 -57.2 -65.88 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.025 0.53 . . . . 74.21 110.576 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.473 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.0 p-90 -69.02 -33.1 73.1 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.968 0.729 . . . . 73.52 112.968 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.473 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.1 mt -57.24 -40.5 77.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.976 0.732 . . . . 74.1 112.976 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.58 ' CE1' HD21 ' A' ' 23' ' ' LEU . 97.1 m-85 -98.65 3.48 47.82 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.544 0.572 . . . . 73.22 112.544 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.3 m -87.44 119.58 70.83 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.985 -0.376 . . . . 74.43 109.985 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 32.2 Cg_exo -62.74 128.84 24.37 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.616 1.544 . . . . 71.23 108.348 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.99 122.57 50.21 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 120.301 -0.56 . . . . 72.43 110.209 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.4 -19.53 59.08 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.411 2.741 . . . . 72.42 113.7 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -107.6 3.86 25.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 111.919 0.34 . . . . 64.03 111.919 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.5 tp -102.64 130.6 49.59 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.74 0.781 . . . . 73.23 110.979 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.9 m -131.28 118.65 20.66 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.476 -1.305 . . . . 41.43 107.476 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.3 pt . . . . . 0 C--O 1.215 -0.716 0 N-CA-C 113.156 0.799 . . . . 71.44 113.156 -174.018 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 109.065 -0.717 . . . . 75.45 109.065 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -83.21 154.46 24.22 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.059 -0.973 . . . . 74.2 111.337 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 78.8 m-20 62.44 40.81 10.56 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.481 1.112 . . . . 75.2 110.949 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 174.41 6.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.16 -0.473 . . . . 62.11 110.858 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -102.69 143.74 27.21 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 116.379 -0.373 . . . . 75.34 111.077 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.431 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.5 Cg_exo -53.36 -24.32 27.07 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.847 3.031 . . . . 74.13 114.595 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.616 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 71.2 t -60.4 -39.83 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 122.158 0.98 . . . . 74.32 110.405 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.18 -30.47 67.6 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.052 -0.976 . . . . 74.23 110.381 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.17 77.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 71.34 111.422 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.71 -36.27 82.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.932 -0.307 . . . . 75.05 111.599 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -66.57 -29.13 69.12 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.68 0.752 . . . . 73.23 109.963 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.89 0.38 53.24 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.883 -1.053 . . . . 64.14 111.608 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.7 t60 64.55 28.7 13.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 122.868 1.318 . . . . 72.41 109.572 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -95.02 25.13 4.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.788 1.28 . . . . 74.33 108.282 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 138' ' ' VAL . . . -53.89 -29.39 41.55 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.508 -1.678 . . . . 54.44 113.491 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -63.61 -37.55 87.75 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.931 -0.766 . . . . 72.13 108.931 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -63.18 -42.56 99.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.231 -0.895 . . . . 70.13 109.173 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.43 -47.93 87.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.585 -0.734 . . . . 71.3 110.342 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 134' ' ' ALA . 99.1 t -59.38 -44.77 93.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.434 -0.348 . . . . 73.35 111.416 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -63.68 -38.4 90.96 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.944 -0.702 . . . . 74.14 111.361 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -69.0 -36.52 77.91 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.829 -0.434 . . . . 73.01 109.829 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.717 -0.674 . . . . 73.24 109.877 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.74 -42.88 94.18 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.939 -0.573 . . . . 62.2 111.015 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.68 -25.96 65.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.23 0.538 . . . . 70.23 111.486 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.47 ' HG3' ' CD1' ' A' ' 101' ' ' TRP . 0.5 OUTLIER -82.18 -39.75 22.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.449 0.642 . . . . 72.22 109.421 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.421 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -81.54 -40.75 22.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.782 0.66 . . . . 75.42 112.782 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 109.453 -0.573 . . . . 74.24 109.453 -177.873 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 106.361 -1.718 . . . . 73.04 106.361 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.6 -110.96 2.97 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.581 -0.819 . . . . 75.45 113.327 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.36 123.18 38.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.256 0.55 . . . . 75.13 111.879 -171.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' A' ' 23' ' ' LEU . 3.5 t70 -61.29 131.94 51.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.285 -0.871 . . . . 75.21 111.75 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.06 -4.78 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 122.07 0.938 . . . . 72.11 109.29 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.438 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 17.6 mt -74.98 165.15 25.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.618 1.199 . . . . 72.43 113.941 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.3 t70 -94.26 134.66 25.37 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 105.314 -2.106 . . . . 75.44 105.314 172.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.84 -21.75 27.14 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 123.406 2.738 . . . . 64.44 114.572 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.86 -23.85 23.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.208 0.447 . . . . 75.02 112.208 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 23.2 mm-40 -65.87 139.22 96.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.07 -0.252 . . . . 73.32 111.676 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.1 128.0 28.36 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.351 2.701 . . . . 75.12 113.102 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.5 p -122.94 170.07 10.5 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 121.629 0.728 . . . . 73.32 111.484 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 24.9 m-85 -130.36 161.21 31.83 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 126.401 1.88 . . . . 72.54 107.851 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -135.03 161.74 34.44 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 103.346 -2.835 . . . . 73.15 103.346 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 mt -53.12 -51.44 75.05 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 112.672 0.619 . . . . 74.34 112.672 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.31 -35.37 98.77 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.161 1.907 . . . . 64.23 112.2 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -70.78 -38.54 73.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.48 -0.327 . . . . 73.43 110.697 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.5 t -68.15 -37.46 78.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.602 -0.518 . . . . 74.23 109.602 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.89 81.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.289 -0.869 . . . . 73.53 109.68 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.8 -45.96 80.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.203 -0.908 . . . . 53.44 109.68 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.408 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 49.7 tp -62.31 -50.66 70.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.906 -1.043 . . . . 74.4 112.3 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.43 -13.92 41.94 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.469 0.544 . . . . 73.12 112.469 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.44 31.5 56.72 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 110.947 -0.861 . . . . 74.31 110.947 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.6 m -121.98 161.26 43.38 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.529 -0.915 . . . . 75.24 108.529 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.07 163.47 35.13 Favored 'Trans proline' 0 C--O 1.262 1.681 0 C-N-CA 121.393 1.395 . . . . 73.14 111.673 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.19 -33.21 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.82 0.848 . . . . 70.42 109.526 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 13.4 m -57.03 -44.38 82.86 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.728 -1.124 . . . . 75.41 110.617 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 51.8 mtpt -69.4 -32.04 70.79 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.101 -0.374 . . . . 75.21 111.425 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HA ' HE21 ' A' ' 49' ' ' GLN . 47.2 t -62.43 -44.38 99.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 109.593 -0.521 . . . . 74.22 109.593 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.83 81.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 64.52 109.996 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 44' ' ' SER . 25.7 mt-30 -64.51 -41.43 96.43 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 116.275 -0.42 . . . . 74.32 111.543 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 43.7 mt-30 -61.04 -42.14 97.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.802 0.81 . . . . 74.32 109.961 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.24 -41.19 98.2 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.074 -1.421 . . . . 75.41 109.696 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -71.57 -21.97 61.81 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.77 -0.65 . . . . 74.02 112.291 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 50.9 mt-10 -81.71 -12.68 58.53 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 122.103 -0.373 . . . . 61.11 110.64 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.2 23.35 77.73 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.52 -1.032 . . . . 74.31 110.52 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -109.26 5.54 23.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.394 0.616 . . . . 74.45 110.523 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 tp -153.6 151.57 29.88 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.279 -1.749 . . . . 75.51 106.279 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.01 148.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.317 -0.623 . . . . 73.5 109.317 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.62 161.8 37.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.972 -0.751 . . . . 44.42 108.972 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.63 160.31 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 123.343 0.402 . . . . 70.42 110.445 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 40.2 ttm180 -115.34 117.84 31.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.393 0.616 . . . . 75.04 111.698 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 26.2 ptt180 -127.96 130.07 47.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.077 -0.712 . . . . 75.0 109.077 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.05 21.63 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.945 0.898 . . . . 74.05 110.384 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.14 -15.06 64.02 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.841 -0.618 . . . . 42.24 112.731 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.45 143.1 16.52 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.02 -0.61 . . . . 62.23 112.244 -177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.14 121.41 47.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 109.366 -0.605 . . . . 75.25 109.366 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.43 152.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.605 -0.725 . . . . 74.23 110.892 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.9 mt -115.1 133.48 22.67 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.283 -1.006 . . . . 75.13 108.283 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.12 130.33 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.755 1.637 . . . . 72.51 111.156 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 7.2 tt0 -62.59 -24.56 67.62 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.164 0.507 . . . . 73.02 111.181 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -67.38 -6.97 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.684 -0.689 . . . . 74.0 112.707 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.55 ' CD2' HD11 ' A' ' 81' ' ' LEU . 5.2 m-85 -81.56 -11.24 59.23 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.217 1.008 . . . . 74.14 109.24 173.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -113.06 164.2 13.77 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.676 -1.147 . . . . 73.34 108.291 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.484 ' HA ' ' CD2' ' A' ' 130' ' ' HIS . 37.5 p -82.34 165.97 19.87 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.131 -0.692 . . . . 74.12 109.131 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -64.71 -19.14 65.59 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.047 -0.524 . . . . 72.21 109.627 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 m -79.51 -19.9 48.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.576 -0.738 . . . . 71.31 110.229 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.46 -5.96 38.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.436 -0.888 . . . . 70.53 113.75 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.84 166.2 11.74 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.086 -0.655 . . . . 74.13 109.489 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.05 139.91 20.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.757 -0.831 . . . . 75.54 108.757 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.76 136.74 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.231 -1.026 . . . . 75.4 108.231 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -54.77 -36.56 64.98 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 112.535 0.569 . . . . 74.22 112.535 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -88.11 -0.76 57.46 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.638 0.607 . . . . 72.32 112.638 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.55 HD11 ' CD2' ' A' ' 70' ' ' PHE . 20.3 tp -65.36 -53.64 37.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.37 -0.348 . . . . 73.53 111.809 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 38.6 Cg_exo -60.28 -30.9 92.12 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.694 1.596 . . . . 73.33 111.304 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.49 90.01 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.864 -0.607 . . . . 73.23 112.838 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 pp -68.39 -40.5 81.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.394 0.616 . . . . 72.43 109.355 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.34 -41.28 98.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.591 -0.731 . . . . 65.35 110.833 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -57.77 -47.72 81.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.477 -0.329 . . . . 71.43 111.795 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -42.11 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 120.812 -0.355 . . . . 74.21 111.345 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.36 -37.17 82.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.467 0.543 . . . . 75.32 112.467 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -66.83 -32.29 73.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.664 -0.244 . . . . 74.35 111.08 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.19 -29.91 71.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.294 0.569 . . . . 63.25 109.778 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.77 6.42 64.71 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.556 -0.747 . . . . 75.21 112.394 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.31 33.43 84.98 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.465 0.546 . . . . 73.15 114.465 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 57.8 m-85 -85.85 131.63 34.27 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 117.626 0.713 . . . . 75.33 112.344 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.445 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 21.8 ptt180 -73.32 170.45 15.01 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-N 115.345 -0.843 . . . . 75.45 111.215 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -55.02 -44.84 74.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 125.899 1.679 . . . . 62.24 112.013 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.9 m -62.64 -42.1 99.41 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.085 -0.961 . . . . 72.54 110.628 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 61.7 mm-40 -66.6 -34.74 78.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.108 -0.496 . . . . 73.12 110.328 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.46 -48.42 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.741 0.781 . . . . 74.34 108.93 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 55.1 mtt -75.13 -18.43 60.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.91 -1.041 . . . . 73.15 111.894 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -60.73 -63.46 1.29 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.989 -0.55 . . . . 72.13 110.574 -174.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.516 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 31.3 p-90 -69.32 -32.82 72.19 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.129 0.418 . . . . 73.43 112.129 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 12.2 mt -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.95 1.093 . . . . 74.34 113.95 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.402 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 84.0 m-85 -95.75 -2.95 46.75 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.008 0.744 . . . . 72.43 113.008 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 m -88.57 109.79 32.0 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 110.193 -0.299 . . . . 73.23 110.193 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 42.9 Cg_exo -60.09 144.66 99.46 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.892 2.395 . . . . 75.05 111.626 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 11.0 t70 -107.47 124.0 36.37 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.626 -0.509 . . . . 71.32 109.626 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.564 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 28.3 Cg_endo -60.62 -25.83 81.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.658 2.905 . . . . 72.5 114.513 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.6 m -102.41 1.49 35.43 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.984 0.421 . . . . 74.21 110.247 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.432 ' HG ' HG12 ' A' ' 111' ' ' ILE . 43.0 tp -101.66 130.58 48.04 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.601 -0.518 . . . . 75.21 109.601 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 m -128.04 110.54 12.59 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.802 -0.814 . . . . 72.41 108.802 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.432 HG12 ' HG ' ' A' ' 109' ' ' LEU . 39.9 mm . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 115.288 -0.869 . . . . 74.24 109.88 -172.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 109.342 -0.614 . . . . 73.4 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -83.04 148.87 27.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.746 -1.575 . . . . 71.43 106.746 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.564 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 34.2 m-80 66.99 41.37 2.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 123.828 0.851 . . . . 75.31 109.08 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.63 150.38 26.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.463 -0.495 . . . . 75.01 110.754 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -80.36 128.1 73.96 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.629 -0.878 . . . . 75.35 108.629 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.53 -24.1 8.7 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.063 3.175 . . . . 75.44 115.11 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.584 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.1 t -60.62 -39.1 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.267 0.556 . . . . 74.12 110.419 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -69.95 -30.27 67.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.187 -0.461 . . . . 74.21 111.149 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.36 82.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.699 -0.682 . . . . 73.11 111.17 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -63.95 -37.68 88.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.501 0.191 . . . . 74.2 111.307 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.484 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 61.1 t-80 -68.7 -36.79 78.92 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.741 -0.663 . . . . 73.32 109.301 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.14 21.2 5.25 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.342 -0.845 . . . . 74.13 112.773 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.8 t60 64.69 27.64 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.77 1.228 . . . . 73.32 111.361 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -110.53 24.42 12.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.965 1.364 . . . . 73.51 107.635 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.62 -25.91 12.07 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 112.416 -2.174 . . . . 74.32 112.627 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -54.78 -39.33 68.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.54 0.736 . . . . 73.25 110.75 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.35 -33.71 74.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.383 0.611 . . . . 73.42 111.072 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.7 t -72.59 -41.96 63.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.48 -0.782 . . . . 75.24 109.651 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.7 -48.06 89.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.234 -0.439 . . . . 75.22 110.264 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -63.59 -37.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.746 -0.382 . . . . 74.24 111.428 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -65.02 -41.58 95.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.644 -0.873 . . . . 75.13 108.644 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.47 -45.08 88.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.103 -0.953 . . . . 74.23 110.262 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -62.13 -38.62 89.65 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.844 -0.616 . . . . 74.34 111.248 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.21 84.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.05 0.453 . . . . 71.33 110.51 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.8 tpt -69.64 -39.28 77.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.809 -0.632 . . . . 70.1 110.736 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.426 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.94 -53.79 5.08 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.353 0.872 . . . . 71.33 113.353 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 118.691 -0.671 . . . . 75.13 109.426 -176.189 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 N-CA-C 107.963 -1.125 . . . . 73.55 107.963 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -105.4 -86.72 1.94 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.336 -0.935 . . . . 74.21 112.796 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -127.53 143.54 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.832 0.349 . . . . 74.23 111.123 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.82 139.07 41.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.553 0.692 . . . . 72.41 112.369 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.9 t -112.12 -14.9 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.295 -0.866 . . . . 74.11 110.894 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.478 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -96.09 -179.63 4.74 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.922 -1.111 . . . . 74.41 111.657 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.64 137.08 19.36 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 108.05 -1.093 . . . . 73.52 108.05 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.88 -21.35 15.22 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.571 2.848 . . . . 62.55 114.191 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.05 -19.52 61.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.085 0.469 . . . . 71.42 111.51 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -88.5 154.68 51.16 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 119.296 -0.383 . . . . 75.32 110.017 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -46.24 110.13 0.25 Allowed 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.984 3.123 . . . . 64.31 114.992 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.0 p -125.0 167.34 14.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.794 0.838 . . . . 75.41 110.686 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.505 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 13.0 m-85 -131.4 158.2 41.39 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.307 1.043 . . . . 74.42 108.193 169.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 35' ' ' VAL . 9.5 t70 -136.95 168.82 18.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 104.281 -2.488 . . . . 73.33 104.281 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -50.6 -56.61 17.65 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 113.964 1.098 . . . . 74.21 113.964 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -57.74 -39.8 84.53 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.205 1.936 . . . . 72.55 112.346 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -70.38 -37.54 74.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 111.972 0.36 . . . . 74.44 111.972 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 31' ' ' ASP . 46.1 t -69.3 -37.64 76.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.061 -0.718 . . . . 74.53 109.061 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.14 83.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.889 -1.051 . . . . 72.1 109.704 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.7 -45.94 84.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.875 0.87 . . . . 73.11 110.061 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -62.07 -43.33 99.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.84 -1.073 . . . . 70.32 111.903 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.407 ' HB2' HG23 ' A' ' 41' ' ' VAL . 83.5 mt -97.31 -12.56 22.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.939 -0.573 . . . . 72.5 112.097 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 17.15 80.18 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.538 -0.625 . . . . 71.11 111.538 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.407 HG23 ' HB2' ' A' ' 39' ' ' LEU . 25.8 m -112.48 159.45 34.05 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.73 -0.841 . . . . 74.25 108.73 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.4 170.01 20.16 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 121.208 1.272 . . . . 72.01 111.246 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.08 -33.16 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.387 0.675 . . . . 71.14 110.484 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 m -56.35 -46.33 80.03 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 114.916 -1.038 . . . . 75.42 110.197 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 92.5 mttt -69.97 -35.27 74.32 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.032 0.382 . . . . 75.14 112.032 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -61.15 -43.72 96.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 N-CA-C 109.548 -0.538 . . . . 73.51 109.548 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.505 ' O ' ' HD3' ' A' ' 51' ' ' ARG . . . -61.04 -38.88 87.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.423 -0.808 . . . . 74.53 109.833 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.56 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 13.3 mm100 -66.84 -36.35 82.13 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 112.91 0.707 . . . . 74.13 112.91 178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.0 mm100 -57.87 -42.8 85.3 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.726 -0.842 . . . . 74.35 108.726 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.53 -40.61 97.33 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.4 -1.273 . . . . 73.02 110.662 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 47' ' ' ALA . 10.2 mpt_? -71.21 -20.87 62.21 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.228 0.825 . . . . 75.21 113.228 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 44.5 mm-40 -76.66 -11.87 59.92 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 120.525 -0.47 . . . . 75.01 109.824 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.72 72.15 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.944 -0.863 . . . . 62.14 110.944 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -105.46 4.28 30.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.119 -0.541 . . . . 74.11 110.206 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.2 tp -161.12 157.51 26.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.612 -0.884 . . . . 71.41 108.612 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 93.9 t -132.82 147.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.362 -0.977 . . . . 74.41 108.362 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.72 157.85 43.85 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.886 -0.783 . . . . 73.0 108.886 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -130.46 166.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 122.92 0.488 . . . . 74.44 110.21 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 43.8 ttp180 -121.07 125.68 47.91 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.59 -0.277 . . . . 73.25 110.801 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.473 ' NH1' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -116.62 117.09 28.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.69 -0.855 . . . . 73.11 108.69 177.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.96 -48.06 0.68 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.083 1.753 . . . . 60.5 111.583 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.23 -12.07 0.02 OUTLIER Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.738 -1.119 . . . . 72.43 112.287 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.53 146.06 16.35 Favored Glycine 0 CA--C 1.493 -1.339 0 C-N-CA 120.634 -0.793 . . . . 71.33 112.122 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.49 128.8 47.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.203 0.525 . . . . 72.22 109.771 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.473 HG12 ' NH1' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -131.54 158.75 43.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.698 1.199 . . . . 72.25 110.107 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.2 mt -124.77 121.93 25.64 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.114 -1.439 . . . . 63.13 107.114 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.67 126.67 22.54 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.057 1.838 . . . . 74.03 111.192 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.505 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.7 tt0 -62.22 -24.65 67.36 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 121.261 0.553 . . . . 74.43 111.447 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.68 -4.54 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.092 -0.958 . . . . 74.13 112.665 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.557 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.1 m-85 -86.29 -7.64 58.34 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.073 0.939 . . . . 74.43 109.848 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -117.11 159.98 21.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.119 . . . . 74.13 107.994 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.0 p -88.02 163.37 16.32 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.823 -1.177 . . . . 62.51 107.823 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -66.26 -16.45 64.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.305 0.574 . . . . 72.43 110.382 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.2 m -79.72 -9.5 59.66 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.777 -0.647 . . . . 74.22 110.898 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.86 -2.43 66.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.304 -0.474 . . . . 75.34 113.164 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -90.37 152.84 20.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.505 -0.554 . . . . 71.23 109.505 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.53 136.19 26.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.259 -1.386 . . . . 72.31 107.259 171.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.25 129.06 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.443 -0.947 . . . . 71.13 108.443 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.504 ' HZ1' ' HB3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.41 -22.33 66.08 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.751 0.648 . . . . 73.55 112.751 -177.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.1 m -87.75 -8.21 56.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.963 -0.562 . . . . 64.24 110.777 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.614 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 18.0 tp -63.45 -56.44 26.77 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 119.015 -0.517 . . . . 74.11 111.248 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.0 Cg_exo -62.83 -25.2 74.51 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.331 1.354 . . . . 72.33 110.706 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -45.36 64.57 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.602 -0.726 . . . . 74.33 111.721 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.81 -40.43 79.54 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.996 -0.742 . . . . 74.55 108.996 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 74.0 mt -59.91 -39.17 84.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.766 -0.652 . . . . 65.42 110.802 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.2 m -61.47 -48.36 81.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.054 -0.521 . . . . 74.32 111.399 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -44.41 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 111.862 0.319 . . . . 74.32 111.862 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.27 -35.79 80.24 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 120.177 -0.609 . . . . 70.14 112.225 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -64.27 -41.48 96.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.616 -0.883 . . . . 75.03 108.616 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.19 -31.2 72.25 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.96 -1.018 . . . . 74.53 110.58 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.38 -9.45 81.77 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.64 -0.709 . . . . 61.05 112.893 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.9 46.09 7.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.088 -0.577 . . . . 72.33 113.723 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.435 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 96.6 m-85 -111.0 142.92 42.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.895 -0.409 . . . . 74.02 109.895 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.422 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 16.9 ptp180 -87.94 171.03 10.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.558 -0.292 . . . . 74.31 111.141 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -55.05 -45.79 75.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.856 1.262 . . . . 70.4 111.87 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.8 m -64.5 -39.99 94.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.188 -0.915 . . . . 73.45 110.41 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 45.3 mt-10 -65.82 -35.1 79.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.079 -0.51 . . . . 74.21 111.615 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.28 -46.97 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.855 -1.165 . . . . 74.41 107.855 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -66.33 -28.64 68.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.028 -1.442 . . . . 74.52 111.029 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.0 -67.33 0.27 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 122.877 0.471 . . . . 75.31 111.037 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.458 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.3 p-90 -69.05 -32.1 71.35 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.89 0.7 . . . . 75.42 112.89 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 mt -61.22 -40.78 95.3 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 113.097 0.777 . . . . 73.5 113.097 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.5 m-85 -91.46 -5.4 54.35 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.803 0.668 . . . . 74.25 112.803 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 92.4 m -78.15 119.94 79.29 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.963 -0.754 . . . . 74.23 108.963 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.14 129.5 20.68 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.579 1.519 . . . . 74.4 109.426 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 34.4 t70 -105.41 116.59 60.0 Favored Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 116.388 -0.369 . . . . 75.32 111.012 -175.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.19 -25.26 80.56 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.728 2.286 . . . . 70.21 112.084 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -17.72 59.63 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.931 -0.577 . . . . 73.24 110.511 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.96 125.63 48.69 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.766 0.793 . . . . 74.4 110.828 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 m -131.28 110.87 11.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.365 -1.346 . . . . 73.22 107.365 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 CA--C 1.476 -1.872 0 N-CA-C 112.739 0.644 . . . . 73.32 112.739 -174.33 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 109.097 -0.705 . . . . 72.24 109.097 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 m -90.1 138.66 31.33 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.775 -1.194 . . . . 73.44 107.775 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 44.6 t-20 69.39 59.23 0.32 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.34 1.067 . . . . 70.51 109.134 176.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.66 164.09 11.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.689 -1.141 . . . . 74.22 109.9 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -87.55 145.85 38.17 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.464 -0.569 . . . . 71.1 109.464 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.53 -28.84 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.403 2.735 . . . . 75.33 113.708 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.644 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 95.8 t -60.34 -41.99 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.242 0.544 . . . . 73.31 110.146 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.01 -30.04 70.99 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.601 0.715 . . . . 74.12 109.796 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.23 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.222 -0.899 . . . . 63.15 112.316 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 3.9 pp -68.14 -34.29 76.07 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.464 -0.494 . . . . 74.22 110.333 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -65.38 -31.85 73.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.722 -0.844 . . . . 73.23 108.722 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.74 8.28 20.4 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.785 -1.098 . . . . 72.42 111.961 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 64.06 28.32 14.26 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 123.011 1.386 . . . . 75.04 109.716 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.57 25.59 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.652 -1.158 . . . . 62.41 108.956 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.93 14.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.434 1.494 . . . . 74.12 112.212 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -56.44 -31.95 64.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.316 0.246 . . . . 72.32 111.659 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.42 -26.87 61.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 74.44 110.773 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.46 -45.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.562 -1.273 . . . . 75.1 107.562 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.418 HG13 HE21 ' A' ' 142' ' ' GLN . 58.7 t -62.26 -42.41 95.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.564 -1.198 . . . . 72.13 109.692 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -58.78 -45.31 90.11 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.44 0.696 . . . . 74.55 110.354 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.1 tpp180 -66.16 -41.28 90.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.161 -0.681 . . . . 74.34 109.161 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.58 88.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 64.32 111.118 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.418 HE21 HG13 ' A' ' 138' ' ' VAL . 79.3 mt-30 -62.16 -41.58 98.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 74.44 110.536 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.67 -27.45 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 70.23 112.113 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 93.8 mmm -86.0 -32.03 21.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 73.22 110.347 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.435 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.5 -60.1 2.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.322 -0.399 . . . . 73.54 112.062 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 109.249 -0.649 . . . . 72.31 109.249 -176.28 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.756 0 N-CA-C 108.503 -0.925 . . . . 72.31 108.503 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.01 -156.85 12.87 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 120.456 -0.878 . . . . 70.13 113.542 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -96.08 136.19 36.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.915 -0.642 . . . . 75.04 109.415 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.5 101.55 0.19 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.617 0.723 . . . . 74.32 111.761 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.95 -40.4 83.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.311 -0.859 . . . . 74.22 110.951 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 173.16 10.63 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.98 -0.554 . . . . 73.22 109.916 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.31 138.44 52.13 Favored Pre-proline 0 C--N 1.291 -1.957 0 N-CA-C 108.463 -0.94 . . . . 75.5 108.463 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.63 -21.71 8.27 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 123.344 2.696 . . . . 75.02 115.676 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.52 4.99 53.15 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.378 0.51 . . . . 75.04 112.378 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -84.53 158.18 60.45 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 110.03 -0.359 . . . . 72.11 110.03 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.407 ' C ' ' HG3' ' A' ' 68' ' ' GLN . 61.6 Cg_exo -42.85 106.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 124.177 3.251 . . . . 73.44 113.879 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.415 ' N ' ' HG3' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -135.41 148.58 49.38 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 113.073 0.768 . . . . 71.41 113.073 -176.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CD2' ' HG2' ' A' ' 68' ' ' GLN . 30.2 m-85 -116.32 162.22 17.85 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 126.34 1.856 . . . . 72.05 106.997 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -132.1 161.76 32.49 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 104.81 -2.293 . . . . 72.04 104.81 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.1 mt -45.28 -56.06 10.23 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 113.384 0.883 . . . . 71.45 113.384 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.28 -35.2 85.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.444 1.43 . . . . 70.34 112.158 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 4.3 tpt180 -70.28 -36.19 74.22 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.022 0.439 . . . . 73.15 110.226 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.86 -37.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.847 0.356 . . . . 75.33 110.047 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.86 76.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.266 -0.642 . . . . 73.4 109.266 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 8.9 mm-40 -63.41 -45.23 91.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 65.31 111.697 173.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 91.1 mt -64.14 -50.13 69.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.082 0.468 . . . . 73.43 111.234 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.59 -18.87 43.27 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.474 -0.784 . . . . 74.14 112.231 -174.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.16 31.83 69.15 Favored Glycine 0 C--O 1.239 0.447 0 N-CA-C 111.301 -0.719 . . . . 72.25 111.301 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.4 m -127.84 161.55 54.9 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.177 -0.675 . . . . 74.21 109.177 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.83 153.93 75.45 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 121.795 1.663 . . . . 72.14 112.069 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.89 -36.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.619 -0.719 . . . . 73.22 110.685 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.497 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 32.5 t -63.22 -33.93 76.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.144 -0.48 . . . . 73.24 110.961 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 62.3 tttp -69.53 -35.04 75.1 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.51 -0.552 . . . . 75.01 109.51 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 61.1 t -63.35 -41.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.837 -0.801 . . . . 74.1 108.837 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.99 -36.98 80.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.784 -0.643 . . . . 73.25 110.425 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 44' ' ' SER . 27.8 mm-40 -69.19 -35.88 76.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.714 0.292 . . . . 75.23 110.266 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.8 mt-30 -64.05 -43.18 96.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.617 0.723 . . . . 75.14 109.608 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.3 mt -61.92 -40.59 95.99 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.452 -1.249 . . . . 71.33 109.412 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -61.52 -31.75 71.77 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.184 0.593 . . . . 71.44 111.781 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.27 -12.05 53.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.177 0.436 . . . . 74.53 112.177 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.9 58.57 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.967 -1.253 . . . . 73.34 109.967 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -82.77 -23.38 33.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.787 -1.19 . . . . 72.31 107.787 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -156.76 159.28 38.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.113 -1.81 . . . . 74.43 106.113 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.34 158.72 41.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.818 -0.438 . . . . 73.1 109.818 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.02 156.19 44.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.278 0.561 . . . . 71.31 111.969 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.41 165.81 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 123.671 0.789 . . . . 73.44 110.52 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 50.7 ttp180 -114.65 125.98 54.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.024 0.379 . . . . 72.43 112.024 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.521 ' NE ' HG12 ' A' ' 65' ' ' VAL . 30.9 ptt180 -116.25 113.63 23.29 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.813 -0.81 . . . . 75.11 108.813 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.11 9.55 0.68 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.326 1.05 . . . . 64.22 113.361 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.86 -28.95 4.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 121.346 -0.454 . . . . 71.44 111.988 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -84.12 141.34 19.91 Favored Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 121.337 -0.459 . . . . 74.42 112.367 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.9 t -97.24 120.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.775 -1.195 . . . . 75.02 107.775 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG12 ' NE ' ' A' ' 60' ' ' ARG . 18.8 m -133.39 159.77 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.035 -0.984 . . . . 75.11 112.974 -171.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.83 126.11 22.42 Favored Pre-proline 0 N--CA 1.434 -1.25 0 N-CA-C 106.75 -1.574 . . . . 73.31 106.75 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.32 130.49 36.18 Favored 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 122.632 2.221 . . . . 70.25 112.721 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.441 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 71.2 mt-30 -53.94 -25.22 19.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.13 0.789 . . . . 71.5 113.13 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.83 -11.48 13.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.945 -0.57 . . . . 73.51 112.299 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.539 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.8 m-85 -85.31 -5.23 59.33 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.593 0.757 . . . . 74.23 110.367 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.41 155.11 29.1 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.6 -0.727 . . . . 75.14 110.056 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.6 p -75.78 175.89 8.28 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.002 -0.999 . . . . 74.12 109.516 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -59.48 -19.38 47.43 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.224 0.61 . . . . 74.22 111.212 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t -87.43 -8.57 56.36 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.159 0.584 . . . . 73.14 110.667 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.54 25.92 55.54 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.351 -0.7 . . . . 74.11 111.351 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -115.76 157.7 23.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.108 -0.701 . . . . 74.02 109.108 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.28 128.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.385 -0.598 . . . . 74.01 109.385 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.25 121.41 9.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 108.039 -1.097 . . . . 65.01 108.039 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -59.96 -22.28 62.3 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 113.826 1.047 . . . . 74.45 113.826 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.5 m -87.68 -15.93 35.79 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.258 0.552 . . . . 63.24 110.987 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.539 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.6 tt -66.46 -45.91 58.85 Favored Pre-proline 0 CA--C 1.565 1.534 0 N-CA-C 115.157 1.54 . . . . 75.02 115.157 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.35 -28.43 62.97 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.401 2.067 . . . . 74.53 112.045 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.58 -42.93 98.68 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.65 -0.705 . . . . 73.23 112.265 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.53 -40.58 80.67 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.542 -0.54 . . . . 74.33 109.542 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.61 -37.67 87.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 75.13 110.777 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.3 m -68.55 -40.05 80.84 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.75 -0.659 . . . . 74.22 112.138 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -42.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 119.935 -0.706 . . . . 73.11 110.5 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.4 ' CB ' HD11 ' A' ' 98' ' ' ILE . 3.4 mm? -67.31 -36.44 81.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.291 -0.564 . . . . 73.45 112.191 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -65.14 -36.99 85.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.145 -0.687 . . . . 74.43 109.145 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.56 -30.81 70.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.415 0.626 . . . . 75.24 110.146 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.18 -9.45 86.59 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.284 -0.871 . . . . 61.51 112.332 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.35 24.0 32.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.25 -0.5 . . . . 72.3 113.129 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -99.59 133.45 43.89 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 122.532 -0.393 . . . . 74.22 110.425 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -88.12 173.4 8.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.582 0.23 . . . . 74.21 111.304 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.8 -45.74 63.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.057 1.343 . . . . 71.43 113.701 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.3 m -62.69 -41.57 99.18 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.607 0.763 . . . . 74.5 110.42 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.56 -38.37 89.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.415 -0.811 . . . . 74.41 110.585 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.4 HD11 ' CB ' ' A' ' 88' ' ' LEU . 7.1 mm -61.3 -47.3 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.742 -1.207 . . . . 75.12 107.742 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.499 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 76.2 mtm -74.17 -15.48 61.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.311 -1.313 . . . . 73.5 113.649 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -56.98 -65.77 0.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.879 -0.415 . . . . 75.45 109.879 177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.415 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.4 p-90 -69.07 -32.81 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.68 0.622 . . . . 75.43 112.68 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 125' ' ' PRO . 13.4 mt -60.79 -40.8 93.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.177 0.806 . . . . 74.2 113.177 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -87.76 -9.38 54.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 112.561 0.578 . . . . 73.54 112.561 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 m -88.04 122.9 69.72 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 108.781 -0.822 . . . . 75.21 108.781 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.76 129.55 35.61 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.639 1.559 . . . . 73.34 108.98 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.8 t70 -90.21 121.08 69.02 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.386 -0.598 . . . . 62.4 109.386 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.55 -16.67 49.46 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.282 2.654 . . . . 72.02 113.74 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -110.98 6.79 21.29 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 121.949 -0.469 . . . . 74.21 111.076 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.426 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.0 tp -102.87 126.06 49.86 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.727 -0.789 . . . . 74.34 111.209 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -126.3 118.23 24.67 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.652 -1.981 . . . . 75.54 105.652 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 CA--C 1.48 -1.729 0 O-C-N 123.34 0.4 . . . . 72.45 111.678 -174.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 107.774 -1.195 . . . . 72.4 107.774 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 p -87.85 146.64 25.49 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.455 0.472 . . . . 75.25 110.3 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 2.9 m-20 61.81 68.32 0.7 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.576 1.15 . . . . 72.22 111.377 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -119.52 170.5 9.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.948 -1.024 . . . . 64.4 110.965 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -78.03 134.22 64.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 116.001 -0.545 . . . . 74.11 109.745 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.5 ' HB2' HD23 ' A' ' 102' ' ' LEU . 73.7 Cg_exo -56.34 -28.48 72.44 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.171 1.914 . . . . 73.53 111.488 172.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.563 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 51.4 t -66.2 -34.43 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.623 0.725 . . . . 74.14 109.622 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.93 -32.37 70.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.69 -0.856 . . . . 74.44 108.69 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.5 75.36 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 114.942 -1.027 . . . . 71.33 112.519 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.83 -36.58 78.38 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.139 -0.624 . . . . 74.52 111.49 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.411 ' N ' HD11 ' A' ' 129' ' ' LEU . 9.4 t-160 -77.71 -15.58 59.05 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.732 0.777 . . . . 73.21 108.939 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -87.78 4.68 43.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 42.42 110.139 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.5 m80 63.7 27.72 14.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.594 1.158 . . . . 74.41 111.307 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -106.71 26.19 10.31 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.267 -1.333 . . . . 63.44 110.886 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -51.51 -28.56 13.9 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 114.156 -1.383 . . . . 73.44 113.665 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -39.44 86.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.029 0.831 . . . . 73.42 111.82 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.408 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -63.98 -32.88 74.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.383 0.611 . . . . 74.43 110.087 177.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.97 -48.11 51.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.331 -0.849 . . . . 73.22 109.311 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 134' ' ' ALA . 86.6 t -60.47 -44.5 96.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 CA-C-N 115.715 -0.675 . . . . 64.15 110.994 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.408 ' NH2' ' HG3' ' A' ' 136' ' ' GLU . 14.8 ptt180 -63.84 -37.99 89.44 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.336 -0.546 . . . . 74.43 112.247 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -64.27 -39.81 94.7 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.76 -0.376 . . . . 75.4 110.35 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.46 -46.5 89.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.696 -0.684 . . . . 74.44 110.379 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.99 -45.45 94.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.706 -0.679 . . . . 74.24 110.757 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.93 65.24 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.494 . . . . 74.52 111.687 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.3 tpp -83.33 -41.25 18.46 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.346 0.594 . . . . 72.41 110.021 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.4 -52.18 7.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.098 -0.501 . . . . 71.33 112.314 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--N 1.307 -1.24 0 CA-C-N 116.648 -0.251 . . . . 73.11 110.333 -175.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 N-CA-C 110.092 -0.336 . . . . 75.45 110.092 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.58 -88.97 1.08 Allowed Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.937 -0.574 . . . . 73.11 112.671 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -121.37 126.07 48.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.805 0.336 . . . . 65.31 111.172 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 23' ' ' LEU . 12.5 t0 -80.4 142.14 34.65 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.548 -0.751 . . . . 74.41 111.361 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.42 -9.56 10.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 C-N-CA 123.679 0.792 . . . . 73.43 110.155 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.406 HD11 ' CG2' ' A' ' 29' ' ' THR . 40.2 mt -64.66 159.69 21.49 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 122.43 1.109 . . . . 75.45 113.663 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.6 t70 -80.23 138.16 52.48 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 105.799 -1.926 . . . . 72.44 105.799 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.68 -28.75 17.92 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.274 2.649 . . . . 75.41 115.452 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.18 23.17 11.09 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.161 0.8 . . . . 75.32 113.161 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 4.5 tp10 -73.83 143.43 81.38 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 105.191 -2.152 . . . . 73.55 105.191 173.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -39.68 107.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.945 3.097 . . . . 64.33 112.373 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.406 ' CG2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -129.72 167.14 18.5 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.612 -0.722 . . . . 73.03 112.7 -174.256 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 26.0 m-85 -130.9 160.28 34.94 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.286 -1.376 . . . . 74.02 107.286 172.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.46 ' O ' HG22 ' A' ' 35' ' ' VAL . 7.2 m-20 -134.91 159.73 40.49 Favored 'General case' 0 C--N 1.264 -3.121 0 N-CA-C 102.978 -2.971 . . . . 72.5 102.978 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.0 mt -48.47 -56.61 13.74 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 114.556 1.317 . . . . 73.24 114.556 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.89 -30.97 67.82 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.525 1.483 . . . . 73.23 112.284 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 17.7 tpt180 -70.41 -34.9 73.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.037 0.535 . . . . 75.42 109.69 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 31' ' ' ASP . 57.8 t -69.31 -39.81 79.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 109.067 -0.716 . . . . 73.32 109.067 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.72 82.39 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.719 -1.128 . . . . 71.25 109.374 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.38 -45.67 79.29 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.37 1.068 . . . . 71.22 110.54 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -60.76 -49.03 79.13 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.577 -0.738 . . . . 75.44 111.693 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -88.89 -18.05 28.35 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.788 -0.642 . . . . 71.34 111.448 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.13 76.99 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 111.229 -0.748 . . . . 72.32 111.229 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 m -104.14 162.12 20.86 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 108.417 -0.957 . . . . 75.3 108.417 -176.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.6 160.13 38.49 Favored 'Trans proline' 0 C--O 1.262 1.698 0 C-N-CA 120.931 1.088 . . . . 72.44 111.249 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.71 -32.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.747 0.784 . . . . 75.11 109.84 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 7.8 p -59.04 -37.68 77.53 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.933 -1.03 . . . . 52.53 111.758 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 19.4 ttmm -69.93 -32.89 71.41 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.408 -0.517 . . . . 73.55 110.553 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.41 -42.04 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.536 -0.913 . . . . 73.25 108.536 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -62.18 -36.53 82.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.582 -0.735 . . . . 65.52 110.399 175.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.1 mt-30 -64.94 -36.29 83.91 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.433 0.293 . . . . 74.21 110.973 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.1 mm-40 -60.46 -46.61 89.46 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.102 -1.073 . . . . 71.51 108.102 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.31 -38.59 89.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.55 -1.205 . . . . 75.31 110.36 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 47' ' ' ALA . 14.6 mmm180 -65.61 -28.81 69.39 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.696 0.628 . . . . 74.32 112.696 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.67 -1.48 30.04 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.604 0.594 . . . . 71.34 112.604 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.69 36.6 83.14 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 110.672 -0.971 . . . . 74.25 110.672 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -96.32 -20.19 18.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.396 -0.594 . . . . 72.13 109.396 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 42.1 tp -159.84 153.38 22.5 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.252 -1.388 . . . . 71.32 107.252 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.31 161.67 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 O-C-N 123.253 0.346 . . . . 73.44 110.572 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.96 159.71 39.89 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.538 -0.756 . . . . 74.45 109.084 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' A' ' 99' ' ' MET . 6.7 m -130.68 166.96 26.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 123.972 0.909 . . . . 74.13 109.746 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -114.02 115.81 28.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 121.119 -0.232 . . . . 73.31 111.608 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.526 ' NE ' HG12 ' A' ' 65' ' ' VAL . 36.6 ptt180 -120.65 136.36 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.928 -1.138 . . . . 75.15 107.928 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 49.36 30.3 3.2 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.421 1.088 . . . . 65.11 113.826 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.96 57.91 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.288 -0.482 . . . . 73.14 113.023 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.2 152.04 20.26 Favored Glycine 0 CA--C 1.496 -1.134 0 N-CA-C 111.28 -0.728 . . . . 73.21 111.28 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -97.62 120.38 46.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.369 -1.345 . . . . 72.51 107.369 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.526 HG12 ' NE ' ' A' ' 60' ' ' ARG . 24.2 m -134.81 164.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.816 -0.629 . . . . 73.3 111.373 -171.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.6 mt -132.48 131.41 22.23 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.541 -1.651 . . . . 64.21 106.541 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 70' ' ' PHE . 23.4 Cg_exo -60.73 135.66 61.56 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.619 1.546 . . . . 74.12 111.221 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -68.66 -31.19 70.13 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.77 0.795 . . . . 75.25 109.353 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.5 m -68.44 -3.67 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 114.201 -1.363 . . . . 74.43 111.881 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -86.17 -11.01 53.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.942 0.877 . . . . 64.55 109.032 177.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.53 161.39 14.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.917 -1.038 . . . . 73.43 108.204 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.7 p -75.8 161.03 29.36 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.189 -0.671 . . . . 72.4 109.189 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -59.63 -17.36 32.87 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.324 0.49 . . . . 74.4 112.324 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.3 m -94.63 -0.94 54.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 116.068 -0.515 . . . . 73.15 111.86 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.08 69.32 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.855 -0.688 . . . . 52.31 114.204 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.02 156.86 16.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.556 -0.905 . . . . 74.11 108.556 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.56 138.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.47 -1.307 . . . . 74.33 107.47 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 92.9 t -62.56 131.52 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.138 -0.689 . . . . 75.51 109.138 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.626 0.602 . . . . 74.15 112.626 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.2 t -88.15 12.15 14.46 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.391 -0.523 . . . . 64.23 111.417 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.56 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.3 tt -65.93 -54.83 25.31 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.519 -0.548 . . . . 75.3 109.519 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.93 -31.78 90.58 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.766 1.644 . . . . 75.25 110.924 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.11 -44.59 97.01 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.444 -0.798 . . . . 75.22 112.294 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.12 -40.38 82.51 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.851 -0.796 . . . . 72.24 108.851 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.02 -36.7 77.81 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.927 -0.578 . . . . 75.24 110.66 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.0 m -60.59 -49.72 76.41 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.864 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -45.35 91.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.457 -0.338 . . . . 74.33 111.906 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.42 -38.56 84.77 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.348 0.87 . . . . 74.11 113.348 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -66.19 -35.14 79.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.538 -0.541 . . . . 63.4 109.538 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.91 -30.71 64.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.973 -0.558 . . . . 72.42 110.396 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.55 -9.33 83.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 112.09 -0.404 . . . . 70.52 112.09 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.97 39.97 12.4 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 121.809 -0.234 . . . . 73.0 113.196 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.59 126.39 52.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.915 0.388 . . . . 74.32 110.749 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.465 ' O ' HG12 ' A' ' 98' ' ' ILE . 12.0 ptm180 -85.39 173.86 9.97 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.656 . . . . 73.32 111.686 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -52.63 -44.01 65.79 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.355 1.862 . . . . 75.31 111.744 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -61.43 -41.02 96.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 123.859 0.864 . . . . 73.31 110.567 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -64.64 -44.55 90.09 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.152 -0.931 . . . . 74.23 108.938 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 94' ' ' ARG . 16.4 mm -60.61 -48.41 88.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 115.431 -0.804 . . . . 72.24 109.262 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.41 ' HG3' HG12 ' A' ' 58' ' ' VAL . 24.6 mmt -68.06 -27.19 66.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 75.01 111.731 -176.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -58.88 -64.95 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 111.609 0.226 . . . . 72.42 111.609 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.425 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 33.2 p-90 -68.45 -32.01 71.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.298 0.481 . . . . 75.5 112.298 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.596 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . 11.5 mt -60.46 -40.14 90.14 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 113.014 0.746 . . . . 75.54 113.014 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.508 ' CE1' HG21 ' A' ' 126' ' ' VAL . 70.9 m-85 -95.63 -1.39 50.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.175 0.806 . . . . 75.42 113.175 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.5 m -88.2 116.0 64.88 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.971 -0.752 . . . . 73.45 108.971 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -52.85 129.55 33.37 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.817 2.345 . . . . 72.43 111.572 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.39 125.7 58.99 Favored Pre-proline 0 C--N 1.304 -1.386 0 CA-C-N 115.908 -0.587 . . . . 73.01 110.702 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HA ' HD21 ' A' ' 122' ' ' ASN . 22.9 Cg_endo -60.75 -27.96 85.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.295 2.663 . . . . 73.25 113.591 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 m -99.84 6.86 45.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 120.807 0.337 . . . . 70.04 111.088 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.3 tp -102.47 120.09 39.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.924 0.868 . . . . 75.13 111.568 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.7 m -132.14 110.88 10.99 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 105.548 -2.019 . . . . 75.43 105.548 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 CA--C 1.472 -2.025 0 N-CA-C 114.026 1.121 . . . . 71.22 114.026 -173.934 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 108.372 -0.973 . . . . 61.22 108.372 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.8 m -90.8 138.12 31.83 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.904 -0.589 . . . . 74.33 109.901 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.418 HD21 ' HA ' ' A' ' 107' ' ' PRO . 23.7 t-20 64.11 59.09 1.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.482 1.134 . . . . 74.31 110.032 176.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.23 161.64 13.6 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.493 -1.231 . . . . 72.21 108.739 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -87.07 139.92 32.58 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.438 -1.319 . . . . 74.13 107.438 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.406 ' HB2' HD23 ' A' ' 102' ' ' LEU . 93.2 Cg_exo -49.66 -29.85 20.62 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 123.319 2.679 . . . . 71.32 114.812 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 24.8 t -67.37 -36.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.438 -0.789 . . . . 75.0 110.562 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.07 -30.67 67.98 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.888 -1.153 . . . . 74.13 107.888 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.34 83.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.426 -1.261 . . . . 74.25 111.097 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -68.26 -33.39 74.27 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 121.939 -0.475 . . . . 74.22 110.806 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -63.86 -34.38 77.8 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 108.155 -1.054 . . . . 75.13 108.155 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.13 10.46 21.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.351 -1.295 . . . . 71.24 111.999 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 68.2 27.97 6.6 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.325 1.05 . . . . 62.11 112.536 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -106.43 24.17 12.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.054 -1.091 . . . . 72.33 108.054 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 138' ' ' VAL . . . -53.17 -30.58 38.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.685 1.194 . . . . 53.22 113.911 -173.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.01 -38.51 79.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.815 0.34 . . . . 75.24 111.187 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.24 -30.32 69.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.677 . . . . 72.1 109.508 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -71.39 -44.93 71.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.917 -1.038 . . . . 71.52 110.025 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 47.4 t -61.3 -42.98 95.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.604 0.716 . . . . 74.54 109.402 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -60.38 -38.78 85.01 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.068 -0.969 . . . . 71.14 111.611 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -37.93 83.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.251 -1.018 . . . . 74.14 108.251 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.7 -42.45 97.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.424 -0.807 . . . . 72.22 111.05 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 74.4 mt-30 -59.03 -41.86 88.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 73.32 110.31 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.89 81.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 72.21 111.604 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 tpp -76.14 -27.56 57.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.647 0.737 . . . . 72.41 111.014 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.0 -47.24 11.93 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.745 -0.597 . . . . 74.04 111.747 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 C--N 1.31 -1.109 0 N-CA-C 109.209 -0.663 . . . . 75.52 109.209 -177.707 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.445 0 N-CA-C 110.415 -0.217 . . . . 75.4 110.415 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.457 ' HA3' ' NH2' ' A' ' 94' ' ' ARG . . . -109.7 -115.81 3.76 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.593 -0.813 . . . . 52.12 114.376 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.22 128.29 40.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.463 0.542 . . . . 75.45 112.463 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.46 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 7.3 t70 -65.23 120.11 12.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.872 -1.058 . . . . 65.32 111.239 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.58 -32.05 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 112.661 0.615 . . . . 75.14 112.661 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.41 HD23 ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -82.96 159.96 22.14 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 114.199 1.185 . . . . 71.21 114.199 -174.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.0 t70 -60.45 146.62 84.41 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.699 -1.137 . . . . 72.34 110.797 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.49 -36.73 40.35 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.568 2.845 . . . . 74.31 115.898 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.9 11.43 39.3 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 114.433 1.272 . . . . 65.31 114.433 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 7.7 mm-40 -68.18 144.57 96.94 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.324 -0.621 . . . . 63.12 109.324 173.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.91 128.85 28.1 Favored 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 122.822 2.348 . . . . 74.21 112.544 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.7 p -130.23 166.17 20.87 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.056 -0.52 . . . . 73.11 111.313 -176.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -131.45 160.19 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 125.55 1.54 . . . . 70.13 108.422 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.5 p-10 -135.6 159.38 41.8 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 106.121 -1.807 . . . . 64.4 106.121 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.0 mt -46.68 -56.87 10.15 Favored Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 114.738 1.385 . . . . 74.44 114.738 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.31 -35.76 96.14 Favored 'Trans proline' 0 C--N 1.366 1.476 0 CA-C-N 120.465 1.202 . . . . 73.24 112.67 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -69.56 -37.5 77.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.924 -0.398 . . . . 72.32 109.924 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 31' ' ' ASP . 60.8 t -69.8 -40.37 78.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.519 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.69 80.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.135 0.969 . . . . 73.41 109.167 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.17 -45.53 73.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.985 -1.462 . . . . 72.25 109.985 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.26 -44.1 89.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 64.11 111.551 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.2 mt -84.38 -19.01 34.29 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 111.901 0.334 . . . . 73.43 111.901 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.28 65.31 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.54 -0.838 . . . . 71.21 111.989 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.0 152.15 77.0 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 108.73 -0.841 . . . . 75.22 108.73 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.98 163.25 29.16 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 122.304 2.003 . . . . 74.22 112.927 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.34 -33.38 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.189 0.996 . . . . 74.21 111.371 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 10.7 p -58.39 -46.15 86.93 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.465 -0.789 . . . . 72.01 111.493 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 mttp -68.93 -36.36 77.9 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.664 -0.244 . . . . 75.02 111.636 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.76 -48.14 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 72.14 109.537 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.754 -0.657 . . . . 64.04 110.463 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 44' ' ' SER . 15.7 mm100 -62.42 -36.44 82.37 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.292 0.479 . . . . 73.52 112.292 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 91.8 mt-30 -63.34 -50.72 68.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.676 0.75 . . . . 74.32 108.995 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.35 -41.4 98.57 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.233 -1.349 . . . . 62.42 111.684 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -63.59 -27.48 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.788 0.292 . . . . 74.24 111.788 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -92.1 -0.36 57.45 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.762 0.315 . . . . 75.22 111.596 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.16 38.31 63.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.798 -0.637 . . . . 52.11 112.501 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -95.06 -15.36 23.5 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.07 -0.715 . . . . 75.22 109.07 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -157.74 152.91 25.76 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.106 -2.183 . . . . 75.31 105.106 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 m -132.1 161.6 41.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 122.609 0.364 . . . . 53.1 110.175 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.32 163.36 32.99 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.061 0.545 . . . . 74.54 109.6 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.71 160.48 34.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 123.427 0.455 . . . . 64.54 110.47 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -113.9 120.92 42.36 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.494 0.664 . . . . 73.33 111.256 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HD2' ' OD1' ' A' ' 21' ' ' ASP . 12.3 ptm180 -142.69 134.95 27.5 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.931 -1.031 . . . . 71.33 108.939 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.65 23.67 13.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.909 0.883 . . . . 52.1 111.406 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.71 5.71 89.64 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.156 -0.545 . . . . 72.4 112.207 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.17 143.64 18.03 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 111.355 -0.698 . . . . 73.22 111.355 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.27 120.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.921 -1.14 . . . . 72.4 107.921 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.78 158.48 41.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.968 -0.56 . . . . 75.54 110.754 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 35' ' ' VAL . 71.3 mt -114.86 132.06 23.15 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.106 -1.072 . . . . 73.43 108.106 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.98 126.12 20.15 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.877 1.718 . . . . 73.02 110.477 173.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.8 tt0 -60.58 -25.21 66.04 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.315 0.646 . . . . 74.03 112.467 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.82 -2.77 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-N 115.681 -0.691 . . . . 75.33 112.65 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.615 ' CD2' HD12 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.38 -2.62 58.59 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.95 0.881 . . . . 74.14 110.026 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -119.61 163.9 16.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.119 -0.946 . . . . 72.33 109.089 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 p -94.78 162.25 13.84 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.588 -0.893 . . . . 70.52 108.588 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.22 -16.55 63.65 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.335 0.588 . . . . 73.23 110.488 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -79.73 -8.32 59.17 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.699 -0.682 . . . . 70.42 110.487 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.72 64.2 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.851 -0.69 . . . . 71.31 112.23 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -108.6 154.01 22.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.438 -0.578 . . . . 74.32 109.438 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -71.34 140.53 18.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.793 -1.188 . . . . 73.34 107.793 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.02 129.22 27.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.934 -1.135 . . . . 64.51 107.934 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -63.69 -28.99 70.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.145 0.424 . . . . 72.23 112.145 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 m -77.77 -6.51 54.3 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.939 -0.573 . . . . 75.3 110.886 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.615 HD12 ' CD2' ' A' ' 70' ' ' PHE . 9.7 tp -64.91 -57.25 16.56 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.384 -0.371 . . . . 73.15 111.882 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.29 -29.03 79.43 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.181 1.254 . . . . 71.23 111.244 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -44.59 93.8 Favored Glycine 0 C--O 1.245 0.832 0 CA-C-N 115.964 -0.562 . . . . 65.43 112.598 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.96 -40.53 83.18 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.38 -0.6 . . . . 72.52 109.38 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.32 -37.57 86.1 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 74.21 110.659 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.9 m -57.45 -47.51 81.63 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 116.239 -0.437 . . . . 63.03 111.582 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.437 HG21 HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -67.95 -41.96 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 120.386 -0.525 . . . . 73.13 111.556 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.437 HD23 HG21 ' A' ' 87' ' ' ILE . 3.5 mm? -67.51 -39.32 85.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.804 0.668 . . . . 75.33 112.804 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -66.5 -33.76 76.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.052 0.453 . . . . 75.32 110.085 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.92 -26.2 65.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.537 -0.756 . . . . 72.31 110.142 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.91 -3.36 73.7 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.829 -0.623 . . . . 63.03 112.016 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.42 33.45 25.46 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.197 -0.525 . . . . 71.32 113.123 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -90.75 159.38 16.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.882 0.372 . . . . 75.35 111.497 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.457 ' NH2' ' HA3' ' A' ' 19' ' ' GLY . 12.0 ptm180 -111.85 171.14 7.67 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.924 -0.58 . . . . 74.41 109.832 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -53.94 -45.87 71.38 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.442 1.897 . . . . 73.14 112.46 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.6 m -61.88 -41.67 98.16 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.275 -0.875 . . . . 71.43 110.418 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.06 -36.15 81.39 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.587 -0.733 . . . . 71.33 111.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.2 mm -61.24 -47.66 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.121 -1.066 . . . . 72.1 108.121 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.407 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 56.3 mtt -73.35 -21.5 60.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.596 -1.183 . . . . 71.14 111.779 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -57.69 -63.37 1.26 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.031 0.443 . . . . 73.43 110.315 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -69.99 -32.38 70.56 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.02 0.748 . . . . 74.51 113.02 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 125' ' ' PRO . 15.3 mt -59.0 -40.73 85.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.585 0.957 . . . . 73.21 113.585 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.41 ' CE2' HD23 ' A' ' 23' ' ' LEU . 50.5 m-85 -89.14 -16.83 30.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.958 0.725 . . . . 75.5 112.958 -176.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.9 m -87.51 118.28 69.63 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.435 -0.348 . . . . 74.55 110.243 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -55.65 129.78 36.91 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.857 2.371 . . . . 72.4 111.359 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.2 t70 -96.73 127.12 40.52 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.866 -0.42 . . . . 75.33 109.866 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 -20.25 61.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.554 2.836 . . . . 73.53 114.423 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.1 p -111.53 6.94 20.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.107 0.48 . . . . 74.14 112.122 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 tp -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.23 0.538 . . . . 74.54 110.107 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -118.95 122.56 42.51 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.885 -0.783 . . . . 75.51 108.885 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 109.432 -0.581 . . . . 74.5 109.432 -174.272 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 109.368 -0.604 . . . . 75.01 109.368 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -87.28 141.42 28.66 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.767 -0.827 . . . . 72.14 108.767 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.3 t30 68.22 70.3 0.32 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.937 0.875 . . . . 64.41 110.806 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.39 173.64 8.28 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 107.762 -1.199 . . . . 75.14 107.762 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 3.5 ptp180 -91.59 137.25 25.86 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.557 . . . . 73.54 109.758 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.485 ' HB2' HD21 ' A' ' 102' ' ' LEU . 84.1 Cg_exo -49.75 -22.44 6.98 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.71 2.94 . . . . 71.13 114.552 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.566 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -60.43 -39.0 79.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 120.87 0.367 . . . . 75.21 110.297 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -63.31 -37.12 86.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.315 0.579 . . . . 64.25 109.695 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.69 76.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.237 -0.892 . . . . 74.33 112.063 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.44 -35.58 80.65 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.644 -0.422 . . . . 74.54 111.408 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -76.02 -20.8 57.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.391 0.615 . . . . 72.31 109.455 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.85 4.61 51.59 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.335 0.865 . . . . 74.02 113.335 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.31 38.74 4.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 123.581 1.658 . . . . 75.45 109.283 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -120.36 23.89 10.66 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.75 -1.574 . . . . 73.5 106.75 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.62 -28.05 30.45 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 112.648 -2.069 . . . . 63.32 112.756 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -55.43 -40.38 71.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.801 0.334 . . . . 75.14 110.915 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.33 -27.98 63.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.171 0.51 . . . . 73.11 110.919 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.72 -48.58 45.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.375 -0.972 . . . . 73.24 108.375 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.52 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 63.5 t -59.2 -41.54 84.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-N 115.007 -0.997 . . . . 73.33 109.176 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -57.15 -45.89 83.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.609 0.764 . . . . 75.13 111.264 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.8 tpp180 -65.89 -39.31 90.51 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.723 -0.473 . . . . 73.45 109.723 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.99 94.15 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.999 -0.546 . . . . 75.51 110.525 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 83.6 mm-40 -57.46 -46.61 83.45 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 123.353 0.661 . . . . 75.1 110.032 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.9 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 74.24 111.551 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.2 mmm -78.48 -37.39 43.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.353 -0.385 . . . . 75.41 111.407 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.8 19.59 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 112.789 0.663 . . . . 63.54 112.789 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 C--N 1.308 -1.239 0 CA-C-O 118.418 -0.801 . . . . 72.22 109.646 -176.498 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.284 0 CA-C-O 120.895 0.379 . . . . 74.01 110.084 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.41 ' O ' ' HD3' ' A' ' 59' ' ' ARG . . . -94.76 -85.15 1.66 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 115.726 -0.67 . . . . 73.31 111.64 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.62 150.09 47.14 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 120.877 0.37 . . . . 75.43 110.321 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.69 161.94 18.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.931 -0.766 . . . . 72.34 108.931 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 22' ' ' VAL . 23.9 t -121.29 13.79 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 123.345 1.545 . . . . 72.22 109.662 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.89 -172.41 2.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.26 -0.882 . . . . 72.01 110.69 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.26 138.01 20.13 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 105.25 -2.13 . . . . 74.22 105.25 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.16 -21.61 22.82 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.658 2.238 . . . . 72.13 114.448 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.57 -16.05 57.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.076 0.398 . . . . 70.13 112.076 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -61.93 141.8 95.36 Favored Pre-proline 0 C--O 1.251 1.134 0 O-C-N 122.089 -0.382 . . . . 75.5 110.31 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.55 117.66 4.21 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.843 2.362 . . . . 73.5 111.1 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.37 161.94 33.18 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 115.369 -0.832 . . . . 75.41 111.519 -176.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -112.89 159.94 18.54 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.611 -1.177 . . . . 74.25 109.058 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.0 m-20 -134.74 169.16 17.77 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.004 -2.221 . . . . 71.55 105.004 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.87 -55.73 35.39 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 113.489 0.922 . . . . 74.33 113.489 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.26 -32.71 90.47 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.881 1.721 . . . . 73.51 112.381 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.435 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 20.7 tpt180 -68.53 -40.79 80.59 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.973 0.509 . . . . 74.15 110.683 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 31' ' ' ASP . 77.1 t -69.0 -37.71 77.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.498 -0.556 . . . . 74.11 109.498 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.84 85.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.327 -0.851 . . . . 73.04 109.659 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.37 -46.7 72.56 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.181 -0.918 . . . . 74.23 109.52 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.79 -50.32 63.05 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.051 -0.977 . . . . 64.32 112.269 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.405 ' HB2' HG21 ' A' ' 41' ' ' VAL . 91.9 mt -82.85 -18.61 39.77 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.495 -0.482 . . . . 73.21 111.357 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.66 30.1 58.56 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.677 -0.969 . . . . 65.42 110.677 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 39' ' ' LEU . 28.0 m -120.94 159.04 50.71 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 109.543 -0.54 . . . . 74.44 109.543 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.54 163.16 39.93 Favored 'Trans proline' 0 C--O 1.256 1.404 0 C-N-CA 122.011 1.807 . . . . 74.25 111.543 174.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.24 -32.37 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.419 0.688 . . . . 75.13 110.359 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 33.1 t -57.32 -43.12 83.02 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.751 -0.659 . . . . 74.31 110.4 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.25 -32.77 72.2 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 111.742 0.275 . . . . 75.55 111.742 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.77 -45.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.056 -0.72 . . . . 73.1 109.056 175.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.98 78.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.464 -0.789 . . . . 74.13 110.777 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 44' ' ' SER . 93.0 mt-30 -61.68 -43.47 98.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.262 -0.426 . . . . 73.14 111.334 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -60.12 -49.63 76.89 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 121.901 0.857 . . . . 72.43 109.043 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.23 -42.46 99.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.078 -1.419 . . . . 74.4 111.278 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.15 -22.33 62.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.109 0.781 . . . . 74.31 113.109 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -102.09 5.0 40.22 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.112 -1.035 . . . . 75.0 111.396 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.59 37.31 68.14 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 115.423 -0.808 . . . . 52.21 112.243 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -95.67 -13.81 23.96 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.546 0.689 . . . . 75.53 109.36 176.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.9 tp -160.66 152.77 20.19 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.693 -1.965 . . . . 74.33 105.693 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 p -133.58 151.38 33.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.204 -0.665 . . . . 75.14 109.204 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 154.94 36.42 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 123.518 0.511 . . . . 75.32 109.737 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.62 169.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 123.711 0.804 . . . . 75.32 111.165 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 24.3 ttt-85 -107.3 121.34 44.37 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.135 -0.691 . . . . 73.42 109.135 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' CZ ' HG11 ' A' ' 65' ' ' VAL . 49.3 ttp180 -115.4 112.81 22.89 Favored 'General case' 0 CA--C 1.482 -1.667 0 CA-C-N 114.225 -1.352 . . . . 74.42 107.61 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.58 -51.68 0.23 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.92 1.688 . . . . 72.32 112.473 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . -178.54 15.15 0.03 OUTLIER Glycine 0 C--N 1.29 -2.01 0 CA-C-N 114.931 -1.031 . . . . 74.24 112.147 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.35 154.96 19.74 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 110.691 -0.963 . . . . 74.22 110.691 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -96.89 120.12 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.781 -1.192 . . . . 75.52 107.781 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 60' ' ' ARG . 16.9 m -137.21 164.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.745 -0.661 . . . . 74.13 111.82 -172.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.61 123.98 26.28 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 107.011 -1.478 . . . . 75.44 107.011 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.84 143.44 91.68 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.43 2.086 . . . . 70.24 114.063 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -48.81 -41.99 34.55 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.313 1.045 . . . . 72.04 111.196 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -65.54 -7.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.48 -1.236 . . . . 65.24 113.911 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.3 m-85 -88.5 -5.02 58.48 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.873 0.844 . . . . 74.0 110.515 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -117.41 159.29 23.02 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.028 -0.987 . . . . 74.31 108.611 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -86.88 175.69 8.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.829 -0.804 . . . . 65.01 108.829 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -63.3 -22.08 66.65 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.333 0.587 . . . . 75.33 110.623 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.3 t -79.52 -10.51 59.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.299 -0.409 . . . . 74.41 110.615 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.64 38.85 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.572 -0.823 . . . . 74.23 111.215 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 151.63 37.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.597 -1.26 . . . . 74.42 107.597 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.46 131.47 34.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.731 -0.84 . . . . 74.42 108.731 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 44.4 t -57.78 125.96 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.323 -0.621 . . . . 74.22 109.323 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 61.1 tttp -61.5 -36.44 80.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.285 0.564 . . . . 72.15 112.281 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -85.19 -5.16 59.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.307 -0.406 . . . . 73.01 111.734 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD11 ' CD2' ' A' ' 70' ' ' PHE . 8.1 tt -66.09 -48.16 60.53 Favored Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 112.894 0.701 . . . . 71.51 112.894 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 74.1 Cg_exo -54.09 -30.57 60.82 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.047 1.831 . . . . 64.33 111.511 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.6 -41.46 99.81 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.473 -0.785 . . . . 72.53 112.207 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.37 -40.45 81.43 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.081 -0.711 . . . . 74.4 109.081 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.52 -39.96 92.9 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.907 -0.588 . . . . 73.25 110.339 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.2 m -57.77 -47.5 82.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 116.144 -0.48 . . . . 75.55 111.662 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -42.93 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 120.943 -0.303 . . . . 74.32 111.697 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.64 -37.44 84.82 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.465 0.543 . . . . 74.31 112.465 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -65.74 -32.86 74.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.893 0.377 . . . . 71.42 110.344 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.86 -30.23 69.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.231 0.539 . . . . 64.54 110.272 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.5 -9.33 75.77 Favored Glycine 0 C--O 1.242 0.655 0 CA-C-N 115.579 -0.737 . . . . 52.53 113.039 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.97 33.05 11.37 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.539 -0.363 . . . . 73.21 112.971 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -98.74 129.8 45.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 122.471 -0.429 . . . . 75.41 111.42 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -87.24 174.24 8.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.702 -0.681 . . . . 75.13 110.881 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.67 -45.9 66.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.925 1.69 . . . . 71.21 112.208 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.583 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 29.3 m -64.92 -41.28 95.69 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 116.031 -0.531 . . . . 60.13 109.589 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -61.72 -42.28 98.74 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.025 -0.989 . . . . 65.34 111.077 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.95 -47.6 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.626 -0.879 . . . . 75.24 108.626 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.508 ' HE2' ' CZ ' ' A' ' 70' ' ' PHE . 51.2 mtt -74.34 -17.56 60.81 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 113.736 1.013 . . . . 75.15 113.736 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 96' ' ' THR . 83.8 mtp180 -55.84 -65.0 0.67 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.877 0.37 . . . . 74.23 111.353 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.516 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 p-90 -68.75 -31.93 71.32 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.358 0.503 . . . . 75.13 112.358 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.4 mt -66.34 -39.87 89.48 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.126 1.158 . . . . 71.1 114.126 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -90.62 -12.03 38.15 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.596 1.332 . . . . 75.2 114.596 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -74.67 114.15 31.41 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 123.817 0.698 . . . . 75.2 109.731 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.94 132.56 35.1 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.713 2.276 . . . . 75.4 110.551 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 16.5 t0 -118.61 117.99 33.87 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 116.299 -0.41 . . . . 72.24 111.298 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.53 -24.92 79.49 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.225 2.616 . . . . 70.34 111.889 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -78.58 -10.06 59.59 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.555 -0.748 . . . . 64.34 110.143 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.9 tp -110.29 129.22 55.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.429 0.633 . . . . 74.34 110.609 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -119.02 125.04 48.43 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.31 -0.996 . . . . 74.53 108.31 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.8 mt . . . . . 0 C--N 1.311 -1.104 0 CA-C-N 115.994 -0.548 . . . . 72.25 110.227 -172.312 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 109.183 -0.673 . . . . 71.11 109.183 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.4 m -90.28 142.95 27.22 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.71 -0.848 . . . . 60.12 108.71 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.2 t30 74.36 72.26 0.11 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.272 0.982 . . . . 72.44 110.381 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.44 172.82 8.42 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.625 -1.62 . . . . 63.4 106.625 171.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.49 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 8.0 ptp180 -92.82 143.79 27.51 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.111 -1.44 . . . . 73.34 107.111 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.28 -25.6 10.09 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.313 2.675 . . . . 72.45 114.897 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.552 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.8 t -63.96 -32.33 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.331 -0.548 . . . . 65.33 110.113 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.49 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 10.5 m-20 -60.45 -30.84 69.92 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.254 -0.43 . . . . 74.52 110.415 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.5 -43.88 72.19 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.883 -0.599 . . . . 60.41 111.092 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -70.18 -33.98 72.41 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.932 -0.48 . . . . 74.43 111.099 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -67.53 -19.53 65.31 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 122.15 0.976 . . . . 73.14 109.238 176.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.94 9.44 32.66 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.924 -1.034 . . . . 74.12 111.838 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.9 m80 61.77 28.47 17.5 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.911 0.862 . . . . 72.25 112.249 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -106.3 25.11 11.47 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.827 1.651 . . . . 72.54 107.512 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.2 -26.87 12.7 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 126.926 2.09 . . . . 75.21 114.237 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -55.69 -37.18 68.01 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.194 0.813 . . . . 74.22 113.194 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -67.54 -32.36 73.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.291 0.567 . . . . 71.55 110.59 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.48 -49.14 68.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.615 -0.883 . . . . 74.42 108.615 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.556 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 67.8 t -58.07 -42.85 83.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 CA-C-N 115.404 -0.817 . . . . 74.12 109.58 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -57.0 -47.47 80.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.72 -0.673 . . . . 65.22 110.822 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -68.79 -34.1 74.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 73.33 111.045 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.71 72.01 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.106 -0.497 . . . . 75.53 110.941 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 15.9 mm100 -59.66 -40.11 86.68 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.028 0.531 . . . . 73.14 110.04 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.02 68.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.424 -0.807 . . . . 42.11 111.257 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.1 tpp -78.04 -47.9 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.904 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.5 -29.29 37.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.543 0.942 . . . . 72.4 113.543 -173.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 C--N 1.312 -1.059 0 CA-C-O 117.989 -1.005 . . . . 75.43 110.038 -179.574 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 106.632 -1.618 . . . . 75.34 106.632 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.88 -118.17 3.11 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.257 -0.973 . . . . 72.2 113.801 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.11 107.1 18.85 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 112.884 0.698 . . . . 72.35 112.884 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.454 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 11.2 t70 -44.69 113.02 0.49 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 126.108 1.763 . . . . 53.3 113.108 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.67 -33.96 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.558 -0.747 . . . . 72.23 111.645 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.406 0.4 OUTLIER -67.18 140.8 57.49 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.283 1.586 . . . . 74.34 115.283 -176.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.36 146.41 84.39 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.222 -1.808 . . . . 71.3 110.993 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.534 ' HA ' HH22 ' A' ' 60' ' ' ARG . 89.9 Cg_exo -50.52 -22.43 9.09 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.409 2.739 . . . . 74.5 115.601 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -97.71 3.53 50.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.942 0.719 . . . . 73.14 112.942 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.42 128.14 76.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.906 -0.776 . . . . 74.32 108.906 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.48 147.09 70.24 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.554 2.169 . . . . 70.12 112.685 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -133.45 173.69 11.21 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.497 0.665 . . . . 75.42 111.645 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 23.2 m-85 -130.25 161.09 31.99 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 126.299 1.84 . . . . 64.44 106.626 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.4 t0 -134.08 167.42 20.68 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.802 -2.296 . . . . 73.53 104.802 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -49.79 -57.0 13.62 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 123.839 0.856 . . . . 75.42 112.999 -172.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.7 -32.25 47.58 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.152 1.234 . . . . 71.34 112.14 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -70.34 -37.74 74.72 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 112.187 0.44 . . . . 75.44 112.187 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 31' ' ' ASP . 58.5 t -67.23 -39.12 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.738 -0.838 . . . . 74.13 108.738 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.89 83.87 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.66 -1.154 . . . . 74.14 110.032 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.04 -43.1 99.59 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.941 0.896 . . . . 72.15 109.814 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 tp -62.16 -50.06 73.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.404 -0.817 . . . . 73.52 111.396 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -86.76 -18.53 30.9 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.038 0.755 . . . . 73.34 113.038 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.01 53.91 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.436 -0.887 . . . . 63.24 110.961 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.09 161.18 46.21 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 107.611 -1.255 . . . . 61.35 107.611 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.63 163.26 31.99 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 121.253 1.302 . . . . 64.34 111.409 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.79 -32.64 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.6 0.714 . . . . 74.23 109.35 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.578 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.1 m -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.723 -1.126 . . . . 74.11 110.606 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.6 mttp -68.94 -32.92 72.87 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.678 -0.409 . . . . 74.3 111.253 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HA ' HE21 ' A' ' 49' ' ' GLN . 61.3 t -62.16 -46.23 96.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.466 -0.568 . . . . 74.45 109.466 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.25 81.29 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.423 -0.808 . . . . 63.42 110.759 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 44' ' ' SER . 29.3 mm-40 -64.35 -37.94 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 62.53 110.772 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.6 mt-30 -68.31 -45.05 74.05 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.896 0.855 . . . . 75.54 109.163 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.86 -45.29 94.43 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.789 -1.551 . . . . 74.22 109.797 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -66.12 -22.28 66.38 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 113.138 0.792 . . . . 65.43 113.138 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.66 11.78 37.24 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.216 -0.994 . . . . 71.11 112.49 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.58 57.48 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.976 -0.63 . . . . 54.11 113.02 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -96.13 -5.74 40.01 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.265 0.555 . . . . 74.13 109.866 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.1 tp -163.42 157.65 20.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.399 -1.704 . . . . 74.14 106.399 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.54 147.05 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 118.393 0.542 . . . . 75.43 109.586 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.59 162.69 19.21 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.346 0.659 . . . . 74.22 110.473 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.44 157.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.001 0.521 . . . . 72.3 110.226 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -110.86 119.07 37.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.204 -0.665 . . . . 73.35 109.204 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.534 HH22 ' HA ' ' A' ' 25' ' ' PRO . 11.4 ptm180 -149.24 130.61 14.71 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.367 -0.378 . . . . 75.44 111.187 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.63 26.58 16.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.995 0.918 . . . . 72.44 112.121 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.1 82.36 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 116.039 -0.528 . . . . 73.24 112.341 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.01 141.0 12.76 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.424 -0.67 . . . . 63.52 111.424 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.52 119.91 48.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.263 -1.384 . . . . 73.32 107.263 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.47 162.29 39.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.861 -0.609 . . . . 74.11 110.13 -175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.7 128.01 26.02 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 108.089 -1.078 . . . . 73.11 108.089 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.28 122.01 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.787 2.324 . . . . 72.11 112.037 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.518 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.5 tt0 -65.74 -24.59 66.99 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.136 0.493 . . . . 63.14 111.699 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.5 -8.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.637 -0.711 . . . . 72.44 112.373 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -86.73 -2.47 58.56 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.388 0.613 . . . . 74.34 110.95 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -116.83 148.51 41.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 73.43 109.248 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.4 p -82.74 175.47 10.1 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.571 -0.9 . . . . 64.21 108.571 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -64.42 -17.21 63.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.931 0.396 . . . . 71.52 111.729 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 m -79.78 -9.14 59.62 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.348 0.595 . . . . 65.41 109.778 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.44 62.85 Favored Glycine 0 C--O 1.215 -1.081 0 N-CA-C 110.73 -0.948 . . . . 70.21 110.73 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -108.06 143.82 36.26 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.759 -0.83 . . . . 75.13 108.759 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.98 134.46 28.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.134 -1.062 . . . . 73.52 108.134 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -57.04 128.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 108.185 -1.043 . . . . 71.53 108.185 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.428 ' HB2' ' HZ1' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -67.03 -23.07 65.86 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.741 0.645 . . . . 74.33 112.741 -174.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.5 m -88.22 -1.93 58.31 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.998 0.428 . . . . 75.01 111.169 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.534 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.0 tt -65.58 -54.24 31.69 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.386 0.513 . . . . 74.44 112.386 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 39.5 Cg_exo -60.76 -29.77 88.95 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 121.265 1.31 . . . . 75.31 110.979 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.15 99.7 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.319 -0.855 . . . . 65.25 112.216 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.92 -42.01 77.36 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.587 -0.523 . . . . 73.22 109.587 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.33 -37.34 85.25 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 116.243 -0.435 . . . . 71.21 110.645 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.6 m -58.69 -48.04 82.47 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.837 -0.619 . . . . 75.03 111.89 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -42.15 84.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.607 -0.437 . . . . 75.42 111.045 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.07 -35.29 79.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.112 -0.635 . . . . 74.3 111.874 176.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -62.94 -33.4 75.27 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.484 -0.562 . . . . 75.01 109.484 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.97 -31.4 71.1 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.017 -0.538 . . . . 72.13 110.148 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.72 -3.96 63.99 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.569 -0.741 . . . . 51.43 111.756 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.22 37.07 55.33 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 113.708 0.243 . . . . 75.44 113.708 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 52.1 m-85 -92.06 126.19 37.05 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 117.55 0.675 . . . . 75.24 111.18 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 26.8 ptt180 -70.43 169.21 14.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.901 . . . . 75.31 111.276 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 99' ' ' MET . 7.7 p-10 -54.87 -44.5 74.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.052 1.341 . . . . 74.34 111.816 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -62.06 -41.02 97.71 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.332 -0.849 . . . . 61.01 110.835 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.45 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 49.8 mm-40 -66.38 -37.92 86.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.747 -0.381 . . . . 74.42 110.482 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.2 -50.07 82.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 109.112 -0.699 . . . . 70.22 109.112 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.9 ptt? -74.67 -17.49 60.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.334 -0.848 . . . . 70.45 112.948 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.31 -65.26 0.72 Allowed 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.47 0.481 . . . . 72.23 110.099 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -70.38 -32.26 69.84 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.245 0.831 . . . . 74.03 113.245 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 125' ' ' PRO . 40.8 tp -68.33 -40.46 81.61 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.038 0.755 . . . . 72.42 113.038 -173.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -87.16 -18.3 30.7 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.367 0.877 . . . . 73.51 113.367 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 63.2 m -81.03 127.37 74.68 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 112.194 0.442 . . . . 63.4 112.194 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.47 132.31 28.84 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.664 2.243 . . . . 53.44 111.31 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 22.7 t70 -118.19 121.45 31.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.465 -0.334 . . . . 62.32 111.839 -178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.98 -26.43 82.38 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.585 2.856 . . . . 73.44 112.205 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.0 m -85.96 -0.21 54.88 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.213 0.53 . . . . 70.2 111.239 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.63 126.89 53.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.207 -0.664 . . . . 73.32 109.207 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -131.28 114.34 14.91 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 73.4 108.206 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 pt . . . . . 0 C--N 1.306 -1.295 0 CA-C-N 116.45 -0.341 . . . . 72.41 110.759 -175.644 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 108.292 -1.003 . . . . 75.32 108.292 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.0 t -89.13 162.02 16.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 65.33 107.964 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 62.7 t30 67.57 44.67 1.66 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 122.647 1.213 . . . . 70.55 108.521 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.86 16.74 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.963 -1.017 . . . . 71.43 110.763 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -95.43 137.97 21.96 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.11 -0.7 . . . . 73.43 109.11 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.477 ' HB2' HD12 ' A' ' 102' ' ' LEU . 87.6 Cg_exo -50.0 -26.24 14.04 Favored 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.638 2.892 . . . . 74.13 114.755 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 94.7 t -60.58 -39.74 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.529 0.68 . . . . 73.35 110.283 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.01 -33.26 75.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.257 -0.883 . . . . 64.33 109.659 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.48 -47.92 62.35 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.245 -0.889 . . . . 64.24 111.45 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -65.81 -34.57 78.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 73.11 110.438 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -66.43 -32.26 73.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.229 -0.896 . . . . 71.03 108.945 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.91 13.16 19.32 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.094 -0.957 . . . . 65.32 111.445 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 64.76 28.05 12.98 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.524 1.13 . . . . 74.12 110.693 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -109.43 23.85 13.9 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.586 1.184 . . . . 74.33 108.99 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.94 -25.4 11.77 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 112.913 -1.949 . . . . 75.01 112.151 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -54.51 -39.69 67.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.95 0.5 . . . . 62.25 111.286 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.236 0.541 . . . . 74.21 110.432 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.75 -48.94 68.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.829 -0.804 . . . . 71.55 108.829 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 89.2 t -60.07 -41.17 85.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 123.559 0.744 . . . . 61.41 109.792 176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -56.97 -46.45 82.17 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.562 -0.744 . . . . 73.43 109.598 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -69.04 -36.48 77.76 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 116.316 -0.402 . . . . 75.11 111.848 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.7 89.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 53.21 109.621 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.2 mt-30 -62.88 -37.53 87.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.708 -0.678 . . . . 74.42 110.442 177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.5 76.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.257 0.551 . . . . 70.01 111.017 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.58 -36.89 57.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.598 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -76.74 -49.62 15.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.613 0.968 . . . . 72.14 113.613 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--O 1.255 1.346 0 CA-C-O 118.975 -0.536 . . . . 72.35 111.218 -174.639 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.626 -0.879 . . . . 74.54 108.626 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.82 -101.37 2.71 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.576 -0.738 . . . . 52.42 113.88 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -98.97 120.78 40.0 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.099 0.476 . . . . 73.32 111.537 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.59 146.29 50.18 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.148 -0.933 . . . . 64.21 110.12 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.35 -12.08 11.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.529 -0.305 . . . . 64.24 111.147 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.282 0.8 OUTLIER -89.16 169.55 11.38 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 114.702 1.371 . . . . 71.42 114.702 -177.435 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -101.48 148.15 34.81 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.346 -1.353 . . . . 64.13 107.346 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.64 -22.6 9.65 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.892 2.395 . . . . 63.34 113.699 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.6 -32.19 73.73 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.86 -0.422 . . . . 73.03 109.86 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.64 126.26 90.85 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.595 -0.891 . . . . 75.33 108.595 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.32 154.87 61.13 Favored 'Trans proline' 0 C--O 1.256 1.416 0 C-N-CA 122.181 1.921 . . . . 72.04 111.047 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 p -136.05 169.57 17.39 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.968 0.89 . . . . 74.31 112.71 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -119.83 160.95 21.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 127.09 2.156 . . . . 73.3 106.127 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 7.1 t70 -134.49 156.91 47.78 Favored 'General case' 0 C--N 1.26 -3.308 0 N-CA-C 102.982 -2.97 . . . . 72.44 102.982 -175.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.51 -51.77 75.43 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.605 0.965 . . . . 74.25 113.605 -173.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 13.4 Cg_endo -60.23 -31.57 93.2 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.792 1.661 . . . . 62.45 112.255 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -70.79 -37.57 73.32 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.886 0.374 . . . . 75.54 110.368 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.03 -37.87 77.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.665 -0.865 . . . . 62.11 108.665 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.77 -37.06 78.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.944 -1.026 . . . . 74.32 110.035 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.63 -46.67 68.61 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.627 0.771 . . . . 70.3 109.504 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.77 -46.38 82.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.688 -1.142 . . . . 73.24 111.617 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.54 -18.41 29.85 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.552 -0.459 . . . . 75.22 111.842 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.02 61.55 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.965 -0.636 . . . . 64.33 111.554 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.99 161.1 48.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 109.324 -0.621 . . . . 73.51 109.324 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.87 158.63 56.17 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 121.908 1.739 . . . . 73.01 112.051 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.2 -33.33 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.868 0.867 . . . . 75.3 110.854 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.0 p -60.34 -40.43 90.63 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.686 -0.688 . . . . 73.11 111.445 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -69.33 -34.12 74.16 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.069 -0.715 . . . . 73.5 109.069 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' HA ' HE21 ' A' ' 49' ' ' GLN . 64.0 t -63.51 -44.1 98.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.742 -0.663 . . . . 71.23 109.615 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.62 -36.5 82.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.109 -0.95 . . . . 52.24 110.357 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.82 -35.09 79.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.064 0.394 . . . . 75.32 112.064 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.429 HE21 ' HA ' ' A' ' 46' ' ' VAL . 37.8 mt-30 -62.56 -42.51 99.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.87 0.843 . . . . 74.14 108.838 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.56 -34.84 78.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.552 -1.204 . . . . 75.13 109.451 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.2 mmt85 -67.16 -29.38 69.07 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.928 0.891 . . . . 74.44 112.33 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.43 6.13 39.99 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.334 -0.546 . . . . 74.14 111.902 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 43.22 76.02 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.12 -0.562 . . . . 63.53 112.173 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.73 -17.0 14.78 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.112 -0.699 . . . . 74.41 109.112 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 tp -149.35 158.39 44.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.675 -1.231 . . . . 72.2 107.675 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.23 147.22 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.0 -0.741 . . . . 73.21 109.0 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.84 161.54 28.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.111 0.565 . . . . 72.44 110.113 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.7 m -136.68 165.61 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.928 0.891 . . . . 74.43 109.093 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -117.03 115.88 26.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.659 -0.497 . . . . 75.25 109.659 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.557 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -116.81 124.44 49.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.016 -0.735 . . . . 70.21 109.016 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.74 22.59 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.835 0.854 . . . . 65.12 112.712 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.13 -24.02 21.92 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.396 -0.906 . . . . 64.24 113.24 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.29 143.55 16.73 Favored Glycine 0 CA--C 1.496 -1.146 0 C-N-CA 120.811 -0.709 . . . . 74.51 112.252 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 124.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.128 -0.694 . . . . 71.22 109.128 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.44 168.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.751 -1.113 . . . . 73.03 111.286 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.0 mm -118.64 135.92 23.9 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 105.875 -1.898 . . . . 74.55 105.875 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.92 139.7 43.92 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 121.606 1.537 . . . . 74.34 112.638 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -54.15 -36.37 63.27 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.655 0.782 . . . . 73.32 110.141 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.411 ' CG2' HG11 ' A' ' 126' ' ' VAL . 20.0 m -70.17 -3.18 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.271 . . . . 73.23 113.92 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.499 ' CD2' HD13 ' A' ' 81' ' ' LEU . 3.2 m-85 -88.4 -5.93 57.99 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.085 0.945 . . . . 72.24 109.64 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.13 155.54 38.25 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.491 -1.231 . . . . 74.23 108.395 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.8 p -83.21 165.0 19.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.39 -1.337 . . . . 74.44 107.39 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -67.1 -16.02 64.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.361 0.6 . . . . 75.12 110.996 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -79.47 -3.67 47.71 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.301 -0.863 . . . . 70.34 111.02 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.63 21.71 55.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.009 -0.615 . . . . 51.43 112.694 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -114.58 161.38 18.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.607 0.241 . . . . 74.14 110.505 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.72 138.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.107 -1.071 . . . . 74.4 108.107 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.82 129.52 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.036 -1.098 . . . . 74.23 108.036 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.87 -26.39 62.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.348 0.87 . . . . 75.32 113.348 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.8 m -99.02 6.91 46.43 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.411 -0.359 . . . . 71.03 111.645 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.499 HD13 ' CD2' ' A' ' 70' ' ' PHE . 19.2 tp -61.12 -54.93 49.09 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 111.98 0.363 . . . . 70.21 111.98 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.99 -22.14 73.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 121.749 1.632 . . . . 75.12 111.73 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.43 -44.46 90.28 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.754 -0.657 . . . . 41.33 112.221 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.07 -39.12 86.78 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.7 -0.852 . . . . 72.05 108.7 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.77 -36.86 84.44 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.694 -1.139 . . . . 74.2 111.294 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 m -57.54 -49.21 77.11 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.611 0.243 . . . . 74.32 111.333 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.95 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.928 0.394 . . . . 74.24 111.353 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.4 mt -66.69 -39.92 88.3 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.36 0.504 . . . . 72.32 112.36 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -68.29 -35.64 78.15 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.496 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.38 -31.67 72.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.597 -0.52 . . . . 72.44 109.597 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.79 -0.77 89.91 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.502 -0.772 . . . . 45.01 112.798 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 34.21 55.29 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.309 -0.472 . . . . 73.03 113.278 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -94.72 123.79 38.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.357 0.598 . . . . 70.01 112.271 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -73.87 173.71 9.54 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.781 -1.1 . . . . 72.53 112.076 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -53.02 -45.32 67.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.061 1.745 . . . . 74.13 111.238 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -64.24 -40.77 96.71 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 123.842 0.857 . . . . 74.2 110.092 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -66.81 -37.49 84.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 74.32 111.601 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.7 mm -60.85 -48.11 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.126 -1.064 . . . . 74.22 108.126 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.442 ' SD ' ' HE1' ' A' ' 103' ' ' PHE . 21.8 mmt -74.2 -22.35 59.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.648 -1.16 . . . . 62.3 111.229 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -54.3 -69.32 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.868 0.867 . . . . 72.55 111.653 -174.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.582 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 55.2 p-90 -70.35 -32.15 69.72 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.214 0.449 . . . . 74.52 112.214 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.589 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 9.3 mt -61.34 -39.81 91.95 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.689 1.366 . . . . 75.12 114.689 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 56.8 m-85 -94.79 -12.17 27.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.599 0.963 . . . . 73.43 113.599 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.1 m -83.17 129.52 60.66 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.741 -0.837 . . . . 64.11 108.741 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.12 128.97 29.61 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.033 1.822 . . . . 63.23 109.626 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.8 118.36 65.96 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.63 -0.878 . . . . 73.5 108.63 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.504 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 23.3 Cg_endo -61.11 -20.25 66.97 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.959 2.44 . . . . 73.0 113.667 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.2 m -101.21 4.83 42.27 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.479 -0.328 . . . . 73.43 110.353 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 tp -107.67 123.28 48.27 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.828 0.823 . . . . 74.11 111.155 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.3 m -131.2 113.0 13.32 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.87 -1.53 . . . . 74.31 106.87 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.0 pt . . . . . 0 C--N 1.301 -1.501 0 N-CA-C 112.372 0.508 . . . . 73.3 112.372 -172.481 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 108.395 -0.965 . . . . 74.53 108.395 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 m -90.23 151.62 21.45 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.537 -0.912 . . . . 72.12 108.537 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 50.1 m-80 54.37 63.66 2.09 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.306 0.642 . . . . 71.3 111.634 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.59 156.38 24.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.259 -0.645 . . . . 53.31 109.259 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -72.8 135.93 80.51 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.348 -0.541 . . . . 74.45 109.907 175.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.454 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.0 Cg_exo -56.06 -21.22 33.7 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.946 2.431 . . . . 73.43 114.47 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.625 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.8 t -61.53 -36.64 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.909 0.861 . . . . 65.31 109.55 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.0 -31.83 72.95 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.767 -1.106 . . . . 71.3 109.201 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.97 71.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.665 -1.152 . . . . 65.14 111.478 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -68.49 -33.02 73.42 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.304 -0.247 . . . . 72.23 111.367 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -64.91 -29.7 70.65 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.013 0.911 . . . . 71.42 108.55 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -98.55 15.95 23.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.49 -1.232 . . . . 73.32 110.584 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.1 m80 58.23 34.2 23.88 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.814 1.413 . . . . 72.14 114.814 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -104.07 23.53 12.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.682 -1.599 . . . . 74.34 106.682 172.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.46 ' O ' HG22 ' A' ' 138' ' ' VAL . . . -52.96 -28.35 23.3 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 126.883 2.073 . . . . 75.5 113.772 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -55.3 -40.18 70.78 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.966 0.412 . . . . 75.25 111.541 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.37 -27.73 61.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.568 0.699 . . . . 73.21 109.746 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.55 -40.9 72.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.29 -0.868 . . . . 75.01 108.903 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 63.3 t -58.73 -46.72 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.599 -0.889 . . . . 74.42 108.599 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.93 -1.032 . . . . 75.42 112.301 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -64.97 -36.12 83.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 120.876 -0.33 . . . . 74.42 110.166 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.14 -43.27 98.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.872 -0.418 . . . . 61.53 109.872 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -59.51 -44.23 93.18 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 115.577 -0.738 . . . . 74.33 109.688 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.3 -26.58 68.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 71.55 111.867 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.5 tpt -81.61 -34.26 31.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.026 0.441 . . . . 72.14 110.608 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.61 -43.45 15.62 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.075 0.464 . . . . 65.24 111.49 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 . . . . . 0 C--O 1.261 1.669 0 CA-C-N 115.73 -0.668 . . . . 73.22 109.264 -177.22 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 120.953 0.406 . . . . 74.12 109.987 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.02 -121.06 3.54 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.841 -0.618 . . . . 75.25 113.946 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -109.22 129.79 55.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.546 0.212 . . . . 74.41 111.315 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -65.96 109.48 2.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.706 -0.679 . . . . 74.01 111.267 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.56 -30.93 6.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 113.205 0.816 . . . . 75.13 113.205 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.454 HD21 ' CE2' ' A' ' 103' ' ' PHE 0.273 0.5 OUTLIER -82.86 171.99 13.31 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 118.88 -1.128 . . . . 75.4 112.294 -178.493 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.19 137.41 75.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 109.233 -0.655 . . . . 71.32 109.233 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.71 -21.61 32.84 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.254 2.636 . . . . 74.24 113.852 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.98 -22.55 59.57 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.687 0.279 . . . . 63.33 111.72 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.48 138.4 97.35 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 116.168 -0.469 . . . . 72.0 110.109 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.642 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 34.5 Cg_endo -67.41 104.81 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.484 2.122 . . . . 45.14 110.425 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p -102.59 170.08 8.25 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 121.431 0.634 . . . . 70.4 112.044 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 107.712 -1.218 . . . . 75.5 107.712 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 13.3 t0 -136.53 164.15 28.84 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 103.528 -2.767 . . . . 63.44 103.528 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.56 -53.76 60.84 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.327 0.862 . . . . 75.35 113.327 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.55 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 12.0 Cg_endo -58.06 -35.83 98.45 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.83 1.686 . . . . 72.24 112.012 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 26.9 tpt180 -67.35 -39.95 85.79 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.9 0.381 . . . . 74.35 111.068 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -36.77 69.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.789 -0.364 . . . . 74.11 110.386 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.82 68.36 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.002 -0.74 . . . . 53.25 109.002 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 42.0 mt-10 -68.48 -45.08 73.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.769 -1.105 . . . . 71.11 111.844 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.5 -46.55 82.48 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.489 -0.778 . . . . 75.55 112.033 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.94 -10.22 34.47 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.608 0.595 . . . . 75.04 112.608 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.05 30.12 72.17 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 111.262 -0.735 . . . . 53.15 111.262 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.65 156.61 67.8 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.765 -0.828 . . . . 64.12 108.765 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.35 156.39 66.4 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 121.391 1.394 . . . . 74.14 111.639 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.02 -33.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 52.24 110.371 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 28.3 t -57.48 -40.85 79.47 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.639 -0.71 . . . . 74.43 110.812 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 62.4 tttp -70.47 -35.99 73.62 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 120.861 0.362 . . . . 74.33 110.202 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.31 -44.51 98.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.221 -0.659 . . . . 72.04 109.221 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.05 -36.61 80.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.047 -0.979 . . . . 60.14 110.21 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.611 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 54.7 mt-30 -63.18 -43.44 98.22 Favored 'General case' 0 C--O 1.197 -1.693 0 CA-C-N 116.055 -0.521 . . . . 75.14 111.133 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.7 mm-40 -58.38 -41.25 84.43 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.326 0.584 . . . . 74.51 110.317 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 56' ' ' VAL . 67.3 tp -61.67 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.627 -1.169 . . . . 75.11 109.116 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -71.26 -23.95 62.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.531 -0.759 . . . . 74.53 112.512 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 10.4 mm-40 -82.97 -12.87 56.94 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.571 -0.529 . . . . 74.31 109.571 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.4 33.16 44.71 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.034 -0.826 . . . . 74.11 111.034 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -99.13 -15.72 18.87 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.771 0.319 . . . . 74.43 110.228 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -161.41 156.95 24.44 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.488 -1.301 . . . . 75.32 107.488 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 18.5 m -129.28 157.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.387 -0.597 . . . . 73.32 109.387 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.8 36.86 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.422 -0.584 . . . . 74.52 109.422 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 m -128.62 166.68 25.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 123.463 0.477 . . . . 74.21 111.044 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.469 ' NE ' ' HA2' ' A' ' 62' ' ' GLY . 19.4 ttt180 -109.63 121.04 44.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.428 0.632 . . . . 75.13 110.537 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -123.0 114.67 20.72 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.673 -1.149 . . . . 71.31 109.063 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.89 19.07 11.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.817 0.847 . . . . 72.33 111.023 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.469 ' HA2' ' NE ' ' A' ' 59' ' ' ARG . . . 99.7 -14.11 60.61 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.664 -0.698 . . . . 34.11 112.112 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.31 151.33 21.91 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.744 -0.942 . . . . 73.14 110.744 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.78 119.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 106.648 -1.612 . . . . 75.12 106.648 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.86 153.75 39.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.618 -0.719 . . . . 72.41 110.486 -174.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -126.45 131.84 24.08 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 108.189 -1.041 . . . . 74.34 108.189 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.39 141.38 86.9 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.238 1.959 . . . . 52.23 112.857 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.642 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.2 tp-100 -48.84 -42.39 36.16 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.213 1.405 . . . . 74.33 110.984 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.74 4.33 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 114.133 -1.394 . . . . 74.12 114.498 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.556 ' CD2' HD13 ' A' ' 81' ' ' LEU . 12.8 m-85 -91.96 -6.23 51.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.168 0.985 . . . . 75.51 109.501 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.51 144.58 47.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.405 -1.27 . . . . 74.14 108.683 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 p -75.85 172.95 11.81 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.253 -1.017 . . . . 75.21 108.253 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.73 -17.3 63.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.895 0.855 . . . . 64.42 109.261 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m -79.87 -6.86 58.21 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.191 -0.913 . . . . 75.03 110.552 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.92 -13.88 66.33 Favored Glycine 0 C--O 1.219 -0.827 0 C-N-CA 121.294 -0.479 . . . . 54.21 113.523 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -95.38 155.04 16.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.228 0.455 . . . . 72.25 112.228 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.37 141.8 17.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.408 -0.814 . . . . 74.54 108.812 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 26.4 t -59.91 134.16 25.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.3 -0.63 . . . . 71.35 109.3 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -55.78 -43.54 76.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.445 0.906 . . . . 75.11 113.445 -173.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.9 t -91.68 3.41 55.13 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.859 -0.336 . . . . 74.23 111.774 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.2 tt -66.46 -49.9 50.23 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 112.671 0.619 . . . . 73.43 112.671 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.06 -30.06 85.38 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.583 1.522 . . . . 54.44 111.028 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.25 -42.48 96.24 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.631 -0.713 . . . . 74.42 111.925 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.99 -40.16 83.12 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.055 -0.72 . . . . 75.53 109.055 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.53 -35.78 78.71 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.978 -0.556 . . . . 74.4 110.402 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.2 m -61.46 -49.09 78.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.947 -0.57 . . . . 72.14 111.677 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -43.37 96.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.635 0.255 . . . . 75.13 111.226 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.49 -36.08 80.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.541 0.571 . . . . 74.42 112.541 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.13 -45.24 95.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.264 0.554 . . . . 72.44 109.866 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.6 -25.7 61.42 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.716 -0.674 . . . . 71.51 110.445 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.11 86.97 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.6 -0.727 . . . . 74.21 112.559 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.44 30.6 24.24 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 121.425 -0.417 . . . . 74.34 113.786 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -106.1 147.73 28.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.128 0.464 . . . . 72.34 111.537 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.401 ' O ' HG12 ' A' ' 98' ' ' ILE . 16.2 ptp180 -99.62 171.39 7.94 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.672 0.789 . . . . 74.35 110.724 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -54.02 -45.51 71.56 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.537 1.535 . . . . 70.24 112.418 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.8 m -64.23 -41.02 97.19 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.636 -0.711 . . . . 71.13 110.16 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.12 -37.42 85.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.86 -0.609 . . . . 75.31 110.352 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 94' ' ' ARG . 14.5 mm -61.53 -49.52 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.831 -0.803 . . . . 74.12 108.831 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.516 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.7 ptp -75.29 -15.92 60.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.187 -0.915 . . . . 73.12 113.251 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.71 -62.94 1.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.26 -0.644 . . . . 74.32 109.26 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -69.98 -32.98 71.47 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.479 0.918 . . . . 74.11 113.479 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 15.0 mt -58.96 -40.32 84.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.212 0.819 . . . . 75.11 113.212 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.454 ' CE2' HD21 ' A' ' 23' ' ' LEU . 39.0 m-85 -86.14 -11.13 53.45 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.602 0.594 . . . . 72.42 112.602 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 m -87.51 121.14 71.26 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 108.902 -0.777 . . . . 65.22 108.902 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.49 130.12 35.83 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 122.568 2.178 . . . . 73.3 111.846 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 8.1 t70 -79.71 122.81 83.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 108.189 -1.041 . . . . 74.41 108.189 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.546 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 31.3 Cg_endo -60.78 -16.88 46.82 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.573 2.849 . . . . 71.22 114.6 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.6 t -119.1 5.74 11.29 Favored 'General case' 0 N--CA 1.421 -1.898 0 O-C-N 122.077 -0.39 . . . . 72.33 110.883 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -100.77 130.63 46.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.314 0.578 . . . . 65.22 110.261 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 120' ' ' VAL . 48.7 m -131.56 114.81 15.32 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.984 -1.117 . . . . 74.42 107.984 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--N 1.313 -1.014 0 N-CA-C 113.883 1.068 . . . . 73.52 113.883 -174.286 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 110' ' ' THR . 48.1 t . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 108.933 -0.766 . . . . 71.45 108.933 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.5 m -88.15 146.97 25.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.77 -0.65 . . . . 72.01 110.162 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 107' ' ' PRO . 17.3 m120 64.72 57.57 1.06 Allowed 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.277 1.031 . . . . 73.13 109.211 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 159.9 15.68 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.737 -1.119 . . . . 72.33 109.696 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -81.03 147.88 62.65 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 108.325 -0.991 . . . . 73.31 108.325 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.446 ' HB2' HD23 ' A' ' 102' ' ' LEU . 52.1 Cg_exo -56.99 -28.15 76.91 Favored 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 121.892 1.728 . . . . 72.11 111.387 174.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 62.0 t -63.68 -35.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.609 0.719 . . . . 75.33 110.409 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.81 -41.57 74.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.68 -1.23 . . . . 60.23 107.68 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -34.86 79.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.485 -1.234 . . . . 65.23 113.173 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.77 -32.96 71.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.584 -0.698 . . . . 74.04 111.263 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -76.74 -13.61 60.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.885 0.85 . . . . 73.35 109.907 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.91 3.85 51.78 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.802 -1.09 . . . . 75.31 110.421 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.9 t60 64.14 27.17 14.03 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.211 1.482 . . . . 74.32 109.689 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -114.13 24.86 11.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.0 -1.455 . . . . 74.45 108.139 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.73 -27.85 19.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.602 -1.635 . . . . 75.52 112.43 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -56.37 -42.84 78.51 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.468 -0.567 . . . . 74.01 109.468 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 22.6 mm-40 -65.64 -39.63 91.65 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.361 -0.836 . . . . 72.42 109.481 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.64 -47.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.4 -0.818 . . . . 73.44 109.786 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 57.9 t -60.83 -41.79 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.816 -0.629 . . . . 52.11 109.805 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -63.42 -40.4 97.07 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 120.923 0.392 . . . . 73.32 111.2 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 14.3 mmt85 -66.22 -35.49 80.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.864 -0.791 . . . . 74.41 108.864 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 138' ' ' VAL . . . -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 70.1 109.888 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.6 mt-30 -61.7 -38.62 88.51 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 116.155 -0.475 . . . . 73.23 109.887 176.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.96 -22.78 65.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.963 0.411 . . . . 63.14 111.366 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 24.1 mmt -89.07 -29.66 19.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.348 0.594 . . . . 64.54 110.013 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.32 -45.17 13.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.077 -0.511 . . . . 74.02 111.8 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 107.785 -1.191 . . . . 70.33 107.785 -178.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 108.798 -0.815 . . . . 73.21 108.798 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.93 -107.77 2.19 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 110.842 -0.903 . . . . 55.23 110.842 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -118.17 141.88 48.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.703 -0.481 . . . . 71.32 109.703 -176.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.09 158.09 34.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.997 0.903 . . . . 73.15 111.696 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 22' ' ' VAL . 38.9 t -121.23 32.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 124.172 1.939 . . . . 74.34 106.262 175.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.49 178.93 4.42 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.239 -1.8 . . . . 72.41 111.266 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 15.3 t70 -90.79 136.05 28.23 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 105.704 -1.961 . . . . 62.5 105.704 169.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.65 -25.47 14.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.393 2.728 . . . . 75.22 115.193 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.52 33.68 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.524 -0.87 . . . . 74.44 110.973 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 25.3 tp10 -72.57 129.46 87.06 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 105.726 -1.953 . . . . 71.42 105.726 172.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 52.4 Cg_exo -55.27 98.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.66 2.24 . . . . 74.34 111.681 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -107.16 -177.66 3.42 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.732 -0.667 . . . . 74.13 112.197 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CZ ' HD23 ' A' ' 38' ' ' LEU . 52.3 m-85 -111.48 159.78 17.75 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.999 -1.001 . . . . 73.43 109.445 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.446 ' O ' HG21 ' A' ' 35' ' ' VAL . 3.3 m-20 -136.52 162.46 33.03 Favored 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 101.84 -3.392 . . . . 73.23 101.84 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -50.94 -51.55 66.18 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-N 119.028 0.831 . . . . 74.01 112.447 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.87 -35.95 85.94 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.021 1.814 . . . . 75.5 112.553 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.412 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 7.7 tpt180 -70.27 -36.99 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.864 0.364 . . . . 75.53 110.181 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 31' ' ' ASP . 66.0 t -69.1 -39.03 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.475 -0.565 . . . . 74.04 109.475 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.75 84.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.465 -0.789 . . . . 70.2 109.52 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.2 -36.69 79.96 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.592 -1.186 . . . . 73.51 110.247 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.434 HD23 ' CZ ' ' A' ' 30' ' ' TYR . 56.9 tp -72.55 -45.46 59.12 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.54 -0.755 . . . . 73.04 111.335 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.0 mt -85.71 -18.44 33.09 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.637 0.606 . . . . 75.24 112.637 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.56 28.04 60.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.796 -0.922 . . . . 75.31 110.796 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.01 159.09 55.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.319 -0.993 . . . . 75.43 108.319 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -67.23 155.25 71.4 Favored 'Trans proline' 0 C--O 1.26 1.597 0 C-N-CA 121.057 1.171 . . . . 75.1 111.644 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.46 -33.5 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.428 0.691 . . . . 73.25 110.424 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 36.8 t -57.33 -45.62 84.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.954 -0.566 . . . . 71.03 110.787 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 64.7 mttm -64.72 -36.74 85.25 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.392 -0.523 . . . . 75.44 110.88 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.33 -45.17 98.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.496 -0.557 . . . . 74.23 109.496 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.45 80.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.581 -0.736 . . . . 72.55 110.552 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.634 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 97.2 mt-30 -61.73 -46.77 88.21 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.802 -0.444 . . . . 54.31 109.802 176.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 77.6 mt-30 -59.39 -42.55 91.95 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.706 0.765 . . . . 71.33 110.556 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.2 -38.33 88.74 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.437 -1.256 . . . . 74.42 109.427 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -71.25 -29.13 64.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.185 0.439 . . . . 75.11 112.185 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 56.0 mt-10 -76.55 -12.26 60.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.737 0.303 . . . . 74.54 110.375 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.44 22.47 64.76 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.545 -1.022 . . . . 62.23 110.545 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -94.62 -0.32 54.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.103 0.478 . . . . 74.11 111.049 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.7 tp -163.23 152.79 15.18 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.403 -1.702 . . . . 74.53 106.403 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -132.09 148.13 32.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.013 -0.736 . . . . 74.32 109.013 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.23 154.3 37.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 123.567 0.542 . . . . 75.32 110.01 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.566 HG12 ' OD2' ' A' ' 95' ' ' ASP . 19.6 m -128.39 166.63 25.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.302 1.041 . . . . 75.15 109.116 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 53.4 mtm180 -110.91 129.37 55.9 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.743 -0.466 . . . . 71.13 109.743 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' A' ' 62' ' ' GLY . 28.9 ptt180 -125.34 123.84 40.26 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.648 -1.612 . . . . 71.15 106.648 173.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.04 -15.78 0.32 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.418 1.087 . . . . 65.22 112.8 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . 134.01 -13.83 4.67 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.927 -0.869 . . . . 63.32 110.927 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -92.7 152.52 21.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.804 -0.918 . . . . 72.53 110.804 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -96.8 120.78 46.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 74.2 107.835 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.39 160.29 40.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.479 -0.782 . . . . 74.12 111.218 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.06 125.7 26.19 Favored Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 106.978 -1.49 . . . . 74.44 106.978 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 139.22 86.6 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.745 2.296 . . . . 75.24 113.625 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.9 tp-100 -53.81 -37.26 63.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.286 1.034 . . . . 75.25 110.165 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 34.3 m -72.18 2.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.574 -1.648 . . . . 74.45 113.95 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.455 ' CD2' HD13 ' A' ' 81' ' ' LEU . 6.3 m-85 -95.49 -1.68 50.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.935 0.874 . . . . 74.43 109.497 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.46 139.32 53.63 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.656 -1.156 . . . . 74.32 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.7 p -79.51 168.94 18.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.016 -0.993 . . . . 72.22 109.519 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -57.56 -23.41 50.46 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.068 0.547 . . . . 73.34 111.35 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 t -79.96 -8.13 59.17 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.191 -0.459 . . . . 73.3 110.345 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.17 18.33 65.03 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.998 -0.62 . . . . 72.14 112.719 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -119.13 161.84 19.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.046 -0.724 . . . . 72.44 109.046 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.27 144.86 11.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.332 -0.988 . . . . 74.52 108.332 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.8 t -64.02 124.64 19.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.406 -0.961 . . . . 74.12 108.406 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -55.26 -44.72 75.84 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.584 1.327 . . . . 70.31 114.584 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.9 m -96.55 9.82 40.29 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 112.758 0.651 . . . . 65.42 112.758 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 7.1 tt -65.64 -45.34 67.11 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 116.368 -0.378 . . . . 74.05 111.864 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.88 -25.76 54.33 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.924 1.749 . . . . 75.32 111.658 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.9 -38.66 96.93 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.658 -0.701 . . . . 74.33 111.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.98 -41.06 78.4 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.971 -0.751 . . . . 63.3 108.971 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.43 -34.39 75.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 74.34 110.355 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.0 m -61.65 -49.02 78.22 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.486 -0.779 . . . . 64.24 110.791 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -41.81 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 111.642 0.238 . . . . 73.22 111.642 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -66.75 -35.19 79.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.029 -0.668 . . . . 74.14 112.511 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -63.72 -35.95 82.27 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.131 -0.692 . . . . 75.0 109.131 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.09 -31.22 67.54 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.481 -0.781 . . . . 71.25 110.002 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.62 -8.63 70.05 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.625 -0.716 . . . . 72.05 112.8 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.04 49.61 5.9 Favored Glycine 0 C--N 1.318 -0.423 0 C-N-CA 121.338 -0.458 . . . . 73.3 113.669 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.94 139.8 49.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.259 -0.553 . . . . 71.11 111.865 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -85.09 170.03 13.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.351 -0.84 . . . . 74.4 110.3 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.566 ' OD2' HG12 ' A' ' 58' ' ' VAL . 19.1 p-10 -55.28 -42.69 73.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.506 1.522 . . . . 74.21 111.945 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.2 m -61.32 -42.24 98.35 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.098 -0.955 . . . . 75.41 110.012 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.73 -37.12 84.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.141 -0.482 . . . . 75.54 110.928 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.09 -48.9 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.844 0.831 . . . . 75.05 108.813 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.425 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 59.0 mtt -75.48 -20.87 58.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.784 -1.098 . . . . 73.21 112.227 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -57.97 -61.13 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.511 0.507 . . . . 72.34 109.736 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.414 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 29.1 p-90 -69.46 -32.53 71.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.19 0.811 . . . . 74.34 113.19 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 126' ' ' VAL . 17.0 mt -60.12 -41.45 92.68 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.812 0.671 . . . . 75.33 112.812 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -85.02 -14.72 46.48 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.605 -0.438 . . . . 72.4 112.081 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 m -87.05 118.59 70.25 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.788 -0.449 . . . . 74.31 109.788 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.93 131.07 40.71 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.903 2.402 . . . . 75.24 111.217 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -90.47 122.84 66.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.26 -0.427 . . . . 63.25 110.966 -174.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.91 -16.31 44.04 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.935 3.09 . . . . 63.45 114.56 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -118.03 10.54 13.08 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.798 -0.564 . . . . 74.45 110.4 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.32 131.3 49.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.488 0.661 . . . . 73.03 111.917 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -125.99 120.28 29.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.867 -1.531 . . . . 71.31 106.867 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.466 HG23 ' NE2' ' A' ' 133' ' ' GLN . 28.1 pt . . . . . 0 C--N 1.302 -1.484 0 CA-C-O 120.429 0.156 . . . . 74.54 111.285 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.9 t . . . . . 0 N--CA 1.438 -1.06 0 N-CA-C 109.393 -0.595 . . . . 74.33 109.393 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.8 m -90.17 139.9 30.19 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.842 -0.617 . . . . 63.13 109.55 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 59.81 67.79 0.84 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.746 1.26 . . . . 72.15 110.619 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -113.1 179.23 4.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.288 -1.324 . . . . 52.32 109.877 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.549 ' HD3' ' N ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -87.12 138.35 32.6 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 109.014 -0.736 . . . . 71.41 109.014 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 71.4 Cg_exo -56.27 -29.93 78.3 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.198 1.932 . . . . 62.24 110.122 170.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.619 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 70.5 t -61.82 -42.8 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.345 0.593 . . . . 74.13 110.37 173.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.98 -34.76 77.15 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.07 -0.652 . . . . 72.21 109.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.79 85.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.915 -1.039 . . . . 63.22 112.853 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.65 -32.51 71.21 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.029 -0.42 . . . . 71.4 110.917 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -71.74 -23.41 61.61 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.686 0.755 . . . . 70.43 109.767 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.38 -0.26 54.28 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.851 -1.068 . . . . 65.24 110.423 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.7 m80 64.03 28.24 14.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.59 1.156 . . . . 71.31 110.256 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.466 ' NE2' HG23 ' A' ' 111' ' ' ILE . 12.7 mt-30 -102.61 25.07 9.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.956 -1.475 . . . . 72.13 107.414 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.49 -28.31 19.86 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 113.914 -1.494 . . . . 73.41 112.675 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -56.77 -41.15 77.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.81 0.338 . . . . 71.41 110.707 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.51 -34.18 77.65 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.909 -0.587 . . . . 72.34 110.165 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.24 -44.87 83.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.685 -0.688 . . . . 74.24 109.144 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 64.2 t -61.1 -42.33 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.458 -0.571 . . . . 71.33 109.458 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -58.11 -43.44 87.15 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.977 -0.556 . . . . 74.24 110.403 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 144' ' ' MET . 73.2 mmt-85 -65.84 -39.0 90.37 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 116.618 -0.265 . . . . 71.33 111.126 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.87 -45.1 90.96 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.365 0.416 . . . . 71.01 110.272 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -43.02 99.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 72.34 109.993 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.07 -19.83 63.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.401 -0.818 . . . . 71.15 112.632 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 91.3 mmm -88.4 -21.49 24.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.313 0.577 . . . . 65.41 109.799 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.37 -61.0 2.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.328 -0.619 . . . . 74.51 109.328 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--N 1.302 -1.457 0 CA-C-O 118.304 -0.855 . . . . 74.11 109.52 -178.847 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . . . . . . 0 CA--C 1.502 -0.866 0 CA-C-O 120.466 0.174 . . . . 72.03 111.388 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.04 -171.53 18.77 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.268 -1.133 . . . . 70.43 110.268 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -87.68 138.28 31.61 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.022 -0.733 . . . . 73.12 109.022 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.08 111.45 7.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.118 0.961 . . . . 73.44 112.421 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.9 t -96.83 45.14 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.525 -1.657 . . . . 74.55 106.525 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD21 ' CE2' ' A' ' 103' ' ' PHE . 57.0 mt -107.97 161.01 15.32 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.315 -1.311 . . . . 74.25 110.645 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.507 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.5 t70 -97.4 143.27 25.87 Favored Pre-proline 0 C--N 1.289 -2.037 0 N-CA-C 105.504 -2.035 . . . . 74.32 105.504 171.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.37 -24.67 12.38 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.318 2.679 . . . . 72.42 114.539 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -96.43 2.59 52.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.759 1.022 . . . . 64.02 113.759 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 41.2 mm-40 -78.15 127.57 81.01 Favored Pre-proline 0 C--O 1.249 1.079 0 N-CA-C 109.139 -0.689 . . . . 74.15 109.139 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.13 142.11 60.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.878 2.385 . . . . 75.2 112.802 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.3 p -123.06 -174.65 2.99 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.286 -0.87 . . . . 75.01 110.552 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 27.0 m-85 -133.15 161.84 33.36 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 127.344 2.258 . . . . 64.24 107.059 172.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.41 156.41 47.73 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 104.132 -2.544 . . . . 73.52 104.132 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.311 4.5 mm? -51.7 -52.61 58.99 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 116.126 1.898 . . . . 75.42 116.126 -172.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.15 -33.74 97.78 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 120.371 1.168 . . . . 75.42 111.935 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -69.35 -41.23 76.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.057 -0.349 . . . . 75.15 110.057 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.4 t -67.65 -39.64 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.306 -0.406 . . . . 72.02 109.972 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.89 91.66 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.428 -0.806 . . . . 71.12 109.612 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.69 -41.01 79.79 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.841 -1.072 . . . . 74.21 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.06 -44.44 72.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.345 -0.843 . . . . 73.04 111.516 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.0 -13.95 40.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.32 -0.4 . . . . 73.54 112.046 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.7 23.77 71.75 Favored Glycine 0 C--O 1.243 0.673 0 C-N-CA 120.888 -0.672 . . . . 74.13 112.339 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 143.71 50.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.652 -0.87 . . . . 65.44 108.652 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.53 155.18 43.32 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.432 2.088 . . . . 75.43 113.064 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -50.8 -35.76 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.338 1.055 . . . . 75.13 111.722 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 t -57.68 -42.98 84.7 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.72 0.408 . . . . 71.01 110.867 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -69.69 -36.01 75.59 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.806 0.336 . . . . 64.14 110.957 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.12 -40.54 89.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.5 -0.555 . . . . 72.23 109.5 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.46 75.36 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.666 -0.697 . . . . 74.55 111.049 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -65.7 -39.99 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 71.02 110.679 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.08 -44.65 95.19 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.0 0.905 . . . . 74.44 109.213 176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.17 -35.16 77.96 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.103 -1.408 . . . . 73.35 110.505 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.229 0.455 . . . . 75.53 112.229 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -84.75 -12.19 54.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.119 -0.632 . . . . 74.11 111.403 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.64 34.47 25.05 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.491 -1.044 . . . . 72.21 110.491 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -82.12 -21.52 36.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.772 -0.825 . . . . 72.04 108.772 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.5 tp -152.32 157.97 42.08 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.989 -1.856 . . . . 74.0 105.989 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.46 146.01 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.554 -0.906 . . . . 73.15 108.554 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -118.61 158.68 25.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.246 -1.02 . . . . 74.44 108.246 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.2 m -132.56 162.37 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.396 0.617 . . . . 74.03 111.204 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -110.55 115.48 29.69 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.591 -1.263 . . . . 74.31 107.591 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -130.38 129.9 43.69 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 106.935 -1.506 . . . . 75.12 106.935 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.33 9.71 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.797 0.839 . . . . 75.22 110.879 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.32 65.53 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.786 -0.643 . . . . 63.55 112.358 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.29 146.52 18.23 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 121.186 -0.53 . . . . 71.43 111.955 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.51 121.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.454 -0.573 . . . . 75.24 109.454 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.29 167.28 18.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 125.264 1.426 . . . . 63.4 108.48 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -115.47 131.49 23.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.397 -0.964 . . . . 74.22 108.397 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.68 126.71 17.27 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 121.861 1.707 . . . . 64.52 112.616 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.5 tt0 -64.03 -23.98 67.54 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 122.951 0.501 . . . . 73.45 111.603 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 m -67.87 -6.81 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 112.332 0.493 . . . . 75.55 112.332 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' A' ' 81' ' ' LEU . 6.8 m-85 -89.37 -3.24 58.53 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.037 0.922 . . . . 75.34 109.847 174.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -117.86 152.35 35.55 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.666 -1.152 . . . . 74.0 108.162 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 p -82.65 175.28 10.28 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 123.441 0.463 . . . . 72.15 110.034 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.04 -33.68 69.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.549 0.74 . . . . 72.34 110.718 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.1 m -79.54 -3.57 47.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.961 -0.563 . . . . 65.25 112.511 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.9 35.59 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.309 -0.948 . . . . 73.2 111.398 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.57 145.51 37.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.272 -1.01 . . . . 74.24 108.272 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.99 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.228 -1.027 . . . . 74.31 108.228 174.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.84 127.87 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.37 -0.974 . . . . 75.45 108.37 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -68.81 -25.46 64.69 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.891 -0.506 . . . . 74.44 112.188 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 56.7 m -90.25 6.92 40.81 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.493 -0.321 . . . . 60.24 111.439 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 13.0 tp -61.23 -53.19 65.35 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 119.235 -0.412 . . . . 72.54 111.029 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.3 Cg_exo -63.12 -29.84 74.79 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.359 1.373 . . . . 74.14 110.984 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.14 91.99 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.721 -0.672 . . . . 64.14 111.923 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.04 -40.19 82.89 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.292 0.567 . . . . 71.21 109.493 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.54 -45.96 88.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 72.42 110.437 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.5 m -62.56 -43.79 97.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.748 0.647 . . . . 72.22 112.748 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -47.7 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 118.128 0.422 . . . . 75.32 111.537 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 84' ' ' LEU . 4.1 mm? -67.28 -42.79 83.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 74.43 112.06 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.35 -35.33 80.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.164 -0.68 . . . . 71.34 109.164 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -71.07 -30.2 66.28 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.433 0.635 . . . . 53.24 110.595 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.22 86.84 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.918 -0.583 . . . . 62.52 112.673 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.62 39.95 4.28 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 120.775 -0.726 . . . . 74.34 112.999 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 65.7 m-85 -119.62 136.82 54.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.251 -0.648 . . . . 72.14 109.251 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.575 ' HG2' ' OE1' ' A' ' 97' ' ' GLU . 7.8 ptp85 -84.61 171.07 12.74 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 123.251 0.345 . . . . 75.21 110.697 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -53.38 -45.29 69.19 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 124.601 1.161 . . . . 62.43 112.969 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -62.04 -40.65 96.47 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.627 -0.715 . . . . 73.51 109.95 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.575 ' OE1' ' HG2' ' A' ' 94' ' ' ARG . 44.7 mt-10 -65.87 -33.83 76.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.941 -0.572 . . . . 63.42 111.798 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.4 mm -62.53 -49.4 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.296 -1.002 . . . . 73.23 108.296 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.9 ptm -75.44 -16.32 60.34 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.243 -0.89 . . . . 74.14 112.634 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -58.59 -64.42 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.351 0.66 . . . . 71.23 110.364 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.488 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.0 p-90 -68.84 -31.67 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.192 -0.458 . . . . 72.13 112.145 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.488 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.9 mt -57.71 -39.56 77.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.007 0.743 . . . . 74.21 113.007 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.447 ' CE2' HD21 ' A' ' 23' ' ' LEU . 30.0 m-85 -86.49 -3.14 58.96 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.241 0.46 . . . . 71.54 112.241 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.5 m -86.2 125.43 68.09 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 107.606 -1.257 . . . . 75.04 107.606 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.56 133.84 59.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.649 2.233 . . . . 64.54 110.94 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.7 t70 -91.45 121.37 67.56 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 109.428 -0.582 . . . . 72.11 109.428 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.78 -16.38 43.73 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.693 2.929 . . . . 72.43 114.779 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 m -123.46 16.02 9.66 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 122.01 -0.431 . . . . 72.4 111.108 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.427 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 28.9 tp -104.28 115.18 29.93 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.726 -0.79 . . . . 71.14 111.231 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.2 m -122.37 110.68 15.95 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.901 -1.518 . . . . 75.02 106.901 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 C--N 1.3 -1.561 0 N-CA-C 112.37 0.507 . . . . 72.42 112.37 -171.666 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 108.806 -0.813 . . . . 72.44 108.806 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.1 m -87.46 149.33 24.49 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 123.059 0.544 . . . . 72.54 109.892 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 4.8 m-20 56.42 43.47 26.03 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.309 1.044 . . . . 64.2 111.138 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.61 175.66 9.1 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.111 -0.949 . . . . 71.25 111.988 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -86.74 124.67 68.89 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.33 -0.85 . . . . 75.44 110.41 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.96 -28.08 30.54 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 124.068 3.179 . . . . 75.11 114.443 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.643 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.9 t -60.39 -39.1 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.515 0.674 . . . . 65.13 109.879 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.13 -30.07 68.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.567 -0.742 . . . . 74.41 111.176 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.22 87.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 64.24 110.213 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -70.2 -34.05 72.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.88 -0.415 . . . . 72.55 109.88 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -68.65 -25.28 64.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.44 -0.8 . . . . 73.51 109.241 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.47 7.03 46.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.15 -0.932 . . . . 71.23 111.071 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.9 m80 69.35 32.79 3.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.931 0.872 . . . . 72.23 112.873 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -112.01 24.69 12.36 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.82 -1.178 . . . . 72.31 107.82 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.444 ' O ' HG21 ' A' ' 138' ' ' VAL . . . -52.93 -29.74 30.45 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 125.22 1.408 . . . . 72.43 113.657 -173.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -57.77 -35.44 70.76 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.835 0.35 . . . . 74.32 111.476 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -32.37 68.01 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.476 0.655 . . . . 73.53 109.845 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.4 t -70.97 -42.83 77.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.964 -1.016 . . . . 65.23 108.523 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 90.2 t -59.46 -42.64 88.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.428 -0.806 . . . . 73.04 109.874 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -60.71 -47.18 87.44 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.658 -0.246 . . . . 75.34 111.255 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -61.14 -39.21 89.22 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.354 -0.61 . . . . 75.23 109.354 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 138' ' ' VAL . . . -59.87 -46.74 88.33 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 115.271 -0.877 . . . . 64.13 110.87 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.3 mt-30 -58.57 -41.18 85.12 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.2 0.6 . . . . 61.25 111.529 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.24 79.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.9 -0.591 . . . . 54.41 111.221 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.1 tpt -80.34 -35.44 35.56 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.889 -0.596 . . . . 71.45 110.697 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.458 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -71.89 -49.87 34.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.294 0.85 . . . . 73.02 113.294 -176.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 C--N 1.307 -1.276 0 CA-C-O 118.628 -0.701 . . . . 73.32 109.575 -175.411 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.454 ' HB1' ' C ' ' A' ' 58' ' ' VAL . . . . . . . . 0 N--CA 1.432 -1.337 0 CA-C-O 120.816 0.341 . . . . 74.41 110.317 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.484 ' HA3' ' OD1' ' A' ' 95' ' ' ASP . . . -83.94 -164.8 37.71 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.173 -0.922 . . . . 73.01 115.06 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.12 112.89 20.22 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 114.342 -0.929 . . . . 63.42 111.224 -173.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -46.23 111.85 0.42 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.92 1.288 . . . . 54.01 113.846 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.8 t -86.67 -37.7 11.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 107.92 -1.141 . . . . 72.21 107.92 172.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.63 164.67 26.33 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.955 -1.02 . . . . 74.02 111.238 177.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.37 150.07 97.43 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.757 -0.46 . . . . 64.15 109.757 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.431 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 59.3 Cg_exo -51.28 -41.0 60.57 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.646 2.231 . . . . 73.31 113.2 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.14 26.74 8.42 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 74.35 113.119 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.66 138.39 90.86 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 105.832 -1.914 . . . . 75.31 105.832 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -36.46 110.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.463 3.442 . . . . 74.21 113.496 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.89 174.98 10.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.353 0.597 . . . . 74.54 112.271 -176.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.491 ' CE2' HD22 ' A' ' 38' ' ' LEU . 35.0 m-85 -130.33 161.52 31.1 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.418 1.487 . . . . 75.31 107.828 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.6 t0 -133.28 166.74 21.8 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 103.344 -2.836 . . . . 72.44 103.344 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -46.62 -56.0 12.73 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 113.706 1.002 . . . . 72.5 113.706 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.32 -40.9 78.5 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 121.794 1.663 . . . . 53.42 112.004 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 34' ' ' ARG . 1.9 mpt_? -70.77 -34.69 72.07 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.055 0.761 . . . . 73.3 113.055 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 31' ' ' ASP . 45.5 t -69.86 -43.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.979 -0.748 . . . . 74.51 108.979 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.71 80.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.911 -1.04 . . . . 74.54 109.475 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.5 -45.45 75.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.279 -0.873 . . . . 73.55 110.436 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.491 HD22 ' CE2' ' A' ' 30' ' ' TYR . 30.2 tp -65.76 -50.12 65.9 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 71.01 111.096 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.6 mt -83.1 -18.37 39.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.795 -0.639 . . . . 72.5 112.217 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.85 63.38 Favored Glycine 0 C--N 1.323 -0.159 0 N-CA-C 111.056 -0.818 . . . . 73.23 111.056 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.1 m -124.28 165.05 26.37 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.835 -0.802 . . . . 74.33 108.835 -177.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -79.45 163.57 24.4 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.205 1.27 . . . . 63.21 110.709 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.48 -34.14 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.452 0.701 . . . . 72.31 111.25 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.533 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.6 p -61.25 -40.85 95.58 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.601 -0.727 . . . . 75.04 111.837 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 83.0 tttt -69.54 -32.21 70.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.898 0.38 . . . . 73.01 110.289 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.16 -42.17 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.239 -0.652 . . . . 75.34 109.239 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.25 74.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.542 -0.754 . . . . 74.54 110.212 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 44' ' ' SER . 73.9 mm-40 -66.39 -35.45 80.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.5 -0.318 . . . . 75.14 111.038 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 76.6 mm-40 -64.34 -47.22 80.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 70.03 108.417 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.81 -45.0 95.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.086 -1.415 . . . . 75.5 110.017 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -65.39 -23.6 67.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 114.187 1.18 . . . . 71.01 114.187 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.27 3.14 37.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.028 -1.069 . . . . 65.41 111.366 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.97 41.25 41.29 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.591 -0.731 . . . . 62.12 112.297 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.12 -12.26 18.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.938 -0.393 . . . . 73.42 109.938 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.3 tp -156.77 161.38 39.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.57 -0.9 . . . . 72.11 108.57 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.23 146.82 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.89 -0.782 . . . . 71.41 108.89 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.39 148.31 43.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 74.25 109.024 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.454 ' C ' ' HB1' ' A' ' 18' ' ' ALA . 17.7 m -127.06 155.07 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.862 0.363 . . . . 74.25 110.877 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -110.41 115.12 29.09 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.7 -0.852 . . . . 71.31 108.7 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -126.82 123.74 38.03 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.206 -0.664 . . . . 75.22 109.206 -179.603 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.93 14.75 8.64 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.375 1.07 . . . . 71.14 111.378 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.92 4.31 60.25 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.656 -0.702 . . . . 53.54 112.362 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.51 145.68 16.13 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.563 -1.015 . . . . 74.44 110.563 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.4 t -97.15 120.03 45.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.591 -0.892 . . . . 74.34 108.591 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.26 169.53 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.212 -0.904 . . . . 75.24 109.228 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.0 mt -119.75 129.19 25.49 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 108.455 -0.943 . . . . 74.13 108.455 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.11 122.23 11.41 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.956 2.438 . . . . 74.54 112.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.5 tt0 -64.66 -25.6 68.02 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.159 -0.473 . . . . 75.42 111.921 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 32.8 m -72.2 -4.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.969 0.414 . . . . 73.35 112.108 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.596 ' CD2' HD12 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.86 -4.94 59.23 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.018 0.914 . . . . 73.24 109.718 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -117.04 151.29 37.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.835 -1.172 . . . . 73.24 107.835 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 p -83.06 166.87 18.39 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.619 -1.252 . . . . 74.22 107.619 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.86 -16.48 64.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.534 0.683 . . . . 72.24 110.112 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -79.96 -1.82 41.18 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.976 -0.556 . . . . 75.11 111.906 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.15 28.1 56.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.311 -0.947 . . . . 55.42 111.883 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -124.5 143.04 50.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.081 -1.081 . . . . 75.11 108.081 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.15 141.12 18.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.059 -1.089 . . . . 74.33 108.059 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.4 t -57.81 122.34 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.38 -0.971 . . . . 70.44 108.38 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -67.33 -27.61 67.29 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.437 0.902 . . . . 74.32 113.437 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -89.92 -6.77 55.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.161 0.505 . . . . 72.14 111.086 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.596 HD12 ' CD2' ' A' ' 70' ' ' PHE . 9.1 tt -65.91 -47.51 63.98 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 113.646 0.98 . . . . 72.04 113.646 -175.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.5 Cg_endo -55.72 -28.89 68.74 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.654 1.569 . . . . 74.52 111.186 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -40.23 93.67 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.663 -0.699 . . . . 74.54 111.987 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -67.97 -40.13 83.21 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.077 -0.712 . . . . 73.43 109.077 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.647 -0.706 . . . . 70.3 109.966 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.6 m -58.81 -50.03 75.49 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-N 115.674 -0.694 . . . . 61.43 111.524 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -41.62 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.634 -0.257 . . . . 71.44 111.516 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 141' ' ' ALA . 4.6 mm? -66.8 -36.31 82.1 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.077 0.399 . . . . 73.32 112.077 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -65.92 -32.81 74.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.486 0.184 . . . . 72.43 110.973 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.75 -30.64 71.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.163 0.506 . . . . 64.42 110.199 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.68 88.43 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.861 -0.608 . . . . 64.23 111.672 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.79 35.91 38.58 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.752 -0.224 . . . . 70.33 113.09 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.465 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 99.4 m-85 -97.67 145.66 26.1 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 122.412 -0.464 . . . . 74.14 111.04 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -95.6 171.43 8.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.594 -0.73 . . . . 75.45 110.205 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' HA3' ' A' ' 19' ' ' GLY . 2.0 p30 -53.65 -45.69 70.31 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.522 1.129 . . . . 74.12 113.092 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.3 m -62.4 -40.74 97.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 122.807 0.443 . . . . 73.31 111.239 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.75 -37.58 86.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.986 -0.552 . . . . 74.0 110.407 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.18 -49.06 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.869 0.842 . . . . 74.25 109.644 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -74.77 -13.52 60.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.864 -1.062 . . . . 74.35 113.356 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -57.43 -66.24 0.49 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.93 -0.308 . . . . 75.23 110.87 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.487 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 32.0 p-90 -67.61 -32.13 72.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.393 0.516 . . . . 72.31 112.393 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.487 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.9 mt -58.49 -40.82 83.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.6 0.593 . . . . 72.11 112.6 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -95.23 -4.19 46.27 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.952 0.723 . . . . 73.43 112.952 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.9 m -87.34 120.09 71.11 Favored Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 109.035 -0.728 . . . . 75.32 109.035 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.96 129.1 23.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.551 1.501 . . . . 73.15 108.788 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 12.3 t70 -80.68 125.13 81.17 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.665 -0.494 . . . . 65.3 109.665 -176.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.567 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 26.9 Cg_endo -60.41 -22.25 70.73 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.518 2.812 . . . . 74.34 114.065 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -109.4 -1.48 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.128 -0.629 . . . . 73.23 111.542 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 23.7 tp -102.57 128.9 49.04 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 119.435 -0.906 . . . . 74.54 111.509 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.3 m -116.56 122.14 43.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.078 -1.823 . . . . 73.24 106.078 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.1 mt . . . . . 0 C--N 1.305 -1.354 0 C-N-CA 120.498 -0.481 . . . . 74.52 110.261 -174.021 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 107.423 -1.325 . . . . 72.33 107.423 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.0 p -81.62 137.95 35.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.315 -0.402 . . . . 74.22 110.23 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.567 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 33.5 m-80 68.12 66.44 0.35 Allowed 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 124.235 1.014 . . . . 63.21 110.299 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -109.45 169.4 8.72 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.055 -0.658 . . . . 73.33 109.824 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -89.37 157.59 47.24 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.555 -0.293 . . . . 75.44 110.443 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.88 -25.61 79.9 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.054 1.836 . . . . 72.3 109.848 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 69' ' ' VAL . 84.9 t -62.56 -38.71 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.22 -0.9 . . . . 73.3 109.716 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.98 -42.28 76.76 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.276 -0.639 . . . . 71.04 109.276 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.0 89.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 71.54 112.857 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.69 -40.5 95.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.061 0.393 . . . . 64.43 112.061 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -77.6 -14.27 59.69 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.381 0.61 . . . . 73.34 111.058 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.53 5.9 50.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.317 -0.856 . . . . 72.42 111.575 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.0 m80 66.97 28.43 8.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.678 0.791 . . . . 71.25 112.028 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.3 23.19 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.077 0.941 . . . . 74.13 108.969 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.03 -28.66 39.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.018 1.727 . . . . 62.11 112.426 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -56.07 -38.44 70.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.366 -0.379 . . . . 74.11 110.62 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.98 -29.67 63.23 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 116.459 -0.337 . . . . 74.24 111.231 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.62 -49.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.118 -0.697 . . . . 74.12 109.118 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 57.6 t -62.53 -47.35 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.66 -0.7 . . . . 74.32 110.03 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.36 -46.59 83.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.8 -0.637 . . . . 73.53 111.121 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.407 ' HE ' ' HB2' ' A' ' 140' ' ' ARG . 7.0 ttm180 -69.0 -33.41 73.62 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 72.3 110.5 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.416 ' HB2' HD22 ' A' ' 88' ' ' LEU . . . -64.96 -43.89 91.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.693 -0.484 . . . . 74.02 109.693 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 14.7 mm100 -57.6 -44.55 85.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.345 0.593 . . . . 74.41 109.747 175.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.28 79.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 61.13 111.817 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -72.18 -38.59 69.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 75.5 109.794 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.465 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -74.93 -51.77 12.93 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.915 -0.584 . . . . 60.0 112.567 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--O 1.255 1.391 0 N-CA-C 109.666 -0.494 . . . . 70.32 109.666 -176.149 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 N-CA-C 110.02 -0.363 . . . . 72.41 110.02 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.13 -99.49 2.07 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 121.38 -0.438 . . . . 61.41 112.305 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.71 135.18 51.05 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 122.327 -0.514 . . . . 72.44 112.238 -174.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.84 146.77 35.51 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.076 -0.965 . . . . 64.24 109.544 175.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.25 -15.85 9.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.396 -0.365 . . . . 65.44 111.342 -174.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 1.6 pp -90.61 179.25 5.87 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.32 -0.952 . . . . 74.14 111.442 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -105.58 137.11 19.21 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.927 -1.508 . . . . 73.41 106.927 173.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.32 -20.94 16.21 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.812 2.341 . . . . 74.1 114.376 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.45 -24.69 61.24 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 122.083 -0.385 . . . . 72.21 110.432 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.83 152.31 84.77 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 74.34 108.203 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.99 111.81 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 122.668 2.245 . . . . 74.34 113.085 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 m -124.59 169.35 12.01 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 108.787 -0.819 . . . . 70.11 108.787 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -128.91 160.98 30.95 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.021 -1.474 . . . . 74.44 107.021 172.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.572 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 10.9 t70 -134.66 168.59 18.72 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 104.429 -2.434 . . . . 75.23 104.429 -173.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -52.01 -57.19 15.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 112.983 0.734 . . . . 74.41 112.983 -173.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.572 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 21.7 Cg_endo -62.61 -31.6 79.54 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.778 1.652 . . . . 75.44 111.756 176.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -70.63 -36.83 73.65 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.428 0.529 . . . . 72.54 112.428 -178.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.59 -41.95 80.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.195 -0.669 . . . . 75.25 109.195 177.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.789 -1.096 . . . . 73.15 109.422 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 38.7 tt0 -65.2 -45.8 83.3 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.833 1.253 . . . . 73.4 110.445 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 30' ' ' TYR . 38.8 tp -65.64 -50.28 65.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 75.04 111.604 -177.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.59 -9.54 58.21 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.531 0.567 . . . . 74.31 112.531 -174.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.41 29.26 71.79 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.672 -0.571 . . . . 64.41 111.672 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.23 160.28 48.44 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.544 -0.91 . . . . 74.22 108.544 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.68 160.08 38.27 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.564 1.51 . . . . 75.21 111.219 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.6 -32.84 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.349 0.659 . . . . 72.44 110.419 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -57.44 -42.84 83.21 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 116.185 -0.461 . . . . 64.45 110.495 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HZ3' ' HB2' ' A' ' 45' ' ' LYS . 2.9 ttmp? -70.16 -32.43 70.4 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.949 0.404 . . . . 75.45 110.603 178.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.7 t -62.28 -44.0 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 109.116 -0.698 . . . . 72.22 109.116 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.532 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -59.36 -36.94 76.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.27 -0.423 . . . . 70.21 110.299 177.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 83.6 mm-40 -69.63 -40.41 76.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.637 0.606 . . . . 74.25 112.637 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.544 ' O ' ' HB3' ' A' ' 54' ' ' HIS . 3.2 pt20 -68.69 -33.71 74.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.929 -0.708 . . . . 73.24 109.854 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.8 mt -62.47 -39.72 94.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.971 -0.752 . . . . 73.31 108.971 174.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 70.2 mtt-85 -70.78 -21.43 62.49 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.979 0.733 . . . . 72.12 112.979 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 44.4 mt-10 -76.77 -12.11 59.93 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 121.161 -0.216 . . . . 71.33 110.63 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.81 30.55 65.84 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.991 -2.043 . . . . 75.23 107.991 -169.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.544 ' HB3' ' O ' ' A' ' 49' ' ' GLN . 11.9 t-160 -97.23 -32.21 12.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 125.139 1.376 . . . . 74.35 108.625 -176.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 41.6 tp -152.61 153.19 32.86 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.1 -1.444 . . . . 73.21 107.1 -179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.75 161.48 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 117.9 0.318 . . . . 64.41 110.467 177.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.34 154.05 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.152 -0.685 . . . . 75.22 109.152 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.43 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 123.449 0.699 . . . . 73.15 110.548 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 98.8 mtt180 -117.24 134.76 54.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.767 -0.197 . . . . 71.0 110.607 -177.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.98 127.36 21.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.864 -1.161 . . . . 75.1 107.864 170.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.97 21.52 7.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.898 1.279 . . . . 73.31 111.882 -177.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.02 -0.88 67.18 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.378 -0.439 . . . . 71.2 112.681 -179.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -98.48 135.77 12.34 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.064 -0.814 . . . . 63.31 111.064 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.19 120.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.024 -1.102 . . . . 73.14 108.024 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.83 161.61 39.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.48 0.657 . . . . 75.21 111.878 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.88 120.75 25.55 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 106.384 -1.71 . . . . 73.14 106.384 178.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.02 124.61 16.36 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.409 2.073 . . . . 73.24 112.705 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.514 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.887 0.851 . . . . 75.54 111.015 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 m -66.53 -12.24 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.562 -1.199 . . . . 74.33 112.208 177.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.464 ' CD2' HD12 ' A' ' 81' ' ' LEU . 3.1 m-85 -78.55 -11.35 59.96 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.889 0.852 . . . . 73.22 110.299 175.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -106.83 149.53 27.3 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.61 -1.255 . . . . 75.23 107.61 178.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 p -76.04 175.64 8.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.498 -0.556 . . . . 75.24 109.498 178.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.56 -22.84 66.65 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.208 0.527 . . . . 61.44 110.079 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 m -84.05 1.01 45.96 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.755 -0.657 . . . . 65.33 112.298 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.67 66.82 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.351 -0.452 . . . . 75.5 112.71 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -113.97 152.77 30.4 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.651 -0.87 . . . . 74.43 108.651 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 135.64 27.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.831 -1.174 . . . . 74.25 107.831 175.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.55 135.21 24.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.335 -0.617 . . . . 74.24 109.335 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -59.09 -31.56 69.01 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.862 0.69 . . . . 74.42 112.862 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.0 m -89.38 3.05 53.5 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.081 -0.509 . . . . 73.52 111.78 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.19 -54.12 48.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.989 -0.374 . . . . 73.14 109.989 179.393 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 32.2 Cg_exo -62.81 -30.87 78.18 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 121.134 1.222 . . . . 74.04 110.598 177.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.12 93.94 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.713 -0.676 . . . . 73.41 112.221 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -67.64 -40.02 84.61 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.17 0.509 . . . . 75.24 109.827 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.86 -46.55 87.35 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.799 -0.637 . . . . 74.14 110.264 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.8 m -60.71 -41.49 95.34 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.952 -0.567 . . . . 70.41 112.529 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -47.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 121.103 -0.239 . . . . 54.2 110.885 -178.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.01 -35.74 78.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.97 0.73 . . . . 74.13 112.97 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.507 0.723 . . . . 73.11 110.338 -177.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.4 -30.37 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.299 0.571 . . . . 63.44 110.572 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.99 -9.47 86.65 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.683 -0.69 . . . . 65.32 112.582 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 24.2 54.93 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 121.713 -0.28 . . . . 52.11 113.146 177.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 94.5 m-85 -89.61 132.98 34.85 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.576 -0.367 . . . . 73.52 111.123 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -78.88 169.88 17.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.597 0.713 . . . . 74.33 112.858 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.39 -45.34 72.84 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.395 1.878 . . . . 63.44 112.003 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.0 m -64.56 -40.39 95.48 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 115.568 -0.742 . . . . 53.55 110.204 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -65.96 -36.79 84.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.612 -0.267 . . . . 73.3 111.273 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.1 mm -61.42 -49.0 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.415 -0.957 . . . . 71.42 108.415 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.425 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 57.4 mtt -74.96 -17.72 60.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.799 -1.092 . . . . 75.44 112.391 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -59.4 -65.05 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.626 -0.509 . . . . 75.42 109.626 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -68.94 -32.56 72.25 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.749 0.648 . . . . 74.55 112.749 177.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 126' ' ' VAL . 13.1 mt -58.59 -40.84 84.31 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 112.477 0.547 . . . . 62.35 112.477 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 54.9 m-85 -92.49 -11.57 34.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.345 0.498 . . . . 75.42 112.345 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -86.62 125.36 67.47 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.654 -0.499 . . . . 71.33 109.654 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.591 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.6 Cg_exo -56.16 129.91 37.37 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.592 2.195 . . . . 74.2 110.693 175.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -90.53 123.41 65.41 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.525 -0.917 . . . . 74.32 108.525 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.21 -24.55 77.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.027 2.485 . . . . 71.43 113.6 -176.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -102.98 3.56 36.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.722 0.296 . . . . 72.14 111.367 -175.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.62 124.0 46.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.562 0.696 . . . . 72.5 111.016 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 m -131.35 110.48 11.1 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.866 -1.161 . . . . 75.23 107.866 177.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 120.924 0.392 . . . . 63.4 111.871 -174.191 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 108.163 -1.051 . . . . 71.23 108.163 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.0 t -90.22 148.44 22.93 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.311 -1.366 . . . . 71.43 107.311 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.591 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 65.6 t30 65.85 44.79 2.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.497 -1.297 . . . . 65.2 107.497 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.79 17.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.335 -0.848 . . . . 73.11 110.423 -178.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -97.27 132.3 25.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.444 -0.576 . . . . 75.34 109.444 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HB2' HD21 ' A' ' 102' ' ' LEU . 80.9 Cg_exo -50.01 -29.53 21.84 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.061 3.174 . . . . 65.01 115.543 -178.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.3 t -61.69 -42.72 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 118.519 0.599 . . . . 75.53 110.274 176.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -67.67 -33.64 75.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.278 -1.008 . . . . 73.33 108.278 -176.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.75 -50.2 72.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.723 -1.126 . . . . 75.11 111.386 177.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -65.7 -34.26 77.8 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.036 0.446 . . . . 74.4 110.946 -179.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -68.58 -23.63 64.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 75.32 109.157 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.66 7.7 45.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.815 -1.084 . . . . 74.41 110.982 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.1 m80 66.27 29.43 9.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.612 0.72 . . . . 75.41 111.773 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -101.36 22.69 12.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.033 -1.469 . . . . 73.23 107.033 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.31 -30.23 59.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.848 -1.524 . . . . 75.41 114.595 -173.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -56.75 -43.29 80.58 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.028 0.442 . . . . 64.45 111.524 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -73.31 -26.21 60.97 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.737 -0.665 . . . . 73.43 110.818 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.05 -42.13 81.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.653 -0.869 . . . . 75.24 108.653 175.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 86.1 t -60.03 -41.92 87.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-N 115.323 -0.853 . . . . 73.13 109.913 176.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.91 -40.28 92.56 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.341 0.591 . . . . 75.13 110.157 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -41.04 93.67 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.457 -0.942 . . . . 74.44 108.457 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.21 -45.12 94.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.967 -1.015 . . . . 73.22 110.549 177.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.6 mt-30 -57.3 -36.18 70.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 73.32 110.574 176.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.49 78.43 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.943 -0.571 . . . . 65.31 111.152 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 29.5 ttm -80.78 -45.39 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.724 -0.79 . . . . 74.21 112.618 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.46 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -69.72 -34.84 74.43 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.031 1.123 . . . . 74.12 114.031 -174.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 109.24 -0.652 . . . . 73.22 109.24 -178.664 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.955 0 CA-C-O 120.571 0.224 . . . . 61.23 110.579 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 -87.17 1.99 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.561 -1.016 . . . . 61.33 110.561 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -141.12 159.95 41.13 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.604 -0.351 . . . . 73.15 110.848 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 9.6 t0 -93.75 137.67 32.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.636 -0.711 . . . . 71.24 112.647 -173.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.01 -26.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.692 -0.685 . . . . 72.24 111.8 -175.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.549 HD22 ' CZ ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -80.45 -178.9 6.89 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 118.663 -1.215 . . . . 74.35 110.655 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -100.79 147.94 34.34 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 107.868 -1.16 . . . . 73.05 107.868 -178.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.08 -21.27 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.992 2.462 . . . . 75.11 113.576 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.78 -27.24 68.14 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.903 0.481 . . . . 72.24 110.548 176.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.15 125.24 85.44 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 107.756 -1.201 . . . . 70.15 107.756 171.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 16.6 Cg_exo -65.31 139.73 61.14 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.218 1.946 . . . . 72.05 112.898 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 65' ' ' VAL . 6.3 p -118.22 156.97 27.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.252 0.834 . . . . 73.14 113.252 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 28.0 m-85 -109.78 161.89 15.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 125.452 1.501 . . . . 74.21 108.858 176.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' HG21 ' A' ' 35' ' ' VAL . 4.3 m-20 -134.56 165.77 24.43 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 104.623 -2.362 . . . . 72.43 104.623 -178.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.04 -56.37 18.15 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 114.415 1.265 . . . . 70.23 114.415 -175.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.05 -31.62 76.05 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.915 1.744 . . . . 75.44 112.424 178.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.44 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 14.8 tpt180 -70.42 -39.37 74.47 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.736 0.814 . . . . 72.03 110.221 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 31' ' ' ASP . 59.3 t -69.2 -38.58 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 71.42 109.372 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.11 91.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.441 -0.799 . . . . 54.42 109.626 177.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.57 -44.98 94.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.016 -1.447 . . . . 75.24 110.06 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.4 tp -65.62 -47.48 75.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.921 -1.036 . . . . 75.25 111.339 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.7 -18.54 40.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.865 0.691 . . . . 74.23 112.865 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.45 55.13 Favored Glycine 0 C--N 1.311 -0.827 0 N-CA-C 111.017 -0.833 . . . . 71.01 111.017 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.22 161.83 45.23 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.148 -1.056 . . . . 73.22 108.148 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.94 156.23 66.7 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 121.362 1.374 . . . . 75.3 112.603 178.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.45 -37.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 61.34 110.256 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 23.0 t -60.69 -34.78 74.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.534 -0.757 . . . . 61.04 110.653 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 60.8 tttp -69.33 -39.02 78.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.837 -0.431 . . . . 75.43 109.837 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.2 t -61.34 -41.16 88.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.249 0.547 . . . . 73.15 109.56 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.81 81.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.41 -0.814 . . . . 73.53 110.498 176.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.2 mt-30 -65.36 -44.0 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.359 -0.382 . . . . 74.21 110.308 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.9 mm-40 -61.86 -43.17 99.38 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.791 0.682 . . . . 74.3 110.226 -178.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.97 -40.81 96.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.589 -1.187 . . . . 73.33 110.343 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.47 -21.49 61.94 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.201 0.815 . . . . 75.13 113.201 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -88.14 -11.88 45.63 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 120.406 0.146 . . . . 70.21 111.272 178.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.98 32.45 49.28 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.234 -1.146 . . . . 63.43 110.234 -175.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -93.74 -13.74 27.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.31 -1.367 . . . . 74.1 107.31 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -157.08 152.86 26.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.193 -2.151 . . . . 75.51 105.193 179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.6 152.05 30.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.162 -0.681 . . . . 73.3 109.162 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -127.26 162.14 26.91 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.086 -0.506 . . . . 64.41 110.575 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.64 166.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 123.397 0.679 . . . . 74.1 109.467 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -120.5 131.65 54.83 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.879 -0.328 . . . . 72.43 110.649 -176.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.453 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 30.1 ptt180 -147.51 138.32 23.46 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.582 -0.895 . . . . 71.33 108.582 175.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.35 17.71 9.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.004 0.922 . . . . 72.04 111.612 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.85 -4.02 74.78 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.976 -0.556 . . . . 61.05 112.245 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.24 144.38 15.77 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.836 -0.697 . . . . 74.21 111.593 -178.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.44 120.12 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.04 -1.467 . . . . 71.11 107.04 178.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.8 m -133.68 154.42 38.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.36 0.6 . . . . 72.21 111.796 -173.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.53 120.75 38.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 107.497 -1.298 . . . . 71.14 107.497 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.74 128.39 29.38 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.698 2.265 . . . . 73.11 112.179 177.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 28' ' ' PRO . 6.1 tt0 -57.34 -25.53 59.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.36 0.504 . . . . 65.24 112.36 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -70.95 -4.24 4.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.782 -0.645 . . . . 75.03 112.446 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 81' ' ' LEU . 4.8 m-85 -83.84 -4.66 58.85 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.248 1.023 . . . . 74.44 109.913 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -122.16 158.84 28.47 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.801 -1.555 . . . . 73.43 106.801 177.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.2 p -91.57 163.87 13.98 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.69 -0.856 . . . . 73.42 108.69 179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.73 -16.29 62.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.336 0.588 . . . . 74.12 110.147 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -79.47 -0.67 34.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.238 0.615 . . . . 63.54 111.187 -178.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.38 60.48 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.851 -0.69 . . . . 64.21 112.005 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -125.9 145.95 50.04 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.607 -1.257 . . . . 75.45 107.607 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.17 155.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.967 -1.123 . . . . 74.21 107.967 176.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 48.4 t -69.82 112.03 4.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.498 -0.927 . . . . 70.34 108.498 177.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -56.18 -35.11 66.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.467 1.284 . . . . 75.43 114.467 -175.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.5 m -90.69 -4.25 56.89 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.223 0.535 . . . . 74.33 111.536 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.6 tt -65.83 -47.48 64.85 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.51 0.929 . . . . 75.54 113.51 -176.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.6 Cg_endo -54.24 -28.73 53.6 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 121.743 1.628 . . . . 73.21 111.514 176.391 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.15 -38.2 95.61 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.709 -0.678 . . . . 54.55 112.048 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -68.17 -40.15 82.37 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.767 -0.827 . . . . 75.21 108.767 178.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.88 -32.69 73.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 74.1 110.233 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 m -62.76 -50.18 72.08 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.66 -0.7 . . . . 71.44 110.289 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -40.25 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.465 -0.334 . . . . 74.45 111.439 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.88 -35.36 79.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.58 0.585 . . . . 75.02 112.58 176.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -61.68 -40.54 95.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 75.5 109.343 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.63 -31.87 73.13 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.791 -0.64 . . . . 70.31 110.854 178.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.53 -9.95 68.46 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.962 -0.637 . . . . 75.12 112.495 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.48 48.98 8.54 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 114.004 0.361 . . . . 71.03 114.004 177.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.44 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 88.4 m-85 -110.17 139.44 45.32 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.408 0.604 . . . . 72.34 111.447 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -81.91 171.79 14.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 72.42 111.851 -179.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.0 p-10 -54.64 -45.51 73.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 72.54 111.83 -177.41 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 m -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.364 0.666 . . . . 73.42 110.052 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.65 -38.74 92.28 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.624 -0.717 . . . . 74.05 111.229 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 mm -61.26 -47.5 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.334 -0.987 . . . . 65.43 108.334 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 22.8 mmt -67.99 -26.07 65.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.677 -1.147 . . . . 75.52 111.656 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -52.56 -71.26 0.07 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.694 0.627 . . . . 75.12 112.694 -176.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -68.58 -31.46 70.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.166 0.432 . . . . 75.41 112.166 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 126' ' ' VAL . 15.7 mt -56.55 -40.64 75.49 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 112.131 0.419 . . . . 75.04 112.131 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.549 ' CZ ' HD22 ' A' ' 23' ' ' LEU . 96.5 m-85 -102.02 2.01 37.21 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.956 0.724 . . . . 72.52 112.956 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -89.08 112.13 49.17 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.712 -0.477 . . . . 71.43 109.712 173.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.1 128.76 21.3 Favored 'Trans proline' 0 C--O 1.251 1.145 0 N-CA-C 108.434 -1.41 . . . . 72.21 108.434 173.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 23.6 t70 -96.85 126.29 43.34 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.698 -0.401 . . . . 64.12 111.501 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.66 -16.9 46.18 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.22 2.613 . . . . 75.53 114.277 -178.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.4 t -114.53 8.99 16.57 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 121.163 0.506 . . . . 72.24 109.924 -178.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.41 HD13 ' NH2' ' A' ' 140' ' ' ARG . 51.6 tp -106.94 118.68 37.33 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.729 0.776 . . . . 74.1 112.328 -178.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.0 m -118.2 117.19 28.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.191 -1.04 . . . . 74.44 108.191 178.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.3 mm . . . . . 0 C--N 1.291 -1.95 0 CA-C-N 115.118 -0.946 . . . . 73.55 109.826 -175.658 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 109.05 -0.722 . . . . 64.1 109.05 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -84.0 149.83 26.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.268 -0.641 . . . . 70.13 109.268 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 22.8 t-20 70.1 40.42 1.22 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.219 1.008 . . . . 74.05 109.798 178.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.55 156.65 22.68 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.734 -0.604 . . . . 74.51 110.348 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -102.95 143.65 27.03 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 108.711 -0.848 . . . . 73.42 108.711 175.821 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.73 -34.08 34.36 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 123.655 2.904 . . . . 73.35 114.856 -177.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.5 t -62.95 -40.46 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.466 0.651 . . . . 74.33 110.782 177.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.23 -37.79 88.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.347 -0.982 . . . . 74.44 108.347 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.94 78.66 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.484 -1.235 . . . . 74.42 112.023 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -66.41 -36.22 82.29 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.013 -0.429 . . . . 74.54 112.114 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.422 ' N ' HD13 ' A' ' 129' ' ' LEU . 16.6 t-80 -73.27 -16.16 61.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.216 1.007 . . . . 74.22 108.975 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.83 5.25 51.75 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.019 -0.991 . . . . 72.22 110.465 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.0 m80 65.22 28.99 11.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.416 1.086 . . . . 63.53 112.296 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -103.83 23.71 12.39 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.653 -1.24 . . . . 73.44 107.653 176.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.38 -26.83 13.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.549 1.94 . . . . 62.5 112.74 -176.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -54.39 -38.2 65.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.881 0.472 . . . . 74.43 111.773 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -73.5 -32.2 64.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.696 -0.483 . . . . 73.14 109.696 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.52 -48.31 77.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.501 -0.772 . . . . 75.45 109.586 -178.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 59.6 t -62.37 -42.79 96.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 N-CA-C 109.279 -0.638 . . . . 74.04 109.279 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -62.61 -39.45 93.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.711 -0.677 . . . . 73.14 111.188 178.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.41 ' NH2' HD13 ' A' ' 109' ' ' LEU . 2.7 tpp180 -64.73 -38.84 92.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.077 -0.712 . . . . 73.34 109.077 178.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.85 -38.66 79.91 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.831 -1.077 . . . . 75.53 110.613 178.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.0 mt-30 -58.87 -49.51 77.47 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.591 -0.277 . . . . 74.12 110.288 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 72.55 111.141 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.463 ' HE2' ' HA ' ' A' ' 144' ' ' MET . 2.5 tpt -83.39 -30.94 26.98 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.346 0.593 . . . . 72.4 110.191 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.44 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.21 -54.07 5.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.186 -0.461 . . . . 72.13 111.638 -177.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--N 1.309 -1.174 0 N-CA-C 108.676 -0.861 . . . . 74.52 108.676 -177.45 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.826 0 N-CA-C 109.306 -0.627 . . . . 64.24 109.306 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.17 -133.99 7.63 Favored Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 121.144 -0.55 . . . . 64.42 112.314 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.28 124.39 46.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.533 -0.543 . . . . 75.33 109.533 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.69 130.78 44.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.25 0.548 . . . . 70.34 111.048 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 22' ' ' VAL . 22.3 t -111.44 27.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 123.294 1.521 . . . . 74.43 109.5 -178.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -118.68 172.94 7.15 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-N 114.994 -1.003 . . . . 74.42 110.098 175.6 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 14.3 t70 -86.5 137.06 34.47 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.724 -1.213 . . . . 72.02 107.724 175.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -50.78 -21.96 9.06 Favored 'Trans proline' 0 CA--C 1.557 1.67 0 C-N-CA 123.149 2.566 . . . . 72.2 115.242 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.91 -1.46 56.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.509 0.929 . . . . 72.14 113.509 178.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 27.1 mm-40 -67.42 151.76 96.84 Favored Pre-proline 0 C--O 1.248 0.979 0 N-CA-C 109.268 -0.642 . . . . 74.33 109.268 176.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.3 119.01 5.46 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.712 2.275 . . . . 73.05 111.371 176.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.1 m -136.29 162.11 33.92 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.679 -0.86 . . . . 64.41 108.679 -174.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.574 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 21.8 m-85 -126.72 160.11 31.77 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.379 -0.971 . . . . 74.44 108.379 174.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.3 t0 -134.69 157.92 45.42 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 103.883 -2.636 . . . . 71.15 103.883 -178.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -46.83 -54.22 21.17 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 114.443 1.275 . . . . 73.43 114.443 -169.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.23 -39.19 86.97 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.833 1.689 . . . . 74.41 112.188 177.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -71.01 -34.74 71.63 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.614 -0.266 . . . . 72.41 110.476 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 31' ' ' ASP . 27.3 t -69.12 -42.3 81.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.71 -0.478 . . . . 74.31 109.71 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.9 82.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.273 -0.876 . . . . 64.31 109.516 178.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.63 -46.02 70.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.36 -1.291 . . . . 62.02 110.467 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.434 HD23 ' CZ ' ' A' ' 30' ' ' TYR . 26.8 tp -64.26 -50.06 69.43 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.118 0.967 . . . . 73.13 112.177 -176.207 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.6 mt -86.07 -18.24 32.95 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.739 -0.664 . . . . 73.23 111.614 -175.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.21 63.58 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.704 -0.958 . . . . 71.23 110.704 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.91 159.61 50.61 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 108.814 -0.81 . . . . 74.35 108.814 -176.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.74 157.93 51.23 Favored 'Trans proline' 0 C--O 1.252 1.217 0 C-N-CA 121.425 1.417 . . . . 72.33 111.846 176.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.11 -33.0 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.765 -0.652 . . . . 74.41 110.642 178.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.6 t -57.67 -42.65 84.02 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.036 -0.529 . . . . 72.3 110.615 177.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 88.2 tttt -69.51 -34.34 74.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.948 0.404 . . . . 74.31 110.127 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.92 -45.07 99.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.847 -0.615 . . . . 72.54 109.432 177.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -61.91 -37.28 84.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.348 -0.842 . . . . 74.24 110.35 178.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.423 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 15.7 mm100 -62.84 -40.1 96.4 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.277 -0.42 . . . . 73.23 111.542 178.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 80.9 mm-40 -59.75 -44.24 93.92 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.577 0.703 . . . . 65.34 109.459 178.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -62.21 -43.95 97.67 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.828 -1.078 . . . . 74.23 109.886 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.477 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -66.1 -21.61 66.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.979 -0.555 . . . . 74.31 112.379 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 43.2 mt-10 -98.91 -7.89 26.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.423 -0.511 . . . . 72.45 111.798 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.04 27.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.482 -0.866 . . . . 61.34 111.615 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.65 -8.92 14.55 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.815 -0.809 . . . . 75.44 108.815 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.4 tp -155.22 154.15 31.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.715 -1.587 . . . . 73.03 106.715 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.2 146.59 33.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 75.43 108.818 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' CB ' HG21 ' A' ' 66' ' ' ILE . . . -126.09 151.17 47.57 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 107.63 -1.248 . . . . 74.31 107.63 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.518 HG12 ' SD ' ' A' ' 99' ' ' MET . 34.4 m -129.85 166.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 123.437 0.695 . . . . 71.45 109.856 -176.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -110.27 121.45 45.32 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.763 -0.828 . . . . 73.14 108.763 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -117.09 113.8 22.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.012 -0.736 . . . . 74.22 109.012 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.96 -53.19 0.68 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.268 1.827 . . . . 71.45 111.191 -179.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.97 0.44 0.03 OUTLIER Glycine 0 C--N 1.286 -2.208 0 CA-C-N 114.913 -1.039 . . . . 61.01 113.0 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.92 149.38 17.02 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.39 -0.91 . . . . 51.42 111.061 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.6 120.6 47.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.535 -1.283 . . . . 74.43 107.535 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.39 171.63 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 124.509 1.124 . . . . 74.35 108.312 -175.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.403 HG21 ' CB ' ' A' ' 57' ' ' ALA . 40.6 pt -127.68 144.06 49.77 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.938 -0.764 . . . . 71.4 108.938 178.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.57 118.31 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.612 1.541 . . . . 75.33 110.799 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.574 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 tt0 -61.44 -24.88 66.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.365 0.666 . . . . 74.1 111.811 -178.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 35.0 m -63.67 -9.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 CA-C-N 115.422 -0.808 . . . . 74.24 112.631 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' A' ' 81' ' ' LEU . 3.2 m-85 -78.77 -6.83 56.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.826 0.822 . . . . 72.53 109.948 175.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -117.0 161.29 19.62 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.937 -1.135 . . . . 75.41 107.937 175.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 63.1 p -90.54 168.22 11.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.501 -1.296 . . . . 71.23 107.501 176.096 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.59 -17.49 64.85 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.656 0.613 . . . . 72.41 112.656 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -80.1 -9.09 59.68 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.376 -0.375 . . . . 72.41 111.311 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.68 9.9 62.27 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.532 -0.842 . . . . 75.35 112.509 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -97.34 140.2 32.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.59 -1.633 . . . . 72.4 106.59 177.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.59 152.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.135 -1.061 . . . . 74.31 108.135 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.52 126.55 22.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.423 -0.584 . . . . 74.2 109.423 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.19 -34.17 77.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 113.288 0.847 . . . . 75.24 113.288 -175.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 t -91.93 8.11 38.98 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.369 0.604 . . . . 54.23 110.281 -177.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 70' ' ' PHE . 14.5 tp -58.83 -54.01 60.68 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.748 -0.66 . . . . 74.32 112.048 -177.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.75 -25.24 74.81 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.53 1.487 . . . . 74.23 111.846 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.95 78.43 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.135 -0.484 . . . . 72.11 111.905 -178.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -67.38 -39.51 85.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.116 -0.698 . . . . 74.25 109.116 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.06 -40.07 95.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.368 -0.833 . . . . 73.22 111.068 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -62.28 -47.35 84.69 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 116.437 -0.347 . . . . 74.12 111.558 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -43.79 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 116.471 -0.331 . . . . 73.34 111.344 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.415 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 4.4 mm? -66.91 -35.79 80.8 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.901 -0.5 . . . . 75.41 112.257 177.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -64.93 -33.14 75.32 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.528 -0.545 . . . . 75.11 109.528 177.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.25 -31.25 70.6 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.143 0.497 . . . . 63.15 110.81 176.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.76 -9.3 78.31 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.762 -0.654 . . . . 74.44 112.036 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.73 48.1 6.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 121.386 -0.435 . . . . 71.0 112.487 178.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.411 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 80.0 m-85 -110.8 138.15 47.56 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.787 0.327 . . . . 74.25 111.335 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 28.5 ptt180 -86.28 170.9 11.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 75.35 109.818 177.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -55.05 -41.27 71.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.511 1.524 . . . . 73.12 111.233 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -61.67 -41.26 97.3 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.496 -0.774 . . . . 71.51 110.608 -179.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HG2' ' CG ' ' A' ' 94' ' ' ARG . 8.8 mm-40 -66.02 -38.06 87.5 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.897 -0.779 . . . . 63.12 108.897 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 94' ' ' ARG . 24.9 mm -61.12 -48.0 90.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.651 -0.87 . . . . 74.43 108.651 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.518 ' SD ' HG12 ' A' ' 58' ' ' VAL . 76.0 mtm -71.49 -22.36 61.81 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.249 -0.887 . . . . 74.02 112.194 -177.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.01 -65.31 0.62 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.798 -0.816 . . . . 75.02 108.798 -179.655 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.565 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 53.2 p-90 -69.78 -33.86 72.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.787 0.662 . . . . 74.23 112.787 179.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.523 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -66.76 -39.06 87.75 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.714 0.806 . . . . 72.42 112.941 -173.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 47.6 m-85 -92.63 7.88 41.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.632 0.605 . . . . 75.41 112.632 -178.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.1 m -86.94 116.51 66.32 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 109.562 -0.533 . . . . 74.42 109.562 177.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.7 129.22 19.42 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 121.516 1.478 . . . . 71.03 108.26 172.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 25.7 t70 -115.71 119.75 37.05 Favored Pre-proline 0 C--N 1.295 -1.774 0 C-N-CA 120.637 -0.425 . . . . 75.44 110.791 -175.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.42 -28.95 87.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.021 2.48 . . . . 65.24 112.815 -177.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -90.88 2.05 56.48 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.487 0.551 . . . . 75.04 112.487 -177.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.9 tp -102.17 125.13 48.78 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 107.869 -1.16 . . . . 74.33 107.869 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 m -118.5 113.35 21.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.07 -1.085 . . . . 75.43 108.07 -177.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 37.9 mm . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 116.116 -0.493 . . . . 74.21 109.7 -173.059 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 108.502 -0.925 . . . . 75.11 108.502 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 m -82.84 138.84 33.79 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.204 -1.406 . . . . 64.15 107.204 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 42.7 t30 78.3 69.0 0.04 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.056 0.942 . . . . 74.11 110.947 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.54 173.1 6.71 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.213 -1.032 . . . . 75.13 108.213 172.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -96.19 156.94 36.43 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 106.391 -1.707 . . . . 75.4 106.391 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 27.7 Cg_exo -61.75 -20.08 67.75 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 121.39 1.394 . . . . 73.55 110.518 173.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 102' ' ' LEU . 74.3 t -60.67 -43.41 94.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 109.131 -0.692 . . . . 71.23 109.131 173.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.47 -39.29 93.52 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.68 -0.691 . . . . 53.3 109.43 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.46 66.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 71.43 112.002 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 130' ' ' HIS . 4.6 pp -66.81 -35.52 80.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.993 0.425 . . . . 75.35 111.598 -177.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 13.8 t60 -70.81 -24.85 62.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.852 0.834 . . . . 75.12 108.939 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -99.05 11.49 38.86 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.16 -0.927 . . . . 73.42 112.24 -178.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.7 27.54 9.32 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.348 1.071 . . . . 71.33 110.889 177.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -109.68 25.09 12.19 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.586 -1.264 . . . . 73.3 107.586 177.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 138' ' ' VAL . . . -52.56 -26.49 13.46 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.366 1.866 . . . . 71.41 113.196 -175.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -54.65 -35.91 63.99 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.657 0.208 . . . . 75.14 110.559 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.17 -28.08 62.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.659 0.742 . . . . 75.22 110.735 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.3 -44.99 54.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.639 -0.875 . . . . 71.13 108.639 177.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.504 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 61.3 t -61.1 -44.25 97.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 115.541 -0.754 . . . . 60.3 110.634 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.11 -38.69 89.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 120.457 -0.497 . . . . 74.24 110.824 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -69.12 -38.01 78.64 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.83 0.348 . . . . 75.41 110.998 175.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.415 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -59.01 -43.32 91.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.743 -0.662 . . . . 63.25 110.256 178.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 93.8 mt-30 -63.06 -45.47 92.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.851 -0.613 . . . . 73.54 110.167 177.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.91 94.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.639 -0.709 . . . . 74.12 111.112 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.565 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 17.0 tpt -70.34 -32.82 70.7 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.757 -0.656 . . . . 74.24 111.031 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.411 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.3 -54.51 5.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.013 -0.54 . . . . 71.3 111.538 -178.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 118.567 -0.73 . . . . 75.02 109.115 -175.842 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 N-CA-C 106.441 -1.689 . . . . 64.2 106.441 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.94 -106.19 2.77 Favored Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.884 -0.674 . . . . 74.01 112.408 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.25 121.56 35.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.931 0.396 . . . . 75.21 110.452 -175.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -61.39 119.17 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.977 -1.01 . . . . 75.33 110.81 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.4 t -77.07 -25.28 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.447 0.641 . . . . 71.4 111.234 -177.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.6 148.44 28.0 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.407 -0.917 . . . . 72.3 111.9 176.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.32 145.19 99.1 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 114.988 -1.006 . . . . 70.31 110.782 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.44 -27.07 30.38 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.347 2.698 . . . . 74.52 114.058 177.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.8 -23.35 58.48 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.734 0.272 . . . . 73.02 111.734 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.09 126.63 91.66 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 108.903 -0.777 . . . . 75.33 108.903 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.64 106.53 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.876 2.384 . . . . 72.23 111.387 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 p -106.67 172.05 7.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.833 -0.621 . . . . 73.21 110.829 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.463 ' CE2' HD12 ' A' ' 38' ' ' LEU . 16.6 m-85 -109.63 161.5 15.32 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.581 -0.896 . . . . 73.14 108.581 177.047 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.14 166.24 22.91 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 103.606 -2.739 . . . . 74.35 103.606 -173.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -52.79 -51.13 76.88 Favored Pre-proline 0 C--N 1.309 -1.188 0 O-C-N 123.881 0.738 . . . . 73.23 112.004 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.52 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 10.9 Cg_endo -57.53 -39.71 86.39 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.794 1.663 . . . . 65.2 112.352 175.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 3.9 mpt_? -70.35 -36.2 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.979 0.733 . . . . 73.14 112.979 -177.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG21 HD11 ' A' ' 66' ' ' ILE . 73.4 t -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.971 -0.692 . . . . 74.13 109.764 175.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.01 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.157 -0.929 . . . . 75.33 109.055 174.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 19.3 mm-40 -65.52 -45.49 83.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 72.11 112.092 175.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.463 HD12 ' CE2' ' A' ' 30' ' ' TYR . 89.1 mt -62.73 -50.74 69.89 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.339 -0.391 . . . . 71.35 111.623 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.01 -15.38 36.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.799 -0.637 . . . . 74.1 112.137 -174.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.6 67.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.39 -1.084 . . . . 64.21 110.39 -177.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.21 164.61 24.79 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 108.671 -0.862 . . . . 63.41 108.671 -177.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.87 167.05 14.72 Favored 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 121.44 1.427 . . . . 71.32 111.638 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.5 t -59.02 -33.09 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.579 0.751 . . . . 75.02 110.644 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 24.6 p -57.58 -43.58 84.67 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.455 -0.793 . . . . 73.04 111.201 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 56.9 mtpt -69.33 -33.61 73.39 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.761 -0.199 . . . . 74.5 111.091 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.5 -43.7 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.626 -0.509 . . . . 74.2 109.626 177.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.47 78.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 62.34 110.479 177.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 44' ' ' SER . 97.9 mt-30 -65.43 -36.54 84.22 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.958 -0.564 . . . . 73.4 111.495 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm100 -63.28 -43.21 98.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.384 -0.969 . . . . 72.23 108.384 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 9.3 mp -61.75 -46.64 88.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.515 -1.22 . . . . 75.02 110.154 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -60.47 -25.72 66.24 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.676 0.991 . . . . 65.13 113.676 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 54' ' ' HIS . 7.6 pt-20 -102.55 2.77 36.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.425 -0.91 . . . . 75.41 111.625 -177.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.32 38.88 71.15 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.507 -0.854 . . . . 64.45 111.476 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 3.4 t60 -96.28 -28.9 14.29 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.853 -1.166 . . . . 74.25 107.853 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 55.9 tp -159.73 156.02 26.97 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.418 -2.068 . . . . 75.23 105.418 -178.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.48 152.29 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.123 -0.695 . . . . 72.51 109.123 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.7 161.82 19.45 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 123.489 0.493 . . . . 73.53 109.747 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.519 HG11 ' SD ' ' A' ' 99' ' ' MET . 22.2 m -126.54 166.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.01 -0.737 . . . . 72.31 109.01 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -116.58 134.84 54.36 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.56 -0.533 . . . . 72.4 109.56 -174.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -148.21 125.96 11.87 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.76 -0.83 . . . . 74.54 108.76 171.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.17 22.89 12.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.075 0.95 . . . . 65.24 112.017 178.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.57 -14.78 64.39 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.847 -0.615 . . . . 72.21 112.495 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.41 150.0 20.53 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 121.306 -0.473 . . . . 60.15 112.426 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.75 120.57 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.592 -1.262 . . . . 74.13 107.592 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.3 160.8 40.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.604 -0.725 . . . . 73.54 109.697 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.425 HD11 HG21 ' A' ' 35' ' ' VAL . 70.7 mt -130.69 129.08 22.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 72.4 108.286 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.4 131.63 47.37 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.566 2.177 . . . . 71.51 111.425 176.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.8 tt0 -65.27 -25.48 67.67 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 120.836 0.351 . . . . 72.3 111.227 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.29 -2.25 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.519 -0.764 . . . . 72.12 112.636 178.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.645 ' CD2' HD12 ' A' ' 81' ' ' LEU . 5.6 m-85 -86.38 -8.21 57.85 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.374 1.083 . . . . 73.03 109.359 173.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.6 m-85 -115.86 155.63 27.58 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.53 -1.656 . . . . 74.51 106.53 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.7 p -80.89 173.73 12.32 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.434 -0.951 . . . . 74.01 108.434 177.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -58.29 -20.57 43.88 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.029 0.752 . . . . 75.52 113.029 -177.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 t -89.04 -2.52 58.61 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 121.9 -0.5 . . . . 74.5 111.488 179.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.39 15.21 58.99 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.087 -0.578 . . . . 62.33 113.509 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -113.08 142.06 46.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.88 -0.785 . . . . 75.2 108.88 178.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 71' ' ' PHE . 11.8 p -62.01 144.18 14.39 Favored 'Isoleucine or valine' 0 C--O 1.249 1.032 0 O-C-N 123.715 0.635 . . . . 72.51 110.869 -175.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 35.2 t -65.46 131.82 31.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.979 -0.749 . . . . 72.42 108.979 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.87 -34.04 75.28 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.523 0.935 . . . . 73.05 113.523 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.0 m -86.2 -6.29 59.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.041 0.448 . . . . 73.15 111.069 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.645 HD12 ' CD2' ' A' ' 70' ' ' PHE . 10.2 tt -66.3 -49.19 55.27 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 114.134 1.161 . . . . 73.54 114.134 -175.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.88 -33.84 73.42 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 121.961 1.774 . . . . 74.51 111.413 176.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.48 95.9 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.212 -0.904 . . . . 70.15 112.725 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.7 pp -67.34 -40.49 85.86 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.57 -0.53 . . . . 72.4 109.57 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.45 -34.61 77.13 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.263 -0.426 . . . . 73.12 110.662 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.2 m -62.34 -48.08 81.4 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.821 -0.627 . . . . 62.52 112.041 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.98 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 111.72 0.267 . . . . 74.22 111.72 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.67 -35.04 79.21 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.552 -0.459 . . . . 73.11 111.66 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -58.7 -43.15 89.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.254 -0.647 . . . . 74.43 109.254 176.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.015 0.822 . . . . 74.41 110.842 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.87 -9.1 81.53 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.986 -0.552 . . . . 71.14 112.643 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 33.55 28.2 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.871 -0.68 . . . . 74.51 112.275 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -102.12 125.52 48.84 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.94 0.4 . . . . 73.21 111.037 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.422 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 37.2 ptt180 -75.67 171.79 13.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.663 -0.698 . . . . 73.13 111.157 178.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -54.2 -40.62 67.77 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.234 1.413 . . . . 74.21 110.866 -178.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.7 m -61.52 -42.32 98.63 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.858 -1.065 . . . . 73.22 110.67 -178.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 12.4 mm-40 -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.128 -0.487 . . . . 74.24 110.228 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.4 mm -60.99 -47.92 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.486 -0.931 . . . . 72.35 108.486 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.519 ' SD ' HG11 ' A' ' 58' ' ' VAL . 70.7 mtm -71.82 -25.04 61.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.85 -1.068 . . . . 74.22 111.415 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -64.18 0.98 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.112 -0.699 . . . . 72.32 109.112 -176.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.448 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 34.5 p-90 -69.44 -32.78 71.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.947 0.721 . . . . 74.22 112.947 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.448 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 14.8 mt -61.22 -40.64 94.77 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.905 0.706 . . . . 64.41 112.905 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -93.15 -1.21 56.59 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.427 0.529 . . . . 75.15 112.427 -177.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.1 m -87.99 127.1 58.88 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 109.236 -0.653 . . . . 75.0 109.236 175.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 44.0 Cg_exo -61.26 129.19 27.46 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 121.903 1.736 . . . . 64.22 110.105 174.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 10.6 t70 -85.91 126.31 66.07 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.812 -0.81 . . . . 63.31 108.812 -177.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.95 -17.39 51.08 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.296 2.664 . . . . 55.24 114.017 -177.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.3 m -122.49 15.68 10.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.892 -0.505 . . . . 73.24 111.443 -176.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 tp -108.47 126.4 52.86 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.738 0.644 . . . . 71.02 112.738 -176.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.4 m -119.72 133.64 55.54 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 105.354 -2.091 . . . . 75.3 105.354 174.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.306 -1.284 0 C-N-CA 119.111 -1.036 . . . . 74.11 113.791 -175.489 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.394 -0.595 . . . . 74.24 109.394 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.8 p -88.32 150.2 23.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.055 -1.091 . . . . 74.44 108.055 173.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 12.7 m120 61.09 42.28 12.65 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.31 1.053 . . . . 74.2 108.405 -173.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.6 163.92 26.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.098 -1.41 . . . . 64.23 111.752 -176.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -97.11 133.02 24.61 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.769 -1.105 . . . . 73.15 109.279 -178.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.16 -31.09 44.03 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.635 2.89 . . . . 74.53 114.423 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 67.8 t -60.83 -42.21 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 73.4 110.709 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.2 -40.38 82.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.096 -0.705 . . . . 74.12 109.096 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.95 83.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.123 -0.944 . . . . 75.02 112.091 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -68.52 -34.62 76.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.58 -0.448 . . . . 74.44 111.778 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.404 ' N ' HD12 ' A' ' 129' ' ' LEU . 46.4 t-80 -77.34 -24.13 50.79 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 107.745 -1.206 . . . . 73.1 107.745 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.18 12.45 7.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.622 -1.172 . . . . 73.13 111.583 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.0 m80 66.85 28.17 8.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.061 0.945 . . . . 71.35 110.927 176.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -112.28 23.22 13.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.049 -1.093 . . . . 75.54 108.049 176.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.52 -31.48 46.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 114.262 -1.335 . . . . 74.5 113.318 -176.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -65.18 -35.12 80.08 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 120.978 -0.289 . . . . 74.33 111.719 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -69.83 -28.56 65.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.679 0.752 . . . . 74.35 109.688 177.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.0 -45.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.957 -0.757 . . . . 70.45 108.957 176.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 82.7 t -59.87 -41.65 86.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 N-CA-C 109.11 -0.7 . . . . 73.22 109.11 175.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.797 0.839 . . . . 73.34 110.945 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.11 -37.25 86.48 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.572 -0.529 . . . . 75.24 109.572 177.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.24 89.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.428 -0.806 . . . . 62.0 110.833 178.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 92.2 mt-30 -67.46 -36.35 80.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.473 -0.331 . . . . 75.11 110.198 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.84 62.48 Favored 'General case' 0 C--O 1.208 -1.085 0 CA-C-N 116.153 -0.476 . . . . 54.2 110.662 176.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.89 -30.85 45.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.389 0.614 . . . . 73.5 109.422 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.79 -41.69 13.1 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.861 -0.609 . . . . 72.13 111.366 178.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.607 -0.711 . . . . 75.54 110.106 -178.683 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 109.765 -0.458 . . . . 74.51 109.765 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.72 -110.19 2.48 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 115.961 -0.563 . . . . 64.12 113.552 -176.363 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.16 123.92 33.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.678 0.275 . . . . 72.23 110.422 -172.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.474 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 17.5 t0 -61.84 130.99 48.33 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.777 1.029 . . . . 71.3 113.777 -175.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.87 -23.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.422 -0.808 . . . . 74.4 112.352 -175.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.439 HD22 ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -89.51 -172.43 3.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 119.075 -1.05 . . . . 72.22 112.173 -178.086 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -90.2 137.01 28.03 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 109.304 -0.628 . . . . 74.31 109.304 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.54 -21.92 70.3 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.54 2.16 . . . . 75.3 111.939 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -68.61 -25.15 64.71 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.89 -0.595 . . . . 70.1 111.464 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.76 117.39 60.58 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 107.857 -1.164 . . . . 74.01 107.857 177.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.88 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.831 2.354 . . . . 72.15 112.041 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 66' ' ' ILE . 42.0 p -98.86 -162.11 0.93 Allowed 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 115.019 -0.992 . . . . 53.54 109.131 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -109.27 159.33 17.04 Favored 'General case' 0 N--CA 1.391 -3.392 0 N-CA-C 107.723 -1.214 . . . . 71.42 107.723 174.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' HG22 ' A' ' 35' ' ' VAL . 5.2 m-20 -135.11 161.24 35.89 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 103.583 -2.747 . . . . 73.34 103.583 -176.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.66 -54.83 23.38 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 113.742 1.015 . . . . 74.01 113.742 -173.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.2 -34.1 46.75 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 121.47 1.447 . . . . 70.54 111.889 177.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -67.02 -34.98 78.9 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.418 -0.355 . . . . 73.52 110.965 -179.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 31' ' ' ASP . 56.7 t -69.33 -40.8 80.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.16 -0.681 . . . . 73.4 109.16 178.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.3 -35.81 78.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 72.32 109.5 176.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -69.0 -45.32 70.85 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.284 -0.871 . . . . 74.21 110.868 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.28 -45.06 81.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.978 -0.555 . . . . 74.24 111.532 -177.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.8 -12.34 58.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.299 -0.41 . . . . 60.31 111.86 -177.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.67 30.67 74.92 Favored Glycine 0 CA--C 1.505 -0.541 0 CA-C-N 115.914 -0.585 . . . . 75.32 111.965 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.28 155.6 80.69 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.84 -0.43 . . . . 74.24 109.84 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.17 166.81 19.9 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.109 1.873 . . . . 73.1 112.001 177.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -56.3 -37.43 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.806 0.843 . . . . 70.34 110.909 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -57.73 -41.53 82.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.365 -0.834 . . . . 72.34 111.479 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.656 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 45.4 mtpt -70.06 -36.83 75.26 Favored 'General case' 0 C--O 1.2 -1.545 0 C-N-CA 119.268 -0.973 . . . . 75.13 111.266 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.5 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.482 -0.562 . . . . 75.01 109.482 177.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -58.9 -43.37 91.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.693 -0.685 . . . . 74.41 110.247 177.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 3.5 pt20 -70.53 -34.2 72.01 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.522 -0.308 . . . . 75.03 111.499 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.656 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.2 mm100 -57.53 -46.59 83.66 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.3 -1.0 . . . . 64.32 108.3 177.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.1 -43.52 98.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.378 -1.283 . . . . 74.13 109.762 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 19.7 mtp180 -63.44 -26.17 68.61 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.71 0.633 . . . . 71.11 112.71 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.13 7.21 45.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.941 0.401 . . . . 73.33 111.51 -178.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.15 81.65 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.774 -0.648 . . . . 72.42 113.602 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -85.19 -31.51 23.17 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.783 -0.367 . . . . 73.35 111.0 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.61 171.26 18.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.642 -0.874 . . . . 71.12 108.642 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.22 161.6 38.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.536 -0.542 . . . . 72.13 109.536 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.89 161.69 33.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.578 -0.897 . . . . 71.1 108.578 -177.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.77 166.18 29.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 123.511 0.507 . . . . 64.21 110.021 179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 17.7 mtp180 -122.75 142.66 50.47 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.054 0.454 . . . . 75.41 111.846 -178.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.474 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 13.5 ptt180 -149.27 127.21 11.88 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.774 -1.195 . . . . 74.31 107.774 175.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.83 17.88 11.21 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.549 1.14 . . . . 63.24 110.566 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.52 80.79 Favored Glycine 0 C--O 1.22 -0.719 0 CA-C-N 115.509 -0.769 . . . . 74.33 112.023 -177.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -88.4 142.52 17.36 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 111.688 -0.565 . . . . 71.44 111.688 -179.222 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.19 119.7 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.476 -1.305 . . . . 74.34 107.476 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 m -133.67 157.74 42.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 75.44 110.29 -175.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' A' ' 29' ' ' THR . 55.0 mt -128.41 125.18 23.17 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.037 -1.097 . . . . 75.15 108.037 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.45 133.95 55.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.782 2.322 . . . . 71.1 112.59 177.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -48.97 -42.2 36.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.681 1.192 . . . . 74.31 111.477 -177.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.22 -7.18 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 115.351 1.611 . . . . 74.24 115.351 -174.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -78.75 -14.53 59.23 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.243 1.02 . . . . 70.33 109.587 174.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.99 156.75 19.37 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.315 -1.365 . . . . 74.21 107.315 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 66.3 p -86.14 172.54 10.48 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.91 -0.404 . . . . 75.22 109.91 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -68.81 -17.26 63.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.335 0.588 . . . . 63.42 110.241 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 m -88.71 2.98 52.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.234 -0.439 . . . . 54.35 111.072 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 20.1 68.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.98 -0.629 . . . . 71.33 113.294 176.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -111.21 166.26 11.24 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.313 -1.365 . . . . 71.53 107.313 178.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.73 3.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.394 -1.322 . . . . 64.34 107.524 178.123 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.0 t -64.77 137.69 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-O 120.892 0.377 . . . . 71.55 110.679 -178.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -64.71 -40.44 95.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.219 0.533 . . . . 75.14 112.208 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -84.44 -0.35 52.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.318 0.58 . . . . 75.13 110.615 -175.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 60.1 tp -65.53 -54.35 31.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 113.005 0.742 . . . . 73.2 113.005 -178.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.09 -33.26 97.15 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 121.475 1.45 . . . . 73.03 111.158 179.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -44.99 87.88 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.669 -0.696 . . . . 72.3 112.293 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.3 pp -65.66 -40.01 91.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.343 0.592 . . . . 75.1 109.878 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.57 -34.46 77.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.903 -0.589 . . . . 74.13 110.762 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.5 m -70.49 -42.06 71.86 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 116.126 -0.488 . . . . 73.32 111.873 -178.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.06 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.786 0.327 . . . . 73.3 110.732 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' ' 84' ' ' LEU . 4.3 mm? -66.26 -35.1 79.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 122.255 -0.278 . . . . 75.41 111.378 176.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 75.31 110.159 176.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.44 -30.77 68.77 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.319 0.581 . . . . 71.43 110.683 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.94 -9.14 83.1 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.633 -0.712 . . . . 71.3 111.441 178.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.17 47.36 11.15 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.592 -0.304 . . . . 73.23 113.154 177.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.16 129.51 55.49 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 122.673 -0.31 . . . . 74.4 111.049 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.488 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 36.1 ptt180 -74.9 170.78 15.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.709 -0.678 . . . . 72.23 110.676 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -54.41 -44.85 72.73 Favored 'General case' 0 C--O 1.25 1.122 0 C-N-CA 126.552 1.941 . . . . 74.44 111.547 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.1 m -63.93 -41.91 97.5 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.869 -1.06 . . . . 74.14 110.375 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.488 ' HG2' ' CG ' ' A' ' 94' ' ' ARG . 16.4 mm-40 -67.52 -34.04 76.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.071 -0.513 . . . . 75.11 111.148 -178.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.54 -49.45 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 108.578 -0.897 . . . . 75.22 108.578 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.456 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.4 ptp -75.68 -14.85 60.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.077 -0.965 . . . . 75.35 113.055 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.49 -62.18 2.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.636 0.374 . . . . 74.12 110.411 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.471 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.0 p-90 -69.19 -31.84 70.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.603 0.594 . . . . 72.02 112.603 176.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.471 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 12.2 mt -62.34 -40.26 95.81 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.931 1.086 . . . . 73.14 113.931 -179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.439 ' CE2' HD22 ' A' ' 23' ' ' LEU . 33.5 m-85 -85.32 -16.65 39.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.538 0.94 . . . . 74.42 113.538 -177.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.8 p -84.36 124.09 74.15 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 109.338 -0.615 . . . . 75.14 109.338 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -52.68 134.91 55.25 Favored 'Trans proline' 0 C--O 1.249 1.055 0 C-N-CA 122.743 2.295 . . . . 72.24 111.766 178.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.0 t70 -93.35 121.33 65.41 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.868 -0.605 . . . . 73.0 110.255 -177.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.71 -23.62 76.66 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.211 2.608 . . . . 75.41 113.708 -177.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -98.48 0.79 45.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.958 0.408 . . . . 71.31 110.757 -176.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -101.89 124.86 48.24 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.675 0.75 . . . . 72.31 110.744 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.9 m -132.45 116.5 16.87 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.685 -1.598 . . . . 74.51 106.685 175.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.2 pt . . . . . 0 C--N 1.309 -1.171 0 CA-C-O 121.16 0.505 . . . . 72.15 112.201 -175.286 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 108.565 -0.902 . . . . 73.24 108.565 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -90.84 137.45 32.35 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.687 -0.688 . . . . 74.14 109.399 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 57.8 t30 65.63 62.98 0.63 Allowed 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.13 0.894 . . . . 65.41 109.43 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.47 162.14 13.98 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.975 -1.011 . . . . 63.43 109.918 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 127.97 76.35 Favored Pre-proline 0 C--O 1.243 0.743 0 C-N-CA 119.944 -0.702 . . . . 74.55 110.545 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.422 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.6 Cg_exo -52.59 -21.7 15.06 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.025 3.15 . . . . 74.41 114.989 -178.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.529 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.6 t -63.75 -39.83 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.183 -0.607 . . . . 75.34 110.371 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.446 -0.946 . . . . 74.44 108.446 -178.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.65 68.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.91 -1.041 . . . . 55.33 111.122 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.3 pp -64.44 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.981 0.419 . . . . 72.43 110.771 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 7.4 t60 -67.62 -36.49 80.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.584 -0.895 . . . . 75.22 108.584 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.16 9.45 28.34 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 74.14 112.006 -178.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.408 ' C ' ' H ' ' A' ' 134' ' ' ALA . 8.0 t-80 67.5 27.77 7.84 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.882 1.325 . . . . 73.4 111.395 178.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -96.94 23.61 7.02 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.178 -1.786 . . . . 74.12 106.178 173.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 132' ' ' HIS . . . -52.78 -26.76 15.26 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 127.172 2.189 . . . . 73.43 114.643 -173.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.442 ' HD2' ' H ' ' A' ' 135' ' ' ARG . 3.4 mpt_? -55.74 -47.58 76.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.057 0.223 . . . . 74.42 111.254 -174.175 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.451 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 9.8 mm-40 -66.64 -32.39 73.68 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.187 0.439 . . . . 75.32 112.187 176.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.09 -49.29 63.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.353 -0.385 . . . . 71.2 110.158 -177.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.73 -42.45 96.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.909 -0.587 . . . . 75.41 109.597 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.451 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 57.8 ttt180 -59.12 -46.92 87.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.854 -0.612 . . . . 74.55 111.05 178.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.63 -38.31 90.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.898 -0.779 . . . . 71.42 108.898 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.64 83.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.684 . . . . 74.4 110.413 178.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.32 -36.59 82.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.847 0.356 . . . . 70.22 111.283 178.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.99 83.91 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.196 0.522 . . . . 75.3 110.58 178.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 tpt -69.8 -45.11 68.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.48 -0.782 . . . . 71.03 111.408 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.34 -31.06 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.017 0.747 . . . . 70.25 113.017 -176.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 C--N 1.312 -1.047 0 C-N-CA 120.621 -0.432 . . . . 73.45 110.539 -178.517 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 N-CA-C 109.836 -0.431 . . . . 73.12 109.836 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.98 -112.13 2.89 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.907 -0.663 . . . . 63.42 112.878 -178.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -95.1 128.05 41.63 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.702 0.286 . . . . 73.31 110.797 -174.335 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -70.2 138.73 52.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.311 -0.858 . . . . 73.14 111.441 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.16 -11.35 8.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.232 -0.895 . . . . 72.54 109.811 -176.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.96 -169.82 2.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.799 0.809 . . . . 70.15 109.539 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -105.75 138.29 19.58 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 105.837 -1.912 . . . . 74.41 105.837 169.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.68 -26.04 16.35 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.978 2.452 . . . . 72.43 115.042 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.74 -3.8 58.94 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.206 0.447 . . . . 74.12 112.206 -177.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -74.61 145.57 82.22 Favored Pre-proline 0 C--O 1.25 1.126 0 O-C-N 121.552 -0.717 . . . . 72.21 110.941 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.42 ' HB2' ' HG3' ' A' ' 68' ' ' GLN . 12.2 Cg_endo -54.65 123.72 14.39 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.214 2.61 . . . . 74.14 111.524 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -140.47 168.93 18.64 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.568 -0.742 . . . . 72.13 111.812 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 36.4 m-85 -109.77 160.38 16.38 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 125.377 1.471 . . . . 75.34 109.325 176.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -135.73 161.13 36.42 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.229 -2.878 . . . . 53.31 103.229 178.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.25 -52.25 70.52 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 113.804 1.039 . . . . 73.4 113.804 -173.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.08 -36.06 96.93 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.826 1.684 . . . . 73.43 112.66 176.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.85 -37.86 85.27 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.883 -0.414 . . . . 74.44 109.883 177.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.75 -40.97 79.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.18 -0.464 . . . . 72.21 110.354 176.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.43 -43.36 83.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.29 -0.868 . . . . 70.23 109.076 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.09 -45.29 92.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.361 -1.291 . . . . 75.31 110.254 178.003 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.6 -40.75 96.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.965 -1.016 . . . . 74.44 111.49 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.76 -18.31 22.21 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.408 -0.36 . . . . 74.02 111.437 -177.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.37 62.08 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.395 -0.682 . . . . 54.41 111.395 -178.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.38 161.89 24.94 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 108.941 -0.763 . . . . 72.31 108.941 -177.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.54 155.81 67.73 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 121.703 1.602 . . . . 75.54 111.963 174.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.72 -35.46 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.375 0.67 . . . . 71.13 109.686 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.444 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 23.3 t -59.58 -38.52 81.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.518 -0.765 . . . . 73.03 110.33 178.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 52.4 mttp -69.15 -32.78 72.36 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.932 -0.48 . . . . 75.04 111.94 177.106 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.53 -42.8 97.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.814 -0.81 . . . . 74.42 108.814 174.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.77 83.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.727 -0.67 . . . . 74.33 110.278 176.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 44' ' ' SER . 16.3 mm100 -66.89 -36.05 81.41 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.992 -0.549 . . . . 75.11 110.978 177.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.6 mt-30 -61.55 -43.29 99.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.456 0.646 . . . . 74.23 109.697 176.155 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.8 -34.69 76.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.448 -1.251 . . . . 72.24 110.473 176.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -71.66 -32.89 68.37 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.541 -0.754 . . . . 73.55 112.748 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -92.04 -11.75 35.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.13 0.49 . . . . 74.13 112.225 -176.027 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.27 35.99 28.45 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.929 -1.129 . . . . 75.35 110.716 -177.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -92.82 -27.42 17.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.113 -1.069 . . . . 73.12 108.113 176.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.6 tp -147.92 152.57 37.78 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.847 -1.538 . . . . 75.53 106.847 -175.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.07 154.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 108.766 -0.827 . . . . 70.24 108.766 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.6 162.02 33.89 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 123.306 0.379 . . . . 75.33 110.264 -174.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.1 m -132.03 166.67 28.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 123.883 0.873 . . . . 71.13 109.471 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 83.3 mtm180 -110.95 131.29 55.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.886 0.699 . . . . 75.44 112.886 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 33.0 ptt180 -116.12 116.07 27.18 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 106.901 -1.518 . . . . 74.13 106.901 176.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.66 14.16 6.94 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.667 0.746 . . . . 62.32 111.019 -177.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.09 -20.89 34.78 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.821 -0.627 . . . . 70.43 112.697 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -78.57 145.7 29.29 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 110.585 -1.006 . . . . 60.22 110.585 -179.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.2 t -95.97 120.23 45.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.962 -0.755 . . . . 73.53 108.962 -175.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.23 163.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.643 -0.708 . . . . 74.21 111.51 -177.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -128.97 125.2 22.79 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.967 -1.123 . . . . 72.13 107.967 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.1 139.24 85.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.575 2.183 . . . . 73.24 113.235 178.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.467 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 73.8 mm-40 -48.72 -34.88 12.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.271 1.028 . . . . 71.44 112.485 177.011 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.13 -3.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 113.883 1.068 . . . . 71.42 113.883 -174.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.51 ' CD2' HD12 ' A' ' 81' ' ' LEU . 8.0 m-85 -86.68 -5.84 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.066 0.936 . . . . 75.14 110.141 175.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -134.42 164.5 27.29 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.799 -1.091 . . . . 74.13 108.104 178.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.6 p -94.6 158.46 15.52 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.204 -1.406 . . . . 64.31 107.204 176.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.78 -15.79 63.19 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.208 0.528 . . . . 74.31 110.647 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.7 m -79.05 -5.56 54.27 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.563 -0.744 . . . . 74.13 111.71 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.24 -7.41 40.41 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 119.641 -1.266 . . . . 71.35 114.312 174.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -106.05 162.86 13.24 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.681 -0.808 . . . . 71.33 110.238 179.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.79 156.19 5.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 106.86 -1.533 . . . . 73.23 106.86 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.92 125.07 22.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.427 -0.953 . . . . 75.44 108.427 177.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HZ2' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -61.95 -22.21 65.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.93 1.085 . . . . 74.25 113.93 -173.938 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 t -103.41 11.81 36.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.887 0.375 . . . . 73.14 110.203 -179.063 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.51 HD12 ' CD2' ' A' ' 70' ' ' PHE . 12.9 tp -63.41 -51.47 67.55 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 119.305 -0.378 . . . . 75.24 111.762 -178.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 31.4 Cg_exo -61.68 -29.59 83.98 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 121.363 1.376 . . . . 64.05 111.78 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.49 -45.04 97.01 Favored Glycine 0 C--O 1.24 0.489 0 O-C-N 123.377 0.423 . . . . 72.5 113.082 -178.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -68.4 -40.36 81.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.316 0.579 . . . . 71.34 109.463 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 96.4 mt -64.02 -42.47 97.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.504 -0.771 . . . . 74.43 111.233 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.0 m -57.54 -46.87 83.36 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 112.044 0.387 . . . . 73.33 112.044 -177.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -41.96 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.013 0.435 . . . . 73.11 110.83 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.8 mt -67.08 -35.86 80.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.359 0.503 . . . . 75.31 112.359 179.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 85' ' ' LEU . 58.3 m170 -65.23 -33.2 75.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.553 -0.294 . . . . 73.35 110.73 177.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.59 -31.64 72.86 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.357 0.411 . . . . 74.35 110.332 178.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.04 -3.2 68.09 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.768 -0.651 . . . . 70.42 112.281 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.49 42.69 55.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 121.502 -0.38 . . . . 74.21 112.903 179.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 56.0 m-85 -93.26 130.61 38.92 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.453 -0.439 . . . . 75.02 111.962 178.528 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -81.1 171.77 14.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.09 -0.959 . . . . 72.15 111.459 -176.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.33 -45.96 72.79 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.725 1.61 . . . . 73.23 112.551 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.4 m -61.65 -40.99 96.88 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.414 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -65.94 -39.39 90.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.446 -0.343 . . . . 73.51 111.587 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.4 mm -61.1 -49.48 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.749 -0.834 . . . . 74.3 108.749 -177.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.5 mtt -76.1 -18.53 59.14 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.738 -1.119 . . . . 75.23 112.336 -177.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -56.81 -67.26 0.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.378 0.671 . . . . 74.32 110.935 -175.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.564 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 52.7 p-90 -68.9 -32.75 72.61 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.363 0.505 . . . . 75.24 112.363 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.564 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.4 mt -60.35 -40.13 89.59 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.201 0.815 . . . . 74.21 113.201 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.19 -0.5 55.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.083 0.771 . . . . 74.45 113.083 -178.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.2 m -87.51 120.32 71.08 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.367 -0.605 . . . . 75.44 109.367 178.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.28 129.75 21.06 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.227 1.951 . . . . 74.4 110.751 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.6 t70 -102.5 124.16 40.29 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 120.264 -0.575 . . . . 62.21 109.519 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.35 -23.92 76.01 Favored 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.603 2.869 . . . . 71.4 113.556 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -104.44 10.27 35.32 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.429 0.633 . . . . 72.44 110.966 -177.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 50.1 tp -103.84 123.16 46.6 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.585 -0.894 . . . . 75.14 108.585 174.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.0 m -131.2 111.34 11.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.665 -1.235 . . . . 73.34 107.665 179.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--N 1.296 -1.73 0 N-CA-C 112.792 0.664 . . . . 73.13 112.792 -172.443 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 107.799 -1.186 . . . . 72.45 107.799 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 t -90.58 148.26 22.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.957 -1.127 . . . . 54.32 107.957 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.9 t30 65.26 63.58 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.439 1.114 . . . . 71.24 108.923 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.71 164.71 18.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.686 -1.143 . . . . 72.31 109.728 -178.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 36.7 ptt180 -87.34 142.94 33.69 Favored Pre-proline 0 C--N 1.299 -1.62 0 CA-C-N 115.863 -0.608 . . . . 75.52 109.756 179.005 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -57.16 -18.34 29.09 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.264 2.642 . . . . 54.53 114.336 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 97.8 t -60.62 -41.96 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.237 0.542 . . . . 74.02 110.351 178.087 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.36 -32.54 73.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.88 -0.6 . . . . 70.42 111.224 -179.18 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.1 74.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 61.45 110.176 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 126' ' ' VAL . 17.0 tp -60.1 -43.65 95.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.478 0.711 . . . . 74.21 112.246 -177.067 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -71.84 -15.67 62.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.55 0.691 . . . . 75.53 110.697 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -101.58 13.38 35.14 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.289 -0.869 . . . . 72.14 111.373 -175.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 65.93 27.32 10.86 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 123.122 1.439 . . . . 63.44 110.225 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -106.29 23.49 14.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.079 -1.452 . . . . 73.53 107.079 176.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.84 17.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.317 -2.22 . . . . 74.04 111.868 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -56.18 -39.19 72.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.288 -0.415 . . . . 73.33 111.405 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.4 mm-40 -69.27 -33.68 73.6 Favored 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 120.77 -0.372 . . . . 73.23 110.887 175.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 129' ' ' LEU . 60.0 t -62.19 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.872 -0.788 . . . . 75.12 108.872 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 66.1 t -61.58 -49.11 85.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 115.673 -0.694 . . . . 75.14 109.41 176.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.411 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 0.7 OUTLIER -57.86 -41.8 83.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.076 -0.511 . . . . 73.33 111.452 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 16.6 mmt180 -68.42 -37.78 80.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.978 -0.378 . . . . 75.55 109.978 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.86 96.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.471 . . . . 71.22 110.228 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 91.3 mt-30 -58.52 -49.16 78.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.469 0.708 . . . . 72.22 110.016 178.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.12 71.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.568 -0.742 . . . . 74.32 111.774 -178.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 96.6 mmm -84.6 -36.8 21.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.568 -0.453 . . . . 64.15 111.208 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.582 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -77.44 -42.82 34.61 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.291 0.848 . . . . 64.53 113.291 -176.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 119.164 -0.446 . . . . 73.23 110.507 -175.86 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.066 0 N-CA-C 110.382 -0.229 . . . . 75.32 110.382 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.14 -96.95 2.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 121.34 -0.457 . . . . 73.11 113.912 -177.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.97 131.99 51.78 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.212 0.529 . . . . 75.32 111.757 -175.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.03 94.36 2.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.294 -0.866 . . . . 55.3 110.329 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.57 -45.96 96.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.875 -1.057 . . . . 72.1 111.035 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.88 150.97 46.21 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.444 0.64 . . . . 75.33 112.583 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.81 151.16 93.21 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.181 -0.918 . . . . 73.4 109.058 178.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.75 -25.51 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.771 2.314 . . . . 74.21 112.826 178.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.66 -28.4 66.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.895 -0.322 . . . . 73.44 110.899 178.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.53 118.16 65.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 106.993 -1.484 . . . . 73.1 106.993 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.84 147.46 89.48 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 122.474 2.116 . . . . 72.34 113.917 -173.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -129.93 172.73 11.4 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.683 -0.69 . . . . 53.55 112.155 -177.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 10.6 m-85 -117.33 160.68 20.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 126.597 1.959 . . . . 74.1 108.184 173.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -133.19 163.75 28.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.31 -2.107 . . . . 74.51 105.31 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -42.35 -54.84 7.39 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.426 1.639 . . . . 73.15 115.426 -174.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.99 -41.1 65.03 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.074 1.849 . . . . 75.32 113.006 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -71.45 -34.8 70.57 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.986 0.422 . . . . 74.11 110.688 -178.654 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.15 -41.34 81.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.349 0.595 . . . . 64.15 109.547 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -60.2 -36.08 76.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.857 -1.065 . . . . 65.33 109.766 176.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 38.0 tt0 -64.12 -45.06 90.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.569 1.148 . . . . 74.31 110.493 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 30' ' ' TYR . 97.0 mt -60.9 -45.6 93.98 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.476 -0.784 . . . . 75.14 111.19 -178.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.8 mt -84.98 -18.35 34.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.209 -0.905 . . . . 73.14 111.395 -176.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.05 69.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 111.35 -0.7 . . . . 73.32 111.35 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.408 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 28.4 m -129.24 158.78 71.97 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.583 -0.525 . . . . 74.43 109.583 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.46 160.89 40.66 Favored 'Trans proline' 0 C--O 1.256 1.42 0 C-N-CA 122.225 1.95 . . . . 75.12 112.136 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.09 -33.02 49.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 123.923 0.889 . . . . 65.14 111.752 -177.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.4 p -60.1 -40.22 88.87 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.225 -0.443 . . . . 70.03 111.226 178.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.75 -32.52 71.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.89 0.376 . . . . 73.15 111.384 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.8 t -64.5 -40.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.962 -0.755 . . . . 75.05 108.962 174.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -61.82 -36.06 80.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.455 -0.793 . . . . 74.43 110.382 176.118 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 44' ' ' SER . 25.5 mt-30 -61.67 -39.32 90.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.348 -0.387 . . . . 74.31 110.342 178.452 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -58.66 -46.21 87.68 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.812 -0.81 . . . . 73.13 108.812 177.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.23 -39.81 94.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.928 -1.033 . . . . 75.0 110.638 179.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 89.1 mtt180 -68.71 -26.9 65.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.203 -0.453 . . . . 73.23 111.921 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.95 -8.19 37.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.587 -0.278 . . . . 74.53 111.398 -176.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.47 25.73 45.95 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.555 -0.831 . . . . 41.34 111.883 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -96.55 -5.54 39.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.486 -0.191 . . . . 74.41 110.486 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 tp -163.12 153.94 16.68 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.223 -1.029 . . . . 74.41 108.223 -176.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 161.42 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.471 -1.307 . . . . 74.52 107.471 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.31 162.66 35.86 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.915 -0.402 . . . . 75.34 109.915 -175.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.04 164.86 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 O-C-N 123.79 0.681 . . . . 71.21 109.709 177.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 32.9 ttp180 -110.83 132.38 54.25 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 116.222 -0.444 . . . . 70.1 110.48 -174.599 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -136.29 124.4 23.0 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.614 -0.513 . . . . 73.01 109.614 175.888 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.84 30.57 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.945 0.898 . . . . 72.2 112.127 176.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.05 -4.33 71.06 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.821 -0.627 . . . . 75.43 113.342 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -107.57 146.35 16.22 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 121.127 -0.559 . . . . 62.41 112.816 -178.178 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.15 120.85 47.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.361 -1.348 . . . . 70.45 107.361 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.79 159.93 41.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.878 -0.601 . . . . 71.23 111.124 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.0 mt -124.32 128.39 25.02 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.217 -1.031 . . . . 74.24 108.217 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.14 138.62 86.2 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.62 2.213 . . . . 74.21 113.099 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.55 -35.58 53.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.333 1.053 . . . . 74.22 111.712 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -69.01 -9.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.898 -1.046 . . . . 74.2 113.641 -175.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.457 ' CZ ' ' HE3' ' A' ' 99' ' ' MET . 7.0 m-85 -80.23 -15.72 56.37 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.745 0.783 . . . . 74.04 110.345 176.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -111.79 162.35 15.35 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 115.167 -0.924 . . . . 75.02 109.528 -178.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 p -85.87 165.78 16.54 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.353 -1.351 . . . . 74.42 107.353 175.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.82 -21.57 66.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.891 0.853 . . . . 74.4 109.506 177.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m -80.23 -1.89 42.57 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 115.108 -0.951 . . . . 55.41 112.092 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.47 -16.91 59.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.391 -0.909 . . . . 72.44 114.941 173.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -92.16 164.87 13.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.178 0.989 . . . . 73.34 109.612 179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.84 155.71 3.7 Favored 'Isoleucine or valine' 0 C--O 1.258 1.546 0 N-CA-C 108.34 -0.985 . . . . 62.15 108.34 -179.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.6 t -65.97 126.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.041 -0.725 . . . . 72.12 109.041 178.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HB2' ' HZ2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -61.34 -26.6 67.92 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.626 0.602 . . . . 71.25 112.626 -178.231 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.6 m -84.33 -0.56 52.99 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.884 -0.598 . . . . 73.2 111.899 -179.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 57.1 tp -60.79 -55.1 48.1 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 113.01 0.745 . . . . 73.1 113.01 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 12.0 Cg_endo -58.29 -28.98 86.47 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.087 1.858 . . . . 75.4 112.594 -178.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.29 96.37 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.057 -0.592 . . . . 73.54 111.941 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 75.12 110.308 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.4 -42.72 95.95 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.576 -0.738 . . . . 72.51 111.845 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -62.49 -45.43 93.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.136 -0.484 . . . . 75.31 112.205 -176.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -43.29 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.829 -0.349 . . . . 73.13 110.687 -179.15 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.61 -35.8 79.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.395 0.517 . . . . 73.15 112.395 176.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -62.29 -42.45 99.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.677 -0.49 . . . . 74.25 109.677 179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.18 -30.51 71.56 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.859 -0.609 . . . . 73.12 110.723 176.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.26 -9.29 85.23 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.479 -0.782 . . . . 73.42 112.104 177.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.37 23.1 55.3 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.577 -0.344 . . . . 74.44 113.837 177.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -87.47 129.6 35.0 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.163 0.506 . . . . 75.14 111.539 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.426 ' O ' HG12 ' A' ' 98' ' ' ILE . 16.6 ptp180 -78.49 172.67 13.32 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.006 0.922 . . . . 75.32 110.897 -177.049 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -53.64 -45.08 70.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.583 1.553 . . . . 73.12 111.035 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.594 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 31.2 m -63.46 -42.12 98.62 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.121 -0.945 . . . . 74.33 110.269 -179.405 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.403 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 41.8 mt-10 -65.41 -39.91 92.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.983 -0.553 . . . . 63.41 110.27 -177.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 94' ' ' ARG . 21.5 mm -61.35 -48.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.773 0.796 . . . . 74.41 109.575 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.457 ' HE3' ' CZ ' ' A' ' 70' ' ' PHE . 51.9 mtt -74.58 -15.98 60.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 113.55 0.945 . . . . 74.45 113.55 -175.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 96' ' ' THR . 84.2 mtt180 -55.77 -65.26 0.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.935 0.398 . . . . 74.0 111.028 178.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.475 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.7 p-90 -68.68 -32.03 71.56 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.707 0.632 . . . . 72.34 112.707 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.475 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 15.7 mt -62.3 -40.84 97.6 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.516 0.932 . . . . 75.34 113.516 -179.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -92.91 -16.03 25.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.554 0.576 . . . . 73.41 112.554 -177.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.0 m -87.32 124.09 68.74 Favored Pre-proline 0 C--N 1.296 -1.761 0 N-CA-C 109.31 -0.626 . . . . 75.31 109.31 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.3 Cg_exo -54.13 129.64 35.46 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.823 2.349 . . . . 64.44 111.938 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 8.9 t70 -80.5 126.26 78.96 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 108.209 -1.034 . . . . 74.13 108.209 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 24.9 Cg_endo -60.52 -20.39 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.039 2.493 . . . . 74.24 114.401 -176.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.7 m -115.98 4.8 13.83 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.953 -0.467 . . . . 71.33 111.887 -176.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 39.9 tp -102.34 119.83 39.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.023 0.916 . . . . 74.2 111.812 -176.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.2 m -120.11 131.1 54.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.699 -1.593 . . . . 75.44 106.699 178.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 C--N 1.297 -1.687 0 C-N-CA 120.265 -0.574 . . . . 75.14 112.301 -177.765 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 109.874 -0.417 . . . . 75.2 109.874 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.5 m -88.93 140.08 29.8 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.81 -1.552 . . . . 74.13 106.81 176.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 44.9 m-80 63.29 55.92 1.78 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.847 0.832 . . . . 71.53 109.566 -175.489 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.8 144.83 28.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.405 -0.816 . . . . 61.21 110.548 179.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -76.94 139.44 65.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 107.174 -1.417 . . . . 73.45 107.174 174.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.424 ' HB2' HD21 ' A' ' 102' ' ' LEU . 95.8 Cg_exo -49.55 -30.46 21.61 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.376 2.717 . . . . 75.31 114.403 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.563 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.3 t -60.78 -43.25 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.443 0.639 . . . . 72.22 110.782 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.34 -31.02 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 73.24 110.783 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.71 76.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.887 -0.597 . . . . 54.0 111.45 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.81 -35.77 80.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.719 0.295 . . . . 75.0 111.01 -179.679 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -72.32 -24.66 61.34 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.86 0.838 . . . . 74.31 109.048 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -93.21 21.4 5.99 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.116 -0.947 . . . . 74.34 111.568 -179.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.73 27.29 16.04 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.148 1.379 . . . . 73.43 112.15 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -115.0 23.73 12.3 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.408 1.099 . . . . 72.43 109.236 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.37 -27.17 22.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.041 -1.89 . . . . 74.45 111.682 177.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -54.75 -46.89 74.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.016 0.526 . . . . 74.02 109.687 178.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 47.2 mm-40 -71.83 -29.2 64.15 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.239 -0.437 . . . . 73.24 111.464 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.18 -47.74 72.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.301 -0.409 . . . . 73.12 110.354 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.529 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.8 t -63.92 -42.66 96.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.303 -0.629 . . . . 73.53 109.303 177.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -58.67 -44.3 90.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.435 0.694 . . . . 73.15 109.942 178.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 2.4 tpp85 -64.92 -38.2 90.19 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.117 -0.947 . . . . 74.05 109.213 -178.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.15 83.82 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.655 0.782 . . . . 73.45 110.564 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -60.48 -49.94 75.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.935 -0.575 . . . . 72.44 109.822 178.768 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 -17.54 63.47 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.86 -1.064 . . . . 62.41 111.957 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.7 tpp -82.27 -40.59 21.33 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.025 0.441 . . . . 74.33 110.035 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.53 -48.74 8.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 62.32 111.716 -177.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 118.085 -0.959 . . . . 71.3 109.615 -177.354 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . . . . . . 0 C--O 1.25 1.088 0 N-CA-C 109.508 -0.553 . . . . 60.32 109.508 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.23 -137.43 7.34 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.595 -0.812 . . . . 75.22 114.369 -177.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -97.51 123.39 41.36 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.418 0.687 . . . . 70.54 111.812 -173.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -70.45 126.07 28.6 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.078 -0.965 . . . . 73.31 109.633 -178.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.6 t -100.36 -19.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.813 -0.631 . . . . 75.13 111.584 -175.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.434 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -98.68 176.0 5.79 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.602 -0.839 . . . . 73.34 111.8 -177.867 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.8 151.36 64.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.901 -0.407 . . . . 71.53 109.901 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 60' ' ' ARG . 32.5 Cg_exo -61.86 -22.11 73.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.596 2.197 . . . . 75.05 112.383 178.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -84.05 -8.28 59.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 64.11 110.72 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -76.37 154.94 84.09 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.533 -0.543 . . . . 74.31 109.533 177.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 28.3 Cg_endo -58.82 111.2 0.82 Allowed 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 122.877 2.385 . . . . 70.31 112.814 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -133.32 167.49 20.3 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.801 -0.636 . . . . 74.42 111.497 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 19.8 m-85 -128.66 161.69 29.09 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 125.08 1.352 . . . . 75.2 108.774 178.33 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' O ' HG21 ' A' ' 35' ' ' VAL . 3.8 m-20 -133.9 161.01 35.95 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 104.365 -2.457 . . . . 73.43 104.365 -174.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.4 mt -47.08 -56.66 11.35 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.84 1.052 . . . . 73.4 113.84 -174.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.56 -29.68 43.92 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 121.242 1.295 . . . . 75.51 112.195 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -70.84 -37.83 73.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.8 0.334 . . . . 75.24 110.534 -178.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 31' ' ' ASP . 47.3 t -69.11 -40.83 81.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.79 -0.819 . . . . 74.54 108.79 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.49 81.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.909 -1.042 . . . . 54.13 109.46 177.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.36 -45.54 72.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.026 -0.988 . . . . 73.13 110.103 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.21 -50.66 69.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.254 -0.884 . . . . 72.33 111.437 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.5 mt -84.07 -16.93 41.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.829 -0.623 . . . . 75.11 112.653 -175.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.84 62.41 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.303 -0.951 . . . . 70.22 110.756 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.99 160.83 57.26 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 107.754 -1.202 . . . . 73.53 107.754 -178.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.89 159.38 52.75 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 121.738 1.625 . . . . 61.12 111.563 176.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.04 -32.84 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.751 -0.833 . . . . 73.35 108.751 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 8.6 m -57.16 -41.35 79.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.644 -1.162 . . . . 73.52 110.73 177.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 57.3 tttm -70.11 -36.25 74.71 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.283 0.563 . . . . 75.22 109.521 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.83 -40.9 90.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.753 0.787 . . . . 73.35 109.096 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.49 80.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.952 -1.022 . . . . 74.05 110.652 177.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 44' ' ' SER . 80.3 mm-40 -61.24 -41.24 96.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.252 -0.647 . . . . 73.53 109.252 178.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.9 mm-40 -58.98 -47.23 85.91 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.477 -0.783 . . . . 75.15 109.142 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -63.92 -34.06 77.1 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.252 -0.886 . . . . 61.42 110.853 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -67.2 -34.47 77.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.963 176.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 19.6 mm-40 -88.21 -11.73 45.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 74.54 110.432 -176.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.95 28.52 49.94 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.662 -0.975 . . . . 73.51 110.662 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -88.98 -10.55 47.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.669 -0.863 . . . . 72.34 108.669 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.5 tp -158.3 158.09 33.71 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.339 -1.726 . . . . 74.23 106.339 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.87 155.48 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.723 -0.843 . . . . 75.54 108.723 177.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -126.54 157.43 38.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.938 -0.764 . . . . 55.21 108.938 -176.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.75 164.44 34.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.671 -0.492 . . . . 72.34 109.671 178.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -122.34 122.35 38.85 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 110.008 -0.368 . . . . 73.33 110.008 -176.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.454 ' C ' ' H ' ' A' ' 62' ' ' GLY . 5.8 ptp180 -117.06 113.73 22.74 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-N 115.926 -0.579 . . . . 75.2 109.477 177.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.68 -40.8 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.372 1.869 . . . . 74.31 112.012 178.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . 174.18 -13.03 0.04 OUTLIER Glycine 0 C--N 1.29 -2.011 0 CA-C-N 114.949 -1.023 . . . . 70.21 111.969 -177.246 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.62 145.35 17.7 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.855 -0.688 . . . . 63.34 111.921 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.8 120.92 46.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.581 -1.266 . . . . 70.31 107.581 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.46 164.94 33.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.04 -0.982 . . . . 70.52 110.708 -174.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.32 132.31 24.25 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 107.404 -1.332 . . . . 74.43 107.404 -179.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.1 119.45 6.47 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 121.685 1.59 . . . . 74.34 111.029 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.0 tt0 -62.99 -25.01 68.18 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.547 0.739 . . . . 74.41 112.091 -177.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.0 m -65.27 -9.64 7.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.482 -0.781 . . . . 72.32 112.605 177.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 81' ' ' LEU . 3.8 m-85 -81.55 -6.16 58.7 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.743 0.782 . . . . 75.24 110.159 175.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -110.86 154.35 24.14 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.163 -0.926 . . . . 72.31 108.991 179.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.1 p -76.83 175.96 8.98 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 123.659 0.784 . . . . 73.34 110.573 179.091 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -56.31 -31.86 64.08 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.466 0.707 . . . . 74.14 110.214 174.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 m -80.17 -2.58 45.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.626 -0.716 . . . . 72.42 111.74 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.53 32.46 59.61 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.103 -0.57 . . . . 61.22 111.977 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -115.7 157.78 23.76 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.343 -0.614 . . . . 75.51 109.343 177.47 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.23 130.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.226 -0.657 . . . . 74.43 109.226 175.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.16 132.34 28.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.432 -0.951 . . . . 75.03 108.432 178.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -57.63 -27.51 62.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.903 0.705 . . . . 72.51 112.903 -178.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.5 m -89.19 -2.61 58.57 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.049 -0.523 . . . . 60.05 111.273 -179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 70' ' ' PHE . 46.0 tp -61.67 -56.99 27.59 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 119.041 -0.504 . . . . 75.24 111.794 -177.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.24 -38.67 94.64 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.437 1.425 . . . . 75.21 110.795 177.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.87 97.11 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.757 -0.656 . . . . 70.12 112.796 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.42 -41.27 80.61 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 117.212 0.506 . . . . 74.41 109.719 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.74 -35.59 81.06 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 116.026 -0.534 . . . . 72.42 110.754 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.6 m -67.24 -41.28 85.89 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 112.075 0.398 . . . . 73.5 112.075 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.02 -40.27 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 120.143 -0.623 . . . . 75.23 110.473 178.58 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 3.3 mm? -67.61 -36.07 80.15 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.623 -0.673 . . . . 73.34 112.285 175.05 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -63.54 -33.03 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.426 -0.583 . . . . 74.41 109.426 177.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 87' ' ' ILE . 18.5 t70 -63.18 -29.9 71.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.226 1.01 . . . . 73.05 109.847 178.244 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.4 -9.32 53.54 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.837 -0.62 . . . . 61.11 111.969 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.02 27.69 36.66 Favored Glycine 0 C--N 1.317 -0.483 0 O-C-N 122.769 -0.253 . . . . 74.33 113.442 178.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.414 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 76.6 m-85 -83.84 128.16 34.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.125 0.488 . . . . 63.44 112.055 -179.114 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 8.0 ptp180 -79.97 171.05 15.61 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.217 -0.901 . . . . 74.11 110.306 -179.509 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -54.35 -43.0 70.91 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.884 1.274 . . . . 72.23 111.667 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -60.03 -41.98 93.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 123.813 0.845 . . . . 71.13 110.502 -179.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -65.1 -39.71 93.53 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.828 -0.624 . . . . 73.22 110.055 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.0 mm -60.24 -47.52 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.244 -1.021 . . . . 74.32 108.244 -176.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.5 mtm -70.92 -26.38 63.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.982 -1.008 . . . . 74.42 112.725 -176.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -58.12 -66.17 0.52 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.885 0.698 . . . . 74.34 112.885 -179.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -68.24 -32.44 72.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.506 0.558 . . . . 71.31 112.506 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.436 ' HG ' HG22 ' A' ' 126' ' ' VAL . 32.3 tp -67.53 -40.38 85.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.826 -0.624 . . . . 72.22 111.519 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.434 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 26.7 m-85 -84.99 -3.05 58.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.422 0.527 . . . . 73.2 112.422 -179.025 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.9 m -86.99 109.85 28.05 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.367 -0.605 . . . . 73.53 109.367 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 103' ' ' PHE . 21.7 Cg_exo -65.87 139.67 57.93 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.637 2.225 . . . . 73.42 110.852 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.0 t70 -99.27 119.34 60.72 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.253 -1.017 . . . . 75.33 108.253 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.05 -24.87 78.14 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.259 2.64 . . . . 74.4 113.647 -176.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.8 p -106.25 8.38 31.88 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.258 0.466 . . . . 73.54 112.258 -176.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 56.4 tp -102.84 129.38 49.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 110.047 -0.353 . . . . 61.13 110.047 -178.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.5 m -112.12 112.72 24.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.451 -0.574 . . . . 71.5 109.451 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 C--N 1.3 -1.551 0 CA-C-N 115.902 -0.59 . . . . 74.33 109.461 -176.711 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.435 -1.184 0 N-CA-C 110.176 -0.305 . . . . 74.22 110.176 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 64.2 m -80.3 132.21 35.78 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.112 -1.069 . . . . 73.44 108.112 173.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.8 t30 75.38 72.97 0.09 Allowed 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.944 1.297 . . . . 75.32 108.274 -171.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.65 168.07 10.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.814 -1.085 . . . . 70.43 110.167 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -93.06 127.06 48.77 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 115.646 -0.706 . . . . 73.12 110.166 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -55.73 -21.3 31.66 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.384 2.723 . . . . 75.43 113.469 178.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 43.0 t -60.35 -44.78 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.85 0.833 . . . . 72.22 109.73 178.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.7 -29.38 64.51 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.685 -1.143 . . . . 55.45 110.131 -176.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.52 -43.29 99.17 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.45 -0.796 . . . . 62.25 111.778 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -69.38 -34.98 75.35 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.638 -0.664 . . . . 65.04 109.779 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -66.65 -25.44 66.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.289 -1.323 . . . . 75.0 108.971 177.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.72 9.01 42.94 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.944 -1.025 . . . . 64.04 111.363 179.091 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.9 m80 65.25 28.23 12.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.322 1.049 . . . . 74.23 112.638 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.44 25.04 11.61 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.056 1.342 . . . . 73.13 107.74 176.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.57 -25.66 7.22 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 126.976 2.11 . . . . 72.43 112.767 -177.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 mmm-85 -54.19 -43.0 70.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.917 0.487 . . . . 75.14 110.286 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.3 -27.77 64.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.07 0.462 . . . . 53.43 111.323 179.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.1 t -73.32 -49.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.543 -0.753 . . . . 72.42 109.762 178.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 79.2 t -59.08 -41.15 82.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.421 -0.809 . . . . 74.33 109.143 177.446 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.37 -46.72 79.91 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.246 -0.888 . . . . 74.3 110.157 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 144' ' ' MET . 43.9 mtp180 -67.92 -37.05 81.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.815 0.34 . . . . 72.51 111.864 176.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.28 99.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.648 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -59.64 -39.0 82.92 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 122.818 0.447 . . . . 73.22 110.404 176.116 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.46 66.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.316 -0.402 . . . . 74.45 110.978 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.6 mmm -82.68 -41.28 19.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.066 0.46 . . . . 72.11 110.526 179.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.74 -51.35 11.59 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.209 0.448 . . . . 75.32 112.209 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.511 -0.757 . . . . 75.45 109.023 -176.973 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.275 0 N-CA-C 106.15 -1.796 . . . . 73.13 106.15 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.17 -96.89 0.96 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 119.734 -1.222 . . . . 73.01 115.169 -175.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.1 119.94 37.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.17 0.509 . . . . 62.13 112.243 -169.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.45 109.77 2.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.996 -1.002 . . . . 63.21 110.421 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.19 -33.42 12.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.354 0.597 . . . . 75.04 110.158 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.44 173.78 11.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.012 -0.54 . . . . 75.55 110.135 176.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.88 129.98 42.31 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 107.985 -1.117 . . . . 72.41 107.985 176.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.63 -21.98 15.95 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.442 2.761 . . . . 70.33 115.061 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.46 -24.39 56.98 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.958 0.408 . . . . 71.44 110.484 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.71 157.19 87.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.724 -0.671 . . . . 73.43 111.844 -177.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -43.19 107.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 124.067 3.178 . . . . 75.15 113.601 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -135.05 164.04 28.53 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.107 -0.951 . . . . 73.23 110.426 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -127.37 160.7 30.59 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 125.623 1.569 . . . . 70.5 107.639 177.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -134.79 172.24 13.25 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 107.622 -1.251 . . . . 75.44 107.622 -178.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -46.04 -64.32 0.98 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 114.626 1.343 . . . . 75.14 114.626 -172.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.64 -27.59 69.11 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 121.569 1.513 . . . . 74.12 112.634 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.421 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 23.5 tpt180 -67.9 -48.29 66.44 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 110.179 -0.304 . . . . 74.5 110.179 178.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.84 -37.95 80.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.216 0.532 . . . . 74.24 109.915 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.47 -37.05 82.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.054 -0.976 . . . . 72.11 110.0 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.14 -44.96 71.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.2 -0.909 . . . . 71.51 109.885 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 97.2 mt -57.5 -41.98 81.82 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.354 -0.839 . . . . 74.4 111.962 -178.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.1 mt -94.29 -17.76 22.31 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.923 -0.58 . . . . 73.35 111.977 -177.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.86 61.55 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.37 -1.092 . . . . 64.42 110.37 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.5 m -122.4 164.05 28.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.239 -0.652 . . . . 74.21 109.239 -178.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.91 158.59 52.43 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.728 1.618 . . . . 73.43 111.341 173.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.28 -34.54 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.368 0.604 . . . . 73.31 110.012 178.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.7 t -62.25 -36.84 83.25 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.535 -0.757 . . . . 73.44 110.655 178.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 38.9 ttmt -69.77 -32.6 71.19 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 120.135 -0.626 . . . . 74.32 110.201 177.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.28 -42.25 92.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.653 -0.869 . . . . 72.14 108.653 175.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.08 82.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.888 -1.051 . . . . 71.32 110.438 176.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.2 mt-30 -66.82 -38.24 86.08 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.16 -0.473 . . . . 72.2 111.06 177.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.4 mm-40 -63.49 -41.29 98.56 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.998 -0.742 . . . . 72.41 108.998 177.313 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.55 -42.5 98.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.78 -1.1 . . . . 74.3 109.228 177.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -60.33 -32.67 71.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.277 1.031 . . . . 74.51 111.87 178.457 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -85.41 -9.91 56.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.937 0.399 . . . . 74.25 111.068 -177.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.18 33.1 54.96 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.6 -1.4 . . . . 64.24 109.6 -174.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.02 -16.91 20.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.475 -0.935 . . . . 72.54 108.475 178.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 tp -151.2 157.22 42.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.647 -1.242 . . . . 75.44 107.647 -179.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.14 147.63 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.82 -0.808 . . . . 72.4 108.82 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.58 161.78 34.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 123.208 0.603 . . . . 75.51 109.471 -178.084 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.21 166.59 28.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 123.612 0.765 . . . . 64.22 109.705 176.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 45.9 mtp180 -112.57 126.84 55.78 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.941 -0.304 . . . . 73.12 110.791 -177.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -129.8 122.68 29.23 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.002 -0.74 . . . . 73.22 109.002 176.66 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 26.14 15.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.716 0.806 . . . . 73.12 111.616 179.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 -7.26 77.17 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.987 -0.551 . . . . 73.55 112.237 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.82 149.4 19.29 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 121.302 -0.475 . . . . 71.25 111.942 -178.204 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.35 120.94 47.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.282 -1.377 . . . . 75.41 107.282 179.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.33 150.83 34.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.528 0.68 . . . . 73.44 110.961 -178.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.79 129.18 25.54 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 106.524 -1.658 . . . . 73.51 106.524 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.13 128.13 24.28 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 121.877 1.718 . . . . 71.53 111.273 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' A' ' 68' ' ' GLN . 5.9 tt0 -60.81 -26.77 67.54 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.198 0.523 . . . . 72.1 111.991 -178.746 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.11 -18.83 24.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.27 -0.877 . . . . 74.3 112.237 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.471 ' CD2' HD13 ' A' ' 81' ' ' LEU . 4.5 m-85 -73.74 -9.86 59.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.455 0.645 . . . . 74.51 110.657 177.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.04 161.94 17.08 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.522 -0.763 . . . . 73.02 109.455 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 p -83.55 176.1 9.28 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.405 -0.961 . . . . 72.12 108.405 175.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -61.79 -21.69 64.81 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.085 0.469 . . . . 70.35 110.961 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.9 t -80.79 -10.47 59.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.411 0.684 . . . . 73.33 110.298 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.2 24.78 53.82 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.641 -0.79 . . . . 74.43 111.773 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -112.89 152.15 29.63 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.142 -1.059 . . . . 74.31 108.142 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.87 135.31 27.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 120.595 0.236 . . . . 73.22 111.053 178.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.97 131.32 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.599 -0.889 . . . . 72.52 108.599 177.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -21.98 27.51 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.76 1.022 . . . . 72.22 113.76 -178.293 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 t -94.58 -10.56 31.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.934 0.397 . . . . 72.04 110.456 -177.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 43.7 tp -60.18 -55.16 48.08 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 119.314 -0.374 . . . . 73.04 111.914 -177.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.34 -28.21 79.0 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.18 1.92 . . . . 75.33 111.716 178.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -45.66 60.44 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 121.103 -0.57 . . . . 73.05 111.935 -178.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.47 -40.31 81.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.42 0.628 . . . . 75.22 109.801 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 84.9 mt -62.18 -44.4 96.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.616 -0.72 . . . . 74.13 110.842 -178.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.4 m -70.39 -34.66 72.82 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 115.831 -0.622 . . . . 74.12 112.081 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -45.55 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 120.281 -0.567 . . . . 75.24 110.718 178.629 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 4.3 mm? -67.17 -35.81 80.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.1 0.407 . . . . 73.15 112.1 176.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.03 -37.36 79.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.273 -0.64 . . . . 65.2 109.273 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.38 -30.17 71.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 61.41 110.909 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.7 -2.31 84.63 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.965 -0.561 . . . . 74.44 112.182 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.19 39.44 11.35 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.479 -0.391 . . . . 73.31 112.591 178.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 68.9 m-85 -100.74 121.02 40.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.972 0.415 . . . . 74.02 111.694 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.485 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 38.1 ptt180 -71.0 171.61 10.53 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.112 0.965 . . . . 70.24 110.307 176.387 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -54.19 -44.97 72.02 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 125.24 1.416 . . . . 73.11 111.174 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.0 m -61.64 -41.4 97.45 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.94 -1.027 . . . . 75.31 110.625 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 41.6 mm-40 -67.31 -33.95 76.34 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.503 -0.317 . . . . 72.31 111.714 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.5 mm -61.16 -47.61 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.308 -0.997 . . . . 74.42 108.308 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.1 mtt -74.74 -18.77 60.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.775 -1.102 . . . . 74.34 112.074 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 77.8 ttt180 -55.97 -65.56 0.58 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.279 0.632 . . . . 75.24 110.371 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.512 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 53.3 p-90 -69.13 -32.06 71.16 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.528 -0.76 . . . . 74.23 112.623 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.512 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.4 mt -64.99 -41.89 95.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.93 1.085 . . . . 63.51 113.93 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -89.5 -11.76 42.0 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 114.004 1.113 . . . . 74.31 114.004 -173.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.3 m -81.47 119.2 74.99 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.532 -0.544 . . . . 73.32 109.532 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.02 130.32 27.08 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.6 2.2 . . . . 64.5 111.21 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.5 t70 -99.86 125.24 41.0 Favored Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.45 -0.5 . . . . 74.13 110.358 -175.338 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.544 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 27.4 Cg_endo -60.86 -23.57 77.16 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.764 2.31 . . . . 73.53 113.645 -177.735 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.2 m -107.85 12.19 27.45 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.965 0.412 . . . . 73.35 110.848 -175.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.418 ' HG ' HG12 ' A' ' 111' ' ' ILE . 35.8 tp -108.37 124.92 51.1 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.193 -0.603 . . . . 65.12 110.793 -179.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 m -116.47 110.7 18.96 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.825 -0.806 . . . . 72.12 108.825 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.418 HG12 ' HG ' ' A' ' 109' ' ' LEU . 48.9 mm . . . . . 0 C--N 1.31 -1.119 0 C-N-CA 123.417 0.687 . . . . 75.5 110.013 -173.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 108.043 -1.095 . . . . 75.51 108.043 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -80.2 155.52 27.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.799 -0.815 . . . . 72.13 108.799 177.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 107' ' ' PRO . 14.6 m120 67.7 37.17 3.35 Favored 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.808 0.692 . . . . 74.2 110.741 176.848 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.98 163.59 13.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.95 -0.389 . . . . 62.32 109.95 -179.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -95.14 150.3 37.47 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.338 -0.615 . . . . 73.3 109.338 178.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.475 ' HB2' HD21 ' A' ' 102' ' ' LEU . 77.2 Cg_exo -54.89 -25.43 43.61 Favored 'Trans proline' 0 CA--C 1.555 1.533 0 C-N-CA 123.294 2.662 . . . . 62.54 114.028 178.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 102' ' ' LEU . 40.9 t -60.37 -43.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 120.858 0.361 . . . . 73.13 111.576 178.199 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.91 -32.79 74.66 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.611 -0.722 . . . . 72.11 109.885 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.53 75.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.4 -0.818 . . . . 72.3 111.961 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.439 ' HB3' HG22 ' A' ' 137' ' ' VAL . 4.1 pp -68.49 -37.39 80.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.525 -0.47 . . . . 74.12 111.277 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.82 -19.08 60.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.692 0.758 . . . . 74.44 109.493 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.09 7.79 45.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.338 -0.847 . . . . 60.33 111.157 177.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 64.3 27.88 13.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.445 1.117 . . . . 74.32 111.77 178.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.46 25.12 12.12 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.53 1.532 . . . . 75.12 108.425 179.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.8 3.88 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 128.204 2.601 . . . . 71.52 113.571 -176.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -53.97 -38.75 65.34 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 109.62 -0.511 . . . . 73.24 109.62 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -68.92 -27.64 65.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.453 0.644 . . . . 71.52 110.944 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 129' ' ' LEU . 61.9 t -73.46 -47.43 45.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.189 -0.914 . . . . 62.52 109.127 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.49 -41.8 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 71.54 109.188 176.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -56.93 -46.31 82.12 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.836 -1.074 . . . . 71.24 109.592 176.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -69.01 -36.44 77.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.147 -0.478 . . . . 72.14 110.734 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.63 89.17 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.438 0.695 . . . . 74.21 110.516 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.87 -38.42 88.74 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.814 -0.63 . . . . 75.31 110.759 178.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.88 73.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.146 0.498 . . . . 73.1 110.594 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.464 ' HE2' ' HA ' ' A' ' 144' ' ' MET . 1.8 tpt -74.69 -47.11 33.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.699 -0.682 . . . . 74.05 110.907 -179.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.77 -32.9 46.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.992 0.738 . . . . 64.01 112.992 -176.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 108.892 -0.781 . . . . 63.41 108.892 -179.177 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 120.465 0.174 . . . . 55.54 110.702 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.3 -105.6 2.84 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 121.365 -0.445 . . . . 73.24 113.52 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -113.64 134.52 54.68 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.692 0.397 . . . . 75.54 110.489 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.18 127.6 33.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.668 0.747 . . . . 71.21 110.907 -179.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.07 -21.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.465 -0.789 . . . . 73.03 110.216 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -78.82 152.08 31.54 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 113.311 0.856 . . . . 73.21 113.311 -178.218 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.21 151.45 94.54 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 107.637 -1.245 . . . . 60.42 107.637 178.149 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.21 -25.0 76.54 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.769 1.646 . . . . 74.34 110.559 174.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -72.97 -13.81 61.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.145 -0.934 . . . . 73.34 111.209 177.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -83.61 131.41 52.43 Favored Pre-proline 0 N--CA 1.435 -1.175 0 N-CA-C 107.74 -1.207 . . . . 74.2 107.74 175.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 58.6 Cg_endo -69.2 146.34 63.31 Favored 'Trans proline' 0 C--O 1.256 1.4 0 C-N-CA 122.871 2.381 . . . . 74.13 113.204 -177.019 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -128.79 165.75 20.35 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.795 0.807 . . . . 74.35 112.165 -178.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.562 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 12.3 m-85 -130.34 161.45 31.26 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 125.927 1.691 . . . . 75.3 107.779 175.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -134.23 169.36 17.3 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 103.819 -2.659 . . . . 75.32 103.819 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.7 -51.99 74.08 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 114.262 1.208 . . . . 74.53 114.262 -171.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.48 -36.12 97.84 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.157 1.904 . . . . 64.45 112.445 176.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.421 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 21.4 tpt180 -69.82 -39.34 76.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 122.912 0.485 . . . . 75.04 110.21 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.44 -38.84 77.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.318 0.58 . . . . 72.33 109.59 176.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 41' ' ' VAL . . . -59.62 -36.14 75.75 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.201 -0.909 . . . . 75.54 109.881 177.1 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 37.8 tt0 -65.2 -43.77 90.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.575 -1.193 . . . . 75.21 109.963 178.165 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 83.9 mt -67.02 -50.24 62.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.799 -0.637 . . . . 74.33 111.285 -178.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -81.06 -17.82 48.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.704 -0.68 . . . . 74.44 112.12 -173.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.71 63.08 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.682 -0.77 . . . . 44.11 111.619 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 34.2 m -120.89 159.25 49.75 Favored Pre-proline 0 C--N 1.312 -1.052 0 N-CA-C 109.926 -0.398 . . . . 75.51 109.926 -177.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -61.32 154.12 60.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 122.269 1.979 . . . . 63.33 113.139 173.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.88 -35.13 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.478 -1.237 . . . . 73.31 110.993 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -64.55 -34.37 78.09 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 116.364 -0.38 . . . . 70.04 110.789 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 68.1 mttm -68.98 -35.78 77.12 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.905 -0.497 . . . . 75.54 110.225 176.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.21 -43.02 98.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.76 -0.655 . . . . 72.41 109.696 175.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.74 79.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.86 -0.609 . . . . 73.2 110.349 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 46.3 mt-30 -67.51 -35.2 78.65 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 115.954 -0.566 . . . . 75.45 111.848 177.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.9 mm-40 -58.26 -48.75 79.45 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.583 -0.895 . . . . 74.5 108.583 177.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -62.3 -42.69 99.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.844 -1.071 . . . . 74.23 110.27 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -70.13 -21.32 63.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.25 1.204 . . . . 75.01 114.25 -179.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 18.2 mm-40 -96.54 -4.85 40.6 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 119.749 -0.78 . . . . 74.53 110.758 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.56 36.49 37.99 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.105 -0.798 . . . . 51.24 111.105 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -106.68 -5.18 18.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.219 -1.03 . . . . 70.2 108.219 178.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -158.11 153.65 26.22 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.697 -1.594 . . . . 74.2 106.697 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.17 146.98 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.996 -0.742 . . . . 75.45 108.996 -176.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.56 153.28 51.03 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.297 -0.631 . . . . 72.33 109.297 -179.024 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.19 168.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 123.777 0.831 . . . . 71.23 109.726 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -108.43 118.01 35.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.439 -0.949 . . . . 73.32 108.439 -176.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -123.9 123.47 40.49 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.089 -1.414 . . . . 74.41 109.473 -176.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.0 16.07 7.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.541 1.136 . . . . 72.53 112.034 177.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.46 -12.87 54.56 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.73 -0.668 . . . . 75.23 112.025 -178.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.15 156.9 17.96 Favored Glycine 0 CA--C 1.497 -1.093 0 C-N-CA 120.498 -0.858 . . . . 72.14 111.337 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.47 120.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.893 -1.151 . . . . 74.44 107.893 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.47 157.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.675 0.75 . . . . 73.44 111.451 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.9 mt -112.29 126.56 28.2 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 106.564 -1.643 . . . . 73.45 106.564 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.35 128.78 28.62 Favored 'Trans proline' 0 C--N 1.329 -0.471 0 C-N-CA 122.341 2.028 . . . . 73.13 112.697 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.562 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -66.31 -25.22 66.74 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 121.499 0.666 . . . . 75.04 110.937 179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.0 -8.1 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 115.181 -0.918 . . . . 72.2 112.44 178.028 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.6 -7.03 59.66 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.085 0.945 . . . . 72.45 109.424 173.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.35 164.12 13.61 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.645 -1.161 . . . . 74.22 108.501 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 p -93.59 173.92 7.45 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.841 -0.8 . . . . 75.2 108.841 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -66.33 -16.86 64.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.881 0.848 . . . . 74.45 109.571 178.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -79.72 -7.3 58.53 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.243 -0.889 . . . . 75.15 111.073 178.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.39 62.06 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.949 -0.644 . . . . 54.15 112.465 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -126.09 152.14 46.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.786 -0.82 . . . . 73.53 108.786 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.84 143.94 14.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 123.557 0.535 . . . . 74.44 109.683 -177.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.6 t -62.52 121.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.253 -1.018 . . . . 73.32 108.253 176.333 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -57.89 -39.69 78.51 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.471 0.708 . . . . 72.52 112.885 -173.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.9 t -93.07 3.18 56.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.206 0.447 . . . . 73.05 112.206 -176.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 8.4 tt -66.22 -45.07 60.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.026 1.121 . . . . 75.04 114.026 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.86 -21.62 34.03 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.123 2.549 . . . . 74.03 113.276 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.83 -41.3 99.13 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.171 -0.772 . . . . 71.23 111.171 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.15 -39.8 82.54 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.24 -0.652 . . . . 73.21 109.24 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.28 -43.85 98.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.367 -0.833 . . . . 73.21 109.903 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.3 m -57.76 -47.32 82.85 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.536 -0.756 . . . . 73.03 111.632 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -46.06 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.588 -0.278 . . . . 61.24 111.724 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 HD23 ' HB3' ' A' ' 141' ' ' ALA . 4.1 mm? -67.21 -37.99 84.55 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.571 0.952 . . . . 75.1 113.571 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -59.99 -44.99 94.16 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.004 0.43 . . . . 72.42 110.42 178.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.05 -27.34 63.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.064 -0.516 . . . . 73.12 110.987 178.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.96 -9.55 86.58 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.084 -0.507 . . . . 73.23 112.632 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.13 6.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.345 -0.455 . . . . 72.34 113.658 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -113.57 139.32 49.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.957 0.379 . . . . 74.41 111.331 177.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 98' ' ' ILE . 14.3 ptp180 -89.93 172.07 9.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.604 -0.726 . . . . 75.24 110.716 -176.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.17 -45.4 72.1 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.429 1.491 . . . . 74.25 112.307 -176.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.0 m -64.63 -41.18 96.35 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.733 -0.667 . . . . 73.3 109.824 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.413 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 47.8 mt-10 -66.08 -38.75 89.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.602 -0.726 . . . . 73.32 111.058 -179.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 94' ' ' ARG . 30.0 mm -60.69 -47.24 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.689 -0.856 . . . . 74.13 108.689 -179.209 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.2 mtt -74.41 -18.42 60.66 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.836 -1.075 . . . . 63.22 113.095 -177.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -57.37 -64.33 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.24 0.543 . . . . 74.34 110.304 178.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.55 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 60.3 p-90 -69.62 -32.33 70.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 74.43 112.617 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.536 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.2 mt -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.572 0.953 . . . . 75.51 113.572 179.438 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.596 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.1 m-85 -98.61 10.76 40.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.303 0.482 . . . . 75.11 112.303 -177.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 101' ' ' TRP . 11.8 t -87.79 122.01 70.52 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 119.144 -1.022 . . . . 75.35 110.154 177.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.6 136.83 37.34 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.578 2.185 . . . . 71.51 110.956 177.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 14.7 t70 -106.93 112.7 63.21 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.79 -0.764 . . . . 73.15 109.472 178.101 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.09 -16.77 48.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.277 2.651 . . . . 74.02 114.596 -176.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -109.51 3.23 21.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.035 -0.416 . . . . 72.0 111.388 -177.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -102.62 125.27 49.29 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.43 0.633 . . . . 73.13 110.88 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.3 m -116.43 120.7 39.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.15 107.571 179.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.406 HD13 ' HB1' ' A' ' 123' ' ' ALA . 32.4 mt . . . . . 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 73.01 109.009 -173.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 107.946 -1.131 . . . . 75.13 107.946 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.8 p -86.92 141.14 28.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.202 -0.666 . . . . 74.24 109.202 177.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.2 t30 68.68 70.55 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.188 0.994 . . . . 72.1 110.315 -177.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.406 ' HB1' HD13 ' A' ' 111' ' ' ILE . . . -108.22 174.67 5.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.238 -0.892 . . . . 61.33 109.181 175.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.14 150.51 38.42 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 109.035 -0.728 . . . . 74.53 109.035 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.7 -34.01 62.2 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.025 2.483 . . . . 73.33 112.544 173.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.54 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.3 t -64.08 -43.61 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 119.771 -0.772 . . . . 75.11 109.6 175.654 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.02 -30.8 70.13 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.886 -0.783 . . . . 73.21 108.886 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.18 82.43 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.247 -0.888 . . . . 70.32 112.054 177.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.15 -33.48 73.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.161 0.505 . . . . 73.42 110.269 -179.167 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -66.33 -28.76 68.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.404 -0.961 . . . . 74.25 108.404 176.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.44 14.37 24.73 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.708 -1.133 . . . . 70.2 112.261 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 62.05 27.41 16.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.901 1.28 . . . . 63.52 111.885 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -110.64 24.69 12.64 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 123.772 1.749 . . . . 73.25 108.241 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.57 -26.31 12.97 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 111.389 -2.641 . . . . 70.14 113.495 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.52 -41.4 73.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.729 0.411 . . . . 74.41 110.875 -174.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.64 -35.6 77.5 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.454 0.645 . . . . 74.3 110.249 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.2 t -66.07 -42.42 91.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.053 -0.976 . . . . 74.52 109.754 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.521 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 98.6 t -61.49 -46.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 65.21 109.471 177.608 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -63.86 -38.96 93.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.117 0.484 . . . . 72.32 111.001 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -36.36 81.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.328 -0.99 . . . . 74.03 108.328 178.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.402 ' HB3' HD23 ' A' ' 88' ' ' LEU . . . -67.69 -46.37 72.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.559 0.744 . . . . 75.23 110.437 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 87.2 mt-30 -57.62 -49.5 76.24 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.046 -0.525 . . . . 73.34 109.851 178.359 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.71 -27.26 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.417 -0.811 . . . . 64.15 111.422 -178.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.55 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 14.9 tpt -77.45 -29.3 52.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.119 0.485 . . . . 73.51 110.171 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.21 -48.12 7.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.489 0.551 . . . . 65.11 112.489 -177.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 119.164 -0.446 . . . . 75.21 109.944 -176.499 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 108.155 -1.054 . . . . 74.52 108.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.89 100.46 1.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.738 1.625 . . . . 63.42 109.897 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.98 96.38 0.17 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.467 -0.873 . . . . 72.32 112.035 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.29 144.49 44.55 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.697 0.284 . . . . 75.11 110.78 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.43 122.72 58.67 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 109.363 -0.606 . . . . 61.31 109.363 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.84 41.92 1.0 Allowed 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.644 2.896 . . . . 75.34 112.242 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.28 64.38 0.43 Allowed Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 109.828 -1.309 . . . . 71.12 109.828 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 p -83.25 -34.6 25.78 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.648 0.737 . . . . 64.33 111.13 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.6 m -119.02 120.28 36.77 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.525 -0.761 . . . . 73.41 110.145 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.55 148.91 31.59 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.505 -0.771 . . . . 73.3 109.89 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.33 93.05 9.4 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.047 -0.723 . . . . 74.42 109.047 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -106.2 15.32 26.42 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.122 -0.945 . . . . 63.05 110.777 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.66 137.25 53.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.684 -1.144 . . . . 71.31 108.161 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.12 -162.77 30.5 Favored Glycine 0 N--CA 1.402 -3.584 0 N-CA-C 108.634 -1.787 . . . . 72.54 108.634 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 m -96.26 102.86 14.71 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 109.22 -0.659 . . . . 71.33 109.22 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.29 121.35 76.83 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.828 -1.175 . . . . 75.23 107.828 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.76 165.92 29.27 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.883 2.388 . . . . 73.2 112.802 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.95 123.81 29.69 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.974 -1.491 . . . . 73.12 106.974 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.11 -109.77 0.83 Allowed Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.675 -1.25 . . . . 70.15 114.395 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.56 121.35 29.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 73.11 112.539 -168.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.03 120.22 9.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.489 -1.232 . . . . 71.21 110.993 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.84 -40.22 13.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.663 -0.699 . . . . 75.44 111.049 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.66 157.21 37.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.957 -0.697 . . . . 73.32 110.965 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.14 141.55 70.92 Favored Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 73.44 108.346 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.95 -21.73 16.47 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.111 2.541 . . . . 74.34 115.011 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.79 -13.41 59.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.984 0.421 . . . . 73.34 110.823 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.3 137.18 71.78 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 109.296 -0.631 . . . . 73.22 109.296 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.36 131.83 37.65 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 123.938 3.092 . . . . 73.04 113.841 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -137.87 158.83 43.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.595 -0.73 . . . . 72.14 111.832 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.465 ' CZ ' HD21 ' A' ' 38' ' ' LEU . 6.2 m-85 -109.5 160.15 16.47 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.339 1.855 . . . . 73.43 107.596 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -135.18 162.48 32.41 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.728 -1.953 . . . . 72.45 105.728 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.26 -54.34 39.43 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 113.239 0.829 . . . . 75.41 113.239 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.02 -36.7 96.15 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 121.807 1.671 . . . . 75.03 111.864 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -70.41 -37.61 74.47 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.373 -0.376 . . . . 73.45 111.856 -177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.35 -37.59 71.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 120.17 -0.612 . . . . 75.22 109.845 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.13 -41.7 84.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.662 -0.866 . . . . 63.42 108.662 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.12 -45.69 90.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.884 -1.053 . . . . 70.03 111.99 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.465 HD21 ' CZ ' ' A' ' 30' ' ' TYR . 60.2 tp -61.49 -50.19 73.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.617 0.767 . . . . 74.41 112.153 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.5 mt -89.09 -12.65 40.57 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.094 0.405 . . . . 71.33 112.094 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.17 27.75 65.57 Favored Glycine 0 C--N 1.316 -0.549 0 N-CA-C 111.212 -0.755 . . . . 75.44 111.212 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.7 m -118.63 160.78 38.78 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.531 -0.544 . . . . 65.44 109.531 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 37.5 Cg_endo -68.7 160.29 50.14 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.138 1.892 . . . . 74.41 111.723 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.51 -34.5 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.563 0.745 . . . . 65.34 110.492 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -61.27 -39.0 88.77 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.292 -0.867 . . . . 62.43 111.695 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD3' ' HD2' ' A' ' 42' ' ' PRO . 26.3 mtpp -69.82 -33.92 72.98 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.815 -0.354 . . . . 74.51 111.258 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -44.43 98.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.852 -0.795 . . . . 74.24 108.852 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.521 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -63.01 -36.41 83.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.239 -0.892 . . . . 72.13 110.433 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 15.4 mm100 -62.01 -40.77 96.8 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-N 117.002 -0.09 . . . . 71.22 111.064 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -58.73 -44.49 90.47 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.464 0.649 . . . . 73.23 109.815 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.5 -38.94 91.86 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.598 -1.183 . . . . 75.45 110.394 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 47' ' ' ALA . 20.0 mmm180 -71.32 -26.56 62.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.374 -0.375 . . . . 74.44 111.673 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 74.7 mm-40 -89.72 -2.64 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.596 -0.275 . . . . 74.12 111.119 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 35.86 54.14 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.776 -0.726 . . . . 63.24 111.907 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -99.81 -17.68 17.55 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 120.63 0.252 . . . . 74.2 111.01 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.9 tp -152.71 160.98 43.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.217 -1.031 . . . . 73.31 108.217 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.65 147.32 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.553 -0.906 . . . . 74.54 108.553 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.48 150.93 51.72 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.228 -0.656 . . . . 63.33 109.228 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -129.85 166.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.03 0.532 . . . . 73.22 110.034 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 37.2 ttt180 -114.61 123.11 48.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.879 -0.415 . . . . 74.3 109.879 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.485 ' C ' ' H ' ' A' ' 62' ' ' GLY . 8.8 ptm180 -116.64 114.07 23.56 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.723 -0.844 . . . . 72.25 108.723 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.03 -16.81 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.138 1.375 . . . . 73.51 113.369 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . 147.0 -18.93 1.58 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.713 -0.955 . . . . 72.44 110.713 -177.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -91.1 146.28 18.25 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 112.346 -0.302 . . . . 73.13 112.346 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.56 121.69 48.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.869 -0.789 . . . . 73.41 108.869 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.11 157.88 43.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.471 0.653 . . . . 74.32 111.659 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.52 122.22 23.7 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 107.144 -1.428 . . . . 75.23 107.144 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.54 132.36 50.04 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.152 1.901 . . . . 74.44 113.08 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -48.8 -38.52 22.27 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.818 0.847 . . . . 75.34 111.375 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 27.0 m -65.66 -11.1 11.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 114.592 1.33 . . . . 73.35 114.592 -174.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.583 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.6 m-85 -77.78 -12.87 60.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.699 0.761 . . . . 72.23 110.292 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.79 145.12 38.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 108.141 -1.059 . . . . 75.34 108.141 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.0 p -75.42 175.58 8.32 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.076 0.55 . . . . 73.33 110.421 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -65.85 -17.21 64.49 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 122.19 0.995 . . . . 71.14 109.863 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -90.15 -0.55 57.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.281 -0.872 . . . . 73.53 111.524 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 26.55 67.54 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.499 -0.382 . . . . 74.41 112.712 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -113.82 157.72 21.94 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.989 -1.115 . . . . 75.22 107.989 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.6 t -73.44 140.9 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.075 -1.083 . . . . 74.23 108.075 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 46.7 t -64.08 128.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.52 -0.919 . . . . 72.35 108.52 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -58.16 -43.9 87.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.342 0.867 . . . . 74.43 113.342 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 t -89.74 1.71 55.76 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 121.01 -0.276 . . . . 61.21 111.502 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 7.9 tt -65.99 -50.24 53.29 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 119.513 -0.279 . . . . 74.23 111.511 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.64 -24.58 75.92 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.464 1.443 . . . . 65.43 110.512 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.95 88.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.353 -0.84 . . . . 72.23 111.574 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -66.46 -39.78 89.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 108.021 -1.103 . . . . 72.53 108.021 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.52 -35.78 78.68 Favored 'General case' 0 C--O 1.202 -1.422 0 CA-C-N 115.44 -0.8 . . . . 72.31 110.652 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.4 m -59.46 -50.98 71.83 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.422 0.451 . . . . 72.12 111.263 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.97 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 116.268 -0.424 . . . . 74.03 111.36 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.72 -35.23 79.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.15 0.426 . . . . 64.15 112.15 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -64.37 -40.96 96.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.404 -0.591 . . . . 74.34 109.404 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.11 -30.14 68.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 75.34 110.067 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.88 -6.31 89.08 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.538 -0.755 . . . . 64.32 112.336 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.22 57.19 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 114.003 0.361 . . . . 74.42 114.003 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -90.87 129.11 36.95 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 122.168 -0.607 . . . . 75.44 112.099 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -78.02 171.8 14.46 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.159 -0.928 . . . . 75.21 110.802 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.26 -45.28 72.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.279 1.432 . . . . 63.0 111.848 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.9 m -61.8 -40.9 96.86 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.281 -0.872 . . . . 70.22 109.88 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.766 -0.652 . . . . 75.54 110.713 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.96 -48.63 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.367 0.603 . . . . 74.43 109.578 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -74.86 -21.33 59.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.346 -0.843 . . . . 73.35 111.941 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -55.59 -64.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.121 0.568 . . . . 75.51 110.954 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -68.89 -32.52 72.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.03 0.443 . . . . 73.01 112.102 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.441 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -67.39 -37.83 83.76 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.584 -0.734 . . . . 73.31 112.429 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -93.39 -1.4 55.88 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 112.779 0.659 . . . . 74.24 112.779 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -87.29 116.96 67.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.575 -0.528 . . . . 74.42 109.575 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.64 128.72 22.96 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.81 1.673 . . . . 72.4 109.383 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.597 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 33.4 t70 -100.43 125.81 38.03 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 120.271 -0.572 . . . . 74.32 111.04 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.56 -30.43 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.111 2.541 . . . . 72.31 113.164 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 p -92.0 5.49 49.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.289 0.566 . . . . 74.44 111.48 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.3 tp -102.79 126.07 49.78 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.205 -0.665 . . . . 73.54 109.205 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.3 m -131.72 110.53 10.95 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.542 -1.281 . . . . 75.43 107.542 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt -134.24 164.97 32.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-N 115.292 -0.867 . . . . 73.34 109.922 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.0 t -87.31 140.69 29.28 Favored 'General case' 0 N--CA 1.407 -2.625 0 N-CA-C 107.097 -1.446 . . . . 73.0 107.097 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -73.15 136.33 44.78 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.981 -1.118 . . . . 71.23 107.981 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.54 126.35 27.23 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.169 0.509 . . . . 73.25 110.861 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.35 -18.08 55.92 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 111.044 -0.822 . . . . 72.53 111.044 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -111.96 -176.82 3.02 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 121.173 0.511 . . . . 53.3 109.769 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -115.07 -23.2 9.14 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 124.442 1.097 . . . . 73.11 108.69 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.05 156.45 27.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.869 -1.059 . . . . 73.25 112.132 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.2 140.54 33.2 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.16 -0.927 . . . . 72.33 110.605 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.01 119.92 57.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.918 -0.771 . . . . 65.14 108.918 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.6 t -86.51 139.04 31.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.441 -1.689 . . . . 73.14 106.441 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.6 t30 67.1 68.63 0.4 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.073 0.94 . . . . 74.0 109.146 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.77 162.81 21.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.648 -1.16 . . . . 73.0 109.581 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -75.4 130.83 78.9 Favored Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.592 0.557 . . . . 75.04 110.161 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 50.5 Cg_exo -55.49 -17.24 16.18 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 123.836 3.024 . . . . 74.21 113.351 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 65.8 t -59.73 -43.03 90.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.144 -0.48 . . . . 74.34 109.891 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -29.88 69.35 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 116.112 -0.495 . . . . 74.43 111.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.18 -52.64 57.95 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.943 -0.571 . . . . 72.21 109.541 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -68.02 -34.11 75.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 111.735 0.272 . . . . 74.03 111.735 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.61 -24.06 63.61 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.688 0.756 . . . . 70.44 109.196 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -104.45 16.47 26.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.965 -1.016 . . . . 74.42 110.833 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.5 m80 64.05 28.33 14.27 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.35 1.06 . . . . 74.03 113.344 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -99.73 23.11 10.04 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.796 -1.928 . . . . 70.05 105.796 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.31 -27.84 25.21 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 127.08 2.152 . . . . 72.42 114.658 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -56.49 -36.9 69.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.218 0.451 . . . . 75.14 112.218 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -67.76 -33.09 74.16 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.721 0.772 . . . . 72.43 109.664 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.1 t -72.01 -40.55 67.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.387 -0.824 . . . . 73.15 108.831 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.85 -44.22 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.086 -0.709 . . . . 73.33 109.086 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -57.87 -47.13 83.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.65 -0.705 . . . . 72.15 110.495 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -65.82 -34.29 77.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.726 -0.67 . . . . 73.03 109.787 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.29 76.5 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.474 -0.784 . . . . 73.14 109.61 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.78 -48.19 82.67 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.292 -0.867 . . . . 72.33 110.483 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.12 -29.8 71.08 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.286 0.366 . . . . 71.25 111.59 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.23 -34.07 70.45 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.286 -0.416 . . . . 72.54 110.925 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.9 -58.75 1.93 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.938 1.088 . . . . 75.11 113.938 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.314 -0.941 0 CA-C-O 119.072 -0.49 . . . . 65.25 110.743 -174.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 C--O 1.238 0.464 0 N-CA-C 110.22 -0.289 . . . . 74.32 110.22 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.32 -9.09 7.25 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.488 2.125 . . . . 75.01 112.16 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.45 -114.09 3.64 Favored Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.163 -0.775 . . . . 53.51 111.163 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -68.73 142.65 54.92 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 120.949 0.404 . . . . 75.11 111.15 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.0 149.45 11.69 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.6 -0.889 . . . . 64.4 108.6 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.86 -171.94 0.87 Allowed 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 122.23 1.953 . . . . 74.34 111.337 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.71 130.23 2.18 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 119.784 -1.198 . . . . 75.35 111.93 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m -75.31 119.45 19.44 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.992 -1.484 . . . . 74.21 106.992 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -81.23 174.26 11.71 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.859 0.361 . . . . 75.54 111.162 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.3 mt -88.14 154.23 20.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.985 -0.552 . . . . 74.32 110.791 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.13 104.61 10.61 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.026 0.441 . . . . 74.33 110.351 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -87.11 95.03 9.81 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.539 0.685 . . . . 73.52 111.817 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 m -111.72 82.87 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 122.395 1.093 . . . . 71.24 110.061 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.47 61.61 1.22 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.894 -1.048 . . . . 75.43 111.21 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 2.4 p -73.78 125.1 27.37 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 121.197 0.522 . . . . 74.24 111.528 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.9 121.4 68.09 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 107.24 -1.393 . . . . 74.1 107.24 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.31 150.23 81.36 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.501 2.134 . . . . 73.42 110.885 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.03 132.83 35.12 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.366 -0.605 . . . . 72.14 109.366 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.4 -120.93 4.62 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 115.998 -0.546 . . . . 61.3 112.847 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -119.91 142.2 48.92 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.8 0.333 . . . . 73.23 110.495 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.92 137.65 51.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.991 -0.549 . . . . 74.43 111.305 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 100' ' ' ARG . 21.8 t -115.45 -13.69 11.1 Favored 'Isoleucine or valine' 0 C--O 1.248 0.978 0 CA-C-O 122.195 0.997 . . . . 70.44 109.866 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.435 HD21 ' CZ ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -78.36 175.97 9.77 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.804 -1.184 . . . . 73.13 107.804 172.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.01 129.52 53.81 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 117.309 -1.756 . . . . 63.51 106.355 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.64 -21.19 7.51 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.215 2.61 . . . . 73.53 113.972 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.34 -21.19 46.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.032 0.382 . . . . 73.24 112.032 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.1 153.61 91.6 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 122.244 -0.285 . . . . 74.54 110.799 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.52 113.67 1.33 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.353 2.702 . . . . 62.54 113.666 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.7 p -126.4 -179.97 5.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 115.504 -0.771 . . . . 74.45 110.236 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CE2' HD23 ' A' ' 38' ' ' LEU . 40.8 m-85 -130.33 161.03 32.2 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.648 -1.612 . . . . 70.05 106.648 170.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 35' ' ' VAL . 4.7 m-20 -133.01 162.88 30.51 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 103.662 -2.718 . . . . 65.34 103.662 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -43.28 -56.04 7.23 Favored Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 114.501 1.297 . . . . 71.22 114.501 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.67 -36.54 51.93 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.381 1.387 . . . . 75.24 111.857 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -70.54 -34.4 72.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.053 -0.521 . . . . 71.4 110.951 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 31' ' ' ASP . 60.7 t -69.24 -41.75 81.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 108.867 -0.79 . . . . 73.13 108.867 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.31 83.19 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.661 -1.154 . . . . 70.41 109.385 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.09 -46.35 84.65 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.315 -0.857 . . . . 72.43 110.627 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.441 HD23 ' CE2' ' A' ' 30' ' ' TYR . 29.3 tp -65.33 -47.26 77.14 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.425 -0.807 . . . . 74.11 111.268 -175.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.6 mt -81.56 -17.46 48.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 72.24 111.688 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.16 29.47 60.39 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.873 -0.891 . . . . 73.22 110.873 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.68 164.14 26.65 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.541 -0.54 . . . . 73.55 109.541 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.27 165.47 27.72 Favored 'Trans proline' 0 C--O 1.264 1.821 0 C-N-CA 121.512 1.475 . . . . 75.41 110.875 172.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.49 -32.51 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.259 0.624 . . . . 73.23 110.408 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -57.06 -43.68 82.29 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.965 -0.561 . . . . 72.41 110.823 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.596 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 29.7 mtpp -69.49 -32.47 71.36 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 120.041 -0.664 . . . . 72.1 111.039 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.41 -42.05 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.31 -0.626 . . . . 75.34 109.31 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -62.63 -37.23 85.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.696 . . . . 54.23 109.787 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.7 -35.93 81.29 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.074 -0.512 . . . . 74.1 111.64 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.4 mm100 -58.42 -46.25 86.86 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 108.086 -1.079 . . . . 75.53 108.086 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 15' ' ' SER . 4.4 mm? -62.67 -38.92 92.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.135 -1.393 . . . . 74.51 110.979 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 97.9 mtt180 -71.05 -22.0 62.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.129 0.572 . . . . 74.01 112.289 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -85.11 -13.42 50.3 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.418 -0.513 . . . . 75.12 109.708 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.94 26.32 73.99 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.781 -1.328 . . . . 52.32 109.781 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -98.38 -9.13 25.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.551 0.691 . . . . 75.42 109.244 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.1 tp -158.21 152.55 24.4 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.932 -1.877 . . . . 73.12 105.932 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.27 158.03 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 120.213 -0.595 . . . . 75.21 109.49 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.0 162.04 29.59 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 122.71 0.404 . . . . 74.21 110.008 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 m -132.63 167.53 26.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 124.121 0.968 . . . . 74.2 109.141 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 75.4 mtm180 -109.9 139.27 45.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.683 -0.488 . . . . 75.43 109.683 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' NE ' HG13 ' A' ' 65' ' ' VAL . 36.7 ptt180 -128.41 120.05 26.17 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.509 -1.293 . . . . 72.34 107.509 173.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.1 16.9 8.66 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.864 0.866 . . . . 63.3 111.877 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.26 -7.31 54.2 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.991 -0.55 . . . . 73.42 112.55 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -95.61 151.83 20.13 Favored Glycine 0 CA--C 1.493 -1.31 0 N-CA-C 111.624 -0.591 . . . . 74.14 111.624 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.2 t -96.46 120.91 46.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.357 -0.979 . . . . 74.03 108.357 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.433 HG13 ' NE ' ' A' ' 60' ' ' ARG . 15.3 m -134.45 160.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.255 -0.884 . . . . 73.23 111.452 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.33 128.87 23.99 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 106.935 -1.505 . . . . 74.32 106.935 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.21 133.99 56.38 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.03 1.82 . . . . 62.24 111.622 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -63.05 -25.27 68.3 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 121.709 0.766 . . . . 62.4 111.312 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.31 -5.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.836 -1.075 . . . . 75.5 112.076 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.622 ' CD2' HD12 ' A' ' 81' ' ' LEU . 3.6 m-85 -87.7 -3.85 58.94 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.7 0.762 . . . . 73.15 110.211 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.16 148.54 43.51 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.395 -0.821 . . . . 75.2 109.179 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -83.64 174.98 10.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.884 -0.598 . . . . 74.14 109.602 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.66 -17.94 64.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.674 0.75 . . . . 71.41 109.171 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -79.52 -7.11 58.25 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.267 -0.879 . . . . 55.14 110.597 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.52 27.54 59.09 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.085 -0.578 . . . . 73.13 111.697 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -123.03 166.03 15.79 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.384 -0.599 . . . . 72.42 109.384 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.0 t -75.92 142.16 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.156 -1.053 . . . . 73.03 108.156 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 25.8 t -62.62 130.79 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 107.914 -1.143 . . . . 75.43 107.914 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -65.29 -24.5 67.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.066 1.135 . . . . 75.12 114.066 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 p -92.84 -2.05 56.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.206 0.526 . . . . 75.31 111.967 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.622 HD12 ' CD2' ' A' ' 70' ' ' PHE . 7.8 tt -65.42 -50.37 58.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-N 115.786 -0.643 . . . . 74.04 112.115 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.78 -29.52 86.17 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.34 1.36 . . . . 72.1 111.358 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.89 -44.33 94.77 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.954 -0.567 . . . . 63.03 111.946 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.01 -40.03 87.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.445 -0.576 . . . . 73.12 109.445 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.6 -37.9 89.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.933 -0.576 . . . . 74.03 110.527 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.8 m -67.39 -43.34 81.59 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 115.844 -0.616 . . . . 72.05 111.831 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -42.0 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.903 -0.319 . . . . 75.31 110.663 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.7 -34.57 78.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.167 0.432 . . . . 73.02 112.167 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -59.67 -35.15 73.86 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.021 -0.733 . . . . 72.33 109.021 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.04 -31.34 72.16 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.293 0.568 . . . . 74.23 110.371 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -9.26 75.91 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.623 -0.717 . . . . 74.25 112.34 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.17 35.24 34.72 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.296 -0.478 . . . . 72.34 112.401 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.16 132.8 42.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.928 0.394 . . . . 73.41 110.983 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -83.35 171.54 13.41 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.507 -0.77 . . . . 75.4 109.629 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 99' ' ' MET . 9.1 p-10 -53.95 -40.99 67.29 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.687 1.595 . . . . 71.13 112.107 -176.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -61.86 -41.25 97.61 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.238 0.615 . . . . 74.2 110.365 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 6.7 mm-40 -66.38 -36.5 83.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.152 -0.476 . . . . 74.51 109.897 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.7 mm -62.07 -47.77 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.842 -0.799 . . . . 71.15 108.842 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 23.9 mmt -69.15 -23.61 63.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.832 -1.077 . . . . 75.4 110.412 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 80.4 ttt180 -58.9 -63.43 1.3 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.618 -0.719 . . . . 72.31 110.773 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.501 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.5 p-90 -69.65 -35.34 75.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.069 0.766 . . . . 63.43 113.069 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.501 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.2 mt -57.77 -41.39 81.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.889 1.07 . . . . 70.52 113.889 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 96.8 m-85 -97.45 -6.04 34.75 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.311 0.856 . . . . 75.31 113.311 -174.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.8 m -87.29 121.24 71.41 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.208 0.317 . . . . 74.21 110.219 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 33.8 Cg_exo -63.99 128.91 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.737 1.625 . . . . 55.21 108.931 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 26.3 t70 -105.45 120.45 49.44 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 120.209 -0.596 . . . . 74.14 110.735 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.8 -22.72 74.6 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 123.332 2.688 . . . . 71.13 113.445 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 m -97.65 2.9 50.32 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.17 0.509 . . . . 72.13 110.109 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.4 tp -109.77 128.69 55.46 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.109 -0.7 . . . . 75.15 109.109 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.9 m -130.61 113.17 13.87 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.188 -1.041 . . . . 73.52 108.188 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.9 mm -119.47 148.78 22.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.993 -0.549 . . . . 73.5 110.75 -172.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 19.1 p -89.79 132.62 35.14 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.106 -1.072 . . . . 64.31 108.106 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -82.41 152.06 26.34 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.528 -0.469 . . . . 74.02 109.785 -174.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.14 115.45 4.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.327 -0.397 . . . . 74.43 110.204 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.53 19.7 47.74 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 111.441 -0.663 . . . . 53.54 111.441 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.9 m -143.1 131.71 22.47 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.368 -0.605 . . . . 71.04 109.368 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -84.01 -22.23 31.4 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 120.873 0.368 . . . . 74.32 110.636 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.62 148.81 38.48 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 115.575 -0.739 . . . . 74.12 110.229 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.48 141.72 38.47 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.881 -0.6 . . . . 62.13 111.017 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 50.0 t -107.19 126.59 63.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.418 -0.956 . . . . 74.31 108.418 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -82.27 154.82 25.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.755 -1.572 . . . . 72.45 106.755 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 16.2 m120 69.26 36.02 2.47 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.434 0.694 . . . . 64.33 110.354 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.11 152.12 29.45 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.211 -1.033 . . . . 74.13 108.211 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -87.71 142.14 32.41 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 105.34 -2.096 . . . . 74.44 105.34 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.431 ' HB2' HD22 ' A' ' 102' ' ' LEU . 92.8 Cg_exo -51.72 -27.35 26.21 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.273 1.982 . . . . 64.41 111.695 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.631 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 93.8 t -62.82 -43.06 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.814 -0.63 . . . . 75.44 110.73 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -60.04 -37.85 81.01 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.433 0.635 . . . . 75.42 109.461 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.78 82.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.285 -1.325 . . . . 74.1 112.194 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -69.23 -38.69 78.63 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.168 -0.613 . . . . 63.35 111.234 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.36 -23.41 63.75 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.614 0.721 . . . . 75.21 109.716 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.55 7.05 44.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.289 -0.869 . . . . 74.53 111.075 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.3 m80 59.51 28.81 18.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 122.144 0.973 . . . . 73.32 112.578 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.13 22.98 6.94 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.253 -1.388 . . . . 74.24 107.253 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.43 -28.81 32.04 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.738 1.615 . . . . 65.54 112.712 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -56.26 -43.14 78.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.373 -0.603 . . . . 74.24 109.373 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -73.67 -30.55 62.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.328 -0.851 . . . . 71.13 110.608 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -63.77 -45.25 97.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.838 -0.801 . . . . 75.51 108.838 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.1 t -62.99 -42.12 95.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 74.41 109.7 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.17 -45.6 83.53 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.023 -0.535 . . . . 74.25 110.025 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.2 mmt85 -68.86 -37.06 78.83 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.044 -0.525 . . . . 73.14 111.362 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.04 93.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.083 0.553 . . . . 73.41 109.903 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -64.7 -38.4 90.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 75.35 110.323 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.86 -17.77 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.0 -0.546 . . . . 74.42 111.664 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 94.1 mmm -87.6 -29.81 20.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.22 0.533 . . . . 74.4 110.253 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.96 -44.56 14.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.177 -0.465 . . . . 71.3 111.042 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 108.075 -1.083 . . . . 64.31 108.075 -178.745 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.7 mmm . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 107.89 -1.152 . . . . 71.54 107.89 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.79 119.93 6.88 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.691 1.594 . . . . 73.32 109.754 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.97 57.46 3.56 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.431 -0.414 . . . . 53.24 113.487 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -74.83 144.72 43.32 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.555 0.742 . . . . 75.14 110.169 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.87 95.19 36.72 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 107.943 -1.132 . . . . 63.41 107.943 173.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.63 107.11 0.47 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.2 2.6 . . . . 74.24 114.219 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.14 21.44 10.94 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 108.025 -2.03 . . . . 75.41 108.025 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -58.76 113.87 2.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 113.415 -1.392 . . . . 70.31 110.247 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 m -116.92 140.78 49.05 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.197 -1.779 . . . . 62.42 106.197 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.87 96.5 1.28 Allowed 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.801 0.81 . . . . 74.14 111.159 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.3 143.82 29.12 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.063 -1.426 . . . . 74.43 109.225 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -84.63 89.02 7.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.282 1.039 . . . . 70.53 110.176 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.66 25.33 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 123.218 1.485 . . . . 71.51 108.239 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.47 48.1 3.71 Favored Glycine 0 C--N 1.309 -0.967 0 CA-C-N 114.276 -1.329 . . . . 73.02 112.508 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.3 m -88.8 51.32 2.14 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.608 0.718 . . . . 74.12 110.753 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.6 133.81 24.37 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 106.205 -1.776 . . . . 75.21 106.205 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.33 133.95 36.99 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 120.989 1.126 . . . . 72.11 110.59 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.93 145.5 50.96 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.894 -0.594 . . . . 43.31 109.958 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.38 -128.15 5.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.41 -0.9 . . . . 71.33 112.377 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 96' ' ' THR . 29.9 t70 -109.68 146.41 34.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.121 -0.696 . . . . 73.31 109.121 -174.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -86.06 125.37 33.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.449 0.642 . . . . 75.11 112.259 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.3 t -97.2 -31.17 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.33 -0.395 . . . . 75.53 111.457 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -69.77 171.72 8.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.011 0.745 . . . . 74.02 113.011 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 10.0 t70 -85.32 139.81 36.33 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 116.508 -0.314 . . . . 64.43 110.495 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.9 -24.6 14.02 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.066 3.177 . . . . 75.14 115.217 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.84 -25.18 28.24 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.134 -0.354 . . . . 74.41 111.568 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' HG3' ' HB3' ' A' ' 24' ' ' ASP . 45.9 mt-10 -62.78 132.81 94.87 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 116.523 -0.308 . . . . 74.13 110.994 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.485 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 38.3 Cg_endo -63.93 141.47 77.74 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 123.175 2.583 . . . . 75.11 113.137 -175.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -136.68 173.95 11.15 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.019 -0.991 . . . . 72.2 110.697 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -124.83 159.26 31.45 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.711 -1.589 . . . . 75.01 106.711 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.9 p-10 -137.04 173.84 11.26 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.334 -1.728 . . . . 74.23 106.334 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -37.32 -60.95 0.77 Allowed Pre-proline 0 CA--C 1.563 1.478 0 N-CA-C 115.45 1.648 . . . . 74.31 115.45 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.82 -33.81 32.77 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.216 1.277 . . . . 72.32 112.888 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.412 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 9.5 tpt180 -70.25 -35.12 73.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.627 0.251 . . . . 71.21 110.916 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 31' ' ' ASP . 62.0 t -69.2 -41.26 81.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.959 -0.756 . . . . 54.2 108.959 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.88 88.28 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 114.905 -1.043 . . . . 71.11 109.679 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.86 -45.49 92.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.131 1.372 . . . . 73.34 109.742 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.75 -50.1 39.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.608 -0.724 . . . . 72.15 112.382 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.04 -18.89 41.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.308 -0.406 . . . . 75.3 111.953 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.95 27.88 57.58 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.099 -0.801 . . . . 73.43 111.099 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -121.41 159.7 49.08 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 108.505 -0.924 . . . . 74.13 108.505 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.77 156.01 64.41 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 121.523 1.482 . . . . 74.41 112.819 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.42 -37.4 63.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.467 -0.788 . . . . 74.03 111.181 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.1 t -62.19 -35.92 80.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.509 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.71 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 53.7 tttp -65.75 -40.64 92.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.133 -1.062 . . . . 73.52 108.133 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.76 -41.26 87.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.404 -0.816 . . . . 75.52 110.333 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.86 88.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.902 -0.59 . . . . 63.31 110.243 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.498 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 1.4 mp0 -68.45 -41.61 79.99 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.764 -0.653 . . . . 73.13 112.051 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.2 mm100 -58.09 -46.06 86.12 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.848 -0.797 . . . . 74.02 108.848 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.9 mt -61.93 -44.23 97.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.99 -1.005 . . . . 74.3 111.447 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -70.95 -21.62 62.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.672 0.619 . . . . 75.24 112.672 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 52.5 mt-10 -87.64 -6.62 58.18 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.654 -0.418 . . . . 74.05 110.898 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.86 39.09 21.69 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.594 -0.812 . . . . 72.1 111.107 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -86.3 -30.0 22.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.862 -1.162 . . . . 74.32 107.862 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -160.82 167.62 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.667 -1.605 . . . . 75.21 106.667 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.42 161.46 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 118.758 0.708 . . . . 65.33 112.084 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.05 51.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.332 -0.849 . . . . 52.32 110.242 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 HG13 ' SD ' ' A' ' 99' ' ' MET . 18.0 m -130.79 162.55 38.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 O-C-N 123.528 0.517 . . . . 71.35 109.82 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -110.42 118.02 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.859 -0.423 . . . . 75.02 109.859 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -124.56 123.83 40.93 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.891 -0.411 . . . . 72.15 109.891 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.89 16.77 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.032 0.933 . . . . 64.05 110.656 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.43 -15.5 62.83 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.602 -0.726 . . . . 65.11 113.05 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.22 137.85 13.83 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.021 -0.831 . . . . 72.22 111.021 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.79 120.77 46.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.55 0.69 . . . . 75.24 109.169 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.06 159.32 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.069 -0.969 . . . . 73.4 112.172 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.3 mm -111.1 132.02 21.9 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 125.937 1.695 . . . . 74.42 106.803 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.69 119.31 6.33 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.981 1.787 . . . . 74.5 111.672 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' A' ' 28' ' ' PRO . 6.2 tt0 -62.95 -25.48 68.37 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.572 0.701 . . . . 74.33 111.556 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 m -70.81 -5.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.413 -0.812 . . . . 73.55 112.451 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.482 ' CD2' HD13 ' A' ' 81' ' ' LEU . 3.2 m-85 -86.13 -4.12 59.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.859 0.837 . . . . 65.41 109.653 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -111.12 160.14 17.18 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.037 -0.983 . . . . 74.33 108.397 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 p -84.06 166.27 17.85 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.247 -1.019 . . . . 74.43 108.247 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -67.53 -16.55 64.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.935 0.874 . . . . 75.1 109.609 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 m -78.76 -11.38 59.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.503 -0.771 . . . . 71.53 111.063 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.05 62.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.572 -0.823 . . . . 72.43 112.536 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -104.98 147.87 27.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.015 -0.365 . . . . 70.21 110.015 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.5 t -63.12 136.05 26.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.457 -0.942 . . . . 74.41 108.457 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.92 133.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.737 -0.468 . . . . 65.53 109.737 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -54.61 -26.29 31.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.393 1.257 . . . . 75.44 114.393 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.7 t -114.62 19.37 16.1 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.342 -0.543 . . . . 71.15 110.849 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 17.6 tp -63.95 -55.69 30.69 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 116.44 -0.346 . . . . 74.32 111.326 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.21 -28.55 87.14 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.887 1.725 . . . . 73.13 111.75 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.82 -44.81 94.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.889 -0.596 . . . . 71.53 112.2 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.18 -40.53 82.21 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 109.395 -0.594 . . . . 73.42 109.395 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.37 -44.51 97.03 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.718 -0.674 . . . . 74.24 110.634 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.7 m -61.41 -37.02 81.98 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.706 1.002 . . . . 64.14 113.706 -176.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.41 HG21 HD23 ' A' ' 88' ' ' LEU 0.25 0.0 OUTLIER -68.17 -45.04 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 119.567 -0.853 . . . . 75.33 110.755 179.485 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 3.2 mm? -67.75 -35.56 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.008 0.433 . . . . 73.42 111.189 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -60.4 -39.54 87.7 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.744 0.818 . . . . 74.5 109.28 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.65 -30.6 70.19 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.728 0.775 . . . . 71.33 109.928 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.4 -3.05 89.9 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.065 -0.971 . . . . 54.13 112.053 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.89 22.46 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.895 -0.193 . . . . 73.44 113.155 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.418 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 93.7 m-85 -87.16 136.57 32.88 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 122.37 -0.488 . . . . 72.41 111.07 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.461 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 37.4 ptt180 -78.06 170.57 16.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.791 -0.641 . . . . 74.13 110.655 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -54.27 -41.01 68.36 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.946 1.298 . . . . 70.24 111.822 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 20' ' ' ASP . 23.4 m -61.74 -42.57 99.14 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.282 -0.872 . . . . 62.41 111.02 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 9.1 mm-40 -67.05 -33.49 75.63 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.141 -0.481 . . . . 75.13 110.965 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.2 mm -61.65 -49.05 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 108.211 -1.033 . . . . 70.33 108.211 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.498 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 10.9 ptp -74.84 -14.14 60.64 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.387 -0.824 . . . . 71.32 112.935 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 71.7 ttt180 -58.83 -65.62 0.63 Allowed 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.616 0.572 . . . . 72.21 109.944 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.54 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 46.0 p-90 -69.12 -32.92 72.65 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.236 0.458 . . . . 73.42 112.236 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.54 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.0 mt -58.93 -40.48 84.73 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.517 0.932 . . . . 75.02 113.517 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 73.0 m-85 -93.22 -2.5 55.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.406 0.521 . . . . 73.21 112.406 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -88.51 117.51 68.43 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 109.07 -0.715 . . . . 72.24 109.07 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 139.96 51.47 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.305 2.003 . . . . 75.41 113.208 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.559 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 17.5 t70 -98.26 119.9 60.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.645 -0.872 . . . . 61.14 108.645 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.08 -22.91 71.57 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.149 2.566 . . . . 74.21 114.016 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 p -104.0 5.63 35.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.036 0.384 . . . . 74.33 112.036 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.3 tp -105.12 135.28 46.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.053 -0.351 . . . . 72.33 110.053 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.6 m -118.53 116.9 27.62 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.41 108.286 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.5 mt -125.37 150.12 30.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.128 -0.693 . . . . 71.34 109.128 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.8 p -105.84 126.29 51.99 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.576 -1.639 . . . . 72.33 106.576 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -80.72 123.61 28.34 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.63 -1.228 . . . . 74.43 109.371 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 25.3 t70 -57.71 124.76 20.24 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.212 -0.904 . . . . 75.02 112.355 -172.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.29 -25.97 8.44 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 108.546 -1.822 . . . . 55.41 108.546 -174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.1 t -120.17 140.75 50.65 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 107.49 -1.3 . . . . 60.03 107.49 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.61 -4.88 54.79 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.648 -0.821 . . . . 73.33 109.667 176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.04 134.79 43.03 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.039 -0.982 . . . . 75.04 109.955 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.53 144.13 25.84 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.125 -0.943 . . . . 62.45 111.773 -173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.53 118.56 59.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.937 -1.135 . . . . 74.21 107.937 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.3 m -89.85 131.34 35.83 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.357 -1.72 . . . . 55.1 106.357 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.0 t30 75.46 69.06 0.08 Allowed 'General case' 0 C--N 1.321 -0.672 0 O-C-N 124.564 1.165 . . . . 73.41 108.235 -172.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.49 163.72 15.98 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.696 -1.138 . . . . 65.23 109.539 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 39.5 ptt180 -88.08 141.1 30.97 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.568 -0.742 . . . . 74.1 109.672 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' A' ' 102' ' ' LEU . 50.7 Cg_exo -55.17 -18.11 16.97 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.083 2.522 . . . . 75.22 114.228 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.603 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -61.03 -42.85 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.444 0.64 . . . . 73.13 109.493 173.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.61 -30.75 71.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.276 -0.874 . . . . 71.4 109.619 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.72 -50.34 65.18 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.734 -0.667 . . . . 73.12 110.556 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -63.99 -36.76 85.05 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 73.54 110.871 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -68.68 -24.7 64.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.38 -0.827 . . . . 74.31 109.54 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -102.53 12.78 35.96 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.406 -0.816 . . . . 75.35 112.85 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 70.02 27.87 4.26 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.638 1.209 . . . . 74.2 110.866 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -105.56 23.96 12.98 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.967 0.907 . . . . 70.22 109.028 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.12 -29.06 28.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.479 1.511 . . . . 71.54 113.817 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -56.7 -40.14 75.09 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.806 0.336 . . . . 71.45 110.752 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -73.12 -24.82 60.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.981 0.419 . . . . 74.42 110.967 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.84 -42.0 77.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 72.22 108.478 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.27 -42.23 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.44 -0.578 . . . . 74.35 109.44 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -59.5 -47.09 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.619 -0.719 . . . . 75.4 109.697 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.553 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.4 tpp180 -64.6 -39.65 94.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.371 -0.831 . . . . 73.02 110.005 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.62 87.36 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.564 0.746 . . . . 75.2 110.832 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.98 -39.02 93.19 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.238 -0.437 . . . . 75.23 110.281 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -21.25 66.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.18 -0.464 . . . . 70.54 111.333 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 85.4 mmm -92.71 -22.49 19.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.022 0.439 . . . . 64.42 110.986 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.83 -27.68 19.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.976 0.417 . . . . 70.01 111.062 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 108.022 -1.103 . . . . 73.11 108.022 178.024 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 ttm . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 109.296 -0.631 . . . . 73.54 109.296 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -82.17 130.17 6.29 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.469 1.446 . . . . 53.3 111.269 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.95 98.56 0.98 Allowed Glycine 0 CA--C 1.504 -0.607 0 N-CA-C 109.339 -1.504 . . . . 74.1 109.339 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -73.5 143.77 46.44 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.349 0.87 . . . . 75.15 113.349 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.57 89.31 3.84 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 106.559 -1.645 . . . . 73.4 106.559 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.42 97.81 0.32 Allowed 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.707 2.271 . . . . 74.12 112.071 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.8 113.16 2.57 Favored Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 115.202 -0.908 . . . . 63.44 111.73 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 t -76.32 97.51 4.24 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.391 -1.337 . . . . 61.3 107.391 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -74.82 148.28 40.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.478 -0.783 . . . . 74.43 111.845 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.97 177.87 4.5 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.181 -1.044 . . . . 74.12 108.181 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.39 109.41 19.53 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.171 0.51 . . . . 63.45 109.762 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.79 97.66 10.57 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.493 0.663 . . . . 75.41 110.543 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.46 146.9 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 107.671 -1.233 . . . . 70.04 107.671 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.05 -64.79 1.45 Allowed Glycine 0 C--N 1.286 -2.223 0 N-CA-C 110.015 -1.234 . . . . 55.34 110.015 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 t 178.33 159.31 0.52 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 104.721 -2.326 . . . . 65.32 104.721 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -88.31 121.05 70.59 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.678 -1.601 . . . . 73.22 106.678 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.21 165.54 29.33 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.858 2.372 . . . . 72.14 112.875 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.24 124.24 47.48 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.052 -1.092 . . . . 75.32 108.052 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.15 -110.27 3.45 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.684 -0.769 . . . . 71.11 113.411 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -110.76 133.56 53.24 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.043 0.386 . . . . 72.01 112.043 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.1 114.97 13.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.313 -0.995 . . . . 75.11 108.313 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.64 -8.61 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 112.409 0.522 . . . . 74.33 112.409 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 -173.11 2.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.772 -1.205 . . . . 74.31 113.936 -175.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -96.5 132.47 26.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.843 -1.169 . . . . 73.31 107.843 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.16 -20.73 32.34 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.452 2.768 . . . . 64.15 111.8 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.334 -0.848 . . . . 72.24 109.823 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -68.0 134.09 91.85 Favored Pre-proline 0 C--O 1.244 0.796 0 N-CA-C 109.365 -0.605 . . . . 75.13 109.365 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.22 128.1 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.57 2.18 . . . . 75.33 111.257 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.3 m -130.16 158.52 39.46 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.47 -0.567 . . . . 61.52 109.47 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -116.48 162.4 17.63 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.521 1.129 . . . . 72.0 109.965 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -134.06 167.25 20.97 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.381 -2.451 . . . . 72.25 104.381 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -48.45 -55.03 21.01 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 114.712 1.375 . . . . 74.43 114.712 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.44 -46.39 33.79 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.118 1.879 . . . . 74.42 112.11 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.456 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 28.0 tpt180 -65.29 -39.04 92.04 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 112.485 0.55 . . . . 75.24 112.485 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.12 -40.53 80.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.164 -0.614 . . . . 74.01 110.239 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.03 -39.52 92.6 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.206 -0.906 . . . . 70.53 108.978 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.59 -44.95 85.06 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.494 -1.23 . . . . 74.14 111.105 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 95.6 mt -62.25 -47.45 84.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.482 0.658 . . . . 73.54 111.572 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.77 -18.44 40.64 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.744 -0.662 . . . . 64.24 111.972 -175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 27.36 60.78 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 110.592 -1.003 . . . . 74.52 110.592 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 m -118.31 159.38 43.7 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 108.564 -0.902 . . . . 74.43 108.564 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.78 161.75 38.74 Favored 'Trans proline' 0 C--O 1.262 1.719 0 C-N-CA 121.149 1.232 . . . . 60.25 110.744 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.7 -33.85 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 115.88 -0.6 . . . . 73.51 109.92 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.6 m -57.66 -41.27 81.14 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.093 -0.958 . . . . 74.23 111.73 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 26.5 mtpp -69.77 -32.59 71.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.27 -0.572 . . . . 70.55 110.929 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.434 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 61.0 t -62.27 -42.27 94.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.68 . . . . 74.1 109.165 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.96 83.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.83 -0.623 . . . . 70.21 110.311 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -66.36 -37.32 85.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.24 -0.437 . . . . 72.04 110.67 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 46.2 mt-30 -63.19 -46.4 87.25 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.938 -0.393 . . . . 73.15 109.938 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 93.8 mt -61.67 -38.43 87.72 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.54 -1.209 . . . . 74.41 110.03 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -61.63 -44.41 97.04 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.164 0.986 . . . . 73.44 112.507 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.59 -11.8 33.38 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.419 -0.512 . . . . 72.43 112.364 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.92 35.53 18.41 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.34 -0.933 . . . . 44.33 111.049 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -92.5 -18.55 23.03 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.154 -1.054 . . . . 75.31 108.154 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -159.88 152.45 21.19 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.751 -1.944 . . . . 72.13 105.751 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.86 161.67 39.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.568 -0.53 . . . . 74.21 109.568 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.22 161.66 35.58 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.119 -0.697 . . . . 74.45 109.119 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.55 166.16 30.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.397 -0.594 . . . . 75.11 109.397 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -121.49 130.48 53.58 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.383 -0.527 . . . . 74.32 110.068 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -125.56 117.31 23.31 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.602 -0.888 . . . . 73.42 108.602 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 20.47 8.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.597 0.759 . . . . 74.32 112.748 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.73 -17.14 30.64 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.068 -0.587 . . . . 74.24 112.976 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.34 140.75 15.22 Favored Glycine 0 CA--C 1.488 -1.61 0 C-N-CA 121.23 -0.51 . . . . 61.43 111.829 -177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.24 120.91 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.254 -1.017 . . . . 74.54 108.254 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.3 154.6 40.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.826 -0.624 . . . . 75.53 110.916 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 64.3 mt -126.28 114.43 23.59 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.872 -1.158 . . . . 73.22 107.872 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.41 133.56 58.81 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.323 2.682 . . . . 75.24 113.102 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -57.12 -25.53 58.98 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 112.948 0.722 . . . . 73.33 112.948 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 21.9 m -60.28 -15.34 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 113.361 0.875 . . . . 72.11 113.361 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.415 ' CD2' HD11 ' A' ' 81' ' ' LEU . 13.9 m-85 -82.28 -6.15 59.04 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.519 0.676 . . . . 75.3 111.001 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -121.06 162.36 20.13 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.553 -0.748 . . . . 74.02 109.126 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.451 ' HG1' ' HB3' ' A' ' 76' ' ' GLN . 41.0 p -88.14 175.53 7.67 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.713 -0.476 . . . . 75.22 109.713 176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -61.25 -16.98 50.99 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.239 0.616 . . . . 72.43 111.176 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.21 3.43 51.46 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.312 0.486 . . . . 73.03 112.312 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.76 57.87 Favored Glycine 0 C--O 1.235 0.166 0 C-N-CA 120.465 -0.874 . . . . 64.3 111.94 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.451 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 29.7 tt0 -112.55 146.23 38.9 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.634 -0.876 . . . . 75.54 108.634 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.9 130.39 32.24 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.546 -0.538 . . . . 71.3 109.546 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.5 t -56.14 130.55 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.798 -0.637 . . . . 73.25 109.459 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -57.32 -23.8 50.98 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.64 1.348 . . . . 75.1 114.64 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.2 t -105.31 10.63 33.48 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.987 -0.446 . . . . 73.03 110.91 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 36.2 tp -66.02 -57.68 12.84 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.39 0.885 . . . . 74.33 113.39 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.63 -33.86 97.26 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 121.864 1.709 . . . . 75.13 112.944 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 87' ' ' ILE . . . -61.94 -44.98 97.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.406 -0.426 . . . . 72.13 112.65 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.57 -40.32 80.64 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 121.289 0.566 . . . . 73.55 109.987 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.77 -42.25 95.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.51 -0.768 . . . . 74.53 111.144 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.1 m -64.41 -45.15 88.82 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.04 -0.527 . . . . 73.4 111.906 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -66.06 -43.85 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.973 0.416 . . . . 71.21 111.017 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.421 ' CD1' ' HZ2' ' A' ' 101' ' ' TRP . 38.1 mt -66.61 -38.33 86.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.286 -0.416 . . . . 75.54 111.77 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -63.27 -42.57 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.842 -0.429 . . . . 71.14 109.842 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.94 -28.63 65.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.12 -0.491 . . . . 74.25 110.737 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.89 -1.56 84.78 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.59 -0.732 . . . . 74.01 112.77 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.88 23.26 30.79 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.867 -0.682 . . . . 73.01 113.087 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -102.84 144.53 31.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.485 -0.42 . . . . 72.02 110.784 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.437 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 31.2 ptt180 -97.01 172.3 7.94 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.232 -0.894 . . . . 74.33 109.156 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.55 -43.18 68.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.791 1.636 . . . . 53.53 111.593 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 m -62.5 -41.04 98.55 Favored 'General case' 0 N--CA 1.415 -2.194 0 C-N-CA 123.854 0.862 . . . . 73.32 110.164 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 28.9 mm-40 -67.04 -33.36 75.36 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.43 -0.35 . . . . 75.44 110.649 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.3 -49.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.993 -1.114 . . . . 75.45 107.993 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 ptp -76.08 -17.89 59.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.289 -0.869 . . . . 65.12 112.8 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -56.47 -67.53 0.29 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.998 0.519 . . . . 72.11 110.66 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.521 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 52.5 p-90 -69.47 -32.13 70.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.277 0.473 . . . . 72.32 112.277 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.521 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 8.7 mt -60.09 -39.97 87.97 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.155 0.798 . . . . 74.11 113.155 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.08 -4.8 59.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.178 0.436 . . . . 74.31 112.178 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 m -87.17 120.2 71.28 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.193 -0.669 . . . . 72.43 109.193 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.83 129.62 31.39 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.251 1.968 . . . . 74.45 110.788 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 35.4 t70 -96.33 124.25 51.94 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.182 -0.463 . . . . 71.24 110.807 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.38 -35.43 96.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.324 2.683 . . . . 73.22 113.057 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 p -90.04 2.98 54.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.802 0.667 . . . . 72.11 112.802 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -102.69 129.51 49.33 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.291 0.567 . . . . 72.3 110.21 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.4 m -131.35 115.34 16.13 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.42 -1.696 . . . . 71.41 106.42 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.454 HG23 ' OE1' ' A' ' 133' ' ' GLN . 13.3 pt -132.45 142.61 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 N-CA-C 112.812 0.671 . . . . 72.34 112.812 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -92.65 136.51 33.17 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.883 -1.053 . . . . 73.11 109.032 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -82.51 153.09 25.75 Favored 'General case' 0 CA--C 1.48 -1.712 0 CA-C-O 121.549 0.69 . . . . 74.33 111.415 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -83.82 140.8 31.81 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.974 -1.121 . . . . 63.33 107.974 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.75 8.05 77.27 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 110.101 -1.2 . . . . 75.33 110.101 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.9 t -151.11 -173.32 4.46 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.611 -1.626 . . . . 70.3 106.611 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -133.76 -24.38 1.73 Allowed 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.547 0.573 . . . . 73.31 112.547 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.76 141.16 51.48 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.212 0.529 . . . . 75.34 111.836 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.42 128.85 41.23 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.035 -0.984 . . . . 74.2 110.248 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 t -93.92 118.9 40.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.991 -0.744 . . . . 71.23 108.991 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.2 m -84.67 134.8 34.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.58 -1.267 . . . . 74.51 107.58 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.4 t30 66.71 64.72 0.47 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.534 1.159 . . . . 74.23 108.908 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.97 163.71 15.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.263 -1.335 . . . . 71.41 108.887 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -82.39 136.18 46.27 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.545 -0.539 . . . . 73.04 109.545 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.481 ' HB2' HD23 ' A' ' 102' ' ' LEU . 31.0 Cg_exo -56.78 -17.08 21.89 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.244 2.63 . . . . 72.14 114.07 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.1 t -59.9 -40.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.454 0.645 . . . . 73.32 109.9 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.2 -30.29 67.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.19 -0.459 . . . . 64.15 111.051 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.1 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.59 . . . . 61.41 111.375 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.45 -33.9 75.01 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.028 -0.269 . . . . 74.24 111.401 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -75.25 -24.68 57.68 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.781 0.8 . . . . 75.41 108.907 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.29 24.41 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.774 -1.103 . . . . 72.44 111.179 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.6 m80 64.39 28.22 13.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.528 1.131 . . . . 75.43 111.512 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.454 ' OE1' HG23 ' A' ' 111' ' ' ILE . 72.7 mt-30 -111.23 23.84 13.58 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.345 -1.354 . . . . 74.14 107.345 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.26 -27.87 24.68 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 113.306 -1.77 . . . . 73.02 113.111 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -56.16 -36.21 68.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.935 0.494 . . . . 73.1 109.926 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.33 -38.58 87.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.405 0.621 . . . . 73.42 109.737 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.7 -46.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.078 -0.964 . . . . 72.32 109.597 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 93.0 t -61.22 -47.8 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.506 -0.77 . . . . 74.13 110.484 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.52 -37.93 89.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.123 -0.631 . . . . 75.24 110.915 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -63.71 -41.64 98.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.229 -0.656 . . . . 72.43 109.229 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.921 -0.581 . . . . 71.43 110.072 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -63.98 -38.66 91.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.414 -0.812 . . . . 72.3 111.411 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.91 -33.03 70.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.147 0.499 . . . . 74.41 110.441 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 tpt -69.71 -32.01 70.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.342 -0.844 . . . . 74.31 110.719 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.27 -58.91 2.16 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.803 0.668 . . . . 71.31 112.803 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.31 -1.126 0 CA-C-O 118.303 -0.856 . . . . 74.2 110.624 -175.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 CA--C 1.519 -0.225 0 N-CA-C 108.331 -0.988 . . . . 75.21 108.331 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.81 -178.18 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.665 2.243 . . . . 74.33 113.057 -174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.46 -143.71 14.62 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.353 -0.699 . . . . 54.24 111.353 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -73.75 133.81 43.37 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.716 -0.846 . . . . 70.11 108.716 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 144.2 51.84 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 110.09 -0.337 . . . . 73.13 110.09 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -85.21 -166.68 0.36 Allowed 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 122.652 2.235 . . . . 62.51 111.94 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.1 -144.49 4.19 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 110.227 -1.149 . . . . 53.32 110.227 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -81.21 98.24 7.99 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.174 -0.676 . . . . 74.51 109.174 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 m -82.18 156.09 24.62 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.572 -0.899 . . . . 73.41 108.572 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.88 119.72 6.71 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 122.812 0.445 . . . . 75.54 110.408 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.75 135.22 50.91 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.961 -1.018 . . . . 72.14 110.045 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -106.62 77.53 1.2 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.669 0.747 . . . . 72.24 110.302 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 52' ' ' GLU . 95.3 t -90.76 -39.04 11.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 CA-C-N 114.398 -1.274 . . . . 72.13 108.61 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.94 169.26 27.21 Favored Glycine 0 N--CA 1.406 -3.306 0 CA-C-N 113.563 -1.653 . . . . 73.24 110.722 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -144.56 99.03 3.29 Favored 'General case' 0 C--N 1.27 -2.868 0 N-CA-C 106.099 -1.815 . . . . 74.32 106.099 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -106.04 127.8 27.64 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.718 -0.673 . . . . 75.43 109.25 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.5 165.28 30.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.334 2.023 . . . . 72.43 110.491 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.36 135.19 33.99 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.922 -0.399 . . . . 74.35 109.922 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.67 -78.79 0.62 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.559 -0.829 . . . . 75.14 113.994 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.73 129.97 33.44 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 122.262 -0.552 . . . . 73.42 110.631 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.549 ' OD2' ' HD2' ' A' ' 60' ' ' ARG . 13.3 t0 -69.22 139.46 54.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.165 -0.471 . . . . 65.42 111.697 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.1 t -106.56 -18.52 7.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.661 -0.7 . . . . 72.34 110.991 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.285 1.0 OUTLIER -89.7 179.37 6.03 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.379 -1.328 . . . . 64.34 112.21 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -98.03 152.21 37.93 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.085 -0.709 . . . . 71.52 109.085 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.89 -22.92 32.01 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.005 2.47 . . . . 65.41 113.035 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.74 -24.98 56.17 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.295 -0.253 . . . . 72.45 111.582 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -72.34 137.21 81.18 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 109.973 -0.38 . . . . 75.53 109.973 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -63.02 136.72 58.1 Favored 'Trans proline' 0 C--O 1.256 1.408 0 C-N-CA 123.105 2.537 . . . . 75.02 112.774 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 p -130.6 169.81 15.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.283 0.563 . . . . 74.03 111.37 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.493 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 20.4 m-85 -130.33 160.2 34.68 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.808 1.243 . . . . 75.4 108.05 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.14 163.97 28.4 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 103.459 -2.793 . . . . 72.14 103.459 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.9 mt -49.93 -52.27 53.86 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 114.812 1.412 . . . . 75.25 114.812 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.91 -38.61 68.16 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 121.6 1.534 . . . . 71.14 111.762 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.8 tpt180 -70.05 -33.98 72.63 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.566 -0.288 . . . . 73.23 111.309 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.1 -42.06 84.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.951 -0.759 . . . . 70.42 108.951 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.07 84.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.406 -0.815 . . . . 74.51 109.597 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 7.5 tp10 -61.68 -44.94 95.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.672 -1.149 . . . . 64.21 109.552 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.443 HD21 ' CE2' ' A' ' 30' ' ' TYR . 27.0 tp -69.63 -46.33 66.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.195 -0.911 . . . . 72.23 111.724 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 75' ' ' GLY . 96.7 mt -81.36 -18.44 45.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.189 -0.46 . . . . 64.03 111.606 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.3 28.2 62.36 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.058 -0.817 . . . . 73.14 111.058 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.61 163.48 38.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 108.333 -0.988 . . . . 73.12 108.333 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.87 157.83 57.15 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 121.352 1.368 . . . . 72.23 111.232 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.9 -34.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.658 0.783 . . . . 74.15 109.786 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 47.1 m -57.66 -42.89 84.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.155 -0.929 . . . . 71.43 111.331 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.602 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.8 mtpt -69.27 -33.48 73.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.409 -0.516 . . . . 75.14 111.204 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.23 -44.94 99.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.164 -0.68 . . . . 73.33 109.164 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.39 -0.823 . . . . 72.22 110.427 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.0 mt-30 -63.49 -39.79 95.37 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.397 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.602 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 72.2 mt-30 -64.1 -42.4 96.93 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.418 0.628 . . . . 65.43 109.699 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.17 -40.77 97.14 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.892 -1.049 . . . . 71.04 109.281 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -68.83 -22.27 64.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.508 -0.769 . . . . 72.22 112.89 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.533 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 49.9 mt-10 -93.04 -12.87 29.53 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.313 -0.555 . . . . 74.21 111.337 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.38 28.96 31.62 Favored Glycine 0 C--N 1.319 -0.41 0 N-CA-C 111.222 -0.751 . . . . 74.35 111.222 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -87.72 -28.38 21.8 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.31 -0.996 . . . . 73.35 108.31 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -145.95 158.6 43.86 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.429 -1.323 . . . . 74.45 107.429 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.71 157.55 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.464 -0.939 . . . . 74.32 108.464 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.4 162.87 32.47 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.122 0.569 . . . . 71.14 110.004 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 m -125.91 166.09 22.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.277 0.56 . . . . 72.14 111.701 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -110.23 124.73 52.14 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.203 -0.908 . . . . 74.13 108.783 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.549 ' HD2' ' OD2' ' A' ' 21' ' ' ASP . 8.9 ptm180 -151.3 138.37 19.17 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-N 115.573 -0.739 . . . . 74.41 110.123 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.63 -59.16 0.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.205 1.802 . . . . 74.22 110.515 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.48 24.77 0.02 OUTLIER Glycine 0 C--N 1.28 -2.573 0 CA-C-N 114.766 -1.106 . . . . 51.33 110.825 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 160.81 27.81 Favored Glycine 0 N--CA 1.427 -1.907 0 C-N-CA 120.395 -0.907 . . . . 71.42 111.893 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.88 119.88 50.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.931 -1.507 . . . . 64.41 106.931 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.8 158.6 39.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 120.926 0.394 . . . . 74.45 110.867 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.07 126.92 27.07 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.497 -1.297 . . . . 65.53 107.497 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.31 132.29 51.38 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.384 2.056 . . . . 75.22 111.539 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.6 tt0 -62.17 -25.8 67.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.38 0.609 . . . . 70.1 112.353 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.408 ' HB ' HG12 ' A' ' 126' ' ' VAL . 31.2 m -71.81 -4.37 4.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.144 -0.934 . . . . 63.42 112.38 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.621 ' CD2' HD12 ' A' ' 81' ' ' LEU . 4.8 m-85 -82.85 -6.18 59.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.956 0.884 . . . . 74.33 110.239 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.65 160.87 20.59 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.579 -0.737 . . . . 75.14 110.52 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.3 p -92.84 168.53 11.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.065 -1.087 . . . . 75.54 108.065 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.93 -15.33 63.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.424 0.631 . . . . 74.24 111.661 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.0 m -78.64 -9.86 59.53 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.739 -0.664 . . . . 61.33 109.335 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.444 ' O ' HD23 ' A' ' 39' ' ' LEU . . . 81.16 25.8 54.2 Favored Glycine 0 C--O 1.212 -1.264 0 N-CA-C 111.0 -0.84 . . . . 74.23 111.0 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -114.52 147.34 39.54 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.092 -1.077 . . . . 75.02 108.092 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.58 137.73 23.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.847 -1.538 . . . . 71.14 106.847 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.8 t -60.87 127.28 20.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 108.666 -0.865 . . . . 74.14 108.666 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -55.3 -32.14 62.19 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 114.095 1.146 . . . . 74.4 114.095 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 m -85.16 -6.4 59.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.088 0.471 . . . . 70.11 111.457 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.621 HD12 ' CD2' ' A' ' 70' ' ' PHE . 7.0 tt -66.18 -50.09 52.13 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 112.616 0.598 . . . . 73.11 112.616 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.28 -31.39 84.28 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.552 1.502 . . . . 64.44 111.337 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.93 99.73 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 115.872 -0.604 . . . . 63.52 112.682 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -67.86 -39.81 83.72 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.32 -0.622 . . . . 74.45 109.32 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.63 -36.33 83.46 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.719 -0.673 . . . . 73.14 110.542 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.7 m -59.5 -50.26 74.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.022 -0.536 . . . . 73.13 110.372 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -44.16 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 116.143 -0.48 . . . . 73.35 111.485 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.36 -36.35 81.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.98 0.733 . . . . 74.24 112.98 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -70.64 -33.72 71.3 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 74.41 109.285 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.05 -31.7 72.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.674 -0.694 . . . . 74.23 109.389 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.17 -9.37 80.18 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.408 -0.814 . . . . 65.33 112.676 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.5 33.48 25.14 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 121.174 -0.536 . . . . 71.44 113.295 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -99.79 136.89 39.02 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.595 -0.356 . . . . 73.33 110.884 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -88.58 174.04 8.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.922 -0.581 . . . . 71.21 112.144 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.85 -42.59 65.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.355 1.862 . . . . 64.43 111.871 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -64.2 -41.73 96.94 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.782 -0.644 . . . . 65.11 110.142 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -66.61 -37.27 84.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.369 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.27 -48.97 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.777 0.799 . . . . 74.4 109.337 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.2 mtt -75.41 -19.28 59.61 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.036 -0.984 . . . . 65.41 112.215 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -56.88 -62.79 1.5 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.356 0.662 . . . . 72.15 111.05 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -69.05 -32.65 72.28 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.2 0.524 . . . . 75.25 111.829 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.412 HD12 ' HB2' ' A' ' 125' ' ' PRO . 19.2 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.13 0.972 . . . . 73.0 112.436 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -93.52 -2.6 54.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.261 0.837 . . . . 75.51 113.261 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.6 m -86.02 113.49 52.07 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.135 0.272 . . . . 72.12 111.224 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 38.4 Cg_endo -68.02 141.11 52.02 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.448 2.099 . . . . 64.43 110.856 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.562 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.9 t0 -112.53 126.94 27.52 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 120.371 -0.532 . . . . 73.02 109.693 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.55 -28.24 85.09 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.645 2.896 . . . . 74.43 112.961 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -96.13 7.18 47.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.05 -0.523 . . . . 74.31 110.504 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.402 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.8 tp -113.89 123.83 50.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.554 0.693 . . . . 74.14 109.891 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.8 m -120.26 120.57 36.49 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.547 -1.279 . . . . 73.2 107.547 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.0 mt -127.48 148.59 32.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.896 -1.15 . . . . 75.22 107.896 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.4 t -118.73 148.41 42.82 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 106.704 -1.591 . . . . 75.34 106.704 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -143.44 174.46 10.73 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.486 -0.561 . . . . 75.32 109.486 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.91 126.87 29.29 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.729 0.643 . . . . 72.31 110.221 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.68 -2.77 58.82 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.694 -0.765 . . . . 73.22 111.259 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.6 m -121.38 116.12 24.19 Favored 'General case' 0 N--CA 1.426 -1.665 0 O-C-N 122.555 -0.379 . . . . 73.31 110.011 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -40.73 30.18 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 104.723 -2.325 . . . . 72.14 104.723 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.27 -177.12 3.89 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 111.402 -2.635 . . . . 75.43 109.089 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.88 148.28 31.82 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 109.071 -0.715 . . . . 65.11 109.071 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.09 118.22 46.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 107.58 -1.267 . . . . 62.32 107.58 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.401 ' C ' HD21 ' A' ' 122' ' ' ASN . 19.3 m -83.46 154.0 24.17 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.262 -1.385 . . . . 74.43 107.262 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 106' ' ' ASP 0.393 0.1 OUTLIER 46.7 62.94 2.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.722 1.209 . . . . 73.01 113.244 -176.668 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 105' ' ' PRO . . . -104.51 172.62 6.7 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.37 -1.344 . . . . 74.21 107.37 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -103.89 151.43 38.88 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 109.137 -0.69 . . . . 74.32 109.137 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.412 ' HB2' HD12 ' A' ' 102' ' ' LEU . 71.1 Cg_exo -50.9 -22.08 9.56 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.06 2.507 . . . . 75.33 113.453 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.408 HG12 ' HB ' ' A' ' 69' ' ' VAL . 94.4 t -60.05 -41.62 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.082 -0.34 . . . . 70.24 110.082 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.07 -40.11 94.69 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.752 -0.658 . . . . 74.22 109.719 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.45 69.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 75.13 109.995 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.75 -44.18 93.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.576 0.751 . . . . 75.41 112.144 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -70.26 -23.58 62.92 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.441 0.638 . . . . 74.41 109.887 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -100.54 10.92 40.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.375 -0.83 . . . . 72.32 112.289 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 65.79 27.55 11.09 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.754 1.264 . . . . 74.41 111.018 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -102.86 24.76 10.18 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.3 -1.741 . . . . 73.41 106.3 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.23 -27.25 14.12 Favored 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 127.044 2.137 . . . . 61.44 115.381 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -56.5 -34.41 66.95 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.557 1.318 . . . . 75.51 114.557 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.417 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -67.39 -34.77 77.96 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.767 0.794 . . . . 61.24 109.338 175.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.62 -48.44 65.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.922 -1.035 . . . . 72.51 108.958 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.77 -43.94 99.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.529 -0.76 . . . . 74.25 109.55 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.417 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 26.1 ttt180 -57.74 -47.2 83.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.449 -0.341 . . . . 75.2 110.916 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -65.92 -33.7 76.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.684 0.278 . . . . 74.52 111.468 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.17 -46.72 79.66 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.47 -0.567 . . . . 74.32 109.47 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.42 -48.01 81.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.106 -0.952 . . . . 75.44 110.509 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.75 -19.42 65.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.703 -0.681 . . . . 71.35 112.335 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 tpt -79.83 -45.84 17.99 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.209 0.528 . . . . 74.13 109.793 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.71 -44.26 17.33 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.539 0.57 . . . . 74.42 112.539 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 108.836 -0.802 . . . . 73.21 108.836 -178.303 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 107.474 -1.306 . . . . 64.4 107.474 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.21 143.15 82.86 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 122.268 1.979 . . . . 72.41 112.41 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.2 -174.18 46.77 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 109.28 -1.528 . . . . 75.13 109.28 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 135.03 48.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 118.162 0.981 . . . . 73.42 110.755 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.44 131.82 22.58 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 108.85 -0.796 . . . . 65.34 108.85 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.69 127.02 24.19 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 122.84 2.36 . . . . 73.31 110.929 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.79 118.37 3.58 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 111.313 -0.715 . . . . 71.4 111.313 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -70.4 -33.99 72.01 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.665 -0.865 . . . . 71.35 108.665 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 m -99.48 128.03 45.58 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.414 -0.812 . . . . 74.11 109.476 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.98 162.55 13.51 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.439 -0.948 . . . . 73.13 108.439 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.34 79.04 9.53 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.571 -1.27 . . . . 72.44 107.571 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.83 128.88 40.33 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.517 -0.765 . . . . 72.42 109.674 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.84 153.38 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.82 0 N-CA-C 108.074 -1.084 . . . . 71.13 108.074 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.81 -175.64 14.02 Favored Glycine 0 N--CA 1.396 -3.986 0 N-CA-C 110.083 -1.207 . . . . 72.03 110.083 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 t -155.06 -177.7 6.72 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 106.592 -1.633 . . . . 72.52 106.592 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -85.03 133.77 42.45 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 107.515 -1.291 . . . . 74.41 107.515 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.51 162.64 23.53 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.896 1.731 . . . . 70.25 110.638 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.67 124.38 29.53 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.025 -0.731 . . . . 72.05 109.025 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.412 ' HA3' HH12 ' A' ' 94' ' ' ARG . . . -97.67 -87.12 1.85 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 116.17 -0.468 . . . . 72.32 113.717 -176.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.94 141.46 52.02 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.468 -0.493 . . . . 72.1 111.965 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -81.5 133.98 35.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.504 -0.771 . . . . 61.33 110.481 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.38 -15.75 9.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.602 -0.727 . . . . 71.0 111.025 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 103' ' ' PHE 0.279 0.9 OUTLIER -82.56 -176.88 6.47 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 118.751 -1.18 . . . . 73.32 112.566 -178.348 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -86.93 136.0 34.69 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 116.286 -0.415 . . . . 75.34 110.263 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.58 -25.44 33.02 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.616 2.877 . . . . 73.1 113.814 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.45 -30.18 70.47 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.102 0.477 . . . . 75.35 110.234 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 43.6 mt-10 -76.35 123.58 87.89 Favored Pre-proline 0 C--O 1.254 1.308 0 CA-C-N 115.457 -0.792 . . . . 74.44 109.935 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.2 Cg_exo -73.69 175.99 9.98 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.318 2.012 . . . . 74.45 110.019 177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.9 p -139.97 177.93 7.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.579 0.704 . . . . 73.41 112.062 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 43.0 m-85 -109.17 160.81 15.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 125.919 1.688 . . . . 74.12 107.905 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 13.3 t0 -135.66 166.86 22.25 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 104.091 -2.559 . . . . 53.3 104.091 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.21 -53.29 63.37 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 113.065 0.765 . . . . 72.03 113.065 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 14.8 Cg_endo -58.3 -35.71 98.43 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.11 1.873 . . . . 74.12 112.66 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -67.38 -38.44 84.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.345 0.658 . . . . 75.12 110.284 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.4 t -69.2 -40.37 80.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 109.406 -0.591 . . . . 75.34 109.406 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 41' ' ' VAL . . . -59.35 -39.49 83.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.822 -1.081 . . . . 75.33 109.646 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.18 -34.72 78.68 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.375 1.47 . . . . 73.53 110.469 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD13 ' CE1' ' A' ' 30' ' ' TYR . 97.1 mt -77.24 -47.5 19.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.284 0.564 . . . . 64.23 111.625 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -85.02 -18.5 34.22 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.315 0.857 . . . . 74.5 113.315 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.39 48.6 Favored Glycine 0 C--N 1.307 -1.038 0 C-N-CA 119.77 -1.205 . . . . 31.21 110.178 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 34.3 m -117.91 157.75 47.58 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.007 -1.108 . . . . 75.45 108.007 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD2' ' HD2' ' A' ' 45' ' ' LYS . 44.3 Cg_endo -72.04 164.53 35.38 Favored 'Trans proline' 0 C--O 1.259 1.558 0 C-N-CA 121.117 1.211 . . . . 64.41 110.958 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.89 -33.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.54 0.686 . . . . 75.15 109.269 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -57.45 -41.79 81.25 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.674 -1.148 . . . . 75.54 110.685 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 54.3 mttm -69.38 -36.93 77.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.625 -0.43 . . . . 74.3 111.658 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.64 -44.69 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.401 -0.592 . . . . 73.44 109.401 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.32 -36.92 79.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.439 -0.801 . . . . 55.44 110.157 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.497 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 96.2 mt-30 -67.38 -43.32 81.69 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.079 -0.51 . . . . 70.15 111.491 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 92.7 mt-30 -58.32 -46.1 86.81 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.486 0.66 . . . . 62.13 110.052 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.42 -45.7 93.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.352 -1.295 . . . . 51.11 110.16 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -70.85 -22.09 62.35 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.118 0.785 . . . . 74.24 113.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 57.5 mt-10 -94.48 -1.16 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.891 -0.505 . . . . 75.33 110.913 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.4 35.04 63.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.882 -0.675 . . . . 55.21 111.979 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -102.17 -16.94 16.2 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.808 -1.182 . . . . 72.33 107.808 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.9 tp -151.26 152.72 33.62 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.054 -1.832 . . . . 75.34 106.054 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.48 161.53 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 109.262 -0.644 . . . . 75.21 109.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.65 164.15 28.91 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.291 0.636 . . . . 75.41 110.902 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.8 m -125.24 165.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 123.826 0.85 . . . . 75.11 108.96 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -123.98 131.74 53.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.882 -0.784 . . . . 72.12 108.882 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -152.24 138.71 18.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.117 -0.697 . . . . 73.42 109.117 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.93 9.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.278 1.031 . . . . 74.41 112.335 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.21 9.7 67.01 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.181 -0.533 . . . . 74.24 112.843 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.47 142.0 15.55 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.596 -0.811 . . . . 55.33 111.168 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.78 120.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.084 -1.45 . . . . 74.51 107.084 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -137.16 164.37 29.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.25 -0.432 . . . . 74.12 111.312 -174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.81 130.61 24.68 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.67 -0.863 . . . . 75.43 108.67 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.71 141.82 83.67 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.086 2.524 . . . . 72.3 113.941 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.459 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -55.2 -39.82 70.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.786 1.234 . . . . 74.2 110.399 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.98 -4.91 4.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 114.129 1.159 . . . . 75.15 114.129 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CD2' HD12 ' A' ' 81' ' ' LEU . 4.7 m-85 -83.49 -5.46 59.17 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.856 0.836 . . . . 75.33 110.836 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -124.34 149.03 47.07 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.691 -1.14 . . . . 72.35 108.644 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.1 p -76.17 169.0 19.04 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.807 -0.812 . . . . 73.12 108.807 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -61.6 -19.15 61.9 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 70.13 110.953 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 m -80.08 -10.1 59.74 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 116.109 -0.496 . . . . 74.52 110.936 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.62 14.06 66.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.004 -0.617 . . . . 62.14 111.887 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -105.06 148.22 27.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.819 -0.224 . . . . 75.24 110.744 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.97 138.65 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 O-C-N 123.811 0.694 . . . . 72.35 109.627 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.0 t -61.94 127.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.264 -1.013 . . . . 71.3 108.264 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -24.02 67.7 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.454 0.645 . . . . 75.24 112.589 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -92.09 2.42 56.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.073 -0.512 . . . . 62.2 110.748 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.544 HD12 ' CD2' ' A' ' 70' ' ' PHE . 11.8 tp -65.05 -55.62 25.78 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.433 -0.349 . . . . 74.24 111.454 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.88 -28.46 86.41 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.815 1.677 . . . . 72.12 111.218 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.7 -45.46 65.78 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.489 -0.778 . . . . 44.3 111.967 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.22 -40.81 81.99 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 120.985 0.422 . . . . 74.32 110.118 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.43 -39.27 92.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.006 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.1 m -71.36 -41.23 70.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.899 -0.592 . . . . 73.43 112.224 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.84 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.32 -0.552 . . . . 73.13 109.535 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.417 HD21 ' O ' ' A' ' 84' ' ' LEU . 4.4 mm? -66.18 -35.67 81.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 122.257 -0.277 . . . . 74.21 111.399 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.34 -37.94 89.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.72 -0.474 . . . . 75.42 109.72 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.47 -24.94 65.66 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.741 0.781 . . . . 75.35 109.976 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -2.93 84.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.665 -0.698 . . . . 73.41 111.795 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 20.95 50.88 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.784 -0.246 . . . . 62.2 113.058 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -86.75 152.8 22.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.109 0.781 . . . . 72.4 113.109 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.436 ' O ' HG12 ' A' ' 98' ' ' ILE . 11.1 ptt180 -123.24 175.96 6.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.82 -1.082 . . . . 74.13 110.063 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 99' ' ' MET . 11.1 p-10 -52.18 -47.06 65.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.851 1.66 . . . . 74.33 113.49 -171.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.1 m -67.93 -40.0 83.41 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-O 121.471 0.653 . . . . 74.21 109.348 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 29.7 mm-40 -66.29 -34.62 78.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.338 -0.847 . . . . 75.24 111.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 94' ' ' ARG . 33.4 mm -61.49 -47.19 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.87 0.843 . . . . 72.04 108.819 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.429 ' SD ' ' HE2' ' A' ' 103' ' ' PHE . 23.0 mmt -70.41 -23.22 62.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.347 -1.297 . . . . 73.34 110.773 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 68.9 ttt180 -55.09 -67.23 0.29 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.474 0.71 . . . . 72.03 110.888 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.589 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 57.3 p-90 -68.93 -32.12 71.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.607 0.595 . . . . 72.35 112.607 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.589 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.2 mt -63.55 -40.6 97.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.328 0.862 . . . . 73.42 113.328 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 96.3 m-85 -98.33 -9.46 25.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.582 0.956 . . . . 70.33 113.582 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.4 m -88.35 110.97 40.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.815 -1.18 . . . . 61.44 107.815 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.26 129.9 37.27 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.65 2.233 . . . . 75.42 111.514 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.3 t70 -89.59 118.8 69.35 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 109.489 -0.559 . . . . 75.41 109.489 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -26.83 83.38 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.143 2.562 . . . . 75.01 112.213 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -94.84 10.05 36.77 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.685 -0.689 . . . . 65.23 111.431 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.9 tp -105.25 125.81 51.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.13 -0.693 . . . . 70.21 109.13 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 120' ' ' VAL . 52.1 m -132.04 110.68 10.89 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.352 -0.981 . . . . 62.31 108.352 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.84 160.99 42.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 115.878 -0.601 . . . . 70.5 110.508 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.6 t -88.85 126.03 35.18 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.0 -2.222 . . . . 75.5 105.0 172.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -84.45 169.07 14.9 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 114.498 1.296 . . . . 74.32 114.498 -169.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -57.01 101.0 0.05 Allowed 'General case' 0 C--O 1.242 0.688 0 CA-C-N 114.316 -1.311 . . . . 72.35 109.76 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.79 42.43 61.33 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.576 -0.738 . . . . 73.41 111.29 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.4 m -142.47 106.28 4.69 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.174 -0.676 . . . . 72.22 109.174 176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -60.17 -27.97 67.54 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.362 0.504 . . . . 73.52 112.362 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -84.56 144.21 28.8 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.897 -0.592 . . . . 65.23 110.802 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.99 127.59 35.68 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.546 -0.752 . . . . 74.54 109.175 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 110' ' ' THR . 44.4 t -104.56 122.8 57.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.177 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.7 m -83.17 139.35 33.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.07 -1.456 . . . . 75.34 107.07 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.5 t30 69.36 69.33 0.26 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.386 1.089 . . . . 73.52 108.779 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.43 159.94 21.98 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.698 -1.137 . . . . 75.3 109.931 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -75.46 125.23 88.99 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.796 -0.816 . . . . 74.31 108.796 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 72.3 Cg_exo -53.89 -23.92 29.46 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.269 2.646 . . . . 75.34 112.958 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.711 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 84.6 t -60.31 -42.16 89.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.642 -0.708 . . . . 75.22 111.553 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.18 -30.71 71.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.358 0.599 . . . . 74.32 110.471 -172.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.9 84.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.008 -0.996 . . . . 61.32 111.786 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.711 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -70.41 -36.82 74.26 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.82 -0.55 . . . . 65.11 111.671 -177.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -76.09 -22.62 55.39 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.588 -0.893 . . . . 75.34 108.588 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.16 43.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.715 -1.129 . . . . 62.45 111.413 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.8 m80 65.52 28.44 11.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.111 0.964 . . . . 75.44 112.127 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -108.64 25.23 11.97 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 125.146 1.378 . . . . 75.22 107.607 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.41 -26.37 7.82 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.89 2.076 . . . . 75.14 113.268 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 39.2 ttp180 -54.37 -41.26 68.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.933 -0.395 . . . . 75.43 109.933 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.464 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 56.6 mm-40 -67.35 -28.51 68.02 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.549 -0.296 . . . . 60.52 111.653 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.07 -45.5 54.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.4 -0.963 . . . . 71.15 108.4 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.66 -49.2 84.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.036 -0.529 . . . . 72.32 110.338 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.464 ' HG3' ' HA ' ' A' ' 136' ' ' GLU 0.318 0.0 OUTLIER -63.64 -37.43 87.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.187 0.81 . . . . 74.22 113.187 178.379 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.433 ' O ' ' HG2' ' A' ' 144' ' ' MET . 1.6 mpt_? -63.6 -40.1 96.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.484 -0.561 . . . . 72.44 109.484 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.78 99.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 73.34 110.614 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -56.89 -49.52 75.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.339 0.656 . . . . 73.5 109.88 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.56 -33.12 74.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.172 -0.922 . . . . 73.33 111.892 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 92.6 mmm -77.01 -47.2 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.835 -0.346 . . . . 72.04 111.093 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.88 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.857 -0.61 . . . . 71.21 112.065 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 N--CA 1.427 -1.576 0 C-N-CA 120.655 -0.418 . . . . 74.23 110.47 -178.61 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.107 0.48 . . . . 73.51 110.532 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -86.16 100.9 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.364 2.042 . . . . 61.14 110.842 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.15 45.47 1.93 Allowed Glycine 0 C--N 1.311 -0.851 0 C-N-CA 121.213 -0.518 . . . . 64.33 113.268 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -74.1 133.0 42.82 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.508 -0.553 . . . . 74.31 109.508 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.29 88.96 20.19 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.685 -0.857 . . . . 71.34 108.685 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -92.17 -174.96 0.58 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.709 2.273 . . . . 70.44 111.922 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.0 28.23 59.01 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 116.011 -0.541 . . . . 75.23 112.359 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -72.94 112.35 8.89 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-O 121.624 0.726 . . . . 74.22 110.154 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -85.21 129.64 34.76 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.429 -0.805 . . . . 73.34 109.741 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.9 mt -67.94 157.54 34.76 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.948 -0.39 . . . . 72.54 109.948 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.86 93.19 3.07 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.963 0.411 . . . . 75.2 110.087 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -115.53 7.07 14.81 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.68 0.752 . . . . 64.13 111.094 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.83 101.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 106.784 -1.561 . . . . 73.32 106.784 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.614 ' O ' ' HA ' ' A' ' 51' ' ' ARG . . . -75.05 89.8 0.79 Allowed Glycine 0 N--CA 1.423 -2.203 0 CA-C-N 114.955 -1.02 . . . . 71.24 112.712 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -88.77 79.56 7.41 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 106.331 -1.729 . . . . 71.43 106.331 174.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -75.13 119.85 78.88 Favored Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 115.442 -0.799 . . . . 75.42 109.738 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -75.98 137.54 19.73 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.006 1.804 . . . . 75.53 107.541 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.5 124.12 30.41 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.664 -0.814 . . . . 71.34 109.758 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.35 -104.28 2.72 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 121.07 -0.586 . . . . 73.41 112.351 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.06 137.28 52.36 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.392 -0.523 . . . . 74.34 111.539 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.58 143.1 35.08 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.346 -0.843 . . . . 75.01 110.937 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.63 -15.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 116.055 -0.52 . . . . 75.34 110.932 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.266 1.0 OUTLIER -86.09 175.55 8.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 118.314 -1.354 . . . . 74.24 111.631 179.02 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -82.21 141.1 46.02 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.172 -0.677 . . . . 73.21 109.172 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.4 -32.06 32.59 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.003 2.469 . . . . 72.43 114.388 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.54 -10.02 59.55 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.942 1.09 . . . . 73.02 113.942 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -66.3 136.32 95.15 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 107.787 -1.19 . . . . 75.03 107.787 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.8 133.71 51.74 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.171 2.581 . . . . 72.43 112.629 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.7 p -132.84 168.55 18.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.057 -0.519 . . . . 72.44 111.092 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 24.6 m-85 -130.83 161.5 31.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 125.23 1.412 . . . . 73.35 108.464 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -134.67 166.57 22.62 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.343 -1.725 . . . . 74.4 106.343 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -43.37 -61.54 1.8 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 116.018 1.859 . . . . 63.12 116.018 -169.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.07 -29.37 74.86 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.448 1.432 . . . . 64.02 112.352 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.9 tpt180 -70.86 -36.22 72.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.081 0.467 . . . . 73.42 110.041 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.81 -37.9 74.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.628 -0.508 . . . . 74.43 109.628 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.15 81.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.458 -0.792 . . . . 74.13 109.393 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 35.9 tt0 -63.9 -45.78 87.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.716 -1.129 . . . . 73.4 110.724 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.457 HD22 ' CE2' ' A' ' 30' ' ' TYR . 39.6 tp -64.81 -46.93 79.94 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.194 -0.912 . . . . 74.45 111.534 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.65 -18.29 35.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.86 0.689 . . . . 70.43 112.86 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.81 53.07 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.07 -1.062 . . . . 71.34 111.448 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.05 158.71 74.39 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.131 -0.692 . . . . 63.31 109.131 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -65.78 159.84 46.66 Favored 'Trans proline' 0 C--O 1.25 1.089 0 C-N-CA 121.856 1.704 . . . . 74.32 112.192 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.2 -33.61 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.247 1.019 . . . . 72.32 111.252 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -57.87 -42.46 84.6 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.617 -0.72 . . . . 71.14 110.946 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.54 ' HA ' ' HG3' ' A' ' 48' ' ' GLN . 68.2 mttm -70.06 -34.82 73.68 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.006 -0.543 . . . . 74.53 112.007 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.36 -41.63 90.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.287 -0.635 . . . . 72.42 109.287 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.37 96.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.203 -0.908 . . . . 72.5 110.589 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HG3' ' HA ' ' A' ' 45' ' ' LYS 0.308 0.0 OUTLIER -70.72 -35.03 72.52 Favored 'General case' 0 C--O 1.201 -1.483 0 C-N-CA 120.216 -0.594 . . . . 70.42 112.241 178.632 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 84.5 mm-40 -58.09 -43.14 86.93 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.482 0.658 . . . . 73.05 109.229 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.67 -46.09 91.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.687 -1.142 . . . . 75.22 108.933 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 94.2 mtt180 -70.68 -21.41 62.59 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.058 -0.974 . . . . 75.33 113.383 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -84.48 -7.39 59.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.904 0.383 . . . . 72.55 110.429 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.53 22.69 58.0 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.482 -0.647 . . . . 71.34 111.482 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 m170 -91.42 -17.95 24.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.058 0.456 . . . . 73.22 109.971 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 tp -151.42 155.37 38.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.43 -0.952 . . . . 72.12 108.43 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.5 t -137.47 147.11 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.028 -1.101 . . . . 70.34 108.028 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.14 156.15 44.36 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.3 -0.63 . . . . 64.21 109.3 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.3 m -127.48 166.03 25.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 O-C-N 123.595 0.559 . . . . 73.21 109.928 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -122.48 137.74 54.78 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.068 -0.716 . . . . 74.02 109.068 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -153.34 138.22 17.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.918 -1.142 . . . . 75.32 107.918 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.93 16.28 10.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.955 0.902 . . . . 74.32 110.875 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.06 78.42 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.614 -0.721 . . . . 71.41 112.133 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.76 143.61 15.68 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 111.312 -0.715 . . . . 64.35 111.312 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 p -97.73 123.27 50.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.777 0.799 . . . . 73.41 109.426 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.61 151.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.963 -1.017 . . . . 74.03 110.534 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 mp -105.35 126.67 30.33 Favored Pre-proline 0 C--N 1.28 -2.43 0 N-CA-C 107.517 -1.29 . . . . 64.12 107.517 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.36 118.03 4.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.091 1.86 . . . . 71.22 110.435 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.476 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 tt0 -60.95 -24.56 66.15 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.184 0.594 . . . . 75.34 111.667 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.83 -5.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 115.265 -0.88 . . . . 75.41 112.436 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -80.42 -14.39 58.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.009 0.909 . . . . 75.34 109.637 173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.3 151.39 26.05 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.127 -1.064 . . . . 75.22 108.127 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.4 p -76.23 175.24 9.21 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.574 -0.528 . . . . 75.15 109.574 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.82 -17.75 63.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.7 0.762 . . . . 74.35 109.994 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 m -83.3 -4.14 58.15 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.075 -0.511 . . . . 75.41 111.186 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.79 26.3 60.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.039 -0.601 . . . . 62.42 112.822 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.58 154.88 39.99 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.716 -0.846 . . . . 72.0 108.716 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.57 135.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.536 -0.542 . . . . 75.02 109.536 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.7 t -61.94 141.61 17.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.064 -1.458 . . . . 73.24 107.064 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -54.32 -44.94 72.47 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.459 1.281 . . . . 74.15 114.459 -169.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 64.6 m -109.31 21.72 16.73 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.543 -0.863 . . . . 73.02 112.246 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.441 ' HB3' ' HD3' ' A' ' 82' ' ' PRO . 17.7 tp -58.04 -48.65 96.71 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 115.041 -0.981 . . . . 72.15 110.799 174.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 50.1 Cg_exo -58.96 -27.47 84.88 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.907 1.738 . . . . 70.53 111.396 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 87' ' ' ILE . . . -62.81 -45.53 95.52 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.949 -0.569 . . . . 63.14 112.388 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.56 -39.9 80.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.699 0.762 . . . . 74.22 109.329 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.55 -44.52 90.51 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.906 -1.043 . . . . 71.53 110.492 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.7 m -67.14 -45.84 75.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.764 -0.653 . . . . 74.14 111.657 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.498 HG21 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -61.58 -45.27 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 120.542 0.211 . . . . 64.15 111.403 -178.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.23 -42.45 84.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.65 0.611 . . . . 70.11 112.65 177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -64.56 -44.46 90.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.824 -0.436 . . . . 70.4 109.824 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -68.18 -26.77 65.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.852 -0.613 . . . . 72.52 109.51 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.48 -9.36 86.98 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.416 -0.811 . . . . 71.42 113.313 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.2 53.39 2.19 Favored Glycine 0 C--O 1.242 0.64 0 C-N-CA 121.03 -0.605 . . . . 71.02 113.009 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.529 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 84.1 m-85 -129.8 136.95 50.19 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.968 0.413 . . . . 71.43 111.46 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.496 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 24.1 ptt180 -81.23 169.97 16.68 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.114 -0.948 . . . . 75.04 110.807 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 99' ' ' MET . 12.3 p-10 -55.13 -45.2 75.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.217 1.407 . . . . 75.34 111.624 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -61.8 -40.38 95.04 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.596 -0.729 . . . . 74.1 111.084 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.496 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 45.1 mm-40 -66.13 -34.64 78.5 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.723 -0.391 . . . . 75.34 111.247 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 mm -63.17 -47.59 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.352 -0.981 . . . . 64.52 108.352 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 22.3 mmt -69.77 -22.1 63.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.201 -1.363 . . . . 74.24 110.543 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -58.2 -67.1 0.38 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.265 0.626 . . . . 74.52 109.734 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.482 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.5 p-90 -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.734 0.642 . . . . 74.23 112.734 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.482 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 mt -61.59 -39.93 92.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.828 0.677 . . . . 74.44 112.828 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 95.6 m-85 -98.69 -9.77 24.16 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 113.235 0.828 . . . . 72.5 113.235 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.9 m -86.0 116.04 64.18 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.552 -0.907 . . . . 72.14 108.552 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.99 154.68 73.86 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.753 2.302 . . . . 75.23 112.953 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.3 t70 -99.71 120.45 57.35 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.173 -1.047 . . . . 72.55 108.173 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.23 -27.32 84.64 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.267 2.645 . . . . 72.2 113.519 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.3 p -100.03 4.3 44.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.442 0.639 . . . . 63.24 112.215 -175.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.5 tp -102.16 139.33 37.92 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.408 -0.59 . . . . 75.55 109.408 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.2 m -129.82 118.49 21.85 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.278 -0.638 . . . . 74.24 109.278 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm -128.38 153.96 38.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 108.262 -1.014 . . . . 71.22 108.262 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.9 p -89.51 126.16 35.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 105.997 -1.853 . . . . 73.04 105.997 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.488 ' HD3' ' N ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -98.57 127.23 44.41 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.797 -0.761 . . . . 72.32 109.755 -172.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 15.7 m-20 -50.21 120.89 4.88 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 124.248 0.967 . . . . 74.0 111.356 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.36 -29.45 3.03 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 107.946 -2.061 . . . . 71.12 107.946 -173.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -145.61 170.51 16.3 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 106.479 -1.674 . . . . 70.3 106.479 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.69 6.56 32.03 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 122.065 0.936 . . . . 73.32 108.644 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.33 145.17 44.11 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.135 -1.393 . . . . 63.42 111.622 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.94 124.21 33.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.065 -0.971 . . . . 74.24 109.619 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.73 120.5 62.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.986 -0.746 . . . . 75.11 108.986 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.1 m -81.81 138.75 35.07 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.051 -1.092 . . . . 64.12 108.051 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 10.3 t30 72.4 69.33 0.14 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.293 1.044 . . . . 71.51 110.09 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.9 167.22 10.41 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.636 -1.165 . . . . 65.53 108.494 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.558 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 6.2 ptp180 -94.18 149.32 36.61 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.024 -0.732 . . . . 74.4 109.024 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.8 -27.54 20.6 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.168 2.579 . . . . 71.13 113.306 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 48.3 t -60.97 -36.78 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.242 0.544 . . . . 74.55 110.375 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 66.4 m-20 -69.04 -36.87 78.2 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.037 -0.727 . . . . 72.31 109.037 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.79 -40.16 79.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.269 -0.878 . . . . 75.23 111.589 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -66.73 -38.85 87.51 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.766 -0.374 . . . . 74.11 111.931 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.419 ' N ' HD12 ' A' ' 129' ' ' LEU . 47.6 t-80 -75.97 -17.17 59.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.91 0.862 . . . . 75.23 109.239 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.76 4.5 36.57 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.131 -0.941 . . . . 72.14 110.055 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 67.88 28.3 7.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.561 1.144 . . . . 75.24 111.763 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -103.93 24.11 11.83 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.581 1.152 . . . . 75.4 108.746 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.43 ' O ' HG21 ' A' ' 138' ' ' VAL . . . -52.49 -27.51 16.61 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 125.126 1.371 . . . . 73.42 112.72 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -55.53 -43.86 76.15 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.825 0.85 . . . . 74.05 110.974 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 2.3 tm-20 -73.2 -32.13 64.6 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.969 -0.752 . . . . 72.3 108.969 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.64 -42.5 89.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.015 -0.539 . . . . 73.12 110.013 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 134' ' ' ALA . 92.6 t -59.23 -41.65 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.956 -0.565 . . . . 71.21 109.523 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 136' ' ' GLU . 43.0 ttt180 -56.88 -47.12 81.2 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.01 -0.996 . . . . 73.03 110.016 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -68.96 -35.58 76.93 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.044 -0.526 . . . . 72.34 111.858 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.2 -43.44 98.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.841 0.353 . . . . 71.44 110.227 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -60.19 -45.86 91.69 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.803 -0.635 . . . . 71.42 110.178 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.4 84.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.196 -0.911 . . . . 54.14 112.075 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.57 -27.84 51.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.119 -0.492 . . . . 61.13 111.856 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -82.83 -63.6 1.33 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.182 0.808 . . . . 65.33 113.182 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 C--N 1.298 -1.665 0 CA-C-O 118.183 -0.913 . . . . 71.33 111.743 -170.863 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptp . . . . . 0 C--O 1.236 0.365 0 N-CA-C 109.682 -0.488 . . . . 73.15 109.682 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.94 136.35 5.07 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.134 1.89 . . . . 74.4 110.042 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.468 ' HA3' ' OE1' ' A' ' 97' ' ' GLU . . . -85.34 -46.64 5.47 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 109.777 -1.329 . . . . 32.42 109.777 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -74.09 132.46 42.31 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.299 -1.001 . . . . 72.22 108.299 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.24 102.94 0.35 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.572 0.225 . . . . 73.32 111.221 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.77 116.16 3.15 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.345 2.03 . . . . 71.14 109.364 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.61 -127.74 2.37 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.407 -0.901 . . . . 73.31 112.947 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m -69.88 106.38 3.14 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.35 0.66 . . . . 74.44 112.057 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.9 m -98.43 133.78 42.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.17 -0.678 . . . . 63.42 109.17 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.36 170.34 12.11 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.485 -0.561 . . . . 73.51 109.485 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.09 108.73 7.07 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.616 -1.624 . . . . 72.42 106.616 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -80.39 86.3 5.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 114.36 1.245 . . . . 71.1 114.36 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.57 79.49 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.162 -1.792 . . . . 75.03 106.162 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.31 74.92 Favored Glycine 0 C--N 1.307 -1.034 0 N-CA-C 110.422 -1.071 . . . . 50.2 110.422 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 m -97.46 129.84 44.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.822 -0.807 . . . . 74.04 108.822 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mp -96.91 126.55 42.22 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 107.273 -1.38 . . . . 73.41 107.273 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -68.69 134.66 30.94 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.191 1.261 . . . . 73.32 111.139 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.11 139.36 49.83 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.924 -1.51 . . . . 70.44 106.924 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.24 -129.17 3.52 Favored Glycine 0 N--CA 1.422 -2.254 0 C-N-CA 120.556 -0.83 . . . . 62.44 111.849 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -109.97 146.75 34.72 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.614 -0.513 . . . . 55.34 109.614 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.599 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 19.1 t0 -78.44 125.24 29.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.349 0.595 . . . . 72.42 111.456 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.67 -15.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.922 -1.036 . . . . 75.4 109.059 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.58 HD21 ' CE1' ' A' ' 103' ' ' PHE . 24.0 mt -85.84 174.4 9.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 115.084 1.512 . . . . 74.14 115.084 -175.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -105.34 141.98 23.75 Favored Pre-proline 0 N--CA 1.423 -1.825 0 CA-C-N 112.379 -2.192 . . . . 74.51 106.636 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -55.38 -27.05 56.24 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.943 2.429 . . . . 65.22 114.412 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -91.55 -13.59 31.79 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.389 0.614 . . . . 73.33 110.755 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.53 ' OE2' ' HD2' ' A' ' 28' ' ' PRO . 9.0 tp10 -77.85 129.37 76.46 Favored Pre-proline 0 C--O 1.242 0.683 0 N-CA-C 105.562 -2.014 . . . . 73.2 105.562 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.53 ' HD2' ' OE2' ' A' ' 27' ' ' GLU . 17.7 Cg_exo -31.08 106.91 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 125.204 3.936 . . . . 73.32 115.381 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.88 155.85 48.27 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.689 -0.687 . . . . 74.53 112.385 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.485 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 22.6 m-85 -129.45 161.38 30.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 125.552 1.541 . . . . 74.43 108.077 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.596 ' OD1' ' HD3' ' A' ' 34' ' ' ARG . 5.5 p-10 -135.13 172.1 13.49 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.38 -1.711 . . . . 71.54 106.38 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -42.98 -61.13 1.89 Allowed Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 115.844 1.794 . . . . 65.22 115.844 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.1 -34.97 99.06 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.915 1.743 . . . . 62.13 112.764 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.596 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 5.2 mpt_? -70.15 -36.09 74.48 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.88 0.326 . . . . 73.42 111.88 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.407 HG23 HD13 ' A' ' 66' ' ' ILE . 79.8 t -69.69 -41.78 80.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.661 -0.496 . . . . 74.24 109.661 177.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.52 91.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.334 -0.848 . . . . 71.15 109.771 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -62.85 -46.11 89.41 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.838 1.255 . . . . 71.1 109.791 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.413 HD21 ' CE2' ' A' ' 30' ' ' TYR . 28.2 tp -70.52 -46.03 64.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.787 -1.097 . . . . 73.41 111.516 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.51 -18.97 34.06 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.42 0.526 . . . . 74.43 112.42 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.57 59.09 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 110.81 -0.916 . . . . 51.12 110.81 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.51 164.25 35.52 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.405 -0.591 . . . . 74.14 109.405 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.99 164.48 27.33 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 121.673 1.582 . . . . 73.33 111.446 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.54 -34.55 65.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.546 -0.752 . . . . 75.32 109.422 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 m -58.73 -38.9 79.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.59 -0.732 . . . . 61.21 111.851 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 24.3 ttmm -69.49 -37.5 77.27 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.481 -0.488 . . . . 73.24 110.285 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 59.7 t -63.84 -42.11 94.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.945 -0.761 . . . . 62.12 108.945 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.62 74.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 72.33 110.556 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.8 -46.38 75.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.26 -0.427 . . . . 72.53 110.577 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 68.3 mt-30 -59.08 -45.95 89.52 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.213 0.53 . . . . 74.41 110.131 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 96.9 mt -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.627 -1.17 . . . . 73.42 110.305 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -70.3 -31.24 68.49 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.811 1.041 . . . . 74.55 113.811 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.71 -11.76 35.94 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.165 -0.614 . . . . 73.35 112.234 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 36.44 6.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.318 -0.944 . . . . 73.2 111.965 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -99.11 -22.37 15.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.444 -0.947 . . . . 72.23 108.444 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.7 tp -157.13 155.26 30.72 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.773 -1.565 . . . . 75.23 106.773 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.83 161.64 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 118.159 0.436 . . . . 73.44 110.434 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.37 158.67 43.83 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.281 0.363 . . . . 60.01 110.21 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 m -127.83 165.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.343 0.657 . . . . 74.21 110.142 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -121.57 128.55 52.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.76 0.314 . . . . 75.5 111.161 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.599 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 20.9 ptt180 -136.2 124.2 22.84 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.394 -0.595 . . . . 74.1 109.394 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.72 14.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 74.43 111.729 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.93 -3.41 84.69 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.933 -0.576 . . . . 60.13 112.303 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.19 138.09 13.74 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 111.056 -0.818 . . . . 63.55 111.056 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.6 123.45 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.874 -1.158 . . . . 65.24 107.874 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.2 m -131.22 151.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.345 0.593 . . . . 73.05 110.936 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 35' ' ' VAL . 76.0 mt -124.45 125.5 25.6 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 107.437 -1.32 . . . . 75.32 107.437 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -56.87 128.98 32.17 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.769 2.313 . . . . 70.13 112.607 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.485 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -64.54 -24.79 67.72 Favored 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 123.421 0.688 . . . . 72.43 111.206 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.83 -3.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.569 -0.741 . . . . 74.04 112.425 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -87.15 -4.1 59.1 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.428 1.109 . . . . 74.43 108.752 173.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -117.35 150.43 38.85 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 113.979 -1.464 . . . . 75.54 107.398 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -83.01 173.03 12.14 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.629 -0.878 . . . . 70.11 108.629 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.28 -17.27 64.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.411 0.624 . . . . 74.12 110.62 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -81.27 -3.91 53.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.692 -0.686 . . . . 63.22 111.478 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 23.84 58.85 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.77 -0.729 . . . . 63.23 112.976 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.12 154.76 44.33 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.285 -1.005 . . . . 74.33 108.285 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.8 t -62.6 142.75 16.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 123.62 0.575 . . . . 74.34 109.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.31 135.08 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.974 0.796 . . . . 63.33 109.346 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -54.91 -43.66 73.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.852 -0.613 . . . . 71.11 112.295 -174.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -98.67 18.35 17.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.904 0.705 . . . . 62.44 112.904 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -60.6 -52.08 75.27 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-N 116.595 -0.275 . . . . 74.11 110.803 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 19.3 Cg_endo -59.85 -27.92 86.03 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 121.881 1.721 . . . . 70.13 111.796 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.58 92.93 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 116.098 -0.501 . . . . 64.42 112.084 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -68.22 -39.98 82.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.285 0.564 . . . . 65.13 109.482 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.29 -36.27 83.57 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.785 -0.643 . . . . 73.41 110.73 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.2 m -61.0 -47.8 84.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.358 -0.383 . . . . 73.04 111.999 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -42.56 86.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 120.67 -0.412 . . . . 71.25 110.607 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.04 -35.62 80.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.499 0.555 . . . . 75.21 112.499 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -63.9 -33.45 75.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.026 -0.361 . . . . 73.53 110.026 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.58 -31.18 71.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.075 -0.511 . . . . 73.4 110.222 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.97 -9.19 81.17 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.715 -0.675 . . . . 43.34 111.473 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.12 55.76 3.96 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 112.402 -0.279 . . . . 64.3 112.402 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 88.7 m-85 -113.77 137.83 51.1 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.236 0.458 . . . . 74.55 112.236 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.449 ' O ' HG12 ' A' ' 98' ' ' ILE . 15.4 ptp180 -88.03 172.23 9.7 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.462 -0.79 . . . . 72.34 111.176 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -53.59 -45.06 69.88 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.267 1.427 . . . . 71.43 112.425 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -60.13 -41.57 92.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.208 0.603 . . . . 75.32 110.059 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' OE1' ' HA3' ' A' ' 3' ' ' GLY . 5.7 mm-40 -63.21 -43.85 96.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.992 -0.549 . . . . 74.12 110.412 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.7 mm -61.15 -48.13 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.587 0.708 . . . . 72.23 109.3 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.44 ' O ' ' HD2' ' A' ' 103' ' ' PHE . 53.8 mtt -74.65 -20.97 59.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.138 -0.937 . . . . 74.52 111.638 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 64.3 ttt180 -57.2 -65.88 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.025 0.53 . . . . 74.21 110.576 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.473 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.0 p-90 -69.02 -33.1 73.1 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.968 0.729 . . . . 73.52 112.968 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.473 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.1 mt -57.24 -40.5 77.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.976 0.732 . . . . 74.1 112.976 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.58 ' CE1' HD21 ' A' ' 23' ' ' LEU . 97.1 m-85 -98.65 3.48 47.82 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.544 0.572 . . . . 73.22 112.544 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.3 m -87.44 119.58 70.83 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.985 -0.376 . . . . 74.43 109.985 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 32.2 Cg_exo -62.74 128.84 24.37 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.616 1.544 . . . . 71.23 108.348 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -99.99 122.57 50.21 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 120.301 -0.56 . . . . 72.43 110.209 -176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.4 -19.53 59.08 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.411 2.741 . . . . 72.42 113.7 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -107.6 3.86 25.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 111.919 0.34 . . . . 64.03 111.919 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.5 tp -102.64 130.6 49.59 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.74 0.781 . . . . 73.23 110.979 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.9 m -131.28 118.65 20.66 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.476 -1.305 . . . . 41.43 107.476 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.1 163.6 33.86 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 N-CA-C 113.156 0.799 . . . . 71.44 113.156 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.9 p -109.4 159.95 16.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.306 -0.861 . . . . 75.21 109.198 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.02 -173.53 3.17 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.024 -1.102 . . . . 75.2 108.024 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -89.2 150.03 22.85 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.426 -0.583 . . . . 75.24 109.426 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.19 -69.22 3.06 Favored Glycine 0 C--N 1.312 -0.782 0 N-CA-C 109.271 -1.532 . . . . 43.34 109.271 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 53.2 p -98.1 101.61 13.13 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.102 -1.444 . . . . 74.3 107.102 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.72 3.68 51.99 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.872 -0.604 . . . . 74.53 112.326 -172.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -73.61 142.17 46.55 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.063 -1.088 . . . . 74.43 108.063 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.95 123.65 29.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.272 0.558 . . . . 75.23 111.307 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.2 t -96.59 128.73 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 124.441 1.096 . . . . 75.45 109.065 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -83.21 154.46 24.22 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.059 -0.973 . . . . 74.2 111.337 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 78.8 m-20 62.44 40.81 10.56 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.481 1.112 . . . . 75.2 110.949 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 174.41 6.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.16 -0.473 . . . . 62.11 110.858 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -102.69 143.74 27.21 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 116.379 -0.373 . . . . 75.34 111.077 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.431 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.5 Cg_exo -53.36 -24.32 27.07 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.847 3.031 . . . . 74.13 114.595 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.616 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 71.2 t -60.4 -39.83 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 122.158 0.98 . . . . 74.32 110.405 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.18 -30.47 67.6 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.052 -0.976 . . . . 74.23 110.381 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.17 77.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 71.34 111.422 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.71 -36.27 82.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.932 -0.307 . . . . 75.05 111.599 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -66.57 -29.13 69.12 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.68 0.752 . . . . 73.23 109.963 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.89 0.38 53.24 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.883 -1.053 . . . . 64.14 111.608 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.7 t60 64.55 28.7 13.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 122.868 1.318 . . . . 72.41 109.572 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -95.02 25.13 4.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.788 1.28 . . . . 74.33 108.282 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 138' ' ' VAL . . . -53.89 -29.39 41.55 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.508 -1.678 . . . . 54.44 113.491 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -63.61 -37.55 87.75 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.931 -0.766 . . . . 72.13 108.931 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -63.18 -42.56 99.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.231 -0.895 . . . . 70.13 109.173 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.43 -47.93 87.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.585 -0.734 . . . . 71.3 110.342 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 134' ' ' ALA . 99.1 t -59.38 -44.77 93.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.434 -0.348 . . . . 73.35 111.416 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -63.68 -38.4 90.96 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.944 -0.702 . . . . 74.14 111.361 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -69.0 -36.52 77.91 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.829 -0.434 . . . . 73.01 109.829 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.717 -0.674 . . . . 73.24 109.877 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.74 -42.88 94.18 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.939 -0.573 . . . . 62.2 111.015 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.68 -25.96 65.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.23 0.538 . . . . 70.23 111.486 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.47 ' HG3' ' CD1' ' A' ' 101' ' ' TRP . 0.5 OUTLIER -82.18 -39.75 22.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.449 0.642 . . . . 72.22 109.421 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.421 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -81.54 -40.75 22.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.782 0.66 . . . . 75.42 112.782 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 109.453 -0.573 . . . . 74.24 109.453 -177.873 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 108.824 -0.806 . . . . 75.32 108.824 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.98 115.7 4.11 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 121.847 1.698 . . . . 71.21 110.72 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.61 133.7 5.7 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.97 -0.633 . . . . 53.45 111.695 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -73.34 144.23 46.58 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 110.124 -0.324 . . . . 75.14 110.124 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.29 137.49 48.88 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.712 -0.847 . . . . 72.05 108.712 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -52.63 153.91 13.26 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 123.218 2.612 . . . . 74.52 112.483 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.62 82.29 0.29 Allowed Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.915 -0.584 . . . . 43.05 113.38 -176.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -144.55 158.87 43.57 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.523 -1.288 . . . . 74.23 107.523 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -162.84 -161.13 0.68 Allowed 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.194 -1.41 . . . . 72.32 107.194 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.5 mt -73.61 145.02 45.73 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.288 -0.634 . . . . 73.41 109.288 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.04 11.38 37.78 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.5 0.666 . . . . 74.31 111.462 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -88.5 107.84 19.09 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.446 -0.797 . . . . 65.02 109.229 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.94 116.74 53.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 108.024 -1.102 . . . . 73.53 108.024 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.8 -165.97 23.34 Favored Glycine 0 N--CA 1.412 -2.933 0 CA-C-N 115.5 -0.773 . . . . 74.21 111.781 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.43 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 6.9 m -65.57 108.52 2.06 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 124.166 0.986 . . . . 74.23 112.87 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.66 124.06 89.95 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 107.27 -1.382 . . . . 72.34 107.27 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.04 166.26 30.03 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.084 2.523 . . . . 74.32 113.021 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.85 123.23 46.55 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.361 -1.718 . . . . 73.04 106.361 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.6 -110.96 2.97 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.581 -0.819 . . . . 75.45 113.327 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.36 123.18 38.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.256 0.55 . . . . 75.13 111.879 -171.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' A' ' 23' ' ' LEU . 3.5 t70 -61.29 131.94 51.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.285 -0.871 . . . . 75.21 111.75 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.06 -4.78 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 122.07 0.938 . . . . 72.11 109.29 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.438 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 17.6 mt -74.98 165.15 25.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.618 1.199 . . . . 72.43 113.941 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.3 t70 -94.26 134.66 25.37 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 105.314 -2.106 . . . . 75.44 105.314 172.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.84 -21.75 27.14 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 123.406 2.738 . . . . 64.44 114.572 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.86 -23.85 23.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.208 0.447 . . . . 75.02 112.208 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 23.2 mm-40 -65.87 139.22 96.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.07 -0.252 . . . . 73.32 111.676 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.1 128.0 28.36 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.351 2.701 . . . . 75.12 113.102 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.5 p -122.94 170.07 10.5 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 121.629 0.728 . . . . 73.32 111.484 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 24.9 m-85 -130.36 161.21 31.83 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 126.401 1.88 . . . . 72.54 107.851 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -135.03 161.74 34.44 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 103.346 -2.835 . . . . 73.15 103.346 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 mt -53.12 -51.44 75.05 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 112.672 0.619 . . . . 74.34 112.672 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.31 -35.37 98.77 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.161 1.907 . . . . 64.23 112.2 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -70.78 -38.54 73.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.48 -0.327 . . . . 73.43 110.697 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.5 t -68.15 -37.46 78.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.602 -0.518 . . . . 74.23 109.602 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.89 81.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.289 -0.869 . . . . 73.53 109.68 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.8 -45.96 80.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.203 -0.908 . . . . 53.44 109.68 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 49.7 tp -62.31 -50.66 70.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.906 -1.043 . . . . 74.4 112.3 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.43 -13.92 41.94 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.469 0.544 . . . . 73.12 112.469 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.44 31.5 56.72 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 110.947 -0.861 . . . . 74.31 110.947 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.6 m -121.98 161.26 43.38 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.529 -0.915 . . . . 75.24 108.529 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.07 163.47 35.13 Favored 'Trans proline' 0 C--O 1.262 1.681 0 C-N-CA 121.393 1.395 . . . . 73.14 111.673 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.19 -33.21 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.82 0.848 . . . . 70.42 109.526 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 13.4 m -57.03 -44.38 82.86 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.728 -1.124 . . . . 75.41 110.617 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 51.8 mtpt -69.4 -32.04 70.79 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.101 -0.374 . . . . 75.21 111.425 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HA ' HE21 ' A' ' 49' ' ' GLN . 47.2 t -62.43 -44.38 99.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 109.593 -0.521 . . . . 74.22 109.593 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.83 81.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 64.52 109.996 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 44' ' ' SER . 25.7 mt-30 -64.51 -41.43 96.43 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 116.275 -0.42 . . . . 74.32 111.543 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 43.7 mt-30 -61.04 -42.14 97.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.802 0.81 . . . . 74.32 109.961 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.24 -41.19 98.2 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.074 -1.421 . . . . 75.41 109.696 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' A' ' 15' ' ' SER . 97.0 mtt180 -71.57 -21.97 61.81 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.77 -0.65 . . . . 74.02 112.291 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 50.9 mt-10 -81.71 -12.68 58.53 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 122.103 -0.373 . . . . 61.11 110.64 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.2 23.35 77.73 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.52 -1.032 . . . . 74.31 110.52 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -109.26 5.54 23.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.394 0.616 . . . . 74.45 110.523 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 tp -153.6 151.57 29.88 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.279 -1.749 . . . . 75.51 106.279 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.01 148.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.317 -0.623 . . . . 73.5 109.317 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.62 161.8 37.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.972 -0.751 . . . . 44.42 108.972 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.63 160.31 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 123.343 0.402 . . . . 70.42 110.445 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 40.2 ttm180 -115.34 117.84 31.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.393 0.616 . . . . 75.04 111.698 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 26.2 ptt180 -127.96 130.07 47.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.077 -0.712 . . . . 75.0 109.077 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.05 21.63 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.945 0.898 . . . . 74.05 110.384 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.14 -15.06 64.02 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.841 -0.618 . . . . 42.24 112.731 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.45 143.1 16.52 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.02 -0.61 . . . . 62.23 112.244 -177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.14 121.41 47.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 109.366 -0.605 . . . . 75.25 109.366 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.43 152.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.605 -0.725 . . . . 74.23 110.892 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 78.9 mt -115.1 133.48 22.67 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.283 -1.006 . . . . 75.13 108.283 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.12 130.33 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.755 1.637 . . . . 72.51 111.156 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 7.2 tt0 -62.59 -24.56 67.62 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.164 0.507 . . . . 73.02 111.181 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -67.38 -6.97 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.684 -0.689 . . . . 74.0 112.707 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.55 ' CD2' HD11 ' A' ' 81' ' ' LEU . 5.2 m-85 -81.56 -11.24 59.23 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.217 1.008 . . . . 74.14 109.24 173.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -113.06 164.2 13.77 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.676 -1.147 . . . . 73.34 108.291 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.484 ' HA ' ' CD2' ' A' ' 130' ' ' HIS . 37.5 p -82.34 165.97 19.87 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.131 -0.692 . . . . 74.12 109.131 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -64.71 -19.14 65.59 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.047 -0.524 . . . . 72.21 109.627 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 m -79.51 -19.9 48.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.576 -0.738 . . . . 71.31 110.229 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.46 -5.96 38.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.436 -0.888 . . . . 70.53 113.75 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.84 166.2 11.74 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.086 -0.655 . . . . 74.13 109.489 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.05 139.91 20.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.757 -0.831 . . . . 75.54 108.757 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.76 136.74 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.231 -1.026 . . . . 75.4 108.231 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -54.77 -36.56 64.98 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 112.535 0.569 . . . . 74.22 112.535 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -88.11 -0.76 57.46 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.638 0.607 . . . . 72.32 112.638 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.55 HD11 ' CD2' ' A' ' 70' ' ' PHE . 20.3 tp -65.36 -53.64 37.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.37 -0.348 . . . . 73.53 111.809 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 38.6 Cg_exo -60.28 -30.9 92.12 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.694 1.596 . . . . 73.33 111.304 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.49 90.01 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.864 -0.607 . . . . 73.23 112.838 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 pp -68.39 -40.5 81.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.394 0.616 . . . . 72.43 109.355 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.34 -41.28 98.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.591 -0.731 . . . . 65.35 110.833 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -57.77 -47.72 81.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.477 -0.329 . . . . 71.43 111.795 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -42.11 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 120.812 -0.355 . . . . 74.21 111.345 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.36 -37.17 82.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.467 0.543 . . . . 75.32 112.467 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -66.83 -32.29 73.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.664 -0.244 . . . . 74.35 111.08 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.19 -29.91 71.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.294 0.569 . . . . 63.25 109.778 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.77 6.42 64.71 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.556 -0.747 . . . . 75.21 112.394 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.31 33.43 84.98 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.465 0.546 . . . . 73.15 114.465 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 57.8 m-85 -85.85 131.63 34.27 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 117.626 0.713 . . . . 75.33 112.344 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.445 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 21.8 ptt180 -73.32 170.45 15.01 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-N 115.345 -0.843 . . . . 75.45 111.215 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -55.02 -44.84 74.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 125.899 1.679 . . . . 62.24 112.013 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.9 m -62.64 -42.1 99.41 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.085 -0.961 . . . . 72.54 110.628 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 61.7 mm-40 -66.6 -34.74 78.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.108 -0.496 . . . . 73.12 110.328 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.46 -48.42 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.741 0.781 . . . . 74.34 108.93 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 55.1 mtt -75.13 -18.43 60.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.91 -1.041 . . . . 73.15 111.894 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -60.73 -63.46 1.29 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.989 -0.55 . . . . 72.13 110.574 -174.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.516 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 31.3 p-90 -69.32 -32.82 72.19 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.129 0.418 . . . . 73.43 112.129 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 12.2 mt -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.95 1.093 . . . . 74.34 113.95 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.402 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 84.0 m-85 -95.75 -2.95 46.75 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.008 0.744 . . . . 72.43 113.008 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 m -88.57 109.79 32.0 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 110.193 -0.299 . . . . 73.23 110.193 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 42.9 Cg_exo -60.09 144.66 99.46 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.892 2.395 . . . . 75.05 111.626 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 11.0 t70 -107.47 124.0 36.37 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.626 -0.509 . . . . 71.32 109.626 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.564 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 28.3 Cg_endo -60.62 -25.83 81.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.658 2.905 . . . . 72.5 114.513 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.6 m -102.41 1.49 35.43 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.984 0.421 . . . . 74.21 110.247 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.432 ' HG ' HG12 ' A' ' 111' ' ' ILE . 43.0 tp -101.66 130.58 48.04 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.601 -0.518 . . . . 75.21 109.601 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.415 HG22 ' HB1' ' A' ' 119' ' ' ALA . 25.3 m -128.04 110.54 12.59 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.802 -0.814 . . . . 72.41 108.802 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.432 HG12 ' HG ' ' A' ' 109' ' ' LEU . 39.9 mm -122.88 149.51 26.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.288 -0.869 . . . . 74.24 109.88 -172.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -102.61 153.1 20.43 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.897 -1.519 . . . . 74.31 106.897 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.605 ' HD3' ' N ' ' A' ' 114' ' ' ASP . 2.7 tmt_? -134.89 152.48 51.78 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.56 -0.856 . . . . 73.31 110.32 -171.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.605 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 10.8 m-20 -63.66 99.37 0.22 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.483 -0.932 . . . . 71.31 108.483 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 130.77 -37.68 2.07 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 110.037 -1.225 . . . . 74.41 110.037 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.0 m -122.09 96.55 5.1 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.752 -0.832 . . . . 71.31 108.752 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -69.8 -33.9 72.99 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.228 0.537 . . . . 75.11 109.863 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.2 133.04 55.73 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.224 -1.353 . . . . 74.34 107.747 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.415 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -67.07 135.08 53.09 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.968 0.413 . . . . 65.32 110.696 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.78 118.71 55.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.342 -0.614 . . . . 73.4 109.342 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -83.04 148.87 27.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.746 -1.575 . . . . 71.43 106.746 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.564 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 34.2 m-80 66.99 41.37 2.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 123.828 0.851 . . . . 75.31 109.08 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.63 150.38 26.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.463 -0.495 . . . . 75.01 110.754 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -80.36 128.1 73.96 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.629 -0.878 . . . . 75.35 108.629 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.53 -24.1 8.7 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.063 3.175 . . . . 75.44 115.11 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.584 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.1 t -60.62 -39.1 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.267 0.556 . . . . 74.12 110.419 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -69.95 -30.27 67.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.187 -0.461 . . . . 74.21 111.149 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.36 82.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.699 -0.682 . . . . 73.11 111.17 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -63.95 -37.68 88.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.501 0.191 . . . . 74.2 111.307 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.484 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 61.1 t-80 -68.7 -36.79 78.92 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.741 -0.663 . . . . 73.32 109.301 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.14 21.2 5.25 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.342 -0.845 . . . . 74.13 112.773 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.8 t60 64.69 27.64 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.77 1.228 . . . . 73.32 111.361 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -110.53 24.42 12.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.965 1.364 . . . . 73.51 107.635 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.62 -25.91 12.07 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 112.416 -2.174 . . . . 74.32 112.627 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -54.78 -39.33 68.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.54 0.736 . . . . 73.25 110.75 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.35 -33.71 74.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.383 0.611 . . . . 73.42 111.072 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.7 t -72.59 -41.96 63.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.48 -0.782 . . . . 75.24 109.651 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.7 -48.06 89.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.234 -0.439 . . . . 75.22 110.264 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -63.59 -37.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.746 -0.382 . . . . 74.24 111.428 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -65.02 -41.58 95.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.644 -0.873 . . . . 75.13 108.644 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.47 -45.08 88.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.103 -0.953 . . . . 74.23 110.262 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -62.13 -38.62 89.65 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.844 -0.616 . . . . 74.34 111.248 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.21 84.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.05 0.453 . . . . 71.33 110.51 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.8 tpt -69.64 -39.28 77.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.809 -0.632 . . . . 70.1 110.736 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.426 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.94 -53.79 5.08 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.353 0.872 . . . . 71.33 113.353 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 118.691 -0.671 . . . . 75.13 109.426 -176.189 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.437 -0.579 . . . . 72.44 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.31 122.69 6.22 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.219 1.946 . . . . 73.52 110.214 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -167.1 126.25 1.42 Allowed Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.65 -0.98 . . . . 55.31 110.65 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -73.97 139.15 44.64 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.066 -0.716 . . . . 75.11 109.066 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.88 121.08 77.34 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 109.122 -0.696 . . . . 51.54 109.122 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -67.66 119.37 6.39 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.754 1.636 . . . . 73.14 110.815 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.56 -43.5 36.53 Favored Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 111.129 -0.788 . . . . 71.04 111.129 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m -69.98 99.91 1.51 Allowed 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.219 0.533 . . . . 73.01 109.746 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.6 m -120.97 138.88 53.93 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.618 -1.253 . . . . 72.2 107.618 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.0 mt -79.89 145.97 32.41 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.764 -0.458 . . . . 72.51 109.764 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.23 146.45 27.07 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 116.085 -0.507 . . . . 55.51 109.701 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.12 107.87 16.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.529 -0.915 . . . . 73.33 108.529 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.88 109.33 16.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.863 -0.792 . . . . 75.45 108.863 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.27 99.38 0.2 Allowed Glycine 0 N--CA 1.418 -2.526 0 C-N-CA 120.271 -0.966 . . . . 64.32 111.238 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 p -72.66 95.24 1.84 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.179 -0.675 . . . . 71.14 109.179 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.69 120.95 76.03 Favored Pre-proline 0 N--CA 1.437 -1.084 0 CA-C-N 115.484 -0.78 . . . . 73.21 109.918 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.72 165.07 29.34 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.467 2.112 . . . . 75.11 110.718 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.75 123.92 42.18 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.963 -1.125 . . . . 73.55 107.963 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -105.4 -86.72 1.94 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.336 -0.935 . . . . 74.21 112.796 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -127.53 143.54 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.832 0.349 . . . . 74.23 111.123 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.82 139.07 41.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.553 0.692 . . . . 72.41 112.369 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.9 t -112.12 -14.9 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.295 -0.866 . . . . 74.11 110.894 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.478 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -96.09 -179.63 4.74 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.922 -1.111 . . . . 74.41 111.657 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.64 137.08 19.36 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 108.05 -1.093 . . . . 73.52 108.05 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.88 -21.35 15.22 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.571 2.848 . . . . 62.55 114.191 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.05 -19.52 61.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.085 0.469 . . . . 71.42 111.51 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -88.5 154.68 51.16 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 119.296 -0.383 . . . . 75.32 110.017 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -46.24 110.13 0.25 Allowed 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.984 3.123 . . . . 64.31 114.992 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.0 p -125.0 167.34 14.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.794 0.838 . . . . 75.41 110.686 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.505 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 13.0 m-85 -131.4 158.2 41.39 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.307 1.043 . . . . 74.42 108.193 169.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 35' ' ' VAL . 9.5 t70 -136.95 168.82 18.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 104.281 -2.488 . . . . 73.33 104.281 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -50.6 -56.61 17.65 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 113.964 1.098 . . . . 74.21 113.964 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -57.74 -39.8 84.53 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.205 1.936 . . . . 72.55 112.346 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -70.38 -37.54 74.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 111.972 0.36 . . . . 74.44 111.972 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 31' ' ' ASP . 46.1 t -69.3 -37.64 76.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.061 -0.718 . . . . 74.53 109.061 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.14 83.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.889 -1.051 . . . . 72.1 109.704 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.7 -45.94 84.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.875 0.87 . . . . 73.11 110.061 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -62.07 -43.33 99.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.84 -1.073 . . . . 70.32 111.903 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.407 ' HB2' HG23 ' A' ' 41' ' ' VAL . 83.5 mt -97.31 -12.56 22.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.939 -0.573 . . . . 72.5 112.097 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 17.15 80.18 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.538 -0.625 . . . . 71.11 111.538 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.407 HG23 ' HB2' ' A' ' 39' ' ' LEU . 25.8 m -112.48 159.45 34.05 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.73 -0.841 . . . . 74.25 108.73 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.4 170.01 20.16 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 121.208 1.272 . . . . 72.01 111.246 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.08 -33.16 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.387 0.675 . . . . 71.14 110.484 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 m -56.35 -46.33 80.03 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 114.916 -1.038 . . . . 75.42 110.197 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 92.5 mttt -69.97 -35.27 74.32 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.032 0.382 . . . . 75.14 112.032 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -61.15 -43.72 96.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 N-CA-C 109.548 -0.538 . . . . 73.51 109.548 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.505 ' O ' ' HD3' ' A' ' 51' ' ' ARG . . . -61.04 -38.88 87.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.423 -0.808 . . . . 74.53 109.833 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.56 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 13.3 mm100 -66.84 -36.35 82.13 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 112.91 0.707 . . . . 74.13 112.91 178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.0 mm100 -57.87 -42.8 85.3 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.726 -0.842 . . . . 74.35 108.726 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.53 -40.61 97.33 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.4 -1.273 . . . . 73.02 110.662 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 47' ' ' ALA . 10.2 mpt_? -71.21 -20.87 62.21 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.228 0.825 . . . . 75.21 113.228 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 44.5 mm-40 -76.66 -11.87 59.92 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 120.525 -0.47 . . . . 75.01 109.824 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.72 72.15 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.944 -0.863 . . . . 62.14 110.944 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -105.46 4.28 30.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.119 -0.541 . . . . 74.11 110.206 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.2 tp -161.12 157.51 26.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.612 -0.884 . . . . 71.41 108.612 -177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 93.9 t -132.82 147.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.362 -0.977 . . . . 74.41 108.362 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.72 157.85 43.85 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.886 -0.783 . . . . 73.0 108.886 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -130.46 166.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 122.92 0.488 . . . . 74.44 110.21 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 43.8 ttp180 -121.07 125.68 47.91 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.59 -0.277 . . . . 73.25 110.801 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.473 ' NH1' HG12 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -116.62 117.09 28.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.69 -0.855 . . . . 73.11 108.69 177.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.96 -48.06 0.68 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.083 1.753 . . . . 60.5 111.583 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.23 -12.07 0.02 OUTLIER Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.738 -1.119 . . . . 72.43 112.287 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.53 146.06 16.35 Favored Glycine 0 CA--C 1.493 -1.339 0 C-N-CA 120.634 -0.793 . . . . 71.33 112.122 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.49 128.8 47.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.203 0.525 . . . . 72.22 109.771 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.473 HG12 ' NH1' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -131.54 158.75 43.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.698 1.199 . . . . 72.25 110.107 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 65.2 mt -124.77 121.93 25.64 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.114 -1.439 . . . . 63.13 107.114 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.67 126.67 22.54 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.057 1.838 . . . . 74.03 111.192 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.505 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.7 tt0 -62.22 -24.65 67.36 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 121.261 0.553 . . . . 74.43 111.447 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.68 -4.54 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.092 -0.958 . . . . 74.13 112.665 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.557 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.1 m-85 -86.29 -7.64 58.34 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.073 0.939 . . . . 74.43 109.848 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -117.11 159.98 21.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.119 . . . . 74.13 107.994 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.0 p -88.02 163.37 16.32 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.823 -1.177 . . . . 62.51 107.823 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -66.26 -16.45 64.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.305 0.574 . . . . 72.43 110.382 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.2 m -79.72 -9.5 59.66 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.777 -0.647 . . . . 74.22 110.898 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.86 -2.43 66.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.304 -0.474 . . . . 75.34 113.164 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -90.37 152.84 20.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.505 -0.554 . . . . 71.23 109.505 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.53 136.19 26.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.259 -1.386 . . . . 72.31 107.259 171.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.8 t -61.25 129.06 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.443 -0.947 . . . . 71.13 108.443 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.504 ' HZ1' ' HB3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.41 -22.33 66.08 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.751 0.648 . . . . 73.55 112.751 -177.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.1 m -87.75 -8.21 56.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.963 -0.562 . . . . 64.24 110.777 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.614 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 18.0 tp -63.45 -56.44 26.77 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 119.015 -0.517 . . . . 74.11 111.248 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.0 Cg_exo -62.83 -25.2 74.51 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.331 1.354 . . . . 72.33 110.706 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -45.36 64.57 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.602 -0.726 . . . . 74.33 111.721 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.81 -40.43 79.54 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.996 -0.742 . . . . 74.55 108.996 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 74.0 mt -59.91 -39.17 84.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.766 -0.652 . . . . 65.42 110.802 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.2 m -61.47 -48.36 81.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.054 -0.521 . . . . 74.32 111.399 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -44.41 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 111.862 0.319 . . . . 74.32 111.862 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.27 -35.79 80.24 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 120.177 -0.609 . . . . 70.14 112.225 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -64.27 -41.48 96.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.616 -0.883 . . . . 75.03 108.616 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.19 -31.2 72.25 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.96 -1.018 . . . . 74.53 110.58 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.38 -9.45 81.77 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.64 -0.709 . . . . 61.05 112.893 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.9 46.09 7.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.088 -0.577 . . . . 72.33 113.723 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.435 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 96.6 m-85 -111.0 142.92 42.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.895 -0.409 . . . . 74.02 109.895 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.422 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 16.9 ptp180 -87.94 171.03 10.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.558 -0.292 . . . . 74.31 111.141 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -55.05 -45.79 75.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.856 1.262 . . . . 70.4 111.87 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.8 m -64.5 -39.99 94.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.188 -0.915 . . . . 73.45 110.41 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 45.3 mt-10 -65.82 -35.1 79.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.079 -0.51 . . . . 74.21 111.615 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.28 -46.97 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.855 -1.165 . . . . 74.41 107.855 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -66.33 -28.64 68.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.028 -1.442 . . . . 74.52 111.029 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.0 -67.33 0.27 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 122.877 0.471 . . . . 75.31 111.037 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.458 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.3 p-90 -69.05 -32.1 71.35 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.89 0.7 . . . . 75.42 112.89 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 mt -61.22 -40.78 95.3 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 113.097 0.777 . . . . 73.5 113.097 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.5 m-85 -91.46 -5.4 54.35 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.803 0.668 . . . . 74.25 112.803 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 92.4 m -78.15 119.94 79.29 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.963 -0.754 . . . . 74.23 108.963 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.14 129.5 20.68 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.579 1.519 . . . . 74.4 109.426 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 34.4 t70 -105.41 116.59 60.0 Favored Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 116.388 -0.369 . . . . 75.32 111.012 -175.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.19 -25.26 80.56 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.728 2.286 . . . . 70.21 112.084 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -17.72 59.63 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.931 -0.577 . . . . 73.24 110.511 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.96 125.63 48.69 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.766 0.793 . . . . 74.4 110.828 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 m -131.28 110.87 11.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.365 -1.346 . . . . 73.22 107.365 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.4 pt -136.64 163.31 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 N-CA-C 112.739 0.644 . . . . 73.32 112.739 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.0 p -90.45 127.57 36.25 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 114.825 -1.08 . . . . 70.24 108.089 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.53 ' HD3' ' N ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -80.54 130.49 35.16 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.697 -0.401 . . . . 74.22 110.475 -172.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.53 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 22.5 t70 -58.31 119.76 7.49 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 123.649 0.779 . . . . 73.44 111.033 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.45 -12.56 47.44 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.506 -1.038 . . . . 70.35 110.506 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.9 m -125.42 161.34 27.28 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 109.27 -0.641 . . . . 73.24 109.27 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -96.74 -22.12 17.16 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 109.153 -0.684 . . . . 74.44 109.153 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -66.56 151.34 47.48 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-N 114.235 -1.348 . . . . 72.42 113.317 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.16 131.08 46.31 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.608 -1.178 . . . . 75.13 108.26 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.78 121.59 62.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.097 -0.705 . . . . 72.24 109.097 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 m -90.1 138.66 31.33 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.775 -1.194 . . . . 73.44 107.775 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 44.6 t-20 69.39 59.23 0.32 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.34 1.067 . . . . 70.51 109.134 176.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.66 164.09 11.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.689 -1.141 . . . . 74.22 109.9 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -87.55 145.85 38.17 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.464 -0.569 . . . . 71.1 109.464 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.53 -28.84 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.403 2.735 . . . . 75.33 113.708 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.644 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 95.8 t -60.34 -41.99 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.242 0.544 . . . . 73.31 110.146 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.411 ' OD2' ' HG2' ' A' ' 113' ' ' ARG . 3.9 t70 -65.01 -30.04 70.99 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.601 0.715 . . . . 74.12 109.796 -172.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.23 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.222 -0.899 . . . . 63.15 112.316 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 3.9 pp -68.14 -34.29 76.07 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.464 -0.494 . . . . 74.22 110.333 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -65.38 -31.85 73.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.722 -0.844 . . . . 73.23 108.722 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.74 8.28 20.4 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.785 -1.098 . . . . 72.42 111.961 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 64.06 28.32 14.26 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 123.011 1.386 . . . . 75.04 109.716 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.57 25.59 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.652 -1.158 . . . . 62.41 108.956 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.93 14.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.434 1.494 . . . . 74.12 112.212 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -56.44 -31.95 64.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.316 0.246 . . . . 72.32 111.659 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.42 -26.87 61.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 74.44 110.773 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.46 -45.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.562 -1.273 . . . . 75.1 107.562 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.418 HG13 HE21 ' A' ' 142' ' ' GLN . 58.7 t -62.26 -42.41 95.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.564 -1.198 . . . . 72.13 109.692 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -58.78 -45.31 90.11 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.44 0.696 . . . . 74.55 110.354 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.1 tpp180 -66.16 -41.28 90.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.161 -0.681 . . . . 74.34 109.161 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.58 88.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 64.32 111.118 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.418 HE21 HG13 ' A' ' 138' ' ' VAL . 79.3 mt-30 -62.16 -41.58 98.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 74.44 110.536 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.67 -27.45 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 70.23 112.113 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 93.8 mmm -86.0 -32.03 21.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 73.22 110.347 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.435 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.5 -60.1 2.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.322 -0.399 . . . . 73.54 112.062 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 109.249 -0.649 . . . . 72.31 109.249 -176.28 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 110.16 -0.311 . . . . 62.43 110.16 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.42 105.8 2.11 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.141 1.894 . . . . 73.05 110.436 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.81 97.9 1.78 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.762 -0.732 . . . . 72.52 112.912 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -75.39 133.63 41.14 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.746 0.308 . . . . 71.13 110.99 172.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.92 128.14 9.26 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.542 -1.281 . . . . 73.42 107.542 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.07 106.41 2.02 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.342 1.361 . . . . 75.52 109.982 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.62 -170.6 16.69 Favored Glycine 0 N--CA 1.407 -3.298 0 C-N-CA 120.458 -0.877 . . . . 73.54 111.452 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.2 t -161.04 164.57 30.78 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 106.404 -1.702 . . . . 72.42 106.404 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.1 m -75.59 119.57 19.81 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.749 -0.834 . . . . 75.33 108.749 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.43 152.87 42.88 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 115.59 -0.732 . . . . 73.31 111.705 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.78 152.89 34.58 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.511 -0.768 . . . . 73.54 110.055 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -58.38 97.73 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.523 1.305 . . . . 75.24 114.523 -175.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.96 18.07 3.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 122.517 1.151 . . . . 72.11 108.155 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.84 32.74 2.37 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.104 -1.598 . . . . 73.34 109.104 -172.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 m -65.89 153.51 41.82 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.469 1.107 . . . . 72.35 111.005 -175.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 16' ' ' ILE . 3.4 mp -120.27 133.66 24.01 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 106.777 -1.564 . . . . 65.25 106.777 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.16 136.22 59.15 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.151 1.234 . . . . 74.32 109.443 173.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -106.01 141.34 37.57 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.503 -0.925 . . . . 72.31 108.503 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.01 -156.85 12.87 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 120.456 -0.878 . . . . 70.13 113.542 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -96.08 136.19 36.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.915 -0.642 . . . . 75.04 109.415 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.5 101.55 0.19 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.617 0.723 . . . . 74.32 111.761 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.95 -40.4 83.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.311 -0.859 . . . . 74.22 110.951 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 173.16 10.63 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.98 -0.554 . . . . 73.22 109.916 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.31 138.44 52.13 Favored Pre-proline 0 C--N 1.291 -1.957 0 N-CA-C 108.463 -0.94 . . . . 75.5 108.463 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.63 -21.71 8.27 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 123.344 2.696 . . . . 75.02 115.676 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.52 4.99 53.15 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.378 0.51 . . . . 75.04 112.378 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -84.53 158.18 60.45 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 110.03 -0.359 . . . . 72.11 110.03 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.407 ' C ' ' HG3' ' A' ' 68' ' ' GLN . 61.6 Cg_exo -42.85 106.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 124.177 3.251 . . . . 73.44 113.879 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.415 ' N ' ' HG3' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -135.41 148.58 49.38 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 113.073 0.768 . . . . 71.41 113.073 -176.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.441 ' CD2' ' HG2' ' A' ' 68' ' ' GLN . 30.2 m-85 -116.32 162.22 17.85 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 126.34 1.856 . . . . 72.05 106.997 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -132.1 161.76 32.49 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 104.81 -2.293 . . . . 72.04 104.81 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.1 mt -45.28 -56.06 10.23 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 113.384 0.883 . . . . 71.45 113.384 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.28 -35.2 85.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.444 1.43 . . . . 70.34 112.158 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 4.3 tpt180 -70.28 -36.19 74.22 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.022 0.439 . . . . 73.15 110.226 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.86 -37.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.847 0.356 . . . . 75.33 110.047 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.86 76.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.266 -0.642 . . . . 73.4 109.266 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 8.9 mm-40 -63.41 -45.23 91.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 65.31 111.697 173.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 91.1 mt -64.14 -50.13 69.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.082 0.468 . . . . 73.43 111.234 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.59 -18.87 43.27 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.474 -0.784 . . . . 74.14 112.231 -174.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.16 31.83 69.15 Favored Glycine 0 C--O 1.239 0.447 0 N-CA-C 111.301 -0.719 . . . . 72.25 111.301 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.4 m -127.84 161.55 54.9 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.177 -0.675 . . . . 74.21 109.177 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.83 153.93 75.45 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 121.795 1.663 . . . . 72.14 112.069 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.89 -36.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.619 -0.719 . . . . 73.22 110.685 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.497 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 32.5 t -63.22 -33.93 76.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.144 -0.48 . . . . 73.24 110.961 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 62.3 tttp -69.53 -35.04 75.1 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.51 -0.552 . . . . 75.01 109.51 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.41 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 61.1 t -63.35 -41.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.837 -0.801 . . . . 74.1 108.837 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 16' ' ' ILE . . . -60.99 -36.98 80.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.784 -0.643 . . . . 73.25 110.425 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 44' ' ' SER . 27.8 mm-40 -69.19 -35.88 76.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.714 0.292 . . . . 75.23 110.266 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.8 mt-30 -64.05 -43.18 96.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.617 0.723 . . . . 75.14 109.608 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.3 mt -61.92 -40.59 95.99 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.452 -1.249 . . . . 71.33 109.412 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -61.52 -31.75 71.77 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.184 0.593 . . . . 71.44 111.781 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.27 -12.05 53.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.177 0.436 . . . . 74.53 112.177 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.9 58.57 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.967 -1.253 . . . . 73.34 109.967 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -82.77 -23.38 33.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.787 -1.19 . . . . 72.31 107.787 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -156.76 159.28 38.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.113 -1.81 . . . . 74.43 106.113 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.34 158.72 41.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.818 -0.438 . . . . 73.1 109.818 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.02 156.19 44.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.278 0.561 . . . . 71.31 111.969 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.41 165.81 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 123.671 0.789 . . . . 73.44 110.52 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 50.7 ttp180 -114.65 125.98 54.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.024 0.379 . . . . 72.43 112.024 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.521 ' NE ' HG12 ' A' ' 65' ' ' VAL . 30.9 ptt180 -116.25 113.63 23.29 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.813 -0.81 . . . . 75.11 108.813 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.11 9.55 0.68 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.326 1.05 . . . . 64.22 113.361 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.86 -28.95 4.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 121.346 -0.454 . . . . 71.44 111.988 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -84.12 141.34 19.91 Favored Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 121.337 -0.459 . . . . 74.42 112.367 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.9 t -97.24 120.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.775 -1.195 . . . . 75.02 107.775 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG12 ' NE ' ' A' ' 60' ' ' ARG . 18.8 m -133.39 159.77 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.035 -0.984 . . . . 75.11 112.974 -171.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.83 126.11 22.42 Favored Pre-proline 0 N--CA 1.434 -1.25 0 N-CA-C 106.75 -1.574 . . . . 73.31 106.75 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.32 130.49 36.18 Favored 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 122.632 2.221 . . . . 70.25 112.721 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.441 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 71.2 mt-30 -53.94 -25.22 19.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.13 0.789 . . . . 71.5 113.13 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.83 -11.48 13.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.945 -0.57 . . . . 73.51 112.299 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.539 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.8 m-85 -85.31 -5.23 59.33 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.593 0.757 . . . . 74.23 110.367 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.41 155.11 29.1 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.6 -0.727 . . . . 75.14 110.056 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.6 p -75.78 175.89 8.28 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.002 -0.999 . . . . 74.12 109.516 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -59.48 -19.38 47.43 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.224 0.61 . . . . 74.22 111.212 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t -87.43 -8.57 56.36 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.159 0.584 . . . . 73.14 110.667 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.54 25.92 55.54 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.351 -0.7 . . . . 74.11 111.351 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -115.76 157.7 23.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.108 -0.701 . . . . 74.02 109.108 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.28 128.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.385 -0.598 . . . . 74.01 109.385 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -61.25 121.41 9.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 108.039 -1.097 . . . . 65.01 108.039 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -59.96 -22.28 62.3 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 113.826 1.047 . . . . 74.45 113.826 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.5 m -87.68 -15.93 35.79 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.258 0.552 . . . . 63.24 110.987 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.539 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.6 tt -66.46 -45.91 58.85 Favored Pre-proline 0 CA--C 1.565 1.534 0 N-CA-C 115.157 1.54 . . . . 75.02 115.157 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.35 -28.43 62.97 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.401 2.067 . . . . 74.53 112.045 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.58 -42.93 98.68 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.65 -0.705 . . . . 73.23 112.265 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.53 -40.58 80.67 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.542 -0.54 . . . . 74.33 109.542 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.61 -37.67 87.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 75.13 110.777 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.3 m -68.55 -40.05 80.84 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.75 -0.659 . . . . 74.22 112.138 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -42.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 119.935 -0.706 . . . . 73.11 110.5 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.4 ' CB ' HD11 ' A' ' 98' ' ' ILE . 3.4 mm? -67.31 -36.44 81.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.291 -0.564 . . . . 73.45 112.191 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -65.14 -36.99 85.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.145 -0.687 . . . . 74.43 109.145 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.56 -30.81 70.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.415 0.626 . . . . 75.24 110.146 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.18 -9.45 86.59 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.284 -0.871 . . . . 61.51 112.332 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.35 24.0 32.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.25 -0.5 . . . . 72.3 113.129 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -99.59 133.45 43.89 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 122.532 -0.393 . . . . 74.22 110.425 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -88.12 173.4 8.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.582 0.23 . . . . 74.21 111.304 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.8 -45.74 63.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.057 1.343 . . . . 71.43 113.701 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.3 m -62.69 -41.57 99.18 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.607 0.763 . . . . 74.5 110.42 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.56 -38.37 89.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.415 -0.811 . . . . 74.41 110.585 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.4 HD11 ' CB ' ' A' ' 88' ' ' LEU . 7.1 mm -61.3 -47.3 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.742 -1.207 . . . . 75.12 107.742 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.499 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 76.2 mtm -74.17 -15.48 61.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.311 -1.313 . . . . 73.5 113.649 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -56.98 -65.77 0.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.879 -0.415 . . . . 75.45 109.879 177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.415 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.4 p-90 -69.07 -32.81 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.68 0.622 . . . . 75.43 112.68 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 125' ' ' PRO . 13.4 mt -60.79 -40.8 93.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.177 0.806 . . . . 74.2 113.177 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -87.76 -9.38 54.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 112.561 0.578 . . . . 73.54 112.561 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 m -88.04 122.9 69.72 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 108.781 -0.822 . . . . 75.21 108.781 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.76 129.55 35.61 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.639 1.559 . . . . 73.34 108.98 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.8 t70 -90.21 121.08 69.02 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.386 -0.598 . . . . 62.4 109.386 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.55 -16.67 49.46 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.282 2.654 . . . . 72.02 113.74 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -110.98 6.79 21.29 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 121.949 -0.469 . . . . 74.21 111.076 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.426 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.0 tp -102.87 126.06 49.86 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.727 -0.789 . . . . 74.34 111.209 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -126.3 118.23 24.67 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.652 -1.981 . . . . 75.54 105.652 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.8 pt -136.09 163.25 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.729 0 O-C-N 123.34 0.4 . . . . 72.45 111.678 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 71.3 p -91.06 125.14 35.76 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 104.949 -2.241 . . . . 75.24 104.949 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -137.83 172.49 12.86 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 117.751 -1.58 . . . . 73.21 113.179 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 t70 47.02 70.87 0.36 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.563 1.945 . . . . 74.33 110.718 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.9 -10.82 73.32 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.502 -1.226 . . . . 71.01 110.503 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m 67.52 25.72 8.35 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.604 1.561 . . . . 45.1 111.528 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -65.24 -27.55 68.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.061 -0.972 . . . . 74.35 112.741 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -162.99 165.22 25.18 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.032 -0.729 . . . . 74.21 109.032 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.31 138.2 31.65 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 124.032 0.832 . . . . 73.12 110.742 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.07 133.07 69.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.774 -1.195 . . . . 72.4 107.774 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 p -87.85 146.64 25.49 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.455 0.472 . . . . 75.25 110.3 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 2.9 m-20 61.81 68.32 0.7 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.576 1.15 . . . . 72.22 111.377 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -119.52 170.5 9.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.948 -1.024 . . . . 64.4 110.965 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -78.03 134.22 64.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 116.001 -0.545 . . . . 74.11 109.745 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.5 ' HB2' HD23 ' A' ' 102' ' ' LEU . 73.7 Cg_exo -56.34 -28.48 72.44 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.171 1.914 . . . . 73.53 111.488 172.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.563 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 51.4 t -66.2 -34.43 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.623 0.725 . . . . 74.14 109.622 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.93 -32.37 70.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.69 -0.856 . . . . 74.44 108.69 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.5 75.36 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 114.942 -1.027 . . . . 71.33 112.519 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.83 -36.58 78.38 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.139 -0.624 . . . . 74.52 111.49 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.411 ' N ' HD11 ' A' ' 129' ' ' LEU . 9.4 t-160 -77.71 -15.58 59.05 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.732 0.777 . . . . 73.21 108.939 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -87.78 4.68 43.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 42.42 110.139 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.5 m80 63.7 27.72 14.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.594 1.158 . . . . 74.41 111.307 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -106.71 26.19 10.31 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.267 -1.333 . . . . 63.44 110.886 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -51.51 -28.56 13.9 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 114.156 -1.383 . . . . 73.44 113.665 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -39.44 86.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.029 0.831 . . . . 73.42 111.82 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.408 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -63.98 -32.88 74.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.383 0.611 . . . . 74.43 110.087 177.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.97 -48.11 51.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.331 -0.849 . . . . 73.22 109.311 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 134' ' ' ALA . 86.6 t -60.47 -44.5 96.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 CA-C-N 115.715 -0.675 . . . . 64.15 110.994 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.408 ' NH2' ' HG3' ' A' ' 136' ' ' GLU . 14.8 ptt180 -63.84 -37.99 89.44 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.336 -0.546 . . . . 74.43 112.247 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -64.27 -39.81 94.7 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.76 -0.376 . . . . 75.4 110.35 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.46 -46.5 89.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.696 -0.684 . . . . 74.44 110.379 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.99 -45.45 94.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.706 -0.679 . . . . 74.24 110.757 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.93 65.24 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.494 . . . . 74.52 111.687 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.3 tpp -83.33 -41.25 18.46 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.346 0.594 . . . . 72.41 110.021 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.4 -52.18 7.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.098 -0.501 . . . . 71.33 112.314 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--N 1.307 -1.24 0 CA-C-N 116.648 -0.251 . . . . 73.11 110.333 -175.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 CA--C 1.503 -0.844 0 N-CA-C 109.304 -0.628 . . . . 72.23 109.304 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' HG2' ' CZ ' ' A' ' 4' ' ' ARG . 14.6 Cg_endo -65.74 119.36 6.37 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.572 1.515 . . . . 63.12 109.353 173.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.12 101.11 2.29 Favored Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 120.833 -0.699 . . . . 70.33 112.352 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.462 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 6.5 mpt_? -73.32 144.32 46.59 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.283 -1.006 . . . . 74.13 108.283 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.04 107.6 44.93 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 123.25 0.344 . . . . 71.14 110.51 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 4' ' ' ARG . 2.6 Cg_exo -79.2 178.73 7.14 Favored 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 122.845 2.363 . . . . 71.24 109.456 174.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.08 136.96 5.05 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 119.678 -1.249 . . . . 73.32 112.657 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.6 m -102.46 108.94 20.42 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.388 -0.967 . . . . 73.31 108.388 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -89.3 138.64 31.26 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.964 -0.384 . . . . 74.24 109.964 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.86 149.99 20.76 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.271 0.558 . . . . 74.44 111.004 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.78 104.9 16.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.621 -0.881 . . . . 74.14 108.621 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -76.54 83.38 3.22 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.18 0.807 . . . . 64.44 113.18 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.66 117.87 51.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 104.495 -2.409 . . . . 71.13 104.495 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.2 -151.95 6.56 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 119.642 -1.266 . . . . 53.23 113.73 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 51' ' ' ARG . 23.8 m -82.73 126.99 33.0 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 123.736 0.814 . . . . 71.3 113.041 -174.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.78 120.57 58.51 Favored Pre-proline 0 N--CA 1.434 -1.256 0 N-CA-C 105.759 -1.941 . . . . 72.54 105.759 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -72.12 149.56 52.41 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.169 1.913 . . . . 73.41 112.239 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.34 133.48 34.95 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 115.904 -0.589 . . . . 75.45 110.092 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.58 -88.97 1.08 Allowed Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.937 -0.574 . . . . 73.11 112.671 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -121.37 126.07 48.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.805 0.336 . . . . 65.31 111.172 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD2' ' HB2' ' A' ' 23' ' ' LEU . 12.5 t0 -80.4 142.14 34.65 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.548 -0.751 . . . . 74.41 111.361 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.42 -9.56 10.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 C-N-CA 123.679 0.792 . . . . 73.43 110.155 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.406 HD11 ' CG2' ' A' ' 29' ' ' THR . 40.2 mt -64.66 159.69 21.49 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 122.43 1.109 . . . . 75.45 113.663 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.6 t70 -80.23 138.16 52.48 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 105.799 -1.926 . . . . 72.44 105.799 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.68 -28.75 17.92 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.274 2.649 . . . . 75.41 115.452 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.18 23.17 11.09 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.161 0.8 . . . . 75.32 113.161 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 4.5 tp10 -73.83 143.43 81.38 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 105.191 -2.152 . . . . 73.55 105.191 173.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -39.68 107.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.945 3.097 . . . . 64.33 112.373 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.406 ' CG2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -129.72 167.14 18.5 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.612 -0.722 . . . . 73.03 112.7 -174.256 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 26.0 m-85 -130.9 160.28 34.94 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.286 -1.376 . . . . 74.02 107.286 172.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.46 ' O ' HG22 ' A' ' 35' ' ' VAL . 7.2 m-20 -134.91 159.73 40.49 Favored 'General case' 0 C--N 1.264 -3.121 0 N-CA-C 102.978 -2.971 . . . . 72.5 102.978 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.0 mt -48.47 -56.61 13.74 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 114.556 1.317 . . . . 73.24 114.556 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.89 -30.97 67.82 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.525 1.483 . . . . 73.23 112.284 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 17.7 tpt180 -70.41 -34.9 73.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.037 0.535 . . . . 75.42 109.69 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 31' ' ' ASP . 57.8 t -69.31 -39.81 79.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 109.067 -0.716 . . . . 73.32 109.067 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.72 82.39 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.719 -1.128 . . . . 71.25 109.374 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.38 -45.67 79.29 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.37 1.068 . . . . 71.22 110.54 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.2 tp -60.76 -49.03 79.13 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.577 -0.738 . . . . 75.44 111.693 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.4 mt -88.89 -18.05 28.35 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.788 -0.642 . . . . 71.34 111.448 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.13 76.99 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 111.229 -0.748 . . . . 72.32 111.229 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.8 m -104.14 162.12 20.86 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 108.417 -0.957 . . . . 75.3 108.417 -176.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.6 160.13 38.49 Favored 'Trans proline' 0 C--O 1.262 1.698 0 C-N-CA 120.931 1.088 . . . . 72.44 111.249 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.71 -32.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.747 0.784 . . . . 75.11 109.84 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 7.8 p -59.04 -37.68 77.53 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.933 -1.03 . . . . 52.53 111.758 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 19.4 ttmm -69.93 -32.89 71.41 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.408 -0.517 . . . . 73.55 110.553 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.41 -42.04 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.536 -0.913 . . . . 73.25 108.536 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -62.18 -36.53 82.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.582 -0.735 . . . . 65.52 110.399 175.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.1 mt-30 -64.94 -36.29 83.91 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.433 0.293 . . . . 74.21 110.973 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.1 mm-40 -60.46 -46.61 89.46 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.102 -1.073 . . . . 71.51 108.102 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 15' ' ' SER . 4.2 mm? -62.31 -38.59 89.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.55 -1.205 . . . . 75.31 110.36 176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.55 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 14.6 mmm180 -65.61 -28.81 69.39 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.696 0.628 . . . . 74.32 112.696 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.67 -1.48 30.04 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.604 0.594 . . . . 71.34 112.604 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.69 36.6 83.14 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 110.672 -0.971 . . . . 74.25 110.672 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -96.32 -20.19 18.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.396 -0.594 . . . . 72.13 109.396 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 42.1 tp -159.84 153.38 22.5 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.252 -1.388 . . . . 71.32 107.252 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.31 161.67 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 O-C-N 123.253 0.346 . . . . 73.44 110.572 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.96 159.71 39.89 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.538 -0.756 . . . . 74.45 109.084 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' A' ' 99' ' ' MET . 6.7 m -130.68 166.96 26.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 123.972 0.909 . . . . 74.13 109.746 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.2 ttp180 -114.02 115.81 28.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 121.119 -0.232 . . . . 73.31 111.608 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.526 ' NE ' HG12 ' A' ' 65' ' ' VAL . 36.6 ptt180 -120.65 136.36 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.928 -1.138 . . . . 75.15 107.928 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 49.36 30.3 3.2 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.421 1.088 . . . . 65.11 113.826 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.96 57.91 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.288 -0.482 . . . . 73.14 113.023 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.2 152.04 20.26 Favored Glycine 0 CA--C 1.496 -1.134 0 N-CA-C 111.28 -0.728 . . . . 73.21 111.28 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -97.62 120.38 46.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.369 -1.345 . . . . 72.51 107.369 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.526 HG12 ' NE ' ' A' ' 60' ' ' ARG . 24.2 m -134.81 164.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.816 -0.629 . . . . 73.3 111.373 -171.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 62.6 mt -132.48 131.41 22.23 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.541 -1.651 . . . . 64.21 106.541 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 70' ' ' PHE . 23.4 Cg_exo -60.73 135.66 61.56 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.619 1.546 . . . . 74.12 111.221 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -68.66 -31.19 70.13 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.77 0.795 . . . . 75.25 109.353 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.5 m -68.44 -3.67 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 114.201 -1.363 . . . . 74.43 111.881 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -86.17 -11.01 53.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.942 0.877 . . . . 64.55 109.032 177.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.53 161.39 14.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.917 -1.038 . . . . 73.43 108.204 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.7 p -75.8 161.03 29.36 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.189 -0.671 . . . . 72.4 109.189 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -59.63 -17.36 32.87 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.324 0.49 . . . . 74.4 112.324 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.3 m -94.63 -0.94 54.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 116.068 -0.515 . . . . 73.15 111.86 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.08 69.32 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.855 -0.688 . . . . 52.31 114.204 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.02 156.86 16.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.556 -0.905 . . . . 74.11 108.556 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.56 138.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.47 -1.307 . . . . 74.33 107.47 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 92.9 t -62.56 131.52 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.138 -0.689 . . . . 75.51 109.138 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.626 0.602 . . . . 74.15 112.626 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.2 t -88.15 12.15 14.46 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.391 -0.523 . . . . 64.23 111.417 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.3 tt -65.93 -54.83 25.31 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.519 -0.548 . . . . 75.3 109.519 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.93 -31.78 90.58 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.766 1.644 . . . . 75.25 110.924 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.11 -44.59 97.01 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.444 -0.798 . . . . 75.22 112.294 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.12 -40.38 82.51 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.851 -0.796 . . . . 72.24 108.851 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.02 -36.7 77.81 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.927 -0.578 . . . . 75.24 110.66 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.0 m -60.59 -49.72 76.41 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.864 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -45.35 91.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.457 -0.338 . . . . 74.33 111.906 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.42 -38.56 84.77 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.348 0.87 . . . . 74.11 113.348 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -66.19 -35.14 79.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.538 -0.541 . . . . 63.4 109.538 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.91 -30.71 64.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.973 -0.558 . . . . 72.42 110.396 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.55 -9.33 83.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 112.09 -0.404 . . . . 70.52 112.09 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.97 39.97 12.4 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 121.809 -0.234 . . . . 73.0 113.196 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.59 126.39 52.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.915 0.388 . . . . 74.32 110.749 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.465 ' O ' HG12 ' A' ' 98' ' ' ILE . 12.0 ptm180 -85.39 173.86 9.97 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.656 . . . . 73.32 111.686 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -52.63 -44.01 65.79 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.355 1.862 . . . . 75.31 111.744 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -61.43 -41.02 96.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 123.859 0.864 . . . . 73.31 110.567 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -64.64 -44.55 90.09 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.152 -0.931 . . . . 74.23 108.938 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 94' ' ' ARG . 16.4 mm -60.61 -48.41 88.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 115.431 -0.804 . . . . 72.24 109.262 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.41 ' HG3' HG12 ' A' ' 58' ' ' VAL . 24.6 mmt -68.06 -27.19 66.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 75.01 111.731 -176.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -58.88 -64.95 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 111.609 0.226 . . . . 72.42 111.609 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.425 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 33.2 p-90 -68.45 -32.01 71.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.298 0.481 . . . . 75.5 112.298 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.596 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . 11.5 mt -60.46 -40.14 90.14 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 113.014 0.746 . . . . 75.54 113.014 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.508 ' CE1' HG21 ' A' ' 126' ' ' VAL . 70.9 m-85 -95.63 -1.39 50.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.175 0.806 . . . . 75.42 113.175 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.5 m -88.2 116.0 64.88 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.971 -0.752 . . . . 73.45 108.971 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -52.85 129.55 33.37 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.817 2.345 . . . . 72.43 111.572 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.39 125.7 58.99 Favored Pre-proline 0 C--N 1.304 -1.386 0 CA-C-N 115.908 -0.587 . . . . 73.01 110.702 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HA ' HD21 ' A' ' 122' ' ' ASN . 22.9 Cg_endo -60.75 -27.96 85.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.295 2.663 . . . . 73.25 113.591 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 m -99.84 6.86 45.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 120.807 0.337 . . . . 70.04 111.088 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.3 tp -102.47 120.09 39.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.924 0.868 . . . . 75.13 111.568 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.7 m -132.14 110.88 10.99 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 105.548 -2.019 . . . . 75.43 105.548 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.43 163.52 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.025 0 N-CA-C 114.026 1.121 . . . . 71.22 114.026 -173.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 45.2 p -89.99 126.71 35.84 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 106.665 -1.606 . . . . 72.42 106.665 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -94.91 136.21 35.5 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.107 -0.637 . . . . 75.43 110.752 -172.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 54.28 25.31 5.75 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.658 1.183 . . . . 72.31 113.653 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.77 15.75 81.1 Favored Glycine 0 C--N 1.309 -0.961 0 C-N-CA 120.64 -0.791 . . . . 73.43 112.855 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.6 t -83.46 172.24 12.63 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 107.905 -1.146 . . . . 63.22 107.905 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.12 -10.38 54.95 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 115.702 -0.681 . . . . 75.11 109.679 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 112' ' ' THR . 30.9 t70 -72.13 137.0 46.71 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.764 -0.653 . . . . 71.33 110.481 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.25 126.97 53.87 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.103 -0.953 . . . . 71.24 110.17 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.56 118.62 56.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.372 -0.973 . . . . 61.22 108.372 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.8 m -90.8 138.12 31.83 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.904 -0.589 . . . . 74.33 109.901 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.418 HD21 ' HA ' ' A' ' 107' ' ' PRO . 23.7 t-20 64.11 59.09 1.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.482 1.134 . . . . 74.31 110.032 176.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.23 161.64 13.6 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.493 -1.231 . . . . 72.21 108.739 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -87.07 139.92 32.58 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.438 -1.319 . . . . 74.13 107.438 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.406 ' HB2' HD23 ' A' ' 102' ' ' LEU . 93.2 Cg_exo -49.66 -29.85 20.62 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 123.319 2.679 . . . . 71.32 114.812 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.602 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 24.8 t -67.37 -36.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.438 -0.789 . . . . 75.0 110.562 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.07 -30.67 67.98 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.888 -1.153 . . . . 74.13 107.888 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.34 83.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.426 -1.261 . . . . 74.25 111.097 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -68.26 -33.39 74.27 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 121.939 -0.475 . . . . 74.22 110.806 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -63.86 -34.38 77.8 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 108.155 -1.054 . . . . 75.13 108.155 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.13 10.46 21.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.351 -1.295 . . . . 71.24 111.999 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 68.2 27.97 6.6 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.325 1.05 . . . . 62.11 112.536 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -106.43 24.17 12.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.054 -1.091 . . . . 72.33 108.054 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 138' ' ' VAL . . . -53.17 -30.58 38.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.685 1.194 . . . . 53.22 113.911 -173.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.01 -38.51 79.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.815 0.34 . . . . 75.24 111.187 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.24 -30.32 69.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.677 . . . . 72.1 109.508 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -71.39 -44.93 71.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.917 -1.038 . . . . 71.52 110.025 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 47.4 t -61.3 -42.98 95.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.604 0.716 . . . . 74.54 109.402 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -60.38 -38.78 85.01 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.068 -0.969 . . . . 71.14 111.611 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -37.93 83.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.251 -1.018 . . . . 74.14 108.251 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.7 -42.45 97.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.424 -0.807 . . . . 72.22 111.05 177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 74.4 mt-30 -59.03 -41.86 88.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 73.32 110.31 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.89 81.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 72.21 111.604 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.8 tpp -76.14 -27.56 57.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.647 0.737 . . . . 72.41 111.014 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.0 -47.24 11.93 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.745 -0.597 . . . . 74.04 111.747 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 C--N 1.31 -1.109 0 N-CA-C 109.209 -0.663 . . . . 75.52 109.209 -177.707 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.826 -0.805 . . . . 72.02 108.826 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.44 52.52 2.0 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 123.451 2.767 . . . . 72.31 112.314 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.34 96.86 0.24 Allowed Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 110.545 -1.022 . . . . 74.24 110.545 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.14 145.73 50.02 Favored 'General case' 0 C--O 1.251 1.16 0 N-CA-C 109.35 -0.611 . . . . 74.43 109.35 176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -36.99 118.05 0.76 Allowed Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 124.743 1.217 . . . . 74.12 111.558 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.75 114.29 2.08 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.964 2.443 . . . . 71.54 113.91 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.33 114.87 2.98 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 108.082 -2.007 . . . . 74.21 108.082 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.0 m -146.0 138.92 25.77 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 122.535 -0.391 . . . . 75.21 110.162 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -101.2 -11.72 19.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 123.017 1.389 . . . . 72.04 108.908 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.71 -160.58 0.79 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.253 -1.794 . . . . 63.43 106.165 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 126.05 27.68 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.824 -0.806 . . . . 74.41 108.824 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.435 ' HB3' ' HA ' ' A' ' 90' ' ' ASP . 12.0 ttp180 -75.41 125.01 28.14 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-O 121.557 0.694 . . . . 74.25 110.299 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -108.3 161.34 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.115 0 N-CA-C 107.743 -1.206 . . . . 74.41 107.743 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.22 151.47 22.94 Favored Glycine 0 N--CA 1.401 -3.659 0 CA-C-O 121.689 0.605 . . . . 64.1 112.975 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t -104.38 110.6 22.91 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 105.241 -2.133 . . . . 73.33 105.241 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.1 mm -113.78 124.59 30.84 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 120.561 -0.455 . . . . 75.33 110.891 -173.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.67 167.31 27.39 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.309 2.673 . . . . 71.41 110.099 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.37 124.62 30.18 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 121.903 -0.498 . . . . 75.4 110.415 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.457 ' HA3' ' NH2' ' A' ' 94' ' ' ARG . . . -109.7 -115.81 3.76 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.593 -0.813 . . . . 52.12 114.376 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.22 128.29 40.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.463 0.542 . . . . 75.45 112.463 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 7.3 t70 -65.23 120.11 12.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.872 -1.058 . . . . 65.32 111.239 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.58 -32.05 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 112.661 0.615 . . . . 75.14 112.661 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.41 HD23 ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -82.96 159.96 22.14 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 114.199 1.185 . . . . 71.21 114.199 -174.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.0 t70 -60.45 146.62 84.41 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.699 -1.137 . . . . 72.34 110.797 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.49 -36.73 40.35 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.568 2.845 . . . . 74.31 115.898 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.9 11.43 39.3 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 114.433 1.272 . . . . 65.31 114.433 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 7.7 mm-40 -68.18 144.57 96.94 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.324 -0.621 . . . . 63.12 109.324 173.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.91 128.85 28.1 Favored 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 122.822 2.348 . . . . 74.21 112.544 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.7 p -130.23 166.17 20.87 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.056 -0.52 . . . . 73.11 111.313 -176.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -131.45 160.19 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 125.55 1.54 . . . . 70.13 108.422 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.5 p-10 -135.6 159.38 41.8 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 106.121 -1.807 . . . . 64.4 106.121 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.0 mt -46.68 -56.87 10.15 Favored Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 114.738 1.385 . . . . 74.44 114.738 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.31 -35.76 96.14 Favored 'Trans proline' 0 C--N 1.366 1.476 0 CA-C-N 120.465 1.202 . . . . 73.24 112.67 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -69.56 -37.5 77.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.924 -0.398 . . . . 72.32 109.924 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 31' ' ' ASP . 60.8 t -69.8 -40.37 78.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.519 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.69 80.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.135 0.969 . . . . 73.41 109.167 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.17 -45.53 73.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.985 -1.462 . . . . 72.25 109.985 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.26 -44.1 89.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 64.11 111.551 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.2 mt -84.38 -19.01 34.29 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 111.901 0.334 . . . . 73.43 111.901 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.28 65.31 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.54 -0.838 . . . . 71.21 111.989 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.0 152.15 77.0 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 108.73 -0.841 . . . . 75.22 108.73 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.98 163.25 29.16 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 122.304 2.003 . . . . 74.22 112.927 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.34 -33.38 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.189 0.996 . . . . 74.21 111.371 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 10.7 p -58.39 -46.15 86.93 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.465 -0.789 . . . . 72.01 111.493 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 mttp -68.93 -36.36 77.9 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.664 -0.244 . . . . 75.02 111.636 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.76 -48.14 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 72.14 109.537 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.754 -0.657 . . . . 64.04 110.463 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 44' ' ' SER . 15.7 mm100 -62.42 -36.44 82.37 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.292 0.479 . . . . 73.52 112.292 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 91.8 mt-30 -63.34 -50.72 68.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.676 0.75 . . . . 74.32 108.995 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.35 -41.4 98.57 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.233 -1.349 . . . . 62.42 111.684 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -63.59 -27.48 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.788 0.292 . . . . 74.24 111.788 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -92.1 -0.36 57.45 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.762 0.315 . . . . 75.22 111.596 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.16 38.31 63.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.798 -0.637 . . . . 52.11 112.501 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -95.06 -15.36 23.5 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.07 -0.715 . . . . 75.22 109.07 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -157.74 152.91 25.76 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.106 -2.183 . . . . 75.31 105.106 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.8 m -132.1 161.6 41.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 122.609 0.364 . . . . 53.1 110.175 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.32 163.36 32.99 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.061 0.545 . . . . 74.54 109.6 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.71 160.48 34.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 123.427 0.455 . . . . 64.54 110.47 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -113.9 120.92 42.36 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.494 0.664 . . . . 73.33 111.256 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HD2' ' OD1' ' A' ' 21' ' ' ASP . 12.3 ptm180 -142.69 134.95 27.5 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.931 -1.031 . . . . 71.33 108.939 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.65 23.67 13.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.909 0.883 . . . . 52.1 111.406 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.71 5.71 89.64 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.156 -0.545 . . . . 72.4 112.207 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.17 143.64 18.03 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 111.355 -0.698 . . . . 73.22 111.355 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.27 120.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.921 -1.14 . . . . 72.4 107.921 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.78 158.48 41.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.968 -0.56 . . . . 75.54 110.754 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 35' ' ' VAL . 71.3 mt -114.86 132.06 23.15 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.106 -1.072 . . . . 73.43 108.106 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.98 126.12 20.15 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.877 1.718 . . . . 73.02 110.477 173.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.8 tt0 -60.58 -25.21 66.04 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.315 0.646 . . . . 74.03 112.467 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.82 -2.77 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-N 115.681 -0.691 . . . . 75.33 112.65 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.615 ' CD2' HD12 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.38 -2.62 58.59 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.95 0.881 . . . . 74.14 110.026 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -119.61 163.9 16.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.119 -0.946 . . . . 72.33 109.089 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 p -94.78 162.25 13.84 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.588 -0.893 . . . . 70.52 108.588 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.22 -16.55 63.65 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.335 0.588 . . . . 73.23 110.488 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -79.73 -8.32 59.17 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.699 -0.682 . . . . 70.42 110.487 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.72 64.2 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.851 -0.69 . . . . 71.31 112.23 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -108.6 154.01 22.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.438 -0.578 . . . . 74.32 109.438 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -71.34 140.53 18.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.793 -1.188 . . . . 73.34 107.793 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.02 129.22 27.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.934 -1.135 . . . . 64.51 107.934 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -63.69 -28.99 70.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.145 0.424 . . . . 72.23 112.145 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 m -77.77 -6.51 54.3 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.939 -0.573 . . . . 75.3 110.886 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.615 HD12 ' CD2' ' A' ' 70' ' ' PHE . 9.7 tp -64.91 -57.25 16.56 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.384 -0.371 . . . . 73.15 111.882 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.29 -29.03 79.43 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.181 1.254 . . . . 71.23 111.244 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -44.59 93.8 Favored Glycine 0 C--O 1.245 0.832 0 CA-C-N 115.964 -0.562 . . . . 65.43 112.598 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.96 -40.53 83.18 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.38 -0.6 . . . . 72.52 109.38 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.32 -37.57 86.1 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 74.21 110.659 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.9 m -57.45 -47.51 81.63 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 116.239 -0.437 . . . . 63.03 111.582 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.437 HG21 HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -67.95 -41.96 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 120.386 -0.525 . . . . 73.13 111.556 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.437 HD23 HG21 ' A' ' 87' ' ' ILE . 3.5 mm? -67.51 -39.32 85.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.804 0.668 . . . . 75.33 112.804 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -66.5 -33.76 76.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.052 0.453 . . . . 75.32 110.085 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 12' ' ' ARG . 32.6 t70 -67.92 -26.2 65.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.537 -0.756 . . . . 72.31 110.142 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.91 -3.36 73.7 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.829 -0.623 . . . . 63.03 112.016 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.42 33.45 25.46 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.197 -0.525 . . . . 71.32 113.123 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -90.75 159.38 16.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.882 0.372 . . . . 75.35 111.497 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.457 ' NH2' ' HA3' ' A' ' 19' ' ' GLY . 12.0 ptm180 -111.85 171.14 7.67 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.924 -0.58 . . . . 74.41 109.832 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -53.94 -45.87 71.38 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.442 1.897 . . . . 73.14 112.46 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.6 m -61.88 -41.67 98.16 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.275 -0.875 . . . . 71.43 110.418 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.06 -36.15 81.39 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.587 -0.733 . . . . 71.33 111.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.2 mm -61.24 -47.66 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.121 -1.066 . . . . 72.1 108.121 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.407 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 56.3 mtt -73.35 -21.5 60.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.596 -1.183 . . . . 71.14 111.779 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -57.69 -63.37 1.26 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.031 0.443 . . . . 73.43 110.315 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -69.99 -32.38 70.56 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.02 0.748 . . . . 74.51 113.02 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 125' ' ' PRO . 15.3 mt -59.0 -40.73 85.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.585 0.957 . . . . 73.21 113.585 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.41 ' CE2' HD23 ' A' ' 23' ' ' LEU . 50.5 m-85 -89.14 -16.83 30.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.958 0.725 . . . . 75.5 112.958 -176.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.9 m -87.51 118.28 69.63 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.435 -0.348 . . . . 74.55 110.243 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -55.65 129.78 36.91 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.857 2.371 . . . . 72.4 111.359 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.2 t70 -96.73 127.12 40.52 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.866 -0.42 . . . . 75.33 109.866 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 -20.25 61.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.554 2.836 . . . . 73.53 114.423 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.1 p -111.53 6.94 20.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.107 0.48 . . . . 74.14 112.122 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 tp -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.23 0.538 . . . . 74.54 110.107 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -118.95 122.56 42.51 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.885 -0.783 . . . . 75.51 108.885 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 112' ' ' THR . 61.1 mt -130.81 154.97 41.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.432 -0.581 . . . . 74.5 109.432 -174.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.44 ' N ' HG22 ' A' ' 111' ' ' ILE . 53.6 m -122.62 126.82 48.45 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.929 -1.508 . . . . 72.14 106.929 171.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -131.03 137.0 48.97 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.214 0.321 . . . . 74.42 111.243 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.9 t70 49.88 88.87 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 126.001 1.72 . . . . 64.32 113.557 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.52 131.39 2.58 Favored Glycine 0 N--CA 1.4 -3.703 0 N-CA-C 110.161 -1.176 . . . . 73.21 110.161 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.0 m -72.3 82.6 1.03 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-O 121.605 0.716 . . . . 64.41 109.399 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -81.61 -51.63 8.03 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.101 -1.444 . . . . 73.22 107.101 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 t70 171.77 -175.6 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 102.975 -2.972 . . . . 73.15 102.975 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.33 140.12 30.08 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.274 -1.01 . . . . 71.15 108.274 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 51.3 t -110.98 118.83 58.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.368 -0.604 . . . . 75.01 109.368 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -87.28 141.42 28.66 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.767 -0.827 . . . . 72.14 108.767 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.3 t30 68.22 70.3 0.32 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.937 0.875 . . . . 64.41 110.806 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -124.39 173.64 8.28 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 107.762 -1.199 . . . . 75.14 107.762 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 3.5 ptp180 -91.59 137.25 25.86 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.557 . . . . 73.54 109.758 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.485 ' HB2' HD21 ' A' ' 102' ' ' LEU . 84.1 Cg_exo -49.75 -22.44 6.98 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.71 2.94 . . . . 71.13 114.552 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.566 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -60.43 -39.0 79.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 120.87 0.367 . . . . 75.21 110.297 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -63.31 -37.12 86.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.315 0.579 . . . . 64.25 109.695 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.69 76.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.237 -0.892 . . . . 74.33 112.063 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.44 -35.58 80.65 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.644 -0.422 . . . . 74.54 111.408 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -76.02 -20.8 57.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.391 0.615 . . . . 72.31 109.455 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.85 4.61 51.59 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.335 0.865 . . . . 74.02 113.335 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.31 38.74 4.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 123.581 1.658 . . . . 75.45 109.283 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -120.36 23.89 10.66 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.75 -1.574 . . . . 73.5 106.75 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.62 -28.05 30.45 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 112.648 -2.069 . . . . 63.32 112.756 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -55.43 -40.38 71.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.801 0.334 . . . . 75.14 110.915 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.33 -27.98 63.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.171 0.51 . . . . 73.11 110.919 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.72 -48.58 45.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.375 -0.972 . . . . 73.24 108.375 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.52 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 63.5 t -59.2 -41.54 84.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-N 115.007 -0.997 . . . . 73.33 109.176 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -57.15 -45.89 83.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.609 0.764 . . . . 75.13 111.264 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.8 tpp180 -65.89 -39.31 90.51 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.723 -0.473 . . . . 73.45 109.723 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.99 94.15 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.999 -0.546 . . . . 75.51 110.525 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 83.6 mm-40 -57.46 -46.61 83.45 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 123.353 0.661 . . . . 75.1 110.032 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.9 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 74.24 111.551 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.2 mmm -78.48 -37.39 43.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.353 -0.385 . . . . 75.41 111.407 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.8 19.59 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 112.789 0.663 . . . . 63.54 112.789 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 C--N 1.308 -1.239 0 CA-C-O 118.418 -0.801 . . . . 72.22 109.646 -176.498 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.237 0.396 0 N-CA-C 110.36 -0.237 . . . . 73.51 110.36 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.6 146.15 21.21 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.403 2.069 . . . . 74.42 112.232 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.68 -98.09 2.28 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 109.287 -1.525 . . . . 75.12 109.287 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -73.48 133.21 43.6 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.164 -1.421 . . . . 74.14 107.164 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.84 119.08 75.98 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-O 120.774 0.321 . . . . 74.32 110.925 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -87.0 33.03 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.002 2.468 . . . . 71.11 109.829 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.0 3.59 67.19 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.261 -0.881 . . . . 75.31 112.375 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.3 p -116.55 157.76 24.74 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.827 -0.805 . . . . 74.22 108.827 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -76.14 130.13 37.81 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.547 -0.909 . . . . 74.24 108.547 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.16 147.62 44.62 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.448 -0.945 . . . . 73.23 108.448 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.89 122.9 41.24 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.681 0.993 . . . . 64.0 113.681 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -104.75 122.11 45.03 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 104.548 -2.39 . . . . 72.51 104.548 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.74 135.52 4.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 C-N-CA 119.367 -0.933 . . . . 72.11 111.782 -173.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.61 -123.71 4.72 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 109.532 -1.427 . . . . 63.45 109.532 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.7 p -82.2 141.58 32.9 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.701 -0.4 . . . . 72.0 109.927 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.47 131.27 53.21 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 107.575 -1.269 . . . . 75.22 107.575 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.02 143.21 99.59 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.147 1.898 . . . . 74.53 110.637 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 124.35 30.35 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 120.895 0.379 . . . . 74.01 110.084 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.41 ' O ' ' HD3' ' A' ' 59' ' ' ARG . . . -94.76 -85.15 1.66 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 115.726 -0.67 . . . . 73.31 111.64 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.62 150.09 47.14 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 120.877 0.37 . . . . 75.43 110.321 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.69 161.94 18.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.931 -0.766 . . . . 72.34 108.931 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 22' ' ' VAL . 23.9 t -121.29 13.79 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 123.345 1.545 . . . . 72.22 109.662 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.89 -172.41 2.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.26 -0.882 . . . . 72.01 110.69 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.26 138.01 20.13 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 105.25 -2.13 . . . . 74.22 105.25 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.16 -21.61 22.82 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.658 2.238 . . . . 72.13 114.448 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.57 -16.05 57.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.076 0.398 . . . . 70.13 112.076 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -61.93 141.8 95.36 Favored Pre-proline 0 C--O 1.251 1.134 0 O-C-N 122.089 -0.382 . . . . 75.5 110.31 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.55 117.66 4.21 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.843 2.362 . . . . 73.5 111.1 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.37 161.94 33.18 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 115.369 -0.832 . . . . 75.41 111.519 -176.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -112.89 159.94 18.54 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.611 -1.177 . . . . 74.25 109.058 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.0 m-20 -134.74 169.16 17.77 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.004 -2.221 . . . . 71.55 105.004 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.87 -55.73 35.39 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 113.489 0.922 . . . . 74.33 113.489 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.26 -32.71 90.47 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.881 1.721 . . . . 73.51 112.381 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.435 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 20.7 tpt180 -68.53 -40.79 80.59 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.973 0.509 . . . . 74.15 110.683 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 31' ' ' ASP . 77.1 t -69.0 -37.71 77.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.498 -0.556 . . . . 74.11 109.498 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.84 85.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.327 -0.851 . . . . 73.04 109.659 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.37 -46.7 72.56 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.181 -0.918 . . . . 74.23 109.52 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.79 -50.32 63.05 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.051 -0.977 . . . . 64.32 112.269 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' HB2' HG21 ' A' ' 41' ' ' VAL . 91.9 mt -82.85 -18.61 39.77 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.495 -0.482 . . . . 73.21 111.357 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.66 30.1 58.56 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.677 -0.969 . . . . 65.42 110.677 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 39' ' ' LEU . 28.0 m -120.94 159.04 50.71 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 109.543 -0.54 . . . . 74.44 109.543 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.54 163.16 39.93 Favored 'Trans proline' 0 C--O 1.256 1.404 0 C-N-CA 122.011 1.807 . . . . 74.25 111.543 174.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.24 -32.37 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.419 0.688 . . . . 75.13 110.359 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 33.1 t -57.32 -43.12 83.02 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.751 -0.659 . . . . 74.31 110.4 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.25 -32.77 72.2 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 111.742 0.275 . . . . 75.55 111.742 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.77 -45.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.056 -0.72 . . . . 73.1 109.056 175.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.98 78.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.464 -0.789 . . . . 74.13 110.777 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 44' ' ' SER . 93.0 mt-30 -61.68 -43.47 98.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.262 -0.426 . . . . 73.14 111.334 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -60.12 -49.63 76.89 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 121.901 0.857 . . . . 72.43 109.043 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.23 -42.46 99.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.078 -1.419 . . . . 74.4 111.278 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.15 -22.33 62.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.109 0.781 . . . . 74.31 113.109 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -102.09 5.0 40.22 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.112 -1.035 . . . . 75.0 111.396 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.59 37.31 68.14 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 115.423 -0.808 . . . . 52.21 112.243 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -95.67 -13.81 23.96 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.546 0.689 . . . . 75.53 109.36 176.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.9 tp -160.66 152.77 20.19 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.693 -1.965 . . . . 74.33 105.693 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 p -133.58 151.38 33.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.204 -0.665 . . . . 75.14 109.204 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 154.94 36.42 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 123.518 0.511 . . . . 75.32 109.737 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.62 169.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 123.711 0.804 . . . . 75.32 111.165 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 24.3 ttt-85 -107.3 121.34 44.37 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.135 -0.691 . . . . 73.42 109.135 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' CZ ' HG11 ' A' ' 65' ' ' VAL . 49.3 ttp180 -115.4 112.81 22.89 Favored 'General case' 0 CA--C 1.482 -1.667 0 CA-C-N 114.225 -1.352 . . . . 74.42 107.61 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.58 -51.68 0.23 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.92 1.688 . . . . 72.32 112.473 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . -178.54 15.15 0.03 OUTLIER Glycine 0 C--N 1.29 -2.01 0 CA-C-N 114.931 -1.031 . . . . 74.24 112.147 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.35 154.96 19.74 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 110.691 -0.963 . . . . 74.22 110.691 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -96.89 120.12 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.781 -1.192 . . . . 75.52 107.781 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' ' 60' ' ' ARG . 16.9 m -137.21 164.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.745 -0.661 . . . . 74.13 111.82 -172.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.61 123.98 26.28 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 107.011 -1.478 . . . . 75.44 107.011 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.84 143.44 91.68 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.43 2.086 . . . . 70.24 114.063 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -48.81 -41.99 34.55 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.313 1.045 . . . . 72.04 111.196 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -65.54 -7.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.48 -1.236 . . . . 65.24 113.911 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.3 m-85 -88.5 -5.02 58.48 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.873 0.844 . . . . 74.0 110.515 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -117.41 159.29 23.02 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.028 -0.987 . . . . 74.31 108.611 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -86.88 175.69 8.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.829 -0.804 . . . . 65.01 108.829 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -63.3 -22.08 66.65 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.333 0.587 . . . . 75.33 110.623 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.3 t -79.52 -10.51 59.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.299 -0.409 . . . . 74.41 110.615 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.64 38.85 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.572 -0.823 . . . . 74.23 111.215 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 151.63 37.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.597 -1.26 . . . . 74.42 107.597 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.46 131.47 34.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.731 -0.84 . . . . 74.42 108.731 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 44.4 t -57.78 125.96 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.323 -0.621 . . . . 74.22 109.323 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 61.1 tttp -61.5 -36.44 80.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.285 0.564 . . . . 72.15 112.281 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -85.19 -5.16 59.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.307 -0.406 . . . . 73.01 111.734 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD11 ' CD2' ' A' ' 70' ' ' PHE . 8.1 tt -66.09 -48.16 60.53 Favored Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 112.894 0.701 . . . . 71.51 112.894 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 74.1 Cg_exo -54.09 -30.57 60.82 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.047 1.831 . . . . 64.33 111.511 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.6 -41.46 99.81 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.473 -0.785 . . . . 72.53 112.207 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.37 -40.45 81.43 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.081 -0.711 . . . . 74.4 109.081 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.52 -39.96 92.9 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.907 -0.588 . . . . 73.25 110.339 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.2 m -57.77 -47.5 82.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 116.144 -0.48 . . . . 75.55 111.662 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -42.93 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 120.943 -0.303 . . . . 74.32 111.697 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.64 -37.44 84.82 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.465 0.543 . . . . 74.31 112.465 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -65.74 -32.86 74.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.893 0.377 . . . . 71.42 110.344 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.86 -30.23 69.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.231 0.539 . . . . 64.54 110.272 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.5 -9.33 75.77 Favored Glycine 0 C--O 1.242 0.655 0 CA-C-N 115.579 -0.737 . . . . 52.53 113.039 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.97 33.05 11.37 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.539 -0.363 . . . . 73.21 112.971 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -98.74 129.8 45.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 122.471 -0.429 . . . . 75.41 111.42 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -87.24 174.24 8.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.702 -0.681 . . . . 75.13 110.881 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.67 -45.9 66.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.925 1.69 . . . . 71.21 112.208 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.583 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 29.3 m -64.92 -41.28 95.69 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 116.031 -0.531 . . . . 60.13 109.589 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -61.72 -42.28 98.74 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.025 -0.989 . . . . 65.34 111.077 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.9 mm -60.95 -47.6 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.626 -0.879 . . . . 75.24 108.626 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.508 ' HE2' ' CZ ' ' A' ' 70' ' ' PHE . 51.2 mtt -74.34 -17.56 60.81 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 113.736 1.013 . . . . 75.15 113.736 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 96' ' ' THR . 83.8 mtp180 -55.84 -65.0 0.67 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.877 0.37 . . . . 74.23 111.353 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.516 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 p-90 -68.75 -31.93 71.32 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.358 0.503 . . . . 75.13 112.358 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.4 mt -66.34 -39.87 89.48 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.126 1.158 . . . . 71.1 114.126 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -90.62 -12.03 38.15 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.596 1.332 . . . . 75.2 114.596 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -74.67 114.15 31.41 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 123.817 0.698 . . . . 75.2 109.731 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.94 132.56 35.1 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.713 2.276 . . . . 75.4 110.551 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 16.5 t0 -118.61 117.99 33.87 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 116.299 -0.41 . . . . 72.24 111.298 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.53 -24.92 79.49 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.225 2.616 . . . . 70.34 111.889 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -78.58 -10.06 59.59 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.555 -0.748 . . . . 64.34 110.143 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.9 tp -110.29 129.22 55.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.429 0.633 . . . . 74.34 110.609 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -119.02 125.04 48.43 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.31 -0.996 . . . . 74.53 108.31 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.8 mt -131.0 156.84 43.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.994 -0.548 . . . . 72.25 110.227 -172.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 p -135.39 135.53 40.73 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.445 1.098 . . . . 75.44 109.226 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -106.83 165.51 11.27 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 122.188 -0.32 . . . . 75.34 110.52 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.09 105.42 3.35 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.739 -0.837 . . . . 74.52 108.739 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.9 7.21 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 110.331 -1.108 . . . . 72.44 110.331 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.7 m -130.37 92.85 3.34 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.726 -0.842 . . . . 75.13 108.726 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -76.52 -17.1 59.44 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.043 -0.526 . . . . 73.04 111.833 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.96 140.08 47.15 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.441 -0.578 . . . . 74.01 109.441 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.11 124.01 27.2 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.832 -0.622 . . . . 71.44 110.758 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.33 117.68 52.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.183 -0.673 . . . . 71.11 109.183 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.4 m -90.28 142.95 27.22 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.71 -0.848 . . . . 60.12 108.71 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.2 t30 74.36 72.26 0.11 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.272 0.982 . . . . 72.44 110.381 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.44 172.82 8.42 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.625 -1.62 . . . . 63.4 106.625 171.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.49 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 8.0 ptp180 -92.82 143.79 27.51 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.111 -1.44 . . . . 73.34 107.111 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.28 -25.6 10.09 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.313 2.675 . . . . 72.45 114.897 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.552 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.8 t -63.96 -32.33 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.331 -0.548 . . . . 65.33 110.113 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.49 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 10.5 m-20 -60.45 -30.84 69.92 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.254 -0.43 . . . . 74.52 110.415 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.5 -43.88 72.19 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.883 -0.599 . . . . 60.41 111.092 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -70.18 -33.98 72.41 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.932 -0.48 . . . . 74.43 111.099 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -67.53 -19.53 65.31 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 122.15 0.976 . . . . 73.14 109.238 176.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.94 9.44 32.66 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.924 -1.034 . . . . 74.12 111.838 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.9 m80 61.77 28.47 17.5 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.911 0.862 . . . . 72.25 112.249 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -106.3 25.11 11.47 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.827 1.651 . . . . 72.54 107.512 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.2 -26.87 12.7 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 126.926 2.09 . . . . 75.21 114.237 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -55.69 -37.18 68.01 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.194 0.813 . . . . 74.22 113.194 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -67.54 -32.36 73.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.291 0.567 . . . . 71.55 110.59 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.48 -49.14 68.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.615 -0.883 . . . . 74.42 108.615 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.556 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 67.8 t -58.07 -42.85 83.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 CA-C-N 115.404 -0.817 . . . . 74.12 109.58 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -57.0 -47.47 80.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.72 -0.673 . . . . 65.22 110.822 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -68.79 -34.1 74.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 73.33 111.045 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.71 72.01 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.106 -0.497 . . . . 75.53 110.941 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 15.9 mm100 -59.66 -40.11 86.68 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.028 0.531 . . . . 73.14 110.04 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.02 68.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.424 -0.807 . . . . 42.11 111.257 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.1 tpp -78.04 -47.9 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.904 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.5 -29.29 37.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.543 0.942 . . . . 72.4 113.543 -173.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 C--N 1.312 -1.059 0 CA-C-O 117.989 -1.005 . . . . 75.43 110.038 -179.574 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.511 -0.526 0 N-CA-C 109.621 -0.511 . . . . 72.23 109.621 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.84 95.53 1.02 Allowed 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.519 1.48 . . . . 65.33 110.382 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.32 95.27 1.55 Allowed Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 110.901 -0.88 . . . . 73.04 110.901 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -72.86 136.66 45.35 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.754 0.312 . . . . 73.4 110.737 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.16 122.92 73.92 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 107.489 -1.3 . . . . 71.41 107.489 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.42 148.87 68.24 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.911 1.74 . . . . 73.01 111.408 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.91 50.35 4.38 Favored Glycine 0 C--N 1.316 -0.561 0 N-CA-C 111.904 -0.479 . . . . 73.43 111.904 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.9 t 177.68 134.92 0.07 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 106.385 -1.709 . . . . 65.31 106.385 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.5 m -67.47 130.75 44.05 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.342 -1.355 . . . . 74.42 107.342 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.85 144.93 51.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.138 0.494 . . . . 74.44 111.559 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.09 145.14 25.65 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -105.76 93.23 4.54 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.729 0.776 . . . . 74.22 110.709 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 t -101.09 80.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.514 -1.291 . . . . 75.22 107.514 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.35 -162.05 10.9 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 110.38 -1.088 . . . . 65.35 110.38 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 16.3 m -54.44 118.03 3.81 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.822 0.849 . . . . 73.15 112.552 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.28 134.06 80.43 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 107.748 -1.204 . . . . 74.12 107.748 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.21 165.11 33.46 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.379 2.053 . . . . 64.02 112.528 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.33 123.72 44.88 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.632 -1.618 . . . . 75.34 106.632 173.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.88 -118.17 3.11 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.257 -0.973 . . . . 72.2 113.801 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.11 107.1 18.85 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 112.884 0.698 . . . . 72.35 112.884 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.454 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 11.2 t70 -44.69 113.02 0.49 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 126.108 1.763 . . . . 53.3 113.108 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.67 -33.96 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.558 -0.747 . . . . 72.23 111.645 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.406 0.4 OUTLIER -67.18 140.8 57.49 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.283 1.586 . . . . 74.34 115.283 -176.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.36 146.41 84.39 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.222 -1.808 . . . . 71.3 110.993 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.534 ' HA ' HH22 ' A' ' 60' ' ' ARG . 89.9 Cg_exo -50.52 -22.43 9.09 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.409 2.739 . . . . 74.5 115.601 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -97.71 3.53 50.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.942 0.719 . . . . 73.14 112.942 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.42 128.14 76.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.906 -0.776 . . . . 74.32 108.906 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.48 147.09 70.24 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.554 2.169 . . . . 70.12 112.685 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -133.45 173.69 11.21 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.497 0.665 . . . . 75.42 111.645 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 23.2 m-85 -130.25 161.09 31.99 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 126.299 1.84 . . . . 64.44 106.626 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.4 t0 -134.08 167.42 20.68 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.802 -2.296 . . . . 73.53 104.802 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -49.79 -57.0 13.62 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 123.839 0.856 . . . . 75.42 112.999 -172.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.7 -32.25 47.58 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.152 1.234 . . . . 71.34 112.14 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -70.34 -37.74 74.72 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 112.187 0.44 . . . . 75.44 112.187 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 31' ' ' ASP . 58.5 t -67.23 -39.12 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.738 -0.838 . . . . 74.13 108.738 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.89 83.87 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.66 -1.154 . . . . 74.14 110.032 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.04 -43.1 99.59 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.941 0.896 . . . . 72.15 109.814 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 tp -62.16 -50.06 73.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.404 -0.817 . . . . 73.52 111.396 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -86.76 -18.53 30.9 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.038 0.755 . . . . 73.34 113.038 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.01 53.91 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.436 -0.887 . . . . 63.24 110.961 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.09 161.18 46.21 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 107.611 -1.255 . . . . 61.35 107.611 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.63 163.26 31.99 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 121.253 1.302 . . . . 64.34 111.409 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.79 -32.64 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.6 0.714 . . . . 74.23 109.35 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.578 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.1 m -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.723 -1.126 . . . . 74.11 110.606 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.6 mttp -68.94 -32.92 72.87 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.678 -0.409 . . . . 74.3 111.253 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HA ' HE21 ' A' ' 49' ' ' GLN . 61.3 t -62.16 -46.23 96.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.466 -0.568 . . . . 74.45 109.466 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.25 81.29 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.423 -0.808 . . . . 63.42 110.759 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 44' ' ' SER . 29.3 mm-40 -64.35 -37.94 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 62.53 110.772 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.6 mt-30 -68.31 -45.05 74.05 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.896 0.855 . . . . 75.54 109.163 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.86 -45.29 94.43 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.789 -1.551 . . . . 74.22 109.797 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 25.9 ptt180 -66.12 -22.28 66.38 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 113.138 0.792 . . . . 65.43 113.138 -175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.66 11.78 37.24 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.216 -0.994 . . . . 71.11 112.49 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.58 57.48 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.976 -0.63 . . . . 54.11 113.02 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -96.13 -5.74 40.01 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.265 0.555 . . . . 74.13 109.866 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.1 tp -163.42 157.65 20.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.399 -1.704 . . . . 74.14 106.399 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.54 147.05 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 118.393 0.542 . . . . 75.43 109.586 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.59 162.69 19.21 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.346 0.659 . . . . 74.22 110.473 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.44 157.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.001 0.521 . . . . 72.3 110.226 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -110.86 119.07 37.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.204 -0.665 . . . . 73.35 109.204 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.534 HH22 ' HA ' ' A' ' 25' ' ' PRO . 11.4 ptm180 -149.24 130.61 14.71 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.367 -0.378 . . . . 75.44 111.187 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.63 26.58 16.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.995 0.918 . . . . 72.44 112.121 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.1 82.36 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 116.039 -0.528 . . . . 73.24 112.341 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.01 141.0 12.76 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.424 -0.67 . . . . 63.52 111.424 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.52 119.91 48.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.263 -1.384 . . . . 73.32 107.263 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.47 162.29 39.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.861 -0.609 . . . . 74.11 110.13 -175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.7 128.01 26.02 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 108.089 -1.078 . . . . 73.11 108.089 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.28 122.01 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.787 2.324 . . . . 72.11 112.037 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.518 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.5 tt0 -65.74 -24.59 66.99 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.136 0.493 . . . . 63.14 111.699 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.5 -8.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.637 -0.711 . . . . 72.44 112.373 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -86.73 -2.47 58.56 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.388 0.613 . . . . 74.34 110.95 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -116.83 148.51 41.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 73.43 109.248 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.4 p -82.74 175.47 10.1 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.571 -0.9 . . . . 64.21 108.571 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -64.42 -17.21 63.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.931 0.396 . . . . 71.52 111.729 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 m -79.78 -9.14 59.62 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.348 0.595 . . . . 65.41 109.778 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.44 62.85 Favored Glycine 0 C--O 1.215 -1.081 0 N-CA-C 110.73 -0.948 . . . . 70.21 110.73 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -108.06 143.82 36.26 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.759 -0.83 . . . . 75.13 108.759 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.98 134.46 28.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.134 -1.062 . . . . 73.52 108.134 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.7 t -57.04 128.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 108.185 -1.043 . . . . 71.53 108.185 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.428 ' HB2' ' HZ1' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -67.03 -23.07 65.86 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.741 0.645 . . . . 74.33 112.741 -174.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.5 m -88.22 -1.93 58.31 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.998 0.428 . . . . 75.01 111.169 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.534 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.0 tt -65.58 -54.24 31.69 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.386 0.513 . . . . 74.44 112.386 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 39.5 Cg_exo -60.76 -29.77 88.95 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 121.265 1.31 . . . . 75.31 110.979 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.15 99.7 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.319 -0.855 . . . . 65.25 112.216 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.92 -42.01 77.36 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.587 -0.523 . . . . 73.22 109.587 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.33 -37.34 85.25 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 116.243 -0.435 . . . . 71.21 110.645 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.6 m -58.69 -48.04 82.47 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.837 -0.619 . . . . 75.03 111.89 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -42.15 84.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.607 -0.437 . . . . 75.42 111.045 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.07 -35.29 79.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.112 -0.635 . . . . 74.3 111.874 176.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -62.94 -33.4 75.27 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.484 -0.562 . . . . 75.01 109.484 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.97 -31.4 71.1 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.017 -0.538 . . . . 72.13 110.148 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.72 -3.96 63.99 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.569 -0.741 . . . . 51.43 111.756 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.22 37.07 55.33 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 113.708 0.243 . . . . 75.44 113.708 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 52.1 m-85 -92.06 126.19 37.05 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 117.55 0.675 . . . . 75.24 111.18 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.45 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 26.8 ptt180 -70.43 169.21 14.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.901 . . . . 75.31 111.276 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 99' ' ' MET . 7.7 p-10 -54.87 -44.5 74.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.052 1.341 . . . . 74.34 111.816 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -62.06 -41.02 97.71 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.332 -0.849 . . . . 61.01 110.835 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.45 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 49.8 mm-40 -66.38 -37.92 86.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.747 -0.381 . . . . 74.42 110.482 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.2 -50.07 82.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 109.112 -0.699 . . . . 70.22 109.112 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.9 ptt? -74.67 -17.49 60.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.334 -0.848 . . . . 70.45 112.948 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.31 -65.26 0.72 Allowed 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.47 0.481 . . . . 72.23 110.099 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -70.38 -32.26 69.84 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.245 0.831 . . . . 74.03 113.245 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 125' ' ' PRO . 40.8 tp -68.33 -40.46 81.61 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.038 0.755 . . . . 72.42 113.038 -173.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -87.16 -18.3 30.7 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.367 0.877 . . . . 73.51 113.367 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 63.2 m -81.03 127.37 74.68 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 112.194 0.442 . . . . 63.4 112.194 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.47 132.31 28.84 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.664 2.243 . . . . 53.44 111.31 176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 22.7 t70 -118.19 121.45 31.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.465 -0.334 . . . . 62.32 111.839 -178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.98 -26.43 82.38 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.585 2.856 . . . . 73.44 112.205 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.0 m -85.96 -0.21 54.88 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.213 0.53 . . . . 70.2 111.239 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.63 126.89 53.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.207 -0.664 . . . . 73.32 109.207 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -131.28 114.34 14.91 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 73.4 108.206 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.5 pt -136.51 163.06 34.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 116.45 -0.341 . . . . 72.41 110.759 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -101.36 126.64 48.15 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 107.969 -1.123 . . . . 54.41 107.969 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -103.14 162.96 12.53 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 114.257 1.206 . . . . 73.22 114.257 -171.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -64.96 116.85 6.82 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.43 -1.714 . . . . 63.02 108.636 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.85 -2.54 38.67 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.7 -0.762 . . . . 75.54 112.094 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.7 t -131.32 156.49 45.4 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.559 -1.274 . . . . 71.43 107.559 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -99.71 -27.93 13.42 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.086 0.47 . . . . 75.02 111.231 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -102.66 -169.92 1.73 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.092 -0.707 . . . . 54.54 109.092 -172.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.94 132.79 49.85 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.005 0.431 . . . . 65.22 110.039 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.83 126.15 64.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.292 -1.003 . . . . 75.32 108.292 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.0 t -89.13 162.02 16.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 65.33 107.964 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 62.7 t30 67.57 44.67 1.66 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 122.647 1.213 . . . . 70.55 108.521 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.86 16.74 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.963 -1.017 . . . . 71.43 110.763 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -95.43 137.97 21.96 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.11 -0.7 . . . . 73.43 109.11 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.477 ' HB2' HD12 ' A' ' 102' ' ' LEU . 87.6 Cg_exo -50.0 -26.24 14.04 Favored 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.638 2.892 . . . . 74.13 114.755 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 94.7 t -60.58 -39.74 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.529 0.68 . . . . 73.35 110.283 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.01 -33.26 75.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.257 -0.883 . . . . 64.33 109.659 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.48 -47.92 62.35 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.245 -0.889 . . . . 64.24 111.45 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -65.81 -34.57 78.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 73.11 110.438 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -66.43 -32.26 73.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.229 -0.896 . . . . 71.03 108.945 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.91 13.16 19.32 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.094 -0.957 . . . . 65.32 111.445 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 64.76 28.05 12.98 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.524 1.13 . . . . 74.12 110.693 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -109.43 23.85 13.9 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.586 1.184 . . . . 74.33 108.99 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.94 -25.4 11.77 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 112.913 -1.949 . . . . 75.01 112.151 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -54.51 -39.69 67.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.95 0.5 . . . . 62.25 111.286 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.236 0.541 . . . . 74.21 110.432 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.75 -48.94 68.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.829 -0.804 . . . . 71.55 108.829 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 89.2 t -60.07 -41.17 85.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 123.559 0.744 . . . . 61.41 109.792 176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -56.97 -46.45 82.17 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.562 -0.744 . . . . 73.43 109.598 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -69.04 -36.48 77.76 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 116.316 -0.402 . . . . 75.11 111.848 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.7 89.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 53.21 109.621 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.2 mt-30 -62.88 -37.53 87.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.708 -0.678 . . . . 74.42 110.442 177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.5 76.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.257 0.551 . . . . 70.01 111.017 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.58 -36.89 57.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.598 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -76.74 -49.62 15.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.613 0.968 . . . . 72.14 113.613 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--O 1.255 1.346 0 CA-C-O 118.975 -0.536 . . . . 72.35 111.218 -174.639 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.509 -0.599 0 N-CA-C 108.821 -0.807 . . . . 72.32 108.821 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.31 113.02 1.22 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.155 1.904 . . . . 73.22 110.046 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.16 -160.98 35.89 Favored Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 115.699 -0.682 . . . . 54.23 113.297 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -66.99 133.58 50.24 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 123.605 0.762 . . . . 61.33 111.693 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.35 126.33 27.28 Favored Pre-proline 0 C--N 1.303 -1.441 0 CA-C-N 115.377 -0.829 . . . . 44.15 109.688 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.93 -169.25 0.72 Allowed 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 122.521 2.147 . . . . 70.53 111.455 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.67 -119.23 1.37 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.869 -0.892 . . . . 63.4 110.869 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 t -157.78 156.71 32.03 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.146 -1.427 . . . . 74.23 107.146 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -89.24 143.93 26.47 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.468 -0.938 . . . . 72.01 108.468 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.78 169.81 9.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.752 0.31 . . . . 71.15 111.418 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.22 -177.85 5.76 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 109.544 -0.539 . . . . 75.24 109.544 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -79.55 80.38 5.94 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 113.775 1.028 . . . . 72.52 113.775 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -114.28 80.99 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 105.361 -2.088 . . . . 70.41 105.361 171.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 51' ' ' ARG . . . -151.17 -120.23 0.92 Allowed Glycine 0 N--CA 1.415 -2.766 0 CA-C-N 115.068 -0.969 . . . . 70.22 112.439 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -88.26 137.81 31.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-O 121.236 0.541 . . . . 75.13 110.404 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.98 127.95 47.55 Favored Pre-proline 0 C--N 1.285 -2.217 0 N-CA-C 106.404 -1.702 . . . . 75.42 106.404 178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.03 137.46 79.29 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.173 1.915 . . . . 72.13 110.708 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.63 123.99 29.17 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 108.626 -0.879 . . . . 74.54 108.626 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.82 -101.37 2.71 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.576 -0.738 . . . . 52.42 113.88 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -98.97 120.78 40.0 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.099 0.476 . . . . 73.32 111.537 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.59 146.29 50.18 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.148 -0.933 . . . . 64.21 110.12 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.35 -12.08 11.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.529 -0.305 . . . . 64.24 111.147 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.282 0.8 OUTLIER -89.16 169.55 11.38 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 114.702 1.371 . . . . 71.42 114.702 -177.435 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -101.48 148.15 34.81 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.346 -1.353 . . . . 64.13 107.346 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.64 -22.6 9.65 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.892 2.395 . . . . 63.34 113.699 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.6 -32.19 73.73 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.86 -0.422 . . . . 73.03 109.86 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.64 126.26 90.85 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.595 -0.891 . . . . 75.33 108.595 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.32 154.87 61.13 Favored 'Trans proline' 0 C--O 1.256 1.416 0 C-N-CA 122.181 1.921 . . . . 72.04 111.047 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 p -136.05 169.57 17.39 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.968 0.89 . . . . 74.31 112.71 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -119.83 160.95 21.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 127.09 2.156 . . . . 73.3 106.127 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 7.1 t70 -134.49 156.91 47.78 Favored 'General case' 0 C--N 1.26 -3.308 0 N-CA-C 102.982 -2.97 . . . . 72.44 102.982 -175.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.51 -51.77 75.43 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.605 0.965 . . . . 74.25 113.605 -173.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 13.4 Cg_endo -60.23 -31.57 93.2 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.792 1.661 . . . . 62.45 112.255 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -70.79 -37.57 73.32 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.886 0.374 . . . . 75.54 110.368 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.03 -37.87 77.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.665 -0.865 . . . . 62.11 108.665 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.77 -37.06 78.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.944 -1.026 . . . . 74.32 110.035 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.63 -46.67 68.61 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.627 0.771 . . . . 70.3 109.504 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.77 -46.38 82.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.688 -1.142 . . . . 73.24 111.617 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.54 -18.41 29.85 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.552 -0.459 . . . . 75.22 111.842 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.02 61.55 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.965 -0.636 . . . . 64.33 111.554 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.99 161.1 48.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 109.324 -0.621 . . . . 73.51 109.324 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.87 158.63 56.17 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 121.908 1.739 . . . . 73.01 112.051 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.2 -33.33 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.868 0.867 . . . . 75.3 110.854 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.0 p -60.34 -40.43 90.63 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.686 -0.688 . . . . 73.11 111.445 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -69.33 -34.12 74.16 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.069 -0.715 . . . . 73.5 109.069 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' HA ' HE21 ' A' ' 49' ' ' GLN . 64.0 t -63.51 -44.1 98.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.742 -0.663 . . . . 71.23 109.615 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.62 -36.5 82.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.109 -0.95 . . . . 52.24 110.357 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.82 -35.09 79.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.064 0.394 . . . . 75.32 112.064 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.429 HE21 ' HA ' ' A' ' 46' ' ' VAL . 37.8 mt-30 -62.56 -42.51 99.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.87 0.843 . . . . 74.14 108.838 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.56 -34.84 78.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.552 -1.204 . . . . 75.13 109.451 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.462 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 13.2 mmt85 -67.16 -29.38 69.07 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.928 0.891 . . . . 74.44 112.33 177.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.43 6.13 39.99 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.334 -0.546 . . . . 74.14 111.902 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 43.22 76.02 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.12 -0.562 . . . . 63.53 112.173 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.73 -17.0 14.78 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.112 -0.699 . . . . 74.41 109.112 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 tp -149.35 158.39 44.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.675 -1.231 . . . . 72.2 107.675 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.23 147.22 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.0 -0.741 . . . . 73.21 109.0 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.84 161.54 28.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.111 0.565 . . . . 72.44 110.113 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.7 m -136.68 165.61 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.928 0.891 . . . . 74.43 109.093 176.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -117.03 115.88 26.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.659 -0.497 . . . . 75.25 109.659 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.557 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -116.81 124.44 49.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.016 -0.735 . . . . 70.21 109.016 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.74 22.59 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.835 0.854 . . . . 65.12 112.712 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.13 -24.02 21.92 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.396 -0.906 . . . . 64.24 113.24 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.29 143.55 16.73 Favored Glycine 0 CA--C 1.496 -1.146 0 C-N-CA 120.811 -0.709 . . . . 74.51 112.252 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 124.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.128 -0.694 . . . . 71.22 109.128 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.44 168.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.751 -1.113 . . . . 73.03 111.286 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.0 mm -118.64 135.92 23.9 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 105.875 -1.898 . . . . 74.55 105.875 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.92 139.7 43.92 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 121.606 1.537 . . . . 74.34 112.638 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -54.15 -36.37 63.27 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.655 0.782 . . . . 73.32 110.141 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.411 ' CG2' HG11 ' A' ' 126' ' ' VAL . 20.0 m -70.17 -3.18 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.271 . . . . 73.23 113.92 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.499 ' CD2' HD13 ' A' ' 81' ' ' LEU . 3.2 m-85 -88.4 -5.93 57.99 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.085 0.945 . . . . 72.24 109.64 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.13 155.54 38.25 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.491 -1.231 . . . . 74.23 108.395 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.8 p -83.21 165.0 19.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.39 -1.337 . . . . 74.44 107.39 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -67.1 -16.02 64.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.361 0.6 . . . . 75.12 110.996 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -79.47 -3.67 47.71 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.301 -0.863 . . . . 70.34 111.02 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.63 21.71 55.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.009 -0.615 . . . . 51.43 112.694 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -114.58 161.38 18.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.607 0.241 . . . . 74.14 110.505 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.72 138.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.107 -1.071 . . . . 74.4 108.107 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.82 129.52 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.036 -1.098 . . . . 74.23 108.036 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.87 -26.39 62.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.348 0.87 . . . . 75.32 113.348 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.8 m -99.02 6.91 46.43 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.411 -0.359 . . . . 71.03 111.645 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.499 HD13 ' CD2' ' A' ' 70' ' ' PHE . 19.2 tp -61.12 -54.93 49.09 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 111.98 0.363 . . . . 70.21 111.98 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.99 -22.14 73.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 121.749 1.632 . . . . 75.12 111.73 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.43 -44.46 90.28 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.754 -0.657 . . . . 41.33 112.221 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.07 -39.12 86.78 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.7 -0.852 . . . . 72.05 108.7 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.77 -36.86 84.44 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.694 -1.139 . . . . 74.2 111.294 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 m -57.54 -49.21 77.11 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.611 0.243 . . . . 74.32 111.333 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.95 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.928 0.394 . . . . 74.24 111.353 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.4 mt -66.69 -39.92 88.3 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.36 0.504 . . . . 72.32 112.36 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -68.29 -35.64 78.15 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.496 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.38 -31.67 72.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.597 -0.52 . . . . 72.44 109.597 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.79 -0.77 89.91 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.502 -0.772 . . . . 45.01 112.798 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 34.21 55.29 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.309 -0.472 . . . . 73.03 113.278 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -94.72 123.79 38.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.357 0.598 . . . . 70.01 112.271 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -73.87 173.71 9.54 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.781 -1.1 . . . . 72.53 112.076 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -53.02 -45.32 67.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.061 1.745 . . . . 74.13 111.238 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -64.24 -40.77 96.71 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 123.842 0.857 . . . . 74.2 110.092 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -66.81 -37.49 84.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 74.32 111.601 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.7 mm -60.85 -48.11 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.126 -1.064 . . . . 74.22 108.126 -179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.442 ' SD ' ' HE1' ' A' ' 103' ' ' PHE . 21.8 mmt -74.2 -22.35 59.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.648 -1.16 . . . . 62.3 111.229 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -54.3 -69.32 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.868 0.867 . . . . 72.55 111.653 -174.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.582 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 55.2 p-90 -70.35 -32.15 69.72 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.214 0.449 . . . . 74.52 112.214 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.589 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 9.3 mt -61.34 -39.81 91.95 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.689 1.366 . . . . 75.12 114.689 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 56.8 m-85 -94.79 -12.17 27.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.599 0.963 . . . . 73.43 113.599 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.1 m -83.17 129.52 60.66 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.741 -0.837 . . . . 64.11 108.741 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.12 128.97 29.61 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.033 1.822 . . . . 63.23 109.626 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.8 118.36 65.96 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.63 -0.878 . . . . 73.5 108.63 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.504 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 23.3 Cg_endo -61.11 -20.25 66.97 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.959 2.44 . . . . 73.0 113.667 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.2 m -101.21 4.83 42.27 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.479 -0.328 . . . . 73.43 110.353 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 tp -107.67 123.28 48.27 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.828 0.823 . . . . 74.11 111.155 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.3 m -131.2 113.0 13.32 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.87 -1.53 . . . . 74.31 106.87 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.0 pt -130.67 163.83 35.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 112.372 0.508 . . . . 73.3 112.372 -172.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.9 t -96.64 159.27 15.02 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.938 -1.875 . . . . 73.53 105.938 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.428 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 41.5 ttm180 -128.82 162.03 28.41 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 110.625 -0.139 . . . . 74.41 110.625 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.91 112.05 1.21 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.087 0.555 . . . . 64.13 110.327 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.38 -1.34 87.39 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.212 -0.518 . . . . 71.23 112.575 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 113' ' ' ARG . 50.8 m -126.34 100.79 6.43 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.712 -0.477 . . . . 71.54 109.712 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -81.53 -11.11 59.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 122.157 0.979 . . . . 73.22 109.006 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -72.59 140.73 48.22 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.361 -1.745 . . . . 65.15 108.131 172.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.94 136.24 33.7 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.133 -0.485 . . . . 55.54 111.133 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 45.4 t -106.67 119.7 56.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.395 -0.965 . . . . 74.53 108.395 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 m -90.23 151.62 21.45 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.537 -0.912 . . . . 72.12 108.537 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 50.1 m-80 54.37 63.66 2.09 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.306 0.642 . . . . 71.3 111.634 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.59 156.38 24.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.259 -0.645 . . . . 53.31 109.259 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -72.8 135.93 80.51 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.348 -0.541 . . . . 74.45 109.907 175.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.454 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.0 Cg_exo -56.06 -21.22 33.7 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.946 2.431 . . . . 73.43 114.47 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.625 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.8 t -61.53 -36.64 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.909 0.861 . . . . 65.31 109.55 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.0 -31.83 72.95 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.767 -1.106 . . . . 71.3 109.201 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.97 71.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.665 -1.152 . . . . 65.14 111.478 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -68.49 -33.02 73.42 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.304 -0.247 . . . . 72.23 111.367 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -64.91 -29.7 70.65 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.013 0.911 . . . . 71.42 108.55 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -98.55 15.95 23.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.49 -1.232 . . . . 73.32 110.584 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.1 m80 58.23 34.2 23.88 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.814 1.413 . . . . 72.14 114.814 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -104.07 23.53 12.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.682 -1.599 . . . . 74.34 106.682 172.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' O ' HG22 ' A' ' 138' ' ' VAL . . . -52.96 -28.35 23.3 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 126.883 2.073 . . . . 75.5 113.772 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -55.3 -40.18 70.78 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.966 0.412 . . . . 75.25 111.541 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.37 -27.73 61.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.568 0.699 . . . . 73.21 109.746 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.55 -40.9 72.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.29 -0.868 . . . . 75.01 108.903 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 63.3 t -58.73 -46.72 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.599 -0.889 . . . . 74.42 108.599 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.93 -1.032 . . . . 75.42 112.301 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -64.97 -36.12 83.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 120.876 -0.33 . . . . 74.42 110.166 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.14 -43.27 98.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.872 -0.418 . . . . 61.53 109.872 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -59.51 -44.23 93.18 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 115.577 -0.738 . . . . 74.33 109.688 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.3 -26.58 68.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 71.55 111.867 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.5 tpt -81.61 -34.26 31.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.026 0.441 . . . . 72.14 110.608 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.61 -43.45 15.62 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.075 0.464 . . . . 65.24 111.49 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 . . . . . 0 C--O 1.261 1.669 0 CA-C-N 115.73 -0.668 . . . . 73.22 109.264 -177.22 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 109.141 -0.688 . . . . 74.31 109.141 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.56 103.58 1.15 Allowed 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.341 2.028 . . . . 74.24 112.677 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.85 25.6 0.02 OUTLIER Glycine 0 C--N 1.311 -0.83 0 C-N-CA 120.009 -1.091 . . . . 72.45 113.813 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -73.9 133.41 43.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.467 -0.568 . . . . 73.25 109.467 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.38 135.66 22.25 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 110.34 -0.244 . . . . 70.04 110.34 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.18 143.33 48.5 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.664 2.243 . . . . 74.31 111.645 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.22 90.51 1.21 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 115.916 -0.584 . . . . 75.43 112.6 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 m -96.38 105.06 17.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.672 -0.492 . . . . 75.24 109.672 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -86.8 144.61 26.97 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.098 -0.704 . . . . 73.43 109.098 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.71 158.24 20.84 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.663 -0.495 . . . . 75.1 109.663 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.11 146.77 41.13 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.178 -0.465 . . . . 72.0 109.889 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -91.55 86.78 6.13 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.574 1.178 . . . . 73.54 108.626 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.1 m -111.88 130.24 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 CA-C-N 114.453 -1.249 . . . . 74.42 110.286 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.67 44.4 0.69 Allowed Glycine 0 C--N 1.269 -3.174 0 N-CA-C 107.765 -2.134 . . . . 71.32 107.765 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 14.0 m -74.95 100.0 4.0 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.582 -0.809 . . . . 73.42 110.992 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.5 mm -114.0 121.38 36.88 Favored Pre-proline 0 C--N 1.289 -2.052 0 N-CA-C 107.42 -1.326 . . . . 72.04 107.42 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.52 166.38 17.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.692 2.261 . . . . 62.23 110.565 176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.92 124.28 29.59 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.002 -0.679 . . . . 74.12 109.987 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.02 -121.06 3.54 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.841 -0.618 . . . . 75.25 113.946 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -109.22 129.79 55.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.546 0.212 . . . . 74.41 111.315 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -65.96 109.48 2.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.706 -0.679 . . . . 74.01 111.267 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.56 -30.93 6.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 113.205 0.816 . . . . 75.13 113.205 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.454 HD21 ' CE2' ' A' ' 103' ' ' PHE 0.273 0.5 OUTLIER -82.86 171.99 13.31 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 118.88 -1.128 . . . . 75.4 112.294 -178.493 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.19 137.41 75.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 109.233 -0.655 . . . . 71.32 109.233 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.71 -21.61 32.84 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.254 2.636 . . . . 74.24 113.852 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.98 -22.55 59.57 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.687 0.279 . . . . 63.33 111.72 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.48 138.4 97.35 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 116.168 -0.469 . . . . 72.0 110.109 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.642 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 34.5 Cg_endo -67.41 104.81 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.484 2.122 . . . . 45.14 110.425 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p -102.59 170.08 8.25 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 121.431 0.634 . . . . 70.4 112.044 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 107.712 -1.218 . . . . 75.5 107.712 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 13.3 t0 -136.53 164.15 28.84 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 103.528 -2.767 . . . . 63.44 103.528 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.56 -53.76 60.84 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.327 0.862 . . . . 75.35 113.327 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.55 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 12.0 Cg_endo -58.06 -35.83 98.45 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.83 1.686 . . . . 72.24 112.012 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 26.9 tpt180 -67.35 -39.95 85.79 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.9 0.381 . . . . 74.35 111.068 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -36.77 69.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.789 -0.364 . . . . 74.11 110.386 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.82 68.36 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.002 -0.74 . . . . 53.25 109.002 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 42.0 mt-10 -68.48 -45.08 73.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.769 -1.105 . . . . 71.11 111.844 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.5 -46.55 82.48 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.489 -0.778 . . . . 75.55 112.033 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.5 mt -93.94 -10.22 34.47 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.608 0.595 . . . . 75.04 112.608 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.05 30.12 72.17 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 111.262 -0.735 . . . . 53.15 111.262 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.65 156.61 67.8 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.765 -0.828 . . . . 64.12 108.765 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.35 156.39 66.4 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 121.391 1.394 . . . . 74.14 111.639 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.02 -33.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 52.24 110.371 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 28.3 t -57.48 -40.85 79.47 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.639 -0.71 . . . . 74.43 110.812 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 62.4 tttp -70.47 -35.99 73.62 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 120.861 0.362 . . . . 74.33 110.202 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.31 -44.51 98.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.221 -0.659 . . . . 72.04 109.221 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.05 -36.61 80.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.047 -0.979 . . . . 60.14 110.21 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.611 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 54.7 mt-30 -63.18 -43.44 98.22 Favored 'General case' 0 C--O 1.197 -1.693 0 CA-C-N 116.055 -0.521 . . . . 75.14 111.133 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.7 mm-40 -58.38 -41.25 84.43 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.326 0.584 . . . . 74.51 110.317 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 56' ' ' VAL . 67.3 tp -61.67 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.627 -1.169 . . . . 75.11 109.116 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 29.3 mtp180 -71.26 -23.95 62.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.531 -0.759 . . . . 74.53 112.512 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.611 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 10.4 mm-40 -82.97 -12.87 56.94 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.571 -0.529 . . . . 74.31 109.571 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.4 33.16 44.71 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.034 -0.826 . . . . 74.11 111.034 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -99.13 -15.72 18.87 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.771 0.319 . . . . 74.43 110.228 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -161.41 156.95 24.44 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.488 -1.301 . . . . 75.32 107.488 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 18.5 m -129.28 157.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.387 -0.597 . . . . 73.32 109.387 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.8 36.86 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.422 -0.584 . . . . 74.52 109.422 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 m -128.62 166.68 25.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 123.463 0.477 . . . . 74.21 111.044 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.469 ' NE ' ' HA2' ' A' ' 62' ' ' GLY . 19.4 ttt180 -109.63 121.04 44.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.428 0.632 . . . . 75.13 110.537 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -123.0 114.67 20.72 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.673 -1.149 . . . . 71.31 109.063 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.89 19.07 11.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.817 0.847 . . . . 72.33 111.023 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.469 ' HA2' ' NE ' ' A' ' 59' ' ' ARG . . . 99.7 -14.11 60.61 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.664 -0.698 . . . . 34.11 112.112 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.31 151.33 21.91 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.744 -0.942 . . . . 73.14 110.744 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.78 119.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 106.648 -1.612 . . . . 75.12 106.648 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.86 153.75 39.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.618 -0.719 . . . . 72.41 110.486 -174.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -126.45 131.84 24.08 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 108.189 -1.041 . . . . 74.34 108.189 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.39 141.38 86.9 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.238 1.959 . . . . 52.23 112.857 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.642 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.2 tp-100 -48.84 -42.39 36.16 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.213 1.405 . . . . 74.33 110.984 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.74 4.33 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 114.133 -1.394 . . . . 74.12 114.498 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.556 ' CD2' HD13 ' A' ' 81' ' ' LEU . 12.8 m-85 -91.96 -6.23 51.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.168 0.985 . . . . 75.51 109.501 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.51 144.58 47.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.405 -1.27 . . . . 74.14 108.683 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 p -75.85 172.95 11.81 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.253 -1.017 . . . . 75.21 108.253 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.73 -17.3 63.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.895 0.855 . . . . 64.42 109.261 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m -79.87 -6.86 58.21 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.191 -0.913 . . . . 75.03 110.552 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.92 -13.88 66.33 Favored Glycine 0 C--O 1.219 -0.827 0 C-N-CA 121.294 -0.479 . . . . 54.21 113.523 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -95.38 155.04 16.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.228 0.455 . . . . 72.25 112.228 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.37 141.8 17.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.408 -0.814 . . . . 74.54 108.812 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 26.4 t -59.91 134.16 25.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.3 -0.63 . . . . 71.35 109.3 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -55.78 -43.54 76.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.445 0.906 . . . . 75.11 113.445 -173.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.9 t -91.68 3.41 55.13 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.859 -0.336 . . . . 74.23 111.774 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.2 tt -66.46 -49.9 50.23 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 112.671 0.619 . . . . 73.43 112.671 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.06 -30.06 85.38 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.583 1.522 . . . . 54.44 111.028 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.25 -42.48 96.24 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.631 -0.713 . . . . 74.42 111.925 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.99 -40.16 83.12 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.055 -0.72 . . . . 75.53 109.055 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.53 -35.78 78.71 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.978 -0.556 . . . . 74.4 110.402 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.2 m -61.46 -49.09 78.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.947 -0.57 . . . . 72.14 111.677 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -43.37 96.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.635 0.255 . . . . 75.13 111.226 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.49 -36.08 80.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.541 0.571 . . . . 74.42 112.541 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.13 -45.24 95.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.264 0.554 . . . . 72.44 109.866 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.6 -25.7 61.42 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.716 -0.674 . . . . 71.51 110.445 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.11 86.97 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.6 -0.727 . . . . 74.21 112.559 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.44 30.6 24.24 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 121.425 -0.417 . . . . 74.34 113.786 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -106.1 147.73 28.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.128 0.464 . . . . 72.34 111.537 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.401 ' O ' HG12 ' A' ' 98' ' ' ILE . 16.2 ptp180 -99.62 171.39 7.94 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.672 0.789 . . . . 74.35 110.724 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -54.02 -45.51 71.56 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.537 1.535 . . . . 70.24 112.418 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.8 m -64.23 -41.02 97.19 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.636 -0.711 . . . . 71.13 110.16 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.12 -37.42 85.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.86 -0.609 . . . . 75.31 110.352 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 94' ' ' ARG . 14.5 mm -61.53 -49.52 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.831 -0.803 . . . . 74.12 108.831 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.516 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.7 ptp -75.29 -15.92 60.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.187 -0.915 . . . . 73.12 113.251 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.71 -62.94 1.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.26 -0.644 . . . . 74.32 109.26 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -69.98 -32.98 71.47 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.479 0.918 . . . . 74.11 113.479 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 15.0 mt -58.96 -40.32 84.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.212 0.819 . . . . 75.11 113.212 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.454 ' CE2' HD21 ' A' ' 23' ' ' LEU . 39.0 m-85 -86.14 -11.13 53.45 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.602 0.594 . . . . 72.42 112.602 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 m -87.51 121.14 71.26 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 108.902 -0.777 . . . . 65.22 108.902 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.49 130.12 35.83 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 122.568 2.178 . . . . 73.3 111.846 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 8.1 t70 -79.71 122.81 83.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 108.189 -1.041 . . . . 74.41 108.189 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.546 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 31.3 Cg_endo -60.78 -16.88 46.82 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.573 2.849 . . . . 71.22 114.6 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.6 t -119.1 5.74 11.29 Favored 'General case' 0 N--CA 1.421 -1.898 0 O-C-N 122.077 -0.39 . . . . 72.33 110.883 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -100.77 130.63 46.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.314 0.578 . . . . 65.22 110.261 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 120' ' ' VAL . 48.7 m -131.56 114.81 15.32 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.984 -1.117 . . . . 74.42 107.984 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.73 158.65 43.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 113.883 1.068 . . . . 73.52 113.883 -174.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 1.4 t -116.86 127.03 53.89 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.763 -1.569 . . . . 75.54 106.763 174.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -108.77 169.49 8.63 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.763 -0.653 . . . . 74.41 110.559 -172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -73.38 99.95 3.07 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.604 -1.628 . . . . 74.01 106.604 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 133.11 -16.94 4.63 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 111.264 -0.734 . . . . 63.24 111.264 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.9 m -145.84 107.97 4.38 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.729 -0.841 . . . . 72.11 108.729 178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -74.43 -20.93 59.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.965 0.412 . . . . 73.33 111.076 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.58 143.83 38.01 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.043 -0.725 . . . . 73.32 109.043 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.95 124.39 32.36 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.065 0.46 . . . . 75.51 110.615 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 110' ' ' THR . 48.1 t -97.23 124.65 50.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.933 -0.766 . . . . 71.45 108.933 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.5 m -88.15 146.97 25.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.77 -0.65 . . . . 72.01 110.162 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 107' ' ' PRO . 17.3 m120 64.72 57.57 1.06 Allowed 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.277 1.031 . . . . 73.13 109.211 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 159.9 15.68 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.737 -1.119 . . . . 72.33 109.696 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -81.03 147.88 62.65 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 108.325 -0.991 . . . . 73.31 108.325 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.446 ' HB2' HD23 ' A' ' 102' ' ' LEU . 52.1 Cg_exo -56.99 -28.15 76.91 Favored 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 121.892 1.728 . . . . 72.11 111.387 174.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 62.0 t -63.68 -35.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.609 0.719 . . . . 75.33 110.409 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.81 -41.57 74.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.68 -1.23 . . . . 60.23 107.68 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -34.86 79.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.485 -1.234 . . . . 65.23 113.173 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.77 -32.96 71.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.584 -0.698 . . . . 74.04 111.263 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -76.74 -13.61 60.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.885 0.85 . . . . 73.35 109.907 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 112' ' ' THR . . . -89.91 3.85 51.78 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.802 -1.09 . . . . 75.31 110.421 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.9 t60 64.14 27.17 14.03 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.211 1.482 . . . . 74.32 109.689 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -114.13 24.86 11.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.0 -1.455 . . . . 74.45 108.139 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.73 -27.85 19.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.602 -1.635 . . . . 75.52 112.43 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -56.37 -42.84 78.51 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.468 -0.567 . . . . 74.01 109.468 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 22.6 mm-40 -65.64 -39.63 91.65 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.361 -0.836 . . . . 72.42 109.481 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.64 -47.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.4 -0.818 . . . . 73.44 109.786 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 57.9 t -60.83 -41.79 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.816 -0.629 . . . . 52.11 109.805 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -63.42 -40.4 97.07 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 120.923 0.392 . . . . 73.32 111.2 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.597 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 14.3 mmt85 -66.22 -35.49 80.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.864 -0.791 . . . . 74.41 108.864 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 138' ' ' VAL . . . -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 70.1 109.888 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.6 mt-30 -61.7 -38.62 88.51 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 116.155 -0.475 . . . . 73.23 109.887 176.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.96 -22.78 65.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.963 0.411 . . . . 63.14 111.366 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 24.1 mmt -89.07 -29.66 19.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.348 0.594 . . . . 64.54 110.013 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.32 -45.17 13.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.077 -0.511 . . . . 74.02 111.8 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 107.785 -1.191 . . . . 70.33 107.785 -178.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 CA--C 1.505 -0.775 0 N-CA-C 107.914 -1.143 . . . . 74.31 107.914 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.0 83.53 2.22 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 121.532 1.488 . . . . 75.34 109.586 173.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.44 68.18 3.57 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.504 -1.039 . . . . 63.55 110.504 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.14 132.58 49.53 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.303 0.573 . . . . 74.53 111.093 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.3 151.47 39.64 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 106.478 -1.675 . . . . 74.54 106.478 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.09 86.19 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.049 1.833 . . . . 62.55 111.973 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.01 -36.31 2.77 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 109.384 -1.486 . . . . 71.23 109.384 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 m -95.31 -177.24 4.04 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.001 -0.74 . . . . 74.1 109.001 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.0 m -146.74 149.89 34.28 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.036 -1.098 . . . . 74.15 108.036 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.1 mt -66.34 144.86 56.3 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.447 0.642 . . . . 73.33 111.281 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.8 167.7 10.77 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.95 -1.023 . . . . 74.4 110.739 -175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 51' ' ' ARG . 52.2 ttt85 -76.08 95.66 3.68 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-O 121.454 0.645 . . . . 74.04 110.494 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.02 -3.77 9.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.38 -1.282 . . . . 73.43 109.857 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.08 67.97 0.45 Allowed Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 109.325 -1.51 . . . . 72.24 109.325 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.478 ' OG ' ' HG2' ' A' ' 12' ' ' ARG . 39.3 m -83.17 77.56 9.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 112.531 0.567 . . . . 75.1 112.531 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.64 119.78 66.82 Favored Pre-proline 0 N--CA 1.438 -1.071 0 N-CA-C 105.923 -1.88 . . . . 73.44 105.923 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.34 146.45 31.48 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.335 2.023 . . . . 75.14 112.192 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.92 129.3 34.93 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.798 -0.815 . . . . 73.21 108.798 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.93 -107.77 2.19 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 110.842 -0.903 . . . . 55.23 110.842 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -118.17 141.88 48.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.703 -0.481 . . . . 71.32 109.703 -176.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.09 158.09 34.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.997 0.903 . . . . 73.15 111.696 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 22' ' ' VAL . 38.9 t -121.23 32.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 124.172 1.939 . . . . 74.34 106.262 175.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.4 mt -104.49 178.93 4.42 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.239 -1.8 . . . . 72.41 111.266 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 15.3 t70 -90.79 136.05 28.23 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 105.704 -1.961 . . . . 62.5 105.704 169.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.65 -25.47 14.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.393 2.728 . . . . 75.22 115.193 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.52 33.68 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.524 -0.87 . . . . 74.44 110.973 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 25.3 tp10 -72.57 129.46 87.06 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 105.726 -1.953 . . . . 71.42 105.726 172.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 52.4 Cg_exo -55.27 98.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.66 2.24 . . . . 74.34 111.681 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -107.16 -177.66 3.42 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.732 -0.667 . . . . 74.13 112.197 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' CZ ' HD23 ' A' ' 38' ' ' LEU . 52.3 m-85 -111.48 159.78 17.75 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.999 -1.001 . . . . 73.43 109.445 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' O ' HG21 ' A' ' 35' ' ' VAL . 3.3 m-20 -136.52 162.46 33.03 Favored 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 101.84 -3.392 . . . . 73.23 101.84 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -50.94 -51.55 66.18 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-N 119.028 0.831 . . . . 74.01 112.447 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.87 -35.95 85.94 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.021 1.814 . . . . 75.5 112.553 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.412 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 7.7 tpt180 -70.27 -36.99 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.864 0.364 . . . . 75.53 110.181 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 31' ' ' ASP . 66.0 t -69.1 -39.03 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.475 -0.565 . . . . 74.04 109.475 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.75 84.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.465 -0.789 . . . . 70.2 109.52 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.2 -36.69 79.96 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.592 -1.186 . . . . 73.51 110.247 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.434 HD23 ' CZ ' ' A' ' 30' ' ' TYR . 56.9 tp -72.55 -45.46 59.12 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.54 -0.755 . . . . 73.04 111.335 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.0 mt -85.71 -18.44 33.09 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.637 0.606 . . . . 75.24 112.637 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.56 28.04 60.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.796 -0.922 . . . . 75.31 110.796 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.01 159.09 55.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.319 -0.993 . . . . 75.43 108.319 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -67.23 155.25 71.4 Favored 'Trans proline' 0 C--O 1.26 1.597 0 C-N-CA 121.057 1.171 . . . . 75.1 111.644 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.46 -33.5 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.428 0.691 . . . . 73.25 110.424 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 36.8 t -57.33 -45.62 84.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.954 -0.566 . . . . 71.03 110.787 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 64.7 mttm -64.72 -36.74 85.25 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.392 -0.523 . . . . 75.44 110.88 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.33 -45.17 98.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.496 -0.557 . . . . 74.23 109.496 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.45 80.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.581 -0.736 . . . . 72.55 110.552 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.634 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 97.2 mt-30 -61.73 -46.77 88.21 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.802 -0.444 . . . . 54.31 109.802 176.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 77.6 mt-30 -59.39 -42.55 91.95 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.706 0.765 . . . . 71.33 110.556 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.2 -38.33 88.74 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.437 -1.256 . . . . 74.42 109.427 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.644 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 59.9 mtm180 -71.25 -29.13 64.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.185 0.439 . . . . 75.11 112.185 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 56.0 mt-10 -76.55 -12.26 60.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.737 0.303 . . . . 74.54 110.375 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.44 22.47 64.76 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.545 -1.022 . . . . 62.23 110.545 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -94.62 -0.32 54.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.103 0.478 . . . . 74.11 111.049 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.7 tp -163.23 152.79 15.18 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.403 -1.702 . . . . 74.53 106.403 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -132.09 148.13 32.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.013 -0.736 . . . . 74.32 109.013 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.23 154.3 37.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 123.567 0.542 . . . . 75.32 110.01 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.566 HG12 ' OD2' ' A' ' 95' ' ' ASP . 19.6 m -128.39 166.63 25.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.302 1.041 . . . . 75.15 109.116 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 53.4 mtm180 -110.91 129.37 55.9 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.743 -0.466 . . . . 71.13 109.743 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' A' ' 62' ' ' GLY . 28.9 ptt180 -125.34 123.84 40.26 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.648 -1.612 . . . . 71.15 106.648 173.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.04 -15.78 0.32 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.418 1.087 . . . . 65.22 112.8 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . 134.01 -13.83 4.67 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.927 -0.869 . . . . 63.32 110.927 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -92.7 152.52 21.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.804 -0.918 . . . . 72.53 110.804 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -96.8 120.78 46.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 74.2 107.835 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.39 160.29 40.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.479 -0.782 . . . . 74.12 111.218 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.06 125.7 26.19 Favored Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 106.978 -1.49 . . . . 74.44 106.978 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 139.22 86.6 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.745 2.296 . . . . 75.24 113.625 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.9 tp-100 -53.81 -37.26 63.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.286 1.034 . . . . 75.25 110.165 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 34.3 m -72.18 2.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.574 -1.648 . . . . 74.45 113.95 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.455 ' CD2' HD13 ' A' ' 81' ' ' LEU . 6.3 m-85 -95.49 -1.68 50.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.935 0.874 . . . . 74.43 109.497 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.46 139.32 53.63 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.656 -1.156 . . . . 74.32 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.7 p -79.51 168.94 18.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.016 -0.993 . . . . 72.22 109.519 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -57.56 -23.41 50.46 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.068 0.547 . . . . 73.34 111.35 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 t -79.96 -8.13 59.17 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.191 -0.459 . . . . 73.3 110.345 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.17 18.33 65.03 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.998 -0.62 . . . . 72.14 112.719 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -119.13 161.84 19.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.046 -0.724 . . . . 72.44 109.046 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.27 144.86 11.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.332 -0.988 . . . . 74.52 108.332 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.8 t -64.02 124.64 19.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.406 -0.961 . . . . 74.12 108.406 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -55.26 -44.72 75.84 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.584 1.327 . . . . 70.31 114.584 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.9 m -96.55 9.82 40.29 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 112.758 0.651 . . . . 65.42 112.758 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 7.1 tt -65.64 -45.34 67.11 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 116.368 -0.378 . . . . 74.05 111.864 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.88 -25.76 54.33 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.924 1.749 . . . . 75.32 111.658 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.9 -38.66 96.93 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.658 -0.701 . . . . 74.33 111.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.98 -41.06 78.4 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.971 -0.751 . . . . 63.3 108.971 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.43 -34.39 75.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 74.34 110.355 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.0 m -61.65 -49.02 78.22 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.486 -0.779 . . . . 64.24 110.791 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -41.81 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 111.642 0.238 . . . . 73.22 111.642 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -66.75 -35.19 79.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.029 -0.668 . . . . 74.14 112.511 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -63.72 -35.95 82.27 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.131 -0.692 . . . . 75.0 109.131 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.09 -31.22 67.54 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.481 -0.781 . . . . 71.25 110.002 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.62 -8.63 70.05 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.625 -0.716 . . . . 72.05 112.8 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.04 49.61 5.9 Favored Glycine 0 C--N 1.318 -0.423 0 C-N-CA 121.338 -0.458 . . . . 73.3 113.669 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.94 139.8 49.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.259 -0.553 . . . . 71.11 111.865 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -85.09 170.03 13.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.351 -0.84 . . . . 74.4 110.3 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.566 ' OD2' HG12 ' A' ' 58' ' ' VAL . 19.1 p-10 -55.28 -42.69 73.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.506 1.522 . . . . 74.21 111.945 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.2 m -61.32 -42.24 98.35 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.098 -0.955 . . . . 75.41 110.012 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.73 -37.12 84.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.141 -0.482 . . . . 75.54 110.928 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.09 -48.9 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.844 0.831 . . . . 75.05 108.813 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.425 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 59.0 mtt -75.48 -20.87 58.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.784 -1.098 . . . . 73.21 112.227 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -57.97 -61.13 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.511 0.507 . . . . 72.34 109.736 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.414 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 29.1 p-90 -69.46 -32.53 71.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.19 0.811 . . . . 74.34 113.19 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 126' ' ' VAL . 17.0 mt -60.12 -41.45 92.68 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.812 0.671 . . . . 75.33 112.812 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -85.02 -14.72 46.48 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.605 -0.438 . . . . 72.4 112.081 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 m -87.05 118.59 70.25 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.788 -0.449 . . . . 74.31 109.788 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.93 131.07 40.71 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.903 2.402 . . . . 75.24 111.217 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -90.47 122.84 66.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.26 -0.427 . . . . 63.25 110.966 -174.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.91 -16.31 44.04 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.935 3.09 . . . . 63.45 114.56 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -118.03 10.54 13.08 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.798 -0.564 . . . . 74.45 110.4 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.32 131.3 49.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.488 0.661 . . . . 73.03 111.917 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -125.99 120.28 29.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.867 -1.531 . . . . 71.31 106.867 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.466 HG23 ' NE2' ' A' ' 133' ' ' GLN . 28.1 pt -130.86 165.01 32.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.429 0.156 . . . . 74.54 111.285 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.519 HG23 ' OE1' ' A' ' 133' ' ' GLN . 15.1 t -89.05 159.48 17.55 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.221 -1.029 . . . . 74.14 108.221 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 2.1 tpm_? -127.71 166.17 18.63 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 110.071 -0.344 . . . . 73.25 110.071 -174.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -87.88 140.27 29.67 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 122.786 0.434 . . . . 75.4 110.435 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.38 -71.35 2.68 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 109.0 -1.64 . . . . 74.33 109.0 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.462 ' C ' ' H ' ' A' ' 118' ' ' ASP . 3.4 p -88.8 78.98 7.53 Favored 'General case' 0 N--CA 1.403 -2.798 0 N-CA-C 106.96 -1.496 . . . . 71.41 106.96 174.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -68.51 16.94 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.828 1.651 . . . . 73.42 114.602 -173.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 116' ' ' SER . 9.0 m-20 -76.87 178.13 7.12 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 123.239 0.616 . . . . 72.03 110.018 -178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.48 125.23 35.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.602 -0.518 . . . . 73.52 109.602 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.15 118.82 54.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.82 -0.627 . . . . 74.33 109.393 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.8 m -90.17 139.9 30.19 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.842 -0.617 . . . . 63.13 109.55 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 59.81 67.79 0.84 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.746 1.26 . . . . 72.15 110.619 -177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -113.1 179.23 4.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.288 -1.324 . . . . 52.32 109.877 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.549 ' HD3' ' N ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -87.12 138.35 32.6 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 109.014 -0.736 . . . . 71.41 109.014 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 71.4 Cg_exo -56.27 -29.93 78.3 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.198 1.932 . . . . 62.24 110.122 170.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.619 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 70.5 t -61.82 -42.8 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.345 0.593 . . . . 74.13 110.37 173.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.98 -34.76 77.15 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.07 -0.652 . . . . 72.21 109.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.79 85.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.915 -1.039 . . . . 63.22 112.853 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.65 -32.51 71.21 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.029 -0.42 . . . . 71.4 110.917 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -71.74 -23.41 61.61 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.686 0.755 . . . . 70.43 109.767 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.38 -0.26 54.28 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.851 -1.068 . . . . 65.24 110.423 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.7 m80 64.03 28.24 14.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.59 1.156 . . . . 71.31 110.256 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.519 ' OE1' HG23 ' A' ' 112' ' ' THR . 12.7 mt-30 -102.61 25.07 9.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.956 -1.475 . . . . 72.13 107.414 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.49 -28.31 19.86 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 113.914 -1.494 . . . . 73.41 112.675 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -56.77 -41.15 77.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.81 0.338 . . . . 71.41 110.707 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.51 -34.18 77.65 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.909 -0.587 . . . . 72.34 110.165 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.24 -44.87 83.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.685 -0.688 . . . . 74.24 109.144 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 64.2 t -61.1 -42.33 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.458 -0.571 . . . . 71.33 109.458 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -58.11 -43.44 87.15 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.977 -0.556 . . . . 74.24 110.403 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 144' ' ' MET . 73.2 mmt-85 -65.84 -39.0 90.37 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 116.618 -0.265 . . . . 71.33 111.126 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.87 -45.1 90.96 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.365 0.416 . . . . 71.01 110.272 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -43.02 99.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 72.34 109.993 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.07 -19.83 63.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.401 -0.818 . . . . 71.15 112.632 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 91.3 mmm -88.4 -21.49 24.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.313 0.577 . . . . 65.41 109.799 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.37 -61.0 2.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.328 -0.619 . . . . 74.51 109.328 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--N 1.302 -1.457 0 CA-C-O 118.304 -0.855 . . . . 74.11 109.52 -178.847 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mmm . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 109.781 -0.452 . . . . 73.33 109.781 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.62 156.45 44.74 Favored 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.242 1.961 . . . . 73.34 111.003 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.86 -59.91 0.05 OUTLIER Glycine 0 C--N 1.307 -1.036 0 N-CA-C 110.795 -0.922 . . . . 64.13 110.795 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -69.09 145.07 53.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.928 -0.397 . . . . 73.3 109.928 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.71 112.05 34.24 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 107.831 -1.174 . . . . 72.51 107.831 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HG2' ' O ' ' A' ' 29' ' ' THR . 27.7 Cg_exo -67.83 -178.63 1.7 Allowed 'Trans proline' 0 C--O 1.253 1.23 0 C-N-CA 122.944 2.43 . . . . 64.32 113.003 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.92 40.67 2.82 Favored Glycine 0 N--CA 1.419 -2.487 0 N-CA-C 106.363 -2.695 . . . . 71.1 106.363 -170.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 m -65.28 -48.29 73.69 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.886 -1.157 . . . . 75.45 108.326 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.3 m -144.05 129.36 18.84 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.227 -1.398 . . . . 72.3 107.227 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.18 143.56 41.03 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.253 -0.647 . . . . 73.5 109.253 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.36 95.55 9.7 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.914 0.709 . . . . 73.04 112.914 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -104.29 75.68 1.27 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.589 -0.732 . . . . 74.3 109.71 173.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -141.46 150.42 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 106.582 -1.636 . . . . 74.31 106.582 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.92 37.29 3.61 Favored Glycine 0 C--N 1.287 -2.167 0 C-N-CA 121.002 -0.618 . . . . 53.12 114.344 -173.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.415 ' HA ' ' NH2' ' A' ' 51' ' ' ARG . 18.3 m -121.24 14.06 11.24 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.565 0.698 . . . . 71.41 110.483 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.4 mt -120.69 121.8 28.86 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 115.27 -0.877 . . . . 74.42 110.765 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.45 134.04 13.61 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 121.393 1.395 . . . . 74.53 108.939 166.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . -132.24 150.24 52.2 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 122.094 -0.379 . . . . 72.03 111.388 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.04 -171.53 18.77 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.268 -1.133 . . . . 70.43 110.268 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -87.68 138.28 31.61 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.022 -0.733 . . . . 73.12 109.022 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.08 111.45 7.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.118 0.961 . . . . 73.44 112.421 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.9 t -96.83 45.14 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.525 -1.657 . . . . 74.55 106.525 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD21 ' CE2' ' A' ' 103' ' ' PHE . 57.0 mt -107.97 161.01 15.32 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.315 -1.311 . . . . 74.25 110.645 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.507 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.5 t70 -97.4 143.27 25.87 Favored Pre-proline 0 C--N 1.289 -2.037 0 N-CA-C 105.504 -2.035 . . . . 74.32 105.504 171.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.37 -24.67 12.38 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.318 2.679 . . . . 72.42 114.539 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -96.43 2.59 52.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.759 1.022 . . . . 64.02 113.759 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 41.2 mm-40 -78.15 127.57 81.01 Favored Pre-proline 0 C--O 1.249 1.079 0 N-CA-C 109.139 -0.689 . . . . 74.15 109.139 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.13 142.11 60.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.878 2.385 . . . . 75.2 112.802 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.576 ' O ' ' HG2' ' A' ' 6' ' ' PRO . 3.3 p -123.06 -174.65 2.99 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.286 -0.87 . . . . 75.01 110.552 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 27.0 m-85 -133.15 161.84 33.36 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 127.344 2.258 . . . . 64.24 107.059 172.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -133.41 156.41 47.73 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 104.132 -2.544 . . . . 73.52 104.132 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.311 4.5 mm? -51.7 -52.61 58.99 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 116.126 1.898 . . . . 75.42 116.126 -172.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.15 -33.74 97.78 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 120.371 1.168 . . . . 75.42 111.935 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -69.35 -41.23 76.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.057 -0.349 . . . . 75.15 110.057 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.4 t -67.65 -39.64 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.306 -0.406 . . . . 72.02 109.972 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.89 91.66 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.428 -0.806 . . . . 71.12 109.612 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.69 -41.01 79.79 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.841 -1.072 . . . . 74.21 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.06 -44.44 72.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.345 -0.843 . . . . 73.04 111.516 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.0 -13.95 40.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.32 -0.4 . . . . 73.54 112.046 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.7 23.77 71.75 Favored Glycine 0 C--O 1.243 0.673 0 C-N-CA 120.888 -0.672 . . . . 74.13 112.339 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 143.71 50.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.652 -0.87 . . . . 65.44 108.652 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.53 155.18 43.32 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.432 2.088 . . . . 75.43 113.064 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -50.8 -35.76 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.338 1.055 . . . . 75.13 111.722 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 t -57.68 -42.98 84.7 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.72 0.408 . . . . 71.01 110.867 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -69.69 -36.01 75.59 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.806 0.336 . . . . 64.14 110.957 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.12 -40.54 89.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.5 -0.555 . . . . 72.23 109.5 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.46 75.36 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.666 -0.697 . . . . 74.55 111.049 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -65.7 -39.99 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 71.02 110.679 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.08 -44.65 95.19 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.0 0.905 . . . . 74.44 109.213 176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.17 -35.16 77.96 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.103 -1.408 . . . . 73.35 110.505 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.415 ' NH2' ' HA ' ' A' ' 15' ' ' SER . 33.2 mmt180 -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.229 0.455 . . . . 75.53 112.229 176.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -84.75 -12.19 54.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.119 -0.632 . . . . 74.11 111.403 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.64 34.47 25.05 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.491 -1.044 . . . . 72.21 110.491 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -82.12 -21.52 36.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.772 -0.825 . . . . 72.04 108.772 177.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.5 tp -152.32 157.97 42.08 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.989 -1.856 . . . . 74.0 105.989 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.46 146.01 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.554 -0.906 . . . . 73.15 108.554 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -118.61 158.68 25.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.246 -1.02 . . . . 74.44 108.246 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.2 m -132.56 162.37 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.396 0.617 . . . . 74.03 111.204 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -110.55 115.48 29.69 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.591 -1.263 . . . . 74.31 107.591 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -130.38 129.9 43.69 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 106.935 -1.506 . . . . 75.12 106.935 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.33 9.71 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.797 0.839 . . . . 75.22 110.879 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.32 65.53 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.786 -0.643 . . . . 63.55 112.358 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.29 146.52 18.23 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 121.186 -0.53 . . . . 71.43 111.955 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.51 121.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.454 -0.573 . . . . 75.24 109.454 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.29 167.28 18.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 125.264 1.426 . . . . 63.4 108.48 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.7 mt -115.47 131.49 23.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.397 -0.964 . . . . 74.22 108.397 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.68 126.71 17.27 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 121.861 1.707 . . . . 64.52 112.616 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.5 tt0 -64.03 -23.98 67.54 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 122.951 0.501 . . . . 73.45 111.603 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 m -67.87 -6.81 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 112.332 0.493 . . . . 75.55 112.332 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' A' ' 81' ' ' LEU . 6.8 m-85 -89.37 -3.24 58.53 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.037 0.922 . . . . 75.34 109.847 174.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -117.86 152.35 35.55 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.666 -1.152 . . . . 74.0 108.162 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 p -82.65 175.28 10.28 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 123.441 0.463 . . . . 72.15 110.034 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.04 -33.68 69.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.549 0.74 . . . . 72.34 110.718 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.1 m -79.54 -3.57 47.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.961 -0.563 . . . . 65.25 112.511 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.9 35.59 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.309 -0.948 . . . . 73.2 111.398 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.57 145.51 37.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.272 -1.01 . . . . 74.24 108.272 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.99 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.228 -1.027 . . . . 74.31 108.228 174.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.84 127.87 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.37 -0.974 . . . . 75.45 108.37 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -68.81 -25.46 64.69 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.891 -0.506 . . . . 74.44 112.188 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 56.7 m -90.25 6.92 40.81 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.493 -0.321 . . . . 60.24 111.439 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 13.0 tp -61.23 -53.19 65.35 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 119.235 -0.412 . . . . 72.54 111.029 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.3 Cg_exo -63.12 -29.84 74.79 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.359 1.373 . . . . 74.14 110.984 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.14 91.99 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.721 -0.672 . . . . 64.14 111.923 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.04 -40.19 82.89 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.292 0.567 . . . . 71.21 109.493 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.54 -45.96 88.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 72.42 110.437 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.5 m -62.56 -43.79 97.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.748 0.647 . . . . 72.22 112.748 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -47.7 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 118.128 0.422 . . . . 75.32 111.537 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 84' ' ' LEU . 4.1 mm? -67.28 -42.79 83.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 74.43 112.06 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.35 -35.33 80.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.164 -0.68 . . . . 71.34 109.164 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -71.07 -30.2 66.28 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.433 0.635 . . . . 53.24 110.595 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.22 86.84 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.918 -0.583 . . . . 62.52 112.673 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.62 39.95 4.28 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 120.775 -0.726 . . . . 74.34 112.999 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 65.7 m-85 -119.62 136.82 54.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.251 -0.648 . . . . 72.14 109.251 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.575 ' HG2' ' OE1' ' A' ' 97' ' ' GLU . 7.8 ptp85 -84.61 171.07 12.74 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 123.251 0.345 . . . . 75.21 110.697 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -53.38 -45.29 69.19 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 124.601 1.161 . . . . 62.43 112.969 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -62.04 -40.65 96.47 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.627 -0.715 . . . . 73.51 109.95 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.575 ' OE1' ' HG2' ' A' ' 94' ' ' ARG . 44.7 mt-10 -65.87 -33.83 76.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.941 -0.572 . . . . 63.42 111.798 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.4 mm -62.53 -49.4 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.296 -1.002 . . . . 73.23 108.296 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 14.9 ptm -75.44 -16.32 60.34 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.243 -0.89 . . . . 74.14 112.634 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -58.59 -64.42 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.351 0.66 . . . . 71.23 110.364 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.488 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.0 p-90 -68.84 -31.67 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.192 -0.458 . . . . 72.13 112.145 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.488 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.9 mt -57.71 -39.56 77.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.007 0.743 . . . . 74.21 113.007 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.447 ' CE2' HD21 ' A' ' 23' ' ' LEU . 30.0 m-85 -86.49 -3.14 58.96 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.241 0.46 . . . . 71.54 112.241 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.5 m -86.2 125.43 68.09 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 107.606 -1.257 . . . . 75.04 107.606 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.56 133.84 59.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.649 2.233 . . . . 64.54 110.94 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.7 t70 -91.45 121.37 67.56 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 109.428 -0.582 . . . . 72.11 109.428 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.78 -16.38 43.73 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.693 2.929 . . . . 72.43 114.779 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 m -123.46 16.02 9.66 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 122.01 -0.431 . . . . 72.4 111.108 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.427 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 28.9 tp -104.28 115.18 29.93 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.726 -0.79 . . . . 71.14 111.231 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.2 m -122.37 110.68 15.95 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.901 -1.518 . . . . 75.02 106.901 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.8 pt -139.38 164.45 24.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 112.37 0.507 . . . . 72.42 112.37 -171.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -88.86 152.9 21.47 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 104.773 -2.306 . . . . 65.13 104.773 169.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -117.17 173.93 6.4 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 108.207 -1.034 . . . . 72.14 108.207 -171.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.79 94.09 9.05 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.389 -1.337 . . . . 74.54 107.389 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.88 -58.18 0.69 Allowed Glycine 0 C--N 1.296 -1.647 0 N-CA-C 109.134 -1.586 . . . . 45.0 109.134 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.0 m -79.8 99.69 7.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.075 -1.454 . . . . 74.33 107.075 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -75.33 -28.26 59.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.218 -0.446 . . . . 75.41 110.991 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.67 152.94 35.6 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.551 -0.75 . . . . 61.24 109.247 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.85 125.85 27.98 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.156 0.503 . . . . 72.22 111.81 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t -107.71 122.74 62.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.392 -0.822 . . . . 72.44 108.806 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.1 m -87.46 149.33 24.49 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 123.059 0.544 . . . . 72.54 109.892 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 4.8 m-20 56.42 43.47 26.03 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.309 1.044 . . . . 64.2 111.138 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.61 175.66 9.1 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.111 -0.949 . . . . 71.25 111.988 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -86.74 124.67 68.89 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.33 -0.85 . . . . 75.44 110.41 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -51.96 -28.08 30.54 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 124.068 3.179 . . . . 75.11 114.443 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.643 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.9 t -60.39 -39.1 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.515 0.674 . . . . 65.13 109.879 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.13 -30.07 68.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.567 -0.742 . . . . 74.41 111.176 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.22 87.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 64.24 110.213 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -70.2 -34.05 72.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.88 -0.415 . . . . 72.55 109.88 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -68.65 -25.28 64.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.44 -0.8 . . . . 73.51 109.241 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.47 7.03 46.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.15 -0.932 . . . . 71.23 111.071 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.9 m80 69.35 32.79 3.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.931 0.872 . . . . 72.23 112.873 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -112.01 24.69 12.36 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.82 -1.178 . . . . 72.31 107.82 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.444 ' O ' HG21 ' A' ' 138' ' ' VAL . . . -52.93 -29.74 30.45 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 125.22 1.408 . . . . 72.43 113.657 -173.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -57.77 -35.44 70.76 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.835 0.35 . . . . 74.32 111.476 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -32.37 68.01 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.476 0.655 . . . . 73.53 109.845 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.4 t -70.97 -42.83 77.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.964 -1.016 . . . . 65.23 108.523 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 90.2 t -59.46 -42.64 88.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.428 -0.806 . . . . 73.04 109.874 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -60.71 -47.18 87.44 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.658 -0.246 . . . . 75.34 111.255 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -61.14 -39.21 89.22 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.354 -0.61 . . . . 75.23 109.354 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 138' ' ' VAL . . . -59.87 -46.74 88.33 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 115.271 -0.877 . . . . 64.13 110.87 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.3 mt-30 -58.57 -41.18 85.12 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.2 0.6 . . . . 61.25 111.529 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.24 79.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.9 -0.591 . . . . 54.41 111.221 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.1 tpt -80.34 -35.44 35.56 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.889 -0.596 . . . . 71.45 110.697 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.458 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -71.89 -49.87 34.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.294 0.85 . . . . 73.02 113.294 -176.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 C--N 1.307 -1.276 0 CA-C-O 118.628 -0.701 . . . . 73.32 109.575 -175.411 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 110.13 -0.322 . . . . 73.34 110.13 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.43 103.46 1.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.769 1.646 . . . . 72.12 110.084 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.57 119.95 2.19 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.195 -1.002 . . . . 75.3 112.653 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.04 139.5 46.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.236 -1.024 . . . . 74.35 108.236 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.46 92.19 45.82 Favored Pre-proline 0 C--N 1.305 -1.366 0 C-N-CA 120.388 -0.525 . . . . 72.43 111.694 -176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -74.32 118.04 5.21 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.47 2.114 . . . . 74.22 110.445 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.21 -127.46 1.63 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 109.835 -1.306 . . . . 73.32 109.835 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.2 t -164.57 124.34 1.95 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.462 -0.94 . . . . 75.23 108.462 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.3 m -65.08 147.32 53.68 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.257 -1.016 . . . . 70.44 108.257 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.0 -174.55 0.79 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 110.599 -0.149 . . . . 74.12 110.599 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.42 104.98 0.56 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.143 0.497 . . . . 75.43 110.677 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 18.0 ptt180 -107.84 125.3 51.28 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.974 -0.557 . . . . 73.1 110.702 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.15 107.87 23.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.244 0.545 . . . . 75.43 110.009 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 51' ' ' ARG . . . 69.03 18.72 73.09 Favored Glycine 0 C--O 1.22 -0.738 0 CA-C-N 115.541 -0.754 . . . . 72.54 112.844 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 12' ' ' ARG . 7.9 m -105.43 114.55 28.79 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.411 -1.329 . . . . 74.02 107.411 -175.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.3 mt -116.82 121.73 32.44 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 115.943 -0.571 . . . . 72.53 110.896 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.61 166.5 13.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.117 2.545 . . . . 73.14 109.837 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.454 ' HB1' ' C ' ' A' ' 58' ' ' VAL . . . -81.83 132.92 35.29 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.96 -0.696 . . . . 74.41 110.317 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.484 ' HA3' ' OD1' ' A' ' 95' ' ' ASP . . . -83.94 -164.8 37.71 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.173 -0.922 . . . . 73.01 115.06 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.12 112.89 20.22 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 114.342 -0.929 . . . . 63.42 111.224 -173.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -46.23 111.85 0.42 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.92 1.288 . . . . 54.01 113.846 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.8 t -86.67 -37.7 11.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 107.92 -1.141 . . . . 72.21 107.92 172.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.63 164.67 26.33 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.955 -1.02 . . . . 74.02 111.238 177.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.37 150.07 97.43 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.757 -0.46 . . . . 64.15 109.757 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.431 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 59.3 Cg_exo -51.28 -41.0 60.57 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.646 2.231 . . . . 73.31 113.2 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.14 26.74 8.42 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 74.35 113.119 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.66 138.39 90.86 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 105.832 -1.914 . . . . 75.31 105.832 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -36.46 110.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.463 3.442 . . . . 74.21 113.496 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.89 174.98 10.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.353 0.597 . . . . 74.54 112.271 -176.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.491 ' CE2' HD22 ' A' ' 38' ' ' LEU . 35.0 m-85 -130.33 161.52 31.1 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.418 1.487 . . . . 75.31 107.828 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.6 t0 -133.28 166.74 21.8 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 103.344 -2.836 . . . . 72.44 103.344 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -46.62 -56.0 12.73 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 113.706 1.002 . . . . 72.5 113.706 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.32 -40.9 78.5 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 121.794 1.663 . . . . 53.42 112.004 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 34' ' ' ARG . 1.9 mpt_? -70.77 -34.69 72.07 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.055 0.761 . . . . 73.3 113.055 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 31' ' ' ASP . 45.5 t -69.86 -43.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.979 -0.748 . . . . 74.51 108.979 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.71 80.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.911 -1.04 . . . . 74.54 109.475 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.5 -45.45 75.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.279 -0.873 . . . . 73.55 110.436 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.491 HD22 ' CE2' ' A' ' 30' ' ' TYR . 30.2 tp -65.76 -50.12 65.9 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 71.01 111.096 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.6 mt -83.1 -18.37 39.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.795 -0.639 . . . . 72.5 112.217 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.85 63.38 Favored Glycine 0 C--N 1.323 -0.159 0 N-CA-C 111.056 -0.818 . . . . 73.23 111.056 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.1 m -124.28 165.05 26.37 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.835 -0.802 . . . . 74.33 108.835 -177.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -79.45 163.57 24.4 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.205 1.27 . . . . 63.21 110.709 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.48 -34.14 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.452 0.701 . . . . 72.31 111.25 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.533 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.6 p -61.25 -40.85 95.58 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.601 -0.727 . . . . 75.04 111.837 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 83.0 tttt -69.54 -32.21 70.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.898 0.38 . . . . 73.01 110.289 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.16 -42.17 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.239 -0.652 . . . . 75.34 109.239 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.25 74.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.542 -0.754 . . . . 74.54 110.212 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 44' ' ' SER . 73.9 mm-40 -66.39 -35.45 80.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.5 -0.318 . . . . 75.14 111.038 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 76.6 mm-40 -64.34 -47.22 80.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 70.03 108.417 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.81 -45.0 95.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.086 -1.415 . . . . 75.5 110.017 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 25.1 mtp85 -65.39 -23.6 67.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 114.187 1.18 . . . . 71.01 114.187 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.27 3.14 37.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.028 -1.069 . . . . 65.41 111.366 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.97 41.25 41.29 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.591 -0.731 . . . . 62.12 112.297 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.12 -12.26 18.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.938 -0.393 . . . . 73.42 109.938 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.3 tp -156.77 161.38 39.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.57 -0.9 . . . . 72.11 108.57 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.23 146.82 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.89 -0.782 . . . . 71.41 108.89 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.39 148.31 43.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 74.25 109.024 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.454 ' C ' ' HB1' ' A' ' 18' ' ' ALA . 17.7 m -127.06 155.07 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.862 0.363 . . . . 74.25 110.877 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -110.41 115.12 29.09 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.7 -0.852 . . . . 71.31 108.7 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -126.82 123.74 38.03 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.206 -0.664 . . . . 75.22 109.206 -179.603 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.93 14.75 8.64 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.375 1.07 . . . . 71.14 111.378 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.92 4.31 60.25 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.656 -0.702 . . . . 53.54 112.362 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.51 145.68 16.13 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.563 -1.015 . . . . 74.44 110.563 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.4 t -97.15 120.03 45.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.591 -0.892 . . . . 74.34 108.591 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.26 169.53 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.212 -0.904 . . . . 75.24 109.228 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.0 mt -119.75 129.19 25.49 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 108.455 -0.943 . . . . 74.13 108.455 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.11 122.23 11.41 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.956 2.438 . . . . 74.54 112.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.5 tt0 -64.66 -25.6 68.02 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.159 -0.473 . . . . 75.42 111.921 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 32.8 m -72.2 -4.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.969 0.414 . . . . 73.35 112.108 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.596 ' CD2' HD12 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.86 -4.94 59.23 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.018 0.914 . . . . 73.24 109.718 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -117.04 151.29 37.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.835 -1.172 . . . . 73.24 107.835 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 p -83.06 166.87 18.39 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.619 -1.252 . . . . 74.22 107.619 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.86 -16.48 64.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.534 0.683 . . . . 72.24 110.112 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -79.96 -1.82 41.18 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.976 -0.556 . . . . 75.11 111.906 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.15 28.1 56.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.311 -0.947 . . . . 55.42 111.883 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -124.5 143.04 50.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.081 -1.081 . . . . 75.11 108.081 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.15 141.12 18.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.059 -1.089 . . . . 74.33 108.059 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.4 t -57.81 122.34 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.38 -0.971 . . . . 70.44 108.38 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -67.33 -27.61 67.29 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.437 0.902 . . . . 74.32 113.437 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -89.92 -6.77 55.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.161 0.505 . . . . 72.14 111.086 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.596 HD12 ' CD2' ' A' ' 70' ' ' PHE . 9.1 tt -65.91 -47.51 63.98 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 113.646 0.98 . . . . 72.04 113.646 -175.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.5 Cg_endo -55.72 -28.89 68.74 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.654 1.569 . . . . 74.52 111.186 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -40.23 93.67 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.663 -0.699 . . . . 74.54 111.987 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -67.97 -40.13 83.21 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.077 -0.712 . . . . 73.43 109.077 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.647 -0.706 . . . . 70.3 109.966 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.6 m -58.81 -50.03 75.49 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-N 115.674 -0.694 . . . . 61.43 111.524 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -41.62 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.634 -0.257 . . . . 71.44 111.516 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 141' ' ' ALA . 4.6 mm? -66.8 -36.31 82.1 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.077 0.399 . . . . 73.32 112.077 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -65.92 -32.81 74.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.486 0.184 . . . . 72.43 110.973 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.75 -30.64 71.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.163 0.506 . . . . 64.42 110.199 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.68 88.43 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.861 -0.608 . . . . 64.23 111.672 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.79 35.91 38.58 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.752 -0.224 . . . . 70.33 113.09 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.465 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 99.4 m-85 -97.67 145.66 26.1 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 122.412 -0.464 . . . . 74.14 111.04 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -95.6 171.43 8.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.594 -0.73 . . . . 75.45 110.205 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' OD1' ' HA3' ' A' ' 19' ' ' GLY . 2.0 p30 -53.65 -45.69 70.31 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.522 1.129 . . . . 74.12 113.092 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.3 m -62.4 -40.74 97.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 122.807 0.443 . . . . 73.31 111.239 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.75 -37.58 86.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.986 -0.552 . . . . 74.0 110.407 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.18 -49.06 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.869 0.842 . . . . 74.25 109.644 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -74.77 -13.52 60.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.864 -1.062 . . . . 74.35 113.356 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -57.43 -66.24 0.49 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.93 -0.308 . . . . 75.23 110.87 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.487 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 32.0 p-90 -67.61 -32.13 72.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.393 0.516 . . . . 72.31 112.393 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.487 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.9 mt -58.49 -40.82 83.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.6 0.593 . . . . 72.11 112.6 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -95.23 -4.19 46.27 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.952 0.723 . . . . 73.43 112.952 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.9 m -87.34 120.09 71.11 Favored Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 109.035 -0.728 . . . . 75.32 109.035 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.96 129.1 23.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.551 1.501 . . . . 73.15 108.788 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 12.3 t70 -80.68 125.13 81.17 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.665 -0.494 . . . . 65.3 109.665 -176.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.567 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 26.9 Cg_endo -60.41 -22.25 70.73 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.518 2.812 . . . . 74.34 114.065 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -109.4 -1.48 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.128 -0.629 . . . . 73.23 111.542 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 23.7 tp -102.57 128.9 49.04 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 119.435 -0.906 . . . . 74.54 111.509 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.3 m -116.56 122.14 43.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.078 -1.823 . . . . 73.24 106.078 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.1 mt -127.42 144.44 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 120.498 -0.481 . . . . 74.52 110.261 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 p -98.7 126.09 44.2 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 105.569 -2.012 . . . . 71.34 105.569 174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -121.9 -173.9 2.76 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.981 -1.087 . . . . 75.03 112.915 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -91.69 130.28 37.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.048 -0.523 . . . . 72.1 109.759 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.98 -69.59 0.21 Allowed Glycine 0 C--N 1.302 -1.322 0 N-CA-C 107.851 -2.1 . . . . 62.2 107.851 -175.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.6 m -102.5 100.42 10.52 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 106.354 -1.721 . . . . 64.52 106.354 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -77.15 0.35 22.01 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.816 1.043 . . . . 73.41 113.816 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -83.23 163.9 20.46 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.962 -0.563 . . . . 64.33 110.781 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.44 123.81 22.22 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.745 -0.661 . . . . 72.22 110.781 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.87 119.73 58.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 107.423 -1.325 . . . . 72.33 107.423 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.0 p -81.62 137.95 35.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.315 -0.402 . . . . 74.22 110.23 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.567 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 33.5 m-80 68.12 66.44 0.35 Allowed 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 124.235 1.014 . . . . 63.21 110.299 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -109.45 169.4 8.72 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.055 -0.658 . . . . 73.33 109.824 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -89.37 157.59 47.24 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.555 -0.293 . . . . 75.44 110.443 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.88 -25.61 79.9 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.054 1.836 . . . . 72.3 109.848 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 69' ' ' VAL . 84.9 t -62.56 -38.71 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.22 -0.9 . . . . 73.3 109.716 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.98 -42.28 76.76 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.276 -0.639 . . . . 71.04 109.276 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.0 89.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 71.54 112.857 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.69 -40.5 95.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.061 0.393 . . . . 64.43 112.061 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -77.6 -14.27 59.69 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.381 0.61 . . . . 73.34 111.058 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.53 5.9 50.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.317 -0.856 . . . . 72.42 111.575 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.0 m80 66.97 28.43 8.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.678 0.791 . . . . 71.25 112.028 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.3 23.19 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.077 0.941 . . . . 74.13 108.969 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.03 -28.66 39.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.018 1.727 . . . . 62.11 112.426 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -56.07 -38.44 70.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.366 -0.379 . . . . 74.11 110.62 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.98 -29.67 63.23 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 116.459 -0.337 . . . . 74.24 111.231 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.62 -49.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.118 -0.697 . . . . 74.12 109.118 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 57.6 t -62.53 -47.35 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.66 -0.7 . . . . 74.32 110.03 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.36 -46.59 83.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.8 -0.637 . . . . 73.53 111.121 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.407 ' HE ' ' HB2' ' A' ' 140' ' ' ARG . 7.0 ttm180 -69.0 -33.41 73.62 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 72.3 110.5 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.416 ' HB2' HD22 ' A' ' 88' ' ' LEU . . . -64.96 -43.89 91.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.693 -0.484 . . . . 74.02 109.693 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 14.7 mm100 -57.6 -44.55 85.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.345 0.593 . . . . 74.41 109.747 175.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.28 79.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 61.13 111.817 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -72.18 -38.59 69.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 75.5 109.794 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.465 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -74.93 -51.77 12.93 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.915 -0.584 . . . . 60.0 112.567 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--O 1.255 1.391 0 N-CA-C 109.666 -0.494 . . . . 70.32 109.666 -176.149 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 110.005 -0.369 . . . . 75.44 110.005 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -90.37 -178.96 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.591 2.194 . . . . 62.31 110.859 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 109.89 -21.96 24.35 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 119.839 -1.172 . . . . 53.31 112.816 175.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -73.1 133.4 44.14 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.746 -0.464 . . . . 74.11 109.746 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.25 103.78 46.82 Favored Pre-proline 0 C--N 1.307 -1.282 0 CA-C-N 116.271 -0.422 . . . . 73.34 110.239 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.38 160.65 44.44 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 122.776 2.317 . . . . 73.31 111.492 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.84 55.51 4.23 Favored Glycine 0 C--N 1.319 -0.383 0 CA-C-O 121.347 0.415 . . . . 75.32 112.395 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -120.4 103.23 9.03 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 107.604 -1.258 . . . . 70.31 107.604 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -139.89 11.5 2.44 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.748 -0.834 . . . . 65.24 108.748 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.0 mt -110.07 143.63 39.83 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.291 -0.868 . . . . 75.32 111.85 -173.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.73 93.92 4.6 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.402 -1.333 . . . . 63.52 107.402 176.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -88.68 25.32 1.76 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.503 -0.772 . . . . 75.54 110.944 -174.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.3 p -84.69 -15.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-O 121.913 0.863 . . . . 61.0 110.076 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -92.63 55.91 2.67 Favored Glycine 0 C--N 1.302 -1.356 0 CA-C-N 114.682 -1.144 . . . . 63.21 110.768 -179.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.0 m -92.92 105.84 17.9 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.827 -0.805 . . . . 72.31 108.827 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mp -104.93 121.04 47.98 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.591 -0.892 . . . . 75.13 108.591 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -67.05 141.93 59.7 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.062 1.841 . . . . 65.44 111.25 177.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.01 125.56 32.82 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 110.02 -0.363 . . . . 72.41 110.02 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.13 -99.49 2.07 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 121.38 -0.438 . . . . 61.41 112.305 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.71 135.18 51.05 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 122.327 -0.514 . . . . 72.44 112.238 -174.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -77.84 146.77 35.51 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.076 -0.965 . . . . 64.24 109.544 175.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.25 -15.85 9.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.396 -0.365 . . . . 65.44 111.342 -174.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 1.6 pp -90.61 179.25 5.87 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.32 -0.952 . . . . 74.14 111.442 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -105.58 137.11 19.21 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.927 -1.508 . . . . 73.41 106.927 173.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.32 -20.94 16.21 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.812 2.341 . . . . 74.1 114.376 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.45 -24.69 61.24 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 122.083 -0.385 . . . . 72.21 110.432 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.83 152.31 84.77 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 74.34 108.203 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.99 111.81 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 122.668 2.245 . . . . 74.34 113.085 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 m -124.59 169.35 12.01 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 108.787 -0.819 . . . . 70.11 108.787 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.514 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -128.91 160.98 30.95 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.021 -1.474 . . . . 74.44 107.021 172.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.572 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 10.9 t70 -134.66 168.59 18.72 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 104.429 -2.434 . . . . 75.23 104.429 -173.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -52.01 -57.19 15.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 112.983 0.734 . . . . 74.41 112.983 -173.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.572 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 21.7 Cg_endo -62.61 -31.6 79.54 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.778 1.652 . . . . 75.44 111.756 176.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -70.63 -36.83 73.65 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.428 0.529 . . . . 72.54 112.428 -178.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.59 -41.95 80.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.195 -0.669 . . . . 75.25 109.195 177.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.789 -1.096 . . . . 73.15 109.422 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 33' ' ' PRO . 38.7 tt0 -65.2 -45.8 83.3 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.833 1.253 . . . . 73.4 110.445 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 30' ' ' TYR . 38.8 tp -65.64 -50.28 65.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 75.04 111.604 -177.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.59 -9.54 58.21 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.531 0.567 . . . . 74.31 112.531 -174.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.41 29.26 71.79 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.672 -0.571 . . . . 64.41 111.672 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.23 160.28 48.44 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.544 -0.91 . . . . 74.22 108.544 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.68 160.08 38.27 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.564 1.51 . . . . 75.21 111.219 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.6 -32.84 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.349 0.659 . . . . 72.44 110.419 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -57.44 -42.84 83.21 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 116.185 -0.461 . . . . 64.45 110.495 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HZ3' ' HB2' ' A' ' 45' ' ' LYS . 2.9 ttmp? -70.16 -32.43 70.4 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.949 0.404 . . . . 75.45 110.603 178.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.7 t -62.28 -44.0 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 109.116 -0.698 . . . . 72.22 109.116 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.532 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -59.36 -36.94 76.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.27 -0.423 . . . . 70.21 110.299 177.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 83.6 mm-40 -69.63 -40.41 76.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.637 0.606 . . . . 74.25 112.637 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.544 ' O ' ' HB3' ' A' ' 54' ' ' HIS . 3.2 pt20 -68.69 -33.71 74.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.929 -0.708 . . . . 73.24 109.854 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.8 mt -62.47 -39.72 94.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.971 -0.752 . . . . 73.31 108.971 174.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 70.2 mtt-85 -70.78 -21.43 62.49 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.979 0.733 . . . . 72.12 112.979 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 44.4 mt-10 -76.77 -12.11 59.93 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 121.161 -0.216 . . . . 71.33 110.63 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.81 30.55 65.84 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.991 -2.043 . . . . 75.23 107.991 -169.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.544 ' HB3' ' O ' ' A' ' 49' ' ' GLN . 11.9 t-160 -97.23 -32.21 12.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 125.139 1.376 . . . . 74.35 108.625 -176.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 41.6 tp -152.61 153.19 32.86 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.1 -1.444 . . . . 73.21 107.1 -179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.75 161.48 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 117.9 0.318 . . . . 64.41 110.467 177.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.34 154.05 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.152 -0.685 . . . . 75.22 109.152 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.43 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 123.449 0.699 . . . . 73.15 110.548 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 98.8 mtt180 -117.24 134.76 54.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.767 -0.197 . . . . 71.0 110.607 -177.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -139.98 127.36 21.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.864 -1.161 . . . . 75.1 107.864 170.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.97 21.52 7.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.898 1.279 . . . . 73.31 111.882 -177.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.02 -0.88 67.18 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.378 -0.439 . . . . 71.2 112.681 -179.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -98.48 135.77 12.34 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.064 -0.814 . . . . 63.31 111.064 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.19 120.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.024 -1.102 . . . . 73.14 108.024 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.83 161.61 39.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.48 0.657 . . . . 75.21 111.878 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.88 120.75 25.55 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 106.384 -1.71 . . . . 73.14 106.384 178.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.02 124.61 16.36 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.409 2.073 . . . . 73.24 112.705 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.514 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.887 0.851 . . . . 75.54 111.015 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 m -66.53 -12.24 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.562 -1.199 . . . . 74.33 112.208 177.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.464 ' CD2' HD12 ' A' ' 81' ' ' LEU . 3.1 m-85 -78.55 -11.35 59.96 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.889 0.852 . . . . 73.22 110.299 175.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -106.83 149.53 27.3 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.61 -1.255 . . . . 75.23 107.61 178.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 p -76.04 175.64 8.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.498 -0.556 . . . . 75.24 109.498 178.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.56 -22.84 66.65 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.208 0.527 . . . . 61.44 110.079 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 m -84.05 1.01 45.96 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.755 -0.657 . . . . 65.33 112.298 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.67 66.82 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.351 -0.452 . . . . 75.5 112.71 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -113.97 152.77 30.4 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.651 -0.87 . . . . 74.43 108.651 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 135.64 27.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.831 -1.174 . . . . 74.25 107.831 175.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.55 135.21 24.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.335 -0.617 . . . . 74.24 109.335 178.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -59.09 -31.56 69.01 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.862 0.69 . . . . 74.42 112.862 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.0 m -89.38 3.05 53.5 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.081 -0.509 . . . . 73.52 111.78 179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.19 -54.12 48.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.989 -0.374 . . . . 73.14 109.989 179.393 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 32.2 Cg_exo -62.81 -30.87 78.18 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 121.134 1.222 . . . . 74.04 110.598 177.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.12 93.94 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.713 -0.676 . . . . 73.41 112.221 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -67.64 -40.02 84.61 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.17 0.509 . . . . 75.24 109.827 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.86 -46.55 87.35 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.799 -0.637 . . . . 74.14 110.264 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.8 m -60.71 -41.49 95.34 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.952 -0.567 . . . . 70.41 112.529 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -47.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 121.103 -0.239 . . . . 54.2 110.885 -178.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.01 -35.74 78.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.97 0.73 . . . . 74.13 112.97 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.507 0.723 . . . . 73.11 110.338 -177.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.4 -30.37 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.299 0.571 . . . . 63.44 110.572 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.99 -9.47 86.65 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.683 -0.69 . . . . 65.32 112.582 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 24.2 54.93 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 121.713 -0.28 . . . . 52.11 113.146 177.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 94.5 m-85 -89.61 132.98 34.85 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.576 -0.367 . . . . 73.52 111.123 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -78.88 169.88 17.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.597 0.713 . . . . 74.33 112.858 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.39 -45.34 72.84 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.395 1.878 . . . . 63.44 112.003 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.0 m -64.56 -40.39 95.48 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 115.568 -0.742 . . . . 53.55 110.204 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -65.96 -36.79 84.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.612 -0.267 . . . . 73.3 111.273 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.1 mm -61.42 -49.0 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.415 -0.957 . . . . 71.42 108.415 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.425 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 57.4 mtt -74.96 -17.72 60.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.799 -1.092 . . . . 75.44 112.391 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -59.4 -65.05 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.626 -0.509 . . . . 75.42 109.626 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -68.94 -32.56 72.25 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.749 0.648 . . . . 74.55 112.749 177.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 126' ' ' VAL . 13.1 mt -58.59 -40.84 84.31 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 112.477 0.547 . . . . 62.35 112.477 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 54.9 m-85 -92.49 -11.57 34.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.345 0.498 . . . . 75.42 112.345 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -86.62 125.36 67.47 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.654 -0.499 . . . . 71.33 109.654 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.591 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.6 Cg_exo -56.16 129.91 37.37 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.592 2.195 . . . . 74.2 110.693 175.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -90.53 123.41 65.41 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.525 -0.917 . . . . 74.32 108.525 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.21 -24.55 77.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.027 2.485 . . . . 71.43 113.6 -176.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -102.98 3.56 36.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.722 0.296 . . . . 72.14 111.367 -175.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.62 124.0 46.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.562 0.696 . . . . 72.5 111.016 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 m -131.35 110.48 11.1 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.866 -1.161 . . . . 75.23 107.866 177.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.2 pt -136.29 157.91 37.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 120.924 0.392 . . . . 63.4 111.871 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 t -89.35 136.28 33.11 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 105.66 -1.978 . . . . 75.24 105.66 169.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HB2' ' OD1' ' A' ' 127' ' ' ASP . 6.0 ptp180 -102.1 166.95 10.33 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.559 -0.856 . . . . 74.31 109.973 -174.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.03 84.96 4.27 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.599 -0.889 . . . . 65.45 108.599 179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.85 -4.25 2.39 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.243 -0.89 . . . . 74.43 111.607 -176.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.0 m -149.71 112.58 4.83 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.634 -0.876 . . . . 75.33 108.634 177.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -68.48 -22.31 64.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.102 0.477 . . . . 75.22 110.976 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.98 159.19 34.22 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.499 -0.773 . . . . 73.4 110.232 175.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.47 124.87 40.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.879 -0.601 . . . . 75.42 110.791 -176.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.6 120.82 46.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.163 -1.051 . . . . 71.23 108.163 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.0 t -90.22 148.44 22.93 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.311 -1.366 . . . . 71.43 107.311 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.591 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 65.6 t30 65.85 44.79 2.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.497 -1.297 . . . . 65.2 107.497 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.79 17.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.335 -0.848 . . . . 73.11 110.423 -178.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -97.27 132.3 25.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.444 -0.576 . . . . 75.34 109.444 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.43 ' HB2' HD21 ' A' ' 102' ' ' LEU . 80.9 Cg_exo -50.01 -29.53 21.84 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.061 3.174 . . . . 65.01 115.543 -178.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.3 t -61.69 -42.72 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 118.519 0.599 . . . . 75.53 110.274 176.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 113' ' ' ARG . 12.5 t70 -67.67 -33.64 75.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.278 -1.008 . . . . 73.33 108.278 -176.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.75 -50.2 72.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.723 -1.126 . . . . 75.11 111.386 177.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -65.7 -34.26 77.8 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.036 0.446 . . . . 74.4 110.946 -179.075 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -68.58 -23.63 64.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 75.32 109.157 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.66 7.7 45.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.815 -1.084 . . . . 74.41 110.982 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.1 m80 66.27 29.43 9.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.612 0.72 . . . . 75.41 111.773 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -101.36 22.69 12.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.033 -1.469 . . . . 73.23 107.033 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.31 -30.23 59.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.848 -1.524 . . . . 75.41 114.595 -173.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -56.75 -43.29 80.58 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.028 0.442 . . . . 64.45 111.524 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -73.31 -26.21 60.97 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.737 -0.665 . . . . 73.43 110.818 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.05 -42.13 81.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.653 -0.869 . . . . 75.24 108.653 175.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 86.1 t -60.03 -41.92 87.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-N 115.323 -0.853 . . . . 73.13 109.913 176.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.91 -40.28 92.56 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.341 0.591 . . . . 75.13 110.157 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -41.04 93.67 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.457 -0.942 . . . . 74.44 108.457 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.21 -45.12 94.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.967 -1.015 . . . . 73.22 110.549 177.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.6 mt-30 -57.3 -36.18 70.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 73.32 110.574 176.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.49 78.43 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.943 -0.571 . . . . 65.31 111.152 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 29.5 ttm -80.78 -45.39 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.724 -0.79 . . . . 74.21 112.618 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.46 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -69.72 -34.84 74.43 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.031 1.123 . . . . 74.12 114.031 -174.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 109.24 -0.652 . . . . 73.22 109.24 -178.664 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 110.096 -0.335 . . . . 72.23 110.096 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.17 113.98 3.26 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.727 2.284 . . . . 74.31 111.892 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.54 -164.57 29.42 Favored Glycine 0 C--N 1.302 -1.358 0 N-CA-C 111.133 -0.787 . . . . 75.13 111.133 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.408 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 31.8 mmm180 -73.58 133.58 43.56 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.205 -1.035 . . . . 72.44 108.205 177.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.81 105.34 44.43 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.657 -0.497 . . . . 55.25 109.657 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 4' ' ' ARG . 15.7 Cg_exo -70.79 143.46 45.93 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 122.262 1.974 . . . . 72.11 110.73 177.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.33 -175.3 49.69 Favored Glycine 0 N--CA 1.398 -3.862 0 N-CA-C 110.28 -1.128 . . . . 72.43 110.28 -179.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -96.57 -174.26 2.98 Favored 'General case' 0 C--N 1.257 -3.42 0 CA-C-N 115.33 -0.435 . . . . 52.54 109.838 -177.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -61.69 152.33 31.29 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.81 -0.811 . . . . 75.33 108.81 174.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.85 103.3 0.56 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.915 -0.772 . . . . 73.01 108.915 177.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.31 124.77 33.72 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.032 -0.985 . . . . 72.3 109.637 -178.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -79.86 96.66 6.4 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.443 -0.947 . . . . 74.4 108.443 178.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.5 m -96.59 136.16 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 115.041 -0.981 . . . . 74.55 110.373 -176.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.85 1.02 49.03 Favored Glycine 0 C--N 1.277 -2.722 0 CA-C-N 114.027 -1.442 . . . . 75.01 109.988 -177.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.3 m -91.53 91.11 7.92 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.506 0.669 . . . . 74.41 110.683 -178.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.62 120.15 50.26 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 107.641 -1.244 . . . . 73.42 107.641 175.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -74.07 165.17 32.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.38 2.053 . . . . 55.21 110.172 176.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.23 133.79 33.62 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 120.571 0.224 . . . . 61.23 110.579 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 -87.17 1.99 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.561 -1.016 . . . . 61.33 110.561 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -141.12 159.95 41.13 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.604 -0.351 . . . . 73.15 110.848 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 9.6 t0 -93.75 137.67 32.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.636 -0.711 . . . . 71.24 112.647 -173.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.01 -26.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.692 -0.685 . . . . 72.24 111.8 -175.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.549 HD22 ' CZ ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -80.45 -178.9 6.89 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 118.663 -1.215 . . . . 74.35 110.655 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -100.79 147.94 34.34 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 107.868 -1.16 . . . . 73.05 107.868 -178.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.08 -21.27 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.992 2.462 . . . . 75.11 113.576 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.78 -27.24 68.14 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.903 0.481 . . . . 72.24 110.548 176.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.15 125.24 85.44 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 107.756 -1.201 . . . . 70.15 107.756 171.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 16.6 Cg_exo -65.31 139.73 61.14 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.218 1.946 . . . . 72.05 112.898 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 65' ' ' VAL . 6.3 p -118.22 156.97 27.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.252 0.834 . . . . 73.14 113.252 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 28.0 m-85 -109.78 161.89 15.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 125.452 1.501 . . . . 74.21 108.858 176.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' HG21 ' A' ' 35' ' ' VAL . 4.3 m-20 -134.56 165.77 24.43 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 104.623 -2.362 . . . . 72.43 104.623 -178.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.04 -56.37 18.15 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 114.415 1.265 . . . . 70.23 114.415 -175.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.05 -31.62 76.05 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.915 1.744 . . . . 75.44 112.424 178.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.44 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 14.8 tpt180 -70.42 -39.37 74.47 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.736 0.814 . . . . 72.03 110.221 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.45 HG21 ' O ' ' A' ' 31' ' ' ASP . 59.3 t -69.2 -38.58 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 71.42 109.372 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.11 91.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.441 -0.799 . . . . 54.42 109.626 177.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.57 -44.98 94.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.016 -1.447 . . . . 75.24 110.06 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.4 tp -65.62 -47.48 75.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.921 -1.036 . . . . 75.25 111.339 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.7 -18.54 40.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.865 0.691 . . . . 74.23 112.865 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.45 55.13 Favored Glycine 0 C--N 1.311 -0.827 0 N-CA-C 111.017 -0.833 . . . . 71.01 111.017 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.22 161.83 45.23 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.148 -1.056 . . . . 73.22 108.148 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -67.94 156.23 66.7 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 121.362 1.374 . . . . 75.3 112.603 178.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.45 -37.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 61.34 110.256 -179.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 23.0 t -60.69 -34.78 74.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.534 -0.757 . . . . 61.04 110.653 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 60.8 tttp -69.33 -39.02 78.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.837 -0.431 . . . . 75.43 109.837 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.2 t -61.34 -41.16 88.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.249 0.547 . . . . 73.15 109.56 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.81 81.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.41 -0.814 . . . . 73.53 110.498 176.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.2 mt-30 -65.36 -44.0 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.359 -0.382 . . . . 74.21 110.308 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.9 mm-40 -61.86 -43.17 99.38 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.791 0.682 . . . . 74.3 110.226 -178.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.97 -40.81 96.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.589 -1.187 . . . . 73.33 110.343 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.47 -21.49 61.94 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.201 0.815 . . . . 75.13 113.201 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -88.14 -11.88 45.63 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 120.406 0.146 . . . . 70.21 111.272 178.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.98 32.45 49.28 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.234 -1.146 . . . . 63.43 110.234 -175.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -93.74 -13.74 27.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.31 -1.367 . . . . 74.1 107.31 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -157.08 152.86 26.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.193 -2.151 . . . . 75.51 105.193 179.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.6 152.05 30.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.162 -0.681 . . . . 73.3 109.162 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -127.26 162.14 26.91 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.086 -0.506 . . . . 64.41 110.575 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.64 166.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 123.397 0.679 . . . . 74.1 109.467 178.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -120.5 131.65 54.83 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.879 -0.328 . . . . 72.43 110.649 -176.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.453 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 30.1 ptt180 -147.51 138.32 23.46 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.582 -0.895 . . . . 71.33 108.582 175.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.35 17.71 9.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.004 0.922 . . . . 72.04 111.612 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.85 -4.02 74.78 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.976 -0.556 . . . . 61.05 112.245 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.24 144.38 15.77 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.836 -0.697 . . . . 74.21 111.593 -178.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.44 120.12 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.04 -1.467 . . . . 71.11 107.04 178.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.8 m -133.68 154.42 38.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.36 0.6 . . . . 72.21 111.796 -173.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.53 120.75 38.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 107.497 -1.298 . . . . 71.14 107.497 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.74 128.39 29.38 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.698 2.265 . . . . 73.11 112.179 177.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.423 ' NE2' ' HB2' ' A' ' 28' ' ' PRO . 6.1 tt0 -57.34 -25.53 59.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.36 0.504 . . . . 65.24 112.36 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -70.95 -4.24 4.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.782 -0.645 . . . . 75.03 112.446 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 81' ' ' LEU . 4.8 m-85 -83.84 -4.66 58.85 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.248 1.023 . . . . 74.44 109.913 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -122.16 158.84 28.47 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.801 -1.555 . . . . 73.43 106.801 177.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.2 p -91.57 163.87 13.98 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.69 -0.856 . . . . 73.42 108.69 179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.73 -16.29 62.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.336 0.588 . . . . 74.12 110.147 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -79.47 -0.67 34.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.238 0.615 . . . . 63.54 111.187 -178.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.38 60.48 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.851 -0.69 . . . . 64.21 112.005 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -125.9 145.95 50.04 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.607 -1.257 . . . . 75.45 107.607 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.17 155.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.967 -1.123 . . . . 74.21 107.967 176.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 48.4 t -69.82 112.03 4.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.498 -0.927 . . . . 70.34 108.498 177.483 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -56.18 -35.11 66.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.467 1.284 . . . . 75.43 114.467 -175.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.5 m -90.69 -4.25 56.89 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.223 0.535 . . . . 74.33 111.536 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.582 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.6 tt -65.83 -47.48 64.85 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.51 0.929 . . . . 75.54 113.51 -176.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.6 Cg_endo -54.24 -28.73 53.6 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 121.743 1.628 . . . . 73.21 111.514 176.391 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.15 -38.2 95.61 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.709 -0.678 . . . . 54.55 112.048 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -68.17 -40.15 82.37 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.767 -0.827 . . . . 75.21 108.767 178.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.88 -32.69 73.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 74.1 110.233 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 m -62.76 -50.18 72.08 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.66 -0.7 . . . . 71.44 110.289 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -40.25 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.465 -0.334 . . . . 74.45 111.439 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.88 -35.36 79.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.58 0.585 . . . . 75.02 112.58 176.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -61.68 -40.54 95.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 75.5 109.343 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.63 -31.87 73.13 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.791 -0.64 . . . . 70.31 110.854 178.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.53 -9.95 68.46 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.962 -0.637 . . . . 75.12 112.495 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.48 48.98 8.54 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 114.004 0.361 . . . . 71.03 114.004 177.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.44 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 88.4 m-85 -110.17 139.44 45.32 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.408 0.604 . . . . 72.34 111.447 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -81.91 171.79 14.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 72.42 111.851 -179.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.0 p-10 -54.64 -45.51 73.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 72.54 111.83 -177.41 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 m -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.364 0.666 . . . . 73.42 110.052 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.65 -38.74 92.28 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.624 -0.717 . . . . 74.05 111.229 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 mm -61.26 -47.5 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.334 -0.987 . . . . 65.43 108.334 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 22.8 mmt -67.99 -26.07 65.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.677 -1.147 . . . . 75.52 111.656 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -52.56 -71.26 0.07 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.694 0.627 . . . . 75.12 112.694 -176.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -68.58 -31.46 70.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.166 0.432 . . . . 75.41 112.166 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 126' ' ' VAL . 15.7 mt -56.55 -40.64 75.49 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 112.131 0.419 . . . . 75.04 112.131 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.549 ' CZ ' HD22 ' A' ' 23' ' ' LEU . 96.5 m-85 -102.02 2.01 37.21 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.956 0.724 . . . . 72.52 112.956 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -89.08 112.13 49.17 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.712 -0.477 . . . . 71.43 109.712 173.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.1 128.76 21.3 Favored 'Trans proline' 0 C--O 1.251 1.145 0 N-CA-C 108.434 -1.41 . . . . 72.21 108.434 173.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 23.6 t70 -96.85 126.29 43.34 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.698 -0.401 . . . . 64.12 111.501 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.66 -16.9 46.18 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.22 2.613 . . . . 75.53 114.277 -178.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.4 t -114.53 8.99 16.57 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 121.163 0.506 . . . . 72.24 109.924 -178.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.41 HD13 ' NH2' ' A' ' 140' ' ' ARG . 51.6 tp -106.94 118.68 37.33 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.729 0.776 . . . . 74.1 112.328 -178.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.0 m -118.2 117.19 28.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.191 -1.04 . . . . 74.44 108.191 178.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.3 mm -117.45 148.88 19.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 115.118 -0.946 . . . . 73.55 109.826 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.4 p -97.87 126.06 43.06 Favored 'General case' 0 C--N 1.263 -3.184 0 N-CA-C 108.46 -0.941 . . . . 73.45 108.46 175.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -82.23 167.39 18.7 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.451 -0.5 . . . . 75.45 111.86 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.26 112.44 2.14 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 124.308 1.005 . . . . 73.01 109.596 -178.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.92 0.83 Allowed Glycine 0 N--CA 1.426 -1.986 0 N-CA-C 106.934 -2.466 . . . . 64.12 106.934 -170.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.5 m -67.19 87.31 0.16 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.837 1.051 . . . . 75.51 113.837 -172.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -100.94 -25.54 14.05 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.325 -1.307 . . . . 75.5 109.369 175.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -163.58 157.82 19.94 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 107.567 -1.272 . . . . 75.31 107.567 -174.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.31 139.08 36.5 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.502 -0.555 . . . . 73.12 109.502 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t -103.73 117.9 49.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.05 -0.722 . . . . 64.1 109.05 -176.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -84.0 149.83 26.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.268 -0.641 . . . . 70.13 109.268 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 22.8 t-20 70.1 40.42 1.22 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.219 1.008 . . . . 74.05 109.798 178.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.55 156.65 22.68 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.734 -0.604 . . . . 74.51 110.348 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -102.95 143.65 27.03 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 108.711 -0.848 . . . . 73.42 108.711 175.821 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.73 -34.08 34.36 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 123.655 2.904 . . . . 73.35 114.856 -177.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.5 t -62.95 -40.46 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.466 0.651 . . . . 74.33 110.782 177.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.23 -37.79 88.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.347 -0.982 . . . . 74.44 108.347 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.94 78.66 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.484 -1.235 . . . . 74.42 112.023 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -66.41 -36.22 82.29 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.013 -0.429 . . . . 74.54 112.114 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.422 ' N ' HD13 ' A' ' 129' ' ' LEU . 16.6 t-80 -73.27 -16.16 61.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.216 1.007 . . . . 74.22 108.975 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.83 5.25 51.75 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.019 -0.991 . . . . 72.22 110.465 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.0 m80 65.22 28.99 11.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.416 1.086 . . . . 63.53 112.296 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -103.83 23.71 12.39 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.653 -1.24 . . . . 73.44 107.653 176.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.38 -26.83 13.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.549 1.94 . . . . 62.5 112.74 -176.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -54.39 -38.2 65.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.881 0.472 . . . . 74.43 111.773 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -73.5 -32.2 64.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.696 -0.483 . . . . 73.14 109.696 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.52 -48.31 77.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.501 -0.772 . . . . 75.45 109.586 -178.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 59.6 t -62.37 -42.79 96.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 N-CA-C 109.279 -0.638 . . . . 74.04 109.279 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -62.61 -39.45 93.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.711 -0.677 . . . . 73.14 111.188 178.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.41 ' NH2' HD13 ' A' ' 109' ' ' LEU . 2.7 tpp180 -64.73 -38.84 92.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.077 -0.712 . . . . 73.34 109.077 178.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.85 -38.66 79.91 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.831 -1.077 . . . . 75.53 110.613 178.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.0 mt-30 -58.87 -49.51 77.47 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.591 -0.277 . . . . 74.12 110.288 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 72.55 111.141 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.463 ' HE2' ' HA ' ' A' ' 144' ' ' MET . 2.5 tpt -83.39 -30.94 26.98 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.346 0.593 . . . . 72.4 110.191 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.44 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.21 -54.07 5.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.186 -0.461 . . . . 72.13 111.638 -177.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--N 1.309 -1.174 0 N-CA-C 108.676 -0.861 . . . . 74.52 108.676 -177.45 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 CA--C 1.516 -0.35 0 N-CA-C 109.897 -0.409 . . . . 62.32 109.897 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.82 -41.61 10.24 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.463 2.109 . . . . 70.35 112.679 -177.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.79 105.67 2.56 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 111.621 -0.591 . . . . 53.35 111.621 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -68.24 138.37 55.5 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.529 -0.545 . . . . 74.05 109.529 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.34 112.04 53.34 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 109.656 -0.498 . . . . 70.44 109.656 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -79.39 -162.47 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.718 2.279 . . . . 74.41 110.728 175.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.42 -65.87 1.6 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 111.079 -0.809 . . . . 63.33 111.079 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -90.45 77.98 6.44 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 122.323 1.059 . . . . 73.13 112.429 -178.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.5 m -155.61 148.68 24.53 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.985 -1.857 . . . . 73.02 105.985 175.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.1 mt -123.5 167.24 14.15 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.514 -0.55 . . . . 74.41 109.514 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.64 87.13 6.3 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.832 -1.173 . . . . 75.5 107.832 174.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -75.83 100.29 4.72 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.836 -1.529 . . . . 73.43 110.102 -177.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.39 83.22 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.644 0.735 . . . . 53.45 111.201 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -92.12 53.92 2.88 Favored Glycine 0 C--N 1.303 -1.255 0 N-CA-C 108.087 -2.005 . . . . 72.11 108.087 173.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 t -145.88 155.94 43.21 Favored 'General case' 0 N--CA 1.409 -2.513 0 N-CA-C 107.841 -1.17 . . . . 74.41 107.841 -172.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.74 125.05 32.57 Favored Pre-proline 0 N--CA 1.422 -1.873 0 N-CA-C 107.08 -1.452 . . . . 71.23 107.08 176.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.77 166.21 14.38 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.036 2.49 . . . . 72.34 110.955 174.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.58 125.55 31.29 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.306 -0.627 . . . . 64.24 109.306 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.17 -133.99 7.63 Favored Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 121.144 -0.55 . . . . 64.42 112.314 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.28 124.39 46.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.533 -0.543 . . . . 75.33 109.533 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.69 130.78 44.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.25 0.548 . . . . 70.34 111.048 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 22' ' ' VAL . 22.3 t -111.44 27.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 123.294 1.521 . . . . 74.43 109.5 -178.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -118.68 172.94 7.15 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-N 114.994 -1.003 . . . . 74.42 110.098 175.6 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.405 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 14.3 t70 -86.5 137.06 34.47 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.724 -1.213 . . . . 72.02 107.724 175.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -50.78 -21.96 9.06 Favored 'Trans proline' 0 CA--C 1.557 1.67 0 C-N-CA 123.149 2.566 . . . . 72.2 115.242 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.91 -1.46 56.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.509 0.929 . . . . 72.14 113.509 178.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 27.1 mm-40 -67.42 151.76 96.84 Favored Pre-proline 0 C--O 1.248 0.979 0 N-CA-C 109.268 -0.642 . . . . 74.33 109.268 176.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.3 119.01 5.46 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.712 2.275 . . . . 73.05 111.371 176.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.1 m -136.29 162.11 33.92 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.679 -0.86 . . . . 64.41 108.679 -174.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.574 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 21.8 m-85 -126.72 160.11 31.77 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.379 -0.971 . . . . 74.44 108.379 174.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.3 t0 -134.69 157.92 45.42 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 103.883 -2.636 . . . . 71.15 103.883 -178.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -46.83 -54.22 21.17 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 114.443 1.275 . . . . 73.43 114.443 -169.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.23 -39.19 86.97 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.833 1.689 . . . . 74.41 112.188 177.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -71.01 -34.74 71.63 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.614 -0.266 . . . . 72.41 110.476 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 31' ' ' ASP . 27.3 t -69.12 -42.3 81.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.71 -0.478 . . . . 74.31 109.71 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.9 82.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.273 -0.876 . . . . 64.31 109.516 178.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.63 -46.02 70.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.36 -1.291 . . . . 62.02 110.467 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.434 HD23 ' CZ ' ' A' ' 30' ' ' TYR . 26.8 tp -64.26 -50.06 69.43 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.118 0.967 . . . . 73.13 112.177 -176.207 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.6 mt -86.07 -18.24 32.95 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.739 -0.664 . . . . 73.23 111.614 -175.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.21 63.58 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.704 -0.958 . . . . 71.23 110.704 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.91 159.61 50.61 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 108.814 -0.81 . . . . 74.35 108.814 -176.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.74 157.93 51.23 Favored 'Trans proline' 0 C--O 1.252 1.217 0 C-N-CA 121.425 1.417 . . . . 72.33 111.846 176.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.11 -33.0 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.765 -0.652 . . . . 74.41 110.642 178.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.6 t -57.67 -42.65 84.02 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.036 -0.529 . . . . 72.3 110.615 177.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 88.2 tttt -69.51 -34.34 74.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.948 0.404 . . . . 74.31 110.127 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.92 -45.07 99.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.847 -0.615 . . . . 72.54 109.432 177.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -61.91 -37.28 84.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.348 -0.842 . . . . 74.24 110.35 178.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.423 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 15.7 mm100 -62.84 -40.1 96.4 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.277 -0.42 . . . . 73.23 111.542 178.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 80.9 mm-40 -59.75 -44.24 93.92 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.577 0.703 . . . . 65.34 109.459 178.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -62.21 -43.95 97.67 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.828 -1.078 . . . . 74.23 109.886 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.477 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -66.1 -21.61 66.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.979 -0.555 . . . . 74.31 112.379 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 43.2 mt-10 -98.91 -7.89 26.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.423 -0.511 . . . . 72.45 111.798 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.04 27.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.482 -0.866 . . . . 61.34 111.615 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.65 -8.92 14.55 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.815 -0.809 . . . . 75.44 108.815 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.4 tp -155.22 154.15 31.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.715 -1.587 . . . . 73.03 106.715 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.2 146.59 33.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 75.43 108.818 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.403 ' CB ' HG21 ' A' ' 66' ' ' ILE . . . -126.09 151.17 47.57 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 107.63 -1.248 . . . . 74.31 107.63 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.518 HG12 ' SD ' ' A' ' 99' ' ' MET . 34.4 m -129.85 166.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 123.437 0.695 . . . . 71.45 109.856 -176.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -110.27 121.45 45.32 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.763 -0.828 . . . . 73.14 108.763 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -117.09 113.8 22.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.012 -0.736 . . . . 74.22 109.012 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.96 -53.19 0.68 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.268 1.827 . . . . 71.45 111.191 -179.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.97 0.44 0.03 OUTLIER Glycine 0 C--N 1.286 -2.208 0 CA-C-N 114.913 -1.039 . . . . 61.01 113.0 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.92 149.38 17.02 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.39 -0.91 . . . . 51.42 111.061 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.6 120.6 47.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.535 -1.283 . . . . 74.43 107.535 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.39 171.63 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 124.509 1.124 . . . . 74.35 108.312 -175.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.403 HG21 ' CB ' ' A' ' 57' ' ' ALA . 40.6 pt -127.68 144.06 49.77 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.938 -0.764 . . . . 71.4 108.938 178.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.57 118.31 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.612 1.541 . . . . 75.33 110.799 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.574 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 tt0 -61.44 -24.88 66.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.365 0.666 . . . . 74.1 111.811 -178.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 35.0 m -63.67 -9.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 CA-C-N 115.422 -0.808 . . . . 74.24 112.631 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.551 ' CD2' HD12 ' A' ' 81' ' ' LEU . 3.2 m-85 -78.77 -6.83 56.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.826 0.822 . . . . 72.53 109.948 175.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -117.0 161.29 19.62 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.937 -1.135 . . . . 75.41 107.937 175.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 63.1 p -90.54 168.22 11.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.501 -1.296 . . . . 71.23 107.501 176.096 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.59 -17.49 64.85 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.656 0.613 . . . . 72.41 112.656 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -80.1 -9.09 59.68 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.376 -0.375 . . . . 72.41 111.311 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.68 9.9 62.27 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.532 -0.842 . . . . 75.35 112.509 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -97.34 140.2 32.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.59 -1.633 . . . . 72.4 106.59 177.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.59 152.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.135 -1.061 . . . . 74.31 108.135 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.52 126.55 22.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.423 -0.584 . . . . 74.2 109.423 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.19 -34.17 77.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 113.288 0.847 . . . . 75.24 113.288 -175.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 t -91.93 8.11 38.98 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.369 0.604 . . . . 54.23 110.281 -177.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 70' ' ' PHE . 14.5 tp -58.83 -54.01 60.68 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.748 -0.66 . . . . 74.32 112.048 -177.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.75 -25.24 74.81 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.53 1.487 . . . . 74.23 111.846 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.95 78.43 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.135 -0.484 . . . . 72.11 111.905 -178.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -67.38 -39.51 85.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.116 -0.698 . . . . 74.25 109.116 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.06 -40.07 95.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.368 -0.833 . . . . 73.22 111.068 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -62.28 -47.35 84.69 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 116.437 -0.347 . . . . 74.12 111.558 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -43.79 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 116.471 -0.331 . . . . 73.34 111.344 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.415 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 4.4 mm? -66.91 -35.79 80.8 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.901 -0.5 . . . . 75.41 112.257 177.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -64.93 -33.14 75.32 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.528 -0.545 . . . . 75.11 109.528 177.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.25 -31.25 70.6 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.143 0.497 . . . . 63.15 110.81 176.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.76 -9.3 78.31 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.762 -0.654 . . . . 74.44 112.036 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.73 48.1 6.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 121.386 -0.435 . . . . 71.0 112.487 178.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.411 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 80.0 m-85 -110.8 138.15 47.56 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.787 0.327 . . . . 74.25 111.335 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 28.5 ptt180 -86.28 170.9 11.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 75.35 109.818 177.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -55.05 -41.27 71.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.511 1.524 . . . . 73.12 111.233 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -61.67 -41.26 97.3 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.496 -0.774 . . . . 71.51 110.608 -179.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HG2' ' CG ' ' A' ' 94' ' ' ARG . 8.8 mm-40 -66.02 -38.06 87.5 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.897 -0.779 . . . . 63.12 108.897 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 94' ' ' ARG . 24.9 mm -61.12 -48.0 90.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.651 -0.87 . . . . 74.43 108.651 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.518 ' SD ' HG12 ' A' ' 58' ' ' VAL . 76.0 mtm -71.49 -22.36 61.81 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.249 -0.887 . . . . 74.02 112.194 -177.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.01 -65.31 0.62 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.798 -0.816 . . . . 75.02 108.798 -179.655 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.565 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 53.2 p-90 -69.78 -33.86 72.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.787 0.662 . . . . 74.23 112.787 179.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.523 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -66.76 -39.06 87.75 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.714 0.806 . . . . 72.42 112.941 -173.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.543 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 47.6 m-85 -92.63 7.88 41.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.632 0.605 . . . . 75.41 112.632 -178.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.1 m -86.94 116.51 66.32 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 109.562 -0.533 . . . . 74.42 109.562 177.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.7 129.22 19.42 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 121.516 1.478 . . . . 71.03 108.26 172.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 25.7 t70 -115.71 119.75 37.05 Favored Pre-proline 0 C--N 1.295 -1.774 0 C-N-CA 120.637 -0.425 . . . . 75.44 110.791 -175.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.42 -28.95 87.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.021 2.48 . . . . 65.24 112.815 -177.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -90.88 2.05 56.48 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.487 0.551 . . . . 75.04 112.487 -177.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.9 tp -102.17 125.13 48.78 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 107.869 -1.16 . . . . 74.33 107.869 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 m -118.5 113.35 21.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.07 -1.085 . . . . 75.43 108.07 -177.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 37.9 mm -131.19 148.73 32.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.116 -0.493 . . . . 74.21 109.7 -173.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -112.95 126.71 55.79 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 106.001 -1.852 . . . . 74.42 106.001 171.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -110.21 167.93 9.82 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.762 -0.654 . . . . 75.44 109.856 -172.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -57.84 135.66 56.87 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.737 0.815 . . . . 64.12 110.168 178.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.73 -21.61 42.42 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-N 115.806 -0.634 . . . . 71.14 111.67 -177.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.8 m -109.39 143.37 39.04 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 108.661 -0.866 . . . . 74.43 108.661 -178.06 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -96.17 -27.26 15.13 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.358 0.599 . . . . 75.24 111.728 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.5 167.8 9.51 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.821 -0.627 . . . . 62.34 110.842 -176.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.59 136.55 33.05 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.044 -0.525 . . . . 74.45 110.339 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.82 129.42 64.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.502 -0.925 . . . . 75.11 108.502 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 m -82.84 138.84 33.79 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.204 -1.406 . . . . 64.15 107.204 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 42.7 t30 78.3 69.0 0.04 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.056 0.942 . . . . 74.11 110.947 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.54 173.1 6.71 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.213 -1.032 . . . . 75.13 108.213 172.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -96.19 156.94 36.43 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 106.391 -1.707 . . . . 75.4 106.391 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 27.7 Cg_exo -61.75 -20.08 67.75 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 121.39 1.394 . . . . 73.55 110.518 173.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 102' ' ' LEU . 74.3 t -60.67 -43.41 94.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 109.131 -0.692 . . . . 71.23 109.131 173.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.47 -39.29 93.52 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.68 -0.691 . . . . 53.3 109.43 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.46 66.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 71.43 112.002 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 130' ' ' HIS . 4.6 pp -66.81 -35.52 80.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.993 0.425 . . . . 75.35 111.598 -177.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 13.8 t60 -70.81 -24.85 62.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.852 0.834 . . . . 75.12 108.939 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -99.05 11.49 38.86 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.16 -0.927 . . . . 73.42 112.24 -178.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.7 27.54 9.32 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.348 1.071 . . . . 71.33 110.889 177.095 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -109.68 25.09 12.19 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.586 -1.264 . . . . 73.3 107.586 177.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 138' ' ' VAL . . . -52.56 -26.49 13.46 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.366 1.866 . . . . 71.41 113.196 -175.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -54.65 -35.91 63.99 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.657 0.208 . . . . 75.14 110.559 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.17 -28.08 62.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.659 0.742 . . . . 75.22 110.735 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.3 -44.99 54.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.639 -0.875 . . . . 71.13 108.639 177.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.504 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 61.3 t -61.1 -44.25 97.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 115.541 -0.754 . . . . 60.3 110.634 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.11 -38.69 89.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 120.457 -0.497 . . . . 74.24 110.824 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -69.12 -38.01 78.64 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.83 0.348 . . . . 75.41 110.998 175.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.415 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -59.01 -43.32 91.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.743 -0.662 . . . . 63.25 110.256 178.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 93.8 mt-30 -63.06 -45.47 92.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.851 -0.613 . . . . 73.54 110.167 177.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.91 94.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.639 -0.709 . . . . 74.12 111.112 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.565 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 17.0 tpt -70.34 -32.82 70.7 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.757 -0.656 . . . . 74.24 111.031 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.411 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.3 -54.51 5.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.013 -0.54 . . . . 71.3 111.538 -178.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 118.567 -0.73 . . . . 75.02 109.115 -175.842 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 C--O 1.239 0.542 0 N-CA-C 109.179 -0.674 . . . . 75.04 109.179 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.3 107.73 2.03 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.836 1.69 . . . . 73.41 109.076 174.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.83 103.64 1.86 Allowed Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 108.729 -1.749 . . . . 64.33 108.729 -172.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -73.09 134.0 44.37 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.438 0.161 . . . . 74.41 110.806 -177.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.06 83.18 0.2 Allowed Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 124.871 1.268 . . . . 75.51 111.762 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.3 143.57 28.29 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.685 2.257 . . . . 70.24 110.083 176.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.41 116.02 3.82 Favored Glycine 0 N--CA 1.411 -2.978 0 C-N-CA 120.325 -0.94 . . . . 71.34 110.992 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.417 ' C ' ' HG1' ' A' ' 9' ' ' THR . 15.8 p -75.14 -24.49 57.99 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.397 1.094 . . . . 74.13 108.288 176.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.417 ' HG1' ' C ' ' A' ' 8' ' ' SER . 37.2 m -159.4 155.44 26.68 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.746 -2.316 . . . . 72.43 104.746 175.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.2 150.38 48.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 118.399 0.545 . . . . 73.34 110.397 177.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.23 141.42 37.14 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.903 -0.589 . . . . 53.24 111.95 -174.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HA ' ' CE1' ' A' ' 89' ' ' HIS . 28.6 ptt180 -144.81 112.0 6.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.538 0.685 . . . . 72.22 110.455 176.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.38 121.67 57.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 107.417 -1.327 . . . . 64.02 107.417 -178.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.77 -32.82 58.71 Favored Glycine 0 C--N 1.317 -0.491 0 C-N-CA 121.04 -0.6 . . . . 73.4 111.768 -177.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -102.18 89.1 3.49 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.571 -0.529 . . . . 72.05 109.571 178.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mp -67.99 121.89 81.69 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.841 -0.618 . . . . 72.43 109.436 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.52 155.14 40.5 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.523 2.148 . . . . 74.31 113.561 -179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.77 132.98 53.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.441 -1.689 . . . . 64.2 106.441 173.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.94 -106.19 2.77 Favored Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.884 -0.674 . . . . 74.01 112.408 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.25 121.56 35.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.931 0.396 . . . . 75.21 110.452 -175.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -61.39 119.17 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.977 -1.01 . . . . 75.33 110.81 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.4 t -77.07 -25.28 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.447 0.641 . . . . 71.4 111.234 -177.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.6 148.44 28.0 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.407 -0.917 . . . . 72.3 111.9 176.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.32 145.19 99.1 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 114.988 -1.006 . . . . 70.31 110.782 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.44 -27.07 30.38 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.347 2.698 . . . . 74.52 114.058 177.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.8 -23.35 58.48 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.734 0.272 . . . . 73.02 111.734 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.09 126.63 91.66 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 108.903 -0.777 . . . . 75.33 108.903 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.64 106.53 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.876 2.384 . . . . 72.23 111.387 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 p -106.67 172.05 7.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.833 -0.621 . . . . 73.21 110.829 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.463 ' CE2' HD12 ' A' ' 38' ' ' LEU . 16.6 m-85 -109.63 161.5 15.32 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.581 -0.896 . . . . 73.14 108.581 177.047 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.14 166.24 22.91 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 103.606 -2.739 . . . . 74.35 103.606 -173.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -52.79 -51.13 76.88 Favored Pre-proline 0 C--N 1.309 -1.188 0 O-C-N 123.881 0.738 . . . . 73.23 112.004 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.52 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 10.9 Cg_endo -57.53 -39.71 86.39 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.794 1.663 . . . . 65.2 112.352 175.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 3.9 mpt_? -70.35 -36.2 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.979 0.733 . . . . 73.14 112.979 -177.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG21 HD11 ' A' ' 66' ' ' ILE . 73.4 t -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.971 -0.692 . . . . 74.13 109.764 175.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.01 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.157 -0.929 . . . . 75.33 109.055 174.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 19.3 mm-40 -65.52 -45.49 83.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 72.11 112.092 175.25 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.463 HD12 ' CE2' ' A' ' 30' ' ' TYR . 89.1 mt -62.73 -50.74 69.89 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.339 -0.391 . . . . 71.35 111.623 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.01 -15.38 36.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.799 -0.637 . . . . 74.1 112.137 -174.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.6 67.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.39 -1.084 . . . . 64.21 110.39 -177.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.21 164.61 24.79 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 108.671 -0.862 . . . . 63.41 108.671 -177.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.87 167.05 14.72 Favored 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 121.44 1.427 . . . . 71.32 111.638 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.5 t -59.02 -33.09 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.579 0.751 . . . . 75.02 110.644 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 24.6 p -57.58 -43.58 84.67 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.455 -0.793 . . . . 73.04 111.201 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 56.9 mtpt -69.33 -33.61 73.39 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.761 -0.199 . . . . 74.5 111.091 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.5 t -62.5 -43.7 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.626 -0.509 . . . . 74.2 109.626 177.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.47 78.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 62.34 110.479 177.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 44' ' ' SER . 97.9 mt-30 -65.43 -36.54 84.22 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.958 -0.564 . . . . 73.4 111.495 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm100 -63.28 -43.21 98.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.384 -0.969 . . . . 72.23 108.384 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.574 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 9.3 mp -61.75 -46.64 88.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.515 -1.22 . . . . 75.02 110.154 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -60.47 -25.72 66.24 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.676 0.991 . . . . 65.13 113.676 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 54' ' ' HIS . 7.6 pt-20 -102.55 2.77 36.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.425 -0.91 . . . . 75.41 111.625 -177.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.32 38.88 71.15 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.507 -0.854 . . . . 64.45 111.476 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 3.4 t60 -96.28 -28.9 14.29 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.853 -1.166 . . . . 74.25 107.853 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 55.9 tp -159.73 156.02 26.97 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.418 -2.068 . . . . 75.23 105.418 -178.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.48 152.29 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.123 -0.695 . . . . 72.51 109.123 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.7 161.82 19.45 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 123.489 0.493 . . . . 73.53 109.747 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.519 HG11 ' SD ' ' A' ' 99' ' ' MET . 22.2 m -126.54 166.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.01 -0.737 . . . . 72.31 109.01 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -116.58 134.84 54.36 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.56 -0.533 . . . . 72.4 109.56 -174.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -148.21 125.96 11.87 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.76 -0.83 . . . . 74.54 108.76 171.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.17 22.89 12.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.075 0.95 . . . . 65.24 112.017 178.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.57 -14.78 64.39 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.847 -0.615 . . . . 72.21 112.495 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.41 150.0 20.53 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 121.306 -0.473 . . . . 60.15 112.426 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.75 120.57 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.592 -1.262 . . . . 74.13 107.592 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.3 160.8 40.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.604 -0.725 . . . . 73.54 109.697 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.425 HD11 HG21 ' A' ' 35' ' ' VAL . 70.7 mt -130.69 129.08 22.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 72.4 108.286 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.4 131.63 47.37 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.566 2.177 . . . . 71.51 111.425 176.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.8 tt0 -65.27 -25.48 67.67 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 120.836 0.351 . . . . 72.3 111.227 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.29 -2.25 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.519 -0.764 . . . . 72.12 112.636 178.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.645 ' CD2' HD12 ' A' ' 81' ' ' LEU . 5.6 m-85 -86.38 -8.21 57.85 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.374 1.083 . . . . 73.03 109.359 173.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.6 m-85 -115.86 155.63 27.58 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.53 -1.656 . . . . 74.51 106.53 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.7 p -80.89 173.73 12.32 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.434 -0.951 . . . . 74.01 108.434 177.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -58.29 -20.57 43.88 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.029 0.752 . . . . 75.52 113.029 -177.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 t -89.04 -2.52 58.61 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 121.9 -0.5 . . . . 74.5 111.488 179.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.39 15.21 58.99 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.087 -0.578 . . . . 62.33 113.509 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -113.08 142.06 46.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.88 -0.785 . . . . 75.2 108.88 178.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 71' ' ' PHE . 11.8 p -62.01 144.18 14.39 Favored 'Isoleucine or valine' 0 C--O 1.249 1.032 0 O-C-N 123.715 0.635 . . . . 72.51 110.869 -175.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 35.2 t -65.46 131.82 31.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.979 -0.749 . . . . 72.42 108.979 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.87 -34.04 75.28 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.523 0.935 . . . . 73.05 113.523 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.0 m -86.2 -6.29 59.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.041 0.448 . . . . 73.15 111.069 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.645 HD12 ' CD2' ' A' ' 70' ' ' PHE . 10.2 tt -66.3 -49.19 55.27 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 114.134 1.161 . . . . 73.54 114.134 -175.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.88 -33.84 73.42 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 121.961 1.774 . . . . 74.51 111.413 176.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.48 95.9 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.212 -0.904 . . . . 70.15 112.725 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.7 pp -67.34 -40.49 85.86 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.57 -0.53 . . . . 72.4 109.57 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.45 -34.61 77.13 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.263 -0.426 . . . . 73.12 110.662 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.2 m -62.34 -48.08 81.4 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.821 -0.627 . . . . 62.52 112.041 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.98 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 111.72 0.267 . . . . 74.22 111.72 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.67 -35.04 79.21 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.552 -0.459 . . . . 73.11 111.66 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.487 ' CE1' ' HA ' ' A' ' 12' ' ' ARG . 26.4 t-80 -58.7 -43.15 89.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.254 -0.647 . . . . 74.43 109.254 176.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.015 0.822 . . . . 74.41 110.842 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.87 -9.1 81.53 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.986 -0.552 . . . . 71.14 112.643 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 33.55 28.2 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.871 -0.68 . . . . 74.51 112.275 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -102.12 125.52 48.84 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.94 0.4 . . . . 73.21 111.037 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.422 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 37.2 ptt180 -75.67 171.79 13.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.663 -0.698 . . . . 73.13 111.157 178.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -54.2 -40.62 67.77 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.234 1.413 . . . . 74.21 110.866 -178.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.7 m -61.52 -42.32 98.63 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.858 -1.065 . . . . 73.22 110.67 -178.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 12.4 mm-40 -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.128 -0.487 . . . . 74.24 110.228 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.4 mm -60.99 -47.92 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.486 -0.931 . . . . 72.35 108.486 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.519 ' SD ' HG11 ' A' ' 58' ' ' VAL . 70.7 mtm -71.82 -25.04 61.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.85 -1.068 . . . . 74.22 111.415 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -64.18 0.98 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.112 -0.699 . . . . 72.32 109.112 -176.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.448 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 34.5 p-90 -69.44 -32.78 71.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.947 0.721 . . . . 74.22 112.947 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.448 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 14.8 mt -61.22 -40.64 94.77 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.905 0.706 . . . . 64.41 112.905 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -93.15 -1.21 56.59 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.427 0.529 . . . . 75.15 112.427 -177.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.1 m -87.99 127.1 58.88 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 109.236 -0.653 . . . . 75.0 109.236 175.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 44.0 Cg_exo -61.26 129.19 27.46 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 121.903 1.736 . . . . 64.22 110.105 174.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 10.6 t70 -85.91 126.31 66.07 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.812 -0.81 . . . . 63.31 108.812 -177.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.95 -17.39 51.08 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.296 2.664 . . . . 55.24 114.017 -177.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.3 m -122.49 15.68 10.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.892 -0.505 . . . . 73.24 111.443 -176.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 tp -108.47 126.4 52.86 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.738 0.644 . . . . 71.02 112.738 -176.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.4 m -119.72 133.64 55.54 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 105.354 -2.091 . . . . 75.3 105.354 174.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.82 160.77 15.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.111 -1.036 . . . . 74.11 113.791 -175.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.2 t -92.71 160.09 15.13 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.396 -1.274 . . . . 74.33 109.604 -177.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.512 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -54.84 120.5 6.93 Favored 'General case' 0 C--O 1.253 1.259 0 O-C-N 123.529 0.518 . . . . 74.13 112.352 178.372 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.463 ' HB3' ' HA ' ' A' ' 131' ' ' ALA . 4.9 t70 161.78 120.33 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 127.403 2.281 . . . . 74.35 104.975 172.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.65 -53.81 4.86 Favored Glycine 0 C--N 1.308 -1.026 0 N-CA-C 108.807 -1.717 . . . . 72.53 108.807 -173.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.6 m -103.94 123.12 46.58 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 106.102 -1.814 . . . . 75.4 106.102 171.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -62.04 -24.25 66.95 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.188 0.995 . . . . 73.1 112.304 -176.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -136.92 178.59 6.96 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 116.199 -0.455 . . . . 74.3 109.786 -174.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.4 131.23 40.06 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 123.577 0.548 . . . . 74.4 110.904 -177.092 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.19 122.19 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.678 -0.692 . . . . 74.24 109.394 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.8 p -88.32 150.2 23.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.055 -1.091 . . . . 74.44 108.055 173.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 12.7 m120 61.09 42.28 12.65 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.31 1.053 . . . . 74.2 108.405 -173.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.6 163.92 26.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.098 -1.41 . . . . 64.23 111.752 -176.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -97.11 133.02 24.61 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.769 -1.105 . . . . 73.15 109.279 -178.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.16 -31.09 44.03 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.635 2.89 . . . . 74.53 114.423 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 67.8 t -60.83 -42.21 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 73.4 110.709 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.2 -40.38 82.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.096 -0.705 . . . . 74.12 109.096 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.95 83.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.123 -0.944 . . . . 75.02 112.091 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -68.52 -34.62 76.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.58 -0.448 . . . . 74.44 111.778 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.404 ' N ' HD12 ' A' ' 129' ' ' LEU . 46.4 t-80 -77.34 -24.13 50.79 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 107.745 -1.206 . . . . 73.1 107.745 179.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 114' ' ' ASP . . . -85.18 12.45 7.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.622 -1.172 . . . . 73.13 111.583 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.0 m80 66.85 28.17 8.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.061 0.945 . . . . 71.35 110.927 176.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -112.28 23.22 13.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.049 -1.093 . . . . 75.54 108.049 176.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.52 -31.48 46.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 114.262 -1.335 . . . . 74.5 113.318 -176.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -65.18 -35.12 80.08 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 120.978 -0.289 . . . . 74.33 111.719 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -69.83 -28.56 65.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.679 0.752 . . . . 74.35 109.688 177.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.0 -45.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.957 -0.757 . . . . 70.45 108.957 176.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 82.7 t -59.87 -41.65 86.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 N-CA-C 109.11 -0.7 . . . . 73.22 109.11 175.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.797 0.839 . . . . 73.34 110.945 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.11 -37.25 86.48 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.572 -0.529 . . . . 75.24 109.572 177.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.14 -44.24 89.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.428 -0.806 . . . . 62.0 110.833 178.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 92.2 mt-30 -67.46 -36.35 80.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.473 -0.331 . . . . 75.11 110.198 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.84 62.48 Favored 'General case' 0 C--O 1.208 -1.085 0 CA-C-N 116.153 -0.476 . . . . 54.2 110.662 176.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.89 -30.85 45.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.389 0.614 . . . . 73.5 109.422 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.79 -41.69 13.1 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.861 -0.609 . . . . 72.13 111.366 178.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.607 -0.711 . . . . 75.54 110.106 -178.683 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 106.478 -1.675 . . . . 64.12 106.478 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.35 122.35 11.4 Favored 'Trans proline' 0 C--O 1.246 0.907 0 C-N-CA 122.848 2.365 . . . . 75.13 112.731 -177.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.41 47.41 1.02 Allowed Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.775 -0.93 . . . . 73.22 110.775 -178.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.476 ' H ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -62.0 141.37 58.1 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 123.117 0.567 . . . . 74.42 110.199 177.819 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.15 103.91 46.89 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 110.03 -0.359 . . . . 70.32 110.03 -178.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.19 126.31 11.63 Favored 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 122.174 1.916 . . . . 73.42 111.226 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.66 97.26 1.42 Allowed Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 120.872 -0.68 . . . . 64.42 111.468 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -68.13 -37.2 80.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.681 0.753 . . . . 73.44 109.915 178.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.6 m -133.96 140.84 47.01 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.273 -1.38 . . . . 61.43 107.273 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.2 mt -79.05 154.46 29.42 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.167 0.508 . . . . 73.31 111.264 -175.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.46 105.1 11.34 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.94 -0.763 . . . . 74.41 108.94 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.95 91.93 6.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.203 -0.665 . . . . 73.34 109.203 -178.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 m -128.8 117.37 44.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.722 -0.672 . . . . 65.12 111.423 -179.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.8 4.12 63.19 Favored Glycine 0 C--N 1.306 -1.086 0 N-CA-C 109.645 -1.382 . . . . 75.51 109.645 176.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.495 ' CB ' ' HA ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -86.02 108.06 18.06 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 114.716 -0.742 . . . . 72.12 112.549 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.04 129.24 56.87 Favored Pre-proline 0 C--N 1.287 -2.125 0 N-CA-C 103.874 -2.639 . . . . 74.43 103.874 168.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.54 158.26 16.52 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.941 1.76 . . . . 63.11 110.944 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.35 124.18 29.76 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.092 -0.643 . . . . 74.51 109.765 -176.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.72 -110.19 2.48 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 115.961 -0.563 . . . . 64.12 113.552 -176.363 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.16 123.92 33.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.678 0.275 . . . . 72.23 110.422 -172.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.474 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 17.5 t0 -61.84 130.99 48.33 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.777 1.029 . . . . 71.3 113.777 -175.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.87 -23.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.422 -0.808 . . . . 74.4 112.352 -175.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.439 HD22 ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -89.51 -172.43 3.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 119.075 -1.05 . . . . 72.22 112.173 -178.086 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -90.2 137.01 28.03 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 109.304 -0.628 . . . . 74.31 109.304 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.54 -21.92 70.3 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.54 2.16 . . . . 75.3 111.939 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -68.61 -25.15 64.71 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.89 -0.595 . . . . 70.1 111.464 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -73.76 117.39 60.58 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 107.857 -1.164 . . . . 74.01 107.857 177.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.88 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.831 2.354 . . . . 72.15 112.041 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 66' ' ' ILE . 42.0 p -98.86 -162.11 0.93 Allowed 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 115.019 -0.992 . . . . 53.54 109.131 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -109.27 159.33 17.04 Favored 'General case' 0 N--CA 1.391 -3.392 0 N-CA-C 107.723 -1.214 . . . . 71.42 107.723 174.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' O ' HG22 ' A' ' 35' ' ' VAL . 5.2 m-20 -135.11 161.24 35.89 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 103.583 -2.747 . . . . 73.34 103.583 -176.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.66 -54.83 23.38 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 113.742 1.015 . . . . 74.01 113.742 -173.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.2 -34.1 46.75 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 121.47 1.447 . . . . 70.54 111.889 177.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -67.02 -34.98 78.9 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.418 -0.355 . . . . 73.52 110.965 -179.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 31' ' ' ASP . 56.7 t -69.33 -40.8 80.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.16 -0.681 . . . . 73.4 109.16 178.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.3 -35.81 78.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 72.32 109.5 176.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -69.0 -45.32 70.85 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.284 -0.871 . . . . 74.21 110.868 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.28 -45.06 81.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.978 -0.555 . . . . 74.24 111.532 -177.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.8 -12.34 58.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.299 -0.41 . . . . 60.31 111.86 -177.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.67 30.67 74.92 Favored Glycine 0 CA--C 1.505 -0.541 0 CA-C-N 115.914 -0.585 . . . . 75.32 111.965 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.28 155.6 80.69 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.84 -0.43 . . . . 74.24 109.84 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.17 166.81 19.9 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.109 1.873 . . . . 73.1 112.001 177.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -56.3 -37.43 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.806 0.843 . . . . 70.34 110.909 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -57.73 -41.53 82.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.365 -0.834 . . . . 72.34 111.479 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.656 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 45.4 mtpt -70.06 -36.83 75.26 Favored 'General case' 0 C--O 1.2 -1.545 0 C-N-CA 119.268 -0.973 . . . . 75.13 111.266 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.5 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.482 -0.562 . . . . 75.01 109.482 177.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -58.9 -43.37 91.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.693 -0.685 . . . . 74.41 110.247 177.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 3.5 pt20 -70.53 -34.2 72.01 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.522 -0.308 . . . . 75.03 111.499 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.656 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.2 mm100 -57.53 -46.59 83.66 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.3 -1.0 . . . . 64.32 108.3 177.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.1 -43.52 98.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.378 -1.283 . . . . 74.13 109.762 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 19.7 mtp180 -63.44 -26.17 68.61 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.71 0.633 . . . . 71.11 112.71 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.13 7.21 45.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.941 0.401 . . . . 73.33 111.51 -178.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.15 81.65 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.774 -0.648 . . . . 72.42 113.602 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -85.19 -31.51 23.17 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.783 -0.367 . . . . 73.35 111.0 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.61 171.26 18.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.642 -0.874 . . . . 71.12 108.642 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.22 161.6 38.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.536 -0.542 . . . . 72.13 109.536 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.89 161.69 33.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.578 -0.897 . . . . 71.1 108.578 -177.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.77 166.18 29.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 123.511 0.507 . . . . 64.21 110.021 179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 17.7 mtp180 -122.75 142.66 50.47 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.054 0.454 . . . . 75.41 111.846 -178.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.474 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 13.5 ptt180 -149.27 127.21 11.88 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.774 -1.195 . . . . 74.31 107.774 175.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.83 17.88 11.21 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.549 1.14 . . . . 63.24 110.566 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.52 80.79 Favored Glycine 0 C--O 1.22 -0.719 0 CA-C-N 115.509 -0.769 . . . . 74.33 112.023 -177.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -88.4 142.52 17.36 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 111.688 -0.565 . . . . 71.44 111.688 -179.222 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.19 119.7 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.476 -1.305 . . . . 74.34 107.476 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 m -133.67 157.74 42.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 75.44 110.29 -175.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' A' ' 29' ' ' THR . 55.0 mt -128.41 125.18 23.17 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.037 -1.097 . . . . 75.15 108.037 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.45 133.95 55.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.782 2.322 . . . . 71.1 112.59 177.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -48.97 -42.2 36.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.681 1.192 . . . . 74.31 111.477 -177.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.0 m -69.22 -7.18 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 115.351 1.611 . . . . 74.24 115.351 -174.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -78.75 -14.53 59.23 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.243 1.02 . . . . 70.33 109.587 174.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.99 156.75 19.37 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.315 -1.365 . . . . 74.21 107.315 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 66.3 p -86.14 172.54 10.48 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.91 -0.404 . . . . 75.22 109.91 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -68.81 -17.26 63.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.335 0.588 . . . . 63.42 110.241 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 m -88.71 2.98 52.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.234 -0.439 . . . . 54.35 111.072 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 20.1 68.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.98 -0.629 . . . . 71.33 113.294 176.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -111.21 166.26 11.24 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.313 -1.365 . . . . 71.53 107.313 178.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.73 3.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.394 -1.322 . . . . 64.34 107.524 178.123 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.0 t -64.77 137.69 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-O 120.892 0.377 . . . . 71.55 110.679 -178.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -64.71 -40.44 95.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.219 0.533 . . . . 75.14 112.208 -179.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -84.44 -0.35 52.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.318 0.58 . . . . 75.13 110.615 -175.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 60.1 tp -65.53 -54.35 31.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 113.005 0.742 . . . . 73.2 113.005 -178.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.09 -33.26 97.15 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 121.475 1.45 . . . . 73.03 111.158 179.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -44.99 87.88 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.669 -0.696 . . . . 72.3 112.293 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.3 pp -65.66 -40.01 91.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.343 0.592 . . . . 75.1 109.878 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.57 -34.46 77.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.903 -0.589 . . . . 74.13 110.762 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.5 m -70.49 -42.06 71.86 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 116.126 -0.488 . . . . 73.32 111.873 -178.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.06 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.786 0.327 . . . . 73.3 110.732 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' ' 84' ' ' LEU . 4.3 mm? -66.26 -35.1 79.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 122.255 -0.278 . . . . 75.41 111.378 176.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 75.31 110.159 176.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.44 -30.77 68.77 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.319 0.581 . . . . 71.43 110.683 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.94 -9.14 83.1 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.633 -0.712 . . . . 71.3 111.441 178.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.17 47.36 11.15 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.592 -0.304 . . . . 73.23 113.154 177.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.16 129.51 55.49 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 122.673 -0.31 . . . . 74.4 111.049 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.488 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 36.1 ptt180 -74.9 170.78 15.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.709 -0.678 . . . . 72.23 110.676 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -54.41 -44.85 72.73 Favored 'General case' 0 C--O 1.25 1.122 0 C-N-CA 126.552 1.941 . . . . 74.44 111.547 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.1 m -63.93 -41.91 97.5 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.869 -1.06 . . . . 74.14 110.375 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.488 ' HG2' ' CG ' ' A' ' 94' ' ' ARG . 16.4 mm-40 -67.52 -34.04 76.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.071 -0.513 . . . . 75.11 111.148 -178.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.54 -49.45 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 108.578 -0.897 . . . . 75.22 108.578 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.456 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.4 ptp -75.68 -14.85 60.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.077 -0.965 . . . . 75.35 113.055 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.49 -62.18 2.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.636 0.374 . . . . 74.12 110.411 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.471 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.0 p-90 -69.19 -31.84 70.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.603 0.594 . . . . 72.02 112.603 176.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.471 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 12.2 mt -62.34 -40.26 95.81 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.931 1.086 . . . . 73.14 113.931 -179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.439 ' CE2' HD22 ' A' ' 23' ' ' LEU . 33.5 m-85 -85.32 -16.65 39.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.538 0.94 . . . . 74.42 113.538 -177.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.8 p -84.36 124.09 74.15 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 109.338 -0.615 . . . . 75.14 109.338 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -52.68 134.91 55.25 Favored 'Trans proline' 0 C--O 1.249 1.055 0 C-N-CA 122.743 2.295 . . . . 72.24 111.766 178.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.0 t70 -93.35 121.33 65.41 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.868 -0.605 . . . . 73.0 110.255 -177.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.71 -23.62 76.66 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.211 2.608 . . . . 75.41 113.708 -177.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -98.48 0.79 45.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.958 0.408 . . . . 71.31 110.757 -176.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -101.89 124.86 48.24 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.675 0.75 . . . . 72.31 110.744 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.9 m -132.45 116.5 16.87 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.685 -1.598 . . . . 74.51 106.685 175.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.2 pt -139.15 163.22 26.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.16 0.505 . . . . 72.15 112.201 -175.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 t -97.77 130.4 44.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.488 -1.301 . . . . 72.21 107.488 171.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.502 ' HG3' ' OD1' ' A' ' 127' ' ' ASP . 32.7 ttt180 -95.05 154.17 17.3 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.21 -0.663 . . . . 75.42 109.21 -175.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.43 104.55 2.33 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 109.345 -0.613 . . . . 63.43 109.345 178.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.95 1.2 24.04 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.296 -0.866 . . . . 71.42 110.955 -176.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.443 ' HB3' ' OD1' ' A' ' 118' ' ' ASP . 54.9 m -140.55 103.64 4.58 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 123.039 0.536 . . . . 74.32 109.634 178.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -72.27 -17.92 61.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.03 -0.532 . . . . 73.25 111.04 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.443 ' OD1' ' HB3' ' A' ' 116' ' ' SER . 9.6 p-10 -74.51 150.13 39.95 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.143 -0.935 . . . . 74.01 109.725 178.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.48 124.07 32.4 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.088 -0.708 . . . . 74.4 109.088 -178.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.5 t -98.48 118.07 44.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.565 -0.902 . . . . 73.24 108.565 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -90.84 137.45 32.35 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.687 -0.688 . . . . 74.14 109.399 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 57.8 t30 65.63 62.98 0.63 Allowed 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.13 0.894 . . . . 65.41 109.43 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.47 162.14 13.98 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.975 -1.011 . . . . 63.43 109.918 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 127.97 76.35 Favored Pre-proline 0 C--O 1.243 0.743 0 C-N-CA 119.944 -0.702 . . . . 74.55 110.545 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.422 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.6 Cg_exo -52.59 -21.7 15.06 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.025 3.15 . . . . 74.41 114.989 -178.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.529 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.6 t -63.75 -39.83 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.183 -0.607 . . . . 75.34 110.371 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 113' ' ' ARG . 14.2 t70 -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.446 -0.946 . . . . 74.44 108.446 -178.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.65 68.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.91 -1.041 . . . . 55.33 111.122 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.3 pp -64.44 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.981 0.419 . . . . 72.43 110.771 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 7.4 t60 -67.62 -36.49 80.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.584 -0.895 . . . . 75.22 108.584 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.16 9.45 28.34 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 74.14 112.006 -178.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.408 ' C ' ' H ' ' A' ' 134' ' ' ALA . 8.0 t-80 67.5 27.77 7.84 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.882 1.325 . . . . 73.4 111.395 178.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -96.94 23.61 7.02 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.178 -1.786 . . . . 74.12 106.178 173.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 132' ' ' HIS . . . -52.78 -26.76 15.26 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 127.172 2.189 . . . . 73.43 114.643 -173.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.442 ' HD2' ' H ' ' A' ' 135' ' ' ARG . 3.4 mpt_? -55.74 -47.58 76.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.057 0.223 . . . . 74.42 111.254 -174.175 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.451 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 9.8 mm-40 -66.64 -32.39 73.68 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.187 0.439 . . . . 75.32 112.187 176.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.09 -49.29 63.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.353 -0.385 . . . . 71.2 110.158 -177.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.73 -42.45 96.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.909 -0.587 . . . . 75.41 109.597 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.451 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 57.8 ttt180 -59.12 -46.92 87.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.854 -0.612 . . . . 74.55 111.05 178.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.63 -38.31 90.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.898 -0.779 . . . . 71.42 108.898 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.15 -46.64 83.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.684 . . . . 74.4 110.413 178.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.32 -36.59 82.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.847 0.356 . . . . 70.22 111.283 178.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.99 83.91 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.196 0.522 . . . . 75.3 110.58 178.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 tpt -69.8 -45.11 68.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.48 -0.782 . . . . 71.03 111.408 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.34 -31.06 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.017 0.747 . . . . 70.25 113.017 -176.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 C--N 1.312 -1.047 0 C-N-CA 120.621 -0.432 . . . . 73.45 110.539 -178.517 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 107.886 -1.154 . . . . 75.45 107.886 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.93 121.13 9.22 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.411 2.074 . . . . 74.25 112.618 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.79 102.75 1.53 Allowed Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 110.39 -1.084 . . . . 62.45 110.39 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.0 ttm105 -72.98 132.63 43.67 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.823 -0.436 . . . . 72.42 109.823 -179.095 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.87 152.78 49.09 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.077 -0.511 . . . . 71.5 111.085 -174.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -87.45 85.22 0.79 Allowed 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 122.626 2.218 . . . . 71.14 111.601 176.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.98 93.73 1.78 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.257 -1.137 . . . . 75.23 110.257 177.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.3 t -123.98 166.55 15.52 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.925 -0.768 . . . . 74.02 108.925 -178.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -73.46 136.85 44.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 122.984 0.514 . . . . 75.54 110.143 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.8 -175.6 5.85 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.717 -0.475 . . . . 72.23 109.717 177.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 123.03 18.35 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.882 -0.414 . . . . 75.11 109.882 178.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -77.68 115.33 17.35 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 115.878 -0.601 . . . . 75.4 111.246 -175.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.8 m -112.81 96.68 4.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 122.047 0.927 . . . . 73.31 110.091 174.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.61 -50.85 4.54 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.643 -1.383 . . . . 70.45 109.643 177.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t 174.24 163.89 0.2 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.138 -1.43 . . . . 73.45 107.138 174.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.24 120.87 43.16 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 106.337 -1.727 . . . . 74.33 106.337 176.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.1 144.36 37.57 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.118 1.878 . . . . 73.05 110.746 178.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.88 128.14 34.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.836 -0.431 . . . . 73.12 109.836 -178.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.98 -112.13 2.89 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.907 -0.663 . . . . 63.42 112.878 -178.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -95.1 128.05 41.63 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.702 0.286 . . . . 73.31 110.797 -174.335 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -70.2 138.73 52.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.311 -0.858 . . . . 73.14 111.441 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.16 -11.35 8.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.232 -0.895 . . . . 72.54 109.811 -176.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.96 -169.82 2.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.799 0.809 . . . . 70.15 109.539 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -105.75 138.29 19.58 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 105.837 -1.912 . . . . 74.41 105.837 169.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.68 -26.04 16.35 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.978 2.452 . . . . 72.43 115.042 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.74 -3.8 58.94 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.206 0.447 . . . . 74.12 112.206 -177.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -74.61 145.57 82.22 Favored Pre-proline 0 C--O 1.25 1.126 0 O-C-N 121.552 -0.717 . . . . 72.21 110.941 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.42 ' HB2' ' HG3' ' A' ' 68' ' ' GLN . 12.2 Cg_endo -54.65 123.72 14.39 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.214 2.61 . . . . 74.14 111.524 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -140.47 168.93 18.64 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.568 -0.742 . . . . 72.13 111.812 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 36.4 m-85 -109.77 160.38 16.38 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 125.377 1.471 . . . . 75.34 109.325 176.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -135.73 161.13 36.42 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.229 -2.878 . . . . 53.31 103.229 178.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.25 -52.25 70.52 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 113.804 1.039 . . . . 73.4 113.804 -173.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.08 -36.06 96.93 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.826 1.684 . . . . 73.43 112.66 176.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.85 -37.86 85.27 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.883 -0.414 . . . . 74.44 109.883 177.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.75 -40.97 79.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.18 -0.464 . . . . 72.21 110.354 176.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.43 -43.36 83.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.29 -0.868 . . . . 70.23 109.076 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.09 -45.29 92.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.361 -1.291 . . . . 75.31 110.254 178.003 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.6 -40.75 96.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.965 -1.016 . . . . 74.44 111.49 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.76 -18.31 22.21 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.408 -0.36 . . . . 74.02 111.437 -177.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.37 62.08 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.395 -0.682 . . . . 54.41 111.395 -178.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.38 161.89 24.94 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 108.941 -0.763 . . . . 72.31 108.941 -177.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.54 155.81 67.73 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 121.703 1.602 . . . . 75.54 111.963 174.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.72 -35.46 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.375 0.67 . . . . 71.13 109.686 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.444 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 23.3 t -59.58 -38.52 81.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.518 -0.765 . . . . 73.03 110.33 178.243 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 52.4 mttp -69.15 -32.78 72.36 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.932 -0.48 . . . . 75.04 111.94 177.106 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.53 -42.8 97.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.814 -0.81 . . . . 74.42 108.814 174.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.77 83.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.727 -0.67 . . . . 74.33 110.278 176.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 44' ' ' SER . 16.3 mm100 -66.89 -36.05 81.41 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.992 -0.549 . . . . 75.11 110.978 177.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.6 mt-30 -61.55 -43.29 99.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.456 0.646 . . . . 74.23 109.697 176.155 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.8 -34.69 76.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.448 -1.251 . . . . 72.24 110.473 176.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -71.66 -32.89 68.37 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.541 -0.754 . . . . 73.55 112.748 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -92.04 -11.75 35.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.13 0.49 . . . . 74.13 112.225 -176.027 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.27 35.99 28.45 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.929 -1.129 . . . . 75.35 110.716 -177.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -92.82 -27.42 17.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.113 -1.069 . . . . 73.12 108.113 176.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.6 tp -147.92 152.57 37.78 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.847 -1.538 . . . . 75.53 106.847 -175.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.07 154.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 108.766 -0.827 . . . . 70.24 108.766 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.6 162.02 33.89 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 123.306 0.379 . . . . 75.33 110.264 -174.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.1 m -132.03 166.67 28.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 123.883 0.873 . . . . 71.13 109.471 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 83.3 mtm180 -110.95 131.29 55.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.886 0.699 . . . . 75.44 112.886 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 33.0 ptt180 -116.12 116.07 27.18 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 106.901 -1.518 . . . . 74.13 106.901 176.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.66 14.16 6.94 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.667 0.746 . . . . 62.32 111.019 -177.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.09 -20.89 34.78 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.821 -0.627 . . . . 70.43 112.697 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -78.57 145.7 29.29 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 110.585 -1.006 . . . . 60.22 110.585 -179.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.2 t -95.97 120.23 45.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.962 -0.755 . . . . 73.53 108.962 -175.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.23 163.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.643 -0.708 . . . . 74.21 111.51 -177.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -128.97 125.2 22.79 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.967 -1.123 . . . . 72.13 107.967 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.1 139.24 85.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.575 2.183 . . . . 73.24 113.235 178.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.467 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 73.8 mm-40 -48.72 -34.88 12.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.271 1.028 . . . . 71.44 112.485 177.011 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.13 -3.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 113.883 1.068 . . . . 71.42 113.883 -174.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.51 ' CD2' HD12 ' A' ' 81' ' ' LEU . 8.0 m-85 -86.68 -5.84 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.066 0.936 . . . . 75.14 110.141 175.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -134.42 164.5 27.29 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.799 -1.091 . . . . 74.13 108.104 178.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.6 p -94.6 158.46 15.52 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.204 -1.406 . . . . 64.31 107.204 176.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.78 -15.79 63.19 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.208 0.528 . . . . 74.31 110.647 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.7 m -79.05 -5.56 54.27 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.563 -0.744 . . . . 74.13 111.71 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.24 -7.41 40.41 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 119.641 -1.266 . . . . 71.35 114.312 174.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -106.05 162.86 13.24 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.681 -0.808 . . . . 71.33 110.238 179.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.79 156.19 5.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 106.86 -1.533 . . . . 73.23 106.86 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.92 125.07 22.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.427 -0.953 . . . . 75.44 108.427 177.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HZ2' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -61.95 -22.21 65.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.93 1.085 . . . . 74.25 113.93 -173.938 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 t -103.41 11.81 36.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.887 0.375 . . . . 73.14 110.203 -179.063 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.51 HD12 ' CD2' ' A' ' 70' ' ' PHE . 12.9 tp -63.41 -51.47 67.55 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 119.305 -0.378 . . . . 75.24 111.762 -178.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 31.4 Cg_exo -61.68 -29.59 83.98 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 121.363 1.376 . . . . 64.05 111.78 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.49 -45.04 97.01 Favored Glycine 0 C--O 1.24 0.489 0 O-C-N 123.377 0.423 . . . . 72.5 113.082 -178.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -68.4 -40.36 81.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.316 0.579 . . . . 71.34 109.463 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.412 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 96.4 mt -64.02 -42.47 97.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.504 -0.771 . . . . 74.43 111.233 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.0 m -57.54 -46.87 83.36 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 112.044 0.387 . . . . 73.33 112.044 -177.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -41.96 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.013 0.435 . . . . 73.11 110.83 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.8 mt -67.08 -35.86 80.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.359 0.503 . . . . 75.31 112.359 179.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 85' ' ' LEU . 58.3 m170 -65.23 -33.2 75.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.553 -0.294 . . . . 73.35 110.73 177.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.59 -31.64 72.86 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.357 0.411 . . . . 74.35 110.332 178.248 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.04 -3.2 68.09 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.768 -0.651 . . . . 70.42 112.281 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.49 42.69 55.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 121.502 -0.38 . . . . 74.21 112.903 179.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 56.0 m-85 -93.26 130.61 38.92 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.453 -0.439 . . . . 75.02 111.962 178.528 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.7 ptp180 -81.1 171.77 14.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.09 -0.959 . . . . 72.15 111.459 -176.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.33 -45.96 72.79 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.725 1.61 . . . . 73.23 112.551 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.4 m -61.65 -40.99 96.88 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.414 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -65.94 -39.39 90.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.446 -0.343 . . . . 73.51 111.587 179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.4 mm -61.1 -49.48 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.749 -0.834 . . . . 74.3 108.749 -177.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.5 mtt -76.1 -18.53 59.14 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.738 -1.119 . . . . 75.23 112.336 -177.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -56.81 -67.26 0.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.378 0.671 . . . . 74.32 110.935 -175.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.564 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 52.7 p-90 -68.9 -32.75 72.61 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.363 0.505 . . . . 75.24 112.363 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.564 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.4 mt -60.35 -40.13 89.59 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.201 0.815 . . . . 74.21 113.201 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.19 -0.5 55.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.083 0.771 . . . . 74.45 113.083 -178.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.2 m -87.51 120.32 71.08 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.367 -0.605 . . . . 75.44 109.367 178.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.28 129.75 21.06 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.227 1.951 . . . . 74.4 110.751 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.6 t70 -102.5 124.16 40.29 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 120.264 -0.575 . . . . 62.21 109.519 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.35 -23.92 76.01 Favored 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.603 2.869 . . . . 71.4 113.556 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -104.44 10.27 35.32 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.429 0.633 . . . . 72.44 110.966 -177.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 50.1 tp -103.84 123.16 46.6 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.585 -0.894 . . . . 75.14 108.585 174.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.0 m -131.2 111.34 11.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.665 -1.235 . . . . 73.34 107.665 179.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.15 145.8 34.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.792 0.664 . . . . 73.13 112.792 -172.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.0 t -89.42 152.63 21.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.688 -1.227 . . . . 74.2 107.688 177.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -141.58 136.12 30.74 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.367 -0.975 . . . . 74.35 108.367 -173.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.19 129.46 31.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.373 0.669 . . . . 73.3 112.391 -177.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.41 -23.33 6.43 Favored Glycine 0 C--N 1.307 -1.035 0 N-CA-C 110.0 -1.24 . . . . 74.45 110.0 -177.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 m -152.55 150.4 29.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.275 -1.38 . . . . 75.42 107.275 178.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -9.07 53.39 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.381 -0.927 . . . . 75.53 111.318 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.04 151.09 38.74 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.858 -1.064 . . . . 74.31 110.936 -179.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -102.45 146.63 27.82 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.561 -0.745 . . . . 75.43 111.267 -178.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.92 121.3 53.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.799 -1.186 . . . . 72.45 107.799 177.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 t -90.58 148.26 22.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.957 -1.127 . . . . 54.32 107.957 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.9 t30 65.26 63.58 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.439 1.114 . . . . 71.24 108.923 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.71 164.71 18.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.686 -1.143 . . . . 72.31 109.728 -178.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 36.7 ptt180 -87.34 142.94 33.69 Favored Pre-proline 0 C--N 1.299 -1.62 0 CA-C-N 115.863 -0.608 . . . . 75.52 109.756 179.005 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -57.16 -18.34 29.09 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.264 2.642 . . . . 54.53 114.336 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 97.8 t -60.62 -41.96 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.237 0.542 . . . . 74.02 110.351 178.087 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.36 -32.54 73.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.88 -0.6 . . . . 70.42 111.224 -179.18 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.1 74.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 61.45 110.176 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 126' ' ' VAL . 17.0 tp -60.1 -43.65 95.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.478 0.711 . . . . 74.21 112.246 -177.067 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -71.84 -15.67 62.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.55 0.691 . . . . 75.53 110.697 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -101.58 13.38 35.14 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.289 -0.869 . . . . 72.14 111.373 -175.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 65.93 27.32 10.86 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 123.122 1.439 . . . . 63.44 110.225 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -106.29 23.49 14.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.079 -1.452 . . . . 73.53 107.079 176.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.84 17.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.317 -2.22 . . . . 74.04 111.868 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -56.18 -39.19 72.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.288 -0.415 . . . . 73.33 111.405 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.4 mm-40 -69.27 -33.68 73.6 Favored 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 120.77 -0.372 . . . . 73.23 110.887 175.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 129' ' ' LEU . 60.0 t -62.19 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.872 -0.788 . . . . 75.12 108.872 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 66.1 t -61.58 -49.11 85.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 115.673 -0.694 . . . . 75.14 109.41 176.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.411 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 0.7 OUTLIER -57.86 -41.8 83.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.076 -0.511 . . . . 73.33 111.452 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 16.6 mmt180 -68.42 -37.78 80.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.978 -0.378 . . . . 75.55 109.978 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.86 96.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.471 . . . . 71.22 110.228 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 91.3 mt-30 -58.52 -49.16 78.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.469 0.708 . . . . 72.22 110.016 178.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.12 71.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.568 -0.742 . . . . 74.32 111.774 -178.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 96.6 mmm -84.6 -36.8 21.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.568 -0.453 . . . . 64.15 111.208 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.582 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -77.44 -42.82 34.61 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.291 0.848 . . . . 64.53 113.291 -176.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 119.164 -0.446 . . . . 73.23 110.507 -175.86 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 108.007 -1.108 . . . . 73.42 108.007 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.96 99.69 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.466 1.444 . . . . 73.25 110.935 175.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.42 55.91 0.19 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 119.722 -1.228 . . . . 64.03 112.705 -179.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.79 144.11 45.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.007 -0.738 . . . . 75.33 109.007 175.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.12 128.23 5.85 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 110.489 -0.189 . . . . 75.32 110.489 -179.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.74 106.78 2.33 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.595 1.53 . . . . 74.32 108.907 172.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.19 -148.32 11.62 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 120.73 -0.748 . . . . 74.31 113.851 -175.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 m -60.62 119.82 8.83 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.116 0.966 . . . . 64.11 112.594 -175.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.7 m -119.77 146.49 45.62 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.864 -1.532 . . . . 73.04 106.864 178.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.0 mt -81.12 151.16 28.42 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.952 0.723 . . . . 74.42 112.952 -175.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.9 146.87 52.45 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.283 -1.006 . . . . 74.45 108.283 177.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.43 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -153.82 133.95 13.28 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.825 0.345 . . . . 74.43 111.013 -177.344 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.4 p -155.82 99.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.208 1.004 . . . . 72.33 109.657 175.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.09 -85.62 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.082 -0.963 . . . . 74.32 112.025 -178.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.2 p -71.09 117.01 12.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.328 0.492 . . . . 63.5 112.328 -176.531 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.68 122.08 73.21 Favored Pre-proline 0 N--CA 1.443 -0.806 0 N-CA-C 108.037 -1.098 . . . . 71.0 108.037 178.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -69.35 158.81 56.11 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 121.947 1.764 . . . . 75.52 110.016 174.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.62 135.87 33.18 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 110.382 -0.229 . . . . 75.32 110.382 -177.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.14 -96.95 2.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 121.34 -0.457 . . . . 73.11 113.912 -177.268 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.97 131.99 51.78 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.212 0.529 . . . . 75.32 111.757 -175.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.03 94.36 2.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.294 -0.866 . . . . 55.3 110.329 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.57 -45.96 96.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.875 -1.057 . . . . 72.1 111.035 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.88 150.97 46.21 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.444 0.64 . . . . 75.33 112.583 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.81 151.16 93.21 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.181 -0.918 . . . . 73.4 109.058 178.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.75 -25.51 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.771 2.314 . . . . 74.21 112.826 178.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.66 -28.4 66.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.895 -0.322 . . . . 73.44 110.899 178.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.53 118.16 65.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 106.993 -1.484 . . . . 73.1 106.993 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.84 147.46 89.48 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 122.474 2.116 . . . . 72.34 113.917 -173.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -129.93 172.73 11.4 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.683 -0.69 . . . . 53.55 112.155 -177.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 10.6 m-85 -117.33 160.68 20.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 126.597 1.959 . . . . 74.1 108.184 173.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -133.19 163.75 28.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.31 -2.107 . . . . 74.51 105.31 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -42.35 -54.84 7.39 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.426 1.639 . . . . 73.15 115.426 -174.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.99 -41.1 65.03 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.074 1.849 . . . . 75.32 113.006 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -71.45 -34.8 70.57 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.986 0.422 . . . . 74.11 110.688 -178.654 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.15 -41.34 81.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.349 0.595 . . . . 64.15 109.547 177.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -60.2 -36.08 76.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.857 -1.065 . . . . 65.33 109.766 176.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 38.0 tt0 -64.12 -45.06 90.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.569 1.148 . . . . 74.31 110.493 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 30' ' ' TYR . 97.0 mt -60.9 -45.6 93.98 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.476 -0.784 . . . . 75.14 111.19 -178.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 84.8 mt -84.98 -18.35 34.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.209 -0.905 . . . . 73.14 111.395 -176.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.05 69.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 111.35 -0.7 . . . . 73.32 111.35 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.408 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 28.4 m -129.24 158.78 71.97 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.583 -0.525 . . . . 74.43 109.583 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.46 160.89 40.66 Favored 'Trans proline' 0 C--O 1.256 1.42 0 C-N-CA 122.225 1.95 . . . . 75.12 112.136 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.09 -33.02 49.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 123.923 0.889 . . . . 65.14 111.752 -177.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.4 p -60.1 -40.22 88.87 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.225 -0.443 . . . . 70.03 111.226 178.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.75 -32.52 71.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.89 0.376 . . . . 73.15 111.384 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.8 t -64.5 -40.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.962 -0.755 . . . . 75.05 108.962 174.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -61.82 -36.06 80.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.455 -0.793 . . . . 74.43 110.382 176.118 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 44' ' ' SER . 25.5 mt-30 -61.67 -39.32 90.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.348 -0.387 . . . . 74.31 110.342 178.452 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -58.66 -46.21 87.68 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.812 -0.81 . . . . 73.13 108.812 177.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.23 -39.81 94.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.928 -1.033 . . . . 75.0 110.638 179.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 89.1 mtt180 -68.71 -26.9 65.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.203 -0.453 . . . . 73.23 111.921 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.95 -8.19 37.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.587 -0.278 . . . . 74.53 111.398 -176.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.47 25.73 45.95 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.555 -0.831 . . . . 41.34 111.883 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -96.55 -5.54 39.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.486 -0.191 . . . . 74.41 110.486 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 tp -163.12 153.94 16.68 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.223 -1.029 . . . . 74.41 108.223 -176.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 161.42 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.471 -1.307 . . . . 74.52 107.471 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.31 162.66 35.86 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.915 -0.402 . . . . 75.34 109.915 -175.218 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.04 164.86 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 O-C-N 123.79 0.681 . . . . 71.21 109.709 177.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 32.9 ttp180 -110.83 132.38 54.25 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 116.222 -0.444 . . . . 70.1 110.48 -174.599 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -136.29 124.4 23.0 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.614 -0.513 . . . . 73.01 109.614 175.888 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.84 30.57 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.945 0.898 . . . . 72.2 112.127 176.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.05 -4.33 71.06 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.821 -0.627 . . . . 75.43 113.342 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -107.57 146.35 16.22 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 121.127 -0.559 . . . . 62.41 112.816 -178.178 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.15 120.85 47.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.361 -1.348 . . . . 70.45 107.361 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.79 159.93 41.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.878 -0.601 . . . . 71.23 111.124 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 56.0 mt -124.32 128.39 25.02 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.217 -1.031 . . . . 74.24 108.217 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.14 138.62 86.2 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.62 2.213 . . . . 74.21 113.099 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.55 -35.58 53.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.333 1.053 . . . . 74.22 111.712 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -69.01 -9.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.898 -1.046 . . . . 74.2 113.641 -175.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.457 ' CZ ' ' HE3' ' A' ' 99' ' ' MET . 7.0 m-85 -80.23 -15.72 56.37 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.745 0.783 . . . . 74.04 110.345 176.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -111.79 162.35 15.35 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 115.167 -0.924 . . . . 75.02 109.528 -178.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 p -85.87 165.78 16.54 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.353 -1.351 . . . . 74.42 107.353 175.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.82 -21.57 66.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.891 0.853 . . . . 74.4 109.506 177.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m -80.23 -1.89 42.57 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 115.108 -0.951 . . . . 55.41 112.092 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.47 -16.91 59.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.391 -0.909 . . . . 72.44 114.941 173.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -92.16 164.87 13.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.178 0.989 . . . . 73.34 109.612 179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.84 155.71 3.7 Favored 'Isoleucine or valine' 0 C--O 1.258 1.546 0 N-CA-C 108.34 -0.985 . . . . 62.15 108.34 -179.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.6 t -65.97 126.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.041 -0.725 . . . . 72.12 109.041 178.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HB2' ' HZ2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -61.34 -26.6 67.92 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.626 0.602 . . . . 71.25 112.626 -178.231 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.6 m -84.33 -0.56 52.99 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.884 -0.598 . . . . 73.2 111.899 -179.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 57.1 tp -60.79 -55.1 48.1 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 113.01 0.745 . . . . 73.1 113.01 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 12.0 Cg_endo -58.29 -28.98 86.47 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.087 1.858 . . . . 75.4 112.594 -178.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.29 96.37 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.057 -0.592 . . . . 73.54 111.941 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 75.12 110.308 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.4 -42.72 95.95 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.576 -0.738 . . . . 72.51 111.845 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -62.49 -45.43 93.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.136 -0.484 . . . . 75.31 112.205 -176.325 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -43.29 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.829 -0.349 . . . . 73.13 110.687 -179.15 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.61 -35.8 79.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.395 0.517 . . . . 73.15 112.395 176.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -62.29 -42.45 99.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.677 -0.49 . . . . 74.25 109.677 179.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.18 -30.51 71.56 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.859 -0.609 . . . . 73.12 110.723 176.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.26 -9.29 85.23 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.479 -0.782 . . . . 73.42 112.104 177.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.37 23.1 55.3 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.577 -0.344 . . . . 74.44 113.837 177.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -87.47 129.6 35.0 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.163 0.506 . . . . 75.14 111.539 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.426 ' O ' HG12 ' A' ' 98' ' ' ILE . 16.6 ptp180 -78.49 172.67 13.32 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.006 0.922 . . . . 75.32 110.897 -177.049 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -53.64 -45.08 70.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.583 1.553 . . . . 73.12 111.035 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.594 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 31.2 m -63.46 -42.12 98.62 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.121 -0.945 . . . . 74.33 110.269 -179.405 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.403 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 41.8 mt-10 -65.41 -39.91 92.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.983 -0.553 . . . . 63.41 110.27 -177.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 94' ' ' ARG . 21.5 mm -61.35 -48.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.773 0.796 . . . . 74.41 109.575 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.457 ' HE3' ' CZ ' ' A' ' 70' ' ' PHE . 51.9 mtt -74.58 -15.98 60.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 113.55 0.945 . . . . 74.45 113.55 -175.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.594 ' HG3' ' O ' ' A' ' 96' ' ' THR . 84.2 mtt180 -55.77 -65.26 0.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.935 0.398 . . . . 74.0 111.028 178.724 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.475 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.7 p-90 -68.68 -32.03 71.56 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.707 0.632 . . . . 72.34 112.707 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.475 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 15.7 mt -62.3 -40.84 97.6 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.516 0.932 . . . . 75.34 113.516 -179.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -92.91 -16.03 25.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.554 0.576 . . . . 73.41 112.554 -177.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.0 m -87.32 124.09 68.74 Favored Pre-proline 0 C--N 1.296 -1.761 0 N-CA-C 109.31 -0.626 . . . . 75.31 109.31 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.3 Cg_exo -54.13 129.64 35.46 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.823 2.349 . . . . 64.44 111.938 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 8.9 t70 -80.5 126.26 78.96 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 108.209 -1.034 . . . . 74.13 108.209 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 24.9 Cg_endo -60.52 -20.39 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.039 2.493 . . . . 74.24 114.401 -176.523 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.7 m -115.98 4.8 13.83 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.953 -0.467 . . . . 71.33 111.887 -176.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 39.9 tp -102.34 119.83 39.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.023 0.916 . . . . 74.2 111.812 -176.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.2 m -120.11 131.1 54.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.699 -1.593 . . . . 75.44 106.699 178.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.5 pt -115.68 155.69 16.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 120.265 -0.574 . . . . 75.14 112.301 -177.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.7 p -89.32 159.23 17.48 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.406 -1.27 . . . . 74.44 112.629 -172.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.427 ' HG2' ' N ' ' A' ' 114' ' ' ASP . 56.2 ttp180 -68.6 171.65 7.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.548 1.139 . . . . 74.41 109.007 179.252 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' N ' ' HG2' ' A' ' 113' ' ' ARG . 17.5 m-20 74.81 14.02 3.37 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 122.436 1.112 . . . . 73.02 110.746 176.639 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.75 -40.87 0.04 OUTLIER Glycine 0 C--N 1.291 -1.918 0 N-CA-C 107.173 -2.371 . . . . 61.01 107.173 177.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 p -113.76 -177.06 3.04 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 106.9 -1.519 . . . . 74.11 106.9 172.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -26.75 66.22 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.089 1.144 . . . . 74.14 114.089 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -175.34 -172.95 0.61 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.413 -2.81 . . . . 72.25 103.413 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.83 123.94 23.15 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 119.588 1.086 . . . . 63.42 108.382 178.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.76 118.58 58.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.874 -0.417 . . . . 75.2 109.874 -176.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.5 m -88.93 140.08 29.8 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.81 -1.552 . . . . 74.13 106.81 176.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 44.9 m-80 63.29 55.92 1.78 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.847 0.832 . . . . 71.53 109.566 -175.489 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.8 144.83 28.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.405 -0.816 . . . . 61.21 110.548 179.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -76.94 139.44 65.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 107.174 -1.417 . . . . 73.45 107.174 174.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.424 ' HB2' HD21 ' A' ' 102' ' ' LEU . 95.8 Cg_exo -49.55 -30.46 21.61 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.376 2.717 . . . . 75.31 114.403 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.563 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.3 t -60.78 -43.25 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.443 0.639 . . . . 72.22 110.782 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.34 -31.02 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 73.24 110.783 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.71 76.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.887 -0.597 . . . . 54.0 111.45 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.81 -35.77 80.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.719 0.295 . . . . 75.0 111.01 -179.679 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -72.32 -24.66 61.34 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.86 0.838 . . . . 74.31 109.048 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -93.21 21.4 5.99 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.116 -0.947 . . . . 74.34 111.568 -179.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.73 27.29 16.04 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.148 1.379 . . . . 73.43 112.15 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -115.0 23.73 12.3 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.408 1.099 . . . . 72.43 109.236 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.37 -27.17 22.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.041 -1.89 . . . . 74.45 111.682 177.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -54.75 -46.89 74.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.016 0.526 . . . . 74.02 109.687 178.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 47.2 mm-40 -71.83 -29.2 64.15 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.239 -0.437 . . . . 73.24 111.464 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.18 -47.74 72.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.301 -0.409 . . . . 73.12 110.354 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.529 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.8 t -63.92 -42.66 96.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.303 -0.629 . . . . 73.53 109.303 177.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -58.67 -44.3 90.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.435 0.694 . . . . 73.15 109.942 178.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 2.4 tpp85 -64.92 -38.2 90.19 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.117 -0.947 . . . . 74.05 109.213 -178.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.15 83.82 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.655 0.782 . . . . 73.45 110.564 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -60.48 -49.94 75.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.935 -0.575 . . . . 72.44 109.822 178.768 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 -17.54 63.47 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.86 -1.064 . . . . 62.41 111.957 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.7 tpp -82.27 -40.59 21.33 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.025 0.441 . . . . 74.33 110.035 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.53 -48.74 8.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 62.32 111.716 -177.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 118.085 -0.959 . . . . 71.3 109.615 -177.354 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 107.733 -1.21 . . . . 71.23 107.733 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.7 155.66 67.96 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.055 1.837 . . . . 64.3 111.998 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.87 113.46 0.57 Allowed Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 108.389 -1.884 . . . . 62.12 108.389 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.0 mtp180 -71.93 142.86 49.45 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 120.953 0.406 . . . . 74.44 111.952 -176.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.35 103.45 9.66 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 106.833 -1.543 . . . . 71.34 106.833 173.754 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 4' ' ' ARG . 17.1 Cg_exo -68.19 132.86 27.03 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.628 2.219 . . . . 73.23 112.151 -176.304 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.84 -116.51 1.23 Allowed Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.247 -1.141 . . . . 74.42 110.247 178.104 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 t -156.73 160.76 39.6 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.854 -1.906 . . . . 74.13 105.854 176.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -66.55 126.88 30.29 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.299 -1.0 . . . . 75.44 108.299 177.017 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.76 148.47 46.69 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.662 0.744 . . . . 73.1 112.624 -176.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.62 129.71 34.75 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.502 -1.295 . . . . 72.2 107.502 177.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -113.86 138.12 50.73 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 120.924 0.392 . . . . 72.5 109.955 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.97 128.11 68.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 115.069 -0.969 . . . . 74.11 109.348 178.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.43 97.91 1.45 Allowed Glycine 0 C--N 1.284 -2.306 0 CA-C-N 115.049 -0.978 . . . . 63.44 114.22 -174.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 p -102.51 154.23 19.31 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.425 -1.324 . . . . 75.31 107.425 172.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 mm -86.94 120.82 71.77 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 119.464 -0.894 . . . . 70.4 110.941 -175.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -76.71 165.39 28.82 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.542 2.161 . . . . 74.22 110.632 173.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . -85.88 137.09 33.0 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.508 -0.553 . . . . 60.32 109.508 177.362 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.23 -137.43 7.34 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.595 -0.812 . . . . 75.22 114.369 -177.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -97.51 123.39 41.36 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.418 0.687 . . . . 70.54 111.812 -173.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -70.45 126.07 28.6 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.078 -0.965 . . . . 73.31 109.633 -178.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.6 t -100.36 -19.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.813 -0.631 . . . . 75.13 111.584 -175.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.434 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -98.68 176.0 5.79 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.602 -0.839 . . . . 73.34 111.8 -177.867 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -82.8 151.36 64.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.901 -0.407 . . . . 71.53 109.901 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 60' ' ' ARG . 32.5 Cg_exo -61.86 -22.11 73.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.596 2.197 . . . . 75.05 112.383 178.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -84.05 -8.28 59.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 64.11 110.72 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -76.37 154.94 84.09 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.533 -0.543 . . . . 74.31 109.533 177.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 28.3 Cg_endo -58.82 111.2 0.82 Allowed 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 122.877 2.385 . . . . 70.31 112.814 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -133.32 167.49 20.3 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.801 -0.636 . . . . 74.42 111.497 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 19.8 m-85 -128.66 161.69 29.09 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 125.08 1.352 . . . . 75.2 108.774 178.33 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' O ' HG21 ' A' ' 35' ' ' VAL . 3.8 m-20 -133.9 161.01 35.95 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 104.365 -2.457 . . . . 73.43 104.365 -174.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.4 mt -47.08 -56.66 11.35 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.84 1.052 . . . . 73.4 113.84 -174.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.56 -29.68 43.92 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 121.242 1.295 . . . . 75.51 112.195 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -70.84 -37.83 73.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.8 0.334 . . . . 75.24 110.534 -178.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 31' ' ' ASP . 47.3 t -69.11 -40.83 81.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.79 -0.819 . . . . 74.54 108.79 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.49 81.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.909 -1.042 . . . . 54.13 109.46 177.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.36 -45.54 72.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.026 -0.988 . . . . 73.13 110.103 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.21 -50.66 69.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.254 -0.884 . . . . 72.33 111.437 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.5 mt -84.07 -16.93 41.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.829 -0.623 . . . . 75.11 112.653 -175.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.84 62.41 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.303 -0.951 . . . . 70.22 110.756 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.99 160.83 57.26 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 107.754 -1.202 . . . . 73.53 107.754 -178.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.89 159.38 52.75 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 121.738 1.625 . . . . 61.12 111.563 176.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.04 -32.84 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.751 -0.833 . . . . 73.35 108.751 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 8.6 m -57.16 -41.35 79.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.644 -1.162 . . . . 73.52 110.73 177.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 57.3 tttm -70.11 -36.25 74.71 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.283 0.563 . . . . 75.22 109.521 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.83 -40.9 90.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.753 0.787 . . . . 73.35 109.096 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.49 80.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.952 -1.022 . . . . 74.05 110.652 177.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 44' ' ' SER . 80.3 mm-40 -61.24 -41.24 96.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.252 -0.647 . . . . 73.53 109.252 178.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.9 mm-40 -58.98 -47.23 85.91 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.477 -0.783 . . . . 75.15 109.142 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -63.92 -34.06 77.1 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.252 -0.886 . . . . 61.42 110.853 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -67.2 -34.47 77.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.963 176.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 19.6 mm-40 -88.21 -11.73 45.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 74.54 110.432 -176.634 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.95 28.52 49.94 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.662 -0.975 . . . . 73.51 110.662 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -88.98 -10.55 47.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.669 -0.863 . . . . 72.34 108.669 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.5 tp -158.3 158.09 33.71 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.339 -1.726 . . . . 74.23 106.339 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.87 155.48 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.723 -0.843 . . . . 75.54 108.723 177.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -126.54 157.43 38.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.938 -0.764 . . . . 55.21 108.938 -176.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.75 164.44 34.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.671 -0.492 . . . . 72.34 109.671 178.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -122.34 122.35 38.85 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 110.008 -0.368 . . . . 73.33 110.008 -176.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.454 ' C ' ' H ' ' A' ' 62' ' ' GLY . 5.8 ptp180 -117.06 113.73 22.74 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-N 115.926 -0.579 . . . . 75.2 109.477 177.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.68 -40.8 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.372 1.869 . . . . 74.31 112.012 178.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . 174.18 -13.03 0.04 OUTLIER Glycine 0 C--N 1.29 -2.011 0 CA-C-N 114.949 -1.023 . . . . 70.21 111.969 -177.246 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.62 145.35 17.7 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.855 -0.688 . . . . 63.34 111.921 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.8 120.92 46.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.581 -1.266 . . . . 70.31 107.581 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.46 164.94 33.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.04 -0.982 . . . . 70.52 110.708 -174.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.32 132.31 24.25 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 107.404 -1.332 . . . . 74.43 107.404 -179.02 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.1 119.45 6.47 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 121.685 1.59 . . . . 74.34 111.029 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.0 tt0 -62.99 -25.01 68.18 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.547 0.739 . . . . 74.41 112.091 -177.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.0 m -65.27 -9.64 7.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.482 -0.781 . . . . 72.32 112.605 177.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' A' ' 81' ' ' LEU . 3.8 m-85 -81.55 -6.16 58.7 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.743 0.782 . . . . 75.24 110.159 175.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -110.86 154.35 24.14 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.163 -0.926 . . . . 72.31 108.991 179.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.1 p -76.83 175.96 8.98 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 123.659 0.784 . . . . 73.34 110.573 179.091 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -56.31 -31.86 64.08 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.466 0.707 . . . . 74.14 110.214 174.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 m -80.17 -2.58 45.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.626 -0.716 . . . . 72.42 111.74 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.53 32.46 59.61 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.103 -0.57 . . . . 61.22 111.977 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -115.7 157.78 23.76 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.343 -0.614 . . . . 75.51 109.343 177.47 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.9 t -66.23 130.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.226 -0.657 . . . . 74.43 109.226 175.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.16 132.34 28.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.432 -0.951 . . . . 75.03 108.432 178.303 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -57.63 -27.51 62.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.903 0.705 . . . . 72.51 112.903 -178.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.5 m -89.19 -2.61 58.57 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.049 -0.523 . . . . 60.05 111.273 -179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 70' ' ' PHE . 46.0 tp -61.67 -56.99 27.59 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 119.041 -0.504 . . . . 75.24 111.794 -177.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.24 -38.67 94.64 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.437 1.425 . . . . 75.21 110.795 177.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.87 97.11 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.757 -0.656 . . . . 70.12 112.796 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.42 -41.27 80.61 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 117.212 0.506 . . . . 74.41 109.719 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.74 -35.59 81.06 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 116.026 -0.534 . . . . 72.42 110.754 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.6 m -67.24 -41.28 85.89 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 112.075 0.398 . . . . 73.5 112.075 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.02 -40.27 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 120.143 -0.623 . . . . 75.23 110.473 178.58 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 3.3 mm? -67.61 -36.07 80.15 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.623 -0.673 . . . . 73.34 112.285 175.05 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -63.54 -33.03 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.426 -0.583 . . . . 74.41 109.426 177.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 87' ' ' ILE . 18.5 t70 -63.18 -29.9 71.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.226 1.01 . . . . 73.05 109.847 178.244 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.4 -9.32 53.54 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.837 -0.62 . . . . 61.11 111.969 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.02 27.69 36.66 Favored Glycine 0 C--N 1.317 -0.483 0 O-C-N 122.769 -0.253 . . . . 74.33 113.442 178.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.414 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 76.6 m-85 -83.84 128.16 34.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.125 0.488 . . . . 63.44 112.055 -179.114 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 8.0 ptp180 -79.97 171.05 15.61 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.217 -0.901 . . . . 74.11 110.306 -179.509 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -54.35 -43.0 70.91 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.884 1.274 . . . . 72.23 111.667 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -60.03 -41.98 93.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 123.813 0.845 . . . . 71.13 110.502 -179.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -65.1 -39.71 93.53 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.828 -0.624 . . . . 73.22 110.055 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.0 mm -60.24 -47.52 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.244 -1.021 . . . . 74.32 108.244 -176.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 73.5 mtm -70.92 -26.38 63.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.982 -1.008 . . . . 74.42 112.725 -176.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -58.12 -66.17 0.52 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.885 0.698 . . . . 74.34 112.885 -179.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -68.24 -32.44 72.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.506 0.558 . . . . 71.31 112.506 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.436 ' HG ' HG22 ' A' ' 126' ' ' VAL . 32.3 tp -67.53 -40.38 85.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.826 -0.624 . . . . 72.22 111.519 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.434 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 26.7 m-85 -84.99 -3.05 58.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.422 0.527 . . . . 73.2 112.422 -179.025 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.9 m -86.99 109.85 28.05 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.367 -0.605 . . . . 73.53 109.367 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 103' ' ' PHE . 21.7 Cg_exo -65.87 139.67 57.93 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.637 2.225 . . . . 73.42 110.852 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.0 t70 -99.27 119.34 60.72 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.253 -1.017 . . . . 75.33 108.253 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.05 -24.87 78.14 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.259 2.64 . . . . 74.4 113.647 -176.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.8 p -106.25 8.38 31.88 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.258 0.466 . . . . 73.54 112.258 -176.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 56.4 tp -102.84 129.38 49.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 110.047 -0.353 . . . . 61.13 110.047 -178.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.5 m -112.12 112.72 24.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.451 -0.574 . . . . 71.5 109.451 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.1 mm -116.84 146.93 20.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.902 -0.59 . . . . 74.33 109.461 -176.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 t -113.69 145.01 41.99 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.35 -1.722 . . . . 61.23 106.35 176.382 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -97.23 146.76 24.79 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.269 -0.972 . . . . 73.21 111.996 -173.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 24.3 t70 -68.05 127.13 31.73 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.902 -0.59 . . . . 61.55 109.991 177.584 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.43 14.19 54.1 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.282 -1.127 . . . . 74.14 110.282 -176.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.4 t -147.27 171.52 15.28 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.499 -0.926 . . . . 73.04 108.499 -178.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.93 -1.84 8.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.54 -0.754 . . . . 75.24 110.9 175.605 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -80.91 133.63 35.59 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.921 -0.582 . . . . 65.21 110.606 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.69 129.25 52.9 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.114 -0.948 . . . . 74.43 108.596 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.25 118.99 60.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 116.353 -0.385 . . . . 74.22 110.176 -177.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 64.2 m -80.3 132.21 35.78 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.112 -1.069 . . . . 73.44 108.112 173.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.8 t30 75.38 72.97 0.09 Allowed 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.944 1.297 . . . . 75.32 108.274 -171.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.65 168.07 10.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.814 -1.085 . . . . 70.43 110.167 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -93.06 127.06 48.77 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 115.646 -0.706 . . . . 73.12 110.166 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -55.73 -21.3 31.66 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.384 2.723 . . . . 75.43 113.469 178.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 43.0 t -60.35 -44.78 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.85 0.833 . . . . 72.22 109.73 178.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.7 -29.38 64.51 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.685 -1.143 . . . . 55.45 110.131 -176.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.52 -43.29 99.17 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.45 -0.796 . . . . 62.25 111.778 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -69.38 -34.98 75.35 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.638 -0.664 . . . . 65.04 109.779 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -66.65 -25.44 66.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.289 -1.323 . . . . 75.0 108.971 177.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -96.72 9.01 42.94 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.944 -1.025 . . . . 64.04 111.363 179.091 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.9 m80 65.25 28.23 12.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.322 1.049 . . . . 74.23 112.638 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.44 25.04 11.61 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.056 1.342 . . . . 73.13 107.74 176.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.57 -25.66 7.22 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 126.976 2.11 . . . . 72.43 112.767 -177.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 mmm-85 -54.19 -43.0 70.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.917 0.487 . . . . 75.14 110.286 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.3 -27.77 64.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.07 0.462 . . . . 53.43 111.323 179.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 99.1 t -73.32 -49.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.543 -0.753 . . . . 72.42 109.762 178.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 79.2 t -59.08 -41.15 82.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.421 -0.809 . . . . 74.33 109.143 177.446 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.37 -46.72 79.91 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.246 -0.888 . . . . 74.3 110.157 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 144' ' ' MET . 43.9 mtp180 -67.92 -37.05 81.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.815 0.34 . . . . 72.51 111.864 176.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.28 99.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.648 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -59.64 -39.0 82.92 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 122.818 0.447 . . . . 73.22 110.404 176.116 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.46 66.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.316 -0.402 . . . . 74.45 110.978 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.6 mmm -82.68 -41.28 19.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.066 0.46 . . . . 72.11 110.526 179.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.74 -51.35 11.59 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.209 0.448 . . . . 75.32 112.209 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.511 -0.757 . . . . 75.45 109.023 -176.973 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 109.791 -0.448 . . . . 73.21 109.791 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -78.92 125.84 6.84 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.432 2.088 . . . . 75.11 111.651 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.23 7.69 58.6 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.999 -0.62 . . . . 73.01 113.294 -178.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 133.34 41.74 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.14 -0.624 . . . . 73.33 109.42 176.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.63 98.36 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 124.636 1.174 . . . . 54.11 112.053 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -86.6 25.65 0.67 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.25 2.633 . . . . 72.42 111.797 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.37 70.29 1.34 Allowed Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.311 -1.515 . . . . 60.22 109.311 -175.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 p -140.38 154.5 46.73 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 109.632 -0.507 . . . . 65.24 109.632 -176.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -110.45 144.51 39.14 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.319 -0.622 . . . . 73.45 109.319 179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.9 mt -104.46 178.63 4.51 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.055 0.455 . . . . 74.43 110.505 -178.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.68 -172.99 2.18 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.415 -1.328 . . . . 54.22 107.415 174.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -140.71 114.4 8.87 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 114.427 1.269 . . . . 74.55 114.427 -177.883 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 p -142.46 106.29 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 114.794 -1.094 . . . . 72.31 108.78 177.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . 67.75 37.34 88.69 Favored Glycine 0 C--O 1.222 -0.651 0 N-CA-C 109.557 -1.417 . . . . 63.13 109.557 -175.099 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.525 ' OG ' ' HB2' ' A' ' 12' ' ' ARG . 36.7 p -91.83 101.37 13.96 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 113.041 0.756 . . . . 74.35 113.041 -171.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.83 121.77 85.71 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 106.415 -1.698 . . . . 75.13 106.415 170.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.77 165.14 32.15 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.367 2.045 . . . . 73.03 113.528 -176.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.26 123.89 31.14 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 106.15 -1.796 . . . . 73.13 106.15 174.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.17 -96.89 0.96 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 119.734 -1.222 . . . . 73.01 115.169 -175.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.1 119.94 37.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.17 0.509 . . . . 62.13 112.243 -169.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.45 109.77 2.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.996 -1.002 . . . . 63.21 110.421 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.19 -33.42 12.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.354 0.597 . . . . 75.04 110.158 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.44 173.78 11.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.012 -0.54 . . . . 75.55 110.135 176.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.88 129.98 42.31 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 107.985 -1.117 . . . . 72.41 107.985 176.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.63 -21.98 15.95 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.442 2.761 . . . . 70.33 115.061 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.46 -24.39 56.98 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.958 0.408 . . . . 71.44 110.484 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.71 157.19 87.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.724 -0.671 . . . . 73.43 111.844 -177.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -43.19 107.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 124.067 3.178 . . . . 75.15 113.601 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -135.05 164.04 28.53 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.107 -0.951 . . . . 73.23 110.426 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -127.37 160.7 30.59 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 125.623 1.569 . . . . 70.5 107.639 177.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -134.79 172.24 13.25 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 107.622 -1.251 . . . . 75.44 107.622 -178.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -46.04 -64.32 0.98 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 114.626 1.343 . . . . 75.14 114.626 -172.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.64 -27.59 69.11 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 121.569 1.513 . . . . 74.12 112.634 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 23.5 tpt180 -67.9 -48.29 66.44 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 110.179 -0.304 . . . . 74.5 110.179 178.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.84 -37.95 80.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.216 0.532 . . . . 74.24 109.915 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.47 -37.05 82.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.054 -0.976 . . . . 72.11 110.0 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.14 -44.96 71.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.2 -0.909 . . . . 71.51 109.885 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 97.2 mt -57.5 -41.98 81.82 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.354 -0.839 . . . . 74.4 111.962 -178.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.1 mt -94.29 -17.76 22.31 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.923 -0.58 . . . . 73.35 111.977 -177.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.86 61.55 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.37 -1.092 . . . . 64.42 110.37 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.5 m -122.4 164.05 28.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.239 -0.652 . . . . 74.21 109.239 -178.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -71.91 158.59 52.43 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.728 1.618 . . . . 73.43 111.341 173.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.28 -34.54 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.368 0.604 . . . . 73.31 110.012 178.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.7 t -62.25 -36.84 83.25 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.535 -0.757 . . . . 73.44 110.655 178.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 38.9 ttmt -69.77 -32.6 71.19 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 120.135 -0.626 . . . . 74.32 110.201 177.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.28 -42.25 92.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.653 -0.869 . . . . 72.14 108.653 175.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.08 82.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.888 -1.051 . . . . 71.32 110.438 176.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.2 mt-30 -66.82 -38.24 86.08 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.16 -0.473 . . . . 72.2 111.06 177.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.4 mm-40 -63.49 -41.29 98.56 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.998 -0.742 . . . . 72.41 108.998 177.313 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.55 -42.5 98.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.78 -1.1 . . . . 74.3 109.228 177.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 14' ' ' GLY . 70.0 ttt180 -60.33 -32.67 71.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.277 1.031 . . . . 74.51 111.87 178.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -85.41 -9.91 56.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.937 0.399 . . . . 74.25 111.068 -177.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.18 33.1 54.96 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.6 -1.4 . . . . 64.24 109.6 -174.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.02 -16.91 20.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.475 -0.935 . . . . 72.54 108.475 178.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 tp -151.2 157.22 42.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.647 -1.242 . . . . 75.44 107.647 -179.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.14 147.63 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.82 -0.808 . . . . 72.4 108.82 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.58 161.78 34.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 123.208 0.603 . . . . 75.51 109.471 -178.084 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.21 166.59 28.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 123.612 0.765 . . . . 64.22 109.705 176.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 45.9 mtp180 -112.57 126.84 55.78 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.941 -0.304 . . . . 73.12 110.791 -177.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -129.8 122.68 29.23 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.002 -0.74 . . . . 73.22 109.002 176.66 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 26.14 15.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.716 0.806 . . . . 73.12 111.616 179.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 -7.26 77.17 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.987 -0.551 . . . . 73.55 112.237 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.82 149.4 19.29 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 121.302 -0.475 . . . . 71.25 111.942 -178.204 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.35 120.94 47.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.282 -1.377 . . . . 75.41 107.282 179.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.33 150.83 34.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.528 0.68 . . . . 73.44 110.961 -178.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.79 129.18 25.54 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 106.524 -1.658 . . . . 73.51 106.524 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.13 128.13 24.28 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 121.877 1.718 . . . . 71.53 111.273 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' A' ' 68' ' ' GLN . 5.9 tt0 -60.81 -26.77 67.54 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.198 0.523 . . . . 72.1 111.991 -178.746 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.11 -18.83 24.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.27 -0.877 . . . . 74.3 112.237 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.471 ' CD2' HD13 ' A' ' 81' ' ' LEU . 4.5 m-85 -73.74 -9.86 59.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.455 0.645 . . . . 74.51 110.657 177.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.04 161.94 17.08 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.522 -0.763 . . . . 73.02 109.455 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 p -83.55 176.1 9.28 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.405 -0.961 . . . . 72.12 108.405 175.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -61.79 -21.69 64.81 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.085 0.469 . . . . 70.35 110.961 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.9 t -80.79 -10.47 59.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.411 0.684 . . . . 73.33 110.298 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.2 24.78 53.82 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.641 -0.79 . . . . 74.43 111.773 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -112.89 152.15 29.63 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.142 -1.059 . . . . 74.31 108.142 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.9 t -62.87 135.31 27.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 120.595 0.236 . . . . 73.22 111.053 178.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.0 t -64.97 131.32 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.599 -0.889 . . . . 72.52 108.599 177.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -21.98 27.51 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.76 1.022 . . . . 72.22 113.76 -178.293 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 t -94.58 -10.56 31.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.934 0.397 . . . . 72.04 110.456 -177.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.535 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 43.7 tp -60.18 -55.16 48.08 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 119.314 -0.374 . . . . 73.04 111.914 -177.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.34 -28.21 79.0 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.18 1.92 . . . . 75.33 111.716 178.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -45.66 60.44 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 121.103 -0.57 . . . . 73.05 111.935 -178.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.47 -40.31 81.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.42 0.628 . . . . 75.22 109.801 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 84.9 mt -62.18 -44.4 96.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.616 -0.72 . . . . 74.13 110.842 -178.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.4 m -70.39 -34.66 72.82 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 115.831 -0.622 . . . . 74.12 112.081 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -45.55 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 120.281 -0.567 . . . . 75.24 110.718 178.629 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 4.3 mm? -67.17 -35.81 80.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.1 0.407 . . . . 73.15 112.1 176.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.03 -37.36 79.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.273 -0.64 . . . . 65.2 109.273 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.38 -30.17 71.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 61.41 110.909 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.7 -2.31 84.63 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.965 -0.561 . . . . 74.44 112.182 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.19 39.44 11.35 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.479 -0.391 . . . . 73.31 112.591 178.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 68.9 m-85 -100.74 121.02 40.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.972 0.415 . . . . 74.02 111.694 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.485 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 38.1 ptt180 -71.0 171.61 10.53 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.112 0.965 . . . . 70.24 110.307 176.387 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -54.19 -44.97 72.02 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 125.24 1.416 . . . . 73.11 111.174 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.0 m -61.64 -41.4 97.45 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.94 -1.027 . . . . 75.31 110.625 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 41.6 mm-40 -67.31 -33.95 76.34 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.503 -0.317 . . . . 72.31 111.714 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.5 mm -61.16 -47.61 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.308 -0.997 . . . . 74.42 108.308 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.1 mtt -74.74 -18.77 60.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.775 -1.102 . . . . 74.34 112.074 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 77.8 ttt180 -55.97 -65.56 0.58 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.279 0.632 . . . . 75.24 110.371 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.512 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 53.3 p-90 -69.13 -32.06 71.16 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.528 -0.76 . . . . 74.23 112.623 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.512 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.4 mt -64.99 -41.89 95.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.93 1.085 . . . . 63.51 113.93 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -89.5 -11.76 42.0 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 114.004 1.113 . . . . 74.31 114.004 -173.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.3 m -81.47 119.2 74.99 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.532 -0.544 . . . . 73.32 109.532 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.02 130.32 27.08 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.6 2.2 . . . . 64.5 111.21 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.5 t70 -99.86 125.24 41.0 Favored Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.45 -0.5 . . . . 74.13 110.358 -175.338 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.544 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 27.4 Cg_endo -60.86 -23.57 77.16 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.764 2.31 . . . . 73.53 113.645 -177.735 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.2 m -107.85 12.19 27.45 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.965 0.412 . . . . 73.35 110.848 -175.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.418 ' HG ' HG12 ' A' ' 111' ' ' ILE . 35.8 tp -108.37 124.92 51.1 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.193 -0.603 . . . . 65.12 110.793 -179.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 m -116.47 110.7 18.96 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.825 -0.806 . . . . 72.12 108.825 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.418 HG12 ' HG ' ' A' ' 109' ' ' LEU . 48.9 mm -123.33 155.49 29.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 123.417 0.687 . . . . 75.5 110.013 -173.46 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -131.6 159.39 38.38 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.515 -1.291 . . . . 74.04 107.515 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -123.13 171.79 9.05 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 118.264 0.483 . . . . 71.02 110.686 -178.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.95 126.84 29.26 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.199 -1.038 . . . . 72.4 108.199 177.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.79 34.93 7.04 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 110.778 -0.929 . . . . 72.53 110.778 -178.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.9 m -147.74 138.51 23.29 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.982 -0.747 . . . . 73.35 108.982 177.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -97.3 -19.2 18.7 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.332 0.587 . . . . 74.12 110.509 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -117.78 173.41 6.76 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.546 -0.752 . . . . 62.51 111.123 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.74 157.46 18.1 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.316 0.579 . . . . 54.42 111.591 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.42 120.75 58.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.043 -1.095 . . . . 75.51 108.043 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -80.2 155.52 27.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.799 -0.815 . . . . 72.13 108.799 177.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 107' ' ' PRO . 14.6 m120 67.7 37.17 3.35 Favored 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.808 0.692 . . . . 74.2 110.741 176.848 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.98 163.59 13.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.95 -0.389 . . . . 62.32 109.95 -179.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.2 ptp85 -95.14 150.3 37.47 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.338 -0.615 . . . . 73.3 109.338 178.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.475 ' HB2' HD21 ' A' ' 102' ' ' LEU . 77.2 Cg_exo -54.89 -25.43 43.61 Favored 'Trans proline' 0 CA--C 1.555 1.533 0 C-N-CA 123.294 2.662 . . . . 62.54 114.028 178.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 102' ' ' LEU . 40.9 t -60.37 -43.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 120.858 0.361 . . . . 73.13 111.576 178.199 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.91 -32.79 74.66 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.611 -0.722 . . . . 72.11 109.885 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.53 75.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.4 -0.818 . . . . 72.3 111.961 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.439 ' HB3' HG22 ' A' ' 137' ' ' VAL . 4.1 pp -68.49 -37.39 80.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.525 -0.47 . . . . 74.12 111.277 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.82 -19.08 60.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.692 0.758 . . . . 74.44 109.493 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.09 7.79 45.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.338 -0.847 . . . . 60.33 111.157 177.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 64.3 27.88 13.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.445 1.117 . . . . 74.32 111.77 178.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.46 25.12 12.12 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.53 1.532 . . . . 75.12 108.425 179.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.8 3.88 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 128.204 2.601 . . . . 71.52 113.571 -176.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -53.97 -38.75 65.34 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 109.62 -0.511 . . . . 73.24 109.62 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -68.92 -27.64 65.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.453 0.644 . . . . 71.52 110.944 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 129' ' ' LEU . 61.9 t -73.46 -47.43 45.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.189 -0.914 . . . . 62.52 109.127 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.49 -41.8 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 71.54 109.188 176.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -56.93 -46.31 82.12 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.836 -1.074 . . . . 71.24 109.592 176.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -69.01 -36.44 77.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.147 -0.478 . . . . 72.14 110.734 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.72 -45.63 89.17 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.438 0.695 . . . . 74.21 110.516 179.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.87 -38.42 88.74 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.814 -0.63 . . . . 75.31 110.759 178.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.88 73.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.146 0.498 . . . . 73.1 110.594 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.464 ' HE2' ' HA ' ' A' ' 144' ' ' MET . 1.8 tpt -74.69 -47.11 33.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.699 -0.682 . . . . 74.05 110.907 -179.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.77 -32.9 46.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.992 0.738 . . . . 64.01 112.992 -176.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 108.892 -0.781 . . . . 63.41 108.892 -179.177 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' H ' ' HD2' ' A' ' 2' ' ' PRO . 15.7 tpt . . . . . 0 CA--C 1.553 1.064 0 N-CA-C 113.726 1.01 . . . . 72.32 113.726 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.433 ' HD2' ' H ' ' A' ' 1' ' ' MET . 57.3 Cg_endo -77.41 150.87 28.9 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 121.686 1.591 . . . . 73.54 112.579 -178.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.82 59.75 4.92 Favored Glycine 0 C--N 1.314 -0.646 0 N-CA-C 110.689 -0.964 . . . . 74.1 110.689 178.088 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.6 ttm180 -73.06 131.93 42.72 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 123.06 0.544 . . . . 73.13 110.188 -177.064 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 159.7 127.8 0.0 OUTLIER Pre-proline 0 C--O 1.24 0.6 0 C-N-CA 126.851 2.06 . . . . 73.2 106.992 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.29 79.93 3.03 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.706 1.604 . . . . 65.23 109.129 174.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.8 106.04 2.83 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 108.48 -1.848 . . . . 73.21 108.48 -172.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 p -69.69 -24.92 63.66 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 114.285 1.217 . . . . 75.1 114.285 -173.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 m -114.16 144.7 42.75 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.824 -0.436 . . . . 71.51 109.824 -178.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.18 152.48 39.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.993 -0.373 . . . . 72.22 109.993 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.14 139.59 51.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.23 -0.656 . . . . 64.45 109.23 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -85.78 92.14 8.52 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.275 0.56 . . . . 74.04 110.19 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.46 117.56 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 CA-C-O 122.037 0.922 . . . . 72.31 109.861 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.24 -47.61 2.64 Favored Glycine 0 C--N 1.286 -2.223 0 CA-C-N 114.383 -1.28 . . . . 74.31 111.144 -179.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.6 t -71.62 99.23 2.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.477 0.656 . . . . 63.33 109.814 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 mm -100.94 122.93 47.1 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.306 -0.998 . . . . 74.33 108.306 179.181 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -73.06 155.23 52.63 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.459 1.439 . . . . 64.22 110.239 174.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.11 124.88 30.91 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.406 0.282 . . . . 55.54 110.702 -176.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.3 -105.6 2.84 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 121.365 -0.445 . . . . 73.24 113.52 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -113.64 134.52 54.68 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.692 0.397 . . . . 75.54 110.489 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.18 127.6 33.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.668 0.747 . . . . 71.21 110.907 -179.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.07 -21.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.465 -0.789 . . . . 73.03 110.216 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -78.82 152.08 31.54 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 113.311 0.856 . . . . 73.21 113.311 -178.218 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.21 151.45 94.54 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 107.637 -1.245 . . . . 60.42 107.637 178.149 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.21 -25.0 76.54 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.769 1.646 . . . . 74.34 110.559 174.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -72.97 -13.81 61.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.145 -0.934 . . . . 73.34 111.209 177.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -83.61 131.41 52.43 Favored Pre-proline 0 N--CA 1.435 -1.175 0 N-CA-C 107.74 -1.207 . . . . 74.2 107.74 175.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 58.6 Cg_endo -69.2 146.34 63.31 Favored 'Trans proline' 0 C--O 1.256 1.4 0 C-N-CA 122.871 2.381 . . . . 74.13 113.204 -177.019 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -128.79 165.75 20.35 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.795 0.807 . . . . 74.35 112.165 -178.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.562 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 12.3 m-85 -130.34 161.45 31.26 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 125.927 1.691 . . . . 75.3 107.779 175.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -134.23 169.36 17.3 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 103.819 -2.659 . . . . 75.32 103.819 178.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.7 -51.99 74.08 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 114.262 1.208 . . . . 74.53 114.262 -171.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.48 -36.12 97.84 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.157 1.904 . . . . 64.45 112.445 176.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 21.4 tpt180 -69.82 -39.34 76.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 122.912 0.485 . . . . 75.04 110.21 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.44 -38.84 77.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.318 0.58 . . . . 72.33 109.59 176.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 41' ' ' VAL . . . -59.62 -36.14 75.75 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.201 -0.909 . . . . 75.54 109.881 177.1 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 37.8 tt0 -65.2 -43.77 90.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.575 -1.193 . . . . 75.21 109.963 178.165 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 83.9 mt -67.02 -50.24 62.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.799 -0.637 . . . . 74.33 111.285 -178.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -81.06 -17.82 48.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.704 -0.68 . . . . 74.44 112.12 -173.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.71 63.08 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.682 -0.77 . . . . 44.11 111.619 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 34.2 m -120.89 159.25 49.75 Favored Pre-proline 0 C--N 1.312 -1.052 0 N-CA-C 109.926 -0.398 . . . . 75.51 109.926 -177.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -61.32 154.12 60.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 122.269 1.979 . . . . 63.33 113.139 173.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.3 t -57.88 -35.13 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.478 -1.237 . . . . 73.31 110.993 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -64.55 -34.37 78.09 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 116.364 -0.38 . . . . 70.04 110.789 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 68.1 mttm -68.98 -35.78 77.12 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.905 -0.497 . . . . 75.54 110.225 176.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.21 -43.02 98.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.76 -0.655 . . . . 72.41 109.696 175.705 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.74 79.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.86 -0.609 . . . . 73.2 110.349 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 46.3 mt-30 -67.51 -35.2 78.65 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 115.954 -0.566 . . . . 75.45 111.848 177.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.9 mm-40 -58.26 -48.75 79.45 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.583 -0.895 . . . . 74.5 108.583 177.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -62.3 -42.69 99.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.844 -1.071 . . . . 74.23 110.27 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -70.13 -21.32 63.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.25 1.204 . . . . 75.01 114.25 -179.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 18.2 mm-40 -96.54 -4.85 40.6 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 119.749 -0.78 . . . . 74.53 110.758 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.56 36.49 37.99 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.105 -0.798 . . . . 51.24 111.105 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -106.68 -5.18 18.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.219 -1.03 . . . . 70.2 108.219 178.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -158.11 153.65 26.22 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.697 -1.594 . . . . 74.2 106.697 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.17 146.98 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.996 -0.742 . . . . 75.45 108.996 -176.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.56 153.28 51.03 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.297 -0.631 . . . . 72.33 109.297 -179.024 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.19 168.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 123.777 0.831 . . . . 71.23 109.726 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -108.43 118.01 35.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.439 -0.949 . . . . 73.32 108.439 -176.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -123.9 123.47 40.49 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.089 -1.414 . . . . 74.41 109.473 -176.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.0 16.07 7.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.541 1.136 . . . . 72.53 112.034 177.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.46 -12.87 54.56 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.73 -0.668 . . . . 75.23 112.025 -178.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.15 156.9 17.96 Favored Glycine 0 CA--C 1.497 -1.093 0 C-N-CA 120.498 -0.858 . . . . 72.14 111.337 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.47 120.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.893 -1.151 . . . . 74.44 107.893 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.47 157.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.675 0.75 . . . . 73.44 111.451 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.9 mt -112.29 126.56 28.2 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 106.564 -1.643 . . . . 73.45 106.564 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.35 128.78 28.62 Favored 'Trans proline' 0 C--N 1.329 -0.471 0 C-N-CA 122.341 2.028 . . . . 73.13 112.697 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.562 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -66.31 -25.22 66.74 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 121.499 0.666 . . . . 75.04 110.937 179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.0 -8.1 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 115.181 -0.918 . . . . 72.2 112.44 178.028 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.6 -7.03 59.66 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.085 0.945 . . . . 72.45 109.424 173.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.35 164.12 13.61 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.645 -1.161 . . . . 74.22 108.501 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 p -93.59 173.92 7.45 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.841 -0.8 . . . . 75.2 108.841 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -66.33 -16.86 64.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.881 0.848 . . . . 74.45 109.571 178.405 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -79.72 -7.3 58.53 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.243 -0.889 . . . . 75.15 111.073 178.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.39 62.06 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.949 -0.644 . . . . 54.15 112.465 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -126.09 152.14 46.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.786 -0.82 . . . . 73.53 108.786 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.84 143.94 14.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 123.557 0.535 . . . . 74.44 109.683 -177.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.6 t -62.52 121.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.253 -1.018 . . . . 73.32 108.253 176.333 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -57.89 -39.69 78.51 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.471 0.708 . . . . 72.52 112.885 -173.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.9 t -93.07 3.18 56.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.206 0.447 . . . . 73.05 112.206 -176.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 8.4 tt -66.22 -45.07 60.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.026 1.121 . . . . 75.04 114.026 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.86 -21.62 34.03 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.123 2.549 . . . . 74.03 113.276 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.83 -41.3 99.13 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.171 -0.772 . . . . 71.23 111.171 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.15 -39.8 82.54 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.24 -0.652 . . . . 73.21 109.24 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.28 -43.85 98.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.367 -0.833 . . . . 73.21 109.903 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.3 m -57.76 -47.32 82.85 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.536 -0.756 . . . . 73.03 111.632 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -46.06 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.588 -0.278 . . . . 61.24 111.724 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 HD23 ' HB3' ' A' ' 141' ' ' ALA . 4.1 mm? -67.21 -37.99 84.55 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.571 0.952 . . . . 75.1 113.571 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -59.99 -44.99 94.16 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.004 0.43 . . . . 72.42 110.42 178.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.05 -27.34 63.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.064 -0.516 . . . . 73.12 110.987 178.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.96 -9.55 86.58 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.084 -0.507 . . . . 73.23 112.632 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.13 6.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.345 -0.455 . . . . 72.34 113.658 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -113.57 139.32 49.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.957 0.379 . . . . 74.41 111.331 177.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 98' ' ' ILE . 14.3 ptp180 -89.93 172.07 9.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.604 -0.726 . . . . 75.24 110.716 -176.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.17 -45.4 72.1 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.429 1.491 . . . . 74.25 112.307 -176.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.0 m -64.63 -41.18 96.35 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.733 -0.667 . . . . 73.3 109.824 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.413 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 47.8 mt-10 -66.08 -38.75 89.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.602 -0.726 . . . . 73.32 111.058 -179.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 94' ' ' ARG . 30.0 mm -60.69 -47.24 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.689 -0.856 . . . . 74.13 108.689 -179.209 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.2 mtt -74.41 -18.42 60.66 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.836 -1.075 . . . . 63.22 113.095 -177.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -57.37 -64.33 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.24 0.543 . . . . 74.34 110.304 178.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.55 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 60.3 p-90 -69.62 -32.33 70.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 74.43 112.617 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.536 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.2 mt -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.572 0.953 . . . . 75.51 113.572 179.438 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.596 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.1 m-85 -98.61 10.76 40.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.303 0.482 . . . . 75.11 112.303 -177.729 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 101' ' ' TRP . 11.8 t -87.79 122.01 70.52 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 119.144 -1.022 . . . . 75.35 110.154 177.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.6 136.83 37.34 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.578 2.185 . . . . 71.51 110.956 177.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 14.7 t70 -106.93 112.7 63.21 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.79 -0.764 . . . . 73.15 109.472 178.101 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.09 -16.77 48.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.277 2.651 . . . . 74.02 114.596 -176.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -109.51 3.23 21.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.035 -0.416 . . . . 72.0 111.388 -177.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -102.62 125.27 49.29 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.43 0.633 . . . . 73.13 110.88 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.3 m -116.43 120.7 39.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.15 107.571 179.137 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.406 HD13 ' HB1' ' A' ' 123' ' ' ALA . 32.4 mt -126.37 150.6 32.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 73.01 109.009 -173.281 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 23.6 p -89.48 126.4 35.56 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.886 -1.524 . . . . 73.22 106.886 175.049 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -88.48 149.49 23.62 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.576 -0.85 . . . . 74.12 111.431 -171.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 29.5 t70 -77.04 153.69 34.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.369 -0.604 . . . . 72.35 109.369 179.081 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.57 -54.02 3.08 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 108.983 -1.647 . . . . 74.52 108.983 -175.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.9 p -95.0 -169.24 1.96 Allowed 'General case' 0 N--CA 1.39 -3.462 0 N-CA-C 108.078 -1.082 . . . . 75.01 108.078 175.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.431 ' N ' ' HD3' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -135.24 9.05 3.46 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.626 -0.879 . . . . 74.51 108.626 177.573 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -92.37 147.69 22.71 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.365 -1.289 . . . . 64.14 110.579 -173.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 112' ' ' THR . . . -87.99 128.57 35.39 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.553 -0.748 . . . . 73.24 109.789 177.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.24 127.59 72.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.946 -1.131 . . . . 75.13 107.946 -179.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.8 p -86.92 141.14 28.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.202 -0.666 . . . . 74.24 109.202 177.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.2 t30 68.68 70.55 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.188 0.994 . . . . 72.1 110.315 -177.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.406 ' HB1' HD13 ' A' ' 111' ' ' ILE . . . -108.22 174.67 5.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.238 -0.892 . . . . 61.33 109.181 175.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.14 150.51 38.42 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 109.035 -0.728 . . . . 74.53 109.035 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.7 -34.01 62.2 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.025 2.483 . . . . 73.33 112.544 173.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.54 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.3 t -64.08 -43.61 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 119.771 -0.772 . . . . 75.11 109.6 175.654 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.02 -30.8 70.13 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.886 -0.783 . . . . 73.21 108.886 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.18 82.43 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.247 -0.888 . . . . 70.32 112.054 177.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.15 -33.48 73.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.161 0.505 . . . . 73.42 110.269 -179.167 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -66.33 -28.76 68.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.404 -0.961 . . . . 74.25 108.404 176.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -96.44 14.37 24.73 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.708 -1.133 . . . . 70.2 112.261 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 62.05 27.41 16.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.901 1.28 . . . . 63.52 111.885 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -110.64 24.69 12.64 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 123.772 1.749 . . . . 73.25 108.241 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.57 -26.31 12.97 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 111.389 -2.641 . . . . 70.14 113.495 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.52 -41.4 73.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.729 0.411 . . . . 74.41 110.875 -174.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.64 -35.6 77.5 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.454 0.645 . . . . 74.3 110.249 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.2 t -66.07 -42.42 91.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.053 -0.976 . . . . 74.52 109.754 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.521 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 98.6 t -61.49 -46.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 65.21 109.471 177.608 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -63.86 -38.96 93.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.117 0.484 . . . . 72.32 111.001 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -36.36 81.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.328 -0.99 . . . . 74.03 108.328 178.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.402 ' HB3' HD23 ' A' ' 88' ' ' LEU . . . -67.69 -46.37 72.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.559 0.744 . . . . 75.23 110.437 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 87.2 mt-30 -57.62 -49.5 76.24 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.046 -0.525 . . . . 73.34 109.851 178.359 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.71 -27.26 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.417 -0.811 . . . . 64.15 111.422 -178.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.55 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 14.9 tpt -77.45 -29.3 52.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.119 0.485 . . . . 73.51 110.171 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.21 -48.12 7.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.489 0.551 . . . . 65.11 112.489 -177.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 119.164 -0.446 . . . . 75.21 109.944 -176.499 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.275 0 N-CA-C 106.974 -1.491 . . . . 73.12 106.974 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.11 -109.77 0.83 Allowed Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.675 -1.25 . . . . 24.11 114.395 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.56 121.35 29.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 70.05 112.539 -168.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.03 120.22 9.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.489 -1.232 . . . . 71.21 110.993 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.84 -40.22 13.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.663 -0.699 . . . . 73.32 111.049 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.66 157.21 37.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.957 -0.697 . . . . 73.32 110.965 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.14 141.55 70.92 Favored Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 73.44 108.346 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.95 -21.73 16.47 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.111 2.541 . . . . 65.24 115.011 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.79 -13.41 59.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.984 0.421 . . . . 73.34 110.823 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.3 137.18 71.78 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 109.296 -0.631 . . . . 71.02 109.296 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.36 131.83 37.65 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 123.938 3.092 . . . . 62.21 113.841 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -137.87 158.83 43.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.595 -0.73 . . . . 72.14 111.832 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 6.2 m-85 -109.5 160.15 16.47 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.339 1.855 . . . . 73.43 107.596 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -135.18 162.48 32.41 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.728 -1.953 . . . . 72.45 105.728 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.26 -54.34 39.43 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 113.239 0.829 . . . . 75.41 113.239 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.02 -36.7 96.15 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 121.807 1.671 . . . . 75.03 111.864 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 2.9 mpt_? -70.41 -37.61 74.47 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.373 -0.376 . . . . 71.12 111.856 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.35 -37.59 71.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 120.17 -0.612 . . . . 72.44 109.845 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.13 -41.7 84.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.662 -0.866 . . . . 63.42 108.662 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 37.0 mt-10 -63.12 -45.69 90.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.884 -1.053 . . . . 65.3 111.99 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.482 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 60.2 tp -61.49 -50.19 73.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.617 0.767 . . . . 54.42 112.153 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 41' ' ' VAL . 91.5 mt -89.09 -12.65 40.57 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.094 0.405 . . . . 65.03 112.094 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.17 27.75 65.57 Favored Glycine 0 C--N 1.316 -0.549 0 N-CA-C 111.212 -0.755 . . . . 75.44 111.212 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 39' ' ' LEU . 32.7 m -118.63 160.78 38.78 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.531 -0.544 . . . . 65.44 109.531 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 37.5 Cg_endo -68.7 160.29 50.14 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.138 1.892 . . . . 55.25 111.723 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.51 -34.5 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.563 0.745 . . . . 65.34 110.492 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -61.27 -39.0 88.77 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.292 -0.867 . . . . 62.43 111.695 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD3' ' HD2' ' A' ' 42' ' ' PRO . 26.3 mtpp -69.82 -33.92 72.98 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.815 -0.354 . . . . 72.03 111.258 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -44.43 98.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.852 -0.795 . . . . 74.14 108.852 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -63.01 -36.41 83.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.239 -0.892 . . . . 64.44 110.433 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 15.4 mm100 -62.01 -40.77 96.8 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-N 117.002 -0.09 . . . . 64.23 111.064 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -58.73 -44.49 90.47 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.464 0.649 . . . . 53.41 109.815 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.5 -38.94 91.86 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.598 -1.183 . . . . 64.11 110.394 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 47' ' ' ALA . 20.0 mmm180 -71.32 -26.56 62.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.374 -0.375 . . . . 70.13 111.673 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 74.7 mm-40 -89.72 -2.64 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.596 -0.275 . . . . 74.12 111.119 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 35.86 54.14 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.776 -0.726 . . . . 63.24 111.907 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -99.81 -17.68 17.55 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 120.63 0.252 . . . . 74.2 111.01 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.9 tp -152.71 160.98 43.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.217 -1.031 . . . . 63.43 108.217 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.65 147.32 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.553 -0.906 . . . . 62.12 108.553 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.48 150.93 51.72 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.228 -0.656 . . . . 61.02 109.228 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -129.85 166.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.03 0.532 . . . . 73.22 110.034 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 37.2 ttt180 -114.61 123.11 48.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.879 -0.415 . . . . 74.3 109.879 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 62' ' ' GLY . 8.8 ptm180 -116.64 114.07 23.56 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.723 -0.844 . . . . 72.1 108.723 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.03 -16.81 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.138 1.375 . . . . 73.51 113.369 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . 147.0 -18.93 1.58 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.713 -0.955 . . . . 41.54 110.713 -177.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -91.1 146.28 18.25 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 112.346 -0.302 . . . . 73.13 112.346 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.56 121.69 48.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.869 -0.789 . . . . 60.43 108.869 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.11 157.88 43.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.471 0.653 . . . . 51.0 111.659 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.52 122.22 23.7 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 107.144 -1.428 . . . . 70.33 107.144 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.54 132.36 50.04 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.152 1.901 . . . . 53.03 113.08 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -48.8 -38.52 22.27 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.818 0.847 . . . . 75.34 111.375 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 27.0 m -65.66 -11.1 11.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 114.592 1.33 . . . . 51.52 114.592 -174.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.597 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.6 m-85 -77.78 -12.87 60.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.699 0.761 . . . . 62.22 110.292 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.79 145.12 38.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 108.141 -1.059 . . . . 74.31 108.141 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.0 p -75.42 175.58 8.32 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.076 0.55 . . . . 73.33 110.421 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -65.85 -17.21 64.49 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 122.19 0.995 . . . . 71.13 109.863 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -90.15 -0.55 57.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.281 -0.872 . . . . 72.12 111.524 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 26.55 67.54 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.499 -0.382 . . . . 43.11 112.712 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -113.82 157.72 21.94 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.989 -1.115 . . . . 75.22 107.989 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.6 t -73.44 140.9 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.075 -1.083 . . . . 74.23 108.075 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 46.7 t -64.08 128.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.52 -0.919 . . . . 72.35 108.52 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -58.16 -43.9 87.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.342 0.867 . . . . 74.43 113.342 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 t -89.74 1.71 55.76 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 121.01 -0.276 . . . . 61.21 111.502 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.651 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 7.9 tt -65.99 -50.24 53.29 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 119.513 -0.279 . . . . 73.03 111.511 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.64 -24.58 75.92 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.464 1.443 . . . . 60.33 110.512 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.95 88.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.353 -0.84 . . . . 72.23 111.574 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -66.46 -39.78 89.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 108.021 -1.103 . . . . 62.43 108.021 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.52 -35.78 78.68 Favored 'General case' 0 C--O 1.202 -1.422 0 CA-C-N 115.44 -0.8 . . . . 72.31 110.652 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.4 m -59.46 -50.98 71.83 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.422 0.451 . . . . 72.12 111.263 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.97 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 116.268 -0.424 . . . . 72.44 111.36 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.3 mm? -66.72 -35.23 79.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.15 0.426 . . . . 64.05 112.15 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -64.37 -40.96 96.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.404 -0.591 . . . . 74.34 109.404 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.11 -30.14 68.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 74.33 110.067 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.88 -6.31 89.08 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.538 -0.755 . . . . 64.32 112.336 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.22 57.19 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 114.003 0.361 . . . . 70.12 114.003 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -90.87 129.11 36.95 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 122.168 -0.607 . . . . 75.44 112.099 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 8.0 ptp180 -78.02 171.8 14.46 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.159 -0.928 . . . . 75.21 110.802 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.26 -45.28 72.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.279 1.432 . . . . 61.12 111.848 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.9 m -61.8 -40.9 96.86 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.281 -0.872 . . . . 70.22 109.88 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 8.1 mm-40 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.766 -0.652 . . . . 74.51 110.713 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.96 -48.63 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.367 0.603 . . . . 71.01 109.578 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -74.86 -21.33 59.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.346 -0.843 . . . . 53.23 111.941 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -55.59 -64.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.121 0.568 . . . . 61.11 110.954 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -68.89 -32.52 72.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.03 0.443 . . . . 71.33 112.102 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -67.39 -37.83 83.76 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.584 -0.734 . . . . 52.55 112.429 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -93.39 -1.4 55.88 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 112.779 0.659 . . . . 74.24 112.779 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -87.29 116.96 67.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.575 -0.528 . . . . 72.34 109.575 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.64 128.72 22.96 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.81 1.673 . . . . 72.4 109.383 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 33.4 t70 -100.43 125.81 38.03 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 120.271 -0.572 . . . . 74.32 111.04 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.56 -30.43 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.111 2.541 . . . . 64.13 113.164 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 p -92.0 5.49 49.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.289 0.566 . . . . 71.44 111.48 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.3 tp -102.79 126.07 49.78 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.205 -0.665 . . . . 73.54 109.205 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.3 m -131.72 110.53 10.95 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.542 -1.281 . . . . 74.21 107.542 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 C--N 1.286 -2.186 0 CA-C-N 115.292 -0.867 . . . . 63.35 109.922 -174.057 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 N--CA 1.431 -1.385 0 N-CA-C 108.918 -0.771 . . . . 63.34 108.918 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.6 t -86.51 139.04 31.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.441 -1.689 . . . . 73.14 106.441 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.6 t30 67.1 68.63 0.4 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.073 0.94 . . . . 74.0 109.146 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.77 162.81 21.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.648 -1.16 . . . . 53.31 109.581 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -75.4 130.83 78.9 Favored Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.592 0.557 . . . . 72.1 110.161 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 50.5 Cg_exo -55.49 -17.24 16.18 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 123.836 3.024 . . . . 74.21 113.351 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 65.8 t -59.73 -43.03 90.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.144 -0.48 . . . . 74.34 109.891 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -29.88 69.35 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 116.112 -0.495 . . . . 74.43 111.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.18 -52.64 57.95 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.943 -0.571 . . . . 72.21 109.541 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -68.02 -34.11 75.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 111.735 0.272 . . . . 74.03 111.735 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.61 -24.06 63.61 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.688 0.756 . . . . 70.44 109.196 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -104.45 16.47 26.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.965 -1.016 . . . . 71.03 110.833 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.5 m80 64.05 28.33 14.27 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.35 1.06 . . . . 71.42 113.344 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -99.73 23.11 10.04 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.796 -1.928 . . . . 70.05 105.796 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.31 -27.84 25.21 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 127.08 2.152 . . . . 62.31 114.658 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -56.49 -36.9 69.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.218 0.451 . . . . 75.14 112.218 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -67.76 -33.09 74.16 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.721 0.772 . . . . 72.43 109.664 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.1 t -72.01 -40.55 67.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.387 -0.824 . . . . 63.12 108.831 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.85 -44.22 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.086 -0.709 . . . . 73.33 109.086 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -57.87 -47.13 83.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.65 -0.705 . . . . 72.15 110.495 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -65.82 -34.29 77.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.726 -0.67 . . . . 73.03 109.787 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -66.57 -46.29 76.5 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.474 -0.784 . . . . 73.14 109.61 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.78 -48.19 82.67 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.292 -0.867 . . . . 72.33 110.483 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.12 -29.8 71.08 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.286 0.366 . . . . 43.11 111.59 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.23 -34.07 70.45 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.286 -0.416 . . . . 65.21 110.925 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.9 -58.75 1.93 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.938 1.088 . . . . 72.41 113.938 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.314 -0.941 0 CA-C-O 119.072 -0.49 . . . . 65.05 110.743 -174.922 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.366 -0.605 . . . . 72.14 109.366 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.4 -120.93 4.62 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 115.998 -0.546 . . . . 61.3 112.847 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -119.91 142.2 48.92 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.8 0.333 . . . . 73.23 110.495 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.92 137.65 51.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.991 -0.549 . . . . 74.43 111.305 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.608 HG11 ' HA ' ' A' ' 100' ' ' ARG . 21.8 t -115.45 -13.69 11.1 Favored 'Isoleucine or valine' 0 C--O 1.248 0.978 0 CA-C-O 122.195 0.997 . . . . 61.23 109.866 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -78.36 175.97 9.77 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.804 -1.184 . . . . 64.04 107.804 172.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 12.4 t70 -86.01 129.52 53.81 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 117.309 -1.756 . . . . 63.51 106.355 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.64 -21.19 7.51 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.215 2.61 . . . . 73.53 113.972 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.34 -21.19 46.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.032 0.382 . . . . 72.31 112.032 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HG3' ' HB3' ' A' ' 24' ' ' ASP . 38.9 mt-10 -66.1 153.61 91.6 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 122.244 -0.285 . . . . 74.54 110.799 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.52 113.67 1.33 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.353 2.702 . . . . 61.02 113.666 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.7 p -126.4 -179.97 5.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 115.504 -0.771 . . . . 25.21 110.236 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' CE2' HD22 ' A' ' 38' ' ' LEU . 40.8 m-85 -130.33 161.03 32.2 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.648 -1.612 . . . . 70.05 106.648 170.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.7 m-20 -133.01 162.88 30.51 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 103.662 -2.718 . . . . 65.34 103.662 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -43.28 -56.04 7.23 Favored Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 114.501 1.297 . . . . 71.22 114.501 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.67 -36.54 51.93 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.381 1.387 . . . . 64.32 111.857 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 1.4 tpt180 -70.54 -34.4 72.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.053 -0.521 . . . . 71.4 110.951 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 31' ' ' ASP . 60.7 t -69.24 -41.75 81.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 108.867 -0.79 . . . . 62.45 108.867 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.31 83.19 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.661 -1.154 . . . . 70.41 109.385 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.09 -46.35 84.65 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.315 -0.857 . . . . 72.32 110.627 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 30' ' ' TYR . 29.3 tp -65.33 -47.26 77.14 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.425 -0.807 . . . . 65.41 111.268 -175.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 41' ' ' VAL . 96.6 mt -81.56 -17.46 48.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 72.24 111.688 -177.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.16 29.47 60.39 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.873 -0.891 . . . . 62.12 110.873 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 39' ' ' LEU . 32.7 m -121.68 164.14 26.65 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.541 -0.54 . . . . 70.12 109.541 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.27 165.47 27.72 Favored 'Trans proline' 0 C--O 1.264 1.821 0 C-N-CA 121.512 1.475 . . . . 75.41 110.875 172.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.49 -32.51 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.259 0.624 . . . . 73.23 110.408 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -57.06 -43.68 82.29 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.965 -0.561 . . . . 42.2 110.823 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 29.7 mtpp -69.49 -32.47 71.36 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 120.041 -0.664 . . . . 72.1 111.039 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.41 -42.05 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.31 -0.626 . . . . 75.34 109.31 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -62.63 -37.23 85.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.696 . . . . 54.23 109.787 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.7 -35.93 81.29 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.074 -0.512 . . . . 33.11 111.64 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.4 mm100 -58.42 -46.25 86.86 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 108.086 -1.079 . . . . 75.53 108.086 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.67 -38.92 92.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.135 -1.393 . . . . 64.53 110.979 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 97.9 mtt180 -71.05 -22.0 62.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.129 0.572 . . . . 72.55 112.289 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -85.11 -13.42 50.3 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.418 -0.513 . . . . 75.12 109.708 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.94 26.32 73.99 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.781 -1.328 . . . . 52.32 109.781 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -98.38 -9.13 25.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.551 0.691 . . . . 75.42 109.244 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.1 tp -158.21 152.55 24.4 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.932 -1.877 . . . . 53.15 105.932 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.27 158.03 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 120.213 -0.595 . . . . 72.4 109.49 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.0 162.04 29.59 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 122.71 0.404 . . . . 52.33 110.008 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 99' ' ' MET . 13.4 m -132.63 167.53 26.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 124.121 0.968 . . . . 74.2 109.141 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 75.4 mtm180 -109.9 139.27 45.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.683 -0.488 . . . . 74.42 109.683 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' NE ' HG11 ' A' ' 65' ' ' VAL . 36.7 ptt180 -128.41 120.05 26.17 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.509 -1.293 . . . . 71.35 107.509 173.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.1 16.9 8.66 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.864 0.866 . . . . 60.23 111.877 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.26 -7.31 54.2 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.991 -0.55 . . . . 52.22 112.55 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -95.61 151.83 20.13 Favored Glycine 0 CA--C 1.493 -1.31 0 N-CA-C 111.624 -0.591 . . . . 74.14 111.624 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.2 t -96.46 120.91 46.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.357 -0.979 . . . . 73.22 108.357 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.446 HG11 ' NE ' ' A' ' 60' ' ' ARG . 15.3 m -134.45 160.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.255 -0.884 . . . . 64.3 111.452 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.33 128.87 23.99 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 106.935 -1.505 . . . . 74.32 106.935 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.21 133.99 56.38 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.03 1.82 . . . . 62.24 111.622 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -63.05 -25.27 68.3 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 121.709 0.766 . . . . 45.44 111.312 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.31 -5.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.836 -1.075 . . . . 75.5 112.076 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.63 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.6 m-85 -87.7 -3.85 58.94 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.7 0.762 . . . . 71.11 110.211 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.16 148.54 43.51 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.395 -0.821 . . . . 75.2 109.179 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -83.64 174.98 10.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.884 -0.598 . . . . 74.14 109.602 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.66 -17.94 64.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.674 0.75 . . . . 70.04 109.171 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -79.52 -7.11 58.25 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.267 -0.879 . . . . 54.1 110.597 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.52 27.54 59.09 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.085 -0.578 . . . . 73.13 111.697 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -123.03 166.03 15.79 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.384 -0.599 . . . . 72.42 109.384 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.0 t -75.92 142.16 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.156 -1.053 . . . . 73.03 108.156 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 25.8 t -62.62 130.79 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 107.914 -1.143 . . . . 75.43 107.914 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -65.29 -24.5 67.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.066 1.135 . . . . 75.12 114.066 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 p -92.84 -2.05 56.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.206 0.526 . . . . 72.31 111.967 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.63 HD11 ' CD2' ' A' ' 70' ' ' PHE . 7.8 tt -65.42 -50.37 58.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-N 115.786 -0.643 . . . . 73.15 112.115 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.78 -29.52 86.17 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.34 1.36 . . . . 53.3 111.358 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.89 -44.33 94.77 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.954 -0.567 . . . . 63.03 111.946 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.01 -40.03 87.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.445 -0.576 . . . . 73.12 109.445 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.6 -37.9 89.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.933 -0.576 . . . . 70.34 110.527 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.8 m -67.39 -43.34 81.59 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 115.844 -0.616 . . . . 72.05 111.831 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -42.0 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.903 -0.319 . . . . 73.12 110.663 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.414 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.4 mm? -66.7 -34.57 78.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.167 0.432 . . . . 65.51 112.167 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -59.67 -35.15 73.86 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.021 -0.733 . . . . 72.33 109.021 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.04 -31.34 72.16 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.293 0.568 . . . . 74.23 110.371 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -9.26 75.91 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.623 -0.717 . . . . 74.25 112.34 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.17 35.24 34.72 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.296 -0.478 . . . . 72.34 112.401 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.16 132.8 42.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.928 0.394 . . . . 73.41 110.983 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -83.35 171.54 13.41 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.507 -0.77 . . . . 71.42 109.629 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 99' ' ' MET . 9.1 p-10 -53.95 -40.99 67.29 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.687 1.595 . . . . 71.13 112.107 -176.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -61.86 -41.25 97.61 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.238 0.615 . . . . 74.2 110.365 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 6.7 mm-40 -66.38 -36.5 83.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.152 -0.476 . . . . 72.11 109.897 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.7 mm -62.07 -47.77 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.842 -0.799 . . . . 71.15 108.842 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 23.9 mmt -69.15 -23.61 63.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.832 -1.077 . . . . 75.4 110.412 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.608 ' HA ' HG11 ' A' ' 22' ' ' VAL . 80.4 ttt180 -58.9 -63.43 1.3 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.618 -0.719 . . . . 52.34 110.773 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.504 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.5 p-90 -69.65 -35.34 75.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.069 0.766 . . . . 63.43 113.069 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 126' ' ' VAL . 11.2 mt -57.77 -41.39 81.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.889 1.07 . . . . 52.54 113.889 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 96.8 m-85 -97.45 -6.04 34.75 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.311 0.856 . . . . 75.31 113.311 -174.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.8 m -87.29 121.24 71.41 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.208 0.317 . . . . 74.21 110.219 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 33.8 Cg_exo -63.99 128.91 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.737 1.625 . . . . 54.45 108.931 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 26.3 t70 -105.45 120.45 49.44 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 120.209 -0.596 . . . . 74.14 110.735 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.8 -22.72 74.6 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 123.332 2.688 . . . . 70.3 113.445 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 m -97.65 2.9 50.32 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.17 0.509 . . . . 72.13 110.109 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HG ' HG12 ' A' ' 111' ' ' ILE . 48.4 tp -109.77 128.69 55.46 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.109 -0.7 . . . . 72.0 109.109 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.9 m -130.61 113.17 13.87 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.188 -1.041 . . . . 72.25 108.188 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.4 HG12 ' HG ' ' A' ' 109' ' ' LEU . 36.9 mm . . . . . 0 C--N 1.298 -1.656 0 CA-C-N 115.993 -0.549 . . . . 72.14 110.75 -172.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 50.0 t . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 108.418 -0.956 . . . . 74.31 108.418 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -82.27 154.82 25.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.755 -1.572 . . . . 72.45 106.755 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 16.2 m120 69.26 36.02 2.47 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.434 0.694 . . . . 52.52 110.354 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.11 152.12 29.45 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.211 -1.033 . . . . 74.13 108.211 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -87.71 142.14 32.41 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 105.34 -2.096 . . . . 73.23 105.34 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.503 ' HB2' HD23 ' A' ' 102' ' ' LEU . 92.8 Cg_exo -51.72 -27.35 26.21 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.273 1.982 . . . . 64.41 111.695 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.641 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 93.8 t -62.82 -43.06 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.814 -0.63 . . . . 72.24 110.73 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -60.04 -37.85 81.01 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.433 0.635 . . . . 64.4 109.461 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.78 82.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.285 -1.325 . . . . 62.41 112.194 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -69.23 -38.69 78.63 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.168 -0.613 . . . . 63.35 111.234 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.36 -23.41 63.75 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.614 0.721 . . . . 75.21 109.716 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.55 7.05 44.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.289 -0.869 . . . . 74.53 111.075 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.3 m80 59.51 28.81 18.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 122.144 0.973 . . . . 61.33 112.578 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.13 22.98 6.94 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.253 -1.388 . . . . 74.24 107.253 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.43 -28.81 32.04 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.738 1.615 . . . . 65.54 112.712 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -56.26 -43.14 78.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.373 -0.603 . . . . 74.24 109.373 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -73.67 -30.55 62.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.328 -0.851 . . . . 71.13 110.608 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -63.77 -45.25 97.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.838 -0.801 . . . . 75.51 108.838 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.1 t -62.99 -42.12 95.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 70.02 109.7 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.17 -45.6 83.53 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.023 -0.535 . . . . 71.14 110.025 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.2 mmt85 -68.86 -37.06 78.83 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.044 -0.525 . . . . 73.14 111.362 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.47 -44.04 93.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.083 0.553 . . . . 73.41 109.903 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -64.7 -38.4 90.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 72.34 110.323 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.86 -17.77 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.0 -0.546 . . . . 54.1 111.664 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 94.1 mmm -87.6 -29.81 20.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.22 0.533 . . . . 74.4 110.253 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.96 -44.56 14.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.177 -0.465 . . . . 71.3 111.042 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 108.075 -1.083 . . . . 63.43 108.075 -178.745 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 109.958 -0.386 . . . . 43.23 109.958 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.38 -128.15 5.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.41 -0.9 . . . . 71.33 112.377 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 96' ' ' THR . 29.9 t70 -109.68 146.41 34.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.121 -0.696 . . . . 73.31 109.121 -174.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -86.06 125.37 33.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.449 0.642 . . . . 75.11 112.259 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.3 t -97.2 -31.17 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.33 -0.395 . . . . 75.53 111.457 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.494 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -69.77 171.72 8.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.011 0.745 . . . . 74.02 113.011 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.504 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 10.0 t70 -85.32 139.81 36.33 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 116.508 -0.314 . . . . 63.32 110.495 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.9 -24.6 14.02 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.066 3.177 . . . . 75.14 115.217 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.84 -25.18 28.24 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.134 -0.354 . . . . 74.41 111.568 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 24' ' ' ASP . 45.9 mt-10 -62.78 132.81 94.87 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 116.523 -0.308 . . . . 64.31 110.994 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.93 141.47 77.74 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 123.175 2.583 . . . . 75.11 113.137 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -136.68 173.95 11.15 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.019 -0.991 . . . . 72.2 110.697 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -124.83 159.26 31.45 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.711 -1.589 . . . . 74.14 106.711 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 6.9 p-10 -137.04 173.84 11.26 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.334 -1.728 . . . . 74.23 106.334 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -37.32 -60.95 0.77 Allowed Pre-proline 0 CA--C 1.563 1.478 0 N-CA-C 115.45 1.648 . . . . 73.02 115.45 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.82 -33.81 32.77 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.216 1.277 . . . . 72.32 112.888 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 9.5 tpt180 -70.25 -35.12 73.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.627 0.251 . . . . 65.23 110.916 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 31' ' ' ASP . 62.0 t -69.2 -41.26 81.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.959 -0.756 . . . . 54.2 108.959 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.88 88.28 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 114.905 -1.043 . . . . 63.24 109.679 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.86 -45.49 92.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.131 1.372 . . . . 73.34 109.742 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.75 -50.1 39.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.608 -0.724 . . . . 64.05 112.382 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.04 -18.89 41.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.308 -0.406 . . . . 75.3 111.953 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.95 27.88 57.58 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.099 -0.801 . . . . 73.43 111.099 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -121.41 159.7 49.08 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 108.505 -0.924 . . . . 74.13 108.505 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.77 156.01 64.41 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 121.523 1.482 . . . . 74.41 112.819 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.42 -37.4 63.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.467 -0.788 . . . . 74.03 111.181 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.1 t -62.19 -35.92 80.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.509 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 53.7 tttp -65.75 -40.64 92.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.133 -1.062 . . . . 71.25 108.133 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.76 -41.26 87.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.404 -0.816 . . . . 75.52 110.333 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.86 88.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.902 -0.59 . . . . 12.41 110.243 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 1.4 mp0 -68.45 -41.61 79.99 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.764 -0.653 . . . . 73.13 112.051 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.717 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.2 mm100 -58.09 -46.06 86.12 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.848 -0.797 . . . . 74.02 108.848 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD23 ' HG ' ' A' ' 55' ' ' LEU . 76.9 mt -61.93 -44.23 97.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.99 -1.005 . . . . 54.55 111.447 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -70.95 -21.62 62.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.672 0.619 . . . . 75.24 112.672 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 52.5 mt-10 -87.64 -6.62 58.18 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.654 -0.418 . . . . 62.52 110.898 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.86 39.09 21.69 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.594 -0.812 . . . . 51.44 111.107 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -86.3 -30.0 22.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.862 -1.162 . . . . 74.32 107.862 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.444 ' HG ' HD23 ' A' ' 50' ' ' LEU . 1.6 pt? -160.82 167.62 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.667 -1.605 . . . . 75.21 106.667 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.42 161.46 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 118.758 0.708 . . . . 61.4 112.084 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.05 51.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.332 -0.849 . . . . 41.32 110.242 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.42 HG11 ' SD ' ' A' ' 99' ' ' MET . 18.0 m -130.79 162.55 38.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 O-C-N 123.528 0.517 . . . . 71.35 109.82 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -110.42 118.02 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.859 -0.423 . . . . 34.54 109.859 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -124.56 123.83 40.93 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.891 -0.411 . . . . 54.4 109.891 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.89 16.77 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.032 0.933 . . . . 64.03 110.656 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.43 -15.5 62.83 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.602 -0.726 . . . . 65.11 113.05 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.22 137.85 13.83 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.021 -0.831 . . . . 64.31 111.021 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.79 120.77 46.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.55 0.69 . . . . 75.24 109.169 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.06 159.32 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.069 -0.969 . . . . 60.44 112.172 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.3 mm -111.1 132.02 21.9 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 125.937 1.695 . . . . 74.42 106.803 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.69 119.31 6.33 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.981 1.787 . . . . 74.5 111.672 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -62.95 -25.48 68.37 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.572 0.701 . . . . 74.33 111.556 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 m -70.81 -5.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.413 -0.812 . . . . 73.55 112.451 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -86.13 -4.12 59.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.859 0.837 . . . . 65.41 109.653 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -111.12 160.14 17.18 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.037 -0.983 . . . . 63.14 108.397 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 p -84.06 166.27 17.85 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.247 -1.019 . . . . 73.11 108.247 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -67.53 -16.55 64.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.935 0.874 . . . . 74.32 109.609 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 m -78.76 -11.38 59.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.503 -0.771 . . . . 54.22 111.063 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.05 62.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.572 -0.823 . . . . 72.43 112.536 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -104.98 147.87 27.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.015 -0.365 . . . . 64.45 110.015 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.5 t -63.12 136.05 26.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.457 -0.942 . . . . 74.41 108.457 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.92 133.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.737 -0.468 . . . . 64.13 109.737 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -54.61 -26.29 31.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.393 1.257 . . . . 53.51 114.393 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.7 t -114.62 19.37 16.1 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.342 -0.543 . . . . 53.23 110.849 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 17.6 tp -63.95 -55.69 30.69 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 116.44 -0.346 . . . . 74.32 111.326 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.21 -28.55 87.14 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.887 1.725 . . . . 73.13 111.75 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.82 -44.81 94.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.889 -0.596 . . . . 71.53 112.2 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.18 -40.53 82.21 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 109.395 -0.594 . . . . 73.03 109.395 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.37 -44.51 97.03 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.718 -0.674 . . . . 74.24 110.634 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.7 m -61.41 -37.02 81.98 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.706 1.002 . . . . 52.14 113.706 -176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.469 HG23 HD22 ' A' ' 88' ' ' LEU 0.25 0.0 OUTLIER -68.17 -45.04 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 119.567 -0.853 . . . . 75.33 110.755 179.485 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 87' ' ' ILE . 3.2 mm? -67.75 -35.56 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.008 0.433 . . . . 73.42 111.189 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -60.4 -39.54 87.7 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.744 0.818 . . . . 74.5 109.28 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.65 -30.6 70.19 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.728 0.775 . . . . 71.33 109.928 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.4 -3.05 89.9 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.065 -0.971 . . . . 54.13 112.053 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.89 22.46 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.895 -0.193 . . . . 54.45 113.155 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 93.7 m-85 -87.16 136.57 32.88 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 122.37 -0.488 . . . . 72.41 111.07 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 37.4 ptt180 -78.06 170.57 16.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.791 -0.641 . . . . 72.31 110.655 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -54.27 -41.01 68.36 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.946 1.298 . . . . 61.14 111.822 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' ASP . 23.4 m -61.74 -42.57 99.14 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.282 -0.872 . . . . 62.41 111.02 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.577 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 9.1 mm-40 -67.05 -33.49 75.63 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.141 -0.481 . . . . 74.24 110.965 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.2 mm -61.65 -49.05 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 108.211 -1.033 . . . . 70.33 108.211 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.592 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 10.9 ptp -74.84 -14.14 60.64 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.387 -0.824 . . . . 62.43 112.935 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 71.7 ttt180 -58.83 -65.62 0.63 Allowed 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.616 0.572 . . . . 72.21 109.944 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.535 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 46.0 p-90 -69.12 -32.92 72.65 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.236 0.458 . . . . 73.42 112.236 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 11.0 mt -58.93 -40.48 84.73 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.517 0.932 . . . . 75.02 113.517 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 73.0 m-85 -93.22 -2.5 55.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.406 0.521 . . . . 73.21 112.406 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -88.51 117.51 68.43 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 109.07 -0.715 . . . . 54.13 109.07 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 139.96 51.47 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.305 2.003 . . . . 75.41 113.208 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 17.5 t70 -98.26 119.9 60.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.645 -0.872 . . . . 61.14 108.645 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.08 -22.91 71.57 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.149 2.566 . . . . 73.2 114.016 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 p -104.0 5.63 35.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.036 0.384 . . . . 50.51 112.036 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.3 tp -105.12 135.28 46.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.053 -0.351 . . . . 61.0 110.053 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.6 m -118.53 116.9 27.62 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.04 108.286 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 109.128 -0.693 . . . . 71.34 109.128 -175.713 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 107.937 -1.135 . . . . 72.44 107.937 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.3 m -89.85 131.34 35.83 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.357 -1.72 . . . . 53.21 106.357 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.0 t30 75.46 69.06 0.08 Allowed 'General case' 0 C--N 1.321 -0.672 0 O-C-N 124.564 1.165 . . . . 73.41 108.235 -172.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.49 163.72 15.98 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.696 -1.138 . . . . 65.23 109.539 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 39.5 ptt180 -88.08 141.1 30.97 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.568 -0.742 . . . . 74.1 109.672 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB2' HD23 ' A' ' 102' ' ' LEU . 50.7 Cg_exo -55.17 -18.11 16.97 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.083 2.522 . . . . 75.22 114.228 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -61.03 -42.85 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.444 0.64 . . . . 64.33 109.493 173.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.61 -30.75 71.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.276 -0.874 . . . . 71.4 109.619 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.72 -50.34 65.18 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.734 -0.667 . . . . 73.12 110.556 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -63.99 -36.76 85.05 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 60.24 110.871 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -68.68 -24.7 64.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.38 -0.827 . . . . 63.41 109.54 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -102.53 12.78 35.96 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.406 -0.816 . . . . 75.35 112.85 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 70.02 27.87 4.26 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.638 1.209 . . . . 73.5 110.866 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -105.56 23.96 12.98 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.967 0.907 . . . . 63.43 109.028 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.12 -29.06 28.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.479 1.511 . . . . 63.3 113.817 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -56.7 -40.14 75.09 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.806 0.336 . . . . 71.45 110.752 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -73.12 -24.82 60.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.981 0.419 . . . . 74.32 110.967 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 129' ' ' LEU . 57.7 t -70.84 -42.0 77.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 62.52 108.478 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.27 -42.23 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.44 -0.578 . . . . 70.31 109.44 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -59.5 -47.09 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.619 -0.719 . . . . 74.32 109.697 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.4 tpp180 -64.6 -39.65 94.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.371 -0.831 . . . . 73.02 110.005 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.62 87.36 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.564 0.746 . . . . 72.14 110.832 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.98 -39.02 93.19 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.281 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -21.25 66.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.18 -0.464 . . . . 70.54 111.333 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 85.4 mmm -92.71 -22.49 19.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.022 0.439 . . . . 53.2 110.986 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.83 -27.68 19.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.976 0.417 . . . . 64.2 111.062 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 108.022 -1.103 . . . . 73.11 108.022 178.024 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.992 0 N-CA-C 108.052 -1.092 . . . . 64.32 108.052 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.15 -110.27 3.45 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.684 -0.769 . . . . 70.13 113.411 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -110.76 133.56 53.24 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.043 0.386 . . . . 72.01 112.043 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.1 114.97 13.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.313 -0.995 . . . . 64.14 108.313 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.64 -8.61 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 112.409 0.522 . . . . 73.2 112.409 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 -173.11 2.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.772 -1.205 . . . . 74.31 113.936 -175.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -96.5 132.47 26.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.843 -1.169 . . . . 73.31 107.843 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.16 -20.73 32.34 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.452 2.768 . . . . 64.15 111.8 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.334 -0.848 . . . . 61.11 109.823 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -68.0 134.09 91.85 Favored Pre-proline 0 C--O 1.244 0.796 0 N-CA-C 109.365 -0.605 . . . . 65.0 109.365 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.22 128.1 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.57 2.18 . . . . 74.13 111.257 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.3 m -130.16 158.52 39.46 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.47 -0.567 . . . . 61.52 109.47 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -116.48 162.4 17.63 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.521 1.129 . . . . 72.0 109.965 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -134.06 167.25 20.97 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.381 -2.451 . . . . 62.33 104.381 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -48.45 -55.03 21.01 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 114.712 1.375 . . . . 72.33 114.712 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.44 -46.39 33.79 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.118 1.879 . . . . 73.53 112.11 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 28.0 tpt180 -65.29 -39.04 92.04 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 112.485 0.55 . . . . 71.13 112.485 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.41 HG21 HD12 ' A' ' 66' ' ' ILE . 77.7 t -69.12 -40.53 80.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.164 -0.614 . . . . 72.44 110.239 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.03 -39.52 92.6 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.206 -0.906 . . . . 70.53 108.978 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.59 -44.95 85.06 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.494 -1.23 . . . . 74.14 111.105 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 95.6 mt -62.25 -47.45 84.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.482 0.658 . . . . 70.43 111.572 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.439 ' HB2' HG22 ' A' ' 41' ' ' VAL . 88.2 mt -82.77 -18.44 40.64 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.744 -0.662 . . . . 61.31 111.972 -175.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 27.36 60.78 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 110.592 -1.003 . . . . 74.52 110.592 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 39' ' ' LEU . 25.5 m -118.31 159.38 43.7 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 108.564 -0.902 . . . . 74.3 108.564 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.78 161.75 38.74 Favored 'Trans proline' 0 C--O 1.262 1.719 0 C-N-CA 121.149 1.232 . . . . 60.25 110.744 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.7 -33.85 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 115.88 -0.6 . . . . 72.11 109.92 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.6 m -57.66 -41.27 81.14 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.093 -0.958 . . . . 74.23 111.73 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 26.5 mtpp -69.77 -32.59 71.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.27 -0.572 . . . . 70.12 110.929 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 61.0 t -62.27 -42.27 94.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.68 . . . . 72.04 109.165 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.96 83.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.83 -0.623 . . . . 60.25 110.311 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -66.36 -37.32 85.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.24 -0.437 . . . . 55.22 110.67 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 46.9 mt-30 -63.19 -46.4 87.25 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.938 -0.393 . . . . 73.15 109.938 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 93.8 mt -61.67 -38.43 87.72 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.54 -1.209 . . . . 54.0 110.03 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -61.63 -44.41 97.04 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.164 0.986 . . . . 55.04 112.507 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.59 -11.8 33.38 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.419 -0.512 . . . . 70.12 112.364 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.92 35.53 18.41 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.34 -0.933 . . . . 44.33 111.049 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -92.5 -18.55 23.03 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.154 -1.054 . . . . 75.31 108.154 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -159.88 152.45 21.19 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.751 -1.944 . . . . 72.13 105.751 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.86 161.67 39.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.568 -0.53 . . . . 74.21 109.568 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.22 161.66 35.58 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.119 -0.697 . . . . 74.45 109.119 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.55 166.16 30.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.397 -0.594 . . . . 75.11 109.397 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 45.0 ttt180 -121.49 130.48 53.58 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.383 -0.527 . . . . 70.13 110.068 -175.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -125.56 117.31 23.31 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.602 -0.888 . . . . 63.22 108.602 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 20.47 8.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.597 0.759 . . . . 63.22 112.748 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.73 -17.14 30.64 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.068 -0.587 . . . . 74.24 112.976 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.34 140.75 15.22 Favored Glycine 0 CA--C 1.488 -1.61 0 C-N-CA 121.23 -0.51 . . . . 51.14 111.829 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.24 120.91 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.254 -1.017 . . . . 74.54 108.254 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.3 154.6 40.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.826 -0.624 . . . . 63.11 110.916 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 35' ' ' VAL . 64.3 mt -126.28 114.43 23.59 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.872 -1.158 . . . . 73.22 107.872 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.41 133.56 58.81 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.323 2.682 . . . . 75.24 113.102 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -57.12 -25.53 58.98 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 112.948 0.722 . . . . 72.54 112.948 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 21.9 m -60.28 -15.34 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 113.361 0.875 . . . . 72.1 113.361 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 81' ' ' LEU . 13.9 m-85 -82.28 -6.15 59.04 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.519 0.676 . . . . 75.3 111.001 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -121.06 162.36 20.13 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.553 -0.748 . . . . 61.43 109.126 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.0 p -88.14 175.53 7.67 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.713 -0.476 . . . . 72.01 109.713 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -61.25 -16.98 50.99 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.239 0.616 . . . . 72.31 111.176 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.21 3.43 51.46 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.312 0.486 . . . . 73.03 112.312 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.76 57.87 Favored Glycine 0 C--O 1.235 0.166 0 C-N-CA 120.465 -0.874 . . . . 23.42 111.94 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -112.55 146.23 38.9 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.634 -0.876 . . . . 75.54 108.634 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.9 130.39 32.24 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.546 -0.538 . . . . 40.32 109.546 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 80' ' ' SER . 60.5 t -56.14 130.55 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.798 -0.637 . . . . 73.25 109.459 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -57.32 -23.8 50.98 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.64 1.348 . . . . 62.33 114.64 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.401 ' H ' HG12 ' A' ' 78' ' ' VAL . 23.2 t -105.31 10.63 33.48 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.987 -0.446 . . . . 73.03 110.91 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 36.2 tp -66.02 -57.68 12.84 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.39 0.885 . . . . 74.33 113.39 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.63 -33.86 97.26 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 121.864 1.709 . . . . 73.52 112.944 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -61.94 -44.98 97.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.406 -0.426 . . . . 72.13 112.65 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.57 -40.32 80.64 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 121.289 0.566 . . . . 71.3 109.987 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.77 -42.25 95.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.51 -0.768 . . . . 74.53 111.144 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.1 m -64.41 -45.15 88.82 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.04 -0.527 . . . . 72.11 111.906 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -66.06 -43.85 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.973 0.416 . . . . 61.51 111.017 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.675 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 38.1 mt -66.61 -38.33 86.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.286 -0.416 . . . . 74.51 111.77 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -63.27 -42.57 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.842 -0.429 . . . . 71.14 109.842 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.94 -28.63 65.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.12 -0.491 . . . . 74.25 110.737 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.89 -1.56 84.78 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.59 -0.732 . . . . 63.33 112.77 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.88 23.26 30.79 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.867 -0.682 . . . . 73.01 113.087 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -102.84 144.53 31.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.485 -0.42 . . . . 63.23 110.784 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.532 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 31.2 ptt180 -97.01 172.3 7.94 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.232 -0.894 . . . . 71.01 109.156 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.55 -43.18 68.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.791 1.636 . . . . 51.0 111.593 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 m -62.5 -41.04 98.55 Favored 'General case' 0 N--CA 1.415 -2.194 0 C-N-CA 123.854 0.862 . . . . 73.32 110.164 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.532 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 28.9 mm-40 -67.04 -33.36 75.36 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.43 -0.35 . . . . 73.4 110.649 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.483 HD12 HD13 ' A' ' 88' ' ' LEU . 18.7 mm -61.3 -49.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.993 -1.114 . . . . 61.11 107.993 -176.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 ptp -76.08 -17.89 59.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.289 -0.869 . . . . 60.33 112.8 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -56.47 -67.53 0.29 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.998 0.519 . . . . 72.11 110.66 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.675 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 52.5 p-90 -69.47 -32.13 70.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.277 0.473 . . . . 72.32 112.277 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.526 HD23 ' HB2' ' A' ' 125' ' ' PRO . 8.7 mt -60.09 -39.97 87.97 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.155 0.798 . . . . 74.11 113.155 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.08 -4.8 59.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.178 0.436 . . . . 63.34 112.178 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 m -87.17 120.2 71.28 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.193 -0.669 . . . . 62.41 109.193 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.83 129.62 31.39 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.251 1.968 . . . . 74.45 110.788 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 35.4 t70 -96.33 124.25 51.94 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.182 -0.463 . . . . 53.55 110.807 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.38 -35.43 96.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.324 2.683 . . . . 73.22 113.057 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 p -90.04 2.98 54.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.802 0.667 . . . . 72.11 112.802 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -102.69 129.51 49.33 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.291 0.567 . . . . 65.21 110.21 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.4 m -131.35 115.34 16.13 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.42 -1.696 . . . . 71.41 106.42 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.467 HG22 ' OE1' ' A' ' 133' ' ' GLN . 13.3 pt . . . . . 0 CA--C 1.493 -1.238 0 N-CA-C 112.812 0.671 . . . . 64.42 112.812 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.432 -1.349 0 N-CA-C 108.991 -0.744 . . . . 71.23 108.991 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.2 m -84.67 134.8 34.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.58 -1.267 . . . . 74.51 107.58 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.4 t30 66.71 64.72 0.47 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.534 1.159 . . . . 74.23 108.908 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.97 163.71 15.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.263 -1.335 . . . . 53.42 108.887 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 39.6 ptt180 -82.39 136.18 46.27 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.545 -0.539 . . . . 71.53 109.545 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.526 ' HB2' HD23 ' A' ' 102' ' ' LEU . 31.0 Cg_exo -56.78 -17.08 21.89 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.244 2.63 . . . . 71.43 114.07 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.618 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.1 t -59.9 -40.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.454 0.645 . . . . 62.04 109.9 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.2 -30.29 67.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.19 -0.459 . . . . 64.15 111.051 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.1 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.59 . . . . 61.41 111.375 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.45 -33.9 75.01 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.028 -0.269 . . . . 74.24 111.401 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -75.25 -24.68 57.68 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.781 0.8 . . . . 62.23 108.907 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.29 24.41 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.774 -1.103 . . . . 72.44 111.179 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.6 m80 64.39 28.22 13.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.528 1.131 . . . . 52.24 111.512 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.467 ' OE1' HG22 ' A' ' 111' ' ' ILE . 72.7 mt-30 -111.23 23.84 13.58 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.345 -1.354 . . . . 74.14 107.345 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.26 -27.87 24.68 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 113.306 -1.77 . . . . 63.32 113.111 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -56.16 -36.21 68.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.935 0.494 . . . . 73.1 109.926 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.33 -38.58 87.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.405 0.621 . . . . 73.42 109.737 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.7 -46.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.078 -0.964 . . . . 70.22 109.597 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 93.0 t -61.22 -47.8 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.506 -0.77 . . . . 74.13 110.484 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.52 -37.93 89.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.123 -0.631 . . . . 64.41 110.915 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -63.71 -41.64 98.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.229 -0.656 . . . . 71.25 109.229 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.921 -0.581 . . . . 61.35 110.072 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -63.98 -38.66 91.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.414 -0.812 . . . . 72.3 111.411 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.91 -33.03 70.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.147 0.499 . . . . 74.41 110.441 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 tpt -69.71 -32.01 70.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.342 -0.844 . . . . 73.4 110.719 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.27 -58.91 2.16 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.803 0.668 . . . . 61.15 112.803 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.31 -1.126 0 CA-C-O 118.303 -0.856 . . . . 74.2 110.624 -175.896 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.678 0 N-CA-C 109.922 -0.399 . . . . 73.12 109.922 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.67 -78.79 0.62 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.559 -0.829 . . . . 75.14 113.994 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.73 129.97 33.44 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 122.262 -0.552 . . . . 53.34 110.631 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.568 ' OD2' ' HD2' ' A' ' 60' ' ' ARG . 13.3 t0 -69.22 139.46 54.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.165 -0.471 . . . . 65.42 111.697 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 100' ' ' ARG . 58.1 t -106.56 -18.52 7.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.661 -0.7 . . . . 43.42 110.991 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.285 1.0 OUTLIER -89.7 179.37 6.03 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.379 -1.328 . . . . 64.34 112.21 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -98.03 152.21 37.93 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.085 -0.709 . . . . 71.52 109.085 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.89 -22.92 32.01 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.005 2.47 . . . . 65.41 113.035 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.74 -24.98 56.17 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.295 -0.253 . . . . 64.3 111.582 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 20.1 mm-40 -72.34 137.21 81.18 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 109.973 -0.38 . . . . 75.53 109.973 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 28.9 Cg_exo -63.02 136.72 58.1 Favored 'Trans proline' 0 C--O 1.256 1.408 0 C-N-CA 123.105 2.537 . . . . 53.23 112.774 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 p -130.6 169.81 15.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.283 0.563 . . . . 74.03 111.37 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 20.4 m-85 -130.33 160.2 34.68 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.808 1.243 . . . . 53.12 108.05 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.14 163.97 28.4 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 103.459 -2.793 . . . . 72.14 103.459 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HB3' HG13 ' A' ' 43' ' ' VAL . 82.9 mt -49.93 -52.27 53.86 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 114.812 1.412 . . . . 75.25 114.812 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.91 -38.61 68.16 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 121.6 1.534 . . . . 71.14 111.762 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.8 tpt180 -70.05 -33.98 72.63 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.566 -0.288 . . . . 73.23 111.309 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.1 -42.06 84.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.951 -0.759 . . . . 70.42 108.951 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.07 84.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.406 -0.815 . . . . 63.44 109.597 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 7.5 tp10 -61.68 -44.94 95.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.672 -1.149 . . . . 55.24 109.552 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.449 HD22 ' CE2' ' A' ' 30' ' ' TYR . 27.0 tp -69.63 -46.33 66.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.195 -0.911 . . . . 72.23 111.724 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 75' ' ' GLY . 96.7 mt -81.36 -18.44 45.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.189 -0.46 . . . . 64.03 111.606 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.3 28.2 62.36 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.058 -0.817 . . . . 70.13 111.058 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 39' ' ' LEU . 21.5 m -125.61 163.48 38.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 108.333 -0.988 . . . . 73.12 108.333 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 46.2 Cg_endo -70.87 157.83 57.15 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 121.352 1.368 . . . . 50.45 111.232 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' A' ' 32' ' ' LEU . 61.2 t -57.9 -34.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.658 0.783 . . . . 74.15 109.786 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 47.1 m -57.66 -42.89 84.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.155 -0.929 . . . . 41.33 111.331 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.8 mtpt -69.27 -33.48 73.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.409 -0.516 . . . . 75.14 111.204 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.23 -44.94 99.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.164 -0.68 . . . . 73.33 109.164 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.39 -0.823 . . . . 70.54 110.427 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.0 mt-30 -63.49 -39.79 95.37 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.241 -0.436 . . . . 61.14 110.397 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.611 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 72.2 mt-30 -64.1 -42.4 96.93 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.418 0.628 . . . . 65.43 109.699 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.17 -40.77 97.14 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.892 -1.049 . . . . 71.04 109.281 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -68.83 -22.27 64.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.508 -0.769 . . . . 62.04 112.89 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 49.9 mt-10 -93.04 -12.87 29.53 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.313 -0.555 . . . . 74.21 111.337 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.38 28.96 31.62 Favored Glycine 0 C--N 1.319 -0.41 0 N-CA-C 111.222 -0.751 . . . . 73.42 111.222 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -87.72 -28.38 21.8 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.31 -0.996 . . . . 73.35 108.31 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -145.95 158.6 43.86 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.429 -1.323 . . . . 65.54 107.429 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.71 157.55 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.464 -0.939 . . . . 41.14 108.464 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.4 162.87 32.47 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.122 0.569 . . . . 71.14 110.004 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 m -125.91 166.09 22.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.277 0.56 . . . . 64.32 111.701 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -110.23 124.73 52.14 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.203 -0.908 . . . . 74.13 108.783 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.568 ' HD2' ' OD2' ' A' ' 21' ' ' ASP . 8.9 ptm180 -151.3 138.37 19.17 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-N 115.573 -0.739 . . . . 74.41 110.123 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.63 -59.16 0.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.205 1.802 . . . . 74.22 110.515 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.48 24.77 0.02 OUTLIER Glycine 0 C--N 1.28 -2.573 0 CA-C-N 114.766 -1.106 . . . . 51.33 110.825 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 160.81 27.81 Favored Glycine 0 N--CA 1.427 -1.907 0 C-N-CA 120.395 -0.907 . . . . 65.02 111.893 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.88 119.88 50.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.931 -1.507 . . . . 64.41 106.931 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.8 158.6 39.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 120.926 0.394 . . . . 42.42 110.867 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.07 126.92 27.07 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.497 -1.297 . . . . 52.45 107.497 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.31 132.29 51.38 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.384 2.056 . . . . 55.31 111.539 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 40.0 tt0 -62.17 -25.8 67.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.38 0.609 . . . . 70.1 112.353 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.461 ' HB ' HG11 ' A' ' 126' ' ' VAL . 31.2 m -71.81 -4.37 4.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.144 -0.934 . . . . 54.14 112.38 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.8 m-85 -82.85 -6.18 59.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.956 0.884 . . . . 73.44 110.239 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.65 160.87 20.59 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.579 -0.737 . . . . 74.32 110.52 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.3 p -92.84 168.53 11.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.065 -1.087 . . . . 71.13 108.065 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.93 -15.33 63.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.424 0.631 . . . . 74.22 111.661 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.0 m -78.64 -9.86 59.53 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.739 -0.664 . . . . 61.33 109.335 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 39' ' ' LEU . . . 81.16 25.8 54.2 Favored Glycine 0 C--O 1.212 -1.264 0 N-CA-C 111.0 -0.84 . . . . 72.1 111.0 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -114.52 147.34 39.54 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.092 -1.077 . . . . 75.02 108.092 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.58 137.73 23.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.847 -1.538 . . . . 62.2 106.847 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.8 t -60.87 127.28 20.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 108.666 -0.865 . . . . 70.23 108.666 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -55.3 -32.14 62.19 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 114.095 1.146 . . . . 73.02 114.095 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 m -85.16 -6.4 59.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.088 0.471 . . . . 44.24 111.457 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD11 ' CD2' ' A' ' 70' ' ' PHE . 7.0 tt -66.18 -50.09 52.13 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 112.616 0.598 . . . . 73.11 112.616 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.28 -31.39 84.28 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.552 1.502 . . . . 62.55 111.337 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.93 99.73 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 115.872 -0.604 . . . . 53.43 112.682 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -67.86 -39.81 83.72 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.32 -0.622 . . . . 74.45 109.32 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.63 -36.33 83.46 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.719 -0.673 . . . . 73.14 110.542 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.7 m -59.5 -50.26 74.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.022 -0.536 . . . . 61.43 110.372 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -44.16 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 116.143 -0.48 . . . . 63.43 111.485 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.427 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.36 -36.35 81.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.98 0.733 . . . . 71.2 112.98 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -70.64 -33.72 71.3 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 74.41 109.285 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.05 -31.7 72.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.674 -0.694 . . . . 74.23 109.389 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.17 -9.37 80.18 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.408 -0.814 . . . . 65.33 112.676 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.5 33.48 25.14 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 121.174 -0.536 . . . . 71.44 113.295 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.403 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 68.9 m-85 -99.79 136.89 39.02 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.595 -0.356 . . . . 61.21 110.884 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -88.58 174.04 8.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.922 -0.581 . . . . 71.21 112.144 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.85 -42.59 65.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.355 1.862 . . . . 64.43 111.871 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -64.2 -41.73 96.94 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.782 -0.644 . . . . 63.53 110.142 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -66.61 -37.27 84.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.369 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.27 -48.97 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.777 0.799 . . . . 74.4 109.337 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.2 mtt -75.41 -19.28 59.61 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.036 -0.984 . . . . 65.15 112.215 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HA ' HG11 ' A' ' 22' ' ' VAL . 79.0 ttt180 -56.88 -62.79 1.5 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.356 0.662 . . . . 62.14 111.05 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -69.05 -32.65 72.28 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.2 0.524 . . . . 63.22 111.829 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 125' ' ' PRO . 19.2 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.13 0.972 . . . . 64.25 112.436 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -93.52 -2.6 54.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.261 0.837 . . . . 75.51 113.261 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.6 m -86.02 113.49 52.07 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.135 0.272 . . . . 71.3 111.224 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 38.4 Cg_endo -68.02 141.11 52.02 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.448 2.099 . . . . 41.35 110.856 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.9 t0 -112.53 126.94 27.52 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 120.371 -0.532 . . . . 53.31 109.693 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 122' ' ' ASN . 32.6 Cg_exo -58.55 -28.24 85.09 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.645 2.896 . . . . 70.2 112.961 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -96.13 7.18 47.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.05 -0.523 . . . . 53.54 110.504 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.414 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.8 tp -113.89 123.83 50.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.554 0.693 . . . . 63.43 109.891 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.8 m -120.26 120.57 36.49 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.547 -1.279 . . . . 60.31 107.547 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 C--N 1.297 -1.708 0 N-CA-C 107.896 -1.15 . . . . 73.21 107.896 -174.63 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 107.58 -1.267 . . . . 62.32 107.58 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.3 m -83.46 154.0 24.17 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.262 -1.385 . . . . 63.41 107.262 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 106' ' ' ASP 0.393 21.6 p-10 46.7 62.94 2.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.722 1.209 . . . . 63.14 113.244 -176.668 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 105' ' ' PRO . . . -104.51 172.62 6.7 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.37 -1.344 . . . . 74.21 107.37 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -103.89 151.43 38.88 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 109.137 -0.69 . . . . 74.14 109.137 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.459 ' HB2' HD12 ' A' ' 102' ' ' LEU . 71.1 Cg_exo -50.9 -22.08 9.56 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.06 2.507 . . . . 73.33 113.453 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.461 HG11 ' HB ' ' A' ' 69' ' ' VAL . 94.4 t -60.05 -41.62 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.082 -0.34 . . . . 34.22 110.082 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.07 -40.11 94.69 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.752 -0.658 . . . . 74.22 109.719 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.45 69.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 73.23 109.995 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.75 -44.18 93.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.576 0.751 . . . . 75.41 112.144 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -70.26 -23.58 62.92 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.441 0.638 . . . . 74.41 109.887 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -100.54 10.92 40.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.375 -0.83 . . . . 62.34 112.289 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 65.79 27.55 11.09 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.754 1.264 . . . . 72.32 111.018 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -102.86 24.76 10.18 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.3 -1.741 . . . . 72.42 106.3 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.23 -27.25 14.12 Favored 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 127.044 2.137 . . . . 14.3 115.381 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -56.5 -34.41 66.95 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.557 1.318 . . . . 71.13 114.557 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -67.39 -34.77 77.96 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.767 0.794 . . . . 50.51 109.338 175.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.62 -48.44 65.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.922 -1.035 . . . . 72.51 108.958 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.77 -43.94 99.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.529 -0.76 . . . . 74.25 109.55 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 26.1 ttt180 -57.74 -47.2 83.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.449 -0.341 . . . . 72.44 110.916 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -65.92 -33.7 76.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.684 0.278 . . . . 74.35 111.468 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.427 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -65.17 -46.72 79.66 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.47 -0.567 . . . . 74.32 109.47 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.42 -48.01 81.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.106 -0.952 . . . . 75.44 110.509 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.75 -19.42 65.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.703 -0.681 . . . . 71.35 112.335 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 tpt -79.83 -45.84 17.99 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.209 0.528 . . . . 61.2 109.793 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.403 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.71 -44.26 17.33 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.539 0.57 . . . . 71.23 112.539 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 108.836 -0.802 . . . . 73.21 108.836 -178.303 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.294 0 N-CA-C 109.025 -0.731 . . . . 71.02 109.025 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' HH12 ' A' ' 94' ' ' ARG . . . -97.67 -87.12 1.85 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 116.17 -0.468 . . . . 72.32 113.717 -176.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.94 141.46 52.02 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.468 -0.493 . . . . 72.1 111.965 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -81.5 133.98 35.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.504 -0.771 . . . . 61.33 110.481 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.38 -15.75 9.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.602 -0.727 . . . . 71.0 111.025 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 103' ' ' PHE 0.279 0.9 OUTLIER -82.56 -176.88 6.47 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 118.751 -1.18 . . . . 73.32 112.566 -178.348 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -86.93 136.0 34.69 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 116.286 -0.415 . . . . 75.34 110.263 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.58 -25.44 33.02 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.616 2.877 . . . . 73.1 113.814 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.45 -30.18 70.47 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.102 0.477 . . . . 75.35 110.234 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 43.6 mt-10 -76.35 123.58 87.89 Favored Pre-proline 0 C--O 1.254 1.308 0 CA-C-N 115.457 -0.792 . . . . 74.44 109.935 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.2 Cg_exo -73.69 175.99 9.98 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.318 2.012 . . . . 74.45 110.019 177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.432 ' HB ' ' HB ' ' A' ' 65' ' ' VAL . 12.9 p -139.97 177.93 7.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.579 0.704 . . . . 61.23 112.062 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 43.0 m-85 -109.17 160.81 15.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 125.919 1.688 . . . . 74.02 107.905 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 13.3 t0 -135.66 166.86 22.25 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 104.091 -2.559 . . . . 53.3 104.091 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.21 -53.29 63.37 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 113.065 0.765 . . . . 65.45 113.065 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 14.8 Cg_endo -58.3 -35.71 98.43 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.11 1.873 . . . . 55.31 112.66 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.435 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 23.9 tpt180 -67.38 -38.44 84.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.345 0.658 . . . . 75.12 110.284 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.4 t -69.2 -40.37 80.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 109.406 -0.591 . . . . 75.34 109.406 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -59.35 -39.49 83.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.822 -1.081 . . . . 73.14 109.646 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.18 -34.72 78.68 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.375 1.47 . . . . 73.53 110.469 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 30' ' ' TYR . 97.1 mt -77.24 -47.5 19.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.284 0.564 . . . . 64.23 111.625 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -85.02 -18.5 34.22 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.315 0.857 . . . . 74.5 113.315 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.39 48.6 Favored Glycine 0 C--N 1.307 -1.038 0 C-N-CA 119.77 -1.205 . . . . 31.21 110.178 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 34.3 m -117.91 157.75 47.58 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.007 -1.108 . . . . 75.3 108.007 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.462 ' HD2' ' HD2' ' A' ' 45' ' ' LYS . 44.3 Cg_endo -72.04 164.53 35.38 Favored 'Trans proline' 0 C--O 1.259 1.558 0 C-N-CA 121.117 1.211 . . . . 53.14 110.958 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.89 -33.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.54 0.686 . . . . 75.15 109.269 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -57.45 -41.79 81.25 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.674 -1.148 . . . . 71.45 110.685 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 54.3 mttm -69.38 -36.93 77.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.625 -0.43 . . . . 73.42 111.658 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.64 -44.69 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.401 -0.592 . . . . 55.05 109.401 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.32 -36.92 79.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.439 -0.801 . . . . 55.44 110.157 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 96.2 mt-30 -67.38 -43.32 81.69 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.079 -0.51 . . . . 70.15 111.491 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 92.7 mt-30 -58.32 -46.1 86.81 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.486 0.66 . . . . 62.13 110.052 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 96.3 mt -61.42 -45.7 93.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.352 -1.295 . . . . 51.11 110.16 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -70.85 -22.09 62.35 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.118 0.785 . . . . 64.44 113.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 57.5 mt-10 -94.48 -1.16 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.891 -0.505 . . . . 72.33 110.913 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.4 35.04 63.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.882 -0.675 . . . . 55.21 111.979 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -102.17 -16.94 16.2 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.808 -1.182 . . . . 72.33 107.808 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 54.9 tp -151.26 152.72 33.62 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.054 -1.832 . . . . 63.33 106.054 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.48 161.53 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 109.262 -0.644 . . . . 64.43 109.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.65 164.15 28.91 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.291 0.636 . . . . 54.23 110.902 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.8 m -125.24 165.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 123.826 0.85 . . . . 75.11 108.96 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -123.98 131.74 53.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.882 -0.784 . . . . 70.11 108.882 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -152.24 138.71 18.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.117 -0.697 . . . . 72.43 109.117 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.93 9.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.278 1.031 . . . . 62.03 112.335 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.21 9.7 67.01 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.181 -0.533 . . . . 74.24 112.843 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.47 142.0 15.55 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.596 -0.811 . . . . 55.33 111.168 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.78 120.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.084 -1.45 . . . . 33.31 107.084 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 12.1 m -137.16 164.37 29.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.25 -0.432 . . . . 64.33 111.312 -174.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.81 130.61 24.68 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.67 -0.863 . . . . 75.43 108.67 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.71 141.82 83.67 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.086 2.524 . . . . 72.3 113.941 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.472 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -55.2 -39.82 70.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.786 1.234 . . . . 73.12 110.399 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.98 -4.91 4.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 114.129 1.159 . . . . 70.25 114.129 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.561 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.7 m-85 -83.49 -5.46 59.17 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.856 0.836 . . . . 74.24 110.836 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -124.34 149.03 47.07 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.691 -1.14 . . . . 72.35 108.644 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.1 p -76.17 169.0 19.04 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.807 -0.812 . . . . 73.12 108.807 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -61.6 -19.15 61.9 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 70.13 110.953 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 m -80.08 -10.1 59.74 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 116.109 -0.496 . . . . 74.52 110.936 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.62 14.06 66.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.004 -0.617 . . . . 62.14 111.887 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -105.06 148.22 27.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.819 -0.224 . . . . 71.41 110.744 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.97 138.65 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 O-C-N 123.811 0.694 . . . . 72.35 109.627 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 80' ' ' SER . 57.0 t -61.94 127.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.264 -1.013 . . . . 62.02 108.264 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -63.14 -24.02 67.7 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.454 0.645 . . . . 75.24 112.589 -176.452 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.421 ' H ' HG12 ' A' ' 78' ' ' VAL . 8.6 m -92.09 2.42 56.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.073 -0.512 . . . . 51.14 110.748 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 70' ' ' PHE . 11.8 tp -65.05 -55.62 25.78 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.433 -0.349 . . . . 41.22 111.454 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.88 -28.46 86.41 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.815 1.677 . . . . 72.12 111.218 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.7 -45.46 65.78 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.489 -0.778 . . . . 44.3 111.967 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.22 -40.81 81.99 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 120.985 0.422 . . . . 72.21 110.118 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.43 -39.27 92.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.006 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.1 m -71.36 -41.23 70.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.899 -0.592 . . . . 65.3 112.224 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -68.11 -39.84 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.32 -0.552 . . . . 61.34 109.535 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 4.4 mm? -66.18 -35.67 81.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 122.257 -0.277 . . . . 63.24 111.399 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.34 -37.94 89.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.72 -0.474 . . . . 75.42 109.72 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.47 -24.94 65.66 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.741 0.781 . . . . 75.35 109.976 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -2.93 84.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.665 -0.698 . . . . 73.41 111.795 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 20.95 50.88 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.784 -0.246 . . . . 62.2 113.058 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 9.1 m-85 -86.75 152.8 22.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.109 0.781 . . . . 72.4 113.109 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.448 HH12 ' HA3' ' A' ' 19' ' ' GLY . 11.1 ptt180 -123.24 175.96 6.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.82 -1.082 . . . . 60.23 110.063 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 99' ' ' MET . 11.1 p-10 -52.18 -47.06 65.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.851 1.66 . . . . 74.33 113.49 -171.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.1 m -67.93 -40.0 83.41 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-O 121.471 0.653 . . . . 74.21 109.348 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 29.7 mm-40 -66.29 -34.62 78.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.338 -0.847 . . . . 75.24 111.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 94' ' ' ARG . 33.4 mm -61.49 -47.19 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.87 0.843 . . . . 61.22 108.819 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 23.0 mmt -70.41 -23.22 62.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.347 -1.297 . . . . 73.34 110.773 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 68.9 ttt180 -55.09 -67.23 0.29 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.474 0.71 . . . . 63.21 110.888 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.588 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 57.3 p-90 -68.93 -32.12 71.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.607 0.595 . . . . 72.35 112.607 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.588 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.2 mt -63.55 -40.6 97.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.328 0.862 . . . . 70.31 113.328 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 96.3 m-85 -98.33 -9.46 25.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.582 0.956 . . . . 63.33 113.582 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.4 m -88.35 110.97 40.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.815 -1.18 . . . . 42.14 107.815 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.26 129.9 37.27 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.65 2.233 . . . . 75.42 111.514 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.3 t70 -89.59 118.8 69.35 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 109.489 -0.559 . . . . 60.23 109.489 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -26.83 83.38 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.143 2.562 . . . . 75.01 112.213 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -94.84 10.05 36.77 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.685 -0.689 . . . . 65.23 111.431 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.9 tp -105.25 125.81 51.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.13 -0.693 . . . . 62.23 109.13 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 120' ' ' VAL . 52.1 m -132.04 110.68 10.89 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.352 -0.981 . . . . 61.11 108.352 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.6 pt . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 115.878 -0.601 . . . . 70.5 110.508 -175.66 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 110' ' ' THR . 44.4 t . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 110.177 -0.305 . . . . 63.14 110.177 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.7 m -83.17 139.35 33.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.07 -1.456 . . . . 75.34 107.07 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.5 t30 69.36 69.33 0.26 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.386 1.089 . . . . 62.33 108.779 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.43 159.94 21.98 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.698 -1.137 . . . . 75.3 109.931 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -75.46 125.23 88.99 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.796 -0.816 . . . . 62.12 108.796 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 72.3 Cg_exo -53.89 -23.92 29.46 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.269 2.646 . . . . 75.34 112.958 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.723 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 84.6 t -60.31 -42.16 89.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.642 -0.708 . . . . 73.43 111.553 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.18 -30.71 71.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.358 0.599 . . . . 71.53 110.471 -172.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.9 84.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.008 -0.996 . . . . 61.32 111.786 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.723 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -70.41 -36.82 74.26 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.82 -0.55 . . . . 44.44 111.671 -177.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -76.09 -22.62 55.39 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.588 -0.893 . . . . 75.34 108.588 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.16 43.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.715 -1.129 . . . . 62.45 111.413 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.8 m80 65.52 28.44 11.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.111 0.964 . . . . 72.13 112.127 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -108.64 25.23 11.97 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 125.146 1.378 . . . . 75.22 107.607 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.41 -26.37 7.82 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.89 2.076 . . . . 74.21 113.268 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 39.2 ttp180 -54.37 -41.26 68.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.933 -0.395 . . . . 75.43 109.933 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.504 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 56.6 mm-40 -67.35 -28.51 68.02 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.549 -0.296 . . . . 52.12 111.653 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.07 -45.5 54.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.4 -0.963 . . . . 60.32 108.4 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.66 -49.2 84.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.036 -0.529 . . . . 72.32 110.338 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 136' ' ' GLU 0.318 0.0 OUTLIER -63.64 -37.43 87.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.187 0.81 . . . . 74.22 113.187 178.379 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 144' ' ' MET . 1.6 mpt_? -63.6 -40.1 96.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.484 -0.561 . . . . 72.44 109.484 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.424 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -61.5 -42.78 99.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 52.42 110.614 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -56.89 -49.52 75.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.339 0.656 . . . . 73.5 109.88 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.56 -33.12 74.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.172 -0.922 . . . . 73.33 111.892 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 92.6 mmm -77.01 -47.2 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.835 -0.346 . . . . 63.01 111.093 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.88 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.857 -0.61 . . . . 60.42 112.065 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 N--CA 1.427 -1.576 0 C-N-CA 120.655 -0.418 . . . . 74.23 110.47 -178.61 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.009 0 N-CA-C 109.758 -0.46 . . . . 64.22 109.758 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.35 -104.28 2.72 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 121.07 -0.586 . . . . 73.41 112.351 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.06 137.28 52.36 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.392 -0.523 . . . . 74.34 111.539 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.58 143.1 35.08 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.346 -0.843 . . . . 75.01 110.937 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.63 -15.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 116.055 -0.52 . . . . 75.34 110.932 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.266 1.0 OUTLIER -86.09 175.55 8.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 118.314 -1.354 . . . . 74.24 111.631 179.02 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.446 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 20.3 t70 -82.21 141.1 46.02 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.172 -0.677 . . . . 73.21 109.172 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.413 ' HA ' ' NH1' ' A' ' 60' ' ' ARG . 71.1 Cg_exo -50.4 -32.06 32.59 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.003 2.469 . . . . 72.43 114.388 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.54 -10.02 59.55 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.942 1.09 . . . . 60.33 113.942 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 9.9 mm-40 -66.3 136.32 95.15 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 107.787 -1.19 . . . . 75.03 107.787 175.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.8 133.71 51.74 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.171 2.581 . . . . 72.43 112.629 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.7 p -132.84 168.55 18.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.057 -0.519 . . . . 63.4 111.092 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.469 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 24.6 m-85 -130.83 161.5 31.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 125.23 1.412 . . . . 73.35 108.464 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -134.67 166.57 22.62 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.343 -1.725 . . . . 62.12 106.343 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -43.37 -61.54 1.8 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 116.018 1.859 . . . . 63.12 116.018 -169.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.07 -29.37 74.86 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.448 1.432 . . . . 63.3 112.352 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.9 tpt180 -70.86 -36.22 72.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.081 0.467 . . . . 73.42 110.041 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.81 -37.9 74.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.628 -0.508 . . . . 74.43 109.628 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.15 81.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.458 -0.792 . . . . 74.13 109.393 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 35.9 tt0 -63.9 -45.78 87.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.716 -1.129 . . . . 54.34 110.724 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.466 HD22 ' CE2' ' A' ' 30' ' ' TYR . 39.6 tp -64.81 -46.93 79.94 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.194 -0.912 . . . . 64.23 111.534 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.65 -18.29 35.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.86 0.689 . . . . 64.11 112.86 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.81 53.07 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.07 -1.062 . . . . 53.22 111.448 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.05 158.71 74.39 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.131 -0.692 . . . . 54.04 109.131 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -65.78 159.84 46.66 Favored 'Trans proline' 0 C--O 1.25 1.089 0 C-N-CA 121.856 1.704 . . . . 62.01 112.192 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.2 -33.61 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.247 1.019 . . . . 63.43 111.252 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -57.87 -42.46 84.6 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.617 -0.72 . . . . 71.14 110.946 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.683 ' HA ' ' HG3' ' A' ' 48' ' ' GLN . 68.2 mttm -70.06 -34.82 73.68 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.006 -0.543 . . . . 74.53 112.007 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.36 -41.63 90.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.287 -0.635 . . . . 64.33 109.287 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.37 96.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.203 -0.908 . . . . 72.5 110.589 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.683 ' HG3' ' HA ' ' A' ' 45' ' ' LYS 0.308 0.0 OUTLIER -70.72 -35.03 72.52 Favored 'General case' 0 C--O 1.201 -1.483 0 C-N-CA 120.216 -0.594 . . . . 70.42 112.241 178.632 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 84.5 mm-40 -58.09 -43.14 86.93 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.482 0.658 . . . . 73.05 109.229 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.67 -46.09 91.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.687 -1.142 . . . . 74.24 108.933 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -70.68 -21.41 62.59 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.058 -0.974 . . . . 75.33 113.383 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -84.48 -7.39 59.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.904 0.383 . . . . 72.55 110.429 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.53 22.69 58.0 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.482 -0.647 . . . . 71.34 111.482 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 m170 -91.42 -17.95 24.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.058 0.456 . . . . 73.22 109.971 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 tp -151.42 155.37 38.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.43 -0.952 . . . . 72.12 108.43 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.5 t -137.47 147.11 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.028 -1.101 . . . . 70.34 108.028 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.14 156.15 44.36 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.3 -0.63 . . . . 64.21 109.3 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.3 m -127.48 166.03 25.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 O-C-N 123.595 0.559 . . . . 60.01 109.928 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -122.48 137.74 54.78 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.068 -0.716 . . . . 74.02 109.068 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' NH1' ' HA ' ' A' ' 25' ' ' PRO . 39.2 ptt180 -153.34 138.22 17.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.918 -1.142 . . . . 75.32 107.918 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.93 16.28 10.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.955 0.902 . . . . 74.32 110.875 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.06 78.42 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.614 -0.721 . . . . 71.41 112.133 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.76 143.61 15.68 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 111.312 -0.715 . . . . 54.05 111.312 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 p -97.73 123.27 50.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.777 0.799 . . . . 73.41 109.426 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.61 151.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.963 -1.017 . . . . 63.24 110.534 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 mp -105.35 126.67 30.33 Favored Pre-proline 0 C--N 1.28 -2.43 0 N-CA-C 107.517 -1.29 . . . . 64.12 107.517 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.36 118.03 4.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.091 1.86 . . . . 63.41 110.435 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.469 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 44.9 tt0 -60.95 -24.56 66.15 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.184 0.594 . . . . 75.34 111.667 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.83 -5.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 115.265 -0.88 . . . . 53.12 112.436 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.42 ' CZ ' ' HE1' ' A' ' 99' ' ' MET . 3.2 m-85 -80.42 -14.39 58.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.009 0.909 . . . . 72.24 109.637 173.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.3 151.39 26.05 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.127 -1.064 . . . . 70.33 108.127 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.4 p -76.23 175.24 9.21 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.574 -0.528 . . . . 75.15 109.574 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.82 -17.75 63.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.7 0.762 . . . . 52.53 109.994 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 m -83.3 -4.14 58.15 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.075 -0.511 . . . . 71.25 111.186 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.79 26.3 60.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.039 -0.601 . . . . 51.24 112.822 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.58 154.88 39.99 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.716 -0.846 . . . . 72.0 108.716 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.57 135.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.536 -0.542 . . . . 74.15 109.536 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 12.7 t -61.94 141.61 17.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.064 -1.458 . . . . 73.24 107.064 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -54.32 -44.94 72.47 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.459 1.281 . . . . 62.3 114.459 -169.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 64.6 m -109.31 21.72 16.73 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.543 -0.863 . . . . 72.2 112.246 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.478 ' HB3' ' HD3' ' A' ' 82' ' ' PRO . 17.7 tp -58.04 -48.65 96.71 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 115.041 -0.981 . . . . 70.43 110.799 174.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 50.1 Cg_exo -58.96 -27.47 84.88 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.907 1.738 . . . . 70.53 111.396 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -62.81 -45.53 95.52 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.949 -0.569 . . . . 63.14 112.388 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.56 -39.9 80.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.699 0.762 . . . . 74.22 109.329 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.55 -44.52 90.51 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.906 -1.043 . . . . 65.04 110.492 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.7 m -67.14 -45.84 75.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.764 -0.653 . . . . 41.22 111.657 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -61.58 -45.27 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 120.542 0.211 . . . . 64.11 111.403 -178.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD13 ' HB2' ' A' ' 145' ' ' ALA . 4.5 mm? -67.23 -42.45 84.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.65 0.611 . . . . 55.51 112.65 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -64.56 -44.46 90.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.824 -0.436 . . . . 61.44 109.824 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -68.18 -26.77 65.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.852 -0.613 . . . . 72.52 109.51 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.48 -9.36 86.98 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.416 -0.811 . . . . 42.45 113.313 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.2 53.39 2.19 Favored Glycine 0 C--O 1.242 0.64 0 C-N-CA 121.03 -0.605 . . . . 65.31 113.009 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 84.1 m-85 -129.8 136.95 50.19 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.968 0.413 . . . . 64.31 111.46 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.657 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 24.1 ptt180 -81.23 169.97 16.68 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.114 -0.948 . . . . 75.04 110.807 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 99' ' ' MET . 12.3 p-10 -55.13 -45.2 75.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.217 1.407 . . . . 75.34 111.624 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -61.8 -40.38 95.04 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.596 -0.729 . . . . 73.04 111.084 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.657 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 45.1 mm-40 -66.13 -34.64 78.5 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.723 -0.391 . . . . 72.42 111.247 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 mm -63.17 -47.59 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.352 -0.981 . . . . 63.04 108.352 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.42 ' HE1' ' CZ ' ' A' ' 70' ' ' PHE . 22.3 mmt -69.77 -22.1 63.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.201 -1.363 . . . . 73.54 110.543 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -58.2 -67.1 0.38 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.265 0.626 . . . . 70.34 109.734 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.484 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.5 p-90 -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.734 0.642 . . . . 74.23 112.734 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.484 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 mt -61.59 -39.93 92.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.828 0.677 . . . . 73.44 112.828 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 95.6 m-85 -98.69 -9.77 24.16 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 113.235 0.828 . . . . 72.35 113.235 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.9 m -86.0 116.04 64.18 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.552 -0.907 . . . . 72.14 108.552 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.99 154.68 73.86 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.753 2.302 . . . . 75.23 112.953 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.3 t70 -99.71 120.45 57.35 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.173 -1.047 . . . . 72.55 108.173 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.23 -27.32 84.64 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.267 2.645 . . . . 72.2 113.519 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.3 p -100.03 4.3 44.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.442 0.639 . . . . 62.11 112.215 -175.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.5 tp -102.16 139.33 37.92 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.408 -0.59 . . . . 75.55 109.408 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.2 m -129.82 118.49 21.85 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.278 -0.638 . . . . 74.24 109.278 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 C--N 1.309 -1.158 0 N-CA-C 108.262 -1.014 . . . . 64.24 108.262 -174.635 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.8 t . . . . . 0 N--CA 1.432 -1.368 0 N-CA-C 108.986 -0.746 . . . . 75.11 108.986 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.1 m -81.81 138.75 35.07 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.051 -1.092 . . . . 62.11 108.051 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 10.3 t30 72.4 69.33 0.14 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.293 1.044 . . . . 71.51 110.09 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.9 167.22 10.41 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.636 -1.165 . . . . 65.53 108.494 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.581 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 6.2 ptp180 -94.18 149.32 36.61 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.024 -0.732 . . . . 74.4 109.024 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.428 ' HB2' HD23 ' A' ' 102' ' ' LEU . 97.9 Cg_exo -50.8 -27.54 20.6 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.168 2.579 . . . . 62.33 113.306 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 48.3 t -60.97 -36.78 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.242 0.544 . . . . 74.35 110.375 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.581 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 66.4 m-20 -69.04 -36.87 78.2 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.037 -0.727 . . . . 62.43 109.037 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.79 -40.16 79.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.269 -0.878 . . . . 75.23 111.589 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -66.73 -38.85 87.51 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.766 -0.374 . . . . 74.11 111.931 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.413 ' N ' HD12 ' A' ' 129' ' ' LEU . 47.6 t-80 -75.97 -17.17 59.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.91 0.862 . . . . 75.23 109.239 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.76 4.5 36.57 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.131 -0.941 . . . . 72.11 110.055 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 67.88 28.3 7.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.561 1.144 . . . . 75.24 111.763 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -103.93 24.11 11.83 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.581 1.152 . . . . 64.42 108.746 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.49 -27.51 16.61 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 125.126 1.371 . . . . 73.42 112.72 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -55.53 -43.86 76.15 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.825 0.85 . . . . 73.05 110.974 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 2.3 tm-20 -73.2 -32.13 64.6 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.969 -0.752 . . . . 72.3 108.969 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.64 -42.5 89.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.015 -0.539 . . . . 62.34 110.013 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 134' ' ' ALA . 92.6 t -59.23 -41.65 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.956 -0.565 . . . . 71.21 109.523 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 136' ' ' GLU . 43.0 ttt180 -56.88 -47.12 81.2 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.01 -0.996 . . . . 73.03 110.016 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -68.96 -35.58 76.93 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.044 -0.526 . . . . 71.31 111.858 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.2 -43.44 98.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.841 0.353 . . . . 71.44 110.227 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -60.19 -45.86 91.69 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.803 -0.635 . . . . 71.42 110.178 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.4 84.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.196 -0.911 . . . . 31.52 112.075 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.57 -27.84 51.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.119 -0.492 . . . . 53.23 111.856 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -82.83 -63.6 1.33 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.182 0.808 . . . . 53.03 113.182 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 C--N 1.298 -1.665 0 CA-C-O 118.183 -0.913 . . . . 71.33 111.743 -170.863 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 106.924 -1.51 . . . . 62.34 106.924 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.24 -129.17 3.52 Favored Glycine 0 N--CA 1.422 -2.254 0 C-N-CA 120.556 -0.83 . . . . 62.2 111.849 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -109.97 146.75 34.72 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.614 -0.513 . . . . 55.34 109.614 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.619 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 19.1 t0 -78.44 125.24 29.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.349 0.595 . . . . 72.42 111.456 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.67 -15.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.922 -1.036 . . . . 70.44 109.059 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 103' ' ' PHE . 24.0 mt -85.84 174.4 9.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 115.084 1.512 . . . . 63.51 115.084 -175.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -105.34 141.98 23.75 Favored Pre-proline 0 N--CA 1.423 -1.825 0 CA-C-N 112.379 -2.192 . . . . 74.51 106.636 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -55.38 -27.05 56.24 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.943 2.429 . . . . 65.22 114.412 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -91.55 -13.59 31.79 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.389 0.614 . . . . 73.33 110.755 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.607 ' HG2' HD22 ' A' ' 23' ' ' LEU . 9.0 tp10 -77.85 129.37 76.46 Favored Pre-proline 0 C--O 1.242 0.683 0 N-CA-C 105.562 -2.014 . . . . 73.2 105.562 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HD2' ' OE2' ' A' ' 27' ' ' GLU . 17.7 Cg_exo -31.08 106.91 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 125.204 3.936 . . . . 35.41 115.381 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.88 155.85 48.27 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.689 -0.687 . . . . 41.32 112.385 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 22.6 m-85 -129.45 161.38 30.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 125.552 1.541 . . . . 74.43 108.077 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.597 ' OD1' ' HD3' ' A' ' 34' ' ' ARG . 5.5 p-10 -135.13 172.1 13.49 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.38 -1.711 . . . . 71.54 106.38 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -42.98 -61.13 1.89 Allowed Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 115.844 1.794 . . . . 63.14 115.844 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.1 -34.97 99.06 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.915 1.743 . . . . 60.31 112.764 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.597 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 5.2 mpt_? -70.15 -36.09 74.48 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.88 0.326 . . . . 73.42 111.88 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.538 HG21 HD12 ' A' ' 66' ' ' ILE . 79.8 t -69.69 -41.78 80.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.661 -0.496 . . . . 74.24 109.661 177.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.52 91.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.334 -0.848 . . . . 71.15 109.771 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -62.85 -46.11 89.41 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.838 1.255 . . . . 71.1 109.791 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.415 HD22 ' CE2' ' A' ' 30' ' ' TYR . 28.2 tp -70.52 -46.03 64.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.787 -1.097 . . . . 73.41 111.516 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB2' HG22 ' A' ' 41' ' ' VAL . 98.0 mt -84.51 -18.97 34.06 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.42 0.526 . . . . 72.22 112.42 -176.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.57 59.09 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 110.81 -0.916 . . . . 51.12 110.81 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 39' ' ' LEU . 19.4 m -126.51 164.25 35.52 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.405 -0.591 . . . . 74.14 109.405 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.99 164.48 27.33 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 121.673 1.582 . . . . 73.33 111.446 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.54 -34.55 65.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.546 -0.752 . . . . 75.32 109.422 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 m -58.73 -38.9 79.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.59 -0.732 . . . . 52.13 111.851 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 24.3 ttmm -69.49 -37.5 77.27 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.481 -0.488 . . . . 70.24 110.285 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 59.7 t -63.84 -42.11 94.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.945 -0.761 . . . . 54.13 108.945 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.62 74.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 72.33 110.556 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.8 -46.38 75.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.26 -0.427 . . . . 63.03 110.577 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 68.3 mt-30 -59.08 -45.95 89.52 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.213 0.53 . . . . 55.15 110.131 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 96.9 mt -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.627 -1.17 . . . . 52.55 110.305 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -70.3 -31.24 68.49 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.811 1.041 . . . . 74.21 113.811 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.71 -11.76 35.94 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.165 -0.614 . . . . 73.35 112.234 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 36.44 6.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.318 -0.944 . . . . 73.2 111.965 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -99.11 -22.37 15.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.444 -0.947 . . . . 62.22 108.444 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.7 tp -157.13 155.26 30.72 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.773 -1.565 . . . . 73.23 106.773 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.83 161.64 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 118.159 0.436 . . . . 73.44 110.434 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.37 158.67 43.83 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.281 0.363 . . . . 50.14 110.21 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 m -127.83 165.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.343 0.657 . . . . 53.22 110.142 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -121.57 128.55 52.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.76 0.314 . . . . 61.24 111.161 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.619 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 20.9 ptt180 -136.2 124.2 22.84 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.394 -0.595 . . . . 74.1 109.394 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.72 14.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 63.53 111.729 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.93 -3.41 84.69 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.933 -0.576 . . . . 60.13 112.303 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.19 138.09 13.74 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 111.056 -0.818 . . . . 54.41 111.056 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.6 123.45 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.874 -1.158 . . . . 65.24 107.874 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.2 m -131.22 151.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.345 0.593 . . . . 72.23 110.936 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 35' ' ' VAL . 76.0 mt -124.45 125.5 25.6 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 107.437 -1.32 . . . . 74.13 107.437 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 54.4 Cg_exo -56.87 128.98 32.17 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.769 2.313 . . . . 63.44 112.607 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 47.5 tt0 -64.54 -24.79 67.72 Favored 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 123.421 0.688 . . . . 72.43 111.206 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.83 -3.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.569 -0.741 . . . . 74.04 112.425 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.415 ' CD1' ' HB2' ' A' ' 67' ' ' PRO . 5.1 m-85 -87.15 -4.1 59.1 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.428 1.109 . . . . 73.53 108.752 173.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -117.35 150.43 38.85 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 113.979 -1.464 . . . . 75.54 107.398 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -83.01 173.03 12.14 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.629 -0.878 . . . . 53.0 108.629 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.28 -17.27 64.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.411 0.624 . . . . 74.12 110.62 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -81.27 -3.91 53.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.692 -0.686 . . . . 63.22 111.478 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 23.84 58.85 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.77 -0.729 . . . . 41.31 112.976 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.12 154.76 44.33 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.285 -1.005 . . . . 74.33 108.285 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.8 t -62.6 142.75 16.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 123.62 0.575 . . . . 65.1 109.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.31 135.08 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.974 0.796 . . . . 63.33 109.346 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -54.91 -43.66 73.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.852 -0.613 . . . . 54.45 112.295 -174.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -98.67 18.35 17.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.904 0.705 . . . . 62.44 112.904 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -60.6 -52.08 75.27 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-N 116.595 -0.275 . . . . 65.53 110.803 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 19.3 Cg_endo -59.85 -27.92 86.03 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 121.881 1.721 . . . . 70.13 111.796 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.58 92.93 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 116.098 -0.501 . . . . 50.43 112.084 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -68.22 -39.98 82.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.285 0.564 . . . . 65.13 109.482 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.29 -36.27 83.57 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.785 -0.643 . . . . 62.51 110.73 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.2 m -61.0 -47.8 84.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.358 -0.383 . . . . 73.04 111.999 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -42.56 86.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 120.67 -0.412 . . . . 71.25 110.607 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.04 -35.62 80.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.499 0.555 . . . . 73.54 112.499 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -63.9 -33.45 75.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.026 -0.361 . . . . 73.53 110.026 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.58 -31.18 71.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.075 -0.511 . . . . 73.11 110.222 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.97 -9.19 81.17 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.715 -0.675 . . . . 43.34 111.473 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.12 55.76 3.96 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 112.402 -0.279 . . . . 64.3 112.402 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 88.7 m-85 -113.77 137.83 51.1 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.236 0.458 . . . . 74.54 112.236 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' O ' HG12 ' A' ' 98' ' ' ILE . 15.4 ptp180 -88.03 172.23 9.7 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.462 -0.79 . . . . 63.31 111.176 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -53.59 -45.06 69.88 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.267 1.427 . . . . 71.43 112.425 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -60.13 -41.57 92.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.208 0.603 . . . . 73.01 110.059 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 5.7 mm-40 -63.21 -43.85 96.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.992 -0.549 . . . . 73.55 110.412 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.7 mm -61.15 -48.13 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.587 0.708 . . . . 72.23 109.3 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.437 ' O ' ' HD2' ' A' ' 103' ' ' PHE . 53.8 mtt -74.65 -20.97 59.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.138 -0.937 . . . . 71.12 111.638 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 64.3 ttt180 -57.2 -65.88 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.025 0.53 . . . . 74.21 110.576 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.486 ' CD1' ' HG3' ' A' ' 144' ' ' MET . 41.0 p-90 -69.02 -33.1 73.1 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.968 0.729 . . . . 72.12 112.968 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.47 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.1 mt -57.24 -40.5 77.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.976 0.732 . . . . 71.25 112.976 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 23' ' ' LEU . 97.1 m-85 -98.65 3.48 47.82 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.544 0.572 . . . . 72.11 112.544 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.3 m -87.44 119.58 70.83 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.985 -0.376 . . . . 45.51 109.985 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 32.2 Cg_exo -62.74 128.84 24.37 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.616 1.544 . . . . 43.24 108.348 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . 30.1 t70 -99.99 122.57 50.21 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 120.301 -0.56 . . . . 72.43 110.209 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.4 -19.53 59.08 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.411 2.741 . . . . 65.14 113.7 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -107.6 3.86 25.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 111.919 0.34 . . . . 64.03 111.919 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.4 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 53.5 tp -102.64 130.6 49.59 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.74 0.781 . . . . 71.31 110.979 -177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.9 m -131.28 118.65 20.66 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.476 -1.305 . . . . 41.43 107.476 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.3 pt . . . . . 0 C--O 1.215 -0.716 0 N-CA-C 113.156 0.799 . . . . 65.42 113.156 -174.018 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 109.065 -0.717 . . . . 75.45 109.065 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -83.21 154.46 24.22 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.059 -0.973 . . . . 70.23 111.337 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 78.8 m-20 62.44 40.81 10.56 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.481 1.112 . . . . 74.12 110.949 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 174.41 6.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.16 -0.473 . . . . 62.11 110.858 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -102.69 143.74 27.21 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 116.379 -0.373 . . . . 75.34 111.077 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.5 Cg_exo -53.36 -24.32 27.07 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.847 3.031 . . . . 70.41 114.595 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.63 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 71.2 t -60.4 -39.83 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 122.158 0.98 . . . . 65.11 110.405 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.18 -30.47 67.6 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.052 -0.976 . . . . 74.21 110.381 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.17 77.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 71.34 111.422 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.71 -36.27 82.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.932 -0.307 . . . . 64.44 111.599 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -66.57 -29.13 69.12 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.68 0.752 . . . . 73.12 109.963 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.89 0.38 53.24 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.883 -1.053 . . . . 44.43 111.608 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.7 t60 64.55 28.7 13.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 122.868 1.318 . . . . 51.42 109.572 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -95.02 25.13 4.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.788 1.28 . . . . 73.12 108.282 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -53.89 -29.39 41.55 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.508 -1.678 . . . . 54.44 113.491 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -63.61 -37.55 87.75 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.931 -0.766 . . . . 71.14 108.931 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -63.18 -42.56 99.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.231 -0.895 . . . . 70.13 109.173 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.43 -47.93 87.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.585 -0.734 . . . . 71.3 110.342 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 134' ' ' ALA . 99.1 t -59.38 -44.77 93.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.434 -0.348 . . . . 73.3 111.416 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -63.68 -38.4 90.96 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.944 -0.702 . . . . 74.14 111.361 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -69.0 -36.52 77.91 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.829 -0.434 . . . . 72.11 109.829 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.37 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.717 -0.674 . . . . 73.1 109.877 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.74 -42.88 94.18 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.939 -0.573 . . . . 52.45 111.015 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.68 -25.96 65.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.23 0.538 . . . . 52.12 111.486 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.486 ' HG3' ' CD1' ' A' ' 101' ' ' TRP . 0.5 OUTLIER -82.18 -39.75 22.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.449 0.642 . . . . 61.11 109.421 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -81.54 -40.75 22.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.782 0.66 . . . . 75.42 112.782 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 109.453 -0.573 . . . . 74.24 109.453 -177.873 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 106.361 -1.718 . . . . 73.04 106.361 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.6 -110.96 2.97 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.581 -0.819 . . . . 71.03 113.327 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.36 123.18 38.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.256 0.55 . . . . 75.13 111.879 -171.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 23' ' ' LEU . 3.5 t70 -61.29 131.94 51.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.285 -0.871 . . . . 71.21 111.75 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.06 -4.78 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 122.07 0.938 . . . . 72.11 109.29 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 17.6 mt -74.98 165.15 25.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.618 1.199 . . . . 72.32 113.941 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.3 t70 -94.26 134.66 25.37 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 105.314 -2.106 . . . . 72.13 105.314 172.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.84 -21.75 27.14 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 123.406 2.738 . . . . 52.52 114.572 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.86 -23.85 23.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.208 0.447 . . . . 54.43 112.208 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 23.2 mm-40 -65.87 139.22 96.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.07 -0.252 . . . . 65.53 111.676 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.1 128.0 28.36 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.351 2.701 . . . . 71.13 113.102 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.5 p -122.94 170.07 10.5 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 121.629 0.728 . . . . 73.32 111.484 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 24.9 m-85 -130.36 161.21 31.83 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 126.401 1.88 . . . . 71.3 107.851 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 66.3 t0 -135.03 161.74 34.44 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 103.346 -2.835 . . . . 73.15 103.346 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 mt -53.12 -51.44 75.05 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 112.672 0.619 . . . . 72.41 112.672 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.31 -35.37 98.77 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.161 1.907 . . . . 55.51 112.2 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 13.5 tpt180 -70.78 -38.54 73.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.48 -0.327 . . . . 73.43 110.697 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 66' ' ' ILE . 59.5 t -68.15 -37.46 78.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.602 -0.518 . . . . 53.21 109.602 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.89 81.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.289 -0.869 . . . . 64.44 109.68 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.8 -45.96 80.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.203 -0.908 . . . . 45.24 109.68 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.417 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 49.7 tp -62.31 -50.66 70.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.906 -1.043 . . . . 71.34 112.3 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.43 -13.92 41.94 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.469 0.544 . . . . 73.12 112.469 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.44 31.5 56.72 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 110.947 -0.861 . . . . 73.32 110.947 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.6 m -121.98 161.26 43.38 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.529 -0.915 . . . . 75.24 108.529 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.07 163.47 35.13 Favored 'Trans proline' 0 C--O 1.262 1.681 0 C-N-CA 121.393 1.395 . . . . 63.12 111.673 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.19 -33.21 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.82 0.848 . . . . 70.42 109.526 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 13.4 m -57.03 -44.38 82.86 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.728 -1.124 . . . . 63.4 110.617 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 51.8 mtpt -69.4 -32.04 70.79 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.101 -0.374 . . . . 71.42 111.425 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.43 -44.38 99.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 109.593 -0.521 . . . . 74.22 109.593 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.83 81.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 64.52 109.996 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 44' ' ' SER . 89.1 mt-30 -64.51 -41.43 96.43 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 116.275 -0.42 . . . . 74.32 111.543 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 44.4 mt-30 -61.04 -42.14 97.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.802 0.81 . . . . 74.32 109.961 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.24 -41.19 98.2 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.074 -1.421 . . . . 72.53 109.696 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -71.57 -21.97 61.81 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.77 -0.65 . . . . 74.02 112.291 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 50.9 mt-10 -81.71 -12.68 58.53 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 122.103 -0.373 . . . . 61.11 110.64 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.2 23.35 77.73 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.52 -1.032 . . . . 74.31 110.52 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -109.26 5.54 23.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.394 0.616 . . . . 74.45 110.523 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 tp -153.6 151.57 29.88 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.279 -1.749 . . . . 75.51 106.279 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.01 148.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.317 -0.623 . . . . 73.11 109.317 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB2' HG12 ' A' ' 66' ' ' ILE . . . -141.62 161.8 37.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.972 -0.751 . . . . 44.42 108.972 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.63 160.31 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 123.343 0.402 . . . . 60.42 110.445 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 40.2 ttm180 -115.34 117.84 31.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.393 0.616 . . . . 75.04 111.698 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 26.2 ptt180 -127.96 130.07 47.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.077 -0.712 . . . . 75.0 109.077 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.05 21.63 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.945 0.898 . . . . 74.05 110.384 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.14 -15.06 64.02 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.841 -0.618 . . . . 42.24 112.731 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.45 143.1 16.52 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.02 -0.61 . . . . 32.42 112.244 -177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.14 121.41 47.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 109.366 -0.605 . . . . 72.22 109.366 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.43 152.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.605 -0.725 . . . . 74.23 110.892 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 57' ' ' ALA . 78.9 mt -115.1 133.48 22.67 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.283 -1.006 . . . . 72.24 108.283 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.12 130.33 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.755 1.637 . . . . 72.51 111.156 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 48.4 tt0 -62.59 -24.56 67.62 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.164 0.507 . . . . 73.02 111.181 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -67.38 -6.97 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.684 -0.689 . . . . 63.34 112.707 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.571 ' CD2' HD11 ' A' ' 81' ' ' LEU . 5.2 m-85 -81.56 -11.24 59.23 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.217 1.008 . . . . 65.31 109.24 173.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -113.06 164.2 13.77 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.676 -1.147 . . . . 73.34 108.291 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.49 ' HA ' ' CD2' ' A' ' 130' ' ' HIS . 37.5 p -82.34 165.97 19.87 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.131 -0.692 . . . . 74.12 109.131 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -64.71 -19.14 65.59 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.047 -0.524 . . . . 72.21 109.627 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 m -79.51 -19.9 48.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.576 -0.738 . . . . 71.31 110.229 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.46 -5.96 38.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.436 -0.888 . . . . 70.53 113.75 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.84 166.2 11.74 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.086 -0.655 . . . . 74.13 109.489 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.05 139.91 20.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.757 -0.831 . . . . 64.15 108.757 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.76 136.74 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.231 -1.026 . . . . 75.4 108.231 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -54.77 -36.56 64.98 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 112.535 0.569 . . . . 52.22 112.535 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -88.11 -0.76 57.46 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.638 0.607 . . . . 64.44 112.638 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 70' ' ' PHE . 20.3 tp -65.36 -53.64 37.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.37 -0.348 . . . . 64.41 111.809 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 38.6 Cg_exo -60.28 -30.9 92.12 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.694 1.596 . . . . 73.33 111.304 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.49 90.01 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.864 -0.607 . . . . 71.04 112.838 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 pp -68.39 -40.5 81.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.394 0.616 . . . . 72.43 109.355 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.34 -41.28 98.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.591 -0.731 . . . . 60.31 110.833 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -57.77 -47.72 81.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.477 -0.329 . . . . 71.4 111.795 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -42.11 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 120.812 -0.355 . . . . 65.43 111.345 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.36 -37.17 82.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.467 0.543 . . . . 75.32 112.467 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -66.83 -32.29 73.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.664 -0.244 . . . . 74.35 111.08 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.19 -29.91 71.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.294 0.569 . . . . 63.25 109.778 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.77 6.42 64.71 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.556 -0.747 . . . . 54.41 112.394 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.31 33.43 84.98 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.465 0.546 . . . . 73.15 114.465 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 57.8 m-85 -85.85 131.63 34.27 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 117.626 0.713 . . . . 75.33 112.344 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.566 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 21.8 ptt180 -73.32 170.45 15.01 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-N 115.345 -0.843 . . . . 75.45 111.215 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -55.02 -44.84 74.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 125.899 1.679 . . . . 54.31 112.013 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.9 m -62.64 -42.1 99.41 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.085 -0.961 . . . . 72.54 110.628 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.566 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 61.7 mm-40 -66.6 -34.74 78.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.108 -0.496 . . . . 61.31 110.328 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.46 -48.42 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.741 0.781 . . . . 74.34 108.93 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 55.1 mtt -75.13 -18.43 60.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.91 -1.041 . . . . 73.15 111.894 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -60.73 -63.46 1.29 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.989 -0.55 . . . . 72.13 110.574 -174.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.514 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 31.3 p-90 -69.32 -32.82 72.19 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.129 0.418 . . . . 73.43 112.129 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 12.2 mt -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.95 1.093 . . . . 74.34 113.95 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.402 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 84.0 m-85 -95.75 -2.95 46.75 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.008 0.744 . . . . 72.43 113.008 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 m -88.57 109.79 32.0 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 110.193 -0.299 . . . . 60.2 110.193 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 42.9 Cg_exo -60.09 144.66 99.46 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.892 2.395 . . . . 75.05 111.626 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 11.0 t70 -107.47 124.0 36.37 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.626 -0.509 . . . . 71.32 109.626 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.526 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 28.3 Cg_endo -60.62 -25.83 81.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.658 2.905 . . . . 65.34 114.513 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.6 m -102.41 1.49 35.43 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.984 0.421 . . . . 74.21 110.247 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.493 ' HG ' HG12 ' A' ' 111' ' ' ILE . 43.0 tp -101.66 130.58 48.04 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.601 -0.518 . . . . 63.51 109.601 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 m -128.04 110.54 12.59 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.802 -0.814 . . . . 63.52 108.802 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.493 HG12 ' HG ' ' A' ' 109' ' ' LEU . 39.9 mm . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 115.288 -0.869 . . . . 74.24 109.88 -172.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 109.342 -0.614 . . . . 73.4 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -83.04 148.87 27.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.746 -1.575 . . . . 61.15 106.746 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 34.2 m-80 66.99 41.37 2.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 123.828 0.851 . . . . 75.31 109.08 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.63 150.38 26.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.463 -0.495 . . . . 63.35 110.754 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -80.36 128.1 73.96 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.629 -0.878 . . . . 75.35 108.629 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.53 -24.1 8.7 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.063 3.175 . . . . 75.44 115.11 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.6 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.1 t -60.62 -39.1 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.267 0.556 . . . . 74.12 110.419 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -69.95 -30.27 67.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.187 -0.461 . . . . 74.21 111.149 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.36 82.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.699 -0.682 . . . . 73.11 111.17 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -63.95 -37.68 88.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.501 0.191 . . . . 74.2 111.307 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.49 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 61.1 t-80 -68.7 -36.79 78.92 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.741 -0.663 . . . . 73.32 109.301 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.14 21.2 5.25 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.342 -0.845 . . . . 74.13 112.773 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.8 t60 64.69 27.64 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.77 1.228 . . . . 70.4 111.361 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -110.53 24.42 12.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.965 1.364 . . . . 62.24 107.635 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.62 -25.91 12.07 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 112.416 -2.174 . . . . 74.32 112.627 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -54.78 -39.33 68.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.54 0.736 . . . . 54.34 110.75 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.35 -33.71 74.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.383 0.611 . . . . 73.42 111.072 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 129' ' ' LEU . 49.7 t -72.59 -41.96 63.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.48 -0.782 . . . . 75.24 109.651 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.7 -48.06 89.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.234 -0.439 . . . . 71.54 110.264 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -63.59 -37.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.746 -0.382 . . . . 70.35 111.428 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -65.02 -41.58 95.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.644 -0.873 . . . . 71.24 108.644 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.47 -45.08 88.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.103 -0.953 . . . . 74.23 110.262 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -62.13 -38.62 89.65 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.844 -0.616 . . . . 74.34 111.248 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.21 84.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.05 0.453 . . . . 71.33 110.51 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.8 tpt -69.64 -39.28 77.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.809 -0.632 . . . . 61.02 110.736 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.94 -53.79 5.08 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.353 0.872 . . . . 62.25 113.353 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 118.691 -0.671 . . . . 73.11 109.426 -176.189 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 N-CA-C 107.963 -1.125 . . . . 65.23 107.963 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -105.4 -86.72 1.94 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.336 -0.935 . . . . 65.52 112.796 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -127.53 143.54 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.832 0.349 . . . . 74.23 111.123 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.82 139.07 41.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.553 0.692 . . . . 72.41 112.369 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.9 t -112.12 -14.9 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.295 -0.866 . . . . 74.11 110.894 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.485 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -96.09 -179.63 4.74 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.922 -1.111 . . . . 65.1 111.657 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.64 137.08 19.36 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 108.05 -1.093 . . . . 73.52 108.05 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.88 -21.35 15.22 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.571 2.848 . . . . 62.55 114.191 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.05 -19.52 61.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.085 0.469 . . . . 64.13 111.51 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -88.5 154.68 51.16 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 119.296 -0.383 . . . . 75.32 110.017 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 4.0 Cg_endo -46.24 110.13 0.25 Allowed 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.984 3.123 . . . . 54.3 114.992 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.0 p -125.0 167.34 14.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.794 0.838 . . . . 75.41 110.686 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.499 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 13.0 m-85 -131.4 158.2 41.39 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.307 1.043 . . . . 72.21 108.193 169.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.5 t70 -136.95 168.82 18.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 104.281 -2.488 . . . . 62.32 104.281 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -50.6 -56.61 17.65 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 113.964 1.098 . . . . 61.43 113.964 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 14.6 Cg_endo -57.74 -39.8 84.53 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.205 1.936 . . . . 72.55 112.346 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -70.38 -37.54 74.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 111.972 0.36 . . . . 65.42 111.972 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 31' ' ' ASP . 46.1 t -69.3 -37.64 76.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.061 -0.718 . . . . 72.03 109.061 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.14 83.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.889 -1.051 . . . . 52.41 109.704 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.7 -45.94 84.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.875 0.87 . . . . 73.11 110.061 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -62.07 -43.33 99.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.84 -1.073 . . . . 53.41 111.903 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' A' ' 41' ' ' VAL . 83.5 mt -97.31 -12.56 22.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.939 -0.573 . . . . 72.01 112.097 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 17.15 80.18 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.538 -0.625 . . . . 71.11 111.538 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 39' ' ' LEU . 25.8 m -112.48 159.45 34.05 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.73 -0.841 . . . . 71.33 108.73 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.4 170.01 20.16 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 121.208 1.272 . . . . 72.01 111.246 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.08 -33.16 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.387 0.675 . . . . 71.14 110.484 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 m -56.35 -46.33 80.03 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 114.916 -1.038 . . . . 75.42 110.197 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 92.5 mttt -69.97 -35.27 74.32 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.032 0.382 . . . . 75.14 112.032 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -61.15 -43.72 96.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 N-CA-C 109.548 -0.538 . . . . 73.51 109.548 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' O ' ' HD3' ' A' ' 51' ' ' ARG . . . -61.04 -38.88 87.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.423 -0.808 . . . . 74.53 109.833 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 79.1 mm-40 -66.84 -36.35 82.13 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 112.91 0.707 . . . . 74.13 112.91 178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.0 mm100 -57.87 -42.8 85.3 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.726 -0.842 . . . . 74.0 108.726 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.53 -40.61 97.33 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.4 -1.273 . . . . 64.03 110.662 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 47' ' ' ALA . 10.2 mpt_? -71.21 -20.87 62.21 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.228 0.825 . . . . 75.21 113.228 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 44.5 mm-40 -76.66 -11.87 59.92 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 120.525 -0.47 . . . . 75.01 109.824 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.72 72.15 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.944 -0.863 . . . . 61.34 110.944 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -105.46 4.28 30.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.119 -0.541 . . . . 74.11 110.206 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD21 HD13 ' A' ' 66' ' ' ILE . 32.2 tp -161.12 157.51 26.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.612 -0.884 . . . . 41.41 108.612 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 93.9 t -132.82 147.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.362 -0.977 . . . . 53.14 108.362 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.72 157.85 43.85 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.886 -0.783 . . . . 73.0 108.886 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -130.46 166.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 122.92 0.488 . . . . 74.44 110.21 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 43.8 ttp180 -121.07 125.68 47.91 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.59 -0.277 . . . . 62.13 110.801 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.486 ' NH1' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -116.62 117.09 28.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.69 -0.855 . . . . 70.42 108.69 177.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.96 -48.06 0.68 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.083 1.753 . . . . 44.44 111.583 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 63' ' ' GLY . . . -176.23 -12.07 0.02 OUTLIER Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.738 -1.119 . . . . 53.13 112.287 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 62' ' ' GLY . . . -103.53 146.06 16.35 Favored Glycine 0 CA--C 1.493 -1.339 0 C-N-CA 120.634 -0.793 . . . . 71.33 112.122 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.49 128.8 47.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.203 0.525 . . . . 72.22 109.771 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG13 ' NH1' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -131.54 158.75 43.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.698 1.199 . . . . 72.25 110.107 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.414 HD13 HD21 ' A' ' 55' ' ' LEU . 65.2 mt -124.77 121.93 25.64 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.114 -1.439 . . . . 63.13 107.114 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.67 126.67 22.54 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.057 1.838 . . . . 73.03 111.192 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.499 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 47.5 tt0 -62.22 -24.65 67.36 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 121.261 0.553 . . . . 74.43 111.447 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.68 -4.54 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.092 -0.958 . . . . 54.31 112.665 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.1 m-85 -86.29 -7.64 58.34 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.073 0.939 . . . . 74.43 109.848 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -117.11 159.98 21.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.119 . . . . 74.13 107.994 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.0 p -88.02 163.37 16.32 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.823 -1.177 . . . . 62.51 107.823 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -66.26 -16.45 64.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.305 0.574 . . . . 72.43 110.382 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.2 m -79.72 -9.5 59.66 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.777 -0.647 . . . . 74.22 110.898 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.86 -2.43 66.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.304 -0.474 . . . . 51.42 113.164 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -90.37 152.84 20.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.505 -0.554 . . . . 71.11 109.505 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.53 136.19 26.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.259 -1.386 . . . . 72.31 107.259 171.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 129' ' ' LEU . 23.8 t -61.25 129.06 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.443 -0.947 . . . . 45.52 108.443 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.41 -22.33 66.08 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.751 0.648 . . . . 72.0 112.751 -177.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.441 ' H ' HG12 ' A' ' 78' ' ' VAL . 7.1 m -87.75 -8.21 56.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.963 -0.562 . . . . 64.24 110.777 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 18.0 tp -63.45 -56.44 26.77 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 119.015 -0.517 . . . . 54.12 111.248 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.0 Cg_exo -62.83 -25.2 74.51 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.331 1.354 . . . . 72.33 110.706 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -45.36 64.57 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.602 -0.726 . . . . 45.44 111.721 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.81 -40.43 79.54 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.996 -0.742 . . . . 73.24 108.996 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 74.0 mt -59.91 -39.17 84.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.766 -0.652 . . . . 65.42 110.802 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.2 m -61.47 -48.36 81.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.054 -0.521 . . . . 71.34 111.399 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -44.41 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 111.862 0.319 . . . . 74.32 111.862 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.27 -35.79 80.24 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 120.177 -0.609 . . . . 62.35 112.225 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -64.27 -41.48 96.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.616 -0.883 . . . . 70.04 108.616 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.19 -31.2 72.25 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.96 -1.018 . . . . 74.53 110.58 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.38 -9.45 81.77 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.64 -0.709 . . . . 60.45 112.893 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.9 46.09 7.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.088 -0.577 . . . . 72.33 113.723 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.439 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 96.6 m-85 -111.0 142.92 42.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.895 -0.409 . . . . 74.02 109.895 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.476 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 16.9 ptp180 -87.94 171.03 10.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.558 -0.292 . . . . 74.31 111.141 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -55.05 -45.79 75.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.856 1.262 . . . . 65.0 111.87 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.8 m -64.5 -39.99 94.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.188 -0.915 . . . . 72.5 110.41 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 45.3 mt-10 -65.82 -35.1 79.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.079 -0.51 . . . . 74.21 111.615 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.28 -46.97 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.855 -1.165 . . . . 74.41 107.855 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -66.33 -28.64 68.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.028 -1.442 . . . . 64.12 111.029 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.0 -67.33 0.27 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 122.877 0.471 . . . . 75.31 111.037 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.457 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.3 p-90 -69.05 -32.1 71.35 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.89 0.7 . . . . 75.42 112.89 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 126' ' ' VAL . 13.6 mt -61.22 -40.78 95.3 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 113.097 0.777 . . . . 72.42 113.097 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.5 m-85 -91.46 -5.4 54.35 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.803 0.668 . . . . 74.25 112.803 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 92.4 m -78.15 119.94 79.29 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.963 -0.754 . . . . 71.33 108.963 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.14 129.5 20.68 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.579 1.519 . . . . 74.4 109.426 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 34.4 t70 -105.41 116.59 60.0 Favored Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 116.388 -0.369 . . . . 74.15 111.012 -175.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.19 -25.26 80.56 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.728 2.286 . . . . 70.21 112.084 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -17.72 59.63 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.931 -0.577 . . . . 62.42 110.511 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.96 125.63 48.69 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.766 0.793 . . . . 65.3 110.828 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 m -131.28 110.87 11.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.365 -1.346 . . . . 64.21 107.365 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 CA--C 1.476 -1.872 0 N-CA-C 112.739 0.644 . . . . 64.12 112.739 -174.33 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 109.097 -0.705 . . . . 72.24 109.097 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 m -90.1 138.66 31.33 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.775 -1.194 . . . . 73.44 107.775 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 44.6 t-20 69.39 59.23 0.32 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.34 1.067 . . . . 70.51 109.134 176.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.66 164.09 11.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.689 -1.141 . . . . 74.22 109.9 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -87.55 145.85 38.17 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.464 -0.569 . . . . 70.11 109.464 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.402 ' HB2' HD23 ' A' ' 102' ' ' LEU . 79.7 Cg_exo -52.53 -28.84 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.403 2.735 . . . . 75.33 113.708 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.654 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 95.8 t -60.34 -41.99 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.242 0.544 . . . . 73.31 110.146 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.01 -30.04 70.99 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.601 0.715 . . . . 72.53 109.796 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.23 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.222 -0.899 . . . . 63.15 112.316 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 3.9 pp -68.14 -34.29 76.07 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.464 -0.494 . . . . 71.25 110.333 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -65.38 -31.85 73.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.722 -0.844 . . . . 73.23 108.722 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.74 8.28 20.4 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.785 -1.098 . . . . 72.42 111.961 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 64.06 28.32 14.26 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 123.011 1.386 . . . . 73.21 109.716 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.57 25.59 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.652 -1.158 . . . . 51.5 108.956 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.93 14.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.434 1.494 . . . . 74.12 112.212 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -56.44 -31.95 64.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.316 0.246 . . . . 72.32 111.659 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.42 -26.87 61.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 74.44 110.773 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.46 -45.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.562 -1.273 . . . . 44.45 107.562 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.26 -42.41 95.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.564 -1.198 . . . . 65.11 109.692 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -58.78 -45.31 90.11 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.44 0.696 . . . . 54.21 110.354 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.1 tpp180 -66.16 -41.28 90.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.161 -0.681 . . . . 74.34 109.161 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.58 88.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 55.34 111.118 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -62.16 -41.58 98.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 72.2 110.536 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.67 -27.45 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 70.23 112.113 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 93.8 mmm -86.0 -32.03 21.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 73.22 110.347 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.439 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.5 -60.1 2.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.322 -0.399 . . . . 73.54 112.062 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 109.249 -0.649 . . . . 72.31 109.249 -176.28 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.756 0 N-CA-C 108.503 -0.925 . . . . 53.23 108.503 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.01 -156.85 12.87 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 120.456 -0.878 . . . . 70.13 113.542 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -96.08 136.19 36.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.915 -0.642 . . . . 75.04 109.415 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.5 101.55 0.19 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.617 0.723 . . . . 74.32 111.761 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.95 -40.4 83.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.311 -0.859 . . . . 74.22 110.951 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 173.16 10.63 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.98 -0.554 . . . . 73.22 109.916 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.31 138.44 52.13 Favored Pre-proline 0 C--N 1.291 -1.957 0 N-CA-C 108.463 -0.94 . . . . 75.5 108.463 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.63 -21.71 8.27 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 123.344 2.696 . . . . 71.34 115.676 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.52 4.99 53.15 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.378 0.51 . . . . 75.04 112.378 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -84.53 158.18 60.45 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 110.03 -0.359 . . . . 72.11 110.03 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.406 ' C ' ' HG3' ' A' ' 68' ' ' GLN . 61.6 Cg_exo -42.85 106.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 124.177 3.251 . . . . 62.22 113.879 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.42 ' N ' ' HG3' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -135.41 148.58 49.38 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 113.073 0.768 . . . . 71.41 113.073 -176.369 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.45 ' CD2' ' HG2' ' A' ' 68' ' ' GLN . 30.2 m-85 -116.32 162.22 17.85 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 126.34 1.856 . . . . 64.53 106.997 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.1 m-20 -132.1 161.76 32.49 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 104.81 -2.293 . . . . 71.11 104.81 -174.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.1 mt -45.28 -56.06 10.23 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 113.384 0.883 . . . . 70.41 113.384 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.28 -35.2 85.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.444 1.43 . . . . 70.34 112.158 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 4.3 tpt180 -70.28 -36.19 74.22 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.022 0.439 . . . . 73.15 110.226 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.86 -37.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.847 0.356 . . . . 63.43 110.047 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.86 76.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.266 -0.642 . . . . 63.3 109.266 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 8.9 mm-40 -63.41 -45.23 91.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 65.31 111.697 173.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 91.1 mt -64.14 -50.13 69.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.082 0.468 . . . . 73.43 111.234 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.1 mt -81.59 -18.87 43.27 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.474 -0.784 . . . . 74.14 112.231 -174.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.16 31.83 69.15 Favored Glycine 0 C--O 1.239 0.447 0 N-CA-C 111.301 -0.719 . . . . 63.23 111.301 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 39' ' ' LEU . 24.4 m -127.84 161.55 54.9 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.177 -0.675 . . . . 73.05 109.177 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 27.8 Cg_endo -64.83 153.93 75.45 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 121.795 1.663 . . . . 72.14 112.069 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.89 -36.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.619 -0.719 . . . . 52.22 110.685 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 32.5 t -63.22 -33.93 76.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.144 -0.48 . . . . 73.03 110.961 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 62.3 tttp -69.53 -35.04 75.1 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.51 -0.552 . . . . 75.01 109.51 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 61.1 t -63.35 -41.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.837 -0.801 . . . . 63.21 108.837 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.99 -36.98 80.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.784 -0.643 . . . . 61.52 110.425 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 44' ' ' SER . 27.8 mm-40 -69.19 -35.88 76.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.714 0.292 . . . . 73.43 110.266 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.8 mt-30 -64.05 -43.18 96.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.617 0.723 . . . . 73.15 109.608 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.3 mt -61.92 -40.59 95.99 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.452 -1.249 . . . . 71.33 109.412 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -61.52 -31.75 71.77 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.184 0.593 . . . . 71.44 111.781 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.27 -12.05 53.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.177 0.436 . . . . 74.53 112.177 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.9 58.57 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.967 -1.253 . . . . 73.34 109.967 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -82.77 -23.38 33.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.787 -1.19 . . . . 63.32 107.787 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -156.76 159.28 38.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.113 -1.81 . . . . 62.42 106.113 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.34 158.72 41.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.818 -0.438 . . . . 73.1 109.818 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.02 156.19 44.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.278 0.561 . . . . 71.24 111.969 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.41 165.81 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 123.671 0.789 . . . . 73.13 110.52 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 50.7 ttp180 -114.65 125.98 54.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.024 0.379 . . . . 60.31 112.024 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.518 ' NE ' HG11 ' A' ' 65' ' ' VAL . 30.9 ptt180 -116.25 113.63 23.29 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.813 -0.81 . . . . 75.11 108.813 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.11 9.55 0.68 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.326 1.05 . . . . 53.25 113.361 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.86 -28.95 4.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 121.346 -0.454 . . . . 64.14 111.988 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -84.12 141.34 19.91 Favored Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 121.337 -0.459 . . . . 74.42 112.367 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.9 t -97.24 120.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.775 -1.195 . . . . 71.13 107.775 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.518 HG11 ' NE ' ' A' ' 60' ' ' ARG . 18.8 m -133.39 159.77 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.035 -0.984 . . . . 72.24 112.974 -171.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.83 126.11 22.42 Favored Pre-proline 0 N--CA 1.434 -1.25 0 N-CA-C 106.75 -1.574 . . . . 73.31 106.75 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.32 130.49 36.18 Favored 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 122.632 2.221 . . . . 64.21 112.721 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 71.2 mt-30 -53.94 -25.22 19.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.13 0.789 . . . . 51.21 113.13 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.83 -11.48 13.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.945 -0.57 . . . . 31.52 112.299 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.8 m-85 -85.31 -5.23 59.33 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.593 0.757 . . . . 73.14 110.367 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.41 155.11 29.1 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.6 -0.727 . . . . 72.22 110.056 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.6 p -75.78 175.89 8.28 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.002 -0.999 . . . . 74.12 109.516 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -59.48 -19.38 47.43 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.224 0.61 . . . . 74.22 111.212 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t -87.43 -8.57 56.36 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.159 0.584 . . . . 73.14 110.667 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.54 25.92 55.54 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.351 -0.7 . . . . 74.11 111.351 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -115.76 157.7 23.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.108 -0.701 . . . . 74.02 109.108 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.28 128.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.385 -0.598 . . . . 74.01 109.385 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 25.0 t -61.25 121.41 9.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 108.039 -1.097 . . . . 65.01 108.039 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -59.96 -22.28 62.3 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 113.826 1.047 . . . . 74.45 113.826 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.5 m -87.68 -15.93 35.79 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.258 0.552 . . . . 54.21 110.987 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.546 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.6 tt -66.46 -45.91 58.85 Favored Pre-proline 0 CA--C 1.565 1.534 0 N-CA-C 115.157 1.54 . . . . 60.45 115.157 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.35 -28.43 62.97 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.401 2.067 . . . . 74.53 112.045 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.58 -42.93 98.68 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.65 -0.705 . . . . 73.23 112.265 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.53 -40.58 80.67 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.542 -0.54 . . . . 74.33 109.542 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.61 -37.67 87.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 64.33 110.777 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.3 m -68.55 -40.05 80.84 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.75 -0.659 . . . . 74.22 112.138 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -42.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 119.935 -0.706 . . . . 65.35 110.5 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.489 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.4 mm? -67.31 -36.44 81.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.291 -0.564 . . . . 73.45 112.191 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -65.14 -36.99 85.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.145 -0.687 . . . . 73.04 109.145 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.56 -30.81 70.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.415 0.626 . . . . 75.24 110.146 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.18 -9.45 86.59 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.284 -0.871 . . . . 61.51 112.332 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.35 24.0 32.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.25 -0.5 . . . . 52.43 113.129 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -99.59 133.45 43.89 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 122.532 -0.393 . . . . 72.42 110.425 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -88.12 173.4 8.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.582 0.23 . . . . 74.21 111.304 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.8 -45.74 63.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.057 1.343 . . . . 71.43 113.701 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.3 m -62.69 -41.57 99.18 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.607 0.763 . . . . 74.5 110.42 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.56 -38.37 89.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.415 -0.811 . . . . 74.21 110.585 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.416 HD12 ' CB ' ' A' ' 88' ' ' LEU . 7.1 mm -61.3 -47.3 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.742 -1.207 . . . . 73.55 107.742 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.62 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 76.2 mtm -74.17 -15.48 61.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.311 -1.313 . . . . 61.13 113.649 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -56.98 -65.77 0.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.879 -0.415 . . . . 75.42 109.879 177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.422 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.4 p-90 -69.07 -32.81 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.68 0.622 . . . . 75.43 112.68 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' HB2' ' A' ' 125' ' ' PRO . 13.4 mt -60.79 -40.8 93.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.177 0.806 . . . . 74.2 113.177 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -87.76 -9.38 54.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 112.561 0.578 . . . . 62.51 112.561 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 m -88.04 122.9 69.72 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 108.781 -0.822 . . . . 75.21 108.781 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.76 129.55 35.61 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.639 1.559 . . . . 73.34 108.98 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.8 t70 -90.21 121.08 69.02 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.386 -0.598 . . . . 54.33 109.386 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.55 -16.67 49.46 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.282 2.654 . . . . 71.34 113.74 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -110.98 6.79 21.29 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 121.949 -0.469 . . . . 51.32 111.076 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.0 tp -102.87 126.06 49.86 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.727 -0.789 . . . . 74.34 111.209 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -126.3 118.23 24.67 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.652 -1.981 . . . . 75.54 105.652 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 128' ' ' ALA . 16.8 pt . . . . . 0 CA--C 1.48 -1.729 0 O-C-N 123.34 0.4 . . . . 72.1 111.678 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 107.774 -1.195 . . . . 72.4 107.774 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 p -87.85 146.64 25.49 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.455 0.472 . . . . 75.25 110.3 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 2.9 m-20 61.81 68.32 0.7 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.576 1.15 . . . . 72.22 111.377 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -119.52 170.5 9.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.948 -1.024 . . . . 63.04 110.965 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -78.03 134.22 64.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 116.001 -0.545 . . . . 74.11 109.745 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.736 ' HB2' HD23 ' A' ' 102' ' ' LEU . 73.7 Cg_exo -56.34 -28.48 72.44 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.171 1.914 . . . . 72.42 111.488 172.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.576 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 51.4 t -66.2 -34.43 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.623 0.725 . . . . 73.22 109.622 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.93 -32.37 70.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.69 -0.856 . . . . 74.44 108.69 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.522 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -69.6 -35.5 75.36 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 114.942 -1.027 . . . . 64.44 112.519 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.83 -36.58 78.38 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.139 -0.624 . . . . 74.52 111.49 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.4 ' N ' HD12 ' A' ' 129' ' ' LEU . 9.4 t-160 -77.71 -15.58 59.05 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.732 0.777 . . . . 73.21 108.939 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -87.78 4.68 43.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 35.04 110.139 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.5 m80 63.7 27.72 14.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.594 1.158 . . . . 74.41 111.307 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -106.71 26.19 10.31 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.267 -1.333 . . . . 61.44 110.886 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -51.51 -28.56 13.9 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 114.156 -1.383 . . . . 73.43 113.665 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -39.44 86.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.029 0.831 . . . . 73.42 111.82 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.421 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -63.98 -32.88 74.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.383 0.611 . . . . 74.43 110.087 177.223 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.97 -48.11 51.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.331 -0.849 . . . . 73.22 109.311 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 134' ' ' ALA . 86.6 t -60.47 -44.5 96.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 CA-C-N 115.715 -0.675 . . . . 64.15 110.994 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.421 ' NH2' ' HG3' ' A' ' 136' ' ' GLU . 14.8 ptt180 -63.84 -37.99 89.44 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.336 -0.546 . . . . 63.3 112.247 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -64.27 -39.81 94.7 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.76 -0.376 . . . . 75.4 110.35 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -61.46 -46.5 89.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.696 -0.684 . . . . 74.44 110.379 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.99 -45.45 94.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.706 -0.679 . . . . 74.24 110.757 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.93 65.24 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.494 . . . . 54.44 111.687 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.3 tpp -83.33 -41.25 18.46 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.346 0.594 . . . . 72.41 110.021 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.4 -52.18 7.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.098 -0.501 . . . . 71.33 112.314 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--N 1.307 -1.24 0 CA-C-N 116.648 -0.251 . . . . 72.52 110.333 -175.933 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 N-CA-C 110.092 -0.336 . . . . 75.45 110.092 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.58 -88.97 1.08 Allowed Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.937 -0.574 . . . . 73.11 112.671 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -121.37 126.07 48.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.805 0.336 . . . . 65.31 111.172 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 23' ' ' LEU . 12.5 t0 -80.4 142.14 34.65 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.548 -0.751 . . . . 74.41 111.361 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.42 -9.56 10.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 C-N-CA 123.679 0.792 . . . . 61.23 110.155 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.437 HD13 ' CG2' ' A' ' 29' ' ' THR . 40.2 mt -64.66 159.69 21.49 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 122.43 1.109 . . . . 75.45 113.663 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.6 t70 -80.23 138.16 52.48 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 105.799 -1.926 . . . . 72.44 105.799 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.68 -28.75 17.92 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.274 2.649 . . . . 73.41 115.452 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.18 23.17 11.09 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.161 0.8 . . . . 75.32 113.161 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 4.5 tp10 -73.83 143.43 81.38 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 105.191 -2.152 . . . . 73.55 105.191 173.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HD2' ' OE1' ' A' ' 27' ' ' GLU . 6.0 Cg_exo -39.68 107.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.945 3.097 . . . . 44.51 112.373 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.437 ' CG2' HD13 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -129.72 167.14 18.5 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.612 -0.722 . . . . 52.31 112.7 -174.256 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 26.0 m-85 -130.9 160.28 34.94 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.286 -1.376 . . . . 74.02 107.286 172.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.541 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 7.2 m-20 -134.91 159.73 40.49 Favored 'General case' 0 C--N 1.264 -3.121 0 N-CA-C 102.978 -2.971 . . . . 72.5 102.978 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.0 mt -48.47 -56.61 13.74 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 114.556 1.317 . . . . 64.01 114.556 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.89 -30.97 67.82 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.525 1.483 . . . . 60.23 112.284 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 17.7 tpt180 -70.41 -34.9 73.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.037 0.535 . . . . 75.42 109.69 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 31' ' ' ASP . 57.8 t -69.31 -39.81 79.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 109.067 -0.716 . . . . 72.23 109.067 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.72 82.39 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.719 -1.128 . . . . 62.14 109.374 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.38 -45.67 79.29 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.37 1.068 . . . . 71.22 110.54 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 30' ' ' TYR . 38.2 tp -60.76 -49.03 79.13 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.577 -0.738 . . . . 75.44 111.693 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HB2' HG22 ' A' ' 41' ' ' VAL . 66.4 mt -88.89 -18.05 28.35 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.788 -0.642 . . . . 64.13 111.448 -174.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.13 76.99 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 111.229 -0.748 . . . . 71.03 111.229 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 39' ' ' LEU . 23.8 m -104.14 162.12 20.86 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 108.417 -0.957 . . . . 73.02 108.417 -176.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.6 160.13 38.49 Favored 'Trans proline' 0 C--O 1.262 1.698 0 C-N-CA 120.931 1.088 . . . . 61.43 111.249 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.71 -32.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.747 0.784 . . . . 55.12 109.84 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 7.8 p -59.04 -37.68 77.53 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.933 -1.03 . . . . 52.53 111.758 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 19.4 ttmm -69.93 -32.89 71.41 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.408 -0.517 . . . . 73.55 110.553 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.41 -42.04 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.536 -0.913 . . . . 73.25 108.536 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -62.18 -36.53 82.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.582 -0.735 . . . . 65.52 110.399 175.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.1 mt-30 -64.94 -36.29 83.91 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.433 0.293 . . . . 61.03 110.973 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.1 mm-40 -60.46 -46.61 89.46 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.102 -1.073 . . . . 71.51 108.102 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.31 -38.59 89.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.55 -1.205 . . . . 74.15 110.36 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 47' ' ' ALA . 14.6 mmm180 -65.61 -28.81 69.39 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.696 0.628 . . . . 74.32 112.696 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.67 -1.48 30.04 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.604 0.594 . . . . 62.5 112.604 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.69 36.6 83.14 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 110.672 -0.971 . . . . 74.25 110.672 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -96.32 -20.19 18.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.396 -0.594 . . . . 72.13 109.396 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 42.1 tp -159.84 153.38 22.5 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.252 -1.388 . . . . 25.0 107.252 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.31 161.67 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 O-C-N 123.253 0.346 . . . . 64.11 110.572 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.96 159.71 39.89 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.538 -0.756 . . . . 52.3 109.084 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.5 HG11 ' HG3' ' A' ' 99' ' ' MET . 6.7 m -130.68 166.96 26.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 123.972 0.909 . . . . 74.13 109.746 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 52.2 ttp180 -114.02 115.81 28.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 121.119 -0.232 . . . . 72.34 111.608 -176.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.54 ' NE ' HG11 ' A' ' 65' ' ' VAL . 36.6 ptt180 -120.65 136.36 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.928 -1.138 . . . . 75.15 107.928 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 49.36 30.3 3.2 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.421 1.088 . . . . 65.11 113.826 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.96 57.91 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.288 -0.482 . . . . 73.14 113.023 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -133.2 152.04 20.26 Favored Glycine 0 CA--C 1.496 -1.134 0 N-CA-C 111.28 -0.728 . . . . 51.51 111.28 177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -97.62 120.38 46.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.369 -1.345 . . . . 72.51 107.369 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.54 HG11 ' NE ' ' A' ' 60' ' ' ARG . 24.2 m -134.81 164.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.816 -0.629 . . . . 63.55 111.373 -171.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 35' ' ' VAL . 62.6 mt -132.48 131.41 22.23 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.541 -1.651 . . . . 63.32 106.541 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 70' ' ' PHE . 23.4 Cg_exo -60.73 135.66 61.56 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.619 1.546 . . . . 25.12 111.221 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 47.0 tt0 -68.66 -31.19 70.13 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.77 0.795 . . . . 74.21 109.353 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.435 HG23 HG11 ' A' ' 126' ' ' VAL . 23.5 m -68.44 -3.67 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 114.201 -1.363 . . . . 74.43 111.881 177.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -86.17 -11.01 53.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.942 0.877 . . . . 63.05 109.032 177.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.53 161.39 14.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.917 -1.038 . . . . 55.5 108.204 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.7 p -75.8 161.03 29.36 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.189 -0.671 . . . . 71.23 109.189 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -59.63 -17.36 32.87 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.324 0.49 . . . . 72.34 112.324 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.3 m -94.63 -0.94 54.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 116.068 -0.515 . . . . 73.15 111.86 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.08 69.32 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.855 -0.688 . . . . 52.31 114.204 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.02 156.86 16.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.556 -0.905 . . . . 74.11 108.556 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.56 138.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.47 -1.307 . . . . 74.33 107.47 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 92.9 t -62.56 131.52 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.138 -0.689 . . . . 75.23 109.138 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.626 0.602 . . . . 52.02 112.626 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.2 t -88.15 12.15 14.46 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.391 -0.523 . . . . 62.41 111.417 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.3 tt -65.93 -54.83 25.31 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.519 -0.548 . . . . 75.3 109.519 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.93 -31.78 90.58 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.766 1.644 . . . . 75.25 110.924 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.11 -44.59 97.01 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.444 -0.798 . . . . 53.14 112.294 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.12 -40.38 82.51 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.851 -0.796 . . . . 62.12 108.851 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.02 -36.7 77.81 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.927 -0.578 . . . . 75.24 110.66 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.0 m -60.59 -49.72 76.41 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.864 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -45.35 91.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.457 -0.338 . . . . 73.25 111.906 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.634 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.0 mm? -67.42 -38.56 84.77 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.348 0.87 . . . . 74.11 113.348 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -66.19 -35.14 79.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.538 -0.541 . . . . 53.51 109.538 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.91 -30.71 64.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.973 -0.558 . . . . 72.42 110.396 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.55 -9.33 83.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 112.09 -0.404 . . . . 54.43 112.09 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.97 39.97 12.4 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 121.809 -0.234 . . . . 51.43 113.196 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.59 126.39 52.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.915 0.388 . . . . 74.32 110.749 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 98' ' ' ILE . 12.0 ptm180 -85.39 173.86 9.97 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.656 . . . . 73.32 111.686 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -52.63 -44.01 65.79 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.355 1.862 . . . . 75.31 111.744 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -61.43 -41.02 96.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 123.859 0.864 . . . . 72.31 110.567 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -64.64 -44.55 90.09 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.152 -0.931 . . . . 74.23 108.938 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 94' ' ' ARG . 16.4 mm -60.61 -48.41 88.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 115.431 -0.804 . . . . 71.13 109.262 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.5 ' HG3' HG11 ' A' ' 58' ' ' VAL . 24.6 mmt -68.06 -27.19 66.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 70.3 111.731 -176.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -58.88 -64.95 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 111.609 0.226 . . . . 61.23 111.609 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.426 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 33.2 p-90 -68.45 -32.01 71.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.298 0.481 . . . . 64.22 112.298 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.628 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . 11.5 mt -60.46 -40.14 90.14 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 113.014 0.746 . . . . 75.54 113.014 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.52 ' CE1' HG21 ' A' ' 126' ' ' VAL . 70.9 m-85 -95.63 -1.39 50.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.175 0.806 . . . . 75.42 113.175 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.5 m -88.2 116.0 64.88 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.971 -0.752 . . . . 73.45 108.971 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 86.9 Cg_exo -52.85 129.55 33.37 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.817 2.345 . . . . 72.43 111.572 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.39 125.7 58.99 Favored Pre-proline 0 C--N 1.304 -1.386 0 CA-C-N 115.908 -0.587 . . . . 73.01 110.702 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -60.75 -27.96 85.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.295 2.663 . . . . 42.11 113.591 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 m -99.84 6.86 45.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 120.807 0.337 . . . . 70.04 111.088 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.3 tp -102.47 120.09 39.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.924 0.868 . . . . 75.13 111.568 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.7 m -132.14 110.88 10.99 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 105.548 -2.019 . . . . 75.43 105.548 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 CA--C 1.472 -2.025 0 N-CA-C 114.026 1.121 . . . . 71.22 114.026 -173.934 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 108.372 -0.973 . . . . 61.22 108.372 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.8 m -90.8 138.12 31.83 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.904 -0.589 . . . . 74.33 109.901 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.1 t30 64.11 59.09 1.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.482 1.134 . . . . 72.13 110.032 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.23 161.64 13.6 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.493 -1.231 . . . . 62.14 108.739 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 8.8 ptp180 -87.07 139.92 32.58 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.438 -1.319 . . . . 74.13 107.438 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.592 ' HB2' HD23 ' A' ' 102' ' ' LEU . 93.2 Cg_exo -49.66 -29.85 20.62 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 123.319 2.679 . . . . 55.33 114.812 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.628 ' CG2' ' HB3' ' A' ' 102' ' ' LEU . 24.8 t -67.37 -36.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.438 -0.789 . . . . 75.0 110.562 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.07 -30.67 67.98 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.888 -1.153 . . . . 73.41 107.888 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.34 83.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.426 -1.261 . . . . 55.13 111.097 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -68.26 -33.39 74.27 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 121.939 -0.475 . . . . 65.01 110.806 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -63.86 -34.38 77.8 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 108.155 -1.054 . . . . 75.13 108.155 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.13 10.46 21.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.351 -1.295 . . . . 71.24 111.999 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 68.2 27.97 6.6 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.325 1.05 . . . . 62.11 112.536 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -106.43 24.17 12.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.054 -1.091 . . . . 63.12 108.054 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -53.17 -30.58 38.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.685 1.194 . . . . 53.22 113.911 -173.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.01 -38.51 79.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.815 0.34 . . . . 75.24 111.187 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.24 -30.32 69.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.677 . . . . 72.1 109.508 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -71.39 -44.93 71.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.917 -1.038 . . . . 52.13 110.025 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 47.4 t -61.3 -42.98 95.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.604 0.716 . . . . 74.11 109.402 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -60.38 -38.78 85.01 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.068 -0.969 . . . . 71.14 111.611 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -37.93 83.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.251 -1.018 . . . . 71.11 108.251 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.634 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -63.7 -42.45 97.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.424 -0.807 . . . . 43.35 111.05 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 74.4 mt-30 -59.03 -41.86 88.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 62.13 110.31 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.89 81.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 62.21 111.604 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.404 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 43.8 tpp -76.14 -27.56 57.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.647 0.737 . . . . 72.22 111.014 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.0 -47.24 11.93 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.745 -0.597 . . . . 54.42 111.747 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 C--N 1.31 -1.109 0 N-CA-C 109.209 -0.663 . . . . 75.52 109.209 -177.707 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.445 0 N-CA-C 110.415 -0.217 . . . . 64.33 110.415 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' NH2' ' A' ' 94' ' ' ARG . . . -109.7 -115.81 3.76 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.593 -0.813 . . . . 52.12 114.376 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.22 128.29 40.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.463 0.542 . . . . 72.41 112.463 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.483 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 7.3 t70 -65.23 120.11 12.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.872 -1.058 . . . . 65.32 111.239 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.58 -32.05 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 112.661 0.615 . . . . 62.32 112.661 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -82.96 159.96 22.14 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 114.199 1.185 . . . . 62.51 114.199 -174.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.0 t70 -60.45 146.62 84.41 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.699 -1.137 . . . . 72.34 110.797 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.49 -36.73 40.35 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.568 2.845 . . . . 74.31 115.898 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.9 11.43 39.3 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 114.433 1.272 . . . . 65.31 114.433 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 7.7 mm-40 -68.18 144.57 96.94 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.324 -0.621 . . . . 63.12 109.324 173.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.91 128.85 28.1 Favored 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 122.822 2.348 . . . . 71.42 112.544 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.7 p -130.23 166.17 20.87 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.056 -0.52 . . . . 73.11 111.313 -176.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -131.45 160.19 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 125.55 1.54 . . . . 62.21 108.422 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.5 p-10 -135.6 159.38 41.8 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 106.121 -1.807 . . . . 64.4 106.121 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.0 mt -46.68 -56.87 10.15 Favored Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 114.738 1.385 . . . . 74.44 114.738 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.31 -35.76 96.14 Favored 'Trans proline' 0 C--N 1.366 1.476 0 CA-C-N 120.465 1.202 . . . . 73.24 112.67 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -69.56 -37.5 77.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.924 -0.398 . . . . 72.32 109.924 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 31' ' ' ASP . 60.8 t -69.8 -40.37 78.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.519 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.69 80.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.135 0.969 . . . . 73.41 109.167 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.17 -45.53 73.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.985 -1.462 . . . . 61.43 109.985 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.26 -44.1 89.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 63.41 111.551 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.2 mt -84.38 -19.01 34.29 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 111.901 0.334 . . . . 65.31 111.901 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.28 65.31 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.54 -0.838 . . . . 70.25 111.989 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.0 152.15 77.0 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 108.73 -0.841 . . . . 75.22 108.73 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.98 163.25 29.16 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 122.304 2.003 . . . . 74.22 112.927 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.34 -33.38 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.189 0.996 . . . . 72.42 111.371 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 10.7 p -58.39 -46.15 86.93 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.465 -0.789 . . . . 72.01 111.493 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 mttp -68.93 -36.36 77.9 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.664 -0.244 . . . . 72.24 111.636 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.76 -48.14 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 71.44 109.537 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.754 -0.657 . . . . 64.04 110.463 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 44' ' ' SER . 15.7 mm100 -62.42 -36.44 82.37 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.292 0.479 . . . . 73.52 112.292 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 91.8 mt-30 -63.34 -50.72 68.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.676 0.75 . . . . 63.52 108.995 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.35 -41.4 98.57 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.233 -1.349 . . . . 62.42 111.684 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -63.59 -27.48 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.788 0.292 . . . . 65.45 111.788 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -92.1 -0.36 57.45 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.762 0.315 . . . . 75.22 111.596 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.16 38.31 63.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.798 -0.637 . . . . 52.11 112.501 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -95.06 -15.36 23.5 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.07 -0.715 . . . . 75.22 109.07 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 56' ' ' VAL . 1.1 tt -157.74 152.91 25.76 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.106 -2.183 . . . . 74.13 105.106 -177.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.41 ' H ' HD23 ' A' ' 55' ' ' LEU . 17.8 m -132.1 161.6 41.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 122.609 0.364 . . . . 44.15 110.175 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.32 163.36 32.99 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.061 0.545 . . . . 74.54 109.6 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.71 160.48 34.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 123.427 0.455 . . . . 62.12 110.47 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -113.9 120.92 42.36 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.494 0.664 . . . . 70.13 111.256 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.483 ' HD2' ' OD1' ' A' ' 21' ' ' ASP . 12.3 ptm180 -142.69 134.95 27.5 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.931 -1.031 . . . . 65.13 108.939 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.65 23.67 13.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.909 0.883 . . . . 44.34 111.406 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.71 5.71 89.64 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.156 -0.545 . . . . 63.2 112.207 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.17 143.64 18.03 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 111.355 -0.698 . . . . 65.35 111.355 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.27 120.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.921 -1.14 . . . . 72.4 107.921 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.78 158.48 41.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.968 -0.56 . . . . 63.12 110.754 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 35' ' ' VAL . 71.3 mt -114.86 132.06 23.15 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.106 -1.072 . . . . 73.24 108.106 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.98 126.12 20.15 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.877 1.718 . . . . 71.22 110.477 173.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.565 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 41.1 tt0 -60.58 -25.21 66.04 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.315 0.646 . . . . 72.33 112.467 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.82 -2.77 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-N 115.681 -0.691 . . . . 71.14 112.65 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.623 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.38 -2.62 58.59 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.95 0.881 . . . . 72.43 110.026 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -119.61 163.9 16.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.119 -0.946 . . . . 70.3 109.089 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 130' ' ' HIS . 63.1 p -94.78 162.25 13.84 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.588 -0.893 . . . . 65.15 108.588 177.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.22 -16.55 63.65 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.335 0.588 . . . . 73.23 110.488 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -79.73 -8.32 59.17 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.699 -0.682 . . . . 44.33 110.487 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.72 64.2 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.851 -0.69 . . . . 60.45 112.23 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -108.6 154.01 22.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.438 -0.578 . . . . 74.12 109.438 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -71.34 140.53 18.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.793 -1.188 . . . . 73.34 107.793 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 80' ' ' SER . 44.7 t -64.02 129.22 27.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.934 -1.135 . . . . 63.32 107.934 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -63.69 -28.99 70.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.145 0.424 . . . . 71.22 112.145 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.417 ' H ' HG12 ' A' ' 78' ' ' VAL . 4.1 m -77.77 -6.51 54.3 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.939 -0.573 . . . . 75.3 110.886 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.623 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.7 tp -64.91 -57.25 16.56 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.384 -0.371 . . . . 73.15 111.882 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.29 -29.03 79.43 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.181 1.254 . . . . 71.23 111.244 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -44.59 93.8 Favored Glycine 0 C--O 1.245 0.832 0 CA-C-N 115.964 -0.562 . . . . 65.24 112.598 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.96 -40.53 83.18 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.38 -0.6 . . . . 71.21 109.38 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.32 -37.57 86.1 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 74.02 110.659 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.9 m -57.45 -47.51 81.63 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 116.239 -0.437 . . . . 63.03 111.582 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.471 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -67.95 -41.96 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 120.386 -0.525 . . . . 73.13 111.556 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.471 HD22 HG23 ' A' ' 87' ' ' ILE . 3.5 mm? -67.51 -39.32 85.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.804 0.668 . . . . 75.33 112.804 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -66.5 -33.76 76.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.052 0.453 . . . . 75.32 110.085 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.92 -26.2 65.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.537 -0.756 . . . . 72.31 110.142 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.91 -3.36 73.7 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.829 -0.623 . . . . 51.14 112.016 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.42 33.45 25.46 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.197 -0.525 . . . . 71.32 113.123 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 8.9 m-85 -90.75 159.38 16.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.882 0.372 . . . . 74.12 111.497 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.47 ' NH2' ' HA3' ' A' ' 19' ' ' GLY . 12.0 ptm180 -111.85 171.14 7.67 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.924 -0.58 . . . . 73.34 109.832 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -53.94 -45.87 71.38 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.442 1.897 . . . . 73.14 112.46 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.6 m -61.88 -41.67 98.16 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.275 -0.875 . . . . 70.23 110.418 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.06 -36.15 81.39 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.587 -0.733 . . . . 71.33 111.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.2 mm -61.24 -47.66 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.121 -1.066 . . . . 72.1 108.121 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.47 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 56.3 mtt -73.35 -21.5 60.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.596 -1.183 . . . . 63.4 111.779 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -57.69 -63.37 1.26 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.031 0.443 . . . . 73.12 110.315 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -69.99 -32.38 70.56 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.02 0.748 . . . . 64.04 113.02 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.3 mt -59.0 -40.73 85.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.585 0.957 . . . . 73.21 113.585 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' HD23 ' A' ' 23' ' ' LEU . 50.5 m-85 -89.14 -16.83 30.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.958 0.725 . . . . 75.5 112.958 -176.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.9 m -87.51 118.28 69.63 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.435 -0.348 . . . . 74.55 110.243 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -55.65 129.78 36.91 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.857 2.371 . . . . 33.11 111.359 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.2 t70 -96.73 127.12 40.52 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.866 -0.42 . . . . 72.41 109.866 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 -20.25 61.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.554 2.836 . . . . 53.32 114.423 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.1 p -111.53 6.94 20.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.107 0.48 . . . . 72.01 112.122 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 tp -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.23 0.538 . . . . 74.12 110.107 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -118.95 122.56 42.51 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.885 -0.783 . . . . 75.51 108.885 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 123' ' ' ALA . 61.1 mt . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 109.432 -0.581 . . . . 70.4 109.432 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 109.368 -0.604 . . . . 63.33 109.368 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -87.28 141.42 28.66 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.767 -0.827 . . . . 72.14 108.767 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.3 t30 68.22 70.3 0.32 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.937 0.875 . . . . 64.41 110.806 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -124.39 173.64 8.28 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 107.762 -1.199 . . . . 63.12 107.762 174.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 3.5 ptp180 -91.59 137.25 25.86 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.557 . . . . 70.43 109.758 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.64 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.1 Cg_exo -49.75 -22.44 6.98 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.71 2.94 . . . . 70.24 114.552 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -60.43 -39.0 79.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 120.87 0.367 . . . . 75.13 110.297 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -63.31 -37.12 86.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.315 0.579 . . . . 64.25 109.695 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.69 76.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.237 -0.892 . . . . 65.21 112.063 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.44 -35.58 80.65 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.644 -0.422 . . . . 63.42 111.408 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.405 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 42.0 t-80 -76.02 -20.8 57.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.391 0.615 . . . . 52.35 109.455 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.85 4.61 51.59 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.335 0.865 . . . . 74.02 113.335 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.31 38.74 4.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 123.581 1.658 . . . . 75.45 109.283 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -120.36 23.89 10.66 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.75 -1.574 . . . . 73.5 106.75 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.62 -28.05 30.45 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 112.648 -2.069 . . . . 63.32 112.756 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -55.43 -40.38 71.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.801 0.334 . . . . 72.24 110.915 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.33 -27.98 63.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.171 0.51 . . . . 70.2 110.919 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.72 -48.58 45.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.375 -0.972 . . . . 73.24 108.375 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 63.5 t -59.2 -41.54 84.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-N 115.007 -0.997 . . . . 72.25 109.176 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -57.15 -45.89 83.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.609 0.764 . . . . 73.04 111.264 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.8 tpp180 -65.89 -39.31 90.51 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.723 -0.473 . . . . 73.45 109.723 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.99 94.15 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.999 -0.546 . . . . 43.25 110.525 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 12.0 mm100 -57.46 -46.61 83.45 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 123.353 0.661 . . . . 72.43 110.032 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.9 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 64.25 111.551 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.526 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.2 mmm -78.48 -37.39 43.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.353 -0.385 . . . . 74.12 111.407 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.8 19.59 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 112.789 0.663 . . . . 63.54 112.789 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 C--N 1.308 -1.239 0 CA-C-O 118.418 -0.801 . . . . 72.22 109.646 -176.498 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.284 0 CA-C-O 120.895 0.379 . . . . 74.01 110.084 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 59' ' ' ARG . . . -94.76 -85.15 1.66 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 115.726 -0.67 . . . . 73.31 111.64 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.62 150.09 47.14 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 120.877 0.37 . . . . 75.43 110.321 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.69 161.94 18.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.931 -0.766 . . . . 72.34 108.931 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 22' ' ' VAL . 23.9 t -121.29 13.79 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 123.345 1.545 . . . . 72.22 109.662 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.89 -172.41 2.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.26 -0.882 . . . . 72.01 110.69 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.26 138.01 20.13 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 105.25 -2.13 . . . . 74.22 105.25 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.16 -21.61 22.82 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.658 2.238 . . . . 50.5 114.448 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.57 -16.05 57.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.076 0.398 . . . . 70.13 112.076 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -61.93 141.8 95.36 Favored Pre-proline 0 C--O 1.251 1.134 0 O-C-N 122.089 -0.382 . . . . 75.5 110.31 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.55 117.66 4.21 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.843 2.362 . . . . 73.5 111.1 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -133.37 161.94 33.18 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 115.369 -0.832 . . . . 60.14 111.519 -176.45 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -112.89 159.94 18.54 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.611 -1.177 . . . . 73.3 109.058 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.583 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.0 m-20 -134.74 169.16 17.77 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.004 -2.221 . . . . 71.55 105.004 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.87 -55.73 35.39 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 113.489 0.922 . . . . 74.33 113.489 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.26 -32.71 90.47 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.881 1.721 . . . . 73.51 112.381 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.583 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 20.7 tpt180 -68.53 -40.79 80.59 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.973 0.509 . . . . 74.15 110.683 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' ASP . 77.1 t -69.0 -37.71 77.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.498 -0.556 . . . . 74.11 109.498 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.84 85.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.327 -0.851 . . . . 73.04 109.659 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.37 -46.7 72.56 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.181 -0.918 . . . . 65.44 109.52 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.79 -50.32 63.05 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.051 -0.977 . . . . 64.32 112.269 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.51 ' HB2' HG22 ' A' ' 41' ' ' VAL . 91.9 mt -82.85 -18.61 39.77 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.495 -0.482 . . . . 73.21 111.357 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.66 30.1 58.56 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.677 -0.969 . . . . 53.01 110.677 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 39' ' ' LEU . 28.0 m -120.94 159.04 50.71 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 109.543 -0.54 . . . . 72.55 109.543 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.54 163.16 39.93 Favored 'Trans proline' 0 C--O 1.256 1.404 0 C-N-CA 122.011 1.807 . . . . 74.25 111.543 174.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.24 -32.37 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.419 0.688 . . . . 54.2 110.359 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 33.1 t -57.32 -43.12 83.02 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.751 -0.659 . . . . 74.31 110.4 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.25 -32.77 72.2 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 111.742 0.275 . . . . 75.54 111.742 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.77 -45.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.056 -0.72 . . . . 72.24 109.056 175.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.98 78.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.464 -0.789 . . . . 72.22 110.777 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 44' ' ' SER . 93.0 mt-30 -61.68 -43.47 98.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.262 -0.426 . . . . 73.11 111.334 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -60.12 -49.63 76.89 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 121.901 0.857 . . . . 71.53 109.043 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.23 -42.46 99.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.078 -1.419 . . . . 74.4 111.278 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.15 -22.33 62.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.109 0.781 . . . . 74.31 113.109 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -102.09 5.0 40.22 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.112 -1.035 . . . . 75.0 111.396 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.59 37.31 68.14 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 115.423 -0.808 . . . . 52.21 112.243 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -95.67 -13.81 23.96 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.546 0.689 . . . . 75.53 109.36 176.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.9 tp -160.66 152.77 20.19 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.693 -1.965 . . . . 74.33 105.693 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 p -133.58 151.38 33.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.204 -0.665 . . . . 70.21 109.204 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 154.94 36.42 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 123.518 0.511 . . . . 64.51 109.737 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.62 169.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 123.711 0.804 . . . . 75.32 111.165 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 24.3 ttt-85 -107.3 121.34 44.37 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.135 -0.691 . . . . 73.42 109.135 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' CZ ' HG11 ' A' ' 65' ' ' VAL . 49.3 ttp180 -115.4 112.81 22.89 Favored 'General case' 0 CA--C 1.482 -1.667 0 CA-C-N 114.225 -1.352 . . . . 74.23 107.61 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.58 -51.68 0.23 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.92 1.688 . . . . 61.44 112.473 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.54 15.15 0.03 OUTLIER Glycine 0 C--N 1.29 -2.01 0 CA-C-N 114.931 -1.031 . . . . 74.24 112.147 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.35 154.96 19.74 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 110.691 -0.963 . . . . 74.22 110.691 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -96.89 120.12 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.781 -1.192 . . . . 63.22 107.781 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.433 HG11 ' CZ ' ' A' ' 60' ' ' ARG . 16.9 m -137.21 164.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.745 -0.661 . . . . 73.21 111.82 -172.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.61 123.98 26.28 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 107.011 -1.478 . . . . 50.32 107.011 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HA ' HG22 ' A' ' 29' ' ' THR . 37.3 Cg_exo -62.84 143.44 91.68 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.43 2.086 . . . . 70.24 114.063 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -48.81 -41.99 34.55 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.313 1.045 . . . . 63.13 111.196 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -65.54 -7.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.48 -1.236 . . . . 65.24 113.911 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.646 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.3 m-85 -88.5 -5.02 58.48 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.873 0.844 . . . . 73.5 110.515 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -117.41 159.29 23.02 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.028 -0.987 . . . . 71.22 108.611 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -86.88 175.69 8.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.829 -0.804 . . . . 64.13 108.829 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -63.3 -22.08 66.65 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.333 0.587 . . . . 75.33 110.623 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.3 t -79.52 -10.51 59.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.299 -0.409 . . . . 72.22 110.615 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.64 38.85 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.572 -0.823 . . . . 64.22 111.215 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 151.63 37.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.597 -1.26 . . . . 73.53 107.597 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.46 131.47 34.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.731 -0.84 . . . . 72.22 108.731 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 44.4 t -57.78 125.96 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.323 -0.621 . . . . 74.22 109.323 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 61.1 tttp -61.5 -36.44 80.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.285 0.564 . . . . 72.15 112.281 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -85.19 -5.16 59.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.307 -0.406 . . . . 73.01 111.734 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD11 ' CD2' ' A' ' 70' ' ' PHE . 8.1 tt -66.09 -48.16 60.53 Favored Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 112.894 0.701 . . . . 71.51 112.894 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 74.1 Cg_exo -54.09 -30.57 60.82 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.047 1.831 . . . . 54.22 111.511 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.6 -41.46 99.81 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.473 -0.785 . . . . 72.53 112.207 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.37 -40.45 81.43 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.081 -0.711 . . . . 74.4 109.081 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.52 -39.96 92.9 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.907 -0.588 . . . . 65.55 110.339 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.2 m -57.77 -47.5 82.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 116.144 -0.48 . . . . 72.45 111.662 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -42.93 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 120.943 -0.303 . . . . 73.25 111.697 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -66.64 -37.44 84.82 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.465 0.543 . . . . 74.2 112.465 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -65.74 -32.86 74.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.893 0.377 . . . . 71.42 110.344 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.86 -30.23 69.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.231 0.539 . . . . 64.54 110.272 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.5 -9.33 75.77 Favored Glycine 0 C--O 1.242 0.655 0 CA-C-N 115.579 -0.737 . . . . 52.53 113.039 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.97 33.05 11.37 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.539 -0.363 . . . . 73.21 112.971 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -98.74 129.8 45.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 122.471 -0.429 . . . . 75.41 111.42 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -87.24 174.24 8.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.702 -0.681 . . . . 70.53 110.881 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.67 -45.9 66.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.925 1.69 . . . . 63.41 112.208 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.595 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 29.3 m -64.92 -41.28 95.69 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 116.031 -0.531 . . . . 55.12 109.589 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -61.72 -42.28 98.74 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.025 -0.989 . . . . 65.34 111.077 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.471 HG22 HD12 ' A' ' 102' ' ' LEU . 19.9 mm -60.95 -47.6 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.626 -0.879 . . . . 74.12 108.626 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.429 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 51.2 mtt -74.34 -17.56 60.81 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 113.736 1.013 . . . . 65.34 113.736 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 96' ' ' THR . 83.8 mtp180 -55.84 -65.0 0.67 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.877 0.37 . . . . 64.21 111.353 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.52 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 p-90 -68.75 -31.93 71.32 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.358 0.503 . . . . 64.01 112.358 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.52 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.4 mt -66.34 -39.87 89.48 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.126 1.158 . . . . 65.35 114.126 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -90.62 -12.03 38.15 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.596 1.332 . . . . 51.14 114.596 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -74.67 114.15 31.41 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 123.817 0.698 . . . . 65.22 109.731 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.94 132.56 35.1 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.713 2.276 . . . . 75.4 110.551 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 16.5 t0 -118.61 117.99 33.87 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 116.299 -0.41 . . . . 43.41 111.298 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.53 -24.92 79.49 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.225 2.616 . . . . 70.34 111.889 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -78.58 -10.06 59.59 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.555 -0.748 . . . . 64.34 110.143 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.9 tp -110.29 129.22 55.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.429 0.633 . . . . 74.34 110.609 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -119.02 125.04 48.43 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.31 -0.996 . . . . 74.53 108.31 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 123' ' ' ALA . 46.8 mt . . . . . 0 C--N 1.311 -1.104 0 CA-C-N 115.994 -0.548 . . . . 70.0 110.227 -172.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 109.183 -0.673 . . . . 70.13 109.183 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.4 m -90.28 142.95 27.22 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.71 -0.848 . . . . 60.12 108.71 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.2 t30 74.36 72.26 0.11 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.272 0.982 . . . . 72.44 110.381 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.439 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -123.44 172.82 8.42 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.625 -1.62 . . . . 63.15 106.625 171.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.504 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 8.0 ptp180 -92.82 143.79 27.51 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.111 -1.44 . . . . 73.34 107.111 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 90.2 Cg_exo -49.28 -25.6 10.09 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.313 2.675 . . . . 72.45 114.897 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.564 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.8 t -63.96 -32.33 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.331 -0.548 . . . . 45.13 110.113 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.504 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 10.5 m-20 -60.45 -30.84 69.92 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.254 -0.43 . . . . 64.23 110.415 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.5 -43.88 72.19 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.883 -0.599 . . . . 60.41 111.092 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -70.18 -33.98 72.41 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.932 -0.48 . . . . 74.43 111.099 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -67.53 -19.53 65.31 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 122.15 0.976 . . . . 73.14 109.238 176.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.94 9.44 32.66 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.924 -1.034 . . . . 60.32 111.838 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.9 m80 61.77 28.47 17.5 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.911 0.862 . . . . 52.34 112.249 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -106.3 25.11 11.47 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.827 1.651 . . . . 72.54 107.512 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.2 -26.87 12.7 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 126.926 2.09 . . . . 74.21 114.237 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -55.69 -37.18 68.01 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.194 0.813 . . . . 64.53 113.194 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -67.54 -32.36 73.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.291 0.567 . . . . 71.13 110.59 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.48 -49.14 68.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.615 -0.883 . . . . 74.42 108.615 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.569 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 67.8 t -58.07 -42.85 83.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 CA-C-N 115.404 -0.817 . . . . 74.12 109.58 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -57.0 -47.47 80.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.72 -0.673 . . . . 65.22 110.822 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -68.79 -34.1 74.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 73.33 111.045 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.416 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -67.53 -46.71 72.01 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.106 -0.497 . . . . 75.53 110.941 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 15.9 mm100 -59.66 -40.11 86.68 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.028 0.531 . . . . 71.43 110.04 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.02 68.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.424 -0.807 . . . . 42.11 111.257 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.1 tpp -78.04 -47.9 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.904 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.5 -29.29 37.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.543 0.942 . . . . 72.4 113.543 -173.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 C--N 1.312 -1.059 0 CA-C-O 117.989 -1.005 . . . . 55.24 110.038 -179.574 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 106.632 -1.618 . . . . 74.51 106.632 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.88 -118.17 3.11 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.257 -0.973 . . . . 55.24 113.801 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.11 107.1 18.85 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 112.884 0.698 . . . . 72.35 112.884 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 11.2 t70 -44.69 113.02 0.49 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 126.108 1.763 . . . . 53.12 113.108 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.67 -33.96 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.558 -0.747 . . . . 70.44 111.645 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' A' ' 103' ' ' PHE 0.406 0.4 OUTLIER -67.18 140.8 57.49 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.283 1.586 . . . . 74.34 115.283 -176.024 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.36 146.41 84.39 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.222 -1.808 . . . . 41.13 110.993 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HA ' HH22 ' A' ' 60' ' ' ARG . 89.9 Cg_exo -50.52 -22.43 9.09 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.409 2.739 . . . . 70.03 115.601 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -97.71 3.53 50.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.942 0.719 . . . . 52.14 112.942 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.42 128.14 76.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.906 -0.776 . . . . 63.43 108.906 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.48 147.09 70.24 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.554 2.169 . . . . 70.12 112.685 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -133.45 173.69 11.21 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.497 0.665 . . . . 75.42 111.645 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 23.2 m-85 -130.25 161.09 31.99 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 126.299 1.84 . . . . 64.11 106.626 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.4 t0 -134.08 167.42 20.68 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.802 -2.296 . . . . 73.53 104.802 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -49.79 -57.0 13.62 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 123.839 0.856 . . . . 72.52 112.999 -172.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.7 -32.25 47.58 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.152 1.234 . . . . 71.12 112.14 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 19.4 tpt180 -70.34 -37.74 74.72 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 112.187 0.44 . . . . 74.25 112.187 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 31' ' ' ASP . 58.5 t -67.23 -39.12 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.738 -0.838 . . . . 74.13 108.738 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.89 83.87 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.66 -1.154 . . . . 70.03 110.032 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.04 -43.1 99.59 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.941 0.896 . . . . 72.15 109.814 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 tp -62.16 -50.06 73.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.404 -0.817 . . . . 73.52 111.396 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -86.76 -18.53 30.9 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.038 0.755 . . . . 73.14 113.038 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.01 53.91 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.436 -0.887 . . . . 63.24 110.961 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.09 161.18 46.21 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 107.611 -1.255 . . . . 61.35 107.611 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.63 163.26 31.99 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 121.253 1.302 . . . . 64.34 111.409 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.79 -32.64 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.6 0.714 . . . . 74.23 109.35 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.587 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.1 m -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.723 -1.126 . . . . 74.11 110.606 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.6 mttp -68.94 -32.92 72.87 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.678 -0.409 . . . . 74.3 111.253 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.16 -46.23 96.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.466 -0.568 . . . . 53.23 109.466 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.25 81.29 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.423 -0.808 . . . . 51.42 110.759 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 44' ' ' SER . 29.3 mm-40 -64.35 -37.94 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 62.53 110.772 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.8 mt-30 -68.31 -45.05 74.05 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.896 0.855 . . . . 75.54 109.163 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.86 -45.29 94.43 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.789 -1.551 . . . . 72.2 109.797 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -66.12 -22.28 66.38 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 113.138 0.792 . . . . 64.02 113.138 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.66 11.78 37.24 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.216 -0.994 . . . . 71.11 112.49 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.58 57.48 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.976 -0.63 . . . . 53.41 113.02 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -96.13 -5.74 40.01 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.265 0.555 . . . . 74.13 109.866 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.1 tp -163.42 157.65 20.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.399 -1.704 . . . . 74.14 106.399 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.54 147.05 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 118.393 0.542 . . . . 75.43 109.586 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.59 162.69 19.21 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.346 0.659 . . . . 74.22 110.473 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.44 157.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.001 0.521 . . . . 62.22 110.226 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -110.86 119.07 37.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.204 -0.665 . . . . 60.51 109.204 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.566 HH22 ' HA ' ' A' ' 25' ' ' PRO . 11.4 ptm180 -149.24 130.61 14.71 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.367 -0.378 . . . . 75.44 111.187 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.63 26.58 16.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.995 0.918 . . . . 72.44 112.121 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.1 82.36 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 116.039 -0.528 . . . . 63.34 112.341 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.01 141.0 12.76 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.424 -0.67 . . . . 62.5 111.424 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.52 119.91 48.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.263 -1.384 . . . . 73.32 107.263 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.47 162.29 39.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.861 -0.609 . . . . 52.1 110.13 -175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.7 128.01 26.02 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 108.089 -1.078 . . . . 53.51 108.089 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.28 122.01 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.787 2.324 . . . . 61.43 112.037 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.521 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 45.4 tt0 -65.74 -24.59 66.99 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.136 0.493 . . . . 62.35 111.699 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.5 -8.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.637 -0.711 . . . . 72.23 112.373 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -86.73 -2.47 58.56 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.388 0.613 . . . . 71.42 110.95 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -116.83 148.51 41.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 73.43 109.248 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.4 p -82.74 175.47 10.1 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.571 -0.9 . . . . 63.54 108.571 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -64.42 -17.21 63.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.931 0.396 . . . . 63.21 111.729 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 m -79.78 -9.14 59.62 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.348 0.595 . . . . 65.41 109.778 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.44 62.85 Favored Glycine 0 C--O 1.215 -1.081 0 N-CA-C 110.73 -0.948 . . . . 70.21 110.73 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -108.06 143.82 36.26 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.759 -0.83 . . . . 75.13 108.759 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.98 134.46 28.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.134 -1.062 . . . . 61.41 108.134 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 58.7 t -57.04 128.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 108.185 -1.043 . . . . 71.53 108.185 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -23.07 65.86 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.741 0.645 . . . . 73.5 112.741 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 78' ' ' VAL . 17.5 m -88.22 -1.93 58.31 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.998 0.428 . . . . 75.01 111.169 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.0 tt -65.58 -54.24 31.69 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.386 0.513 . . . . 61.21 112.386 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 39.5 Cg_exo -60.76 -29.77 88.95 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 121.265 1.31 . . . . 75.31 110.979 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.15 99.7 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.319 -0.855 . . . . 55.02 112.216 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.92 -42.01 77.36 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.587 -0.523 . . . . 73.22 109.587 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.33 -37.34 85.25 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 116.243 -0.435 . . . . 71.21 110.645 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.6 m -58.69 -48.04 82.47 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.837 -0.619 . . . . 60.24 111.89 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.427 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -68.27 -42.15 84.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.607 -0.437 . . . . 75.42 111.045 -177.333 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.427 HD22 HG23 ' A' ' 87' ' ' ILE . 3.2 mm? -67.07 -35.29 79.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.112 -0.635 . . . . 72.14 111.874 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -62.94 -33.4 75.27 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.484 -0.562 . . . . 75.01 109.484 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.97 -31.4 71.1 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.017 -0.538 . . . . 53.12 110.148 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.72 -3.96 63.99 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.569 -0.741 . . . . 51.43 111.756 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.22 37.07 55.33 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 113.708 0.243 . . . . 75.44 113.708 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 52.1 m-85 -92.06 126.19 37.05 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 117.55 0.675 . . . . 75.24 111.18 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.57 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 26.8 ptt180 -70.43 169.21 14.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.901 . . . . 75.3 111.276 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 99' ' ' MET . 7.7 p-10 -54.87 -44.5 74.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.052 1.341 . . . . 74.34 111.816 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -62.06 -41.02 97.71 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.332 -0.849 . . . . 52.44 110.835 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.57 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 49.8 mm-40 -66.38 -37.92 86.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.747 -0.381 . . . . 74.42 110.482 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.2 -50.07 82.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 109.112 -0.699 . . . . 62.44 109.112 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.9 ptt? -74.67 -17.49 60.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.334 -0.848 . . . . 70.45 112.948 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.31 -65.26 0.72 Allowed 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.47 0.481 . . . . 72.23 110.099 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -70.38 -32.26 69.84 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.245 0.831 . . . . 74.03 113.245 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 125' ' ' PRO . 40.8 tp -68.33 -40.46 81.61 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.038 0.755 . . . . 72.42 113.038 -173.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CE2' HD23 ' A' ' 23' ' ' LEU . 26.6 m-85 -87.16 -18.3 30.7 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.367 0.877 . . . . 73.51 113.367 -175.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 63.2 m -81.03 127.37 74.68 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 112.194 0.442 . . . . 52.23 112.194 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 23.4 Cg_exo -66.47 132.31 28.84 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.664 2.243 . . . . 44.25 111.31 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -118.19 121.45 31.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.465 -0.334 . . . . 62.32 111.839 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.98 -26.43 82.38 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.585 2.856 . . . . 73.44 112.205 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.0 m -85.96 -0.21 54.88 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.213 0.53 . . . . 53.43 111.239 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.63 126.89 53.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.207 -0.664 . . . . 73.32 109.207 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 27.2 m -131.28 114.34 14.91 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 73.4 108.206 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 128' ' ' ALA . 11.5 pt . . . . . 0 C--N 1.306 -1.295 0 CA-C-N 116.45 -0.341 . . . . 71.13 110.759 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 108.292 -1.003 . . . . 62.02 108.292 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 6.0 t -89.13 162.02 16.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 65.33 107.964 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.7 t30 67.57 44.67 1.66 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 122.647 1.213 . . . . 70.55 108.521 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.86 16.74 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.963 -1.017 . . . . 71.43 110.763 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -95.43 137.97 21.96 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.11 -0.7 . . . . 63.31 109.11 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.602 ' HB2' HD12 ' A' ' 102' ' ' LEU . 87.6 Cg_exo -50.0 -26.24 14.04 Favored 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.638 2.892 . . . . 74.13 114.755 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 94.7 t -60.58 -39.74 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.529 0.68 . . . . 73.35 110.283 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.01 -33.26 75.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.257 -0.883 . . . . 64.33 109.659 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.45 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -69.48 -47.92 62.35 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.245 -0.889 . . . . 52.02 111.45 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -65.81 -34.57 78.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 70.53 110.438 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -66.43 -32.26 73.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.229 -0.896 . . . . 71.03 108.945 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.91 13.16 19.32 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.094 -0.957 . . . . 65.32 111.445 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 64.76 28.05 12.98 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.524 1.13 . . . . 74.12 110.693 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -109.43 23.85 13.9 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.586 1.184 . . . . 74.33 108.99 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.94 -25.4 11.77 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 112.913 -1.949 . . . . 75.01 112.151 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -54.51 -39.69 67.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.95 0.5 . . . . 60.12 111.286 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.236 0.541 . . . . 74.21 110.432 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.75 -48.94 68.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.829 -0.804 . . . . 61.24 108.829 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 89.2 t -60.07 -41.17 85.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 123.559 0.744 . . . . 61.41 109.792 176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -56.97 -46.45 82.17 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.562 -0.744 . . . . 73.43 109.598 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -69.04 -36.48 77.76 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 116.316 -0.402 . . . . 75.11 111.848 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.7 89.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 53.21 109.621 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.2 mt-30 -62.88 -37.53 87.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.708 -0.678 . . . . 74.42 110.442 177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.5 76.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.257 0.551 . . . . 70.01 111.017 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.58 -36.89 57.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.598 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -76.74 -49.62 15.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.613 0.968 . . . . 61.21 113.613 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--O 1.255 1.346 0 CA-C-O 118.975 -0.536 . . . . 72.35 111.218 -174.639 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.626 -0.879 . . . . 35.31 108.626 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.82 -101.37 2.71 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.576 -0.738 . . . . 34.22 113.88 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -98.97 120.78 40.0 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.099 0.476 . . . . 73.32 111.537 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.59 146.29 50.18 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.148 -0.933 . . . . 63.35 110.12 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.35 -12.08 11.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.529 -0.305 . . . . 61.41 111.147 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.282 0.8 OUTLIER -89.16 169.55 11.38 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 114.702 1.371 . . . . 71.42 114.702 -177.435 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -101.48 148.15 34.81 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.346 -1.353 . . . . 61.43 107.346 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.64 -22.6 9.65 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.892 2.395 . . . . 61.14 113.699 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.6 -32.19 73.73 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.86 -0.422 . . . . 73.03 109.86 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.64 126.26 90.85 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.595 -0.891 . . . . 74.1 108.595 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.32 154.87 61.13 Favored 'Trans proline' 0 C--O 1.256 1.416 0 C-N-CA 122.181 1.921 . . . . 70.14 111.047 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 p -136.05 169.57 17.39 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.968 0.89 . . . . 74.31 112.71 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -119.83 160.95 21.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 127.09 2.156 . . . . 73.3 106.127 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.467 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 7.1 t70 -134.49 156.91 47.78 Favored 'General case' 0 C--N 1.26 -3.308 0 N-CA-C 102.982 -2.97 . . . . 72.44 102.982 -175.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.51 -51.77 75.43 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.605 0.965 . . . . 72.31 113.605 -173.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 13.4 Cg_endo -60.23 -31.57 93.2 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.792 1.661 . . . . 62.44 112.255 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.467 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 19.9 tpt180 -70.79 -37.57 73.32 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.886 0.374 . . . . 75.54 110.368 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.03 -37.87 77.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.665 -0.865 . . . . 61.2 108.665 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.77 -37.06 78.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.944 -1.026 . . . . 71.34 110.035 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.63 -46.67 68.61 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.627 0.771 . . . . 70.3 109.504 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.77 -46.38 82.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.688 -1.142 . . . . 72.52 111.617 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.54 -18.41 29.85 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.552 -0.459 . . . . 75.22 111.842 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.02 61.55 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.965 -0.636 . . . . 64.33 111.554 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.99 161.1 48.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 109.324 -0.621 . . . . 73.51 109.324 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.87 158.63 56.17 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 121.908 1.739 . . . . 73.01 112.051 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.2 -33.33 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.868 0.867 . . . . 75.3 110.854 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.0 p -60.34 -40.43 90.63 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.686 -0.688 . . . . 73.11 111.445 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 65.0 tttm -69.33 -34.12 74.16 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.069 -0.715 . . . . 71.05 109.069 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.51 -44.1 98.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.742 -0.663 . . . . 63.42 109.615 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.62 -36.5 82.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.109 -0.95 . . . . 52.24 110.357 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.82 -35.09 79.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.064 0.394 . . . . 75.32 112.064 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 39.8 mt-30 -62.56 -42.51 99.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.87 0.843 . . . . 71.45 108.838 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.56 -34.84 78.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.552 -1.204 . . . . 75.13 109.451 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.2 mmt85 -67.16 -29.38 69.07 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.928 0.891 . . . . 74.44 112.33 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.43 6.13 39.99 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.334 -0.546 . . . . 74.14 111.902 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 43.22 76.02 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.12 -0.562 . . . . 62.03 112.173 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.73 -17.0 14.78 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.112 -0.699 . . . . 74.41 109.112 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 tp -149.35 158.39 44.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.675 -1.231 . . . . 62.23 107.675 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.23 147.22 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.0 -0.741 . . . . 40.23 109.0 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.84 161.54 28.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.111 0.565 . . . . 71.35 110.113 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.426 HG11 ' HG3' ' A' ' 99' ' ' MET . 6.7 m -136.68 165.61 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.928 0.891 . . . . 60.23 109.093 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -117.03 115.88 26.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.659 -0.497 . . . . 43.54 109.659 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -116.81 124.44 49.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.016 -0.735 . . . . 63.14 109.016 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.74 22.59 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.835 0.854 . . . . 65.12 112.712 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.13 -24.02 21.92 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.396 -0.906 . . . . 64.24 113.24 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.29 143.55 16.73 Favored Glycine 0 CA--C 1.496 -1.146 0 C-N-CA 120.811 -0.709 . . . . 74.51 112.252 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 124.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.128 -0.694 . . . . 71.14 109.128 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.44 168.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.751 -1.113 . . . . 61.03 111.286 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.0 mm -118.64 135.92 23.9 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 105.875 -1.898 . . . . 74.55 105.875 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.92 139.7 43.92 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 121.606 1.537 . . . . 65.41 112.638 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -54.15 -36.37 63.27 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.655 0.782 . . . . 64.44 110.141 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.418 ' CG2' HG11 ' A' ' 126' ' ' VAL . 20.0 m -70.17 -3.18 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.271 . . . . 63.21 113.92 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -88.4 -5.93 57.99 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.085 0.945 . . . . 72.24 109.64 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.13 155.54 38.25 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.491 -1.231 . . . . 74.23 108.395 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.8 p -83.21 165.0 19.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.39 -1.337 . . . . 74.44 107.39 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -67.1 -16.02 64.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.361 0.6 . . . . 75.12 110.996 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -79.47 -3.67 47.71 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.301 -0.863 . . . . 70.34 111.02 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.63 21.71 55.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.009 -0.615 . . . . 51.43 112.694 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -114.58 161.38 18.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.607 0.241 . . . . 74.14 110.505 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.72 138.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.107 -1.071 . . . . 71.34 108.107 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.82 129.52 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.036 -1.098 . . . . 74.23 108.036 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.87 -26.39 62.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.348 0.87 . . . . 75.32 113.348 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.8 m -99.02 6.91 46.43 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.411 -0.359 . . . . 71.03 111.645 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 70' ' ' PHE . 19.2 tp -61.12 -54.93 49.09 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 111.98 0.363 . . . . 64.43 111.98 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.99 -22.14 73.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 121.749 1.632 . . . . 75.12 111.73 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.43 -44.46 90.28 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.754 -0.657 . . . . 34.11 112.221 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.07 -39.12 86.78 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.7 -0.852 . . . . 72.05 108.7 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.77 -36.86 84.44 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.694 -1.139 . . . . 71.41 111.294 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 m -57.54 -49.21 77.11 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.611 0.243 . . . . 73.32 111.333 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.95 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.928 0.394 . . . . 74.24 111.353 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.654 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 83.4 mt -66.69 -39.92 88.3 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.36 0.504 . . . . 64.1 112.36 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -68.29 -35.64 78.15 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.496 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.38 -31.67 72.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.597 -0.52 . . . . 72.44 109.597 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.79 -0.77 89.91 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.502 -0.772 . . . . 45.01 112.798 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 34.21 55.29 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.309 -0.472 . . . . 62.34 113.278 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -94.72 123.79 38.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.357 0.598 . . . . 61.3 112.271 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 14.2 ptm180 -73.87 173.71 9.54 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.781 -1.1 . . . . 72.53 112.076 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -53.02 -45.32 67.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.061 1.745 . . . . 54.44 111.238 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -64.24 -40.77 96.71 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 123.842 0.857 . . . . 74.2 110.092 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 25.1 mm-40 -66.81 -37.49 84.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 74.32 111.601 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.547 HD12 HD13 ' A' ' 88' ' ' LEU . 20.7 mm -60.85 -48.11 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.126 -1.064 . . . . 72.22 108.126 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.435 ' SD ' ' HE1' ' A' ' 103' ' ' PHE . 21.8 mmt -74.2 -22.35 59.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.648 -1.16 . . . . 52.0 111.229 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 77.9 ttt180 -54.3 -69.32 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.868 0.867 . . . . 72.55 111.653 -174.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.654 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 55.2 p-90 -70.35 -32.15 69.72 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.214 0.449 . . . . 74.52 112.214 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.588 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 9.3 mt -61.34 -39.81 91.95 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.689 1.366 . . . . 64.31 114.689 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 56.8 m-85 -94.79 -12.17 27.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.599 0.963 . . . . 62.44 113.599 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.1 m -83.17 129.52 60.66 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.741 -0.837 . . . . 62.4 108.741 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.12 128.97 29.61 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.033 1.822 . . . . 61.54 109.626 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.8 118.36 65.96 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.63 -0.878 . . . . 73.5 108.63 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 23.3 Cg_endo -61.11 -20.25 66.97 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.959 2.44 . . . . 64.5 113.667 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.2 m -101.21 4.83 42.27 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.479 -0.328 . . . . 73.43 110.353 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 tp -107.67 123.28 48.27 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.828 0.823 . . . . 74.11 111.155 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.3 m -131.2 113.0 13.32 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.87 -1.53 . . . . 74.11 106.87 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.0 pt . . . . . 0 C--N 1.301 -1.501 0 N-CA-C 112.372 0.508 . . . . 72.42 112.372 -172.481 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 108.395 -0.965 . . . . 63.5 108.395 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 m -90.23 151.62 21.45 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.537 -0.912 . . . . 72.12 108.537 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 50.1 m-80 54.37 63.66 2.09 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.306 0.642 . . . . 64.01 111.634 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.59 156.38 24.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.259 -0.645 . . . . 43.15 109.259 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -72.8 135.93 80.51 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.348 -0.541 . . . . 74.45 109.907 175.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.505 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.0 Cg_exo -56.06 -21.22 33.7 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.946 2.431 . . . . 62.0 114.47 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.8 t -61.53 -36.64 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.909 0.861 . . . . 62.33 109.55 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.0 -31.83 72.95 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.767 -1.106 . . . . 71.3 109.201 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.97 71.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.665 -1.152 . . . . 52.3 111.478 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -68.49 -33.02 73.42 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.304 -0.247 . . . . 72.23 111.367 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -64.91 -29.7 70.65 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.013 0.911 . . . . 71.42 108.55 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -98.55 15.95 23.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.49 -1.232 . . . . 64.41 110.584 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.1 m80 58.23 34.2 23.88 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.814 1.413 . . . . 72.14 114.814 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -104.07 23.53 12.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.682 -1.599 . . . . 74.32 106.682 172.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.96 -28.35 23.3 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 126.883 2.073 . . . . 75.5 113.772 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -55.3 -40.18 70.78 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.966 0.412 . . . . 70.52 111.541 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.37 -27.73 61.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.568 0.699 . . . . 61.1 109.746 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.55 -40.9 72.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.29 -0.868 . . . . 72.33 108.903 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.477 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 63.3 t -58.73 -46.72 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.599 -0.889 . . . . 74.42 108.599 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.93 -1.032 . . . . 75.42 112.301 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -64.97 -36.12 83.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 120.876 -0.33 . . . . 64.34 110.166 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.14 -43.27 98.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.872 -0.418 . . . . 61.53 109.872 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -59.51 -44.23 93.18 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 115.577 -0.738 . . . . 74.33 109.688 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.3 -26.58 68.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 60.0 111.867 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.5 tpt -81.61 -34.26 31.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.026 0.441 . . . . 72.14 110.608 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.61 -43.45 15.62 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.075 0.464 . . . . 62.32 111.49 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 . . . . . 0 C--O 1.261 1.669 0 CA-C-N 115.73 -0.668 . . . . 73.22 109.264 -177.22 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 120.953 0.406 . . . . 62.41 109.987 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.02 -121.06 3.54 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.841 -0.618 . . . . 75.25 113.946 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -109.22 129.79 55.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.546 0.212 . . . . 74.41 111.315 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -65.96 109.48 2.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.706 -0.679 . . . . 74.01 111.267 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.56 -30.93 6.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 113.205 0.816 . . . . 64.34 113.205 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.484 HD23 ' CE2' ' A' ' 103' ' ' PHE 0.273 0.5 OUTLIER -82.86 171.99 13.31 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 118.88 -1.128 . . . . 63.44 112.294 -178.493 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.19 137.41 75.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 109.233 -0.655 . . . . 52.12 109.233 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.71 -21.61 32.84 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.254 2.636 . . . . 74.24 113.852 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.98 -22.55 59.57 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.687 0.279 . . . . 63.33 111.72 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.48 138.4 97.35 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 116.168 -0.469 . . . . 64.42 110.109 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.655 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 34.5 Cg_endo -67.41 104.81 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.484 2.122 . . . . 43.21 110.425 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p -102.59 170.08 8.25 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 121.431 0.634 . . . . 70.4 112.044 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 107.712 -1.218 . . . . 70.32 107.712 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.565 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 13.3 t0 -136.53 164.15 28.84 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 103.528 -2.767 . . . . 63.44 103.528 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.501 ' HB3' HG13 ' A' ' 43' ' ' VAL . 93.5 mt -56.56 -53.76 60.84 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.327 0.862 . . . . 71.42 113.327 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.565 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 12.0 Cg_endo -58.06 -35.83 98.45 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.83 1.686 . . . . 72.24 112.012 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 26.9 tpt180 -67.35 -39.95 85.79 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.9 0.381 . . . . 73.14 111.068 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -36.77 69.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.789 -0.364 . . . . 74.11 110.386 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.82 68.36 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.002 -0.74 . . . . 42.41 109.002 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 42.0 mt-10 -68.48 -45.08 73.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.769 -1.105 . . . . 71.11 111.844 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.5 -46.55 82.48 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.489 -0.778 . . . . 75.55 112.033 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.419 ' HB2' HG22 ' A' ' 41' ' ' VAL . 97.5 mt -93.94 -10.22 34.47 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.608 0.595 . . . . 73.1 112.608 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.05 30.12 72.17 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 111.262 -0.735 . . . . 51.54 111.262 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.419 HG22 ' HB2' ' A' ' 39' ' ' LEU . 20.4 m -124.65 156.61 67.8 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.765 -0.828 . . . . 64.12 108.765 -177.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.35 156.39 66.4 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 121.391 1.394 . . . . 54.0 111.639 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 32' ' ' LEU . 74.5 t -57.02 -33.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 52.24 110.371 178.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 28.3 t -57.48 -40.85 79.47 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.639 -0.71 . . . . 74.43 110.812 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 62.4 tttp -70.47 -35.99 73.62 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 120.861 0.362 . . . . 72.11 110.202 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.31 -44.51 98.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.221 -0.659 . . . . 55.31 109.221 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.05 -36.61 80.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.047 -0.979 . . . . 43.2 110.21 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.623 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 54.7 mt-30 -63.18 -43.44 98.22 Favored 'General case' 0 C--O 1.197 -1.693 0 CA-C-N 116.055 -0.521 . . . . 75.14 111.133 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.7 mm-40 -58.38 -41.25 84.43 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.326 0.584 . . . . 74.51 110.317 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 tp -61.67 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.627 -1.169 . . . . 72.11 109.116 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -71.26 -23.95 62.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.531 -0.759 . . . . 64.1 112.512 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 10.4 mm-40 -82.97 -12.87 56.94 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.571 -0.529 . . . . 74.31 109.571 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.4 33.16 44.71 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.034 -0.826 . . . . 74.11 111.034 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -99.13 -15.72 18.87 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.771 0.319 . . . . 74.43 110.228 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -161.41 156.95 24.44 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.488 -1.301 . . . . 65.3 107.488 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.5 m -129.28 157.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.387 -0.597 . . . . 72.31 109.387 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.8 36.86 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.422 -0.584 . . . . 71.12 109.422 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 m -128.62 166.68 25.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 123.463 0.477 . . . . 73.2 111.044 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.476 ' NE ' ' HA2' ' A' ' 62' ' ' GLY . 19.4 ttt180 -109.63 121.04 44.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.428 0.632 . . . . 75.13 110.537 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -123.0 114.67 20.72 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.673 -1.149 . . . . 71.31 109.063 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.89 19.07 11.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.817 0.847 . . . . 54.11 111.023 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.476 ' HA2' ' NE ' ' A' ' 59' ' ' ARG . . . 99.7 -14.11 60.61 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.664 -0.698 . . . . 32.52 112.112 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -89.31 151.33 21.91 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.744 -0.942 . . . . 73.14 110.744 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.78 119.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 106.648 -1.612 . . . . 75.12 106.648 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.86 153.75 39.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.618 -0.719 . . . . 72.4 110.486 -174.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -126.45 131.84 24.08 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 108.189 -1.041 . . . . 71.54 108.189 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.39 141.38 86.9 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.238 1.959 . . . . 43.31 112.857 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.655 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.2 tp-100 -48.84 -42.39 36.16 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.213 1.405 . . . . 73.31 110.984 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.74 4.33 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 114.133 -1.394 . . . . 43.23 114.498 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.573 ' CD2' HD11 ' A' ' 81' ' ' LEU . 12.8 m-85 -91.96 -6.23 51.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.168 0.985 . . . . 53.34 109.501 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.51 144.58 47.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.405 -1.27 . . . . 74.14 108.683 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 p -75.85 172.95 11.81 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.253 -1.017 . . . . 71.42 108.253 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.73 -17.3 63.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.895 0.855 . . . . 64.42 109.261 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m -79.87 -6.86 58.21 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.191 -0.913 . . . . 74.22 110.552 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.92 -13.88 66.33 Favored Glycine 0 C--O 1.219 -0.827 0 C-N-CA 121.294 -0.479 . . . . 33.13 113.523 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -95.38 155.04 16.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.228 0.455 . . . . 62.3 112.228 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.37 141.8 17.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.408 -0.814 . . . . 73.12 108.812 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 26.4 t -59.91 134.16 25.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.3 -0.63 . . . . 60.15 109.3 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -55.78 -43.54 76.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.445 0.906 . . . . 75.11 113.445 -173.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.9 t -91.68 3.41 55.13 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.859 -0.336 . . . . 74.23 111.774 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.647 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.2 tt -66.46 -49.9 50.23 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 112.671 0.619 . . . . 73.43 112.671 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.06 -30.06 85.38 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.583 1.522 . . . . 54.44 111.028 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.25 -42.48 96.24 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.631 -0.713 . . . . 74.42 111.925 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.99 -40.16 83.12 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.055 -0.72 . . . . 75.53 109.055 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.53 -35.78 78.71 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.978 -0.556 . . . . 74.4 110.402 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.2 m -61.46 -49.09 78.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.947 -0.57 . . . . 62.1 111.677 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.412 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -64.53 -43.37 96.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.635 0.255 . . . . 71.02 111.226 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.565 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.8 mm? -67.49 -36.08 80.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.541 0.571 . . . . 74.41 112.541 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.13 -45.24 95.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.264 0.554 . . . . 72.44 109.866 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.6 -25.7 61.42 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.716 -0.674 . . . . 71.51 110.445 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.11 86.97 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.6 -0.727 . . . . 74.21 112.559 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.44 30.6 24.24 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 121.425 -0.417 . . . . 42.02 113.786 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -106.1 147.73 28.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.128 0.464 . . . . 71.55 111.537 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.407 ' O ' HG12 ' A' ' 98' ' ' ILE . 16.2 ptp180 -99.62 171.39 7.94 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.672 0.789 . . . . 71.15 110.724 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -54.02 -45.51 71.56 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.537 1.535 . . . . 70.24 112.418 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.8 m -64.23 -41.02 97.19 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.636 -0.711 . . . . 54.23 110.16 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 47.7 mt-10 -66.12 -37.42 85.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.86 -0.609 . . . . 75.31 110.352 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 94' ' ' ARG . 14.5 mm -61.53 -49.52 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.831 -0.803 . . . . 60.22 108.831 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.567 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.7 ptp -75.29 -15.92 60.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.187 -0.915 . . . . 52.33 113.251 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.71 -62.94 1.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.26 -0.644 . . . . 72.14 109.26 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -69.98 -32.98 71.47 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.479 0.918 . . . . 74.11 113.479 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.583 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.0 mt -58.96 -40.32 84.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.212 0.819 . . . . 75.11 113.212 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CE2' HD23 ' A' ' 23' ' ' LEU . 39.0 m-85 -86.14 -11.13 53.45 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.602 0.594 . . . . 70.53 112.602 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 m -87.51 121.14 71.26 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 108.902 -0.777 . . . . 65.22 108.902 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.49 130.12 35.83 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 122.568 2.178 . . . . 60.31 111.846 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 8.1 t70 -79.71 122.81 83.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 108.189 -1.041 . . . . 74.41 108.189 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 31.3 Cg_endo -60.78 -16.88 46.82 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.573 2.849 . . . . 71.22 114.6 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.6 t -119.1 5.74 11.29 Favored 'General case' 0 N--CA 1.421 -1.898 0 O-C-N 122.077 -0.39 . . . . 63.53 110.883 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -100.77 130.63 46.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.314 0.578 . . . . 64.51 110.261 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 120' ' ' VAL . 48.7 m -131.56 114.81 15.32 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.984 -1.117 . . . . 74.42 107.984 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--N 1.313 -1.014 0 N-CA-C 113.883 1.068 . . . . 73.52 113.883 -174.286 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 110' ' ' THR . 48.1 t . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 108.933 -0.766 . . . . 54.42 108.933 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.5 m -88.15 146.97 25.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.77 -0.65 . . . . 63.53 110.162 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 25.5 m-80 64.72 57.57 1.06 Allowed 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.277 1.031 . . . . 73.13 109.211 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 159.9 15.68 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.737 -1.119 . . . . 72.33 109.696 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -81.03 147.88 62.65 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 108.325 -0.991 . . . . 72.33 108.325 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.583 ' HB2' HD23 ' A' ' 102' ' ' LEU . 52.1 Cg_exo -56.99 -28.15 76.91 Favored 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 121.892 1.728 . . . . 72.11 111.387 174.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 62.0 t -63.68 -35.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.609 0.719 . . . . 73.52 110.409 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.81 -41.57 74.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.68 -1.23 . . . . 60.23 107.68 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -34.86 79.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.485 -1.234 . . . . 63.02 113.173 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.77 -32.96 71.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.584 -0.698 . . . . 72.42 111.263 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -76.74 -13.61 60.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.885 0.85 . . . . 73.35 109.907 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.91 3.85 51.78 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.802 -1.09 . . . . 75.31 110.421 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.9 t60 64.14 27.17 14.03 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.211 1.482 . . . . 73.22 109.689 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -114.13 24.86 11.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.0 -1.455 . . . . 74.45 108.139 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.73 -27.85 19.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.602 -1.635 . . . . 75.52 112.43 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -56.37 -42.84 78.51 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.468 -0.567 . . . . 52.4 109.468 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 22.6 mm-40 -65.64 -39.63 91.65 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.361 -0.836 . . . . 72.42 109.481 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.64 -47.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.4 -0.818 . . . . 62.12 109.786 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 57.9 t -60.83 -41.79 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.816 -0.629 . . . . 52.11 109.805 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -63.42 -40.4 97.07 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 120.923 0.392 . . . . 73.32 111.2 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 14.3 mmt85 -66.22 -35.49 80.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.864 -0.791 . . . . 70.1 108.864 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.565 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 63.11 109.888 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.6 mt-30 -61.7 -38.62 88.51 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 116.155 -0.475 . . . . 73.21 109.887 176.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.96 -22.78 65.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.963 0.411 . . . . 53.12 111.366 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 24.1 mmt -89.07 -29.66 19.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.348 0.594 . . . . 64.54 110.013 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.32 -45.17 13.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.077 -0.511 . . . . 74.02 111.8 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 107.785 -1.191 . . . . 70.33 107.785 -178.954 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 108.798 -0.815 . . . . 63.32 108.798 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.93 -107.77 2.19 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 110.842 -0.903 . . . . 52.04 110.842 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -118.17 141.88 48.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.703 -0.481 . . . . 61.11 109.703 -176.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.09 158.09 34.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.997 0.903 . . . . 73.15 111.696 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 22' ' ' VAL . 38.9 t -121.23 32.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 124.172 1.939 . . . . 74.34 106.262 175.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.458 HD13 HG21 ' A' ' 29' ' ' THR . 40.4 mt -104.49 178.93 4.42 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.239 -1.8 . . . . 43.4 111.266 -175.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 15.3 t70 -90.79 136.05 28.23 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 105.704 -1.961 . . . . 61.25 105.704 169.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.65 -25.47 14.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.393 2.728 . . . . 75.22 115.193 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.52 33.68 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.524 -0.87 . . . . 74.44 110.973 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 25.3 tp10 -72.57 129.46 87.06 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 105.726 -1.953 . . . . 71.42 105.726 172.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 52.4 Cg_exo -55.27 98.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.66 2.24 . . . . 74.34 111.681 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.458 HG21 HD13 ' A' ' 23' ' ' LEU . 6.1 p -107.16 -177.66 3.42 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.732 -0.667 . . . . 73.31 112.197 -176.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.445 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 52.3 m-85 -111.48 159.78 17.75 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.999 -1.001 . . . . 71.12 109.445 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.3 m-20 -136.52 162.46 33.03 Favored 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 101.84 -3.392 . . . . 73.23 101.84 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -50.94 -51.55 66.18 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-N 119.028 0.831 . . . . 72.12 112.447 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.87 -35.95 85.94 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.021 1.814 . . . . 65.04 112.553 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 7.7 tpt180 -70.27 -36.99 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.864 0.364 . . . . 73.52 110.181 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 31' ' ' ASP . 66.0 t -69.1 -39.03 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.475 -0.565 . . . . 71.33 109.475 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.75 84.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.465 -0.789 . . . . 63.04 109.52 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.2 -36.69 79.96 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.592 -1.186 . . . . 73.51 110.247 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 56.9 tp -72.55 -45.46 59.12 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.54 -0.755 . . . . 70.31 111.335 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 41' ' ' VAL . 94.0 mt -85.71 -18.44 33.09 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.637 0.606 . . . . 54.41 112.637 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.56 28.04 60.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.796 -0.922 . . . . 34.43 110.796 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 39' ' ' LEU . 31.6 m -123.01 159.09 55.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.319 -0.993 . . . . 75.43 108.319 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -67.23 155.25 71.4 Favored 'Trans proline' 0 C--O 1.26 1.597 0 C-N-CA 121.057 1.171 . . . . 75.1 111.644 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.46 -33.5 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.428 0.691 . . . . 73.25 110.424 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 36.8 t -57.33 -45.62 84.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.954 -0.566 . . . . 71.03 110.787 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 64.7 mttm -64.72 -36.74 85.25 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.392 -0.523 . . . . 64.5 110.88 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.33 -45.17 98.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.496 -0.557 . . . . 60.55 109.496 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.45 80.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.581 -0.736 . . . . 72.55 110.552 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.641 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 97.2 mt-30 -61.73 -46.77 88.21 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.802 -0.444 . . . . 54.31 109.802 176.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 77.6 mt-30 -59.39 -42.55 91.95 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.706 0.765 . . . . 64.33 110.556 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.2 -38.33 88.74 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.437 -1.256 . . . . 74.42 109.427 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -71.25 -29.13 64.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.185 0.439 . . . . 75.11 112.185 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.641 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 56.0 mt-10 -76.55 -12.26 60.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.737 0.303 . . . . 74.54 110.375 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.44 22.47 64.76 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.545 -1.022 . . . . 62.23 110.545 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -94.62 -0.32 54.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.103 0.478 . . . . 70.34 111.049 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.7 tp -163.23 152.79 15.18 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.403 -1.702 . . . . 74.53 106.403 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -132.09 148.13 32.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.013 -0.736 . . . . 71.33 109.013 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.23 154.3 37.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 123.567 0.542 . . . . 75.32 110.01 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.576 HG12 ' OD2' ' A' ' 95' ' ' ASP . 19.6 m -128.39 166.63 25.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.302 1.041 . . . . 75.15 109.116 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 53.4 mtm180 -110.91 129.37 55.9 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.743 -0.466 . . . . 71.13 109.743 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -125.34 123.84 40.26 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.648 -1.612 . . . . 70.13 106.648 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.04 -15.78 0.32 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.418 1.087 . . . . 60.03 112.8 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.01 -13.83 4.67 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.927 -0.869 . . . . 63.32 110.927 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -92.7 152.52 21.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.804 -0.918 . . . . 63.15 110.804 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -96.8 120.78 46.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 71.52 107.835 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.39 160.29 40.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.479 -0.782 . . . . 63.31 111.218 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.06 125.7 26.19 Favored Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 106.978 -1.49 . . . . 74.44 106.978 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 29' ' ' THR . 51.3 Cg_exo -56.43 139.22 86.6 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.745 2.296 . . . . 75.24 113.625 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.9 tp-100 -53.81 -37.26 63.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.286 1.034 . . . . 70.25 110.165 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.459 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 34.3 m -72.18 2.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.574 -1.648 . . . . 74.45 113.95 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.3 m-85 -95.49 -1.68 50.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.935 0.874 . . . . 74.43 109.497 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.46 139.32 53.63 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.656 -1.156 . . . . 73.51 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.7 p -79.51 168.94 18.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.016 -0.993 . . . . 70.04 109.519 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -57.56 -23.41 50.46 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.068 0.547 . . . . 73.34 111.35 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 t -79.96 -8.13 59.17 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.191 -0.459 . . . . 73.3 110.345 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.17 18.33 65.03 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.998 -0.62 . . . . 65.33 112.719 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -119.13 161.84 19.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.046 -0.724 . . . . 72.44 109.046 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.27 144.86 11.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.332 -0.988 . . . . 72.33 108.332 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.8 t -64.02 124.64 19.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.406 -0.961 . . . . 73.23 108.406 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -55.26 -44.72 75.84 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.584 1.327 . . . . 62.22 114.584 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.9 m -96.55 9.82 40.29 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 112.758 0.651 . . . . 65.42 112.758 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 7.1 tt -65.64 -45.34 67.11 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 116.368 -0.378 . . . . 72.43 111.864 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.88 -25.76 54.33 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.924 1.749 . . . . 75.32 111.658 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.9 -38.66 96.93 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.658 -0.701 . . . . 33.0 111.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.98 -41.06 78.4 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.971 -0.751 . . . . 63.3 108.971 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.43 -34.39 75.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 72.3 110.355 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.0 m -61.65 -49.02 78.22 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.486 -0.779 . . . . 64.24 110.791 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -41.81 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 111.642 0.238 . . . . 71.42 111.642 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.409 HD21 ' HB1' ' A' ' 141' ' ' ALA . 2.9 mm? -66.75 -35.19 79.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.029 -0.668 . . . . 74.14 112.511 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -63.72 -35.95 82.27 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.131 -0.692 . . . . 75.0 109.131 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.09 -31.22 67.54 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.481 -0.781 . . . . 71.25 110.002 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.62 -8.63 70.05 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.625 -0.716 . . . . 72.05 112.8 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.04 49.61 5.9 Favored Glycine 0 C--N 1.318 -0.423 0 C-N-CA 121.338 -0.458 . . . . 62.33 113.669 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.94 139.8 49.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.259 -0.553 . . . . 71.11 111.865 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -85.09 170.03 13.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.351 -0.84 . . . . 74.4 110.3 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.576 ' OD2' HG12 ' A' ' 58' ' ' VAL . 19.1 p-10 -55.28 -42.69 73.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.506 1.522 . . . . 74.21 111.945 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.2 m -61.32 -42.24 98.35 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.098 -0.955 . . . . 73.55 110.012 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.73 -37.12 84.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.141 -0.482 . . . . 75.54 110.928 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.09 -48.9 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.844 0.831 . . . . 75.05 108.813 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.489 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 59.0 mtt -75.48 -20.87 58.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.784 -1.098 . . . . 73.21 112.227 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -57.97 -61.13 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.511 0.507 . . . . 72.34 109.736 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.419 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 29.1 p-90 -69.46 -32.53 71.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.19 0.811 . . . . 64.05 113.19 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 126' ' ' VAL . 17.0 mt -60.12 -41.45 92.68 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.812 0.671 . . . . 75.33 112.812 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -85.02 -14.72 46.48 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.605 -0.438 . . . . 70.51 112.081 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 m -87.05 118.59 70.25 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.788 -0.449 . . . . 74.31 109.788 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.93 131.07 40.71 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.903 2.402 . . . . 74.32 111.217 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.6 t70 -90.47 122.84 66.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.26 -0.427 . . . . 61.12 110.966 -174.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.91 -16.31 44.04 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.935 3.09 . . . . 50.25 114.56 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -118.03 10.54 13.08 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.798 -0.564 . . . . 55.34 110.4 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.32 131.3 49.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.488 0.661 . . . . 71.13 111.917 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -125.99 120.28 29.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.867 -1.531 . . . . 62.0 106.867 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.1 pt . . . . . 0 C--N 1.302 -1.484 0 CA-C-O 120.429 0.156 . . . . 72.44 111.285 -178.416 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.9 t . . . . . 0 N--CA 1.438 -1.06 0 N-CA-C 109.393 -0.595 . . . . 63.44 109.393 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.8 m -90.17 139.9 30.19 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.842 -0.617 . . . . 52.52 109.55 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 11.1 t30 59.81 67.79 0.84 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.746 1.26 . . . . 72.15 110.619 -177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -113.1 179.23 4.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.288 -1.324 . . . . 52.32 109.877 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.451 ' HD3' ' N ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -87.12 138.35 32.6 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 109.014 -0.736 . . . . 63.11 109.014 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.505 ' HB2' HD23 ' A' ' 102' ' ' LEU . 71.4 Cg_exo -56.27 -29.93 78.3 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.198 1.932 . . . . 61.14 110.122 170.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.633 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 70.5 t -61.82 -42.8 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.345 0.593 . . . . 74.13 110.37 173.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.98 -34.76 77.15 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.07 -0.652 . . . . 72.21 109.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.79 85.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.915 -1.039 . . . . 63.22 112.853 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.65 -32.51 71.21 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.029 -0.42 . . . . 71.4 110.917 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -71.74 -23.41 61.61 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.686 0.755 . . . . 70.43 109.767 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.38 -0.26 54.28 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.851 -1.068 . . . . 61.31 110.423 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.7 m80 64.03 28.24 14.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.59 1.156 . . . . 71.31 110.256 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -102.61 25.07 9.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.956 -1.475 . . . . 72.13 107.414 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.49 -28.31 19.86 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 113.914 -1.494 . . . . 73.41 112.675 -178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -56.77 -41.15 77.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.81 0.338 . . . . 71.41 110.707 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.51 -34.18 77.65 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.909 -0.587 . . . . 63.33 110.165 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.24 -44.87 83.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.685 -0.688 . . . . 52.23 109.144 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 134' ' ' ALA . 64.2 t -61.1 -42.33 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.458 -0.571 . . . . 61.55 109.458 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -58.11 -43.44 87.15 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.977 -0.556 . . . . 72.21 110.403 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 144' ' ' MET . 73.2 mmt-85 -65.84 -39.0 90.37 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 116.618 -0.265 . . . . 71.33 111.126 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.409 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -58.87 -45.1 90.96 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.365 0.416 . . . . 23.4 110.272 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -43.02 99.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 72.34 109.993 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.07 -19.83 63.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.401 -0.818 . . . . 51.4 112.632 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 91.3 mmm -88.4 -21.49 24.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.313 0.577 . . . . 65.41 109.799 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.37 -61.0 2.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.328 -0.619 . . . . 74.51 109.328 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--N 1.302 -1.457 0 CA-C-O 118.304 -0.855 . . . . 65.44 109.52 -178.847 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . . . . . . 0 CA--C 1.502 -0.866 0 CA-C-O 120.466 0.174 . . . . 72.03 111.388 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.04 -171.53 18.77 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.268 -1.133 . . . . 31.24 110.268 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -87.68 138.28 31.61 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.022 -0.733 . . . . 73.12 109.022 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.08 111.45 7.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.118 0.961 . . . . 73.44 112.421 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 100' ' ' ARG . 25.9 t -96.83 45.14 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.525 -1.657 . . . . 74.55 106.525 171.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.473 HD23 ' CE2' ' A' ' 103' ' ' PHE . 57.0 mt -107.97 161.01 15.32 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.315 -1.311 . . . . 74.25 110.645 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.589 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.5 t70 -97.4 143.27 25.87 Favored Pre-proline 0 C--N 1.289 -2.037 0 N-CA-C 105.504 -2.035 . . . . 74.32 105.504 171.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.37 -24.67 12.38 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.318 2.679 . . . . 45.35 114.539 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -96.43 2.59 52.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.759 1.022 . . . . 62.51 113.759 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.589 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 41.2 mm-40 -78.15 127.57 81.01 Favored Pre-proline 0 C--O 1.249 1.079 0 N-CA-C 109.139 -0.689 . . . . 74.15 109.139 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.13 142.11 60.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.878 2.385 . . . . 75.2 112.802 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.3 p -123.06 -174.65 2.99 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.286 -0.87 . . . . 71.45 110.552 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -133.15 161.84 33.36 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 127.344 2.258 . . . . 64.24 107.059 172.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.9 p30 -133.41 156.41 47.73 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 104.132 -2.544 . . . . 73.52 104.132 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.311 4.5 mm? -51.7 -52.61 58.99 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 116.126 1.898 . . . . 75.42 116.126 -172.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.15 -33.74 97.78 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 120.371 1.168 . . . . 74.15 111.935 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -69.35 -41.23 76.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.057 -0.349 . . . . 74.11 110.057 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG21 HD12 ' A' ' 66' ' ' ILE . 62.4 t -67.65 -39.64 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.306 -0.406 . . . . 72.02 109.972 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.89 91.66 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.428 -0.806 . . . . 71.12 109.612 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.69 -41.01 79.79 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.841 -1.072 . . . . 54.21 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.06 -44.44 72.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.345 -0.843 . . . . 61.35 111.516 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.0 -13.95 40.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.32 -0.4 . . . . 72.55 112.046 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.7 23.77 71.75 Favored Glycine 0 C--O 1.243 0.673 0 C-N-CA 120.888 -0.672 . . . . 61.33 112.339 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 143.71 50.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.652 -0.87 . . . . 63.4 108.652 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.53 155.18 43.32 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.432 2.088 . . . . 75.43 113.064 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -50.8 -35.76 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.338 1.055 . . . . 62.15 111.722 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 t -57.68 -42.98 84.7 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.72 0.408 . . . . 71.01 110.867 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -69.69 -36.01 75.59 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.806 0.336 . . . . 52.13 110.957 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.12 -40.54 89.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.5 -0.555 . . . . 72.23 109.5 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.46 75.36 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.666 -0.697 . . . . 74.55 111.049 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 48' ' ' GLN . 12.4 mm-40 -65.7 -39.99 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 71.02 110.679 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.08 -44.65 95.19 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.0 0.905 . . . . 74.44 109.213 176.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.17 -35.16 77.96 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.103 -1.408 . . . . 64.52 110.505 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.229 0.455 . . . . 73.13 112.229 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -84.75 -12.19 54.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.119 -0.632 . . . . 70.34 111.403 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.64 34.47 25.05 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.491 -1.044 . . . . 72.21 110.491 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.408 ' O ' HD23 ' A' ' 81' ' ' LEU . 36.9 t-80 -82.12 -21.52 36.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.772 -0.825 . . . . 71.22 108.772 177.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.5 tp -152.32 157.97 42.08 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.989 -1.856 . . . . 74.0 105.989 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.46 146.01 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.554 -0.906 . . . . 73.15 108.554 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -118.61 158.68 25.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.246 -1.02 . . . . 74.44 108.246 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.2 m -132.56 162.37 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.396 0.617 . . . . 74.03 111.204 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -110.55 115.48 29.69 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.591 -1.263 . . . . 61.02 107.591 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -130.38 129.9 43.69 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 106.935 -1.506 . . . . 73.44 106.935 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.33 9.71 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.797 0.839 . . . . 75.22 110.879 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.32 65.53 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.786 -0.643 . . . . 63.12 112.358 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.29 146.52 18.23 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 121.186 -0.53 . . . . 71.43 111.955 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.51 121.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.454 -0.573 . . . . 75.24 109.454 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.29 167.28 18.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 125.264 1.426 . . . . 63.4 108.48 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.438 HD12 HG21 ' A' ' 35' ' ' VAL . 74.7 mt -115.47 131.49 23.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.397 -0.964 . . . . 73.33 108.397 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.68 126.71 17.27 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 121.861 1.707 . . . . 64.52 112.616 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -64.03 -23.98 67.54 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 122.951 0.501 . . . . 73.45 111.603 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 m -67.87 -6.81 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 112.332 0.493 . . . . 61.23 112.332 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.8 m-85 -89.37 -3.24 58.53 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.037 0.922 . . . . 73.44 109.847 174.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -117.86 152.35 35.55 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.666 -1.152 . . . . 74.0 108.162 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 p -82.65 175.28 10.28 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 123.441 0.463 . . . . 72.14 110.034 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.04 -33.68 69.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.549 0.74 . . . . 72.34 110.718 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.1 m -79.54 -3.57 47.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.961 -0.563 . . . . 65.25 112.511 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.9 35.59 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.309 -0.948 . . . . 73.2 111.398 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.57 145.51 37.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.272 -1.01 . . . . 74.24 108.272 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.435 HG13 HD22 ' A' ' 81' ' ' LEU . 55.2 t -68.99 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.228 -1.027 . . . . 74.31 108.228 174.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.84 127.87 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.37 -0.974 . . . . 72.11 108.37 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -68.81 -25.46 64.69 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.891 -0.506 . . . . 70.51 112.188 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 56.7 m -90.25 6.92 40.81 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.493 -0.321 . . . . 60.24 111.439 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 13.0 tp -61.23 -53.19 65.35 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 119.235 -0.412 . . . . 71.41 111.029 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.3 Cg_exo -63.12 -29.84 74.79 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.359 1.373 . . . . 74.14 110.984 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.14 91.99 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.721 -0.672 . . . . 41.12 111.923 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.04 -40.19 82.89 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.292 0.567 . . . . 71.21 109.493 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.54 -45.96 88.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 52.35 110.437 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.5 m -62.56 -43.79 97.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.748 0.647 . . . . 72.22 112.748 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.503 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -61.94 -47.7 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 118.128 0.422 . . . . 71.13 111.537 -178.598 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.586 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -67.28 -42.79 83.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 74.43 112.06 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.35 -35.33 80.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.164 -0.68 . . . . 52.23 109.164 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -71.07 -30.2 66.28 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.433 0.635 . . . . 52.14 110.595 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.22 86.84 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.918 -0.583 . . . . 50.01 112.673 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.62 39.95 4.28 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 120.775 -0.726 . . . . 73.11 112.999 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 65.7 m-85 -119.62 136.82 54.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.251 -0.648 . . . . 65.45 109.251 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.587 ' HG2' ' OE1' ' A' ' 97' ' ' GLU . 7.8 ptp85 -84.61 171.07 12.74 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 123.251 0.345 . . . . 75.21 110.697 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -53.38 -45.29 69.19 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 124.601 1.161 . . . . 62.43 112.969 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -62.04 -40.65 96.47 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.627 -0.715 . . . . 73.51 109.95 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.587 ' OE1' ' HG2' ' A' ' 94' ' ' ARG . 44.7 mt-10 -65.87 -33.83 76.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.941 -0.572 . . . . 62.12 111.798 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.414 HD12 ' CB ' ' A' ' 88' ' ' LEU . 9.4 mm -62.53 -49.4 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.296 -1.002 . . . . 64.14 108.296 -177.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.493 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 14.9 ptm -75.44 -16.32 60.34 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.243 -0.89 . . . . 54.12 112.634 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HA ' HG11 ' A' ' 22' ' ' VAL . 68.4 ttt180 -58.59 -64.42 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.351 0.66 . . . . 71.23 110.364 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.486 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.0 p-90 -68.84 -31.67 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.192 -0.458 . . . . 72.13 112.145 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 11.9 mt -57.71 -39.56 77.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.007 0.743 . . . . 70.42 113.007 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CE2' HD23 ' A' ' 23' ' ' LEU . 30.0 m-85 -86.49 -3.14 58.96 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.241 0.46 . . . . 71.54 112.241 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.5 m -86.2 125.43 68.09 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 107.606 -1.257 . . . . 63.44 107.606 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.56 133.84 59.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.649 2.233 . . . . 64.54 110.94 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.7 t70 -91.45 121.37 67.56 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 109.428 -0.582 . . . . 72.11 109.428 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.78 -16.38 43.73 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.693 2.929 . . . . 72.43 114.779 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 m -123.46 16.02 9.66 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 122.01 -0.431 . . . . 72.4 111.108 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 28.9 tp -104.28 115.18 29.93 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.726 -0.79 . . . . 65.43 111.231 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.2 m -122.37 110.68 15.95 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.901 -1.518 . . . . 75.02 106.901 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 C--N 1.3 -1.561 0 N-CA-C 112.37 0.507 . . . . 72.42 112.37 -171.666 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 108.806 -0.813 . . . . 54.14 108.806 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.1 m -87.46 149.33 24.49 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 123.059 0.544 . . . . 72.54 109.892 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 4.8 m-20 56.42 43.47 26.03 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.309 1.044 . . . . 41.14 111.138 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.61 175.66 9.1 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.111 -0.949 . . . . 71.25 111.988 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -86.74 124.67 68.89 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.33 -0.85 . . . . 75.44 110.41 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.6 Cg_exo -51.96 -28.08 30.54 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 124.068 3.179 . . . . 72.11 114.443 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.9 t -60.39 -39.1 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.515 0.674 . . . . 65.13 109.879 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.13 -30.07 68.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.567 -0.742 . . . . 62.54 111.176 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.22 87.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 62.14 110.213 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -70.2 -34.05 72.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.88 -0.415 . . . . 62.22 109.88 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -68.65 -25.28 64.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.44 -0.8 . . . . 73.51 109.241 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.47 7.03 46.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.15 -0.932 . . . . 71.23 111.071 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.9 m80 69.35 32.79 3.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.931 0.872 . . . . 70.12 112.873 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -112.01 24.69 12.36 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.82 -1.178 . . . . 72.24 107.82 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.93 -29.74 30.45 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 125.22 1.408 . . . . 55.33 113.657 -173.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -57.77 -35.44 70.76 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.835 0.35 . . . . 74.32 111.476 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -32.37 68.01 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.476 0.655 . . . . 73.01 109.845 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.4 t -70.97 -42.83 77.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.964 -1.016 . . . . 63.34 108.523 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 90.2 t -59.46 -42.64 88.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.428 -0.806 . . . . 73.04 109.874 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -60.71 -47.18 87.44 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.658 -0.246 . . . . 71.42 111.255 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -61.14 -39.21 89.22 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.354 -0.61 . . . . 75.23 109.354 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.586 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.87 -46.74 88.33 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 115.271 -0.877 . . . . 63.13 110.87 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.3 mt-30 -58.57 -41.18 85.12 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.2 0.6 . . . . 61.25 111.529 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.24 79.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.9 -0.591 . . . . 42.13 111.221 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.1 tpt -80.34 -35.44 35.56 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.889 -0.596 . . . . 71.45 110.697 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -71.89 -49.87 34.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.294 0.85 . . . . 71.51 113.294 -176.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 C--N 1.307 -1.276 0 CA-C-O 118.628 -0.701 . . . . 71.11 109.575 -175.411 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB1' ' C ' ' A' ' 58' ' ' VAL . . . . . . . . 0 N--CA 1.432 -1.337 0 CA-C-O 120.816 0.341 . . . . 74.41 110.317 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.491 ' HA3' ' OD1' ' A' ' 95' ' ' ASP . . . -83.94 -164.8 37.71 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.173 -0.922 . . . . 73.01 115.06 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.12 112.89 20.22 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 114.342 -0.929 . . . . 63.42 111.224 -173.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -46.23 111.85 0.42 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.92 1.288 . . . . 54.01 113.846 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 100' ' ' ARG . 91.8 t -86.67 -37.7 11.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 107.92 -1.141 . . . . 72.21 107.92 172.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HB3' ' CD2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -73.63 164.67 26.33 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.955 -1.02 . . . . 74.02 111.238 177.601 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.37 150.07 97.43 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.757 -0.46 . . . . 64.15 109.757 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 59.3 Cg_exo -51.28 -41.0 60.57 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.646 2.231 . . . . 73.31 113.2 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.14 26.74 8.42 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 63.23 113.119 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.66 138.39 90.86 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 105.832 -1.914 . . . . 75.31 105.832 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -36.46 110.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.463 3.442 . . . . 74.21 113.496 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.89 174.98 10.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.353 0.597 . . . . 74.54 112.271 -176.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.494 ' CE2' HD22 ' A' ' 38' ' ' LEU . 35.0 m-85 -130.33 161.52 31.1 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.418 1.487 . . . . 75.31 107.828 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.6 t0 -133.28 166.74 21.8 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 103.344 -2.836 . . . . 72.25 103.344 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -46.62 -56.0 12.73 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 113.706 1.002 . . . . 72.5 113.706 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.32 -40.9 78.5 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 121.794 1.663 . . . . 44.33 112.004 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 34' ' ' ARG . 1.9 mpt_? -70.77 -34.69 72.07 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.055 0.761 . . . . 73.3 113.055 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 31' ' ' ASP . 45.5 t -69.86 -43.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.979 -0.748 . . . . 74.51 108.979 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.71 80.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.911 -1.04 . . . . 72.24 109.475 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.5 -45.45 75.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.279 -0.873 . . . . 63.24 110.436 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.494 HD22 ' CE2' ' A' ' 30' ' ' TYR . 30.2 tp -65.76 -50.12 65.9 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 71.01 111.096 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.501 ' HB2' HG22 ' A' ' 41' ' ' VAL . 93.6 mt -83.1 -18.37 39.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.795 -0.639 . . . . 71.45 112.217 -176.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.85 63.38 Favored Glycine 0 C--N 1.323 -0.159 0 N-CA-C 111.056 -0.818 . . . . 73.23 111.056 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 39' ' ' LEU . 21.1 m -124.28 165.05 26.37 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.835 -0.802 . . . . 74.24 108.835 -177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -79.45 163.57 24.4 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.205 1.27 . . . . 63.21 110.709 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.48 -34.14 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.452 0.701 . . . . 61.32 111.25 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.6 p -61.25 -40.85 95.58 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.601 -0.727 . . . . 75.04 111.837 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 83.0 tttt -69.54 -32.21 70.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.898 0.38 . . . . 71.14 110.289 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.16 -42.17 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.239 -0.652 . . . . 73.21 109.239 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.25 74.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.542 -0.754 . . . . 61.42 110.212 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 44' ' ' SER . 73.9 mm-40 -66.39 -35.45 80.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.5 -0.318 . . . . 75.14 111.038 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 76.6 mm-40 -64.34 -47.22 80.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 70.03 108.417 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.81 -45.0 95.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.086 -1.415 . . . . 65.13 110.017 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -65.39 -23.6 67.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 114.187 1.18 . . . . 62.32 114.187 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.27 3.14 37.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.028 -1.069 . . . . 65.41 111.366 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.97 41.25 41.29 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.591 -0.731 . . . . 54.04 112.297 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.12 -12.26 18.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.938 -0.393 . . . . 73.42 109.938 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.3 tp -156.77 161.38 39.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.57 -0.9 . . . . 60.34 108.57 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.23 146.82 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.89 -0.782 . . . . 61.55 108.89 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.39 148.31 43.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 63.41 109.024 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.486 ' C ' ' HB1' ' A' ' 18' ' ' ALA . 17.7 m -127.06 155.07 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.862 0.363 . . . . 54.21 110.877 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -110.41 115.12 29.09 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.7 -0.852 . . . . 71.31 108.7 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -126.82 123.74 38.03 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.206 -0.664 . . . . 61.22 109.206 -179.603 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.93 14.75 8.64 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.375 1.07 . . . . 71.14 111.378 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.92 4.31 60.25 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.656 -0.702 . . . . 41.44 112.362 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.51 145.68 16.13 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.563 -1.015 . . . . 74.44 110.563 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' A' ' 18' ' ' ALA . 95.4 t -97.15 120.03 45.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.591 -0.892 . . . . 74.34 108.591 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.26 169.53 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.212 -0.904 . . . . 72.1 109.228 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.433 HD12 HG21 ' A' ' 35' ' ' VAL . 57.0 mt -119.75 129.19 25.49 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 108.455 -0.943 . . . . 74.13 108.455 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.11 122.23 11.41 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.956 2.438 . . . . 74.54 112.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.486 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 46.3 tt0 -64.66 -25.6 68.02 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.159 -0.473 . . . . 64.33 111.921 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 32.8 m -72.2 -4.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.969 0.414 . . . . 73.35 112.108 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.86 -4.94 59.23 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.018 0.914 . . . . 65.43 109.718 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -117.04 151.29 37.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.835 -1.172 . . . . 65.23 107.835 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 p -83.06 166.87 18.39 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.619 -1.252 . . . . 74.22 107.619 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.86 -16.48 64.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.534 0.683 . . . . 72.24 110.112 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -79.96 -1.82 41.18 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.976 -0.556 . . . . 75.11 111.906 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.15 28.1 56.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.311 -0.947 . . . . 55.42 111.883 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -124.5 143.04 50.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.081 -1.081 . . . . 74.22 108.081 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.15 141.12 18.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.059 -1.089 . . . . 60.54 108.059 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.631 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.4 t -57.81 122.34 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.38 -0.971 . . . . 53.05 108.38 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -67.33 -27.61 67.29 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.437 0.902 . . . . 74.13 113.437 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -89.92 -6.77 55.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.161 0.505 . . . . 72.14 111.086 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.631 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 9.1 tt -65.91 -47.51 63.98 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 113.646 0.98 . . . . 63.24 113.646 -175.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.5 Cg_endo -55.72 -28.89 68.74 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.654 1.569 . . . . 64.14 111.186 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -40.23 93.67 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.663 -0.699 . . . . 74.54 111.987 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -67.97 -40.13 83.21 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.077 -0.712 . . . . 73.43 109.077 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.647 -0.706 . . . . 63.52 109.966 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.6 m -58.81 -50.03 75.49 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-N 115.674 -0.694 . . . . 61.43 111.524 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -41.62 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.634 -0.257 . . . . 71.44 111.516 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.487 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.6 mm? -66.8 -36.31 82.1 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.077 0.399 . . . . 73.32 112.077 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -65.92 -32.81 74.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.486 0.184 . . . . 72.43 110.973 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.75 -30.64 71.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.163 0.506 . . . . 62.04 110.199 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.68 88.43 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.861 -0.608 . . . . 63.35 111.672 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.79 35.91 38.58 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.752 -0.224 . . . . 70.33 113.09 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 99.4 m-85 -97.67 145.66 26.1 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 122.412 -0.464 . . . . 73.35 111.04 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -95.6 171.43 8.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.594 -0.73 . . . . 75.24 110.205 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.491 ' OD1' ' HA3' ' A' ' 19' ' ' GLY . 2.0 p30 -53.65 -45.69 70.31 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.522 1.129 . . . . 74.12 113.092 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.3 m -62.4 -40.74 97.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 122.807 0.443 . . . . 71.43 111.239 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.75 -37.58 86.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.986 -0.552 . . . . 72.22 110.407 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.18 -49.06 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.869 0.842 . . . . 74.25 109.644 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 13.0 ptt? -74.77 -13.52 60.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.864 -1.062 . . . . 74.35 113.356 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' HA ' HG11 ' A' ' 22' ' ' VAL . 77.3 ttt180 -57.43 -66.24 0.49 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.93 -0.308 . . . . 75.23 110.87 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.482 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 32.0 p-90 -67.61 -32.13 72.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.393 0.516 . . . . 72.31 112.393 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.482 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.9 mt -58.49 -40.82 83.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.6 0.593 . . . . 63.35 112.6 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.406 ' CD2' ' HB3' ' A' ' 23' ' ' LEU . 82.3 m-85 -95.23 -4.19 46.27 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.952 0.723 . . . . 73.43 112.952 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.9 m -87.34 120.09 71.11 Favored Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 109.035 -0.728 . . . . 75.32 109.035 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.96 129.1 23.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.551 1.501 . . . . 63.33 108.788 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 12.3 t70 -80.68 125.13 81.17 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.665 -0.494 . . . . 65.3 109.665 -176.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 26.9 Cg_endo -60.41 -22.25 70.73 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.518 2.812 . . . . 72.44 114.065 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -109.4 -1.48 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.128 -0.629 . . . . 73.23 111.542 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 23.7 tp -102.57 128.9 49.04 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 119.435 -0.906 . . . . 71.52 111.509 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.3 m -116.56 122.14 43.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.078 -1.823 . . . . 73.24 106.078 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 128' ' ' ALA . 40.1 mt . . . . . 0 C--N 1.305 -1.354 0 C-N-CA 120.498 -0.481 . . . . 71.43 110.261 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 107.423 -1.325 . . . . 70.53 107.423 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.0 p -81.62 137.95 35.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.315 -0.402 . . . . 54.32 110.23 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.595 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 33.5 m-80 68.12 66.44 0.35 Allowed 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 124.235 1.014 . . . . 63.21 110.299 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.429 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -109.45 169.4 8.72 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.055 -0.658 . . . . 73.33 109.824 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -89.37 157.59 47.24 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.555 -0.293 . . . . 72.03 110.443 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.88 -25.61 79.9 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.054 1.836 . . . . 64.53 109.848 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 69' ' ' VAL . 84.9 t -62.56 -38.71 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.22 -0.9 . . . . 61.11 109.716 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.98 -42.28 76.76 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.276 -0.639 . . . . 71.04 109.276 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -59.53 -41.0 89.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 64.44 112.857 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.69 -40.5 95.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.061 0.393 . . . . 64.22 112.061 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -77.6 -14.27 59.69 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.381 0.61 . . . . 73.34 111.058 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.53 5.9 50.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.317 -0.856 . . . . 12.4 111.575 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.0 m80 66.97 28.43 8.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.678 0.791 . . . . 64.52 112.028 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.3 23.19 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.077 0.941 . . . . 64.1 108.969 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.03 -28.66 39.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.018 1.727 . . . . 54.21 112.426 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -56.07 -38.44 70.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.366 -0.379 . . . . 74.11 110.62 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.98 -29.67 63.23 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 116.459 -0.337 . . . . 72.32 111.231 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.62 -49.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.118 -0.697 . . . . 60.13 109.118 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 57.6 t -62.53 -47.35 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.66 -0.7 . . . . 74.32 110.03 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.36 -46.59 83.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.8 -0.637 . . . . 73.53 111.121 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 140' ' ' ARG . 7.0 ttm180 -69.0 -33.41 73.62 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 63.52 110.5 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -64.96 -43.89 91.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.693 -0.484 . . . . 74.02 109.693 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 14.7 mm100 -57.6 -44.55 85.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.345 0.593 . . . . 74.41 109.747 175.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.28 79.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 61.13 111.817 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -72.18 -38.59 69.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 75.5 109.794 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -74.93 -51.77 12.93 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.915 -0.584 . . . . 60.0 112.567 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--O 1.255 1.391 0 N-CA-C 109.666 -0.494 . . . . 64.12 109.666 -176.149 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 N-CA-C 110.02 -0.363 . . . . 54.51 110.02 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.13 -99.49 2.07 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 121.38 -0.438 . . . . 61.41 112.305 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.71 135.18 51.05 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 122.327 -0.514 . . . . 60.44 112.238 -174.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 25.1 t0 -77.84 146.77 35.51 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.076 -0.965 . . . . 62.44 109.544 175.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.25 -15.85 9.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.396 -0.365 . . . . 65.44 111.342 -174.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 1.6 pp -90.61 179.25 5.87 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.32 -0.952 . . . . 71.54 111.442 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -105.58 137.11 19.21 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.927 -1.508 . . . . 73.41 106.927 173.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.32 -20.94 16.21 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.812 2.341 . . . . 74.1 114.376 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.45 -24.69 61.24 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 122.083 -0.385 . . . . 72.21 110.432 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.83 152.31 84.77 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 74.34 108.203 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.99 111.81 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 122.668 2.245 . . . . 74.34 113.085 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.407 ' HA ' ' H ' ' A' ' 68' ' ' GLN . 1.7 m -124.59 169.35 12.01 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 108.787 -0.819 . . . . 61.33 108.787 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -128.91 160.98 30.95 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.021 -1.474 . . . . 74.44 107.021 172.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.587 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 10.9 t70 -134.66 168.59 18.72 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 104.429 -2.434 . . . . 75.23 104.429 -173.039 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -52.01 -57.19 15.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 112.983 0.734 . . . . 54.14 112.983 -173.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.587 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 21.7 Cg_endo -62.61 -31.6 79.54 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.778 1.652 . . . . 75.44 111.756 176.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.505 ' HB2' ' H ' ' A' ' 31' ' ' ASP . 2.4 mpt_? -70.63 -36.83 73.65 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.428 0.529 . . . . 72.54 112.428 -178.392 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.59 -41.95 80.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.195 -0.669 . . . . 75.25 109.195 177.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.789 -1.096 . . . . 73.15 109.422 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.2 -45.8 83.3 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.833 1.253 . . . . 73.4 110.445 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 30' ' ' TYR . 38.8 tp -65.64 -50.28 65.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 73.1 111.604 -177.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.59 -9.54 58.21 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.531 0.567 . . . . 71.53 112.531 -174.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.41 29.26 71.79 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.672 -0.571 . . . . 63.22 111.672 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.23 160.28 48.44 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.544 -0.91 . . . . 74.22 108.544 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.68 160.08 38.27 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.564 1.51 . . . . 75.21 111.219 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.6 -32.84 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.349 0.659 . . . . 72.44 110.419 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -57.44 -42.84 83.21 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 116.185 -0.461 . . . . 64.45 110.495 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -70.16 -32.43 70.4 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.949 0.404 . . . . 73.42 110.603 178.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.7 t -62.28 -44.0 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 109.116 -0.698 . . . . 72.22 109.116 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -59.36 -36.94 76.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.27 -0.423 . . . . 52.21 110.299 177.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 83.6 mm-40 -69.63 -40.41 76.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.637 0.606 . . . . 73.35 112.637 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.548 ' O ' ' HB3' ' A' ' 54' ' ' HIS . 3.2 pt20 -68.69 -33.71 74.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.929 -0.708 . . . . 73.24 109.854 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.8 mt -62.47 -39.72 94.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.971 -0.752 . . . . 65.13 108.971 174.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 70.2 mtt-85 -70.78 -21.43 62.49 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.979 0.733 . . . . 72.12 112.979 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 44.4 mt-10 -76.77 -12.11 59.93 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 121.161 -0.216 . . . . 71.31 110.63 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.81 30.55 65.84 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.991 -2.043 . . . . 64.53 107.991 -169.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 49' ' ' GLN . 11.9 t-160 -97.23 -32.21 12.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 125.139 1.376 . . . . 71.14 108.625 -176.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 41.6 tp -152.61 153.19 32.86 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.1 -1.444 . . . . 73.21 107.1 -179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.75 161.48 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 117.9 0.318 . . . . 13.45 110.467 177.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.34 154.05 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.152 -0.685 . . . . 75.22 109.152 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.43 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 123.449 0.699 . . . . 61.33 110.548 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 98.8 mtt180 -117.24 134.76 54.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.767 -0.197 . . . . 64.32 110.607 -177.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -139.98 127.36 21.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.864 -1.161 . . . . 75.1 107.864 170.845 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.97 21.52 7.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.898 1.279 . . . . 63.11 111.882 -177.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.02 -0.88 67.18 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.378 -0.439 . . . . 71.2 112.681 -179.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -98.48 135.77 12.34 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.064 -0.814 . . . . 63.31 111.064 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.19 120.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.024 -1.102 . . . . 65.15 108.024 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.83 161.61 39.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.48 0.657 . . . . 64.51 111.878 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.88 120.75 25.55 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 106.384 -1.71 . . . . 73.14 106.384 178.144 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.02 124.61 16.36 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.409 2.073 . . . . 65.02 112.705 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.509 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 46.7 tt0 -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.887 0.851 . . . . 75.54 111.015 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 m -66.53 -12.24 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.562 -1.199 . . . . 74.33 112.208 177.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.1 m-85 -78.55 -11.35 59.96 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.889 0.852 . . . . 64.21 110.299 175.372 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -106.83 149.53 27.3 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.61 -1.255 . . . . 75.23 107.61 178.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 p -76.04 175.64 8.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.498 -0.556 . . . . 75.24 109.498 178.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.56 -22.84 66.65 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.208 0.527 . . . . 54.15 110.079 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 m -84.05 1.01 45.96 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.755 -0.657 . . . . 65.33 112.298 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.67 66.82 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.351 -0.452 . . . . 75.5 112.71 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -113.97 152.77 30.4 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.651 -0.87 . . . . 71.51 108.651 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 135.64 27.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.831 -1.174 . . . . 65.3 107.831 175.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.437 HG12 ' H ' ' A' ' 80' ' ' SER . 58.0 t -59.55 135.21 24.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.335 -0.617 . . . . 74.24 109.335 178.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -59.09 -31.56 69.01 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.862 0.69 . . . . 64.33 112.862 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.437 ' H ' HG12 ' A' ' 78' ' ' VAL . 33.0 m -89.38 3.05 53.5 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.081 -0.509 . . . . 72.23 111.78 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.549 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.19 -54.12 48.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.989 -0.374 . . . . 73.14 109.989 179.393 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 32.2 Cg_exo -62.81 -30.87 78.18 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 121.134 1.222 . . . . 64.12 110.598 177.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.12 93.94 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.713 -0.676 . . . . 73.4 112.221 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -67.64 -40.02 84.61 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.17 0.509 . . . . 54.35 109.827 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.86 -46.55 87.35 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.799 -0.637 . . . . 74.14 110.264 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.8 m -60.71 -41.49 95.34 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.952 -0.567 . . . . 52.12 112.529 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -47.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 121.103 -0.239 . . . . 54.2 110.885 -178.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.498 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -68.01 -35.74 78.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.97 0.73 . . . . 74.13 112.97 176.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.507 0.723 . . . . 72.13 110.338 -177.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.4 -30.37 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.299 0.571 . . . . 61.4 110.572 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.99 -9.47 86.65 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.683 -0.69 . . . . 64.3 112.582 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 24.2 54.93 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 121.713 -0.28 . . . . 52.11 113.146 177.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 94.5 m-85 -89.61 132.98 34.85 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.576 -0.367 . . . . 73.52 111.123 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -78.88 169.88 17.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.597 0.713 . . . . 74.33 112.858 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.39 -45.34 72.84 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.395 1.878 . . . . 52.11 112.003 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.0 m -64.56 -40.39 95.48 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 115.568 -0.742 . . . . 52.13 110.204 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -65.96 -36.79 84.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.612 -0.267 . . . . 64.22 111.273 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.1 mm -61.42 -49.0 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.415 -0.957 . . . . 71.42 108.415 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.52 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 57.4 mtt -74.96 -17.72 60.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.799 -1.092 . . . . 75.44 112.391 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -59.4 -65.05 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.626 -0.509 . . . . 75.42 109.626 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.4 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 36.0 p-90 -68.94 -32.56 72.25 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.749 0.648 . . . . 72.23 112.749 177.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 125' ' ' PRO . 13.1 mt -58.59 -40.84 84.31 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 112.477 0.547 . . . . 62.35 112.477 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 54.9 m-85 -92.49 -11.57 34.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.345 0.498 . . . . 75.32 112.345 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -86.62 125.36 67.47 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.654 -0.499 . . . . 71.33 109.654 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.604 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.6 Cg_exo -56.16 129.91 37.37 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.592 2.195 . . . . 74.2 110.693 175.27 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -90.53 123.41 65.41 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.525 -0.917 . . . . 74.32 108.525 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.21 -24.55 77.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.027 2.485 . . . . 71.43 113.6 -176.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -102.98 3.56 36.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.722 0.296 . . . . 72.14 111.367 -175.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.62 124.0 46.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.562 0.696 . . . . 54.51 111.016 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 m -131.35 110.48 11.1 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.866 -1.161 . . . . 75.23 107.866 177.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 128' ' ' ALA . 23.2 pt . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 120.924 0.392 . . . . 63.4 111.871 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 108.163 -1.051 . . . . 71.23 108.163 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.0 t -90.22 148.44 22.93 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.311 -1.366 . . . . 71.43 107.311 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 65.6 t30 65.85 44.79 2.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.497 -1.297 . . . . 65.2 107.497 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.79 17.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.335 -0.848 . . . . 73.11 110.423 -178.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -97.27 132.3 25.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.444 -0.576 . . . . 75.34 109.444 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.556 ' HB2' HD23 ' A' ' 102' ' ' LEU . 80.9 Cg_exo -50.01 -29.53 21.84 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.061 3.174 . . . . 65.01 115.543 -178.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.538 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.3 t -61.69 -42.72 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 118.519 0.599 . . . . 75.53 110.274 176.639 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -67.67 -33.64 75.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.278 -1.008 . . . . 52.54 108.278 -176.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -62.75 -50.2 72.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.723 -1.126 . . . . 62.41 111.386 177.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -65.7 -34.26 77.8 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.036 0.446 . . . . 74.4 110.946 -179.075 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -68.58 -23.63 64.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 75.32 109.157 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.66 7.7 45.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.815 -1.084 . . . . 74.41 110.982 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.1 m80 66.27 29.43 9.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.612 0.72 . . . . 75.41 111.773 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -101.36 22.69 12.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.033 -1.469 . . . . 73.23 107.033 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.31 -30.23 59.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.848 -1.524 . . . . 75.41 114.595 -173.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -56.75 -43.29 80.58 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.028 0.442 . . . . 54.23 111.524 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -73.31 -26.21 60.97 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.737 -0.665 . . . . 73.43 110.818 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.05 -42.13 81.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.653 -0.869 . . . . 75.24 108.653 175.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 86.1 t -60.03 -41.92 87.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-N 115.323 -0.853 . . . . 73.13 109.913 176.343 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.91 -40.28 92.56 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.341 0.591 . . . . 74.41 110.157 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -41.04 93.67 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.457 -0.942 . . . . 74.44 108.457 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.498 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.21 -45.12 94.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.967 -1.015 . . . . 73.22 110.549 177.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.6 mt-30 -57.3 -36.18 70.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 73.32 110.574 176.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.49 78.43 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.943 -0.571 . . . . 65.31 111.152 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 29.5 ttm -80.78 -45.39 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.724 -0.79 . . . . 74.21 112.618 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -69.72 -34.84 74.43 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.031 1.123 . . . . 74.12 114.031 -174.073 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 109.24 -0.652 . . . . 70.55 109.24 -178.664 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.955 0 CA-C-O 120.571 0.224 . . . . 61.23 110.579 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 -87.17 1.99 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.561 -1.016 . . . . 61.33 110.561 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -141.12 159.95 41.13 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.604 -0.351 . . . . 73.15 110.848 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 9.6 t0 -93.75 137.67 32.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.636 -0.711 . . . . 45.32 112.647 -173.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 100' ' ' ARG . 86.1 t -100.01 -26.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.692 -0.685 . . . . 72.24 111.8 -175.594 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.555 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -80.45 -178.9 6.89 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 118.663 -1.215 . . . . 74.35 110.655 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -100.79 147.94 34.34 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 107.868 -1.16 . . . . 73.05 107.868 -178.254 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.08 -21.27 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.992 2.462 . . . . 71.15 113.576 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.78 -27.24 68.14 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.903 0.481 . . . . 72.24 110.548 176.401 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.15 125.24 85.44 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 107.756 -1.201 . . . . 64.3 107.756 171.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -65.31 139.73 61.14 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.218 1.946 . . . . 61.44 112.898 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 65' ' ' VAL . 6.3 p -118.22 156.97 27.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.252 0.834 . . . . 72.4 113.252 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 28.0 m-85 -109.78 161.89 15.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 125.452 1.501 . . . . 74.21 108.858 176.12 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.569 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 4.3 m-20 -134.56 165.77 24.43 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 104.623 -2.362 . . . . 72.43 104.623 -178.154 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.04 -56.37 18.15 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 114.415 1.265 . . . . 70.23 114.415 -175.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HA ' HG22 ' A' ' 43' ' ' VAL . 28.7 Cg_endo -63.05 -31.62 76.05 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.915 1.744 . . . . 75.44 112.424 178.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 14.8 tpt180 -70.42 -39.37 74.47 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.736 0.814 . . . . 72.03 110.221 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 31' ' ' ASP . 59.3 t -69.2 -38.58 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 71.42 109.372 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.11 91.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.441 -0.799 . . . . 54.42 109.626 177.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.57 -44.98 94.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.016 -1.447 . . . . 71.2 110.06 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.4 tp -65.62 -47.48 75.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.921 -1.036 . . . . 73.02 111.339 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.7 -18.54 40.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.865 0.691 . . . . 54.44 112.865 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.45 55.13 Favored Glycine 0 C--N 1.311 -0.827 0 N-CA-C 111.017 -0.833 . . . . 30.13 111.017 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 20.4 m -124.22 161.83 45.23 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.148 -1.056 . . . . 70.15 108.148 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 36.1 Cg_endo -67.94 156.23 66.7 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 121.362 1.374 . . . . 64.44 112.603 178.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 33' ' ' PRO . 42.9 t -60.45 -37.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 51.03 110.256 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 23.0 t -60.69 -34.78 74.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.534 -0.757 . . . . 45.12 110.653 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 60.8 tttp -69.33 -39.02 78.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.837 -0.431 . . . . 71.3 109.837 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.2 t -61.34 -41.16 88.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.249 0.547 . . . . 65.11 109.56 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.81 81.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.41 -0.814 . . . . 73.53 110.498 176.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.2 mt-30 -65.36 -44.0 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.359 -0.382 . . . . 74.21 110.308 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.9 mm-40 -61.86 -43.17 99.38 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.791 0.682 . . . . 74.3 110.226 -178.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.97 -40.81 96.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.589 -1.187 . . . . 73.33 110.343 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.47 -21.49 61.94 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.201 0.815 . . . . 75.13 113.201 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -88.14 -11.88 45.63 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 120.406 0.146 . . . . 70.21 111.272 178.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.98 32.45 49.28 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.234 -1.146 . . . . 33.43 110.234 -175.312 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -93.74 -13.74 27.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.31 -1.367 . . . . 74.1 107.31 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -157.08 152.86 26.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.193 -2.151 . . . . 75.51 105.193 179.42 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.6 152.05 30.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.162 -0.681 . . . . 65.11 109.162 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -127.26 162.14 26.91 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.086 -0.506 . . . . 64.32 110.575 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.433 HG11 ' HG3' ' A' ' 99' ' ' MET . 5.2 m -126.64 166.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 123.397 0.679 . . . . 74.1 109.467 178.406 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -120.5 131.65 54.83 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.879 -0.328 . . . . 72.43 110.649 -176.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 30.1 ptt180 -147.51 138.32 23.46 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.582 -0.895 . . . . 71.33 108.582 175.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.35 17.71 9.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.004 0.922 . . . . 72.04 111.612 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.85 -4.02 74.78 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.976 -0.556 . . . . 42.01 112.245 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.24 144.38 15.77 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.836 -0.697 . . . . 74.21 111.593 -178.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.44 120.12 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.04 -1.467 . . . . 65.22 107.04 178.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.8 m -133.68 154.42 38.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.36 0.6 . . . . 72.21 111.796 -173.695 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.53 120.75 38.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 107.497 -1.298 . . . . 65.32 107.497 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.439 ' HB3' HD21 ' A' ' 23' ' ' LEU . 88.0 Cg_exo -53.74 128.39 29.38 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.698 2.265 . . . . 73.11 112.179 177.013 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 42.1 tt0 -57.34 -25.53 59.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.36 0.504 . . . . 65.0 112.36 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -70.95 -4.24 4.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.782 -0.645 . . . . 73.31 112.446 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.8 m-85 -83.84 -4.66 58.85 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.248 1.023 . . . . 74.44 109.913 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -122.16 158.84 28.47 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.801 -1.555 . . . . 72.43 106.801 177.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.2 p -91.57 163.87 13.98 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.69 -0.856 . . . . 45.2 108.69 179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.73 -16.29 62.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.336 0.588 . . . . 74.12 110.147 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -79.47 -0.67 34.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.238 0.615 . . . . 52.15 111.187 -178.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.38 60.48 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.851 -0.69 . . . . 23.14 112.005 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -125.9 145.95 50.04 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.607 -1.257 . . . . 43.14 107.607 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.17 155.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.967 -1.123 . . . . 63.13 107.967 176.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 48.4 t -69.82 112.03 4.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.498 -0.927 . . . . 70.23 108.498 177.483 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -56.18 -35.11 66.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.467 1.284 . . . . 54.3 114.467 -175.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.5 m -90.69 -4.25 56.89 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.223 0.535 . . . . 74.33 111.536 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 8.6 tt -65.83 -47.48 64.85 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.51 0.929 . . . . 73.44 113.51 -176.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.6 Cg_endo -54.24 -28.73 53.6 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 121.743 1.628 . . . . 73.21 111.514 176.391 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.15 -38.2 95.61 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.709 -0.678 . . . . 42.41 112.048 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -68.17 -40.15 82.37 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.767 -0.827 . . . . 75.21 108.767 178.456 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.88 -32.69 73.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 74.1 110.233 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 m -62.76 -50.18 72.08 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.66 -0.7 . . . . 54.31 110.289 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -40.25 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.465 -0.334 . . . . 52.11 111.439 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.7 mm? -66.88 -35.36 79.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.58 0.585 . . . . 71.4 112.58 176.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -61.68 -40.54 95.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 60.25 109.343 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.63 -31.87 73.13 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.791 -0.64 . . . . 70.31 110.854 178.565 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.53 -9.95 68.46 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.962 -0.637 . . . . 75.12 112.495 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.48 48.98 8.54 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 114.004 0.361 . . . . 41.11 114.004 177.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 88.4 m-85 -110.17 139.44 45.32 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.408 0.604 . . . . 72.34 111.447 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -81.91 171.79 14.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 72.42 111.851 -179.254 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.0 p-10 -54.64 -45.51 73.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 72.54 111.83 -177.41 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 m -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.364 0.666 . . . . 73.42 110.052 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.65 -38.74 92.28 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.624 -0.717 . . . . 74.05 111.229 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 mm -61.26 -47.5 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.334 -0.987 . . . . 65.43 108.334 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 22.8 mmt -67.99 -26.07 65.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.677 -1.147 . . . . 75.52 111.656 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.413 ' HA ' HG11 ' A' ' 22' ' ' VAL . 45.3 ttp85 -52.56 -71.26 0.07 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.694 0.627 . . . . 75.12 112.694 -176.425 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -68.58 -31.46 70.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.166 0.432 . . . . 75.41 112.166 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.7 mt -56.55 -40.64 75.49 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 112.131 0.419 . . . . 71.22 112.131 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 96.5 m-85 -102.02 2.01 37.21 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.956 0.724 . . . . 70.13 112.956 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -89.08 112.13 49.17 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.712 -0.477 . . . . 71.43 109.712 173.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.1 128.76 21.3 Favored 'Trans proline' 0 C--O 1.251 1.145 0 N-CA-C 108.434 -1.41 . . . . 64.04 108.434 173.011 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 23.6 t70 -96.85 126.29 43.34 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.698 -0.401 . . . . 60.54 111.501 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.66 -16.9 46.18 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.22 2.613 . . . . 61.23 114.277 -178.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.4 t -114.53 8.99 16.57 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 121.163 0.506 . . . . 63.2 109.924 -178.165 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 51.6 tp -106.94 118.68 37.33 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.729 0.776 . . . . 73.04 112.328 -178.325 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.0 m -118.2 117.19 28.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.191 -1.04 . . . . 71.41 108.191 178.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.41 HG12 ' HG ' ' A' ' 109' ' ' LEU . 29.3 mm . . . . . 0 C--N 1.291 -1.95 0 CA-C-N 115.118 -0.946 . . . . 73.55 109.826 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 109.05 -0.722 . . . . 64.1 109.05 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -84.0 149.83 26.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.268 -0.641 . . . . 70.13 109.268 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.9 t30 70.1 40.42 1.22 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.219 1.008 . . . . 73.31 109.798 178.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.55 156.65 22.68 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.734 -0.604 . . . . 43.23 110.348 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.578 ' HD3' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -102.95 143.65 27.03 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 108.711 -0.848 . . . . 73.42 108.711 175.821 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.434 ' HB2' HD23 ' A' ' 102' ' ' LEU . 82.1 Cg_exo -49.73 -34.08 34.36 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 123.655 2.904 . . . . 61.42 114.856 -177.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.5 t -62.95 -40.46 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.466 0.651 . . . . 54.23 110.782 177.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.23 -37.79 88.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.347 -0.982 . . . . 74.44 108.347 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.94 78.66 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.484 -1.235 . . . . 54.32 112.023 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -66.41 -36.22 82.29 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.013 -0.429 . . . . 74.54 112.114 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.419 ' N ' HD12 ' A' ' 129' ' ' LEU . 16.6 t-80 -73.27 -16.16 61.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.216 1.007 . . . . 74.22 108.975 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.83 5.25 51.75 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.019 -0.991 . . . . 64.23 110.465 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.0 m80 65.22 28.99 11.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.416 1.086 . . . . 63.53 112.296 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -103.83 23.71 12.39 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.653 -1.24 . . . . 73.44 107.653 176.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.38 -26.83 13.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.549 1.94 . . . . 51.31 112.74 -176.321 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -54.39 -38.2 65.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.881 0.472 . . . . 74.43 111.773 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.43 ' HG2' HD11 ' A' ' 109' ' ' LEU . 13.9 tp10 -73.5 -32.2 64.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.696 -0.483 . . . . 73.14 109.696 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.52 -48.31 77.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.501 -0.772 . . . . 75.45 109.586 -178.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.503 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 59.6 t -62.37 -42.79 96.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 N-CA-C 109.279 -0.638 . . . . 73.35 109.279 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -62.61 -39.45 93.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.711 -0.677 . . . . 73.14 111.188 178.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.417 ' NH2' HD13 ' A' ' 109' ' ' LEU . 2.7 tpp180 -64.73 -38.84 92.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.077 -0.712 . . . . 73.34 109.077 178.253 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -68.85 -38.66 79.91 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.831 -1.077 . . . . 75.53 110.613 178.33 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.0 mt-30 -58.87 -49.51 77.47 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.591 -0.277 . . . . 74.12 110.288 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 72.55 111.141 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpt -83.39 -30.94 26.98 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.346 0.593 . . . . 72.4 110.191 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.452 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.21 -54.07 5.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.186 -0.461 . . . . 72.13 111.638 -177.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--N 1.309 -1.174 0 N-CA-C 108.676 -0.861 . . . . 74.52 108.676 -177.45 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.826 0 N-CA-C 109.306 -0.627 . . . . 64.24 109.306 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.17 -133.99 7.63 Favored Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 121.144 -0.55 . . . . 64.42 112.314 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.28 124.39 46.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.533 -0.543 . . . . 71.25 109.533 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.69 130.78 44.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.25 0.548 . . . . 62.02 111.048 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.519 HG23 ' HE3' ' A' ' 99' ' ' MET . 22.3 t -111.44 27.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 123.294 1.521 . . . . 74.43 109.5 -178.443 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -118.68 172.94 7.15 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-N 114.994 -1.003 . . . . 63.44 110.098 175.6 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 14.3 t70 -86.5 137.06 34.47 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.724 -1.213 . . . . 63.1 107.724 175.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -50.78 -21.96 9.06 Favored 'Trans proline' 0 CA--C 1.557 1.67 0 C-N-CA 123.149 2.566 . . . . 72.2 115.242 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.91 -1.46 56.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.509 0.929 . . . . 72.14 113.509 178.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 27.1 mm-40 -67.42 151.76 96.84 Favored Pre-proline 0 C--O 1.248 0.979 0 N-CA-C 109.268 -0.642 . . . . 73.11 109.268 176.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.3 119.01 5.46 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.712 2.275 . . . . 64.54 111.371 176.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.1 m -136.29 162.11 33.92 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.679 -0.86 . . . . 62.23 108.679 -174.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 21.8 m-85 -126.72 160.11 31.77 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.379 -0.971 . . . . 74.44 108.379 174.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.3 t0 -134.69 157.92 45.42 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 103.883 -2.636 . . . . 71.15 103.883 -178.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -46.83 -54.22 21.17 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 114.443 1.275 . . . . 71.13 114.443 -169.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.23 -39.19 86.97 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.833 1.689 . . . . 55.24 112.188 177.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -71.01 -34.74 71.63 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.614 -0.266 . . . . 71.54 110.476 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 31' ' ' ASP . 27.3 t -69.12 -42.3 81.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.71 -0.478 . . . . 63.02 109.71 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.9 82.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.273 -0.876 . . . . 61.23 109.516 178.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.63 -46.02 70.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.36 -1.291 . . . . 52.11 110.467 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 26.8 tp -64.26 -50.06 69.43 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.118 0.967 . . . . 63.02 112.177 -176.207 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.435 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.6 mt -86.07 -18.24 32.95 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.739 -0.664 . . . . 65.43 111.614 -175.436 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.21 63.58 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.704 -0.958 . . . . 71.23 110.704 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 39' ' ' LEU . 11.7 m -121.91 159.61 50.61 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 108.814 -0.81 . . . . 74.35 108.814 -176.377 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.74 157.93 51.23 Favored 'Trans proline' 0 C--O 1.252 1.217 0 C-N-CA 121.425 1.417 . . . . 64.45 111.846 176.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.11 -33.0 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.765 -0.652 . . . . 74.41 110.642 178.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.6 t -57.67 -42.65 84.02 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.036 -0.529 . . . . 72.3 110.615 177.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 88.2 tttt -69.51 -34.34 74.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.948 0.404 . . . . 72.41 110.127 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.92 -45.07 99.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.847 -0.615 . . . . 72.54 109.432 177.156 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -61.91 -37.28 84.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.348 -0.842 . . . . 74.24 110.35 178.344 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 15.7 mm100 -62.84 -40.1 96.4 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.277 -0.42 . . . . 73.23 111.542 178.15 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 80.9 mm-40 -59.75 -44.24 93.92 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.577 0.703 . . . . 60.12 109.459 178.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -62.21 -43.95 97.67 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.828 -1.078 . . . . 74.23 109.886 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -66.1 -21.61 66.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.979 -0.555 . . . . 74.31 112.379 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 43.2 mt-10 -98.91 -7.89 26.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.423 -0.511 . . . . 72.45 111.798 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.04 27.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.482 -0.866 . . . . 61.34 111.615 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.65 -8.92 14.55 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.815 -0.809 . . . . 75.44 108.815 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.4 tp -155.22 154.15 31.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.715 -1.587 . . . . 64.45 106.715 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.2 146.59 33.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 74.33 108.818 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 66' ' ' ILE . . . -126.09 151.17 47.57 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 107.63 -1.248 . . . . 50.31 107.63 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.523 HG11 ' SD ' ' A' ' 99' ' ' MET . 34.4 m -129.85 166.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 123.437 0.695 . . . . 53.04 109.856 -176.543 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -110.27 121.45 45.32 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.763 -0.828 . . . . 73.14 108.763 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -117.09 113.8 22.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.012 -0.736 . . . . 64.42 109.012 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.96 -53.19 0.68 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.268 1.827 . . . . 64.53 111.191 -179.084 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.97 0.44 0.03 OUTLIER Glycine 0 C--N 1.286 -2.208 0 CA-C-N 114.913 -1.039 . . . . 61.01 113.0 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.92 149.38 17.02 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.39 -0.91 . . . . 43.52 111.061 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.6 120.6 47.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.535 -1.283 . . . . 73.13 107.535 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.39 171.63 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 124.509 1.124 . . . . 53.13 108.312 -175.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.419 HG22 ' CB ' ' A' ' 57' ' ' ALA . 40.6 pt -127.68 144.06 49.77 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.938 -0.764 . . . . 43.11 108.938 178.047 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.57 118.31 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.612 1.541 . . . . 72.42 110.799 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 46.2 tt0 -61.44 -24.88 66.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.365 0.666 . . . . 74.0 111.811 -178.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 35.0 m -63.67 -9.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 CA-C-N 115.422 -0.808 . . . . 74.24 112.631 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.557 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -78.77 -6.83 56.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.826 0.822 . . . . 71.44 109.948 175.043 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -117.0 161.29 19.62 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.937 -1.135 . . . . 75.41 107.937 175.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.458 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 63.1 p -90.54 168.22 11.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.501 -1.296 . . . . 71.23 107.501 176.096 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -66.59 -17.49 64.85 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.656 0.613 . . . . 61.34 112.656 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -80.1 -9.09 59.68 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.376 -0.375 . . . . 72.41 111.311 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.68 9.9 62.27 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.532 -0.842 . . . . 51.2 112.509 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -97.34 140.2 32.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.59 -1.633 . . . . 72.02 106.59 177.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.59 152.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.135 -1.061 . . . . 74.31 108.135 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.52 126.55 22.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.423 -0.584 . . . . 74.2 109.423 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.19 -34.17 77.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 113.288 0.847 . . . . 73.13 113.288 -175.315 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 t -91.93 8.11 38.98 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.369 0.604 . . . . 32.51 110.281 -177.051 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 70' ' ' PHE . 14.5 tp -58.83 -54.01 60.68 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.748 -0.66 . . . . 73.42 112.048 -177.234 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.75 -25.24 74.81 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.53 1.487 . . . . 73.32 111.846 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.95 78.43 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.135 -0.484 . . . . 72.11 111.905 -178.021 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -67.38 -39.51 85.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.116 -0.698 . . . . 62.44 109.116 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.06 -40.07 95.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.368 -0.833 . . . . 71.33 111.068 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -62.28 -47.35 84.69 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 116.437 -0.347 . . . . 64.52 111.558 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -43.79 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 116.471 -0.331 . . . . 62.44 111.344 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 4.4 mm? -66.91 -35.79 80.8 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.901 -0.5 . . . . 75.41 112.257 177.273 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -64.93 -33.14 75.32 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.528 -0.545 . . . . 75.11 109.528 177.404 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.25 -31.25 70.6 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.143 0.497 . . . . 63.15 110.81 176.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.76 -9.3 78.31 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.762 -0.654 . . . . 74.44 112.036 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.73 48.1 6.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 121.386 -0.435 . . . . 51.2 112.487 178.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 80.0 m-85 -110.8 138.15 47.56 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.787 0.327 . . . . 74.25 111.335 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.557 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 28.5 ptt180 -86.28 170.9 11.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 75.35 109.818 177.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -55.05 -41.27 71.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.511 1.524 . . . . 44.22 111.233 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -61.67 -41.26 97.3 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.496 -0.774 . . . . 71.51 110.608 -179.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 8.8 mm-40 -66.02 -38.06 87.5 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.897 -0.779 . . . . 63.12 108.897 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 94' ' ' ARG . 24.9 mm -61.12 -48.0 90.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.651 -0.87 . . . . 61.21 108.651 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.523 ' SD ' HG11 ' A' ' 58' ' ' VAL . 76.0 mtm -71.49 -22.36 61.81 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.249 -0.887 . . . . 71.33 112.194 -177.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.01 -65.31 0.62 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.798 -0.816 . . . . 75.02 108.798 -179.655 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.577 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 53.2 p-90 -69.78 -33.86 72.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.787 0.662 . . . . 71.35 112.787 179.172 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -66.76 -39.06 87.75 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.714 0.806 . . . . 72.33 112.941 -173.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 47.6 m-85 -92.63 7.88 41.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.632 0.605 . . . . 75.41 112.632 -178.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.1 m -86.94 116.51 66.32 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 109.562 -0.533 . . . . 73.23 109.562 177.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.7 129.22 19.42 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 121.516 1.478 . . . . 62.23 108.26 172.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 25.7 t70 -115.71 119.75 37.05 Favored Pre-proline 0 C--N 1.295 -1.774 0 C-N-CA 120.637 -0.425 . . . . 75.44 110.791 -175.689 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.42 -28.95 87.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.021 2.48 . . . . 63.15 112.815 -177.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -90.88 2.05 56.48 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.487 0.551 . . . . 55.3 112.487 -177.471 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.9 tp -102.17 125.13 48.78 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 107.869 -1.16 . . . . 74.33 107.869 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 m -118.5 113.35 21.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.07 -1.085 . . . . 64.14 108.07 -177.022 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 37.9 mm . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 116.116 -0.493 . . . . 74.21 109.7 -173.059 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 108.502 -0.925 . . . . 71.44 108.502 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 m -82.84 138.84 33.79 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.204 -1.406 . . . . 64.15 107.204 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 42.7 t30 78.3 69.0 0.04 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.056 0.942 . . . . 72.53 110.947 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.54 173.1 6.71 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.213 -1.032 . . . . 65.52 108.213 172.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -96.19 156.94 36.43 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 106.391 -1.707 . . . . 75.4 106.391 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 27.7 Cg_exo -61.75 -20.08 67.75 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 121.39 1.394 . . . . 73.55 110.518 173.419 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 102' ' ' LEU . 74.3 t -60.67 -43.41 94.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 109.131 -0.692 . . . . 71.23 109.131 173.676 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.47 -39.29 93.52 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.68 -0.691 . . . . 43.22 109.43 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.46 66.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 44.43 112.002 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 130' ' ' HIS . 4.6 pp -66.81 -35.52 80.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.993 0.425 . . . . 51.12 111.598 -177.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.458 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 13.8 t60 -70.81 -24.85 62.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.852 0.834 . . . . 75.12 108.939 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -99.05 11.49 38.86 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.16 -0.927 . . . . 73.42 112.24 -178.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.7 27.54 9.32 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.348 1.071 . . . . 71.33 110.889 177.095 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -109.68 25.09 12.19 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.586 -1.264 . . . . 73.22 107.586 177.068 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.56 -26.49 13.46 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.366 1.866 . . . . 71.41 113.196 -175.092 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -54.65 -35.91 63.99 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.657 0.208 . . . . 75.14 110.559 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.17 -28.08 62.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.659 0.742 . . . . 73.22 110.735 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.3 -44.99 54.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.639 -0.875 . . . . 44.32 108.639 177.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 61.3 t -61.1 -44.25 97.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 115.541 -0.754 . . . . 54.02 110.634 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.11 -38.69 89.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 120.457 -0.497 . . . . 73.42 110.824 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -69.12 -38.01 78.64 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.83 0.348 . . . . 74.45 110.998 175.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.447 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -59.01 -43.32 91.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.743 -0.662 . . . . 62.52 110.256 178.044 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 93.8 mt-30 -63.06 -45.47 92.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.851 -0.613 . . . . 73.54 110.167 177.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.91 94.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.639 -0.709 . . . . 42.11 111.112 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.577 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 17.0 tpt -70.34 -32.82 70.7 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.757 -0.656 . . . . 74.24 111.031 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.3 -54.51 5.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.013 -0.54 . . . . 70.41 111.538 -178.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 118.567 -0.73 . . . . 75.02 109.115 -175.842 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 N-CA-C 106.441 -1.689 . . . . 64.2 106.441 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.94 -106.19 2.77 Favored Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.884 -0.674 . . . . 72.15 112.408 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.25 121.56 35.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.931 0.396 . . . . 75.21 110.452 -175.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -61.39 119.17 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.977 -1.01 . . . . 75.33 110.81 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' HE3' ' A' ' 99' ' ' MET . 93.4 t -77.07 -25.28 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.447 0.641 . . . . 53.43 111.234 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.6 148.44 28.0 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.407 -0.917 . . . . 54.01 111.9 176.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.32 145.19 99.1 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 114.988 -1.006 . . . . 60.24 110.782 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.44 -27.07 30.38 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.347 2.698 . . . . 62.03 114.058 177.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.8 -23.35 58.48 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.734 0.272 . . . . 73.02 111.734 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.09 126.63 91.66 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 108.903 -0.777 . . . . 70.3 108.903 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.64 106.53 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.876 2.384 . . . . 72.23 111.387 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 p -106.67 172.05 7.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.833 -0.621 . . . . 73.21 110.829 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 38' ' ' LEU . 16.6 m-85 -109.63 161.5 15.32 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.581 -0.896 . . . . 73.14 108.581 177.047 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.14 166.24 22.91 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 103.606 -2.739 . . . . 74.35 103.606 -173.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -52.79 -51.13 76.88 Favored Pre-proline 0 C--N 1.309 -1.188 0 O-C-N 123.881 0.738 . . . . 53.21 112.004 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.528 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 10.9 Cg_endo -57.53 -39.71 86.39 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.794 1.663 . . . . 65.2 112.352 175.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 3.9 mpt_? -70.35 -36.2 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.979 0.733 . . . . 73.14 112.979 -177.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 66' ' ' ILE . 73.4 t -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.971 -0.692 . . . . 52.53 109.764 175.399 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.01 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.157 -0.929 . . . . 75.33 109.055 174.402 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 19.3 mm-40 -65.52 -45.49 83.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 72.11 112.092 175.25 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 30' ' ' TYR . 89.1 mt -62.73 -50.74 69.89 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.339 -0.391 . . . . 71.35 111.623 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' HG22 ' A' ' 41' ' ' VAL . 90.9 mt -88.01 -15.38 36.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.799 -0.637 . . . . 74.1 112.137 -174.18 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.6 67.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.39 -1.084 . . . . 64.21 110.39 -177.311 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 39' ' ' LEU . 20.8 m -122.21 164.61 24.79 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 108.671 -0.862 . . . . 61.53 108.671 -177.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.87 167.05 14.72 Favored 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 121.44 1.427 . . . . 71.32 111.638 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.5 t -59.02 -33.09 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.579 0.751 . . . . 64.45 110.644 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 24.6 p -57.58 -43.58 84.67 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.455 -0.793 . . . . 72.54 111.201 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.585 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 56.9 mtpt -69.33 -33.61 73.39 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.761 -0.199 . . . . 74.5 111.091 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.403 ' O ' HD13 ' A' ' 50' ' ' LEU . 57.5 t -62.5 -43.7 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.626 -0.509 . . . . 52.3 109.626 177.172 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.47 78.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 62.34 110.479 177.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 44' ' ' SER . 97.9 mt-30 -65.43 -36.54 84.22 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.958 -0.564 . . . . 62.53 111.495 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm100 -63.28 -43.21 98.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.384 -0.969 . . . . 72.23 108.384 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 9.3 mp -61.75 -46.64 88.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.515 -1.22 . . . . 75.02 110.154 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -60.47 -25.72 66.24 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.676 0.991 . . . . 65.13 113.676 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 54' ' ' HIS . 7.6 pt-20 -102.55 2.77 36.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.425 -0.91 . . . . 63.43 111.625 -177.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.32 38.88 71.15 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.507 -0.854 . . . . 54.22 111.476 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.564 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 3.4 t60 -96.28 -28.9 14.29 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.853 -1.166 . . . . 74.25 107.853 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 55.9 tp -159.73 156.02 26.97 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.418 -2.068 . . . . 63.32 105.418 -178.413 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.48 152.29 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.123 -0.695 . . . . 72.51 109.123 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.7 161.82 19.45 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 123.489 0.493 . . . . 73.53 109.747 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 99' ' ' MET . 22.2 m -126.54 166.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.01 -0.737 . . . . 31.14 109.01 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -116.58 134.84 54.36 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.56 -0.533 . . . . 72.4 109.56 -174.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -148.21 125.96 11.87 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.76 -0.83 . . . . 72.54 108.76 171.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.17 22.89 12.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.075 0.95 . . . . 65.24 112.017 178.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.57 -14.78 64.39 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.847 -0.615 . . . . 72.21 112.495 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.41 150.0 20.53 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 121.306 -0.473 . . . . 60.15 112.426 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.75 120.57 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.592 -1.262 . . . . 74.13 107.592 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.3 160.8 40.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.604 -0.725 . . . . 73.54 109.697 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 35' ' ' VAL . 70.7 mt -130.69 129.08 22.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 62.43 108.286 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.4 131.63 47.37 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.566 2.177 . . . . 62.33 111.425 176.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 40.6 tt0 -65.27 -25.48 67.67 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 120.836 0.351 . . . . 72.3 111.227 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.29 -2.25 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.519 -0.764 . . . . 72.12 112.636 178.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.657 ' CD2' HD11 ' A' ' 81' ' ' LEU . 5.6 m-85 -86.38 -8.21 57.85 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.374 1.083 . . . . 70.33 109.359 173.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.6 m-85 -115.86 155.63 27.58 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.53 -1.656 . . . . 74.51 106.53 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.7 p -80.89 173.73 12.32 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.434 -0.951 . . . . 65.11 108.434 177.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -58.29 -20.57 43.88 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.029 0.752 . . . . 75.41 113.029 -177.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 t -89.04 -2.52 58.61 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 121.9 -0.5 . . . . 74.5 111.488 179.048 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.39 15.21 58.99 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.087 -0.578 . . . . 62.33 113.509 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -113.08 142.06 46.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.88 -0.785 . . . . 64.23 108.88 178.315 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 71' ' ' PHE . 11.8 p -62.01 144.18 14.39 Favored 'Isoleucine or valine' 0 C--O 1.249 1.032 0 O-C-N 123.715 0.635 . . . . 62.24 110.869 -175.06 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 35.2 t -65.46 131.82 31.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.979 -0.749 . . . . 44.44 108.979 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.87 -34.04 75.28 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.523 0.935 . . . . 72.51 113.523 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.0 m -86.2 -6.29 59.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.041 0.448 . . . . 65.1 111.069 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.657 HD11 ' CD2' ' A' ' 70' ' ' PHE . 10.2 tt -66.3 -49.19 55.27 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 114.134 1.161 . . . . 53.12 114.134 -175.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.88 -33.84 73.42 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 121.961 1.774 . . . . 64.44 111.413 176.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.48 95.9 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.212 -0.904 . . . . 64.41 112.725 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.7 pp -67.34 -40.49 85.86 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.57 -0.53 . . . . 65.52 109.57 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.45 -34.61 77.13 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.263 -0.426 . . . . 73.12 110.662 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.2 m -62.34 -48.08 81.4 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.821 -0.627 . . . . 62.52 112.041 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.98 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 111.72 0.267 . . . . 65.34 111.72 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.562 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.4 mm? -66.67 -35.04 79.21 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.552 -0.459 . . . . 73.11 111.66 176.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -58.7 -43.15 89.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.254 -0.647 . . . . 73.43 109.254 176.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.015 0.822 . . . . 64.05 110.842 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.87 -9.1 81.53 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.986 -0.552 . . . . 71.14 112.643 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 33.55 28.2 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.871 -0.68 . . . . 74.51 112.275 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -102.12 125.52 48.84 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.94 0.4 . . . . 73.21 111.037 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 37.2 ptt180 -75.67 171.79 13.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.663 -0.698 . . . . 73.13 111.157 178.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -54.2 -40.62 67.77 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.234 1.413 . . . . 74.21 110.866 -178.162 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.7 m -61.52 -42.32 98.63 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.858 -1.065 . . . . 73.22 110.67 -178.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 12.4 mm-40 -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.228 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.4 mm -60.99 -47.92 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.486 -0.931 . . . . 63.21 108.486 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.52 ' SD ' HG11 ' A' ' 58' ' ' VAL . 70.7 mtm -71.82 -25.04 61.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.85 -1.068 . . . . 71.14 111.415 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -64.18 0.98 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.112 -0.699 . . . . 60.51 109.112 -176.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 34.5 p-90 -69.44 -32.78 71.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.947 0.721 . . . . 71.11 112.947 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 125' ' ' PRO . 14.8 mt -61.22 -40.64 94.77 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.905 0.706 . . . . 61.32 112.905 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -93.15 -1.21 56.59 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.427 0.529 . . . . 65.3 112.427 -177.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.1 m -87.99 127.1 58.88 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 109.236 -0.653 . . . . 74.01 109.236 175.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 44.0 Cg_exo -61.26 129.19 27.46 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 121.903 1.736 . . . . 64.22 110.105 174.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 10.6 t70 -85.91 126.31 66.07 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.812 -0.81 . . . . 61.23 108.812 -177.529 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.95 -17.39 51.08 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.296 2.664 . . . . 52.43 114.017 -177.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.3 m -122.49 15.68 10.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.892 -0.505 . . . . 73.24 111.443 -176.209 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 53.2 tp -108.47 126.4 52.86 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.738 0.644 . . . . 53.25 112.738 -176.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.4 m -119.72 133.64 55.54 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 105.354 -2.091 . . . . 73.22 105.354 174.144 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.306 -1.284 0 C-N-CA 119.111 -1.036 . . . . 74.11 113.791 -175.489 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.394 -0.595 . . . . 72.43 109.394 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.8 p -88.32 150.2 23.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.055 -1.091 . . . . 61.52 108.055 173.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 93.1 m-20 61.09 42.28 12.65 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.31 1.053 . . . . 73.42 108.405 -173.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.6 163.92 26.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.098 -1.41 . . . . 60.32 111.752 -176.222 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -97.11 133.02 24.61 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.769 -1.105 . . . . 72.12 109.279 -178.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.489 ' HB2' HD23 ' A' ' 102' ' ' LEU . 86.3 Cg_exo -52.16 -31.09 44.03 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.635 2.89 . . . . 74.53 114.423 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.588 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 67.8 t -60.83 -42.21 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 73.4 110.709 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.2 -40.38 82.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.096 -0.705 . . . . 74.12 109.096 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.95 83.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.123 -0.944 . . . . 75.02 112.091 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -68.52 -34.62 76.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.58 -0.448 . . . . 74.43 111.778 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -77.34 -24.13 50.79 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 107.745 -1.206 . . . . 73.1 107.745 179.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.18 12.45 7.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.622 -1.172 . . . . 71.31 111.583 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.0 m80 66.85 28.17 8.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.061 0.945 . . . . 71.35 110.927 176.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -112.28 23.22 13.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.049 -1.093 . . . . 75.54 108.049 176.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.52 -31.48 46.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 114.262 -1.335 . . . . 63.35 113.318 -176.168 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -65.18 -35.12 80.08 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 120.978 -0.289 . . . . 73.34 111.719 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -69.83 -28.56 65.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.679 0.752 . . . . 62.11 109.688 177.61 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.0 -45.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.957 -0.757 . . . . 61.22 108.957 176.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.449 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 82.7 t -59.87 -41.65 86.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 N-CA-C 109.11 -0.7 . . . . 65.11 109.11 175.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.797 0.839 . . . . 63.41 110.945 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.11 -37.25 86.48 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.572 -0.529 . . . . 75.24 109.572 177.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.562 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -65.14 -44.24 89.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.428 -0.806 . . . . 45.5 110.833 178.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 92.2 mt-30 -67.46 -36.35 80.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.473 -0.331 . . . . 73.35 110.198 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.84 62.48 Favored 'General case' 0 C--O 1.208 -1.085 0 CA-C-N 116.153 -0.476 . . . . 54.2 110.662 176.422 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.89 -30.85 45.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.389 0.614 . . . . 73.5 109.422 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.79 -41.69 13.1 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.861 -0.609 . . . . 53.01 111.366 178.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.607 -0.711 . . . . 63.3 110.106 -178.683 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 109.765 -0.458 . . . . 74.42 109.765 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.72 -110.19 2.48 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 115.961 -0.563 . . . . 64.12 113.552 -176.363 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.16 123.92 33.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.678 0.275 . . . . 72.23 110.422 -172.707 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 17.5 t0 -61.84 130.99 48.33 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.777 1.029 . . . . 71.3 113.777 -175.408 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.87 -23.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.422 -0.808 . . . . 60.4 112.352 -175.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD23 ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -89.51 -172.43 3.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 119.075 -1.05 . . . . 64.52 112.173 -178.086 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -90.2 137.01 28.03 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 109.304 -0.628 . . . . 74.31 109.304 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.54 -21.92 70.3 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.54 2.16 . . . . 64.53 111.939 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -68.61 -25.15 64.71 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.89 -0.595 . . . . 70.1 111.464 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 29' ' ' THR . 5.6 mm-40 -73.76 117.39 60.58 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 107.857 -1.164 . . . . 74.01 107.857 177.031 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 37.0 Cg_exo -60.88 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.831 2.354 . . . . 62.42 112.041 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 66' ' ' ILE . 42.0 p -98.86 -162.11 0.93 Allowed 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 115.019 -0.992 . . . . 53.54 109.131 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -109.27 159.33 17.04 Favored 'General case' 0 N--CA 1.391 -3.392 0 N-CA-C 107.723 -1.214 . . . . 64.41 107.723 174.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 35' ' ' VAL . 5.2 m-20 -135.11 161.24 35.89 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 103.583 -2.747 . . . . 73.34 103.583 -176.71 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.66 -54.83 23.38 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 113.742 1.015 . . . . 63.23 113.742 -173.217 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.2 -34.1 46.75 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 121.47 1.447 . . . . 54.14 111.889 177.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 22.7 tpt180 -67.02 -34.98 78.9 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.418 -0.355 . . . . 64.14 110.965 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 31' ' ' ASP . 56.7 t -69.33 -40.8 80.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.16 -0.681 . . . . 73.4 109.16 178.186 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.3 -35.81 78.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 61.41 109.5 176.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -69.0 -45.32 70.85 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.284 -0.871 . . . . 74.21 110.868 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.28 -45.06 81.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.978 -0.555 . . . . 63.51 111.532 -177.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.8 -12.34 58.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.299 -0.41 . . . . 52.15 111.86 -177.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.67 30.67 74.92 Favored Glycine 0 CA--C 1.505 -0.541 0 CA-C-N 115.914 -0.585 . . . . 75.32 111.965 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.28 155.6 80.69 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.84 -0.43 . . . . 71.22 109.84 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.17 166.81 19.9 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.109 1.873 . . . . 73.1 112.001 177.027 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -56.3 -37.43 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.806 0.843 . . . . 70.34 110.909 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -57.73 -41.53 82.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.365 -0.834 . . . . 72.34 111.479 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.658 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 45.4 mtpt -70.06 -36.83 75.26 Favored 'General case' 0 C--O 1.2 -1.545 0 C-N-CA 119.268 -0.973 . . . . 75.13 111.266 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.5 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.482 -0.562 . . . . 75.01 109.482 177.205 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -58.9 -43.37 91.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.693 -0.685 . . . . 74.41 110.247 177.086 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 3.5 pt20 -70.53 -34.2 72.01 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.522 -0.308 . . . . 75.03 111.499 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.2 mm100 -57.53 -46.59 83.66 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.3 -1.0 . . . . 61.55 108.3 177.423 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.1 -43.52 98.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.378 -1.283 . . . . 74.13 109.762 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 19.7 mtp180 -63.44 -26.17 68.61 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.71 0.633 . . . . 63.04 112.71 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.13 7.21 45.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.941 0.401 . . . . 73.33 111.51 -178.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.15 81.65 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.774 -0.648 . . . . 54.35 113.602 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -85.19 -31.51 23.17 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.783 -0.367 . . . . 73.35 111.0 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.61 171.26 18.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.642 -0.874 . . . . 70.01 108.642 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.22 161.6 38.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.536 -0.542 . . . . 71.24 109.536 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.89 161.69 33.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.578 -0.897 . . . . 64.41 108.578 -177.297 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.77 166.18 29.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 123.511 0.507 . . . . 62.44 110.021 179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 17.7 mtp180 -122.75 142.66 50.47 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.054 0.454 . . . . 75.41 111.846 -178.628 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.491 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 13.5 ptt180 -149.27 127.21 11.88 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.774 -1.195 . . . . 64.44 107.774 175.474 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.83 17.88 11.21 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.549 1.14 . . . . 51.41 110.566 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.52 80.79 Favored Glycine 0 C--O 1.22 -0.719 0 CA-C-N 115.509 -0.769 . . . . 74.33 112.023 -177.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -88.4 142.52 17.36 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 111.688 -0.565 . . . . 71.44 111.688 -179.222 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.19 119.7 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.476 -1.305 . . . . 73.33 107.476 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 m -133.67 157.74 42.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 72.11 110.29 -175.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.438 ' O ' ' HB ' ' A' ' 29' ' ' THR . 55.0 mt -128.41 125.18 23.17 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.037 -1.097 . . . . 75.15 108.037 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 29' ' ' THR . 72.6 Cg_exo -53.45 133.95 55.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.782 2.322 . . . . 33.23 112.59 177.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.3 tp-100 -48.97 -42.2 36.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.681 1.192 . . . . 64.13 111.477 -177.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.409 ' CG2' HG11 ' A' ' 126' ' ' VAL . 16.0 m -69.22 -7.18 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 115.351 1.611 . . . . 44.33 115.351 -174.377 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -78.75 -14.53 59.23 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.243 1.02 . . . . 62.21 109.587 174.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.99 156.75 19.37 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.315 -1.365 . . . . 73.03 107.315 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p -86.14 172.54 10.48 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.91 -0.404 . . . . 75.22 109.91 -179.11 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -68.81 -17.26 63.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.335 0.588 . . . . 55.02 110.241 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 m -88.71 2.98 52.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.234 -0.439 . . . . 52.32 111.072 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 20.1 68.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.98 -0.629 . . . . 71.33 113.294 176.408 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -111.21 166.26 11.24 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.313 -1.365 . . . . 65.2 107.313 178.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.73 3.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.394 -1.322 . . . . 64.34 107.524 178.123 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.0 t -64.77 137.69 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-O 120.892 0.377 . . . . 71.55 110.679 -178.158 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 58.2 tttp -64.71 -40.44 95.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.219 0.533 . . . . 75.14 112.208 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -84.44 -0.35 52.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.318 0.58 . . . . 63.31 110.615 -175.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 60.1 tp -65.53 -54.35 31.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 113.005 0.742 . . . . 64.33 113.005 -178.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 51.9 Cg_exo -58.09 -33.26 97.15 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 121.475 1.45 . . . . 73.03 111.158 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -44.99 87.88 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.669 -0.696 . . . . 72.3 112.293 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.3 pp -65.66 -40.01 91.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.343 0.592 . . . . 75.1 109.878 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.57 -34.46 77.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.903 -0.589 . . . . 70.32 110.762 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.5 m -70.49 -42.06 71.86 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 116.126 -0.488 . . . . 63.1 111.873 -178.203 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.06 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.786 0.327 . . . . 65.45 110.732 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.515 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.3 mm? -66.26 -35.1 79.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 122.255 -0.278 . . . . 75.41 111.378 176.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 75.31 110.159 176.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.44 -30.77 68.77 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.319 0.581 . . . . 65.4 110.683 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.94 -9.14 83.1 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.633 -0.712 . . . . 71.3 111.441 178.188 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.17 47.36 11.15 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.592 -0.304 . . . . 73.23 113.154 177.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.16 129.51 55.49 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 122.673 -0.31 . . . . 74.4 111.049 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.61 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 36.1 ptt180 -74.9 170.78 15.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.709 -0.678 . . . . 72.23 110.676 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -54.41 -44.85 72.73 Favored 'General case' 0 C--O 1.25 1.122 0 C-N-CA 126.552 1.941 . . . . 74.44 111.547 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.1 m -63.93 -41.91 97.5 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.869 -1.06 . . . . 62.42 110.375 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.61 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 16.4 mm-40 -67.52 -34.04 76.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.071 -0.513 . . . . 72.22 111.148 -178.263 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.54 -49.45 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 108.578 -0.897 . . . . 75.22 108.578 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.55 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.4 ptp -75.68 -14.85 60.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.077 -0.965 . . . . 50.13 113.055 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.49 -62.18 2.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.636 0.374 . . . . 74.12 110.411 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.471 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.0 p-90 -69.19 -31.84 70.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.603 0.594 . . . . 72.02 112.603 176.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 12.2 mt -62.34 -40.26 95.81 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.931 1.086 . . . . 72.3 113.931 -179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.468 ' CE2' HD23 ' A' ' 23' ' ' LEU . 33.5 m-85 -85.32 -16.65 39.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.538 0.94 . . . . 74.42 113.538 -177.251 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.8 p -84.36 124.09 74.15 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 109.338 -0.615 . . . . 34.25 109.338 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -52.68 134.91 55.25 Favored 'Trans proline' 0 C--O 1.249 1.055 0 C-N-CA 122.743 2.295 . . . . 53.45 111.766 178.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.0 t70 -93.35 121.33 65.41 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.868 -0.605 . . . . 73.0 110.255 -177.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.71 -23.62 76.66 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.211 2.608 . . . . 71.24 113.708 -177.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -98.48 0.79 45.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.958 0.408 . . . . 55.44 110.757 -176.3 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -101.89 124.86 48.24 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.675 0.75 . . . . 53.34 110.744 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.9 m -132.45 116.5 16.87 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.685 -1.598 . . . . 74.31 106.685 175.002 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.2 pt . . . . . 0 C--N 1.309 -1.171 0 CA-C-O 121.16 0.505 . . . . 72.15 112.201 -175.286 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 108.565 -0.902 . . . . 73.24 108.565 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -90.84 137.45 32.35 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.687 -0.688 . . . . 70.45 109.399 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 57.8 t30 65.63 62.98 0.63 Allowed 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.13 0.894 . . . . 60.44 109.43 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.47 162.14 13.98 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.975 -1.011 . . . . 53.2 109.918 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 127.97 76.35 Favored Pre-proline 0 C--O 1.243 0.743 0 C-N-CA 119.944 -0.702 . . . . 74.55 110.545 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.538 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.6 Cg_exo -52.59 -21.7 15.06 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.025 3.15 . . . . 73.22 114.989 -178.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.6 t -63.75 -39.83 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.183 -0.607 . . . . 73.11 110.371 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.446 -0.946 . . . . 63.41 108.446 -178.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.65 68.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.91 -1.041 . . . . 55.33 111.122 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.3 pp -64.44 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.981 0.419 . . . . 71.35 110.771 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -67.62 -36.49 80.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.584 -0.895 . . . . 75.22 108.584 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.16 9.45 28.34 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 45.4 112.006 -178.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 67.5 27.77 7.84 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.882 1.325 . . . . 73.4 111.395 178.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -96.94 23.61 7.02 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.178 -1.786 . . . . 70.24 106.178 173.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.78 -26.76 15.26 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 127.172 2.189 . . . . 72.35 114.643 -173.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.572 ' HD2' ' H ' ' A' ' 135' ' ' ARG . 3.4 mpt_? -55.74 -47.58 76.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.057 0.223 . . . . 74.42 111.254 -174.175 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 9.8 mm-40 -66.64 -32.39 73.68 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.187 0.439 . . . . 73.34 112.187 176.483 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.09 -49.29 63.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.353 -0.385 . . . . 62.42 110.158 -177.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.73 -42.45 96.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.909 -0.587 . . . . 75.41 109.597 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 57.8 ttt180 -59.12 -46.92 87.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.854 -0.612 . . . . 74.55 111.05 178.219 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.63 -38.31 90.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.898 -0.779 . . . . 52.11 108.898 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -64.15 -46.64 83.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.684 . . . . 32.12 110.413 178.125 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.32 -36.59 82.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.847 0.356 . . . . 63.32 111.283 178.031 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.99 83.91 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.196 0.522 . . . . 72.31 110.58 178.367 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 tpt -69.8 -45.11 68.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.48 -0.782 . . . . 51.0 111.408 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.34 -31.06 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.017 0.747 . . . . 63.53 113.017 -176.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 C--N 1.312 -1.047 0 C-N-CA 120.621 -0.432 . . . . 71.3 110.539 -178.517 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 N-CA-C 109.836 -0.431 . . . . 64.13 109.836 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.98 -112.13 2.89 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.907 -0.663 . . . . 63.42 112.878 -178.642 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -95.1 128.05 41.63 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.702 0.286 . . . . 73.31 110.797 -174.335 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -70.2 138.73 52.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.311 -0.858 . . . . 73.14 111.441 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.16 -11.35 8.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.232 -0.895 . . . . 70.2 109.811 -176.31 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.96 -169.82 2.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.799 0.809 . . . . 70.15 109.539 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.434 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 29.2 t70 -105.75 138.29 19.58 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 105.837 -1.912 . . . . 71.41 105.837 169.235 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.68 -26.04 16.35 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.978 2.452 . . . . 72.43 115.042 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.74 -3.8 58.94 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.206 0.447 . . . . 74.12 112.206 -177.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 26.6 mm-40 -74.61 145.57 82.22 Favored Pre-proline 0 C--O 1.25 1.126 0 O-C-N 121.552 -0.717 . . . . 64.51 110.941 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.49 ' HB2' ' HG3' ' A' ' 68' ' ' GLN . 12.2 Cg_endo -54.65 123.72 14.39 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.214 2.61 . . . . 74.14 111.524 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -140.47 168.93 18.64 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.568 -0.742 . . . . 53.4 111.812 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.479 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 36.4 m-85 -109.77 160.38 16.38 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 125.377 1.471 . . . . 75.34 109.325 176.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -135.73 161.13 36.42 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.229 -2.878 . . . . 41.55 103.229 178.051 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.25 -52.25 70.52 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 113.804 1.039 . . . . 72.25 113.804 -173.358 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.08 -36.06 96.93 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.826 1.684 . . . . 73.43 112.66 176.252 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.85 -37.86 85.27 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.883 -0.414 . . . . 74.44 109.883 177.277 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.75 -40.97 79.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.18 -0.464 . . . . 72.21 110.354 176.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.43 -43.36 83.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.29 -0.868 . . . . 60.32 109.076 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.09 -45.29 92.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.361 -1.291 . . . . 74.13 110.254 178.003 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.6 -40.75 96.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.965 -1.016 . . . . 74.44 111.49 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.76 -18.31 22.21 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.408 -0.36 . . . . 55.53 111.437 -177.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.37 62.08 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.395 -0.682 . . . . 54.41 111.395 -178.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.38 161.89 24.94 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 108.941 -0.763 . . . . 64.52 108.941 -177.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.54 155.81 67.73 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 121.703 1.602 . . . . 75.54 111.963 174.628 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.72 -35.46 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.375 0.67 . . . . 71.05 109.686 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 23.3 t -59.58 -38.52 81.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.518 -0.765 . . . . 73.03 110.33 178.243 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 52.4 mttp -69.15 -32.78 72.36 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.932 -0.48 . . . . 75.04 111.94 177.106 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.53 -42.8 97.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.814 -0.81 . . . . 65.13 108.814 174.45 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.77 83.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.727 -0.67 . . . . 74.33 110.278 176.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 44' ' ' SER . 90.1 mm-40 -66.89 -36.05 81.41 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.992 -0.549 . . . . 73.35 110.978 177.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.6 mt-30 -61.55 -43.29 99.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.456 0.646 . . . . 73.03 109.697 176.155 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.8 -34.69 76.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.448 -1.251 . . . . 61.45 110.473 176.758 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -71.66 -32.89 68.37 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.541 -0.754 . . . . 73.55 112.748 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -92.04 -11.75 35.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.13 0.49 . . . . 72.3 112.225 -176.027 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.27 35.99 28.45 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.929 -1.129 . . . . 75.35 110.716 -177.739 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -92.82 -27.42 17.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.113 -1.069 . . . . 63.52 108.113 176.039 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.6 tp -147.92 152.57 37.78 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.847 -1.538 . . . . 42.22 106.847 -175.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.07 154.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 108.766 -0.827 . . . . 60.34 108.766 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.6 162.02 33.89 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 123.306 0.379 . . . . 75.33 110.264 -174.141 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.1 m -132.03 166.67 28.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 123.883 0.873 . . . . 62.25 109.471 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 83.3 mtm180 -110.95 131.29 55.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.886 0.699 . . . . 75.44 112.886 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 33.0 ptt180 -116.12 116.07 27.18 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 106.901 -1.518 . . . . 74.13 106.901 176.499 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.66 14.16 6.94 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.667 0.746 . . . . 62.32 111.019 -177.05 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.09 -20.89 34.78 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.821 -0.627 . . . . 70.43 112.697 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -78.57 145.7 29.29 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 110.585 -1.006 . . . . 60.22 110.585 -179.037 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.2 t -95.97 120.23 45.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.962 -0.755 . . . . 43.11 108.962 -175.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.23 163.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.643 -0.708 . . . . 73.22 111.51 -177.306 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -128.97 125.2 22.79 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.967 -1.123 . . . . 70.35 107.967 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.1 139.24 85.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.575 2.183 . . . . 73.24 113.235 178.64 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HG3' ' HB2' ' A' ' 28' ' ' PRO . 73.8 mm-40 -48.72 -34.88 12.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.271 1.028 . . . . 71.44 112.485 177.011 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.13 -3.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 113.883 1.068 . . . . 42.02 113.883 -174.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 81' ' ' LEU . 8.0 m-85 -86.68 -5.84 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.066 0.936 . . . . 75.12 110.141 175.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -134.42 164.5 27.29 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.799 -1.091 . . . . 62.11 108.104 178.66 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.6 p -94.6 158.46 15.52 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.204 -1.406 . . . . 63.41 107.204 176.203 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.78 -15.79 63.19 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.208 0.528 . . . . 74.31 110.647 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.7 m -79.05 -5.56 54.27 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.563 -0.744 . . . . 71.25 111.71 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.24 -7.41 40.41 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 119.641 -1.266 . . . . 71.35 114.312 174.308 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -106.05 162.86 13.24 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.681 -0.808 . . . . 71.33 110.238 179.053 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.79 156.19 5.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 106.86 -1.533 . . . . 73.23 106.86 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.92 125.07 22.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.427 -0.953 . . . . 65.33 108.427 177.559 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.95 -22.21 65.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.93 1.085 . . . . 74.25 113.93 -173.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 t -103.41 11.81 36.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.887 0.375 . . . . 73.14 110.203 -179.063 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 70' ' ' PHE . 12.9 tp -63.41 -51.47 67.55 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 119.305 -0.378 . . . . 65.12 111.762 -178.665 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 31.4 Cg_exo -61.68 -29.59 83.98 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 121.363 1.376 . . . . 64.05 111.78 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.49 -45.04 97.01 Favored Glycine 0 C--O 1.24 0.489 0 O-C-N 123.377 0.423 . . . . 72.5 113.082 -178.092 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -68.4 -40.36 81.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.316 0.579 . . . . 71.34 109.463 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.02 -42.47 97.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.504 -0.771 . . . . 72.22 111.233 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.0 m -57.54 -46.87 83.36 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 112.044 0.387 . . . . 73.33 112.044 -177.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -41.96 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.013 0.435 . . . . 73.11 110.83 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.684 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 55.8 mt -67.08 -35.86 80.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.359 0.503 . . . . 72.02 112.359 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -65.23 -33.2 75.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.553 -0.294 . . . . 53.1 110.73 177.292 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.59 -31.64 72.86 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.357 0.411 . . . . 74.35 110.332 178.248 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.04 -3.2 68.09 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.768 -0.651 . . . . 70.42 112.281 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.49 42.69 55.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 121.502 -0.38 . . . . 74.21 112.903 179.172 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 56.0 m-85 -93.26 130.61 38.92 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.453 -0.439 . . . . 72.11 111.962 178.528 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 18.7 ptp180 -81.1 171.77 14.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.09 -0.959 . . . . 62.41 111.459 -176.841 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.33 -45.96 72.79 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.725 1.61 . . . . 73.23 112.551 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.4 m -61.65 -40.99 96.88 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.414 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 17.9 mm-40 -65.94 -39.39 90.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.446 -0.343 . . . . 73.42 111.587 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 88' ' ' LEU . 24.4 mm -61.1 -49.48 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.749 -0.834 . . . . 60.44 108.749 -177.104 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.5 mtt -76.1 -18.53 59.14 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.738 -1.119 . . . . 75.23 112.336 -177.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -56.81 -67.26 0.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.378 0.671 . . . . 65.02 110.935 -175.66 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.684 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 52.7 p-90 -68.9 -32.75 72.61 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.363 0.505 . . . . 75.24 112.363 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.56 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.4 mt -60.35 -40.13 89.59 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.201 0.815 . . . . 74.21 113.201 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.19 -0.5 55.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.083 0.771 . . . . 74.45 113.083 -178.473 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.2 m -87.51 120.32 71.08 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.367 -0.605 . . . . 71.12 109.367 178.087 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.28 129.75 21.06 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.227 1.951 . . . . 74.4 110.751 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.6 t70 -102.5 124.16 40.29 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 120.264 -0.575 . . . . 62.21 109.519 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.35 -23.92 76.01 Favored 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.603 2.869 . . . . 71.4 113.556 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -104.44 10.27 35.32 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.429 0.633 . . . . 62.24 110.966 -177.647 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 50.1 tp -103.84 123.16 46.6 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.585 -0.894 . . . . 72.22 108.585 174.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.0 m -131.2 111.34 11.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.665 -1.235 . . . . 63.4 107.665 179.305 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--N 1.296 -1.73 0 N-CA-C 112.792 0.664 . . . . 72.4 112.792 -172.443 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 107.799 -1.186 . . . . 64.32 107.799 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 t -90.58 148.26 22.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.957 -1.127 . . . . 52.44 107.957 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.9 t30 65.26 63.58 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.439 1.114 . . . . 71.24 108.923 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.71 164.71 18.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.686 -1.143 . . . . 72.31 109.728 -178.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 36.7 ptt180 -87.34 142.94 33.69 Favored Pre-proline 0 C--N 1.299 -1.62 0 CA-C-N 115.863 -0.608 . . . . 61.41 109.756 179.005 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HB2' HD23 ' A' ' 102' ' ' LEU . 48.7 Cg_exo -57.16 -18.34 29.09 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.264 2.642 . . . . 54.53 114.336 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 97.8 t -60.62 -41.96 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.237 0.542 . . . . 64.43 110.351 178.087 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.36 -32.54 73.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.88 -0.6 . . . . 70.42 111.224 -179.18 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.1 74.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 55.13 110.176 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 126' ' ' VAL . 17.0 tp -60.1 -43.65 95.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.478 0.711 . . . . 74.21 112.246 -177.067 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -71.84 -15.67 62.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.55 0.691 . . . . 75.53 110.697 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -101.58 13.38 35.14 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.289 -0.869 . . . . 44.23 111.373 -175.096 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 65.93 27.32 10.86 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 123.122 1.439 . . . . 63.44 110.225 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -106.29 23.49 14.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.079 -1.452 . . . . 64.41 107.079 176.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.84 17.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.317 -2.22 . . . . 74.04 111.868 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -56.18 -39.19 72.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.288 -0.415 . . . . 71.01 111.405 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.4 mm-40 -69.27 -33.68 73.6 Favored 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 120.77 -0.372 . . . . 72.31 110.887 175.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 129' ' ' LEU . 60.0 t -62.19 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.872 -0.788 . . . . 72.45 108.872 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 66.1 t -61.58 -49.11 85.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 115.673 -0.694 . . . . 75.14 109.41 176.544 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.416 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 0.7 OUTLIER -57.86 -41.8 83.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.076 -0.511 . . . . 71.14 111.452 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 16.6 mmt180 -68.42 -37.78 80.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.978 -0.378 . . . . 75.55 109.978 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.86 96.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.471 . . . . 71.22 110.228 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 91.3 mt-30 -58.52 -49.16 78.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.469 0.708 . . . . 65.31 110.016 178.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.12 71.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.568 -0.742 . . . . 74.32 111.774 -178.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 96.6 mmm -84.6 -36.8 21.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.568 -0.453 . . . . 64.15 111.208 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.583 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -77.44 -42.82 34.61 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.291 0.848 . . . . 53.54 113.291 -176.835 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 119.164 -0.446 . . . . 65.13 110.507 -175.86 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.066 0 N-CA-C 110.382 -0.229 . . . . 75.32 110.382 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.14 -96.95 2.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 121.34 -0.457 . . . . 71.42 113.912 -177.268 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.97 131.99 51.78 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.212 0.529 . . . . 75.32 111.757 -175.202 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.03 94.36 2.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.294 -0.866 . . . . 43.12 110.329 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.57 -45.96 96.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.875 -1.057 . . . . 72.1 111.035 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.88 150.97 46.21 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.444 0.64 . . . . 64.15 112.583 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.81 151.16 93.21 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.181 -0.918 . . . . 73.4 109.058 178.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.75 -25.51 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.771 2.314 . . . . 74.21 112.826 178.181 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.66 -28.4 66.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.895 -0.322 . . . . 61.05 110.899 178.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.53 118.16 65.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 106.993 -1.484 . . . . 73.1 106.993 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.84 147.46 89.48 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 122.474 2.116 . . . . 72.34 113.917 -173.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -129.93 172.73 11.4 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.683 -0.69 . . . . 53.55 112.155 -177.516 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.447 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 10.6 m-85 -117.33 160.68 20.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 126.597 1.959 . . . . 74.1 108.184 173.797 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -133.19 163.75 28.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.31 -2.107 . . . . 74.51 105.31 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.433 HD22 ' H ' ' A' ' 32' ' ' LEU . 3.2 mm? -42.35 -54.84 7.39 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.426 1.639 . . . . 72.42 115.426 -174.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.99 -41.1 65.03 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.074 1.849 . . . . 45.31 113.006 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -71.45 -34.8 70.57 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.986 0.422 . . . . 74.11 110.688 -178.654 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 66' ' ' ILE . 76.0 t -69.15 -41.34 81.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.349 0.595 . . . . 64.15 109.547 177.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -60.2 -36.08 76.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.857 -1.065 . . . . 65.13 109.766 176.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 38.0 tt0 -64.12 -45.06 90.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.569 1.148 . . . . 72.21 110.493 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.447 HD11 ' CZ ' ' A' ' 30' ' ' TYR . 97.0 mt -60.9 -45.6 93.98 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.476 -0.784 . . . . 75.14 111.19 -178.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.8 mt -84.98 -18.35 34.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.209 -0.905 . . . . 54.53 111.395 -176.493 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.05 69.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 111.35 -0.7 . . . . 73.32 111.35 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 39' ' ' LEU . 28.4 m -129.24 158.78 71.97 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.583 -0.525 . . . . 74.43 109.583 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.46 160.89 40.66 Favored 'Trans proline' 0 C--O 1.256 1.42 0 C-N-CA 122.225 1.95 . . . . 75.12 112.136 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.09 -33.02 49.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 123.923 0.889 . . . . 61.51 111.752 -177.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.4 p -60.1 -40.22 88.87 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.225 -0.443 . . . . 65.35 111.226 178.834 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.75 -32.52 71.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.89 0.376 . . . . 65.23 111.384 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.8 t -64.5 -40.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.962 -0.755 . . . . 71.03 108.962 174.208 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -61.82 -36.06 80.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.455 -0.793 . . . . 62.23 110.382 176.118 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 44' ' ' SER . 93.4 mt-30 -61.67 -39.32 90.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.348 -0.387 . . . . 73.1 110.342 178.452 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -58.66 -46.21 87.68 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.812 -0.81 . . . . 60.21 108.812 177.76 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.23 -39.81 94.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.928 -1.033 . . . . 71.32 110.638 179.338 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 89.1 mtt180 -68.71 -26.9 65.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.203 -0.453 . . . . 73.23 111.921 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.95 -8.19 37.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.587 -0.278 . . . . 74.53 111.398 -176.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.47 25.73 45.95 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.555 -0.831 . . . . 41.34 111.883 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -96.55 -5.54 39.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.486 -0.191 . . . . 63.35 110.486 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 tp -163.12 153.94 16.68 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.223 -1.029 . . . . 74.41 108.223 -176.027 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 161.42 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.471 -1.307 . . . . 74.52 107.471 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.31 162.66 35.86 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.915 -0.402 . . . . 75.34 109.915 -175.218 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.418 HG13 ' HE1' ' A' ' 99' ' ' MET . 6.4 m -126.04 164.86 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 O-C-N 123.79 0.681 . . . . 71.21 109.709 177.819 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 32.9 ttp180 -110.83 132.38 54.25 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 116.222 -0.444 . . . . 70.1 110.48 -174.599 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.559 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -136.29 124.4 23.0 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.614 -0.513 . . . . 72.43 109.614 175.888 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.84 30.57 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.945 0.898 . . . . 63.42 112.127 176.053 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.05 -4.33 71.06 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.821 -0.627 . . . . 61.24 113.342 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -107.57 146.35 16.22 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 121.127 -0.559 . . . . 62.41 112.816 -178.178 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.15 120.85 47.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.361 -1.348 . . . . 64.32 107.361 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.79 159.93 41.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.878 -0.601 . . . . 71.23 111.124 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 35' ' ' VAL . 56.0 mt -124.32 128.39 25.02 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.217 -1.031 . . . . 71.13 108.217 179.634 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.14 138.62 86.2 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.62 2.213 . . . . 74.21 113.099 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.55 -35.58 53.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.333 1.053 . . . . 74.22 111.712 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -69.01 -9.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.898 -1.046 . . . . 50.31 113.641 -175.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -80.23 -15.72 56.37 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.745 0.783 . . . . 73.03 110.345 176.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -111.79 162.35 15.35 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 115.167 -0.924 . . . . 75.02 109.528 -178.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 p -85.87 165.78 16.54 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.353 -1.351 . . . . 61.43 107.353 175.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.82 -21.57 66.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.891 0.853 . . . . 74.4 109.506 177.616 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m -80.23 -1.89 42.57 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 115.108 -0.951 . . . . 55.41 112.092 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.47 -16.91 59.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.391 -0.909 . . . . 72.34 114.941 173.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -92.16 164.87 13.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.178 0.989 . . . . 73.34 109.612 179.632 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.84 155.71 3.7 Favored 'Isoleucine or valine' 0 C--O 1.258 1.546 0 N-CA-C 108.34 -0.985 . . . . 62.15 108.34 -179.141 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 80' ' ' SER . 42.6 t -65.97 126.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.041 -0.725 . . . . 72.12 109.041 178.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -26.6 67.92 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.626 0.602 . . . . 64.31 112.626 -178.231 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.475 ' H ' HG12 ' A' ' 78' ' ' VAL . 13.6 m -84.33 -0.56 52.99 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.884 -0.598 . . . . 73.2 111.899 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.515 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 57.1 tp -60.79 -55.1 48.1 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 113.01 0.745 . . . . 62.41 113.01 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.29 -28.98 86.47 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.087 1.858 . . . . 64.23 112.594 -178.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.29 96.37 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.057 -0.592 . . . . 53.34 111.941 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 60.13 110.308 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.4 -42.72 95.95 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.576 -0.738 . . . . 62.34 111.845 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -62.49 -45.43 93.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.136 -0.484 . . . . 71.23 112.205 -176.325 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -43.29 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.829 -0.349 . . . . 72.24 110.687 -179.15 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.61 -35.8 79.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.395 0.517 . . . . 60.12 112.395 176.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -62.29 -42.45 99.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.677 -0.49 . . . . 74.25 109.677 179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.18 -30.51 71.56 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.859 -0.609 . . . . 60.11 110.723 176.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.26 -9.29 85.23 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.479 -0.782 . . . . 63.03 112.104 177.785 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.37 23.1 55.3 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.577 -0.344 . . . . 71.11 113.837 177.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -87.47 129.6 35.0 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.163 0.506 . . . . 75.14 111.539 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 16.6 ptp180 -78.49 172.67 13.32 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.006 0.922 . . . . 74.23 110.897 -177.049 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -53.64 -45.08 70.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.583 1.553 . . . . 73.12 111.035 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.607 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 31.2 m -63.46 -42.12 98.62 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.121 -0.945 . . . . 64.41 110.269 -179.405 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.462 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 41.8 mt-10 -65.41 -39.91 92.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.983 -0.553 . . . . 62.42 110.27 -177.909 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 94' ' ' ARG . 21.5 mm -61.35 -48.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.773 0.796 . . . . 74.41 109.575 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.423 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 51.9 mtt -74.58 -15.98 60.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 113.55 0.945 . . . . 74.45 113.55 -175.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.607 ' HG3' ' O ' ' A' ' 96' ' ' THR . 84.2 mtt180 -55.77 -65.26 0.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.935 0.398 . . . . 72.25 111.028 178.724 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.476 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.7 p-90 -68.68 -32.03 71.56 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.707 0.632 . . . . 72.34 112.707 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.7 mt -62.3 -40.84 97.6 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.516 0.932 . . . . 71.34 113.516 -179.443 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -92.91 -16.03 25.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.554 0.576 . . . . 73.41 112.554 -177.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.0 m -87.32 124.09 68.74 Favored Pre-proline 0 C--N 1.296 -1.761 0 N-CA-C 109.31 -0.626 . . . . 75.31 109.31 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.519 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.3 Cg_exo -54.13 129.64 35.46 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.823 2.349 . . . . 64.44 111.938 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 8.9 t70 -80.5 126.26 78.96 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 108.209 -1.034 . . . . 73.34 108.209 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 24.9 Cg_endo -60.52 -20.39 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.039 2.493 . . . . 74.24 114.401 -176.523 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.7 m -115.98 4.8 13.83 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.953 -0.467 . . . . 71.33 111.887 -176.267 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 39.9 tp -102.34 119.83 39.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.023 0.916 . . . . 51.34 111.812 -176.324 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.2 m -120.11 131.1 54.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.699 -1.593 . . . . 75.44 106.699 178.031 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.4 HG12 ' HB2' ' A' ' 123' ' ' ALA . 14.5 pt . . . . . 0 C--N 1.297 -1.687 0 C-N-CA 120.265 -0.574 . . . . 61.33 112.301 -177.765 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 109.874 -0.417 . . . . 71.23 109.874 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.5 m -88.93 140.08 29.8 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.81 -1.552 . . . . 74.13 106.81 176.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 44.9 m-80 63.29 55.92 1.78 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.847 0.832 . . . . 71.53 109.566 -175.489 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB2' HG12 ' A' ' 111' ' ' ILE . . . -84.8 144.83 28.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.405 -0.816 . . . . 54.42 110.548 179.183 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -76.94 139.44 65.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 107.174 -1.417 . . . . 63.44 107.174 174.281 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB2' HD23 ' A' ' 102' ' ' LEU . 95.8 Cg_exo -49.55 -30.46 21.61 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.376 2.717 . . . . 72.22 114.403 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.3 t -60.78 -43.25 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.443 0.639 . . . . 72.22 110.782 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.34 -31.02 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 73.24 110.783 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.71 76.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.887 -0.597 . . . . 31.33 111.45 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.81 -35.77 80.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.719 0.295 . . . . 61.24 111.01 -179.679 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -72.32 -24.66 61.34 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.86 0.838 . . . . 71.11 109.048 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -93.21 21.4 5.99 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.116 -0.947 . . . . 63.52 111.568 -179.481 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.73 27.29 16.04 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.148 1.379 . . . . 73.43 112.15 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -115.0 23.73 12.3 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.408 1.099 . . . . 65.11 109.236 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.37 -27.17 22.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.041 -1.89 . . . . 74.45 111.682 177.787 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -54.75 -46.89 74.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.016 0.526 . . . . 71.2 109.687 178.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 47.2 mm-40 -71.83 -29.2 64.15 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.239 -0.437 . . . . 73.24 111.464 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.18 -47.74 72.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.301 -0.409 . . . . 73.1 110.354 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.8 t -63.92 -42.66 96.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.303 -0.629 . . . . 73.53 109.303 177.86 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -58.67 -44.3 90.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.435 0.694 . . . . 73.15 109.942 178.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 2.4 tpp85 -64.92 -38.2 90.19 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.117 -0.947 . . . . 61.22 109.213 -178.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -66.4 -44.15 83.82 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.655 0.782 . . . . 73.45 110.564 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -60.48 -49.94 75.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.935 -0.575 . . . . 72.44 109.822 178.768 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 -17.54 63.47 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.86 -1.064 . . . . 61.12 111.957 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.7 tpp -82.27 -40.59 21.33 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.025 0.441 . . . . 72.43 110.035 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.53 -48.74 8.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 61.23 111.716 -177.017 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 118.085 -0.959 . . . . 71.3 109.615 -177.354 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . . . . . . 0 C--O 1.25 1.088 0 N-CA-C 109.508 -0.553 . . . . 52.01 109.508 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.23 -137.43 7.34 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.595 -0.812 . . . . 75.22 114.369 -177.604 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -97.51 123.39 41.36 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.418 0.687 . . . . 70.54 111.812 -173.558 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -70.45 126.07 28.6 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.078 -0.965 . . . . 51.22 109.633 -178.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.6 t -100.36 -19.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.813 -0.631 . . . . 73.11 111.584 -175.337 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -98.68 176.0 5.79 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.602 -0.839 . . . . 61.24 111.8 -177.867 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' ' HG2' ' A' ' 27' ' ' GLU . 20.7 m-20 -82.8 151.36 64.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.901 -0.407 . . . . 71.53 109.901 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 60' ' ' ARG . 32.5 Cg_exo -61.86 -22.11 73.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.596 2.197 . . . . 75.05 112.383 178.642 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -84.05 -8.28 59.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 54.15 110.72 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 24' ' ' ASP . 16.2 mm-40 -76.37 154.94 84.09 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.533 -0.543 . . . . 74.31 109.533 177.35 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 28.3 Cg_endo -58.82 111.2 0.82 Allowed 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 122.877 2.385 . . . . 63.44 112.814 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -133.32 167.49 20.3 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.801 -0.636 . . . . 74.41 111.497 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 19.8 m-85 -128.66 161.69 29.09 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 125.08 1.352 . . . . 75.2 108.774 178.33 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.8 m-20 -133.9 161.01 35.95 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 104.365 -2.457 . . . . 73.43 104.365 -174.75 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.4 mt -47.08 -56.66 11.35 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.84 1.052 . . . . 62.24 113.84 -174.276 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.56 -29.68 43.92 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 121.242 1.295 . . . . 75.51 112.195 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.462 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 9.7 tpt180 -70.84 -37.83 73.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.8 0.334 . . . . 75.24 110.534 -178.04 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' ASP . 47.3 t -69.11 -40.83 81.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.79 -0.819 . . . . 74.54 108.79 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.49 81.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.909 -1.042 . . . . 54.13 109.46 177.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.36 -45.54 72.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.026 -0.988 . . . . 61.31 110.103 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.21 -50.66 69.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.254 -0.884 . . . . 72.33 111.437 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HB2' HG22 ' A' ' 41' ' ' VAL . 97.5 mt -84.07 -16.93 41.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.829 -0.623 . . . . 64.21 112.653 -175.326 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.84 62.41 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.303 -0.951 . . . . 70.22 110.756 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 39' ' ' LEU . 18.6 m -126.99 160.83 57.26 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 107.754 -1.202 . . . . 73.31 107.754 -178.379 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.89 159.38 52.75 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 121.738 1.625 . . . . 54.31 111.563 176.577 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.04 -32.84 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.751 -0.833 . . . . 70.25 108.751 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 8.6 m -57.16 -41.35 79.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.644 -1.162 . . . . 53.04 110.73 177.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 57.3 tttm -70.11 -36.25 74.71 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.283 0.563 . . . . 75.22 109.521 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.83 -40.9 90.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.753 0.787 . . . . 71.21 109.096 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.49 80.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.952 -1.022 . . . . 64.52 110.652 177.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 44' ' ' SER . 80.3 mm-40 -61.24 -41.24 96.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.252 -0.647 . . . . 73.53 109.252 178.697 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.9 mm-40 -58.98 -47.23 85.91 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.477 -0.783 . . . . 74.12 109.142 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -63.92 -34.06 77.1 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.252 -0.886 . . . . 55.35 110.853 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -67.2 -34.47 77.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.0 111.963 176.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 19.6 mm-40 -88.21 -11.73 45.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 74.54 110.432 -176.634 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.95 28.52 49.94 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.662 -0.975 . . . . 73.51 110.662 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -88.98 -10.55 47.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.669 -0.863 . . . . 72.34 108.669 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.5 tp -158.3 158.09 33.71 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.339 -1.726 . . . . 70.43 106.339 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.87 155.48 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.723 -0.843 . . . . 74.51 108.723 177.074 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -126.54 157.43 38.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.938 -0.764 . . . . 55.21 108.938 -176.823 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG11 ' CE ' ' A' ' 99' ' ' MET . 35.1 m -131.75 164.44 34.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.671 -0.492 . . . . 64.53 109.671 178.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -122.34 122.35 38.85 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 110.008 -0.368 . . . . 73.33 110.008 -176.604 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 25' ' ' PRO . 5.8 ptp180 -117.06 113.73 22.74 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-N 115.926 -0.579 . . . . 72.22 109.477 177.602 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.68 -40.8 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.372 1.869 . . . . 61.32 112.012 178.304 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.18 -13.03 0.04 OUTLIER Glycine 0 C--N 1.29 -2.011 0 CA-C-N 114.949 -1.023 . . . . 55.14 111.969 -177.246 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.62 145.35 17.7 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.855 -0.688 . . . . 63.34 111.921 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.8 120.92 46.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.581 -1.266 . . . . 70.31 107.581 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.46 164.94 33.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.04 -0.982 . . . . 64.31 110.708 -174.558 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.32 132.31 24.25 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 107.404 -1.332 . . . . 74.43 107.404 -179.02 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.1 119.45 6.47 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 121.685 1.59 . . . . 74.34 111.029 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 42.8 tt0 -62.99 -25.01 68.18 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.547 0.739 . . . . 74.41 112.091 -177.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.0 m -65.27 -9.64 7.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.482 -0.781 . . . . 72.32 112.605 177.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.525 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.8 m-85 -81.55 -6.16 58.7 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.743 0.782 . . . . 75.24 110.159 175.333 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -110.86 154.35 24.14 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.163 -0.926 . . . . 70.22 108.991 179.18 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.1 p -76.83 175.96 8.98 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 123.659 0.784 . . . . 73.34 110.573 179.091 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -56.31 -31.86 64.08 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.466 0.707 . . . . 74.14 110.214 174.499 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 m -80.17 -2.58 45.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.626 -0.716 . . . . 71.34 111.74 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.53 32.46 59.61 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.103 -0.57 . . . . 61.22 111.977 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -115.7 157.78 23.76 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.343 -0.614 . . . . 75.51 109.343 177.47 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.418 HG13 HD23 ' A' ' 81' ' ' LEU . 43.9 t -66.23 130.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.226 -0.657 . . . . 74.43 109.226 175.708 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 80' ' ' SER . 42.0 t -63.16 132.34 28.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.432 -0.951 . . . . 55.22 108.432 178.303 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -57.63 -27.51 62.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.903 0.705 . . . . 72.51 112.903 -178.178 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.442 ' H ' HG12 ' A' ' 78' ' ' VAL . 9.5 m -89.19 -2.61 58.57 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.049 -0.523 . . . . 60.05 111.273 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.525 HD11 ' CD2' ' A' ' 70' ' ' PHE . 46.0 tp -61.67 -56.99 27.59 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 119.041 -0.504 . . . . 75.24 111.794 -177.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.24 -38.67 94.64 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.437 1.425 . . . . 74.2 110.795 177.174 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.87 97.11 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.757 -0.656 . . . . 70.12 112.796 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.42 -41.27 80.61 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 117.212 0.506 . . . . 74.41 109.719 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.74 -35.59 81.06 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 116.026 -0.534 . . . . 64.35 110.754 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.6 m -67.24 -41.28 85.89 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 112.075 0.398 . . . . 72.33 112.075 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.02 -40.27 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 120.143 -0.623 . . . . 71.12 110.473 178.58 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 3.3 mm? -67.61 -36.07 80.15 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.623 -0.673 . . . . 63.24 112.285 175.05 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -63.54 -33.03 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.426 -0.583 . . . . 74.41 109.426 177.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 87' ' ' ILE . 18.5 t70 -63.18 -29.9 71.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.226 1.01 . . . . 73.05 109.847 178.244 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.4 -9.32 53.54 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.837 -0.62 . . . . 53.1 111.969 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.02 27.69 36.66 Favored Glycine 0 C--N 1.317 -0.483 0 O-C-N 122.769 -0.253 . . . . 23.24 113.442 178.276 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 76.6 m-85 -83.84 128.16 34.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.125 0.488 . . . . 63.31 112.055 -179.114 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 8.0 ptp180 -79.97 171.05 15.61 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.217 -0.901 . . . . 71.44 110.306 -179.509 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -54.35 -43.0 70.91 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.884 1.274 . . . . 72.23 111.667 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -60.03 -41.98 93.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 123.813 0.845 . . . . 63.32 110.502 -179.35 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -65.1 -39.71 93.53 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.828 -0.624 . . . . 71.53 110.055 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.0 mm -60.24 -47.52 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.244 -1.021 . . . . 63.34 108.244 -176.67 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.409 ' CE ' HG11 ' A' ' 58' ' ' VAL . 73.5 mtm -70.92 -26.38 63.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.982 -1.008 . . . . 71.5 112.725 -176.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -58.12 -66.17 0.52 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.885 0.698 . . . . 74.34 112.885 -179.323 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -68.24 -32.44 72.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.506 0.558 . . . . 65.33 112.506 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.568 ' HG ' HG22 ' A' ' 126' ' ' VAL . 32.3 tp -67.53 -40.38 85.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.826 -0.624 . . . . 61.34 111.519 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 26.7 m-85 -84.99 -3.05 58.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.422 0.527 . . . . 64.41 112.422 -179.025 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.9 m -86.99 109.85 28.05 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.367 -0.605 . . . . 65.12 109.367 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 103' ' ' PHE . 21.7 Cg_exo -65.87 139.67 57.93 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.637 2.225 . . . . 72.14 110.852 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.0 t70 -99.27 119.34 60.72 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.253 -1.017 . . . . 75.33 108.253 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.05 -24.87 78.14 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.259 2.64 . . . . 73.05 113.647 -176.066 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.8 p -106.25 8.38 31.88 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.258 0.466 . . . . 73.54 112.258 -176.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 56.4 tp -102.84 129.38 49.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 110.047 -0.353 . . . . 51.51 110.047 -178.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.5 m -112.12 112.72 24.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.451 -0.574 . . . . 60.44 109.451 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 C--N 1.3 -1.551 0 CA-C-N 115.902 -0.59 . . . . 72.22 109.461 -176.711 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.435 -1.184 0 N-CA-C 110.176 -0.305 . . . . 71.41 110.176 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 64.2 m -80.3 132.21 35.78 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.112 -1.069 . . . . 73.1 108.112 173.274 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.8 t30 75.38 72.97 0.09 Allowed 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.944 1.297 . . . . 75.32 108.274 -171.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.65 168.07 10.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.814 -1.085 . . . . 23.23 110.167 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -93.06 127.06 48.77 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 115.646 -0.706 . . . . 73.12 110.166 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.467 ' HB2' HD12 ' A' ' 102' ' ' LEU . 65.4 Cg_exo -55.73 -21.3 31.66 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.384 2.723 . . . . 75.43 113.469 178.487 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.568 HG22 ' HG ' ' A' ' 102' ' ' LEU . 43.0 t -60.35 -44.78 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.85 0.833 . . . . 72.22 109.73 178.433 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.7 -29.38 64.51 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.685 -1.143 . . . . 55.45 110.131 -176.626 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.52 -43.29 99.17 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.45 -0.796 . . . . 62.25 111.778 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -69.38 -34.98 75.35 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.638 -0.664 . . . . 65.04 109.779 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -66.65 -25.44 66.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.289 -1.323 . . . . 74.31 108.971 177.603 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.72 9.01 42.94 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.944 -1.025 . . . . 62.12 111.363 179.091 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.9 m80 65.25 28.23 12.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.322 1.049 . . . . 73.43 112.638 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.44 25.04 11.61 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.056 1.342 . . . . 63.41 107.74 176.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.57 -25.66 7.22 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 126.976 2.11 . . . . 72.43 112.767 -177.494 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 mmm-85 -54.19 -43.0 70.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.917 0.487 . . . . 74.43 110.286 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.3 -27.77 64.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.07 0.462 . . . . 53.43 111.323 179.16 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 129' ' ' LEU . 99.1 t -73.32 -49.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.543 -0.753 . . . . 60.44 109.762 178.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.493 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 79.2 t -59.08 -41.15 82.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.421 -0.809 . . . . 61.24 109.143 177.446 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.37 -46.72 79.91 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.246 -0.888 . . . . 74.3 110.157 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 144' ' ' MET . 43.9 mtp180 -67.92 -37.05 81.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.815 0.34 . . . . 72.51 111.864 176.503 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.28 99.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.648 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -59.64 -39.0 82.92 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 122.818 0.447 . . . . 73.22 110.404 176.116 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.46 66.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.316 -0.402 . . . . 74.45 110.978 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.6 mmm -82.68 -41.28 19.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.066 0.46 . . . . 72.11 110.526 179.27 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.74 -51.35 11.59 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.209 0.448 . . . . 72.33 112.209 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.511 -0.757 . . . . 74.53 109.023 -176.973 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.275 0 N-CA-C 106.15 -1.796 . . . . 73.13 106.15 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.17 -96.89 0.96 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 119.734 -1.222 . . . . 53.34 115.169 -175.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.1 119.94 37.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.17 0.509 . . . . 42.53 112.243 -169.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.45 109.77 2.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.996 -1.002 . . . . 54.25 110.421 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.19 -33.42 12.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.354 0.597 . . . . 75.04 110.158 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -78.44 173.78 11.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.012 -0.54 . . . . 75.55 110.135 176.075 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.88 129.98 42.31 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 107.985 -1.117 . . . . 72.41 107.985 176.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.63 -21.98 15.95 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.442 2.761 . . . . 64.03 115.061 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.46 -24.39 56.98 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.958 0.408 . . . . 71.44 110.484 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.71 157.19 87.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.724 -0.671 . . . . 73.43 111.844 -177.579 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -43.19 107.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 124.067 3.178 . . . . 74.45 113.601 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -135.05 164.04 28.53 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.107 -0.951 . . . . 73.23 110.426 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -127.37 160.7 30.59 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 125.623 1.569 . . . . 64.22 107.639 177.13 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.509 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.0 p30 -134.79 172.24 13.25 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 107.622 -1.251 . . . . 75.44 107.622 -178.554 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -46.04 -64.32 0.98 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 114.626 1.343 . . . . 75.14 114.626 -172.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.64 -27.59 69.11 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 121.569 1.513 . . . . 73.05 112.634 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.509 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 23.5 tpt180 -67.9 -48.29 66.44 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 110.179 -0.304 . . . . 65.52 110.179 178.598 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.84 -37.95 80.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.216 0.532 . . . . 74.24 109.915 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.47 -37.05 82.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.054 -0.976 . . . . 72.11 110.0 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.14 -44.96 71.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.2 -0.909 . . . . 71.51 109.885 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 97.2 mt -57.5 -41.98 81.82 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.354 -0.839 . . . . 74.4 111.962 -178.753 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.507 ' HB2' HG22 ' A' ' 41' ' ' VAL . 86.1 mt -94.29 -17.76 22.31 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.923 -0.58 . . . . 73.35 111.977 -177.178 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.86 61.55 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.37 -1.092 . . . . 63.52 110.37 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 39' ' ' LEU . 23.5 m -122.4 164.05 28.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.239 -0.652 . . . . 74.21 109.239 -178.593 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 39.6 Cg_endo -71.91 158.59 52.43 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.728 1.618 . . . . 73.43 111.341 173.434 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.28 -34.54 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.368 0.604 . . . . 73.31 110.012 178.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.7 t -62.25 -36.84 83.25 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.535 -0.757 . . . . 73.44 110.655 178.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 38.9 ttmt -69.77 -32.6 71.19 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 120.135 -0.626 . . . . 64.41 110.201 177.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.28 -42.25 92.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.653 -0.869 . . . . 52.53 108.653 175.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.08 82.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.888 -1.051 . . . . 23.31 110.438 176.655 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.2 mt-30 -66.82 -38.24 86.08 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.16 -0.473 . . . . 71.03 111.06 177.771 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.4 mm-40 -63.49 -41.29 98.56 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.998 -0.742 . . . . 71.12 108.998 177.313 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.55 -42.5 98.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.78 -1.1 . . . . 74.3 109.228 177.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -60.33 -32.67 71.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.277 1.031 . . . . 63.2 111.87 178.457 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -85.41 -9.91 56.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.937 0.399 . . . . 73.13 111.068 -177.494 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.18 33.1 54.96 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.6 -1.4 . . . . 53.33 109.6 -174.236 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.02 -16.91 20.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.475 -0.935 . . . . 72.54 108.475 178.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 tp -151.2 157.22 42.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.647 -1.242 . . . . 72.1 107.647 -179.293 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.14 147.63 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.82 -0.808 . . . . 65.13 108.82 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.58 161.78 34.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 123.208 0.603 . . . . 64.13 109.471 -178.084 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.21 166.59 28.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 123.612 0.765 . . . . 64.22 109.705 176.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 45.9 mtp180 -112.57 126.84 55.78 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.941 -0.304 . . . . 72.41 110.791 -177.924 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -129.8 122.68 29.23 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.002 -0.74 . . . . 71.32 109.002 176.66 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 26.14 15.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.716 0.806 . . . . 70.5 111.616 179.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 -7.26 77.17 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.987 -0.551 . . . . 61.12 112.237 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.82 149.4 19.29 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 121.302 -0.475 . . . . 64.54 111.942 -178.204 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.35 120.94 47.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.282 -1.377 . . . . 75.41 107.282 179.466 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.33 150.83 34.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.528 0.68 . . . . 73.44 110.961 -178.395 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.79 129.18 25.54 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 106.524 -1.658 . . . . 73.51 106.524 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.13 128.13 24.28 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 121.877 1.718 . . . . 71.53 111.273 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -60.81 -26.77 67.54 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.198 0.523 . . . . 72.1 111.991 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.11 -18.83 24.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.27 -0.877 . . . . 74.3 112.237 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.5 m-85 -73.74 -9.86 59.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.455 0.645 . . . . 74.51 110.657 177.779 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.04 161.94 17.08 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.522 -0.763 . . . . 61.3 109.455 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 p -83.55 176.1 9.28 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.405 -0.961 . . . . 63.24 108.405 175.249 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -61.79 -21.69 64.81 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.085 0.469 . . . . 70.35 110.961 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.9 t -80.79 -10.47 59.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.411 0.684 . . . . 73.33 110.298 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.2 24.78 53.82 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.641 -0.79 . . . . 74.43 111.773 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -112.89 152.15 29.63 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.142 -1.059 . . . . 63.12 108.142 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.478 HG13 HD23 ' A' ' 81' ' ' LEU . 41.9 t -62.87 135.31 27.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 120.595 0.236 . . . . 62.45 111.053 178.673 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 80' ' ' SER . 39.0 t -64.97 131.32 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.599 -0.889 . . . . 72.52 108.599 177.294 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -21.98 27.51 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.76 1.022 . . . . 61.13 113.76 -178.293 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.426 ' H ' HG12 ' A' ' 78' ' ' VAL . 17.9 t -94.58 -10.56 31.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.934 0.397 . . . . 62.21 110.456 -177.702 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 43.7 tp -60.18 -55.16 48.08 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 119.314 -0.374 . . . . 73.04 111.914 -177.684 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.34 -28.21 79.0 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.18 1.92 . . . . 63.14 111.716 178.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -45.66 60.44 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 121.103 -0.57 . . . . 73.05 111.935 -178.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.47 -40.31 81.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.42 0.628 . . . . 75.22 109.801 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 84.9 mt -62.18 -44.4 96.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.616 -0.72 . . . . 74.13 110.842 -178.668 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.4 m -70.39 -34.66 72.82 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 115.831 -0.622 . . . . 74.12 112.081 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -45.55 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 120.281 -0.567 . . . . 70.15 110.718 178.629 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 4.3 mm? -67.17 -35.81 80.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.1 0.407 . . . . 73.15 112.1 176.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.03 -37.36 79.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.273 -0.64 . . . . 65.2 109.273 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.38 -30.17 71.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 61.41 110.909 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.7 -2.31 84.63 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.965 -0.561 . . . . 74.44 112.182 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.19 39.44 11.35 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.479 -0.391 . . . . 73.31 112.591 178.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.451 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 68.9 m-85 -100.74 121.02 40.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.972 0.415 . . . . 71.23 111.694 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.623 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 38.1 ptt180 -71.0 171.61 10.53 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.112 0.965 . . . . 64.21 110.307 176.387 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -54.19 -44.97 72.02 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 125.24 1.416 . . . . 73.11 111.174 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.0 m -61.64 -41.4 97.45 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.94 -1.027 . . . . 75.31 110.625 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.623 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 41.6 mm-40 -67.31 -33.95 76.34 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.503 -0.317 . . . . 72.31 111.714 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.5 mm -61.16 -47.61 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.308 -0.997 . . . . 42.54 108.308 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.1 mtt -74.74 -18.77 60.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.775 -1.102 . . . . 74.34 112.074 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 77.8 ttt180 -55.97 -65.56 0.58 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.279 0.632 . . . . 70.42 110.371 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.51 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 53.3 p-90 -69.13 -32.06 71.16 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.528 -0.76 . . . . 72.53 112.623 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 125' ' ' PRO . 11.4 mt -64.99 -41.89 95.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.93 1.085 . . . . 63.11 113.93 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 124' ' ' ARG . 68.7 m-85 -89.5 -11.76 42.0 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 114.004 1.113 . . . . 71.21 114.004 -173.844 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.3 m -81.47 119.2 74.99 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.532 -0.544 . . . . 72.01 109.532 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.02 130.32 27.08 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.6 2.2 . . . . 61.34 111.21 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.5 t70 -99.86 125.24 41.0 Favored Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.45 -0.5 . . . . 74.13 110.358 -175.338 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.86 -23.57 77.16 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.764 2.31 . . . . 64.43 113.645 -177.735 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.2 m -107.85 12.19 27.45 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.965 0.412 . . . . 73.35 110.848 -175.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.47 ' HG ' HG12 ' A' ' 111' ' ' ILE . 35.8 tp -108.37 124.92 51.1 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.193 -0.603 . . . . 44.32 110.793 -179.565 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 m -116.47 110.7 18.96 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.825 -0.806 . . . . 71.12 108.825 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.47 HG12 ' HG ' ' A' ' 109' ' ' LEU . 48.9 mm . . . . . 0 C--N 1.31 -1.119 0 C-N-CA 123.417 0.687 . . . . 74.42 110.013 -173.46 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 108.043 -1.095 . . . . 75.51 108.043 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -80.2 155.52 27.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.799 -0.815 . . . . 72.13 108.799 177.433 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 14.9 m-80 67.7 37.17 3.35 Favored 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.808 0.692 . . . . 74.2 110.741 176.848 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.98 163.59 13.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.95 -0.389 . . . . 52.31 109.95 -179.058 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 103' ' ' PHE . 12.2 ptp85 -95.14 150.3 37.47 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.338 -0.615 . . . . 73.3 109.338 178.826 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.624 ' HB2' HD23 ' A' ' 102' ' ' LEU . 77.2 Cg_exo -54.89 -25.43 43.61 Favored 'Trans proline' 0 CA--C 1.555 1.533 0 C-N-CA 123.294 2.662 . . . . 62.54 114.028 178.254 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 102' ' ' LEU . 40.9 t -60.37 -43.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 120.858 0.361 . . . . 53.1 111.576 178.199 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.91 -32.79 74.66 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.611 -0.722 . . . . 72.11 109.885 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.53 75.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.4 -0.818 . . . . 72.3 111.961 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.478 ' HB3' HG21 ' A' ' 137' ' ' VAL . 4.1 pp -68.49 -37.39 80.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.525 -0.47 . . . . 70.4 111.277 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.82 -19.08 60.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.692 0.758 . . . . 74.44 109.493 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.09 7.79 45.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.338 -0.847 . . . . 60.33 111.157 177.291 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 64.3 27.88 13.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.445 1.117 . . . . 55.14 111.77 178.609 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.46 25.12 12.12 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.53 1.532 . . . . 75.12 108.425 179.567 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.8 3.88 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 128.204 2.601 . . . . 63.12 113.571 -176.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -53.97 -38.75 65.34 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 109.62 -0.511 . . . . 73.24 109.62 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -68.92 -27.64 65.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.453 0.644 . . . . 71.52 110.944 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 129' ' ' LEU . 61.9 t -73.46 -47.43 45.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.189 -0.914 . . . . 62.52 109.127 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.49 -41.8 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 64.22 109.188 176.708 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -56.93 -46.31 82.12 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.836 -1.074 . . . . 62.33 109.592 176.674 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -69.01 -36.44 77.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.147 -0.478 . . . . 72.1 110.734 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -58.72 -45.63 89.17 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.438 0.695 . . . . 54.13 110.516 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.87 -38.42 88.74 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.814 -0.63 . . . . 75.31 110.759 178.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.88 73.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.146 0.498 . . . . 73.1 110.594 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tpt -74.69 -47.11 33.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.699 -0.682 . . . . 73.45 110.907 -179.495 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.77 -32.9 46.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.992 0.738 . . . . 64.01 112.992 -176.491 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 108.892 -0.781 . . . . 61.24 108.892 -179.177 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 120.465 0.174 . . . . 55.54 110.702 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.3 -105.6 2.84 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 121.365 -0.445 . . . . 73.24 113.52 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -113.64 134.52 54.68 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.692 0.397 . . . . 65.32 110.489 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.18 127.6 33.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.668 0.747 . . . . 71.21 110.907 -179.138 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.07 -21.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.465 -0.789 . . . . 63.52 110.216 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -78.82 152.08 31.54 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 113.311 0.856 . . . . 71.43 113.311 -178.218 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.21 151.45 94.54 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 107.637 -1.245 . . . . 60.42 107.637 178.149 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.21 -25.0 76.54 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.769 1.646 . . . . 74.34 110.559 174.5 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -72.97 -13.81 61.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.145 -0.934 . . . . 73.34 111.209 177.276 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -83.61 131.41 52.43 Favored Pre-proline 0 N--CA 1.435 -1.175 0 N-CA-C 107.74 -1.207 . . . . 74.2 107.74 175.114 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.2 146.34 63.31 Favored 'Trans proline' 0 C--O 1.256 1.4 0 C-N-CA 122.871 2.381 . . . . 72.5 113.204 -177.019 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -128.79 165.75 20.35 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.795 0.807 . . . . 74.35 112.165 -178.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.558 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 12.3 m-85 -130.34 161.45 31.26 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 125.927 1.691 . . . . 75.3 107.779 175.754 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 9.4 t70 -134.23 169.36 17.3 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 103.819 -2.659 . . . . 61.23 103.819 178.889 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HB3' HG13 ' A' ' 43' ' ' VAL . 6.2 mp -54.7 -51.99 74.08 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 114.262 1.208 . . . . 73.24 114.262 -171.363 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 15.8 Cg_endo -58.48 -36.12 97.84 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.157 1.904 . . . . 64.45 112.445 176.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 21.4 tpt180 -69.82 -39.34 76.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 122.912 0.485 . . . . 75.04 110.21 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.44 -38.84 77.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.318 0.58 . . . . 72.33 109.59 176.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -59.62 -36.14 75.75 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.201 -0.909 . . . . 75.54 109.881 177.1 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 37.8 tt0 -65.2 -43.77 90.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.575 -1.193 . . . . 75.05 109.963 178.165 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 83.9 mt -67.02 -50.24 62.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.799 -0.637 . . . . 64.34 111.285 -178.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.433 ' HB2' HG22 ' A' ' 41' ' ' VAL . 81.7 mt -81.06 -17.82 48.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.704 -0.68 . . . . 54.41 112.12 -173.321 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.71 63.08 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.682 -0.77 . . . . 42.55 111.619 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 39' ' ' LEU . 34.2 m -120.89 159.25 49.75 Favored Pre-proline 0 C--N 1.312 -1.052 0 N-CA-C 109.926 -0.398 . . . . 71.14 109.926 -177.636 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -61.32 154.12 60.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 122.269 1.979 . . . . 55.31 113.139 173.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 32' ' ' LEU . 90.3 t -57.88 -35.13 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.478 -1.237 . . . . 72.25 110.993 -179.367 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -64.55 -34.37 78.09 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 116.364 -0.38 . . . . 63.32 110.789 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 68.1 mttm -68.98 -35.78 77.12 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.905 -0.497 . . . . 75.54 110.225 176.72 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.21 -43.02 98.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.76 -0.655 . . . . 63.32 109.696 175.705 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.74 79.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.86 -0.609 . . . . 71.22 110.349 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 46.3 mt-30 -67.51 -35.2 78.65 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 115.954 -0.566 . . . . 63.44 111.848 177.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.9 mm-40 -58.26 -48.75 79.45 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.583 -0.895 . . . . 74.31 108.583 177.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -62.3 -42.69 99.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.844 -1.071 . . . . 64.12 110.27 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -70.13 -21.32 63.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.25 1.204 . . . . 71.44 114.25 -179.232 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 18.2 mm-40 -96.54 -4.85 40.6 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 119.749 -0.78 . . . . 74.53 110.758 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.56 36.49 37.99 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.105 -0.798 . . . . 41.02 111.105 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -106.68 -5.18 18.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.219 -1.03 . . . . 70.2 108.219 178.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -158.11 153.65 26.22 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.697 -1.594 . . . . 73.23 106.697 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.17 146.98 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.996 -0.742 . . . . 74.2 108.996 -176.43 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.56 153.28 51.03 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.297 -0.631 . . . . 72.33 109.297 -179.024 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.19 168.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 123.777 0.831 . . . . 61.42 109.726 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 59' ' ' ARG . 33.7 ttt180 -108.43 118.01 35.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.439 -0.949 . . . . 72.43 108.439 -176.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -123.9 123.47 40.49 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.089 -1.414 . . . . 74.41 109.473 -176.545 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.0 16.07 7.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.541 1.136 . . . . 52.44 112.034 177.754 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.46 -12.87 54.56 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.73 -0.668 . . . . 44.23 112.025 -178.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.15 156.9 17.96 Favored Glycine 0 CA--C 1.497 -1.093 0 C-N-CA 120.498 -0.858 . . . . 72.14 111.337 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.47 120.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.893 -1.151 . . . . 74.35 107.893 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.47 157.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.675 0.75 . . . . 62.35 111.451 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.9 mt -112.29 126.56 28.2 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 106.564 -1.643 . . . . 71.32 106.564 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.35 128.78 28.62 Favored 'Trans proline' 0 C--N 1.329 -0.471 0 C-N-CA 122.341 2.028 . . . . 63.55 112.697 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 46.1 tt0 -66.31 -25.22 66.74 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 121.499 0.666 . . . . 75.04 110.937 179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.0 -8.1 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 115.181 -0.918 . . . . 72.11 112.44 178.028 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.6 -7.03 59.66 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.085 0.945 . . . . 71.43 109.424 173.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.35 164.12 13.61 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.645 -1.161 . . . . 74.22 108.501 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 p -93.59 173.92 7.45 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.841 -0.8 . . . . 75.2 108.841 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -66.33 -16.86 64.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.881 0.848 . . . . 71.42 109.571 178.405 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -79.72 -7.3 58.53 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.243 -0.889 . . . . 72.11 111.073 178.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.39 62.06 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.949 -0.644 . . . . 54.15 112.465 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -126.09 152.14 46.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.786 -0.82 . . . . 64.31 108.786 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.84 143.94 14.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 123.557 0.535 . . . . 73.54 109.683 -177.371 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.6 t -62.52 121.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.253 -1.018 . . . . 65.32 108.253 176.333 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -57.89 -39.69 78.51 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.471 0.708 . . . . 65.54 112.885 -173.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.9 t -93.07 3.18 56.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.206 0.447 . . . . 73.05 112.206 -176.395 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 8.4 tt -66.22 -45.07 60.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.026 1.121 . . . . 72.32 114.026 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.86 -21.62 34.03 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.123 2.549 . . . . 74.03 113.276 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.83 -41.3 99.13 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.171 -0.772 . . . . 51.54 111.171 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.15 -39.8 82.54 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.24 -0.652 . . . . 71.21 109.24 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.28 -43.85 98.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.367 -0.833 . . . . 62.24 109.903 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.3 m -57.76 -47.32 82.85 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.536 -0.756 . . . . 71.42 111.632 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -46.06 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.588 -0.278 . . . . 45.35 111.724 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.563 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -67.21 -37.99 84.55 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.571 0.952 . . . . 65.23 113.571 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -59.99 -44.99 94.16 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.004 0.43 . . . . 72.42 110.42 178.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.05 -27.34 63.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.064 -0.516 . . . . 73.12 110.987 178.43 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.96 -9.55 86.58 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.084 -0.507 . . . . 73.23 112.632 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.13 6.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.345 -0.455 . . . . 70.44 113.658 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -113.57 139.32 49.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.957 0.379 . . . . 74.41 111.331 177.762 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.497 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 14.3 ptp180 -89.93 172.07 9.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.604 -0.726 . . . . 75.24 110.716 -176.588 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.17 -45.4 72.1 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.429 1.491 . . . . 74.25 112.307 -176.408 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.0 m -64.63 -41.18 96.35 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.733 -0.667 . . . . 63.35 109.824 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.497 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 47.8 mt-10 -66.08 -38.75 89.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.602 -0.726 . . . . 64.13 111.058 -179.443 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 102' ' ' LEU . 30.0 mm -60.69 -47.24 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.689 -0.856 . . . . 74.13 108.689 -179.209 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.2 mtt -74.41 -18.42 60.66 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.836 -1.075 . . . . 63.22 113.095 -177.364 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -57.37 -64.33 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.24 0.543 . . . . 74.34 110.304 178.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.559 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 60.3 p-90 -69.62 -32.33 70.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 74.43 112.617 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.542 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.2 mt -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.572 0.953 . . . . 75.23 113.572 179.438 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.1 m-85 -98.61 10.76 40.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.303 0.482 . . . . 65.34 112.303 -177.729 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 101' ' ' TRP . 11.8 t -87.79 122.01 70.52 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 119.144 -1.022 . . . . 71.41 110.154 177.786 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.6 136.83 37.34 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.578 2.185 . . . . 71.51 110.956 177.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 14.7 t70 -106.93 112.7 63.21 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.79 -0.764 . . . . 73.15 109.472 178.101 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.09 -16.77 48.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.277 2.651 . . . . 61.53 114.596 -176.535 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -109.51 3.23 21.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.035 -0.416 . . . . 54.3 111.388 -177.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -102.62 125.27 49.29 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.43 0.633 . . . . 71.12 110.88 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.3 m -116.43 120.7 39.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.15 107.571 179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 123' ' ' ALA . 32.4 mt . . . . . 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 64.44 109.009 -173.281 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 107.946 -1.131 . . . . 75.13 107.946 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.8 p -86.92 141.14 28.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.202 -0.666 . . . . 63.13 109.202 177.265 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.2 t30 68.68 70.55 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.188 0.994 . . . . 55.0 110.315 -177.464 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.578 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -108.22 174.67 5.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.238 -0.892 . . . . 61.33 109.181 175.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.14 150.51 38.42 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 109.035 -0.728 . . . . 74.53 109.035 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.473 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.9 Cg_exo -52.7 -34.01 62.2 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.025 2.483 . . . . 64.1 112.544 173.296 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.3 t -64.08 -43.61 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 119.771 -0.772 . . . . 63.31 109.6 175.654 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.02 -30.8 70.13 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.886 -0.783 . . . . 71.01 108.886 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -66.02 -45.18 82.43 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.247 -0.888 . . . . 60.41 112.054 177.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.15 -33.48 73.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.161 0.505 . . . . 73.25 110.269 -179.167 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -66.33 -28.76 68.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.404 -0.961 . . . . 70.32 108.404 176.394 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.44 14.37 24.73 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.708 -1.133 . . . . 70.2 112.261 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 62.05 27.41 16.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.901 1.28 . . . . 63.52 111.885 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -110.64 24.69 12.64 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 123.772 1.749 . . . . 72.44 108.241 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.57 -26.31 12.97 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 111.389 -2.641 . . . . 70.14 113.495 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.52 -41.4 73.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.729 0.411 . . . . 72.3 110.875 -174.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.64 -35.6 77.5 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.454 0.645 . . . . 74.3 110.249 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.2 t -66.07 -42.42 91.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.053 -0.976 . . . . 74.52 109.754 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 98.6 t -61.49 -46.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 65.21 109.471 177.608 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -63.86 -38.96 93.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.117 0.484 . . . . 72.02 111.001 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -36.36 81.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.328 -0.99 . . . . 71.4 108.328 178.473 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.563 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -67.69 -46.37 72.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.559 0.744 . . . . 75.23 110.437 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 87.2 mt-30 -57.62 -49.5 76.24 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.046 -0.525 . . . . 73.34 109.851 178.359 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.71 -27.26 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.417 -0.811 . . . . 63.33 111.422 -178.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.559 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 14.9 tpt -77.45 -29.3 52.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.119 0.485 . . . . 72.24 110.171 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.21 -48.12 7.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.489 0.551 . . . . 54.24 112.489 -177.794 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 119.164 -0.446 . . . . 75.21 109.944 -176.499 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 108.155 -1.054 . . . . 70.0 108.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.89 100.46 1.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.738 1.625 . . . . 63.42 109.897 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.98 96.38 0.17 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.467 -0.873 . . . . 72.32 112.035 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.29 144.49 44.55 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.697 0.284 . . . . 72.43 110.78 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.43 122.72 58.67 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 109.363 -0.606 . . . . 61.31 109.363 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.84 41.92 1.0 Allowed 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.644 2.896 . . . . 74.03 112.242 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.28 64.38 0.43 Allowed Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 109.828 -1.309 . . . . 71.12 109.828 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 p -83.25 -34.6 25.78 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.648 0.737 . . . . 63.12 111.13 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.6 m -119.02 120.28 36.77 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.525 -0.761 . . . . 73.04 110.145 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.55 148.91 31.59 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.505 -0.771 . . . . 55.54 109.89 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.33 93.05 9.4 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.047 -0.723 . . . . 74.42 109.047 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -106.2 15.32 26.42 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.122 -0.945 . . . . 61.55 110.777 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.66 137.25 53.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.684 -1.144 . . . . 70.05 108.161 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.12 -162.77 30.5 Favored Glycine 0 N--CA 1.402 -3.584 0 N-CA-C 108.634 -1.787 . . . . 52.34 108.634 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 m -96.26 102.86 14.71 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 109.22 -0.659 . . . . 71.33 109.22 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.29 121.35 76.83 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.828 -1.175 . . . . 75.13 107.828 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.76 165.92 29.27 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.883 2.388 . . . . 73.2 112.802 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.95 123.81 29.69 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.974 -1.491 . . . . 73.12 106.974 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.11 -109.77 0.83 Allowed Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.675 -1.25 . . . . 24.11 114.395 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.56 121.35 29.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 70.05 112.539 -168.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.03 120.22 9.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.489 -1.232 . . . . 71.21 110.993 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.84 -40.22 13.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.663 -0.699 . . . . 73.32 111.049 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.66 157.21 37.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.957 -0.697 . . . . 73.32 110.965 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.14 141.55 70.92 Favored Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 73.44 108.346 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.95 -21.73 16.47 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.111 2.541 . . . . 65.24 115.011 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.79 -13.41 59.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.984 0.421 . . . . 73.34 110.823 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.3 137.18 71.78 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 109.296 -0.631 . . . . 71.02 109.296 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.36 131.83 37.65 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 123.938 3.092 . . . . 62.21 113.841 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -137.87 158.83 43.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.595 -0.73 . . . . 72.14 111.832 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 6.2 m-85 -109.5 160.15 16.47 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.339 1.855 . . . . 73.43 107.596 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -135.18 162.48 32.41 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.728 -1.953 . . . . 72.45 105.728 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.26 -54.34 39.43 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 113.239 0.829 . . . . 75.41 113.239 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.02 -36.7 96.15 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 121.807 1.671 . . . . 75.03 111.864 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 2.9 mpt_? -70.41 -37.61 74.47 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.373 -0.376 . . . . 71.12 111.856 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.35 -37.59 71.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 120.17 -0.612 . . . . 72.44 109.845 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.13 -41.7 84.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.662 -0.866 . . . . 63.42 108.662 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 37.0 mt-10 -63.12 -45.69 90.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.884 -1.053 . . . . 65.3 111.99 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.482 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 60.2 tp -61.49 -50.19 73.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.617 0.767 . . . . 54.42 112.153 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 41' ' ' VAL . 91.5 mt -89.09 -12.65 40.57 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.094 0.405 . . . . 65.03 112.094 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.17 27.75 65.57 Favored Glycine 0 C--N 1.316 -0.549 0 N-CA-C 111.212 -0.755 . . . . 75.44 111.212 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 39' ' ' LEU . 32.7 m -118.63 160.78 38.78 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.531 -0.544 . . . . 65.44 109.531 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 37.5 Cg_endo -68.7 160.29 50.14 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.138 1.892 . . . . 55.25 111.723 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.51 -34.5 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.563 0.745 . . . . 65.34 110.492 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -61.27 -39.0 88.77 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.292 -0.867 . . . . 62.43 111.695 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD3' ' HD2' ' A' ' 42' ' ' PRO . 26.3 mtpp -69.82 -33.92 72.98 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.815 -0.354 . . . . 72.03 111.258 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -44.43 98.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.852 -0.795 . . . . 74.14 108.852 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -63.01 -36.41 83.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.239 -0.892 . . . . 64.44 110.433 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 15.4 mm100 -62.01 -40.77 96.8 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-N 117.002 -0.09 . . . . 64.23 111.064 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -58.73 -44.49 90.47 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.464 0.649 . . . . 53.41 109.815 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.5 -38.94 91.86 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.598 -1.183 . . . . 64.11 110.394 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 47' ' ' ALA . 20.0 mmm180 -71.32 -26.56 62.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.374 -0.375 . . . . 70.13 111.673 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 74.7 mm-40 -89.72 -2.64 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.596 -0.275 . . . . 74.12 111.119 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 35.86 54.14 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.776 -0.726 . . . . 63.24 111.907 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -99.81 -17.68 17.55 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 120.63 0.252 . . . . 74.2 111.01 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.9 tp -152.71 160.98 43.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.217 -1.031 . . . . 63.43 108.217 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.65 147.32 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.553 -0.906 . . . . 62.12 108.553 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.48 150.93 51.72 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.228 -0.656 . . . . 61.02 109.228 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -129.85 166.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.03 0.532 . . . . 73.22 110.034 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 37.2 ttt180 -114.61 123.11 48.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.879 -0.415 . . . . 74.3 109.879 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 62' ' ' GLY . 8.8 ptm180 -116.64 114.07 23.56 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.723 -0.844 . . . . 72.1 108.723 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.03 -16.81 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.138 1.375 . . . . 73.51 113.369 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . 147.0 -18.93 1.58 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.713 -0.955 . . . . 41.54 110.713 -177.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -91.1 146.28 18.25 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 112.346 -0.302 . . . . 73.13 112.346 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.56 121.69 48.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.869 -0.789 . . . . 60.43 108.869 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.11 157.88 43.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.471 0.653 . . . . 51.0 111.659 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.52 122.22 23.7 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 107.144 -1.428 . . . . 70.33 107.144 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.54 132.36 50.04 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.152 1.901 . . . . 53.03 113.08 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -48.8 -38.52 22.27 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.818 0.847 . . . . 75.34 111.375 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 27.0 m -65.66 -11.1 11.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 114.592 1.33 . . . . 51.52 114.592 -174.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.597 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.6 m-85 -77.78 -12.87 60.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.699 0.761 . . . . 62.22 110.292 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.79 145.12 38.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 108.141 -1.059 . . . . 74.31 108.141 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.0 p -75.42 175.58 8.32 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.076 0.55 . . . . 73.33 110.421 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -65.85 -17.21 64.49 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 122.19 0.995 . . . . 71.13 109.863 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -90.15 -0.55 57.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.281 -0.872 . . . . 72.12 111.524 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 26.55 67.54 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.499 -0.382 . . . . 43.11 112.712 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -113.82 157.72 21.94 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.989 -1.115 . . . . 75.22 107.989 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.6 t -73.44 140.9 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.075 -1.083 . . . . 74.23 108.075 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 46.7 t -64.08 128.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.52 -0.919 . . . . 72.35 108.52 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -58.16 -43.9 87.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.342 0.867 . . . . 74.43 113.342 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 t -89.74 1.71 55.76 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 121.01 -0.276 . . . . 61.21 111.502 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.651 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 7.9 tt -65.99 -50.24 53.29 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 119.513 -0.279 . . . . 73.03 111.511 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.64 -24.58 75.92 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.464 1.443 . . . . 60.33 110.512 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.95 88.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.353 -0.84 . . . . 72.23 111.574 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -66.46 -39.78 89.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 108.021 -1.103 . . . . 62.43 108.021 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.52 -35.78 78.68 Favored 'General case' 0 C--O 1.202 -1.422 0 CA-C-N 115.44 -0.8 . . . . 72.31 110.652 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.4 m -59.46 -50.98 71.83 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.422 0.451 . . . . 72.12 111.263 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.97 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 116.268 -0.424 . . . . 72.44 111.36 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.3 mm? -66.72 -35.23 79.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.15 0.426 . . . . 64.05 112.15 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -64.37 -40.96 96.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.404 -0.591 . . . . 74.34 109.404 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.11 -30.14 68.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 74.33 110.067 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.88 -6.31 89.08 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.538 -0.755 . . . . 64.32 112.336 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.22 57.19 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 114.003 0.361 . . . . 70.12 114.003 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -90.87 129.11 36.95 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 122.168 -0.607 . . . . 75.44 112.099 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 8.0 ptp180 -78.02 171.8 14.46 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.159 -0.928 . . . . 75.21 110.802 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.26 -45.28 72.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.279 1.432 . . . . 61.12 111.848 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.9 m -61.8 -40.9 96.86 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.281 -0.872 . . . . 70.22 109.88 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 8.1 mm-40 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.766 -0.652 . . . . 74.51 110.713 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.96 -48.63 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.367 0.603 . . . . 71.01 109.578 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -74.86 -21.33 59.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.346 -0.843 . . . . 53.23 111.941 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -55.59 -64.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.121 0.568 . . . . 61.11 110.954 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -68.89 -32.52 72.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.03 0.443 . . . . 71.33 112.102 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -67.39 -37.83 83.76 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.584 -0.734 . . . . 52.55 112.429 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -93.39 -1.4 55.88 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 112.779 0.659 . . . . 74.24 112.779 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -87.29 116.96 67.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.575 -0.528 . . . . 72.34 109.575 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.64 128.72 22.96 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.81 1.673 . . . . 72.4 109.383 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 33.4 t70 -100.43 125.81 38.03 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 120.271 -0.572 . . . . 74.32 111.04 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.56 -30.43 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.111 2.541 . . . . 64.13 113.164 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 p -92.0 5.49 49.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.289 0.566 . . . . 71.44 111.48 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.3 tp -102.79 126.07 49.78 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.205 -0.665 . . . . 73.54 109.205 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.3 m -131.72 110.53 10.95 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.542 -1.281 . . . . 74.21 107.542 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt -134.24 164.97 32.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-N 115.292 -0.867 . . . . 63.35 109.922 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.0 t -87.31 140.69 29.28 Favored 'General case' 0 N--CA 1.407 -2.625 0 N-CA-C 107.097 -1.446 . . . . 72.53 107.097 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -73.15 136.33 44.78 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.981 -1.118 . . . . 64.54 107.981 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.54 126.35 27.23 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.169 0.509 . . . . 72.22 110.861 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.35 -18.08 55.92 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 111.044 -0.822 . . . . 72.53 111.044 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -111.96 -176.82 3.02 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 121.173 0.511 . . . . 53.3 109.769 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -115.07 -23.2 9.14 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 124.442 1.097 . . . . 72.32 108.69 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.05 156.45 27.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.869 -1.059 . . . . 73.25 112.132 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.2 140.54 33.2 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.16 -0.927 . . . . 72.33 110.605 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.01 119.92 57.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.918 -0.771 . . . . 63.34 108.918 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.6 t -86.51 139.04 31.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.441 -1.689 . . . . 73.14 106.441 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.6 t30 67.1 68.63 0.4 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.073 0.94 . . . . 74.0 109.146 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.77 162.81 21.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.648 -1.16 . . . . 53.31 109.581 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -75.4 130.83 78.9 Favored Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.592 0.557 . . . . 72.1 110.161 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 50.5 Cg_exo -55.49 -17.24 16.18 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 123.836 3.024 . . . . 74.21 113.351 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 65.8 t -59.73 -43.03 90.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.144 -0.48 . . . . 74.34 109.891 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -29.88 69.35 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 116.112 -0.495 . . . . 74.43 111.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.18 -52.64 57.95 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.943 -0.571 . . . . 72.21 109.541 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -68.02 -34.11 75.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 111.735 0.272 . . . . 74.03 111.735 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.61 -24.06 63.61 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.688 0.756 . . . . 70.44 109.196 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -104.45 16.47 26.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.965 -1.016 . . . . 71.03 110.833 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.5 m80 64.05 28.33 14.27 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.35 1.06 . . . . 71.42 113.344 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -99.73 23.11 10.04 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.796 -1.928 . . . . 70.05 105.796 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.31 -27.84 25.21 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 127.08 2.152 . . . . 62.31 114.658 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -56.49 -36.9 69.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.218 0.451 . . . . 75.14 112.218 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -67.76 -33.09 74.16 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.721 0.772 . . . . 72.43 109.664 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.1 t -72.01 -40.55 67.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.387 -0.824 . . . . 63.12 108.831 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.85 -44.22 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.086 -0.709 . . . . 73.33 109.086 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -57.87 -47.13 83.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.65 -0.705 . . . . 72.15 110.495 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -65.82 -34.29 77.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.726 -0.67 . . . . 73.03 109.787 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -66.57 -46.29 76.5 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.474 -0.784 . . . . 73.14 109.61 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.78 -48.19 82.67 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.292 -0.867 . . . . 72.33 110.483 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.12 -29.8 71.08 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.286 0.366 . . . . 43.11 111.59 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.23 -34.07 70.45 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.286 -0.416 . . . . 65.21 110.925 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.9 -58.75 1.93 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.938 1.088 . . . . 72.41 113.938 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.314 -0.941 0 CA-C-O 119.072 -0.49 . . . . 65.05 110.743 -174.922 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 C--O 1.238 0.464 0 N-CA-C 110.22 -0.289 . . . . 74.32 110.22 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.32 -9.09 7.25 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.488 2.125 . . . . 51.55 112.16 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.45 -114.09 3.64 Favored Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.163 -0.775 . . . . 44.44 111.163 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -68.73 142.65 54.92 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 120.949 0.404 . . . . 71.15 111.15 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.0 149.45 11.69 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.6 -0.889 . . . . 62.34 108.6 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.86 -171.94 0.87 Allowed 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 122.23 1.953 . . . . 71.21 111.337 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.71 130.23 2.18 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 119.784 -1.198 . . . . 71.13 111.93 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m -75.31 119.45 19.44 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.992 -1.484 . . . . 74.21 106.992 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -81.23 174.26 11.71 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.859 0.361 . . . . 60.22 111.162 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.3 mt -88.14 154.23 20.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.985 -0.552 . . . . 74.32 110.791 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.13 104.61 10.61 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.026 0.441 . . . . 71.3 110.351 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -87.11 95.03 9.81 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.539 0.685 . . . . 73.52 111.817 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 m -111.72 82.87 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 122.395 1.093 . . . . 71.24 110.061 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.47 61.61 1.22 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.894 -1.048 . . . . 75.43 111.21 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 2.4 p -73.78 125.1 27.37 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 121.197 0.522 . . . . 74.24 111.528 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.9 121.4 68.09 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 107.24 -1.393 . . . . 72.14 107.24 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.31 150.23 81.36 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.501 2.134 . . . . 73.42 110.885 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.03 132.83 35.12 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.366 -0.605 . . . . 72.14 109.366 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.4 -120.93 4.62 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 115.998 -0.546 . . . . 61.3 112.847 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -119.91 142.2 48.92 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.8 0.333 . . . . 73.23 110.495 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.92 137.65 51.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.991 -0.549 . . . . 74.43 111.305 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.608 HG11 ' HA ' ' A' ' 100' ' ' ARG . 21.8 t -115.45 -13.69 11.1 Favored 'Isoleucine or valine' 0 C--O 1.248 0.978 0 CA-C-O 122.195 0.997 . . . . 61.23 109.866 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -78.36 175.97 9.77 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.804 -1.184 . . . . 64.04 107.804 172.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 12.4 t70 -86.01 129.52 53.81 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 117.309 -1.756 . . . . 63.51 106.355 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.64 -21.19 7.51 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.215 2.61 . . . . 73.53 113.972 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.34 -21.19 46.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.032 0.382 . . . . 72.31 112.032 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HG3' ' HB3' ' A' ' 24' ' ' ASP . 38.9 mt-10 -66.1 153.61 91.6 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 122.244 -0.285 . . . . 74.54 110.799 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.52 113.67 1.33 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.353 2.702 . . . . 61.02 113.666 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.7 p -126.4 -179.97 5.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 115.504 -0.771 . . . . 25.21 110.236 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' CE2' HD22 ' A' ' 38' ' ' LEU . 40.8 m-85 -130.33 161.03 32.2 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.648 -1.612 . . . . 70.05 106.648 170.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.7 m-20 -133.01 162.88 30.51 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 103.662 -2.718 . . . . 65.34 103.662 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -43.28 -56.04 7.23 Favored Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 114.501 1.297 . . . . 71.22 114.501 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.67 -36.54 51.93 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.381 1.387 . . . . 64.32 111.857 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 1.4 tpt180 -70.54 -34.4 72.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.053 -0.521 . . . . 71.4 110.951 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 31' ' ' ASP . 60.7 t -69.24 -41.75 81.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 108.867 -0.79 . . . . 62.45 108.867 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.31 83.19 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.661 -1.154 . . . . 70.41 109.385 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.09 -46.35 84.65 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.315 -0.857 . . . . 72.32 110.627 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 30' ' ' TYR . 29.3 tp -65.33 -47.26 77.14 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.425 -0.807 . . . . 65.41 111.268 -175.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 41' ' ' VAL . 96.6 mt -81.56 -17.46 48.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 72.24 111.688 -177.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.16 29.47 60.39 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.873 -0.891 . . . . 62.12 110.873 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 39' ' ' LEU . 32.7 m -121.68 164.14 26.65 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.541 -0.54 . . . . 70.12 109.541 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.27 165.47 27.72 Favored 'Trans proline' 0 C--O 1.264 1.821 0 C-N-CA 121.512 1.475 . . . . 75.41 110.875 172.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.49 -32.51 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.259 0.624 . . . . 73.23 110.408 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -57.06 -43.68 82.29 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.965 -0.561 . . . . 42.2 110.823 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 29.7 mtpp -69.49 -32.47 71.36 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 120.041 -0.664 . . . . 72.1 111.039 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.41 -42.05 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.31 -0.626 . . . . 75.34 109.31 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -62.63 -37.23 85.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.696 . . . . 54.23 109.787 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.7 -35.93 81.29 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.074 -0.512 . . . . 33.11 111.64 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.4 mm100 -58.42 -46.25 86.86 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 108.086 -1.079 . . . . 75.53 108.086 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 15' ' ' SER . 4.4 mm? -62.67 -38.92 92.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.135 -1.393 . . . . 64.53 110.979 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' A' ' 15' ' ' SER . 97.9 mtt180 -71.05 -22.0 62.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.129 0.572 . . . . 72.55 112.289 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -85.11 -13.42 50.3 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.418 -0.513 . . . . 75.12 109.708 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.94 26.32 73.99 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.781 -1.328 . . . . 52.32 109.781 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -98.38 -9.13 25.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.551 0.691 . . . . 75.42 109.244 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.1 tp -158.21 152.55 24.4 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.932 -1.877 . . . . 53.15 105.932 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.27 158.03 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 120.213 -0.595 . . . . 72.4 109.49 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.0 162.04 29.59 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 122.71 0.404 . . . . 52.33 110.008 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 99' ' ' MET . 13.4 m -132.63 167.53 26.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 124.121 0.968 . . . . 74.2 109.141 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 75.4 mtm180 -109.9 139.27 45.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.683 -0.488 . . . . 74.42 109.683 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' NE ' HG11 ' A' ' 65' ' ' VAL . 36.7 ptt180 -128.41 120.05 26.17 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.509 -1.293 . . . . 71.35 107.509 173.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.1 16.9 8.66 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.864 0.866 . . . . 60.23 111.877 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.26 -7.31 54.2 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.991 -0.55 . . . . 52.22 112.55 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -95.61 151.83 20.13 Favored Glycine 0 CA--C 1.493 -1.31 0 N-CA-C 111.624 -0.591 . . . . 74.14 111.624 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.2 t -96.46 120.91 46.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.357 -0.979 . . . . 73.22 108.357 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.446 HG11 ' NE ' ' A' ' 60' ' ' ARG . 15.3 m -134.45 160.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.255 -0.884 . . . . 64.3 111.452 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.33 128.87 23.99 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 106.935 -1.505 . . . . 74.32 106.935 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.21 133.99 56.38 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.03 1.82 . . . . 62.24 111.622 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -63.05 -25.27 68.3 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 121.709 0.766 . . . . 45.44 111.312 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.31 -5.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.836 -1.075 . . . . 75.5 112.076 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.63 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.6 m-85 -87.7 -3.85 58.94 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.7 0.762 . . . . 71.11 110.211 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.16 148.54 43.51 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.395 -0.821 . . . . 75.2 109.179 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -83.64 174.98 10.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.884 -0.598 . . . . 74.14 109.602 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.66 -17.94 64.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.674 0.75 . . . . 70.04 109.171 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -79.52 -7.11 58.25 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.267 -0.879 . . . . 54.1 110.597 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.52 27.54 59.09 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.085 -0.578 . . . . 73.13 111.697 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -123.03 166.03 15.79 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.384 -0.599 . . . . 72.42 109.384 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.0 t -75.92 142.16 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.156 -1.053 . . . . 73.03 108.156 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 25.8 t -62.62 130.79 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 107.914 -1.143 . . . . 75.43 107.914 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -65.29 -24.5 67.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.066 1.135 . . . . 75.12 114.066 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 p -92.84 -2.05 56.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.206 0.526 . . . . 72.31 111.967 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.63 HD11 ' CD2' ' A' ' 70' ' ' PHE . 7.8 tt -65.42 -50.37 58.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-N 115.786 -0.643 . . . . 73.15 112.115 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.78 -29.52 86.17 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.34 1.36 . . . . 53.3 111.358 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.89 -44.33 94.77 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.954 -0.567 . . . . 63.03 111.946 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.01 -40.03 87.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.445 -0.576 . . . . 73.12 109.445 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.6 -37.9 89.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.933 -0.576 . . . . 70.34 110.527 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.8 m -67.39 -43.34 81.59 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 115.844 -0.616 . . . . 72.05 111.831 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -42.0 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.903 -0.319 . . . . 73.12 110.663 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.414 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.4 mm? -66.7 -34.57 78.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.167 0.432 . . . . 65.51 112.167 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -59.67 -35.15 73.86 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.021 -0.733 . . . . 72.33 109.021 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.04 -31.34 72.16 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.293 0.568 . . . . 74.23 110.371 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -9.26 75.91 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.623 -0.717 . . . . 74.25 112.34 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.17 35.24 34.72 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.296 -0.478 . . . . 72.34 112.401 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.16 132.8 42.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.928 0.394 . . . . 73.41 110.983 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -83.35 171.54 13.41 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.507 -0.77 . . . . 71.42 109.629 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 99' ' ' MET . 9.1 p-10 -53.95 -40.99 67.29 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.687 1.595 . . . . 71.13 112.107 -176.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -61.86 -41.25 97.61 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.238 0.615 . . . . 74.2 110.365 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 6.7 mm-40 -66.38 -36.5 83.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.152 -0.476 . . . . 72.11 109.897 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.7 mm -62.07 -47.77 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.842 -0.799 . . . . 71.15 108.842 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 23.9 mmt -69.15 -23.61 63.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.832 -1.077 . . . . 75.4 110.412 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.608 ' HA ' HG11 ' A' ' 22' ' ' VAL . 80.4 ttt180 -58.9 -63.43 1.3 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.618 -0.719 . . . . 52.34 110.773 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.504 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.5 p-90 -69.65 -35.34 75.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.069 0.766 . . . . 63.43 113.069 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 126' ' ' VAL . 11.2 mt -57.77 -41.39 81.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.889 1.07 . . . . 52.54 113.889 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 96.8 m-85 -97.45 -6.04 34.75 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.311 0.856 . . . . 75.31 113.311 -174.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.8 m -87.29 121.24 71.41 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.208 0.317 . . . . 74.21 110.219 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 33.8 Cg_exo -63.99 128.91 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.737 1.625 . . . . 54.45 108.931 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 26.3 t70 -105.45 120.45 49.44 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 120.209 -0.596 . . . . 74.14 110.735 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.8 -22.72 74.6 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 123.332 2.688 . . . . 70.3 113.445 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 m -97.65 2.9 50.32 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.17 0.509 . . . . 72.13 110.109 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HG ' HG12 ' A' ' 111' ' ' ILE . 48.4 tp -109.77 128.69 55.46 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.109 -0.7 . . . . 72.0 109.109 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.487 HG22 ' HB1' ' A' ' 119' ' ' ALA . 30.9 m -130.61 113.17 13.87 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.188 -1.041 . . . . 72.25 108.188 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.4 HG12 ' HG ' ' A' ' 109' ' ' LEU . 36.9 mm -119.47 148.78 22.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.993 -0.549 . . . . 72.14 110.75 -172.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 19.1 p -89.79 132.62 35.14 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.106 -1.072 . . . . 62.4 108.106 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -82.41 152.06 26.34 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.528 -0.469 . . . . 74.02 109.785 -174.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.14 115.45 4.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.327 -0.397 . . . . 64.14 110.204 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.53 19.7 47.74 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 111.441 -0.663 . . . . 51.22 111.441 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.9 m -143.1 131.71 22.47 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.368 -0.605 . . . . 71.04 109.368 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -84.01 -22.23 31.4 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 120.873 0.368 . . . . 71.51 110.636 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.62 148.81 38.48 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 115.575 -0.739 . . . . 71.33 110.229 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.487 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -107.48 141.72 38.47 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.881 -0.6 . . . . 45.02 111.017 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 50.0 t -107.19 126.59 63.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.418 -0.956 . . . . 74.31 108.418 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -82.27 154.82 25.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.755 -1.572 . . . . 72.45 106.755 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 16.2 m120 69.26 36.02 2.47 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.434 0.694 . . . . 52.52 110.354 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.11 152.12 29.45 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.211 -1.033 . . . . 74.13 108.211 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -87.71 142.14 32.41 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 105.34 -2.096 . . . . 73.23 105.34 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.503 ' HB2' HD23 ' A' ' 102' ' ' LEU . 92.8 Cg_exo -51.72 -27.35 26.21 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.273 1.982 . . . . 64.41 111.695 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.641 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 93.8 t -62.82 -43.06 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.814 -0.63 . . . . 72.24 110.73 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -60.04 -37.85 81.01 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.433 0.635 . . . . 64.4 109.461 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.78 82.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.285 -1.325 . . . . 62.41 112.194 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -69.23 -38.69 78.63 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.168 -0.613 . . . . 63.35 111.234 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.36 -23.41 63.75 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.614 0.721 . . . . 75.21 109.716 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.55 7.05 44.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.289 -0.869 . . . . 74.53 111.075 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.3 m80 59.51 28.81 18.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 122.144 0.973 . . . . 61.33 112.578 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.13 22.98 6.94 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.253 -1.388 . . . . 74.24 107.253 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.43 -28.81 32.04 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.738 1.615 . . . . 65.54 112.712 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -56.26 -43.14 78.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.373 -0.603 . . . . 74.24 109.373 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -73.67 -30.55 62.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.328 -0.851 . . . . 71.13 110.608 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -63.77 -45.25 97.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.838 -0.801 . . . . 75.51 108.838 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.1 t -62.99 -42.12 95.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 70.02 109.7 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.17 -45.6 83.53 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.023 -0.535 . . . . 71.14 110.025 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.2 mmt85 -68.86 -37.06 78.83 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.044 -0.525 . . . . 73.14 111.362 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.47 -44.04 93.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.083 0.553 . . . . 73.41 109.903 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -64.7 -38.4 90.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 72.34 110.323 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.86 -17.77 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.0 -0.546 . . . . 54.1 111.664 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 94.1 mmm -87.6 -29.81 20.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.22 0.533 . . . . 74.4 110.253 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.96 -44.56 14.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.177 -0.465 . . . . 71.3 111.042 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 108.075 -1.083 . . . . 63.43 108.075 -178.745 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.7 mmm . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 107.89 -1.152 . . . . 70.03 107.89 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.79 119.93 6.88 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.691 1.594 . . . . 44.24 109.754 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.97 57.46 3.56 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.431 -0.414 . . . . 53.24 113.487 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -74.83 144.72 43.32 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.555 0.742 . . . . 75.14 110.169 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.87 95.19 36.72 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 107.943 -1.132 . . . . 63.41 107.943 173.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.63 107.11 0.47 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.2 2.6 . . . . 74.24 114.219 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.14 21.44 10.94 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 108.025 -2.03 . . . . 71.43 108.025 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -58.76 113.87 2.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 113.415 -1.392 . . . . 70.31 110.247 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 m -116.92 140.78 49.05 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.197 -1.779 . . . . 62.24 106.197 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.87 96.5 1.28 Allowed 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.801 0.81 . . . . 61.02 111.159 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.3 143.82 29.12 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.063 -1.426 . . . . 74.43 109.225 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -84.63 89.02 7.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.282 1.039 . . . . 70.53 110.176 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.66 25.33 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 123.218 1.485 . . . . 71.51 108.239 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.47 48.1 3.71 Favored Glycine 0 C--N 1.309 -0.967 0 CA-C-N 114.276 -1.329 . . . . 73.02 112.508 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.3 m -88.8 51.32 2.14 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.608 0.718 . . . . 73.13 110.753 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.6 133.81 24.37 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 106.205 -1.776 . . . . 75.21 106.205 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.33 133.95 36.99 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 120.989 1.126 . . . . 72.05 110.59 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.93 145.5 50.96 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.894 -0.594 . . . . 43.23 109.958 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.38 -128.15 5.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.41 -0.9 . . . . 71.33 112.377 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 96' ' ' THR . 29.9 t70 -109.68 146.41 34.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.121 -0.696 . . . . 73.31 109.121 -174.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -86.06 125.37 33.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.449 0.642 . . . . 75.11 112.259 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.3 t -97.2 -31.17 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.33 -0.395 . . . . 75.53 111.457 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.494 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -69.77 171.72 8.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.011 0.745 . . . . 74.02 113.011 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.504 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 10.0 t70 -85.32 139.81 36.33 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 116.508 -0.314 . . . . 63.32 110.495 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.9 -24.6 14.02 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.066 3.177 . . . . 75.14 115.217 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.84 -25.18 28.24 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.134 -0.354 . . . . 74.41 111.568 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 24' ' ' ASP . 45.9 mt-10 -62.78 132.81 94.87 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 116.523 -0.308 . . . . 64.31 110.994 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.93 141.47 77.74 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 123.175 2.583 . . . . 75.11 113.137 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -136.68 173.95 11.15 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.019 -0.991 . . . . 72.2 110.697 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -124.83 159.26 31.45 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.711 -1.589 . . . . 74.14 106.711 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 6.9 p-10 -137.04 173.84 11.26 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.334 -1.728 . . . . 74.23 106.334 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -37.32 -60.95 0.77 Allowed Pre-proline 0 CA--C 1.563 1.478 0 N-CA-C 115.45 1.648 . . . . 73.02 115.45 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.82 -33.81 32.77 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.216 1.277 . . . . 72.32 112.888 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 9.5 tpt180 -70.25 -35.12 73.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.627 0.251 . . . . 65.23 110.916 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 31' ' ' ASP . 62.0 t -69.2 -41.26 81.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.959 -0.756 . . . . 54.2 108.959 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.88 88.28 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 114.905 -1.043 . . . . 63.24 109.679 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.86 -45.49 92.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.131 1.372 . . . . 73.34 109.742 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.75 -50.1 39.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.608 -0.724 . . . . 64.05 112.382 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.04 -18.89 41.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.308 -0.406 . . . . 75.3 111.953 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.95 27.88 57.58 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.099 -0.801 . . . . 73.43 111.099 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -121.41 159.7 49.08 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 108.505 -0.924 . . . . 74.13 108.505 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.77 156.01 64.41 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 121.523 1.482 . . . . 74.41 112.819 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.42 -37.4 63.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.467 -0.788 . . . . 74.03 111.181 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.1 t -62.19 -35.92 80.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.13 -0.486 . . . . 71.4 110.509 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 53.7 tttp -65.75 -40.64 92.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.133 -1.062 . . . . 71.25 108.133 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.76 -41.26 87.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.404 -0.816 . . . . 75.52 110.333 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.86 88.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.902 -0.59 . . . . 12.41 110.243 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 1.4 mp0 -68.45 -41.61 79.99 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.764 -0.653 . . . . 73.13 112.051 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.717 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.2 mm100 -58.09 -46.06 86.12 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.848 -0.797 . . . . 74.02 108.848 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD23 ' HG ' ' A' ' 55' ' ' LEU . 76.9 mt -61.93 -44.23 97.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.99 -1.005 . . . . 54.55 111.447 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -70.95 -21.62 62.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.672 0.619 . . . . 75.24 112.672 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 52.5 mt-10 -87.64 -6.62 58.18 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.654 -0.418 . . . . 62.52 110.898 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.86 39.09 21.69 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.594 -0.812 . . . . 51.44 111.107 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -86.3 -30.0 22.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.862 -1.162 . . . . 74.32 107.862 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.444 ' HG ' HD23 ' A' ' 50' ' ' LEU . 1.6 pt? -160.82 167.62 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.667 -1.605 . . . . 75.21 106.667 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.42 161.46 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 118.758 0.708 . . . . 61.4 112.084 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.05 51.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.332 -0.849 . . . . 41.32 110.242 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.42 HG11 ' SD ' ' A' ' 99' ' ' MET . 18.0 m -130.79 162.55 38.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 O-C-N 123.528 0.517 . . . . 71.35 109.82 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -110.42 118.02 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.859 -0.423 . . . . 34.54 109.859 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -124.56 123.83 40.93 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.891 -0.411 . . . . 54.4 109.891 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.89 16.77 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.032 0.933 . . . . 64.03 110.656 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.43 -15.5 62.83 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.602 -0.726 . . . . 65.11 113.05 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.22 137.85 13.83 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.021 -0.831 . . . . 64.31 111.021 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.79 120.77 46.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.55 0.69 . . . . 75.24 109.169 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.06 159.32 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.069 -0.969 . . . . 60.44 112.172 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.3 mm -111.1 132.02 21.9 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 125.937 1.695 . . . . 74.42 106.803 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.69 119.31 6.33 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.981 1.787 . . . . 74.5 111.672 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -62.95 -25.48 68.37 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.572 0.701 . . . . 74.33 111.556 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 m -70.81 -5.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.413 -0.812 . . . . 73.55 112.451 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -86.13 -4.12 59.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.859 0.837 . . . . 65.41 109.653 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -111.12 160.14 17.18 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.037 -0.983 . . . . 63.14 108.397 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 p -84.06 166.27 17.85 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.247 -1.019 . . . . 73.11 108.247 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -67.53 -16.55 64.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.935 0.874 . . . . 74.32 109.609 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 m -78.76 -11.38 59.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.503 -0.771 . . . . 54.22 111.063 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.05 62.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.572 -0.823 . . . . 72.43 112.536 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -104.98 147.87 27.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.015 -0.365 . . . . 64.45 110.015 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.5 t -63.12 136.05 26.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.457 -0.942 . . . . 74.41 108.457 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.92 133.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.737 -0.468 . . . . 64.13 109.737 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -54.61 -26.29 31.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.393 1.257 . . . . 53.51 114.393 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.7 t -114.62 19.37 16.1 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.342 -0.543 . . . . 53.23 110.849 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 17.6 tp -63.95 -55.69 30.69 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 116.44 -0.346 . . . . 74.32 111.326 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.21 -28.55 87.14 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.887 1.725 . . . . 73.13 111.75 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.82 -44.81 94.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.889 -0.596 . . . . 71.53 112.2 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.18 -40.53 82.21 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 109.395 -0.594 . . . . 73.03 109.395 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.37 -44.51 97.03 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.718 -0.674 . . . . 74.24 110.634 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.7 m -61.41 -37.02 81.98 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.706 1.002 . . . . 52.14 113.706 -176.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.469 HG23 HD22 ' A' ' 88' ' ' LEU 0.25 0.0 OUTLIER -68.17 -45.04 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 119.567 -0.853 . . . . 75.33 110.755 179.485 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 87' ' ' ILE . 3.2 mm? -67.75 -35.56 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.008 0.433 . . . . 73.42 111.189 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -60.4 -39.54 87.7 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.744 0.818 . . . . 74.5 109.28 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.65 -30.6 70.19 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.728 0.775 . . . . 71.33 109.928 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.4 -3.05 89.9 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.065 -0.971 . . . . 54.13 112.053 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.89 22.46 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.895 -0.193 . . . . 54.45 113.155 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 93.7 m-85 -87.16 136.57 32.88 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 122.37 -0.488 . . . . 72.41 111.07 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 37.4 ptt180 -78.06 170.57 16.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.791 -0.641 . . . . 72.31 110.655 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -54.27 -41.01 68.36 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.946 1.298 . . . . 61.14 111.822 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' ASP . 23.4 m -61.74 -42.57 99.14 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.282 -0.872 . . . . 62.41 111.02 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.577 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 9.1 mm-40 -67.05 -33.49 75.63 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.141 -0.481 . . . . 74.24 110.965 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.2 mm -61.65 -49.05 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 108.211 -1.033 . . . . 70.33 108.211 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.592 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 10.9 ptp -74.84 -14.14 60.64 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.387 -0.824 . . . . 62.43 112.935 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 71.7 ttt180 -58.83 -65.62 0.63 Allowed 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.616 0.572 . . . . 72.21 109.944 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.535 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 46.0 p-90 -69.12 -32.92 72.65 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.236 0.458 . . . . 73.42 112.236 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 11.0 mt -58.93 -40.48 84.73 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.517 0.932 . . . . 75.02 113.517 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 73.0 m-85 -93.22 -2.5 55.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.406 0.521 . . . . 73.21 112.406 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -88.51 117.51 68.43 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 109.07 -0.715 . . . . 54.13 109.07 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 139.96 51.47 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.305 2.003 . . . . 75.41 113.208 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 17.5 t70 -98.26 119.9 60.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.645 -0.872 . . . . 61.14 108.645 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.08 -22.91 71.57 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.149 2.566 . . . . 73.2 114.016 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 p -104.0 5.63 35.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.036 0.384 . . . . 50.51 112.036 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.3 tp -105.12 135.28 46.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.053 -0.351 . . . . 61.0 110.053 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.6 m -118.53 116.9 27.62 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.04 108.286 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.5 mt -125.37 150.12 30.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.128 -0.693 . . . . 71.34 109.128 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.8 p -105.84 126.29 51.99 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.576 -1.639 . . . . 34.51 106.576 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -80.72 123.61 28.34 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.63 -1.228 . . . . 73.21 109.371 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 25.3 t70 -57.71 124.76 20.24 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.212 -0.904 . . . . 75.02 112.355 -172.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.29 -25.97 8.44 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 108.546 -1.822 . . . . 54.43 108.546 -174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.1 t -120.17 140.75 50.65 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 107.49 -1.3 . . . . 44.44 107.49 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -91.61 -4.88 54.79 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.648 -0.821 . . . . 73.33 109.667 176.086 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.04 134.79 43.03 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.039 -0.982 . . . . 75.04 109.955 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.53 144.13 25.84 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.125 -0.943 . . . . 62.45 111.773 -173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.53 118.56 59.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.937 -1.135 . . . . 72.44 107.937 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.3 m -89.85 131.34 35.83 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.357 -1.72 . . . . 53.21 106.357 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.0 t30 75.46 69.06 0.08 Allowed 'General case' 0 C--N 1.321 -0.672 0 O-C-N 124.564 1.165 . . . . 73.41 108.235 -172.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.49 163.72 15.98 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.696 -1.138 . . . . 65.23 109.539 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 39.5 ptt180 -88.08 141.1 30.97 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.568 -0.742 . . . . 74.1 109.672 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB2' HD23 ' A' ' 102' ' ' LEU . 50.7 Cg_exo -55.17 -18.11 16.97 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.083 2.522 . . . . 75.22 114.228 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -61.03 -42.85 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.444 0.64 . . . . 64.33 109.493 173.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.61 -30.75 71.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.276 -0.874 . . . . 71.4 109.619 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.72 -50.34 65.18 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.734 -0.667 . . . . 73.12 110.556 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -63.99 -36.76 85.05 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 60.24 110.871 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -68.68 -24.7 64.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.38 -0.827 . . . . 63.41 109.54 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -102.53 12.78 35.96 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.406 -0.816 . . . . 75.35 112.85 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 70.02 27.87 4.26 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.638 1.209 . . . . 73.5 110.866 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -105.56 23.96 12.98 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.967 0.907 . . . . 63.43 109.028 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.12 -29.06 28.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.479 1.511 . . . . 63.3 113.817 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -56.7 -40.14 75.09 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.806 0.336 . . . . 71.45 110.752 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -73.12 -24.82 60.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.981 0.419 . . . . 74.32 110.967 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 129' ' ' LEU . 57.7 t -70.84 -42.0 77.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 62.52 108.478 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.27 -42.23 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.44 -0.578 . . . . 70.31 109.44 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -59.5 -47.09 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.619 -0.719 . . . . 74.32 109.697 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.4 tpp180 -64.6 -39.65 94.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.371 -0.831 . . . . 73.02 110.005 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.62 87.36 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.564 0.746 . . . . 72.14 110.832 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.98 -39.02 93.19 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.281 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -21.25 66.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.18 -0.464 . . . . 70.54 111.333 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 85.4 mmm -92.71 -22.49 19.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.022 0.439 . . . . 53.2 110.986 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.83 -27.68 19.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.976 0.417 . . . . 64.2 111.062 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 108.022 -1.103 . . . . 73.11 108.022 178.024 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 ttm . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 109.296 -0.631 . . . . 73.54 109.296 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -82.17 130.17 6.29 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.469 1.446 . . . . 52.24 111.269 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.95 98.56 0.98 Allowed Glycine 0 CA--C 1.504 -0.607 0 N-CA-C 109.339 -1.504 . . . . 74.1 109.339 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -73.5 143.77 46.44 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.349 0.87 . . . . 75.15 113.349 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.57 89.31 3.84 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 106.559 -1.645 . . . . 73.4 106.559 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.42 97.81 0.32 Allowed 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.707 2.271 . . . . 71.21 112.071 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.8 113.16 2.57 Favored Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 115.202 -0.908 . . . . 63.44 111.73 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 t -76.32 97.51 4.24 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.391 -1.337 . . . . 61.3 107.391 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -74.82 148.28 40.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.478 -0.783 . . . . 72.02 111.845 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.97 177.87 4.5 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.181 -1.044 . . . . 74.12 108.181 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.39 109.41 19.53 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.171 0.51 . . . . 61.51 109.762 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.79 97.66 10.57 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.493 0.663 . . . . 75.41 110.543 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.46 146.9 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 107.671 -1.233 . . . . 63.24 107.671 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.05 -64.79 1.45 Allowed Glycine 0 C--N 1.286 -2.223 0 N-CA-C 110.015 -1.234 . . . . 53.54 110.015 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 t 178.33 159.31 0.52 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 104.721 -2.326 . . . . 52.43 104.721 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.405 HG21 HG12 ' A' ' 56' ' ' VAL . 1.9 mp -88.31 121.05 70.59 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.678 -1.601 . . . . 72.24 106.678 173.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.21 165.54 29.33 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.858 2.372 . . . . 71.31 112.875 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.24 124.24 47.48 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.052 -1.092 . . . . 64.32 108.052 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.15 -110.27 3.45 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.684 -0.769 . . . . 70.13 113.411 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -110.76 133.56 53.24 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.043 0.386 . . . . 72.01 112.043 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.1 114.97 13.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.313 -0.995 . . . . 64.14 108.313 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.64 -8.61 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 112.409 0.522 . . . . 73.2 112.409 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 -173.11 2.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.772 -1.205 . . . . 74.31 113.936 -175.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -96.5 132.47 26.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.843 -1.169 . . . . 73.31 107.843 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.16 -20.73 32.34 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.452 2.768 . . . . 64.15 111.8 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.334 -0.848 . . . . 61.11 109.823 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -68.0 134.09 91.85 Favored Pre-proline 0 C--O 1.244 0.796 0 N-CA-C 109.365 -0.605 . . . . 65.0 109.365 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.22 128.1 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.57 2.18 . . . . 74.13 111.257 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.3 m -130.16 158.52 39.46 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.47 -0.567 . . . . 61.52 109.47 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -116.48 162.4 17.63 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.521 1.129 . . . . 72.0 109.965 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -134.06 167.25 20.97 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.381 -2.451 . . . . 62.33 104.381 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -48.45 -55.03 21.01 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 114.712 1.375 . . . . 72.33 114.712 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.44 -46.39 33.79 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.118 1.879 . . . . 73.53 112.11 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 28.0 tpt180 -65.29 -39.04 92.04 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 112.485 0.55 . . . . 71.13 112.485 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.41 HG21 HD12 ' A' ' 66' ' ' ILE . 77.7 t -69.12 -40.53 80.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.164 -0.614 . . . . 72.44 110.239 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.03 -39.52 92.6 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.206 -0.906 . . . . 70.53 108.978 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.59 -44.95 85.06 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.494 -1.23 . . . . 74.14 111.105 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 95.6 mt -62.25 -47.45 84.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.482 0.658 . . . . 70.43 111.572 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.439 ' HB2' HG22 ' A' ' 41' ' ' VAL . 88.2 mt -82.77 -18.44 40.64 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.744 -0.662 . . . . 61.31 111.972 -175.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 27.36 60.78 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 110.592 -1.003 . . . . 74.52 110.592 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 39' ' ' LEU . 25.5 m -118.31 159.38 43.7 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 108.564 -0.902 . . . . 74.3 108.564 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.78 161.75 38.74 Favored 'Trans proline' 0 C--O 1.262 1.719 0 C-N-CA 121.149 1.232 . . . . 60.25 110.744 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.7 -33.85 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 115.88 -0.6 . . . . 72.11 109.92 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.6 m -57.66 -41.27 81.14 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.093 -0.958 . . . . 74.23 111.73 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 26.5 mtpp -69.77 -32.59 71.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.27 -0.572 . . . . 70.12 110.929 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 61.0 t -62.27 -42.27 94.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.68 . . . . 72.04 109.165 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.96 83.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.83 -0.623 . . . . 60.25 110.311 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -66.36 -37.32 85.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.24 -0.437 . . . . 55.22 110.67 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 46.9 mt-30 -63.19 -46.4 87.25 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.938 -0.393 . . . . 73.15 109.938 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 93.8 mt -61.67 -38.43 87.72 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.54 -1.209 . . . . 54.0 110.03 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -61.63 -44.41 97.04 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.164 0.986 . . . . 55.04 112.507 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.59 -11.8 33.38 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.419 -0.512 . . . . 70.12 112.364 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.92 35.53 18.41 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.34 -0.933 . . . . 44.33 111.049 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -92.5 -18.55 23.03 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.154 -1.054 . . . . 75.31 108.154 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -159.88 152.45 21.19 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.751 -1.944 . . . . 72.13 105.751 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG12 HG21 ' A' ' 16' ' ' ILE . 35.5 m -129.86 161.67 39.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.568 -0.53 . . . . 74.21 109.568 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.22 161.66 35.58 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.119 -0.697 . . . . 74.45 109.119 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.55 166.16 30.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.397 -0.594 . . . . 75.11 109.397 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 45.0 ttt180 -121.49 130.48 53.58 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.383 -0.527 . . . . 70.13 110.068 -175.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -125.56 117.31 23.31 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.602 -0.888 . . . . 63.22 108.602 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 20.47 8.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.597 0.759 . . . . 63.22 112.748 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.73 -17.14 30.64 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.068 -0.587 . . . . 74.24 112.976 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.34 140.75 15.22 Favored Glycine 0 CA--C 1.488 -1.61 0 C-N-CA 121.23 -0.51 . . . . 51.14 111.829 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.24 120.91 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.254 -1.017 . . . . 74.54 108.254 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.3 154.6 40.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.826 -0.624 . . . . 63.11 110.916 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 35' ' ' VAL . 64.3 mt -126.28 114.43 23.59 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.872 -1.158 . . . . 73.22 107.872 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.41 133.56 58.81 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.323 2.682 . . . . 75.24 113.102 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -57.12 -25.53 58.98 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 112.948 0.722 . . . . 72.54 112.948 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 21.9 m -60.28 -15.34 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 113.361 0.875 . . . . 72.1 113.361 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 81' ' ' LEU . 13.9 m-85 -82.28 -6.15 59.04 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.519 0.676 . . . . 75.3 111.001 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -121.06 162.36 20.13 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.553 -0.748 . . . . 61.43 109.126 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.0 p -88.14 175.53 7.67 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.713 -0.476 . . . . 72.01 109.713 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -61.25 -16.98 50.99 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.239 0.616 . . . . 72.31 111.176 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.21 3.43 51.46 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.312 0.486 . . . . 73.03 112.312 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.76 57.87 Favored Glycine 0 C--O 1.235 0.166 0 C-N-CA 120.465 -0.874 . . . . 23.42 111.94 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -112.55 146.23 38.9 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.634 -0.876 . . . . 75.54 108.634 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.9 130.39 32.24 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.546 -0.538 . . . . 40.32 109.546 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 80' ' ' SER . 60.5 t -56.14 130.55 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.798 -0.637 . . . . 73.25 109.459 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -57.32 -23.8 50.98 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.64 1.348 . . . . 62.33 114.64 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.401 ' H ' HG12 ' A' ' 78' ' ' VAL . 23.2 t -105.31 10.63 33.48 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.987 -0.446 . . . . 73.03 110.91 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 36.2 tp -66.02 -57.68 12.84 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.39 0.885 . . . . 74.33 113.39 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.63 -33.86 97.26 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 121.864 1.709 . . . . 73.52 112.944 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -61.94 -44.98 97.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.406 -0.426 . . . . 72.13 112.65 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.57 -40.32 80.64 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 121.289 0.566 . . . . 71.3 109.987 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.77 -42.25 95.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.51 -0.768 . . . . 74.53 111.144 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.1 m -64.41 -45.15 88.82 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.04 -0.527 . . . . 72.11 111.906 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -66.06 -43.85 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.973 0.416 . . . . 61.51 111.017 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.675 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 38.1 mt -66.61 -38.33 86.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.286 -0.416 . . . . 74.51 111.77 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -63.27 -42.57 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.842 -0.429 . . . . 71.14 109.842 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.94 -28.63 65.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.12 -0.491 . . . . 74.25 110.737 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.89 -1.56 84.78 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.59 -0.732 . . . . 63.33 112.77 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.88 23.26 30.79 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.867 -0.682 . . . . 73.01 113.087 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -102.84 144.53 31.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.485 -0.42 . . . . 63.23 110.784 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.532 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 31.2 ptt180 -97.01 172.3 7.94 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.232 -0.894 . . . . 71.01 109.156 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.55 -43.18 68.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.791 1.636 . . . . 51.0 111.593 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 m -62.5 -41.04 98.55 Favored 'General case' 0 N--CA 1.415 -2.194 0 C-N-CA 123.854 0.862 . . . . 73.32 110.164 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.532 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 28.9 mm-40 -67.04 -33.36 75.36 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.43 -0.35 . . . . 73.4 110.649 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.483 HD12 HD13 ' A' ' 88' ' ' LEU . 18.7 mm -61.3 -49.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.993 -1.114 . . . . 61.11 107.993 -176.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 ptp -76.08 -17.89 59.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.289 -0.869 . . . . 60.33 112.8 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -56.47 -67.53 0.29 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.998 0.519 . . . . 72.11 110.66 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.675 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 52.5 p-90 -69.47 -32.13 70.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.277 0.473 . . . . 72.32 112.277 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.526 HD23 ' HB2' ' A' ' 125' ' ' PRO . 8.7 mt -60.09 -39.97 87.97 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.155 0.798 . . . . 74.11 113.155 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.08 -4.8 59.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.178 0.436 . . . . 63.34 112.178 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 m -87.17 120.2 71.28 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.193 -0.669 . . . . 62.41 109.193 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.83 129.62 31.39 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.251 1.968 . . . . 74.45 110.788 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 35.4 t70 -96.33 124.25 51.94 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.182 -0.463 . . . . 53.55 110.807 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.38 -35.43 96.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.324 2.683 . . . . 73.22 113.057 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 p -90.04 2.98 54.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.802 0.667 . . . . 72.11 112.802 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -102.69 129.51 49.33 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.291 0.567 . . . . 65.21 110.21 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.4 m -131.35 115.34 16.13 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.42 -1.696 . . . . 71.41 106.42 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.467 HG22 ' OE1' ' A' ' 133' ' ' GLN . 13.3 pt -132.45 142.61 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 N-CA-C 112.812 0.671 . . . . 64.42 112.812 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -92.65 136.51 33.17 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.883 -1.053 . . . . 73.11 109.032 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -82.51 153.09 25.75 Favored 'General case' 0 CA--C 1.48 -1.712 0 CA-C-O 121.549 0.69 . . . . 74.33 111.415 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -83.82 140.8 31.81 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.974 -1.121 . . . . 52.11 107.974 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.75 8.05 77.27 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 110.101 -1.2 . . . . 75.33 110.101 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.9 t -151.11 -173.32 4.46 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.611 -1.626 . . . . 63.22 106.611 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -133.76 -24.38 1.73 Allowed 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.547 0.573 . . . . 72.55 112.547 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.76 141.16 51.48 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.212 0.529 . . . . 75.34 111.836 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.42 128.85 41.23 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.035 -0.984 . . . . 32.42 110.248 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 t -93.92 118.9 40.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.991 -0.744 . . . . 71.23 108.991 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.2 m -84.67 134.8 34.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.58 -1.267 . . . . 74.51 107.58 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.4 t30 66.71 64.72 0.47 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.534 1.159 . . . . 74.23 108.908 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.97 163.71 15.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.263 -1.335 . . . . 53.42 108.887 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 39.6 ptt180 -82.39 136.18 46.27 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.545 -0.539 . . . . 71.53 109.545 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.526 ' HB2' HD23 ' A' ' 102' ' ' LEU . 31.0 Cg_exo -56.78 -17.08 21.89 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.244 2.63 . . . . 71.43 114.07 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.618 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.1 t -59.9 -40.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.454 0.645 . . . . 62.04 109.9 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.2 -30.29 67.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.19 -0.459 . . . . 64.15 111.051 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.1 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.59 . . . . 61.41 111.375 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.45 -33.9 75.01 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.028 -0.269 . . . . 74.24 111.401 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -75.25 -24.68 57.68 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.781 0.8 . . . . 62.23 108.907 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.29 24.41 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.774 -1.103 . . . . 72.44 111.179 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.6 m80 64.39 28.22 13.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.528 1.131 . . . . 52.24 111.512 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.467 ' OE1' HG22 ' A' ' 111' ' ' ILE . 72.7 mt-30 -111.23 23.84 13.58 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.345 -1.354 . . . . 74.14 107.345 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.26 -27.87 24.68 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 113.306 -1.77 . . . . 63.32 113.111 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -56.16 -36.21 68.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.935 0.494 . . . . 73.1 109.926 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.33 -38.58 87.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.405 0.621 . . . . 73.42 109.737 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.7 -46.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.078 -0.964 . . . . 70.22 109.597 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 93.0 t -61.22 -47.8 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.506 -0.77 . . . . 74.13 110.484 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.52 -37.93 89.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.123 -0.631 . . . . 64.41 110.915 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -63.71 -41.64 98.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.229 -0.656 . . . . 71.25 109.229 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.921 -0.581 . . . . 61.35 110.072 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -63.98 -38.66 91.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.414 -0.812 . . . . 72.3 111.411 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.91 -33.03 70.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.147 0.499 . . . . 74.41 110.441 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 tpt -69.71 -32.01 70.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.342 -0.844 . . . . 73.4 110.719 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.27 -58.91 2.16 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.803 0.668 . . . . 61.15 112.803 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.31 -1.126 0 CA-C-O 118.303 -0.856 . . . . 74.2 110.624 -175.896 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 CA--C 1.519 -0.225 0 N-CA-C 108.331 -0.988 . . . . 74.02 108.331 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.81 -178.18 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.665 2.243 . . . . 74.33 113.057 -174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.46 -143.71 14.62 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.353 -0.699 . . . . 45.25 111.353 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -73.75 133.81 43.37 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.716 -0.846 . . . . 64.11 108.716 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 144.2 51.84 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 110.09 -0.337 . . . . 72.34 110.09 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -85.21 -166.68 0.36 Allowed 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 122.652 2.235 . . . . 43.13 111.94 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.1 -144.49 4.19 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 110.227 -1.149 . . . . 53.32 110.227 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -81.21 98.24 7.99 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.174 -0.676 . . . . 65.1 109.174 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 m -82.18 156.09 24.62 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.572 -0.899 . . . . 73.41 108.572 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.88 119.72 6.71 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 122.812 0.445 . . . . 63.35 110.408 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.75 135.22 50.91 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.961 -1.018 . . . . 61.03 110.045 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.409 ' HA ' ' HE ' ' A' ' 12' ' ' ARG . 1.9 mmp_? -106.62 77.53 1.2 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.669 0.747 . . . . 72.24 110.302 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 52' ' ' GLU . 95.3 t -90.76 -39.04 11.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 CA-C-N 114.398 -1.274 . . . . 72.13 108.61 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.94 169.26 27.21 Favored Glycine 0 N--CA 1.406 -3.306 0 CA-C-N 113.563 -1.653 . . . . 73.24 110.722 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -144.56 99.03 3.29 Favored 'General case' 0 C--N 1.27 -2.868 0 N-CA-C 106.099 -1.815 . . . . 74.32 106.099 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -106.04 127.8 27.64 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.718 -0.673 . . . . 64.41 109.25 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.5 165.28 30.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.334 2.023 . . . . 72.43 110.491 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.36 135.19 33.99 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.922 -0.399 . . . . 73.12 109.922 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.67 -78.79 0.62 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.559 -0.829 . . . . 75.14 113.994 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.73 129.97 33.44 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 122.262 -0.552 . . . . 53.34 110.631 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.568 ' OD2' ' HD2' ' A' ' 60' ' ' ARG . 13.3 t0 -69.22 139.46 54.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.165 -0.471 . . . . 65.42 111.697 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 100' ' ' ARG . 58.1 t -106.56 -18.52 7.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.661 -0.7 . . . . 43.42 110.991 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.285 1.0 OUTLIER -89.7 179.37 6.03 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.379 -1.328 . . . . 64.34 112.21 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -98.03 152.21 37.93 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.085 -0.709 . . . . 71.52 109.085 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.89 -22.92 32.01 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.005 2.47 . . . . 65.41 113.035 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.74 -24.98 56.17 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.295 -0.253 . . . . 64.3 111.582 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 20.1 mm-40 -72.34 137.21 81.18 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 109.973 -0.38 . . . . 75.53 109.973 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 28.9 Cg_exo -63.02 136.72 58.1 Favored 'Trans proline' 0 C--O 1.256 1.408 0 C-N-CA 123.105 2.537 . . . . 53.23 112.774 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 p -130.6 169.81 15.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.283 0.563 . . . . 74.03 111.37 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 20.4 m-85 -130.33 160.2 34.68 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.808 1.243 . . . . 53.12 108.05 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.14 163.97 28.4 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 103.459 -2.793 . . . . 72.14 103.459 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HB3' HG13 ' A' ' 43' ' ' VAL . 82.9 mt -49.93 -52.27 53.86 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 114.812 1.412 . . . . 75.25 114.812 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.91 -38.61 68.16 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 121.6 1.534 . . . . 71.14 111.762 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.8 tpt180 -70.05 -33.98 72.63 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.566 -0.288 . . . . 73.23 111.309 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.1 -42.06 84.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.951 -0.759 . . . . 70.42 108.951 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.07 84.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.406 -0.815 . . . . 63.44 109.597 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 7.5 tp10 -61.68 -44.94 95.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.672 -1.149 . . . . 55.24 109.552 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.449 HD22 ' CE2' ' A' ' 30' ' ' TYR . 27.0 tp -69.63 -46.33 66.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.195 -0.911 . . . . 72.23 111.724 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 75' ' ' GLY . 96.7 mt -81.36 -18.44 45.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.189 -0.46 . . . . 64.03 111.606 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.3 28.2 62.36 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.058 -0.817 . . . . 70.13 111.058 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 39' ' ' LEU . 21.5 m -125.61 163.48 38.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 108.333 -0.988 . . . . 73.12 108.333 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 46.2 Cg_endo -70.87 157.83 57.15 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 121.352 1.368 . . . . 50.45 111.232 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' A' ' 32' ' ' LEU . 61.2 t -57.9 -34.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.658 0.783 . . . . 74.15 109.786 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 47.1 m -57.66 -42.89 84.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.155 -0.929 . . . . 41.33 111.331 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.8 mtpt -69.27 -33.48 73.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.409 -0.516 . . . . 75.14 111.204 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.23 -44.94 99.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.164 -0.68 . . . . 73.33 109.164 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.39 -0.823 . . . . 70.54 110.427 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.0 mt-30 -63.49 -39.79 95.37 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.241 -0.436 . . . . 61.14 110.397 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.611 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 72.2 mt-30 -64.1 -42.4 96.93 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.418 0.628 . . . . 65.43 109.699 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.17 -40.77 97.14 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.892 -1.049 . . . . 71.04 109.281 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -68.83 -22.27 64.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.508 -0.769 . . . . 62.04 112.89 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 49.9 mt-10 -93.04 -12.87 29.53 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.313 -0.555 . . . . 74.21 111.337 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.38 28.96 31.62 Favored Glycine 0 C--N 1.319 -0.41 0 N-CA-C 111.222 -0.751 . . . . 73.42 111.222 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -87.72 -28.38 21.8 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.31 -0.996 . . . . 73.35 108.31 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -145.95 158.6 43.86 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.429 -1.323 . . . . 65.54 107.429 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.71 157.55 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.464 -0.939 . . . . 41.14 108.464 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.4 162.87 32.47 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.122 0.569 . . . . 71.14 110.004 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 m -125.91 166.09 22.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.277 0.56 . . . . 64.32 111.701 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -110.23 124.73 52.14 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.203 -0.908 . . . . 74.13 108.783 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.568 ' HD2' ' OD2' ' A' ' 21' ' ' ASP . 8.9 ptm180 -151.3 138.37 19.17 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-N 115.573 -0.739 . . . . 74.41 110.123 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.63 -59.16 0.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.205 1.802 . . . . 74.22 110.515 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.48 24.77 0.02 OUTLIER Glycine 0 C--N 1.28 -2.573 0 CA-C-N 114.766 -1.106 . . . . 51.33 110.825 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 160.81 27.81 Favored Glycine 0 N--CA 1.427 -1.907 0 C-N-CA 120.395 -0.907 . . . . 65.02 111.893 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.88 119.88 50.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.931 -1.507 . . . . 64.41 106.931 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.8 158.6 39.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 120.926 0.394 . . . . 42.42 110.867 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.07 126.92 27.07 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.497 -1.297 . . . . 52.45 107.497 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.31 132.29 51.38 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.384 2.056 . . . . 55.31 111.539 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 40.0 tt0 -62.17 -25.8 67.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.38 0.609 . . . . 70.1 112.353 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.461 ' HB ' HG11 ' A' ' 126' ' ' VAL . 31.2 m -71.81 -4.37 4.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.144 -0.934 . . . . 54.14 112.38 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.8 m-85 -82.85 -6.18 59.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.956 0.884 . . . . 73.44 110.239 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.65 160.87 20.59 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.579 -0.737 . . . . 74.32 110.52 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.3 p -92.84 168.53 11.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.065 -1.087 . . . . 71.13 108.065 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.93 -15.33 63.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.424 0.631 . . . . 74.22 111.661 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.0 m -78.64 -9.86 59.53 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.739 -0.664 . . . . 61.33 109.335 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 39' ' ' LEU . . . 81.16 25.8 54.2 Favored Glycine 0 C--O 1.212 -1.264 0 N-CA-C 111.0 -0.84 . . . . 72.1 111.0 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -114.52 147.34 39.54 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.092 -1.077 . . . . 75.02 108.092 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.58 137.73 23.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.847 -1.538 . . . . 62.2 106.847 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.8 t -60.87 127.28 20.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 108.666 -0.865 . . . . 70.23 108.666 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -55.3 -32.14 62.19 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 114.095 1.146 . . . . 73.02 114.095 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 m -85.16 -6.4 59.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.088 0.471 . . . . 44.24 111.457 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD11 ' CD2' ' A' ' 70' ' ' PHE . 7.0 tt -66.18 -50.09 52.13 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 112.616 0.598 . . . . 73.11 112.616 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.28 -31.39 84.28 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.552 1.502 . . . . 62.55 111.337 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.93 99.73 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 115.872 -0.604 . . . . 53.43 112.682 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -67.86 -39.81 83.72 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.32 -0.622 . . . . 74.45 109.32 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.63 -36.33 83.46 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.719 -0.673 . . . . 73.14 110.542 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.7 m -59.5 -50.26 74.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.022 -0.536 . . . . 61.43 110.372 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -44.16 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 116.143 -0.48 . . . . 63.43 111.485 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.427 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.36 -36.35 81.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.98 0.733 . . . . 71.2 112.98 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -70.64 -33.72 71.3 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 74.41 109.285 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.05 -31.7 72.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.674 -0.694 . . . . 74.23 109.389 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.17 -9.37 80.18 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.408 -0.814 . . . . 65.33 112.676 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.5 33.48 25.14 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 121.174 -0.536 . . . . 71.44 113.295 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.403 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 68.9 m-85 -99.79 136.89 39.02 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.595 -0.356 . . . . 61.21 110.884 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -88.58 174.04 8.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.922 -0.581 . . . . 71.21 112.144 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.85 -42.59 65.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.355 1.862 . . . . 64.43 111.871 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -64.2 -41.73 96.94 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.782 -0.644 . . . . 63.53 110.142 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -66.61 -37.27 84.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.369 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.27 -48.97 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.777 0.799 . . . . 74.4 109.337 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.2 mtt -75.41 -19.28 59.61 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.036 -0.984 . . . . 65.15 112.215 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HA ' HG11 ' A' ' 22' ' ' VAL . 79.0 ttt180 -56.88 -62.79 1.5 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.356 0.662 . . . . 62.14 111.05 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -69.05 -32.65 72.28 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.2 0.524 . . . . 63.22 111.829 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 125' ' ' PRO . 19.2 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.13 0.972 . . . . 64.25 112.436 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -93.52 -2.6 54.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.261 0.837 . . . . 75.51 113.261 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.6 m -86.02 113.49 52.07 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.135 0.272 . . . . 71.3 111.224 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 38.4 Cg_endo -68.02 141.11 52.02 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.448 2.099 . . . . 41.35 110.856 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.9 t0 -112.53 126.94 27.52 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 120.371 -0.532 . . . . 53.31 109.693 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 122' ' ' ASN . 32.6 Cg_exo -58.55 -28.24 85.09 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.645 2.896 . . . . 70.2 112.961 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -96.13 7.18 47.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.05 -0.523 . . . . 53.54 110.504 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.414 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.8 tp -113.89 123.83 50.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.554 0.693 . . . . 63.43 109.891 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.47 HG22 ' HB1' ' A' ' 119' ' ' ALA . 12.8 m -120.26 120.57 36.49 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.547 -1.279 . . . . 60.31 107.547 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.0 mt -127.48 148.59 32.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.896 -1.15 . . . . 73.21 107.896 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.4 t -118.73 148.41 42.82 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 106.704 -1.591 . . . . 73.44 106.704 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -143.44 174.46 10.73 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.486 -0.561 . . . . 74.42 109.486 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.91 126.87 29.29 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.729 0.643 . . . . 72.31 110.221 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.68 -2.77 58.82 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.694 -0.765 . . . . 33.53 111.259 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.6 m -121.38 116.12 24.19 Favored 'General case' 0 N--CA 1.426 -1.665 0 O-C-N 122.555 -0.379 . . . . 64.35 110.011 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.423 ' H ' ' HD3' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -79.16 -40.73 30.18 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 104.723 -2.325 . . . . 71.35 104.723 174.623 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.27 -177.12 3.89 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 111.402 -2.635 . . . . 75.43 109.089 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.47 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -109.88 148.28 31.82 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 109.071 -0.715 . . . . 65.11 109.071 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.09 118.22 46.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 107.58 -1.267 . . . . 62.32 107.58 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.3 m -83.46 154.0 24.17 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.262 -1.385 . . . . 63.41 107.262 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 106' ' ' ASP 0.393 21.6 p-10 46.7 62.94 2.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.722 1.209 . . . . 63.14 113.244 -176.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 105' ' ' PRO . . . -104.51 172.62 6.7 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.37 -1.344 . . . . 74.21 107.37 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -103.89 151.43 38.88 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 109.137 -0.69 . . . . 74.14 109.137 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.459 ' HB2' HD12 ' A' ' 102' ' ' LEU . 71.1 Cg_exo -50.9 -22.08 9.56 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.06 2.507 . . . . 73.33 113.453 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.461 HG11 ' HB ' ' A' ' 69' ' ' VAL . 94.4 t -60.05 -41.62 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.082 -0.34 . . . . 34.22 110.082 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.07 -40.11 94.69 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.752 -0.658 . . . . 74.22 109.719 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.45 69.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 73.23 109.995 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.75 -44.18 93.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.576 0.751 . . . . 75.41 112.144 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -70.26 -23.58 62.92 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.441 0.638 . . . . 74.41 109.887 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -100.54 10.92 40.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.375 -0.83 . . . . 62.34 112.289 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 65.79 27.55 11.09 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.754 1.264 . . . . 72.32 111.018 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -102.86 24.76 10.18 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.3 -1.741 . . . . 72.42 106.3 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.23 -27.25 14.12 Favored 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 127.044 2.137 . . . . 14.3 115.381 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -56.5 -34.41 66.95 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.557 1.318 . . . . 71.13 114.557 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -67.39 -34.77 77.96 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.767 0.794 . . . . 50.51 109.338 175.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.62 -48.44 65.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.922 -1.035 . . . . 72.51 108.958 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.77 -43.94 99.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.529 -0.76 . . . . 74.25 109.55 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 26.1 ttt180 -57.74 -47.2 83.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.449 -0.341 . . . . 72.44 110.916 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -65.92 -33.7 76.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.684 0.278 . . . . 74.35 111.468 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.427 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -65.17 -46.72 79.66 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.47 -0.567 . . . . 74.32 109.47 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.42 -48.01 81.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.106 -0.952 . . . . 75.44 110.509 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.75 -19.42 65.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.703 -0.681 . . . . 71.35 112.335 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 tpt -79.83 -45.84 17.99 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.209 0.528 . . . . 61.2 109.793 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.403 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.71 -44.26 17.33 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.539 0.57 . . . . 71.23 112.539 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 108.836 -0.802 . . . . 73.21 108.836 -178.303 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 107.474 -1.306 . . . . 64.4 107.474 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.21 143.15 82.86 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 122.268 1.979 . . . . 72.41 112.41 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.2 -174.18 46.77 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 109.28 -1.528 . . . . 75.13 109.28 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 135.03 48.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 118.162 0.981 . . . . 72.12 110.755 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.44 131.82 22.58 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 108.85 -0.796 . . . . 55.53 108.85 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.69 127.02 24.19 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 122.84 2.36 . . . . 73.0 110.929 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.79 118.37 3.58 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 111.313 -0.715 . . . . 52.52 111.313 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -70.4 -33.99 72.01 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.665 -0.865 . . . . 65.52 108.665 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 m -99.48 128.03 45.58 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.414 -0.812 . . . . 71.42 109.476 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.98 162.55 13.51 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.439 -0.948 . . . . 71.33 108.439 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.34 79.04 9.53 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.571 -1.27 . . . . 72.44 107.571 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.492 ' H ' ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -93.83 128.88 40.33 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.517 -0.765 . . . . 71.54 109.674 -176.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.84 153.38 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.82 0 N-CA-C 108.074 -1.084 . . . . 70.03 108.074 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.81 -175.64 14.02 Favored Glycine 0 N--CA 1.396 -3.986 0 N-CA-C 110.083 -1.207 . . . . 72.03 110.083 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 t -155.06 -177.7 6.72 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 106.592 -1.633 . . . . 72.52 106.592 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 94' ' ' ARG . 39.6 mm -85.03 133.77 42.45 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 107.515 -1.291 . . . . 71.41 107.515 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.51 162.64 23.53 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.896 1.731 . . . . 70.25 110.638 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.67 124.38 29.53 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.025 -0.731 . . . . 71.02 109.025 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' HH12 ' A' ' 94' ' ' ARG . . . -97.67 -87.12 1.85 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 116.17 -0.468 . . . . 72.32 113.717 -176.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.94 141.46 52.02 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.468 -0.493 . . . . 72.1 111.965 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -81.5 133.98 35.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.504 -0.771 . . . . 61.33 110.481 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.38 -15.75 9.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.602 -0.727 . . . . 71.0 111.025 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 103' ' ' PHE 0.279 0.9 OUTLIER -82.56 -176.88 6.47 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 118.751 -1.18 . . . . 73.32 112.566 -178.348 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -86.93 136.0 34.69 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 116.286 -0.415 . . . . 75.34 110.263 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.58 -25.44 33.02 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.616 2.877 . . . . 73.1 113.814 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.45 -30.18 70.47 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.102 0.477 . . . . 75.35 110.234 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 43.6 mt-10 -76.35 123.58 87.89 Favored Pre-proline 0 C--O 1.254 1.308 0 CA-C-N 115.457 -0.792 . . . . 74.44 109.935 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.2 Cg_exo -73.69 175.99 9.98 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.318 2.012 . . . . 74.45 110.019 177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.432 ' HB ' ' HB ' ' A' ' 65' ' ' VAL . 12.9 p -139.97 177.93 7.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.579 0.704 . . . . 61.23 112.062 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 43.0 m-85 -109.17 160.81 15.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 125.919 1.688 . . . . 74.02 107.905 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 13.3 t0 -135.66 166.86 22.25 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 104.091 -2.559 . . . . 53.3 104.091 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.21 -53.29 63.37 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 113.065 0.765 . . . . 65.45 113.065 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 14.8 Cg_endo -58.3 -35.71 98.43 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.11 1.873 . . . . 55.31 112.66 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.435 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 23.9 tpt180 -67.38 -38.44 84.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.345 0.658 . . . . 75.12 110.284 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.4 t -69.2 -40.37 80.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 109.406 -0.591 . . . . 75.34 109.406 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -59.35 -39.49 83.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.822 -1.081 . . . . 73.14 109.646 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.18 -34.72 78.68 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.375 1.47 . . . . 73.53 110.469 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 30' ' ' TYR . 97.1 mt -77.24 -47.5 19.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.284 0.564 . . . . 64.23 111.625 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -85.02 -18.5 34.22 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.315 0.857 . . . . 74.5 113.315 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.39 48.6 Favored Glycine 0 C--N 1.307 -1.038 0 C-N-CA 119.77 -1.205 . . . . 31.21 110.178 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 34.3 m -117.91 157.75 47.58 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.007 -1.108 . . . . 75.3 108.007 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.462 ' HD2' ' HD2' ' A' ' 45' ' ' LYS . 44.3 Cg_endo -72.04 164.53 35.38 Favored 'Trans proline' 0 C--O 1.259 1.558 0 C-N-CA 121.117 1.211 . . . . 53.14 110.958 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.89 -33.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.54 0.686 . . . . 75.15 109.269 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -57.45 -41.79 81.25 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.674 -1.148 . . . . 71.45 110.685 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 54.3 mttm -69.38 -36.93 77.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.625 -0.43 . . . . 73.42 111.658 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.64 -44.69 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.401 -0.592 . . . . 55.05 109.401 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.32 -36.92 79.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.439 -0.801 . . . . 55.44 110.157 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 96.2 mt-30 -67.38 -43.32 81.69 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.079 -0.51 . . . . 70.15 111.491 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 92.7 mt-30 -58.32 -46.1 86.81 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.486 0.66 . . . . 62.13 110.052 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 96.3 mt -61.42 -45.7 93.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.352 -1.295 . . . . 51.11 110.16 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -70.85 -22.09 62.35 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.118 0.785 . . . . 64.44 113.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 57.5 mt-10 -94.48 -1.16 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.891 -0.505 . . . . 72.33 110.913 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.4 35.04 63.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.882 -0.675 . . . . 55.21 111.979 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -102.17 -16.94 16.2 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.808 -1.182 . . . . 72.33 107.808 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 54.9 tp -151.26 152.72 33.62 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.054 -1.832 . . . . 63.33 106.054 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.48 161.53 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 109.262 -0.644 . . . . 64.43 109.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.65 164.15 28.91 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.291 0.636 . . . . 54.23 110.902 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.8 m -125.24 165.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 123.826 0.85 . . . . 75.11 108.96 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -123.98 131.74 53.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.882 -0.784 . . . . 70.11 108.882 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -152.24 138.71 18.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.117 -0.697 . . . . 72.43 109.117 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.93 9.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.278 1.031 . . . . 62.03 112.335 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.21 9.7 67.01 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.181 -0.533 . . . . 74.24 112.843 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.47 142.0 15.55 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.596 -0.811 . . . . 55.33 111.168 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.78 120.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.084 -1.45 . . . . 33.31 107.084 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 12.1 m -137.16 164.37 29.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.25 -0.432 . . . . 64.33 111.312 -174.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.81 130.61 24.68 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.67 -0.863 . . . . 75.43 108.67 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.71 141.82 83.67 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.086 2.524 . . . . 72.3 113.941 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.472 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -55.2 -39.82 70.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.786 1.234 . . . . 73.12 110.399 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.98 -4.91 4.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 114.129 1.159 . . . . 70.25 114.129 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.561 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.7 m-85 -83.49 -5.46 59.17 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.856 0.836 . . . . 74.24 110.836 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -124.34 149.03 47.07 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.691 -1.14 . . . . 72.35 108.644 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.1 p -76.17 169.0 19.04 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.807 -0.812 . . . . 73.12 108.807 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -61.6 -19.15 61.9 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 70.13 110.953 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 m -80.08 -10.1 59.74 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 116.109 -0.496 . . . . 74.52 110.936 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.62 14.06 66.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.004 -0.617 . . . . 62.14 111.887 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -105.06 148.22 27.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.819 -0.224 . . . . 71.41 110.744 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.97 138.65 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 O-C-N 123.811 0.694 . . . . 72.35 109.627 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 80' ' ' SER . 57.0 t -61.94 127.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.264 -1.013 . . . . 62.02 108.264 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -63.14 -24.02 67.7 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.454 0.645 . . . . 75.24 112.589 -176.452 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.421 ' H ' HG12 ' A' ' 78' ' ' VAL . 8.6 m -92.09 2.42 56.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.073 -0.512 . . . . 51.14 110.748 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 70' ' ' PHE . 11.8 tp -65.05 -55.62 25.78 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.433 -0.349 . . . . 41.22 111.454 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.88 -28.46 86.41 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.815 1.677 . . . . 72.12 111.218 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.7 -45.46 65.78 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.489 -0.778 . . . . 44.3 111.967 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.22 -40.81 81.99 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 120.985 0.422 . . . . 72.21 110.118 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.43 -39.27 92.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.006 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.1 m -71.36 -41.23 70.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.899 -0.592 . . . . 65.3 112.224 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -68.11 -39.84 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.32 -0.552 . . . . 61.34 109.535 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 4.4 mm? -66.18 -35.67 81.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 122.257 -0.277 . . . . 63.24 111.399 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.34 -37.94 89.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.72 -0.474 . . . . 75.42 109.72 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.47 -24.94 65.66 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.741 0.781 . . . . 75.35 109.976 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -2.93 84.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.665 -0.698 . . . . 73.41 111.795 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 20.95 50.88 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.784 -0.246 . . . . 62.2 113.058 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 9.1 m-85 -86.75 152.8 22.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.109 0.781 . . . . 72.4 113.109 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.448 HH12 ' HA3' ' A' ' 19' ' ' GLY . 11.1 ptt180 -123.24 175.96 6.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.82 -1.082 . . . . 60.23 110.063 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 99' ' ' MET . 11.1 p-10 -52.18 -47.06 65.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.851 1.66 . . . . 74.33 113.49 -171.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.1 m -67.93 -40.0 83.41 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-O 121.471 0.653 . . . . 74.21 109.348 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 29.7 mm-40 -66.29 -34.62 78.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.338 -0.847 . . . . 75.24 111.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 94' ' ' ARG . 33.4 mm -61.49 -47.19 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.87 0.843 . . . . 61.22 108.819 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 23.0 mmt -70.41 -23.22 62.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.347 -1.297 . . . . 73.34 110.773 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 68.9 ttt180 -55.09 -67.23 0.29 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.474 0.71 . . . . 63.21 110.888 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.588 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 57.3 p-90 -68.93 -32.12 71.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.607 0.595 . . . . 72.35 112.607 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.588 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.2 mt -63.55 -40.6 97.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.328 0.862 . . . . 70.31 113.328 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 96.3 m-85 -98.33 -9.46 25.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.582 0.956 . . . . 63.33 113.582 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.4 m -88.35 110.97 40.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.815 -1.18 . . . . 42.14 107.815 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.26 129.9 37.27 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.65 2.233 . . . . 75.42 111.514 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.3 t70 -89.59 118.8 69.35 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 109.489 -0.559 . . . . 60.23 109.489 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -26.83 83.38 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.143 2.562 . . . . 75.01 112.213 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -94.84 10.05 36.77 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.685 -0.689 . . . . 65.23 111.431 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.9 tp -105.25 125.81 51.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.13 -0.693 . . . . 62.23 109.13 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 120' ' ' VAL . 52.1 m -132.04 110.68 10.89 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.352 -0.981 . . . . 61.11 108.352 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.84 160.99 42.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 115.878 -0.601 . . . . 70.5 110.508 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.442 HG23 HE22 ' A' ' 133' ' ' GLN . 1.6 t -88.85 126.03 35.18 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.0 -2.222 . . . . 62.23 105.0 172.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 57.2 mtp180 -84.45 169.07 14.9 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 114.498 1.296 . . . . 72.45 114.498 -169.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -57.01 101.0 0.05 Allowed 'General case' 0 C--O 1.242 0.688 0 CA-C-N 114.316 -1.311 . . . . 64.5 109.76 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.79 42.43 61.33 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.576 -0.738 . . . . 53.25 111.29 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 113' ' ' ARG . 17.4 m -142.47 106.28 4.69 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.174 -0.676 . . . . 72.22 109.174 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -60.17 -27.97 67.54 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.362 0.504 . . . . 73.52 112.362 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -84.56 144.21 28.8 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.897 -0.592 . . . . 65.23 110.802 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.99 127.59 35.68 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.546 -0.752 . . . . 74.54 109.175 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 110' ' ' THR . 44.4 t -104.56 122.8 57.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 116.164 -0.471 . . . . 63.14 110.177 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.7 m -83.17 139.35 33.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.07 -1.456 . . . . 75.34 107.07 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.5 t30 69.36 69.33 0.26 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.386 1.089 . . . . 62.33 108.779 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.43 159.94 21.98 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.698 -1.137 . . . . 75.3 109.931 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -75.46 125.23 88.99 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.796 -0.816 . . . . 62.12 108.796 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 72.3 Cg_exo -53.89 -23.92 29.46 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.269 2.646 . . . . 75.34 112.958 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.723 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 84.6 t -60.31 -42.16 89.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.642 -0.708 . . . . 73.43 111.553 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.18 -30.71 71.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.358 0.599 . . . . 71.53 110.471 -172.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.9 84.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.008 -0.996 . . . . 61.32 111.786 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.723 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -70.41 -36.82 74.26 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.82 -0.55 . . . . 44.44 111.671 -177.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -76.09 -22.62 55.39 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.588 -0.893 . . . . 75.34 108.588 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.16 43.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.715 -1.129 . . . . 62.45 111.413 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.8 m80 65.52 28.44 11.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.111 0.964 . . . . 72.13 112.127 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.442 HE22 HG23 ' A' ' 112' ' ' THR . 72.7 mt-30 -108.64 25.23 11.97 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 125.146 1.378 . . . . 75.22 107.607 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.41 -26.37 7.82 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.89 2.076 . . . . 74.21 113.268 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 39.2 ttp180 -54.37 -41.26 68.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.933 -0.395 . . . . 75.43 109.933 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.504 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 56.6 mm-40 -67.35 -28.51 68.02 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.549 -0.296 . . . . 52.12 111.653 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.07 -45.5 54.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.4 -0.963 . . . . 60.32 108.4 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.66 -49.2 84.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.036 -0.529 . . . . 72.32 110.338 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 136' ' ' GLU 0.318 0.0 OUTLIER -63.64 -37.43 87.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.187 0.81 . . . . 74.22 113.187 178.379 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 144' ' ' MET . 1.6 mpt_? -63.6 -40.1 96.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.484 -0.561 . . . . 72.44 109.484 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.424 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -61.5 -42.78 99.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 52.42 110.614 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -56.89 -49.52 75.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.339 0.656 . . . . 73.5 109.88 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.56 -33.12 74.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.172 -0.922 . . . . 73.33 111.892 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 92.6 mmm -77.01 -47.2 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.835 -0.346 . . . . 63.01 111.093 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.88 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.857 -0.61 . . . . 60.42 112.065 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 N--CA 1.427 -1.576 0 C-N-CA 120.655 -0.418 . . . . 74.23 110.47 -178.61 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.107 0.48 . . . . 70.15 110.532 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -86.16 100.9 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.364 2.042 . . . . 54.23 110.842 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.15 45.47 1.93 Allowed Glycine 0 C--N 1.311 -0.851 0 C-N-CA 121.213 -0.518 . . . . 61.34 113.268 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -74.1 133.0 42.82 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.508 -0.553 . . . . 54.13 109.508 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.29 88.96 20.19 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.685 -0.857 . . . . 64.44 108.685 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -92.17 -174.96 0.58 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.709 2.273 . . . . 70.44 111.922 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.0 28.23 59.01 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 116.011 -0.541 . . . . 75.11 112.359 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -72.94 112.35 8.89 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-O 121.624 0.726 . . . . 74.22 110.154 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -85.21 129.64 34.76 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.429 -0.805 . . . . 73.25 109.741 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.9 mt -67.94 157.54 34.76 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.948 -0.39 . . . . 71.33 109.948 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.86 93.19 3.07 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.963 0.411 . . . . 75.2 110.087 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -115.53 7.07 14.81 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.68 0.752 . . . . 62.44 111.094 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.83 101.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 106.784 -1.561 . . . . 54.35 106.784 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 51' ' ' ARG . . . -75.05 89.8 0.79 Allowed Glycine 0 N--CA 1.423 -2.203 0 CA-C-N 114.955 -1.02 . . . . 71.24 112.712 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -88.77 79.56 7.41 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 106.331 -1.729 . . . . 71.43 106.331 174.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -75.13 119.85 78.88 Favored Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 115.442 -0.799 . . . . 73.25 109.738 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -75.98 137.54 19.73 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.006 1.804 . . . . 75.53 107.541 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.5 124.12 30.41 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.664 -0.814 . . . . 64.22 109.758 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.35 -104.28 2.72 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 121.07 -0.586 . . . . 73.41 112.351 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.06 137.28 52.36 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.392 -0.523 . . . . 74.34 111.539 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.58 143.1 35.08 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.346 -0.843 . . . . 75.01 110.937 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.63 -15.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 116.055 -0.52 . . . . 75.34 110.932 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.266 1.0 OUTLIER -86.09 175.55 8.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 118.314 -1.354 . . . . 74.24 111.631 179.02 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.446 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 20.3 t70 -82.21 141.1 46.02 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.172 -0.677 . . . . 73.21 109.172 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.413 ' HA ' ' NH1' ' A' ' 60' ' ' ARG . 71.1 Cg_exo -50.4 -32.06 32.59 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.003 2.469 . . . . 72.43 114.388 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.54 -10.02 59.55 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.942 1.09 . . . . 60.33 113.942 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 9.9 mm-40 -66.3 136.32 95.15 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 107.787 -1.19 . . . . 75.03 107.787 175.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.8 133.71 51.74 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.171 2.581 . . . . 72.43 112.629 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.7 p -132.84 168.55 18.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.057 -0.519 . . . . 63.4 111.092 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.469 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 24.6 m-85 -130.83 161.5 31.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 125.23 1.412 . . . . 73.35 108.464 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -134.67 166.57 22.62 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.343 -1.725 . . . . 62.12 106.343 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -43.37 -61.54 1.8 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 116.018 1.859 . . . . 63.12 116.018 -169.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.07 -29.37 74.86 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.448 1.432 . . . . 63.3 112.352 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.9 tpt180 -70.86 -36.22 72.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.081 0.467 . . . . 73.42 110.041 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.81 -37.9 74.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.628 -0.508 . . . . 74.43 109.628 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.15 81.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.458 -0.792 . . . . 74.13 109.393 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 35.9 tt0 -63.9 -45.78 87.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.716 -1.129 . . . . 54.34 110.724 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.466 HD22 ' CE2' ' A' ' 30' ' ' TYR . 39.6 tp -64.81 -46.93 79.94 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.194 -0.912 . . . . 64.23 111.534 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.65 -18.29 35.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.86 0.689 . . . . 64.11 112.86 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.81 53.07 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.07 -1.062 . . . . 53.22 111.448 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.05 158.71 74.39 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.131 -0.692 . . . . 54.04 109.131 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -65.78 159.84 46.66 Favored 'Trans proline' 0 C--O 1.25 1.089 0 C-N-CA 121.856 1.704 . . . . 62.01 112.192 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.2 -33.61 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.247 1.019 . . . . 63.43 111.252 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -57.87 -42.46 84.6 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.617 -0.72 . . . . 71.14 110.946 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.683 ' HA ' ' HG3' ' A' ' 48' ' ' GLN . 68.2 mttm -70.06 -34.82 73.68 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.006 -0.543 . . . . 74.53 112.007 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.36 -41.63 90.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.287 -0.635 . . . . 64.33 109.287 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.37 96.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.203 -0.908 . . . . 72.5 110.589 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.683 ' HG3' ' HA ' ' A' ' 45' ' ' LYS 0.308 0.0 OUTLIER -70.72 -35.03 72.52 Favored 'General case' 0 C--O 1.201 -1.483 0 C-N-CA 120.216 -0.594 . . . . 70.42 112.241 178.632 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 84.5 mm-40 -58.09 -43.14 86.93 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.482 0.658 . . . . 73.05 109.229 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.67 -46.09 91.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.687 -1.142 . . . . 74.24 108.933 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 94.2 mtt180 -70.68 -21.41 62.59 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.058 -0.974 . . . . 75.33 113.383 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -84.48 -7.39 59.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.904 0.383 . . . . 72.55 110.429 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.53 22.69 58.0 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.482 -0.647 . . . . 71.34 111.482 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 m170 -91.42 -17.95 24.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.058 0.456 . . . . 73.22 109.971 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 tp -151.42 155.37 38.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.43 -0.952 . . . . 72.12 108.43 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.5 t -137.47 147.11 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.028 -1.101 . . . . 70.34 108.028 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.14 156.15 44.36 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.3 -0.63 . . . . 64.21 109.3 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.3 m -127.48 166.03 25.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 O-C-N 123.595 0.559 . . . . 60.01 109.928 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -122.48 137.74 54.78 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.068 -0.716 . . . . 74.02 109.068 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' NH1' ' HA ' ' A' ' 25' ' ' PRO . 39.2 ptt180 -153.34 138.22 17.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.918 -1.142 . . . . 75.32 107.918 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.93 16.28 10.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.955 0.902 . . . . 74.32 110.875 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.06 78.42 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.614 -0.721 . . . . 71.41 112.133 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.76 143.61 15.68 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 111.312 -0.715 . . . . 54.05 111.312 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 p -97.73 123.27 50.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.777 0.799 . . . . 73.41 109.426 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.61 151.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.963 -1.017 . . . . 63.24 110.534 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 mp -105.35 126.67 30.33 Favored Pre-proline 0 C--N 1.28 -2.43 0 N-CA-C 107.517 -1.29 . . . . 64.12 107.517 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.36 118.03 4.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.091 1.86 . . . . 63.41 110.435 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.469 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 44.9 tt0 -60.95 -24.56 66.15 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.184 0.594 . . . . 75.34 111.667 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.83 -5.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 115.265 -0.88 . . . . 53.12 112.436 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.42 ' CZ ' ' HE1' ' A' ' 99' ' ' MET . 3.2 m-85 -80.42 -14.39 58.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.009 0.909 . . . . 72.24 109.637 173.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.3 151.39 26.05 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.127 -1.064 . . . . 70.33 108.127 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.4 p -76.23 175.24 9.21 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.574 -0.528 . . . . 75.15 109.574 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.82 -17.75 63.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.7 0.762 . . . . 52.53 109.994 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 m -83.3 -4.14 58.15 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.075 -0.511 . . . . 71.25 111.186 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.79 26.3 60.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.039 -0.601 . . . . 51.24 112.822 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.58 154.88 39.99 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.716 -0.846 . . . . 72.0 108.716 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.57 135.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.536 -0.542 . . . . 74.15 109.536 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 12.7 t -61.94 141.61 17.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.064 -1.458 . . . . 73.24 107.064 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -54.32 -44.94 72.47 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.459 1.281 . . . . 62.3 114.459 -169.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 64.6 m -109.31 21.72 16.73 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.543 -0.863 . . . . 72.2 112.246 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.478 ' HB3' ' HD3' ' A' ' 82' ' ' PRO . 17.7 tp -58.04 -48.65 96.71 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 115.041 -0.981 . . . . 70.43 110.799 174.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 50.1 Cg_exo -58.96 -27.47 84.88 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.907 1.738 . . . . 70.53 111.396 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -62.81 -45.53 95.52 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.949 -0.569 . . . . 63.14 112.388 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.56 -39.9 80.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.699 0.762 . . . . 74.22 109.329 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.55 -44.52 90.51 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.906 -1.043 . . . . 65.04 110.492 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.7 m -67.14 -45.84 75.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.764 -0.653 . . . . 41.22 111.657 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -61.58 -45.27 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 120.542 0.211 . . . . 64.11 111.403 -178.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD13 ' HB2' ' A' ' 145' ' ' ALA . 4.5 mm? -67.23 -42.45 84.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.65 0.611 . . . . 55.51 112.65 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -64.56 -44.46 90.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.824 -0.436 . . . . 61.44 109.824 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -68.18 -26.77 65.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.852 -0.613 . . . . 72.52 109.51 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.48 -9.36 86.98 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.416 -0.811 . . . . 42.45 113.313 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.2 53.39 2.19 Favored Glycine 0 C--O 1.242 0.64 0 C-N-CA 121.03 -0.605 . . . . 65.31 113.009 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 84.1 m-85 -129.8 136.95 50.19 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.968 0.413 . . . . 64.31 111.46 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.657 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 24.1 ptt180 -81.23 169.97 16.68 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.114 -0.948 . . . . 75.04 110.807 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 99' ' ' MET . 12.3 p-10 -55.13 -45.2 75.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.217 1.407 . . . . 75.34 111.624 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -61.8 -40.38 95.04 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.596 -0.729 . . . . 73.04 111.084 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.657 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 45.1 mm-40 -66.13 -34.64 78.5 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.723 -0.391 . . . . 72.42 111.247 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 mm -63.17 -47.59 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.352 -0.981 . . . . 63.04 108.352 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.42 ' HE1' ' CZ ' ' A' ' 70' ' ' PHE . 22.3 mmt -69.77 -22.1 63.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.201 -1.363 . . . . 73.54 110.543 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -58.2 -67.1 0.38 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.265 0.626 . . . . 70.34 109.734 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.484 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.5 p-90 -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.734 0.642 . . . . 74.23 112.734 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.484 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 mt -61.59 -39.93 92.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.828 0.677 . . . . 73.44 112.828 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 95.6 m-85 -98.69 -9.77 24.16 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 113.235 0.828 . . . . 72.35 113.235 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.9 m -86.0 116.04 64.18 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.552 -0.907 . . . . 72.14 108.552 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.99 154.68 73.86 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.753 2.302 . . . . 75.23 112.953 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.3 t70 -99.71 120.45 57.35 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.173 -1.047 . . . . 72.55 108.173 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.23 -27.32 84.64 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.267 2.645 . . . . 72.2 113.519 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.3 p -100.03 4.3 44.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.442 0.639 . . . . 62.11 112.215 -175.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.5 tp -102.16 139.33 37.92 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.408 -0.59 . . . . 75.55 109.408 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.2 m -129.82 118.49 21.85 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.278 -0.638 . . . . 74.24 109.278 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm -128.38 153.96 38.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 108.262 -1.014 . . . . 64.24 108.262 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.9 p -89.51 126.16 35.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 105.997 -1.853 . . . . 54.51 105.997 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.496 ' HD3' ' N ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -98.57 127.23 44.41 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.797 -0.761 . . . . 72.32 109.755 -172.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.496 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 15.7 m-20 -50.21 120.89 4.88 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 124.248 0.967 . . . . 74.0 111.356 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.36 -29.45 3.03 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 107.946 -2.061 . . . . 70.0 107.946 -173.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -145.61 170.51 16.3 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 106.479 -1.674 . . . . 60.21 106.479 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.69 6.56 32.03 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 122.065 0.936 . . . . 73.32 108.644 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.33 145.17 44.11 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.135 -1.393 . . . . 63.42 111.622 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.94 124.21 33.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.065 -0.971 . . . . 62.22 109.619 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.73 120.5 62.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.986 -0.746 . . . . 75.11 108.986 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.1 m -81.81 138.75 35.07 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.051 -1.092 . . . . 62.11 108.051 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 10.3 t30 72.4 69.33 0.14 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.293 1.044 . . . . 71.51 110.09 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.9 167.22 10.41 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.636 -1.165 . . . . 65.53 108.494 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.581 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 6.2 ptp180 -94.18 149.32 36.61 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.024 -0.732 . . . . 74.4 109.024 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.428 ' HB2' HD23 ' A' ' 102' ' ' LEU . 97.9 Cg_exo -50.8 -27.54 20.6 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.168 2.579 . . . . 62.33 113.306 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 48.3 t -60.97 -36.78 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.242 0.544 . . . . 74.35 110.375 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.581 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 66.4 m-20 -69.04 -36.87 78.2 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.037 -0.727 . . . . 62.43 109.037 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.79 -40.16 79.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.269 -0.878 . . . . 75.23 111.589 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -66.73 -38.85 87.51 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.766 -0.374 . . . . 74.11 111.931 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.413 ' N ' HD12 ' A' ' 129' ' ' LEU . 47.6 t-80 -75.97 -17.17 59.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.91 0.862 . . . . 75.23 109.239 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.76 4.5 36.57 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.131 -0.941 . . . . 72.11 110.055 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 67.88 28.3 7.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.561 1.144 . . . . 75.24 111.763 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -103.93 24.11 11.83 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.581 1.152 . . . . 64.42 108.746 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.49 -27.51 16.61 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 125.126 1.371 . . . . 73.42 112.72 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -55.53 -43.86 76.15 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.825 0.85 . . . . 73.05 110.974 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 2.3 tm-20 -73.2 -32.13 64.6 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.969 -0.752 . . . . 72.3 108.969 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.64 -42.5 89.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.015 -0.539 . . . . 62.34 110.013 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 134' ' ' ALA . 92.6 t -59.23 -41.65 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.956 -0.565 . . . . 71.21 109.523 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 136' ' ' GLU . 43.0 ttt180 -56.88 -47.12 81.2 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.01 -0.996 . . . . 73.03 110.016 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -68.96 -35.58 76.93 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.044 -0.526 . . . . 71.31 111.858 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.2 -43.44 98.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.841 0.353 . . . . 71.44 110.227 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -60.19 -45.86 91.69 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.803 -0.635 . . . . 71.42 110.178 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.4 84.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.196 -0.911 . . . . 31.52 112.075 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.57 -27.84 51.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.119 -0.492 . . . . 53.23 111.856 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -82.83 -63.6 1.33 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.182 0.808 . . . . 53.03 113.182 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 C--N 1.298 -1.665 0 CA-C-O 118.183 -0.913 . . . . 71.33 111.743 -170.863 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptp . . . . . 0 C--O 1.236 0.365 0 N-CA-C 109.682 -0.488 . . . . 62.13 109.682 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.94 136.35 5.07 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.134 1.89 . . . . 74.4 110.042 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.459 ' HA3' ' OE1' ' A' ' 97' ' ' GLU . . . -85.34 -46.64 5.47 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 109.777 -1.329 . . . . 32.42 109.777 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -74.09 132.46 42.31 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.299 -1.001 . . . . 72.22 108.299 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.24 102.94 0.35 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.572 0.225 . . . . 72.44 111.221 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.77 116.16 3.15 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.345 2.03 . . . . 71.14 109.364 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.61 -127.74 2.37 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.407 -0.901 . . . . 71.34 112.947 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m -69.88 106.38 3.14 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.35 0.66 . . . . 63.11 112.057 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.9 m -98.43 133.78 42.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.17 -0.678 . . . . 63.42 109.17 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.36 170.34 12.11 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.485 -0.561 . . . . 65.13 109.485 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.09 108.73 7.07 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.616 -1.624 . . . . 54.51 106.616 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -80.39 86.3 5.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 114.36 1.245 . . . . 63.55 114.36 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.57 79.49 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.162 -1.792 . . . . 75.03 106.162 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.31 74.92 Favored Glycine 0 C--N 1.307 -1.034 0 N-CA-C 110.422 -1.071 . . . . 44.25 110.422 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 m -97.46 129.84 44.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.822 -0.807 . . . . 72.31 108.822 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 16' ' ' ILE . 3.4 mp -96.91 126.55 42.22 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 107.273 -1.38 . . . . 73.41 107.273 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -68.69 134.66 30.94 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.191 1.261 . . . . 70.11 111.139 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.11 139.36 49.83 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.924 -1.51 . . . . 62.34 106.924 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.24 -129.17 3.52 Favored Glycine 0 N--CA 1.422 -2.254 0 C-N-CA 120.556 -0.83 . . . . 62.2 111.849 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -109.97 146.75 34.72 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.614 -0.513 . . . . 55.34 109.614 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.619 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 19.1 t0 -78.44 125.24 29.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.349 0.595 . . . . 72.42 111.456 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.67 -15.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.922 -1.036 . . . . 70.44 109.059 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 103' ' ' PHE . 24.0 mt -85.84 174.4 9.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 115.084 1.512 . . . . 63.51 115.084 -175.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -105.34 141.98 23.75 Favored Pre-proline 0 N--CA 1.423 -1.825 0 CA-C-N 112.379 -2.192 . . . . 74.51 106.636 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -55.38 -27.05 56.24 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.943 2.429 . . . . 65.22 114.412 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -91.55 -13.59 31.79 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.389 0.614 . . . . 73.33 110.755 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.607 ' HG2' HD22 ' A' ' 23' ' ' LEU . 9.0 tp10 -77.85 129.37 76.46 Favored Pre-proline 0 C--O 1.242 0.683 0 N-CA-C 105.562 -2.014 . . . . 73.2 105.562 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HD2' ' OE2' ' A' ' 27' ' ' GLU . 17.7 Cg_exo -31.08 106.91 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 125.204 3.936 . . . . 35.41 115.381 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.88 155.85 48.27 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.689 -0.687 . . . . 41.32 112.385 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 22.6 m-85 -129.45 161.38 30.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 125.552 1.541 . . . . 74.43 108.077 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.597 ' OD1' ' HD3' ' A' ' 34' ' ' ARG . 5.5 p-10 -135.13 172.1 13.49 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.38 -1.711 . . . . 71.54 106.38 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -42.98 -61.13 1.89 Allowed Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 115.844 1.794 . . . . 63.14 115.844 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.1 -34.97 99.06 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.915 1.743 . . . . 60.31 112.764 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.597 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 5.2 mpt_? -70.15 -36.09 74.48 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.88 0.326 . . . . 73.42 111.88 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.538 HG21 HD12 ' A' ' 66' ' ' ILE . 79.8 t -69.69 -41.78 80.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.661 -0.496 . . . . 74.24 109.661 177.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.52 91.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.334 -0.848 . . . . 71.15 109.771 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -62.85 -46.11 89.41 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.838 1.255 . . . . 71.1 109.791 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.415 HD22 ' CE2' ' A' ' 30' ' ' TYR . 28.2 tp -70.52 -46.03 64.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.787 -1.097 . . . . 73.41 111.516 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB2' HG22 ' A' ' 41' ' ' VAL . 98.0 mt -84.51 -18.97 34.06 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.42 0.526 . . . . 72.22 112.42 -176.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.57 59.09 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 110.81 -0.916 . . . . 51.12 110.81 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 39' ' ' LEU . 19.4 m -126.51 164.25 35.52 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.405 -0.591 . . . . 74.14 109.405 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.99 164.48 27.33 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 121.673 1.582 . . . . 73.33 111.446 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.54 -34.55 65.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.546 -0.752 . . . . 75.32 109.422 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 m -58.73 -38.9 79.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.59 -0.732 . . . . 52.13 111.851 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 24.3 ttmm -69.49 -37.5 77.27 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.481 -0.488 . . . . 70.24 110.285 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 59.7 t -63.84 -42.11 94.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.945 -0.761 . . . . 54.13 108.945 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.62 74.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 72.33 110.556 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.8 -46.38 75.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.26 -0.427 . . . . 63.03 110.577 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 68.3 mt-30 -59.08 -45.95 89.52 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.213 0.53 . . . . 55.15 110.131 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 96.9 mt -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.627 -1.17 . . . . 52.55 110.305 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -70.3 -31.24 68.49 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.811 1.041 . . . . 74.21 113.811 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.71 -11.76 35.94 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.165 -0.614 . . . . 73.35 112.234 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 36.44 6.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.318 -0.944 . . . . 73.2 111.965 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -99.11 -22.37 15.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.444 -0.947 . . . . 62.22 108.444 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.7 tp -157.13 155.26 30.72 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.773 -1.565 . . . . 73.23 106.773 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.83 161.64 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 118.159 0.436 . . . . 73.44 110.434 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.37 158.67 43.83 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.281 0.363 . . . . 50.14 110.21 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 m -127.83 165.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.343 0.657 . . . . 53.22 110.142 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -121.57 128.55 52.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.76 0.314 . . . . 61.24 111.161 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.619 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 20.9 ptt180 -136.2 124.2 22.84 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.394 -0.595 . . . . 74.1 109.394 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.72 14.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 63.53 111.729 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.93 -3.41 84.69 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.933 -0.576 . . . . 60.13 112.303 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.19 138.09 13.74 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 111.056 -0.818 . . . . 54.41 111.056 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.6 123.45 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.874 -1.158 . . . . 65.24 107.874 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.2 m -131.22 151.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.345 0.593 . . . . 72.23 110.936 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 35' ' ' VAL . 76.0 mt -124.45 125.5 25.6 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 107.437 -1.32 . . . . 74.13 107.437 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 54.4 Cg_exo -56.87 128.98 32.17 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.769 2.313 . . . . 63.44 112.607 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 47.5 tt0 -64.54 -24.79 67.72 Favored 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 123.421 0.688 . . . . 72.43 111.206 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.83 -3.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.569 -0.741 . . . . 74.04 112.425 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.415 ' CD1' ' HB2' ' A' ' 67' ' ' PRO . 5.1 m-85 -87.15 -4.1 59.1 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.428 1.109 . . . . 73.53 108.752 173.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -117.35 150.43 38.85 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 113.979 -1.464 . . . . 75.54 107.398 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -83.01 173.03 12.14 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.629 -0.878 . . . . 53.0 108.629 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.28 -17.27 64.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.411 0.624 . . . . 74.12 110.62 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -81.27 -3.91 53.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.692 -0.686 . . . . 63.22 111.478 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 23.84 58.85 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.77 -0.729 . . . . 41.31 112.976 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.12 154.76 44.33 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.285 -1.005 . . . . 74.33 108.285 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.8 t -62.6 142.75 16.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 123.62 0.575 . . . . 65.1 109.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.31 135.08 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.974 0.796 . . . . 63.33 109.346 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -54.91 -43.66 73.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.852 -0.613 . . . . 54.45 112.295 -174.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -98.67 18.35 17.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.904 0.705 . . . . 62.44 112.904 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -60.6 -52.08 75.27 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-N 116.595 -0.275 . . . . 65.53 110.803 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 19.3 Cg_endo -59.85 -27.92 86.03 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 121.881 1.721 . . . . 70.13 111.796 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.58 92.93 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 116.098 -0.501 . . . . 50.43 112.084 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -68.22 -39.98 82.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.285 0.564 . . . . 65.13 109.482 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.29 -36.27 83.57 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.785 -0.643 . . . . 62.51 110.73 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.2 m -61.0 -47.8 84.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.358 -0.383 . . . . 73.04 111.999 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -42.56 86.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 120.67 -0.412 . . . . 71.25 110.607 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.04 -35.62 80.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.499 0.555 . . . . 73.54 112.499 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -63.9 -33.45 75.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.026 -0.361 . . . . 73.53 110.026 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.58 -31.18 71.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.075 -0.511 . . . . 73.11 110.222 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.97 -9.19 81.17 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.715 -0.675 . . . . 43.34 111.473 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.12 55.76 3.96 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 112.402 -0.279 . . . . 64.3 112.402 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 88.7 m-85 -113.77 137.83 51.1 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.236 0.458 . . . . 74.54 112.236 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' O ' HG12 ' A' ' 98' ' ' ILE . 15.4 ptp180 -88.03 172.23 9.7 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.462 -0.79 . . . . 63.31 111.176 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -53.59 -45.06 69.88 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.267 1.427 . . . . 71.43 112.425 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -60.13 -41.57 92.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.208 0.603 . . . . 73.01 110.059 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 5.7 mm-40 -63.21 -43.85 96.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.992 -0.549 . . . . 73.55 110.412 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.7 mm -61.15 -48.13 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.587 0.708 . . . . 72.23 109.3 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.437 ' O ' ' HD2' ' A' ' 103' ' ' PHE . 53.8 mtt -74.65 -20.97 59.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.138 -0.937 . . . . 71.12 111.638 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 64.3 ttt180 -57.2 -65.88 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.025 0.53 . . . . 74.21 110.576 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.486 ' CD1' ' HG3' ' A' ' 144' ' ' MET . 41.0 p-90 -69.02 -33.1 73.1 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.968 0.729 . . . . 72.12 112.968 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.47 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.1 mt -57.24 -40.5 77.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.976 0.732 . . . . 71.25 112.976 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 23' ' ' LEU . 97.1 m-85 -98.65 3.48 47.82 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.544 0.572 . . . . 72.11 112.544 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.3 m -87.44 119.58 70.83 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.985 -0.376 . . . . 45.51 109.985 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 32.2 Cg_exo -62.74 128.84 24.37 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.616 1.544 . . . . 43.24 108.348 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . 30.1 t70 -99.99 122.57 50.21 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 120.301 -0.56 . . . . 72.43 110.209 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.4 -19.53 59.08 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.411 2.741 . . . . 65.14 113.7 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -107.6 3.86 25.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 111.919 0.34 . . . . 64.03 111.919 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.4 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 53.5 tp -102.64 130.6 49.59 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.74 0.781 . . . . 71.31 110.979 -177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.538 HG22 ' HB1' ' A' ' 119' ' ' ALA . 29.9 m -131.28 118.65 20.66 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.476 -1.305 . . . . 41.43 107.476 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.1 163.6 33.86 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 N-CA-C 113.156 0.799 . . . . 65.42 113.156 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.9 p -109.4 159.95 16.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.306 -0.861 . . . . 75.21 109.198 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.02 -173.53 3.17 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.024 -1.102 . . . . 75.2 108.024 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -89.2 150.03 22.85 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.426 -0.583 . . . . 75.24 109.426 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.19 -69.22 3.06 Favored Glycine 0 C--N 1.312 -0.782 0 N-CA-C 109.271 -1.532 . . . . 43.34 109.271 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 53.2 p -98.1 101.61 13.13 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.102 -1.444 . . . . 74.3 107.102 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.536 ' H ' ' HD3' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -89.72 3.68 51.99 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.872 -0.604 . . . . 74.51 112.326 -172.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -73.61 142.17 46.55 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.063 -1.088 . . . . 74.43 108.063 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -81.95 123.65 29.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.272 0.558 . . . . 74.32 111.307 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.2 t -96.59 128.73 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 124.441 1.096 . . . . 75.45 109.065 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -83.21 154.46 24.22 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.059 -0.973 . . . . 70.23 111.337 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 78.8 m-20 62.44 40.81 10.56 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.481 1.112 . . . . 74.12 110.949 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 174.41 6.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.16 -0.473 . . . . 62.11 110.858 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -102.69 143.74 27.21 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 116.379 -0.373 . . . . 75.34 111.077 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.5 Cg_exo -53.36 -24.32 27.07 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.847 3.031 . . . . 70.41 114.595 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.63 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 71.2 t -60.4 -39.83 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 122.158 0.98 . . . . 65.11 110.405 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.18 -30.47 67.6 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.052 -0.976 . . . . 74.21 110.381 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.17 77.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 71.34 111.422 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.71 -36.27 82.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.932 -0.307 . . . . 64.44 111.599 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -66.57 -29.13 69.12 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.68 0.752 . . . . 73.12 109.963 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.89 0.38 53.24 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.883 -1.053 . . . . 44.43 111.608 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.7 t60 64.55 28.7 13.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 122.868 1.318 . . . . 51.42 109.572 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -95.02 25.13 4.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.788 1.28 . . . . 73.12 108.282 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -53.89 -29.39 41.55 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.508 -1.678 . . . . 54.44 113.491 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -63.61 -37.55 87.75 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.931 -0.766 . . . . 71.14 108.931 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -63.18 -42.56 99.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.231 -0.895 . . . . 70.13 109.173 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.43 -47.93 87.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.585 -0.734 . . . . 71.3 110.342 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 134' ' ' ALA . 99.1 t -59.38 -44.77 93.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.434 -0.348 . . . . 73.3 111.416 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -63.68 -38.4 90.96 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.944 -0.702 . . . . 74.14 111.361 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -69.0 -36.52 77.91 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.829 -0.434 . . . . 72.11 109.829 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.37 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.717 -0.674 . . . . 73.1 109.877 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.74 -42.88 94.18 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.939 -0.573 . . . . 52.45 111.015 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.68 -25.96 65.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.23 0.538 . . . . 52.12 111.486 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.486 ' HG3' ' CD1' ' A' ' 101' ' ' TRP . 0.5 OUTLIER -82.18 -39.75 22.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.449 0.642 . . . . 61.11 109.421 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -81.54 -40.75 22.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.782 0.66 . . . . 75.42 112.782 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 109.453 -0.573 . . . . 74.24 109.453 -177.873 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 108.824 -0.806 . . . . 62.04 108.824 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.98 115.7 4.11 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 121.847 1.698 . . . . 71.21 110.72 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.61 133.7 5.7 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.97 -0.633 . . . . 43.4 111.695 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -73.34 144.23 46.58 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 110.124 -0.324 . . . . 71.53 110.124 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.29 137.49 48.88 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.712 -0.847 . . . . 72.05 108.712 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -52.63 153.91 13.26 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 123.218 2.612 . . . . 54.14 112.483 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.62 82.29 0.29 Allowed Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.915 -0.584 . . . . 41.43 113.38 -176.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -144.55 158.87 43.57 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.523 -1.288 . . . . 74.23 107.523 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -162.84 -161.13 0.68 Allowed 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.194 -1.41 . . . . 72.14 107.194 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.5 mt -73.61 145.02 45.73 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.288 -0.634 . . . . 73.31 109.288 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.04 11.38 37.78 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.5 0.666 . . . . 73.21 111.462 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -88.5 107.84 19.09 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.446 -0.797 . . . . 64.01 109.229 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.94 116.74 53.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 108.024 -1.102 . . . . 54.22 108.024 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.8 -165.97 23.34 Favored Glycine 0 N--CA 1.412 -2.933 0 CA-C-N 115.5 -0.773 . . . . 74.21 111.781 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 6.9 m -65.57 108.52 2.06 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 124.166 0.986 . . . . 74.23 112.87 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.66 124.06 89.95 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 107.27 -1.382 . . . . 50.21 107.27 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.04 166.26 30.03 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.084 2.523 . . . . 74.32 113.021 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.85 123.23 46.55 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.361 -1.718 . . . . 73.04 106.361 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.6 -110.96 2.97 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.581 -0.819 . . . . 71.03 113.327 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.36 123.18 38.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.256 0.55 . . . . 75.13 111.879 -171.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 23' ' ' LEU . 3.5 t70 -61.29 131.94 51.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.285 -0.871 . . . . 71.21 111.75 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.06 -4.78 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 122.07 0.938 . . . . 72.11 109.29 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 17.6 mt -74.98 165.15 25.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.618 1.199 . . . . 72.32 113.941 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.3 t70 -94.26 134.66 25.37 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 105.314 -2.106 . . . . 72.13 105.314 172.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.84 -21.75 27.14 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 123.406 2.738 . . . . 52.52 114.572 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.86 -23.85 23.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.208 0.447 . . . . 54.43 112.208 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 23.2 mm-40 -65.87 139.22 96.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.07 -0.252 . . . . 65.53 111.676 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.1 128.0 28.36 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.351 2.701 . . . . 71.13 113.102 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.5 p -122.94 170.07 10.5 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 121.629 0.728 . . . . 73.32 111.484 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 24.9 m-85 -130.36 161.21 31.83 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 126.401 1.88 . . . . 71.3 107.851 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 66.3 t0 -135.03 161.74 34.44 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 103.346 -2.835 . . . . 73.15 103.346 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 mt -53.12 -51.44 75.05 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 112.672 0.619 . . . . 72.41 112.672 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.31 -35.37 98.77 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.161 1.907 . . . . 55.51 112.2 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 13.5 tpt180 -70.78 -38.54 73.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.48 -0.327 . . . . 73.43 110.697 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 66' ' ' ILE . 59.5 t -68.15 -37.46 78.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.602 -0.518 . . . . 53.21 109.602 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.89 81.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.289 -0.869 . . . . 64.44 109.68 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.8 -45.96 80.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.203 -0.908 . . . . 45.24 109.68 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.417 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 49.7 tp -62.31 -50.66 70.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.906 -1.043 . . . . 71.34 112.3 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.43 -13.92 41.94 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.469 0.544 . . . . 73.12 112.469 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.44 31.5 56.72 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 110.947 -0.861 . . . . 73.32 110.947 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.6 m -121.98 161.26 43.38 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.529 -0.915 . . . . 75.24 108.529 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.07 163.47 35.13 Favored 'Trans proline' 0 C--O 1.262 1.681 0 C-N-CA 121.393 1.395 . . . . 63.12 111.673 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.19 -33.21 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.82 0.848 . . . . 70.42 109.526 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 13.4 m -57.03 -44.38 82.86 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.728 -1.124 . . . . 63.4 110.617 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 51.8 mtpt -69.4 -32.04 70.79 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.101 -0.374 . . . . 71.42 111.425 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -62.43 -44.38 99.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 109.593 -0.521 . . . . 74.22 109.593 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.83 81.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 64.52 109.996 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 44' ' ' SER . 89.1 mt-30 -64.51 -41.43 96.43 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 116.275 -0.42 . . . . 74.32 111.543 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 44.4 mt-30 -61.04 -42.14 97.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.802 0.81 . . . . 74.32 109.961 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.24 -41.19 98.2 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.074 -1.421 . . . . 72.53 109.696 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 15' ' ' SER . 97.0 mtt180 -71.57 -21.97 61.81 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.77 -0.65 . . . . 74.02 112.291 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 50.9 mt-10 -81.71 -12.68 58.53 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 122.103 -0.373 . . . . 61.11 110.64 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.2 23.35 77.73 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.52 -1.032 . . . . 74.31 110.52 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -109.26 5.54 23.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.394 0.616 . . . . 74.45 110.523 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 tp -153.6 151.57 29.88 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.279 -1.749 . . . . 75.51 106.279 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.01 148.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.317 -0.623 . . . . 73.11 109.317 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB2' HG12 ' A' ' 66' ' ' ILE . . . -141.62 161.8 37.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.972 -0.751 . . . . 44.42 108.972 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.63 160.31 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 123.343 0.402 . . . . 60.42 110.445 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 40.2 ttm180 -115.34 117.84 31.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.393 0.616 . . . . 75.04 111.698 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 26.2 ptt180 -127.96 130.07 47.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.077 -0.712 . . . . 75.0 109.077 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.05 21.63 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.945 0.898 . . . . 74.05 110.384 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.14 -15.06 64.02 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.841 -0.618 . . . . 42.24 112.731 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.45 143.1 16.52 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.02 -0.61 . . . . 32.42 112.244 -177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.14 121.41 47.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 109.366 -0.605 . . . . 72.22 109.366 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.43 152.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.605 -0.725 . . . . 74.23 110.892 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 57' ' ' ALA . 78.9 mt -115.1 133.48 22.67 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.283 -1.006 . . . . 72.24 108.283 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.12 130.33 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.755 1.637 . . . . 72.51 111.156 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 48.4 tt0 -62.59 -24.56 67.62 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.164 0.507 . . . . 73.02 111.181 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -67.38 -6.97 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.684 -0.689 . . . . 63.34 112.707 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.571 ' CD2' HD11 ' A' ' 81' ' ' LEU . 5.2 m-85 -81.56 -11.24 59.23 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.217 1.008 . . . . 65.31 109.24 173.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -113.06 164.2 13.77 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.676 -1.147 . . . . 73.34 108.291 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.49 ' HA ' ' CD2' ' A' ' 130' ' ' HIS . 37.5 p -82.34 165.97 19.87 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.131 -0.692 . . . . 74.12 109.131 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -64.71 -19.14 65.59 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.047 -0.524 . . . . 72.21 109.627 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 m -79.51 -19.9 48.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.576 -0.738 . . . . 71.31 110.229 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.46 -5.96 38.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.436 -0.888 . . . . 70.53 113.75 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.84 166.2 11.74 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.086 -0.655 . . . . 74.13 109.489 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.05 139.91 20.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.757 -0.831 . . . . 64.15 108.757 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.76 136.74 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.231 -1.026 . . . . 75.4 108.231 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -54.77 -36.56 64.98 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 112.535 0.569 . . . . 52.22 112.535 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -88.11 -0.76 57.46 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.638 0.607 . . . . 64.44 112.638 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 70' ' ' PHE . 20.3 tp -65.36 -53.64 37.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.37 -0.348 . . . . 64.41 111.809 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 38.6 Cg_exo -60.28 -30.9 92.12 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.694 1.596 . . . . 73.33 111.304 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.49 90.01 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.864 -0.607 . . . . 71.04 112.838 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 pp -68.39 -40.5 81.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.394 0.616 . . . . 72.43 109.355 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.34 -41.28 98.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.591 -0.731 . . . . 60.31 110.833 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -57.77 -47.72 81.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.477 -0.329 . . . . 71.4 111.795 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -42.11 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 120.812 -0.355 . . . . 65.43 111.345 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.36 -37.17 82.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.467 0.543 . . . . 75.32 112.467 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -66.83 -32.29 73.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.664 -0.244 . . . . 74.35 111.08 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.19 -29.91 71.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.294 0.569 . . . . 63.25 109.778 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.77 6.42 64.71 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.556 -0.747 . . . . 54.41 112.394 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.31 33.43 84.98 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.465 0.546 . . . . 73.15 114.465 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 57.8 m-85 -85.85 131.63 34.27 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 117.626 0.713 . . . . 75.33 112.344 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.566 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 21.8 ptt180 -73.32 170.45 15.01 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-N 115.345 -0.843 . . . . 75.45 111.215 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -55.02 -44.84 74.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 125.899 1.679 . . . . 54.31 112.013 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.9 m -62.64 -42.1 99.41 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.085 -0.961 . . . . 72.54 110.628 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.566 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 61.7 mm-40 -66.6 -34.74 78.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.108 -0.496 . . . . 61.31 110.328 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.46 -48.42 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.741 0.781 . . . . 74.34 108.93 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 55.1 mtt -75.13 -18.43 60.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.91 -1.041 . . . . 73.15 111.894 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -60.73 -63.46 1.29 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.989 -0.55 . . . . 72.13 110.574 -174.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.514 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 31.3 p-90 -69.32 -32.82 72.19 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.129 0.418 . . . . 73.43 112.129 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 12.2 mt -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.95 1.093 . . . . 74.34 113.95 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.402 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 84.0 m-85 -95.75 -2.95 46.75 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.008 0.744 . . . . 72.43 113.008 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 m -88.57 109.79 32.0 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 110.193 -0.299 . . . . 60.2 110.193 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 42.9 Cg_exo -60.09 144.66 99.46 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.892 2.395 . . . . 75.05 111.626 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 11.0 t70 -107.47 124.0 36.37 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.626 -0.509 . . . . 71.32 109.626 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.526 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 28.3 Cg_endo -60.62 -25.83 81.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.658 2.905 . . . . 65.34 114.513 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.6 m -102.41 1.49 35.43 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.984 0.421 . . . . 74.21 110.247 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.493 ' HG ' HG12 ' A' ' 111' ' ' ILE . 43.0 tp -101.66 130.58 48.04 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.601 -0.518 . . . . 63.51 109.601 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.524 HG22 ' HB1' ' A' ' 119' ' ' ALA . 25.3 m -128.04 110.54 12.59 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.802 -0.814 . . . . 63.52 108.802 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.493 HG12 ' HG ' ' A' ' 109' ' ' LEU . 39.9 mm -122.88 149.51 26.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.288 -0.869 . . . . 74.24 109.88 -172.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -102.61 153.1 20.43 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.897 -1.519 . . . . 62.44 106.897 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.617 ' HD3' ' N ' ' A' ' 114' ' ' ASP . 2.7 tmt_? -134.89 152.48 51.78 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.56 -0.856 . . . . 72.21 110.32 -171.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.617 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 10.8 m-20 -63.66 99.37 0.22 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.483 -0.932 . . . . 71.31 108.483 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 130.77 -37.68 2.07 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 110.037 -1.225 . . . . 74.41 110.037 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.0 m -122.09 96.55 5.1 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.752 -0.832 . . . . 71.12 108.752 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -69.8 -33.9 72.99 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.228 0.537 . . . . 75.11 109.863 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.2 133.04 55.73 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.224 -1.353 . . . . 74.34 107.747 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.524 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -67.07 135.08 53.09 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.968 0.413 . . . . 65.32 110.696 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.78 118.71 55.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.342 -0.614 . . . . 73.4 109.342 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -83.04 148.87 27.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.746 -1.575 . . . . 61.15 106.746 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 34.2 m-80 66.99 41.37 2.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 123.828 0.851 . . . . 75.31 109.08 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.63 150.38 26.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.463 -0.495 . . . . 63.35 110.754 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -80.36 128.1 73.96 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.629 -0.878 . . . . 75.35 108.629 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.53 -24.1 8.7 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.063 3.175 . . . . 75.44 115.11 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.6 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.1 t -60.62 -39.1 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.267 0.556 . . . . 74.12 110.419 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -69.95 -30.27 67.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.187 -0.461 . . . . 74.21 111.149 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.36 82.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.699 -0.682 . . . . 73.11 111.17 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -63.95 -37.68 88.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.501 0.191 . . . . 74.2 111.307 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.49 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 61.1 t-80 -68.7 -36.79 78.92 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.741 -0.663 . . . . 73.32 109.301 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.14 21.2 5.25 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.342 -0.845 . . . . 74.13 112.773 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.8 t60 64.69 27.64 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.77 1.228 . . . . 70.4 111.361 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -110.53 24.42 12.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.965 1.364 . . . . 62.24 107.635 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.62 -25.91 12.07 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 112.416 -2.174 . . . . 74.32 112.627 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -54.78 -39.33 68.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.54 0.736 . . . . 54.34 110.75 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.35 -33.71 74.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.383 0.611 . . . . 73.42 111.072 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 129' ' ' LEU . 49.7 t -72.59 -41.96 63.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.48 -0.782 . . . . 75.24 109.651 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.7 -48.06 89.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.234 -0.439 . . . . 71.54 110.264 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -63.59 -37.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.746 -0.382 . . . . 70.35 111.428 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -65.02 -41.58 95.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.644 -0.873 . . . . 71.24 108.644 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.47 -45.08 88.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.103 -0.953 . . . . 74.23 110.262 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -62.13 -38.62 89.65 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.844 -0.616 . . . . 74.34 111.248 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.21 84.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.05 0.453 . . . . 71.33 110.51 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.8 tpt -69.64 -39.28 77.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.809 -0.632 . . . . 61.02 110.736 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.94 -53.79 5.08 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.353 0.872 . . . . 62.25 113.353 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 118.691 -0.671 . . . . 73.11 109.426 -176.189 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.437 -0.579 . . . . 72.44 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.31 122.69 6.22 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.219 1.946 . . . . 73.52 110.214 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -167.1 126.25 1.42 Allowed Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.65 -0.98 . . . . 53.23 110.65 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -73.97 139.15 44.64 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.066 -0.716 . . . . 75.11 109.066 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.88 121.08 77.34 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 109.122 -0.696 . . . . 43.04 109.122 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -67.66 119.37 6.39 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.754 1.636 . . . . 64.2 110.815 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.56 -43.5 36.53 Favored Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 111.129 -0.788 . . . . 71.04 111.129 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m -69.98 99.91 1.51 Allowed 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.219 0.533 . . . . 72.14 109.746 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.6 m -120.97 138.88 53.93 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.618 -1.253 . . . . 72.2 107.618 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.0 mt -79.89 145.97 32.41 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.764 -0.458 . . . . 72.51 109.764 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.23 146.45 27.07 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 116.085 -0.507 . . . . 51.11 109.701 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.12 107.87 16.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.529 -0.915 . . . . 64.02 108.529 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.88 109.33 16.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.863 -0.792 . . . . 71.11 108.863 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.27 99.38 0.2 Allowed Glycine 0 N--CA 1.418 -2.526 0 C-N-CA 120.271 -0.966 . . . . 64.32 111.238 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 p -72.66 95.24 1.84 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.179 -0.675 . . . . 53.12 109.179 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.69 120.95 76.03 Favored Pre-proline 0 N--CA 1.437 -1.084 0 CA-C-N 115.484 -0.78 . . . . 73.21 109.918 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.72 165.07 29.34 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.467 2.112 . . . . 75.11 110.718 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.75 123.92 42.18 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.963 -1.125 . . . . 65.23 107.963 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -105.4 -86.72 1.94 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.336 -0.935 . . . . 65.52 112.796 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -127.53 143.54 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.832 0.349 . . . . 74.23 111.123 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.82 139.07 41.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.553 0.692 . . . . 72.41 112.369 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.9 t -112.12 -14.9 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.295 -0.866 . . . . 74.11 110.894 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.485 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -96.09 -179.63 4.74 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.922 -1.111 . . . . 65.1 111.657 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.64 137.08 19.36 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 108.05 -1.093 . . . . 73.52 108.05 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.88 -21.35 15.22 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.571 2.848 . . . . 62.55 114.191 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.05 -19.52 61.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.085 0.469 . . . . 64.13 111.51 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -88.5 154.68 51.16 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 119.296 -0.383 . . . . 75.32 110.017 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 4.0 Cg_endo -46.24 110.13 0.25 Allowed 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.984 3.123 . . . . 54.3 114.992 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.0 p -125.0 167.34 14.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.794 0.838 . . . . 75.41 110.686 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.499 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 13.0 m-85 -131.4 158.2 41.39 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.307 1.043 . . . . 72.21 108.193 169.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.5 t70 -136.95 168.82 18.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 104.281 -2.488 . . . . 62.32 104.281 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -50.6 -56.61 17.65 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 113.964 1.098 . . . . 61.43 113.964 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 14.6 Cg_endo -57.74 -39.8 84.53 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.205 1.936 . . . . 72.55 112.346 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -70.38 -37.54 74.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 111.972 0.36 . . . . 65.42 111.972 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 31' ' ' ASP . 46.1 t -69.3 -37.64 76.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.061 -0.718 . . . . 72.03 109.061 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.14 83.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.889 -1.051 . . . . 52.41 109.704 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.7 -45.94 84.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.875 0.87 . . . . 73.11 110.061 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -62.07 -43.33 99.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.84 -1.073 . . . . 53.41 111.903 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' A' ' 41' ' ' VAL . 83.5 mt -97.31 -12.56 22.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.939 -0.573 . . . . 72.01 112.097 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 17.15 80.18 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.538 -0.625 . . . . 71.11 111.538 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 39' ' ' LEU . 25.8 m -112.48 159.45 34.05 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.73 -0.841 . . . . 71.33 108.73 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.4 170.01 20.16 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 121.208 1.272 . . . . 72.01 111.246 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.08 -33.16 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.387 0.675 . . . . 71.14 110.484 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 m -56.35 -46.33 80.03 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 114.916 -1.038 . . . . 75.42 110.197 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 92.5 mttt -69.97 -35.27 74.32 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.032 0.382 . . . . 75.14 112.032 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -61.15 -43.72 96.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 N-CA-C 109.548 -0.538 . . . . 73.51 109.548 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' O ' ' HD3' ' A' ' 51' ' ' ARG . . . -61.04 -38.88 87.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.423 -0.808 . . . . 74.53 109.833 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 79.1 mm-40 -66.84 -36.35 82.13 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 112.91 0.707 . . . . 74.13 112.91 178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.0 mm100 -57.87 -42.8 85.3 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.726 -0.842 . . . . 74.0 108.726 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.53 -40.61 97.33 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.4 -1.273 . . . . 64.03 110.662 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 47' ' ' ALA . 10.2 mpt_? -71.21 -20.87 62.21 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.228 0.825 . . . . 75.21 113.228 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 44.5 mm-40 -76.66 -11.87 59.92 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 120.525 -0.47 . . . . 75.01 109.824 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.72 72.15 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.944 -0.863 . . . . 61.34 110.944 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -105.46 4.28 30.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.119 -0.541 . . . . 74.11 110.206 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD21 HD13 ' A' ' 66' ' ' ILE . 32.2 tp -161.12 157.51 26.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.612 -0.884 . . . . 41.41 108.612 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 93.9 t -132.82 147.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.362 -0.977 . . . . 53.14 108.362 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.72 157.85 43.85 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.886 -0.783 . . . . 73.0 108.886 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -130.46 166.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 122.92 0.488 . . . . 74.44 110.21 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 43.8 ttp180 -121.07 125.68 47.91 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.59 -0.277 . . . . 62.13 110.801 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.486 ' NH1' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -116.62 117.09 28.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.69 -0.855 . . . . 70.42 108.69 177.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.96 -48.06 0.68 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.083 1.753 . . . . 44.44 111.583 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 63' ' ' GLY . . . -176.23 -12.07 0.02 OUTLIER Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.738 -1.119 . . . . 53.13 112.287 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 62' ' ' GLY . . . -103.53 146.06 16.35 Favored Glycine 0 CA--C 1.493 -1.339 0 C-N-CA 120.634 -0.793 . . . . 71.33 112.122 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.49 128.8 47.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.203 0.525 . . . . 72.22 109.771 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG13 ' NH1' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -131.54 158.75 43.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.698 1.199 . . . . 72.25 110.107 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.414 HD13 HD21 ' A' ' 55' ' ' LEU . 65.2 mt -124.77 121.93 25.64 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.114 -1.439 . . . . 63.13 107.114 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.67 126.67 22.54 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.057 1.838 . . . . 73.03 111.192 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.499 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 47.5 tt0 -62.22 -24.65 67.36 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 121.261 0.553 . . . . 74.43 111.447 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.68 -4.54 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.092 -0.958 . . . . 54.31 112.665 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.1 m-85 -86.29 -7.64 58.34 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.073 0.939 . . . . 74.43 109.848 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -117.11 159.98 21.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.119 . . . . 74.13 107.994 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.0 p -88.02 163.37 16.32 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.823 -1.177 . . . . 62.51 107.823 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -66.26 -16.45 64.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.305 0.574 . . . . 72.43 110.382 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.2 m -79.72 -9.5 59.66 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.777 -0.647 . . . . 74.22 110.898 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.86 -2.43 66.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.304 -0.474 . . . . 51.42 113.164 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -90.37 152.84 20.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.505 -0.554 . . . . 71.11 109.505 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.53 136.19 26.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.259 -1.386 . . . . 72.31 107.259 171.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 129' ' ' LEU . 23.8 t -61.25 129.06 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.443 -0.947 . . . . 45.52 108.443 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.41 -22.33 66.08 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.751 0.648 . . . . 72.0 112.751 -177.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.441 ' H ' HG12 ' A' ' 78' ' ' VAL . 7.1 m -87.75 -8.21 56.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.963 -0.562 . . . . 64.24 110.777 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 18.0 tp -63.45 -56.44 26.77 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 119.015 -0.517 . . . . 54.12 111.248 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.0 Cg_exo -62.83 -25.2 74.51 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.331 1.354 . . . . 72.33 110.706 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -45.36 64.57 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.602 -0.726 . . . . 45.44 111.721 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.81 -40.43 79.54 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.996 -0.742 . . . . 73.24 108.996 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 74.0 mt -59.91 -39.17 84.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.766 -0.652 . . . . 65.42 110.802 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.2 m -61.47 -48.36 81.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.054 -0.521 . . . . 71.34 111.399 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -44.41 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 111.862 0.319 . . . . 74.32 111.862 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.27 -35.79 80.24 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 120.177 -0.609 . . . . 62.35 112.225 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -64.27 -41.48 96.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.616 -0.883 . . . . 70.04 108.616 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.19 -31.2 72.25 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.96 -1.018 . . . . 74.53 110.58 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.38 -9.45 81.77 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.64 -0.709 . . . . 60.45 112.893 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.9 46.09 7.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.088 -0.577 . . . . 72.33 113.723 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.439 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 96.6 m-85 -111.0 142.92 42.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.895 -0.409 . . . . 74.02 109.895 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.476 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 16.9 ptp180 -87.94 171.03 10.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.558 -0.292 . . . . 74.31 111.141 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -55.05 -45.79 75.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.856 1.262 . . . . 65.0 111.87 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.8 m -64.5 -39.99 94.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.188 -0.915 . . . . 72.5 110.41 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 45.3 mt-10 -65.82 -35.1 79.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.079 -0.51 . . . . 74.21 111.615 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.28 -46.97 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.855 -1.165 . . . . 74.41 107.855 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -66.33 -28.64 68.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.028 -1.442 . . . . 64.12 111.029 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.0 -67.33 0.27 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 122.877 0.471 . . . . 75.31 111.037 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.457 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.3 p-90 -69.05 -32.1 71.35 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.89 0.7 . . . . 75.42 112.89 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 126' ' ' VAL . 13.6 mt -61.22 -40.78 95.3 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 113.097 0.777 . . . . 72.42 113.097 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.5 m-85 -91.46 -5.4 54.35 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.803 0.668 . . . . 74.25 112.803 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 92.4 m -78.15 119.94 79.29 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.963 -0.754 . . . . 71.33 108.963 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.14 129.5 20.68 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.579 1.519 . . . . 74.4 109.426 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 34.4 t70 -105.41 116.59 60.0 Favored Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 116.388 -0.369 . . . . 74.15 111.012 -175.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.19 -25.26 80.56 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.728 2.286 . . . . 70.21 112.084 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -17.72 59.63 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.931 -0.577 . . . . 62.42 110.511 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.96 125.63 48.69 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.766 0.793 . . . . 65.3 110.828 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 m -131.28 110.87 11.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.365 -1.346 . . . . 64.21 107.365 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.4 pt -136.64 163.31 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 N-CA-C 112.739 0.644 . . . . 64.12 112.739 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.0 p -90.45 127.57 36.25 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 114.825 -1.08 . . . . 70.24 108.089 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.542 ' HD3' ' N ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -80.54 130.49 35.16 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.697 -0.401 . . . . 73.52 110.475 -172.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.542 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 22.5 t70 -58.31 119.76 7.49 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 123.649 0.779 . . . . 71.53 111.033 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.45 -12.56 47.44 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.506 -1.038 . . . . 70.35 110.506 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.9 m -125.42 161.34 27.28 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 109.27 -0.641 . . . . 73.24 109.27 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -96.74 -22.12 17.16 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 109.153 -0.684 . . . . 74.44 109.153 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -66.56 151.34 47.48 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-N 114.235 -1.348 . . . . 72.42 113.317 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.16 131.08 46.31 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.608 -1.178 . . . . 61.13 108.26 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.78 121.59 62.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.097 -0.705 . . . . 72.24 109.097 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 m -90.1 138.66 31.33 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.775 -1.194 . . . . 73.44 107.775 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 44.6 t-20 69.39 59.23 0.32 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.34 1.067 . . . . 70.51 109.134 176.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.66 164.09 11.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.689 -1.141 . . . . 74.22 109.9 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -87.55 145.85 38.17 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.464 -0.569 . . . . 70.11 109.464 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.402 ' HB2' HD23 ' A' ' 102' ' ' LEU . 79.7 Cg_exo -52.53 -28.84 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.403 2.735 . . . . 75.33 113.708 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.654 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 95.8 t -60.34 -41.99 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.242 0.544 . . . . 73.31 110.146 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.415 ' OD2' ' HG2' ' A' ' 113' ' ' ARG . 3.9 t70 -65.01 -30.04 70.99 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.601 0.715 . . . . 72.53 109.796 -172.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.23 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.222 -0.899 . . . . 63.15 112.316 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 3.9 pp -68.14 -34.29 76.07 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.464 -0.494 . . . . 71.25 110.333 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -65.38 -31.85 73.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.722 -0.844 . . . . 73.23 108.722 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.74 8.28 20.4 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.785 -1.098 . . . . 72.42 111.961 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 64.06 28.32 14.26 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 123.011 1.386 . . . . 73.21 109.716 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.57 25.59 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.652 -1.158 . . . . 51.5 108.956 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.93 14.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.434 1.494 . . . . 74.12 112.212 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -56.44 -31.95 64.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.316 0.246 . . . . 72.32 111.659 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.42 -26.87 61.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 74.44 110.773 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.46 -45.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.562 -1.273 . . . . 44.45 107.562 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 58.7 t -62.26 -42.41 95.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.564 -1.198 . . . . 65.11 109.692 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -58.78 -45.31 90.11 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.44 0.696 . . . . 54.21 110.354 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.1 tpp180 -66.16 -41.28 90.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.161 -0.681 . . . . 74.34 109.161 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.58 88.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 55.34 111.118 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -62.16 -41.58 98.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 72.2 110.536 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.67 -27.45 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 70.23 112.113 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 93.8 mmm -86.0 -32.03 21.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 73.22 110.347 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.439 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.5 -60.1 2.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.322 -0.399 . . . . 73.54 112.062 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 109.249 -0.649 . . . . 72.31 109.249 -176.28 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 110.16 -0.311 . . . . 52.33 110.16 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.42 105.8 2.11 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.141 1.894 . . . . 72.23 110.436 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.81 97.9 1.78 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.762 -0.732 . . . . 72.52 112.912 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -75.39 133.63 41.14 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.746 0.308 . . . . 71.13 110.99 172.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.92 128.14 9.26 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.542 -1.281 . . . . 72.12 107.542 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.07 106.41 2.02 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.342 1.361 . . . . 75.52 109.982 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.62 -170.6 16.69 Favored Glycine 0 N--CA 1.407 -3.298 0 C-N-CA 120.458 -0.877 . . . . 73.54 111.452 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.2 t -161.04 164.57 30.78 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 106.404 -1.702 . . . . 62.31 106.404 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.1 m -75.59 119.57 19.81 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.749 -0.834 . . . . 73.54 108.749 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.43 152.87 42.88 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 115.59 -0.732 . . . . 73.31 111.705 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.78 152.89 34.58 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.511 -0.768 . . . . 73.54 110.055 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -58.38 97.73 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.523 1.305 . . . . 74.15 114.523 -175.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.96 18.07 3.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 122.517 1.151 . . . . 72.11 108.155 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.84 32.74 2.37 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.104 -1.598 . . . . 73.34 109.104 -172.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 m -65.89 153.51 41.82 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.469 1.107 . . . . 72.35 111.005 -175.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 16' ' ' ILE . 3.4 mp -120.27 133.66 24.01 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 106.777 -1.564 . . . . 65.25 106.777 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.16 136.22 59.15 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.151 1.234 . . . . 74.32 109.443 173.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -106.01 141.34 37.57 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.503 -0.925 . . . . 53.23 108.503 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.01 -156.85 12.87 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 120.456 -0.878 . . . . 70.13 113.542 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -96.08 136.19 36.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.915 -0.642 . . . . 75.04 109.415 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.5 101.55 0.19 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.617 0.723 . . . . 74.32 111.761 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.95 -40.4 83.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.311 -0.859 . . . . 74.22 110.951 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 173.16 10.63 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.98 -0.554 . . . . 73.22 109.916 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.31 138.44 52.13 Favored Pre-proline 0 C--N 1.291 -1.957 0 N-CA-C 108.463 -0.94 . . . . 75.5 108.463 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.63 -21.71 8.27 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 123.344 2.696 . . . . 71.34 115.676 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.52 4.99 53.15 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.378 0.51 . . . . 75.04 112.378 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -84.53 158.18 60.45 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 110.03 -0.359 . . . . 72.11 110.03 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.406 ' C ' ' HG3' ' A' ' 68' ' ' GLN . 61.6 Cg_exo -42.85 106.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 124.177 3.251 . . . . 62.22 113.879 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.42 ' N ' ' HG3' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -135.41 148.58 49.38 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 113.073 0.768 . . . . 71.41 113.073 -176.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.45 ' CD2' ' HG2' ' A' ' 68' ' ' GLN . 30.2 m-85 -116.32 162.22 17.85 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 126.34 1.856 . . . . 64.53 106.997 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.1 m-20 -132.1 161.76 32.49 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 104.81 -2.293 . . . . 71.11 104.81 -174.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.1 mt -45.28 -56.06 10.23 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 113.384 0.883 . . . . 70.41 113.384 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.28 -35.2 85.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.444 1.43 . . . . 70.34 112.158 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 4.3 tpt180 -70.28 -36.19 74.22 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.022 0.439 . . . . 73.15 110.226 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.86 -37.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.847 0.356 . . . . 63.43 110.047 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.86 76.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.266 -0.642 . . . . 63.3 109.266 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 8.9 mm-40 -63.41 -45.23 91.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 65.31 111.697 173.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 91.1 mt -64.14 -50.13 69.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.082 0.468 . . . . 73.43 111.234 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.1 mt -81.59 -18.87 43.27 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.474 -0.784 . . . . 74.14 112.231 -174.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.16 31.83 69.15 Favored Glycine 0 C--O 1.239 0.447 0 N-CA-C 111.301 -0.719 . . . . 63.23 111.301 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 39' ' ' LEU . 24.4 m -127.84 161.55 54.9 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.177 -0.675 . . . . 73.05 109.177 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 27.8 Cg_endo -64.83 153.93 75.45 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 121.795 1.663 . . . . 72.14 112.069 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.89 -36.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.619 -0.719 . . . . 52.22 110.685 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 32.5 t -63.22 -33.93 76.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.144 -0.48 . . . . 73.03 110.961 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 62.3 tttp -69.53 -35.04 75.1 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.51 -0.552 . . . . 75.01 109.51 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 61.1 t -63.35 -41.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.837 -0.801 . . . . 63.21 108.837 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.426 ' O ' HD11 ' A' ' 16' ' ' ILE . . . -60.99 -36.98 80.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.784 -0.643 . . . . 61.52 110.425 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 44' ' ' SER . 27.8 mm-40 -69.19 -35.88 76.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.714 0.292 . . . . 73.43 110.266 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.8 mt-30 -64.05 -43.18 96.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.617 0.723 . . . . 73.15 109.608 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.3 mt -61.92 -40.59 95.99 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.452 -1.249 . . . . 71.33 109.412 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -61.52 -31.75 71.77 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.184 0.593 . . . . 71.44 111.781 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.27 -12.05 53.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.177 0.436 . . . . 74.53 112.177 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.9 58.57 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.967 -1.253 . . . . 73.34 109.967 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -82.77 -23.38 33.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.787 -1.19 . . . . 63.32 107.787 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -156.76 159.28 38.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.113 -1.81 . . . . 62.42 106.113 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.34 158.72 41.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.818 -0.438 . . . . 73.1 109.818 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.02 156.19 44.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.278 0.561 . . . . 71.24 111.969 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.41 165.81 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 123.671 0.789 . . . . 73.13 110.52 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 50.7 ttp180 -114.65 125.98 54.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.024 0.379 . . . . 60.31 112.024 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.518 ' NE ' HG11 ' A' ' 65' ' ' VAL . 30.9 ptt180 -116.25 113.63 23.29 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.813 -0.81 . . . . 75.11 108.813 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.11 9.55 0.68 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.326 1.05 . . . . 53.25 113.361 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.86 -28.95 4.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 121.346 -0.454 . . . . 64.14 111.988 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -84.12 141.34 19.91 Favored Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 121.337 -0.459 . . . . 74.42 112.367 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.9 t -97.24 120.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.775 -1.195 . . . . 71.13 107.775 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.518 HG11 ' NE ' ' A' ' 60' ' ' ARG . 18.8 m -133.39 159.77 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.035 -0.984 . . . . 72.24 112.974 -171.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.83 126.11 22.42 Favored Pre-proline 0 N--CA 1.434 -1.25 0 N-CA-C 106.75 -1.574 . . . . 73.31 106.75 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.32 130.49 36.18 Favored 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 122.632 2.221 . . . . 64.21 112.721 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 71.2 mt-30 -53.94 -25.22 19.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.13 0.789 . . . . 51.21 113.13 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.83 -11.48 13.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.945 -0.57 . . . . 31.52 112.299 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.8 m-85 -85.31 -5.23 59.33 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.593 0.757 . . . . 73.14 110.367 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.41 155.11 29.1 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.6 -0.727 . . . . 72.22 110.056 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.6 p -75.78 175.89 8.28 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.002 -0.999 . . . . 74.12 109.516 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -59.48 -19.38 47.43 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.224 0.61 . . . . 74.22 111.212 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t -87.43 -8.57 56.36 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.159 0.584 . . . . 73.14 110.667 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.54 25.92 55.54 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.351 -0.7 . . . . 74.11 111.351 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -115.76 157.7 23.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.108 -0.701 . . . . 74.02 109.108 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.28 128.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.385 -0.598 . . . . 74.01 109.385 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 25.0 t -61.25 121.41 9.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 108.039 -1.097 . . . . 65.01 108.039 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -59.96 -22.28 62.3 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 113.826 1.047 . . . . 74.45 113.826 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.5 m -87.68 -15.93 35.79 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.258 0.552 . . . . 54.21 110.987 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.546 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.6 tt -66.46 -45.91 58.85 Favored Pre-proline 0 CA--C 1.565 1.534 0 N-CA-C 115.157 1.54 . . . . 60.45 115.157 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.35 -28.43 62.97 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.401 2.067 . . . . 74.53 112.045 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.58 -42.93 98.68 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.65 -0.705 . . . . 73.23 112.265 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.53 -40.58 80.67 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.542 -0.54 . . . . 74.33 109.542 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.61 -37.67 87.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 64.33 110.777 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.3 m -68.55 -40.05 80.84 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.75 -0.659 . . . . 74.22 112.138 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -42.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 119.935 -0.706 . . . . 65.35 110.5 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.489 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.4 mm? -67.31 -36.44 81.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.291 -0.564 . . . . 73.45 112.191 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -65.14 -36.99 85.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.145 -0.687 . . . . 73.04 109.145 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.56 -30.81 70.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.415 0.626 . . . . 75.24 110.146 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.18 -9.45 86.59 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.284 -0.871 . . . . 61.51 112.332 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.35 24.0 32.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.25 -0.5 . . . . 52.43 113.129 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -99.59 133.45 43.89 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 122.532 -0.393 . . . . 72.42 110.425 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -88.12 173.4 8.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.582 0.23 . . . . 74.21 111.304 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.8 -45.74 63.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.057 1.343 . . . . 71.43 113.701 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.3 m -62.69 -41.57 99.18 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.607 0.763 . . . . 74.5 110.42 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.56 -38.37 89.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.415 -0.811 . . . . 74.21 110.585 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.416 HD12 ' CB ' ' A' ' 88' ' ' LEU . 7.1 mm -61.3 -47.3 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.742 -1.207 . . . . 73.55 107.742 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.62 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 76.2 mtm -74.17 -15.48 61.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.311 -1.313 . . . . 61.13 113.649 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -56.98 -65.77 0.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.879 -0.415 . . . . 75.42 109.879 177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.422 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.4 p-90 -69.07 -32.81 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.68 0.622 . . . . 75.43 112.68 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' HB2' ' A' ' 125' ' ' PRO . 13.4 mt -60.79 -40.8 93.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.177 0.806 . . . . 74.2 113.177 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -87.76 -9.38 54.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 112.561 0.578 . . . . 62.51 112.561 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 m -88.04 122.9 69.72 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 108.781 -0.822 . . . . 75.21 108.781 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.76 129.55 35.61 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.639 1.559 . . . . 73.34 108.98 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.8 t70 -90.21 121.08 69.02 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.386 -0.598 . . . . 54.33 109.386 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.55 -16.67 49.46 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.282 2.654 . . . . 71.34 113.74 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -110.98 6.79 21.29 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 121.949 -0.469 . . . . 51.32 111.076 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.0 tp -102.87 126.06 49.86 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.727 -0.789 . . . . 74.34 111.209 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -126.3 118.23 24.67 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.652 -1.981 . . . . 75.54 105.652 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 128' ' ' ALA . 16.8 pt -136.09 163.25 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.729 0 O-C-N 123.34 0.4 . . . . 72.1 111.678 -174.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 71.3 p -91.06 125.14 35.76 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 104.949 -2.241 . . . . 74.53 104.949 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -137.83 172.49 12.86 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 117.751 -1.58 . . . . 73.21 113.179 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 t70 47.02 70.87 0.36 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.563 1.945 . . . . 72.02 110.718 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.9 -10.82 73.32 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.502 -1.226 . . . . 41.34 110.503 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m 67.52 25.72 8.35 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.604 1.561 . . . . 44.14 111.528 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -65.24 -27.55 68.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.061 -0.972 . . . . 64.14 112.741 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 112' ' ' THR . 23.9 t0 -162.99 165.22 25.18 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.032 -0.729 . . . . 64.14 109.032 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.31 138.2 31.65 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 124.032 0.832 . . . . 73.12 110.742 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.07 133.07 69.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.774 -1.195 . . . . 72.4 107.774 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 p -87.85 146.64 25.49 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.455 0.472 . . . . 75.25 110.3 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 2.9 m-20 61.81 68.32 0.7 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.576 1.15 . . . . 72.22 111.377 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -119.52 170.5 9.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.948 -1.024 . . . . 63.04 110.965 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -78.03 134.22 64.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 116.001 -0.545 . . . . 74.11 109.745 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.736 ' HB2' HD23 ' A' ' 102' ' ' LEU . 73.7 Cg_exo -56.34 -28.48 72.44 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.171 1.914 . . . . 72.42 111.488 172.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.576 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 51.4 t -66.2 -34.43 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.623 0.725 . . . . 73.22 109.622 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.93 -32.37 70.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.69 -0.856 . . . . 74.44 108.69 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.522 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -69.6 -35.5 75.36 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 114.942 -1.027 . . . . 64.44 112.519 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.83 -36.58 78.38 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.139 -0.624 . . . . 74.52 111.49 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.4 ' N ' HD12 ' A' ' 129' ' ' LEU . 9.4 t-160 -77.71 -15.58 59.05 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.732 0.777 . . . . 73.21 108.939 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -87.78 4.68 43.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 35.04 110.139 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.5 m80 63.7 27.72 14.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.594 1.158 . . . . 74.41 111.307 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -106.71 26.19 10.31 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.267 -1.333 . . . . 61.44 110.886 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -51.51 -28.56 13.9 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 114.156 -1.383 . . . . 73.43 113.665 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -39.44 86.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.029 0.831 . . . . 73.42 111.82 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.421 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -63.98 -32.88 74.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.383 0.611 . . . . 74.43 110.087 177.223 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.97 -48.11 51.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.331 -0.849 . . . . 73.22 109.311 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 134' ' ' ALA . 86.6 t -60.47 -44.5 96.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 CA-C-N 115.715 -0.675 . . . . 64.15 110.994 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.421 ' NH2' ' HG3' ' A' ' 136' ' ' GLU . 14.8 ptt180 -63.84 -37.99 89.44 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.336 -0.546 . . . . 63.3 112.247 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -64.27 -39.81 94.7 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.76 -0.376 . . . . 75.4 110.35 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -61.46 -46.5 89.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.696 -0.684 . . . . 74.44 110.379 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.99 -45.45 94.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.706 -0.679 . . . . 74.24 110.757 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.93 65.24 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.494 . . . . 54.44 111.687 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.3 tpp -83.33 -41.25 18.46 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.346 0.594 . . . . 72.41 110.021 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.4 -52.18 7.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.098 -0.501 . . . . 71.33 112.314 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--N 1.307 -1.24 0 CA-C-N 116.648 -0.251 . . . . 72.52 110.333 -175.933 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 CA--C 1.503 -0.844 0 N-CA-C 109.304 -0.628 . . . . 72.23 109.304 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 4' ' ' ARG . 14.6 Cg_endo -65.74 119.36 6.37 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.572 1.515 . . . . 62.12 109.353 173.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.12 101.11 2.29 Favored Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 120.833 -0.699 . . . . 41.41 112.352 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.467 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 6.5 mpt_? -73.32 144.32 46.59 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.283 -1.006 . . . . 73.11 108.283 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.04 107.6 44.93 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 123.25 0.344 . . . . 71.14 110.51 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 4' ' ' ARG . 2.6 Cg_exo -79.2 178.73 7.14 Favored 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 122.845 2.363 . . . . 50.13 109.456 174.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.08 136.96 5.05 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 119.678 -1.249 . . . . 54.0 112.657 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.6 m -102.46 108.94 20.42 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.388 -0.967 . . . . 73.31 108.388 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -89.3 138.64 31.26 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.964 -0.384 . . . . 61.51 109.964 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.86 149.99 20.76 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.271 0.558 . . . . 74.44 111.004 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.78 104.9 16.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.621 -0.881 . . . . 64.12 108.621 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -76.54 83.38 3.22 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.18 0.807 . . . . 54.44 113.18 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.66 117.87 51.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 104.495 -2.409 . . . . 43.15 104.495 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.2 -151.95 6.56 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 119.642 -1.266 . . . . 42.42 113.73 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' A' ' 51' ' ' ARG . 23.8 m -82.73 126.99 33.0 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 123.736 0.814 . . . . 52.41 113.041 -174.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.78 120.57 58.51 Favored Pre-proline 0 N--CA 1.434 -1.256 0 N-CA-C 105.759 -1.941 . . . . 72.54 105.759 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -72.12 149.56 52.41 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.169 1.913 . . . . 73.41 112.239 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.34 133.48 34.95 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 115.904 -0.589 . . . . 75.45 110.092 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.58 -88.97 1.08 Allowed Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.937 -0.574 . . . . 73.11 112.671 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -121.37 126.07 48.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.805 0.336 . . . . 65.31 111.172 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 23' ' ' LEU . 12.5 t0 -80.4 142.14 34.65 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.548 -0.751 . . . . 74.41 111.361 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.42 -9.56 10.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 C-N-CA 123.679 0.792 . . . . 61.23 110.155 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.437 HD13 ' CG2' ' A' ' 29' ' ' THR . 40.2 mt -64.66 159.69 21.49 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 122.43 1.109 . . . . 75.45 113.663 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.6 t70 -80.23 138.16 52.48 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 105.799 -1.926 . . . . 72.44 105.799 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.68 -28.75 17.92 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.274 2.649 . . . . 73.41 115.452 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.18 23.17 11.09 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.161 0.8 . . . . 75.32 113.161 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 4.5 tp10 -73.83 143.43 81.38 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 105.191 -2.152 . . . . 73.55 105.191 173.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HD2' ' OE1' ' A' ' 27' ' ' GLU . 6.0 Cg_exo -39.68 107.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.945 3.097 . . . . 44.51 112.373 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.437 ' CG2' HD13 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -129.72 167.14 18.5 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.612 -0.722 . . . . 52.31 112.7 -174.256 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 26.0 m-85 -130.9 160.28 34.94 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.286 -1.376 . . . . 74.02 107.286 172.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.541 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 7.2 m-20 -134.91 159.73 40.49 Favored 'General case' 0 C--N 1.264 -3.121 0 N-CA-C 102.978 -2.971 . . . . 72.5 102.978 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.0 mt -48.47 -56.61 13.74 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 114.556 1.317 . . . . 64.01 114.556 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.89 -30.97 67.82 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.525 1.483 . . . . 60.23 112.284 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 17.7 tpt180 -70.41 -34.9 73.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.037 0.535 . . . . 75.42 109.69 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 31' ' ' ASP . 57.8 t -69.31 -39.81 79.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 109.067 -0.716 . . . . 72.23 109.067 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.72 82.39 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.719 -1.128 . . . . 62.14 109.374 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.38 -45.67 79.29 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.37 1.068 . . . . 71.22 110.54 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 30' ' ' TYR . 38.2 tp -60.76 -49.03 79.13 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.577 -0.738 . . . . 75.44 111.693 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HB2' HG22 ' A' ' 41' ' ' VAL . 66.4 mt -88.89 -18.05 28.35 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.788 -0.642 . . . . 64.13 111.448 -174.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.13 76.99 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 111.229 -0.748 . . . . 71.03 111.229 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 39' ' ' LEU . 23.8 m -104.14 162.12 20.86 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 108.417 -0.957 . . . . 73.02 108.417 -176.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.6 160.13 38.49 Favored 'Trans proline' 0 C--O 1.262 1.698 0 C-N-CA 120.931 1.088 . . . . 61.43 111.249 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.71 -32.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.747 0.784 . . . . 55.12 109.84 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 7.8 p -59.04 -37.68 77.53 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.933 -1.03 . . . . 52.53 111.758 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 19.4 ttmm -69.93 -32.89 71.41 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.408 -0.517 . . . . 73.55 110.553 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.41 -42.04 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.536 -0.913 . . . . 73.25 108.536 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -62.18 -36.53 82.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.582 -0.735 . . . . 65.52 110.399 175.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.1 mt-30 -64.94 -36.29 83.91 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.433 0.293 . . . . 61.03 110.973 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.1 mm-40 -60.46 -46.61 89.46 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.102 -1.073 . . . . 71.51 108.102 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.31 -38.59 89.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.55 -1.205 . . . . 74.15 110.36 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.568 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 14.6 mmm180 -65.61 -28.81 69.39 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.696 0.628 . . . . 74.32 112.696 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.67 -1.48 30.04 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.604 0.594 . . . . 62.5 112.604 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.69 36.6 83.14 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 110.672 -0.971 . . . . 74.25 110.672 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -96.32 -20.19 18.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.396 -0.594 . . . . 72.13 109.396 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 42.1 tp -159.84 153.38 22.5 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.252 -1.388 . . . . 25.0 107.252 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.31 161.67 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 O-C-N 123.253 0.346 . . . . 64.11 110.572 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.96 159.71 39.89 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.538 -0.756 . . . . 52.3 109.084 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.5 HG11 ' HG3' ' A' ' 99' ' ' MET . 6.7 m -130.68 166.96 26.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 123.972 0.909 . . . . 74.13 109.746 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 52.2 ttp180 -114.02 115.81 28.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 121.119 -0.232 . . . . 72.34 111.608 -176.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.54 ' NE ' HG11 ' A' ' 65' ' ' VAL . 36.6 ptt180 -120.65 136.36 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.928 -1.138 . . . . 75.15 107.928 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 49.36 30.3 3.2 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.421 1.088 . . . . 65.11 113.826 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.96 57.91 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.288 -0.482 . . . . 73.14 113.023 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -133.2 152.04 20.26 Favored Glycine 0 CA--C 1.496 -1.134 0 N-CA-C 111.28 -0.728 . . . . 51.51 111.28 177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -97.62 120.38 46.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.369 -1.345 . . . . 72.51 107.369 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG11 ' NE ' ' A' ' 60' ' ' ARG . 24.2 m -134.81 164.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.816 -0.629 . . . . 63.55 111.373 -171.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 35' ' ' VAL . 62.6 mt -132.48 131.41 22.23 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.541 -1.651 . . . . 63.32 106.541 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 70' ' ' PHE . 23.4 Cg_exo -60.73 135.66 61.56 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.619 1.546 . . . . 25.12 111.221 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 47.0 tt0 -68.66 -31.19 70.13 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.77 0.795 . . . . 74.21 109.353 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.435 HG23 HG11 ' A' ' 126' ' ' VAL . 23.5 m -68.44 -3.67 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 114.201 -1.363 . . . . 74.43 111.881 177.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -86.17 -11.01 53.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.942 0.877 . . . . 63.05 109.032 177.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.53 161.39 14.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.917 -1.038 . . . . 55.5 108.204 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.7 p -75.8 161.03 29.36 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.189 -0.671 . . . . 71.23 109.189 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -59.63 -17.36 32.87 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.324 0.49 . . . . 72.34 112.324 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.3 m -94.63 -0.94 54.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 116.068 -0.515 . . . . 73.15 111.86 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.08 69.32 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.855 -0.688 . . . . 52.31 114.204 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.02 156.86 16.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.556 -0.905 . . . . 74.11 108.556 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.56 138.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.47 -1.307 . . . . 74.33 107.47 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 92.9 t -62.56 131.52 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.138 -0.689 . . . . 75.23 109.138 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.626 0.602 . . . . 52.02 112.626 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.2 t -88.15 12.15 14.46 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.391 -0.523 . . . . 62.41 111.417 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.3 tt -65.93 -54.83 25.31 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.519 -0.548 . . . . 75.3 109.519 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.93 -31.78 90.58 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.766 1.644 . . . . 75.25 110.924 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.11 -44.59 97.01 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.444 -0.798 . . . . 53.14 112.294 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.12 -40.38 82.51 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.851 -0.796 . . . . 62.12 108.851 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.02 -36.7 77.81 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.927 -0.578 . . . . 75.24 110.66 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.0 m -60.59 -49.72 76.41 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.864 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -45.35 91.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.457 -0.338 . . . . 73.25 111.906 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.634 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.0 mm? -67.42 -38.56 84.77 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.348 0.87 . . . . 74.11 113.348 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -66.19 -35.14 79.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.538 -0.541 . . . . 53.51 109.538 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.91 -30.71 64.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.973 -0.558 . . . . 72.42 110.396 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.55 -9.33 83.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 112.09 -0.404 . . . . 54.43 112.09 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.97 39.97 12.4 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 121.809 -0.234 . . . . 51.43 113.196 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.59 126.39 52.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.915 0.388 . . . . 74.32 110.749 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 98' ' ' ILE . 12.0 ptm180 -85.39 173.86 9.97 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.656 . . . . 73.32 111.686 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -52.63 -44.01 65.79 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.355 1.862 . . . . 75.31 111.744 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -61.43 -41.02 96.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 123.859 0.864 . . . . 72.31 110.567 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -64.64 -44.55 90.09 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.152 -0.931 . . . . 74.23 108.938 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 94' ' ' ARG . 16.4 mm -60.61 -48.41 88.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 115.431 -0.804 . . . . 71.13 109.262 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.5 ' HG3' HG11 ' A' ' 58' ' ' VAL . 24.6 mmt -68.06 -27.19 66.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 70.3 111.731 -176.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -58.88 -64.95 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 111.609 0.226 . . . . 61.23 111.609 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.426 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 33.2 p-90 -68.45 -32.01 71.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.298 0.481 . . . . 64.22 112.298 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.628 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . 11.5 mt -60.46 -40.14 90.14 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 113.014 0.746 . . . . 75.54 113.014 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.52 ' CE1' HG21 ' A' ' 126' ' ' VAL . 70.9 m-85 -95.63 -1.39 50.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.175 0.806 . . . . 75.42 113.175 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.5 m -88.2 116.0 64.88 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.971 -0.752 . . . . 73.45 108.971 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 86.9 Cg_exo -52.85 129.55 33.37 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.817 2.345 . . . . 72.43 111.572 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.39 125.7 58.99 Favored Pre-proline 0 C--N 1.304 -1.386 0 CA-C-N 115.908 -0.587 . . . . 73.01 110.702 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -60.75 -27.96 85.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.295 2.663 . . . . 42.11 113.591 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 m -99.84 6.86 45.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 120.807 0.337 . . . . 70.04 111.088 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.3 tp -102.47 120.09 39.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.924 0.868 . . . . 75.13 111.568 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.7 m -132.14 110.88 10.99 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 105.548 -2.019 . . . . 75.43 105.548 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.43 163.52 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.025 0 N-CA-C 114.026 1.121 . . . . 71.22 114.026 -173.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 45.2 p -89.99 126.71 35.84 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 106.665 -1.606 . . . . 72.42 106.665 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -94.91 136.21 35.5 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.107 -0.637 . . . . 75.43 110.752 -172.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 54.28 25.31 5.75 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.658 1.183 . . . . 72.31 113.653 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.77 15.75 81.1 Favored Glycine 0 C--N 1.309 -0.961 0 C-N-CA 120.64 -0.791 . . . . 73.43 112.855 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.6 t -83.46 172.24 12.63 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 107.905 -1.146 . . . . 63.22 107.905 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.499 ' H ' ' HD3' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -86.12 -10.38 54.95 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 115.702 -0.681 . . . . 75.11 109.679 178.147 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 112' ' ' THR . 30.9 t70 -72.13 137.0 46.71 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.764 -0.653 . . . . 71.33 110.481 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.25 126.97 53.87 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.103 -0.953 . . . . 71.24 110.17 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.56 118.62 56.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.372 -0.973 . . . . 61.22 108.372 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.8 m -90.8 138.12 31.83 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.904 -0.589 . . . . 74.33 109.901 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.1 t30 64.11 59.09 1.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.482 1.134 . . . . 72.13 110.032 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.23 161.64 13.6 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.493 -1.231 . . . . 62.14 108.739 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 8.8 ptp180 -87.07 139.92 32.58 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.438 -1.319 . . . . 74.13 107.438 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.592 ' HB2' HD23 ' A' ' 102' ' ' LEU . 93.2 Cg_exo -49.66 -29.85 20.62 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 123.319 2.679 . . . . 55.33 114.812 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.628 ' CG2' ' HB3' ' A' ' 102' ' ' LEU . 24.8 t -67.37 -36.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.438 -0.789 . . . . 75.0 110.562 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.07 -30.67 67.98 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.888 -1.153 . . . . 73.41 107.888 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.34 83.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.426 -1.261 . . . . 55.13 111.097 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -68.26 -33.39 74.27 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 121.939 -0.475 . . . . 65.01 110.806 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -63.86 -34.38 77.8 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 108.155 -1.054 . . . . 75.13 108.155 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.13 10.46 21.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.351 -1.295 . . . . 71.24 111.999 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 68.2 27.97 6.6 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.325 1.05 . . . . 62.11 112.536 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -106.43 24.17 12.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.054 -1.091 . . . . 63.12 108.054 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -53.17 -30.58 38.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.685 1.194 . . . . 53.22 113.911 -173.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.01 -38.51 79.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.815 0.34 . . . . 75.24 111.187 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.24 -30.32 69.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.677 . . . . 72.1 109.508 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -71.39 -44.93 71.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.917 -1.038 . . . . 52.13 110.025 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 47.4 t -61.3 -42.98 95.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.604 0.716 . . . . 74.11 109.402 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -60.38 -38.78 85.01 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.068 -0.969 . . . . 71.14 111.611 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -37.93 83.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.251 -1.018 . . . . 71.11 108.251 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.634 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -63.7 -42.45 97.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.424 -0.807 . . . . 43.35 111.05 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 74.4 mt-30 -59.03 -41.86 88.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 62.13 110.31 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.89 81.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 62.21 111.604 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.404 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 43.8 tpp -76.14 -27.56 57.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.647 0.737 . . . . 72.22 111.014 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.0 -47.24 11.93 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.745 -0.597 . . . . 54.42 111.747 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 C--N 1.31 -1.109 0 N-CA-C 109.209 -0.663 . . . . 75.52 109.209 -177.707 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.826 -0.805 . . . . 71.21 108.826 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.44 52.52 2.0 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 123.451 2.767 . . . . 72.31 112.314 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.34 96.86 0.24 Allowed Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 110.545 -1.022 . . . . 74.24 110.545 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.14 145.73 50.02 Favored 'General case' 0 C--O 1.251 1.16 0 N-CA-C 109.35 -0.611 . . . . 74.24 109.35 176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -36.99 118.05 0.76 Allowed Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 124.743 1.217 . . . . 72.45 111.558 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.75 114.29 2.08 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.964 2.443 . . . . 70.54 113.91 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.33 114.87 2.98 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 108.082 -2.007 . . . . 51.11 108.082 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.0 m -146.0 138.92 25.77 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 122.535 -0.391 . . . . 75.21 110.162 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.404 HG23 HD22 ' A' ' 10' ' ' LEU . 13.8 t -101.2 -11.72 19.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 123.017 1.389 . . . . 45.3 108.908 176.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.404 HD22 HG23 ' A' ' 9' ' ' THR . 4.0 mm? -94.71 -160.58 0.79 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.253 -1.794 . . . . 45.02 106.165 170.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 126.05 27.68 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.824 -0.806 . . . . 41.24 108.824 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 90' ' ' ASP . 12.0 ttp180 -75.41 125.01 28.14 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-O 121.557 0.694 . . . . 74.25 110.299 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -108.3 161.34 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.115 0 N-CA-C 107.743 -1.206 . . . . 71.11 107.743 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.22 151.47 22.94 Favored Glycine 0 N--CA 1.401 -3.659 0 CA-C-O 121.689 0.605 . . . . 64.1 112.975 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t -104.38 110.6 22.91 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 105.241 -2.133 . . . . 71.35 105.241 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.1 mm -113.78 124.59 30.84 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 120.561 -0.455 . . . . 73.01 110.891 -173.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.67 167.31 27.39 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.309 2.673 . . . . 63.04 110.099 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.37 124.62 30.18 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 121.903 -0.498 . . . . 64.33 110.415 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' NH2' ' A' ' 94' ' ' ARG . . . -109.7 -115.81 3.76 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.593 -0.813 . . . . 52.12 114.376 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.22 128.29 40.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.463 0.542 . . . . 72.41 112.463 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.483 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 7.3 t70 -65.23 120.11 12.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.872 -1.058 . . . . 65.32 111.239 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.58 -32.05 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 112.661 0.615 . . . . 62.32 112.661 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -82.96 159.96 22.14 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 114.199 1.185 . . . . 62.51 114.199 -174.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.0 t70 -60.45 146.62 84.41 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.699 -1.137 . . . . 72.34 110.797 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.49 -36.73 40.35 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.568 2.845 . . . . 74.31 115.898 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.9 11.43 39.3 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 114.433 1.272 . . . . 65.31 114.433 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 7.7 mm-40 -68.18 144.57 96.94 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.324 -0.621 . . . . 63.12 109.324 173.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.91 128.85 28.1 Favored 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 122.822 2.348 . . . . 71.42 112.544 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.7 p -130.23 166.17 20.87 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.056 -0.52 . . . . 73.11 111.313 -176.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -131.45 160.19 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 125.55 1.54 . . . . 62.21 108.422 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.5 p-10 -135.6 159.38 41.8 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 106.121 -1.807 . . . . 64.4 106.121 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.0 mt -46.68 -56.87 10.15 Favored Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 114.738 1.385 . . . . 74.44 114.738 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.31 -35.76 96.14 Favored 'Trans proline' 0 C--N 1.366 1.476 0 CA-C-N 120.465 1.202 . . . . 73.24 112.67 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -69.56 -37.5 77.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.924 -0.398 . . . . 72.32 109.924 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 31' ' ' ASP . 60.8 t -69.8 -40.37 78.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.519 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.69 80.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.135 0.969 . . . . 73.41 109.167 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.17 -45.53 73.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.985 -1.462 . . . . 61.43 109.985 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.26 -44.1 89.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 63.41 111.551 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.2 mt -84.38 -19.01 34.29 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 111.901 0.334 . . . . 65.31 111.901 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.28 65.31 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.54 -0.838 . . . . 70.25 111.989 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.0 152.15 77.0 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 108.73 -0.841 . . . . 75.22 108.73 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.98 163.25 29.16 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 122.304 2.003 . . . . 74.22 112.927 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.34 -33.38 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.189 0.996 . . . . 72.42 111.371 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 10.7 p -58.39 -46.15 86.93 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.465 -0.789 . . . . 72.01 111.493 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 mttp -68.93 -36.36 77.9 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.664 -0.244 . . . . 72.24 111.636 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.76 -48.14 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 71.44 109.537 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.754 -0.657 . . . . 64.04 110.463 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 44' ' ' SER . 15.7 mm100 -62.42 -36.44 82.37 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.292 0.479 . . . . 73.52 112.292 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 91.8 mt-30 -63.34 -50.72 68.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.676 0.75 . . . . 63.52 108.995 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.35 -41.4 98.57 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.233 -1.349 . . . . 62.42 111.684 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -63.59 -27.48 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.788 0.292 . . . . 65.45 111.788 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -92.1 -0.36 57.45 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.762 0.315 . . . . 75.22 111.596 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.16 38.31 63.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.798 -0.637 . . . . 52.11 112.501 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -95.06 -15.36 23.5 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.07 -0.715 . . . . 75.22 109.07 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 56' ' ' VAL . 1.1 tt -157.74 152.91 25.76 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.106 -2.183 . . . . 74.13 105.106 -177.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.41 ' H ' HD23 ' A' ' 55' ' ' LEU . 17.8 m -132.1 161.6 41.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 122.609 0.364 . . . . 44.15 110.175 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.32 163.36 32.99 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.061 0.545 . . . . 74.54 109.6 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.71 160.48 34.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 123.427 0.455 . . . . 62.12 110.47 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -113.9 120.92 42.36 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.494 0.664 . . . . 70.13 111.256 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.483 ' HD2' ' OD1' ' A' ' 21' ' ' ASP . 12.3 ptm180 -142.69 134.95 27.5 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.931 -1.031 . . . . 65.13 108.939 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.65 23.67 13.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.909 0.883 . . . . 44.34 111.406 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.71 5.71 89.64 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.156 -0.545 . . . . 63.2 112.207 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.17 143.64 18.03 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 111.355 -0.698 . . . . 65.35 111.355 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.27 120.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.921 -1.14 . . . . 72.4 107.921 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.78 158.48 41.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.968 -0.56 . . . . 63.12 110.754 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 35' ' ' VAL . 71.3 mt -114.86 132.06 23.15 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.106 -1.072 . . . . 73.24 108.106 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.98 126.12 20.15 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.877 1.718 . . . . 71.22 110.477 173.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.565 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 41.1 tt0 -60.58 -25.21 66.04 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.315 0.646 . . . . 72.33 112.467 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.82 -2.77 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-N 115.681 -0.691 . . . . 71.14 112.65 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.623 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.38 -2.62 58.59 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.95 0.881 . . . . 72.43 110.026 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -119.61 163.9 16.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.119 -0.946 . . . . 70.3 109.089 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 130' ' ' HIS . 63.1 p -94.78 162.25 13.84 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.588 -0.893 . . . . 65.15 108.588 177.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.22 -16.55 63.65 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.335 0.588 . . . . 73.23 110.488 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -79.73 -8.32 59.17 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.699 -0.682 . . . . 44.33 110.487 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.72 64.2 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.851 -0.69 . . . . 60.45 112.23 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -108.6 154.01 22.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.438 -0.578 . . . . 74.12 109.438 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -71.34 140.53 18.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.793 -1.188 . . . . 73.34 107.793 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 80' ' ' SER . 44.7 t -64.02 129.22 27.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.934 -1.135 . . . . 63.32 107.934 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -63.69 -28.99 70.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.145 0.424 . . . . 71.22 112.145 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.417 ' H ' HG12 ' A' ' 78' ' ' VAL . 4.1 m -77.77 -6.51 54.3 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.939 -0.573 . . . . 75.3 110.886 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.623 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.7 tp -64.91 -57.25 16.56 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.384 -0.371 . . . . 73.15 111.882 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.29 -29.03 79.43 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.181 1.254 . . . . 71.23 111.244 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -44.59 93.8 Favored Glycine 0 C--O 1.245 0.832 0 CA-C-N 115.964 -0.562 . . . . 65.24 112.598 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.96 -40.53 83.18 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.38 -0.6 . . . . 71.21 109.38 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 95.9 mt -62.32 -37.57 86.1 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 74.02 110.659 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.9 m -57.45 -47.51 81.63 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 116.239 -0.437 . . . . 63.03 111.582 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.471 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -67.95 -41.96 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 120.386 -0.525 . . . . 73.13 111.556 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.471 HD22 HG23 ' A' ' 87' ' ' ILE . 3.5 mm? -67.51 -39.32 85.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.804 0.668 . . . . 75.33 112.804 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 85' ' ' LEU . 62.1 m170 -66.5 -33.76 76.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.052 0.453 . . . . 75.32 110.085 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 12' ' ' ARG . 32.6 t70 -67.92 -26.2 65.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.537 -0.756 . . . . 72.31 110.142 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.91 -3.36 73.7 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.829 -0.623 . . . . 51.14 112.016 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.42 33.45 25.46 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.197 -0.525 . . . . 71.32 113.123 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 8.9 m-85 -90.75 159.38 16.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.882 0.372 . . . . 74.12 111.497 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.47 ' NH2' ' HA3' ' A' ' 19' ' ' GLY . 12.0 ptm180 -111.85 171.14 7.67 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.924 -0.58 . . . . 73.34 109.832 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -53.94 -45.87 71.38 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.442 1.897 . . . . 73.14 112.46 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.6 m -61.88 -41.67 98.16 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.275 -0.875 . . . . 70.23 110.418 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.06 -36.15 81.39 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.587 -0.733 . . . . 71.33 111.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.2 mm -61.24 -47.66 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.121 -1.066 . . . . 72.1 108.121 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.47 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 56.3 mtt -73.35 -21.5 60.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.596 -1.183 . . . . 63.4 111.779 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -57.69 -63.37 1.26 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.031 0.443 . . . . 73.12 110.315 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -69.99 -32.38 70.56 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.02 0.748 . . . . 64.04 113.02 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.3 mt -59.0 -40.73 85.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.585 0.957 . . . . 73.21 113.585 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' HD23 ' A' ' 23' ' ' LEU . 50.5 m-85 -89.14 -16.83 30.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.958 0.725 . . . . 75.5 112.958 -176.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.9 m -87.51 118.28 69.63 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.435 -0.348 . . . . 74.55 110.243 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -55.65 129.78 36.91 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.857 2.371 . . . . 33.11 111.359 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.2 t70 -96.73 127.12 40.52 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.866 -0.42 . . . . 72.41 109.866 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 -20.25 61.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.554 2.836 . . . . 53.32 114.423 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.1 p -111.53 6.94 20.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.107 0.48 . . . . 72.01 112.122 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 tp -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.23 0.538 . . . . 74.12 110.107 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -118.95 122.56 42.51 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.885 -0.783 . . . . 75.51 108.885 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 123' ' ' ALA . 61.1 mt -130.81 154.97 41.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.432 -0.581 . . . . 70.4 109.432 -174.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 53.6 m -122.62 126.82 48.45 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.929 -1.508 . . . . 72.14 106.929 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -131.03 137.0 48.97 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.214 0.321 . . . . 74.42 111.243 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.9 t70 49.88 88.87 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 126.001 1.72 . . . . 64.32 113.557 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.52 131.39 2.58 Favored Glycine 0 N--CA 1.4 -3.703 0 N-CA-C 110.161 -1.176 . . . . 73.21 110.161 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.0 m -72.3 82.6 1.03 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-O 121.605 0.716 . . . . 64.41 109.399 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -81.61 -51.63 8.03 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.101 -1.444 . . . . 72.43 107.101 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 t70 171.77 -175.6 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 102.975 -2.972 . . . . 73.15 102.975 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.33 140.12 30.08 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.274 -1.01 . . . . 71.15 108.274 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 51.3 t -110.98 118.83 58.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.368 -0.604 . . . . 63.33 109.368 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -87.28 141.42 28.66 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.767 -0.827 . . . . 72.14 108.767 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.3 t30 68.22 70.3 0.32 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.937 0.875 . . . . 64.41 110.806 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -124.39 173.64 8.28 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 107.762 -1.199 . . . . 63.12 107.762 174.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 3.5 ptp180 -91.59 137.25 25.86 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.557 . . . . 70.43 109.758 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.64 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.1 Cg_exo -49.75 -22.44 6.98 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.71 2.94 . . . . 70.24 114.552 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -60.43 -39.0 79.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 120.87 0.367 . . . . 75.13 110.297 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -63.31 -37.12 86.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.315 0.579 . . . . 64.25 109.695 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.69 76.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.237 -0.892 . . . . 65.21 112.063 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.44 -35.58 80.65 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.644 -0.422 . . . . 63.42 111.408 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.405 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 42.0 t-80 -76.02 -20.8 57.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.391 0.615 . . . . 52.35 109.455 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.85 4.61 51.59 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.335 0.865 . . . . 74.02 113.335 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.31 38.74 4.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 123.581 1.658 . . . . 75.45 109.283 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -120.36 23.89 10.66 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.75 -1.574 . . . . 73.5 106.75 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.62 -28.05 30.45 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 112.648 -2.069 . . . . 63.32 112.756 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -55.43 -40.38 71.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.801 0.334 . . . . 72.24 110.915 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.33 -27.98 63.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.171 0.51 . . . . 70.2 110.919 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.72 -48.58 45.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.375 -0.972 . . . . 73.24 108.375 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 63.5 t -59.2 -41.54 84.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-N 115.007 -0.997 . . . . 72.25 109.176 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -57.15 -45.89 83.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.609 0.764 . . . . 73.04 111.264 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.8 tpp180 -65.89 -39.31 90.51 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.723 -0.473 . . . . 73.45 109.723 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.99 94.15 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.999 -0.546 . . . . 43.25 110.525 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 12.0 mm100 -57.46 -46.61 83.45 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 123.353 0.661 . . . . 72.43 110.032 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.9 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 64.25 111.551 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.526 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.2 mmm -78.48 -37.39 43.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.353 -0.385 . . . . 74.12 111.407 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.8 19.59 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 112.789 0.663 . . . . 63.54 112.789 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 C--N 1.308 -1.239 0 CA-C-O 118.418 -0.801 . . . . 72.22 109.646 -176.498 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.237 0.396 0 N-CA-C 110.36 -0.237 . . . . 73.51 110.36 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.6 146.15 21.21 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.403 2.069 . . . . 74.42 112.232 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.68 -98.09 2.28 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 109.287 -1.525 . . . . 52.01 109.287 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -73.48 133.21 43.6 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.164 -1.421 . . . . 70.34 107.164 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.84 119.08 75.98 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-O 120.774 0.321 . . . . 74.32 110.925 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -87.0 33.03 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.002 2.468 . . . . 64.34 109.829 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.0 3.59 67.19 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.261 -0.881 . . . . 75.31 112.375 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.3 p -116.55 157.76 24.74 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.827 -0.805 . . . . 74.22 108.827 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -76.14 130.13 37.81 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.547 -0.909 . . . . 63.22 108.547 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.16 147.62 44.62 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.448 -0.945 . . . . 73.23 108.448 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.89 122.9 41.24 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.681 0.993 . . . . 64.0 113.681 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -104.75 122.11 45.03 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 104.548 -2.39 . . . . 72.51 104.548 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.74 135.52 4.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 C-N-CA 119.367 -0.933 . . . . 71.1 111.782 -173.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.61 -123.71 4.72 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 109.532 -1.427 . . . . 55.22 109.532 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.7 p -82.2 141.58 32.9 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.701 -0.4 . . . . 72.0 109.927 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.47 131.27 53.21 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 107.575 -1.269 . . . . 73.51 107.575 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.02 143.21 99.59 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.147 1.898 . . . . 64.3 110.637 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 124.35 30.35 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 120.895 0.379 . . . . 74.01 110.084 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 59' ' ' ARG . . . -94.76 -85.15 1.66 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 115.726 -0.67 . . . . 73.31 111.64 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.62 150.09 47.14 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 120.877 0.37 . . . . 75.43 110.321 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.69 161.94 18.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.931 -0.766 . . . . 72.34 108.931 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 22' ' ' VAL . 23.9 t -121.29 13.79 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 123.345 1.545 . . . . 72.22 109.662 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.89 -172.41 2.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.26 -0.882 . . . . 72.01 110.69 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.26 138.01 20.13 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 105.25 -2.13 . . . . 74.22 105.25 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.16 -21.61 22.82 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.658 2.238 . . . . 50.5 114.448 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.57 -16.05 57.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.076 0.398 . . . . 70.13 112.076 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -61.93 141.8 95.36 Favored Pre-proline 0 C--O 1.251 1.134 0 O-C-N 122.089 -0.382 . . . . 75.5 110.31 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.55 117.66 4.21 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.843 2.362 . . . . 73.5 111.1 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -133.37 161.94 33.18 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 115.369 -0.832 . . . . 60.14 111.519 -176.45 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -112.89 159.94 18.54 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.611 -1.177 . . . . 73.3 109.058 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.583 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.0 m-20 -134.74 169.16 17.77 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.004 -2.221 . . . . 71.55 105.004 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.87 -55.73 35.39 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 113.489 0.922 . . . . 74.33 113.489 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.26 -32.71 90.47 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.881 1.721 . . . . 73.51 112.381 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.583 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 20.7 tpt180 -68.53 -40.79 80.59 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.973 0.509 . . . . 74.15 110.683 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' ASP . 77.1 t -69.0 -37.71 77.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.498 -0.556 . . . . 74.11 109.498 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.84 85.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.327 -0.851 . . . . 73.04 109.659 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.37 -46.7 72.56 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.181 -0.918 . . . . 65.44 109.52 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.79 -50.32 63.05 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.051 -0.977 . . . . 64.32 112.269 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.51 ' HB2' HG22 ' A' ' 41' ' ' VAL . 91.9 mt -82.85 -18.61 39.77 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.495 -0.482 . . . . 73.21 111.357 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.66 30.1 58.56 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.677 -0.969 . . . . 53.01 110.677 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 39' ' ' LEU . 28.0 m -120.94 159.04 50.71 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 109.543 -0.54 . . . . 72.55 109.543 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.54 163.16 39.93 Favored 'Trans proline' 0 C--O 1.256 1.404 0 C-N-CA 122.011 1.807 . . . . 74.25 111.543 174.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.24 -32.37 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.419 0.688 . . . . 54.2 110.359 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 33.1 t -57.32 -43.12 83.02 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.751 -0.659 . . . . 74.31 110.4 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.25 -32.77 72.2 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 111.742 0.275 . . . . 75.54 111.742 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.77 -45.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.056 -0.72 . . . . 72.24 109.056 175.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.98 78.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.464 -0.789 . . . . 72.22 110.777 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 44' ' ' SER . 93.0 mt-30 -61.68 -43.47 98.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.262 -0.426 . . . . 73.11 111.334 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -60.12 -49.63 76.89 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 121.901 0.857 . . . . 71.53 109.043 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.23 -42.46 99.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.078 -1.419 . . . . 74.4 111.278 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.15 -22.33 62.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.109 0.781 . . . . 74.31 113.109 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -102.09 5.0 40.22 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.112 -1.035 . . . . 75.0 111.396 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.59 37.31 68.14 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 115.423 -0.808 . . . . 52.21 112.243 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -95.67 -13.81 23.96 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.546 0.689 . . . . 75.53 109.36 176.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.9 tp -160.66 152.77 20.19 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.693 -1.965 . . . . 74.33 105.693 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 p -133.58 151.38 33.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.204 -0.665 . . . . 70.21 109.204 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 154.94 36.42 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 123.518 0.511 . . . . 64.51 109.737 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.62 169.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 123.711 0.804 . . . . 75.32 111.165 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 24.3 ttt-85 -107.3 121.34 44.37 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.135 -0.691 . . . . 73.42 109.135 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' CZ ' HG11 ' A' ' 65' ' ' VAL . 49.3 ttp180 -115.4 112.81 22.89 Favored 'General case' 0 CA--C 1.482 -1.667 0 CA-C-N 114.225 -1.352 . . . . 74.23 107.61 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.58 -51.68 0.23 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.92 1.688 . . . . 61.44 112.473 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.54 15.15 0.03 OUTLIER Glycine 0 C--N 1.29 -2.01 0 CA-C-N 114.931 -1.031 . . . . 74.24 112.147 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.35 154.96 19.74 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 110.691 -0.963 . . . . 74.22 110.691 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -96.89 120.12 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.781 -1.192 . . . . 63.22 107.781 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.433 HG11 ' CZ ' ' A' ' 60' ' ' ARG . 16.9 m -137.21 164.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.745 -0.661 . . . . 73.21 111.82 -172.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.61 123.98 26.28 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 107.011 -1.478 . . . . 50.32 107.011 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HA ' HG22 ' A' ' 29' ' ' THR . 37.3 Cg_exo -62.84 143.44 91.68 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.43 2.086 . . . . 70.24 114.063 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -48.81 -41.99 34.55 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.313 1.045 . . . . 63.13 111.196 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -65.54 -7.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.48 -1.236 . . . . 65.24 113.911 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.646 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.3 m-85 -88.5 -5.02 58.48 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.873 0.844 . . . . 73.5 110.515 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -117.41 159.29 23.02 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.028 -0.987 . . . . 71.22 108.611 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -86.88 175.69 8.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.829 -0.804 . . . . 64.13 108.829 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -63.3 -22.08 66.65 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.333 0.587 . . . . 75.33 110.623 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.3 t -79.52 -10.51 59.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.299 -0.409 . . . . 72.22 110.615 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.64 38.85 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.572 -0.823 . . . . 64.22 111.215 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 151.63 37.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.597 -1.26 . . . . 73.53 107.597 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.46 131.47 34.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.731 -0.84 . . . . 72.22 108.731 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 44.4 t -57.78 125.96 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.323 -0.621 . . . . 74.22 109.323 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 61.1 tttp -61.5 -36.44 80.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.285 0.564 . . . . 72.15 112.281 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -85.19 -5.16 59.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.307 -0.406 . . . . 73.01 111.734 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD11 ' CD2' ' A' ' 70' ' ' PHE . 8.1 tt -66.09 -48.16 60.53 Favored Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 112.894 0.701 . . . . 71.51 112.894 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 74.1 Cg_exo -54.09 -30.57 60.82 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.047 1.831 . . . . 54.22 111.511 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.6 -41.46 99.81 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.473 -0.785 . . . . 72.53 112.207 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.37 -40.45 81.43 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.081 -0.711 . . . . 74.4 109.081 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.52 -39.96 92.9 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.907 -0.588 . . . . 65.55 110.339 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.2 m -57.77 -47.5 82.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 116.144 -0.48 . . . . 72.45 111.662 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -42.93 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 120.943 -0.303 . . . . 73.25 111.697 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -66.64 -37.44 84.82 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.465 0.543 . . . . 74.2 112.465 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -65.74 -32.86 74.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.893 0.377 . . . . 71.42 110.344 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.86 -30.23 69.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.231 0.539 . . . . 64.54 110.272 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.5 -9.33 75.77 Favored Glycine 0 C--O 1.242 0.655 0 CA-C-N 115.579 -0.737 . . . . 52.53 113.039 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.97 33.05 11.37 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.539 -0.363 . . . . 73.21 112.971 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -98.74 129.8 45.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 122.471 -0.429 . . . . 75.41 111.42 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -87.24 174.24 8.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.702 -0.681 . . . . 70.53 110.881 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.67 -45.9 66.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.925 1.69 . . . . 63.41 112.208 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.595 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 29.3 m -64.92 -41.28 95.69 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 116.031 -0.531 . . . . 55.12 109.589 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -61.72 -42.28 98.74 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.025 -0.989 . . . . 65.34 111.077 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.471 HG22 HD12 ' A' ' 102' ' ' LEU . 19.9 mm -60.95 -47.6 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.626 -0.879 . . . . 74.12 108.626 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.429 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 51.2 mtt -74.34 -17.56 60.81 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 113.736 1.013 . . . . 65.34 113.736 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 96' ' ' THR . 83.8 mtp180 -55.84 -65.0 0.67 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.877 0.37 . . . . 64.21 111.353 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.52 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 p-90 -68.75 -31.93 71.32 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.358 0.503 . . . . 64.01 112.358 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.52 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.4 mt -66.34 -39.87 89.48 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.126 1.158 . . . . 65.35 114.126 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -90.62 -12.03 38.15 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.596 1.332 . . . . 51.14 114.596 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -74.67 114.15 31.41 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 123.817 0.698 . . . . 65.22 109.731 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.94 132.56 35.1 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.713 2.276 . . . . 75.4 110.551 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 16.5 t0 -118.61 117.99 33.87 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 116.299 -0.41 . . . . 43.41 111.298 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.53 -24.92 79.49 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.225 2.616 . . . . 70.34 111.889 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -78.58 -10.06 59.59 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.555 -0.748 . . . . 64.34 110.143 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.9 tp -110.29 129.22 55.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.429 0.633 . . . . 74.34 110.609 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -119.02 125.04 48.43 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.31 -0.996 . . . . 74.53 108.31 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 123' ' ' ALA . 46.8 mt -131.0 156.84 43.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.994 -0.548 . . . . 70.0 110.227 -172.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 p -135.39 135.53 40.73 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.445 1.098 . . . . 75.44 109.226 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -106.83 165.51 11.27 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 122.188 -0.32 . . . . 75.13 110.52 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.09 105.42 3.35 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.739 -0.837 . . . . 70.15 108.739 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.9 7.21 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 110.331 -1.108 . . . . 72.44 110.331 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.7 m -130.37 92.85 3.34 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.726 -0.842 . . . . 75.13 108.726 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -76.52 -17.1 59.44 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.043 -0.526 . . . . 73.04 111.833 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.96 140.08 47.15 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.441 -0.578 . . . . 74.01 109.441 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.11 124.01 27.2 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.832 -0.622 . . . . 71.2 110.758 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.33 117.68 52.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.183 -0.673 . . . . 70.13 109.183 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.4 m -90.28 142.95 27.22 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.71 -0.848 . . . . 60.12 108.71 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.2 t30 74.36 72.26 0.11 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.272 0.982 . . . . 72.44 110.381 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.439 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -123.44 172.82 8.42 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.625 -1.62 . . . . 63.15 106.625 171.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.504 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 8.0 ptp180 -92.82 143.79 27.51 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.111 -1.44 . . . . 73.34 107.111 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 90.2 Cg_exo -49.28 -25.6 10.09 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.313 2.675 . . . . 72.45 114.897 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.564 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.8 t -63.96 -32.33 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.331 -0.548 . . . . 45.13 110.113 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.504 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 10.5 m-20 -60.45 -30.84 69.92 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.254 -0.43 . . . . 64.23 110.415 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.5 -43.88 72.19 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.883 -0.599 . . . . 60.41 111.092 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -70.18 -33.98 72.41 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.932 -0.48 . . . . 74.43 111.099 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -67.53 -19.53 65.31 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 122.15 0.976 . . . . 73.14 109.238 176.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.94 9.44 32.66 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.924 -1.034 . . . . 60.32 111.838 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.9 m80 61.77 28.47 17.5 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.911 0.862 . . . . 52.34 112.249 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -106.3 25.11 11.47 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.827 1.651 . . . . 72.54 107.512 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.2 -26.87 12.7 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 126.926 2.09 . . . . 74.21 114.237 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -55.69 -37.18 68.01 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.194 0.813 . . . . 64.53 113.194 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -67.54 -32.36 73.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.291 0.567 . . . . 71.13 110.59 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.48 -49.14 68.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.615 -0.883 . . . . 74.42 108.615 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.569 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 67.8 t -58.07 -42.85 83.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 CA-C-N 115.404 -0.817 . . . . 74.12 109.58 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -57.0 -47.47 80.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.72 -0.673 . . . . 65.22 110.822 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -68.79 -34.1 74.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 73.33 111.045 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.416 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -67.53 -46.71 72.01 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.106 -0.497 . . . . 75.53 110.941 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 15.9 mm100 -59.66 -40.11 86.68 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.028 0.531 . . . . 71.43 110.04 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.02 68.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.424 -0.807 . . . . 42.11 111.257 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.1 tpp -78.04 -47.9 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.904 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.5 -29.29 37.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.543 0.942 . . . . 72.4 113.543 -173.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 C--N 1.312 -1.059 0 CA-C-O 117.989 -1.005 . . . . 55.24 110.038 -179.574 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.511 -0.526 0 N-CA-C 109.621 -0.511 . . . . 72.0 109.621 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.84 95.53 1.02 Allowed 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.519 1.48 . . . . 65.33 110.382 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.32 95.27 1.55 Allowed Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 110.901 -0.88 . . . . 73.04 110.901 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -72.86 136.66 45.35 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.754 0.312 . . . . 62.31 110.737 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.16 122.92 73.92 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 107.489 -1.3 . . . . 71.14 107.489 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.42 148.87 68.24 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.911 1.74 . . . . 73.01 111.408 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.91 50.35 4.38 Favored Glycine 0 C--N 1.316 -0.561 0 N-CA-C 111.904 -0.479 . . . . 73.43 111.904 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.9 t 177.68 134.92 0.07 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 106.385 -1.709 . . . . 60.11 106.385 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.5 m -67.47 130.75 44.05 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.342 -1.355 . . . . 74.42 107.342 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.85 144.93 51.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.138 0.494 . . . . 74.44 111.559 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.09 145.14 25.65 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -105.76 93.23 4.54 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.729 0.776 . . . . 74.22 110.709 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 t -101.09 80.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.514 -1.291 . . . . 73.03 107.514 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.35 -162.05 10.9 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 110.38 -1.088 . . . . 65.35 110.38 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 16.3 m -54.44 118.03 3.81 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.822 0.849 . . . . 52.3 112.552 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.28 134.06 80.43 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 107.748 -1.204 . . . . 72.04 107.748 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.21 165.11 33.46 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.379 2.053 . . . . 44.12 112.528 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.33 123.72 44.88 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.632 -1.618 . . . . 74.51 106.632 173.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.88 -118.17 3.11 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.257 -0.973 . . . . 55.24 113.801 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.11 107.1 18.85 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 112.884 0.698 . . . . 72.35 112.884 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 11.2 t70 -44.69 113.02 0.49 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 126.108 1.763 . . . . 53.12 113.108 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.67 -33.96 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.558 -0.747 . . . . 70.44 111.645 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' A' ' 103' ' ' PHE 0.406 0.4 OUTLIER -67.18 140.8 57.49 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.283 1.586 . . . . 74.34 115.283 -176.024 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.36 146.41 84.39 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.222 -1.808 . . . . 41.13 110.993 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HA ' HH22 ' A' ' 60' ' ' ARG . 89.9 Cg_exo -50.52 -22.43 9.09 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.409 2.739 . . . . 70.03 115.601 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -97.71 3.53 50.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.942 0.719 . . . . 52.14 112.942 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.42 128.14 76.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.906 -0.776 . . . . 63.43 108.906 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.48 147.09 70.24 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.554 2.169 . . . . 70.12 112.685 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -133.45 173.69 11.21 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.497 0.665 . . . . 75.42 111.645 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 23.2 m-85 -130.25 161.09 31.99 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 126.299 1.84 . . . . 64.11 106.626 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.4 t0 -134.08 167.42 20.68 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.802 -2.296 . . . . 73.53 104.802 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -49.79 -57.0 13.62 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 123.839 0.856 . . . . 72.52 112.999 -172.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.7 -32.25 47.58 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.152 1.234 . . . . 71.12 112.14 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 19.4 tpt180 -70.34 -37.74 74.72 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 112.187 0.44 . . . . 74.25 112.187 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 31' ' ' ASP . 58.5 t -67.23 -39.12 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.738 -0.838 . . . . 74.13 108.738 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.89 83.87 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.66 -1.154 . . . . 70.03 110.032 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.04 -43.1 99.59 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.941 0.896 . . . . 72.15 109.814 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 tp -62.16 -50.06 73.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.404 -0.817 . . . . 73.52 111.396 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -86.76 -18.53 30.9 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.038 0.755 . . . . 73.14 113.038 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.01 53.91 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.436 -0.887 . . . . 63.24 110.961 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.09 161.18 46.21 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 107.611 -1.255 . . . . 61.35 107.611 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.63 163.26 31.99 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 121.253 1.302 . . . . 64.34 111.409 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.79 -32.64 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.6 0.714 . . . . 74.23 109.35 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.587 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.1 m -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.723 -1.126 . . . . 74.11 110.606 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.6 mttp -68.94 -32.92 72.87 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.678 -0.409 . . . . 74.3 111.253 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.16 -46.23 96.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.466 -0.568 . . . . 53.23 109.466 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.25 81.29 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.423 -0.808 . . . . 51.42 110.759 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 44' ' ' SER . 29.3 mm-40 -64.35 -37.94 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 62.53 110.772 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.8 mt-30 -68.31 -45.05 74.05 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.896 0.855 . . . . 75.54 109.163 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.86 -45.29 94.43 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.789 -1.551 . . . . 72.2 109.797 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 25.9 ptt180 -66.12 -22.28 66.38 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 113.138 0.792 . . . . 64.02 113.138 -175.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.66 11.78 37.24 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.216 -0.994 . . . . 71.11 112.49 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.58 57.48 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.976 -0.63 . . . . 53.41 113.02 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -96.13 -5.74 40.01 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.265 0.555 . . . . 74.13 109.866 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.1 tp -163.42 157.65 20.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.399 -1.704 . . . . 74.14 106.399 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.54 147.05 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 118.393 0.542 . . . . 75.43 109.586 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.59 162.69 19.21 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.346 0.659 . . . . 74.22 110.473 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.44 157.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.001 0.521 . . . . 62.22 110.226 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -110.86 119.07 37.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.204 -0.665 . . . . 60.51 109.204 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.566 HH22 ' HA ' ' A' ' 25' ' ' PRO . 11.4 ptm180 -149.24 130.61 14.71 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.367 -0.378 . . . . 75.44 111.187 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.63 26.58 16.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.995 0.918 . . . . 72.44 112.121 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.1 82.36 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 116.039 -0.528 . . . . 63.34 112.341 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.01 141.0 12.76 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.424 -0.67 . . . . 62.5 111.424 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.52 119.91 48.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.263 -1.384 . . . . 73.32 107.263 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.47 162.29 39.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.861 -0.609 . . . . 52.1 110.13 -175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.7 128.01 26.02 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 108.089 -1.078 . . . . 53.51 108.089 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.28 122.01 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.787 2.324 . . . . 61.43 112.037 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.521 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 45.4 tt0 -65.74 -24.59 66.99 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.136 0.493 . . . . 62.35 111.699 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.5 -8.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.637 -0.711 . . . . 72.23 112.373 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -86.73 -2.47 58.56 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.388 0.613 . . . . 71.42 110.95 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -116.83 148.51 41.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 73.43 109.248 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.4 p -82.74 175.47 10.1 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.571 -0.9 . . . . 63.54 108.571 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -64.42 -17.21 63.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.931 0.396 . . . . 63.21 111.729 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 m -79.78 -9.14 59.62 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.348 0.595 . . . . 65.41 109.778 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.44 62.85 Favored Glycine 0 C--O 1.215 -1.081 0 N-CA-C 110.73 -0.948 . . . . 70.21 110.73 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -108.06 143.82 36.26 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.759 -0.83 . . . . 75.13 108.759 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.98 134.46 28.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.134 -1.062 . . . . 61.41 108.134 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 58.7 t -57.04 128.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 108.185 -1.043 . . . . 71.53 108.185 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -23.07 65.86 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.741 0.645 . . . . 73.5 112.741 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 78' ' ' VAL . 17.5 m -88.22 -1.93 58.31 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.998 0.428 . . . . 75.01 111.169 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.0 tt -65.58 -54.24 31.69 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.386 0.513 . . . . 61.21 112.386 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 39.5 Cg_exo -60.76 -29.77 88.95 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 121.265 1.31 . . . . 75.31 110.979 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.15 99.7 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.319 -0.855 . . . . 55.02 112.216 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.92 -42.01 77.36 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.587 -0.523 . . . . 73.22 109.587 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.33 -37.34 85.25 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 116.243 -0.435 . . . . 71.21 110.645 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.6 m -58.69 -48.04 82.47 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.837 -0.619 . . . . 60.24 111.89 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.427 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -68.27 -42.15 84.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.607 -0.437 . . . . 75.42 111.045 -177.333 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.427 HD22 HG23 ' A' ' 87' ' ' ILE . 3.2 mm? -67.07 -35.29 79.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.112 -0.635 . . . . 72.14 111.874 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -62.94 -33.4 75.27 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.484 -0.562 . . . . 75.01 109.484 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.97 -31.4 71.1 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.017 -0.538 . . . . 53.12 110.148 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.72 -3.96 63.99 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.569 -0.741 . . . . 51.43 111.756 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.22 37.07 55.33 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 113.708 0.243 . . . . 75.44 113.708 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 52.1 m-85 -92.06 126.19 37.05 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 117.55 0.675 . . . . 75.24 111.18 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.57 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 26.8 ptt180 -70.43 169.21 14.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.901 . . . . 75.3 111.276 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 99' ' ' MET . 7.7 p-10 -54.87 -44.5 74.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.052 1.341 . . . . 74.34 111.816 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -62.06 -41.02 97.71 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.332 -0.849 . . . . 52.44 110.835 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.57 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 49.8 mm-40 -66.38 -37.92 86.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.747 -0.381 . . . . 74.42 110.482 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.2 -50.07 82.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 109.112 -0.699 . . . . 62.44 109.112 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.9 ptt? -74.67 -17.49 60.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.334 -0.848 . . . . 70.45 112.948 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.31 -65.26 0.72 Allowed 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.47 0.481 . . . . 72.23 110.099 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -70.38 -32.26 69.84 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.245 0.831 . . . . 74.03 113.245 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 125' ' ' PRO . 40.8 tp -68.33 -40.46 81.61 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.038 0.755 . . . . 72.42 113.038 -173.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CE2' HD23 ' A' ' 23' ' ' LEU . 26.6 m-85 -87.16 -18.3 30.7 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.367 0.877 . . . . 73.51 113.367 -175.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 63.2 m -81.03 127.37 74.68 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 112.194 0.442 . . . . 52.23 112.194 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 23.4 Cg_exo -66.47 132.31 28.84 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.664 2.243 . . . . 44.25 111.31 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -118.19 121.45 31.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.465 -0.334 . . . . 62.32 111.839 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.98 -26.43 82.38 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.585 2.856 . . . . 73.44 112.205 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.0 m -85.96 -0.21 54.88 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.213 0.53 . . . . 53.43 111.239 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.63 126.89 53.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.207 -0.664 . . . . 73.32 109.207 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 27.2 m -131.28 114.34 14.91 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 73.4 108.206 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 128' ' ' ALA . 11.5 pt -136.51 163.06 34.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 116.45 -0.341 . . . . 71.13 110.759 -175.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -101.36 126.64 48.15 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 107.969 -1.123 . . . . 54.41 107.969 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -103.14 162.96 12.53 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 114.257 1.206 . . . . 73.22 114.257 -171.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -64.96 116.85 6.82 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.43 -1.714 . . . . 63.02 108.636 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.85 -2.54 38.67 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.7 -0.762 . . . . 62.35 112.094 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.7 t -131.32 156.49 45.4 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.559 -1.274 . . . . 71.43 107.559 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -99.71 -27.93 13.42 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.086 0.47 . . . . 74.34 111.231 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -102.66 -169.92 1.73 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.092 -0.707 . . . . 54.54 109.092 -172.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.94 132.79 49.85 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.005 0.431 . . . . 65.22 110.039 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.83 126.15 64.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.292 -1.003 . . . . 62.02 108.292 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 6.0 t -89.13 162.02 16.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 65.33 107.964 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.7 t30 67.57 44.67 1.66 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 122.647 1.213 . . . . 70.55 108.521 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.86 16.74 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.963 -1.017 . . . . 71.43 110.763 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -95.43 137.97 21.96 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.11 -0.7 . . . . 63.31 109.11 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.602 ' HB2' HD12 ' A' ' 102' ' ' LEU . 87.6 Cg_exo -50.0 -26.24 14.04 Favored 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.638 2.892 . . . . 74.13 114.755 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 94.7 t -60.58 -39.74 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.529 0.68 . . . . 73.35 110.283 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.01 -33.26 75.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.257 -0.883 . . . . 64.33 109.659 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.45 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -69.48 -47.92 62.35 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.245 -0.889 . . . . 52.02 111.45 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -65.81 -34.57 78.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 70.53 110.438 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -66.43 -32.26 73.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.229 -0.896 . . . . 71.03 108.945 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.91 13.16 19.32 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.094 -0.957 . . . . 65.32 111.445 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 64.76 28.05 12.98 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.524 1.13 . . . . 74.12 110.693 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -109.43 23.85 13.9 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.586 1.184 . . . . 74.33 108.99 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.94 -25.4 11.77 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 112.913 -1.949 . . . . 75.01 112.151 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -54.51 -39.69 67.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.95 0.5 . . . . 60.12 111.286 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.236 0.541 . . . . 74.21 110.432 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.75 -48.94 68.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.829 -0.804 . . . . 61.24 108.829 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 89.2 t -60.07 -41.17 85.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 123.559 0.744 . . . . 61.41 109.792 176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -56.97 -46.45 82.17 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.562 -0.744 . . . . 73.43 109.598 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -69.04 -36.48 77.76 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 116.316 -0.402 . . . . 75.11 111.848 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.7 89.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 53.21 109.621 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.2 mt-30 -62.88 -37.53 87.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.708 -0.678 . . . . 74.42 110.442 177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.5 76.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.257 0.551 . . . . 70.01 111.017 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.58 -36.89 57.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.598 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -76.74 -49.62 15.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.613 0.968 . . . . 61.21 113.613 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--O 1.255 1.346 0 CA-C-O 118.975 -0.536 . . . . 72.35 111.218 -174.639 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.509 -0.599 0 N-CA-C 108.821 -0.807 . . . . 52.33 108.821 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.31 113.02 1.22 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.155 1.904 . . . . 73.22 110.046 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.16 -160.98 35.89 Favored Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 115.699 -0.682 . . . . 54.23 113.297 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -66.99 133.58 50.24 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 123.605 0.762 . . . . 43.5 111.693 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.35 126.33 27.28 Favored Pre-proline 0 C--N 1.303 -1.441 0 CA-C-N 115.377 -0.829 . . . . 44.15 109.688 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.93 -169.25 0.72 Allowed 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 122.521 2.147 . . . . 70.53 111.455 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.67 -119.23 1.37 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.869 -0.892 . . . . 63.4 110.869 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 t -157.78 156.71 32.03 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.146 -1.427 . . . . 74.23 107.146 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -89.24 143.93 26.47 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.468 -0.938 . . . . 72.01 108.468 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.78 169.81 9.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.752 0.31 . . . . 71.03 111.418 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.22 -177.85 5.76 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 109.544 -0.539 . . . . 62.51 109.544 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 12' ' ' ARG . 20.0 mmt180 -79.55 80.38 5.94 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 113.775 1.028 . . . . 71.14 113.775 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -114.28 80.99 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 105.361 -2.088 . . . . 70.41 105.361 171.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 51' ' ' ARG . . . -151.17 -120.23 0.92 Allowed Glycine 0 N--CA 1.415 -2.766 0 CA-C-N 115.068 -0.969 . . . . 70.22 112.439 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -88.26 137.81 31.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-O 121.236 0.541 . . . . 75.13 110.404 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.415 HG21 ' HB2' ' A' ' 94' ' ' ARG . 3.4 mp -91.98 127.95 47.55 Favored Pre-proline 0 C--N 1.285 -2.217 0 N-CA-C 106.404 -1.702 . . . . 75.42 106.404 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.03 137.46 79.29 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.173 1.915 . . . . 70.14 110.708 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.63 123.99 29.17 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 108.626 -0.879 . . . . 35.31 108.626 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.82 -101.37 2.71 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.576 -0.738 . . . . 34.22 113.88 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -98.97 120.78 40.0 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.099 0.476 . . . . 73.32 111.537 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.59 146.29 50.18 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.148 -0.933 . . . . 63.35 110.12 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.35 -12.08 11.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.529 -0.305 . . . . 61.41 111.147 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.282 0.8 OUTLIER -89.16 169.55 11.38 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 114.702 1.371 . . . . 71.42 114.702 -177.435 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -101.48 148.15 34.81 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.346 -1.353 . . . . 61.43 107.346 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.64 -22.6 9.65 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.892 2.395 . . . . 61.14 113.699 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.6 -32.19 73.73 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.86 -0.422 . . . . 73.03 109.86 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.64 126.26 90.85 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.595 -0.891 . . . . 74.1 108.595 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.32 154.87 61.13 Favored 'Trans proline' 0 C--O 1.256 1.416 0 C-N-CA 122.181 1.921 . . . . 70.14 111.047 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 p -136.05 169.57 17.39 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.968 0.89 . . . . 74.31 112.71 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -119.83 160.95 21.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 127.09 2.156 . . . . 73.3 106.127 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.467 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 7.1 t70 -134.49 156.91 47.78 Favored 'General case' 0 C--N 1.26 -3.308 0 N-CA-C 102.982 -2.97 . . . . 72.44 102.982 -175.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.51 -51.77 75.43 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.605 0.965 . . . . 72.31 113.605 -173.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 13.4 Cg_endo -60.23 -31.57 93.2 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.792 1.661 . . . . 62.44 112.255 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.467 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 19.9 tpt180 -70.79 -37.57 73.32 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.886 0.374 . . . . 75.54 110.368 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.03 -37.87 77.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.665 -0.865 . . . . 61.2 108.665 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.77 -37.06 78.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.944 -1.026 . . . . 71.34 110.035 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.63 -46.67 68.61 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.627 0.771 . . . . 70.3 109.504 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.77 -46.38 82.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.688 -1.142 . . . . 72.52 111.617 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.54 -18.41 29.85 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.552 -0.459 . . . . 75.22 111.842 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.02 61.55 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.965 -0.636 . . . . 64.33 111.554 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.99 161.1 48.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 109.324 -0.621 . . . . 73.51 109.324 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.87 158.63 56.17 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 121.908 1.739 . . . . 73.01 112.051 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.2 -33.33 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.868 0.867 . . . . 75.3 110.854 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.0 p -60.34 -40.43 90.63 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.686 -0.688 . . . . 73.11 111.445 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 65.0 tttm -69.33 -34.12 74.16 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.069 -0.715 . . . . 71.05 109.069 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.0 t -63.51 -44.1 98.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.742 -0.663 . . . . 63.42 109.615 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.62 -36.5 82.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.109 -0.95 . . . . 52.24 110.357 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.82 -35.09 79.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.064 0.394 . . . . 75.32 112.064 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 39.8 mt-30 -62.56 -42.51 99.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.87 0.843 . . . . 71.45 108.838 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.56 -34.84 78.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.552 -1.204 . . . . 75.13 109.451 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.468 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 13.2 mmt85 -67.16 -29.38 69.07 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.928 0.891 . . . . 74.44 112.33 177.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.43 6.13 39.99 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.334 -0.546 . . . . 74.14 111.902 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 43.22 76.02 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.12 -0.562 . . . . 62.03 112.173 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.73 -17.0 14.78 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.112 -0.699 . . . . 74.41 109.112 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 tp -149.35 158.39 44.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.675 -1.231 . . . . 62.23 107.675 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.23 147.22 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.0 -0.741 . . . . 40.23 109.0 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.84 161.54 28.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.111 0.565 . . . . 71.35 110.113 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.426 HG11 ' HG3' ' A' ' 99' ' ' MET . 6.7 m -136.68 165.61 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.928 0.891 . . . . 60.23 109.093 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -117.03 115.88 26.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.659 -0.497 . . . . 43.54 109.659 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -116.81 124.44 49.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.016 -0.735 . . . . 63.14 109.016 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.74 22.59 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.835 0.854 . . . . 65.12 112.712 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.13 -24.02 21.92 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.396 -0.906 . . . . 64.24 113.24 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.29 143.55 16.73 Favored Glycine 0 CA--C 1.496 -1.146 0 C-N-CA 120.811 -0.709 . . . . 74.51 112.252 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 124.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.128 -0.694 . . . . 71.14 109.128 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.44 168.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.751 -1.113 . . . . 61.03 111.286 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.0 mm -118.64 135.92 23.9 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 105.875 -1.898 . . . . 74.55 105.875 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.92 139.7 43.92 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 121.606 1.537 . . . . 65.41 112.638 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -54.15 -36.37 63.27 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.655 0.782 . . . . 64.44 110.141 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.418 ' CG2' HG11 ' A' ' 126' ' ' VAL . 20.0 m -70.17 -3.18 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.271 . . . . 63.21 113.92 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -88.4 -5.93 57.99 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.085 0.945 . . . . 72.24 109.64 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.13 155.54 38.25 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.491 -1.231 . . . . 74.23 108.395 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.8 p -83.21 165.0 19.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.39 -1.337 . . . . 74.44 107.39 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -67.1 -16.02 64.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.361 0.6 . . . . 75.12 110.996 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -79.47 -3.67 47.71 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.301 -0.863 . . . . 70.34 111.02 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.63 21.71 55.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.009 -0.615 . . . . 51.43 112.694 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -114.58 161.38 18.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.607 0.241 . . . . 74.14 110.505 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.72 138.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.107 -1.071 . . . . 71.34 108.107 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.82 129.52 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.036 -1.098 . . . . 74.23 108.036 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.87 -26.39 62.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.348 0.87 . . . . 75.32 113.348 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.8 m -99.02 6.91 46.43 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.411 -0.359 . . . . 71.03 111.645 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 70' ' ' PHE . 19.2 tp -61.12 -54.93 49.09 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 111.98 0.363 . . . . 64.43 111.98 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.99 -22.14 73.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 121.749 1.632 . . . . 75.12 111.73 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.43 -44.46 90.28 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.754 -0.657 . . . . 34.11 112.221 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.07 -39.12 86.78 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.7 -0.852 . . . . 72.05 108.7 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.77 -36.86 84.44 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.694 -1.139 . . . . 71.41 111.294 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 m -57.54 -49.21 77.11 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.611 0.243 . . . . 73.32 111.333 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.95 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.928 0.394 . . . . 74.24 111.353 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.654 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 83.4 mt -66.69 -39.92 88.3 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.36 0.504 . . . . 64.1 112.36 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -68.29 -35.64 78.15 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.117 -0.492 . . . . 73.42 110.496 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.38 -31.67 72.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.597 -0.52 . . . . 72.44 109.597 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.79 -0.77 89.91 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.502 -0.772 . . . . 45.01 112.798 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 34.21 55.29 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.309 -0.472 . . . . 62.34 113.278 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -94.72 123.79 38.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.357 0.598 . . . . 61.3 112.271 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.415 ' HB2' HG21 ' A' ' 16' ' ' ILE . 14.2 ptm180 -73.87 173.71 9.54 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.781 -1.1 . . . . 72.53 112.076 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -53.02 -45.32 67.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.061 1.745 . . . . 54.44 111.238 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -64.24 -40.77 96.71 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 123.842 0.857 . . . . 74.2 110.092 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 25.1 mm-40 -66.81 -37.49 84.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 74.32 111.601 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.547 HD12 HD13 ' A' ' 88' ' ' LEU . 20.7 mm -60.85 -48.11 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.126 -1.064 . . . . 72.22 108.126 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.435 ' SD ' ' HE1' ' A' ' 103' ' ' PHE . 21.8 mmt -74.2 -22.35 59.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.648 -1.16 . . . . 52.0 111.229 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 77.9 ttt180 -54.3 -69.32 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.868 0.867 . . . . 72.55 111.653 -174.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.654 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 55.2 p-90 -70.35 -32.15 69.72 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.214 0.449 . . . . 74.52 112.214 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.588 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 9.3 mt -61.34 -39.81 91.95 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.689 1.366 . . . . 64.31 114.689 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 56.8 m-85 -94.79 -12.17 27.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.599 0.963 . . . . 62.44 113.599 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.1 m -83.17 129.52 60.66 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.741 -0.837 . . . . 62.4 108.741 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.12 128.97 29.61 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.033 1.822 . . . . 61.54 109.626 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.8 118.36 65.96 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.63 -0.878 . . . . 73.5 108.63 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 23.3 Cg_endo -61.11 -20.25 66.97 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.959 2.44 . . . . 64.5 113.667 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.2 m -101.21 4.83 42.27 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.479 -0.328 . . . . 73.43 110.353 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 tp -107.67 123.28 48.27 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.828 0.823 . . . . 74.11 111.155 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.3 m -131.2 113.0 13.32 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.87 -1.53 . . . . 74.11 106.87 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.0 pt -130.67 163.83 35.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 112.372 0.508 . . . . 72.42 112.372 -172.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.9 t -96.64 159.27 15.02 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.938 -1.875 . . . . 73.45 105.938 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 41.5 ttm180 -128.82 162.03 28.41 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 110.625 -0.139 . . . . 74.41 110.625 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.91 112.05 1.21 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.087 0.555 . . . . 64.13 110.327 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.38 -1.34 87.39 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.212 -0.518 . . . . 71.23 112.575 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 113' ' ' ARG . 50.8 m -126.34 100.79 6.43 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.712 -0.477 . . . . 71.54 109.712 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -81.53 -11.11 59.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 122.157 0.979 . . . . 62.31 109.006 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -72.59 140.73 48.22 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.361 -1.745 . . . . 65.15 108.131 172.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.94 136.24 33.7 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.133 -0.485 . . . . 55.54 111.133 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 45.4 t -106.67 119.7 56.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.395 -0.965 . . . . 63.5 108.395 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 m -90.23 151.62 21.45 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.537 -0.912 . . . . 72.12 108.537 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 50.1 m-80 54.37 63.66 2.09 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.306 0.642 . . . . 64.01 111.634 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.59 156.38 24.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.259 -0.645 . . . . 43.15 109.259 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -72.8 135.93 80.51 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.348 -0.541 . . . . 74.45 109.907 175.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.505 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.0 Cg_exo -56.06 -21.22 33.7 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.946 2.431 . . . . 62.0 114.47 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.8 t -61.53 -36.64 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.909 0.861 . . . . 62.33 109.55 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.0 -31.83 72.95 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.767 -1.106 . . . . 71.3 109.201 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.97 71.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.665 -1.152 . . . . 52.3 111.478 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -68.49 -33.02 73.42 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.304 -0.247 . . . . 72.23 111.367 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -64.91 -29.7 70.65 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.013 0.911 . . . . 71.42 108.55 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HB3' HE21 ' A' ' 133' ' ' GLN . . . -98.55 15.95 23.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.49 -1.232 . . . . 64.41 110.584 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.1 m80 58.23 34.2 23.88 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.814 1.413 . . . . 72.14 114.814 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 131' ' ' ALA . 46.7 mt-30 -104.07 23.53 12.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.682 -1.599 . . . . 74.32 106.682 172.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.96 -28.35 23.3 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 126.883 2.073 . . . . 75.5 113.772 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -55.3 -40.18 70.78 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.966 0.412 . . . . 70.52 111.541 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.37 -27.73 61.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.568 0.699 . . . . 61.1 109.746 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.55 -40.9 72.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.29 -0.868 . . . . 72.33 108.903 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.477 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 63.3 t -58.73 -46.72 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.599 -0.889 . . . . 74.42 108.599 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.93 -1.032 . . . . 75.42 112.301 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -64.97 -36.12 83.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 120.876 -0.33 . . . . 64.34 110.166 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.14 -43.27 98.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.872 -0.418 . . . . 61.53 109.872 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -59.51 -44.23 93.18 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 115.577 -0.738 . . . . 74.33 109.688 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.3 -26.58 68.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 60.0 111.867 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.5 tpt -81.61 -34.26 31.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.026 0.441 . . . . 72.14 110.608 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.61 -43.45 15.62 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.075 0.464 . . . . 62.32 111.49 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 . . . . . 0 C--O 1.261 1.669 0 CA-C-N 115.73 -0.668 . . . . 73.22 109.264 -177.22 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 109.141 -0.688 . . . . 54.23 109.141 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.56 103.58 1.15 Allowed 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.341 2.028 . . . . 74.24 112.677 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.85 25.6 0.02 OUTLIER Glycine 0 C--N 1.311 -0.83 0 C-N-CA 120.009 -1.091 . . . . 72.45 113.813 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -73.9 133.41 43.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.467 -0.568 . . . . 73.25 109.467 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.38 135.66 22.25 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 110.34 -0.244 . . . . 61.22 110.34 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.18 143.33 48.5 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.664 2.243 . . . . 74.31 111.645 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.22 90.51 1.21 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 115.916 -0.584 . . . . 73.21 112.6 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 m -96.38 105.06 17.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.672 -0.492 . . . . 75.24 109.672 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -86.8 144.61 26.97 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.098 -0.704 . . . . 73.43 109.098 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.71 158.24 20.84 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.663 -0.495 . . . . 71.41 109.663 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.11 146.77 41.13 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.178 -0.465 . . . . 35.3 109.889 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.56 ' H ' ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -91.55 86.78 6.13 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.574 1.178 . . . . 71.12 108.626 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.1 m -111.88 130.24 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 CA-C-N 114.453 -1.249 . . . . 51.23 110.286 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.67 44.4 0.69 Allowed Glycine 0 C--N 1.269 -3.174 0 N-CA-C 107.765 -2.134 . . . . 71.32 107.765 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 14.0 m -74.95 100.0 4.0 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.582 -0.809 . . . . 73.42 110.992 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.5 mm -114.0 121.38 36.88 Favored Pre-proline 0 C--N 1.289 -2.052 0 N-CA-C 107.42 -1.326 . . . . 71.33 107.42 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.52 166.38 17.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.692 2.261 . . . . 55.01 110.565 176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.92 124.28 29.59 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.002 -0.679 . . . . 62.41 109.987 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.02 -121.06 3.54 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.841 -0.618 . . . . 75.25 113.946 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -109.22 129.79 55.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.546 0.212 . . . . 74.41 111.315 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -65.96 109.48 2.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.706 -0.679 . . . . 74.01 111.267 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.56 -30.93 6.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 113.205 0.816 . . . . 64.34 113.205 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.484 HD23 ' CE2' ' A' ' 103' ' ' PHE 0.273 0.5 OUTLIER -82.86 171.99 13.31 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 118.88 -1.128 . . . . 63.44 112.294 -178.493 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.19 137.41 75.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 109.233 -0.655 . . . . 52.12 109.233 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.71 -21.61 32.84 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.254 2.636 . . . . 74.24 113.852 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.98 -22.55 59.57 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.687 0.279 . . . . 63.33 111.72 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.48 138.4 97.35 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 116.168 -0.469 . . . . 64.42 110.109 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.655 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 34.5 Cg_endo -67.41 104.81 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.484 2.122 . . . . 43.21 110.425 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p -102.59 170.08 8.25 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 121.431 0.634 . . . . 70.4 112.044 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 107.712 -1.218 . . . . 70.32 107.712 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.565 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 13.3 t0 -136.53 164.15 28.84 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 103.528 -2.767 . . . . 63.44 103.528 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.501 ' HB3' HG13 ' A' ' 43' ' ' VAL . 93.5 mt -56.56 -53.76 60.84 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.327 0.862 . . . . 71.42 113.327 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.565 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 12.0 Cg_endo -58.06 -35.83 98.45 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.83 1.686 . . . . 72.24 112.012 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 26.9 tpt180 -67.35 -39.95 85.79 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.9 0.381 . . . . 73.14 111.068 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -36.77 69.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.789 -0.364 . . . . 74.11 110.386 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.82 68.36 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.002 -0.74 . . . . 42.41 109.002 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 42.0 mt-10 -68.48 -45.08 73.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.769 -1.105 . . . . 71.11 111.844 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.5 -46.55 82.48 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.489 -0.778 . . . . 75.55 112.033 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.419 ' HB2' HG22 ' A' ' 41' ' ' VAL . 97.5 mt -93.94 -10.22 34.47 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.608 0.595 . . . . 73.1 112.608 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.05 30.12 72.17 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 111.262 -0.735 . . . . 51.54 111.262 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.419 HG22 ' HB2' ' A' ' 39' ' ' LEU . 20.4 m -124.65 156.61 67.8 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.765 -0.828 . . . . 64.12 108.765 -177.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.35 156.39 66.4 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 121.391 1.394 . . . . 54.0 111.639 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 32' ' ' LEU . 74.5 t -57.02 -33.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 52.24 110.371 178.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 28.3 t -57.48 -40.85 79.47 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.639 -0.71 . . . . 74.43 110.812 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 62.4 tttp -70.47 -35.99 73.62 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 120.861 0.362 . . . . 72.11 110.202 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.31 -44.51 98.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.221 -0.659 . . . . 55.31 109.221 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.05 -36.61 80.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.047 -0.979 . . . . 43.2 110.21 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.623 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 54.7 mt-30 -63.18 -43.44 98.22 Favored 'General case' 0 C--O 1.197 -1.693 0 CA-C-N 116.055 -0.521 . . . . 75.14 111.133 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.7 mm-40 -58.38 -41.25 84.43 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.326 0.584 . . . . 74.51 110.317 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 tp -61.67 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.627 -1.169 . . . . 72.11 109.116 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 29.3 mtp180 -71.26 -23.95 62.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.531 -0.759 . . . . 64.1 112.512 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 10.4 mm-40 -82.97 -12.87 56.94 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.571 -0.529 . . . . 74.31 109.571 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.4 33.16 44.71 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.034 -0.826 . . . . 74.11 111.034 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -99.13 -15.72 18.87 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.771 0.319 . . . . 74.43 110.228 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -161.41 156.95 24.44 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.488 -1.301 . . . . 65.3 107.488 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.5 m -129.28 157.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.387 -0.597 . . . . 72.31 109.387 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.8 36.86 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.422 -0.584 . . . . 71.12 109.422 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 m -128.62 166.68 25.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 123.463 0.477 . . . . 73.2 111.044 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.476 ' NE ' ' HA2' ' A' ' 62' ' ' GLY . 19.4 ttt180 -109.63 121.04 44.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.428 0.632 . . . . 75.13 110.537 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -123.0 114.67 20.72 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.673 -1.149 . . . . 71.31 109.063 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.89 19.07 11.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.817 0.847 . . . . 54.11 111.023 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.476 ' HA2' ' NE ' ' A' ' 59' ' ' ARG . . . 99.7 -14.11 60.61 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.664 -0.698 . . . . 32.52 112.112 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -89.31 151.33 21.91 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.744 -0.942 . . . . 73.14 110.744 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.78 119.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 106.648 -1.612 . . . . 75.12 106.648 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.86 153.75 39.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.618 -0.719 . . . . 72.4 110.486 -174.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -126.45 131.84 24.08 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 108.189 -1.041 . . . . 71.54 108.189 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.39 141.38 86.9 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.238 1.959 . . . . 43.31 112.857 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.655 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.2 tp-100 -48.84 -42.39 36.16 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.213 1.405 . . . . 73.31 110.984 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.74 4.33 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 114.133 -1.394 . . . . 43.23 114.498 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.573 ' CD2' HD11 ' A' ' 81' ' ' LEU . 12.8 m-85 -91.96 -6.23 51.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.168 0.985 . . . . 53.34 109.501 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.51 144.58 47.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.405 -1.27 . . . . 74.14 108.683 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 p -75.85 172.95 11.81 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.253 -1.017 . . . . 71.42 108.253 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.73 -17.3 63.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.895 0.855 . . . . 64.42 109.261 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m -79.87 -6.86 58.21 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.191 -0.913 . . . . 74.22 110.552 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.92 -13.88 66.33 Favored Glycine 0 C--O 1.219 -0.827 0 C-N-CA 121.294 -0.479 . . . . 33.13 113.523 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -95.38 155.04 16.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.228 0.455 . . . . 62.3 112.228 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.37 141.8 17.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.408 -0.814 . . . . 73.12 108.812 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 26.4 t -59.91 134.16 25.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.3 -0.63 . . . . 60.15 109.3 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -55.78 -43.54 76.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.445 0.906 . . . . 75.11 113.445 -173.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.9 t -91.68 3.41 55.13 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.859 -0.336 . . . . 74.23 111.774 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.647 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.2 tt -66.46 -49.9 50.23 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 112.671 0.619 . . . . 73.43 112.671 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.06 -30.06 85.38 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.583 1.522 . . . . 54.44 111.028 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.25 -42.48 96.24 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.631 -0.713 . . . . 74.42 111.925 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.99 -40.16 83.12 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.055 -0.72 . . . . 75.53 109.055 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.53 -35.78 78.71 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.978 -0.556 . . . . 74.4 110.402 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.2 m -61.46 -49.09 78.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.947 -0.57 . . . . 62.1 111.677 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.412 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -64.53 -43.37 96.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.635 0.255 . . . . 71.02 111.226 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.565 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.8 mm? -67.49 -36.08 80.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.541 0.571 . . . . 74.41 112.541 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.13 -45.24 95.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.264 0.554 . . . . 72.44 109.866 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.6 -25.7 61.42 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.716 -0.674 . . . . 71.51 110.445 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.11 86.97 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.6 -0.727 . . . . 74.21 112.559 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.44 30.6 24.24 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 121.425 -0.417 . . . . 42.02 113.786 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -106.1 147.73 28.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.128 0.464 . . . . 71.55 111.537 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.407 ' O ' HG12 ' A' ' 98' ' ' ILE . 16.2 ptp180 -99.62 171.39 7.94 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.672 0.789 . . . . 71.15 110.724 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -54.02 -45.51 71.56 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.537 1.535 . . . . 70.24 112.418 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.8 m -64.23 -41.02 97.19 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.636 -0.711 . . . . 54.23 110.16 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 47.7 mt-10 -66.12 -37.42 85.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.86 -0.609 . . . . 75.31 110.352 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 94' ' ' ARG . 14.5 mm -61.53 -49.52 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.831 -0.803 . . . . 60.22 108.831 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.567 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.7 ptp -75.29 -15.92 60.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.187 -0.915 . . . . 52.33 113.251 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.71 -62.94 1.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.26 -0.644 . . . . 72.14 109.26 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -69.98 -32.98 71.47 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.479 0.918 . . . . 74.11 113.479 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.583 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.0 mt -58.96 -40.32 84.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.212 0.819 . . . . 75.11 113.212 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CE2' HD23 ' A' ' 23' ' ' LEU . 39.0 m-85 -86.14 -11.13 53.45 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.602 0.594 . . . . 70.53 112.602 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 m -87.51 121.14 71.26 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 108.902 -0.777 . . . . 65.22 108.902 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.49 130.12 35.83 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 122.568 2.178 . . . . 60.31 111.846 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 8.1 t70 -79.71 122.81 83.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 108.189 -1.041 . . . . 74.41 108.189 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 31.3 Cg_endo -60.78 -16.88 46.82 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.573 2.849 . . . . 71.22 114.6 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.6 t -119.1 5.74 11.29 Favored 'General case' 0 N--CA 1.421 -1.898 0 O-C-N 122.077 -0.39 . . . . 63.53 110.883 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -100.77 130.63 46.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.314 0.578 . . . . 64.51 110.261 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.561 HG22 ' HB1' ' A' ' 119' ' ' ALA . 48.7 m -131.56 114.81 15.32 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.984 -1.117 . . . . 74.42 107.984 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.73 158.65 43.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 113.883 1.068 . . . . 73.52 113.883 -174.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.424 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 1.4 t -116.86 127.03 53.89 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.763 -1.569 . . . . 75.54 106.763 174.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 116' ' ' SER . 12.1 ptp85 -108.77 169.49 8.63 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.763 -0.653 . . . . 74.41 110.559 -172.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -73.38 99.95 3.07 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.604 -1.628 . . . . 74.01 106.604 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 133.11 -16.94 4.63 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 111.264 -0.734 . . . . 63.24 111.264 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.401 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 14.9 m -145.84 107.97 4.38 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.729 -0.841 . . . . 61.51 108.729 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -74.43 -20.93 59.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.965 0.412 . . . . 73.33 111.076 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.58 143.83 38.01 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.043 -0.725 . . . . 65.24 109.043 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.561 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -85.95 124.39 32.36 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.065 0.46 . . . . 75.51 110.615 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 110' ' ' THR . 48.1 t -97.23 124.65 50.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.933 -0.766 . . . . 54.42 108.933 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.5 m -88.15 146.97 25.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.77 -0.65 . . . . 63.53 110.162 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 25.5 m-80 64.72 57.57 1.06 Allowed 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.277 1.031 . . . . 73.13 109.211 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 159.9 15.68 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.737 -1.119 . . . . 72.33 109.696 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -81.03 147.88 62.65 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 108.325 -0.991 . . . . 72.33 108.325 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.583 ' HB2' HD23 ' A' ' 102' ' ' LEU . 52.1 Cg_exo -56.99 -28.15 76.91 Favored 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 121.892 1.728 . . . . 72.11 111.387 174.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 62.0 t -63.68 -35.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.609 0.719 . . . . 73.52 110.409 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.81 -41.57 74.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.68 -1.23 . . . . 60.23 107.68 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -34.86 79.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.485 -1.234 . . . . 63.02 113.173 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.77 -32.96 71.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.584 -0.698 . . . . 72.42 111.263 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -76.74 -13.61 60.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.885 0.85 . . . . 73.35 109.907 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 112' ' ' THR . . . -89.91 3.85 51.78 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.802 -1.09 . . . . 75.31 110.421 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.9 t60 64.14 27.17 14.03 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.211 1.482 . . . . 73.22 109.689 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -114.13 24.86 11.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.0 -1.455 . . . . 74.45 108.139 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.73 -27.85 19.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.602 -1.635 . . . . 75.52 112.43 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -56.37 -42.84 78.51 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.468 -0.567 . . . . 52.4 109.468 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 22.6 mm-40 -65.64 -39.63 91.65 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.361 -0.836 . . . . 72.42 109.481 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.64 -47.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.4 -0.818 . . . . 62.12 109.786 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 57.9 t -60.83 -41.79 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.816 -0.629 . . . . 52.11 109.805 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -63.42 -40.4 97.07 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 120.923 0.392 . . . . 73.32 111.2 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 14.3 mmt85 -66.22 -35.49 80.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.864 -0.791 . . . . 70.1 108.864 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.565 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 63.11 109.888 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.6 mt-30 -61.7 -38.62 88.51 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 116.155 -0.475 . . . . 73.21 109.887 176.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.96 -22.78 65.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.963 0.411 . . . . 53.12 111.366 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 24.1 mmt -89.07 -29.66 19.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.348 0.594 . . . . 64.54 110.013 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.32 -45.17 13.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.077 -0.511 . . . . 74.02 111.8 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 107.785 -1.191 . . . . 70.33 107.785 -178.954 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 CA--C 1.505 -0.775 0 N-CA-C 107.914 -1.143 . . . . 74.31 107.914 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.0 83.53 2.22 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 121.532 1.488 . . . . 60.21 109.586 173.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.44 68.18 3.57 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.504 -1.039 . . . . 41.03 110.504 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.14 132.58 49.53 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.303 0.573 . . . . 74.53 111.093 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.3 151.47 39.64 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 106.478 -1.675 . . . . 74.54 106.478 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.09 86.19 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.049 1.833 . . . . 62.55 111.973 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.01 -36.31 2.77 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 109.384 -1.486 . . . . 71.23 109.384 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 m -95.31 -177.24 4.04 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.001 -0.74 . . . . 74.1 109.001 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.0 m -146.74 149.89 34.28 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.036 -1.098 . . . . 74.15 108.036 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.1 mt -66.34 144.86 56.3 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.447 0.642 . . . . 73.33 111.281 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.8 167.7 10.77 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.95 -1.023 . . . . 74.4 110.739 -175.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 51' ' ' ARG . 52.2 ttt85 -76.08 95.66 3.68 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-O 121.454 0.645 . . . . 74.04 110.494 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.02 -3.77 9.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.38 -1.282 . . . . 64.32 109.857 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.08 67.97 0.45 Allowed Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 109.325 -1.51 . . . . 64.44 109.325 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.497 ' OG ' ' HG2' ' A' ' 12' ' ' ARG . 39.3 m -83.17 77.56 9.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 112.531 0.567 . . . . 52.3 112.531 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.64 119.78 66.82 Favored Pre-proline 0 N--CA 1.438 -1.071 0 N-CA-C 105.923 -1.88 . . . . 62.32 105.923 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.34 146.45 31.48 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.335 2.023 . . . . 75.03 112.192 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.92 129.3 34.93 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.798 -0.815 . . . . 63.32 108.798 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.93 -107.77 2.19 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 110.842 -0.903 . . . . 52.04 110.842 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -118.17 141.88 48.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.703 -0.481 . . . . 61.11 109.703 -176.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.09 158.09 34.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.997 0.903 . . . . 73.15 111.696 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 22' ' ' VAL . 38.9 t -121.23 32.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 124.172 1.939 . . . . 74.34 106.262 175.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.458 HD13 HG21 ' A' ' 29' ' ' THR . 40.4 mt -104.49 178.93 4.42 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.239 -1.8 . . . . 43.4 111.266 -175.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 15.3 t70 -90.79 136.05 28.23 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 105.704 -1.961 . . . . 61.25 105.704 169.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.65 -25.47 14.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.393 2.728 . . . . 75.22 115.193 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.52 33.68 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.524 -0.87 . . . . 74.44 110.973 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 25.3 tp10 -72.57 129.46 87.06 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 105.726 -1.953 . . . . 71.42 105.726 172.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 52.4 Cg_exo -55.27 98.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.66 2.24 . . . . 74.34 111.681 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.458 HG21 HD13 ' A' ' 23' ' ' LEU . 6.1 p -107.16 -177.66 3.42 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.732 -0.667 . . . . 73.31 112.197 -176.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.445 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 52.3 m-85 -111.48 159.78 17.75 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.999 -1.001 . . . . 71.12 109.445 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.3 m-20 -136.52 162.46 33.03 Favored 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 101.84 -3.392 . . . . 73.23 101.84 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -50.94 -51.55 66.18 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-N 119.028 0.831 . . . . 72.12 112.447 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.87 -35.95 85.94 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.021 1.814 . . . . 65.04 112.553 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 7.7 tpt180 -70.27 -36.99 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.864 0.364 . . . . 73.52 110.181 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 31' ' ' ASP . 66.0 t -69.1 -39.03 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.475 -0.565 . . . . 71.33 109.475 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.75 84.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.465 -0.789 . . . . 63.04 109.52 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.2 -36.69 79.96 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.592 -1.186 . . . . 73.51 110.247 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 56.9 tp -72.55 -45.46 59.12 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.54 -0.755 . . . . 70.31 111.335 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 41' ' ' VAL . 94.0 mt -85.71 -18.44 33.09 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.637 0.606 . . . . 54.41 112.637 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.56 28.04 60.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.796 -0.922 . . . . 34.43 110.796 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 39' ' ' LEU . 31.6 m -123.01 159.09 55.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.319 -0.993 . . . . 75.43 108.319 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -67.23 155.25 71.4 Favored 'Trans proline' 0 C--O 1.26 1.597 0 C-N-CA 121.057 1.171 . . . . 75.1 111.644 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.46 -33.5 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.428 0.691 . . . . 73.25 110.424 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 36.8 t -57.33 -45.62 84.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.954 -0.566 . . . . 71.03 110.787 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 64.7 mttm -64.72 -36.74 85.25 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.392 -0.523 . . . . 64.5 110.88 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.33 -45.17 98.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.496 -0.557 . . . . 60.55 109.496 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.45 80.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.581 -0.736 . . . . 72.55 110.552 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.641 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 97.2 mt-30 -61.73 -46.77 88.21 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.802 -0.444 . . . . 54.31 109.802 176.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 77.6 mt-30 -59.39 -42.55 91.95 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.706 0.765 . . . . 64.33 110.556 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.2 -38.33 88.74 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.437 -1.256 . . . . 74.42 109.427 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 59.9 mtm180 -71.25 -29.13 64.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.185 0.439 . . . . 75.11 112.185 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.641 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 56.0 mt-10 -76.55 -12.26 60.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.737 0.303 . . . . 74.54 110.375 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.44 22.47 64.76 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.545 -1.022 . . . . 62.23 110.545 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -94.62 -0.32 54.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.103 0.478 . . . . 70.34 111.049 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.7 tp -163.23 152.79 15.18 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.403 -1.702 . . . . 74.53 106.403 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -132.09 148.13 32.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.013 -0.736 . . . . 71.33 109.013 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.23 154.3 37.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 123.567 0.542 . . . . 75.32 110.01 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.576 HG12 ' OD2' ' A' ' 95' ' ' ASP . 19.6 m -128.39 166.63 25.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.302 1.041 . . . . 75.15 109.116 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 53.4 mtm180 -110.91 129.37 55.9 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.743 -0.466 . . . . 71.13 109.743 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -125.34 123.84 40.26 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.648 -1.612 . . . . 70.13 106.648 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.04 -15.78 0.32 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.418 1.087 . . . . 60.03 112.8 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.01 -13.83 4.67 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.927 -0.869 . . . . 63.32 110.927 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -92.7 152.52 21.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.804 -0.918 . . . . 63.15 110.804 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -96.8 120.78 46.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 71.52 107.835 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.39 160.29 40.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.479 -0.782 . . . . 63.31 111.218 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.06 125.7 26.19 Favored Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 106.978 -1.49 . . . . 74.44 106.978 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 29' ' ' THR . 51.3 Cg_exo -56.43 139.22 86.6 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.745 2.296 . . . . 75.24 113.625 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.9 tp-100 -53.81 -37.26 63.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.286 1.034 . . . . 70.25 110.165 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.459 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 34.3 m -72.18 2.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.574 -1.648 . . . . 74.45 113.95 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.3 m-85 -95.49 -1.68 50.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.935 0.874 . . . . 74.43 109.497 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.46 139.32 53.63 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.656 -1.156 . . . . 73.51 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.7 p -79.51 168.94 18.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.016 -0.993 . . . . 70.04 109.519 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -57.56 -23.41 50.46 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.068 0.547 . . . . 73.34 111.35 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 t -79.96 -8.13 59.17 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.191 -0.459 . . . . 73.3 110.345 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.17 18.33 65.03 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.998 -0.62 . . . . 65.33 112.719 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -119.13 161.84 19.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.046 -0.724 . . . . 72.44 109.046 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.27 144.86 11.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.332 -0.988 . . . . 72.33 108.332 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.8 t -64.02 124.64 19.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.406 -0.961 . . . . 73.23 108.406 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -55.26 -44.72 75.84 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.584 1.327 . . . . 62.22 114.584 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.9 m -96.55 9.82 40.29 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 112.758 0.651 . . . . 65.42 112.758 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 7.1 tt -65.64 -45.34 67.11 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 116.368 -0.378 . . . . 72.43 111.864 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.88 -25.76 54.33 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.924 1.749 . . . . 75.32 111.658 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.9 -38.66 96.93 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.658 -0.701 . . . . 33.0 111.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.98 -41.06 78.4 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.971 -0.751 . . . . 63.3 108.971 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.43 -34.39 75.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 72.3 110.355 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.0 m -61.65 -49.02 78.22 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.486 -0.779 . . . . 64.24 110.791 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -41.81 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 111.642 0.238 . . . . 71.42 111.642 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.409 HD21 ' HB1' ' A' ' 141' ' ' ALA . 2.9 mm? -66.75 -35.19 79.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.029 -0.668 . . . . 74.14 112.511 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -63.72 -35.95 82.27 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.131 -0.692 . . . . 75.0 109.131 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.09 -31.22 67.54 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.481 -0.781 . . . . 71.25 110.002 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.62 -8.63 70.05 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.625 -0.716 . . . . 72.05 112.8 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.04 49.61 5.9 Favored Glycine 0 C--N 1.318 -0.423 0 C-N-CA 121.338 -0.458 . . . . 62.33 113.669 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.94 139.8 49.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.259 -0.553 . . . . 71.11 111.865 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -85.09 170.03 13.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.351 -0.84 . . . . 74.4 110.3 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.576 ' OD2' HG12 ' A' ' 58' ' ' VAL . 19.1 p-10 -55.28 -42.69 73.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.506 1.522 . . . . 74.21 111.945 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.2 m -61.32 -42.24 98.35 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.098 -0.955 . . . . 73.55 110.012 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.73 -37.12 84.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.141 -0.482 . . . . 75.54 110.928 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.09 -48.9 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.844 0.831 . . . . 75.05 108.813 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.489 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 59.0 mtt -75.48 -20.87 58.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.784 -1.098 . . . . 73.21 112.227 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -57.97 -61.13 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.511 0.507 . . . . 72.34 109.736 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.419 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 29.1 p-90 -69.46 -32.53 71.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.19 0.811 . . . . 64.05 113.19 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 126' ' ' VAL . 17.0 mt -60.12 -41.45 92.68 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.812 0.671 . . . . 75.33 112.812 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -85.02 -14.72 46.48 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.605 -0.438 . . . . 70.51 112.081 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 m -87.05 118.59 70.25 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.788 -0.449 . . . . 74.31 109.788 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.93 131.07 40.71 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.903 2.402 . . . . 74.32 111.217 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.6 t70 -90.47 122.84 66.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.26 -0.427 . . . . 61.12 110.966 -174.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.91 -16.31 44.04 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.935 3.09 . . . . 50.25 114.56 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -118.03 10.54 13.08 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.798 -0.564 . . . . 55.34 110.4 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.32 131.3 49.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.488 0.661 . . . . 71.13 111.917 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -125.99 120.28 29.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.867 -1.531 . . . . 62.0 106.867 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.464 HG22 ' NE2' ' A' ' 133' ' ' GLN . 28.1 pt -130.86 165.01 32.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.429 0.156 . . . . 72.44 111.285 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.522 HG22 ' OE1' ' A' ' 133' ' ' GLN . 15.1 t -89.05 159.48 17.55 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.221 -1.029 . . . . 61.34 108.221 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 2.1 tpm_? -127.71 166.17 18.63 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 110.071 -0.344 . . . . 71.12 110.071 -174.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.403 ' H ' ' NE ' ' A' ' 113' ' ' ARG . 5.9 m-20 -87.88 140.27 29.67 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 122.786 0.434 . . . . 73.5 110.435 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.38 -71.35 2.68 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 109.0 -1.64 . . . . 74.33 109.0 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 113' ' ' ARG . 3.4 p -88.8 78.98 7.53 Favored 'General case' 0 N--CA 1.403 -2.798 0 N-CA-C 106.96 -1.496 . . . . 64.51 106.96 174.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -68.51 16.94 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.828 1.651 . . . . 65.44 114.602 -173.058 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -76.87 178.13 7.12 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 123.239 0.616 . . . . 72.03 110.018 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.48 125.23 35.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.602 -0.518 . . . . 73.52 109.602 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.15 118.82 54.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.82 -0.627 . . . . 63.44 109.393 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.8 m -90.17 139.9 30.19 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.842 -0.617 . . . . 52.52 109.55 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 11.1 t30 59.81 67.79 0.84 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.746 1.26 . . . . 72.15 110.619 -177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -113.1 179.23 4.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.288 -1.324 . . . . 52.32 109.877 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.451 ' HD3' ' N ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -87.12 138.35 32.6 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 109.014 -0.736 . . . . 63.11 109.014 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.505 ' HB2' HD23 ' A' ' 102' ' ' LEU . 71.4 Cg_exo -56.27 -29.93 78.3 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.198 1.932 . . . . 61.14 110.122 170.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.633 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 70.5 t -61.82 -42.8 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.345 0.593 . . . . 74.13 110.37 173.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.98 -34.76 77.15 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.07 -0.652 . . . . 72.21 109.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.79 85.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.915 -1.039 . . . . 63.22 112.853 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.65 -32.51 71.21 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.029 -0.42 . . . . 71.4 110.917 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -71.74 -23.41 61.61 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.686 0.755 . . . . 70.43 109.767 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.38 -0.26 54.28 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.851 -1.068 . . . . 61.31 110.423 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.7 m80 64.03 28.24 14.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.59 1.156 . . . . 71.31 110.256 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.522 ' OE1' HG22 ' A' ' 112' ' ' THR . 12.7 mt-30 -102.61 25.07 9.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.956 -1.475 . . . . 72.13 107.414 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.49 -28.31 19.86 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 113.914 -1.494 . . . . 73.41 112.675 -178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -56.77 -41.15 77.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.81 0.338 . . . . 71.41 110.707 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.51 -34.18 77.65 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.909 -0.587 . . . . 63.33 110.165 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.24 -44.87 83.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.685 -0.688 . . . . 52.23 109.144 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 134' ' ' ALA . 64.2 t -61.1 -42.33 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.458 -0.571 . . . . 61.55 109.458 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -58.11 -43.44 87.15 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.977 -0.556 . . . . 72.21 110.403 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 144' ' ' MET . 73.2 mmt-85 -65.84 -39.0 90.37 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 116.618 -0.265 . . . . 71.33 111.126 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.409 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -58.87 -45.1 90.96 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.365 0.416 . . . . 23.4 110.272 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -43.02 99.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 72.34 109.993 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.07 -19.83 63.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.401 -0.818 . . . . 51.4 112.632 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 91.3 mmm -88.4 -21.49 24.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.313 0.577 . . . . 65.41 109.799 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.37 -61.0 2.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.328 -0.619 . . . . 74.51 109.328 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--N 1.302 -1.457 0 CA-C-O 118.304 -0.855 . . . . 65.44 109.52 -178.847 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mmm . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 109.781 -0.452 . . . . 72.33 109.781 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.62 156.45 44.74 Favored 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.242 1.961 . . . . 60.44 111.003 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.86 -59.91 0.05 OUTLIER Glycine 0 C--N 1.307 -1.036 0 N-CA-C 110.795 -0.922 . . . . 64.13 110.795 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -69.09 145.07 53.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.928 -0.397 . . . . 73.3 109.928 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -82.71 112.05 34.24 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 107.831 -1.174 . . . . 72.51 107.831 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HG2' ' O ' ' A' ' 29' ' ' THR . 27.7 Cg_exo -67.83 -178.63 1.7 Allowed 'Trans proline' 0 C--O 1.253 1.23 0 C-N-CA 122.944 2.43 . . . . 54.04 113.003 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.92 40.67 2.82 Favored Glycine 0 N--CA 1.419 -2.487 0 N-CA-C 106.363 -2.695 . . . . 71.02 106.363 -170.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 m -65.28 -48.29 73.69 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.886 -1.157 . . . . 75.45 108.326 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.3 m -144.05 129.36 18.84 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.227 -1.398 . . . . 63.13 107.227 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.18 143.56 41.03 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.253 -0.647 . . . . 73.5 109.253 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.36 95.55 9.7 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.914 0.709 . . . . 53.03 112.914 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -104.29 75.68 1.27 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.589 -0.732 . . . . 72.42 109.71 173.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -141.46 150.42 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 106.582 -1.636 . . . . 74.31 106.582 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.92 37.29 3.61 Favored Glycine 0 C--N 1.287 -2.167 0 C-N-CA 121.002 -0.618 . . . . 53.12 114.344 -173.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.437 ' HA ' ' NH2' ' A' ' 51' ' ' ARG . 18.3 m -121.24 14.06 11.24 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.565 0.698 . . . . 71.41 110.483 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.456 HG23 HD13 ' A' ' 50' ' ' LEU . 73.4 mt -120.69 121.8 28.86 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 115.27 -0.877 . . . . 65.54 110.765 -175.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.45 134.04 13.61 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 121.393 1.395 . . . . 74.53 108.939 166.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . -132.24 150.24 52.2 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 122.094 -0.379 . . . . 72.03 111.388 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.04 -171.53 18.77 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.268 -1.133 . . . . 31.24 110.268 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -87.68 138.28 31.61 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.022 -0.733 . . . . 73.12 109.022 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.08 111.45 7.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.118 0.961 . . . . 73.44 112.421 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 100' ' ' ARG . 25.9 t -96.83 45.14 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.525 -1.657 . . . . 74.55 106.525 171.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.473 HD23 ' CE2' ' A' ' 103' ' ' PHE . 57.0 mt -107.97 161.01 15.32 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.315 -1.311 . . . . 74.25 110.645 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.589 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.5 t70 -97.4 143.27 25.87 Favored Pre-proline 0 C--N 1.289 -2.037 0 N-CA-C 105.504 -2.035 . . . . 74.32 105.504 171.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.37 -24.67 12.38 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.318 2.679 . . . . 45.35 114.539 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -96.43 2.59 52.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.759 1.022 . . . . 62.51 113.759 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.589 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 41.2 mm-40 -78.15 127.57 81.01 Favored Pre-proline 0 C--O 1.249 1.079 0 N-CA-C 109.139 -0.689 . . . . 74.15 109.139 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.13 142.11 60.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.878 2.385 . . . . 75.2 112.802 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.576 ' O ' ' HG2' ' A' ' 6' ' ' PRO . 3.3 p -123.06 -174.65 2.99 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.286 -0.87 . . . . 71.45 110.552 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -133.15 161.84 33.36 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 127.344 2.258 . . . . 64.24 107.059 172.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.9 p30 -133.41 156.41 47.73 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 104.132 -2.544 . . . . 73.52 104.132 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.311 4.5 mm? -51.7 -52.61 58.99 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 116.126 1.898 . . . . 75.42 116.126 -172.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.15 -33.74 97.78 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 120.371 1.168 . . . . 74.15 111.935 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -69.35 -41.23 76.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.057 -0.349 . . . . 74.11 110.057 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG21 HD12 ' A' ' 66' ' ' ILE . 62.4 t -67.65 -39.64 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.306 -0.406 . . . . 72.02 109.972 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.89 91.66 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.428 -0.806 . . . . 71.12 109.612 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.69 -41.01 79.79 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.841 -1.072 . . . . 54.21 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.06 -44.44 72.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.345 -0.843 . . . . 61.35 111.516 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.0 -13.95 40.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.32 -0.4 . . . . 72.55 112.046 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.7 23.77 71.75 Favored Glycine 0 C--O 1.243 0.673 0 C-N-CA 120.888 -0.672 . . . . 61.33 112.339 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 143.71 50.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.652 -0.87 . . . . 63.4 108.652 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.53 155.18 43.32 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.432 2.088 . . . . 75.43 113.064 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -50.8 -35.76 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.338 1.055 . . . . 62.15 111.722 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 t -57.68 -42.98 84.7 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.72 0.408 . . . . 71.01 110.867 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -69.69 -36.01 75.59 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.806 0.336 . . . . 52.13 110.957 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.12 -40.54 89.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.5 -0.555 . . . . 72.23 109.5 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.46 75.36 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.666 -0.697 . . . . 74.55 111.049 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 48' ' ' GLN . 12.4 mm-40 -65.7 -39.99 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 71.02 110.679 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.08 -44.65 95.19 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.0 0.905 . . . . 74.44 109.213 176.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.456 HD13 HG23 ' A' ' 16' ' ' ILE . 92.3 mt -62.17 -35.16 77.96 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.103 -1.408 . . . . 64.52 110.505 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.437 ' NH2' ' HA ' ' A' ' 15' ' ' SER . 33.2 mmt180 -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.229 0.455 . . . . 73.13 112.229 176.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -84.75 -12.19 54.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.119 -0.632 . . . . 70.34 111.403 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.64 34.47 25.05 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.491 -1.044 . . . . 72.21 110.491 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.408 ' O ' HD23 ' A' ' 81' ' ' LEU . 36.9 t-80 -82.12 -21.52 36.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.772 -0.825 . . . . 71.22 108.772 177.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.5 tp -152.32 157.97 42.08 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.989 -1.856 . . . . 74.0 105.989 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.46 146.01 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.554 -0.906 . . . . 73.15 108.554 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -118.61 158.68 25.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.246 -1.02 . . . . 74.44 108.246 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.2 m -132.56 162.37 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.396 0.617 . . . . 74.03 111.204 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -110.55 115.48 29.69 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.591 -1.263 . . . . 61.02 107.591 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -130.38 129.9 43.69 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 106.935 -1.506 . . . . 73.44 106.935 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.33 9.71 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.797 0.839 . . . . 75.22 110.879 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.32 65.53 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.786 -0.643 . . . . 63.12 112.358 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.29 146.52 18.23 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 121.186 -0.53 . . . . 71.43 111.955 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.51 121.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.454 -0.573 . . . . 75.24 109.454 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.29 167.28 18.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 125.264 1.426 . . . . 63.4 108.48 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.438 HD12 HG21 ' A' ' 35' ' ' VAL . 74.7 mt -115.47 131.49 23.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.397 -0.964 . . . . 73.33 108.397 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.68 126.71 17.27 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 121.861 1.707 . . . . 64.52 112.616 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -64.03 -23.98 67.54 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 122.951 0.501 . . . . 73.45 111.603 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 m -67.87 -6.81 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 112.332 0.493 . . . . 61.23 112.332 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.8 m-85 -89.37 -3.24 58.53 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.037 0.922 . . . . 73.44 109.847 174.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -117.86 152.35 35.55 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.666 -1.152 . . . . 74.0 108.162 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 p -82.65 175.28 10.28 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 123.441 0.463 . . . . 72.14 110.034 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.04 -33.68 69.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.549 0.74 . . . . 72.34 110.718 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.1 m -79.54 -3.57 47.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.961 -0.563 . . . . 65.25 112.511 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.9 35.59 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.309 -0.948 . . . . 73.2 111.398 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.57 145.51 37.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.272 -1.01 . . . . 74.24 108.272 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.435 HG13 HD22 ' A' ' 81' ' ' LEU . 55.2 t -68.99 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.228 -1.027 . . . . 74.31 108.228 174.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.84 127.87 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.37 -0.974 . . . . 72.11 108.37 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -68.81 -25.46 64.69 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.891 -0.506 . . . . 70.51 112.188 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 56.7 m -90.25 6.92 40.81 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.493 -0.321 . . . . 60.24 111.439 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 13.0 tp -61.23 -53.19 65.35 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 119.235 -0.412 . . . . 71.41 111.029 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.3 Cg_exo -63.12 -29.84 74.79 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.359 1.373 . . . . 74.14 110.984 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.14 91.99 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.721 -0.672 . . . . 41.12 111.923 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.04 -40.19 82.89 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.292 0.567 . . . . 71.21 109.493 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.54 -45.96 88.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 52.35 110.437 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.5 m -62.56 -43.79 97.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.748 0.647 . . . . 72.22 112.748 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.503 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -61.94 -47.7 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 118.128 0.422 . . . . 71.13 111.537 -178.598 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.586 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -67.28 -42.79 83.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 74.43 112.06 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.35 -35.33 80.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.164 -0.68 . . . . 52.23 109.164 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -71.07 -30.2 66.28 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.433 0.635 . . . . 52.14 110.595 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.22 86.84 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.918 -0.583 . . . . 50.01 112.673 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.62 39.95 4.28 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 120.775 -0.726 . . . . 73.11 112.999 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 65.7 m-85 -119.62 136.82 54.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.251 -0.648 . . . . 65.45 109.251 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.587 ' HG2' ' OE1' ' A' ' 97' ' ' GLU . 7.8 ptp85 -84.61 171.07 12.74 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 123.251 0.345 . . . . 75.21 110.697 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -53.38 -45.29 69.19 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 124.601 1.161 . . . . 62.43 112.969 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -62.04 -40.65 96.47 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.627 -0.715 . . . . 73.51 109.95 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.587 ' OE1' ' HG2' ' A' ' 94' ' ' ARG . 44.7 mt-10 -65.87 -33.83 76.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.941 -0.572 . . . . 62.12 111.798 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.414 HD12 ' CB ' ' A' ' 88' ' ' LEU . 9.4 mm -62.53 -49.4 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.296 -1.002 . . . . 64.14 108.296 -177.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.493 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 14.9 ptm -75.44 -16.32 60.34 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.243 -0.89 . . . . 54.12 112.634 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HA ' HG11 ' A' ' 22' ' ' VAL . 68.4 ttt180 -58.59 -64.42 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.351 0.66 . . . . 71.23 110.364 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.486 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.0 p-90 -68.84 -31.67 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.192 -0.458 . . . . 72.13 112.145 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 11.9 mt -57.71 -39.56 77.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.007 0.743 . . . . 70.42 113.007 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CE2' HD23 ' A' ' 23' ' ' LEU . 30.0 m-85 -86.49 -3.14 58.96 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.241 0.46 . . . . 71.54 112.241 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.5 m -86.2 125.43 68.09 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 107.606 -1.257 . . . . 63.44 107.606 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.56 133.84 59.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.649 2.233 . . . . 64.54 110.94 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.7 t70 -91.45 121.37 67.56 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 109.428 -0.582 . . . . 72.11 109.428 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.78 -16.38 43.73 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.693 2.929 . . . . 72.43 114.779 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 m -123.46 16.02 9.66 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 122.01 -0.431 . . . . 72.4 111.108 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 28.9 tp -104.28 115.18 29.93 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.726 -0.79 . . . . 65.43 111.231 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.2 m -122.37 110.68 15.95 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.901 -1.518 . . . . 75.02 106.901 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.8 pt -139.38 164.45 24.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 112.37 0.507 . . . . 72.42 112.37 -171.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -88.86 152.9 21.47 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 104.773 -2.306 . . . . 65.13 104.773 169.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -117.17 173.93 6.4 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 108.207 -1.034 . . . . 72.14 108.207 -171.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.79 94.09 9.05 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.389 -1.337 . . . . 74.54 107.389 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.88 -58.18 0.69 Allowed Glycine 0 C--N 1.296 -1.647 0 N-CA-C 109.134 -1.586 . . . . 45.0 109.134 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.0 m -79.8 99.69 7.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.075 -1.454 . . . . 74.33 107.075 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -75.33 -28.26 59.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.218 -0.446 . . . . 75.41 110.991 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.67 152.94 35.6 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.551 -0.75 . . . . 61.24 109.247 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.85 125.85 27.98 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.156 0.503 . . . . 72.22 111.81 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t -107.71 122.74 62.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.392 -0.822 . . . . 54.14 108.806 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.1 m -87.46 149.33 24.49 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 123.059 0.544 . . . . 72.54 109.892 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 4.8 m-20 56.42 43.47 26.03 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.309 1.044 . . . . 41.14 111.138 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.61 175.66 9.1 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.111 -0.949 . . . . 71.25 111.988 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -86.74 124.67 68.89 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.33 -0.85 . . . . 75.44 110.41 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.6 Cg_exo -51.96 -28.08 30.54 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 124.068 3.179 . . . . 72.11 114.443 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.9 t -60.39 -39.1 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.515 0.674 . . . . 65.13 109.879 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.13 -30.07 68.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.567 -0.742 . . . . 62.54 111.176 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.22 87.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 62.14 110.213 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -70.2 -34.05 72.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.88 -0.415 . . . . 62.22 109.88 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -68.65 -25.28 64.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.44 -0.8 . . . . 73.51 109.241 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.47 7.03 46.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.15 -0.932 . . . . 71.23 111.071 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.9 m80 69.35 32.79 3.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.931 0.872 . . . . 70.12 112.873 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -112.01 24.69 12.36 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.82 -1.178 . . . . 72.24 107.82 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.93 -29.74 30.45 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 125.22 1.408 . . . . 55.33 113.657 -173.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -57.77 -35.44 70.76 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.835 0.35 . . . . 74.32 111.476 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -32.37 68.01 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.476 0.655 . . . . 73.01 109.845 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.4 t -70.97 -42.83 77.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.964 -1.016 . . . . 63.34 108.523 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 90.2 t -59.46 -42.64 88.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.428 -0.806 . . . . 73.04 109.874 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -60.71 -47.18 87.44 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.658 -0.246 . . . . 71.42 111.255 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -61.14 -39.21 89.22 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.354 -0.61 . . . . 75.23 109.354 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.586 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.87 -46.74 88.33 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 115.271 -0.877 . . . . 63.13 110.87 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.3 mt-30 -58.57 -41.18 85.12 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.2 0.6 . . . . 61.25 111.529 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.24 79.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.9 -0.591 . . . . 42.13 111.221 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.1 tpt -80.34 -35.44 35.56 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.889 -0.596 . . . . 71.45 110.697 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -71.89 -49.87 34.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.294 0.85 . . . . 71.51 113.294 -176.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 C--N 1.307 -1.276 0 CA-C-O 118.628 -0.701 . . . . 71.11 109.575 -175.411 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 110.13 -0.322 . . . . 52.33 110.13 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.43 103.46 1.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.769 1.646 . . . . 72.12 110.084 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.57 119.95 2.19 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.195 -1.002 . . . . 61.03 112.653 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.04 139.5 46.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.236 -1.024 . . . . 72.12 108.236 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.46 92.19 45.82 Favored Pre-proline 0 C--N 1.305 -1.366 0 C-N-CA 120.388 -0.525 . . . . 52.31 111.694 -176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -74.32 118.04 5.21 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.47 2.114 . . . . 63.04 110.445 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.21 -127.46 1.63 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 109.835 -1.306 . . . . 73.1 109.835 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.2 t -164.57 124.34 1.95 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.462 -0.94 . . . . 45.21 108.462 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.3 m -65.08 147.32 53.68 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.257 -1.016 . . . . 70.44 108.257 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.0 -174.55 0.79 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 110.599 -0.149 . . . . 71.34 110.599 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.42 104.98 0.56 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.143 0.497 . . . . 73.42 110.677 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.508 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 18.0 ptt180 -107.84 125.3 51.28 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.974 -0.557 . . . . 73.02 110.702 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.15 107.87 23.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.244 0.545 . . . . 74.44 110.009 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 51' ' ' ARG . . . 69.03 18.72 73.09 Favored Glycine 0 C--O 1.22 -0.738 0 CA-C-N 115.541 -0.754 . . . . 72.54 112.844 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 12' ' ' ARG . 7.9 m -105.43 114.55 28.79 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.411 -1.329 . . . . 74.02 107.411 -175.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.3 mt -116.82 121.73 32.44 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 115.943 -0.571 . . . . 62.44 110.896 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.61 166.5 13.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.117 2.545 . . . . 72.31 109.837 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB1' ' C ' ' A' ' 58' ' ' VAL . . . -81.83 132.92 35.29 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.96 -0.696 . . . . 74.41 110.317 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.491 ' HA3' ' OD1' ' A' ' 95' ' ' ASP . . . -83.94 -164.8 37.71 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.173 -0.922 . . . . 73.01 115.06 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.12 112.89 20.22 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 114.342 -0.929 . . . . 63.42 111.224 -173.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -46.23 111.85 0.42 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.92 1.288 . . . . 54.01 113.846 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 100' ' ' ARG . 91.8 t -86.67 -37.7 11.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 107.92 -1.141 . . . . 72.21 107.92 172.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HB3' ' CD2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -73.63 164.67 26.33 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.955 -1.02 . . . . 74.02 111.238 177.601 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.37 150.07 97.43 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.757 -0.46 . . . . 64.15 109.757 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 59.3 Cg_exo -51.28 -41.0 60.57 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.646 2.231 . . . . 73.31 113.2 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.14 26.74 8.42 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 63.23 113.119 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.66 138.39 90.86 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 105.832 -1.914 . . . . 75.31 105.832 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -36.46 110.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.463 3.442 . . . . 74.21 113.496 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.89 174.98 10.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.353 0.597 . . . . 74.54 112.271 -176.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.494 ' CE2' HD22 ' A' ' 38' ' ' LEU . 35.0 m-85 -130.33 161.52 31.1 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.418 1.487 . . . . 75.31 107.828 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.6 t0 -133.28 166.74 21.8 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 103.344 -2.836 . . . . 72.25 103.344 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -46.62 -56.0 12.73 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 113.706 1.002 . . . . 72.5 113.706 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.32 -40.9 78.5 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 121.794 1.663 . . . . 44.33 112.004 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 34' ' ' ARG . 1.9 mpt_? -70.77 -34.69 72.07 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.055 0.761 . . . . 73.3 113.055 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 31' ' ' ASP . 45.5 t -69.86 -43.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.979 -0.748 . . . . 74.51 108.979 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.71 80.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.911 -1.04 . . . . 72.24 109.475 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.5 -45.45 75.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.279 -0.873 . . . . 63.24 110.436 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.494 HD22 ' CE2' ' A' ' 30' ' ' TYR . 30.2 tp -65.76 -50.12 65.9 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 71.01 111.096 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.501 ' HB2' HG22 ' A' ' 41' ' ' VAL . 93.6 mt -83.1 -18.37 39.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.795 -0.639 . . . . 71.45 112.217 -176.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.85 63.38 Favored Glycine 0 C--N 1.323 -0.159 0 N-CA-C 111.056 -0.818 . . . . 73.23 111.056 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 39' ' ' LEU . 21.1 m -124.28 165.05 26.37 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.835 -0.802 . . . . 74.24 108.835 -177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -79.45 163.57 24.4 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.205 1.27 . . . . 63.21 110.709 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.48 -34.14 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.452 0.701 . . . . 61.32 111.25 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.6 p -61.25 -40.85 95.58 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.601 -0.727 . . . . 75.04 111.837 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 83.0 tttt -69.54 -32.21 70.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.898 0.38 . . . . 71.14 110.289 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.16 -42.17 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.239 -0.652 . . . . 73.21 109.239 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.25 74.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.542 -0.754 . . . . 61.42 110.212 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 44' ' ' SER . 73.9 mm-40 -66.39 -35.45 80.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.5 -0.318 . . . . 75.14 111.038 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 76.6 mm-40 -64.34 -47.22 80.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 70.03 108.417 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.81 -45.0 95.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.086 -1.415 . . . . 65.13 110.017 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 25.1 mtp85 -65.39 -23.6 67.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 114.187 1.18 . . . . 62.32 114.187 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.27 3.14 37.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.028 -1.069 . . . . 65.41 111.366 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.97 41.25 41.29 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.591 -0.731 . . . . 54.04 112.297 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.12 -12.26 18.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.938 -0.393 . . . . 73.42 109.938 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.3 tp -156.77 161.38 39.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.57 -0.9 . . . . 60.34 108.57 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.23 146.82 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.89 -0.782 . . . . 61.55 108.89 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.39 148.31 43.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 63.41 109.024 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.486 ' C ' ' HB1' ' A' ' 18' ' ' ALA . 17.7 m -127.06 155.07 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.862 0.363 . . . . 54.21 110.877 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -110.41 115.12 29.09 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.7 -0.852 . . . . 71.31 108.7 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -126.82 123.74 38.03 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.206 -0.664 . . . . 61.22 109.206 -179.603 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.93 14.75 8.64 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.375 1.07 . . . . 71.14 111.378 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.92 4.31 60.25 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.656 -0.702 . . . . 41.44 112.362 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.51 145.68 16.13 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.563 -1.015 . . . . 74.44 110.563 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' A' ' 18' ' ' ALA . 95.4 t -97.15 120.03 45.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.591 -0.892 . . . . 74.34 108.591 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.26 169.53 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.212 -0.904 . . . . 72.1 109.228 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.433 HD12 HG21 ' A' ' 35' ' ' VAL . 57.0 mt -119.75 129.19 25.49 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 108.455 -0.943 . . . . 74.13 108.455 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.11 122.23 11.41 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.956 2.438 . . . . 74.54 112.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.486 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 46.3 tt0 -64.66 -25.6 68.02 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.159 -0.473 . . . . 64.33 111.921 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 32.8 m -72.2 -4.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.969 0.414 . . . . 73.35 112.108 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.86 -4.94 59.23 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.018 0.914 . . . . 65.43 109.718 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -117.04 151.29 37.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.835 -1.172 . . . . 65.23 107.835 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 p -83.06 166.87 18.39 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.619 -1.252 . . . . 74.22 107.619 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.86 -16.48 64.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.534 0.683 . . . . 72.24 110.112 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -79.96 -1.82 41.18 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.976 -0.556 . . . . 75.11 111.906 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.15 28.1 56.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.311 -0.947 . . . . 55.42 111.883 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -124.5 143.04 50.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.081 -1.081 . . . . 74.22 108.081 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.15 141.12 18.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.059 -1.089 . . . . 60.54 108.059 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.631 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.4 t -57.81 122.34 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.38 -0.971 . . . . 53.05 108.38 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -67.33 -27.61 67.29 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.437 0.902 . . . . 74.13 113.437 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -89.92 -6.77 55.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.161 0.505 . . . . 72.14 111.086 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.631 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 9.1 tt -65.91 -47.51 63.98 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 113.646 0.98 . . . . 63.24 113.646 -175.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.5 Cg_endo -55.72 -28.89 68.74 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.654 1.569 . . . . 64.14 111.186 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -40.23 93.67 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.663 -0.699 . . . . 74.54 111.987 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -67.97 -40.13 83.21 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.077 -0.712 . . . . 73.43 109.077 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.647 -0.706 . . . . 63.52 109.966 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.6 m -58.81 -50.03 75.49 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-N 115.674 -0.694 . . . . 61.43 111.524 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -41.62 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.634 -0.257 . . . . 71.44 111.516 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.487 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.6 mm? -66.8 -36.31 82.1 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.077 0.399 . . . . 73.32 112.077 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -65.92 -32.81 74.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.486 0.184 . . . . 72.43 110.973 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.75 -30.64 71.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.163 0.506 . . . . 62.04 110.199 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.68 88.43 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.861 -0.608 . . . . 63.35 111.672 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.79 35.91 38.58 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.752 -0.224 . . . . 70.33 113.09 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 99.4 m-85 -97.67 145.66 26.1 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 122.412 -0.464 . . . . 73.35 111.04 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -95.6 171.43 8.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.594 -0.73 . . . . 75.24 110.205 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.491 ' OD1' ' HA3' ' A' ' 19' ' ' GLY . 2.0 p30 -53.65 -45.69 70.31 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.522 1.129 . . . . 74.12 113.092 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.3 m -62.4 -40.74 97.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 122.807 0.443 . . . . 71.43 111.239 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.75 -37.58 86.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.986 -0.552 . . . . 72.22 110.407 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.18 -49.06 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.869 0.842 . . . . 74.25 109.644 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 13.0 ptt? -74.77 -13.52 60.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.864 -1.062 . . . . 74.35 113.356 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' HA ' HG11 ' A' ' 22' ' ' VAL . 77.3 ttt180 -57.43 -66.24 0.49 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.93 -0.308 . . . . 75.23 110.87 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.482 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 32.0 p-90 -67.61 -32.13 72.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.393 0.516 . . . . 72.31 112.393 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.482 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.9 mt -58.49 -40.82 83.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.6 0.593 . . . . 63.35 112.6 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.406 ' CD2' ' HB3' ' A' ' 23' ' ' LEU . 82.3 m-85 -95.23 -4.19 46.27 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.952 0.723 . . . . 73.43 112.952 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.9 m -87.34 120.09 71.11 Favored Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 109.035 -0.728 . . . . 75.32 109.035 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.96 129.1 23.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.551 1.501 . . . . 63.33 108.788 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 12.3 t70 -80.68 125.13 81.17 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.665 -0.494 . . . . 65.3 109.665 -176.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 26.9 Cg_endo -60.41 -22.25 70.73 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.518 2.812 . . . . 72.44 114.065 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -109.4 -1.48 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.128 -0.629 . . . . 73.23 111.542 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 23.7 tp -102.57 128.9 49.04 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 119.435 -0.906 . . . . 71.52 111.509 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.3 m -116.56 122.14 43.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.078 -1.823 . . . . 73.24 106.078 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 128' ' ' ALA . 40.1 mt -127.42 144.44 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 120.498 -0.481 . . . . 71.43 110.261 -174.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 p -98.7 126.09 44.2 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 105.569 -2.012 . . . . 71.34 105.569 174.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -121.9 -173.9 2.76 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.981 -1.087 . . . . 75.03 112.915 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -91.69 130.28 37.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.048 -0.523 . . . . 72.1 109.759 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.98 -69.59 0.21 Allowed Glycine 0 C--N 1.302 -1.322 0 N-CA-C 107.851 -2.1 . . . . 62.2 107.851 -175.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.6 m -102.5 100.42 10.52 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 106.354 -1.721 . . . . 64.52 106.354 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -77.15 0.35 22.01 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.816 1.043 . . . . 72.43 113.816 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -83.23 163.9 20.46 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.962 -0.563 . . . . 64.33 110.781 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.44 123.81 22.22 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.745 -0.661 . . . . 71.21 110.781 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.87 119.73 58.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 107.423 -1.325 . . . . 70.53 107.423 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.0 p -81.62 137.95 35.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.315 -0.402 . . . . 54.32 110.23 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.595 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 33.5 m-80 68.12 66.44 0.35 Allowed 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 124.235 1.014 . . . . 63.21 110.299 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.429 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -109.45 169.4 8.72 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.055 -0.658 . . . . 73.33 109.824 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -89.37 157.59 47.24 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.555 -0.293 . . . . 72.03 110.443 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.88 -25.61 79.9 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.054 1.836 . . . . 64.53 109.848 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 69' ' ' VAL . 84.9 t -62.56 -38.71 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.22 -0.9 . . . . 61.11 109.716 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.98 -42.28 76.76 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.276 -0.639 . . . . 71.04 109.276 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -59.53 -41.0 89.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 64.44 112.857 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.69 -40.5 95.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.061 0.393 . . . . 64.22 112.061 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -77.6 -14.27 59.69 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.381 0.61 . . . . 73.34 111.058 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.53 5.9 50.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.317 -0.856 . . . . 12.4 111.575 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.0 m80 66.97 28.43 8.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.678 0.791 . . . . 64.52 112.028 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.3 23.19 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.077 0.941 . . . . 64.1 108.969 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.03 -28.66 39.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.018 1.727 . . . . 54.21 112.426 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -56.07 -38.44 70.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.366 -0.379 . . . . 74.11 110.62 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.98 -29.67 63.23 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 116.459 -0.337 . . . . 72.32 111.231 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.62 -49.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.118 -0.697 . . . . 60.13 109.118 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 57.6 t -62.53 -47.35 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.66 -0.7 . . . . 74.32 110.03 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.36 -46.59 83.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.8 -0.637 . . . . 73.53 111.121 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 140' ' ' ARG . 7.0 ttm180 -69.0 -33.41 73.62 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 63.52 110.5 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -64.96 -43.89 91.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.693 -0.484 . . . . 74.02 109.693 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 14.7 mm100 -57.6 -44.55 85.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.345 0.593 . . . . 74.41 109.747 175.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.28 79.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 61.13 111.817 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -72.18 -38.59 69.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 75.5 109.794 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -74.93 -51.77 12.93 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.915 -0.584 . . . . 60.0 112.567 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--O 1.255 1.391 0 N-CA-C 109.666 -0.494 . . . . 64.12 109.666 -176.149 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 110.005 -0.369 . . . . 75.44 110.005 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -90.37 -178.96 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.591 2.194 . . . . 62.31 110.859 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 109.89 -21.96 24.35 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 119.839 -1.172 . . . . 53.31 112.816 175.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -73.1 133.4 44.14 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.746 -0.464 . . . . 72.04 109.746 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.25 103.78 46.82 Favored Pre-proline 0 C--N 1.307 -1.282 0 CA-C-N 116.271 -0.422 . . . . 73.34 110.239 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.38 160.65 44.44 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 122.776 2.317 . . . . 60.11 111.492 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.84 55.51 4.23 Favored Glycine 0 C--N 1.319 -0.383 0 CA-C-O 121.347 0.415 . . . . 72.02 112.395 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -120.4 103.23 9.03 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 107.604 -1.258 . . . . 70.31 107.604 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -139.89 11.5 2.44 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.748 -0.834 . . . . 64.32 108.748 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.0 mt -110.07 143.63 39.83 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.291 -0.868 . . . . 65.14 111.85 -173.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.73 93.92 4.6 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.402 -1.333 . . . . 60.33 107.402 176.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -88.68 25.32 1.76 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.503 -0.772 . . . . 75.54 110.944 -174.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.3 p -84.69 -15.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-O 121.913 0.863 . . . . 53.22 110.076 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -92.63 55.91 2.67 Favored Glycine 0 C--N 1.302 -1.356 0 CA-C-N 114.682 -1.144 . . . . 34.24 110.768 -179.144 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.0 m -92.92 105.84 17.9 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.827 -0.805 . . . . 72.14 108.827 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mp -104.93 121.04 47.98 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.591 -0.892 . . . . 63.25 108.591 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -67.05 141.93 59.7 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.062 1.841 . . . . 65.44 111.25 177.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.01 125.56 32.82 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 110.02 -0.363 . . . . 54.51 110.02 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.13 -99.49 2.07 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 121.38 -0.438 . . . . 61.41 112.305 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.71 135.18 51.05 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 122.327 -0.514 . . . . 60.44 112.238 -174.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 25.1 t0 -77.84 146.77 35.51 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.076 -0.965 . . . . 62.44 109.544 175.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.25 -15.85 9.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.396 -0.365 . . . . 65.44 111.342 -174.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 1.6 pp -90.61 179.25 5.87 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.32 -0.952 . . . . 71.54 111.442 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -105.58 137.11 19.21 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.927 -1.508 . . . . 73.41 106.927 173.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.32 -20.94 16.21 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.812 2.341 . . . . 74.1 114.376 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.45 -24.69 61.24 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 122.083 -0.385 . . . . 72.21 110.432 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.83 152.31 84.77 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 74.34 108.203 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.99 111.81 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 122.668 2.245 . . . . 74.34 113.085 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.407 ' HA ' ' H ' ' A' ' 68' ' ' GLN . 1.7 m -124.59 169.35 12.01 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 108.787 -0.819 . . . . 61.33 108.787 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -128.91 160.98 30.95 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.021 -1.474 . . . . 74.44 107.021 172.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.587 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 10.9 t70 -134.66 168.59 18.72 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 104.429 -2.434 . . . . 75.23 104.429 -173.039 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -52.01 -57.19 15.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 112.983 0.734 . . . . 54.14 112.983 -173.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.587 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 21.7 Cg_endo -62.61 -31.6 79.54 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.778 1.652 . . . . 75.44 111.756 176.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.505 ' HB2' ' H ' ' A' ' 31' ' ' ASP . 2.4 mpt_? -70.63 -36.83 73.65 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.428 0.529 . . . . 72.54 112.428 -178.392 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.59 -41.95 80.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.195 -0.669 . . . . 75.25 109.195 177.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.789 -1.096 . . . . 73.15 109.422 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.2 -45.8 83.3 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.833 1.253 . . . . 73.4 110.445 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 30' ' ' TYR . 38.8 tp -65.64 -50.28 65.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 73.1 111.604 -177.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.59 -9.54 58.21 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.531 0.567 . . . . 71.53 112.531 -174.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.41 29.26 71.79 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.672 -0.571 . . . . 63.22 111.672 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.23 160.28 48.44 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.544 -0.91 . . . . 74.22 108.544 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.68 160.08 38.27 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.564 1.51 . . . . 75.21 111.219 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.6 -32.84 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.349 0.659 . . . . 72.44 110.419 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -57.44 -42.84 83.21 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 116.185 -0.461 . . . . 64.45 110.495 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -70.16 -32.43 70.4 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.949 0.404 . . . . 73.42 110.603 178.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.7 t -62.28 -44.0 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 109.116 -0.698 . . . . 72.22 109.116 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -59.36 -36.94 76.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.27 -0.423 . . . . 52.21 110.299 177.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 83.6 mm-40 -69.63 -40.41 76.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.637 0.606 . . . . 73.35 112.637 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.548 ' O ' ' HB3' ' A' ' 54' ' ' HIS . 3.2 pt20 -68.69 -33.71 74.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.929 -0.708 . . . . 73.24 109.854 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.8 mt -62.47 -39.72 94.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.971 -0.752 . . . . 65.13 108.971 174.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 70.2 mtt-85 -70.78 -21.43 62.49 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.979 0.733 . . . . 72.12 112.979 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 44.4 mt-10 -76.77 -12.11 59.93 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 121.161 -0.216 . . . . 71.31 110.63 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.81 30.55 65.84 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.991 -2.043 . . . . 64.53 107.991 -169.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 49' ' ' GLN . 11.9 t-160 -97.23 -32.21 12.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 125.139 1.376 . . . . 71.14 108.625 -176.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 41.6 tp -152.61 153.19 32.86 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.1 -1.444 . . . . 73.21 107.1 -179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.75 161.48 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 117.9 0.318 . . . . 13.45 110.467 177.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.34 154.05 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.152 -0.685 . . . . 75.22 109.152 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.43 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 123.449 0.699 . . . . 61.33 110.548 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 98.8 mtt180 -117.24 134.76 54.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.767 -0.197 . . . . 64.32 110.607 -177.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -139.98 127.36 21.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.864 -1.161 . . . . 75.1 107.864 170.845 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.97 21.52 7.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.898 1.279 . . . . 63.11 111.882 -177.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.02 -0.88 67.18 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.378 -0.439 . . . . 71.2 112.681 -179.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -98.48 135.77 12.34 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.064 -0.814 . . . . 63.31 111.064 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.19 120.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.024 -1.102 . . . . 65.15 108.024 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.83 161.61 39.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.48 0.657 . . . . 64.51 111.878 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.88 120.75 25.55 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 106.384 -1.71 . . . . 73.14 106.384 178.144 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.02 124.61 16.36 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.409 2.073 . . . . 65.02 112.705 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.509 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 46.7 tt0 -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.887 0.851 . . . . 75.54 111.015 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 m -66.53 -12.24 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.562 -1.199 . . . . 74.33 112.208 177.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.1 m-85 -78.55 -11.35 59.96 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.889 0.852 . . . . 64.21 110.299 175.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -106.83 149.53 27.3 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.61 -1.255 . . . . 75.23 107.61 178.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 p -76.04 175.64 8.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.498 -0.556 . . . . 75.24 109.498 178.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.56 -22.84 66.65 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.208 0.527 . . . . 54.15 110.079 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 m -84.05 1.01 45.96 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.755 -0.657 . . . . 65.33 112.298 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.67 66.82 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.351 -0.452 . . . . 75.5 112.71 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -113.97 152.77 30.4 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.651 -0.87 . . . . 71.51 108.651 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 135.64 27.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.831 -1.174 . . . . 65.3 107.831 175.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.437 HG12 ' H ' ' A' ' 80' ' ' SER . 58.0 t -59.55 135.21 24.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.335 -0.617 . . . . 74.24 109.335 178.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -59.09 -31.56 69.01 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.862 0.69 . . . . 64.33 112.862 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.437 ' H ' HG12 ' A' ' 78' ' ' VAL . 33.0 m -89.38 3.05 53.5 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.081 -0.509 . . . . 72.23 111.78 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.549 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.19 -54.12 48.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.989 -0.374 . . . . 73.14 109.989 179.393 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 32.2 Cg_exo -62.81 -30.87 78.18 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 121.134 1.222 . . . . 64.12 110.598 177.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.12 93.94 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.713 -0.676 . . . . 73.4 112.221 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -67.64 -40.02 84.61 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.17 0.509 . . . . 54.35 109.827 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.86 -46.55 87.35 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.799 -0.637 . . . . 74.14 110.264 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.8 m -60.71 -41.49 95.34 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.952 -0.567 . . . . 52.12 112.529 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -47.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 121.103 -0.239 . . . . 54.2 110.885 -178.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.498 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -68.01 -35.74 78.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.97 0.73 . . . . 74.13 112.97 176.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.507 0.723 . . . . 72.13 110.338 -177.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.4 -30.37 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.299 0.571 . . . . 61.4 110.572 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.99 -9.47 86.65 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.683 -0.69 . . . . 64.3 112.582 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 24.2 54.93 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 121.713 -0.28 . . . . 52.11 113.146 177.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 94.5 m-85 -89.61 132.98 34.85 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.576 -0.367 . . . . 73.52 111.123 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -78.88 169.88 17.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.597 0.713 . . . . 74.33 112.858 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.39 -45.34 72.84 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.395 1.878 . . . . 52.11 112.003 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.0 m -64.56 -40.39 95.48 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 115.568 -0.742 . . . . 52.13 110.204 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -65.96 -36.79 84.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.612 -0.267 . . . . 64.22 111.273 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.1 mm -61.42 -49.0 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.415 -0.957 . . . . 71.42 108.415 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.52 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 57.4 mtt -74.96 -17.72 60.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.799 -1.092 . . . . 75.44 112.391 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -59.4 -65.05 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.626 -0.509 . . . . 75.42 109.626 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.4 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 36.0 p-90 -68.94 -32.56 72.25 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.749 0.648 . . . . 72.23 112.749 177.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 125' ' ' PRO . 13.1 mt -58.59 -40.84 84.31 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 112.477 0.547 . . . . 62.35 112.477 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 54.9 m-85 -92.49 -11.57 34.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.345 0.498 . . . . 75.32 112.345 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -86.62 125.36 67.47 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.654 -0.499 . . . . 71.33 109.654 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.604 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.6 Cg_exo -56.16 129.91 37.37 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.592 2.195 . . . . 74.2 110.693 175.27 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -90.53 123.41 65.41 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.525 -0.917 . . . . 74.32 108.525 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.21 -24.55 77.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.027 2.485 . . . . 71.43 113.6 -176.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -102.98 3.56 36.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.722 0.296 . . . . 72.14 111.367 -175.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.62 124.0 46.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.562 0.696 . . . . 54.51 111.016 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.41 HG22 ' HB1' ' A' ' 119' ' ' ALA . 37.7 m -131.35 110.48 11.1 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.866 -1.161 . . . . 75.23 107.866 177.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 128' ' ' ALA . 23.2 pt -136.29 157.91 37.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 120.924 0.392 . . . . 63.4 111.871 -174.191 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 t -89.35 136.28 33.11 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 105.66 -1.978 . . . . 62.45 105.66 169.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.486 ' HB2' ' OD1' ' A' ' 127' ' ' ASP . 6.0 ptp180 -102.1 166.95 10.33 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.559 -0.856 . . . . 74.31 109.973 -174.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 33.9 t70 -78.03 84.96 4.27 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.599 -0.889 . . . . 65.45 108.599 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.85 -4.25 2.39 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.243 -0.89 . . . . 72.2 111.607 -176.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.424 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 17.0 m -149.71 112.58 4.83 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.634 -0.876 . . . . 75.33 108.634 177.253 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -68.48 -22.31 64.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.102 0.477 . . . . 75.22 110.976 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.98 159.19 34.22 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.499 -0.773 . . . . 62.02 110.232 175.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.41 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -96.47 124.87 40.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.879 -0.601 . . . . 52.01 110.791 -176.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.6 120.82 46.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.163 -1.051 . . . . 71.23 108.163 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.0 t -90.22 148.44 22.93 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.311 -1.366 . . . . 71.43 107.311 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 65.6 t30 65.85 44.79 2.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.497 -1.297 . . . . 65.2 107.497 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.79 17.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.335 -0.848 . . . . 73.11 110.423 -178.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -97.27 132.3 25.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.444 -0.576 . . . . 75.34 109.444 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.556 ' HB2' HD23 ' A' ' 102' ' ' LEU . 80.9 Cg_exo -50.01 -29.53 21.84 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.061 3.174 . . . . 65.01 115.543 -178.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.538 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.3 t -61.69 -42.72 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 118.519 0.599 . . . . 75.53 110.274 176.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 113' ' ' ARG . 12.5 t70 -67.67 -33.64 75.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.278 -1.008 . . . . 52.54 108.278 -176.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -62.75 -50.2 72.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.723 -1.126 . . . . 62.41 111.386 177.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -65.7 -34.26 77.8 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.036 0.446 . . . . 74.4 110.946 -179.075 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -68.58 -23.63 64.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 75.32 109.157 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -96.66 7.7 45.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.815 -1.084 . . . . 74.41 110.982 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.1 m80 66.27 29.43 9.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.612 0.72 . . . . 75.41 111.773 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -101.36 22.69 12.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.033 -1.469 . . . . 73.23 107.033 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.31 -30.23 59.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.848 -1.524 . . . . 75.41 114.595 -173.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -56.75 -43.29 80.58 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.028 0.442 . . . . 54.23 111.524 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -73.31 -26.21 60.97 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.737 -0.665 . . . . 73.43 110.818 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.05 -42.13 81.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.653 -0.869 . . . . 75.24 108.653 175.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 86.1 t -60.03 -41.92 87.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-N 115.323 -0.853 . . . . 73.13 109.913 176.343 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.91 -40.28 92.56 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.341 0.591 . . . . 74.41 110.157 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -41.04 93.67 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.457 -0.942 . . . . 74.44 108.457 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.498 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.21 -45.12 94.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.967 -1.015 . . . . 73.22 110.549 177.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.6 mt-30 -57.3 -36.18 70.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 73.32 110.574 176.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.49 78.43 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.943 -0.571 . . . . 65.31 111.152 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 29.5 ttm -80.78 -45.39 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.724 -0.79 . . . . 74.21 112.618 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -69.72 -34.84 74.43 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.031 1.123 . . . . 74.12 114.031 -174.073 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 109.24 -0.652 . . . . 70.55 109.24 -178.664 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 110.096 -0.335 . . . . 61.21 110.096 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.17 113.98 3.26 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.727 2.284 . . . . 74.31 111.892 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.54 -164.57 29.42 Favored Glycine 0 C--N 1.302 -1.358 0 N-CA-C 111.133 -0.787 . . . . 75.13 111.133 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 31.8 mmm180 -73.58 133.58 43.56 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.205 -1.035 . . . . 71.35 108.205 177.232 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.81 105.34 44.43 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.657 -0.497 . . . . 52.32 109.657 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 4' ' ' ARG . 15.7 Cg_exo -70.79 143.46 45.93 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 122.262 1.974 . . . . 62.3 110.73 177.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.33 -175.3 49.69 Favored Glycine 0 N--CA 1.398 -3.862 0 N-CA-C 110.28 -1.128 . . . . 72.43 110.28 -179.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -96.57 -174.26 2.98 Favored 'General case' 0 C--N 1.257 -3.42 0 CA-C-N 115.33 -0.435 . . . . 52.54 109.838 -177.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -61.69 152.33 31.29 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.81 -0.811 . . . . 44.11 108.81 174.625 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.85 103.3 0.56 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.915 -0.772 . . . . 71.13 108.915 177.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.31 124.77 33.72 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.032 -0.985 . . . . 72.3 109.637 -178.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -79.86 96.66 6.4 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.443 -0.947 . . . . 74.4 108.443 178.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.5 m -96.59 136.16 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 115.041 -0.981 . . . . 72.32 110.373 -176.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.85 1.02 49.03 Favored Glycine 0 C--N 1.277 -2.722 0 CA-C-N 114.027 -1.442 . . . . 75.01 109.988 -177.621 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.3 m -91.53 91.11 7.92 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.506 0.669 . . . . 74.41 110.683 -178.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.62 120.15 50.26 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 107.641 -1.244 . . . . 62.13 107.641 175.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -74.07 165.17 32.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.38 2.053 . . . . 55.21 110.172 176.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.23 133.79 33.62 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 120.571 0.224 . . . . 61.23 110.579 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 -87.17 1.99 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.561 -1.016 . . . . 61.33 110.561 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -141.12 159.95 41.13 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.604 -0.351 . . . . 73.15 110.848 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 9.6 t0 -93.75 137.67 32.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.636 -0.711 . . . . 45.32 112.647 -173.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 100' ' ' ARG . 86.1 t -100.01 -26.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.692 -0.685 . . . . 72.24 111.8 -175.594 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.555 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -80.45 -178.9 6.89 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 118.663 -1.215 . . . . 74.35 110.655 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -100.79 147.94 34.34 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 107.868 -1.16 . . . . 73.05 107.868 -178.254 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.08 -21.27 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.992 2.462 . . . . 71.15 113.576 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.78 -27.24 68.14 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.903 0.481 . . . . 72.24 110.548 176.401 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.15 125.24 85.44 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 107.756 -1.201 . . . . 64.3 107.756 171.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -65.31 139.73 61.14 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.218 1.946 . . . . 61.44 112.898 -177.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 65' ' ' VAL . 6.3 p -118.22 156.97 27.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.252 0.834 . . . . 72.4 113.252 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 28.0 m-85 -109.78 161.89 15.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 125.452 1.501 . . . . 74.21 108.858 176.12 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.569 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 4.3 m-20 -134.56 165.77 24.43 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 104.623 -2.362 . . . . 72.43 104.623 -178.154 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.04 -56.37 18.15 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 114.415 1.265 . . . . 70.23 114.415 -175.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HA ' HG22 ' A' ' 43' ' ' VAL . 28.7 Cg_endo -63.05 -31.62 76.05 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.915 1.744 . . . . 75.44 112.424 178.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 14.8 tpt180 -70.42 -39.37 74.47 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.736 0.814 . . . . 72.03 110.221 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 31' ' ' ASP . 59.3 t -69.2 -38.58 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 71.42 109.372 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.11 91.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.441 -0.799 . . . . 54.42 109.626 177.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.57 -44.98 94.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.016 -1.447 . . . . 71.2 110.06 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.4 tp -65.62 -47.48 75.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.921 -1.036 . . . . 73.02 111.339 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.7 -18.54 40.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.865 0.691 . . . . 54.44 112.865 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.45 55.13 Favored Glycine 0 C--N 1.311 -0.827 0 N-CA-C 111.017 -0.833 . . . . 30.13 111.017 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 20.4 m -124.22 161.83 45.23 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.148 -1.056 . . . . 70.15 108.148 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 36.1 Cg_endo -67.94 156.23 66.7 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 121.362 1.374 . . . . 64.44 112.603 178.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 33' ' ' PRO . 42.9 t -60.45 -37.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 51.03 110.256 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 23.0 t -60.69 -34.78 74.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.534 -0.757 . . . . 45.12 110.653 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 60.8 tttp -69.33 -39.02 78.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.837 -0.431 . . . . 71.3 109.837 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.2 t -61.34 -41.16 88.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.249 0.547 . . . . 65.11 109.56 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.81 81.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.41 -0.814 . . . . 73.53 110.498 176.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.2 mt-30 -65.36 -44.0 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.359 -0.382 . . . . 74.21 110.308 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.9 mm-40 -61.86 -43.17 99.38 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.791 0.682 . . . . 74.3 110.226 -178.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.97 -40.81 96.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.589 -1.187 . . . . 73.33 110.343 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.47 -21.49 61.94 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.201 0.815 . . . . 75.13 113.201 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -88.14 -11.88 45.63 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 120.406 0.146 . . . . 70.21 111.272 178.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.98 32.45 49.28 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.234 -1.146 . . . . 33.43 110.234 -175.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -93.74 -13.74 27.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.31 -1.367 . . . . 74.1 107.31 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -157.08 152.86 26.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.193 -2.151 . . . . 75.51 105.193 179.42 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.6 152.05 30.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.162 -0.681 . . . . 65.11 109.162 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -127.26 162.14 26.91 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.086 -0.506 . . . . 64.32 110.575 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.433 HG11 ' HG3' ' A' ' 99' ' ' MET . 5.2 m -126.64 166.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 123.397 0.679 . . . . 74.1 109.467 178.406 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -120.5 131.65 54.83 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.879 -0.328 . . . . 72.43 110.649 -176.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 30.1 ptt180 -147.51 138.32 23.46 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.582 -0.895 . . . . 71.33 108.582 175.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.35 17.71 9.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.004 0.922 . . . . 72.04 111.612 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.85 -4.02 74.78 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.976 -0.556 . . . . 42.01 112.245 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.24 144.38 15.77 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.836 -0.697 . . . . 74.21 111.593 -178.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.44 120.12 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.04 -1.467 . . . . 65.22 107.04 178.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.8 m -133.68 154.42 38.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.36 0.6 . . . . 72.21 111.796 -173.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.53 120.75 38.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 107.497 -1.298 . . . . 65.32 107.497 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.439 ' HB3' HD21 ' A' ' 23' ' ' LEU . 88.0 Cg_exo -53.74 128.39 29.38 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.698 2.265 . . . . 73.11 112.179 177.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 42.1 tt0 -57.34 -25.53 59.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.36 0.504 . . . . 65.0 112.36 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -70.95 -4.24 4.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.782 -0.645 . . . . 73.31 112.446 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.8 m-85 -83.84 -4.66 58.85 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.248 1.023 . . . . 74.44 109.913 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -122.16 158.84 28.47 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.801 -1.555 . . . . 72.43 106.801 177.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.2 p -91.57 163.87 13.98 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.69 -0.856 . . . . 45.2 108.69 179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.73 -16.29 62.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.336 0.588 . . . . 74.12 110.147 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -79.47 -0.67 34.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.238 0.615 . . . . 52.15 111.187 -178.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.38 60.48 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.851 -0.69 . . . . 23.14 112.005 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -125.9 145.95 50.04 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.607 -1.257 . . . . 43.14 107.607 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.17 155.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.967 -1.123 . . . . 63.13 107.967 176.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 48.4 t -69.82 112.03 4.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.498 -0.927 . . . . 70.23 108.498 177.483 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -56.18 -35.11 66.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.467 1.284 . . . . 54.3 114.467 -175.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.5 m -90.69 -4.25 56.89 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.223 0.535 . . . . 74.33 111.536 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 8.6 tt -65.83 -47.48 64.85 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.51 0.929 . . . . 73.44 113.51 -176.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.6 Cg_endo -54.24 -28.73 53.6 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 121.743 1.628 . . . . 73.21 111.514 176.391 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.15 -38.2 95.61 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.709 -0.678 . . . . 42.41 112.048 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -68.17 -40.15 82.37 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.767 -0.827 . . . . 75.21 108.767 178.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.88 -32.69 73.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 74.1 110.233 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 m -62.76 -50.18 72.08 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.66 -0.7 . . . . 54.31 110.289 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -40.25 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.465 -0.334 . . . . 52.11 111.439 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.7 mm? -66.88 -35.36 79.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.58 0.585 . . . . 71.4 112.58 176.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -61.68 -40.54 95.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 60.25 109.343 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.63 -31.87 73.13 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.791 -0.64 . . . . 70.31 110.854 178.565 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.53 -9.95 68.46 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.962 -0.637 . . . . 75.12 112.495 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.48 48.98 8.54 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 114.004 0.361 . . . . 41.11 114.004 177.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 88.4 m-85 -110.17 139.44 45.32 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.408 0.604 . . . . 72.34 111.447 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -81.91 171.79 14.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 72.42 111.851 -179.254 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.0 p-10 -54.64 -45.51 73.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 72.54 111.83 -177.41 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 m -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.364 0.666 . . . . 73.42 110.052 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.65 -38.74 92.28 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.624 -0.717 . . . . 74.05 111.229 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 mm -61.26 -47.5 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.334 -0.987 . . . . 65.43 108.334 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 22.8 mmt -67.99 -26.07 65.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.677 -1.147 . . . . 75.52 111.656 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.413 ' HA ' HG11 ' A' ' 22' ' ' VAL . 45.3 ttp85 -52.56 -71.26 0.07 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.694 0.627 . . . . 75.12 112.694 -176.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -68.58 -31.46 70.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.166 0.432 . . . . 75.41 112.166 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.7 mt -56.55 -40.64 75.49 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 112.131 0.419 . . . . 71.22 112.131 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 96.5 m-85 -102.02 2.01 37.21 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.956 0.724 . . . . 70.13 112.956 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -89.08 112.13 49.17 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.712 -0.477 . . . . 71.43 109.712 173.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.1 128.76 21.3 Favored 'Trans proline' 0 C--O 1.251 1.145 0 N-CA-C 108.434 -1.41 . . . . 64.04 108.434 173.011 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 23.6 t70 -96.85 126.29 43.34 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.698 -0.401 . . . . 60.54 111.501 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.66 -16.9 46.18 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.22 2.613 . . . . 61.23 114.277 -178.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.4 t -114.53 8.99 16.57 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 121.163 0.506 . . . . 63.2 109.924 -178.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 51.6 tp -106.94 118.68 37.33 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.729 0.776 . . . . 73.04 112.328 -178.325 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.0 m -118.2 117.19 28.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.191 -1.04 . . . . 71.41 108.191 178.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.41 HG12 ' HG ' ' A' ' 109' ' ' LEU . 29.3 mm -117.45 148.88 19.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 115.118 -0.946 . . . . 73.55 109.826 -175.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.4 p -97.87 126.06 43.06 Favored 'General case' 0 C--N 1.263 -3.184 0 N-CA-C 108.46 -0.941 . . . . 64.41 108.46 175.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -82.23 167.39 18.7 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.451 -0.5 . . . . 71.43 111.86 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.26 112.44 2.14 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 124.308 1.005 . . . . 73.01 109.596 -178.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.92 0.83 Allowed Glycine 0 N--CA 1.426 -1.986 0 N-CA-C 106.934 -2.466 . . . . 61.1 106.934 -170.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.5 m -67.19 87.31 0.16 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.837 1.051 . . . . 75.51 113.837 -172.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -100.94 -25.54 14.05 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.325 -1.307 . . . . 75.5 109.369 175.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -163.58 157.82 19.94 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 107.567 -1.272 . . . . 74.33 107.567 -174.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.31 139.08 36.5 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.502 -0.555 . . . . 73.12 109.502 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t -103.73 117.9 49.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.05 -0.722 . . . . 64.1 109.05 -176.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -84.0 149.83 26.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.268 -0.641 . . . . 70.13 109.268 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.9 t30 70.1 40.42 1.22 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.219 1.008 . . . . 73.31 109.798 178.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.55 156.65 22.68 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.734 -0.604 . . . . 43.23 110.348 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.578 ' HD3' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -102.95 143.65 27.03 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 108.711 -0.848 . . . . 73.42 108.711 175.821 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' HB2' HD23 ' A' ' 102' ' ' LEU . 82.1 Cg_exo -49.73 -34.08 34.36 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 123.655 2.904 . . . . 61.42 114.856 -177.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.5 t -62.95 -40.46 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.466 0.651 . . . . 54.23 110.782 177.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.23 -37.79 88.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.347 -0.982 . . . . 74.44 108.347 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.94 78.66 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.484 -1.235 . . . . 54.32 112.023 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -66.41 -36.22 82.29 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.013 -0.429 . . . . 74.54 112.114 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.419 ' N ' HD12 ' A' ' 129' ' ' LEU . 16.6 t-80 -73.27 -16.16 61.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.216 1.007 . . . . 74.22 108.975 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.83 5.25 51.75 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.019 -0.991 . . . . 64.23 110.465 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.0 m80 65.22 28.99 11.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.416 1.086 . . . . 63.53 112.296 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -103.83 23.71 12.39 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.653 -1.24 . . . . 73.44 107.653 176.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.38 -26.83 13.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.549 1.94 . . . . 51.31 112.74 -176.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -54.39 -38.2 65.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.881 0.472 . . . . 74.43 111.773 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.43 ' HG2' HD11 ' A' ' 109' ' ' LEU . 13.9 tp10 -73.5 -32.2 64.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.696 -0.483 . . . . 73.14 109.696 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.52 -48.31 77.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.501 -0.772 . . . . 75.45 109.586 -178.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.503 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 59.6 t -62.37 -42.79 96.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 N-CA-C 109.279 -0.638 . . . . 73.35 109.279 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -62.61 -39.45 93.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.711 -0.677 . . . . 73.14 111.188 178.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.417 ' NH2' HD13 ' A' ' 109' ' ' LEU . 2.7 tpp180 -64.73 -38.84 92.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.077 -0.712 . . . . 73.34 109.077 178.253 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -68.85 -38.66 79.91 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.831 -1.077 . . . . 75.53 110.613 178.33 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.0 mt-30 -58.87 -49.51 77.47 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.591 -0.277 . . . . 74.12 110.288 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 72.55 111.141 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpt -83.39 -30.94 26.98 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.346 0.593 . . . . 72.4 110.191 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.452 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.21 -54.07 5.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.186 -0.461 . . . . 72.13 111.638 -177.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--N 1.309 -1.174 0 N-CA-C 108.676 -0.861 . . . . 74.52 108.676 -177.45 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 CA--C 1.516 -0.35 0 N-CA-C 109.897 -0.409 . . . . 60.24 109.897 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.82 -41.61 10.24 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.463 2.109 . . . . 53.4 112.679 -177.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.79 105.67 2.56 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 111.621 -0.591 . . . . 15.43 111.621 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -68.24 138.37 55.5 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.529 -0.545 . . . . 64.34 109.529 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.34 112.04 53.34 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 109.656 -0.498 . . . . 53.54 109.656 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -79.39 -162.47 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.718 2.279 . . . . 43.22 110.728 175.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.42 -65.87 1.6 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 111.079 -0.809 . . . . 63.33 111.079 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -90.45 77.98 6.44 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 122.323 1.059 . . . . 62.54 112.429 -178.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.5 m -155.61 148.68 24.53 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.985 -1.857 . . . . 64.42 105.985 175.107 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.1 mt -123.5 167.24 14.15 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.514 -0.55 . . . . 74.22 109.514 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.64 87.13 6.3 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.832 -1.173 . . . . 74.14 107.832 174.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -75.83 100.29 4.72 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.836 -1.529 . . . . 73.33 110.102 -177.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.39 83.22 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.644 0.735 . . . . 52.13 111.201 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -92.12 53.92 2.88 Favored Glycine 0 C--N 1.303 -1.255 0 N-CA-C 108.087 -2.005 . . . . 53.23 108.087 173.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 51' ' ' ARG . 35.1 t -145.88 155.94 43.21 Favored 'General case' 0 N--CA 1.409 -2.513 0 N-CA-C 107.841 -1.17 . . . . 74.41 107.841 -172.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.74 125.05 32.57 Favored Pre-proline 0 N--CA 1.422 -1.873 0 N-CA-C 107.08 -1.452 . . . . 52.15 107.08 176.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.77 166.21 14.38 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.036 2.49 . . . . 70.43 110.955 174.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.58 125.55 31.29 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.306 -0.627 . . . . 64.24 109.306 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.17 -133.99 7.63 Favored Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 121.144 -0.55 . . . . 64.42 112.314 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.28 124.39 46.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.533 -0.543 . . . . 71.25 109.533 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.69 130.78 44.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.25 0.548 . . . . 62.02 111.048 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.519 HG23 ' HE3' ' A' ' 99' ' ' MET . 22.3 t -111.44 27.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 123.294 1.521 . . . . 74.43 109.5 -178.443 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -118.68 172.94 7.15 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-N 114.994 -1.003 . . . . 63.44 110.098 175.6 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.449 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 14.3 t70 -86.5 137.06 34.47 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.724 -1.213 . . . . 63.1 107.724 175.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -50.78 -21.96 9.06 Favored 'Trans proline' 0 CA--C 1.557 1.67 0 C-N-CA 123.149 2.566 . . . . 72.2 115.242 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.91 -1.46 56.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.509 0.929 . . . . 72.14 113.509 178.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 27.1 mm-40 -67.42 151.76 96.84 Favored Pre-proline 0 C--O 1.248 0.979 0 N-CA-C 109.268 -0.642 . . . . 73.11 109.268 176.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.3 119.01 5.46 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.712 2.275 . . . . 64.54 111.371 176.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.1 m -136.29 162.11 33.92 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.679 -0.86 . . . . 62.23 108.679 -174.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 21.8 m-85 -126.72 160.11 31.77 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.379 -0.971 . . . . 74.44 108.379 174.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.3 t0 -134.69 157.92 45.42 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 103.883 -2.636 . . . . 71.15 103.883 -178.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -46.83 -54.22 21.17 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 114.443 1.275 . . . . 71.13 114.443 -169.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.23 -39.19 86.97 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.833 1.689 . . . . 55.24 112.188 177.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -71.01 -34.74 71.63 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.614 -0.266 . . . . 71.54 110.476 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 31' ' ' ASP . 27.3 t -69.12 -42.3 81.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.71 -0.478 . . . . 63.02 109.71 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.9 82.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.273 -0.876 . . . . 61.23 109.516 178.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.63 -46.02 70.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.36 -1.291 . . . . 52.11 110.467 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 26.8 tp -64.26 -50.06 69.43 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.118 0.967 . . . . 63.02 112.177 -176.207 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.435 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.6 mt -86.07 -18.24 32.95 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.739 -0.664 . . . . 65.43 111.614 -175.436 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.21 63.58 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.704 -0.958 . . . . 71.23 110.704 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 39' ' ' LEU . 11.7 m -121.91 159.61 50.61 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 108.814 -0.81 . . . . 74.35 108.814 -176.377 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.74 157.93 51.23 Favored 'Trans proline' 0 C--O 1.252 1.217 0 C-N-CA 121.425 1.417 . . . . 64.45 111.846 176.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.11 -33.0 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.765 -0.652 . . . . 74.41 110.642 178.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.6 t -57.67 -42.65 84.02 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.036 -0.529 . . . . 72.3 110.615 177.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 88.2 tttt -69.51 -34.34 74.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.948 0.404 . . . . 72.41 110.127 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.92 -45.07 99.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.847 -0.615 . . . . 72.54 109.432 177.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -61.91 -37.28 84.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.348 -0.842 . . . . 74.24 110.35 178.344 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 15.7 mm100 -62.84 -40.1 96.4 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.277 -0.42 . . . . 73.23 111.542 178.15 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 80.9 mm-40 -59.75 -44.24 93.92 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.577 0.703 . . . . 60.12 109.459 178.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -62.21 -43.95 97.67 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.828 -1.078 . . . . 74.23 109.886 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -66.1 -21.61 66.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.979 -0.555 . . . . 74.31 112.379 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 43.2 mt-10 -98.91 -7.89 26.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.423 -0.511 . . . . 72.45 111.798 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.04 27.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.482 -0.866 . . . . 61.34 111.615 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.65 -8.92 14.55 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.815 -0.809 . . . . 75.44 108.815 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.4 tp -155.22 154.15 31.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.715 -1.587 . . . . 64.45 106.715 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.2 146.59 33.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 74.33 108.818 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 66' ' ' ILE . . . -126.09 151.17 47.57 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 107.63 -1.248 . . . . 50.31 107.63 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.523 HG11 ' SD ' ' A' ' 99' ' ' MET . 34.4 m -129.85 166.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 123.437 0.695 . . . . 53.04 109.856 -176.543 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -110.27 121.45 45.32 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.763 -0.828 . . . . 73.14 108.763 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -117.09 113.8 22.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.012 -0.736 . . . . 64.42 109.012 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.96 -53.19 0.68 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.268 1.827 . . . . 64.53 111.191 -179.084 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.97 0.44 0.03 OUTLIER Glycine 0 C--N 1.286 -2.208 0 CA-C-N 114.913 -1.039 . . . . 61.01 113.0 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.92 149.38 17.02 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.39 -0.91 . . . . 43.52 111.061 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.6 120.6 47.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.535 -1.283 . . . . 73.13 107.535 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.39 171.63 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 124.509 1.124 . . . . 53.13 108.312 -175.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.419 HG22 ' CB ' ' A' ' 57' ' ' ALA . 40.6 pt -127.68 144.06 49.77 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.938 -0.764 . . . . 43.11 108.938 178.047 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.57 118.31 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.612 1.541 . . . . 72.42 110.799 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 46.2 tt0 -61.44 -24.88 66.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.365 0.666 . . . . 74.0 111.811 -178.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 35.0 m -63.67 -9.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 CA-C-N 115.422 -0.808 . . . . 74.24 112.631 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.557 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -78.77 -6.83 56.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.826 0.822 . . . . 71.44 109.948 175.043 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -117.0 161.29 19.62 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.937 -1.135 . . . . 75.41 107.937 175.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.458 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 63.1 p -90.54 168.22 11.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.501 -1.296 . . . . 71.23 107.501 176.096 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.59 -17.49 64.85 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.656 0.613 . . . . 61.34 112.656 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -80.1 -9.09 59.68 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.376 -0.375 . . . . 72.41 111.311 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.68 9.9 62.27 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.532 -0.842 . . . . 51.2 112.509 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -97.34 140.2 32.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.59 -1.633 . . . . 72.02 106.59 177.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.59 152.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.135 -1.061 . . . . 74.31 108.135 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.52 126.55 22.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.423 -0.584 . . . . 74.2 109.423 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.19 -34.17 77.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 113.288 0.847 . . . . 73.13 113.288 -175.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 t -91.93 8.11 38.98 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.369 0.604 . . . . 32.51 110.281 -177.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 70' ' ' PHE . 14.5 tp -58.83 -54.01 60.68 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.748 -0.66 . . . . 73.42 112.048 -177.234 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.75 -25.24 74.81 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.53 1.487 . . . . 73.32 111.846 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.95 78.43 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.135 -0.484 . . . . 72.11 111.905 -178.021 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -67.38 -39.51 85.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.116 -0.698 . . . . 62.44 109.116 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.06 -40.07 95.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.368 -0.833 . . . . 71.33 111.068 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -62.28 -47.35 84.69 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 116.437 -0.347 . . . . 64.52 111.558 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -43.79 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 116.471 -0.331 . . . . 62.44 111.344 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 4.4 mm? -66.91 -35.79 80.8 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.901 -0.5 . . . . 75.41 112.257 177.273 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -64.93 -33.14 75.32 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.528 -0.545 . . . . 75.11 109.528 177.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.25 -31.25 70.6 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.143 0.497 . . . . 63.15 110.81 176.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.76 -9.3 78.31 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.762 -0.654 . . . . 74.44 112.036 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.73 48.1 6.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 121.386 -0.435 . . . . 51.2 112.487 178.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 80.0 m-85 -110.8 138.15 47.56 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.787 0.327 . . . . 74.25 111.335 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.557 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 28.5 ptt180 -86.28 170.9 11.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 75.35 109.818 177.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -55.05 -41.27 71.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.511 1.524 . . . . 44.22 111.233 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -61.67 -41.26 97.3 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.496 -0.774 . . . . 71.51 110.608 -179.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 8.8 mm-40 -66.02 -38.06 87.5 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.897 -0.779 . . . . 63.12 108.897 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 94' ' ' ARG . 24.9 mm -61.12 -48.0 90.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.651 -0.87 . . . . 61.21 108.651 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.523 ' SD ' HG11 ' A' ' 58' ' ' VAL . 76.0 mtm -71.49 -22.36 61.81 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.249 -0.887 . . . . 71.33 112.194 -177.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.01 -65.31 0.62 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.798 -0.816 . . . . 75.02 108.798 -179.655 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.577 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 53.2 p-90 -69.78 -33.86 72.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.787 0.662 . . . . 71.35 112.787 179.172 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -66.76 -39.06 87.75 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.714 0.806 . . . . 72.33 112.941 -173.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 47.6 m-85 -92.63 7.88 41.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.632 0.605 . . . . 75.41 112.632 -178.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.1 m -86.94 116.51 66.32 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 109.562 -0.533 . . . . 73.23 109.562 177.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.7 129.22 19.42 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 121.516 1.478 . . . . 62.23 108.26 172.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 25.7 t70 -115.71 119.75 37.05 Favored Pre-proline 0 C--N 1.295 -1.774 0 C-N-CA 120.637 -0.425 . . . . 75.44 110.791 -175.689 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.42 -28.95 87.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.021 2.48 . . . . 63.15 112.815 -177.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -90.88 2.05 56.48 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.487 0.551 . . . . 55.3 112.487 -177.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.9 tp -102.17 125.13 48.78 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 107.869 -1.16 . . . . 74.33 107.869 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 m -118.5 113.35 21.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.07 -1.085 . . . . 64.14 108.07 -177.022 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 37.9 mm -131.19 148.73 32.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.116 -0.493 . . . . 74.21 109.7 -173.059 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -112.95 126.71 55.79 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 106.001 -1.852 . . . . 74.42 106.001 171.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.429 ' HA ' ' HB2' ' A' ' 131' ' ' ALA . 15.9 ttp180 -110.21 167.93 9.82 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.762 -0.654 . . . . 62.54 109.856 -172.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -57.84 135.66 56.87 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.737 0.815 . . . . 64.12 110.168 178.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.73 -21.61 42.42 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-N 115.806 -0.634 . . . . 71.14 111.67 -177.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.8 m -109.39 143.37 39.04 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 108.661 -0.866 . . . . 65.33 108.661 -178.06 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -96.17 -27.26 15.13 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.358 0.599 . . . . 73.41 111.728 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.5 167.8 9.51 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.821 -0.627 . . . . 62.34 110.842 -176.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.59 136.55 33.05 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.044 -0.525 . . . . 62.2 110.339 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.82 129.42 64.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.502 -0.925 . . . . 71.44 108.502 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 m -82.84 138.84 33.79 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.204 -1.406 . . . . 64.15 107.204 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 42.7 t30 78.3 69.0 0.04 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.056 0.942 . . . . 72.53 110.947 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.54 173.1 6.71 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.213 -1.032 . . . . 65.52 108.213 172.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -96.19 156.94 36.43 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 106.391 -1.707 . . . . 75.4 106.391 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 27.7 Cg_exo -61.75 -20.08 67.75 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 121.39 1.394 . . . . 73.55 110.518 173.419 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 102' ' ' LEU . 74.3 t -60.67 -43.41 94.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 109.131 -0.692 . . . . 71.23 109.131 173.676 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.47 -39.29 93.52 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.68 -0.691 . . . . 43.22 109.43 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.46 66.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 44.43 112.002 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 130' ' ' HIS . 4.6 pp -66.81 -35.52 80.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.993 0.425 . . . . 51.12 111.598 -177.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.458 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 13.8 t60 -70.81 -24.85 62.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.852 0.834 . . . . 75.12 108.939 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 113' ' ' ARG . . . -99.05 11.49 38.86 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.16 -0.927 . . . . 73.42 112.24 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.7 27.54 9.32 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.348 1.071 . . . . 71.33 110.889 177.095 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -109.68 25.09 12.19 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.586 -1.264 . . . . 73.22 107.586 177.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.56 -26.49 13.46 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.366 1.866 . . . . 71.41 113.196 -175.092 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -54.65 -35.91 63.99 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.657 0.208 . . . . 75.14 110.559 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.17 -28.08 62.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.659 0.742 . . . . 73.22 110.735 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.3 -44.99 54.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.639 -0.875 . . . . 44.32 108.639 177.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 61.3 t -61.1 -44.25 97.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 115.541 -0.754 . . . . 54.02 110.634 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.11 -38.69 89.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 120.457 -0.497 . . . . 73.42 110.824 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -69.12 -38.01 78.64 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.83 0.348 . . . . 74.45 110.998 175.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.447 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -59.01 -43.32 91.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.743 -0.662 . . . . 62.52 110.256 178.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 93.8 mt-30 -63.06 -45.47 92.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.851 -0.613 . . . . 73.54 110.167 177.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.91 94.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.639 -0.709 . . . . 42.11 111.112 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.577 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 17.0 tpt -70.34 -32.82 70.7 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.757 -0.656 . . . . 74.24 111.031 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.3 -54.51 5.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.013 -0.54 . . . . 70.41 111.538 -178.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 118.567 -0.73 . . . . 75.02 109.115 -175.842 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 C--O 1.239 0.542 0 N-CA-C 109.179 -0.674 . . . . 75.04 109.179 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.3 107.73 2.03 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.836 1.69 . . . . 63.43 109.076 174.486 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.83 103.64 1.86 Allowed Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 108.729 -1.749 . . . . 64.33 108.729 -172.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -73.09 134.0 44.37 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.438 0.161 . . . . 65.41 110.806 -177.654 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.06 83.18 0.2 Allowed Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 124.871 1.268 . . . . 35.04 111.762 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.3 143.57 28.29 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.685 2.257 . . . . 70.24 110.083 176.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.41 116.02 3.82 Favored Glycine 0 N--CA 1.411 -2.978 0 C-N-CA 120.325 -0.94 . . . . 71.34 110.992 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 p -75.14 -24.49 57.99 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.397 1.094 . . . . 74.13 108.288 176.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 m -159.4 155.44 26.68 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.746 -2.316 . . . . 52.43 104.746 175.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.2 150.38 48.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 118.399 0.545 . . . . 73.34 110.397 177.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.23 141.42 37.14 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.903 -0.589 . . . . 53.24 111.95 -174.098 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.505 ' HA ' ' CE1' ' A' ' 89' ' ' HIS . 28.6 ptt180 -144.81 112.0 6.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.538 0.685 . . . . 53.02 110.455 176.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.38 121.67 57.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 107.417 -1.327 . . . . 64.02 107.417 -178.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.77 -32.82 58.71 Favored Glycine 0 C--N 1.317 -0.491 0 C-N-CA 121.04 -0.6 . . . . 73.4 111.768 -177.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -102.18 89.1 3.49 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.571 -0.529 . . . . 72.05 109.571 178.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mp -67.99 121.89 81.69 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.841 -0.618 . . . . 64.0 109.436 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.52 155.14 40.5 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.523 2.148 . . . . 73.13 113.561 -179.203 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.77 132.98 53.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.441 -1.689 . . . . 64.2 106.441 173.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.94 -106.19 2.77 Favored Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.884 -0.674 . . . . 72.15 112.408 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.25 121.56 35.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.931 0.396 . . . . 75.21 110.452 -175.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -61.39 119.17 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.977 -1.01 . . . . 75.33 110.81 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' HE3' ' A' ' 99' ' ' MET . 93.4 t -77.07 -25.28 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.447 0.641 . . . . 53.43 111.234 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.6 148.44 28.0 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.407 -0.917 . . . . 54.01 111.9 176.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.32 145.19 99.1 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 114.988 -1.006 . . . . 60.24 110.782 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.44 -27.07 30.38 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.347 2.698 . . . . 62.03 114.058 177.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.8 -23.35 58.48 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.734 0.272 . . . . 73.02 111.734 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.09 126.63 91.66 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 108.903 -0.777 . . . . 70.3 108.903 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.64 106.53 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.876 2.384 . . . . 72.23 111.387 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 p -106.67 172.05 7.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.833 -0.621 . . . . 73.21 110.829 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 38' ' ' LEU . 16.6 m-85 -109.63 161.5 15.32 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.581 -0.896 . . . . 73.14 108.581 177.047 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.14 166.24 22.91 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 103.606 -2.739 . . . . 74.35 103.606 -173.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -52.79 -51.13 76.88 Favored Pre-proline 0 C--N 1.309 -1.188 0 O-C-N 123.881 0.738 . . . . 53.21 112.004 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.528 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 10.9 Cg_endo -57.53 -39.71 86.39 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.794 1.663 . . . . 65.2 112.352 175.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 3.9 mpt_? -70.35 -36.2 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.979 0.733 . . . . 73.14 112.979 -177.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 66' ' ' ILE . 73.4 t -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.971 -0.692 . . . . 52.53 109.764 175.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.01 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.157 -0.929 . . . . 75.33 109.055 174.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 19.3 mm-40 -65.52 -45.49 83.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 72.11 112.092 175.25 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 30' ' ' TYR . 89.1 mt -62.73 -50.74 69.89 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.339 -0.391 . . . . 71.35 111.623 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' HG22 ' A' ' 41' ' ' VAL . 90.9 mt -88.01 -15.38 36.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.799 -0.637 . . . . 74.1 112.137 -174.18 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.6 67.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.39 -1.084 . . . . 64.21 110.39 -177.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 39' ' ' LEU . 20.8 m -122.21 164.61 24.79 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 108.671 -0.862 . . . . 61.53 108.671 -177.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.87 167.05 14.72 Favored 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 121.44 1.427 . . . . 71.32 111.638 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.5 t -59.02 -33.09 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.579 0.751 . . . . 64.45 110.644 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 24.6 p -57.58 -43.58 84.67 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.455 -0.793 . . . . 72.54 111.201 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.585 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 56.9 mtpt -69.33 -33.61 73.39 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.761 -0.199 . . . . 74.5 111.091 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.403 ' O ' HD13 ' A' ' 50' ' ' LEU . 57.5 t -62.5 -43.7 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.626 -0.509 . . . . 52.3 109.626 177.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.47 78.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 62.34 110.479 177.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 44' ' ' SER . 97.9 mt-30 -65.43 -36.54 84.22 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.958 -0.564 . . . . 62.53 111.495 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm100 -63.28 -43.21 98.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.384 -0.969 . . . . 72.23 108.384 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 9.3 mp -61.75 -46.64 88.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.515 -1.22 . . . . 75.02 110.154 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -60.47 -25.72 66.24 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.676 0.991 . . . . 65.13 113.676 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 54' ' ' HIS . 7.6 pt-20 -102.55 2.77 36.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.425 -0.91 . . . . 63.43 111.625 -177.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.32 38.88 71.15 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.507 -0.854 . . . . 54.22 111.476 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.564 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 3.4 t60 -96.28 -28.9 14.29 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.853 -1.166 . . . . 74.25 107.853 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 55.9 tp -159.73 156.02 26.97 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.418 -2.068 . . . . 63.32 105.418 -178.413 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.48 152.29 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.123 -0.695 . . . . 72.51 109.123 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.7 161.82 19.45 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 123.489 0.493 . . . . 73.53 109.747 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 99' ' ' MET . 22.2 m -126.54 166.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.01 -0.737 . . . . 31.14 109.01 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -116.58 134.84 54.36 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.56 -0.533 . . . . 72.4 109.56 -174.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -148.21 125.96 11.87 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.76 -0.83 . . . . 72.54 108.76 171.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.17 22.89 12.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.075 0.95 . . . . 65.24 112.017 178.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.57 -14.78 64.39 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.847 -0.615 . . . . 72.21 112.495 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.41 150.0 20.53 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 121.306 -0.473 . . . . 60.15 112.426 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.75 120.57 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.592 -1.262 . . . . 74.13 107.592 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.3 160.8 40.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.604 -0.725 . . . . 73.54 109.697 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 35' ' ' VAL . 70.7 mt -130.69 129.08 22.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 62.43 108.286 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.4 131.63 47.37 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.566 2.177 . . . . 62.33 111.425 176.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 40.6 tt0 -65.27 -25.48 67.67 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 120.836 0.351 . . . . 72.3 111.227 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.29 -2.25 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.519 -0.764 . . . . 72.12 112.636 178.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.657 ' CD2' HD11 ' A' ' 81' ' ' LEU . 5.6 m-85 -86.38 -8.21 57.85 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.374 1.083 . . . . 70.33 109.359 173.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.6 m-85 -115.86 155.63 27.58 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.53 -1.656 . . . . 74.51 106.53 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.7 p -80.89 173.73 12.32 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.434 -0.951 . . . . 65.11 108.434 177.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -58.29 -20.57 43.88 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.029 0.752 . . . . 75.41 113.029 -177.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 t -89.04 -2.52 58.61 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 121.9 -0.5 . . . . 74.5 111.488 179.048 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.39 15.21 58.99 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.087 -0.578 . . . . 62.33 113.509 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -113.08 142.06 46.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.88 -0.785 . . . . 64.23 108.88 178.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 71' ' ' PHE . 11.8 p -62.01 144.18 14.39 Favored 'Isoleucine or valine' 0 C--O 1.249 1.032 0 O-C-N 123.715 0.635 . . . . 62.24 110.869 -175.06 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 35.2 t -65.46 131.82 31.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.979 -0.749 . . . . 44.44 108.979 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.87 -34.04 75.28 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.523 0.935 . . . . 72.51 113.523 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.0 m -86.2 -6.29 59.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.041 0.448 . . . . 65.1 111.069 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.657 HD11 ' CD2' ' A' ' 70' ' ' PHE . 10.2 tt -66.3 -49.19 55.27 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 114.134 1.161 . . . . 53.12 114.134 -175.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.88 -33.84 73.42 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 121.961 1.774 . . . . 64.44 111.413 176.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.48 95.9 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.212 -0.904 . . . . 64.41 112.725 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.7 pp -67.34 -40.49 85.86 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.57 -0.53 . . . . 65.52 109.57 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.45 -34.61 77.13 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.263 -0.426 . . . . 73.12 110.662 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.2 m -62.34 -48.08 81.4 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.821 -0.627 . . . . 62.52 112.041 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.98 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 111.72 0.267 . . . . 65.34 111.72 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.562 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.4 mm? -66.67 -35.04 79.21 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.552 -0.459 . . . . 73.11 111.66 176.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.505 ' CE1' ' HA ' ' A' ' 12' ' ' ARG . 26.4 t-80 -58.7 -43.15 89.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.254 -0.647 . . . . 73.43 109.254 176.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.015 0.822 . . . . 64.05 110.842 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.87 -9.1 81.53 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.986 -0.552 . . . . 71.14 112.643 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 33.55 28.2 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.871 -0.68 . . . . 74.51 112.275 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -102.12 125.52 48.84 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.94 0.4 . . . . 73.21 111.037 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 37.2 ptt180 -75.67 171.79 13.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.663 -0.698 . . . . 73.13 111.157 178.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -54.2 -40.62 67.77 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.234 1.413 . . . . 74.21 110.866 -178.162 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.7 m -61.52 -42.32 98.63 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.858 -1.065 . . . . 73.22 110.67 -178.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 12.4 mm-40 -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.228 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.4 mm -60.99 -47.92 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.486 -0.931 . . . . 63.21 108.486 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.52 ' SD ' HG11 ' A' ' 58' ' ' VAL . 70.7 mtm -71.82 -25.04 61.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.85 -1.068 . . . . 71.14 111.415 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -64.18 0.98 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.112 -0.699 . . . . 60.51 109.112 -176.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 34.5 p-90 -69.44 -32.78 71.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.947 0.721 . . . . 71.11 112.947 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 125' ' ' PRO . 14.8 mt -61.22 -40.64 94.77 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.905 0.706 . . . . 61.32 112.905 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -93.15 -1.21 56.59 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.427 0.529 . . . . 65.3 112.427 -177.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.1 m -87.99 127.1 58.88 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 109.236 -0.653 . . . . 74.01 109.236 175.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 44.0 Cg_exo -61.26 129.19 27.46 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 121.903 1.736 . . . . 64.22 110.105 174.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 10.6 t70 -85.91 126.31 66.07 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.812 -0.81 . . . . 61.23 108.812 -177.529 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.95 -17.39 51.08 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.296 2.664 . . . . 52.43 114.017 -177.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.3 m -122.49 15.68 10.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.892 -0.505 . . . . 73.24 111.443 -176.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 53.2 tp -108.47 126.4 52.86 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.738 0.644 . . . . 53.25 112.738 -176.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.4 m -119.72 133.64 55.54 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 105.354 -2.091 . . . . 73.22 105.354 174.144 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.82 160.77 15.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.111 -1.036 . . . . 74.11 113.791 -175.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.404 HG22 ' OE1' ' A' ' 133' ' ' GLN . 11.2 t -92.71 160.09 15.13 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.396 -1.274 . . . . 74.33 109.604 -177.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -54.84 120.5 6.93 Favored 'General case' 0 C--O 1.253 1.259 0 O-C-N 123.529 0.518 . . . . 74.13 112.352 178.372 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.547 ' HB3' ' HA ' ' A' ' 131' ' ' ALA . 4.9 t70 161.78 120.33 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 127.403 2.281 . . . . 74.35 104.975 172.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.65 -53.81 4.86 Favored Glycine 0 C--N 1.308 -1.026 0 N-CA-C 108.807 -1.717 . . . . 72.53 108.807 -173.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.6 m -103.94 123.12 46.58 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 106.102 -1.814 . . . . 65.14 106.102 171.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -62.04 -24.25 66.95 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.188 0.995 . . . . 72.01 112.304 -176.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -136.92 178.59 6.96 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 116.199 -0.455 . . . . 73.33 109.786 -174.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.4 131.23 40.06 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 123.577 0.548 . . . . 74.4 110.904 -177.092 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.19 122.19 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.678 -0.692 . . . . 72.43 109.394 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.8 p -88.32 150.2 23.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.055 -1.091 . . . . 61.52 108.055 173.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 93.1 m-20 61.09 42.28 12.65 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.31 1.053 . . . . 73.42 108.405 -173.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.6 163.92 26.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.098 -1.41 . . . . 60.32 111.752 -176.222 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -97.11 133.02 24.61 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.769 -1.105 . . . . 72.12 109.279 -178.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.489 ' HB2' HD23 ' A' ' 102' ' ' LEU . 86.3 Cg_exo -52.16 -31.09 44.03 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.635 2.89 . . . . 74.53 114.423 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.588 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 67.8 t -60.83 -42.21 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 73.4 110.709 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.2 -40.38 82.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.096 -0.705 . . . . 74.12 109.096 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.95 83.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.123 -0.944 . . . . 75.02 112.091 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -68.52 -34.62 76.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.58 -0.448 . . . . 74.43 111.778 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -77.34 -24.13 50.79 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 107.745 -1.206 . . . . 73.1 107.745 179.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 114' ' ' ASP . . . -85.18 12.45 7.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.622 -1.172 . . . . 71.31 111.583 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.0 m80 66.85 28.17 8.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.061 0.945 . . . . 71.35 110.927 176.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.404 ' OE1' HG22 ' A' ' 112' ' ' THR . 53.6 mt-30 -112.28 23.22 13.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.049 -1.093 . . . . 75.54 108.049 176.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.52 -31.48 46.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 114.262 -1.335 . . . . 63.35 113.318 -176.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -65.18 -35.12 80.08 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 120.978 -0.289 . . . . 73.34 111.719 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -69.83 -28.56 65.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.679 0.752 . . . . 62.11 109.688 177.61 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.0 -45.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.957 -0.757 . . . . 61.22 108.957 176.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.449 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 82.7 t -59.87 -41.65 86.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 N-CA-C 109.11 -0.7 . . . . 65.11 109.11 175.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.797 0.839 . . . . 63.41 110.945 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.11 -37.25 86.48 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.572 -0.529 . . . . 75.24 109.572 177.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.562 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -65.14 -44.24 89.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.428 -0.806 . . . . 45.5 110.833 178.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 92.2 mt-30 -67.46 -36.35 80.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.473 -0.331 . . . . 73.35 110.198 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.84 62.48 Favored 'General case' 0 C--O 1.208 -1.085 0 CA-C-N 116.153 -0.476 . . . . 54.2 110.662 176.422 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.89 -30.85 45.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.389 0.614 . . . . 73.5 109.422 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.79 -41.69 13.1 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.861 -0.609 . . . . 53.01 111.366 178.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.607 -0.711 . . . . 63.3 110.106 -178.683 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 106.478 -1.675 . . . . 64.12 106.478 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.35 122.35 11.4 Favored 'Trans proline' 0 C--O 1.246 0.907 0 C-N-CA 122.848 2.365 . . . . 75.13 112.731 -177.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.41 47.41 1.02 Allowed Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.775 -0.93 . . . . 53.34 110.775 -178.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.598 ' H ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -62.0 141.37 58.1 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 123.117 0.567 . . . . 74.42 110.199 177.819 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.15 103.91 46.89 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 110.03 -0.359 . . . . 70.32 110.03 -178.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.19 126.31 11.63 Favored 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 122.174 1.916 . . . . 73.42 111.226 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.66 97.26 1.42 Allowed Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 120.872 -0.68 . . . . 64.42 111.468 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -68.13 -37.2 80.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.681 0.753 . . . . 73.44 109.915 178.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.6 m -133.96 140.84 47.01 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.273 -1.38 . . . . 53.41 107.273 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.2 mt -79.05 154.46 29.42 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.167 0.508 . . . . 63.13 111.264 -175.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.46 105.1 11.34 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.94 -0.763 . . . . 74.41 108.94 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.95 91.93 6.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.203 -0.665 . . . . 63.33 109.203 -178.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 m -128.8 117.37 44.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.722 -0.672 . . . . 65.12 111.423 -179.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.8 4.12 63.19 Favored Glycine 0 C--N 1.306 -1.086 0 N-CA-C 109.645 -1.382 . . . . 64.34 109.645 176.36 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.525 ' CB ' ' HA ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -86.02 108.06 18.06 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 114.716 -0.742 . . . . 72.12 112.549 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.04 129.24 56.87 Favored Pre-proline 0 C--N 1.287 -2.125 0 N-CA-C 103.874 -2.639 . . . . 73.45 103.874 168.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.54 158.26 16.52 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.941 1.76 . . . . 53.42 110.944 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.35 124.18 29.76 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.092 -0.643 . . . . 74.42 109.765 -176.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.72 -110.19 2.48 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 115.961 -0.563 . . . . 64.12 113.552 -176.363 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.16 123.92 33.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.678 0.275 . . . . 72.23 110.422 -172.707 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 17.5 t0 -61.84 130.99 48.33 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.777 1.029 . . . . 71.3 113.777 -175.408 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.87 -23.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.422 -0.808 . . . . 60.4 112.352 -175.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD23 ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -89.51 -172.43 3.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 119.075 -1.05 . . . . 64.52 112.173 -178.086 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -90.2 137.01 28.03 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 109.304 -0.628 . . . . 74.31 109.304 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.54 -21.92 70.3 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.54 2.16 . . . . 64.53 111.939 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -68.61 -25.15 64.71 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.89 -0.595 . . . . 70.1 111.464 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 29' ' ' THR . 5.6 mm-40 -73.76 117.39 60.58 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 107.857 -1.164 . . . . 74.01 107.857 177.031 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 37.0 Cg_exo -60.88 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.831 2.354 . . . . 62.42 112.041 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 66' ' ' ILE . 42.0 p -98.86 -162.11 0.93 Allowed 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 115.019 -0.992 . . . . 53.54 109.131 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -109.27 159.33 17.04 Favored 'General case' 0 N--CA 1.391 -3.392 0 N-CA-C 107.723 -1.214 . . . . 64.41 107.723 174.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 35' ' ' VAL . 5.2 m-20 -135.11 161.24 35.89 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 103.583 -2.747 . . . . 73.34 103.583 -176.71 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.66 -54.83 23.38 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 113.742 1.015 . . . . 63.23 113.742 -173.217 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.2 -34.1 46.75 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 121.47 1.447 . . . . 54.14 111.889 177.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 22.7 tpt180 -67.02 -34.98 78.9 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.418 -0.355 . . . . 64.14 110.965 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 31' ' ' ASP . 56.7 t -69.33 -40.8 80.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.16 -0.681 . . . . 73.4 109.16 178.186 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.3 -35.81 78.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 61.41 109.5 176.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -69.0 -45.32 70.85 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.284 -0.871 . . . . 74.21 110.868 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.28 -45.06 81.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.978 -0.555 . . . . 63.51 111.532 -177.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.8 -12.34 58.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.299 -0.41 . . . . 52.15 111.86 -177.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.67 30.67 74.92 Favored Glycine 0 CA--C 1.505 -0.541 0 CA-C-N 115.914 -0.585 . . . . 75.32 111.965 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.28 155.6 80.69 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.84 -0.43 . . . . 71.22 109.84 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.17 166.81 19.9 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.109 1.873 . . . . 73.1 112.001 177.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -56.3 -37.43 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.806 0.843 . . . . 70.34 110.909 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -57.73 -41.53 82.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.365 -0.834 . . . . 72.34 111.479 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.658 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 45.4 mtpt -70.06 -36.83 75.26 Favored 'General case' 0 C--O 1.2 -1.545 0 C-N-CA 119.268 -0.973 . . . . 75.13 111.266 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.5 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.482 -0.562 . . . . 75.01 109.482 177.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -58.9 -43.37 91.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.693 -0.685 . . . . 74.41 110.247 177.086 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 3.5 pt20 -70.53 -34.2 72.01 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.522 -0.308 . . . . 75.03 111.499 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.2 mm100 -57.53 -46.59 83.66 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.3 -1.0 . . . . 61.55 108.3 177.423 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.1 -43.52 98.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.378 -1.283 . . . . 74.13 109.762 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.525 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 19.7 mtp180 -63.44 -26.17 68.61 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.71 0.633 . . . . 63.04 112.71 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.13 7.21 45.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.941 0.401 . . . . 73.33 111.51 -178.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.15 81.65 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.774 -0.648 . . . . 54.35 113.602 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -85.19 -31.51 23.17 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.783 -0.367 . . . . 73.35 111.0 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.61 171.26 18.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.642 -0.874 . . . . 70.01 108.642 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.22 161.6 38.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.536 -0.542 . . . . 71.24 109.536 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.89 161.69 33.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.578 -0.897 . . . . 64.41 108.578 -177.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.77 166.18 29.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 123.511 0.507 . . . . 62.44 110.021 179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 17.7 mtp180 -122.75 142.66 50.47 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.054 0.454 . . . . 75.41 111.846 -178.628 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.491 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 13.5 ptt180 -149.27 127.21 11.88 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.774 -1.195 . . . . 64.44 107.774 175.474 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.83 17.88 11.21 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.549 1.14 . . . . 51.41 110.566 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.52 80.79 Favored Glycine 0 C--O 1.22 -0.719 0 CA-C-N 115.509 -0.769 . . . . 74.33 112.023 -177.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -88.4 142.52 17.36 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 111.688 -0.565 . . . . 71.44 111.688 -179.222 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.19 119.7 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.476 -1.305 . . . . 73.33 107.476 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 m -133.67 157.74 42.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 72.11 110.29 -175.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.438 ' O ' ' HB ' ' A' ' 29' ' ' THR . 55.0 mt -128.41 125.18 23.17 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.037 -1.097 . . . . 75.15 108.037 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 29' ' ' THR . 72.6 Cg_exo -53.45 133.95 55.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.782 2.322 . . . . 33.23 112.59 177.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.3 tp-100 -48.97 -42.2 36.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.681 1.192 . . . . 64.13 111.477 -177.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.409 ' CG2' HG11 ' A' ' 126' ' ' VAL . 16.0 m -69.22 -7.18 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 115.351 1.611 . . . . 44.33 115.351 -174.377 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -78.75 -14.53 59.23 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.243 1.02 . . . . 62.21 109.587 174.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.99 156.75 19.37 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.315 -1.365 . . . . 73.03 107.315 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.3 p -86.14 172.54 10.48 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.91 -0.404 . . . . 75.22 109.91 -179.11 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -68.81 -17.26 63.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.335 0.588 . . . . 55.02 110.241 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 m -88.71 2.98 52.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.234 -0.439 . . . . 52.32 111.072 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 20.1 68.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.98 -0.629 . . . . 71.33 113.294 176.408 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -111.21 166.26 11.24 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.313 -1.365 . . . . 65.2 107.313 178.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.73 3.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.394 -1.322 . . . . 64.34 107.524 178.123 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.0 t -64.77 137.69 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-O 120.892 0.377 . . . . 71.55 110.679 -178.158 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 58.2 tttp -64.71 -40.44 95.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.219 0.533 . . . . 75.14 112.208 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -84.44 -0.35 52.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.318 0.58 . . . . 63.31 110.615 -175.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 60.1 tp -65.53 -54.35 31.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 113.005 0.742 . . . . 64.33 113.005 -178.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 51.9 Cg_exo -58.09 -33.26 97.15 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 121.475 1.45 . . . . 73.03 111.158 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -44.99 87.88 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.669 -0.696 . . . . 72.3 112.293 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.3 pp -65.66 -40.01 91.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.343 0.592 . . . . 75.1 109.878 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.57 -34.46 77.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.903 -0.589 . . . . 70.32 110.762 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.5 m -70.49 -42.06 71.86 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 116.126 -0.488 . . . . 63.1 111.873 -178.203 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.06 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.786 0.327 . . . . 65.45 110.732 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.515 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.3 mm? -66.26 -35.1 79.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 122.255 -0.278 . . . . 75.41 111.378 176.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 75.31 110.159 176.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.44 -30.77 68.77 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.319 0.581 . . . . 65.4 110.683 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.94 -9.14 83.1 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.633 -0.712 . . . . 71.3 111.441 178.188 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.17 47.36 11.15 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.592 -0.304 . . . . 73.23 113.154 177.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.16 129.51 55.49 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 122.673 -0.31 . . . . 74.4 111.049 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.61 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 36.1 ptt180 -74.9 170.78 15.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.709 -0.678 . . . . 72.23 110.676 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -54.41 -44.85 72.73 Favored 'General case' 0 C--O 1.25 1.122 0 C-N-CA 126.552 1.941 . . . . 74.44 111.547 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.1 m -63.93 -41.91 97.5 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.869 -1.06 . . . . 62.42 110.375 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.61 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 16.4 mm-40 -67.52 -34.04 76.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.071 -0.513 . . . . 72.22 111.148 -178.263 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.54 -49.45 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 108.578 -0.897 . . . . 75.22 108.578 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.55 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.4 ptp -75.68 -14.85 60.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.077 -0.965 . . . . 50.13 113.055 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.49 -62.18 2.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.636 0.374 . . . . 74.12 110.411 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.471 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.0 p-90 -69.19 -31.84 70.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.603 0.594 . . . . 72.02 112.603 176.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 12.2 mt -62.34 -40.26 95.81 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.931 1.086 . . . . 72.3 113.931 -179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.468 ' CE2' HD23 ' A' ' 23' ' ' LEU . 33.5 m-85 -85.32 -16.65 39.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.538 0.94 . . . . 74.42 113.538 -177.251 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.8 p -84.36 124.09 74.15 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 109.338 -0.615 . . . . 34.25 109.338 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -52.68 134.91 55.25 Favored 'Trans proline' 0 C--O 1.249 1.055 0 C-N-CA 122.743 2.295 . . . . 53.45 111.766 178.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.0 t70 -93.35 121.33 65.41 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.868 -0.605 . . . . 73.0 110.255 -177.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.71 -23.62 76.66 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.211 2.608 . . . . 71.24 113.708 -177.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -98.48 0.79 45.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.958 0.408 . . . . 55.44 110.757 -176.3 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -101.89 124.86 48.24 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.675 0.75 . . . . 53.34 110.744 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.9 m -132.45 116.5 16.87 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.685 -1.598 . . . . 74.31 106.685 175.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.2 pt -139.15 163.22 26.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.16 0.505 . . . . 72.15 112.201 -175.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 t -97.77 130.4 44.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.488 -1.301 . . . . 61.44 107.488 171.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.512 ' HG3' ' OD1' ' A' ' 127' ' ' ASP . 32.7 ttt180 -95.05 154.17 17.3 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.21 -0.663 . . . . 75.42 109.21 -175.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.43 104.55 2.33 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 109.345 -0.613 . . . . 63.43 109.345 178.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.95 1.2 24.04 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.296 -0.866 . . . . 71.42 110.955 -176.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.444 ' HB3' ' OD1' ' A' ' 118' ' ' ASP . 54.9 m -140.55 103.64 4.58 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 123.039 0.536 . . . . 52.41 109.634 178.644 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -72.27 -17.92 61.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.03 -0.532 . . . . 70.3 111.04 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 116' ' ' SER . 9.6 p-10 -74.51 150.13 39.95 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.143 -0.935 . . . . 74.01 109.725 178.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.48 124.07 32.4 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.088 -0.708 . . . . 74.4 109.088 -178.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.5 t -98.48 118.07 44.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.565 -0.902 . . . . 73.24 108.565 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -90.84 137.45 32.35 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.687 -0.688 . . . . 70.45 109.399 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 57.8 t30 65.63 62.98 0.63 Allowed 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.13 0.894 . . . . 60.44 109.43 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.47 162.14 13.98 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.975 -1.011 . . . . 53.2 109.918 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 127.97 76.35 Favored Pre-proline 0 C--O 1.243 0.743 0 C-N-CA 119.944 -0.702 . . . . 74.55 110.545 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.538 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.6 Cg_exo -52.59 -21.7 15.06 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.025 3.15 . . . . 73.22 114.989 -178.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.6 t -63.75 -39.83 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.183 -0.607 . . . . 73.11 110.371 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.512 ' OD1' ' HG3' ' A' ' 113' ' ' ARG . 14.2 t70 -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.446 -0.946 . . . . 63.41 108.446 -178.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.65 68.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.91 -1.041 . . . . 55.33 111.122 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.3 pp -64.44 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.981 0.419 . . . . 71.35 110.771 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -67.62 -36.49 80.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.584 -0.895 . . . . 75.22 108.584 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.16 9.45 28.34 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 45.4 112.006 -178.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 67.5 27.77 7.84 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.882 1.325 . . . . 73.4 111.395 178.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -96.94 23.61 7.02 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.178 -1.786 . . . . 70.24 106.178 173.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.78 -26.76 15.26 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 127.172 2.189 . . . . 72.35 114.643 -173.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.572 ' HD2' ' H ' ' A' ' 135' ' ' ARG . 3.4 mpt_? -55.74 -47.58 76.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.057 0.223 . . . . 74.42 111.254 -174.175 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 9.8 mm-40 -66.64 -32.39 73.68 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.187 0.439 . . . . 73.34 112.187 176.483 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.09 -49.29 63.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.353 -0.385 . . . . 62.42 110.158 -177.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.73 -42.45 96.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.909 -0.587 . . . . 75.41 109.597 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 57.8 ttt180 -59.12 -46.92 87.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.854 -0.612 . . . . 74.55 111.05 178.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.63 -38.31 90.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.898 -0.779 . . . . 52.11 108.898 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -64.15 -46.64 83.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.684 . . . . 32.12 110.413 178.125 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.32 -36.59 82.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.847 0.356 . . . . 63.32 111.283 178.031 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.99 83.91 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.196 0.522 . . . . 72.31 110.58 178.367 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 tpt -69.8 -45.11 68.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.48 -0.782 . . . . 51.0 111.408 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.34 -31.06 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.017 0.747 . . . . 63.53 113.017 -176.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 C--N 1.312 -1.047 0 C-N-CA 120.621 -0.432 . . . . 71.3 110.539 -178.517 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 107.886 -1.154 . . . . 75.45 107.886 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.93 121.13 9.22 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.411 2.074 . . . . 74.25 112.618 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.79 102.75 1.53 Allowed Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 110.39 -1.084 . . . . 62.45 110.39 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.0 ttm105 -72.98 132.63 43.67 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.823 -0.436 . . . . 52.33 109.823 -179.095 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -88.87 152.78 49.09 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.077 -0.511 . . . . 24.34 111.085 -174.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 5.2 Cg_endo -87.45 85.22 0.79 Allowed 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 122.626 2.218 . . . . 71.14 111.601 176.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.98 93.73 1.78 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.257 -1.137 . . . . 75.23 110.257 177.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.3 t -123.98 166.55 15.52 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.925 -0.768 . . . . 72.42 108.925 -178.234 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -73.46 136.85 44.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 122.984 0.514 . . . . 62.51 110.143 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.8 -175.6 5.85 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.717 -0.475 . . . . 72.23 109.717 177.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 123.03 18.35 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.882 -0.414 . . . . 62.51 109.882 178.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -77.68 115.33 17.35 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 115.878 -0.601 . . . . 70.52 111.246 -175.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.8 m -112.81 96.68 4.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 122.047 0.927 . . . . 71.3 110.091 174.552 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.61 -50.85 4.54 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.643 -1.383 . . . . 70.45 109.643 177.599 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t 174.24 163.89 0.2 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.138 -1.43 . . . . 73.45 107.138 174.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.24 120.87 43.16 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 106.337 -1.727 . . . . 74.33 106.337 176.209 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.1 144.36 37.57 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.118 1.878 . . . . 73.05 110.746 178.52 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.88 128.14 34.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.836 -0.431 . . . . 64.13 109.836 -178.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.98 -112.13 2.89 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.907 -0.663 . . . . 63.42 112.878 -178.642 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -95.1 128.05 41.63 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.702 0.286 . . . . 73.31 110.797 -174.335 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -70.2 138.73 52.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.311 -0.858 . . . . 73.14 111.441 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.16 -11.35 8.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.232 -0.895 . . . . 70.2 109.811 -176.31 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.96 -169.82 2.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.799 0.809 . . . . 70.15 109.539 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.434 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 29.2 t70 -105.75 138.29 19.58 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 105.837 -1.912 . . . . 71.41 105.837 169.235 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.68 -26.04 16.35 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.978 2.452 . . . . 72.43 115.042 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.74 -3.8 58.94 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.206 0.447 . . . . 74.12 112.206 -177.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 26.6 mm-40 -74.61 145.57 82.22 Favored Pre-proline 0 C--O 1.25 1.126 0 O-C-N 121.552 -0.717 . . . . 64.51 110.941 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.49 ' HB2' ' HG3' ' A' ' 68' ' ' GLN . 12.2 Cg_endo -54.65 123.72 14.39 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.214 2.61 . . . . 74.14 111.524 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -140.47 168.93 18.64 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.568 -0.742 . . . . 53.4 111.812 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.479 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 36.4 m-85 -109.77 160.38 16.38 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 125.377 1.471 . . . . 75.34 109.325 176.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -135.73 161.13 36.42 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.229 -2.878 . . . . 41.55 103.229 178.051 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.25 -52.25 70.52 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 113.804 1.039 . . . . 72.25 113.804 -173.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.08 -36.06 96.93 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.826 1.684 . . . . 73.43 112.66 176.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.85 -37.86 85.27 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.883 -0.414 . . . . 74.44 109.883 177.277 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.75 -40.97 79.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.18 -0.464 . . . . 72.21 110.354 176.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.43 -43.36 83.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.29 -0.868 . . . . 60.32 109.076 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.09 -45.29 92.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.361 -1.291 . . . . 74.13 110.254 178.003 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.6 -40.75 96.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.965 -1.016 . . . . 74.44 111.49 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.76 -18.31 22.21 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.408 -0.36 . . . . 55.53 111.437 -177.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.37 62.08 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.395 -0.682 . . . . 54.41 111.395 -178.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.38 161.89 24.94 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 108.941 -0.763 . . . . 64.52 108.941 -177.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.54 155.81 67.73 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 121.703 1.602 . . . . 75.54 111.963 174.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.72 -35.46 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.375 0.67 . . . . 71.05 109.686 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 23.3 t -59.58 -38.52 81.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.518 -0.765 . . . . 73.03 110.33 178.243 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 52.4 mttp -69.15 -32.78 72.36 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.932 -0.48 . . . . 75.04 111.94 177.106 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.53 -42.8 97.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.814 -0.81 . . . . 65.13 108.814 174.45 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.77 83.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.727 -0.67 . . . . 74.33 110.278 176.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 44' ' ' SER . 90.1 mm-40 -66.89 -36.05 81.41 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.992 -0.549 . . . . 73.35 110.978 177.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.6 mt-30 -61.55 -43.29 99.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.456 0.646 . . . . 73.03 109.697 176.155 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.8 -34.69 76.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.448 -1.251 . . . . 61.45 110.473 176.758 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -71.66 -32.89 68.37 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.541 -0.754 . . . . 73.55 112.748 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -92.04 -11.75 35.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.13 0.49 . . . . 72.3 112.225 -176.027 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.27 35.99 28.45 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.929 -1.129 . . . . 75.35 110.716 -177.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -92.82 -27.42 17.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.113 -1.069 . . . . 63.52 108.113 176.039 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.6 tp -147.92 152.57 37.78 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.847 -1.538 . . . . 42.22 106.847 -175.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.07 154.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 108.766 -0.827 . . . . 60.34 108.766 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.6 162.02 33.89 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 123.306 0.379 . . . . 75.33 110.264 -174.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.1 m -132.03 166.67 28.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 123.883 0.873 . . . . 62.25 109.471 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 83.3 mtm180 -110.95 131.29 55.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.886 0.699 . . . . 75.44 112.886 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 33.0 ptt180 -116.12 116.07 27.18 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 106.901 -1.518 . . . . 74.13 106.901 176.499 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.66 14.16 6.94 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.667 0.746 . . . . 62.32 111.019 -177.05 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.09 -20.89 34.78 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.821 -0.627 . . . . 70.43 112.697 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -78.57 145.7 29.29 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 110.585 -1.006 . . . . 60.22 110.585 -179.037 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.2 t -95.97 120.23 45.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.962 -0.755 . . . . 43.11 108.962 -175.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.23 163.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.643 -0.708 . . . . 73.22 111.51 -177.306 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -128.97 125.2 22.79 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.967 -1.123 . . . . 70.35 107.967 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.1 139.24 85.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.575 2.183 . . . . 73.24 113.235 178.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HG3' ' HB2' ' A' ' 28' ' ' PRO . 73.8 mm-40 -48.72 -34.88 12.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.271 1.028 . . . . 71.44 112.485 177.011 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.13 -3.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 113.883 1.068 . . . . 42.02 113.883 -174.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 81' ' ' LEU . 8.0 m-85 -86.68 -5.84 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.066 0.936 . . . . 75.12 110.141 175.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -134.42 164.5 27.29 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.799 -1.091 . . . . 62.11 108.104 178.66 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.6 p -94.6 158.46 15.52 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.204 -1.406 . . . . 63.41 107.204 176.203 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.78 -15.79 63.19 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.208 0.528 . . . . 74.31 110.647 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.7 m -79.05 -5.56 54.27 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.563 -0.744 . . . . 71.25 111.71 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.24 -7.41 40.41 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 119.641 -1.266 . . . . 71.35 114.312 174.308 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -106.05 162.86 13.24 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.681 -0.808 . . . . 71.33 110.238 179.053 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.79 156.19 5.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 106.86 -1.533 . . . . 73.23 106.86 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.92 125.07 22.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.427 -0.953 . . . . 65.33 108.427 177.559 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.95 -22.21 65.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.93 1.085 . . . . 74.25 113.93 -173.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 t -103.41 11.81 36.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.887 0.375 . . . . 73.14 110.203 -179.063 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 70' ' ' PHE . 12.9 tp -63.41 -51.47 67.55 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 119.305 -0.378 . . . . 65.12 111.762 -178.665 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 31.4 Cg_exo -61.68 -29.59 83.98 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 121.363 1.376 . . . . 64.05 111.78 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.49 -45.04 97.01 Favored Glycine 0 C--O 1.24 0.489 0 O-C-N 123.377 0.423 . . . . 72.5 113.082 -178.092 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -68.4 -40.36 81.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.316 0.579 . . . . 71.34 109.463 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.02 -42.47 97.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.504 -0.771 . . . . 72.22 111.233 -179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.0 m -57.54 -46.87 83.36 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 112.044 0.387 . . . . 73.33 112.044 -177.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -41.96 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.013 0.435 . . . . 73.11 110.83 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.684 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 55.8 mt -67.08 -35.86 80.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.359 0.503 . . . . 72.02 112.359 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -65.23 -33.2 75.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.553 -0.294 . . . . 53.1 110.73 177.292 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.59 -31.64 72.86 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.357 0.411 . . . . 74.35 110.332 178.248 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.04 -3.2 68.09 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.768 -0.651 . . . . 70.42 112.281 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.49 42.69 55.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 121.502 -0.38 . . . . 74.21 112.903 179.172 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 56.0 m-85 -93.26 130.61 38.92 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.453 -0.439 . . . . 72.11 111.962 178.528 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 18.7 ptp180 -81.1 171.77 14.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.09 -0.959 . . . . 62.41 111.459 -176.841 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.33 -45.96 72.79 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.725 1.61 . . . . 73.23 112.551 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.4 m -61.65 -40.99 96.88 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.414 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 17.9 mm-40 -65.94 -39.39 90.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.446 -0.343 . . . . 73.42 111.587 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 88' ' ' LEU . 24.4 mm -61.1 -49.48 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.749 -0.834 . . . . 60.44 108.749 -177.104 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.5 mtt -76.1 -18.53 59.14 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.738 -1.119 . . . . 75.23 112.336 -177.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -56.81 -67.26 0.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.378 0.671 . . . . 65.02 110.935 -175.66 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.684 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 52.7 p-90 -68.9 -32.75 72.61 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.363 0.505 . . . . 75.24 112.363 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.56 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.4 mt -60.35 -40.13 89.59 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.201 0.815 . . . . 74.21 113.201 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.19 -0.5 55.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.083 0.771 . . . . 74.45 113.083 -178.473 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.2 m -87.51 120.32 71.08 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.367 -0.605 . . . . 71.12 109.367 178.087 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.28 129.75 21.06 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.227 1.951 . . . . 74.4 110.751 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.6 t70 -102.5 124.16 40.29 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 120.264 -0.575 . . . . 62.21 109.519 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.35 -23.92 76.01 Favored 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.603 2.869 . . . . 71.4 113.556 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -104.44 10.27 35.32 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.429 0.633 . . . . 62.24 110.966 -177.647 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 50.1 tp -103.84 123.16 46.6 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.585 -0.894 . . . . 72.22 108.585 174.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.0 m -131.2 111.34 11.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.665 -1.235 . . . . 63.4 107.665 179.305 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.15 145.8 34.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.792 0.664 . . . . 72.4 112.792 -172.443 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 10.0 t -89.42 152.63 21.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.688 -1.227 . . . . 71.1 107.688 177.359 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -141.58 136.12 30.74 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.367 -0.975 . . . . 72.45 108.367 -173.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.19 129.46 31.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.373 0.669 . . . . 73.3 112.391 -177.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.41 -23.33 6.43 Favored Glycine 0 C--N 1.307 -1.035 0 N-CA-C 110.0 -1.24 . . . . 74.45 110.0 -177.183 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 m -152.55 150.4 29.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.275 -1.38 . . . . 54.31 107.275 178.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -9.07 53.39 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.381 -0.927 . . . . 75.12 111.318 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.04 151.09 38.74 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.858 -1.064 . . . . 74.31 110.936 -179.632 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 112' ' ' THR . . . -102.45 146.63 27.82 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.561 -0.745 . . . . 30.12 111.267 -178.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.92 121.3 53.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.799 -1.186 . . . . 64.32 107.799 177.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 t -90.58 148.26 22.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.957 -1.127 . . . . 52.44 107.957 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.9 t30 65.26 63.58 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.439 1.114 . . . . 71.24 108.923 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.71 164.71 18.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.686 -1.143 . . . . 72.31 109.728 -178.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 36.7 ptt180 -87.34 142.94 33.69 Favored Pre-proline 0 C--N 1.299 -1.62 0 CA-C-N 115.863 -0.608 . . . . 61.41 109.756 179.005 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HB2' HD23 ' A' ' 102' ' ' LEU . 48.7 Cg_exo -57.16 -18.34 29.09 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.264 2.642 . . . . 54.53 114.336 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 97.8 t -60.62 -41.96 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.237 0.542 . . . . 64.43 110.351 178.087 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.36 -32.54 73.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.88 -0.6 . . . . 70.42 111.224 -179.18 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.1 74.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 55.13 110.176 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 126' ' ' VAL . 17.0 tp -60.1 -43.65 95.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.478 0.711 . . . . 74.21 112.246 -177.067 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -71.84 -15.67 62.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.55 0.691 . . . . 75.53 110.697 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -101.58 13.38 35.14 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.289 -0.869 . . . . 44.23 111.373 -175.096 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 65.93 27.32 10.86 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 123.122 1.439 . . . . 63.44 110.225 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -106.29 23.49 14.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.079 -1.452 . . . . 64.41 107.079 176.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.84 17.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.317 -2.22 . . . . 74.04 111.868 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -56.18 -39.19 72.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.288 -0.415 . . . . 71.01 111.405 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.4 mm-40 -69.27 -33.68 73.6 Favored 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 120.77 -0.372 . . . . 72.31 110.887 175.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 129' ' ' LEU . 60.0 t -62.19 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.872 -0.788 . . . . 72.45 108.872 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 66.1 t -61.58 -49.11 85.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 115.673 -0.694 . . . . 75.14 109.41 176.544 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.416 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 0.7 OUTLIER -57.86 -41.8 83.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.076 -0.511 . . . . 71.14 111.452 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 16.6 mmt180 -68.42 -37.78 80.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.978 -0.378 . . . . 75.55 109.978 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.86 96.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.471 . . . . 71.22 110.228 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 91.3 mt-30 -58.52 -49.16 78.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.469 0.708 . . . . 65.31 110.016 178.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.12 71.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.568 -0.742 . . . . 74.32 111.774 -178.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 96.6 mmm -84.6 -36.8 21.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.568 -0.453 . . . . 64.15 111.208 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.583 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -77.44 -42.82 34.61 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.291 0.848 . . . . 53.54 113.291 -176.835 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 119.164 -0.446 . . . . 65.13 110.507 -175.86 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 108.007 -1.108 . . . . 71.31 108.007 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.96 99.69 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.466 1.444 . . . . 71.42 110.935 175.751 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.42 55.91 0.19 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 119.722 -1.228 . . . . 64.03 112.705 -179.279 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.426 ' H ' ' HD2' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -73.79 144.11 45.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.007 -0.738 . . . . 72.51 109.007 175.992 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.12 128.23 5.85 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 110.489 -0.189 . . . . 75.32 110.489 -179.301 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.74 106.78 2.33 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.595 1.53 . . . . 74.32 108.907 172.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.19 -148.32 11.62 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 120.73 -0.748 . . . . 43.34 113.851 -175.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 m -60.62 119.82 8.83 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.116 0.966 . . . . 64.11 112.594 -175.227 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.7 m -119.77 146.49 45.62 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.864 -1.532 . . . . 73.04 106.864 178.227 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.0 mt -81.12 151.16 28.42 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.952 0.723 . . . . 51.41 112.952 -175.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.9 146.87 52.45 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.283 -1.006 . . . . 74.45 108.283 177.479 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -153.82 133.95 13.28 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.825 0.345 . . . . 72.24 111.013 -177.344 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.4 p -155.82 99.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.208 1.004 . . . . 60.04 109.657 175.537 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.09 -85.62 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.082 -0.963 . . . . 74.32 112.025 -178.447 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.2 p -71.09 117.01 12.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.328 0.492 . . . . 63.5 112.328 -176.531 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.418 ' H ' HD12 ' A' ' 16' ' ' ILE . 3.9 mp -85.68 122.08 73.21 Favored Pre-proline 0 N--CA 1.443 -0.806 0 N-CA-C 108.037 -1.098 . . . . 63.22 108.037 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -69.35 158.81 56.11 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 121.947 1.764 . . . . 75.52 110.016 174.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.62 135.87 33.18 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 110.382 -0.229 . . . . 75.32 110.382 -177.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.14 -96.95 2.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 121.34 -0.457 . . . . 71.42 113.912 -177.268 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.97 131.99 51.78 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.212 0.529 . . . . 75.32 111.757 -175.202 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.03 94.36 2.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.294 -0.866 . . . . 43.12 110.329 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.57 -45.96 96.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.875 -1.057 . . . . 72.1 111.035 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.88 150.97 46.21 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.444 0.64 . . . . 64.15 112.583 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.81 151.16 93.21 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.181 -0.918 . . . . 73.4 109.058 178.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.75 -25.51 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.771 2.314 . . . . 74.21 112.826 178.181 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.66 -28.4 66.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.895 -0.322 . . . . 61.05 110.899 178.103 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.53 118.16 65.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 106.993 -1.484 . . . . 73.1 106.993 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.84 147.46 89.48 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 122.474 2.116 . . . . 72.34 113.917 -173.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -129.93 172.73 11.4 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.683 -0.69 . . . . 53.55 112.155 -177.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.447 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 10.6 m-85 -117.33 160.68 20.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 126.597 1.959 . . . . 74.1 108.184 173.797 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -133.19 163.75 28.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.31 -2.107 . . . . 74.51 105.31 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.433 HD22 ' H ' ' A' ' 32' ' ' LEU . 3.2 mm? -42.35 -54.84 7.39 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.426 1.639 . . . . 72.42 115.426 -174.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.99 -41.1 65.03 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.074 1.849 . . . . 45.31 113.006 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -71.45 -34.8 70.57 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.986 0.422 . . . . 74.11 110.688 -178.654 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 66' ' ' ILE . 76.0 t -69.15 -41.34 81.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.349 0.595 . . . . 64.15 109.547 177.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -60.2 -36.08 76.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.857 -1.065 . . . . 65.13 109.766 176.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 38.0 tt0 -64.12 -45.06 90.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.569 1.148 . . . . 72.21 110.493 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.447 HD11 ' CZ ' ' A' ' 30' ' ' TYR . 97.0 mt -60.9 -45.6 93.98 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.476 -0.784 . . . . 75.14 111.19 -178.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.8 mt -84.98 -18.35 34.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.209 -0.905 . . . . 54.53 111.395 -176.493 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.05 69.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 111.35 -0.7 . . . . 73.32 111.35 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 39' ' ' LEU . 28.4 m -129.24 158.78 71.97 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.583 -0.525 . . . . 74.43 109.583 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.46 160.89 40.66 Favored 'Trans proline' 0 C--O 1.256 1.42 0 C-N-CA 122.225 1.95 . . . . 75.12 112.136 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.09 -33.02 49.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 123.923 0.889 . . . . 61.51 111.752 -177.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.4 p -60.1 -40.22 88.87 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.225 -0.443 . . . . 65.35 111.226 178.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.75 -32.52 71.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.89 0.376 . . . . 65.23 111.384 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.8 t -64.5 -40.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.962 -0.755 . . . . 71.03 108.962 174.208 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -61.82 -36.06 80.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.455 -0.793 . . . . 62.23 110.382 176.118 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 44' ' ' SER . 93.4 mt-30 -61.67 -39.32 90.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.348 -0.387 . . . . 73.1 110.342 178.452 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -58.66 -46.21 87.68 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.812 -0.81 . . . . 60.21 108.812 177.76 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.23 -39.81 94.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.928 -1.033 . . . . 71.32 110.638 179.338 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 89.1 mtt180 -68.71 -26.9 65.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.203 -0.453 . . . . 73.23 111.921 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.95 -8.19 37.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.587 -0.278 . . . . 74.53 111.398 -176.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.47 25.73 45.95 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.555 -0.831 . . . . 41.34 111.883 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -96.55 -5.54 39.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.486 -0.191 . . . . 63.35 110.486 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 tp -163.12 153.94 16.68 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.223 -1.029 . . . . 74.41 108.223 -176.027 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 161.42 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.471 -1.307 . . . . 74.52 107.471 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.31 162.66 35.86 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.915 -0.402 . . . . 75.34 109.915 -175.218 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.418 HG13 ' HE1' ' A' ' 99' ' ' MET . 6.4 m -126.04 164.86 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 O-C-N 123.79 0.681 . . . . 71.21 109.709 177.819 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 32.9 ttp180 -110.83 132.38 54.25 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 116.222 -0.444 . . . . 70.1 110.48 -174.599 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.559 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -136.29 124.4 23.0 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.614 -0.513 . . . . 72.43 109.614 175.888 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.84 30.57 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.945 0.898 . . . . 63.42 112.127 176.053 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.05 -4.33 71.06 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.821 -0.627 . . . . 61.24 113.342 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -107.57 146.35 16.22 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 121.127 -0.559 . . . . 62.41 112.816 -178.178 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.15 120.85 47.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.361 -1.348 . . . . 64.32 107.361 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.79 159.93 41.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.878 -0.601 . . . . 71.23 111.124 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 35' ' ' VAL . 56.0 mt -124.32 128.39 25.02 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.217 -1.031 . . . . 71.13 108.217 179.634 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.14 138.62 86.2 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.62 2.213 . . . . 74.21 113.099 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.55 -35.58 53.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.333 1.053 . . . . 74.22 111.712 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -69.01 -9.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.898 -1.046 . . . . 50.31 113.641 -175.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -80.23 -15.72 56.37 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.745 0.783 . . . . 73.03 110.345 176.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -111.79 162.35 15.35 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 115.167 -0.924 . . . . 75.02 109.528 -178.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 p -85.87 165.78 16.54 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.353 -1.351 . . . . 61.43 107.353 175.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.82 -21.57 66.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.891 0.853 . . . . 74.4 109.506 177.616 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m -80.23 -1.89 42.57 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 115.108 -0.951 . . . . 55.41 112.092 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.47 -16.91 59.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.391 -0.909 . . . . 72.34 114.941 173.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -92.16 164.87 13.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.178 0.989 . . . . 73.34 109.612 179.632 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.84 155.71 3.7 Favored 'Isoleucine or valine' 0 C--O 1.258 1.546 0 N-CA-C 108.34 -0.985 . . . . 62.15 108.34 -179.141 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 80' ' ' SER . 42.6 t -65.97 126.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.041 -0.725 . . . . 72.12 109.041 178.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -26.6 67.92 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.626 0.602 . . . . 64.31 112.626 -178.231 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.475 ' H ' HG12 ' A' ' 78' ' ' VAL . 13.6 m -84.33 -0.56 52.99 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.884 -0.598 . . . . 73.2 111.899 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.515 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 57.1 tp -60.79 -55.1 48.1 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 113.01 0.745 . . . . 62.41 113.01 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.29 -28.98 86.47 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.087 1.858 . . . . 64.23 112.594 -178.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.29 96.37 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.057 -0.592 . . . . 53.34 111.941 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 60.13 110.308 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.4 -42.72 95.95 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.576 -0.738 . . . . 62.34 111.845 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -62.49 -45.43 93.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.136 -0.484 . . . . 71.23 112.205 -176.325 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -43.29 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.829 -0.349 . . . . 72.24 110.687 -179.15 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.61 -35.8 79.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.395 0.517 . . . . 60.12 112.395 176.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -62.29 -42.45 99.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.677 -0.49 . . . . 74.25 109.677 179.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.18 -30.51 71.56 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.859 -0.609 . . . . 60.11 110.723 176.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.26 -9.29 85.23 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.479 -0.782 . . . . 63.03 112.104 177.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.37 23.1 55.3 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.577 -0.344 . . . . 71.11 113.837 177.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -87.47 129.6 35.0 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.163 0.506 . . . . 75.14 111.539 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 16.6 ptp180 -78.49 172.67 13.32 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.006 0.922 . . . . 74.23 110.897 -177.049 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -53.64 -45.08 70.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.583 1.553 . . . . 73.12 111.035 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.607 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 31.2 m -63.46 -42.12 98.62 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.121 -0.945 . . . . 64.41 110.269 -179.405 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.462 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 41.8 mt-10 -65.41 -39.91 92.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.983 -0.553 . . . . 62.42 110.27 -177.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 94' ' ' ARG . 21.5 mm -61.35 -48.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.773 0.796 . . . . 74.41 109.575 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.423 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 51.9 mtt -74.58 -15.98 60.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 113.55 0.945 . . . . 74.45 113.55 -175.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.607 ' HG3' ' O ' ' A' ' 96' ' ' THR . 84.2 mtt180 -55.77 -65.26 0.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.935 0.398 . . . . 72.25 111.028 178.724 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.476 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.7 p-90 -68.68 -32.03 71.56 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.707 0.632 . . . . 72.34 112.707 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.7 mt -62.3 -40.84 97.6 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.516 0.932 . . . . 71.34 113.516 -179.443 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -92.91 -16.03 25.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.554 0.576 . . . . 73.41 112.554 -177.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.0 m -87.32 124.09 68.74 Favored Pre-proline 0 C--N 1.296 -1.761 0 N-CA-C 109.31 -0.626 . . . . 75.31 109.31 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.519 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.3 Cg_exo -54.13 129.64 35.46 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.823 2.349 . . . . 64.44 111.938 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 8.9 t70 -80.5 126.26 78.96 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 108.209 -1.034 . . . . 73.34 108.209 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 24.9 Cg_endo -60.52 -20.39 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.039 2.493 . . . . 74.24 114.401 -176.523 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.7 m -115.98 4.8 13.83 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.953 -0.467 . . . . 71.33 111.887 -176.267 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 39.9 tp -102.34 119.83 39.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.023 0.916 . . . . 51.34 111.812 -176.324 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.2 m -120.11 131.1 54.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.699 -1.593 . . . . 75.44 106.699 178.031 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 14.5 pt -115.68 155.69 16.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 120.265 -0.574 . . . . 61.33 112.301 -177.765 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.7 p -89.32 159.23 17.48 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.406 -1.27 . . . . 74.44 112.629 -172.721 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.434 ' HG2' ' N ' ' A' ' 114' ' ' ASP . 56.2 ttp180 -68.6 171.65 7.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.548 1.139 . . . . 71.51 109.007 179.252 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.434 ' N ' ' HG2' ' A' ' 113' ' ' ARG . 17.5 m-20 74.81 14.02 3.37 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 122.436 1.112 . . . . 73.02 110.746 176.639 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.75 -40.87 0.04 OUTLIER Glycine 0 C--N 1.291 -1.918 0 N-CA-C 107.173 -2.371 . . . . 61.01 107.173 177.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 p -113.76 -177.06 3.04 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 106.9 -1.519 . . . . 73.03 106.9 172.357 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -26.75 66.22 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.089 1.144 . . . . 74.14 114.089 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -175.34 -172.95 0.61 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.413 -2.81 . . . . 71.21 103.413 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' ILE . . . -70.83 123.94 23.15 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 119.588 1.086 . . . . 63.42 108.382 178.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.76 118.58 58.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.874 -0.417 . . . . 71.23 109.874 -176.012 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.5 m -88.93 140.08 29.8 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.81 -1.552 . . . . 74.13 106.81 176.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 44.9 m-80 63.29 55.92 1.78 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.847 0.832 . . . . 71.53 109.566 -175.489 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB2' HG12 ' A' ' 111' ' ' ILE . . . -84.8 144.83 28.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.405 -0.816 . . . . 54.42 110.548 179.183 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -76.94 139.44 65.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 107.174 -1.417 . . . . 63.44 107.174 174.281 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB2' HD23 ' A' ' 102' ' ' LEU . 95.8 Cg_exo -49.55 -30.46 21.61 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.376 2.717 . . . . 72.22 114.403 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.3 t -60.78 -43.25 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.443 0.639 . . . . 72.22 110.782 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.34 -31.02 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 73.24 110.783 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.71 76.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.887 -0.597 . . . . 31.33 111.45 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.81 -35.77 80.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.719 0.295 . . . . 61.24 111.01 -179.679 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -72.32 -24.66 61.34 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.86 0.838 . . . . 71.11 109.048 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -93.21 21.4 5.99 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.116 -0.947 . . . . 63.52 111.568 -179.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.73 27.29 16.04 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.148 1.379 . . . . 73.43 112.15 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -115.0 23.73 12.3 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.408 1.099 . . . . 65.11 109.236 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.37 -27.17 22.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.041 -1.89 . . . . 74.45 111.682 177.787 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -54.75 -46.89 74.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.016 0.526 . . . . 71.2 109.687 178.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 47.2 mm-40 -71.83 -29.2 64.15 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.239 -0.437 . . . . 73.24 111.464 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.18 -47.74 72.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.301 -0.409 . . . . 73.1 110.354 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.8 t -63.92 -42.66 96.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.303 -0.629 . . . . 73.53 109.303 177.86 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -58.67 -44.3 90.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.435 0.694 . . . . 73.15 109.942 178.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 2.4 tpp85 -64.92 -38.2 90.19 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.117 -0.947 . . . . 61.22 109.213 -178.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -66.4 -44.15 83.82 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.655 0.782 . . . . 73.45 110.564 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -60.48 -49.94 75.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.935 -0.575 . . . . 72.44 109.822 178.768 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 -17.54 63.47 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.86 -1.064 . . . . 61.12 111.957 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.7 tpp -82.27 -40.59 21.33 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.025 0.441 . . . . 72.43 110.035 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.53 -48.74 8.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 61.23 111.716 -177.017 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 118.085 -0.959 . . . . 71.3 109.615 -177.354 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 107.733 -1.21 . . . . 64.12 107.733 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.7 155.66 67.96 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.055 1.837 . . . . 64.3 111.998 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.87 113.46 0.57 Allowed Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 108.389 -1.884 . . . . 42.41 108.389 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.416 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.0 mtp180 -71.93 142.86 49.45 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 120.953 0.406 . . . . 60.04 111.952 -176.471 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.35 103.45 9.66 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 106.833 -1.543 . . . . 71.34 106.833 173.754 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 4' ' ' ARG . 17.1 Cg_exo -68.19 132.86 27.03 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.628 2.219 . . . . 73.23 112.151 -176.304 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.84 -116.51 1.23 Allowed Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.247 -1.141 . . . . 74.42 110.247 178.104 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 t -156.73 160.76 39.6 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.854 -1.906 . . . . 74.13 105.854 176.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -66.55 126.88 30.29 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.299 -1.0 . . . . 62.44 108.299 177.017 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.76 148.47 46.69 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.662 0.744 . . . . 73.1 112.624 -176.264 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.62 129.71 34.75 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.502 -1.295 . . . . 72.2 107.502 177.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -113.86 138.12 50.73 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 120.924 0.392 . . . . 72.2 109.955 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.97 128.11 68.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 115.069 -0.969 . . . . 74.11 109.348 178.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.43 97.91 1.45 Allowed Glycine 0 C--N 1.284 -2.306 0 CA-C-N 115.049 -0.978 . . . . 43.22 114.22 -174.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 p -102.51 154.23 19.31 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.425 -1.324 . . . . 75.31 107.425 172.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 mm -86.94 120.82 71.77 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 119.464 -0.894 . . . . 70.4 110.941 -175.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -76.71 165.39 28.82 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.542 2.161 . . . . 74.22 110.632 173.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . -85.88 137.09 33.0 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.508 -0.553 . . . . 52.01 109.508 177.362 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.23 -137.43 7.34 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.595 -0.812 . . . . 75.22 114.369 -177.604 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -97.51 123.39 41.36 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.418 0.687 . . . . 70.54 111.812 -173.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -70.45 126.07 28.6 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.078 -0.965 . . . . 51.22 109.633 -178.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.6 t -100.36 -19.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.813 -0.631 . . . . 73.11 111.584 -175.337 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -98.68 176.0 5.79 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.602 -0.839 . . . . 61.24 111.8 -177.867 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' ' HG2' ' A' ' 27' ' ' GLU . 20.7 m-20 -82.8 151.36 64.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.901 -0.407 . . . . 71.53 109.901 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 60' ' ' ARG . 32.5 Cg_exo -61.86 -22.11 73.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.596 2.197 . . . . 75.05 112.383 178.642 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -84.05 -8.28 59.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 54.15 110.72 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 24' ' ' ASP . 16.2 mm-40 -76.37 154.94 84.09 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.533 -0.543 . . . . 74.31 109.533 177.35 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 28.3 Cg_endo -58.82 111.2 0.82 Allowed 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 122.877 2.385 . . . . 63.44 112.814 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -133.32 167.49 20.3 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.801 -0.636 . . . . 74.41 111.497 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 19.8 m-85 -128.66 161.69 29.09 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 125.08 1.352 . . . . 75.2 108.774 178.33 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.8 m-20 -133.9 161.01 35.95 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 104.365 -2.457 . . . . 73.43 104.365 -174.75 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.4 mt -47.08 -56.66 11.35 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.84 1.052 . . . . 62.24 113.84 -174.276 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.56 -29.68 43.92 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 121.242 1.295 . . . . 75.51 112.195 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.462 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 9.7 tpt180 -70.84 -37.83 73.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.8 0.334 . . . . 75.24 110.534 -178.04 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' ASP . 47.3 t -69.11 -40.83 81.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.79 -0.819 . . . . 74.54 108.79 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.49 81.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.909 -1.042 . . . . 54.13 109.46 177.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.36 -45.54 72.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.026 -0.988 . . . . 61.31 110.103 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.21 -50.66 69.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.254 -0.884 . . . . 72.33 111.437 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HB2' HG22 ' A' ' 41' ' ' VAL . 97.5 mt -84.07 -16.93 41.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.829 -0.623 . . . . 64.21 112.653 -175.326 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.84 62.41 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.303 -0.951 . . . . 70.22 110.756 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 39' ' ' LEU . 18.6 m -126.99 160.83 57.26 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 107.754 -1.202 . . . . 73.31 107.754 -178.379 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.89 159.38 52.75 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 121.738 1.625 . . . . 54.31 111.563 176.577 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.04 -32.84 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.751 -0.833 . . . . 70.25 108.751 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 8.6 m -57.16 -41.35 79.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.644 -1.162 . . . . 53.04 110.73 177.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 57.3 tttm -70.11 -36.25 74.71 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.283 0.563 . . . . 75.22 109.521 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.83 -40.9 90.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.753 0.787 . . . . 71.21 109.096 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.49 80.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.952 -1.022 . . . . 64.52 110.652 177.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 44' ' ' SER . 80.3 mm-40 -61.24 -41.24 96.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.252 -0.647 . . . . 73.53 109.252 178.697 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.9 mm-40 -58.98 -47.23 85.91 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.477 -0.783 . . . . 74.12 109.142 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -63.92 -34.06 77.1 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.252 -0.886 . . . . 55.35 110.853 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -67.2 -34.47 77.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.0 111.963 176.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 19.6 mm-40 -88.21 -11.73 45.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 74.54 110.432 -176.634 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.95 28.52 49.94 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.662 -0.975 . . . . 73.51 110.662 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -88.98 -10.55 47.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.669 -0.863 . . . . 72.34 108.669 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.5 tp -158.3 158.09 33.71 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.339 -1.726 . . . . 70.43 106.339 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.87 155.48 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.723 -0.843 . . . . 74.51 108.723 177.074 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -126.54 157.43 38.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.938 -0.764 . . . . 55.21 108.938 -176.823 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG11 ' CE ' ' A' ' 99' ' ' MET . 35.1 m -131.75 164.44 34.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.671 -0.492 . . . . 64.53 109.671 178.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -122.34 122.35 38.85 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 110.008 -0.368 . . . . 73.33 110.008 -176.604 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 25' ' ' PRO . 5.8 ptp180 -117.06 113.73 22.74 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-N 115.926 -0.579 . . . . 72.22 109.477 177.602 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.68 -40.8 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.372 1.869 . . . . 61.32 112.012 178.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.18 -13.03 0.04 OUTLIER Glycine 0 C--N 1.29 -2.011 0 CA-C-N 114.949 -1.023 . . . . 55.14 111.969 -177.246 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.62 145.35 17.7 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.855 -0.688 . . . . 63.34 111.921 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.8 120.92 46.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.581 -1.266 . . . . 70.31 107.581 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.46 164.94 33.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.04 -0.982 . . . . 64.31 110.708 -174.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.32 132.31 24.25 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 107.404 -1.332 . . . . 74.43 107.404 -179.02 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.1 119.45 6.47 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 121.685 1.59 . . . . 74.34 111.029 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 42.8 tt0 -62.99 -25.01 68.18 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.547 0.739 . . . . 74.41 112.091 -177.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.0 m -65.27 -9.64 7.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.482 -0.781 . . . . 72.32 112.605 177.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.525 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.8 m-85 -81.55 -6.16 58.7 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.743 0.782 . . . . 75.24 110.159 175.333 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -110.86 154.35 24.14 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.163 -0.926 . . . . 70.22 108.991 179.18 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.1 p -76.83 175.96 8.98 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 123.659 0.784 . . . . 73.34 110.573 179.091 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -56.31 -31.86 64.08 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.466 0.707 . . . . 74.14 110.214 174.499 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 m -80.17 -2.58 45.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.626 -0.716 . . . . 71.34 111.74 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.53 32.46 59.61 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.103 -0.57 . . . . 61.22 111.977 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -115.7 157.78 23.76 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.343 -0.614 . . . . 75.51 109.343 177.47 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.418 HG13 HD23 ' A' ' 81' ' ' LEU . 43.9 t -66.23 130.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.226 -0.657 . . . . 74.43 109.226 175.708 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 80' ' ' SER . 42.0 t -63.16 132.34 28.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.432 -0.951 . . . . 55.22 108.432 178.303 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -57.63 -27.51 62.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.903 0.705 . . . . 72.51 112.903 -178.178 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.442 ' H ' HG12 ' A' ' 78' ' ' VAL . 9.5 m -89.19 -2.61 58.57 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.049 -0.523 . . . . 60.05 111.273 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.525 HD11 ' CD2' ' A' ' 70' ' ' PHE . 46.0 tp -61.67 -56.99 27.59 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 119.041 -0.504 . . . . 75.24 111.794 -177.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.24 -38.67 94.64 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.437 1.425 . . . . 74.2 110.795 177.174 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.87 97.11 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.757 -0.656 . . . . 70.12 112.796 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.42 -41.27 80.61 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 117.212 0.506 . . . . 74.41 109.719 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.74 -35.59 81.06 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 116.026 -0.534 . . . . 64.35 110.754 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.6 m -67.24 -41.28 85.89 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 112.075 0.398 . . . . 72.33 112.075 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.02 -40.27 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 120.143 -0.623 . . . . 71.12 110.473 178.58 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 3.3 mm? -67.61 -36.07 80.15 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.623 -0.673 . . . . 63.24 112.285 175.05 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -63.54 -33.03 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.426 -0.583 . . . . 74.41 109.426 177.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 87' ' ' ILE . 18.5 t70 -63.18 -29.9 71.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.226 1.01 . . . . 73.05 109.847 178.244 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.4 -9.32 53.54 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.837 -0.62 . . . . 53.1 111.969 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.02 27.69 36.66 Favored Glycine 0 C--N 1.317 -0.483 0 O-C-N 122.769 -0.253 . . . . 23.24 113.442 178.276 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 76.6 m-85 -83.84 128.16 34.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.125 0.488 . . . . 63.31 112.055 -179.114 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 8.0 ptp180 -79.97 171.05 15.61 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.217 -0.901 . . . . 71.44 110.306 -179.509 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -54.35 -43.0 70.91 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.884 1.274 . . . . 72.23 111.667 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -60.03 -41.98 93.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 123.813 0.845 . . . . 63.32 110.502 -179.35 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -65.1 -39.71 93.53 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.828 -0.624 . . . . 71.53 110.055 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.0 mm -60.24 -47.52 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.244 -1.021 . . . . 63.34 108.244 -176.67 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.409 ' CE ' HG11 ' A' ' 58' ' ' VAL . 73.5 mtm -70.92 -26.38 63.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.982 -1.008 . . . . 71.5 112.725 -176.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -58.12 -66.17 0.52 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.885 0.698 . . . . 74.34 112.885 -179.323 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -68.24 -32.44 72.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.506 0.558 . . . . 65.33 112.506 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.568 ' HG ' HG22 ' A' ' 126' ' ' VAL . 32.3 tp -67.53 -40.38 85.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.826 -0.624 . . . . 61.34 111.519 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 26.7 m-85 -84.99 -3.05 58.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.422 0.527 . . . . 64.41 112.422 -179.025 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.9 m -86.99 109.85 28.05 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.367 -0.605 . . . . 65.12 109.367 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 103' ' ' PHE . 21.7 Cg_exo -65.87 139.67 57.93 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.637 2.225 . . . . 72.14 110.852 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.0 t70 -99.27 119.34 60.72 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.253 -1.017 . . . . 75.33 108.253 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.05 -24.87 78.14 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.259 2.64 . . . . 73.05 113.647 -176.066 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.8 p -106.25 8.38 31.88 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.258 0.466 . . . . 73.54 112.258 -176.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 56.4 tp -102.84 129.38 49.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 110.047 -0.353 . . . . 51.51 110.047 -178.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.5 m -112.12 112.72 24.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.451 -0.574 . . . . 60.44 109.451 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.1 mm -116.84 146.93 20.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.902 -0.59 . . . . 72.22 109.461 -176.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 t -113.69 145.01 41.99 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.35 -1.722 . . . . 61.23 106.35 176.382 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -97.23 146.76 24.79 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.269 -0.972 . . . . 73.21 111.996 -173.397 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 24.3 t70 -68.05 127.13 31.73 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.902 -0.59 . . . . 61.55 109.991 177.584 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.43 14.19 54.1 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.282 -1.127 . . . . 31.12 110.282 -176.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.4 t -147.27 171.52 15.28 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.499 -0.926 . . . . 71.25 108.499 -178.54 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.93 -1.84 8.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.54 -0.754 . . . . 74.3 110.9 175.605 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -80.91 133.63 35.59 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.921 -0.582 . . . . 64.51 110.606 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.69 129.25 52.9 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.114 -0.948 . . . . 74.43 108.596 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.25 118.99 60.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 116.353 -0.385 . . . . 71.41 110.176 -177.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 64.2 m -80.3 132.21 35.78 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.112 -1.069 . . . . 73.1 108.112 173.274 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.8 t30 75.38 72.97 0.09 Allowed 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.944 1.297 . . . . 75.32 108.274 -171.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.65 168.07 10.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.814 -1.085 . . . . 23.23 110.167 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -93.06 127.06 48.77 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 115.646 -0.706 . . . . 73.12 110.166 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.467 ' HB2' HD12 ' A' ' 102' ' ' LEU . 65.4 Cg_exo -55.73 -21.3 31.66 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.384 2.723 . . . . 75.43 113.469 178.487 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.568 HG22 ' HG ' ' A' ' 102' ' ' LEU . 43.0 t -60.35 -44.78 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.85 0.833 . . . . 72.22 109.73 178.433 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.7 -29.38 64.51 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.685 -1.143 . . . . 55.45 110.131 -176.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.52 -43.29 99.17 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.45 -0.796 . . . . 62.25 111.778 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -69.38 -34.98 75.35 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.638 -0.664 . . . . 65.04 109.779 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -66.65 -25.44 66.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.289 -1.323 . . . . 74.31 108.971 177.603 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -96.72 9.01 42.94 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.944 -1.025 . . . . 62.12 111.363 179.091 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.9 m80 65.25 28.23 12.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.322 1.049 . . . . 73.43 112.638 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.44 25.04 11.61 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.056 1.342 . . . . 63.41 107.74 176.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.57 -25.66 7.22 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 126.976 2.11 . . . . 72.43 112.767 -177.494 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 mmm-85 -54.19 -43.0 70.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.917 0.487 . . . . 74.43 110.286 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.3 -27.77 64.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.07 0.462 . . . . 53.43 111.323 179.16 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 129' ' ' LEU . 99.1 t -73.32 -49.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.543 -0.753 . . . . 60.44 109.762 178.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.493 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 79.2 t -59.08 -41.15 82.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.421 -0.809 . . . . 61.24 109.143 177.446 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.37 -46.72 79.91 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.246 -0.888 . . . . 74.3 110.157 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 144' ' ' MET . 43.9 mtp180 -67.92 -37.05 81.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.815 0.34 . . . . 72.51 111.864 176.503 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.28 99.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.229 -0.441 . . . . 72.21 110.648 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -59.64 -39.0 82.92 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 122.818 0.447 . . . . 73.22 110.404 176.116 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.46 66.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.316 -0.402 . . . . 74.45 110.978 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.6 mmm -82.68 -41.28 19.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.066 0.46 . . . . 72.11 110.526 179.27 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.74 -51.35 11.59 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.209 0.448 . . . . 72.33 112.209 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.511 -0.757 . . . . 74.53 109.023 -176.973 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 109.791 -0.448 . . . . 52.33 109.791 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -78.92 125.84 6.84 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.432 2.088 . . . . 73.54 111.651 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.23 7.69 58.6 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.999 -0.62 . . . . 72.23 113.294 -178.465 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 133.34 41.74 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.14 -0.624 . . . . 73.33 109.42 176.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.63 98.36 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 124.636 1.174 . . . . 52.35 112.053 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -86.6 25.65 0.67 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.25 2.633 . . . . 72.42 111.797 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.37 70.29 1.34 Allowed Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.311 -1.515 . . . . 60.12 109.311 -175.062 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 p -140.38 154.5 46.73 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 109.632 -0.507 . . . . 65.24 109.632 -176.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -110.45 144.51 39.14 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.319 -0.622 . . . . 73.45 109.319 179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.9 mt -104.46 178.63 4.51 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.055 0.455 . . . . 63.41 110.505 -178.397 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.68 -172.99 2.18 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.415 -1.328 . . . . 54.22 107.415 174.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.535 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -140.71 114.4 8.87 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 114.427 1.269 . . . . 74.55 114.427 -177.883 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 p -142.46 106.29 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 114.794 -1.094 . . . . 72.31 108.78 177.418 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.432 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . 67.75 37.34 88.69 Favored Glycine 0 C--O 1.222 -0.651 0 N-CA-C 109.557 -1.417 . . . . 53.24 109.557 -175.099 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.535 ' OG ' ' HB2' ' A' ' 12' ' ' ARG . 36.7 p -91.83 101.37 13.96 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 113.041 0.756 . . . . 74.35 113.041 -171.615 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.83 121.77 85.71 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 106.415 -1.698 . . . . 75.13 106.415 170.398 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.77 165.14 32.15 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.367 2.045 . . . . 73.03 113.528 -176.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.26 123.89 31.14 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 106.15 -1.796 . . . . 73.13 106.15 174.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.17 -96.89 0.96 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 119.734 -1.222 . . . . 53.34 115.169 -175.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.1 119.94 37.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.17 0.509 . . . . 42.53 112.243 -169.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.45 109.77 2.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.996 -1.002 . . . . 54.25 110.421 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.19 -33.42 12.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.354 0.597 . . . . 75.04 110.158 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -78.44 173.78 11.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.012 -0.54 . . . . 75.55 110.135 176.075 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.88 129.98 42.31 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 107.985 -1.117 . . . . 72.41 107.985 176.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.63 -21.98 15.95 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.442 2.761 . . . . 64.03 115.061 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.46 -24.39 56.98 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.958 0.408 . . . . 71.44 110.484 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.71 157.19 87.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.724 -0.671 . . . . 73.43 111.844 -177.579 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -43.19 107.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 124.067 3.178 . . . . 74.45 113.601 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -135.05 164.04 28.53 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.107 -0.951 . . . . 73.23 110.426 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -127.37 160.7 30.59 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 125.623 1.569 . . . . 64.22 107.639 177.13 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.509 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.0 p30 -134.79 172.24 13.25 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 107.622 -1.251 . . . . 75.44 107.622 -178.554 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -46.04 -64.32 0.98 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 114.626 1.343 . . . . 75.14 114.626 -172.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.64 -27.59 69.11 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 121.569 1.513 . . . . 73.05 112.634 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.509 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 23.5 tpt180 -67.9 -48.29 66.44 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 110.179 -0.304 . . . . 65.52 110.179 178.598 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.84 -37.95 80.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.216 0.532 . . . . 74.24 109.915 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.47 -37.05 82.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.054 -0.976 . . . . 72.11 110.0 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.14 -44.96 71.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.2 -0.909 . . . . 71.51 109.885 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 97.2 mt -57.5 -41.98 81.82 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.354 -0.839 . . . . 74.4 111.962 -178.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.507 ' HB2' HG22 ' A' ' 41' ' ' VAL . 86.1 mt -94.29 -17.76 22.31 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.923 -0.58 . . . . 73.35 111.977 -177.178 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.86 61.55 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.37 -1.092 . . . . 63.52 110.37 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 39' ' ' LEU . 23.5 m -122.4 164.05 28.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.239 -0.652 . . . . 74.21 109.239 -178.593 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 39.6 Cg_endo -71.91 158.59 52.43 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.728 1.618 . . . . 73.43 111.341 173.434 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.28 -34.54 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.368 0.604 . . . . 73.31 110.012 178.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.7 t -62.25 -36.84 83.25 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.535 -0.757 . . . . 73.44 110.655 178.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 38.9 ttmt -69.77 -32.6 71.19 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 120.135 -0.626 . . . . 64.41 110.201 177.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.28 -42.25 92.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.653 -0.869 . . . . 52.53 108.653 175.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.08 82.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.888 -1.051 . . . . 23.31 110.438 176.655 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.2 mt-30 -66.82 -38.24 86.08 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.16 -0.473 . . . . 71.03 111.06 177.771 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.4 mm-40 -63.49 -41.29 98.56 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.998 -0.742 . . . . 71.12 108.998 177.313 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.55 -42.5 98.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.78 -1.1 . . . . 74.3 109.228 177.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 14' ' ' GLY . 70.0 ttt180 -60.33 -32.67 71.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.277 1.031 . . . . 63.2 111.87 178.457 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -85.41 -9.91 56.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.937 0.399 . . . . 73.13 111.068 -177.494 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.18 33.1 54.96 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.6 -1.4 . . . . 53.33 109.6 -174.236 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.02 -16.91 20.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.475 -0.935 . . . . 72.54 108.475 178.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 tp -151.2 157.22 42.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.647 -1.242 . . . . 72.1 107.647 -179.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.14 147.63 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.82 -0.808 . . . . 65.13 108.82 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.58 161.78 34.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 123.208 0.603 . . . . 64.13 109.471 -178.084 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.21 166.59 28.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 123.612 0.765 . . . . 64.22 109.705 176.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 45.9 mtp180 -112.57 126.84 55.78 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.941 -0.304 . . . . 72.41 110.791 -177.924 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -129.8 122.68 29.23 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.002 -0.74 . . . . 71.32 109.002 176.66 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 26.14 15.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.716 0.806 . . . . 70.5 111.616 179.188 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 -7.26 77.17 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.987 -0.551 . . . . 61.12 112.237 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.82 149.4 19.29 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 121.302 -0.475 . . . . 64.54 111.942 -178.204 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.35 120.94 47.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.282 -1.377 . . . . 75.41 107.282 179.466 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.33 150.83 34.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.528 0.68 . . . . 73.44 110.961 -178.395 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.79 129.18 25.54 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 106.524 -1.658 . . . . 73.51 106.524 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.13 128.13 24.28 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 121.877 1.718 . . . . 71.53 111.273 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -60.81 -26.77 67.54 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.198 0.523 . . . . 72.1 111.991 -178.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.11 -18.83 24.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.27 -0.877 . . . . 74.3 112.237 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.5 m-85 -73.74 -9.86 59.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.455 0.645 . . . . 74.51 110.657 177.779 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.04 161.94 17.08 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.522 -0.763 . . . . 61.3 109.455 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 p -83.55 176.1 9.28 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.405 -0.961 . . . . 63.24 108.405 175.249 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -61.79 -21.69 64.81 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.085 0.469 . . . . 70.35 110.961 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.9 t -80.79 -10.47 59.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.411 0.684 . . . . 73.33 110.298 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.2 24.78 53.82 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.641 -0.79 . . . . 74.43 111.773 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -112.89 152.15 29.63 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.142 -1.059 . . . . 63.12 108.142 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.478 HG13 HD23 ' A' ' 81' ' ' LEU . 41.9 t -62.87 135.31 27.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 120.595 0.236 . . . . 62.45 111.053 178.673 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 80' ' ' SER . 39.0 t -64.97 131.32 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.599 -0.889 . . . . 72.52 108.599 177.294 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -21.98 27.51 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.76 1.022 . . . . 61.13 113.76 -178.293 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.426 ' H ' HG12 ' A' ' 78' ' ' VAL . 17.9 t -94.58 -10.56 31.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.934 0.397 . . . . 62.21 110.456 -177.702 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 43.7 tp -60.18 -55.16 48.08 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 119.314 -0.374 . . . . 73.04 111.914 -177.684 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.34 -28.21 79.0 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.18 1.92 . . . . 63.14 111.716 178.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -45.66 60.44 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 121.103 -0.57 . . . . 73.05 111.935 -178.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.47 -40.31 81.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.42 0.628 . . . . 75.22 109.801 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 84.9 mt -62.18 -44.4 96.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.616 -0.72 . . . . 74.13 110.842 -178.668 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.4 m -70.39 -34.66 72.82 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 115.831 -0.622 . . . . 74.12 112.081 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -45.55 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 120.281 -0.567 . . . . 70.15 110.718 178.629 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 4.3 mm? -67.17 -35.81 80.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.1 0.407 . . . . 73.15 112.1 176.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.03 -37.36 79.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.273 -0.64 . . . . 65.2 109.273 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.38 -30.17 71.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 61.41 110.909 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.7 -2.31 84.63 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.965 -0.561 . . . . 74.44 112.182 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.19 39.44 11.35 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.479 -0.391 . . . . 73.31 112.591 178.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.451 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 68.9 m-85 -100.74 121.02 40.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.972 0.415 . . . . 71.23 111.694 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.623 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 38.1 ptt180 -71.0 171.61 10.53 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.112 0.965 . . . . 64.21 110.307 176.387 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -54.19 -44.97 72.02 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 125.24 1.416 . . . . 73.11 111.174 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.0 m -61.64 -41.4 97.45 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.94 -1.027 . . . . 75.31 110.625 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.623 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 41.6 mm-40 -67.31 -33.95 76.34 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.503 -0.317 . . . . 72.31 111.714 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.5 mm -61.16 -47.61 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.308 -0.997 . . . . 42.54 108.308 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.1 mtt -74.74 -18.77 60.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.775 -1.102 . . . . 74.34 112.074 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 77.8 ttt180 -55.97 -65.56 0.58 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.279 0.632 . . . . 70.42 110.371 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.51 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 53.3 p-90 -69.13 -32.06 71.16 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.528 -0.76 . . . . 72.53 112.623 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 125' ' ' PRO . 11.4 mt -64.99 -41.89 95.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.93 1.085 . . . . 63.11 113.93 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 124' ' ' ARG . 68.7 m-85 -89.5 -11.76 42.0 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 114.004 1.113 . . . . 71.21 114.004 -173.844 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.3 m -81.47 119.2 74.99 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.532 -0.544 . . . . 72.01 109.532 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.02 130.32 27.08 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.6 2.2 . . . . 61.34 111.21 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.5 t70 -99.86 125.24 41.0 Favored Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.45 -0.5 . . . . 74.13 110.358 -175.338 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.86 -23.57 77.16 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.764 2.31 . . . . 64.43 113.645 -177.735 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.2 m -107.85 12.19 27.45 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.965 0.412 . . . . 73.35 110.848 -175.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.47 ' HG ' HG12 ' A' ' 111' ' ' ILE . 35.8 tp -108.37 124.92 51.1 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.193 -0.603 . . . . 44.32 110.793 -179.565 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 m -116.47 110.7 18.96 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.825 -0.806 . . . . 71.12 108.825 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.47 HG12 ' HG ' ' A' ' 109' ' ' LEU . 48.9 mm -123.33 155.49 29.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 123.417 0.687 . . . . 74.42 110.013 -173.46 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.479 HG23 HE22 ' A' ' 133' ' ' GLN . 9.8 t -131.6 159.39 38.38 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.515 -1.291 . . . . 72.0 107.515 179.137 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -123.13 171.79 9.05 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 118.264 0.483 . . . . 71.02 110.686 -178.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.95 126.84 29.26 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.199 -1.038 . . . . 62.1 108.199 177.672 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.79 34.93 7.04 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 110.778 -0.929 . . . . 72.53 110.778 -178.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.9 m -147.74 138.51 23.29 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.982 -0.747 . . . . 73.35 108.982 177.378 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -97.3 -19.2 18.7 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.332 0.587 . . . . 74.12 110.509 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -117.78 173.41 6.76 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.546 -0.752 . . . . 60.54 111.123 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.74 157.46 18.1 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.316 0.579 . . . . 54.42 111.591 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.42 120.75 58.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.043 -1.095 . . . . 75.51 108.043 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -80.2 155.52 27.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.799 -0.815 . . . . 72.13 108.799 177.433 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 14.9 m-80 67.7 37.17 3.35 Favored 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.808 0.692 . . . . 74.2 110.741 176.848 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.98 163.59 13.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.95 -0.389 . . . . 52.31 109.95 -179.058 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 103' ' ' PHE . 12.2 ptp85 -95.14 150.3 37.47 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.338 -0.615 . . . . 73.3 109.338 178.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.624 ' HB2' HD23 ' A' ' 102' ' ' LEU . 77.2 Cg_exo -54.89 -25.43 43.61 Favored 'Trans proline' 0 CA--C 1.555 1.533 0 C-N-CA 123.294 2.662 . . . . 62.54 114.028 178.254 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 102' ' ' LEU . 40.9 t -60.37 -43.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 120.858 0.361 . . . . 53.1 111.576 178.199 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.91 -32.79 74.66 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.611 -0.722 . . . . 72.11 109.885 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.53 75.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.4 -0.818 . . . . 72.3 111.961 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.478 ' HB3' HG21 ' A' ' 137' ' ' VAL . 4.1 pp -68.49 -37.39 80.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.525 -0.47 . . . . 70.4 111.277 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.82 -19.08 60.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.692 0.758 . . . . 74.44 109.493 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.09 7.79 45.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.338 -0.847 . . . . 60.33 111.157 177.291 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 64.3 27.88 13.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.445 1.117 . . . . 55.14 111.77 178.609 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.479 HE22 HG23 ' A' ' 112' ' ' THR . 76.9 mt-30 -110.46 25.12 12.12 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.53 1.532 . . . . 75.12 108.425 179.567 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.8 3.88 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 128.204 2.601 . . . . 63.12 113.571 -176.207 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -53.97 -38.75 65.34 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 109.62 -0.511 . . . . 73.24 109.62 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -68.92 -27.64 65.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.453 0.644 . . . . 71.52 110.944 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 129' ' ' LEU . 61.9 t -73.46 -47.43 45.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.189 -0.914 . . . . 62.52 109.127 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.49 -41.8 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 64.22 109.188 176.708 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -56.93 -46.31 82.12 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.836 -1.074 . . . . 62.33 109.592 176.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -69.01 -36.44 77.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.147 -0.478 . . . . 72.1 110.734 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -58.72 -45.63 89.17 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.438 0.695 . . . . 54.13 110.516 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.87 -38.42 88.74 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.814 -0.63 . . . . 75.31 110.759 178.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.88 73.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.146 0.498 . . . . 73.1 110.594 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tpt -74.69 -47.11 33.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.699 -0.682 . . . . 73.45 110.907 -179.495 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.77 -32.9 46.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.992 0.738 . . . . 64.01 112.992 -176.491 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 108.892 -0.781 . . . . 61.24 108.892 -179.177 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 15.7 tpt . . . . . 0 CA--C 1.553 1.064 0 N-CA-C 113.726 1.01 . . . . 72.32 113.726 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 57.3 Cg_endo -77.41 150.87 28.9 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 121.686 1.591 . . . . 73.54 112.579 -178.283 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.82 59.75 4.92 Favored Glycine 0 C--N 1.314 -0.646 0 N-CA-C 110.689 -0.964 . . . . 74.1 110.689 178.088 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.6 ttm180 -73.06 131.93 42.72 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 123.06 0.544 . . . . 72.23 110.188 -177.064 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 159.7 127.8 0.0 OUTLIER Pre-proline 0 C--O 1.24 0.6 0 C-N-CA 126.851 2.06 . . . . 63.44 106.992 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.29 79.93 3.03 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.706 1.604 . . . . 53.33 109.129 174.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.8 106.04 2.83 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 108.48 -1.848 . . . . 44.33 108.48 -172.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 p -69.69 -24.92 63.66 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 114.285 1.217 . . . . 71.32 114.285 -173.479 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 m -114.16 144.7 42.75 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.824 -0.436 . . . . 64.21 109.824 -178.583 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.18 152.48 39.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.993 -0.373 . . . . 72.04 109.993 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.14 139.59 51.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.23 -0.656 . . . . 64.45 109.23 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -85.78 92.14 8.52 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.275 0.56 . . . . 65.4 110.19 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.46 117.56 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 CA-C-O 122.037 0.922 . . . . 63.23 109.861 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.24 -47.61 2.64 Favored Glycine 0 C--N 1.286 -2.223 0 CA-C-N 114.383 -1.28 . . . . 74.31 111.144 -179.171 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.6 t -71.62 99.23 2.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.477 0.656 . . . . 63.33 109.814 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 mm -100.94 122.93 47.1 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.306 -0.998 . . . . 64.15 108.306 179.181 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -73.06 155.23 52.63 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.459 1.439 . . . . 64.22 110.239 174.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.11 124.88 30.91 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.406 0.282 . . . . 55.54 110.702 -176.278 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.3 -105.6 2.84 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 121.365 -0.445 . . . . 73.24 113.52 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -113.64 134.52 54.68 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.692 0.397 . . . . 65.32 110.489 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.18 127.6 33.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.668 0.747 . . . . 71.21 110.907 -179.138 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.07 -21.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.465 -0.789 . . . . 63.52 110.216 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -78.82 152.08 31.54 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 113.311 0.856 . . . . 71.43 113.311 -178.218 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.21 151.45 94.54 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 107.637 -1.245 . . . . 60.42 107.637 178.149 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.21 -25.0 76.54 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.769 1.646 . . . . 74.34 110.559 174.5 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -72.97 -13.81 61.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.145 -0.934 . . . . 73.34 111.209 177.276 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -83.61 131.41 52.43 Favored Pre-proline 0 N--CA 1.435 -1.175 0 N-CA-C 107.74 -1.207 . . . . 74.2 107.74 175.114 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.2 146.34 63.31 Favored 'Trans proline' 0 C--O 1.256 1.4 0 C-N-CA 122.871 2.381 . . . . 72.5 113.204 -177.019 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -128.79 165.75 20.35 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.795 0.807 . . . . 74.35 112.165 -178.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.558 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 12.3 m-85 -130.34 161.45 31.26 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 125.927 1.691 . . . . 75.3 107.779 175.754 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 9.4 t70 -134.23 169.36 17.3 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 103.819 -2.659 . . . . 61.23 103.819 178.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HB3' HG13 ' A' ' 43' ' ' VAL . 6.2 mp -54.7 -51.99 74.08 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 114.262 1.208 . . . . 73.24 114.262 -171.363 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 15.8 Cg_endo -58.48 -36.12 97.84 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.157 1.904 . . . . 64.45 112.445 176.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 21.4 tpt180 -69.82 -39.34 76.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 122.912 0.485 . . . . 75.04 110.21 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.44 -38.84 77.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.318 0.58 . . . . 72.33 109.59 176.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -59.62 -36.14 75.75 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.201 -0.909 . . . . 75.54 109.881 177.1 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 37.8 tt0 -65.2 -43.77 90.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.575 -1.193 . . . . 75.05 109.963 178.165 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 83.9 mt -67.02 -50.24 62.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.799 -0.637 . . . . 64.34 111.285 -178.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.433 ' HB2' HG22 ' A' ' 41' ' ' VAL . 81.7 mt -81.06 -17.82 48.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.704 -0.68 . . . . 54.41 112.12 -173.321 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.71 63.08 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.682 -0.77 . . . . 42.55 111.619 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 39' ' ' LEU . 34.2 m -120.89 159.25 49.75 Favored Pre-proline 0 C--N 1.312 -1.052 0 N-CA-C 109.926 -0.398 . . . . 71.14 109.926 -177.636 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -61.32 154.12 60.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 122.269 1.979 . . . . 55.31 113.139 173.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 32' ' ' LEU . 90.3 t -57.88 -35.13 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.478 -1.237 . . . . 72.25 110.993 -179.367 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -64.55 -34.37 78.09 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 116.364 -0.38 . . . . 63.32 110.789 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 68.1 mttm -68.98 -35.78 77.12 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.905 -0.497 . . . . 75.54 110.225 176.72 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.21 -43.02 98.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.76 -0.655 . . . . 63.32 109.696 175.705 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.74 79.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.86 -0.609 . . . . 71.22 110.349 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 46.3 mt-30 -67.51 -35.2 78.65 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 115.954 -0.566 . . . . 63.44 111.848 177.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.9 mm-40 -58.26 -48.75 79.45 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.583 -0.895 . . . . 74.31 108.583 177.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -62.3 -42.69 99.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.844 -1.071 . . . . 64.12 110.27 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -70.13 -21.32 63.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.25 1.204 . . . . 71.44 114.25 -179.232 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 18.2 mm-40 -96.54 -4.85 40.6 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 119.749 -0.78 . . . . 74.53 110.758 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.56 36.49 37.99 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.105 -0.798 . . . . 41.02 111.105 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -106.68 -5.18 18.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.219 -1.03 . . . . 70.2 108.219 178.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -158.11 153.65 26.22 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.697 -1.594 . . . . 73.23 106.697 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.17 146.98 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.996 -0.742 . . . . 74.2 108.996 -176.43 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.56 153.28 51.03 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.297 -0.631 . . . . 72.33 109.297 -179.024 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.19 168.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 123.777 0.831 . . . . 61.42 109.726 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 59' ' ' ARG . 33.7 ttt180 -108.43 118.01 35.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.439 -0.949 . . . . 72.43 108.439 -176.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -123.9 123.47 40.49 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.089 -1.414 . . . . 74.41 109.473 -176.545 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.0 16.07 7.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.541 1.136 . . . . 52.44 112.034 177.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.46 -12.87 54.56 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.73 -0.668 . . . . 44.23 112.025 -178.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.15 156.9 17.96 Favored Glycine 0 CA--C 1.497 -1.093 0 C-N-CA 120.498 -0.858 . . . . 72.14 111.337 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.47 120.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.893 -1.151 . . . . 74.35 107.893 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.47 157.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.675 0.75 . . . . 62.35 111.451 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.9 mt -112.29 126.56 28.2 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 106.564 -1.643 . . . . 71.32 106.564 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.35 128.78 28.62 Favored 'Trans proline' 0 C--N 1.329 -0.471 0 C-N-CA 122.341 2.028 . . . . 63.55 112.697 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 46.1 tt0 -66.31 -25.22 66.74 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 121.499 0.666 . . . . 75.04 110.937 179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.0 -8.1 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 115.181 -0.918 . . . . 72.11 112.44 178.028 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.6 -7.03 59.66 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.085 0.945 . . . . 71.43 109.424 173.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.35 164.12 13.61 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.645 -1.161 . . . . 74.22 108.501 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 p -93.59 173.92 7.45 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.841 -0.8 . . . . 75.2 108.841 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -66.33 -16.86 64.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.881 0.848 . . . . 71.42 109.571 178.405 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -79.72 -7.3 58.53 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.243 -0.889 . . . . 72.11 111.073 178.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.39 62.06 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.949 -0.644 . . . . 54.15 112.465 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -126.09 152.14 46.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.786 -0.82 . . . . 64.31 108.786 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.84 143.94 14.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 123.557 0.535 . . . . 73.54 109.683 -177.371 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.6 t -62.52 121.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.253 -1.018 . . . . 65.32 108.253 176.333 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -57.89 -39.69 78.51 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.471 0.708 . . . . 65.54 112.885 -173.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.9 t -93.07 3.18 56.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.206 0.447 . . . . 73.05 112.206 -176.395 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 8.4 tt -66.22 -45.07 60.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.026 1.121 . . . . 72.32 114.026 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.86 -21.62 34.03 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.123 2.549 . . . . 74.03 113.276 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.83 -41.3 99.13 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.171 -0.772 . . . . 51.54 111.171 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.15 -39.8 82.54 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.24 -0.652 . . . . 71.21 109.24 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.28 -43.85 98.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.367 -0.833 . . . . 62.24 109.903 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.3 m -57.76 -47.32 82.85 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.536 -0.756 . . . . 71.42 111.632 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -46.06 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.588 -0.278 . . . . 45.35 111.724 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.563 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -67.21 -37.99 84.55 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.571 0.952 . . . . 65.23 113.571 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -59.99 -44.99 94.16 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.004 0.43 . . . . 72.42 110.42 178.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.05 -27.34 63.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.064 -0.516 . . . . 73.12 110.987 178.43 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.96 -9.55 86.58 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.084 -0.507 . . . . 73.23 112.632 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.13 6.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.345 -0.455 . . . . 70.44 113.658 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -113.57 139.32 49.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.957 0.379 . . . . 74.41 111.331 177.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.497 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 14.3 ptp180 -89.93 172.07 9.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.604 -0.726 . . . . 75.24 110.716 -176.588 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.17 -45.4 72.1 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.429 1.491 . . . . 74.25 112.307 -176.408 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.0 m -64.63 -41.18 96.35 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.733 -0.667 . . . . 63.35 109.824 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.497 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 47.8 mt-10 -66.08 -38.75 89.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.602 -0.726 . . . . 64.13 111.058 -179.443 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 102' ' ' LEU . 30.0 mm -60.69 -47.24 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.689 -0.856 . . . . 74.13 108.689 -179.209 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.2 mtt -74.41 -18.42 60.66 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.836 -1.075 . . . . 63.22 113.095 -177.364 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -57.37 -64.33 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.24 0.543 . . . . 74.34 110.304 178.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.559 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 60.3 p-90 -69.62 -32.33 70.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 74.43 112.617 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.542 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.2 mt -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.572 0.953 . . . . 75.23 113.572 179.438 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.1 m-85 -98.61 10.76 40.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.303 0.482 . . . . 65.34 112.303 -177.729 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 101' ' ' TRP . 11.8 t -87.79 122.01 70.52 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 119.144 -1.022 . . . . 71.41 110.154 177.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.6 136.83 37.34 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.578 2.185 . . . . 71.51 110.956 177.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 14.7 t70 -106.93 112.7 63.21 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.79 -0.764 . . . . 73.15 109.472 178.101 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.09 -16.77 48.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.277 2.651 . . . . 61.53 114.596 -176.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -109.51 3.23 21.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.035 -0.416 . . . . 54.3 111.388 -177.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -102.62 125.27 49.29 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.43 0.633 . . . . 71.12 110.88 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.3 m -116.43 120.7 39.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.15 107.571 179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 123' ' ' ALA . 32.4 mt -126.37 150.6 32.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 64.44 109.009 -173.281 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 23.6 p -89.48 126.4 35.56 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.886 -1.524 . . . . 71.02 106.886 175.049 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -88.48 149.49 23.62 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.576 -0.85 . . . . 74.12 111.431 -171.281 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 29.5 t70 -77.04 153.69 34.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.369 -0.604 . . . . 72.35 109.369 179.081 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.57 -54.02 3.08 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 108.983 -1.647 . . . . 63.2 108.983 -175.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.9 p -95.0 -169.24 1.96 Allowed 'General case' 0 N--CA 1.39 -3.462 0 N-CA-C 108.078 -1.082 . . . . 75.01 108.078 175.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.441 ' N ' ' HD3' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -135.24 9.05 3.46 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.626 -0.879 . . . . 61.34 108.626 177.573 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -92.37 147.69 22.71 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.365 -1.289 . . . . 63.42 110.579 -173.138 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' THR . . . -87.99 128.57 35.39 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.553 -0.748 . . . . 73.24 109.789 177.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.24 127.59 72.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.946 -1.131 . . . . 75.13 107.946 -179.044 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.8 p -86.92 141.14 28.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.202 -0.666 . . . . 63.13 109.202 177.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.2 t30 68.68 70.55 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.188 0.994 . . . . 55.0 110.315 -177.464 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.578 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -108.22 174.67 5.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.238 -0.892 . . . . 61.33 109.181 175.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.14 150.51 38.42 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 109.035 -0.728 . . . . 74.53 109.035 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.473 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.9 Cg_exo -52.7 -34.01 62.2 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.025 2.483 . . . . 64.1 112.544 173.296 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.3 t -64.08 -43.61 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 119.771 -0.772 . . . . 63.31 109.6 175.654 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.02 -30.8 70.13 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.886 -0.783 . . . . 71.01 108.886 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -66.02 -45.18 82.43 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.247 -0.888 . . . . 60.41 112.054 177.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.15 -33.48 73.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.161 0.505 . . . . 73.25 110.269 -179.167 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -66.33 -28.76 68.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.404 -0.961 . . . . 70.32 108.404 176.394 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -96.44 14.37 24.73 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.708 -1.133 . . . . 70.2 112.261 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 62.05 27.41 16.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.901 1.28 . . . . 63.52 111.885 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -110.64 24.69 12.64 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 123.772 1.749 . . . . 72.44 108.241 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.57 -26.31 12.97 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 111.389 -2.641 . . . . 70.14 113.495 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.52 -41.4 73.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.729 0.411 . . . . 72.3 110.875 -174.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.64 -35.6 77.5 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.454 0.645 . . . . 74.3 110.249 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.2 t -66.07 -42.42 91.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.053 -0.976 . . . . 74.52 109.754 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 98.6 t -61.49 -46.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 65.21 109.471 177.608 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -63.86 -38.96 93.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.117 0.484 . . . . 72.02 111.001 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -36.36 81.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.328 -0.99 . . . . 71.4 108.328 178.473 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.563 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -67.69 -46.37 72.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.559 0.744 . . . . 75.23 110.437 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 87.2 mt-30 -57.62 -49.5 76.24 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.046 -0.525 . . . . 73.34 109.851 178.359 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.71 -27.26 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.417 -0.811 . . . . 63.33 111.422 -178.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.559 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 14.9 tpt -77.45 -29.3 52.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.119 0.485 . . . . 72.24 110.171 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.21 -48.12 7.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.489 0.551 . . . . 54.24 112.489 -177.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 119.164 -0.446 . . . . 75.21 109.944 -176.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.275 0 N-CA-C 106.974 -1.491 . . . . 73.120000000000005 106.974 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.11 -109.77 0.83 Allowed Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.675 -1.25 . . . . 24.109999999999999 114.395 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.56 121.35 29.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 70.049999999999997 112.539 -168.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.03 120.22 9.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.489 -1.232 . . . . 71.209999999999994 110.993 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.84 -40.22 13.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.663 -0.699 . . . . 73.319999999999993 111.049 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.66 157.21 37.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.957 -0.697 . . . . 73.319999999999993 110.965 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.14 141.55 70.92 Favored Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 73.439999999999998 108.346 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.95 -21.73 16.47 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.111 2.541 . . . . 65.239999999999995 115.011 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.79 -13.41 59.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.984 0.421 . . . . 73.340000000000003 110.823 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.3 137.18 71.78 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 109.296 -0.631 . . . . 71.019999999999996 109.296 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.36 131.83 37.65 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 123.938 3.092 . . . . 62.210000000000001 113.841 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -137.87 158.83 43.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.595 -0.73 . . . . 72.140000000000001 111.832 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 6.2 m-85 -109.5 160.15 16.47 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.339 1.855 . . . . 73.430000000000007 107.596 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -135.18 162.48 32.41 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.728 -1.953 . . . . 72.450000000000003 105.728 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.26 -54.34 39.43 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 113.239 0.829 . . . . 75.409999999999997 113.239 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.02 -36.7 96.15 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 121.807 1.671 . . . . 75.030000000000001 111.864 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 2.9 mpt_? -70.41 -37.61 74.47 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.373 -0.376 . . . . 71.120000000000005 111.856 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.35 -37.59 71.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 120.17 -0.612 . . . . 72.439999999999998 109.845 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.13 -41.7 84.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.662 -0.866 . . . . 63.420000000000002 108.662 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 37.0 mt-10 -63.12 -45.69 90.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.884 -1.053 . . . . 65.299999999999997 111.99 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.482 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 60.2 tp -61.49 -50.19 73.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.617 0.767 . . . . 54.420000000000002 112.153 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 41' ' ' VAL . 91.5 mt -89.09 -12.65 40.57 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.094 0.405 . . . . 65.030000000000001 112.094 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.17 27.75 65.57 Favored Glycine 0 C--N 1.316 -0.549 0 N-CA-C 111.212 -0.755 . . . . 75.439999999999998 111.212 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 39' ' ' LEU . 32.7 m -118.63 160.78 38.78 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.531 -0.544 . . . . 65.439999999999998 109.531 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 37.5 Cg_endo -68.7 160.29 50.14 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.138 1.892 . . . . 55.25 111.723 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.51 -34.5 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.563 0.745 . . . . 65.340000000000003 110.492 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -61.27 -39.0 88.77 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.292 -0.867 . . . . 62.43 111.695 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD3' ' HD2' ' A' ' 42' ' ' PRO . 26.3 mtpp -69.82 -33.92 72.98 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.815 -0.354 . . . . 72.030000000000001 111.258 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -44.43 98.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.852 -0.795 . . . . 74.140000000000001 108.852 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -63.01 -36.41 83.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.239 -0.892 . . . . 64.439999999999998 110.433 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 15.4 mm100 -62.01 -40.77 96.8 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-N 117.002 -0.09 . . . . 64.230000000000004 111.064 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -58.73 -44.49 90.47 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.464 0.649 . . . . 53.409999999999997 109.815 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.5 -38.94 91.86 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.598 -1.183 . . . . 64.109999999999999 110.394 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 47' ' ' ALA . 20.0 mmm180 -71.32 -26.56 62.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.374 -0.375 . . . . 70.129999999999995 111.673 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 74.7 mm-40 -89.72 -2.64 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.596 -0.275 . . . . 74.120000000000005 111.119 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 35.86 54.14 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.776 -0.726 . . . . 63.240000000000002 111.907 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -99.81 -17.68 17.55 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 120.63 0.252 . . . . 74.200000000000003 111.01 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.9 tp -152.71 160.98 43.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.217 -1.031 . . . . 63.43 108.217 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.65 147.32 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.553 -0.906 . . . . 62.119999999999997 108.553 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.48 150.93 51.72 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.228 -0.656 . . . . 61.020000000000003 109.228 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -129.85 166.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.03 0.532 . . . . 73.219999999999999 110.034 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 37.2 ttt180 -114.61 123.11 48.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.879 -0.415 . . . . 74.299999999999997 109.879 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 62' ' ' GLY . 8.8 ptm180 -116.64 114.07 23.56 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.723 -0.844 . . . . 72.099999999999994 108.723 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.03 -16.81 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.138 1.375 . . . . 73.510000000000005 113.369 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . 147.0 -18.93 1.58 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.713 -0.955 . . . . 41.539999999999999 110.713 -177.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -91.1 146.28 18.25 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 112.346 -0.302 . . . . 73.129999999999995 112.346 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.56 121.69 48.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.869 -0.789 . . . . 60.43 108.869 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.11 157.88 43.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.471 0.653 . . . . 51.0 111.659 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.52 122.22 23.7 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 107.144 -1.428 . . . . 70.329999999999998 107.144 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.54 132.36 50.04 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.152 1.901 . . . . 53.030000000000001 113.08 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -48.8 -38.52 22.27 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.818 0.847 . . . . 75.340000000000003 111.375 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 27.0 m -65.66 -11.1 11.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 114.592 1.33 . . . . 51.520000000000003 114.592 -174.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.597 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.6 m-85 -77.78 -12.87 60.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.699 0.761 . . . . 62.219999999999999 110.292 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.79 145.12 38.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 108.141 -1.059 . . . . 74.310000000000002 108.141 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.0 p -75.42 175.58 8.32 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.076 0.55 . . . . 73.329999999999998 110.421 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -65.85 -17.21 64.49 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 122.19 0.995 . . . . 71.129999999999995 109.863 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -90.15 -0.55 57.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.281 -0.872 . . . . 72.120000000000005 111.524 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 26.55 67.54 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.499 -0.382 . . . . 43.109999999999999 112.712 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -113.82 157.72 21.94 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.989 -1.115 . . . . 75.219999999999999 107.989 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.6 t -73.44 140.9 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.075 -1.083 . . . . 74.230000000000004 108.075 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 46.7 t -64.08 128.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.52 -0.919 . . . . 72.349999999999994 108.52 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -58.16 -43.9 87.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.342 0.867 . . . . 74.430000000000007 113.342 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 t -89.74 1.71 55.76 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 121.01 -0.276 . . . . 61.210000000000001 111.502 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.651 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 7.9 tt -65.99 -50.24 53.29 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 119.513 -0.279 . . . . 73.030000000000001 111.511 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.64 -24.58 75.92 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.464 1.443 . . . . 60.329999999999998 110.512 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.95 88.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.353 -0.84 . . . . 72.230000000000004 111.574 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -66.46 -39.78 89.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 108.021 -1.103 . . . . 62.43 108.021 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.52 -35.78 78.68 Favored 'General case' 0 C--O 1.202 -1.422 0 CA-C-N 115.44 -0.8 . . . . 72.310000000000002 110.652 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.4 m -59.46 -50.98 71.83 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.422 0.451 . . . . 72.120000000000005 111.263 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.97 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 116.268 -0.424 . . . . 72.439999999999998 111.36 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.3 mm? -66.72 -35.23 79.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.15 0.426 . . . . 64.049999999999997 112.15 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -64.37 -40.96 96.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.404 -0.591 . . . . 74.340000000000003 109.404 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.11 -30.14 68.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 74.329999999999998 110.067 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.88 -6.31 89.08 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.538 -0.755 . . . . 64.319999999999993 112.336 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.22 57.19 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 114.003 0.361 . . . . 70.120000000000005 114.003 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -90.87 129.11 36.95 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 122.168 -0.607 . . . . 75.439999999999998 112.099 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 8.0 ptp180 -78.02 171.8 14.46 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.159 -0.928 . . . . 75.209999999999994 110.802 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.26 -45.28 72.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.279 1.432 . . . . 61.119999999999997 111.848 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.9 m -61.8 -40.9 96.86 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.281 -0.872 . . . . 70.219999999999999 109.88 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 8.1 mm-40 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.766 -0.652 . . . . 74.510000000000005 110.713 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.96 -48.63 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.367 0.603 . . . . 71.010000000000005 109.578 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -74.86 -21.33 59.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.346 -0.843 . . . . 53.229999999999997 111.941 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -55.59 -64.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.121 0.568 . . . . 61.109999999999999 110.954 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -68.89 -32.52 72.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.03 0.443 . . . . 71.329999999999998 112.102 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -67.39 -37.83 83.76 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.584 -0.734 . . . . 52.549999999999997 112.429 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -93.39 -1.4 55.88 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 112.779 0.659 . . . . 74.239999999999995 112.779 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -87.29 116.96 67.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.575 -0.528 . . . . 72.340000000000003 109.575 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.64 128.72 22.96 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.81 1.673 . . . . 72.400000000000006 109.383 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 33.4 t70 -100.43 125.81 38.03 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 120.271 -0.572 . . . . 74.319999999999993 111.04 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.56 -30.43 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.111 2.541 . . . . 64.129999999999995 113.164 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 p -92.0 5.49 49.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.289 0.566 . . . . 71.439999999999998 111.48 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.3 tp -102.79 126.07 49.78 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.205 -0.665 . . . . 73.540000000000006 109.205 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.3 m -131.72 110.53 10.95 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.542 -1.281 . . . . 74.209999999999994 107.542 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 C--N 1.286 -2.186 0 CA-C-N 115.292 -0.867 . . . . 63.350000000000001 109.922 -174.057 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.9 t . . . . . 0 N--CA 1.431 -1.385 0 N-CA-C 108.918 -0.771 . . . . 63.340000000000003 108.918 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.6 t -86.51 139.04 31.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.441 -1.689 . . . . 73.140000000000001 106.441 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.6 t30 67.1 68.63 0.4 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.073 0.94 . . . . 74.0 109.146 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.77 162.81 21.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.648 -1.16 . . . . 53.310000000000002 109.581 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -75.4 130.83 78.9 Favored Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.592 0.557 . . . . 72.099999999999994 110.161 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 50.5 Cg_exo -55.49 -17.24 16.18 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 123.836 3.024 . . . . 74.209999999999994 113.351 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 65.8 t -59.73 -43.03 90.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 109.891 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -29.88 69.35 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 116.112 -0.495 . . . . 74.430000000000007 111.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.18 -52.64 57.95 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.943 -0.571 . . . . 72.209999999999994 109.541 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -68.02 -34.11 75.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 111.735 0.272 . . . . 74.030000000000001 111.735 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.61 -24.06 63.61 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.688 0.756 . . . . 70.439999999999998 109.196 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.423 ' HB3' HE21 ' A' ' 133' ' ' GLN . . . -104.45 16.47 26.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.965 -1.016 . . . . 71.030000000000001 110.833 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.5 m80 64.05 28.33 14.27 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.35 1.06 . . . . 71.420000000000002 113.344 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 131' ' ' ALA . 39.8 mt-30 -99.73 23.11 10.04 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.796 -1.928 . . . . 70.049999999999997 105.796 174.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.31 -27.84 25.21 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 127.08 2.152 . . . . 62.310000000000002 114.658 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -56.49 -36.9 69.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.218 0.451 . . . . 75.140000000000001 112.218 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -67.76 -33.09 74.16 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.721 0.772 . . . . 72.430000000000007 109.664 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.1 t -72.01 -40.55 67.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.387 -0.824 . . . . 63.119999999999997 108.831 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.85 -44.22 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.086 -0.709 . . . . 73.329999999999998 109.086 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -57.87 -47.13 83.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.65 -0.705 . . . . 72.150000000000006 110.495 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -65.82 -34.29 77.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.726 -0.67 . . . . 73.030000000000001 109.787 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -66.57 -46.29 76.5 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.474 -0.784 . . . . 73.140000000000001 109.61 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.78 -48.19 82.67 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.292 -0.867 . . . . 72.329999999999998 110.483 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.12 -29.8 71.08 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.286 0.366 . . . . 43.109999999999999 111.59 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.23 -34.07 70.45 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.286 -0.416 . . . . 65.209999999999994 110.925 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.9 -58.75 1.93 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.938 1.088 . . . . 72.409999999999997 113.938 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.314 -0.941 0 CA-C-O 119.072 -0.49 . . . . 65.049999999999997 110.743 -174.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.366 -0.605 . . . . 72.140000000000001 109.366 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.4 -120.93 4.62 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 115.998 -0.546 . . . . 61.299999999999997 112.847 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -119.91 142.2 48.92 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.8 0.333 . . . . 73.230000000000004 110.495 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.92 137.65 51.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.991 -0.549 . . . . 74.430000000000007 111.305 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.608 HG11 ' HA ' ' A' ' 100' ' ' ARG . 21.8 t -115.45 -13.69 11.1 Favored 'Isoleucine or valine' 0 C--O 1.248 0.978 0 CA-C-O 122.195 0.997 . . . . 61.229999999999997 109.866 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -78.36 175.97 9.77 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.804 -1.184 . . . . 64.040000000000006 107.804 172.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 12.4 t70 -86.01 129.52 53.81 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 117.309 -1.756 . . . . 63.509999999999998 106.355 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.64 -21.19 7.51 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.215 2.61 . . . . 73.530000000000001 113.972 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.34 -21.19 46.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.032 0.382 . . . . 72.310000000000002 112.032 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HG3' ' HB3' ' A' ' 24' ' ' ASP . 38.9 mt-10 -66.1 153.61 91.6 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 122.244 -0.285 . . . . 74.540000000000006 110.799 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.52 113.67 1.33 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.353 2.702 . . . . 61.020000000000003 113.666 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.7 p -126.4 -179.97 5.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 115.504 -0.771 . . . . 25.210000000000001 110.236 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' CE2' HD22 ' A' ' 38' ' ' LEU . 40.8 m-85 -130.33 161.03 32.2 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.648 -1.612 . . . . 70.049999999999997 106.648 170.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.7 m-20 -133.01 162.88 30.51 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 103.662 -2.718 . . . . 65.340000000000003 103.662 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -43.28 -56.04 7.23 Favored Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 114.501 1.297 . . . . 71.219999999999999 114.501 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.67 -36.54 51.93 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.381 1.387 . . . . 64.319999999999993 111.857 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 1.4 tpt180 -70.54 -34.4 72.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.053 -0.521 . . . . 71.400000000000006 110.951 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 31' ' ' ASP . 60.7 t -69.24 -41.75 81.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 108.867 -0.79 . . . . 62.450000000000003 108.867 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.31 83.19 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.661 -1.154 . . . . 70.409999999999997 109.385 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.09 -46.35 84.65 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.315 -0.857 . . . . 72.319999999999993 110.627 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 30' ' ' TYR . 29.3 tp -65.33 -47.26 77.14 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.425 -0.807 . . . . 65.409999999999997 111.268 -175.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 41' ' ' VAL . 96.6 mt -81.56 -17.46 48.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 72.239999999999995 111.688 -177.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.16 29.47 60.39 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.873 -0.891 . . . . 62.119999999999997 110.873 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 39' ' ' LEU . 32.7 m -121.68 164.14 26.65 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.541 -0.54 . . . . 70.120000000000005 109.541 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.27 165.47 27.72 Favored 'Trans proline' 0 C--O 1.264 1.821 0 C-N-CA 121.512 1.475 . . . . 75.409999999999997 110.875 172.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.49 -32.51 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.259 0.624 . . . . 73.230000000000004 110.408 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -57.06 -43.68 82.29 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.965 -0.561 . . . . 42.200000000000003 110.823 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 29.7 mtpp -69.49 -32.47 71.36 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 120.041 -0.664 . . . . 72.099999999999994 111.039 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.41 -42.05 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.31 -0.626 . . . . 75.340000000000003 109.31 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -62.63 -37.23 85.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.696 . . . . 54.229999999999997 109.787 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.7 -35.93 81.29 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.074 -0.512 . . . . 33.109999999999999 111.64 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.4 mm100 -58.42 -46.25 86.86 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 108.086 -1.079 . . . . 75.530000000000001 108.086 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.67 -38.92 92.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.135 -1.393 . . . . 64.530000000000001 110.979 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 97.9 mtt180 -71.05 -22.0 62.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.129 0.572 . . . . 72.549999999999997 112.289 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -85.11 -13.42 50.3 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.418 -0.513 . . . . 75.120000000000005 109.708 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.94 26.32 73.99 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.781 -1.328 . . . . 52.32 109.781 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -98.38 -9.13 25.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.551 0.691 . . . . 75.420000000000002 109.244 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.1 tp -158.21 152.55 24.4 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.932 -1.877 . . . . 53.149999999999999 105.932 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.27 158.03 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 120.213 -0.595 . . . . 72.400000000000006 109.49 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.0 162.04 29.59 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 122.71 0.404 . . . . 52.329999999999998 110.008 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 99' ' ' MET . 13.4 m -132.63 167.53 26.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 124.121 0.968 . . . . 74.200000000000003 109.141 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 75.4 mtm180 -109.9 139.27 45.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.683 -0.488 . . . . 74.420000000000002 109.683 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' NE ' HG11 ' A' ' 65' ' ' VAL . 36.7 ptt180 -128.41 120.05 26.17 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.509 -1.293 . . . . 71.349999999999994 107.509 173.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.1 16.9 8.66 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.864 0.866 . . . . 60.229999999999997 111.877 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.26 -7.31 54.2 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.991 -0.55 . . . . 52.219999999999999 112.55 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -95.61 151.83 20.13 Favored Glycine 0 CA--C 1.493 -1.31 0 N-CA-C 111.624 -0.591 . . . . 74.140000000000001 111.624 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.2 t -96.46 120.91 46.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.357 -0.979 . . . . 73.219999999999999 108.357 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.446 HG11 ' NE ' ' A' ' 60' ' ' ARG . 15.3 m -134.45 160.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.255 -0.884 . . . . 64.299999999999997 111.452 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.33 128.87 23.99 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 106.935 -1.505 . . . . 74.319999999999993 106.935 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.21 133.99 56.38 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.03 1.82 . . . . 62.240000000000002 111.622 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 68' ' ' GLN . 5.8 tt0 -63.05 -25.27 68.3 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 121.709 0.766 . . . . 45.439999999999998 111.312 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.31 -5.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.836 -1.075 . . . . 75.5 112.076 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.63 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.6 m-85 -87.7 -3.85 58.94 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.7 0.762 . . . . 71.109999999999999 110.211 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.16 148.54 43.51 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.395 -0.821 . . . . 75.200000000000003 109.179 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -83.64 174.98 10.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.884 -0.598 . . . . 74.140000000000001 109.602 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.66 -17.94 64.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.674 0.75 . . . . 70.040000000000006 109.171 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -79.52 -7.11 58.25 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.267 -0.879 . . . . 54.100000000000001 110.597 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.52 27.54 59.09 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.085 -0.578 . . . . 73.129999999999995 111.697 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -123.03 166.03 15.79 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.384 -0.599 . . . . 72.420000000000002 109.384 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.0 t -75.92 142.16 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.156 -1.053 . . . . 73.030000000000001 108.156 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 25.8 t -62.62 130.79 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 107.914 -1.143 . . . . 75.430000000000007 107.914 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -65.29 -24.5 67.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.066 1.135 . . . . 75.120000000000005 114.066 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 p -92.84 -2.05 56.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.206 0.526 . . . . 72.310000000000002 111.967 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.63 HD11 ' CD2' ' A' ' 70' ' ' PHE . 7.8 tt -65.42 -50.37 58.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-N 115.786 -0.643 . . . . 73.150000000000006 112.115 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.78 -29.52 86.17 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.34 1.36 . . . . 53.299999999999997 111.358 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.89 -44.33 94.77 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.954 -0.567 . . . . 63.030000000000001 111.946 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.01 -40.03 87.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.445 -0.576 . . . . 73.120000000000005 109.445 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.6 -37.9 89.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.933 -0.576 . . . . 70.340000000000003 110.527 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.8 m -67.39 -43.34 81.59 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 115.844 -0.616 . . . . 72.049999999999997 111.831 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -42.0 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.903 -0.319 . . . . 73.120000000000005 110.663 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.414 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.4 mm? -66.7 -34.57 78.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.167 0.432 . . . . 65.510000000000005 112.167 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -59.67 -35.15 73.86 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.021 -0.733 . . . . 72.329999999999998 109.021 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.04 -31.34 72.16 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.293 0.568 . . . . 74.230000000000004 110.371 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -9.26 75.91 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.623 -0.717 . . . . 74.25 112.34 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.17 35.24 34.72 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.296 -0.478 . . . . 72.340000000000003 112.401 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.16 132.8 42.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.928 0.394 . . . . 73.409999999999997 110.983 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -83.35 171.54 13.41 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.507 -0.77 . . . . 71.420000000000002 109.629 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 99' ' ' MET . 9.1 p-10 -53.95 -40.99 67.29 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.687 1.595 . . . . 71.129999999999995 112.107 -176.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -61.86 -41.25 97.61 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.238 0.615 . . . . 74.200000000000003 110.365 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 6.7 mm-40 -66.38 -36.5 83.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.152 -0.476 . . . . 72.109999999999999 109.897 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.7 mm -62.07 -47.77 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.842 -0.799 . . . . 71.150000000000006 108.842 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 23.9 mmt -69.15 -23.61 63.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.832 -1.077 . . . . 75.400000000000006 110.412 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.608 ' HA ' HG11 ' A' ' 22' ' ' VAL . 80.4 ttt180 -58.9 -63.43 1.3 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.618 -0.719 . . . . 52.340000000000003 110.773 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.504 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.5 p-90 -69.65 -35.34 75.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.069 0.766 . . . . 63.43 113.069 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 126' ' ' VAL . 11.2 mt -57.77 -41.39 81.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.889 1.07 . . . . 52.539999999999999 113.889 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 96.8 m-85 -97.45 -6.04 34.75 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.311 0.856 . . . . 75.310000000000002 113.311 -174.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.8 m -87.29 121.24 71.41 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.208 0.317 . . . . 74.209999999999994 110.219 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 33.8 Cg_exo -63.99 128.91 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.737 1.625 . . . . 54.450000000000003 108.931 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 26.3 t70 -105.45 120.45 49.44 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 120.209 -0.596 . . . . 74.140000000000001 110.735 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.8 -22.72 74.6 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 123.332 2.688 . . . . 70.299999999999997 113.445 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 m -97.65 2.9 50.32 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.17 0.509 . . . . 72.129999999999995 110.109 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HG ' HG12 ' A' ' 111' ' ' ILE . 48.4 tp -109.77 128.69 55.46 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.109 -0.7 . . . . 72.0 109.109 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.9 m -130.61 113.17 13.87 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.188 -1.041 . . . . 72.25 108.188 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.4 HG12 ' HG ' ' A' ' 109' ' ' LEU . 36.9 mm . . . . . 0 C--N 1.298 -1.656 0 CA-C-N 115.993 -0.549 . . . . 72.140000000000001 110.75 -172.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 50.0 t . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 108.418 -0.956 . . . . 74.310000000000002 108.418 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -82.27 154.82 25.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.755 -1.572 . . . . 72.450000000000003 106.755 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 16.2 m120 69.26 36.02 2.47 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.434 0.694 . . . . 52.520000000000003 110.354 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.11 152.12 29.45 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.211 -1.033 . . . . 74.129999999999995 108.211 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -87.71 142.14 32.41 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 105.34 -2.096 . . . . 73.230000000000004 105.34 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.503 ' HB2' HD23 ' A' ' 102' ' ' LEU . 92.8 Cg_exo -51.72 -27.35 26.21 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.273 1.982 . . . . 64.409999999999997 111.695 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.641 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 93.8 t -62.82 -43.06 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.814 -0.63 . . . . 72.239999999999995 110.73 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -60.04 -37.85 81.01 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.433 0.635 . . . . 64.400000000000006 109.461 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.78 82.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.285 -1.325 . . . . 62.409999999999997 112.194 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -69.23 -38.69 78.63 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.168 -0.613 . . . . 63.350000000000001 111.234 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.36 -23.41 63.75 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.614 0.721 . . . . 75.209999999999994 109.716 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.55 7.05 44.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.289 -0.869 . . . . 74.530000000000001 111.075 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.3 m80 59.51 28.81 18.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 122.144 0.973 . . . . 61.329999999999998 112.578 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.13 22.98 6.94 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.253 -1.388 . . . . 74.239999999999995 107.253 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.43 -28.81 32.04 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.738 1.615 . . . . 65.540000000000006 112.712 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -56.26 -43.14 78.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.373 -0.603 . . . . 74.239999999999995 109.373 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -73.67 -30.55 62.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.328 -0.851 . . . . 71.129999999999995 110.608 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -63.77 -45.25 97.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.838 -0.801 . . . . 75.510000000000005 108.838 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.1 t -62.99 -42.12 95.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 70.019999999999996 109.7 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.17 -45.6 83.53 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.023 -0.535 . . . . 71.140000000000001 110.025 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.2 mmt85 -68.86 -37.06 78.83 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.044 -0.525 . . . . 73.140000000000001 111.362 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.47 -44.04 93.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.083 0.553 . . . . 73.409999999999997 109.903 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -64.7 -38.4 90.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 72.340000000000003 110.323 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.86 -17.77 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.0 -0.546 . . . . 54.100000000000001 111.664 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 94.1 mmm -87.6 -29.81 20.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.22 0.533 . . . . 74.400000000000006 110.253 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.96 -44.56 14.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 111.042 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 108.075 -1.083 . . . . 63.43 108.075 -178.745 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.963 0 N-CA-C 109.958 -0.386 . . . . 43.229999999999997 109.958 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.38 -128.15 5.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.41 -0.9 . . . . 71.329999999999998 112.377 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 96' ' ' THR . 29.9 t70 -109.68 146.41 34.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.121 -0.696 . . . . 73.310000000000002 109.121 -174.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -86.06 125.37 33.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.449 0.642 . . . . 75.109999999999999 112.259 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.3 t -97.2 -31.17 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.33 -0.395 . . . . 75.530000000000001 111.457 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.494 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -69.77 171.72 8.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.011 0.745 . . . . 74.019999999999996 113.011 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.504 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 10.0 t70 -85.32 139.81 36.33 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 116.508 -0.314 . . . . 63.32 110.495 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.9 -24.6 14.02 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.066 3.177 . . . . 75.140000000000001 115.217 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.84 -25.18 28.24 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.134 -0.354 . . . . 74.409999999999997 111.568 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 24' ' ' ASP . 45.9 mt-10 -62.78 132.81 94.87 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 116.523 -0.308 . . . . 64.310000000000002 110.994 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 38.3 Cg_endo -63.93 141.47 77.74 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 123.175 2.583 . . . . 75.109999999999999 113.137 -175.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -136.68 173.95 11.15 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.019 -0.991 . . . . 72.200000000000003 110.697 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -124.83 159.26 31.45 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.711 -1.589 . . . . 74.140000000000001 106.711 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 6.9 p-10 -137.04 173.84 11.26 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.334 -1.728 . . . . 74.230000000000004 106.334 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -37.32 -60.95 0.77 Allowed Pre-proline 0 CA--C 1.563 1.478 0 N-CA-C 115.45 1.648 . . . . 73.019999999999996 115.45 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.82 -33.81 32.77 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.216 1.277 . . . . 72.319999999999993 112.888 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 9.5 tpt180 -70.25 -35.12 73.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.627 0.251 . . . . 65.230000000000004 110.916 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 31' ' ' ASP . 62.0 t -69.2 -41.26 81.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.959 -0.756 . . . . 54.200000000000003 108.959 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.88 88.28 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 114.905 -1.043 . . . . 63.240000000000002 109.679 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.86 -45.49 92.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.131 1.372 . . . . 73.340000000000003 109.742 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.75 -50.1 39.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.608 -0.724 . . . . 64.049999999999997 112.382 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.04 -18.89 41.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.308 -0.406 . . . . 75.299999999999997 111.953 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.95 27.88 57.58 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.099 -0.801 . . . . 73.430000000000007 111.099 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -121.41 159.7 49.08 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 108.505 -0.924 . . . . 74.129999999999995 108.505 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.77 156.01 64.41 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 121.523 1.482 . . . . 74.409999999999997 112.819 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.42 -37.4 63.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.467 -0.788 . . . . 74.030000000000001 111.181 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.1 t -62.19 -35.92 80.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.13 -0.486 . . . . 71.400000000000006 110.509 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 53.7 tttp -65.75 -40.64 92.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.133 -1.062 . . . . 71.25 108.133 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.76 -41.26 87.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.404 -0.816 . . . . 75.519999999999996 110.333 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.86 88.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.902 -0.59 . . . . 12.41 110.243 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 1.4 mp0 -68.45 -41.61 79.99 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.764 -0.653 . . . . 73.129999999999995 112.051 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.717 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.2 mm100 -58.09 -46.06 86.12 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.848 -0.797 . . . . 74.019999999999996 108.848 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD23 ' HG ' ' A' ' 55' ' ' LEU . 76.9 mt -61.93 -44.23 97.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.99 -1.005 . . . . 54.549999999999997 111.447 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -70.95 -21.62 62.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.672 0.619 . . . . 75.239999999999995 112.672 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 52.5 mt-10 -87.64 -6.62 58.18 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.654 -0.418 . . . . 62.520000000000003 110.898 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.86 39.09 21.69 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.594 -0.812 . . . . 51.439999999999998 111.107 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -86.3 -30.0 22.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.862 -1.162 . . . . 74.319999999999993 107.862 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.444 ' HG ' HD23 ' A' ' 50' ' ' LEU . 1.6 pt? -160.82 167.62 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.667 -1.605 . . . . 75.209999999999994 106.667 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.42 161.46 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 118.758 0.708 . . . . 61.399999999999999 112.084 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.05 51.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.332 -0.849 . . . . 41.32 110.242 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.42 HG11 ' SD ' ' A' ' 99' ' ' MET . 18.0 m -130.79 162.55 38.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 O-C-N 123.528 0.517 . . . . 71.349999999999994 109.82 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -110.42 118.02 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.859 -0.423 . . . . 34.539999999999999 109.859 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -124.56 123.83 40.93 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.891 -0.411 . . . . 54.399999999999999 109.891 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.89 16.77 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.032 0.933 . . . . 64.030000000000001 110.656 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.43 -15.5 62.83 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.602 -0.726 . . . . 65.109999999999999 113.05 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.22 137.85 13.83 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.021 -0.831 . . . . 64.310000000000002 111.021 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.79 120.77 46.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.55 0.69 . . . . 75.239999999999995 109.169 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.06 159.32 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.069 -0.969 . . . . 60.439999999999998 112.172 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.3 mm -111.1 132.02 21.9 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 125.937 1.695 . . . . 74.420000000000002 106.803 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.69 119.31 6.33 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.981 1.787 . . . . 74.5 111.672 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' A' ' 28' ' ' PRO . 6.2 tt0 -62.95 -25.48 68.37 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.572 0.701 . . . . 74.329999999999998 111.556 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 m -70.81 -5.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.413 -0.812 . . . . 73.549999999999997 112.451 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -86.13 -4.12 59.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.859 0.837 . . . . 65.409999999999997 109.653 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -111.12 160.14 17.18 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.037 -0.983 . . . . 63.140000000000001 108.397 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 p -84.06 166.27 17.85 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.247 -1.019 . . . . 73.109999999999999 108.247 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -67.53 -16.55 64.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.935 0.874 . . . . 74.319999999999993 109.609 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 m -78.76 -11.38 59.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.503 -0.771 . . . . 54.219999999999999 111.063 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.05 62.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.572 -0.823 . . . . 72.430000000000007 112.536 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -104.98 147.87 27.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.015 -0.365 . . . . 64.450000000000003 110.015 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.5 t -63.12 136.05 26.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.457 -0.942 . . . . 74.409999999999997 108.457 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.92 133.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.737 -0.468 . . . . 64.129999999999995 109.737 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -54.61 -26.29 31.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.393 1.257 . . . . 53.509999999999998 114.393 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.7 t -114.62 19.37 16.1 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.342 -0.543 . . . . 53.229999999999997 110.849 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 17.6 tp -63.95 -55.69 30.69 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 116.44 -0.346 . . . . 74.319999999999993 111.326 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.21 -28.55 87.14 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.887 1.725 . . . . 73.129999999999995 111.75 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.82 -44.81 94.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.889 -0.596 . . . . 71.530000000000001 112.2 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.18 -40.53 82.21 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 109.395 -0.594 . . . . 73.030000000000001 109.395 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.37 -44.51 97.03 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.718 -0.674 . . . . 74.239999999999995 110.634 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.7 m -61.41 -37.02 81.98 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.706 1.002 . . . . 52.140000000000001 113.706 -176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.469 HG23 HD22 ' A' ' 88' ' ' LEU 0.25 0.0 OUTLIER -68.17 -45.04 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 119.567 -0.853 . . . . 75.329999999999998 110.755 179.485 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 87' ' ' ILE . 3.2 mm? -67.75 -35.56 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.008 0.433 . . . . 73.420000000000002 111.189 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -60.4 -39.54 87.7 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.744 0.818 . . . . 74.5 109.28 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.65 -30.6 70.19 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.728 0.775 . . . . 71.329999999999998 109.928 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.4 -3.05 89.9 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.065 -0.971 . . . . 54.130000000000003 112.053 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.89 22.46 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.895 -0.193 . . . . 54.450000000000003 113.155 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 93.7 m-85 -87.16 136.57 32.88 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 122.37 -0.488 . . . . 72.409999999999997 111.07 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 37.4 ptt180 -78.06 170.57 16.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.791 -0.641 . . . . 72.310000000000002 110.655 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -54.27 -41.01 68.36 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.946 1.298 . . . . 61.140000000000001 111.822 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' ASP . 23.4 m -61.74 -42.57 99.14 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.282 -0.872 . . . . 62.409999999999997 111.02 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.577 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 9.1 mm-40 -67.05 -33.49 75.63 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.141 -0.481 . . . . 74.239999999999995 110.965 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.2 mm -61.65 -49.05 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 108.211 -1.033 . . . . 70.329999999999998 108.211 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.592 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 10.9 ptp -74.84 -14.14 60.64 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.387 -0.824 . . . . 62.43 112.935 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.515 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 71.7 ttt180 -58.83 -65.62 0.63 Allowed 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.616 0.572 . . . . 72.209999999999994 109.944 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.535 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 46.0 p-90 -69.12 -32.92 72.65 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.236 0.458 . . . . 73.420000000000002 112.236 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 11.0 mt -58.93 -40.48 84.73 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.517 0.932 . . . . 75.019999999999996 113.517 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 73.0 m-85 -93.22 -2.5 55.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.406 0.521 . . . . 73.209999999999994 112.406 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -88.51 117.51 68.43 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 109.07 -0.715 . . . . 54.130000000000003 109.07 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 139.96 51.47 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.305 2.003 . . . . 75.409999999999997 113.208 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 17.5 t70 -98.26 119.9 60.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.645 -0.872 . . . . 61.140000000000001 108.645 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.08 -22.91 71.57 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.149 2.566 . . . . 73.200000000000003 114.016 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 p -104.0 5.63 35.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.036 0.384 . . . . 50.509999999999998 112.036 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.3 tp -105.12 135.28 46.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.053 -0.351 . . . . 61.0 110.053 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.6 m -118.53 116.9 27.62 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.040000000000006 108.286 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 109.128 -0.693 . . . . 71.340000000000003 109.128 -175.713 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 107.937 -1.135 . . . . 72.439999999999998 107.937 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.3 m -89.85 131.34 35.83 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.357 -1.72 . . . . 53.210000000000001 106.357 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.0 t30 75.46 69.06 0.08 Allowed 'General case' 0 C--N 1.321 -0.672 0 O-C-N 124.564 1.165 . . . . 73.409999999999997 108.235 -172.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.49 163.72 15.98 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.696 -1.138 . . . . 65.230000000000004 109.539 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 39.5 ptt180 -88.08 141.1 30.97 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.568 -0.742 . . . . 74.099999999999994 109.672 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB2' HD23 ' A' ' 102' ' ' LEU . 50.7 Cg_exo -55.17 -18.11 16.97 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.083 2.522 . . . . 75.219999999999999 114.228 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -61.03 -42.85 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.444 0.64 . . . . 64.329999999999998 109.493 173.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.61 -30.75 71.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.276 -0.874 . . . . 71.400000000000006 109.619 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.72 -50.34 65.18 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.734 -0.667 . . . . 73.120000000000005 110.556 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -63.99 -36.76 85.05 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 60.240000000000002 110.871 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -68.68 -24.7 64.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.38 -0.827 . . . . 63.409999999999997 109.54 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -102.53 12.78 35.96 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.406 -0.816 . . . . 75.349999999999994 112.85 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 70.02 27.87 4.26 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.638 1.209 . . . . 73.5 110.866 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -105.56 23.96 12.98 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.967 0.907 . . . . 63.43 109.028 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.12 -29.06 28.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.479 1.511 . . . . 63.299999999999997 113.817 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -56.7 -40.14 75.09 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.806 0.336 . . . . 71.450000000000003 110.752 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -73.12 -24.82 60.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.981 0.419 . . . . 74.319999999999993 110.967 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 129' ' ' LEU . 57.7 t -70.84 -42.0 77.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 62.520000000000003 108.478 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.27 -42.23 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.44 -0.578 . . . . 70.310000000000002 109.44 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -59.5 -47.09 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.619 -0.719 . . . . 74.319999999999993 109.697 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.4 tpp180 -64.6 -39.65 94.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.371 -0.831 . . . . 73.019999999999996 110.005 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.62 87.36 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.564 0.746 . . . . 72.140000000000001 110.832 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.98 -39.02 93.19 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.238 -0.437 . . . . 74.120000000000005 110.281 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -21.25 66.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.18 -0.464 . . . . 70.540000000000006 111.333 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 85.4 mmm -92.71 -22.49 19.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.022 0.439 . . . . 53.200000000000003 110.986 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.83 -27.68 19.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.976 0.417 . . . . 64.200000000000003 111.062 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 108.022 -1.103 . . . . 73.109999999999999 108.022 178.024 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.992 0 N-CA-C 108.052 -1.092 . . . . 64.319999999999993 108.052 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.15 -110.27 3.45 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.684 -0.769 . . . . 70.129999999999995 113.411 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -110.76 133.56 53.24 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.043 0.386 . . . . 72.010000000000005 112.043 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.1 114.97 13.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.313 -0.995 . . . . 64.140000000000001 108.313 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.64 -8.61 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 112.409 0.522 . . . . 73.200000000000003 112.409 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 -173.11 2.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.772 -1.205 . . . . 74.310000000000002 113.936 -175.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -96.5 132.47 26.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.843 -1.169 . . . . 73.310000000000002 107.843 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.16 -20.73 32.34 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.452 2.768 . . . . 64.150000000000006 111.8 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.334 -0.848 . . . . 61.109999999999999 109.823 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -68.0 134.09 91.85 Favored Pre-proline 0 C--O 1.244 0.796 0 N-CA-C 109.365 -0.605 . . . . 65.0 109.365 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.22 128.1 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.57 2.18 . . . . 74.129999999999995 111.257 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.3 m -130.16 158.52 39.46 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.47 -0.567 . . . . 61.520000000000003 109.47 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -116.48 162.4 17.63 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.521 1.129 . . . . 72.0 109.965 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -134.06 167.25 20.97 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.381 -2.451 . . . . 62.329999999999998 104.381 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -48.45 -55.03 21.01 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 114.712 1.375 . . . . 72.329999999999998 114.712 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.44 -46.39 33.79 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.118 1.879 . . . . 73.530000000000001 112.11 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 28.0 tpt180 -65.29 -39.04 92.04 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 112.485 0.55 . . . . 71.129999999999995 112.485 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.41 HG21 HD12 ' A' ' 66' ' ' ILE . 77.7 t -69.12 -40.53 80.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.164 -0.614 . . . . 72.439999999999998 110.239 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.03 -39.52 92.6 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.206 -0.906 . . . . 70.530000000000001 108.978 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.59 -44.95 85.06 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.494 -1.23 . . . . 74.140000000000001 111.105 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 95.6 mt -62.25 -47.45 84.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.482 0.658 . . . . 70.430000000000007 111.572 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.439 ' HB2' HG22 ' A' ' 41' ' ' VAL . 88.2 mt -82.77 -18.44 40.64 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.744 -0.662 . . . . 61.310000000000002 111.972 -175.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 27.36 60.78 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 110.592 -1.003 . . . . 74.519999999999996 110.592 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 39' ' ' LEU . 25.5 m -118.31 159.38 43.7 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 108.564 -0.902 . . . . 74.299999999999997 108.564 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.78 161.75 38.74 Favored 'Trans proline' 0 C--O 1.262 1.719 0 C-N-CA 121.149 1.232 . . . . 60.25 110.744 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.7 -33.85 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 115.88 -0.6 . . . . 72.109999999999999 109.92 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.6 m -57.66 -41.27 81.14 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.093 -0.958 . . . . 74.230000000000004 111.73 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 26.5 mtpp -69.77 -32.59 71.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.27 -0.572 . . . . 70.120000000000005 110.929 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.49 ' HA ' HE21 ' A' ' 49' ' ' GLN . 61.0 t -62.27 -42.27 94.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.68 . . . . 72.040000000000006 109.165 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.96 83.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.83 -0.623 . . . . 60.25 110.311 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -66.36 -37.32 85.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.24 -0.437 . . . . 55.219999999999999 110.67 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.49 HE21 ' HA ' ' A' ' 46' ' ' VAL . 46.2 mt-30 -63.19 -46.4 87.25 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.938 -0.393 . . . . 73.150000000000006 109.938 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 93.8 mt -61.67 -38.43 87.72 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.54 -1.209 . . . . 54.0 110.03 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -61.63 -44.41 97.04 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.164 0.986 . . . . 55.039999999999999 112.507 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.59 -11.8 33.38 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.419 -0.512 . . . . 70.120000000000005 112.364 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.92 35.53 18.41 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.34 -0.933 . . . . 44.329999999999998 111.049 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -92.5 -18.55 23.03 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.154 -1.054 . . . . 75.310000000000002 108.154 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -159.88 152.45 21.19 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.751 -1.944 . . . . 72.129999999999995 105.751 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.86 161.67 39.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.568 -0.53 . . . . 74.209999999999994 109.568 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.22 161.66 35.58 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.119 -0.697 . . . . 74.450000000000003 109.119 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.55 166.16 30.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.397 -0.594 . . . . 75.109999999999999 109.397 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 45.0 ttt180 -121.49 130.48 53.58 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.383 -0.527 . . . . 70.129999999999995 110.068 -175.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -125.56 117.31 23.31 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.602 -0.888 . . . . 63.219999999999999 108.602 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 20.47 8.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.597 0.759 . . . . 63.219999999999999 112.748 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.73 -17.14 30.64 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.068 -0.587 . . . . 74.239999999999995 112.976 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.34 140.75 15.22 Favored Glycine 0 CA--C 1.488 -1.61 0 C-N-CA 121.23 -0.51 . . . . 51.140000000000001 111.829 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.24 120.91 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.254 -1.017 . . . . 74.540000000000006 108.254 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.3 154.6 40.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.826 -0.624 . . . . 63.109999999999999 110.916 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 35' ' ' VAL . 64.3 mt -126.28 114.43 23.59 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.872 -1.158 . . . . 73.219999999999999 107.872 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.41 133.56 58.81 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.323 2.682 . . . . 75.239999999999995 113.102 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -57.12 -25.53 58.98 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 112.948 0.722 . . . . 72.540000000000006 112.948 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 21.9 m -60.28 -15.34 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 113.361 0.875 . . . . 72.099999999999994 113.361 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 81' ' ' LEU . 13.9 m-85 -82.28 -6.15 59.04 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.519 0.676 . . . . 75.299999999999997 111.001 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -121.06 162.36 20.13 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.553 -0.748 . . . . 61.43 109.126 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.0 p -88.14 175.53 7.67 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.713 -0.476 . . . . 72.010000000000005 109.713 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -61.25 -16.98 50.99 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.239 0.616 . . . . 72.310000000000002 111.176 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.21 3.43 51.46 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.312 0.486 . . . . 73.030000000000001 112.312 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.76 57.87 Favored Glycine 0 C--O 1.235 0.166 0 C-N-CA 120.465 -0.874 . . . . 23.420000000000002 111.94 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -112.55 146.23 38.9 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.634 -0.876 . . . . 75.540000000000006 108.634 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.9 130.39 32.24 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.546 -0.538 . . . . 40.32 109.546 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 80' ' ' SER . 60.5 t -56.14 130.55 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.798 -0.637 . . . . 73.25 109.459 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -57.32 -23.8 50.98 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.64 1.348 . . . . 62.329999999999998 114.64 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.401 ' H ' HG12 ' A' ' 78' ' ' VAL . 23.2 t -105.31 10.63 33.48 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.987 -0.446 . . . . 73.030000000000001 110.91 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 36.2 tp -66.02 -57.68 12.84 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.39 0.885 . . . . 74.329999999999998 113.39 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.63 -33.86 97.26 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 121.864 1.709 . . . . 73.519999999999996 112.944 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -61.94 -44.98 97.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.406 -0.426 . . . . 72.129999999999995 112.65 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.57 -40.32 80.64 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 121.289 0.566 . . . . 71.299999999999997 109.987 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.77 -42.25 95.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.51 -0.768 . . . . 74.530000000000001 111.144 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.1 m -64.41 -45.15 88.82 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.04 -0.527 . . . . 72.109999999999999 111.906 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -66.06 -43.85 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.973 0.416 . . . . 61.509999999999998 111.017 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.675 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 38.1 mt -66.61 -38.33 86.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.286 -0.416 . . . . 74.510000000000005 111.77 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -63.27 -42.57 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.842 -0.429 . . . . 71.140000000000001 109.842 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.94 -28.63 65.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.12 -0.491 . . . . 74.25 110.737 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.89 -1.56 84.78 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.59 -0.732 . . . . 63.329999999999998 112.77 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.88 23.26 30.79 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.867 -0.682 . . . . 73.010000000000005 113.087 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -102.84 144.53 31.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.485 -0.42 . . . . 63.229999999999997 110.784 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.532 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 31.2 ptt180 -97.01 172.3 7.94 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.232 -0.894 . . . . 71.010000000000005 109.156 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.55 -43.18 68.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.791 1.636 . . . . 51.0 111.593 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 m -62.5 -41.04 98.55 Favored 'General case' 0 N--CA 1.415 -2.194 0 C-N-CA 123.854 0.862 . . . . 73.319999999999993 110.164 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.532 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 28.9 mm-40 -67.04 -33.36 75.36 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.43 -0.35 . . . . 73.400000000000006 110.649 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.483 HD12 HD13 ' A' ' 88' ' ' LEU . 18.7 mm -61.3 -49.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.993 -1.114 . . . . 61.109999999999999 107.993 -176.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 ptp -76.08 -17.89 59.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.289 -0.869 . . . . 60.329999999999998 112.8 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -56.47 -67.53 0.29 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.998 0.519 . . . . 72.109999999999999 110.66 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.675 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 52.5 p-90 -69.47 -32.13 70.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.277 0.473 . . . . 72.319999999999993 112.277 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.526 HD23 ' HB2' ' A' ' 125' ' ' PRO . 8.7 mt -60.09 -39.97 87.97 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.155 0.798 . . . . 74.109999999999999 113.155 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.08 -4.8 59.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.178 0.436 . . . . 63.340000000000003 112.178 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 m -87.17 120.2 71.28 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.193 -0.669 . . . . 62.409999999999997 109.193 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.83 129.62 31.39 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.251 1.968 . . . . 74.450000000000003 110.788 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 35.4 t70 -96.33 124.25 51.94 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.182 -0.463 . . . . 53.549999999999997 110.807 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.38 -35.43 96.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.324 2.683 . . . . 73.219999999999999 113.057 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 p -90.04 2.98 54.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.802 0.667 . . . . 72.109999999999999 112.802 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -102.69 129.51 49.33 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.291 0.567 . . . . 65.209999999999994 110.21 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.4 m -131.35 115.34 16.13 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.42 -1.696 . . . . 71.409999999999997 106.42 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.467 HG22 ' OE1' ' A' ' 133' ' ' GLN . 13.3 pt . . . . . 0 CA--C 1.493 -1.238 0 N-CA-C 112.812 0.671 . . . . 64.420000000000002 112.812 -175.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.432 -1.349 0 N-CA-C 108.991 -0.744 . . . . 71.230000000000004 108.991 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.2 m -84.67 134.8 34.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.58 -1.267 . . . . 74.510000000000005 107.58 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.4 t30 66.71 64.72 0.47 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.534 1.159 . . . . 74.230000000000004 108.908 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.97 163.71 15.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.263 -1.335 . . . . 53.420000000000002 108.887 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 39.6 ptt180 -82.39 136.18 46.27 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.545 -0.539 . . . . 71.530000000000001 109.545 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.526 ' HB2' HD23 ' A' ' 102' ' ' LEU . 31.0 Cg_exo -56.78 -17.08 21.89 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.244 2.63 . . . . 71.430000000000007 114.07 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.618 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.1 t -59.9 -40.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.454 0.645 . . . . 62.039999999999999 109.9 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.2 -30.29 67.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.19 -0.459 . . . . 64.150000000000006 111.051 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.1 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.59 . . . . 61.409999999999997 111.375 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.45 -33.9 75.01 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.028 -0.269 . . . . 74.239999999999995 111.401 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -75.25 -24.68 57.68 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.781 0.8 . . . . 62.229999999999997 108.907 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.29 24.41 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.774 -1.103 . . . . 72.439999999999998 111.179 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.6 m80 64.39 28.22 13.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.528 1.131 . . . . 52.240000000000002 111.512 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.467 ' OE1' HG22 ' A' ' 111' ' ' ILE . 72.7 mt-30 -111.23 23.84 13.58 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.345 -1.354 . . . . 74.140000000000001 107.345 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.26 -27.87 24.68 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 113.306 -1.77 . . . . 63.32 113.111 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -56.16 -36.21 68.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.935 0.494 . . . . 73.099999999999994 109.926 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.33 -38.58 87.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.405 0.621 . . . . 73.420000000000002 109.737 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.7 -46.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.078 -0.964 . . . . 70.219999999999999 109.597 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 93.0 t -61.22 -47.8 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.506 -0.77 . . . . 74.129999999999995 110.484 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.52 -37.93 89.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.123 -0.631 . . . . 64.409999999999997 110.915 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -63.71 -41.64 98.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.229 -0.656 . . . . 71.25 109.229 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.921 -0.581 . . . . 61.350000000000001 110.072 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -63.98 -38.66 91.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.414 -0.812 . . . . 72.299999999999997 111.411 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.91 -33.03 70.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.147 0.499 . . . . 74.409999999999997 110.441 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 tpt -69.71 -32.01 70.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.342 -0.844 . . . . 73.400000000000006 110.719 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.27 -58.91 2.16 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.803 0.668 . . . . 61.149999999999999 112.803 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.31 -1.126 0 CA-C-O 118.303 -0.856 . . . . 74.200000000000003 110.624 -175.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.678 0 N-CA-C 109.922 -0.399 . . . . 73.120000000000005 109.922 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.67 -78.79 0.62 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.559 -0.829 . . . . 75.140000000000001 113.994 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.73 129.97 33.44 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 122.262 -0.552 . . . . 53.340000000000003 110.631 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.568 ' OD2' ' HD2' ' A' ' 60' ' ' ARG . 13.3 t0 -69.22 139.46 54.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.165 -0.471 . . . . 65.420000000000002 111.697 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 100' ' ' ARG . 58.1 t -106.56 -18.52 7.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.661 -0.7 . . . . 43.420000000000002 110.991 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.285 1.0 OUTLIER -89.7 179.37 6.03 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.379 -1.328 . . . . 64.340000000000003 112.21 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -98.03 152.21 37.93 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.085 -0.709 . . . . 71.519999999999996 109.085 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.89 -22.92 32.01 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.005 2.47 . . . . 65.409999999999997 113.035 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.74 -24.98 56.17 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.295 -0.253 . . . . 64.299999999999997 111.582 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 20.1 mm-40 -72.34 137.21 81.18 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 109.973 -0.38 . . . . 75.530000000000001 109.973 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 28.9 Cg_exo -63.02 136.72 58.1 Favored 'Trans proline' 0 C--O 1.256 1.408 0 C-N-CA 123.105 2.537 . . . . 53.229999999999997 112.774 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 p -130.6 169.81 15.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.283 0.563 . . . . 74.030000000000001 111.37 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 20.4 m-85 -130.33 160.2 34.68 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.808 1.243 . . . . 53.119999999999997 108.05 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.14 163.97 28.4 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 103.459 -2.793 . . . . 72.140000000000001 103.459 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HB3' HG13 ' A' ' 43' ' ' VAL . 82.9 mt -49.93 -52.27 53.86 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 114.812 1.412 . . . . 75.25 114.812 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.91 -38.61 68.16 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 121.6 1.534 . . . . 71.140000000000001 111.762 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.8 tpt180 -70.05 -33.98 72.63 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.566 -0.288 . . . . 73.230000000000004 111.309 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.1 -42.06 84.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.951 -0.759 . . . . 70.420000000000002 108.951 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.07 84.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.406 -0.815 . . . . 63.439999999999998 109.597 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 7.5 tp10 -61.68 -44.94 95.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.672 -1.149 . . . . 55.240000000000002 109.552 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.449 HD22 ' CE2' ' A' ' 30' ' ' TYR . 27.0 tp -69.63 -46.33 66.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.195 -0.911 . . . . 72.230000000000004 111.724 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 75' ' ' GLY . 96.7 mt -81.36 -18.44 45.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.189 -0.46 . . . . 64.030000000000001 111.606 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.3 28.2 62.36 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.058 -0.817 . . . . 70.129999999999995 111.058 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 39' ' ' LEU . 21.5 m -125.61 163.48 38.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 108.333 -0.988 . . . . 73.120000000000005 108.333 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 46.2 Cg_endo -70.87 157.83 57.15 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 121.352 1.368 . . . . 50.450000000000003 111.232 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' A' ' 32' ' ' LEU . 61.2 t -57.9 -34.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.658 0.783 . . . . 74.150000000000006 109.786 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 47.1 m -57.66 -42.89 84.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.155 -0.929 . . . . 41.329999999999998 111.331 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.8 mtpt -69.27 -33.48 73.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.409 -0.516 . . . . 75.140000000000001 111.204 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.23 -44.94 99.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.164 -0.68 . . . . 73.329999999999998 109.164 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.39 -0.823 . . . . 70.540000000000006 110.427 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.0 mt-30 -63.49 -39.79 95.37 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.241 -0.436 . . . . 61.140000000000001 110.397 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.611 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 72.2 mt-30 -64.1 -42.4 96.93 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.418 0.628 . . . . 65.430000000000007 109.699 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.17 -40.77 97.14 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.892 -1.049 . . . . 71.040000000000006 109.281 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -68.83 -22.27 64.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.508 -0.769 . . . . 62.039999999999999 112.89 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 49.9 mt-10 -93.04 -12.87 29.53 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.313 -0.555 . . . . 74.209999999999994 111.337 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.38 28.96 31.62 Favored Glycine 0 C--N 1.319 -0.41 0 N-CA-C 111.222 -0.751 . . . . 73.420000000000002 111.222 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -87.72 -28.38 21.8 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.31 -0.996 . . . . 73.349999999999994 108.31 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -145.95 158.6 43.86 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.429 -1.323 . . . . 65.540000000000006 107.429 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.71 157.55 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.464 -0.939 . . . . 41.140000000000001 108.464 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.4 162.87 32.47 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.122 0.569 . . . . 71.140000000000001 110.004 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 m -125.91 166.09 22.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.277 0.56 . . . . 64.319999999999993 111.701 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -110.23 124.73 52.14 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.203 -0.908 . . . . 74.129999999999995 108.783 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.568 ' HD2' ' OD2' ' A' ' 21' ' ' ASP . 8.9 ptm180 -151.3 138.37 19.17 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-N 115.573 -0.739 . . . . 74.409999999999997 110.123 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.63 -59.16 0.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.205 1.802 . . . . 74.219999999999999 110.515 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.48 24.77 0.02 OUTLIER Glycine 0 C--N 1.28 -2.573 0 CA-C-N 114.766 -1.106 . . . . 51.329999999999998 110.825 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 160.81 27.81 Favored Glycine 0 N--CA 1.427 -1.907 0 C-N-CA 120.395 -0.907 . . . . 65.019999999999996 111.893 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.88 119.88 50.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.931 -1.507 . . . . 64.409999999999997 106.931 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.8 158.6 39.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 120.926 0.394 . . . . 42.420000000000002 110.867 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.07 126.92 27.07 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.497 -1.297 . . . . 52.450000000000003 107.497 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.31 132.29 51.38 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.384 2.056 . . . . 55.310000000000002 111.539 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.6 tt0 -62.17 -25.8 67.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.38 0.609 . . . . 70.099999999999994 112.353 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.461 ' HB ' HG11 ' A' ' 126' ' ' VAL . 31.2 m -71.81 -4.37 4.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.144 -0.934 . . . . 54.140000000000001 112.38 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.8 m-85 -82.85 -6.18 59.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.956 0.884 . . . . 73.439999999999998 110.239 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.65 160.87 20.59 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.579 -0.737 . . . . 74.319999999999993 110.52 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.412 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 47.3 p -92.84 168.53 11.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.065 -1.087 . . . . 71.129999999999995 108.065 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.93 -15.33 63.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.424 0.631 . . . . 74.219999999999999 111.661 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.0 m -78.64 -9.86 59.53 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.739 -0.664 . . . . 61.329999999999998 109.335 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 39' ' ' LEU . . . 81.16 25.8 54.2 Favored Glycine 0 C--O 1.212 -1.264 0 N-CA-C 111.0 -0.84 . . . . 72.099999999999994 111.0 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -114.52 147.34 39.54 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.092 -1.077 . . . . 75.019999999999996 108.092 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.58 137.73 23.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.847 -1.538 . . . . 62.200000000000003 106.847 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.8 t -60.87 127.28 20.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 108.666 -0.865 . . . . 70.230000000000004 108.666 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -55.3 -32.14 62.19 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 114.095 1.146 . . . . 73.019999999999996 114.095 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 m -85.16 -6.4 59.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.088 0.471 . . . . 44.240000000000002 111.457 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD11 ' CD2' ' A' ' 70' ' ' PHE . 7.0 tt -66.18 -50.09 52.13 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 112.616 0.598 . . . . 73.109999999999999 112.616 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.28 -31.39 84.28 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.552 1.502 . . . . 62.549999999999997 111.337 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.93 99.73 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 115.872 -0.604 . . . . 53.43 112.682 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -67.86 -39.81 83.72 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.32 -0.622 . . . . 74.450000000000003 109.32 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.63 -36.33 83.46 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.719 -0.673 . . . . 73.140000000000001 110.542 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.7 m -59.5 -50.26 74.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.022 -0.536 . . . . 61.43 110.372 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -44.16 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 116.143 -0.48 . . . . 63.43 111.485 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.427 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.36 -36.35 81.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.98 0.733 . . . . 71.200000000000003 112.98 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -70.64 -33.72 71.3 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 74.409999999999997 109.285 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.05 -31.7 72.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.674 -0.694 . . . . 74.230000000000004 109.389 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.17 -9.37 80.18 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.408 -0.814 . . . . 65.329999999999998 112.676 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.5 33.48 25.14 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 121.174 -0.536 . . . . 71.439999999999998 113.295 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.403 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 68.9 m-85 -99.79 136.89 39.02 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.595 -0.356 . . . . 61.210000000000001 110.884 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -88.58 174.04 8.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.922 -0.581 . . . . 71.209999999999994 112.144 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.85 -42.59 65.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.355 1.862 . . . . 64.430000000000007 111.871 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -64.2 -41.73 96.94 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.782 -0.644 . . . . 63.530000000000001 110.142 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -66.61 -37.27 84.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.171 -0.468 . . . . 75.430000000000007 110.369 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.27 -48.97 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.777 0.799 . . . . 74.400000000000006 109.337 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.2 mtt -75.41 -19.28 59.61 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.036 -0.984 . . . . 65.150000000000006 112.215 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HA ' HG11 ' A' ' 22' ' ' VAL . 79.0 ttt180 -56.88 -62.79 1.5 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.356 0.662 . . . . 62.140000000000001 111.05 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -69.05 -32.65 72.28 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.2 0.524 . . . . 63.219999999999999 111.829 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 125' ' ' PRO . 19.2 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.13 0.972 . . . . 64.25 112.436 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -93.52 -2.6 54.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.261 0.837 . . . . 75.510000000000005 113.261 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.6 m -86.02 113.49 52.07 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.135 0.272 . . . . 71.299999999999997 111.224 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 38.4 Cg_endo -68.02 141.11 52.02 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.448 2.099 . . . . 41.350000000000001 110.856 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.9 t0 -112.53 126.94 27.52 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 120.371 -0.532 . . . . 53.310000000000002 109.693 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 122' ' ' ASN . 32.6 Cg_exo -58.55 -28.24 85.09 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.645 2.896 . . . . 70.200000000000003 112.961 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -96.13 7.18 47.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.05 -0.523 . . . . 53.539999999999999 110.504 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.414 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.8 tp -113.89 123.83 50.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.554 0.693 . . . . 63.43 109.891 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.8 m -120.26 120.57 36.49 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.547 -1.279 . . . . 60.310000000000002 107.547 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 C--N 1.297 -1.708 0 N-CA-C 107.896 -1.15 . . . . 73.209999999999994 107.896 -174.63 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 107.58 -1.267 . . . . 62.32 107.58 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.429 ' C ' HD22 ' A' ' 122' ' ' ASN . 19.3 m -83.46 154.0 24.17 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.262 -1.385 . . . . 63.409999999999997 107.262 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 106' ' ' ASP 0.393 0.1 OUTLIER 46.7 62.94 2.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.722 1.209 . . . . 63.140000000000001 113.244 -176.668 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 105' ' ' PRO . . . -104.51 172.62 6.7 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.37 -1.344 . . . . 74.209999999999994 107.37 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -103.89 151.43 38.88 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 109.137 -0.69 . . . . 74.140000000000001 109.137 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.459 ' HB2' HD12 ' A' ' 102' ' ' LEU . 71.1 Cg_exo -50.9 -22.08 9.56 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.06 2.507 . . . . 73.329999999999998 113.453 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.461 HG11 ' HB ' ' A' ' 69' ' ' VAL . 94.4 t -60.05 -41.62 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.082 -0.34 . . . . 34.219999999999999 110.082 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.07 -40.11 94.69 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.752 -0.658 . . . . 74.219999999999999 109.719 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.45 69.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 73.230000000000004 109.995 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.75 -44.18 93.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.576 0.751 . . . . 75.409999999999997 112.144 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.412 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 16.8 t60 -70.26 -23.58 62.92 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.441 0.638 . . . . 74.409999999999997 109.887 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -100.54 10.92 40.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.375 -0.83 . . . . 62.340000000000003 112.289 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 65.79 27.55 11.09 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.754 1.264 . . . . 72.319999999999993 111.018 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -102.86 24.76 10.18 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.3 -1.741 . . . . 72.420000000000002 106.3 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.23 -27.25 14.12 Favored 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 127.044 2.137 . . . . 14.300000000000001 115.381 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -56.5 -34.41 66.95 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.557 1.318 . . . . 71.129999999999995 114.557 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -67.39 -34.77 77.96 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.767 0.794 . . . . 50.509999999999998 109.338 175.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.62 -48.44 65.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.922 -1.035 . . . . 72.510000000000005 108.958 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.77 -43.94 99.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.529 -0.76 . . . . 74.25 109.55 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 26.1 ttt180 -57.74 -47.2 83.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.449 -0.341 . . . . 72.439999999999998 110.916 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -65.92 -33.7 76.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.684 0.278 . . . . 74.349999999999994 111.468 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.427 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -65.17 -46.72 79.66 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.47 -0.567 . . . . 74.319999999999993 109.47 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.42 -48.01 81.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.106 -0.952 . . . . 75.439999999999998 110.509 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.75 -19.42 65.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.703 -0.681 . . . . 71.349999999999994 112.335 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 tpt -79.83 -45.84 17.99 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.209 0.528 . . . . 61.200000000000003 109.793 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.403 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.71 -44.26 17.33 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.539 0.57 . . . . 71.230000000000004 112.539 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 108.836 -0.802 . . . . 73.209999999999994 108.836 -178.303 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.294 0 N-CA-C 109.025 -0.731 . . . . 71.019999999999996 109.025 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' HH12 ' A' ' 94' ' ' ARG . . . -97.67 -87.12 1.85 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 116.17 -0.468 . . . . 72.319999999999993 113.717 -176.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.94 141.46 52.02 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.468 -0.493 . . . . 72.099999999999994 111.965 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -81.5 133.98 35.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.504 -0.771 . . . . 61.329999999999998 110.481 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.38 -15.75 9.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.602 -0.727 . . . . 71.0 111.025 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 103' ' ' PHE 0.279 0.9 OUTLIER -82.56 -176.88 6.47 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 118.751 -1.18 . . . . 73.319999999999993 112.566 -178.348 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -86.93 136.0 34.69 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 116.286 -0.415 . . . . 75.340000000000003 110.263 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.58 -25.44 33.02 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.616 2.877 . . . . 73.099999999999994 113.814 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.45 -30.18 70.47 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.102 0.477 . . . . 75.349999999999994 110.234 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 43.6 mt-10 -76.35 123.58 87.89 Favored Pre-proline 0 C--O 1.254 1.308 0 CA-C-N 115.457 -0.792 . . . . 74.439999999999998 109.935 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.2 Cg_exo -73.69 175.99 9.98 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.318 2.012 . . . . 74.450000000000003 110.019 177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.432 ' HB ' ' HB ' ' A' ' 65' ' ' VAL . 12.9 p -139.97 177.93 7.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.579 0.704 . . . . 61.229999999999997 112.062 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 43.0 m-85 -109.17 160.81 15.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 125.919 1.688 . . . . 74.019999999999996 107.905 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 13.3 t0 -135.66 166.86 22.25 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 104.091 -2.559 . . . . 53.299999999999997 104.091 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.21 -53.29 63.37 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 113.065 0.765 . . . . 65.450000000000003 113.065 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 14.8 Cg_endo -58.3 -35.71 98.43 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.11 1.873 . . . . 55.310000000000002 112.66 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.435 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 23.9 tpt180 -67.38 -38.44 84.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.345 0.658 . . . . 75.120000000000005 110.284 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.4 t -69.2 -40.37 80.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 109.406 -0.591 . . . . 75.340000000000003 109.406 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -59.35 -39.49 83.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.822 -1.081 . . . . 73.140000000000001 109.646 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.18 -34.72 78.68 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.375 1.47 . . . . 73.530000000000001 110.469 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 30' ' ' TYR . 97.1 mt -77.24 -47.5 19.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.284 0.564 . . . . 64.230000000000004 111.625 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -85.02 -18.5 34.22 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.315 0.857 . . . . 74.5 113.315 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.39 48.6 Favored Glycine 0 C--N 1.307 -1.038 0 C-N-CA 119.77 -1.205 . . . . 31.210000000000001 110.178 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 34.3 m -117.91 157.75 47.58 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.007 -1.108 . . . . 75.299999999999997 108.007 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.462 ' HD2' ' HD2' ' A' ' 45' ' ' LYS . 44.3 Cg_endo -72.04 164.53 35.38 Favored 'Trans proline' 0 C--O 1.259 1.558 0 C-N-CA 121.117 1.211 . . . . 53.140000000000001 110.958 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.89 -33.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.54 0.686 . . . . 75.150000000000006 109.269 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -57.45 -41.79 81.25 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.674 -1.148 . . . . 71.450000000000003 110.685 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 54.3 mttm -69.38 -36.93 77.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.625 -0.43 . . . . 73.420000000000002 111.658 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.64 -44.69 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.401 -0.592 . . . . 55.049999999999997 109.401 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.32 -36.92 79.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.439 -0.801 . . . . 55.439999999999998 110.157 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 96.2 mt-30 -67.38 -43.32 81.69 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.079 -0.51 . . . . 70.150000000000006 111.491 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 92.7 mt-30 -58.32 -46.1 86.81 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.486 0.66 . . . . 62.130000000000003 110.052 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 96.3 mt -61.42 -45.7 93.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.352 -1.295 . . . . 51.109999999999999 110.16 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -70.85 -22.09 62.35 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.118 0.785 . . . . 64.439999999999998 113.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 57.5 mt-10 -94.48 -1.16 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.891 -0.505 . . . . 72.329999999999998 110.913 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.4 35.04 63.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.882 -0.675 . . . . 55.210000000000001 111.979 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -102.17 -16.94 16.2 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.808 -1.182 . . . . 72.329999999999998 107.808 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 54.9 tp -151.26 152.72 33.62 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.054 -1.832 . . . . 63.329999999999998 106.054 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.48 161.53 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 109.262 -0.644 . . . . 64.430000000000007 109.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.65 164.15 28.91 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.291 0.636 . . . . 54.229999999999997 110.902 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.8 m -125.24 165.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 123.826 0.85 . . . . 75.109999999999999 108.96 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -123.98 131.74 53.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.882 -0.784 . . . . 70.109999999999999 108.882 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -152.24 138.71 18.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.117 -0.697 . . . . 72.430000000000007 109.117 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.93 9.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.278 1.031 . . . . 62.030000000000001 112.335 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.21 9.7 67.01 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.181 -0.533 . . . . 74.239999999999995 112.843 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.47 142.0 15.55 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.596 -0.811 . . . . 55.329999999999998 111.168 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.78 120.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.084 -1.45 . . . . 33.310000000000002 107.084 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 12.1 m -137.16 164.37 29.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.25 -0.432 . . . . 64.329999999999998 111.312 -174.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.81 130.61 24.68 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.67 -0.863 . . . . 75.430000000000007 108.67 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.71 141.82 83.67 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.086 2.524 . . . . 72.299999999999997 113.941 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.472 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -55.2 -39.82 70.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.786 1.234 . . . . 73.120000000000005 110.399 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.98 -4.91 4.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 114.129 1.159 . . . . 70.25 114.129 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.561 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.7 m-85 -83.49 -5.46 59.17 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.856 0.836 . . . . 74.239999999999995 110.836 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -124.34 149.03 47.07 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.691 -1.14 . . . . 72.349999999999994 108.644 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.1 p -76.17 169.0 19.04 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.807 -0.812 . . . . 73.120000000000005 108.807 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -61.6 -19.15 61.9 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 70.129999999999995 110.953 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 m -80.08 -10.1 59.74 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 116.109 -0.496 . . . . 74.519999999999996 110.936 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.62 14.06 66.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.004 -0.617 . . . . 62.140000000000001 111.887 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -105.06 148.22 27.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.819 -0.224 . . . . 71.409999999999997 110.744 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.97 138.65 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 O-C-N 123.811 0.694 . . . . 72.349999999999994 109.627 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 80' ' ' SER . 57.0 t -61.94 127.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.264 -1.013 . . . . 62.020000000000003 108.264 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -63.14 -24.02 67.7 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.454 0.645 . . . . 75.239999999999995 112.589 -176.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.421 ' H ' HG12 ' A' ' 78' ' ' VAL . 8.6 m -92.09 2.42 56.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.073 -0.512 . . . . 51.140000000000001 110.748 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 70' ' ' PHE . 11.8 tp -65.05 -55.62 25.78 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.433 -0.349 . . . . 41.219999999999999 111.454 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.88 -28.46 86.41 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.815 1.677 . . . . 72.120000000000005 111.218 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.7 -45.46 65.78 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.489 -0.778 . . . . 44.299999999999997 111.967 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.22 -40.81 81.99 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 120.985 0.422 . . . . 72.209999999999994 110.118 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.43 -39.27 92.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.148 -0.478 . . . . 75.409999999999997 111.006 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.1 m -71.36 -41.23 70.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.899 -0.592 . . . . 65.299999999999997 112.224 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -68.11 -39.84 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.32 -0.552 . . . . 61.340000000000003 109.535 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 4.4 mm? -66.18 -35.67 81.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 122.257 -0.277 . . . . 63.240000000000002 111.399 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.34 -37.94 89.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.72 -0.474 . . . . 75.420000000000002 109.72 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.47 -24.94 65.66 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.741 0.781 . . . . 75.349999999999994 109.976 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -2.93 84.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.665 -0.698 . . . . 73.409999999999997 111.795 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 20.95 50.88 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.784 -0.246 . . . . 62.200000000000003 113.058 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 9.1 m-85 -86.75 152.8 22.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.109 0.781 . . . . 72.400000000000006 113.109 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.448 HH12 ' HA3' ' A' ' 19' ' ' GLY . 11.1 ptt180 -123.24 175.96 6.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.82 -1.082 . . . . 60.229999999999997 110.063 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 99' ' ' MET . 11.1 p-10 -52.18 -47.06 65.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.851 1.66 . . . . 74.329999999999998 113.49 -171.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.1 m -67.93 -40.0 83.41 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-O 121.471 0.653 . . . . 74.209999999999994 109.348 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 29.7 mm-40 -66.29 -34.62 78.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.338 -0.847 . . . . 75.239999999999995 111.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 94' ' ' ARG . 33.4 mm -61.49 -47.19 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.87 0.843 . . . . 61.219999999999999 108.819 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 23.0 mmt -70.41 -23.22 62.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.347 -1.297 . . . . 73.340000000000003 110.773 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 68.9 ttt180 -55.09 -67.23 0.29 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.474 0.71 . . . . 63.210000000000001 110.888 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.588 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 57.3 p-90 -68.93 -32.12 71.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.607 0.595 . . . . 72.349999999999994 112.607 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.588 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.2 mt -63.55 -40.6 97.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.328 0.862 . . . . 70.310000000000002 113.328 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 96.3 m-85 -98.33 -9.46 25.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.582 0.956 . . . . 63.329999999999998 113.582 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.4 m -88.35 110.97 40.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.815 -1.18 . . . . 42.140000000000001 107.815 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.26 129.9 37.27 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.65 2.233 . . . . 75.420000000000002 111.514 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.3 t70 -89.59 118.8 69.35 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 109.489 -0.559 . . . . 60.229999999999997 109.489 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -26.83 83.38 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.143 2.562 . . . . 75.010000000000005 112.213 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -94.84 10.05 36.77 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.685 -0.689 . . . . 65.230000000000004 111.431 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.9 tp -105.25 125.81 51.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.13 -0.693 . . . . 62.229999999999997 109.13 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 120' ' ' VAL . 52.1 m -132.04 110.68 10.89 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.352 -0.981 . . . . 61.109999999999999 108.352 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.6 pt . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 115.878 -0.601 . . . . 70.5 110.508 -175.66 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 110' ' ' THR . 44.4 t . . . . . 0 N--CA 1.428 -1.542 0 N-CA-C 110.177 -0.305 . . . . 63.140000000000001 110.177 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.7 m -83.17 139.35 33.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.07 -1.456 . . . . 75.340000000000003 107.07 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.5 t30 69.36 69.33 0.26 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.386 1.089 . . . . 62.329999999999998 108.779 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.43 159.94 21.98 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.698 -1.137 . . . . 75.299999999999997 109.931 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -75.46 125.23 88.99 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.796 -0.816 . . . . 62.119999999999997 108.796 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 72.3 Cg_exo -53.89 -23.92 29.46 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.269 2.646 . . . . 75.340000000000003 112.958 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.723 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 84.6 t -60.31 -42.16 89.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.642 -0.708 . . . . 73.430000000000007 111.553 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.18 -30.71 71.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.358 0.599 . . . . 71.530000000000001 110.471 -172.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.9 84.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.008 -0.996 . . . . 61.32 111.786 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.723 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -70.41 -36.82 74.26 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.82 -0.55 . . . . 44.439999999999998 111.671 -177.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -76.09 -22.62 55.39 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.588 -0.893 . . . . 75.340000000000003 108.588 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.16 43.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.715 -1.129 . . . . 62.450000000000003 111.413 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.8 m80 65.52 28.44 11.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.111 0.964 . . . . 72.129999999999995 112.127 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -108.64 25.23 11.97 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 125.146 1.378 . . . . 75.219999999999999 107.607 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.41 -26.37 7.82 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.89 2.076 . . . . 74.209999999999994 113.268 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 39.2 ttp180 -54.37 -41.26 68.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.933 -0.395 . . . . 75.430000000000007 109.933 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.504 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 56.6 mm-40 -67.35 -28.51 68.02 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.549 -0.296 . . . . 52.119999999999997 111.653 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.07 -45.5 54.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.4 -0.963 . . . . 60.32 108.4 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.66 -49.2 84.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.036 -0.529 . . . . 72.319999999999993 110.338 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 136' ' ' GLU 0.318 0.0 OUTLIER -63.64 -37.43 87.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.187 0.81 . . . . 74.219999999999999 113.187 178.379 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 144' ' ' MET . 1.6 mpt_? -63.6 -40.1 96.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.484 -0.561 . . . . 72.439999999999998 109.484 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.424 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -61.5 -42.78 99.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 52.420000000000002 110.614 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -56.89 -49.52 75.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.339 0.656 . . . . 73.5 109.88 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.56 -33.12 74.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.172 -0.922 . . . . 73.329999999999998 111.892 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 92.6 mmm -77.01 -47.2 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.835 -0.346 . . . . 63.009999999999998 111.093 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.88 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.857 -0.61 . . . . 60.420000000000002 112.065 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 N--CA 1.427 -1.576 0 C-N-CA 120.655 -0.418 . . . . 74.230000000000004 110.47 -178.61 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.009 0 N-CA-C 109.758 -0.46 . . . . 64.219999999999999 109.758 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.35 -104.28 2.72 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 121.07 -0.586 . . . . 73.409999999999997 112.351 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.06 137.28 52.36 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.392 -0.523 . . . . 74.340000000000003 111.539 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.58 143.1 35.08 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.346 -0.843 . . . . 75.010000000000005 110.937 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.63 -15.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 116.055 -0.52 . . . . 75.340000000000003 110.932 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.266 1.0 OUTLIER -86.09 175.55 8.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 118.314 -1.354 . . . . 74.239999999999995 111.631 179.02 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.446 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 20.3 t70 -82.21 141.1 46.02 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.172 -0.677 . . . . 73.209999999999994 109.172 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.413 ' HA ' ' NH1' ' A' ' 60' ' ' ARG . 71.1 Cg_exo -50.4 -32.06 32.59 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.003 2.469 . . . . 72.430000000000007 114.388 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.54 -10.02 59.55 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.942 1.09 . . . . 60.329999999999998 113.942 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 9.9 mm-40 -66.3 136.32 95.15 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 107.787 -1.19 . . . . 75.030000000000001 107.787 175.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.8 133.71 51.74 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.171 2.581 . . . . 72.430000000000007 112.629 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.7 p -132.84 168.55 18.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.057 -0.519 . . . . 63.399999999999999 111.092 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.469 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 24.6 m-85 -130.83 161.5 31.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 125.23 1.412 . . . . 73.349999999999994 108.464 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -134.67 166.57 22.62 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.343 -1.725 . . . . 62.119999999999997 106.343 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -43.37 -61.54 1.8 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 116.018 1.859 . . . . 63.119999999999997 116.018 -169.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.07 -29.37 74.86 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.448 1.432 . . . . 63.299999999999997 112.352 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.9 tpt180 -70.86 -36.22 72.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.081 0.467 . . . . 73.420000000000002 110.041 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.81 -37.9 74.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.628 -0.508 . . . . 74.430000000000007 109.628 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.15 81.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.458 -0.792 . . . . 74.129999999999995 109.393 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 35.9 tt0 -63.9 -45.78 87.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.716 -1.129 . . . . 54.340000000000003 110.724 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.466 HD22 ' CE2' ' A' ' 30' ' ' TYR . 39.6 tp -64.81 -46.93 79.94 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.194 -0.912 . . . . 64.230000000000004 111.534 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.65 -18.29 35.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.86 0.689 . . . . 64.109999999999999 112.86 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.81 53.07 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.07 -1.062 . . . . 53.219999999999999 111.448 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.05 158.71 74.39 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.131 -0.692 . . . . 54.039999999999999 109.131 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -65.78 159.84 46.66 Favored 'Trans proline' 0 C--O 1.25 1.089 0 C-N-CA 121.856 1.704 . . . . 62.009999999999998 112.192 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.2 -33.61 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.247 1.019 . . . . 63.43 111.252 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -57.87 -42.46 84.6 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.617 -0.72 . . . . 71.140000000000001 110.946 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.683 ' HA ' ' HG3' ' A' ' 48' ' ' GLN . 68.2 mttm -70.06 -34.82 73.68 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.006 -0.543 . . . . 74.530000000000001 112.007 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.36 -41.63 90.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.287 -0.635 . . . . 64.329999999999998 109.287 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.37 96.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.203 -0.908 . . . . 72.5 110.589 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.683 ' HG3' ' HA ' ' A' ' 45' ' ' LYS 0.308 0.0 OUTLIER -70.72 -35.03 72.52 Favored 'General case' 0 C--O 1.201 -1.483 0 C-N-CA 120.216 -0.594 . . . . 70.420000000000002 112.241 178.632 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 84.5 mm-40 -58.09 -43.14 86.93 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.482 0.658 . . . . 73.049999999999997 109.229 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.67 -46.09 91.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.687 -1.142 . . . . 74.239999999999995 108.933 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -70.68 -21.41 62.59 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.058 -0.974 . . . . 75.329999999999998 113.383 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -84.48 -7.39 59.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.904 0.383 . . . . 72.549999999999997 110.429 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.53 22.69 58.0 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.482 -0.647 . . . . 71.340000000000003 111.482 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 m170 -91.42 -17.95 24.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.058 0.456 . . . . 73.219999999999999 109.971 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 tp -151.42 155.37 38.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.43 -0.952 . . . . 72.120000000000005 108.43 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.5 t -137.47 147.11 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.028 -1.101 . . . . 70.340000000000003 108.028 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.14 156.15 44.36 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.3 -0.63 . . . . 64.209999999999994 109.3 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.3 m -127.48 166.03 25.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 O-C-N 123.595 0.559 . . . . 60.009999999999998 109.928 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -122.48 137.74 54.78 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.068 -0.716 . . . . 74.019999999999996 109.068 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' NH1' ' HA ' ' A' ' 25' ' ' PRO . 39.2 ptt180 -153.34 138.22 17.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.918 -1.142 . . . . 75.319999999999993 107.918 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.93 16.28 10.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.955 0.902 . . . . 74.319999999999993 110.875 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.06 78.42 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.614 -0.721 . . . . 71.409999999999997 112.133 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.76 143.61 15.68 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 111.312 -0.715 . . . . 54.049999999999997 111.312 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 p -97.73 123.27 50.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.777 0.799 . . . . 73.409999999999997 109.426 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.61 151.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.963 -1.017 . . . . 63.240000000000002 110.534 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 mp -105.35 126.67 30.33 Favored Pre-proline 0 C--N 1.28 -2.43 0 N-CA-C 107.517 -1.29 . . . . 64.120000000000005 107.517 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.36 118.03 4.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.091 1.86 . . . . 63.409999999999997 110.435 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.469 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 tt0 -60.95 -24.56 66.15 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.184 0.594 . . . . 75.340000000000003 111.667 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.83 -5.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 115.265 -0.88 . . . . 53.119999999999997 112.436 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.42 ' CZ ' ' HE1' ' A' ' 99' ' ' MET . 3.2 m-85 -80.42 -14.39 58.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.009 0.909 . . . . 72.239999999999995 109.637 173.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.3 151.39 26.05 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.127 -1.064 . . . . 70.329999999999998 108.127 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.4 p -76.23 175.24 9.21 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.574 -0.528 . . . . 75.150000000000006 109.574 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.82 -17.75 63.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.7 0.762 . . . . 52.530000000000001 109.994 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 m -83.3 -4.14 58.15 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.075 -0.511 . . . . 71.25 111.186 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.79 26.3 60.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.039 -0.601 . . . . 51.240000000000002 112.822 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.58 154.88 39.99 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.716 -0.846 . . . . 72.0 108.716 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.57 135.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.536 -0.542 . . . . 74.150000000000006 109.536 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 12.7 t -61.94 141.61 17.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.064 -1.458 . . . . 73.239999999999995 107.064 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -54.32 -44.94 72.47 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.459 1.281 . . . . 62.299999999999997 114.459 -169.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 64.6 m -109.31 21.72 16.73 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.543 -0.863 . . . . 72.200000000000003 112.246 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.478 ' HB3' ' HD3' ' A' ' 82' ' ' PRO . 17.7 tp -58.04 -48.65 96.71 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 115.041 -0.981 . . . . 70.430000000000007 110.799 174.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 50.1 Cg_exo -58.96 -27.47 84.88 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.907 1.738 . . . . 70.530000000000001 111.396 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -62.81 -45.53 95.52 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.949 -0.569 . . . . 63.140000000000001 112.388 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.56 -39.9 80.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.699 0.762 . . . . 74.219999999999999 109.329 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.55 -44.52 90.51 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.906 -1.043 . . . . 65.040000000000006 110.492 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.7 m -67.14 -45.84 75.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.764 -0.653 . . . . 41.219999999999999 111.657 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -61.58 -45.27 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 120.542 0.211 . . . . 64.109999999999999 111.403 -178.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD13 ' HB2' ' A' ' 145' ' ' ALA . 4.5 mm? -67.23 -42.45 84.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.65 0.611 . . . . 55.509999999999998 112.65 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -64.56 -44.46 90.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.824 -0.436 . . . . 61.439999999999998 109.824 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -68.18 -26.77 65.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.852 -0.613 . . . . 72.519999999999996 109.51 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.48 -9.36 86.98 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.416 -0.811 . . . . 42.450000000000003 113.313 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.2 53.39 2.19 Favored Glycine 0 C--O 1.242 0.64 0 C-N-CA 121.03 -0.605 . . . . 65.310000000000002 113.009 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 84.1 m-85 -129.8 136.95 50.19 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.968 0.413 . . . . 64.310000000000002 111.46 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.657 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 24.1 ptt180 -81.23 169.97 16.68 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.114 -0.948 . . . . 75.040000000000006 110.807 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 99' ' ' MET . 12.3 p-10 -55.13 -45.2 75.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.217 1.407 . . . . 75.340000000000003 111.624 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -61.8 -40.38 95.04 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.596 -0.729 . . . . 73.040000000000006 111.084 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.657 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 45.1 mm-40 -66.13 -34.64 78.5 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.723 -0.391 . . . . 72.420000000000002 111.247 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 mm -63.17 -47.59 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.352 -0.981 . . . . 63.039999999999999 108.352 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.42 ' HE1' ' CZ ' ' A' ' 70' ' ' PHE . 22.3 mmt -69.77 -22.1 63.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.201 -1.363 . . . . 73.540000000000006 110.543 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -58.2 -67.1 0.38 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.265 0.626 . . . . 70.340000000000003 109.734 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.484 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.5 p-90 -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.734 0.642 . . . . 74.230000000000004 112.734 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.484 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 mt -61.59 -39.93 92.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.828 0.677 . . . . 73.439999999999998 112.828 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 95.6 m-85 -98.69 -9.77 24.16 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 113.235 0.828 . . . . 72.349999999999994 113.235 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.9 m -86.0 116.04 64.18 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.552 -0.907 . . . . 72.140000000000001 108.552 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.99 154.68 73.86 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.753 2.302 . . . . 75.230000000000004 112.953 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.3 t70 -99.71 120.45 57.35 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.173 -1.047 . . . . 72.549999999999997 108.173 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.23 -27.32 84.64 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.267 2.645 . . . . 72.200000000000003 113.519 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.3 p -100.03 4.3 44.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.442 0.639 . . . . 62.109999999999999 112.215 -175.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.5 tp -102.16 139.33 37.92 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.408 -0.59 . . . . 75.549999999999997 109.408 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.2 m -129.82 118.49 21.85 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.278 -0.638 . . . . 74.239999999999995 109.278 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 C--N 1.309 -1.158 0 N-CA-C 108.262 -1.014 . . . . 64.239999999999995 108.262 -174.635 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.8 t . . . . . 0 N--CA 1.432 -1.368 0 N-CA-C 108.986 -0.746 . . . . 75.109999999999999 108.986 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.1 m -81.81 138.75 35.07 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.051 -1.092 . . . . 62.109999999999999 108.051 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 10.3 t30 72.4 69.33 0.14 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.293 1.044 . . . . 71.510000000000005 110.09 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.9 167.22 10.41 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.636 -1.165 . . . . 65.530000000000001 108.494 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.581 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 6.2 ptp180 -94.18 149.32 36.61 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.024 -0.732 . . . . 74.400000000000006 109.024 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.428 ' HB2' HD23 ' A' ' 102' ' ' LEU . 97.9 Cg_exo -50.8 -27.54 20.6 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.168 2.579 . . . . 62.329999999999998 113.306 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 48.3 t -60.97 -36.78 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.242 0.544 . . . . 74.349999999999994 110.375 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.581 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 66.4 m-20 -69.04 -36.87 78.2 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.037 -0.727 . . . . 62.43 109.037 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.79 -40.16 79.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.269 -0.878 . . . . 75.230000000000004 111.589 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -66.73 -38.85 87.51 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.766 -0.374 . . . . 74.109999999999999 111.931 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.413 ' N ' HD12 ' A' ' 129' ' ' LEU . 47.6 t-80 -75.97 -17.17 59.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.91 0.862 . . . . 75.230000000000004 109.239 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.76 4.5 36.57 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.131 -0.941 . . . . 72.109999999999999 110.055 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 67.88 28.3 7.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.561 1.144 . . . . 75.239999999999995 111.763 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -103.93 24.11 11.83 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.581 1.152 . . . . 64.420000000000002 108.746 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.49 -27.51 16.61 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 125.126 1.371 . . . . 73.420000000000002 112.72 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -55.53 -43.86 76.15 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.825 0.85 . . . . 73.049999999999997 110.974 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 2.3 tm-20 -73.2 -32.13 64.6 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.969 -0.752 . . . . 72.299999999999997 108.969 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.64 -42.5 89.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.015 -0.539 . . . . 62.340000000000003 110.013 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 134' ' ' ALA . 92.6 t -59.23 -41.65 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.956 -0.565 . . . . 71.209999999999994 109.523 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 136' ' ' GLU . 43.0 ttt180 -56.88 -47.12 81.2 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.01 -0.996 . . . . 73.030000000000001 110.016 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -68.96 -35.58 76.93 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.044 -0.526 . . . . 71.310000000000002 111.858 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.2 -43.44 98.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.841 0.353 . . . . 71.439999999999998 110.227 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -60.19 -45.86 91.69 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.803 -0.635 . . . . 71.420000000000002 110.178 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.4 84.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.196 -0.911 . . . . 31.52 112.075 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.57 -27.84 51.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.119 -0.492 . . . . 53.229999999999997 111.856 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -82.83 -63.6 1.33 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.182 0.808 . . . . 53.030000000000001 113.182 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 C--N 1.298 -1.665 0 CA-C-O 118.183 -0.913 . . . . 71.329999999999998 111.743 -170.863 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 106.924 -1.51 . . . . 62.340000000000003 106.924 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.24 -129.17 3.52 Favored Glycine 0 N--CA 1.422 -2.254 0 C-N-CA 120.556 -0.83 . . . . 62.200000000000003 111.849 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -109.97 146.75 34.72 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.614 -0.513 . . . . 55.340000000000003 109.614 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.619 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 19.1 t0 -78.44 125.24 29.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.349 0.595 . . . . 72.420000000000002 111.456 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.67 -15.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.922 -1.036 . . . . 70.439999999999998 109.059 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 103' ' ' PHE . 24.0 mt -85.84 174.4 9.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 115.084 1.512 . . . . 63.509999999999998 115.084 -175.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -105.34 141.98 23.75 Favored Pre-proline 0 N--CA 1.423 -1.825 0 CA-C-N 112.379 -2.192 . . . . 74.510000000000005 106.636 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -55.38 -27.05 56.24 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.943 2.429 . . . . 65.219999999999999 114.412 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -91.55 -13.59 31.79 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.389 0.614 . . . . 73.329999999999998 110.755 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.607 ' HG2' HD22 ' A' ' 23' ' ' LEU . 9.0 tp10 -77.85 129.37 76.46 Favored Pre-proline 0 C--O 1.242 0.683 0 N-CA-C 105.562 -2.014 . . . . 73.200000000000003 105.562 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HD2' ' OE2' ' A' ' 27' ' ' GLU . 17.7 Cg_exo -31.08 106.91 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 125.204 3.936 . . . . 35.409999999999997 115.381 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.88 155.85 48.27 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.689 -0.687 . . . . 41.32 112.385 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 22.6 m-85 -129.45 161.38 30.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 125.552 1.541 . . . . 74.430000000000007 108.077 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.597 ' OD1' ' HD3' ' A' ' 34' ' ' ARG . 5.5 p-10 -135.13 172.1 13.49 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.38 -1.711 . . . . 71.540000000000006 106.38 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -42.98 -61.13 1.89 Allowed Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 115.844 1.794 . . . . 63.140000000000001 115.844 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.1 -34.97 99.06 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.915 1.743 . . . . 60.310000000000002 112.764 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.597 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 5.2 mpt_? -70.15 -36.09 74.48 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.88 0.326 . . . . 73.420000000000002 111.88 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.538 HG21 HD12 ' A' ' 66' ' ' ILE . 79.8 t -69.69 -41.78 80.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.661 -0.496 . . . . 74.239999999999995 109.661 177.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.52 91.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.334 -0.848 . . . . 71.150000000000006 109.771 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -62.85 -46.11 89.41 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.838 1.255 . . . . 71.099999999999994 109.791 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.415 HD22 ' CE2' ' A' ' 30' ' ' TYR . 28.2 tp -70.52 -46.03 64.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.787 -1.097 . . . . 73.409999999999997 111.516 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB2' HG22 ' A' ' 41' ' ' VAL . 98.0 mt -84.51 -18.97 34.06 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.42 0.526 . . . . 72.219999999999999 112.42 -176.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.57 59.09 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 110.81 -0.916 . . . . 51.119999999999997 110.81 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 39' ' ' LEU . 19.4 m -126.51 164.25 35.52 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.405 -0.591 . . . . 74.140000000000001 109.405 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.99 164.48 27.33 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 121.673 1.582 . . . . 73.329999999999998 111.446 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.54 -34.55 65.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.546 -0.752 . . . . 75.319999999999993 109.422 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 m -58.73 -38.9 79.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.59 -0.732 . . . . 52.130000000000003 111.851 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 24.3 ttmm -69.49 -37.5 77.27 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.481 -0.488 . . . . 70.239999999999995 110.285 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 59.7 t -63.84 -42.11 94.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.945 -0.761 . . . . 54.130000000000003 108.945 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.62 74.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 72.329999999999998 110.556 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.8 -46.38 75.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.26 -0.427 . . . . 63.030000000000001 110.577 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 68.3 mt-30 -59.08 -45.95 89.52 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.213 0.53 . . . . 55.149999999999999 110.131 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 96.9 mt -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.627 -1.17 . . . . 52.549999999999997 110.305 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -70.3 -31.24 68.49 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.811 1.041 . . . . 74.209999999999994 113.811 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.71 -11.76 35.94 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.165 -0.614 . . . . 73.349999999999994 112.234 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 36.44 6.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.318 -0.944 . . . . 73.200000000000003 111.965 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -99.11 -22.37 15.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.444 -0.947 . . . . 62.219999999999999 108.444 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.7 tp -157.13 155.26 30.72 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.773 -1.565 . . . . 73.230000000000004 106.773 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.83 161.64 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 118.159 0.436 . . . . 73.439999999999998 110.434 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.37 158.67 43.83 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.281 0.363 . . . . 50.140000000000001 110.21 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 m -127.83 165.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.343 0.657 . . . . 53.219999999999999 110.142 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -121.57 128.55 52.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.76 0.314 . . . . 61.240000000000002 111.161 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.619 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 20.9 ptt180 -136.2 124.2 22.84 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.394 -0.595 . . . . 74.099999999999994 109.394 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.72 14.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 63.530000000000001 111.729 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.93 -3.41 84.69 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.933 -0.576 . . . . 60.130000000000003 112.303 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.19 138.09 13.74 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 111.056 -0.818 . . . . 54.409999999999997 111.056 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.6 123.45 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.874 -1.158 . . . . 65.239999999999995 107.874 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.2 m -131.22 151.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.345 0.593 . . . . 72.230000000000004 110.936 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 35' ' ' VAL . 76.0 mt -124.45 125.5 25.6 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 107.437 -1.32 . . . . 74.129999999999995 107.437 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 54.4 Cg_exo -56.87 128.98 32.17 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.769 2.313 . . . . 63.439999999999998 112.607 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -64.54 -24.79 67.72 Favored 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 123.421 0.688 . . . . 72.430000000000007 111.206 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.83 -3.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.569 -0.741 . . . . 74.040000000000006 112.425 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.415 ' CD1' ' HB2' ' A' ' 67' ' ' PRO . 5.1 m-85 -87.15 -4.1 59.1 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.428 1.109 . . . . 73.530000000000001 108.752 173.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -117.35 150.43 38.85 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 113.979 -1.464 . . . . 75.540000000000006 107.398 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -83.01 173.03 12.14 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.629 -0.878 . . . . 53.0 108.629 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.28 -17.27 64.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.411 0.624 . . . . 74.120000000000005 110.62 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -81.27 -3.91 53.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.692 -0.686 . . . . 63.219999999999999 111.478 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 23.84 58.85 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.77 -0.729 . . . . 41.310000000000002 112.976 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.12 154.76 44.33 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.285 -1.005 . . . . 74.329999999999998 108.285 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.8 t -62.6 142.75 16.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 123.62 0.575 . . . . 65.099999999999994 109.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.31 135.08 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.974 0.796 . . . . 63.329999999999998 109.346 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -54.91 -43.66 73.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.852 -0.613 . . . . 54.450000000000003 112.295 -174.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -98.67 18.35 17.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.904 0.705 . . . . 62.439999999999998 112.904 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -60.6 -52.08 75.27 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-N 116.595 -0.275 . . . . 65.530000000000001 110.803 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 19.3 Cg_endo -59.85 -27.92 86.03 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 121.881 1.721 . . . . 70.129999999999995 111.796 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.58 92.93 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 116.098 -0.501 . . . . 50.43 112.084 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -68.22 -39.98 82.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.285 0.564 . . . . 65.129999999999995 109.482 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.29 -36.27 83.57 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.785 -0.643 . . . . 62.509999999999998 110.73 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.2 m -61.0 -47.8 84.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.358 -0.383 . . . . 73.040000000000006 111.999 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -42.56 86.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 120.67 -0.412 . . . . 71.25 110.607 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.04 -35.62 80.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.499 0.555 . . . . 73.540000000000006 112.499 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -63.9 -33.45 75.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.026 -0.361 . . . . 73.530000000000001 110.026 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.58 -31.18 71.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.075 -0.511 . . . . 73.109999999999999 110.222 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.97 -9.19 81.17 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.715 -0.675 . . . . 43.340000000000003 111.473 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.12 55.76 3.96 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 112.402 -0.279 . . . . 64.299999999999997 112.402 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 88.7 m-85 -113.77 137.83 51.1 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.236 0.458 . . . . 74.540000000000006 112.236 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' O ' HG12 ' A' ' 98' ' ' ILE . 15.4 ptp180 -88.03 172.23 9.7 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.462 -0.79 . . . . 63.310000000000002 111.176 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -53.59 -45.06 69.88 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.267 1.427 . . . . 71.430000000000007 112.425 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -60.13 -41.57 92.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.208 0.603 . . . . 73.010000000000005 110.059 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 5.7 mm-40 -63.21 -43.85 96.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.992 -0.549 . . . . 73.549999999999997 110.412 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.7 mm -61.15 -48.13 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.587 0.708 . . . . 72.230000000000004 109.3 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.437 ' O ' ' HD2' ' A' ' 103' ' ' PHE . 53.8 mtt -74.65 -20.97 59.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.138 -0.937 . . . . 71.120000000000005 111.638 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 64.3 ttt180 -57.2 -65.88 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.025 0.53 . . . . 74.209999999999994 110.576 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.486 ' CD1' ' HG3' ' A' ' 144' ' ' MET . 41.0 p-90 -69.02 -33.1 73.1 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.968 0.729 . . . . 72.120000000000005 112.968 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.47 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.1 mt -57.24 -40.5 77.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.976 0.732 . . . . 71.25 112.976 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 23' ' ' LEU . 97.1 m-85 -98.65 3.48 47.82 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.544 0.572 . . . . 72.109999999999999 112.544 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.3 m -87.44 119.58 70.83 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.985 -0.376 . . . . 45.509999999999998 109.985 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 32.2 Cg_exo -62.74 128.84 24.37 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.616 1.544 . . . . 43.240000000000002 108.348 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . 30.1 t70 -99.99 122.57 50.21 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 120.301 -0.56 . . . . 72.430000000000007 110.209 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.4 -19.53 59.08 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.411 2.741 . . . . 65.140000000000001 113.7 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -107.6 3.86 25.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 111.919 0.34 . . . . 64.030000000000001 111.919 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.4 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 53.5 tp -102.64 130.6 49.59 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.74 0.781 . . . . 71.310000000000002 110.979 -177.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.9 m -131.28 118.65 20.66 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.476 -1.305 . . . . 41.43 107.476 176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.3 pt . . . . . 0 C--O 1.215 -0.716 0 N-CA-C 113.156 0.799 . . . . 65.420000000000002 113.156 -174.018 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 109.065 -0.717 . . . . 75.450000000000003 109.065 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -83.21 154.46 24.22 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.059 -0.973 . . . . 70.230000000000004 111.337 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 78.8 m-20 62.44 40.81 10.56 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.481 1.112 . . . . 74.120000000000005 110.949 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 174.41 6.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.16 -0.473 . . . . 62.109999999999999 110.858 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -102.69 143.74 27.21 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 116.379 -0.373 . . . . 75.340000000000003 111.077 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.5 Cg_exo -53.36 -24.32 27.07 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.847 3.031 . . . . 70.409999999999997 114.595 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.63 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 71.2 t -60.4 -39.83 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 122.158 0.98 . . . . 65.109999999999999 110.405 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.18 -30.47 67.6 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.052 -0.976 . . . . 74.209999999999994 110.381 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.17 77.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 71.340000000000003 111.422 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.71 -36.27 82.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.932 -0.307 . . . . 64.439999999999998 111.599 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -66.57 -29.13 69.12 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.68 0.752 . . . . 73.120000000000005 109.963 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.89 0.38 53.24 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.883 -1.053 . . . . 44.43 111.608 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.7 t60 64.55 28.7 13.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 122.868 1.318 . . . . 51.420000000000002 109.572 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -95.02 25.13 4.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.788 1.28 . . . . 73.120000000000005 108.282 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -53.89 -29.39 41.55 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.508 -1.678 . . . . 54.439999999999998 113.491 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -63.61 -37.55 87.75 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.931 -0.766 . . . . 71.140000000000001 108.931 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -63.18 -42.56 99.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.231 -0.895 . . . . 70.129999999999995 109.173 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.43 -47.93 87.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.585 -0.734 . . . . 71.299999999999997 110.342 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 134' ' ' ALA . 99.1 t -59.38 -44.77 93.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.434 -0.348 . . . . 73.299999999999997 111.416 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -63.68 -38.4 90.96 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.944 -0.702 . . . . 74.140000000000001 111.361 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -69.0 -36.52 77.91 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.829 -0.434 . . . . 72.109999999999999 109.829 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.37 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.717 -0.674 . . . . 73.099999999999994 109.877 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.74 -42.88 94.18 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.939 -0.573 . . . . 52.450000000000003 111.015 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.68 -25.96 65.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.23 0.538 . . . . 52.119999999999997 111.486 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.486 ' HG3' ' CD1' ' A' ' 101' ' ' TRP . 0.5 OUTLIER -82.18 -39.75 22.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.449 0.642 . . . . 61.109999999999999 109.421 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -81.54 -40.75 22.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.782 0.66 . . . . 75.420000000000002 112.782 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 109.453 -0.573 . . . . 74.239999999999995 109.453 -177.873 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 106.361 -1.718 . . . . 73.040000000000006 106.361 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.6 -110.96 2.97 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.581 -0.819 . . . . 71.030000000000001 113.327 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.36 123.18 38.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.256 0.55 . . . . 75.129999999999995 111.879 -171.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 23' ' ' LEU . 3.5 t70 -61.29 131.94 51.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.285 -0.871 . . . . 71.209999999999994 111.75 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.06 -4.78 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 122.07 0.938 . . . . 72.109999999999999 109.29 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 17.6 mt -74.98 165.15 25.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.618 1.199 . . . . 72.319999999999993 113.941 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.3 t70 -94.26 134.66 25.37 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 105.314 -2.106 . . . . 72.129999999999995 105.314 172.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.84 -21.75 27.14 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 123.406 2.738 . . . . 52.520000000000003 114.572 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.86 -23.85 23.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.208 0.447 . . . . 54.43 112.208 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 23.2 mm-40 -65.87 139.22 96.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.07 -0.252 . . . . 65.530000000000001 111.676 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.1 128.0 28.36 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.351 2.701 . . . . 71.129999999999995 113.102 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.5 p -122.94 170.07 10.5 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 121.629 0.728 . . . . 73.319999999999993 111.484 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 24.9 m-85 -130.36 161.21 31.83 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 126.401 1.88 . . . . 71.299999999999997 107.851 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 66.3 t0 -135.03 161.74 34.44 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 103.346 -2.835 . . . . 73.150000000000006 103.346 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 mt -53.12 -51.44 75.05 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 112.672 0.619 . . . . 72.409999999999997 112.672 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.31 -35.37 98.77 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.161 1.907 . . . . 55.509999999999998 112.2 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 13.5 tpt180 -70.78 -38.54 73.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.48 -0.327 . . . . 73.430000000000007 110.697 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 66' ' ' ILE . 59.5 t -68.15 -37.46 78.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.602 -0.518 . . . . 53.210000000000001 109.602 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.89 81.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.289 -0.869 . . . . 64.439999999999998 109.68 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.8 -45.96 80.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.203 -0.908 . . . . 45.240000000000002 109.68 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.417 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 49.7 tp -62.31 -50.66 70.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.906 -1.043 . . . . 71.340000000000003 112.3 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.43 -13.92 41.94 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.469 0.544 . . . . 73.120000000000005 112.469 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.44 31.5 56.72 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 110.947 -0.861 . . . . 73.319999999999993 110.947 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.6 m -121.98 161.26 43.38 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.529 -0.915 . . . . 75.239999999999995 108.529 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.07 163.47 35.13 Favored 'Trans proline' 0 C--O 1.262 1.681 0 C-N-CA 121.393 1.395 . . . . 63.119999999999997 111.673 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.19 -33.21 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.82 0.848 . . . . 70.420000000000002 109.526 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 13.4 m -57.03 -44.38 82.86 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.728 -1.124 . . . . 63.399999999999999 110.617 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 51.8 mtpt -69.4 -32.04 70.79 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.101 -0.374 . . . . 71.420000000000002 111.425 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.485 ' HA ' HE21 ' A' ' 49' ' ' GLN . 47.2 t -62.43 -44.38 99.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 109.593 -0.521 . . . . 74.219999999999999 109.593 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.83 81.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 64.519999999999996 109.996 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 44' ' ' SER . 25.7 mt-30 -64.51 -41.43 96.43 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 116.275 -0.42 . . . . 74.319999999999993 111.543 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.485 HE21 ' HA ' ' A' ' 46' ' ' VAL . 43.7 mt-30 -61.04 -42.14 97.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.802 0.81 . . . . 74.319999999999993 109.961 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.24 -41.19 98.2 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.074 -1.421 . . . . 72.530000000000001 109.696 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -71.57 -21.97 61.81 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.77 -0.65 . . . . 74.019999999999996 112.291 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 50.9 mt-10 -81.71 -12.68 58.53 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 122.103 -0.373 . . . . 61.109999999999999 110.64 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.2 23.35 77.73 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.52 -1.032 . . . . 74.310000000000002 110.52 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -109.26 5.54 23.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.394 0.616 . . . . 74.450000000000003 110.523 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 tp -153.6 151.57 29.88 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.279 -1.749 . . . . 75.510000000000005 106.279 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.01 148.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.317 -0.623 . . . . 73.109999999999999 109.317 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB2' HG12 ' A' ' 66' ' ' ILE . . . -141.62 161.8 37.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.972 -0.751 . . . . 44.420000000000002 108.972 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.63 160.31 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 123.343 0.402 . . . . 60.420000000000002 110.445 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 40.2 ttm180 -115.34 117.84 31.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.393 0.616 . . . . 75.040000000000006 111.698 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 26.2 ptt180 -127.96 130.07 47.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.077 -0.712 . . . . 75.0 109.077 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.05 21.63 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.945 0.898 . . . . 74.049999999999997 110.384 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.14 -15.06 64.02 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.841 -0.618 . . . . 42.240000000000002 112.731 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.45 143.1 16.52 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.02 -0.61 . . . . 32.420000000000002 112.244 -177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.14 121.41 47.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 109.366 -0.605 . . . . 72.219999999999999 109.366 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.43 152.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.605 -0.725 . . . . 74.230000000000004 110.892 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 57' ' ' ALA . 78.9 mt -115.1 133.48 22.67 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.283 -1.006 . . . . 72.239999999999995 108.283 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.12 130.33 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.755 1.637 . . . . 72.510000000000005 111.156 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.432 HE21 ' HB2' ' A' ' 68' ' ' GLN . 7.2 tt0 -62.59 -24.56 67.62 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.164 0.507 . . . . 73.019999999999996 111.181 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -67.38 -6.97 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.684 -0.689 . . . . 63.340000000000003 112.707 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.571 ' CD2' HD11 ' A' ' 81' ' ' LEU . 5.2 m-85 -81.56 -11.24 59.23 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.217 1.008 . . . . 65.310000000000002 109.24 173.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -113.06 164.2 13.77 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.676 -1.147 . . . . 73.340000000000003 108.291 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.49 ' HA ' ' CD2' ' A' ' 130' ' ' HIS . 37.5 p -82.34 165.97 19.87 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.131 -0.692 . . . . 74.120000000000005 109.131 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -64.71 -19.14 65.59 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.047 -0.524 . . . . 72.209999999999994 109.627 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 m -79.51 -19.9 48.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.576 -0.738 . . . . 71.310000000000002 110.229 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.46 -5.96 38.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.436 -0.888 . . . . 70.530000000000001 113.75 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.84 166.2 11.74 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.086 -0.655 . . . . 74.129999999999995 109.489 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.05 139.91 20.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.757 -0.831 . . . . 64.150000000000006 108.757 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.76 136.74 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.231 -1.026 . . . . 75.400000000000006 108.231 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -54.77 -36.56 64.98 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 112.535 0.569 . . . . 52.219999999999999 112.535 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -88.11 -0.76 57.46 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.638 0.607 . . . . 64.439999999999998 112.638 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 70' ' ' PHE . 20.3 tp -65.36 -53.64 37.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.37 -0.348 . . . . 64.409999999999997 111.809 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 38.6 Cg_exo -60.28 -30.9 92.12 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.694 1.596 . . . . 73.329999999999998 111.304 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.49 90.01 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.864 -0.607 . . . . 71.040000000000006 112.838 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 pp -68.39 -40.5 81.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.394 0.616 . . . . 72.430000000000007 109.355 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.34 -41.28 98.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.591 -0.731 . . . . 60.310000000000002 110.833 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -57.77 -47.72 81.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.477 -0.329 . . . . 71.400000000000006 111.795 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -42.11 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 120.812 -0.355 . . . . 65.430000000000007 111.345 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.36 -37.17 82.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.467 0.543 . . . . 75.319999999999993 112.467 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -66.83 -32.29 73.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.664 -0.244 . . . . 74.349999999999994 111.08 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.19 -29.91 71.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.294 0.569 . . . . 63.25 109.778 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.77 6.42 64.71 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.556 -0.747 . . . . 54.409999999999997 112.394 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.31 33.43 84.98 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.465 0.546 . . . . 73.150000000000006 114.465 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 57.8 m-85 -85.85 131.63 34.27 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 117.626 0.713 . . . . 75.329999999999998 112.344 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.566 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 21.8 ptt180 -73.32 170.45 15.01 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-N 115.345 -0.843 . . . . 75.450000000000003 111.215 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -55.02 -44.84 74.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 125.899 1.679 . . . . 54.310000000000002 112.013 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.9 m -62.64 -42.1 99.41 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.085 -0.961 . . . . 72.540000000000006 110.628 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.566 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 61.7 mm-40 -66.6 -34.74 78.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.108 -0.496 . . . . 61.310000000000002 110.328 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.46 -48.42 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.741 0.781 . . . . 74.340000000000003 108.93 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 55.1 mtt -75.13 -18.43 60.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.91 -1.041 . . . . 73.150000000000006 111.894 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -60.73 -63.46 1.29 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.989 -0.55 . . . . 72.129999999999995 110.574 -174.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.514 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 31.3 p-90 -69.32 -32.82 72.19 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.129 0.418 . . . . 73.430000000000007 112.129 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 12.2 mt -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.95 1.093 . . . . 74.340000000000003 113.95 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.402 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 84.0 m-85 -95.75 -2.95 46.75 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.008 0.744 . . . . 72.430000000000007 113.008 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 m -88.57 109.79 32.0 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 110.193 -0.299 . . . . 60.200000000000003 110.193 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 42.9 Cg_exo -60.09 144.66 99.46 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.892 2.395 . . . . 75.049999999999997 111.626 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 11.0 t70 -107.47 124.0 36.37 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.626 -0.509 . . . . 71.319999999999993 109.626 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.526 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 28.3 Cg_endo -60.62 -25.83 81.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.658 2.905 . . . . 65.340000000000003 114.513 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.6 m -102.41 1.49 35.43 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.984 0.421 . . . . 74.209999999999994 110.247 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.493 ' HG ' HG12 ' A' ' 111' ' ' ILE . 43.0 tp -101.66 130.58 48.04 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.601 -0.518 . . . . 63.509999999999998 109.601 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 m -128.04 110.54 12.59 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.802 -0.814 . . . . 63.520000000000003 108.802 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.493 HG12 ' HG ' ' A' ' 109' ' ' LEU . 39.9 mm . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 115.288 -0.869 . . . . 74.239999999999995 109.88 -172.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.432 -1.364 0 N-CA-C 109.342 -0.614 . . . . 73.400000000000006 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -83.04 148.87 27.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.746 -1.575 . . . . 61.149999999999999 106.746 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 34.2 m-80 66.99 41.37 2.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 123.828 0.851 . . . . 75.310000000000002 109.08 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.63 150.38 26.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.463 -0.495 . . . . 63.350000000000001 110.754 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -80.36 128.1 73.96 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.629 -0.878 . . . . 75.349999999999994 108.629 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.53 -24.1 8.7 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.063 3.175 . . . . 75.439999999999998 115.11 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.6 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.1 t -60.62 -39.1 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.267 0.556 . . . . 74.120000000000005 110.419 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -69.95 -30.27 67.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.187 -0.461 . . . . 74.209999999999994 111.149 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.36 82.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.699 -0.682 . . . . 73.109999999999999 111.17 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -63.95 -37.68 88.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.501 0.191 . . . . 74.200000000000003 111.307 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.49 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 61.1 t-80 -68.7 -36.79 78.92 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.741 -0.663 . . . . 73.319999999999993 109.301 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.14 21.2 5.25 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.342 -0.845 . . . . 74.129999999999995 112.773 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.8 t60 64.69 27.64 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.77 1.228 . . . . 70.400000000000006 111.361 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -110.53 24.42 12.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.965 1.364 . . . . 62.240000000000002 107.635 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.62 -25.91 12.07 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 112.416 -2.174 . . . . 74.319999999999993 112.627 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -54.78 -39.33 68.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.54 0.736 . . . . 54.340000000000003 110.75 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.35 -33.71 74.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.383 0.611 . . . . 73.420000000000002 111.072 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 129' ' ' LEU . 49.7 t -72.59 -41.96 63.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.48 -0.782 . . . . 75.239999999999995 109.651 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.7 -48.06 89.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.234 -0.439 . . . . 71.540000000000006 110.264 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -63.59 -37.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.746 -0.382 . . . . 70.349999999999994 111.428 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -65.02 -41.58 95.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.644 -0.873 . . . . 71.239999999999995 108.644 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.47 -45.08 88.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.103 -0.953 . . . . 74.230000000000004 110.262 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -62.13 -38.62 89.65 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.844 -0.616 . . . . 74.340000000000003 111.248 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.21 84.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.05 0.453 . . . . 71.329999999999998 110.51 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.8 tpt -69.64 -39.28 77.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.809 -0.632 . . . . 61.020000000000003 110.736 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.94 -53.79 5.08 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.353 0.872 . . . . 62.25 113.353 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 118.691 -0.671 . . . . 73.109999999999999 109.426 -176.189 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 N-CA-C 107.963 -1.125 . . . . 65.230000000000004 107.963 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -105.4 -86.72 1.94 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.336 -0.935 . . . . 65.519999999999996 112.796 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -127.53 143.54 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.832 0.349 . . . . 74.230000000000004 111.123 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.82 139.07 41.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.553 0.692 . . . . 72.409999999999997 112.369 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.9 t -112.12 -14.9 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.295 -0.866 . . . . 74.109999999999999 110.894 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.485 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -96.09 -179.63 4.74 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.922 -1.111 . . . . 65.099999999999994 111.657 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.64 137.08 19.36 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 108.05 -1.093 . . . . 73.519999999999996 108.05 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.88 -21.35 15.22 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.571 2.848 . . . . 62.549999999999997 114.191 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.05 -19.52 61.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.085 0.469 . . . . 64.129999999999995 111.51 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -88.5 154.68 51.16 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 119.296 -0.383 . . . . 75.319999999999993 110.017 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 4.0 Cg_endo -46.24 110.13 0.25 Allowed 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.984 3.123 . . . . 54.299999999999997 114.992 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.0 p -125.0 167.34 14.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.794 0.838 . . . . 75.409999999999997 110.686 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.499 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 13.0 m-85 -131.4 158.2 41.39 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.307 1.043 . . . . 72.209999999999994 108.193 169.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.5 t70 -136.95 168.82 18.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 104.281 -2.488 . . . . 62.32 104.281 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -50.6 -56.61 17.65 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 113.964 1.098 . . . . 61.43 113.964 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 14.6 Cg_endo -57.74 -39.8 84.53 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.205 1.936 . . . . 72.549999999999997 112.346 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -70.38 -37.54 74.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 111.972 0.36 . . . . 65.420000000000002 111.972 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 31' ' ' ASP . 46.1 t -69.3 -37.64 76.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.061 -0.718 . . . . 72.030000000000001 109.061 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.14 83.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.889 -1.051 . . . . 52.409999999999997 109.704 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.7 -45.94 84.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.875 0.87 . . . . 73.109999999999999 110.061 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -62.07 -43.33 99.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.84 -1.073 . . . . 53.409999999999997 111.903 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' A' ' 41' ' ' VAL . 83.5 mt -97.31 -12.56 22.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.939 -0.573 . . . . 72.010000000000005 112.097 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 17.15 80.18 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.538 -0.625 . . . . 71.109999999999999 111.538 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 39' ' ' LEU . 25.8 m -112.48 159.45 34.05 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.73 -0.841 . . . . 71.329999999999998 108.73 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.4 170.01 20.16 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 121.208 1.272 . . . . 72.010000000000005 111.246 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.08 -33.16 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.387 0.675 . . . . 71.140000000000001 110.484 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 m -56.35 -46.33 80.03 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 114.916 -1.038 . . . . 75.420000000000002 110.197 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 92.5 mttt -69.97 -35.27 74.32 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.032 0.382 . . . . 75.140000000000001 112.032 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -61.15 -43.72 96.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 N-CA-C 109.548 -0.538 . . . . 73.510000000000005 109.548 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' O ' ' HD3' ' A' ' 51' ' ' ARG . . . -61.04 -38.88 87.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.423 -0.808 . . . . 74.530000000000001 109.833 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 13.3 mm100 -66.84 -36.35 82.13 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 112.91 0.707 . . . . 74.129999999999995 112.91 178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.0 mm100 -57.87 -42.8 85.3 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.726 -0.842 . . . . 74.0 108.726 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.53 -40.61 97.33 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.4 -1.273 . . . . 64.030000000000001 110.662 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 47' ' ' ALA . 10.2 mpt_? -71.21 -20.87 62.21 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.228 0.825 . . . . 75.209999999999994 113.228 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 44.5 mm-40 -76.66 -11.87 59.92 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 120.525 -0.47 . . . . 75.010000000000005 109.824 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.72 72.15 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.944 -0.863 . . . . 61.340000000000003 110.944 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -105.46 4.28 30.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.119 -0.541 . . . . 74.109999999999999 110.206 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD21 HD13 ' A' ' 66' ' ' ILE . 32.2 tp -161.12 157.51 26.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.612 -0.884 . . . . 41.409999999999997 108.612 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 93.9 t -132.82 147.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.362 -0.977 . . . . 53.140000000000001 108.362 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.72 157.85 43.85 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.886 -0.783 . . . . 73.0 108.886 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -130.46 166.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 122.92 0.488 . . . . 74.439999999999998 110.21 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 43.8 ttp180 -121.07 125.68 47.91 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.59 -0.277 . . . . 62.130000000000003 110.801 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.486 ' NH1' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -116.62 117.09 28.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.69 -0.855 . . . . 70.420000000000002 108.69 177.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.96 -48.06 0.68 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.083 1.753 . . . . 44.439999999999998 111.583 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 63' ' ' GLY . . . -176.23 -12.07 0.02 OUTLIER Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.738 -1.119 . . . . 53.130000000000003 112.287 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 62' ' ' GLY . . . -103.53 146.06 16.35 Favored Glycine 0 CA--C 1.493 -1.339 0 C-N-CA 120.634 -0.793 . . . . 71.329999999999998 112.122 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.49 128.8 47.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.203 0.525 . . . . 72.219999999999999 109.771 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG13 ' NH1' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -131.54 158.75 43.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.698 1.199 . . . . 72.25 110.107 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.414 HD13 HD21 ' A' ' 55' ' ' LEU . 65.2 mt -124.77 121.93 25.64 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.114 -1.439 . . . . 63.130000000000003 107.114 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.67 126.67 22.54 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.057 1.838 . . . . 73.030000000000001 111.192 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.499 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.7 tt0 -62.22 -24.65 67.36 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 121.261 0.553 . . . . 74.430000000000007 111.447 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.68 -4.54 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.092 -0.958 . . . . 54.310000000000002 112.665 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.1 m-85 -86.29 -7.64 58.34 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.073 0.939 . . . . 74.430000000000007 109.848 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -117.11 159.98 21.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.119 . . . . 74.129999999999995 107.994 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.0 p -88.02 163.37 16.32 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.823 -1.177 . . . . 62.509999999999998 107.823 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -66.26 -16.45 64.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.305 0.574 . . . . 72.430000000000007 110.382 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.2 m -79.72 -9.5 59.66 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.777 -0.647 . . . . 74.219999999999999 110.898 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.86 -2.43 66.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.304 -0.474 . . . . 51.420000000000002 113.164 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -90.37 152.84 20.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.505 -0.554 . . . . 71.109999999999999 109.505 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.53 136.19 26.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.259 -1.386 . . . . 72.310000000000002 107.259 171.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 129' ' ' LEU . 23.8 t -61.25 129.06 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.443 -0.947 . . . . 45.520000000000003 108.443 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.41 -22.33 66.08 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.751 0.648 . . . . 72.0 112.751 -177.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.441 ' H ' HG12 ' A' ' 78' ' ' VAL . 7.1 m -87.75 -8.21 56.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.963 -0.562 . . . . 64.239999999999995 110.777 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 18.0 tp -63.45 -56.44 26.77 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 119.015 -0.517 . . . . 54.119999999999997 111.248 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.0 Cg_exo -62.83 -25.2 74.51 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.331 1.354 . . . . 72.329999999999998 110.706 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -45.36 64.57 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.602 -0.726 . . . . 45.439999999999998 111.721 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.81 -40.43 79.54 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.996 -0.742 . . . . 73.239999999999995 108.996 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 74.0 mt -59.91 -39.17 84.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.766 -0.652 . . . . 65.420000000000002 110.802 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.2 m -61.47 -48.36 81.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.054 -0.521 . . . . 71.340000000000003 111.399 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -44.41 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 111.862 0.319 . . . . 74.319999999999993 111.862 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.27 -35.79 80.24 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 120.177 -0.609 . . . . 62.350000000000001 112.225 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -64.27 -41.48 96.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.616 -0.883 . . . . 70.040000000000006 108.616 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.19 -31.2 72.25 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.96 -1.018 . . . . 74.530000000000001 110.58 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.38 -9.45 81.77 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.64 -0.709 . . . . 60.450000000000003 112.893 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.9 46.09 7.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.088 -0.577 . . . . 72.329999999999998 113.723 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.439 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 96.6 m-85 -111.0 142.92 42.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.895 -0.409 . . . . 74.019999999999996 109.895 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.476 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 16.9 ptp180 -87.94 171.03 10.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.558 -0.292 . . . . 74.310000000000002 111.141 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -55.05 -45.79 75.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.856 1.262 . . . . 65.0 111.87 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.8 m -64.5 -39.99 94.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.188 -0.915 . . . . 72.5 110.41 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 45.3 mt-10 -65.82 -35.1 79.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.079 -0.51 . . . . 74.209999999999994 111.615 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.28 -46.97 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.855 -1.165 . . . . 74.409999999999997 107.855 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -66.33 -28.64 68.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.028 -1.442 . . . . 64.120000000000005 111.029 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.0 -67.33 0.27 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 122.877 0.471 . . . . 75.310000000000002 111.037 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.457 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.3 p-90 -69.05 -32.1 71.35 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.89 0.7 . . . . 75.420000000000002 112.89 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 126' ' ' VAL . 13.6 mt -61.22 -40.78 95.3 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 113.097 0.777 . . . . 72.420000000000002 113.097 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.5 m-85 -91.46 -5.4 54.35 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.803 0.668 . . . . 74.25 112.803 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 92.4 m -78.15 119.94 79.29 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.963 -0.754 . . . . 71.329999999999998 108.963 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.14 129.5 20.68 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.579 1.519 . . . . 74.400000000000006 109.426 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 34.4 t70 -105.41 116.59 60.0 Favored Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 116.388 -0.369 . . . . 74.150000000000006 111.012 -175.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.19 -25.26 80.56 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.728 2.286 . . . . 70.209999999999994 112.084 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -17.72 59.63 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.931 -0.577 . . . . 62.420000000000002 110.511 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.96 125.63 48.69 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.766 0.793 . . . . 65.299999999999997 110.828 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 m -131.28 110.87 11.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.365 -1.346 . . . . 64.209999999999994 107.365 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 CA--C 1.476 -1.872 0 N-CA-C 112.739 0.644 . . . . 64.120000000000005 112.739 -174.33 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 109.097 -0.705 . . . . 72.239999999999995 109.097 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 m -90.1 138.66 31.33 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.775 -1.194 . . . . 73.439999999999998 107.775 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 44.6 t-20 69.39 59.23 0.32 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.34 1.067 . . . . 70.510000000000005 109.134 176.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.66 164.09 11.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.689 -1.141 . . . . 74.219999999999999 109.9 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -87.55 145.85 38.17 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.464 -0.569 . . . . 70.109999999999999 109.464 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.402 ' HB2' HD23 ' A' ' 102' ' ' LEU . 79.7 Cg_exo -52.53 -28.84 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.403 2.735 . . . . 75.329999999999998 113.708 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.654 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 95.8 t -60.34 -41.99 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.242 0.544 . . . . 73.310000000000002 110.146 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -65.01 -30.04 70.99 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.601 0.715 . . . . 72.530000000000001 109.796 -172.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.23 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.222 -0.899 . . . . 63.149999999999999 112.316 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 3.9 pp -68.14 -34.29 76.07 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.464 -0.494 . . . . 71.25 110.333 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -65.38 -31.85 73.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.722 -0.844 . . . . 73.230000000000004 108.722 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.74 8.28 20.4 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.785 -1.098 . . . . 72.420000000000002 111.961 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 64.06 28.32 14.26 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 123.011 1.386 . . . . 73.209999999999994 109.716 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.57 25.59 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.652 -1.158 . . . . 51.5 108.956 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.93 14.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.434 1.494 . . . . 74.120000000000005 112.212 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -56.44 -31.95 64.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.316 0.246 . . . . 72.319999999999993 111.659 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.42 -26.87 61.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 74.439999999999998 110.773 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.46 -45.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.562 -1.273 . . . . 44.450000000000003 107.562 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.48 HG12 HE21 ' A' ' 142' ' ' GLN . 58.7 t -62.26 -42.41 95.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.564 -1.198 . . . . 65.109999999999999 109.692 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -58.78 -45.31 90.11 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.44 0.696 . . . . 54.210000000000001 110.354 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.1 tpp180 -66.16 -41.28 90.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.161 -0.681 . . . . 74.340000000000003 109.161 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.58 88.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 55.340000000000003 111.118 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.48 HE21 HG12 ' A' ' 138' ' ' VAL . 79.3 mt-30 -62.16 -41.58 98.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 72.200000000000003 110.536 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.67 -27.45 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 70.230000000000004 112.113 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 93.8 mmm -86.0 -32.03 21.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 73.219999999999999 110.347 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.439 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.5 -60.1 2.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.322 -0.399 . . . . 73.540000000000006 112.062 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 109.249 -0.649 . . . . 72.310000000000002 109.249 -176.28 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.756 0 N-CA-C 108.503 -0.925 . . . . 53.229999999999997 108.503 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.01 -156.85 12.87 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 120.456 -0.878 . . . . 70.129999999999995 113.542 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -96.08 136.19 36.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.915 -0.642 . . . . 75.040000000000006 109.415 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.5 101.55 0.19 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.617 0.723 . . . . 74.319999999999993 111.761 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.95 -40.4 83.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.311 -0.859 . . . . 74.219999999999999 110.951 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 173.16 10.63 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.98 -0.554 . . . . 73.219999999999999 109.916 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.31 138.44 52.13 Favored Pre-proline 0 C--N 1.291 -1.957 0 N-CA-C 108.463 -0.94 . . . . 75.5 108.463 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.63 -21.71 8.27 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 123.344 2.696 . . . . 71.340000000000003 115.676 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.52 4.99 53.15 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.378 0.51 . . . . 75.040000000000006 112.378 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -84.53 158.18 60.45 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 110.03 -0.359 . . . . 72.109999999999999 110.03 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.406 ' C ' ' HG3' ' A' ' 68' ' ' GLN . 61.6 Cg_exo -42.85 106.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 124.177 3.251 . . . . 62.219999999999999 113.879 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.42 ' N ' ' HG3' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -135.41 148.58 49.38 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 113.073 0.768 . . . . 71.409999999999997 113.073 -176.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.45 ' CD2' ' HG2' ' A' ' 68' ' ' GLN . 30.2 m-85 -116.32 162.22 17.85 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 126.34 1.856 . . . . 64.530000000000001 106.997 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.1 m-20 -132.1 161.76 32.49 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 104.81 -2.293 . . . . 71.109999999999999 104.81 -174.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.1 mt -45.28 -56.06 10.23 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 113.384 0.883 . . . . 70.409999999999997 113.384 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.28 -35.2 85.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.444 1.43 . . . . 70.340000000000003 112.158 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 4.3 tpt180 -70.28 -36.19 74.22 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.022 0.439 . . . . 73.150000000000006 110.226 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.86 -37.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.847 0.356 . . . . 63.43 110.047 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.86 76.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.266 -0.642 . . . . 63.299999999999997 109.266 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 8.9 mm-40 -63.41 -45.23 91.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 65.310000000000002 111.697 173.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 91.1 mt -64.14 -50.13 69.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.082 0.468 . . . . 73.430000000000007 111.234 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.1 mt -81.59 -18.87 43.27 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.474 -0.784 . . . . 74.140000000000001 112.231 -174.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.16 31.83 69.15 Favored Glycine 0 C--O 1.239 0.447 0 N-CA-C 111.301 -0.719 . . . . 63.229999999999997 111.301 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 39' ' ' LEU . 24.4 m -127.84 161.55 54.9 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.177 -0.675 . . . . 73.049999999999997 109.177 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 27.8 Cg_endo -64.83 153.93 75.45 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 121.795 1.663 . . . . 72.140000000000001 112.069 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.89 -36.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.619 -0.719 . . . . 52.219999999999999 110.685 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 32.5 t -63.22 -33.93 76.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.144 -0.48 . . . . 73.030000000000001 110.961 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 62.3 tttp -69.53 -35.04 75.1 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.51 -0.552 . . . . 75.010000000000005 109.51 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 61.1 t -63.35 -41.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.837 -0.801 . . . . 63.210000000000001 108.837 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.99 -36.98 80.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.784 -0.643 . . . . 61.520000000000003 110.425 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 44' ' ' SER . 27.8 mm-40 -69.19 -35.88 76.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.714 0.292 . . . . 73.430000000000007 110.266 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.8 mt-30 -64.05 -43.18 96.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.617 0.723 . . . . 73.150000000000006 109.608 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.3 mt -61.92 -40.59 95.99 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.452 -1.249 . . . . 71.329999999999998 109.412 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -61.52 -31.75 71.77 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.184 0.593 . . . . 71.439999999999998 111.781 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.27 -12.05 53.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.177 0.436 . . . . 74.530000000000001 112.177 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.9 58.57 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.967 -1.253 . . . . 73.340000000000003 109.967 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -82.77 -23.38 33.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.787 -1.19 . . . . 63.32 107.787 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -156.76 159.28 38.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.113 -1.81 . . . . 62.420000000000002 106.113 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.34 158.72 41.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.818 -0.438 . . . . 73.099999999999994 109.818 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.02 156.19 44.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.278 0.561 . . . . 71.239999999999995 111.969 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.41 165.81 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 123.671 0.789 . . . . 73.129999999999995 110.52 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 50.7 ttp180 -114.65 125.98 54.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.024 0.379 . . . . 60.310000000000002 112.024 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.518 ' NE ' HG11 ' A' ' 65' ' ' VAL . 30.9 ptt180 -116.25 113.63 23.29 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.813 -0.81 . . . . 75.109999999999999 108.813 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.11 9.55 0.68 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.326 1.05 . . . . 53.25 113.361 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.86 -28.95 4.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 121.346 -0.454 . . . . 64.140000000000001 111.988 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -84.12 141.34 19.91 Favored Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 121.337 -0.459 . . . . 74.420000000000002 112.367 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.9 t -97.24 120.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.775 -1.195 . . . . 71.129999999999995 107.775 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.518 HG11 ' NE ' ' A' ' 60' ' ' ARG . 18.8 m -133.39 159.77 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.035 -0.984 . . . . 72.239999999999995 112.974 -171.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.83 126.11 22.42 Favored Pre-proline 0 N--CA 1.434 -1.25 0 N-CA-C 106.75 -1.574 . . . . 73.310000000000002 106.75 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.32 130.49 36.18 Favored 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 122.632 2.221 . . . . 64.209999999999994 112.721 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 71.2 mt-30 -53.94 -25.22 19.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.13 0.789 . . . . 51.210000000000001 113.13 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.83 -11.48 13.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.945 -0.57 . . . . 31.52 112.299 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.8 m-85 -85.31 -5.23 59.33 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.593 0.757 . . . . 73.140000000000001 110.367 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.41 155.11 29.1 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.6 -0.727 . . . . 72.219999999999999 110.056 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.6 p -75.78 175.89 8.28 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.002 -0.999 . . . . 74.120000000000005 109.516 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -59.48 -19.38 47.43 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.224 0.61 . . . . 74.219999999999999 111.212 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t -87.43 -8.57 56.36 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.159 0.584 . . . . 73.140000000000001 110.667 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.54 25.92 55.54 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.351 -0.7 . . . . 74.109999999999999 111.351 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -115.76 157.7 23.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.108 -0.701 . . . . 74.019999999999996 109.108 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.28 128.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.385 -0.598 . . . . 74.010000000000005 109.385 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 25.0 t -61.25 121.41 9.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 108.039 -1.097 . . . . 65.010000000000005 108.039 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -59.96 -22.28 62.3 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 113.826 1.047 . . . . 74.450000000000003 113.826 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.5 m -87.68 -15.93 35.79 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.258 0.552 . . . . 54.210000000000001 110.987 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.546 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.6 tt -66.46 -45.91 58.85 Favored Pre-proline 0 CA--C 1.565 1.534 0 N-CA-C 115.157 1.54 . . . . 60.450000000000003 115.157 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.35 -28.43 62.97 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.401 2.067 . . . . 74.530000000000001 112.045 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.58 -42.93 98.68 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.65 -0.705 . . . . 73.230000000000004 112.265 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.53 -40.58 80.67 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.542 -0.54 . . . . 74.329999999999998 109.542 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.61 -37.67 87.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 64.329999999999998 110.777 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.3 m -68.55 -40.05 80.84 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.75 -0.659 . . . . 74.219999999999999 112.138 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -42.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 119.935 -0.706 . . . . 65.349999999999994 110.5 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.489 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.4 mm? -67.31 -36.44 81.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.291 -0.564 . . . . 73.450000000000003 112.191 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -65.14 -36.99 85.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.145 -0.687 . . . . 73.040000000000006 109.145 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.56 -30.81 70.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.415 0.626 . . . . 75.239999999999995 110.146 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.18 -9.45 86.59 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.284 -0.871 . . . . 61.509999999999998 112.332 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.35 24.0 32.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.25 -0.5 . . . . 52.43 113.129 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -99.59 133.45 43.89 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 122.532 -0.393 . . . . 72.420000000000002 110.425 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -88.12 173.4 8.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.582 0.23 . . . . 74.209999999999994 111.304 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.8 -45.74 63.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.057 1.343 . . . . 71.430000000000007 113.701 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.3 m -62.69 -41.57 99.18 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.607 0.763 . . . . 74.5 110.42 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.56 -38.37 89.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.415 -0.811 . . . . 74.209999999999994 110.585 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.416 HD12 ' CB ' ' A' ' 88' ' ' LEU . 7.1 mm -61.3 -47.3 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.742 -1.207 . . . . 73.549999999999997 107.742 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.62 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 76.2 mtm -74.17 -15.48 61.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.311 -1.313 . . . . 61.130000000000003 113.649 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -56.98 -65.77 0.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.879 -0.415 . . . . 75.420000000000002 109.879 177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.422 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.4 p-90 -69.07 -32.81 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.68 0.622 . . . . 75.430000000000007 112.68 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' HB2' ' A' ' 125' ' ' PRO . 13.4 mt -60.79 -40.8 93.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.177 0.806 . . . . 74.200000000000003 113.177 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -87.76 -9.38 54.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 112.561 0.578 . . . . 62.509999999999998 112.561 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 m -88.04 122.9 69.72 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 108.781 -0.822 . . . . 75.209999999999994 108.781 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.76 129.55 35.61 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.639 1.559 . . . . 73.340000000000003 108.98 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.8 t70 -90.21 121.08 69.02 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.386 -0.598 . . . . 54.329999999999998 109.386 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.55 -16.67 49.46 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.282 2.654 . . . . 71.340000000000003 113.74 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -110.98 6.79 21.29 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 121.949 -0.469 . . . . 51.32 111.076 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.0 tp -102.87 126.06 49.86 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.727 -0.789 . . . . 74.340000000000003 111.209 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -126.3 118.23 24.67 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.652 -1.981 . . . . 75.540000000000006 105.652 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 128' ' ' ALA . 16.8 pt . . . . . 0 CA--C 1.48 -1.729 0 O-C-N 123.34 0.4 . . . . 72.099999999999994 111.678 -174.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 N--CA 1.435 -1.206 0 N-CA-C 107.774 -1.195 . . . . 72.400000000000006 107.774 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 p -87.85 146.64 25.49 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.455 0.472 . . . . 75.25 110.3 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 2.9 m-20 61.81 68.32 0.7 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.576 1.15 . . . . 72.219999999999999 111.377 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -119.52 170.5 9.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.948 -1.024 . . . . 63.039999999999999 110.965 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -78.03 134.22 64.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 116.001 -0.545 . . . . 74.109999999999999 109.745 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.736 ' HB2' HD23 ' A' ' 102' ' ' LEU . 73.7 Cg_exo -56.34 -28.48 72.44 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.171 1.914 . . . . 72.420000000000002 111.488 172.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.576 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 51.4 t -66.2 -34.43 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.623 0.725 . . . . 73.219999999999999 109.622 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.93 -32.37 70.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.69 -0.856 . . . . 74.439999999999998 108.69 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.522 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -69.6 -35.5 75.36 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 114.942 -1.027 . . . . 64.439999999999998 112.519 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.83 -36.58 78.38 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.139 -0.624 . . . . 74.519999999999996 111.49 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.4 ' N ' HD12 ' A' ' 129' ' ' LEU . 9.4 t-160 -77.71 -15.58 59.05 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.732 0.777 . . . . 73.209999999999994 108.939 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -87.78 4.68 43.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 35.039999999999999 110.139 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.5 m80 63.7 27.72 14.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.594 1.158 . . . . 74.409999999999997 111.307 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -106.71 26.19 10.31 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.267 -1.333 . . . . 61.439999999999998 110.886 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -51.51 -28.56 13.9 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 114.156 -1.383 . . . . 73.430000000000007 113.665 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -39.44 86.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.029 0.831 . . . . 73.420000000000002 111.82 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.421 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -63.98 -32.88 74.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.383 0.611 . . . . 74.430000000000007 110.087 177.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.97 -48.11 51.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.331 -0.849 . . . . 73.219999999999999 109.311 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 134' ' ' ALA . 86.6 t -60.47 -44.5 96.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 CA-C-N 115.715 -0.675 . . . . 64.150000000000006 110.994 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.421 ' NH2' ' HG3' ' A' ' 136' ' ' GLU . 14.8 ptt180 -63.84 -37.99 89.44 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.336 -0.546 . . . . 63.299999999999997 112.247 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -64.27 -39.81 94.7 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.76 -0.376 . . . . 75.400000000000006 110.35 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -61.46 -46.5 89.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.696 -0.684 . . . . 74.439999999999998 110.379 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.99 -45.45 94.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.706 -0.679 . . . . 74.239999999999995 110.757 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.93 65.24 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.494 . . . . 54.439999999999998 111.687 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.3 tpp -83.33 -41.25 18.46 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.346 0.594 . . . . 72.409999999999997 110.021 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.4 -52.18 7.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.098 -0.501 . . . . 71.329999999999998 112.314 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--N 1.307 -1.24 0 CA-C-N 116.648 -0.251 . . . . 72.519999999999996 110.333 -175.933 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 N-CA-C 110.092 -0.336 . . . . 75.450000000000003 110.092 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.58 -88.97 1.08 Allowed Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.937 -0.574 . . . . 73.109999999999999 112.671 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -121.37 126.07 48.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.805 0.336 . . . . 65.310000000000002 111.172 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 23' ' ' LEU . 12.5 t0 -80.4 142.14 34.65 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.548 -0.751 . . . . 74.409999999999997 111.361 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.42 -9.56 10.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 C-N-CA 123.679 0.792 . . . . 61.229999999999997 110.155 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.437 HD13 ' CG2' ' A' ' 29' ' ' THR . 40.2 mt -64.66 159.69 21.49 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 122.43 1.109 . . . . 75.450000000000003 113.663 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.6 t70 -80.23 138.16 52.48 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 105.799 -1.926 . . . . 72.439999999999998 105.799 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.68 -28.75 17.92 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.274 2.649 . . . . 73.409999999999997 115.452 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.18 23.17 11.09 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.161 0.8 . . . . 75.319999999999993 113.161 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 4.5 tp10 -73.83 143.43 81.38 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 105.191 -2.152 . . . . 73.549999999999997 105.191 173.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HD2' ' OE1' ' A' ' 27' ' ' GLU . 6.0 Cg_exo -39.68 107.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.945 3.097 . . . . 44.509999999999998 112.373 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.437 ' CG2' HD13 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -129.72 167.14 18.5 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.612 -0.722 . . . . 52.310000000000002 112.7 -174.256 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 26.0 m-85 -130.9 160.28 34.94 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.286 -1.376 . . . . 74.019999999999996 107.286 172.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.541 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 7.2 m-20 -134.91 159.73 40.49 Favored 'General case' 0 C--N 1.264 -3.121 0 N-CA-C 102.978 -2.971 . . . . 72.5 102.978 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.0 mt -48.47 -56.61 13.74 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 114.556 1.317 . . . . 64.010000000000005 114.556 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.89 -30.97 67.82 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.525 1.483 . . . . 60.229999999999997 112.284 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 17.7 tpt180 -70.41 -34.9 73.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.037 0.535 . . . . 75.420000000000002 109.69 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 31' ' ' ASP . 57.8 t -69.31 -39.81 79.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 109.067 -0.716 . . . . 72.230000000000004 109.067 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.72 82.39 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.719 -1.128 . . . . 62.140000000000001 109.374 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.38 -45.67 79.29 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.37 1.068 . . . . 71.219999999999999 110.54 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 30' ' ' TYR . 38.2 tp -60.76 -49.03 79.13 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.577 -0.738 . . . . 75.439999999999998 111.693 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HB2' HG22 ' A' ' 41' ' ' VAL . 66.4 mt -88.89 -18.05 28.35 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.788 -0.642 . . . . 64.129999999999995 111.448 -174.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.13 76.99 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 111.229 -0.748 . . . . 71.030000000000001 111.229 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 39' ' ' LEU . 23.8 m -104.14 162.12 20.86 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 108.417 -0.957 . . . . 73.019999999999996 108.417 -176.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.6 160.13 38.49 Favored 'Trans proline' 0 C--O 1.262 1.698 0 C-N-CA 120.931 1.088 . . . . 61.43 111.249 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.71 -32.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.747 0.784 . . . . 55.119999999999997 109.84 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 7.8 p -59.04 -37.68 77.53 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.933 -1.03 . . . . 52.530000000000001 111.758 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 19.4 ttmm -69.93 -32.89 71.41 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.408 -0.517 . . . . 73.549999999999997 110.553 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.41 -42.04 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.536 -0.913 . . . . 73.25 108.536 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -62.18 -36.53 82.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.582 -0.735 . . . . 65.519999999999996 110.399 175.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.1 mt-30 -64.94 -36.29 83.91 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.433 0.293 . . . . 61.030000000000001 110.973 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.1 mm-40 -60.46 -46.61 89.46 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.102 -1.073 . . . . 71.510000000000005 108.102 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.31 -38.59 89.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.55 -1.205 . . . . 74.150000000000006 110.36 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 47' ' ' ALA . 14.6 mmm180 -65.61 -28.81 69.39 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.696 0.628 . . . . 74.319999999999993 112.696 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.67 -1.48 30.04 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.604 0.594 . . . . 62.5 112.604 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.69 36.6 83.14 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 110.672 -0.971 . . . . 74.25 110.672 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -96.32 -20.19 18.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.396 -0.594 . . . . 72.129999999999995 109.396 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 42.1 tp -159.84 153.38 22.5 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.252 -1.388 . . . . 25.0 107.252 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.31 161.67 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 O-C-N 123.253 0.346 . . . . 64.109999999999999 110.572 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.96 159.71 39.89 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.538 -0.756 . . . . 52.299999999999997 109.084 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.5 HG11 ' HG3' ' A' ' 99' ' ' MET . 6.7 m -130.68 166.96 26.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 123.972 0.909 . . . . 74.129999999999995 109.746 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 52.2 ttp180 -114.02 115.81 28.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 121.119 -0.232 . . . . 72.340000000000003 111.608 -176.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.54 ' NE ' HG11 ' A' ' 65' ' ' VAL . 36.6 ptt180 -120.65 136.36 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.928 -1.138 . . . . 75.150000000000006 107.928 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 49.36 30.3 3.2 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.421 1.088 . . . . 65.109999999999999 113.826 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.96 57.91 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.288 -0.482 . . . . 73.140000000000001 113.023 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -133.2 152.04 20.26 Favored Glycine 0 CA--C 1.496 -1.134 0 N-CA-C 111.28 -0.728 . . . . 51.509999999999998 111.28 177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -97.62 120.38 46.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.369 -1.345 . . . . 72.510000000000005 107.369 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.54 HG11 ' NE ' ' A' ' 60' ' ' ARG . 24.2 m -134.81 164.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.816 -0.629 . . . . 63.549999999999997 111.373 -171.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 35' ' ' VAL . 62.6 mt -132.48 131.41 22.23 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.541 -1.651 . . . . 63.32 106.541 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 70' ' ' PHE . 23.4 Cg_exo -60.73 135.66 61.56 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.619 1.546 . . . . 25.120000000000001 111.221 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -68.66 -31.19 70.13 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.77 0.795 . . . . 74.209999999999994 109.353 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.435 HG23 HG11 ' A' ' 126' ' ' VAL . 23.5 m -68.44 -3.67 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 114.201 -1.363 . . . . 74.430000000000007 111.881 177.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -86.17 -11.01 53.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.942 0.877 . . . . 63.049999999999997 109.032 177.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.53 161.39 14.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.917 -1.038 . . . . 55.5 108.204 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.7 p -75.8 161.03 29.36 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.189 -0.671 . . . . 71.230000000000004 109.189 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -59.63 -17.36 32.87 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.324 0.49 . . . . 72.340000000000003 112.324 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.3 m -94.63 -0.94 54.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 116.068 -0.515 . . . . 73.150000000000006 111.86 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.08 69.32 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.855 -0.688 . . . . 52.310000000000002 114.204 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.02 156.86 16.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.556 -0.905 . . . . 74.109999999999999 108.556 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.56 138.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.47 -1.307 . . . . 74.329999999999998 107.47 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 92.9 t -62.56 131.52 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.138 -0.689 . . . . 75.230000000000004 109.138 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.626 0.602 . . . . 52.020000000000003 112.626 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.2 t -88.15 12.15 14.46 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.391 -0.523 . . . . 62.409999999999997 111.417 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.3 tt -65.93 -54.83 25.31 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.519 -0.548 . . . . 75.299999999999997 109.519 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.93 -31.78 90.58 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.766 1.644 . . . . 75.25 110.924 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.11 -44.59 97.01 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.444 -0.798 . . . . 53.140000000000001 112.294 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.12 -40.38 82.51 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.851 -0.796 . . . . 62.119999999999997 108.851 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.02 -36.7 77.81 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.927 -0.578 . . . . 75.239999999999995 110.66 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.0 m -60.59 -49.72 76.41 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.864 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -45.35 91.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.457 -0.338 . . . . 73.25 111.906 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.634 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.0 mm? -67.42 -38.56 84.77 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.348 0.87 . . . . 74.109999999999999 113.348 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -66.19 -35.14 79.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.538 -0.541 . . . . 53.509999999999998 109.538 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.91 -30.71 64.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.973 -0.558 . . . . 72.420000000000002 110.396 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.55 -9.33 83.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 112.09 -0.404 . . . . 54.43 112.09 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.97 39.97 12.4 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 121.809 -0.234 . . . . 51.43 113.196 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.59 126.39 52.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.915 0.388 . . . . 74.319999999999993 110.749 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 98' ' ' ILE . 12.0 ptm180 -85.39 173.86 9.97 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.656 . . . . 73.319999999999993 111.686 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -52.63 -44.01 65.79 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.355 1.862 . . . . 75.310000000000002 111.744 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -61.43 -41.02 96.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 123.859 0.864 . . . . 72.310000000000002 110.567 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -64.64 -44.55 90.09 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.152 -0.931 . . . . 74.230000000000004 108.938 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 94' ' ' ARG . 16.4 mm -60.61 -48.41 88.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 115.431 -0.804 . . . . 71.129999999999995 109.262 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.5 ' HG3' HG11 ' A' ' 58' ' ' VAL . 24.6 mmt -68.06 -27.19 66.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 70.299999999999997 111.731 -176.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -58.88 -64.95 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 111.609 0.226 . . . . 61.229999999999997 111.609 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.426 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 33.2 p-90 -68.45 -32.01 71.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.298 0.481 . . . . 64.219999999999999 112.298 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.628 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . 11.5 mt -60.46 -40.14 90.14 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 113.014 0.746 . . . . 75.540000000000006 113.014 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.52 ' CE1' HG21 ' A' ' 126' ' ' VAL . 70.9 m-85 -95.63 -1.39 50.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.175 0.806 . . . . 75.420000000000002 113.175 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.5 m -88.2 116.0 64.88 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.971 -0.752 . . . . 73.450000000000003 108.971 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 86.9 Cg_exo -52.85 129.55 33.37 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.817 2.345 . . . . 72.430000000000007 111.572 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.39 125.7 58.99 Favored Pre-proline 0 C--N 1.304 -1.386 0 CA-C-N 115.908 -0.587 . . . . 73.010000000000005 110.702 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.487 ' HA ' HD22 ' A' ' 122' ' ' ASN . 22.9 Cg_endo -60.75 -27.96 85.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.295 2.663 . . . . 42.109999999999999 113.591 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 m -99.84 6.86 45.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 120.807 0.337 . . . . 70.040000000000006 111.088 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.3 tp -102.47 120.09 39.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.924 0.868 . . . . 75.129999999999995 111.568 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.7 m -132.14 110.88 10.99 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 105.548 -2.019 . . . . 75.430000000000007 105.548 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 CA--C 1.472 -2.025 0 N-CA-C 114.026 1.121 . . . . 71.219999999999999 114.026 -173.934 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.436 -1.129 0 N-CA-C 108.372 -0.973 . . . . 61.219999999999999 108.372 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.8 m -90.8 138.12 31.83 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.904 -0.589 . . . . 74.329999999999998 109.901 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.487 HD22 ' HA ' ' A' ' 107' ' ' PRO . 23.7 t-20 64.11 59.09 1.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.482 1.134 . . . . 72.129999999999995 110.032 176.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.23 161.64 13.6 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.493 -1.231 . . . . 62.140000000000001 108.739 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 8.8 ptp180 -87.07 139.92 32.58 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.438 -1.319 . . . . 74.129999999999995 107.438 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.592 ' HB2' HD23 ' A' ' 102' ' ' LEU . 93.2 Cg_exo -49.66 -29.85 20.62 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 123.319 2.679 . . . . 55.329999999999998 114.812 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.628 ' CG2' ' HB3' ' A' ' 102' ' ' LEU . 24.8 t -67.37 -36.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.438 -0.789 . . . . 75.0 110.562 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.07 -30.67 67.98 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.888 -1.153 . . . . 73.409999999999997 107.888 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.34 83.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.426 -1.261 . . . . 55.130000000000003 111.097 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -68.26 -33.39 74.27 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 121.939 -0.475 . . . . 65.010000000000005 110.806 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -63.86 -34.38 77.8 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 108.155 -1.054 . . . . 75.129999999999995 108.155 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.13 10.46 21.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.351 -1.295 . . . . 71.239999999999995 111.999 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 68.2 27.97 6.6 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.325 1.05 . . . . 62.109999999999999 112.536 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -106.43 24.17 12.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.054 -1.091 . . . . 63.119999999999997 108.054 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -53.17 -30.58 38.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.685 1.194 . . . . 53.219999999999999 113.911 -173.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.01 -38.51 79.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.815 0.34 . . . . 75.239999999999995 111.187 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.24 -30.32 69.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.677 . . . . 72.099999999999994 109.508 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -71.39 -44.93 71.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.917 -1.038 . . . . 52.130000000000003 110.025 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 47.4 t -61.3 -42.98 95.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.604 0.716 . . . . 74.109999999999999 109.402 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -60.38 -38.78 85.01 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.068 -0.969 . . . . 71.140000000000001 111.611 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -37.93 83.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.251 -1.018 . . . . 71.109999999999999 108.251 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.634 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -63.7 -42.45 97.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.424 -0.807 . . . . 43.350000000000001 111.05 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 74.4 mt-30 -59.03 -41.86 88.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 62.130000000000003 110.31 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.89 81.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 62.210000000000001 111.604 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.404 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 43.8 tpp -76.14 -27.56 57.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.647 0.737 . . . . 72.219999999999999 111.014 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.0 -47.24 11.93 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.745 -0.597 . . . . 54.420000000000002 111.747 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 C--N 1.31 -1.109 0 N-CA-C 109.209 -0.663 . . . . 75.519999999999996 109.209 -177.707 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.445 0 N-CA-C 110.415 -0.217 . . . . 64.329999999999998 110.415 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' NH2' ' A' ' 94' ' ' ARG . . . -109.7 -115.81 3.76 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.593 -0.813 . . . . 52.119999999999997 114.376 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.22 128.29 40.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.463 0.542 . . . . 72.409999999999997 112.463 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.483 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 7.3 t70 -65.23 120.11 12.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.872 -1.058 . . . . 65.319999999999993 111.239 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.58 -32.05 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 112.661 0.615 . . . . 62.32 112.661 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -82.96 159.96 22.14 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 114.199 1.185 . . . . 62.509999999999998 114.199 -174.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.0 t70 -60.45 146.62 84.41 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.699 -1.137 . . . . 72.340000000000003 110.797 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.49 -36.73 40.35 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.568 2.845 . . . . 74.310000000000002 115.898 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.9 11.43 39.3 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 114.433 1.272 . . . . 65.310000000000002 114.433 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 7.7 mm-40 -68.18 144.57 96.94 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.324 -0.621 . . . . 63.119999999999997 109.324 173.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.91 128.85 28.1 Favored 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 122.822 2.348 . . . . 71.420000000000002 112.544 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.7 p -130.23 166.17 20.87 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.056 -0.52 . . . . 73.109999999999999 111.313 -176.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -131.45 160.19 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 125.55 1.54 . . . . 62.210000000000001 108.422 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.5 p-10 -135.6 159.38 41.8 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 106.121 -1.807 . . . . 64.400000000000006 106.121 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.0 mt -46.68 -56.87 10.15 Favored Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 114.738 1.385 . . . . 74.439999999999998 114.738 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.31 -35.76 96.14 Favored 'Trans proline' 0 C--N 1.366 1.476 0 CA-C-N 120.465 1.202 . . . . 73.239999999999995 112.67 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -69.56 -37.5 77.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.924 -0.398 . . . . 72.319999999999993 109.924 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 31' ' ' ASP . 60.8 t -69.8 -40.37 78.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.212 -0.449 . . . . 75.310000000000002 110.519 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.69 80.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.135 0.969 . . . . 73.409999999999997 109.167 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.17 -45.53 73.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.985 -1.462 . . . . 61.43 109.985 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.26 -44.1 89.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 63.409999999999997 111.551 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.2 mt -84.38 -19.01 34.29 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 111.901 0.334 . . . . 65.310000000000002 111.901 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.28 65.31 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.54 -0.838 . . . . 70.25 111.989 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.0 152.15 77.0 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 108.73 -0.841 . . . . 75.219999999999999 108.73 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.98 163.25 29.16 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 122.304 2.003 . . . . 74.219999999999999 112.927 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.34 -33.38 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.189 0.996 . . . . 72.420000000000002 111.371 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 10.7 p -58.39 -46.15 86.93 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.465 -0.789 . . . . 72.010000000000005 111.493 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 mttp -68.93 -36.36 77.9 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.664 -0.244 . . . . 72.239999999999995 111.636 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.76 -48.14 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 71.439999999999998 109.537 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.754 -0.657 . . . . 64.040000000000006 110.463 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 44' ' ' SER . 15.7 mm100 -62.42 -36.44 82.37 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.292 0.479 . . . . 73.519999999999996 112.292 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 91.8 mt-30 -63.34 -50.72 68.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.676 0.75 . . . . 63.520000000000003 108.995 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.35 -41.4 98.57 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.233 -1.349 . . . . 62.420000000000002 111.684 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -63.59 -27.48 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.788 0.292 . . . . 65.450000000000003 111.788 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -92.1 -0.36 57.45 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.762 0.315 . . . . 75.219999999999999 111.596 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.16 38.31 63.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.798 -0.637 . . . . 52.109999999999999 112.501 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -95.06 -15.36 23.5 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.07 -0.715 . . . . 75.219999999999999 109.07 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 56' ' ' VAL . 1.1 tt -157.74 152.91 25.76 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.106 -2.183 . . . . 74.129999999999995 105.106 -177.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.41 ' H ' HD23 ' A' ' 55' ' ' LEU . 17.8 m -132.1 161.6 41.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 122.609 0.364 . . . . 44.149999999999999 110.175 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.32 163.36 32.99 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.061 0.545 . . . . 74.540000000000006 109.6 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.71 160.48 34.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 123.427 0.455 . . . . 62.119999999999997 110.47 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -113.9 120.92 42.36 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.494 0.664 . . . . 70.129999999999995 111.256 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.483 ' HD2' ' OD1' ' A' ' 21' ' ' ASP . 12.3 ptm180 -142.69 134.95 27.5 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.931 -1.031 . . . . 65.129999999999995 108.939 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.65 23.67 13.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.909 0.883 . . . . 44.340000000000003 111.406 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.71 5.71 89.64 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.156 -0.545 . . . . 63.200000000000003 112.207 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.17 143.64 18.03 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 111.355 -0.698 . . . . 65.349999999999994 111.355 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.27 120.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.921 -1.14 . . . . 72.400000000000006 107.921 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.78 158.48 41.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.968 -0.56 . . . . 63.119999999999997 110.754 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 35' ' ' VAL . 71.3 mt -114.86 132.06 23.15 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.106 -1.072 . . . . 73.239999999999995 108.106 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.98 126.12 20.15 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.877 1.718 . . . . 71.219999999999999 110.477 173.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.565 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.8 tt0 -60.58 -25.21 66.04 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.315 0.646 . . . . 72.329999999999998 112.467 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.82 -2.77 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-N 115.681 -0.691 . . . . 71.140000000000001 112.65 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.623 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.38 -2.62 58.59 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.95 0.881 . . . . 72.430000000000007 110.026 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -119.61 163.9 16.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.119 -0.946 . . . . 70.299999999999997 109.089 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 130' ' ' HIS . 63.1 p -94.78 162.25 13.84 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.588 -0.893 . . . . 65.150000000000006 108.588 177.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.22 -16.55 63.65 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.335 0.588 . . . . 73.230000000000004 110.488 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -79.73 -8.32 59.17 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.699 -0.682 . . . . 44.329999999999998 110.487 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.72 64.2 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.851 -0.69 . . . . 60.450000000000003 112.23 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -108.6 154.01 22.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.438 -0.578 . . . . 74.120000000000005 109.438 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -71.34 140.53 18.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.793 -1.188 . . . . 73.340000000000003 107.793 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 80' ' ' SER . 44.7 t -64.02 129.22 27.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.934 -1.135 . . . . 63.32 107.934 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -63.69 -28.99 70.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.145 0.424 . . . . 71.219999999999999 112.145 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.417 ' H ' HG12 ' A' ' 78' ' ' VAL . 4.1 m -77.77 -6.51 54.3 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.939 -0.573 . . . . 75.299999999999997 110.886 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.623 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.7 tp -64.91 -57.25 16.56 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.384 -0.371 . . . . 73.150000000000006 111.882 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.29 -29.03 79.43 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.181 1.254 . . . . 71.230000000000004 111.244 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -44.59 93.8 Favored Glycine 0 C--O 1.245 0.832 0 CA-C-N 115.964 -0.562 . . . . 65.239999999999995 112.598 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.96 -40.53 83.18 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.38 -0.6 . . . . 71.209999999999994 109.38 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 95.9 mt -62.32 -37.57 86.1 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 74.019999999999996 110.659 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.9 m -57.45 -47.51 81.63 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 116.239 -0.437 . . . . 63.030000000000001 111.582 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.471 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -67.95 -41.96 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 120.386 -0.525 . . . . 73.129999999999995 111.556 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.471 HD22 HG23 ' A' ' 87' ' ' ILE . 3.5 mm? -67.51 -39.32 85.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.804 0.668 . . . . 75.329999999999998 112.804 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 85' ' ' LEU . 62.1 m170 -66.5 -33.76 76.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.052 0.453 . . . . 75.319999999999993 110.085 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.92 -26.2 65.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.537 -0.756 . . . . 72.310000000000002 110.142 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.91 -3.36 73.7 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.829 -0.623 . . . . 51.140000000000001 112.016 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.42 33.45 25.46 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.197 -0.525 . . . . 71.319999999999993 113.123 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 8.9 m-85 -90.75 159.38 16.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.882 0.372 . . . . 74.120000000000005 111.497 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.47 ' NH2' ' HA3' ' A' ' 19' ' ' GLY . 12.0 ptm180 -111.85 171.14 7.67 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.924 -0.58 . . . . 73.340000000000003 109.832 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -53.94 -45.87 71.38 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.442 1.897 . . . . 73.140000000000001 112.46 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.6 m -61.88 -41.67 98.16 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.275 -0.875 . . . . 70.230000000000004 110.418 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.06 -36.15 81.39 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.587 -0.733 . . . . 71.329999999999998 111.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.2 mm -61.24 -47.66 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.121 -1.066 . . . . 72.099999999999994 108.121 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.47 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 56.3 mtt -73.35 -21.5 60.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.596 -1.183 . . . . 63.399999999999999 111.779 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -57.69 -63.37 1.26 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.031 0.443 . . . . 73.120000000000005 110.315 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -69.99 -32.38 70.56 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.02 0.748 . . . . 64.040000000000006 113.02 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.3 mt -59.0 -40.73 85.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.585 0.957 . . . . 73.209999999999994 113.585 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' HD23 ' A' ' 23' ' ' LEU . 50.5 m-85 -89.14 -16.83 30.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.958 0.725 . . . . 75.5 112.958 -176.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.9 m -87.51 118.28 69.63 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.435 -0.348 . . . . 74.549999999999997 110.243 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -55.65 129.78 36.91 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.857 2.371 . . . . 33.109999999999999 111.359 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.2 t70 -96.73 127.12 40.52 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.866 -0.42 . . . . 72.409999999999997 109.866 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 -20.25 61.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.554 2.836 . . . . 53.32 114.423 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.1 p -111.53 6.94 20.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.107 0.48 . . . . 72.010000000000005 112.122 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 tp -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.23 0.538 . . . . 74.120000000000005 110.107 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -118.95 122.56 42.51 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.885 -0.783 . . . . 75.510000000000005 108.885 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 123' ' ' ALA . 61.1 mt . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 109.432 -0.581 . . . . 70.400000000000006 109.432 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 51.3 t . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 109.368 -0.604 . . . . 63.329999999999998 109.368 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -87.28 141.42 28.66 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.767 -0.827 . . . . 72.140000000000001 108.767 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.3 t30 68.22 70.3 0.32 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.937 0.875 . . . . 64.409999999999997 110.806 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -124.39 173.64 8.28 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 107.762 -1.199 . . . . 63.119999999999997 107.762 174.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 3.5 ptp180 -91.59 137.25 25.86 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.557 . . . . 70.430000000000007 109.758 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.64 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.1 Cg_exo -49.75 -22.44 6.98 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.71 2.94 . . . . 70.239999999999995 114.552 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -60.43 -39.0 79.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 120.87 0.367 . . . . 75.129999999999995 110.297 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -63.31 -37.12 86.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.315 0.579 . . . . 64.25 109.695 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.69 76.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.237 -0.892 . . . . 65.209999999999994 112.063 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.44 -35.58 80.65 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.644 -0.422 . . . . 63.420000000000002 111.408 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.405 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 42.0 t-80 -76.02 -20.8 57.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.391 0.615 . . . . 52.350000000000001 109.455 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.85 4.61 51.59 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.335 0.865 . . . . 74.019999999999996 113.335 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.31 38.74 4.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 123.581 1.658 . . . . 75.450000000000003 109.283 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -120.36 23.89 10.66 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.75 -1.574 . . . . 73.5 106.75 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.62 -28.05 30.45 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 112.648 -2.069 . . . . 63.32 112.756 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -55.43 -40.38 71.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.801 0.334 . . . . 72.239999999999995 110.915 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.33 -27.98 63.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.171 0.51 . . . . 70.200000000000003 110.919 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.72 -48.58 45.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.375 -0.972 . . . . 73.239999999999995 108.375 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 63.5 t -59.2 -41.54 84.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-N 115.007 -0.997 . . . . 72.25 109.176 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -57.15 -45.89 83.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.609 0.764 . . . . 73.040000000000006 111.264 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.8 tpp180 -65.89 -39.31 90.51 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.723 -0.473 . . . . 73.450000000000003 109.723 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.99 94.15 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.999 -0.546 . . . . 43.25 110.525 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 83.6 mm-40 -57.46 -46.61 83.45 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 123.353 0.661 . . . . 72.430000000000007 110.032 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.9 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 64.25 111.551 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.526 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.2 mmm -78.48 -37.39 43.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.353 -0.385 . . . . 74.120000000000005 111.407 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.8 19.59 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 112.789 0.663 . . . . 63.539999999999999 112.789 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 C--N 1.308 -1.239 0 CA-C-O 118.418 -0.801 . . . . 72.219999999999999 109.646 -176.498 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.284 0 CA-C-O 120.895 0.379 . . . . 74.010000000000005 110.084 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 59' ' ' ARG . . . -94.76 -85.15 1.66 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 115.726 -0.67 . . . . 73.310000000000002 111.64 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.62 150.09 47.14 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 120.877 0.37 . . . . 75.430000000000007 110.321 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.69 161.94 18.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.931 -0.766 . . . . 72.340000000000003 108.931 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 22' ' ' VAL . 23.9 t -121.29 13.79 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 123.345 1.545 . . . . 72.219999999999999 109.662 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.89 -172.41 2.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.26 -0.882 . . . . 72.010000000000005 110.69 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.26 138.01 20.13 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 105.25 -2.13 . . . . 74.219999999999999 105.25 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.16 -21.61 22.82 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.658 2.238 . . . . 50.5 114.448 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.57 -16.05 57.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.076 0.398 . . . . 70.129999999999995 112.076 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -61.93 141.8 95.36 Favored Pre-proline 0 C--O 1.251 1.134 0 O-C-N 122.089 -0.382 . . . . 75.5 110.31 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.55 117.66 4.21 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.843 2.362 . . . . 73.5 111.1 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -133.37 161.94 33.18 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 115.369 -0.832 . . . . 60.140000000000001 111.519 -176.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -112.89 159.94 18.54 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.611 -1.177 . . . . 73.299999999999997 109.058 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.583 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.0 m-20 -134.74 169.16 17.77 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.004 -2.221 . . . . 71.549999999999997 105.004 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.87 -55.73 35.39 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 113.489 0.922 . . . . 74.329999999999998 113.489 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.26 -32.71 90.47 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.881 1.721 . . . . 73.510000000000005 112.381 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.583 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 20.7 tpt180 -68.53 -40.79 80.59 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.973 0.509 . . . . 74.150000000000006 110.683 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' ASP . 77.1 t -69.0 -37.71 77.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.498 -0.556 . . . . 74.109999999999999 109.498 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.84 85.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.327 -0.851 . . . . 73.040000000000006 109.659 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.37 -46.7 72.56 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.181 -0.918 . . . . 65.439999999999998 109.52 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.79 -50.32 63.05 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.051 -0.977 . . . . 64.319999999999993 112.269 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.51 ' HB2' HG22 ' A' ' 41' ' ' VAL . 91.9 mt -82.85 -18.61 39.77 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.495 -0.482 . . . . 73.209999999999994 111.357 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.66 30.1 58.56 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.677 -0.969 . . . . 53.009999999999998 110.677 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 39' ' ' LEU . 28.0 m -120.94 159.04 50.71 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 109.543 -0.54 . . . . 72.549999999999997 109.543 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.54 163.16 39.93 Favored 'Trans proline' 0 C--O 1.256 1.404 0 C-N-CA 122.011 1.807 . . . . 74.25 111.543 174.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.24 -32.37 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.419 0.688 . . . . 54.200000000000003 110.359 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 33.1 t -57.32 -43.12 83.02 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.751 -0.659 . . . . 74.310000000000002 110.4 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.25 -32.77 72.2 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 111.742 0.275 . . . . 75.540000000000006 111.742 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.77 -45.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.056 -0.72 . . . . 72.239999999999995 109.056 175.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.98 78.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.464 -0.789 . . . . 72.219999999999999 110.777 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 44' ' ' SER . 93.0 mt-30 -61.68 -43.47 98.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.262 -0.426 . . . . 73.109999999999999 111.334 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -60.12 -49.63 76.89 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 121.901 0.857 . . . . 71.530000000000001 109.043 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.23 -42.46 99.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.078 -1.419 . . . . 74.400000000000006 111.278 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.15 -22.33 62.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.109 0.781 . . . . 74.310000000000002 113.109 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -102.09 5.0 40.22 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.112 -1.035 . . . . 75.0 111.396 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.59 37.31 68.14 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 115.423 -0.808 . . . . 52.210000000000001 112.243 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -95.67 -13.81 23.96 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.546 0.689 . . . . 75.530000000000001 109.36 176.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.9 tp -160.66 152.77 20.19 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.693 -1.965 . . . . 74.329999999999998 105.693 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 p -133.58 151.38 33.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.204 -0.665 . . . . 70.209999999999994 109.204 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 154.94 36.42 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 123.518 0.511 . . . . 64.510000000000005 109.737 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.62 169.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 123.711 0.804 . . . . 75.319999999999993 111.165 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 24.3 ttt-85 -107.3 121.34 44.37 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.135 -0.691 . . . . 73.420000000000002 109.135 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' CZ ' HG11 ' A' ' 65' ' ' VAL . 49.3 ttp180 -115.4 112.81 22.89 Favored 'General case' 0 CA--C 1.482 -1.667 0 CA-C-N 114.225 -1.352 . . . . 74.230000000000004 107.61 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.58 -51.68 0.23 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.92 1.688 . . . . 61.439999999999998 112.473 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.54 15.15 0.03 OUTLIER Glycine 0 C--N 1.29 -2.01 0 CA-C-N 114.931 -1.031 . . . . 74.239999999999995 112.147 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.35 154.96 19.74 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 110.691 -0.963 . . . . 74.219999999999999 110.691 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -96.89 120.12 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.781 -1.192 . . . . 63.219999999999999 107.781 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.433 HG11 ' CZ ' ' A' ' 60' ' ' ARG . 16.9 m -137.21 164.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.745 -0.661 . . . . 73.209999999999994 111.82 -172.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.61 123.98 26.28 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 107.011 -1.478 . . . . 50.32 107.011 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HA ' HG22 ' A' ' 29' ' ' THR . 37.3 Cg_exo -62.84 143.44 91.68 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.43 2.086 . . . . 70.239999999999995 114.063 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -48.81 -41.99 34.55 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.313 1.045 . . . . 63.130000000000003 111.196 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -65.54 -7.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.48 -1.236 . . . . 65.239999999999995 113.911 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.646 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.3 m-85 -88.5 -5.02 58.48 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.873 0.844 . . . . 73.5 110.515 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -117.41 159.29 23.02 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.028 -0.987 . . . . 71.219999999999999 108.611 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -86.88 175.69 8.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.829 -0.804 . . . . 64.129999999999995 108.829 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -63.3 -22.08 66.65 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.333 0.587 . . . . 75.329999999999998 110.623 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.3 t -79.52 -10.51 59.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.299 -0.409 . . . . 72.219999999999999 110.615 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.64 38.85 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.572 -0.823 . . . . 64.219999999999999 111.215 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 151.63 37.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.597 -1.26 . . . . 73.530000000000001 107.597 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.46 131.47 34.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.731 -0.84 . . . . 72.219999999999999 108.731 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 44.4 t -57.78 125.96 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.323 -0.621 . . . . 74.219999999999999 109.323 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 61.1 tttp -61.5 -36.44 80.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.285 0.564 . . . . 72.150000000000006 112.281 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -85.19 -5.16 59.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.307 -0.406 . . . . 73.010000000000005 111.734 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD11 ' CD2' ' A' ' 70' ' ' PHE . 8.1 tt -66.09 -48.16 60.53 Favored Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 112.894 0.701 . . . . 71.510000000000005 112.894 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 74.1 Cg_exo -54.09 -30.57 60.82 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.047 1.831 . . . . 54.219999999999999 111.511 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.6 -41.46 99.81 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.473 -0.785 . . . . 72.530000000000001 112.207 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.37 -40.45 81.43 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.081 -0.711 . . . . 74.400000000000006 109.081 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.52 -39.96 92.9 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.907 -0.588 . . . . 65.549999999999997 110.339 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.2 m -57.77 -47.5 82.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 116.144 -0.48 . . . . 72.450000000000003 111.662 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -42.93 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 120.943 -0.303 . . . . 73.25 111.697 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -66.64 -37.44 84.82 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.465 0.543 . . . . 74.200000000000003 112.465 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -65.74 -32.86 74.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.893 0.377 . . . . 71.420000000000002 110.344 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.86 -30.23 69.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.231 0.539 . . . . 64.540000000000006 110.272 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.5 -9.33 75.77 Favored Glycine 0 C--O 1.242 0.655 0 CA-C-N 115.579 -0.737 . . . . 52.530000000000001 113.039 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.97 33.05 11.37 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.539 -0.363 . . . . 73.209999999999994 112.971 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -98.74 129.8 45.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 122.471 -0.429 . . . . 75.409999999999997 111.42 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -87.24 174.24 8.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.702 -0.681 . . . . 70.530000000000001 110.881 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.67 -45.9 66.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.925 1.69 . . . . 63.409999999999997 112.208 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.595 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 29.3 m -64.92 -41.28 95.69 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 116.031 -0.531 . . . . 55.119999999999997 109.589 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -61.72 -42.28 98.74 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.025 -0.989 . . . . 65.340000000000003 111.077 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.471 HG22 HD12 ' A' ' 102' ' ' LEU . 19.9 mm -60.95 -47.6 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.626 -0.879 . . . . 74.120000000000005 108.626 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.429 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 51.2 mtt -74.34 -17.56 60.81 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 113.736 1.013 . . . . 65.340000000000003 113.736 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 96' ' ' THR . 83.8 mtp180 -55.84 -65.0 0.67 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.877 0.37 . . . . 64.209999999999994 111.353 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.52 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 p-90 -68.75 -31.93 71.32 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.358 0.503 . . . . 64.010000000000005 112.358 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.52 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.4 mt -66.34 -39.87 89.48 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.126 1.158 . . . . 65.349999999999994 114.126 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -90.62 -12.03 38.15 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.596 1.332 . . . . 51.140000000000001 114.596 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -74.67 114.15 31.41 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 123.817 0.698 . . . . 65.219999999999999 109.731 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.94 132.56 35.1 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.713 2.276 . . . . 75.400000000000006 110.551 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 16.5 t0 -118.61 117.99 33.87 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 116.299 -0.41 . . . . 43.409999999999997 111.298 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.53 -24.92 79.49 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.225 2.616 . . . . 70.340000000000003 111.889 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -78.58 -10.06 59.59 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.555 -0.748 . . . . 64.340000000000003 110.143 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.9 tp -110.29 129.22 55.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.429 0.633 . . . . 74.340000000000003 110.609 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -119.02 125.04 48.43 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.31 -0.996 . . . . 74.530000000000001 108.31 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 123' ' ' ALA . 46.8 mt . . . . . 0 C--N 1.311 -1.104 0 CA-C-N 115.994 -0.548 . . . . 70.0 110.227 -172.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 109.183 -0.673 . . . . 70.129999999999995 109.183 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.4 m -90.28 142.95 27.22 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.71 -0.848 . . . . 60.119999999999997 108.71 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.2 t30 74.36 72.26 0.11 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.272 0.982 . . . . 72.439999999999998 110.381 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.439 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -123.44 172.82 8.42 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.625 -1.62 . . . . 63.149999999999999 106.625 171.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.504 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 8.0 ptp180 -92.82 143.79 27.51 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.111 -1.44 . . . . 73.340000000000003 107.111 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 90.2 Cg_exo -49.28 -25.6 10.09 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.313 2.675 . . . . 72.450000000000003 114.897 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.564 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.8 t -63.96 -32.33 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.331 -0.548 . . . . 45.130000000000003 110.113 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.504 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 10.5 m-20 -60.45 -30.84 69.92 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.254 -0.43 . . . . 64.230000000000004 110.415 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.5 -43.88 72.19 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.883 -0.599 . . . . 60.409999999999997 111.092 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -70.18 -33.98 72.41 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.932 -0.48 . . . . 74.430000000000007 111.099 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -67.53 -19.53 65.31 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 122.15 0.976 . . . . 73.140000000000001 109.238 176.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.94 9.44 32.66 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.924 -1.034 . . . . 60.32 111.838 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.9 m80 61.77 28.47 17.5 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.911 0.862 . . . . 52.340000000000003 112.249 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -106.3 25.11 11.47 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.827 1.651 . . . . 72.540000000000006 107.512 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.2 -26.87 12.7 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 126.926 2.09 . . . . 74.209999999999994 114.237 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -55.69 -37.18 68.01 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.194 0.813 . . . . 64.530000000000001 113.194 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -67.54 -32.36 73.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.291 0.567 . . . . 71.129999999999995 110.59 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.48 -49.14 68.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.615 -0.883 . . . . 74.420000000000002 108.615 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.569 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 67.8 t -58.07 -42.85 83.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 CA-C-N 115.404 -0.817 . . . . 74.120000000000005 109.58 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -57.0 -47.47 80.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.72 -0.673 . . . . 65.219999999999999 110.822 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -68.79 -34.1 74.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 73.329999999999998 111.045 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.416 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -67.53 -46.71 72.01 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.106 -0.497 . . . . 75.530000000000001 110.941 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 15.9 mm100 -59.66 -40.11 86.68 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.028 0.531 . . . . 71.430000000000007 110.04 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.02 68.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.424 -0.807 . . . . 42.109999999999999 111.257 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.1 tpp -78.04 -47.9 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.904 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.5 -29.29 37.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.543 0.942 . . . . 72.400000000000006 113.543 -173.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 C--N 1.312 -1.059 0 CA-C-O 117.989 -1.005 . . . . 55.240000000000002 110.038 -179.574 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 106.632 -1.618 . . . . 74.510000000000005 106.632 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.88 -118.17 3.11 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.257 -0.973 . . . . 55.240000000000002 113.801 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.11 107.1 18.85 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 112.884 0.698 . . . . 72.349999999999994 112.884 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 11.2 t70 -44.69 113.02 0.49 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 126.108 1.763 . . . . 53.119999999999997 113.108 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.67 -33.96 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.558 -0.747 . . . . 70.439999999999998 111.645 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' A' ' 103' ' ' PHE 0.406 0.4 OUTLIER -67.18 140.8 57.49 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.283 1.586 . . . . 74.340000000000003 115.283 -176.024 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.36 146.41 84.39 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.222 -1.808 . . . . 41.130000000000003 110.993 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HA ' HH22 ' A' ' 60' ' ' ARG . 89.9 Cg_exo -50.52 -22.43 9.09 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.409 2.739 . . . . 70.030000000000001 115.601 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -97.71 3.53 50.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.942 0.719 . . . . 52.140000000000001 112.942 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.42 128.14 76.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.906 -0.776 . . . . 63.43 108.906 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.48 147.09 70.24 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.554 2.169 . . . . 70.120000000000005 112.685 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -133.45 173.69 11.21 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.497 0.665 . . . . 75.420000000000002 111.645 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 23.2 m-85 -130.25 161.09 31.99 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 126.299 1.84 . . . . 64.109999999999999 106.626 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.4 t0 -134.08 167.42 20.68 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.802 -2.296 . . . . 73.530000000000001 104.802 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -49.79 -57.0 13.62 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 123.839 0.856 . . . . 72.519999999999996 112.999 -172.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.7 -32.25 47.58 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.152 1.234 . . . . 71.120000000000005 112.14 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 19.4 tpt180 -70.34 -37.74 74.72 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 112.187 0.44 . . . . 74.25 112.187 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 31' ' ' ASP . 58.5 t -67.23 -39.12 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.738 -0.838 . . . . 74.129999999999995 108.738 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.89 83.87 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.66 -1.154 . . . . 70.030000000000001 110.032 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.04 -43.1 99.59 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.941 0.896 . . . . 72.150000000000006 109.814 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 tp -62.16 -50.06 73.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.404 -0.817 . . . . 73.519999999999996 111.396 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -86.76 -18.53 30.9 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.038 0.755 . . . . 73.140000000000001 113.038 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.01 53.91 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.436 -0.887 . . . . 63.240000000000002 110.961 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.09 161.18 46.21 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 107.611 -1.255 . . . . 61.350000000000001 107.611 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.63 163.26 31.99 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 121.253 1.302 . . . . 64.340000000000003 111.409 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.79 -32.64 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.6 0.714 . . . . 74.230000000000004 109.35 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.587 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.1 m -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.723 -1.126 . . . . 74.109999999999999 110.606 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.6 mttp -68.94 -32.92 72.87 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.678 -0.409 . . . . 74.299999999999997 111.253 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.473 ' HA ' HE21 ' A' ' 49' ' ' GLN . 61.3 t -62.16 -46.23 96.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.466 -0.568 . . . . 53.229999999999997 109.466 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.25 81.29 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.423 -0.808 . . . . 51.420000000000002 110.759 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 44' ' ' SER . 29.3 mm-40 -64.35 -37.94 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 62.530000000000001 110.772 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.6 mt-30 -68.31 -45.05 74.05 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.896 0.855 . . . . 75.540000000000006 109.163 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.86 -45.29 94.43 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.789 -1.551 . . . . 72.200000000000003 109.797 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -66.12 -22.28 66.38 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 113.138 0.792 . . . . 64.019999999999996 113.138 -175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.66 11.78 37.24 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.216 -0.994 . . . . 71.109999999999999 112.49 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.58 57.48 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.976 -0.63 . . . . 53.409999999999997 113.02 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -96.13 -5.74 40.01 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.265 0.555 . . . . 74.129999999999995 109.866 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.1 tp -163.42 157.65 20.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.399 -1.704 . . . . 74.140000000000001 106.399 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.54 147.05 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 118.393 0.542 . . . . 75.430000000000007 109.586 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.59 162.69 19.21 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.346 0.659 . . . . 74.219999999999999 110.473 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.44 157.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.001 0.521 . . . . 62.219999999999999 110.226 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -110.86 119.07 37.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.204 -0.665 . . . . 60.509999999999998 109.204 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.566 HH22 ' HA ' ' A' ' 25' ' ' PRO . 11.4 ptm180 -149.24 130.61 14.71 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.367 -0.378 . . . . 75.439999999999998 111.187 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.63 26.58 16.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.995 0.918 . . . . 72.439999999999998 112.121 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.1 82.36 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 116.039 -0.528 . . . . 63.340000000000003 112.341 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.01 141.0 12.76 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.424 -0.67 . . . . 62.5 111.424 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.52 119.91 48.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.263 -1.384 . . . . 73.319999999999993 107.263 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.47 162.29 39.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.861 -0.609 . . . . 52.100000000000001 110.13 -175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.7 128.01 26.02 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 108.089 -1.078 . . . . 53.509999999999998 108.089 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.28 122.01 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.787 2.324 . . . . 61.43 112.037 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.521 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.5 tt0 -65.74 -24.59 66.99 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.136 0.493 . . . . 62.350000000000001 111.699 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.5 -8.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.637 -0.711 . . . . 72.230000000000004 112.373 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -86.73 -2.47 58.56 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.388 0.613 . . . . 71.420000000000002 110.95 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -116.83 148.51 41.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 73.430000000000007 109.248 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.4 p -82.74 175.47 10.1 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.571 -0.9 . . . . 63.539999999999999 108.571 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -64.42 -17.21 63.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.931 0.396 . . . . 63.210000000000001 111.729 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 m -79.78 -9.14 59.62 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.348 0.595 . . . . 65.409999999999997 109.778 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.44 62.85 Favored Glycine 0 C--O 1.215 -1.081 0 N-CA-C 110.73 -0.948 . . . . 70.209999999999994 110.73 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -108.06 143.82 36.26 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.759 -0.83 . . . . 75.129999999999995 108.759 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.98 134.46 28.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.134 -1.062 . . . . 61.409999999999997 108.134 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 58.7 t -57.04 128.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 108.185 -1.043 . . . . 71.530000000000001 108.185 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -23.07 65.86 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.741 0.645 . . . . 73.5 112.741 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 78' ' ' VAL . 17.5 m -88.22 -1.93 58.31 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.998 0.428 . . . . 75.010000000000005 111.169 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.0 tt -65.58 -54.24 31.69 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.386 0.513 . . . . 61.210000000000001 112.386 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 39.5 Cg_exo -60.76 -29.77 88.95 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 121.265 1.31 . . . . 75.310000000000002 110.979 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.15 99.7 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.319 -0.855 . . . . 55.020000000000003 112.216 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.92 -42.01 77.36 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.587 -0.523 . . . . 73.219999999999999 109.587 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.33 -37.34 85.25 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 116.243 -0.435 . . . . 71.209999999999994 110.645 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.6 m -58.69 -48.04 82.47 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.837 -0.619 . . . . 60.240000000000002 111.89 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.427 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -68.27 -42.15 84.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.607 -0.437 . . . . 75.420000000000002 111.045 -177.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.427 HD22 HG23 ' A' ' 87' ' ' ILE . 3.2 mm? -67.07 -35.29 79.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.112 -0.635 . . . . 72.140000000000001 111.874 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -62.94 -33.4 75.27 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.484 -0.562 . . . . 75.010000000000005 109.484 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.97 -31.4 71.1 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.017 -0.538 . . . . 53.119999999999997 110.148 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.72 -3.96 63.99 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.569 -0.741 . . . . 51.43 111.756 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.22 37.07 55.33 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 113.708 0.243 . . . . 75.439999999999998 113.708 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 52.1 m-85 -92.06 126.19 37.05 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 117.55 0.675 . . . . 75.239999999999995 111.18 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.57 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 26.8 ptt180 -70.43 169.21 14.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.901 . . . . 75.299999999999997 111.276 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 99' ' ' MET . 7.7 p-10 -54.87 -44.5 74.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.052 1.341 . . . . 74.340000000000003 111.816 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -62.06 -41.02 97.71 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.332 -0.849 . . . . 52.439999999999998 110.835 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.57 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 49.8 mm-40 -66.38 -37.92 86.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.747 -0.381 . . . . 74.420000000000002 110.482 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.2 -50.07 82.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 109.112 -0.699 . . . . 62.439999999999998 109.112 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.9 ptt? -74.67 -17.49 60.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.334 -0.848 . . . . 70.450000000000003 112.948 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.31 -65.26 0.72 Allowed 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.47 0.481 . . . . 72.230000000000004 110.099 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -70.38 -32.26 69.84 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.245 0.831 . . . . 74.030000000000001 113.245 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 125' ' ' PRO . 40.8 tp -68.33 -40.46 81.61 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.038 0.755 . . . . 72.420000000000002 113.038 -173.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CE2' HD23 ' A' ' 23' ' ' LEU . 26.6 m-85 -87.16 -18.3 30.7 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.367 0.877 . . . . 73.510000000000005 113.367 -175.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 63.2 m -81.03 127.37 74.68 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 112.194 0.442 . . . . 52.229999999999997 112.194 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 23.4 Cg_exo -66.47 132.31 28.84 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.664 2.243 . . . . 44.25 111.31 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -118.19 121.45 31.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.465 -0.334 . . . . 62.32 111.839 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.98 -26.43 82.38 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.585 2.856 . . . . 73.439999999999998 112.205 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.0 m -85.96 -0.21 54.88 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.213 0.53 . . . . 53.43 111.239 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.63 126.89 53.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.207 -0.664 . . . . 73.319999999999993 109.207 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 27.2 m -131.28 114.34 14.91 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 73.400000000000006 108.206 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 128' ' ' ALA . 11.5 pt . . . . . 0 C--N 1.306 -1.295 0 CA-C-N 116.45 -0.341 . . . . 71.129999999999995 110.759 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 108.292 -1.003 . . . . 62.020000000000003 108.292 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 6.0 t -89.13 162.02 16.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 65.329999999999998 107.964 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.7 t30 67.57 44.67 1.66 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 122.647 1.213 . . . . 70.549999999999997 108.521 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.86 16.74 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.963 -1.017 . . . . 71.430000000000007 110.763 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -95.43 137.97 21.96 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.11 -0.7 . . . . 63.310000000000002 109.11 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.602 ' HB2' HD12 ' A' ' 102' ' ' LEU . 87.6 Cg_exo -50.0 -26.24 14.04 Favored 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.638 2.892 . . . . 74.129999999999995 114.755 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 94.7 t -60.58 -39.74 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.529 0.68 . . . . 73.349999999999994 110.283 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.01 -33.26 75.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.257 -0.883 . . . . 64.329999999999998 109.659 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.45 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -69.48 -47.92 62.35 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.245 -0.889 . . . . 52.020000000000003 111.45 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -65.81 -34.57 78.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 70.530000000000001 110.438 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -66.43 -32.26 73.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.229 -0.896 . . . . 71.030000000000001 108.945 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.91 13.16 19.32 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.094 -0.957 . . . . 65.319999999999993 111.445 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 64.76 28.05 12.98 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.524 1.13 . . . . 74.120000000000005 110.693 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -109.43 23.85 13.9 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.586 1.184 . . . . 74.329999999999998 108.99 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.94 -25.4 11.77 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 112.913 -1.949 . . . . 75.010000000000005 112.151 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -54.51 -39.69 67.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.95 0.5 . . . . 60.119999999999997 111.286 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.236 0.541 . . . . 74.209999999999994 110.432 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.75 -48.94 68.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.829 -0.804 . . . . 61.240000000000002 108.829 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 89.2 t -60.07 -41.17 85.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 123.559 0.744 . . . . 61.409999999999997 109.792 176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -56.97 -46.45 82.17 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.562 -0.744 . . . . 73.430000000000007 109.598 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -69.04 -36.48 77.76 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 116.316 -0.402 . . . . 75.109999999999999 111.848 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.7 89.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 53.210000000000001 109.621 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.2 mt-30 -62.88 -37.53 87.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.708 -0.678 . . . . 74.420000000000002 110.442 177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.5 76.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.257 0.551 . . . . 70.010000000000005 111.017 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.58 -36.89 57.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.146 -0.479 . . . . 73.409999999999997 110.598 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -76.74 -49.62 15.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.613 0.968 . . . . 61.210000000000001 113.613 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--O 1.255 1.346 0 CA-C-O 118.975 -0.536 . . . . 72.349999999999994 111.218 -174.639 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 N-CA-C 108.626 -0.879 . . . . 35.310000000000002 108.626 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.82 -101.37 2.71 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.576 -0.738 . . . . 34.219999999999999 113.88 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -98.97 120.78 40.0 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.099 0.476 . . . . 73.319999999999993 111.537 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.59 146.29 50.18 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.148 -0.933 . . . . 63.350000000000001 110.12 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.35 -12.08 11.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.529 -0.305 . . . . 61.409999999999997 111.147 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.282 0.8 OUTLIER -89.16 169.55 11.38 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 114.702 1.371 . . . . 71.420000000000002 114.702 -177.435 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -101.48 148.15 34.81 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.346 -1.353 . . . . 61.43 107.346 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.64 -22.6 9.65 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.892 2.395 . . . . 61.140000000000001 113.699 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.6 -32.19 73.73 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.86 -0.422 . . . . 73.030000000000001 109.86 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.64 126.26 90.85 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.595 -0.891 . . . . 74.099999999999994 108.595 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.32 154.87 61.13 Favored 'Trans proline' 0 C--O 1.256 1.416 0 C-N-CA 122.181 1.921 . . . . 70.140000000000001 111.047 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 p -136.05 169.57 17.39 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.968 0.89 . . . . 74.310000000000002 112.71 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -119.83 160.95 21.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 127.09 2.156 . . . . 73.299999999999997 106.127 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.467 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 7.1 t70 -134.49 156.91 47.78 Favored 'General case' 0 C--N 1.26 -3.308 0 N-CA-C 102.982 -2.97 . . . . 72.439999999999998 102.982 -175.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.51 -51.77 75.43 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.605 0.965 . . . . 72.310000000000002 113.605 -173.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 13.4 Cg_endo -60.23 -31.57 93.2 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.792 1.661 . . . . 62.439999999999998 112.255 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.467 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 19.9 tpt180 -70.79 -37.57 73.32 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.886 0.374 . . . . 75.540000000000006 110.368 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.03 -37.87 77.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.665 -0.865 . . . . 61.200000000000003 108.665 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.77 -37.06 78.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.944 -1.026 . . . . 71.340000000000003 110.035 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.63 -46.67 68.61 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.627 0.771 . . . . 70.299999999999997 109.504 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.77 -46.38 82.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.688 -1.142 . . . . 72.519999999999996 111.617 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.54 -18.41 29.85 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.552 -0.459 . . . . 75.219999999999999 111.842 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.02 61.55 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.965 -0.636 . . . . 64.329999999999998 111.554 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.99 161.1 48.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 109.324 -0.621 . . . . 73.510000000000005 109.324 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.87 158.63 56.17 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 121.908 1.739 . . . . 73.010000000000005 112.051 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.2 -33.33 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.868 0.867 . . . . 75.299999999999997 110.854 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.0 p -60.34 -40.43 90.63 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.686 -0.688 . . . . 73.109999999999999 111.445 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 65.0 tttm -69.33 -34.12 74.16 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.069 -0.715 . . . . 71.049999999999997 109.069 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.487 ' HA ' HE21 ' A' ' 49' ' ' GLN . 64.0 t -63.51 -44.1 98.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.742 -0.663 . . . . 63.420000000000002 109.615 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.62 -36.5 82.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.109 -0.95 . . . . 52.240000000000002 110.357 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.82 -35.09 79.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.064 0.394 . . . . 75.319999999999993 112.064 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 46' ' ' VAL . 37.8 mt-30 -62.56 -42.51 99.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.87 0.843 . . . . 71.450000000000003 108.838 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.56 -34.84 78.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.552 -1.204 . . . . 75.129999999999995 109.451 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.2 mmt85 -67.16 -29.38 69.07 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.928 0.891 . . . . 74.439999999999998 112.33 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.43 6.13 39.99 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.334 -0.546 . . . . 74.140000000000001 111.902 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 43.22 76.02 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.12 -0.562 . . . . 62.030000000000001 112.173 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.73 -17.0 14.78 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.112 -0.699 . . . . 74.409999999999997 109.112 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 tp -149.35 158.39 44.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.675 -1.231 . . . . 62.229999999999997 107.675 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.23 147.22 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.0 -0.741 . . . . 40.229999999999997 109.0 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.84 161.54 28.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.111 0.565 . . . . 71.349999999999994 110.113 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.426 HG11 ' HG3' ' A' ' 99' ' ' MET . 6.7 m -136.68 165.61 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.928 0.891 . . . . 60.229999999999997 109.093 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -117.03 115.88 26.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.659 -0.497 . . . . 43.539999999999999 109.659 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -116.81 124.44 49.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.016 -0.735 . . . . 63.140000000000001 109.016 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.74 22.59 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.835 0.854 . . . . 65.120000000000005 112.712 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.13 -24.02 21.92 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.396 -0.906 . . . . 64.239999999999995 113.24 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.29 143.55 16.73 Favored Glycine 0 CA--C 1.496 -1.146 0 C-N-CA 120.811 -0.709 . . . . 74.510000000000005 112.252 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 124.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.128 -0.694 . . . . 71.140000000000001 109.128 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.44 168.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.751 -1.113 . . . . 61.030000000000001 111.286 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.0 mm -118.64 135.92 23.9 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 105.875 -1.898 . . . . 74.549999999999997 105.875 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.92 139.7 43.92 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 121.606 1.537 . . . . 65.409999999999997 112.638 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -54.15 -36.37 63.27 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.655 0.782 . . . . 64.439999999999998 110.141 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.418 ' CG2' HG11 ' A' ' 126' ' ' VAL . 20.0 m -70.17 -3.18 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.271 . . . . 63.210000000000001 113.92 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -88.4 -5.93 57.99 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.085 0.945 . . . . 72.239999999999995 109.64 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.13 155.54 38.25 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.491 -1.231 . . . . 74.230000000000004 108.395 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.8 p -83.21 165.0 19.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.39 -1.337 . . . . 74.439999999999998 107.39 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -67.1 -16.02 64.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.361 0.6 . . . . 75.120000000000005 110.996 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -79.47 -3.67 47.71 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.301 -0.863 . . . . 70.340000000000003 111.02 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.63 21.71 55.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.009 -0.615 . . . . 51.43 112.694 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -114.58 161.38 18.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.607 0.241 . . . . 74.140000000000001 110.505 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.72 138.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.107 -1.071 . . . . 71.340000000000003 108.107 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.82 129.52 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.036 -1.098 . . . . 74.230000000000004 108.036 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.87 -26.39 62.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.348 0.87 . . . . 75.319999999999993 113.348 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.8 m -99.02 6.91 46.43 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.411 -0.359 . . . . 71.030000000000001 111.645 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 70' ' ' PHE . 19.2 tp -61.12 -54.93 49.09 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 111.98 0.363 . . . . 64.430000000000007 111.98 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.99 -22.14 73.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 121.749 1.632 . . . . 75.120000000000005 111.73 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.43 -44.46 90.28 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.754 -0.657 . . . . 34.109999999999999 112.221 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.07 -39.12 86.78 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.7 -0.852 . . . . 72.049999999999997 108.7 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.77 -36.86 84.44 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.694 -1.139 . . . . 71.409999999999997 111.294 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 m -57.54 -49.21 77.11 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.611 0.243 . . . . 73.319999999999993 111.333 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.95 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.928 0.394 . . . . 74.239999999999995 111.353 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.654 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 83.4 mt -66.69 -39.92 88.3 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.36 0.504 . . . . 64.099999999999994 112.36 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -68.29 -35.64 78.15 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.117 -0.492 . . . . 73.420000000000002 110.496 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.38 -31.67 72.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.597 -0.52 . . . . 72.439999999999998 109.597 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.79 -0.77 89.91 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.502 -0.772 . . . . 45.009999999999998 112.798 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 34.21 55.29 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.309 -0.472 . . . . 62.340000000000003 113.278 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -94.72 123.79 38.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.357 0.598 . . . . 61.299999999999997 112.271 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 14.2 ptm180 -73.87 173.71 9.54 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.781 -1.1 . . . . 72.530000000000001 112.076 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -53.02 -45.32 67.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.061 1.745 . . . . 54.439999999999998 111.238 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -64.24 -40.77 96.71 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 123.842 0.857 . . . . 74.200000000000003 110.092 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 25.1 mm-40 -66.81 -37.49 84.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 74.319999999999993 111.601 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.547 HD12 HD13 ' A' ' 88' ' ' LEU . 20.7 mm -60.85 -48.11 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.126 -1.064 . . . . 72.219999999999999 108.126 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.435 ' SD ' ' HE1' ' A' ' 103' ' ' PHE . 21.8 mmt -74.2 -22.35 59.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.648 -1.16 . . . . 52.0 111.229 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 77.9 ttt180 -54.3 -69.32 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.868 0.867 . . . . 72.549999999999997 111.653 -174.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.654 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 55.2 p-90 -70.35 -32.15 69.72 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.214 0.449 . . . . 74.519999999999996 112.214 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.588 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 9.3 mt -61.34 -39.81 91.95 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.689 1.366 . . . . 64.310000000000002 114.689 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 56.8 m-85 -94.79 -12.17 27.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.599 0.963 . . . . 62.439999999999998 113.599 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.1 m -83.17 129.52 60.66 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.741 -0.837 . . . . 62.399999999999999 108.741 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.12 128.97 29.61 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.033 1.822 . . . . 61.539999999999999 109.626 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.8 118.36 65.96 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.63 -0.878 . . . . 73.5 108.63 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 23.3 Cg_endo -61.11 -20.25 66.97 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.959 2.44 . . . . 64.5 113.667 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.2 m -101.21 4.83 42.27 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.479 -0.328 . . . . 73.430000000000007 110.353 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 tp -107.67 123.28 48.27 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.828 0.823 . . . . 74.109999999999999 111.155 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.3 m -131.2 113.0 13.32 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.87 -1.53 . . . . 74.109999999999999 106.87 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.0 pt . . . . . 0 C--N 1.301 -1.501 0 N-CA-C 112.372 0.508 . . . . 72.420000000000002 112.372 -172.481 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 108.395 -0.965 . . . . 63.5 108.395 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 m -90.23 151.62 21.45 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.537 -0.912 . . . . 72.120000000000005 108.537 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 50.1 m-80 54.37 63.66 2.09 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.306 0.642 . . . . 64.010000000000005 111.634 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.59 156.38 24.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.259 -0.645 . . . . 43.149999999999999 109.259 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -72.8 135.93 80.51 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.348 -0.541 . . . . 74.450000000000003 109.907 175.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.505 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.0 Cg_exo -56.06 -21.22 33.7 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.946 2.431 . . . . 62.0 114.47 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.8 t -61.53 -36.64 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.909 0.861 . . . . 62.329999999999998 109.55 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.0 -31.83 72.95 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.767 -1.106 . . . . 71.299999999999997 109.201 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.97 71.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.665 -1.152 . . . . 52.299999999999997 111.478 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -68.49 -33.02 73.42 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.304 -0.247 . . . . 72.230000000000004 111.367 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -64.91 -29.7 70.65 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.013 0.911 . . . . 71.420000000000002 108.55 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HB3' HE21 ' A' ' 133' ' ' GLN . . . -98.55 15.95 23.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.49 -1.232 . . . . 64.409999999999997 110.584 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.1 m80 58.23 34.2 23.88 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.814 1.413 . . . . 72.140000000000001 114.814 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 131' ' ' ALA . 46.7 mt-30 -104.07 23.53 12.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.682 -1.599 . . . . 74.319999999999993 106.682 172.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.96 -28.35 23.3 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 126.883 2.073 . . . . 75.5 113.772 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -55.3 -40.18 70.78 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.966 0.412 . . . . 70.519999999999996 111.541 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.37 -27.73 61.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.568 0.699 . . . . 61.100000000000001 109.746 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.55 -40.9 72.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.29 -0.868 . . . . 72.329999999999998 108.903 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.477 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 63.3 t -58.73 -46.72 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.599 -0.889 . . . . 74.420000000000002 108.599 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.93 -1.032 . . . . 75.420000000000002 112.301 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -64.97 -36.12 83.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 120.876 -0.33 . . . . 64.340000000000003 110.166 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.14 -43.27 98.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.872 -0.418 . . . . 61.530000000000001 109.872 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -59.51 -44.23 93.18 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 115.577 -0.738 . . . . 74.329999999999998 109.688 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.3 -26.58 68.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 60.0 111.867 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.5 tpt -81.61 -34.26 31.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.026 0.441 . . . . 72.140000000000001 110.608 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.61 -43.45 15.62 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.075 0.464 . . . . 62.32 111.49 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 . . . . . 0 C--O 1.261 1.669 0 CA-C-N 115.73 -0.668 . . . . 73.219999999999999 109.264 -177.22 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 120.953 0.406 . . . . 62.409999999999997 109.987 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.02 -121.06 3.54 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.841 -0.618 . . . . 75.25 113.946 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -109.22 129.79 55.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.546 0.212 . . . . 74.409999999999997 111.315 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -65.96 109.48 2.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.706 -0.679 . . . . 74.010000000000005 111.267 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.56 -30.93 6.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 113.205 0.816 . . . . 64.340000000000003 113.205 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.484 HD23 ' CE2' ' A' ' 103' ' ' PHE 0.273 0.5 OUTLIER -82.86 171.99 13.31 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 118.88 -1.128 . . . . 63.439999999999998 112.294 -178.493 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.19 137.41 75.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 109.233 -0.655 . . . . 52.119999999999997 109.233 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.71 -21.61 32.84 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.254 2.636 . . . . 74.239999999999995 113.852 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.98 -22.55 59.57 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.687 0.279 . . . . 63.329999999999998 111.72 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.48 138.4 97.35 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 116.168 -0.469 . . . . 64.420000000000002 110.109 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.655 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 34.5 Cg_endo -67.41 104.81 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.484 2.122 . . . . 43.210000000000001 110.425 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p -102.59 170.08 8.25 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 121.431 0.634 . . . . 70.400000000000006 112.044 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 107.712 -1.218 . . . . 70.319999999999993 107.712 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.565 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 13.3 t0 -136.53 164.15 28.84 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 103.528 -2.767 . . . . 63.439999999999998 103.528 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.501 ' HB3' HG13 ' A' ' 43' ' ' VAL . 93.5 mt -56.56 -53.76 60.84 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.327 0.862 . . . . 71.420000000000002 113.327 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.565 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 12.0 Cg_endo -58.06 -35.83 98.45 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.83 1.686 . . . . 72.239999999999995 112.012 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 26.9 tpt180 -67.35 -39.95 85.79 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.9 0.381 . . . . 73.140000000000001 111.068 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -36.77 69.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.789 -0.364 . . . . 74.109999999999999 110.386 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.82 68.36 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.002 -0.74 . . . . 42.409999999999997 109.002 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 42.0 mt-10 -68.48 -45.08 73.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.769 -1.105 . . . . 71.109999999999999 111.844 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.5 -46.55 82.48 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.489 -0.778 . . . . 75.549999999999997 112.033 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.419 ' HB2' HG22 ' A' ' 41' ' ' VAL . 97.5 mt -93.94 -10.22 34.47 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.608 0.595 . . . . 73.099999999999994 112.608 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.05 30.12 72.17 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 111.262 -0.735 . . . . 51.539999999999999 111.262 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.419 HG22 ' HB2' ' A' ' 39' ' ' LEU . 20.4 m -124.65 156.61 67.8 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.765 -0.828 . . . . 64.120000000000005 108.765 -177.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.35 156.39 66.4 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 121.391 1.394 . . . . 54.0 111.639 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 32' ' ' LEU . 74.5 t -57.02 -33.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 52.240000000000002 110.371 178.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 28.3 t -57.48 -40.85 79.47 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.639 -0.71 . . . . 74.430000000000007 110.812 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 62.4 tttp -70.47 -35.99 73.62 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 120.861 0.362 . . . . 72.109999999999999 110.202 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.31 -44.51 98.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.221 -0.659 . . . . 55.310000000000002 109.221 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.05 -36.61 80.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.047 -0.979 . . . . 43.200000000000003 110.21 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.623 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 54.7 mt-30 -63.18 -43.44 98.22 Favored 'General case' 0 C--O 1.197 -1.693 0 CA-C-N 116.055 -0.521 . . . . 75.140000000000001 111.133 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.7 mm-40 -58.38 -41.25 84.43 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.326 0.584 . . . . 74.510000000000005 110.317 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 tp -61.67 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.627 -1.169 . . . . 72.109999999999999 109.116 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -71.26 -23.95 62.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.531 -0.759 . . . . 64.099999999999994 112.512 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 10.4 mm-40 -82.97 -12.87 56.94 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.571 -0.529 . . . . 74.310000000000002 109.571 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.4 33.16 44.71 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.034 -0.826 . . . . 74.109999999999999 111.034 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -99.13 -15.72 18.87 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.771 0.319 . . . . 74.430000000000007 110.228 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -161.41 156.95 24.44 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.488 -1.301 . . . . 65.299999999999997 107.488 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.5 m -129.28 157.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.387 -0.597 . . . . 72.310000000000002 109.387 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.8 36.86 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.422 -0.584 . . . . 71.120000000000005 109.422 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 m -128.62 166.68 25.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 123.463 0.477 . . . . 73.200000000000003 111.044 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.476 ' NE ' ' HA2' ' A' ' 62' ' ' GLY . 19.4 ttt180 -109.63 121.04 44.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.428 0.632 . . . . 75.129999999999995 110.537 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -123.0 114.67 20.72 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.673 -1.149 . . . . 71.310000000000002 109.063 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.89 19.07 11.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.817 0.847 . . . . 54.109999999999999 111.023 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.476 ' HA2' ' NE ' ' A' ' 59' ' ' ARG . . . 99.7 -14.11 60.61 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.664 -0.698 . . . . 32.520000000000003 112.112 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -89.31 151.33 21.91 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.744 -0.942 . . . . 73.140000000000001 110.744 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.78 119.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 106.648 -1.612 . . . . 75.120000000000005 106.648 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.86 153.75 39.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.618 -0.719 . . . . 72.400000000000006 110.486 -174.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -126.45 131.84 24.08 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 108.189 -1.041 . . . . 71.540000000000006 108.189 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.39 141.38 86.9 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.238 1.959 . . . . 43.310000000000002 112.857 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.655 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.2 tp-100 -48.84 -42.39 36.16 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.213 1.405 . . . . 73.310000000000002 110.984 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.74 4.33 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 114.133 -1.394 . . . . 43.229999999999997 114.498 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.573 ' CD2' HD11 ' A' ' 81' ' ' LEU . 12.8 m-85 -91.96 -6.23 51.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.168 0.985 . . . . 53.340000000000003 109.501 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.51 144.58 47.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.405 -1.27 . . . . 74.140000000000001 108.683 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 p -75.85 172.95 11.81 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.253 -1.017 . . . . 71.420000000000002 108.253 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.73 -17.3 63.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.895 0.855 . . . . 64.420000000000002 109.261 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m -79.87 -6.86 58.21 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.191 -0.913 . . . . 74.219999999999999 110.552 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.92 -13.88 66.33 Favored Glycine 0 C--O 1.219 -0.827 0 C-N-CA 121.294 -0.479 . . . . 33.130000000000003 113.523 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -95.38 155.04 16.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.228 0.455 . . . . 62.299999999999997 112.228 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.37 141.8 17.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.408 -0.814 . . . . 73.120000000000005 108.812 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 26.4 t -59.91 134.16 25.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.3 -0.63 . . . . 60.149999999999999 109.3 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -55.78 -43.54 76.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.445 0.906 . . . . 75.109999999999999 113.445 -173.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.9 t -91.68 3.41 55.13 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.859 -0.336 . . . . 74.230000000000004 111.774 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.647 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.2 tt -66.46 -49.9 50.23 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 112.671 0.619 . . . . 73.430000000000007 112.671 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.06 -30.06 85.38 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.583 1.522 . . . . 54.439999999999998 111.028 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.25 -42.48 96.24 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.631 -0.713 . . . . 74.420000000000002 111.925 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.99 -40.16 83.12 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.055 -0.72 . . . . 75.530000000000001 109.055 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.53 -35.78 78.71 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.978 -0.556 . . . . 74.400000000000006 110.402 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.2 m -61.46 -49.09 78.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.947 -0.57 . . . . 62.100000000000001 111.677 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.412 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -64.53 -43.37 96.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.635 0.255 . . . . 71.019999999999996 111.226 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.565 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.8 mm? -67.49 -36.08 80.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.541 0.571 . . . . 74.409999999999997 112.541 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.13 -45.24 95.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.264 0.554 . . . . 72.439999999999998 109.866 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.6 -25.7 61.42 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.716 -0.674 . . . . 71.510000000000005 110.445 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.11 86.97 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.6 -0.727 . . . . 74.209999999999994 112.559 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.44 30.6 24.24 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 121.425 -0.417 . . . . 42.020000000000003 113.786 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -106.1 147.73 28.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.128 0.464 . . . . 71.549999999999997 111.537 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.407 ' O ' HG12 ' A' ' 98' ' ' ILE . 16.2 ptp180 -99.62 171.39 7.94 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.672 0.789 . . . . 71.150000000000006 110.724 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -54.02 -45.51 71.56 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.537 1.535 . . . . 70.239999999999995 112.418 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.8 m -64.23 -41.02 97.19 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.636 -0.711 . . . . 54.229999999999997 110.16 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 47.7 mt-10 -66.12 -37.42 85.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.86 -0.609 . . . . 75.310000000000002 110.352 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 94' ' ' ARG . 14.5 mm -61.53 -49.52 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.831 -0.803 . . . . 60.219999999999999 108.831 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.567 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.7 ptp -75.29 -15.92 60.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.187 -0.915 . . . . 52.329999999999998 113.251 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.71 -62.94 1.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.26 -0.644 . . . . 72.140000000000001 109.26 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -69.98 -32.98 71.47 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.479 0.918 . . . . 74.109999999999999 113.479 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.583 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.0 mt -58.96 -40.32 84.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.212 0.819 . . . . 75.109999999999999 113.212 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CE2' HD23 ' A' ' 23' ' ' LEU . 39.0 m-85 -86.14 -11.13 53.45 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.602 0.594 . . . . 70.530000000000001 112.602 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 m -87.51 121.14 71.26 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 108.902 -0.777 . . . . 65.219999999999999 108.902 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.49 130.12 35.83 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 122.568 2.178 . . . . 60.310000000000002 111.846 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 8.1 t70 -79.71 122.81 83.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 108.189 -1.041 . . . . 74.409999999999997 108.189 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.568 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 31.3 Cg_endo -60.78 -16.88 46.82 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.573 2.849 . . . . 71.219999999999999 114.6 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.6 t -119.1 5.74 11.29 Favored 'General case' 0 N--CA 1.421 -1.898 0 O-C-N 122.077 -0.39 . . . . 63.530000000000001 110.883 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -100.77 130.63 46.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.314 0.578 . . . . 64.510000000000005 110.261 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 120' ' ' VAL . 48.7 m -131.56 114.81 15.32 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.984 -1.117 . . . . 74.420000000000002 107.984 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--N 1.313 -1.014 0 N-CA-C 113.883 1.068 . . . . 73.519999999999996 113.883 -174.286 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 110' ' ' THR . 48.1 t . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 108.933 -0.766 . . . . 54.420000000000002 108.933 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.5 m -88.15 146.97 25.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.77 -0.65 . . . . 63.530000000000001 110.162 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.568 ' ND2' ' HA ' ' A' ' 107' ' ' PRO . 17.3 m120 64.72 57.57 1.06 Allowed 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.277 1.031 . . . . 73.129999999999995 109.211 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 159.9 15.68 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.737 -1.119 . . . . 72.329999999999998 109.696 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -81.03 147.88 62.65 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 108.325 -0.991 . . . . 72.329999999999998 108.325 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.583 ' HB2' HD23 ' A' ' 102' ' ' LEU . 52.1 Cg_exo -56.99 -28.15 76.91 Favored 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 121.892 1.728 . . . . 72.109999999999999 111.387 174.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 62.0 t -63.68 -35.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.609 0.719 . . . . 73.519999999999996 110.409 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.81 -41.57 74.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.68 -1.23 . . . . 60.229999999999997 107.68 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -34.86 79.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.485 -1.234 . . . . 63.020000000000003 113.173 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.77 -32.96 71.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.584 -0.698 . . . . 72.420000000000002 111.263 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -76.74 -13.61 60.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.885 0.85 . . . . 73.349999999999994 109.907 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.91 3.85 51.78 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.802 -1.09 . . . . 75.310000000000002 110.421 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.9 t60 64.14 27.17 14.03 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.211 1.482 . . . . 73.219999999999999 109.689 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -114.13 24.86 11.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.0 -1.455 . . . . 74.450000000000003 108.139 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.73 -27.85 19.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.602 -1.635 . . . . 75.519999999999996 112.43 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -56.37 -42.84 78.51 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.468 -0.567 . . . . 52.399999999999999 109.468 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 22.6 mm-40 -65.64 -39.63 91.65 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.361 -0.836 . . . . 72.420000000000002 109.481 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.64 -47.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.4 -0.818 . . . . 62.119999999999997 109.786 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 57.9 t -60.83 -41.79 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.816 -0.629 . . . . 52.109999999999999 109.805 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -63.42 -40.4 97.07 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 120.923 0.392 . . . . 73.319999999999993 111.2 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 14.3 mmt85 -66.22 -35.49 80.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.864 -0.791 . . . . 70.099999999999994 108.864 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.565 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 63.109999999999999 109.888 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.6 mt-30 -61.7 -38.62 88.51 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 109.887 176.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.96 -22.78 65.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.963 0.411 . . . . 53.119999999999997 111.366 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 24.1 mmt -89.07 -29.66 19.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.348 0.594 . . . . 64.540000000000006 110.013 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.32 -45.17 13.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.077 -0.511 . . . . 74.019999999999996 111.8 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 107.785 -1.191 . . . . 70.329999999999998 107.785 -178.954 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 108.798 -0.815 . . . . 63.32 108.798 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.93 -107.77 2.19 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 110.842 -0.903 . . . . 52.039999999999999 110.842 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -118.17 141.88 48.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.703 -0.481 . . . . 61.109999999999999 109.703 -176.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.09 158.09 34.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.997 0.903 . . . . 73.150000000000006 111.696 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 22' ' ' VAL . 38.9 t -121.23 32.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 124.172 1.939 . . . . 74.340000000000003 106.262 175.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.458 HD13 HG21 ' A' ' 29' ' ' THR . 40.4 mt -104.49 178.93 4.42 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.239 -1.8 . . . . 43.399999999999999 111.266 -175.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 15.3 t70 -90.79 136.05 28.23 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 105.704 -1.961 . . . . 61.25 105.704 169.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.65 -25.47 14.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.393 2.728 . . . . 75.219999999999999 115.193 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.52 33.68 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.524 -0.87 . . . . 74.439999999999998 110.973 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 25.3 tp10 -72.57 129.46 87.06 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 105.726 -1.953 . . . . 71.420000000000002 105.726 172.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 52.4 Cg_exo -55.27 98.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.66 2.24 . . . . 74.340000000000003 111.681 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.458 HG21 HD13 ' A' ' 23' ' ' LEU . 6.1 p -107.16 -177.66 3.42 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.732 -0.667 . . . . 73.310000000000002 112.197 -176.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.445 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 52.3 m-85 -111.48 159.78 17.75 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.999 -1.001 . . . . 71.120000000000005 109.445 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.3 m-20 -136.52 162.46 33.03 Favored 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 101.84 -3.392 . . . . 73.230000000000004 101.84 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -50.94 -51.55 66.18 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-N 119.028 0.831 . . . . 72.120000000000005 112.447 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.87 -35.95 85.94 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.021 1.814 . . . . 65.040000000000006 112.553 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 7.7 tpt180 -70.27 -36.99 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.864 0.364 . . . . 73.519999999999996 110.181 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 31' ' ' ASP . 66.0 t -69.1 -39.03 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.475 -0.565 . . . . 71.329999999999998 109.475 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.75 84.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.465 -0.789 . . . . 63.039999999999999 109.52 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.2 -36.69 79.96 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.592 -1.186 . . . . 73.510000000000005 110.247 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 56.9 tp -72.55 -45.46 59.12 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.54 -0.755 . . . . 70.310000000000002 111.335 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 41' ' ' VAL . 94.0 mt -85.71 -18.44 33.09 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.637 0.606 . . . . 54.409999999999997 112.637 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.56 28.04 60.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.796 -0.922 . . . . 34.43 110.796 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 39' ' ' LEU . 31.6 m -123.01 159.09 55.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.319 -0.993 . . . . 75.430000000000007 108.319 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -67.23 155.25 71.4 Favored 'Trans proline' 0 C--O 1.26 1.597 0 C-N-CA 121.057 1.171 . . . . 75.099999999999994 111.644 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.46 -33.5 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.428 0.691 . . . . 73.25 110.424 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 36.8 t -57.33 -45.62 84.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.954 -0.566 . . . . 71.030000000000001 110.787 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 64.7 mttm -64.72 -36.74 85.25 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.392 -0.523 . . . . 64.5 110.88 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.33 -45.17 98.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.496 -0.557 . . . . 60.549999999999997 109.496 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.45 80.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.581 -0.736 . . . . 72.549999999999997 110.552 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.641 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 97.2 mt-30 -61.73 -46.77 88.21 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.802 -0.444 . . . . 54.310000000000002 109.802 176.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 77.6 mt-30 -59.39 -42.55 91.95 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.706 0.765 . . . . 64.329999999999998 110.556 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.2 -38.33 88.74 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.437 -1.256 . . . . 74.420000000000002 109.427 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -71.25 -29.13 64.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.185 0.439 . . . . 75.109999999999999 112.185 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.641 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 56.0 mt-10 -76.55 -12.26 60.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.737 0.303 . . . . 74.540000000000006 110.375 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.44 22.47 64.76 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.545 -1.022 . . . . 62.229999999999997 110.545 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -94.62 -0.32 54.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.103 0.478 . . . . 70.340000000000003 111.049 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.7 tp -163.23 152.79 15.18 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.403 -1.702 . . . . 74.530000000000001 106.403 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -132.09 148.13 32.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.013 -0.736 . . . . 71.329999999999998 109.013 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.23 154.3 37.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 123.567 0.542 . . . . 75.319999999999993 110.01 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.576 HG12 ' OD2' ' A' ' 95' ' ' ASP . 19.6 m -128.39 166.63 25.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.302 1.041 . . . . 75.150000000000006 109.116 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 53.4 mtm180 -110.91 129.37 55.9 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.743 -0.466 . . . . 71.129999999999995 109.743 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -125.34 123.84 40.26 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.648 -1.612 . . . . 70.129999999999995 106.648 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.04 -15.78 0.32 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.418 1.087 . . . . 60.030000000000001 112.8 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.01 -13.83 4.67 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.927 -0.869 . . . . 63.32 110.927 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -92.7 152.52 21.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.804 -0.918 . . . . 63.149999999999999 110.804 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -96.8 120.78 46.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 71.519999999999996 107.835 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.39 160.29 40.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.479 -0.782 . . . . 63.310000000000002 111.218 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.06 125.7 26.19 Favored Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 106.978 -1.49 . . . . 74.439999999999998 106.978 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 29' ' ' THR . 51.3 Cg_exo -56.43 139.22 86.6 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.745 2.296 . . . . 75.239999999999995 113.625 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.9 tp-100 -53.81 -37.26 63.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.286 1.034 . . . . 70.25 110.165 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.459 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 34.3 m -72.18 2.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.574 -1.648 . . . . 74.450000000000003 113.95 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.3 m-85 -95.49 -1.68 50.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.935 0.874 . . . . 74.430000000000007 109.497 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.46 139.32 53.63 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.656 -1.156 . . . . 73.510000000000005 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.7 p -79.51 168.94 18.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.016 -0.993 . . . . 70.040000000000006 109.519 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -57.56 -23.41 50.46 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.068 0.547 . . . . 73.340000000000003 111.35 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 t -79.96 -8.13 59.17 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.191 -0.459 . . . . 73.299999999999997 110.345 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.17 18.33 65.03 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.998 -0.62 . . . . 65.329999999999998 112.719 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -119.13 161.84 19.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.046 -0.724 . . . . 72.439999999999998 109.046 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.27 144.86 11.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.332 -0.988 . . . . 72.329999999999998 108.332 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.8 t -64.02 124.64 19.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.406 -0.961 . . . . 73.230000000000004 108.406 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -55.26 -44.72 75.84 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.584 1.327 . . . . 62.219999999999999 114.584 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.9 m -96.55 9.82 40.29 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 112.758 0.651 . . . . 65.420000000000002 112.758 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 7.1 tt -65.64 -45.34 67.11 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 116.368 -0.378 . . . . 72.430000000000007 111.864 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.88 -25.76 54.33 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.924 1.749 . . . . 75.319999999999993 111.658 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.9 -38.66 96.93 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.658 -0.701 . . . . 33.0 111.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.98 -41.06 78.4 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.971 -0.751 . . . . 63.299999999999997 108.971 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.43 -34.39 75.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 72.299999999999997 110.355 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.0 m -61.65 -49.02 78.22 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.486 -0.779 . . . . 64.239999999999995 110.791 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -41.81 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 111.642 0.238 . . . . 71.420000000000002 111.642 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.409 HD21 ' HB1' ' A' ' 141' ' ' ALA . 2.9 mm? -66.75 -35.19 79.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.029 -0.668 . . . . 74.140000000000001 112.511 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -63.72 -35.95 82.27 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.131 -0.692 . . . . 75.0 109.131 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.09 -31.22 67.54 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.481 -0.781 . . . . 71.25 110.002 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.62 -8.63 70.05 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.625 -0.716 . . . . 72.049999999999997 112.8 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.04 49.61 5.9 Favored Glycine 0 C--N 1.318 -0.423 0 C-N-CA 121.338 -0.458 . . . . 62.329999999999998 113.669 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.94 139.8 49.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.259 -0.553 . . . . 71.109999999999999 111.865 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -85.09 170.03 13.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.351 -0.84 . . . . 74.400000000000006 110.3 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.576 ' OD2' HG12 ' A' ' 58' ' ' VAL . 19.1 p-10 -55.28 -42.69 73.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.506 1.522 . . . . 74.209999999999994 111.945 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.2 m -61.32 -42.24 98.35 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.098 -0.955 . . . . 73.549999999999997 110.012 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.73 -37.12 84.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.141 -0.482 . . . . 75.540000000000006 110.928 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.09 -48.9 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.844 0.831 . . . . 75.049999999999997 108.813 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.489 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 59.0 mtt -75.48 -20.87 58.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.784 -1.098 . . . . 73.209999999999994 112.227 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -57.97 -61.13 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.511 0.507 . . . . 72.340000000000003 109.736 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.419 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 29.1 p-90 -69.46 -32.53 71.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.19 0.811 . . . . 64.049999999999997 113.19 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 126' ' ' VAL . 17.0 mt -60.12 -41.45 92.68 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.812 0.671 . . . . 75.329999999999998 112.812 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -85.02 -14.72 46.48 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.605 -0.438 . . . . 70.510000000000005 112.081 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 m -87.05 118.59 70.25 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.788 -0.449 . . . . 74.310000000000002 109.788 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.93 131.07 40.71 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.903 2.402 . . . . 74.319999999999993 111.217 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.6 t70 -90.47 122.84 66.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.26 -0.427 . . . . 61.119999999999997 110.966 -174.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.91 -16.31 44.04 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.935 3.09 . . . . 50.25 114.56 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -118.03 10.54 13.08 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.798 -0.564 . . . . 55.340000000000003 110.4 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.32 131.3 49.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.488 0.661 . . . . 71.129999999999995 111.917 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -125.99 120.28 29.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.867 -1.531 . . . . 62.0 106.867 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.464 HG22 ' NE2' ' A' ' 133' ' ' GLN . 28.1 pt . . . . . 0 C--N 1.302 -1.484 0 CA-C-O 120.429 0.156 . . . . 72.439999999999998 111.285 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.9 t . . . . . 0 N--CA 1.438 -1.06 0 N-CA-C 109.393 -0.595 . . . . 63.439999999999998 109.393 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.8 m -90.17 139.9 30.19 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.842 -0.617 . . . . 52.520000000000003 109.55 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 29.0 t-20 59.81 67.79 0.84 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.746 1.26 . . . . 72.150000000000006 110.619 -177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -113.1 179.23 4.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.288 -1.324 . . . . 52.32 109.877 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.451 ' HD3' ' N ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -87.12 138.35 32.6 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 109.014 -0.736 . . . . 63.109999999999999 109.014 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.505 ' HB2' HD23 ' A' ' 102' ' ' LEU . 71.4 Cg_exo -56.27 -29.93 78.3 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.198 1.932 . . . . 61.140000000000001 110.122 170.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.633 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 70.5 t -61.82 -42.8 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.345 0.593 . . . . 74.129999999999995 110.37 173.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.98 -34.76 77.15 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.07 -0.652 . . . . 72.209999999999994 109.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.79 85.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.915 -1.039 . . . . 63.219999999999999 112.853 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.65 -32.51 71.21 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.029 -0.42 . . . . 71.400000000000006 110.917 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -71.74 -23.41 61.61 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.686 0.755 . . . . 70.430000000000007 109.767 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.38 -0.26 54.28 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.851 -1.068 . . . . 61.310000000000002 110.423 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.7 m80 64.03 28.24 14.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.59 1.156 . . . . 71.310000000000002 110.256 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.464 ' NE2' HG22 ' A' ' 111' ' ' ILE . 12.7 mt-30 -102.61 25.07 9.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.956 -1.475 . . . . 72.129999999999995 107.414 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.49 -28.31 19.86 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 113.914 -1.494 . . . . 73.409999999999997 112.675 -178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -56.77 -41.15 77.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.81 0.338 . . . . 71.409999999999997 110.707 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.51 -34.18 77.65 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.909 -0.587 . . . . 63.329999999999998 110.165 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.24 -44.87 83.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.685 -0.688 . . . . 52.229999999999997 109.144 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 134' ' ' ALA . 64.2 t -61.1 -42.33 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.458 -0.571 . . . . 61.549999999999997 109.458 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -58.11 -43.44 87.15 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.977 -0.556 . . . . 72.209999999999994 110.403 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 144' ' ' MET . 73.2 mmt-85 -65.84 -39.0 90.37 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 116.618 -0.265 . . . . 71.329999999999998 111.126 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.409 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -58.87 -45.1 90.96 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.365 0.416 . . . . 23.399999999999999 110.272 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -43.02 99.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 72.340000000000003 109.993 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.07 -19.83 63.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.401 -0.818 . . . . 51.399999999999999 112.632 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 91.3 mmm -88.4 -21.49 24.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.313 0.577 . . . . 65.409999999999997 109.799 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.37 -61.0 2.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.328 -0.619 . . . . 74.510000000000005 109.328 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--N 1.302 -1.457 0 CA-C-O 118.304 -0.855 . . . . 65.439999999999998 109.52 -178.847 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . . . . . . 0 CA--C 1.502 -0.866 0 CA-C-O 120.466 0.174 . . . . 72.030000000000001 111.388 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.04 -171.53 18.77 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.268 -1.133 . . . . 31.239999999999998 110.268 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -87.68 138.28 31.61 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.022 -0.733 . . . . 73.120000000000005 109.022 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.08 111.45 7.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.118 0.961 . . . . 73.439999999999998 112.421 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 100' ' ' ARG . 25.9 t -96.83 45.14 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.525 -1.657 . . . . 74.549999999999997 106.525 171.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.473 HD23 ' CE2' ' A' ' 103' ' ' PHE . 57.0 mt -107.97 161.01 15.32 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.315 -1.311 . . . . 74.25 110.645 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.589 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.5 t70 -97.4 143.27 25.87 Favored Pre-proline 0 C--N 1.289 -2.037 0 N-CA-C 105.504 -2.035 . . . . 74.319999999999993 105.504 171.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.37 -24.67 12.38 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.318 2.679 . . . . 45.350000000000001 114.539 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -96.43 2.59 52.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.759 1.022 . . . . 62.509999999999998 113.759 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.589 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 41.2 mm-40 -78.15 127.57 81.01 Favored Pre-proline 0 C--O 1.249 1.079 0 N-CA-C 109.139 -0.689 . . . . 74.150000000000006 109.139 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.13 142.11 60.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.878 2.385 . . . . 75.200000000000003 112.802 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.3 p -123.06 -174.65 2.99 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.286 -0.87 . . . . 71.450000000000003 110.552 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -133.15 161.84 33.36 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 127.344 2.258 . . . . 64.239999999999995 107.059 172.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.9 p30 -133.41 156.41 47.73 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 104.132 -2.544 . . . . 73.519999999999996 104.132 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.311 4.5 mm? -51.7 -52.61 58.99 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 116.126 1.898 . . . . 75.420000000000002 116.126 -172.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.15 -33.74 97.78 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 120.371 1.168 . . . . 74.150000000000006 111.935 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -69.35 -41.23 76.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.057 -0.349 . . . . 74.109999999999999 110.057 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG21 HD12 ' A' ' 66' ' ' ILE . 62.4 t -67.65 -39.64 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.306 -0.406 . . . . 72.019999999999996 109.972 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.89 91.66 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.428 -0.806 . . . . 71.120000000000005 109.612 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.69 -41.01 79.79 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.841 -1.072 . . . . 54.210000000000001 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.06 -44.44 72.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.345 -0.843 . . . . 61.350000000000001 111.516 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.0 -13.95 40.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.32 -0.4 . . . . 72.549999999999997 112.046 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.7 23.77 71.75 Favored Glycine 0 C--O 1.243 0.673 0 C-N-CA 120.888 -0.672 . . . . 61.329999999999998 112.339 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 143.71 50.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.652 -0.87 . . . . 63.399999999999999 108.652 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.53 155.18 43.32 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.432 2.088 . . . . 75.430000000000007 113.064 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -50.8 -35.76 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.338 1.055 . . . . 62.149999999999999 111.722 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 t -57.68 -42.98 84.7 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.72 0.408 . . . . 71.010000000000005 110.867 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -69.69 -36.01 75.59 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.806 0.336 . . . . 52.130000000000003 110.957 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.12 -40.54 89.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.5 -0.555 . . . . 72.230000000000004 109.5 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.46 75.36 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.666 -0.697 . . . . 74.549999999999997 111.049 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 48' ' ' GLN . 12.4 mm-40 -65.7 -39.99 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 71.019999999999996 110.679 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.08 -44.65 95.19 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.0 0.905 . . . . 74.439999999999998 109.213 176.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.17 -35.16 77.96 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.103 -1.408 . . . . 64.519999999999996 110.505 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.229 0.455 . . . . 73.129999999999995 112.229 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -84.75 -12.19 54.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.119 -0.632 . . . . 70.340000000000003 111.403 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.64 34.47 25.05 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.491 -1.044 . . . . 72.209999999999994 110.491 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.408 ' O ' HD23 ' A' ' 81' ' ' LEU . 36.9 t-80 -82.12 -21.52 36.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.772 -0.825 . . . . 71.219999999999999 108.772 177.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.5 tp -152.32 157.97 42.08 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.989 -1.856 . . . . 74.0 105.989 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.46 146.01 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.554 -0.906 . . . . 73.150000000000006 108.554 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -118.61 158.68 25.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.246 -1.02 . . . . 74.439999999999998 108.246 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.2 m -132.56 162.37 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.396 0.617 . . . . 74.030000000000001 111.204 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -110.55 115.48 29.69 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.591 -1.263 . . . . 61.020000000000003 107.591 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -130.38 129.9 43.69 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 106.935 -1.506 . . . . 73.439999999999998 106.935 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.33 9.71 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.797 0.839 . . . . 75.219999999999999 110.879 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.32 65.53 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.786 -0.643 . . . . 63.119999999999997 112.358 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.29 146.52 18.23 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 121.186 -0.53 . . . . 71.430000000000007 111.955 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.51 121.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.454 -0.573 . . . . 75.239999999999995 109.454 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.29 167.28 18.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 125.264 1.426 . . . . 63.399999999999999 108.48 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.438 HD12 HG21 ' A' ' 35' ' ' VAL . 74.7 mt -115.47 131.49 23.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.397 -0.964 . . . . 73.329999999999998 108.397 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.68 126.71 17.27 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 121.861 1.707 . . . . 64.519999999999996 112.616 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.41 ' HB2' HE21 ' A' ' 68' ' ' GLN . 6.5 tt0 -64.03 -23.98 67.54 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 122.951 0.501 . . . . 73.450000000000003 111.603 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 m -67.87 -6.81 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 112.332 0.493 . . . . 61.229999999999997 112.332 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.8 m-85 -89.37 -3.24 58.53 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.037 0.922 . . . . 73.439999999999998 109.847 174.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -117.86 152.35 35.55 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.666 -1.152 . . . . 74.0 108.162 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 p -82.65 175.28 10.28 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 123.441 0.463 . . . . 72.140000000000001 110.034 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.04 -33.68 69.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.549 0.74 . . . . 72.340000000000003 110.718 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.1 m -79.54 -3.57 47.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.961 -0.563 . . . . 65.25 112.511 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.9 35.59 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.309 -0.948 . . . . 73.200000000000003 111.398 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.57 145.51 37.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.272 -1.01 . . . . 74.239999999999995 108.272 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.435 HG13 HD22 ' A' ' 81' ' ' LEU . 55.2 t -68.99 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.228 -1.027 . . . . 74.310000000000002 108.228 174.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.84 127.87 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.37 -0.974 . . . . 72.109999999999999 108.37 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -68.81 -25.46 64.69 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.891 -0.506 . . . . 70.510000000000005 112.188 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 56.7 m -90.25 6.92 40.81 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.493 -0.321 . . . . 60.240000000000002 111.439 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 13.0 tp -61.23 -53.19 65.35 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 119.235 -0.412 . . . . 71.409999999999997 111.029 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.3 Cg_exo -63.12 -29.84 74.79 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.359 1.373 . . . . 74.140000000000001 110.984 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.14 91.99 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.721 -0.672 . . . . 41.119999999999997 111.923 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.04 -40.19 82.89 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.292 0.567 . . . . 71.209999999999994 109.493 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.54 -45.96 88.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 52.350000000000001 110.437 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.5 m -62.56 -43.79 97.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.748 0.647 . . . . 72.219999999999999 112.748 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.503 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -61.94 -47.7 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 118.128 0.422 . . . . 71.129999999999995 111.537 -178.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.586 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -67.28 -42.79 83.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 74.430000000000007 112.06 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.35 -35.33 80.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.164 -0.68 . . . . 52.229999999999997 109.164 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -71.07 -30.2 66.28 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.433 0.635 . . . . 52.140000000000001 110.595 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.22 86.84 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.918 -0.583 . . . . 50.009999999999998 112.673 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.62 39.95 4.28 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 120.775 -0.726 . . . . 73.109999999999999 112.999 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 65.7 m-85 -119.62 136.82 54.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.251 -0.648 . . . . 65.450000000000003 109.251 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.587 ' HG2' ' OE1' ' A' ' 97' ' ' GLU . 7.8 ptp85 -84.61 171.07 12.74 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 123.251 0.345 . . . . 75.209999999999994 110.697 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -53.38 -45.29 69.19 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 124.601 1.161 . . . . 62.43 112.969 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -62.04 -40.65 96.47 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.627 -0.715 . . . . 73.510000000000005 109.95 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.587 ' OE1' ' HG2' ' A' ' 94' ' ' ARG . 44.7 mt-10 -65.87 -33.83 76.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.941 -0.572 . . . . 62.119999999999997 111.798 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.414 HD12 ' CB ' ' A' ' 88' ' ' LEU . 9.4 mm -62.53 -49.4 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.296 -1.002 . . . . 64.140000000000001 108.296 -177.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.493 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 14.9 ptm -75.44 -16.32 60.34 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.243 -0.89 . . . . 54.119999999999997 112.634 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HA ' HG11 ' A' ' 22' ' ' VAL . 68.4 ttt180 -58.59 -64.42 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.351 0.66 . . . . 71.230000000000004 110.364 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.486 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.0 p-90 -68.84 -31.67 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.192 -0.458 . . . . 72.129999999999995 112.145 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 11.9 mt -57.71 -39.56 77.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.007 0.743 . . . . 70.420000000000002 113.007 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CE2' HD23 ' A' ' 23' ' ' LEU . 30.0 m-85 -86.49 -3.14 58.96 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.241 0.46 . . . . 71.540000000000006 112.241 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.5 m -86.2 125.43 68.09 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 107.606 -1.257 . . . . 63.439999999999998 107.606 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.56 133.84 59.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.649 2.233 . . . . 64.540000000000006 110.94 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.7 t70 -91.45 121.37 67.56 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 109.428 -0.582 . . . . 72.109999999999999 109.428 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.78 -16.38 43.73 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.693 2.929 . . . . 72.430000000000007 114.779 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 m -123.46 16.02 9.66 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 122.01 -0.431 . . . . 72.400000000000006 111.108 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 28.9 tp -104.28 115.18 29.93 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.726 -0.79 . . . . 65.430000000000007 111.231 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.2 m -122.37 110.68 15.95 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.901 -1.518 . . . . 75.019999999999996 106.901 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 C--N 1.3 -1.561 0 N-CA-C 112.37 0.507 . . . . 72.420000000000002 112.37 -171.666 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 108.806 -0.813 . . . . 54.140000000000001 108.806 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.1 m -87.46 149.33 24.49 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 123.059 0.544 . . . . 72.540000000000006 109.892 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 4.8 m-20 56.42 43.47 26.03 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.309 1.044 . . . . 41.140000000000001 111.138 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.61 175.66 9.1 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.111 -0.949 . . . . 71.25 111.988 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -86.74 124.67 68.89 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.33 -0.85 . . . . 75.439999999999998 110.41 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.6 Cg_exo -51.96 -28.08 30.54 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 124.068 3.179 . . . . 72.109999999999999 114.443 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.9 t -60.39 -39.1 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.515 0.674 . . . . 65.129999999999995 109.879 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.13 -30.07 68.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.567 -0.742 . . . . 62.539999999999999 111.176 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.22 87.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 62.140000000000001 110.213 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -70.2 -34.05 72.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.88 -0.415 . . . . 62.219999999999999 109.88 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -68.65 -25.28 64.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.44 -0.8 . . . . 73.510000000000005 109.241 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.47 7.03 46.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.15 -0.932 . . . . 71.230000000000004 111.071 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.9 m80 69.35 32.79 3.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.931 0.872 . . . . 70.120000000000005 112.873 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -112.01 24.69 12.36 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.82 -1.178 . . . . 72.239999999999995 107.82 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.93 -29.74 30.45 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 125.22 1.408 . . . . 55.329999999999998 113.657 -173.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -57.77 -35.44 70.76 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.835 0.35 . . . . 74.319999999999993 111.476 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -32.37 68.01 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.476 0.655 . . . . 73.010000000000005 109.845 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.4 t -70.97 -42.83 77.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.964 -1.016 . . . . 63.340000000000003 108.523 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 90.2 t -59.46 -42.64 88.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.428 -0.806 . . . . 73.040000000000006 109.874 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -60.71 -47.18 87.44 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.658 -0.246 . . . . 71.420000000000002 111.255 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -61.14 -39.21 89.22 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.354 -0.61 . . . . 75.230000000000004 109.354 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.586 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.87 -46.74 88.33 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 115.271 -0.877 . . . . 63.130000000000003 110.87 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.3 mt-30 -58.57 -41.18 85.12 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.2 0.6 . . . . 61.25 111.529 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.24 79.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.9 -0.591 . . . . 42.130000000000003 111.221 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.1 tpt -80.34 -35.44 35.56 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.889 -0.596 . . . . 71.450000000000003 110.697 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -71.89 -49.87 34.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.294 0.85 . . . . 71.510000000000005 113.294 -176.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 C--N 1.307 -1.276 0 CA-C-O 118.628 -0.701 . . . . 71.109999999999999 109.575 -175.411 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB1' ' C ' ' A' ' 58' ' ' VAL . . . . . . . . 0 N--CA 1.432 -1.337 0 CA-C-O 120.816 0.341 . . . . 74.409999999999997 110.317 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.491 ' HA3' ' OD1' ' A' ' 95' ' ' ASP . . . -83.94 -164.8 37.71 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.173 -0.922 . . . . 73.010000000000005 115.06 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.12 112.89 20.22 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 114.342 -0.929 . . . . 63.420000000000002 111.224 -173.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -46.23 111.85 0.42 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.92 1.288 . . . . 54.009999999999998 113.846 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 100' ' ' ARG . 91.8 t -86.67 -37.7 11.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 107.92 -1.141 . . . . 72.209999999999994 107.92 172.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HB3' ' CD2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -73.63 164.67 26.33 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.955 -1.02 . . . . 74.019999999999996 111.238 177.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.37 150.07 97.43 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.757 -0.46 . . . . 64.150000000000006 109.757 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 59.3 Cg_exo -51.28 -41.0 60.57 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.646 2.231 . . . . 73.310000000000002 113.2 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.14 26.74 8.42 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 63.229999999999997 113.119 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.66 138.39 90.86 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 105.832 -1.914 . . . . 75.310000000000002 105.832 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -36.46 110.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.463 3.442 . . . . 74.209999999999994 113.496 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.89 174.98 10.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.353 0.597 . . . . 74.540000000000006 112.271 -176.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.494 ' CE2' HD22 ' A' ' 38' ' ' LEU . 35.0 m-85 -130.33 161.52 31.1 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.418 1.487 . . . . 75.310000000000002 107.828 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.6 t0 -133.28 166.74 21.8 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 103.344 -2.836 . . . . 72.25 103.344 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -46.62 -56.0 12.73 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 113.706 1.002 . . . . 72.5 113.706 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.32 -40.9 78.5 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 121.794 1.663 . . . . 44.329999999999998 112.004 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.43 ' N ' ' HD2' ' A' ' 34' ' ' ARG . 1.9 mpt_? -70.77 -34.69 72.07 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.055 0.761 . . . . 73.299999999999997 113.055 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 31' ' ' ASP . 45.5 t -69.86 -43.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.979 -0.748 . . . . 74.510000000000005 108.979 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.71 80.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.911 -1.04 . . . . 72.239999999999995 109.475 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.5 -45.45 75.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.279 -0.873 . . . . 63.240000000000002 110.436 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.494 HD22 ' CE2' ' A' ' 30' ' ' TYR . 30.2 tp -65.76 -50.12 65.9 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 71.010000000000005 111.096 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.501 ' HB2' HG22 ' A' ' 41' ' ' VAL . 93.6 mt -83.1 -18.37 39.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.795 -0.639 . . . . 71.450000000000003 112.217 -176.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.85 63.38 Favored Glycine 0 C--N 1.323 -0.159 0 N-CA-C 111.056 -0.818 . . . . 73.230000000000004 111.056 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 39' ' ' LEU . 21.1 m -124.28 165.05 26.37 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.835 -0.802 . . . . 74.239999999999995 108.835 -177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -79.45 163.57 24.4 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.205 1.27 . . . . 63.210000000000001 110.709 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.48 -34.14 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.452 0.701 . . . . 61.32 111.25 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.6 p -61.25 -40.85 95.58 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.601 -0.727 . . . . 75.040000000000006 111.837 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 83.0 tttt -69.54 -32.21 70.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.898 0.38 . . . . 71.140000000000001 110.289 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.16 -42.17 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.239 -0.652 . . . . 73.209999999999994 109.239 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.25 74.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.542 -0.754 . . . . 61.420000000000002 110.212 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 44' ' ' SER . 73.9 mm-40 -66.39 -35.45 80.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.5 -0.318 . . . . 75.140000000000001 111.038 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 76.6 mm-40 -64.34 -47.22 80.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 70.030000000000001 108.417 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.81 -45.0 95.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.086 -1.415 . . . . 65.129999999999995 110.017 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -65.39 -23.6 67.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 114.187 1.18 . . . . 62.32 114.187 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.27 3.14 37.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.028 -1.069 . . . . 65.409999999999997 111.366 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.97 41.25 41.29 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.591 -0.731 . . . . 54.039999999999999 112.297 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.12 -12.26 18.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.938 -0.393 . . . . 73.420000000000002 109.938 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.3 tp -156.77 161.38 39.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.57 -0.9 . . . . 60.340000000000003 108.57 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.23 146.82 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.89 -0.782 . . . . 61.549999999999997 108.89 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.39 148.31 43.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 63.409999999999997 109.024 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.486 ' C ' ' HB1' ' A' ' 18' ' ' ALA . 17.7 m -127.06 155.07 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.862 0.363 . . . . 54.210000000000001 110.877 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -110.41 115.12 29.09 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.7 -0.852 . . . . 71.310000000000002 108.7 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -126.82 123.74 38.03 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.206 -0.664 . . . . 61.219999999999999 109.206 -179.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.93 14.75 8.64 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.375 1.07 . . . . 71.140000000000001 111.378 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.92 4.31 60.25 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.656 -0.702 . . . . 41.439999999999998 112.362 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.51 145.68 16.13 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.563 -1.015 . . . . 74.439999999999998 110.563 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' A' ' 18' ' ' ALA . 95.4 t -97.15 120.03 45.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.591 -0.892 . . . . 74.340000000000003 108.591 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.26 169.53 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.212 -0.904 . . . . 72.099999999999994 109.228 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.433 HD12 HG21 ' A' ' 35' ' ' VAL . 57.0 mt -119.75 129.19 25.49 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 108.455 -0.943 . . . . 74.129999999999995 108.455 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.11 122.23 11.41 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.956 2.438 . . . . 74.540000000000006 112.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.486 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.5 tt0 -64.66 -25.6 68.02 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 111.921 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 32.8 m -72.2 -4.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.969 0.414 . . . . 73.349999999999994 112.108 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.86 -4.94 59.23 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.018 0.914 . . . . 65.430000000000007 109.718 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -117.04 151.29 37.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.835 -1.172 . . . . 65.230000000000004 107.835 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 p -83.06 166.87 18.39 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.86 -16.48 64.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.534 0.683 . . . . 72.239999999999995 110.112 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -79.96 -1.82 41.18 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.976 -0.556 . . . . 75.109999999999999 111.906 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.15 28.1 56.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.311 -0.947 . . . . 55.420000000000002 111.883 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -124.5 143.04 50.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.081 -1.081 . . . . 74.219999999999999 108.081 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.15 141.12 18.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.059 -1.089 . . . . 60.539999999999999 108.059 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.631 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.4 t -57.81 122.34 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.38 -0.971 . . . . 53.049999999999997 108.38 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -67.33 -27.61 67.29 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.437 0.902 . . . . 74.129999999999995 113.437 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -89.92 -6.77 55.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.161 0.505 . . . . 72.140000000000001 111.086 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.631 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 9.1 tt -65.91 -47.51 63.98 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 113.646 0.98 . . . . 63.240000000000002 113.646 -175.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.5 Cg_endo -55.72 -28.89 68.74 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.654 1.569 . . . . 64.140000000000001 111.186 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -40.23 93.67 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.663 -0.699 . . . . 74.540000000000006 111.987 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -67.97 -40.13 83.21 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.077 -0.712 . . . . 73.430000000000007 109.077 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.647 -0.706 . . . . 63.520000000000003 109.966 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.6 m -58.81 -50.03 75.49 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-N 115.674 -0.694 . . . . 61.43 111.524 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -41.62 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.634 -0.257 . . . . 71.439999999999998 111.516 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.487 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.6 mm? -66.8 -36.31 82.1 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.077 0.399 . . . . 73.319999999999993 112.077 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -65.92 -32.81 74.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.486 0.184 . . . . 72.430000000000007 110.973 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.75 -30.64 71.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.163 0.506 . . . . 62.039999999999999 110.199 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.68 88.43 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.861 -0.608 . . . . 63.350000000000001 111.672 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.79 35.91 38.58 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.752 -0.224 . . . . 70.329999999999998 113.09 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 99.4 m-85 -97.67 145.66 26.1 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 122.412 -0.464 . . . . 73.349999999999994 111.04 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -95.6 171.43 8.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.594 -0.73 . . . . 75.239999999999995 110.205 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.491 ' OD1' ' HA3' ' A' ' 19' ' ' GLY . 2.0 p30 -53.65 -45.69 70.31 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.522 1.129 . . . . 74.120000000000005 113.092 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.3 m -62.4 -40.74 97.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 122.807 0.443 . . . . 71.430000000000007 111.239 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.75 -37.58 86.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.986 -0.552 . . . . 72.219999999999999 110.407 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.18 -49.06 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.869 0.842 . . . . 74.25 109.644 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 13.0 ptt? -74.77 -13.52 60.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.864 -1.062 . . . . 74.349999999999994 113.356 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.511 ' HA ' HG11 ' A' ' 22' ' ' VAL . 77.3 ttt180 -57.43 -66.24 0.49 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.93 -0.308 . . . . 75.230000000000004 110.87 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.482 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 32.0 p-90 -67.61 -32.13 72.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.393 0.516 . . . . 72.310000000000002 112.393 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.482 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.9 mt -58.49 -40.82 83.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.6 0.593 . . . . 63.350000000000001 112.6 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.406 ' CD2' ' HB3' ' A' ' 23' ' ' LEU . 82.3 m-85 -95.23 -4.19 46.27 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.952 0.723 . . . . 73.430000000000007 112.952 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.9 m -87.34 120.09 71.11 Favored Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 109.035 -0.728 . . . . 75.319999999999993 109.035 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.96 129.1 23.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.551 1.501 . . . . 63.329999999999998 108.788 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 12.3 t70 -80.68 125.13 81.17 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.665 -0.494 . . . . 65.299999999999997 109.665 -176.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 26.9 Cg_endo -60.41 -22.25 70.73 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.518 2.812 . . . . 72.439999999999998 114.065 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -109.4 -1.48 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.128 -0.629 . . . . 73.230000000000004 111.542 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 23.7 tp -102.57 128.9 49.04 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 119.435 -0.906 . . . . 71.519999999999996 111.509 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.3 m -116.56 122.14 43.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.078 -1.823 . . . . 73.239999999999995 106.078 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 128' ' ' ALA . 40.1 mt . . . . . 0 C--N 1.305 -1.354 0 C-N-CA 120.498 -0.481 . . . . 71.430000000000007 110.261 -174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 107.423 -1.325 . . . . 70.530000000000001 107.423 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.0 p -81.62 137.95 35.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.315 -0.402 . . . . 54.32 110.23 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.595 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 33.5 m-80 68.12 66.44 0.35 Allowed 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 124.235 1.014 . . . . 63.210000000000001 110.299 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.429 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -109.45 169.4 8.72 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.055 -0.658 . . . . 73.329999999999998 109.824 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -89.37 157.59 47.24 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.555 -0.293 . . . . 72.030000000000001 110.443 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.88 -25.61 79.9 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.054 1.836 . . . . 64.530000000000001 109.848 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 69' ' ' VAL . 84.9 t -62.56 -38.71 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.22 -0.9 . . . . 61.109999999999999 109.716 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.98 -42.28 76.76 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.276 -0.639 . . . . 71.040000000000006 109.276 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -59.53 -41.0 89.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 64.439999999999998 112.857 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.69 -40.5 95.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.061 0.393 . . . . 64.219999999999999 112.061 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -77.6 -14.27 59.69 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.381 0.61 . . . . 73.340000000000003 111.058 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.53 5.9 50.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.317 -0.856 . . . . 12.4 111.575 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.0 m80 66.97 28.43 8.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.678 0.791 . . . . 64.519999999999996 112.028 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.3 23.19 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.077 0.941 . . . . 64.099999999999994 108.969 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.03 -28.66 39.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.018 1.727 . . . . 54.210000000000001 112.426 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -56.07 -38.44 70.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.366 -0.379 . . . . 74.109999999999999 110.62 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.98 -29.67 63.23 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 116.459 -0.337 . . . . 72.319999999999993 111.231 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.62 -49.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.118 -0.697 . . . . 60.130000000000003 109.118 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 57.6 t -62.53 -47.35 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.66 -0.7 . . . . 74.319999999999993 110.03 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.36 -46.59 83.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.8 -0.637 . . . . 73.530000000000001 111.121 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 140' ' ' ARG . 7.0 ttm180 -69.0 -33.41 73.62 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 63.520000000000003 110.5 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -64.96 -43.89 91.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.693 -0.484 . . . . 74.019999999999996 109.693 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 14.7 mm100 -57.6 -44.55 85.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.345 0.593 . . . . 74.409999999999997 109.747 175.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.28 79.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 61.130000000000003 111.817 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -72.18 -38.59 69.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 75.5 109.794 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -74.93 -51.77 12.93 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.915 -0.584 . . . . 60.0 112.567 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--O 1.255 1.391 0 N-CA-C 109.666 -0.494 . . . . 64.120000000000005 109.666 -176.149 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.74 0 N-CA-C 110.02 -0.363 . . . . 54.509999999999998 110.02 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.13 -99.49 2.07 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 121.38 -0.438 . . . . 61.409999999999997 112.305 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.71 135.18 51.05 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 122.327 -0.514 . . . . 60.439999999999998 112.238 -174.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 25.1 t0 -77.84 146.77 35.51 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.076 -0.965 . . . . 62.439999999999998 109.544 175.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.25 -15.85 9.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.396 -0.365 . . . . 65.439999999999998 111.342 -174.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 1.6 pp -90.61 179.25 5.87 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.32 -0.952 . . . . 71.540000000000006 111.442 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -105.58 137.11 19.21 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.927 -1.508 . . . . 73.409999999999997 106.927 173.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.32 -20.94 16.21 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.812 2.341 . . . . 74.099999999999994 114.376 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.45 -24.69 61.24 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 122.083 -0.385 . . . . 72.209999999999994 110.432 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.83 152.31 84.77 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 74.340000000000003 108.203 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.99 111.81 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 122.668 2.245 . . . . 74.340000000000003 113.085 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.407 ' HA ' ' H ' ' A' ' 68' ' ' GLN . 1.7 m -124.59 169.35 12.01 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 108.787 -0.819 . . . . 61.329999999999998 108.787 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -128.91 160.98 30.95 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.021 -1.474 . . . . 74.439999999999998 107.021 172.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.587 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 10.9 t70 -134.66 168.59 18.72 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 104.429 -2.434 . . . . 75.230000000000004 104.429 -173.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -52.01 -57.19 15.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 112.983 0.734 . . . . 54.140000000000001 112.983 -173.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.587 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 21.7 Cg_endo -62.61 -31.6 79.54 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.778 1.652 . . . . 75.439999999999998 111.756 176.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.505 ' HB2' ' H ' ' A' ' 31' ' ' ASP . 2.4 mpt_? -70.63 -36.83 73.65 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.428 0.529 . . . . 72.540000000000006 112.428 -178.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.59 -41.95 80.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.195 -0.669 . . . . 75.25 109.195 177.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.789 -1.096 . . . . 73.150000000000006 109.422 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.2 -45.8 83.3 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.833 1.253 . . . . 73.400000000000006 110.445 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 30' ' ' TYR . 38.8 tp -65.64 -50.28 65.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 73.099999999999994 111.604 -177.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.59 -9.54 58.21 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.531 0.567 . . . . 71.530000000000001 112.531 -174.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.41 29.26 71.79 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.672 -0.571 . . . . 63.219999999999999 111.672 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.23 160.28 48.44 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.544 -0.91 . . . . 74.219999999999999 108.544 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.68 160.08 38.27 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.564 1.51 . . . . 75.209999999999994 111.219 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.6 -32.84 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.349 0.659 . . . . 72.439999999999998 110.419 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -57.44 -42.84 83.21 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 116.185 -0.461 . . . . 64.450000000000003 110.495 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -70.16 -32.43 70.4 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.949 0.404 . . . . 73.420000000000002 110.603 178.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.7 t -62.28 -44.0 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 109.116 -0.698 . . . . 72.219999999999999 109.116 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -59.36 -36.94 76.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.27 -0.423 . . . . 52.210000000000001 110.299 177.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 83.6 mm-40 -69.63 -40.41 76.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.637 0.606 . . . . 73.349999999999994 112.637 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.548 ' O ' ' HB3' ' A' ' 54' ' ' HIS . 3.2 pt20 -68.69 -33.71 74.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.929 -0.708 . . . . 73.239999999999995 109.854 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.8 mt -62.47 -39.72 94.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.971 -0.752 . . . . 65.129999999999995 108.971 174.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 70.2 mtt-85 -70.78 -21.43 62.49 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.979 0.733 . . . . 72.120000000000005 112.979 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 44.4 mt-10 -76.77 -12.11 59.93 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 121.161 -0.216 . . . . 71.310000000000002 110.63 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.81 30.55 65.84 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.991 -2.043 . . . . 64.530000000000001 107.991 -169.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 49' ' ' GLN . 11.9 t-160 -97.23 -32.21 12.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 125.139 1.376 . . . . 71.140000000000001 108.625 -176.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 41.6 tp -152.61 153.19 32.86 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.1 -1.444 . . . . 73.209999999999994 107.1 -179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.75 161.48 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 117.9 0.318 . . . . 13.449999999999999 110.467 177.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.34 154.05 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.152 -0.685 . . . . 75.219999999999999 109.152 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.43 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 123.449 0.699 . . . . 61.329999999999998 110.548 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 98.8 mtt180 -117.24 134.76 54.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.767 -0.197 . . . . 64.319999999999993 110.607 -177.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -139.98 127.36 21.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.864 -1.161 . . . . 75.099999999999994 107.864 170.845 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.97 21.52 7.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.898 1.279 . . . . 63.109999999999999 111.882 -177.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.02 -0.88 67.18 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.378 -0.439 . . . . 71.200000000000003 112.681 -179.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -98.48 135.77 12.34 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.064 -0.814 . . . . 63.310000000000002 111.064 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.19 120.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.024 -1.102 . . . . 65.150000000000006 108.024 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.83 161.61 39.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.48 0.657 . . . . 64.510000000000005 111.878 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.88 120.75 25.55 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 106.384 -1.71 . . . . 73.140000000000001 106.384 178.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.02 124.61 16.36 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.409 2.073 . . . . 65.019999999999996 112.705 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.509 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.887 0.851 . . . . 75.540000000000006 111.015 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 m -66.53 -12.24 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.562 -1.199 . . . . 74.329999999999998 112.208 177.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.1 m-85 -78.55 -11.35 59.96 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.889 0.852 . . . . 64.209999999999994 110.299 175.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -106.83 149.53 27.3 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.61 -1.255 . . . . 75.230000000000004 107.61 178.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 p -76.04 175.64 8.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.498 -0.556 . . . . 75.239999999999995 109.498 178.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.56 -22.84 66.65 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.208 0.527 . . . . 54.149999999999999 110.079 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 m -84.05 1.01 45.96 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.755 -0.657 . . . . 65.329999999999998 112.298 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.67 66.82 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.351 -0.452 . . . . 75.5 112.71 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -113.97 152.77 30.4 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.651 -0.87 . . . . 71.510000000000005 108.651 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 135.64 27.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.831 -1.174 . . . . 65.299999999999997 107.831 175.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.437 HG12 ' H ' ' A' ' 80' ' ' SER . 58.0 t -59.55 135.21 24.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.335 -0.617 . . . . 74.239999999999995 109.335 178.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -59.09 -31.56 69.01 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.862 0.69 . . . . 64.329999999999998 112.862 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.437 ' H ' HG12 ' A' ' 78' ' ' VAL . 33.0 m -89.38 3.05 53.5 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.081 -0.509 . . . . 72.230000000000004 111.78 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.549 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.19 -54.12 48.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.989 -0.374 . . . . 73.140000000000001 109.989 179.393 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 32.2 Cg_exo -62.81 -30.87 78.18 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 121.134 1.222 . . . . 64.120000000000005 110.598 177.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.12 93.94 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.713 -0.676 . . . . 73.400000000000006 112.221 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -67.64 -40.02 84.61 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.17 0.509 . . . . 54.350000000000001 109.827 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.86 -46.55 87.35 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.799 -0.637 . . . . 74.140000000000001 110.264 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.8 m -60.71 -41.49 95.34 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.952 -0.567 . . . . 52.119999999999997 112.529 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -47.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 121.103 -0.239 . . . . 54.200000000000003 110.885 -178.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.498 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -68.01 -35.74 78.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.97 0.73 . . . . 74.129999999999995 112.97 176.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.507 0.723 . . . . 72.129999999999995 110.338 -177.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.4 -30.37 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.299 0.571 . . . . 61.399999999999999 110.572 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.99 -9.47 86.65 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.683 -0.69 . . . . 64.299999999999997 112.582 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 24.2 54.93 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 121.713 -0.28 . . . . 52.109999999999999 113.146 177.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 94.5 m-85 -89.61 132.98 34.85 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.576 -0.367 . . . . 73.519999999999996 111.123 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -78.88 169.88 17.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.597 0.713 . . . . 74.329999999999998 112.858 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.39 -45.34 72.84 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.395 1.878 . . . . 52.109999999999999 112.003 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.0 m -64.56 -40.39 95.48 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 115.568 -0.742 . . . . 52.130000000000003 110.204 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -65.96 -36.79 84.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.612 -0.267 . . . . 64.219999999999999 111.273 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.1 mm -61.42 -49.0 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.415 -0.957 . . . . 71.420000000000002 108.415 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.52 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 57.4 mtt -74.96 -17.72 60.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.799 -1.092 . . . . 75.439999999999998 112.391 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -59.4 -65.05 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.626 -0.509 . . . . 75.420000000000002 109.626 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.4 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 36.0 p-90 -68.94 -32.56 72.25 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.749 0.648 . . . . 72.230000000000004 112.749 177.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 125' ' ' PRO . 13.1 mt -58.59 -40.84 84.31 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 112.477 0.547 . . . . 62.350000000000001 112.477 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 54.9 m-85 -92.49 -11.57 34.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.345 0.498 . . . . 75.319999999999993 112.345 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -86.62 125.36 67.47 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.654 -0.499 . . . . 71.329999999999998 109.654 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.604 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.6 Cg_exo -56.16 129.91 37.37 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.592 2.195 . . . . 74.200000000000003 110.693 175.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -90.53 123.41 65.41 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.525 -0.917 . . . . 74.319999999999993 108.525 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.21 -24.55 77.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.027 2.485 . . . . 71.430000000000007 113.6 -176.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -102.98 3.56 36.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.722 0.296 . . . . 72.140000000000001 111.367 -175.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.62 124.0 46.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.562 0.696 . . . . 54.509999999999998 111.016 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 37.7 m -131.35 110.48 11.1 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.866 -1.161 . . . . 75.230000000000004 107.866 177.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 128' ' ' ALA . 23.2 pt . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 120.924 0.392 . . . . 63.399999999999999 111.871 -174.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 108.163 -1.051 . . . . 71.230000000000004 108.163 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.0 t -90.22 148.44 22.93 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.311 -1.366 . . . . 71.430000000000007 107.311 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 65.6 t30 65.85 44.79 2.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.497 -1.297 . . . . 65.200000000000003 107.497 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.79 17.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.335 -0.848 . . . . 73.109999999999999 110.423 -178.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -97.27 132.3 25.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.444 -0.576 . . . . 75.340000000000003 109.444 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.556 ' HB2' HD23 ' A' ' 102' ' ' LEU . 80.9 Cg_exo -50.01 -29.53 21.84 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.061 3.174 . . . . 65.010000000000005 115.543 -178.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.538 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.3 t -61.69 -42.72 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 118.519 0.599 . . . . 75.530000000000001 110.274 176.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -67.67 -33.64 75.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.278 -1.008 . . . . 52.539999999999999 108.278 -176.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -62.75 -50.2 72.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.723 -1.126 . . . . 62.409999999999997 111.386 177.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -65.7 -34.26 77.8 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.036 0.446 . . . . 74.400000000000006 110.946 -179.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -68.58 -23.63 64.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 75.319999999999993 109.157 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.66 7.7 45.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.815 -1.084 . . . . 74.409999999999997 110.982 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.1 m80 66.27 29.43 9.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.612 0.72 . . . . 75.409999999999997 111.773 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -101.36 22.69 12.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.033 -1.469 . . . . 73.230000000000004 107.033 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.31 -30.23 59.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.848 -1.524 . . . . 75.409999999999997 114.595 -173.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -56.75 -43.29 80.58 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.028 0.442 . . . . 54.229999999999997 111.524 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -73.31 -26.21 60.97 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.737 -0.665 . . . . 73.430000000000007 110.818 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.05 -42.13 81.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.653 -0.869 . . . . 75.239999999999995 108.653 175.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 86.1 t -60.03 -41.92 87.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-N 115.323 -0.853 . . . . 73.129999999999995 109.913 176.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.91 -40.28 92.56 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.341 0.591 . . . . 74.409999999999997 110.157 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -41.04 93.67 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.457 -0.942 . . . . 74.439999999999998 108.457 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.498 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.21 -45.12 94.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.967 -1.015 . . . . 73.219999999999999 110.549 177.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.6 mt-30 -57.3 -36.18 70.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 73.319999999999993 110.574 176.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.49 78.43 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.943 -0.571 . . . . 65.310000000000002 111.152 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 29.5 ttm -80.78 -45.39 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.724 -0.79 . . . . 74.209999999999994 112.618 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -69.72 -34.84 74.43 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.031 1.123 . . . . 74.120000000000005 114.031 -174.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 109.24 -0.652 . . . . 70.549999999999997 109.24 -178.664 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.955 0 CA-C-O 120.571 0.224 . . . . 61.229999999999997 110.579 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 -87.17 1.99 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.561 -1.016 . . . . 61.329999999999998 110.561 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -141.12 159.95 41.13 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.604 -0.351 . . . . 73.150000000000006 110.848 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 9.6 t0 -93.75 137.67 32.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.636 -0.711 . . . . 45.32 112.647 -173.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 100' ' ' ARG . 86.1 t -100.01 -26.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.692 -0.685 . . . . 72.239999999999995 111.8 -175.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.555 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -80.45 -178.9 6.89 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 118.663 -1.215 . . . . 74.349999999999994 110.655 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -100.79 147.94 34.34 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 107.868 -1.16 . . . . 73.049999999999997 107.868 -178.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.08 -21.27 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.992 2.462 . . . . 71.150000000000006 113.576 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.78 -27.24 68.14 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.903 0.481 . . . . 72.239999999999995 110.548 176.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.15 125.24 85.44 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 107.756 -1.201 . . . . 64.299999999999997 107.756 171.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 16.6 Cg_exo -65.31 139.73 61.14 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.218 1.946 . . . . 61.439999999999998 112.898 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 65' ' ' VAL . 6.3 p -118.22 156.97 27.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.252 0.834 . . . . 72.400000000000006 113.252 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 28.0 m-85 -109.78 161.89 15.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 125.452 1.501 . . . . 74.209999999999994 108.858 176.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.569 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 4.3 m-20 -134.56 165.77 24.43 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 104.623 -2.362 . . . . 72.430000000000007 104.623 -178.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.04 -56.37 18.15 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 114.415 1.265 . . . . 70.230000000000004 114.415 -175.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HA ' HG22 ' A' ' 43' ' ' VAL . 28.7 Cg_endo -63.05 -31.62 76.05 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.915 1.744 . . . . 75.439999999999998 112.424 178.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 14.8 tpt180 -70.42 -39.37 74.47 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.736 0.814 . . . . 72.030000000000001 110.221 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 31' ' ' ASP . 59.3 t -69.2 -38.58 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 71.420000000000002 109.372 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.11 91.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.441 -0.799 . . . . 54.420000000000002 109.626 177.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.57 -44.98 94.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.016 -1.447 . . . . 71.200000000000003 110.06 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.4 tp -65.62 -47.48 75.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.921 -1.036 . . . . 73.019999999999996 111.339 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.7 -18.54 40.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.865 0.691 . . . . 54.439999999999998 112.865 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.45 55.13 Favored Glycine 0 C--N 1.311 -0.827 0 N-CA-C 111.017 -0.833 . . . . 30.129999999999999 111.017 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 20.4 m -124.22 161.83 45.23 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.148 -1.056 . . . . 70.150000000000006 108.148 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 36.1 Cg_endo -67.94 156.23 66.7 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 121.362 1.374 . . . . 64.439999999999998 112.603 178.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 33' ' ' PRO . 42.9 t -60.45 -37.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 51.030000000000001 110.256 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 23.0 t -60.69 -34.78 74.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.534 -0.757 . . . . 45.119999999999997 110.653 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 60.8 tttp -69.33 -39.02 78.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.837 -0.431 . . . . 71.299999999999997 109.837 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.2 t -61.34 -41.16 88.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.249 0.547 . . . . 65.109999999999999 109.56 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.81 81.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.41 -0.814 . . . . 73.530000000000001 110.498 176.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.2 mt-30 -65.36 -44.0 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.359 -0.382 . . . . 74.209999999999994 110.308 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.9 mm-40 -61.86 -43.17 99.38 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.791 0.682 . . . . 74.299999999999997 110.226 -178.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.97 -40.81 96.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.589 -1.187 . . . . 73.329999999999998 110.343 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.47 -21.49 61.94 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.201 0.815 . . . . 75.129999999999995 113.201 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -88.14 -11.88 45.63 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 120.406 0.146 . . . . 70.209999999999994 111.272 178.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.98 32.45 49.28 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.234 -1.146 . . . . 33.43 110.234 -175.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -93.74 -13.74 27.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.31 -1.367 . . . . 74.099999999999994 107.31 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -157.08 152.86 26.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.193 -2.151 . . . . 75.510000000000005 105.193 179.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.6 152.05 30.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.162 -0.681 . . . . 65.109999999999999 109.162 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -127.26 162.14 26.91 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.086 -0.506 . . . . 64.319999999999993 110.575 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.433 HG11 ' HG3' ' A' ' 99' ' ' MET . 5.2 m -126.64 166.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 123.397 0.679 . . . . 74.099999999999994 109.467 178.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -120.5 131.65 54.83 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.879 -0.328 . . . . 72.430000000000007 110.649 -176.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 30.1 ptt180 -147.51 138.32 23.46 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.582 -0.895 . . . . 71.329999999999998 108.582 175.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.35 17.71 9.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.004 0.922 . . . . 72.040000000000006 111.612 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.85 -4.02 74.78 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.976 -0.556 . . . . 42.009999999999998 112.245 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.24 144.38 15.77 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.836 -0.697 . . . . 74.209999999999994 111.593 -178.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.44 120.12 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.04 -1.467 . . . . 65.219999999999999 107.04 178.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.8 m -133.68 154.42 38.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.36 0.6 . . . . 72.209999999999994 111.796 -173.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.53 120.75 38.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 107.497 -1.298 . . . . 65.319999999999993 107.497 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.439 ' HB3' HD21 ' A' ' 23' ' ' LEU . 88.0 Cg_exo -53.74 128.39 29.38 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.698 2.265 . . . . 73.109999999999999 112.179 177.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.45 ' NE2' ' HB2' ' A' ' 28' ' ' PRO . 6.1 tt0 -57.34 -25.53 59.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.36 0.504 . . . . 65.0 112.36 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -70.95 -4.24 4.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.782 -0.645 . . . . 73.310000000000002 112.446 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.8 m-85 -83.84 -4.66 58.85 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.248 1.023 . . . . 74.439999999999998 109.913 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -122.16 158.84 28.47 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.801 -1.555 . . . . 72.430000000000007 106.801 177.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.2 p -91.57 163.87 13.98 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.69 -0.856 . . . . 45.200000000000003 108.69 179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.73 -16.29 62.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.336 0.588 . . . . 74.120000000000005 110.147 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -79.47 -0.67 34.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.238 0.615 . . . . 52.149999999999999 111.187 -178.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.38 60.48 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.851 -0.69 . . . . 23.140000000000001 112.005 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -125.9 145.95 50.04 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.607 -1.257 . . . . 43.140000000000001 107.607 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.17 155.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.967 -1.123 . . . . 63.130000000000003 107.967 176.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 48.4 t -69.82 112.03 4.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.498 -0.927 . . . . 70.230000000000004 108.498 177.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -56.18 -35.11 66.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.467 1.284 . . . . 54.299999999999997 114.467 -175.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.5 m -90.69 -4.25 56.89 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.223 0.535 . . . . 74.329999999999998 111.536 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 8.6 tt -65.83 -47.48 64.85 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.51 0.929 . . . . 73.439999999999998 113.51 -176.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.6 Cg_endo -54.24 -28.73 53.6 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 121.743 1.628 . . . . 73.209999999999994 111.514 176.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.15 -38.2 95.61 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.709 -0.678 . . . . 42.409999999999997 112.048 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -68.17 -40.15 82.37 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.767 -0.827 . . . . 75.209999999999994 108.767 178.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.88 -32.69 73.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 74.099999999999994 110.233 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 m -62.76 -50.18 72.08 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.66 -0.7 . . . . 54.310000000000002 110.289 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -40.25 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.465 -0.334 . . . . 52.109999999999999 111.439 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.7 mm? -66.88 -35.36 79.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.58 0.585 . . . . 71.400000000000006 112.58 176.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -61.68 -40.54 95.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 60.25 109.343 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.63 -31.87 73.13 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.791 -0.64 . . . . 70.310000000000002 110.854 178.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.53 -9.95 68.46 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.962 -0.637 . . . . 75.120000000000005 112.495 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.48 48.98 8.54 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 114.004 0.361 . . . . 41.109999999999999 114.004 177.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 88.4 m-85 -110.17 139.44 45.32 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.408 0.604 . . . . 72.340000000000003 111.447 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -81.91 171.79 14.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 72.420000000000002 111.851 -179.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.0 p-10 -54.64 -45.51 73.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 72.540000000000006 111.83 -177.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 m -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.364 0.666 . . . . 73.420000000000002 110.052 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.65 -38.74 92.28 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.624 -0.717 . . . . 74.049999999999997 111.229 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 mm -61.26 -47.5 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.334 -0.987 . . . . 65.430000000000007 108.334 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 22.8 mmt -67.99 -26.07 65.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.677 -1.147 . . . . 75.519999999999996 111.656 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.413 ' HA ' HG11 ' A' ' 22' ' ' VAL . 45.3 ttp85 -52.56 -71.26 0.07 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.694 0.627 . . . . 75.120000000000005 112.694 -176.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -68.58 -31.46 70.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.166 0.432 . . . . 75.409999999999997 112.166 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.7 mt -56.55 -40.64 75.49 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 112.131 0.419 . . . . 71.219999999999999 112.131 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 96.5 m-85 -102.02 2.01 37.21 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.956 0.724 . . . . 70.129999999999995 112.956 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -89.08 112.13 49.17 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.712 -0.477 . . . . 71.430000000000007 109.712 173.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.1 128.76 21.3 Favored 'Trans proline' 0 C--O 1.251 1.145 0 N-CA-C 108.434 -1.41 . . . . 64.040000000000006 108.434 173.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 23.6 t70 -96.85 126.29 43.34 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.698 -0.401 . . . . 60.539999999999999 111.501 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.66 -16.9 46.18 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.22 2.613 . . . . 61.229999999999997 114.277 -178.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.4 t -114.53 8.99 16.57 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 121.163 0.506 . . . . 63.200000000000003 109.924 -178.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 51.6 tp -106.94 118.68 37.33 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.729 0.776 . . . . 73.040000000000006 112.328 -178.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.0 m -118.2 117.19 28.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.191 -1.04 . . . . 71.409999999999997 108.191 178.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.41 HG12 ' HG ' ' A' ' 109' ' ' LEU . 29.3 mm . . . . . 0 C--N 1.291 -1.95 0 CA-C-N 115.118 -0.946 . . . . 73.549999999999997 109.826 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 109.05 -0.722 . . . . 64.099999999999994 109.05 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -84.0 149.83 26.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.268 -0.641 . . . . 70.129999999999995 109.268 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 22.8 t-20 70.1 40.42 1.22 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.219 1.008 . . . . 73.310000000000002 109.798 178.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.55 156.65 22.68 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.734 -0.604 . . . . 43.229999999999997 110.348 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.578 ' HD3' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -102.95 143.65 27.03 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 108.711 -0.848 . . . . 73.420000000000002 108.711 175.821 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.434 ' HB2' HD23 ' A' ' 102' ' ' LEU . 82.1 Cg_exo -49.73 -34.08 34.36 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 123.655 2.904 . . . . 61.420000000000002 114.856 -177.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.5 t -62.95 -40.46 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.466 0.651 . . . . 54.229999999999997 110.782 177.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.23 -37.79 88.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.347 -0.982 . . . . 74.439999999999998 108.347 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.94 78.66 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.484 -1.235 . . . . 54.32 112.023 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -66.41 -36.22 82.29 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.013 -0.429 . . . . 74.540000000000006 112.114 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.419 ' N ' HD12 ' A' ' 129' ' ' LEU . 16.6 t-80 -73.27 -16.16 61.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.216 1.007 . . . . 74.219999999999999 108.975 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.83 5.25 51.75 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.019 -0.991 . . . . 64.230000000000004 110.465 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.0 m80 65.22 28.99 11.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.416 1.086 . . . . 63.530000000000001 112.296 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -103.83 23.71 12.39 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.653 -1.24 . . . . 73.439999999999998 107.653 176.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.38 -26.83 13.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.549 1.94 . . . . 51.310000000000002 112.74 -176.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -54.39 -38.2 65.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.881 0.472 . . . . 74.430000000000007 111.773 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.43 ' HG2' HD11 ' A' ' 109' ' ' LEU . 13.9 tp10 -73.5 -32.2 64.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.696 -0.483 . . . . 73.140000000000001 109.696 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.52 -48.31 77.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.501 -0.772 . . . . 75.450000000000003 109.586 -178.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.503 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 59.6 t -62.37 -42.79 96.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 N-CA-C 109.279 -0.638 . . . . 73.349999999999994 109.279 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -62.61 -39.45 93.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.711 -0.677 . . . . 73.140000000000001 111.188 178.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.417 ' NH2' HD13 ' A' ' 109' ' ' LEU . 2.7 tpp180 -64.73 -38.84 92.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.077 -0.712 . . . . 73.340000000000003 109.077 178.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -68.85 -38.66 79.91 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.831 -1.077 . . . . 75.530000000000001 110.613 178.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.0 mt-30 -58.87 -49.51 77.47 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.591 -0.277 . . . . 74.120000000000005 110.288 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 72.549999999999997 111.141 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpt -83.39 -30.94 26.98 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.346 0.593 . . . . 72.400000000000006 110.191 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.452 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.21 -54.07 5.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 111.638 -177.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--N 1.309 -1.174 0 N-CA-C 108.676 -0.861 . . . . 74.519999999999996 108.676 -177.45 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.826 0 N-CA-C 109.306 -0.627 . . . . 64.239999999999995 109.306 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.17 -133.99 7.63 Favored Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 121.144 -0.55 . . . . 64.420000000000002 112.314 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.28 124.39 46.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.533 -0.543 . . . . 71.25 109.533 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.69 130.78 44.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.25 0.548 . . . . 62.020000000000003 111.048 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.519 HG23 ' HE3' ' A' ' 99' ' ' MET . 22.3 t -111.44 27.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 123.294 1.521 . . . . 74.430000000000007 109.5 -178.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -118.68 172.94 7.15 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-N 114.994 -1.003 . . . . 63.439999999999998 110.098 175.6 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.449 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 14.3 t70 -86.5 137.06 34.47 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.724 -1.213 . . . . 63.100000000000001 107.724 175.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -50.78 -21.96 9.06 Favored 'Trans proline' 0 CA--C 1.557 1.67 0 C-N-CA 123.149 2.566 . . . . 72.200000000000003 115.242 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.91 -1.46 56.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.509 0.929 . . . . 72.140000000000001 113.509 178.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 27.1 mm-40 -67.42 151.76 96.84 Favored Pre-proline 0 C--O 1.248 0.979 0 N-CA-C 109.268 -0.642 . . . . 73.109999999999999 109.268 176.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.3 119.01 5.46 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.712 2.275 . . . . 64.540000000000006 111.371 176.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.1 m -136.29 162.11 33.92 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.679 -0.86 . . . . 62.229999999999997 108.679 -174.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 21.8 m-85 -126.72 160.11 31.77 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.379 -0.971 . . . . 74.439999999999998 108.379 174.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.3 t0 -134.69 157.92 45.42 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 103.883 -2.636 . . . . 71.150000000000006 103.883 -178.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -46.83 -54.22 21.17 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 114.443 1.275 . . . . 71.129999999999995 114.443 -169.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.23 -39.19 86.97 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.833 1.689 . . . . 55.240000000000002 112.188 177.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -71.01 -34.74 71.63 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.614 -0.266 . . . . 71.540000000000006 110.476 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 31' ' ' ASP . 27.3 t -69.12 -42.3 81.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.71 -0.478 . . . . 63.020000000000003 109.71 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.9 82.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.273 -0.876 . . . . 61.229999999999997 109.516 178.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.63 -46.02 70.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.36 -1.291 . . . . 52.109999999999999 110.467 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 26.8 tp -64.26 -50.06 69.43 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.118 0.967 . . . . 63.020000000000003 112.177 -176.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.435 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.6 mt -86.07 -18.24 32.95 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.739 -0.664 . . . . 65.430000000000007 111.614 -175.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.21 63.58 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.704 -0.958 . . . . 71.230000000000004 110.704 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 39' ' ' LEU . 11.7 m -121.91 159.61 50.61 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 108.814 -0.81 . . . . 74.349999999999994 108.814 -176.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.74 157.93 51.23 Favored 'Trans proline' 0 C--O 1.252 1.217 0 C-N-CA 121.425 1.417 . . . . 64.450000000000003 111.846 176.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.11 -33.0 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.765 -0.652 . . . . 74.409999999999997 110.642 178.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.6 t -57.67 -42.65 84.02 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.036 -0.529 . . . . 72.299999999999997 110.615 177.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 88.2 tttt -69.51 -34.34 74.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.948 0.404 . . . . 72.409999999999997 110.127 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.92 -45.07 99.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.847 -0.615 . . . . 72.540000000000006 109.432 177.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -61.91 -37.28 84.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.348 -0.842 . . . . 74.239999999999995 110.35 178.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 15.7 mm100 -62.84 -40.1 96.4 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.277 -0.42 . . . . 73.230000000000004 111.542 178.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 80.9 mm-40 -59.75 -44.24 93.92 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.577 0.703 . . . . 60.119999999999997 109.459 178.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -62.21 -43.95 97.67 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.828 -1.078 . . . . 74.230000000000004 109.886 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.506 ' HE ' ' HA ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -66.1 -21.61 66.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.979 -0.555 . . . . 74.310000000000002 112.379 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 43.2 mt-10 -98.91 -7.89 26.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.423 -0.511 . . . . 72.450000000000003 111.798 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.04 27.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.482 -0.866 . . . . 61.340000000000003 111.615 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.65 -8.92 14.55 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.815 -0.809 . . . . 75.439999999999998 108.815 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.4 tp -155.22 154.15 31.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.715 -1.587 . . . . 64.450000000000003 106.715 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.2 146.59 33.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 74.329999999999998 108.818 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 66' ' ' ILE . . . -126.09 151.17 47.57 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 107.63 -1.248 . . . . 50.310000000000002 107.63 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.523 HG11 ' SD ' ' A' ' 99' ' ' MET . 34.4 m -129.85 166.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 123.437 0.695 . . . . 53.039999999999999 109.856 -176.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -110.27 121.45 45.32 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.763 -0.828 . . . . 73.140000000000001 108.763 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -117.09 113.8 22.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.012 -0.736 . . . . 64.420000000000002 109.012 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.96 -53.19 0.68 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.268 1.827 . . . . 64.530000000000001 111.191 -179.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.97 0.44 0.03 OUTLIER Glycine 0 C--N 1.286 -2.208 0 CA-C-N 114.913 -1.039 . . . . 61.009999999999998 113.0 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.92 149.38 17.02 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.39 -0.91 . . . . 43.520000000000003 111.061 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.6 120.6 47.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.535 -1.283 . . . . 73.129999999999995 107.535 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.39 171.63 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 124.509 1.124 . . . . 53.130000000000003 108.312 -175.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.419 HG22 ' CB ' ' A' ' 57' ' ' ALA . 40.6 pt -127.68 144.06 49.77 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.938 -0.764 . . . . 43.109999999999999 108.938 178.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.57 118.31 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.612 1.541 . . . . 72.420000000000002 110.799 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 tt0 -61.44 -24.88 66.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.365 0.666 . . . . 74.0 111.811 -178.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 35.0 m -63.67 -9.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 CA-C-N 115.422 -0.808 . . . . 74.239999999999995 112.631 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.557 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -78.77 -6.83 56.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.826 0.822 . . . . 71.439999999999998 109.948 175.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -117.0 161.29 19.62 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.937 -1.135 . . . . 75.409999999999997 107.937 175.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.458 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 63.1 p -90.54 168.22 11.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.501 -1.296 . . . . 71.230000000000004 107.501 176.096 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.59 -17.49 64.85 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.656 0.613 . . . . 61.340000000000003 112.656 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -80.1 -9.09 59.68 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.376 -0.375 . . . . 72.409999999999997 111.311 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.68 9.9 62.27 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.532 -0.842 . . . . 51.200000000000003 112.509 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -97.34 140.2 32.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.59 -1.633 . . . . 72.019999999999996 106.59 177.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.59 152.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.135 -1.061 . . . . 74.310000000000002 108.135 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.52 126.55 22.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.423 -0.584 . . . . 74.200000000000003 109.423 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.19 -34.17 77.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 113.288 0.847 . . . . 73.129999999999995 113.288 -175.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 t -91.93 8.11 38.98 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.369 0.604 . . . . 32.509999999999998 110.281 -177.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 70' ' ' PHE . 14.5 tp -58.83 -54.01 60.68 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.748 -0.66 . . . . 73.420000000000002 112.048 -177.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.75 -25.24 74.81 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.53 1.487 . . . . 73.319999999999993 111.846 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.95 78.43 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.135 -0.484 . . . . 72.109999999999999 111.905 -178.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -67.38 -39.51 85.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.116 -0.698 . . . . 62.439999999999998 109.116 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.06 -40.07 95.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.368 -0.833 . . . . 71.329999999999998 111.068 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -62.28 -47.35 84.69 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 116.437 -0.347 . . . . 64.519999999999996 111.558 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -43.79 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 116.471 -0.331 . . . . 62.439999999999998 111.344 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 4.4 mm? -66.91 -35.79 80.8 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.901 -0.5 . . . . 75.409999999999997 112.257 177.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -64.93 -33.14 75.32 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.528 -0.545 . . . . 75.109999999999999 109.528 177.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.25 -31.25 70.6 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.143 0.497 . . . . 63.149999999999999 110.81 176.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.76 -9.3 78.31 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.762 -0.654 . . . . 74.439999999999998 112.036 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.73 48.1 6.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 121.386 -0.435 . . . . 51.200000000000003 112.487 178.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 80.0 m-85 -110.8 138.15 47.56 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.787 0.327 . . . . 74.25 111.335 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.557 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 28.5 ptt180 -86.28 170.9 11.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 75.349999999999994 109.818 177.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -55.05 -41.27 71.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.511 1.524 . . . . 44.219999999999999 111.233 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -61.67 -41.26 97.3 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.496 -0.774 . . . . 71.510000000000005 110.608 -179.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 8.8 mm-40 -66.02 -38.06 87.5 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.897 -0.779 . . . . 63.119999999999997 108.897 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 94' ' ' ARG . 24.9 mm -61.12 -48.0 90.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.651 -0.87 . . . . 61.210000000000001 108.651 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.523 ' SD ' HG11 ' A' ' 58' ' ' VAL . 76.0 mtm -71.49 -22.36 61.81 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.249 -0.887 . . . . 71.329999999999998 112.194 -177.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.01 -65.31 0.62 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.798 -0.816 . . . . 75.019999999999996 108.798 -179.655 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.577 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 53.2 p-90 -69.78 -33.86 72.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.787 0.662 . . . . 71.349999999999994 112.787 179.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -66.76 -39.06 87.75 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.714 0.806 . . . . 72.329999999999998 112.941 -173.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 47.6 m-85 -92.63 7.88 41.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.632 0.605 . . . . 75.409999999999997 112.632 -178.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.1 m -86.94 116.51 66.32 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 109.562 -0.533 . . . . 73.230000000000004 109.562 177.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.7 129.22 19.42 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 121.516 1.478 . . . . 62.229999999999997 108.26 172.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 25.7 t70 -115.71 119.75 37.05 Favored Pre-proline 0 C--N 1.295 -1.774 0 C-N-CA 120.637 -0.425 . . . . 75.439999999999998 110.791 -175.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.42 -28.95 87.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.021 2.48 . . . . 63.149999999999999 112.815 -177.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -90.88 2.05 56.48 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.487 0.551 . . . . 55.299999999999997 112.487 -177.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.9 tp -102.17 125.13 48.78 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 107.869 -1.16 . . . . 74.329999999999998 107.869 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 m -118.5 113.35 21.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.07 -1.085 . . . . 64.140000000000001 108.07 -177.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 37.9 mm . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 116.116 -0.493 . . . . 74.209999999999994 109.7 -173.059 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 108.502 -0.925 . . . . 71.439999999999998 108.502 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 m -82.84 138.84 33.79 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.204 -1.406 . . . . 64.150000000000006 107.204 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 42.7 t30 78.3 69.0 0.04 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.056 0.942 . . . . 72.530000000000001 110.947 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.54 173.1 6.71 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.213 -1.032 . . . . 65.519999999999996 108.213 172.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -96.19 156.94 36.43 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 106.391 -1.707 . . . . 75.400000000000006 106.391 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 27.7 Cg_exo -61.75 -20.08 67.75 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 121.39 1.394 . . . . 73.549999999999997 110.518 173.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 102' ' ' LEU . 74.3 t -60.67 -43.41 94.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 109.131 -0.692 . . . . 71.230000000000004 109.131 173.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.47 -39.29 93.52 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.68 -0.691 . . . . 43.219999999999999 109.43 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.46 66.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 44.43 112.002 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 130' ' ' HIS . 4.6 pp -66.81 -35.52 80.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.993 0.425 . . . . 51.119999999999997 111.598 -177.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.458 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 13.8 t60 -70.81 -24.85 62.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.852 0.834 . . . . 75.120000000000005 108.939 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -99.05 11.49 38.86 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.16 -0.927 . . . . 73.420000000000002 112.24 -178.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.7 27.54 9.32 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.348 1.071 . . . . 71.329999999999998 110.889 177.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -109.68 25.09 12.19 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.586 -1.264 . . . . 73.219999999999999 107.586 177.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.56 -26.49 13.46 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.366 1.866 . . . . 71.409999999999997 113.196 -175.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -54.65 -35.91 63.99 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.657 0.208 . . . . 75.140000000000001 110.559 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.17 -28.08 62.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.659 0.742 . . . . 73.219999999999999 110.735 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.3 -44.99 54.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.639 -0.875 . . . . 44.32 108.639 177.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 61.3 t -61.1 -44.25 97.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 115.541 -0.754 . . . . 54.020000000000003 110.634 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.11 -38.69 89.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 120.457 -0.497 . . . . 73.420000000000002 110.824 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -69.12 -38.01 78.64 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.83 0.348 . . . . 74.450000000000003 110.998 175.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.447 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -59.01 -43.32 91.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.743 -0.662 . . . . 62.520000000000003 110.256 178.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 93.8 mt-30 -63.06 -45.47 92.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.851 -0.613 . . . . 73.540000000000006 110.167 177.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.91 94.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.639 -0.709 . . . . 42.109999999999999 111.112 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.577 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 17.0 tpt -70.34 -32.82 70.7 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.757 -0.656 . . . . 74.239999999999995 111.031 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.3 -54.51 5.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.013 -0.54 . . . . 70.409999999999997 111.538 -178.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 118.567 -0.73 . . . . 75.019999999999996 109.115 -175.842 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 N-CA-C 106.441 -1.689 . . . . 64.200000000000003 106.441 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.94 -106.19 2.77 Favored Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.884 -0.674 . . . . 72.150000000000006 112.408 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.25 121.56 35.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.931 0.396 . . . . 75.209999999999994 110.452 -175.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -61.39 119.17 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.977 -1.01 . . . . 75.329999999999998 110.81 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' HE3' ' A' ' 99' ' ' MET . 93.4 t -77.07 -25.28 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.447 0.641 . . . . 53.43 111.234 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.6 148.44 28.0 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.407 -0.917 . . . . 54.009999999999998 111.9 176.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.32 145.19 99.1 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 114.988 -1.006 . . . . 60.240000000000002 110.782 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.44 -27.07 30.38 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.347 2.698 . . . . 62.030000000000001 114.058 177.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.8 -23.35 58.48 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.734 0.272 . . . . 73.019999999999996 111.734 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.09 126.63 91.66 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 108.903 -0.777 . . . . 70.299999999999997 108.903 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.64 106.53 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.876 2.384 . . . . 72.230000000000004 111.387 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 p -106.67 172.05 7.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.833 -0.621 . . . . 73.209999999999994 110.829 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 38' ' ' LEU . 16.6 m-85 -109.63 161.5 15.32 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.581 -0.896 . . . . 73.140000000000001 108.581 177.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.14 166.24 22.91 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 103.606 -2.739 . . . . 74.349999999999994 103.606 -173.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -52.79 -51.13 76.88 Favored Pre-proline 0 C--N 1.309 -1.188 0 O-C-N 123.881 0.738 . . . . 53.210000000000001 112.004 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.528 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 10.9 Cg_endo -57.53 -39.71 86.39 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.794 1.663 . . . . 65.200000000000003 112.352 175.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 3.9 mpt_? -70.35 -36.2 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.979 0.733 . . . . 73.140000000000001 112.979 -177.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 66' ' ' ILE . 73.4 t -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.971 -0.692 . . . . 52.530000000000001 109.764 175.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.01 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.157 -0.929 . . . . 75.329999999999998 109.055 174.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 19.3 mm-40 -65.52 -45.49 83.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 72.109999999999999 112.092 175.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 30' ' ' TYR . 89.1 mt -62.73 -50.74 69.89 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.339 -0.391 . . . . 71.349999999999994 111.623 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' HG22 ' A' ' 41' ' ' VAL . 90.9 mt -88.01 -15.38 36.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.799 -0.637 . . . . 74.099999999999994 112.137 -174.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.6 67.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.39 -1.084 . . . . 64.209999999999994 110.39 -177.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 39' ' ' LEU . 20.8 m -122.21 164.61 24.79 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 108.671 -0.862 . . . . 61.530000000000001 108.671 -177.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.87 167.05 14.72 Favored 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 121.44 1.427 . . . . 71.319999999999993 111.638 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.5 t -59.02 -33.09 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.579 0.751 . . . . 64.450000000000003 110.644 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 24.6 p -57.58 -43.58 84.67 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.455 -0.793 . . . . 72.540000000000006 111.201 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.585 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 56.9 mtpt -69.33 -33.61 73.39 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.761 -0.199 . . . . 74.5 111.091 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.403 ' O ' HD13 ' A' ' 50' ' ' LEU . 57.5 t -62.5 -43.7 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.626 -0.509 . . . . 52.299999999999997 109.626 177.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.47 78.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 62.340000000000003 110.479 177.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 44' ' ' SER . 97.9 mt-30 -65.43 -36.54 84.22 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.958 -0.564 . . . . 62.530000000000001 111.495 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm100 -63.28 -43.21 98.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.384 -0.969 . . . . 72.230000000000004 108.384 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 9.3 mp -61.75 -46.64 88.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.515 -1.22 . . . . 75.019999999999996 110.154 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -60.47 -25.72 66.24 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.676 0.991 . . . . 65.129999999999995 113.676 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 54' ' ' HIS . 7.6 pt-20 -102.55 2.77 36.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.425 -0.91 . . . . 63.43 111.625 -177.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.32 38.88 71.15 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.507 -0.854 . . . . 54.219999999999999 111.476 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.564 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 3.4 t60 -96.28 -28.9 14.29 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.853 -1.166 . . . . 74.25 107.853 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 55.9 tp -159.73 156.02 26.97 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.418 -2.068 . . . . 63.32 105.418 -178.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.48 152.29 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.123 -0.695 . . . . 72.510000000000005 109.123 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.7 161.82 19.45 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 123.489 0.493 . . . . 73.530000000000001 109.747 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 99' ' ' MET . 22.2 m -126.54 166.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.01 -0.737 . . . . 31.140000000000001 109.01 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -116.58 134.84 54.36 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.56 -0.533 . . . . 72.400000000000006 109.56 -174.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -148.21 125.96 11.87 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.76 -0.83 . . . . 72.540000000000006 108.76 171.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.17 22.89 12.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.075 0.95 . . . . 65.239999999999995 112.017 178.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.57 -14.78 64.39 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.847 -0.615 . . . . 72.209999999999994 112.495 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.41 150.0 20.53 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 121.306 -0.473 . . . . 60.149999999999999 112.426 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.75 120.57 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.592 -1.262 . . . . 74.129999999999995 107.592 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.3 160.8 40.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.604 -0.725 . . . . 73.540000000000006 109.697 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 35' ' ' VAL . 70.7 mt -130.69 129.08 22.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 62.43 108.286 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.4 131.63 47.37 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.566 2.177 . . . . 62.329999999999998 111.425 176.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.8 tt0 -65.27 -25.48 67.67 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 120.836 0.351 . . . . 72.299999999999997 111.227 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.29 -2.25 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.519 -0.764 . . . . 72.120000000000005 112.636 178.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.657 ' CD2' HD11 ' A' ' 81' ' ' LEU . 5.6 m-85 -86.38 -8.21 57.85 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.374 1.083 . . . . 70.329999999999998 109.359 173.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.6 m-85 -115.86 155.63 27.58 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.53 -1.656 . . . . 74.510000000000005 106.53 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.7 p -80.89 173.73 12.32 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.434 -0.951 . . . . 65.109999999999999 108.434 177.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -58.29 -20.57 43.88 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.029 0.752 . . . . 75.409999999999997 113.029 -177.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 t -89.04 -2.52 58.61 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 121.9 -0.5 . . . . 74.5 111.488 179.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.39 15.21 58.99 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.087 -0.578 . . . . 62.329999999999998 113.509 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -113.08 142.06 46.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.88 -0.785 . . . . 64.230000000000004 108.88 178.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 71' ' ' PHE . 11.8 p -62.01 144.18 14.39 Favored 'Isoleucine or valine' 0 C--O 1.249 1.032 0 O-C-N 123.715 0.635 . . . . 62.240000000000002 110.869 -175.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 35.2 t -65.46 131.82 31.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.979 -0.749 . . . . 44.439999999999998 108.979 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.87 -34.04 75.28 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.523 0.935 . . . . 72.510000000000005 113.523 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.0 m -86.2 -6.29 59.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.041 0.448 . . . . 65.099999999999994 111.069 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.657 HD11 ' CD2' ' A' ' 70' ' ' PHE . 10.2 tt -66.3 -49.19 55.27 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 114.134 1.161 . . . . 53.119999999999997 114.134 -175.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.88 -33.84 73.42 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 121.961 1.774 . . . . 64.439999999999998 111.413 176.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.48 95.9 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.212 -0.904 . . . . 64.409999999999997 112.725 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.7 pp -67.34 -40.49 85.86 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.57 -0.53 . . . . 65.519999999999996 109.57 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.45 -34.61 77.13 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.263 -0.426 . . . . 73.120000000000005 110.662 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.2 m -62.34 -48.08 81.4 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.821 -0.627 . . . . 62.520000000000003 112.041 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.98 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 111.72 0.267 . . . . 65.340000000000003 111.72 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.562 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.4 mm? -66.67 -35.04 79.21 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.552 -0.459 . . . . 73.109999999999999 111.66 176.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -58.7 -43.15 89.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.254 -0.647 . . . . 73.430000000000007 109.254 176.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.015 0.822 . . . . 64.049999999999997 110.842 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.87 -9.1 81.53 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.986 -0.552 . . . . 71.140000000000001 112.643 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 33.55 28.2 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.871 -0.68 . . . . 74.510000000000005 112.275 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -102.12 125.52 48.84 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.94 0.4 . . . . 73.209999999999994 111.037 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 37.2 ptt180 -75.67 171.79 13.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.663 -0.698 . . . . 73.129999999999995 111.157 178.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -54.2 -40.62 67.77 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.234 1.413 . . . . 74.209999999999994 110.866 -178.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.7 m -61.52 -42.32 98.63 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.858 -1.065 . . . . 73.219999999999999 110.67 -178.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 12.4 mm-40 -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.128 -0.487 . . . . 74.140000000000001 110.228 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.4 mm -60.99 -47.92 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.486 -0.931 . . . . 63.210000000000001 108.486 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.52 ' SD ' HG11 ' A' ' 58' ' ' VAL . 70.7 mtm -71.82 -25.04 61.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.85 -1.068 . . . . 71.140000000000001 111.415 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -64.18 0.98 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.112 -0.699 . . . . 60.509999999999998 109.112 -176.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 34.5 p-90 -69.44 -32.78 71.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.947 0.721 . . . . 71.109999999999999 112.947 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 125' ' ' PRO . 14.8 mt -61.22 -40.64 94.77 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.905 0.706 . . . . 61.32 112.905 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -93.15 -1.21 56.59 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.427 0.529 . . . . 65.299999999999997 112.427 -177.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.1 m -87.99 127.1 58.88 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 109.236 -0.653 . . . . 74.010000000000005 109.236 175.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 44.0 Cg_exo -61.26 129.19 27.46 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 121.903 1.736 . . . . 64.219999999999999 110.105 174.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 10.6 t70 -85.91 126.31 66.07 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.812 -0.81 . . . . 61.229999999999997 108.812 -177.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.95 -17.39 51.08 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.296 2.664 . . . . 52.43 114.017 -177.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.3 m -122.49 15.68 10.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.892 -0.505 . . . . 73.239999999999995 111.443 -176.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 53.2 tp -108.47 126.4 52.86 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.738 0.644 . . . . 53.25 112.738 -176.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.4 m -119.72 133.64 55.54 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 105.354 -2.091 . . . . 73.219999999999999 105.354 174.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.306 -1.284 0 C-N-CA 119.111 -1.036 . . . . 74.109999999999999 113.791 -175.489 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.443 -0.784 0 N-CA-C 109.394 -0.595 . . . . 72.430000000000007 109.394 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.8 p -88.32 150.2 23.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.055 -1.091 . . . . 61.520000000000003 108.055 173.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 12.7 m120 61.09 42.28 12.65 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.31 1.053 . . . . 73.420000000000002 108.405 -173.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.6 163.92 26.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.098 -1.41 . . . . 60.32 111.752 -176.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -97.11 133.02 24.61 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.769 -1.105 . . . . 72.120000000000005 109.279 -178.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.489 ' HB2' HD23 ' A' ' 102' ' ' LEU . 86.3 Cg_exo -52.16 -31.09 44.03 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.635 2.89 . . . . 74.530000000000001 114.423 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.588 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 67.8 t -60.83 -42.21 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 73.400000000000006 110.709 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.2 -40.38 82.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.096 -0.705 . . . . 74.120000000000005 109.096 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.95 83.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.123 -0.944 . . . . 75.019999999999996 112.091 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -68.52 -34.62 76.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.58 -0.448 . . . . 74.430000000000007 111.778 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -77.34 -24.13 50.79 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 107.745 -1.206 . . . . 73.099999999999994 107.745 179.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.18 12.45 7.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.622 -1.172 . . . . 71.310000000000002 111.583 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.0 m80 66.85 28.17 8.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.061 0.945 . . . . 71.349999999999994 110.927 176.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -112.28 23.22 13.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.049 -1.093 . . . . 75.540000000000006 108.049 176.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.52 -31.48 46.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 114.262 -1.335 . . . . 63.350000000000001 113.318 -176.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -65.18 -35.12 80.08 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 120.978 -0.289 . . . . 73.340000000000003 111.719 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -69.83 -28.56 65.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.679 0.752 . . . . 62.109999999999999 109.688 177.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.0 -45.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.957 -0.757 . . . . 61.219999999999999 108.957 176.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.449 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 82.7 t -59.87 -41.65 86.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 N-CA-C 109.11 -0.7 . . . . 65.109999999999999 109.11 175.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.797 0.839 . . . . 63.409999999999997 110.945 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.11 -37.25 86.48 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.572 -0.529 . . . . 75.239999999999995 109.572 177.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.562 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -65.14 -44.24 89.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.428 -0.806 . . . . 45.5 110.833 178.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 92.2 mt-30 -67.46 -36.35 80.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.473 -0.331 . . . . 73.349999999999994 110.198 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.84 62.48 Favored 'General case' 0 C--O 1.208 -1.085 0 CA-C-N 116.153 -0.476 . . . . 54.200000000000003 110.662 176.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.89 -30.85 45.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.389 0.614 . . . . 73.5 109.422 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.79 -41.69 13.1 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.861 -0.609 . . . . 53.009999999999998 111.366 178.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.607 -0.711 . . . . 63.299999999999997 110.106 -178.683 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 109.765 -0.458 . . . . 74.420000000000002 109.765 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.72 -110.19 2.48 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 115.961 -0.563 . . . . 64.120000000000005 113.552 -176.363 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.16 123.92 33.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.678 0.275 . . . . 72.230000000000004 110.422 -172.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 17.5 t0 -61.84 130.99 48.33 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.777 1.029 . . . . 71.299999999999997 113.777 -175.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.87 -23.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.422 -0.808 . . . . 60.399999999999999 112.352 -175.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD23 ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -89.51 -172.43 3.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 119.075 -1.05 . . . . 64.519999999999996 112.173 -178.086 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -90.2 137.01 28.03 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 109.304 -0.628 . . . . 74.310000000000002 109.304 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.54 -21.92 70.3 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.54 2.16 . . . . 64.530000000000001 111.939 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -68.61 -25.15 64.71 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.89 -0.595 . . . . 70.099999999999994 111.464 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 29' ' ' THR . 5.6 mm-40 -73.76 117.39 60.58 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 107.857 -1.164 . . . . 74.010000000000005 107.857 177.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 37.0 Cg_exo -60.88 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.831 2.354 . . . . 62.420000000000002 112.041 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 66' ' ' ILE . 42.0 p -98.86 -162.11 0.93 Allowed 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 115.019 -0.992 . . . . 53.539999999999999 109.131 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -109.27 159.33 17.04 Favored 'General case' 0 N--CA 1.391 -3.392 0 N-CA-C 107.723 -1.214 . . . . 64.409999999999997 107.723 174.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 35' ' ' VAL . 5.2 m-20 -135.11 161.24 35.89 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 103.583 -2.747 . . . . 73.340000000000003 103.583 -176.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.66 -54.83 23.38 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 113.742 1.015 . . . . 63.229999999999997 113.742 -173.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.2 -34.1 46.75 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 121.47 1.447 . . . . 54.140000000000001 111.889 177.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 22.7 tpt180 -67.02 -34.98 78.9 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.418 -0.355 . . . . 64.140000000000001 110.965 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 31' ' ' ASP . 56.7 t -69.33 -40.8 80.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.16 -0.681 . . . . 73.400000000000006 109.16 178.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.3 -35.81 78.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 61.409999999999997 109.5 176.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -69.0 -45.32 70.85 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.284 -0.871 . . . . 74.209999999999994 110.868 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.28 -45.06 81.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.978 -0.555 . . . . 63.509999999999998 111.532 -177.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.8 -12.34 58.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.299 -0.41 . . . . 52.149999999999999 111.86 -177.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.67 30.67 74.92 Favored Glycine 0 CA--C 1.505 -0.541 0 CA-C-N 115.914 -0.585 . . . . 75.319999999999993 111.965 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.28 155.6 80.69 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.84 -0.43 . . . . 71.219999999999999 109.84 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.17 166.81 19.9 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.109 1.873 . . . . 73.099999999999994 112.001 177.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -56.3 -37.43 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.806 0.843 . . . . 70.340000000000003 110.909 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -57.73 -41.53 82.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.365 -0.834 . . . . 72.340000000000003 111.479 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.658 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 45.4 mtpt -70.06 -36.83 75.26 Favored 'General case' 0 C--O 1.2 -1.545 0 C-N-CA 119.268 -0.973 . . . . 75.129999999999995 111.266 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.5 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.482 -0.562 . . . . 75.010000000000005 109.482 177.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -58.9 -43.37 91.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.693 -0.685 . . . . 74.409999999999997 110.247 177.086 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 3.5 pt20 -70.53 -34.2 72.01 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.522 -0.308 . . . . 75.030000000000001 111.499 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.2 mm100 -57.53 -46.59 83.66 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.3 -1.0 . . . . 61.549999999999997 108.3 177.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.1 -43.52 98.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.378 -1.283 . . . . 74.129999999999995 109.762 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 19.7 mtp180 -63.44 -26.17 68.61 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.71 0.633 . . . . 63.039999999999999 112.71 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.13 7.21 45.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.941 0.401 . . . . 73.329999999999998 111.51 -178.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.15 81.65 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.774 -0.648 . . . . 54.350000000000001 113.602 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -85.19 -31.51 23.17 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.783 -0.367 . . . . 73.349999999999994 111.0 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.61 171.26 18.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.642 -0.874 . . . . 70.010000000000005 108.642 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.22 161.6 38.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.536 -0.542 . . . . 71.239999999999995 109.536 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.89 161.69 33.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.578 -0.897 . . . . 64.409999999999997 108.578 -177.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.77 166.18 29.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 123.511 0.507 . . . . 62.439999999999998 110.021 179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 17.7 mtp180 -122.75 142.66 50.47 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.054 0.454 . . . . 75.409999999999997 111.846 -178.628 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.491 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 13.5 ptt180 -149.27 127.21 11.88 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.774 -1.195 . . . . 64.439999999999998 107.774 175.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.83 17.88 11.21 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.549 1.14 . . . . 51.409999999999997 110.566 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.52 80.79 Favored Glycine 0 C--O 1.22 -0.719 0 CA-C-N 115.509 -0.769 . . . . 74.329999999999998 112.023 -177.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -88.4 142.52 17.36 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 111.688 -0.565 . . . . 71.439999999999998 111.688 -179.222 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.19 119.7 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.476 -1.305 . . . . 73.329999999999998 107.476 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 m -133.67 157.74 42.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 72.109999999999999 110.29 -175.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.438 ' O ' ' HB ' ' A' ' 29' ' ' THR . 55.0 mt -128.41 125.18 23.17 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.037 -1.097 . . . . 75.150000000000006 108.037 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 29' ' ' THR . 72.6 Cg_exo -53.45 133.95 55.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.782 2.322 . . . . 33.229999999999997 112.59 177.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.3 tp-100 -48.97 -42.2 36.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.681 1.192 . . . . 64.129999999999995 111.477 -177.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.409 ' CG2' HG11 ' A' ' 126' ' ' VAL . 16.0 m -69.22 -7.18 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 115.351 1.611 . . . . 44.329999999999998 115.351 -174.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -78.75 -14.53 59.23 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.243 1.02 . . . . 62.210000000000001 109.587 174.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.99 156.75 19.37 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.315 -1.365 . . . . 73.030000000000001 107.315 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.503 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 66.3 p -86.14 172.54 10.48 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.91 -0.404 . . . . 75.219999999999999 109.91 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -68.81 -17.26 63.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.335 0.588 . . . . 55.020000000000003 110.241 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 m -88.71 2.98 52.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.234 -0.439 . . . . 52.32 111.072 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 20.1 68.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.98 -0.629 . . . . 71.329999999999998 113.294 176.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -111.21 166.26 11.24 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.313 -1.365 . . . . 65.200000000000003 107.313 178.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.73 3.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.394 -1.322 . . . . 64.340000000000003 107.524 178.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.0 t -64.77 137.69 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-O 120.892 0.377 . . . . 71.549999999999997 110.679 -178.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 58.2 tttp -64.71 -40.44 95.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.219 0.533 . . . . 75.140000000000001 112.208 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -84.44 -0.35 52.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.318 0.58 . . . . 63.310000000000002 110.615 -175.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 60.1 tp -65.53 -54.35 31.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 113.005 0.742 . . . . 64.329999999999998 113.005 -178.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 51.9 Cg_exo -58.09 -33.26 97.15 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 121.475 1.45 . . . . 73.030000000000001 111.158 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -44.99 87.88 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.669 -0.696 . . . . 72.299999999999997 112.293 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.3 pp -65.66 -40.01 91.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.343 0.592 . . . . 75.099999999999994 109.878 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.57 -34.46 77.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.903 -0.589 . . . . 70.319999999999993 110.762 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.5 m -70.49 -42.06 71.86 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 116.126 -0.488 . . . . 63.100000000000001 111.873 -178.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.06 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.786 0.327 . . . . 65.450000000000003 110.732 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.515 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.3 mm? -66.26 -35.1 79.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 122.255 -0.278 . . . . 75.409999999999997 111.378 176.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 75.310000000000002 110.159 176.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.44 -30.77 68.77 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.319 0.581 . . . . 65.400000000000006 110.683 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.94 -9.14 83.1 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.633 -0.712 . . . . 71.299999999999997 111.441 178.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.17 47.36 11.15 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.592 -0.304 . . . . 73.230000000000004 113.154 177.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.16 129.51 55.49 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 122.673 -0.31 . . . . 74.400000000000006 111.049 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.61 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 36.1 ptt180 -74.9 170.78 15.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.709 -0.678 . . . . 72.230000000000004 110.676 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -54.41 -44.85 72.73 Favored 'General case' 0 C--O 1.25 1.122 0 C-N-CA 126.552 1.941 . . . . 74.439999999999998 111.547 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.1 m -63.93 -41.91 97.5 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.869 -1.06 . . . . 62.420000000000002 110.375 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.61 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 16.4 mm-40 -67.52 -34.04 76.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.071 -0.513 . . . . 72.219999999999999 111.148 -178.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.54 -49.45 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 108.578 -0.897 . . . . 75.219999999999999 108.578 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.55 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.4 ptp -75.68 -14.85 60.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.077 -0.965 . . . . 50.130000000000003 113.055 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.49 -62.18 2.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.636 0.374 . . . . 74.120000000000005 110.411 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.471 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.0 p-90 -69.19 -31.84 70.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.603 0.594 . . . . 72.019999999999996 112.603 176.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 12.2 mt -62.34 -40.26 95.81 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.931 1.086 . . . . 72.299999999999997 113.931 -179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.468 ' CE2' HD23 ' A' ' 23' ' ' LEU . 33.5 m-85 -85.32 -16.65 39.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.538 0.94 . . . . 74.420000000000002 113.538 -177.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.8 p -84.36 124.09 74.15 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 109.338 -0.615 . . . . 34.25 109.338 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -52.68 134.91 55.25 Favored 'Trans proline' 0 C--O 1.249 1.055 0 C-N-CA 122.743 2.295 . . . . 53.450000000000003 111.766 178.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.0 t70 -93.35 121.33 65.41 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.868 -0.605 . . . . 73.0 110.255 -177.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.71 -23.62 76.66 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.211 2.608 . . . . 71.239999999999995 113.708 -177.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -98.48 0.79 45.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.958 0.408 . . . . 55.439999999999998 110.757 -176.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -101.89 124.86 48.24 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.675 0.75 . . . . 53.340000000000003 110.744 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.9 m -132.45 116.5 16.87 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.685 -1.598 . . . . 74.310000000000002 106.685 175.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.2 pt . . . . . 0 C--N 1.309 -1.171 0 CA-C-O 121.16 0.505 . . . . 72.150000000000006 112.201 -175.286 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 108.565 -0.902 . . . . 73.239999999999995 108.565 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -90.84 137.45 32.35 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.687 -0.688 . . . . 70.450000000000003 109.399 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 57.8 t30 65.63 62.98 0.63 Allowed 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.13 0.894 . . . . 60.439999999999998 109.43 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.47 162.14 13.98 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.975 -1.011 . . . . 53.200000000000003 109.918 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 127.97 76.35 Favored Pre-proline 0 C--O 1.243 0.743 0 C-N-CA 119.944 -0.702 . . . . 74.549999999999997 110.545 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.538 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.6 Cg_exo -52.59 -21.7 15.06 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.025 3.15 . . . . 73.219999999999999 114.989 -178.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.6 t -63.75 -39.83 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.183 -0.607 . . . . 73.109999999999999 110.371 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.446 -0.946 . . . . 63.409999999999997 108.446 -178.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.65 68.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.91 -1.041 . . . . 55.329999999999998 111.122 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.3 pp -64.44 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.981 0.419 . . . . 71.349999999999994 110.771 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.503 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 7.4 t60 -67.62 -36.49 80.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.584 -0.895 . . . . 75.219999999999999 108.584 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.16 9.45 28.34 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 45.399999999999999 112.006 -178.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 67.5 27.77 7.84 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.882 1.325 . . . . 73.400000000000006 111.395 178.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -96.94 23.61 7.02 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.178 -1.786 . . . . 70.239999999999995 106.178 173.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.78 -26.76 15.26 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 127.172 2.189 . . . . 72.349999999999994 114.643 -173.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.572 ' HD2' ' H ' ' A' ' 135' ' ' ARG . 3.4 mpt_? -55.74 -47.58 76.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.057 0.223 . . . . 74.420000000000002 111.254 -174.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 9.8 mm-40 -66.64 -32.39 73.68 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.187 0.439 . . . . 73.340000000000003 112.187 176.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.09 -49.29 63.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.353 -0.385 . . . . 62.420000000000002 110.158 -177.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.73 -42.45 96.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.909 -0.587 . . . . 75.409999999999997 109.597 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 57.8 ttt180 -59.12 -46.92 87.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.854 -0.612 . . . . 74.549999999999997 111.05 178.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.63 -38.31 90.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.898 -0.779 . . . . 52.109999999999999 108.898 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -64.15 -46.64 83.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.684 . . . . 32.119999999999997 110.413 178.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.32 -36.59 82.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.847 0.356 . . . . 63.32 111.283 178.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.99 83.91 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.196 0.522 . . . . 72.310000000000002 110.58 178.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 tpt -69.8 -45.11 68.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.48 -0.782 . . . . 51.0 111.408 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.34 -31.06 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.017 0.747 . . . . 63.530000000000001 113.017 -176.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 C--N 1.312 -1.047 0 C-N-CA 120.621 -0.432 . . . . 71.299999999999997 110.539 -178.517 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 N-CA-C 109.836 -0.431 . . . . 64.129999999999995 109.836 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.98 -112.13 2.89 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.907 -0.663 . . . . 63.420000000000002 112.878 -178.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -95.1 128.05 41.63 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.702 0.286 . . . . 73.310000000000002 110.797 -174.335 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -70.2 138.73 52.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.311 -0.858 . . . . 73.140000000000001 111.441 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.16 -11.35 8.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.232 -0.895 . . . . 70.200000000000003 109.811 -176.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.96 -169.82 2.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.799 0.809 . . . . 70.150000000000006 109.539 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.434 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 29.2 t70 -105.75 138.29 19.58 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 105.837 -1.912 . . . . 71.409999999999997 105.837 169.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.68 -26.04 16.35 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.978 2.452 . . . . 72.430000000000007 115.042 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.74 -3.8 58.94 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.206 0.447 . . . . 74.120000000000005 112.206 -177.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 26.6 mm-40 -74.61 145.57 82.22 Favored Pre-proline 0 C--O 1.25 1.126 0 O-C-N 121.552 -0.717 . . . . 64.510000000000005 110.941 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.49 ' HB2' ' HG3' ' A' ' 68' ' ' GLN . 12.2 Cg_endo -54.65 123.72 14.39 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.214 2.61 . . . . 74.140000000000001 111.524 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -140.47 168.93 18.64 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.568 -0.742 . . . . 53.399999999999999 111.812 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.479 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 36.4 m-85 -109.77 160.38 16.38 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 125.377 1.471 . . . . 75.340000000000003 109.325 176.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -135.73 161.13 36.42 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.229 -2.878 . . . . 41.549999999999997 103.229 178.051 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.25 -52.25 70.52 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 113.804 1.039 . . . . 72.25 113.804 -173.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.08 -36.06 96.93 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.826 1.684 . . . . 73.430000000000007 112.66 176.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.85 -37.86 85.27 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.883 -0.414 . . . . 74.439999999999998 109.883 177.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.75 -40.97 79.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.18 -0.464 . . . . 72.209999999999994 110.354 176.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.43 -43.36 83.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.29 -0.868 . . . . 60.32 109.076 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.09 -45.29 92.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.361 -1.291 . . . . 74.129999999999995 110.254 178.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.6 -40.75 96.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.965 -1.016 . . . . 74.439999999999998 111.49 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.76 -18.31 22.21 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.408 -0.36 . . . . 55.530000000000001 111.437 -177.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.37 62.08 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.395 -0.682 . . . . 54.409999999999997 111.395 -178.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.38 161.89 24.94 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 108.941 -0.763 . . . . 64.519999999999996 108.941 -177.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.54 155.81 67.73 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 121.703 1.602 . . . . 75.540000000000006 111.963 174.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.72 -35.46 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.375 0.67 . . . . 71.049999999999997 109.686 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 23.3 t -59.58 -38.52 81.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.518 -0.765 . . . . 73.030000000000001 110.33 178.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 52.4 mttp -69.15 -32.78 72.36 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.932 -0.48 . . . . 75.040000000000006 111.94 177.106 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.53 -42.8 97.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.814 -0.81 . . . . 65.129999999999995 108.814 174.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.77 83.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.727 -0.67 . . . . 74.329999999999998 110.278 176.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 44' ' ' SER . 16.3 mm100 -66.89 -36.05 81.41 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.992 -0.549 . . . . 73.349999999999994 110.978 177.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.6 mt-30 -61.55 -43.29 99.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.456 0.646 . . . . 73.030000000000001 109.697 176.155 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.8 -34.69 76.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.448 -1.251 . . . . 61.450000000000003 110.473 176.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -71.66 -32.89 68.37 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.541 -0.754 . . . . 73.549999999999997 112.748 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -92.04 -11.75 35.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.13 0.49 . . . . 72.299999999999997 112.225 -176.027 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.27 35.99 28.45 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.929 -1.129 . . . . 75.349999999999994 110.716 -177.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -92.82 -27.42 17.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.113 -1.069 . . . . 63.520000000000003 108.113 176.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.6 tp -147.92 152.57 37.78 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.847 -1.538 . . . . 42.219999999999999 106.847 -175.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.07 154.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 108.766 -0.827 . . . . 60.340000000000003 108.766 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.6 162.02 33.89 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 123.306 0.379 . . . . 75.329999999999998 110.264 -174.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.1 m -132.03 166.67 28.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 123.883 0.873 . . . . 62.25 109.471 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 83.3 mtm180 -110.95 131.29 55.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.886 0.699 . . . . 75.439999999999998 112.886 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 33.0 ptt180 -116.12 116.07 27.18 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 106.901 -1.518 . . . . 74.129999999999995 106.901 176.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.66 14.16 6.94 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.667 0.746 . . . . 62.32 111.019 -177.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.09 -20.89 34.78 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.821 -0.627 . . . . 70.430000000000007 112.697 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -78.57 145.7 29.29 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 110.585 -1.006 . . . . 60.219999999999999 110.585 -179.037 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.2 t -95.97 120.23 45.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.962 -0.755 . . . . 43.109999999999999 108.962 -175.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.23 163.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.643 -0.708 . . . . 73.219999999999999 111.51 -177.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -128.97 125.2 22.79 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.967 -1.123 . . . . 70.349999999999994 107.967 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.1 139.24 85.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.575 2.183 . . . . 73.239999999999995 113.235 178.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HG3' ' HB2' ' A' ' 28' ' ' PRO . 73.8 mm-40 -48.72 -34.88 12.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.271 1.028 . . . . 71.439999999999998 112.485 177.011 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.13 -3.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 113.883 1.068 . . . . 42.020000000000003 113.883 -174.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 81' ' ' LEU . 8.0 m-85 -86.68 -5.84 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.066 0.936 . . . . 75.120000000000005 110.141 175.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -134.42 164.5 27.29 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.799 -1.091 . . . . 62.109999999999999 108.104 178.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.6 p -94.6 158.46 15.52 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.204 -1.406 . . . . 63.409999999999997 107.204 176.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.78 -15.79 63.19 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.208 0.528 . . . . 74.310000000000002 110.647 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.7 m -79.05 -5.56 54.27 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.563 -0.744 . . . . 71.25 111.71 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.24 -7.41 40.41 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 119.641 -1.266 . . . . 71.349999999999994 114.312 174.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -106.05 162.86 13.24 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.681 -0.808 . . . . 71.329999999999998 110.238 179.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.79 156.19 5.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 106.86 -1.533 . . . . 73.230000000000004 106.86 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.92 125.07 22.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.427 -0.953 . . . . 65.329999999999998 108.427 177.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.95 -22.21 65.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.93 1.085 . . . . 74.25 113.93 -173.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 t -103.41 11.81 36.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.887 0.375 . . . . 73.140000000000001 110.203 -179.063 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 70' ' ' PHE . 12.9 tp -63.41 -51.47 67.55 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 119.305 -0.378 . . . . 65.120000000000005 111.762 -178.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 31.4 Cg_exo -61.68 -29.59 83.98 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 121.363 1.376 . . . . 64.049999999999997 111.78 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.49 -45.04 97.01 Favored Glycine 0 C--O 1.24 0.489 0 O-C-N 123.377 0.423 . . . . 72.5 113.082 -178.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -68.4 -40.36 81.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.316 0.579 . . . . 71.340000000000003 109.463 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 96.4 mt -64.02 -42.47 97.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.504 -0.771 . . . . 72.219999999999999 111.233 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.0 m -57.54 -46.87 83.36 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 112.044 0.387 . . . . 73.329999999999998 112.044 -177.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -41.96 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.013 0.435 . . . . 73.109999999999999 110.83 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.684 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 55.8 mt -67.08 -35.86 80.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.359 0.503 . . . . 72.019999999999996 112.359 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.422 ' CE1' ' HB3' ' A' ' 85' ' ' LEU . 58.3 m170 -65.23 -33.2 75.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.553 -0.294 . . . . 53.100000000000001 110.73 177.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.59 -31.64 72.86 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.357 0.411 . . . . 74.349999999999994 110.332 178.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.04 -3.2 68.09 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.768 -0.651 . . . . 70.420000000000002 112.281 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.49 42.69 55.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 121.502 -0.38 . . . . 74.209999999999994 112.903 179.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 56.0 m-85 -93.26 130.61 38.92 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.453 -0.439 . . . . 72.109999999999999 111.962 178.528 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 18.7 ptp180 -81.1 171.77 14.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.09 -0.959 . . . . 62.409999999999997 111.459 -176.841 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.33 -45.96 72.79 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.725 1.61 . . . . 73.230000000000004 112.551 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.4 m -61.65 -40.99 96.88 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.414 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 17.9 mm-40 -65.94 -39.39 90.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.446 -0.343 . . . . 73.420000000000002 111.587 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 88' ' ' LEU . 24.4 mm -61.1 -49.48 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.749 -0.834 . . . . 60.439999999999998 108.749 -177.104 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.5 mtt -76.1 -18.53 59.14 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.738 -1.119 . . . . 75.230000000000004 112.336 -177.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -56.81 -67.26 0.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.378 0.671 . . . . 65.019999999999996 110.935 -175.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.684 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 52.7 p-90 -68.9 -32.75 72.61 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.363 0.505 . . . . 75.239999999999995 112.363 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.56 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.4 mt -60.35 -40.13 89.59 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.201 0.815 . . . . 74.209999999999994 113.201 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.19 -0.5 55.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.083 0.771 . . . . 74.450000000000003 113.083 -178.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.2 m -87.51 120.32 71.08 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.367 -0.605 . . . . 71.120000000000005 109.367 178.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.28 129.75 21.06 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.227 1.951 . . . . 74.400000000000006 110.751 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.6 t70 -102.5 124.16 40.29 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 120.264 -0.575 . . . . 62.210000000000001 109.519 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.35 -23.92 76.01 Favored 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.603 2.869 . . . . 71.400000000000006 113.556 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -104.44 10.27 35.32 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.429 0.633 . . . . 62.240000000000002 110.966 -177.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 50.1 tp -103.84 123.16 46.6 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.585 -0.894 . . . . 72.219999999999999 108.585 174.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.0 m -131.2 111.34 11.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.665 -1.235 . . . . 63.399999999999999 107.665 179.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--N 1.296 -1.73 0 N-CA-C 112.792 0.664 . . . . 72.400000000000006 112.792 -172.443 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 107.799 -1.186 . . . . 64.319999999999993 107.799 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 t -90.58 148.26 22.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.957 -1.127 . . . . 52.439999999999998 107.957 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.9 t30 65.26 63.58 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.439 1.114 . . . . 71.239999999999995 108.923 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.71 164.71 18.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.686 -1.143 . . . . 72.310000000000002 109.728 -178.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 36.7 ptt180 -87.34 142.94 33.69 Favored Pre-proline 0 C--N 1.299 -1.62 0 CA-C-N 115.863 -0.608 . . . . 61.409999999999997 109.756 179.005 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HB2' HD23 ' A' ' 102' ' ' LEU . 48.7 Cg_exo -57.16 -18.34 29.09 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.264 2.642 . . . . 54.530000000000001 114.336 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 97.8 t -60.62 -41.96 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.237 0.542 . . . . 64.430000000000007 110.351 178.087 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.36 -32.54 73.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.88 -0.6 . . . . 70.420000000000002 111.224 -179.18 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.1 74.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 55.130000000000003 110.176 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 126' ' ' VAL . 17.0 tp -60.1 -43.65 95.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.478 0.711 . . . . 74.209999999999994 112.246 -177.067 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -71.84 -15.67 62.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.55 0.691 . . . . 75.530000000000001 110.697 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -101.58 13.38 35.14 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.289 -0.869 . . . . 44.229999999999997 111.373 -175.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 65.93 27.32 10.86 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 123.122 1.439 . . . . 63.439999999999998 110.225 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -106.29 23.49 14.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.079 -1.452 . . . . 64.409999999999997 107.079 176.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.84 17.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.317 -2.22 . . . . 74.040000000000006 111.868 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -56.18 -39.19 72.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.288 -0.415 . . . . 71.010000000000005 111.405 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.4 mm-40 -69.27 -33.68 73.6 Favored 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 120.77 -0.372 . . . . 72.310000000000002 110.887 175.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 129' ' ' LEU . 60.0 t -62.19 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.872 -0.788 . . . . 72.450000000000003 108.872 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 66.1 t -61.58 -49.11 85.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 115.673 -0.694 . . . . 75.140000000000001 109.41 176.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.416 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 0.7 OUTLIER -57.86 -41.8 83.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.076 -0.511 . . . . 71.140000000000001 111.452 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 16.6 mmt180 -68.42 -37.78 80.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.978 -0.378 . . . . 75.549999999999997 109.978 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.86 96.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.471 . . . . 71.219999999999999 110.228 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 91.3 mt-30 -58.52 -49.16 78.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.469 0.708 . . . . 65.310000000000002 110.016 178.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.12 71.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.568 -0.742 . . . . 74.319999999999993 111.774 -178.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 96.6 mmm -84.6 -36.8 21.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.568 -0.453 . . . . 64.150000000000006 111.208 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.583 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -77.44 -42.82 34.61 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.291 0.848 . . . . 53.539999999999999 113.291 -176.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 119.164 -0.446 . . . . 65.129999999999995 110.507 -175.86 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.066 0 N-CA-C 110.382 -0.229 . . . . 75.319999999999993 110.382 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.14 -96.95 2.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 121.34 -0.457 . . . . 71.420000000000002 113.912 -177.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.97 131.99 51.78 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.212 0.529 . . . . 75.319999999999993 111.757 -175.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.03 94.36 2.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.294 -0.866 . . . . 43.119999999999997 110.329 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.57 -45.96 96.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.875 -1.057 . . . . 72.099999999999994 111.035 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.88 150.97 46.21 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.444 0.64 . . . . 64.150000000000006 112.583 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.81 151.16 93.21 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.181 -0.918 . . . . 73.400000000000006 109.058 178.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.75 -25.51 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.771 2.314 . . . . 74.209999999999994 112.826 178.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.66 -28.4 66.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.895 -0.322 . . . . 61.049999999999997 110.899 178.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.53 118.16 65.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 106.993 -1.484 . . . . 73.099999999999994 106.993 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.84 147.46 89.48 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 122.474 2.116 . . . . 72.340000000000003 113.917 -173.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -129.93 172.73 11.4 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.683 -0.69 . . . . 53.549999999999997 112.155 -177.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.447 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 10.6 m-85 -117.33 160.68 20.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 126.597 1.959 . . . . 74.099999999999994 108.184 173.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -133.19 163.75 28.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.31 -2.107 . . . . 74.510000000000005 105.31 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.433 ' H ' HD22 ' A' ' 32' ' ' LEU . 3.2 mm? -42.35 -54.84 7.39 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.426 1.639 . . . . 72.420000000000002 115.426 -174.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.99 -41.1 65.03 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.074 1.849 . . . . 45.310000000000002 113.006 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -71.45 -34.8 70.57 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.986 0.422 . . . . 74.109999999999999 110.688 -178.654 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 66' ' ' ILE . 76.0 t -69.15 -41.34 81.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.349 0.595 . . . . 64.150000000000006 109.547 177.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -60.2 -36.08 76.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.857 -1.065 . . . . 65.129999999999995 109.766 176.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 38.0 tt0 -64.12 -45.06 90.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.569 1.148 . . . . 72.209999999999994 110.493 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.447 HD11 ' CZ ' ' A' ' 30' ' ' TYR . 97.0 mt -60.9 -45.6 93.98 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.476 -0.784 . . . . 75.140000000000001 111.19 -178.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.8 mt -84.98 -18.35 34.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.209 -0.905 . . . . 54.530000000000001 111.395 -176.493 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.05 69.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 111.35 -0.7 . . . . 73.319999999999993 111.35 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 39' ' ' LEU . 28.4 m -129.24 158.78 71.97 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.583 -0.525 . . . . 74.430000000000007 109.583 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.46 160.89 40.66 Favored 'Trans proline' 0 C--O 1.256 1.42 0 C-N-CA 122.225 1.95 . . . . 75.120000000000005 112.136 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.09 -33.02 49.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 123.923 0.889 . . . . 61.509999999999998 111.752 -177.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.4 p -60.1 -40.22 88.87 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.225 -0.443 . . . . 65.349999999999994 111.226 178.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.75 -32.52 71.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.89 0.376 . . . . 65.230000000000004 111.384 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.8 t -64.5 -40.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.962 -0.755 . . . . 71.030000000000001 108.962 174.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -61.82 -36.06 80.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.455 -0.793 . . . . 62.229999999999997 110.382 176.118 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 44' ' ' SER . 25.5 mt-30 -61.67 -39.32 90.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.348 -0.387 . . . . 73.099999999999994 110.342 178.452 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -58.66 -46.21 87.68 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.812 -0.81 . . . . 60.210000000000001 108.812 177.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.23 -39.81 94.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.928 -1.033 . . . . 71.319999999999993 110.638 179.338 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 89.1 mtt180 -68.71 -26.9 65.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.921 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.95 -8.19 37.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.587 -0.278 . . . . 74.530000000000001 111.398 -176.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.47 25.73 45.95 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.555 -0.831 . . . . 41.340000000000003 111.883 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -96.55 -5.54 39.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.486 -0.191 . . . . 63.350000000000001 110.486 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 tp -163.12 153.94 16.68 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.223 -1.029 . . . . 74.409999999999997 108.223 -176.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 161.42 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.471 -1.307 . . . . 74.519999999999996 107.471 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.31 162.66 35.86 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.915 -0.402 . . . . 75.340000000000003 109.915 -175.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.418 HG13 ' HE1' ' A' ' 99' ' ' MET . 6.4 m -126.04 164.86 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 O-C-N 123.79 0.681 . . . . 71.209999999999994 109.709 177.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 32.9 ttp180 -110.83 132.38 54.25 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 116.222 -0.444 . . . . 70.099999999999994 110.48 -174.599 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.559 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -136.29 124.4 23.0 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.614 -0.513 . . . . 72.430000000000007 109.614 175.888 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.84 30.57 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.945 0.898 . . . . 63.420000000000002 112.127 176.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.05 -4.33 71.06 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.821 -0.627 . . . . 61.240000000000002 113.342 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -107.57 146.35 16.22 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 121.127 -0.559 . . . . 62.409999999999997 112.816 -178.178 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.15 120.85 47.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.361 -1.348 . . . . 64.319999999999993 107.361 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.79 159.93 41.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.878 -0.601 . . . . 71.230000000000004 111.124 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 35' ' ' VAL . 56.0 mt -124.32 128.39 25.02 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.217 -1.031 . . . . 71.129999999999995 108.217 179.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.14 138.62 86.2 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.62 2.213 . . . . 74.209999999999994 113.099 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.55 -35.58 53.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.333 1.053 . . . . 74.219999999999999 111.712 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -69.01 -9.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.898 -1.046 . . . . 50.310000000000002 113.641 -175.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -80.23 -15.72 56.37 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.745 0.783 . . . . 73.030000000000001 110.345 176.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -111.79 162.35 15.35 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 115.167 -0.924 . . . . 75.019999999999996 109.528 -178.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 p -85.87 165.78 16.54 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.353 -1.351 . . . . 61.43 107.353 175.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.82 -21.57 66.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.891 0.853 . . . . 74.400000000000006 109.506 177.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m -80.23 -1.89 42.57 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 115.108 -0.951 . . . . 55.409999999999997 112.092 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.47 -16.91 59.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.391 -0.909 . . . . 72.340000000000003 114.941 173.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -92.16 164.87 13.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.178 0.989 . . . . 73.340000000000003 109.612 179.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.84 155.71 3.7 Favored 'Isoleucine or valine' 0 C--O 1.258 1.546 0 N-CA-C 108.34 -0.985 . . . . 62.149999999999999 108.34 -179.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 80' ' ' SER . 42.6 t -65.97 126.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.041 -0.725 . . . . 72.120000000000005 109.041 178.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -26.6 67.92 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.626 0.602 . . . . 64.310000000000002 112.626 -178.231 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.475 ' H ' HG12 ' A' ' 78' ' ' VAL . 13.6 m -84.33 -0.56 52.99 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.884 -0.598 . . . . 73.200000000000003 111.899 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.515 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 57.1 tp -60.79 -55.1 48.1 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 113.01 0.745 . . . . 62.409999999999997 113.01 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.29 -28.98 86.47 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.087 1.858 . . . . 64.230000000000004 112.594 -178.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.29 96.37 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.057 -0.592 . . . . 53.340000000000003 111.941 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 60.130000000000003 110.308 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.4 -42.72 95.95 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.576 -0.738 . . . . 62.340000000000003 111.845 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -62.49 -45.43 93.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.136 -0.484 . . . . 71.230000000000004 112.205 -176.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -43.29 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.829 -0.349 . . . . 72.239999999999995 110.687 -179.15 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.61 -35.8 79.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.395 0.517 . . . . 60.119999999999997 112.395 176.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -62.29 -42.45 99.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.677 -0.49 . . . . 74.25 109.677 179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.18 -30.51 71.56 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.859 -0.609 . . . . 60.109999999999999 110.723 176.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.26 -9.29 85.23 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.479 -0.782 . . . . 63.030000000000001 112.104 177.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.37 23.1 55.3 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.577 -0.344 . . . . 71.109999999999999 113.837 177.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -87.47 129.6 35.0 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.163 0.506 . . . . 75.140000000000001 111.539 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 16.6 ptp180 -78.49 172.67 13.32 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.006 0.922 . . . . 74.230000000000004 110.897 -177.049 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -53.64 -45.08 70.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.583 1.553 . . . . 73.120000000000005 111.035 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.607 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 31.2 m -63.46 -42.12 98.62 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.121 -0.945 . . . . 64.409999999999997 110.269 -179.405 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.462 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 41.8 mt-10 -65.41 -39.91 92.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.983 -0.553 . . . . 62.420000000000002 110.27 -177.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 94' ' ' ARG . 21.5 mm -61.35 -48.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.773 0.796 . . . . 74.409999999999997 109.575 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.423 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 51.9 mtt -74.58 -15.98 60.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 113.55 0.945 . . . . 74.450000000000003 113.55 -175.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.607 ' HG3' ' O ' ' A' ' 96' ' ' THR . 84.2 mtt180 -55.77 -65.26 0.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.935 0.398 . . . . 72.25 111.028 178.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.476 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.7 p-90 -68.68 -32.03 71.56 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.707 0.632 . . . . 72.340000000000003 112.707 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.7 mt -62.3 -40.84 97.6 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.516 0.932 . . . . 71.340000000000003 113.516 -179.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -92.91 -16.03 25.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.554 0.576 . . . . 73.409999999999997 112.554 -177.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.0 m -87.32 124.09 68.74 Favored Pre-proline 0 C--N 1.296 -1.761 0 N-CA-C 109.31 -0.626 . . . . 75.310000000000002 109.31 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.519 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.3 Cg_exo -54.13 129.64 35.46 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.823 2.349 . . . . 64.439999999999998 111.938 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 8.9 t70 -80.5 126.26 78.96 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 108.209 -1.034 . . . . 73.340000000000003 108.209 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 24.9 Cg_endo -60.52 -20.39 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.039 2.493 . . . . 74.239999999999995 114.401 -176.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.7 m -115.98 4.8 13.83 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.953 -0.467 . . . . 71.329999999999998 111.887 -176.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 39.9 tp -102.34 119.83 39.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.023 0.916 . . . . 51.340000000000003 111.812 -176.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.2 m -120.11 131.1 54.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.699 -1.593 . . . . 75.439999999999998 106.699 178.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.4 HG12 ' HB2' ' A' ' 123' ' ' ALA . 14.5 pt . . . . . 0 C--N 1.297 -1.687 0 C-N-CA 120.265 -0.574 . . . . 61.329999999999998 112.301 -177.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.44 -0.934 0 N-CA-C 109.874 -0.417 . . . . 71.230000000000004 109.874 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.5 m -88.93 140.08 29.8 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.81 -1.552 . . . . 74.129999999999995 106.81 176.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 44.9 m-80 63.29 55.92 1.78 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.847 0.832 . . . . 71.530000000000001 109.566 -175.489 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB2' HG12 ' A' ' 111' ' ' ILE . . . -84.8 144.83 28.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.405 -0.816 . . . . 54.420000000000002 110.548 179.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -76.94 139.44 65.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 107.174 -1.417 . . . . 63.439999999999998 107.174 174.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB2' HD23 ' A' ' 102' ' ' LEU . 95.8 Cg_exo -49.55 -30.46 21.61 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.376 2.717 . . . . 72.219999999999999 114.403 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.3 t -60.78 -43.25 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.443 0.639 . . . . 72.219999999999999 110.782 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.34 -31.02 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 73.239999999999995 110.783 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.71 76.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.887 -0.597 . . . . 31.329999999999998 111.45 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.81 -35.77 80.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.719 0.295 . . . . 61.240000000000002 111.01 -179.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -72.32 -24.66 61.34 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.86 0.838 . . . . 71.109999999999999 109.048 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -93.21 21.4 5.99 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.116 -0.947 . . . . 63.520000000000003 111.568 -179.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.73 27.29 16.04 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.148 1.379 . . . . 73.430000000000007 112.15 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -115.0 23.73 12.3 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.408 1.099 . . . . 65.109999999999999 109.236 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.37 -27.17 22.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.041 -1.89 . . . . 74.450000000000003 111.682 177.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -54.75 -46.89 74.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.016 0.526 . . . . 71.200000000000003 109.687 178.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 47.2 mm-40 -71.83 -29.2 64.15 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.239 -0.437 . . . . 73.239999999999995 111.464 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.18 -47.74 72.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.301 -0.409 . . . . 73.099999999999994 110.354 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.8 t -63.92 -42.66 96.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.303 -0.629 . . . . 73.530000000000001 109.303 177.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -58.67 -44.3 90.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.435 0.694 . . . . 73.150000000000006 109.942 178.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 2.4 tpp85 -64.92 -38.2 90.19 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.117 -0.947 . . . . 61.219999999999999 109.213 -178.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -66.4 -44.15 83.82 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.655 0.782 . . . . 73.450000000000003 110.564 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -60.48 -49.94 75.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.935 -0.575 . . . . 72.439999999999998 109.822 178.768 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 -17.54 63.47 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.86 -1.064 . . . . 61.119999999999997 111.957 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.7 tpp -82.27 -40.59 21.33 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.025 0.441 . . . . 72.430000000000007 110.035 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.53 -48.74 8.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 61.229999999999997 111.716 -177.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 118.085 -0.959 . . . . 71.299999999999997 109.615 -177.354 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . . . . . . 0 C--O 1.25 1.088 0 N-CA-C 109.508 -0.553 . . . . 52.009999999999998 109.508 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.23 -137.43 7.34 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.595 -0.812 . . . . 75.219999999999999 114.369 -177.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -97.51 123.39 41.36 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.418 0.687 . . . . 70.540000000000006 111.812 -173.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -70.45 126.07 28.6 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.078 -0.965 . . . . 51.219999999999999 109.633 -178.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.6 t -100.36 -19.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.813 -0.631 . . . . 73.109999999999999 111.584 -175.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -98.68 176.0 5.79 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.602 -0.839 . . . . 61.240000000000002 111.8 -177.867 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' ' HG2' ' A' ' 27' ' ' GLU . 20.7 m-20 -82.8 151.36 64.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.901 -0.407 . . . . 71.530000000000001 109.901 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 60' ' ' ARG . 32.5 Cg_exo -61.86 -22.11 73.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.596 2.197 . . . . 75.049999999999997 112.383 178.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -84.05 -8.28 59.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 54.149999999999999 110.72 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 24' ' ' ASP . 16.2 mm-40 -76.37 154.94 84.09 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.533 -0.543 . . . . 74.310000000000002 109.533 177.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 28.3 Cg_endo -58.82 111.2 0.82 Allowed 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 122.877 2.385 . . . . 63.439999999999998 112.814 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -133.32 167.49 20.3 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.801 -0.636 . . . . 74.409999999999997 111.497 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 19.8 m-85 -128.66 161.69 29.09 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 125.08 1.352 . . . . 75.200000000000003 108.774 178.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.8 m-20 -133.9 161.01 35.95 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 104.365 -2.457 . . . . 73.430000000000007 104.365 -174.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.4 mt -47.08 -56.66 11.35 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.84 1.052 . . . . 62.240000000000002 113.84 -174.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.56 -29.68 43.92 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 121.242 1.295 . . . . 75.510000000000005 112.195 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.462 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 9.7 tpt180 -70.84 -37.83 73.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.8 0.334 . . . . 75.239999999999995 110.534 -178.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' ASP . 47.3 t -69.11 -40.83 81.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.79 -0.819 . . . . 74.540000000000006 108.79 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.49 81.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.909 -1.042 . . . . 54.130000000000003 109.46 177.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.36 -45.54 72.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.026 -0.988 . . . . 61.310000000000002 110.103 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.21 -50.66 69.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.254 -0.884 . . . . 72.329999999999998 111.437 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HB2' HG22 ' A' ' 41' ' ' VAL . 97.5 mt -84.07 -16.93 41.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.829 -0.623 . . . . 64.209999999999994 112.653 -175.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.84 62.41 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.303 -0.951 . . . . 70.219999999999999 110.756 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 39' ' ' LEU . 18.6 m -126.99 160.83 57.26 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 107.754 -1.202 . . . . 73.310000000000002 107.754 -178.379 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.89 159.38 52.75 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 121.738 1.625 . . . . 54.310000000000002 111.563 176.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.04 -32.84 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.751 -0.833 . . . . 70.25 108.751 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 8.6 m -57.16 -41.35 79.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.644 -1.162 . . . . 53.039999999999999 110.73 177.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 57.3 tttm -70.11 -36.25 74.71 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.283 0.563 . . . . 75.219999999999999 109.521 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.83 -40.9 90.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.753 0.787 . . . . 71.209999999999994 109.096 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.49 80.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.952 -1.022 . . . . 64.519999999999996 110.652 177.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 44' ' ' SER . 80.3 mm-40 -61.24 -41.24 96.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.252 -0.647 . . . . 73.530000000000001 109.252 178.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.9 mm-40 -58.98 -47.23 85.91 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.477 -0.783 . . . . 74.120000000000005 109.142 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -63.92 -34.06 77.1 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.252 -0.886 . . . . 55.350000000000001 110.853 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -67.2 -34.47 77.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.0 111.963 176.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 19.6 mm-40 -88.21 -11.73 45.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 74.540000000000006 110.432 -176.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.95 28.52 49.94 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.662 -0.975 . . . . 73.510000000000005 110.662 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -88.98 -10.55 47.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.669 -0.863 . . . . 72.340000000000003 108.669 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.5 tp -158.3 158.09 33.71 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.339 -1.726 . . . . 70.430000000000007 106.339 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.87 155.48 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.723 -0.843 . . . . 74.510000000000005 108.723 177.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -126.54 157.43 38.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.938 -0.764 . . . . 55.210000000000001 108.938 -176.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG11 ' CE ' ' A' ' 99' ' ' MET . 35.1 m -131.75 164.44 34.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.671 -0.492 . . . . 64.530000000000001 109.671 178.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -122.34 122.35 38.85 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 110.008 -0.368 . . . . 73.329999999999998 110.008 -176.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 25' ' ' PRO . 5.8 ptp180 -117.06 113.73 22.74 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-N 115.926 -0.579 . . . . 72.219999999999999 109.477 177.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.68 -40.8 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.372 1.869 . . . . 61.32 112.012 178.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.18 -13.03 0.04 OUTLIER Glycine 0 C--N 1.29 -2.011 0 CA-C-N 114.949 -1.023 . . . . 55.140000000000001 111.969 -177.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.62 145.35 17.7 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.855 -0.688 . . . . 63.340000000000003 111.921 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.8 120.92 46.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.581 -1.266 . . . . 70.310000000000002 107.581 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.46 164.94 33.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.04 -0.982 . . . . 64.310000000000002 110.708 -174.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.32 132.31 24.25 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 107.404 -1.332 . . . . 74.430000000000007 107.404 -179.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.1 119.45 6.47 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 121.685 1.59 . . . . 74.340000000000003 111.029 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.0 tt0 -62.99 -25.01 68.18 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.547 0.739 . . . . 74.409999999999997 112.091 -177.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.0 m -65.27 -9.64 7.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.482 -0.781 . . . . 72.319999999999993 112.605 177.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.525 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.8 m-85 -81.55 -6.16 58.7 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.743 0.782 . . . . 75.239999999999995 110.159 175.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -110.86 154.35 24.14 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.163 -0.926 . . . . 70.219999999999999 108.991 179.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.1 p -76.83 175.96 8.98 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 123.659 0.784 . . . . 73.340000000000003 110.573 179.091 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -56.31 -31.86 64.08 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.466 0.707 . . . . 74.140000000000001 110.214 174.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 m -80.17 -2.58 45.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.626 -0.716 . . . . 71.340000000000003 111.74 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.53 32.46 59.61 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.103 -0.57 . . . . 61.219999999999999 111.977 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -115.7 157.78 23.76 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.343 -0.614 . . . . 75.510000000000005 109.343 177.47 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.418 HG13 HD23 ' A' ' 81' ' ' LEU . 43.9 t -66.23 130.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.226 -0.657 . . . . 74.430000000000007 109.226 175.708 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 80' ' ' SER . 42.0 t -63.16 132.34 28.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.432 -0.951 . . . . 55.219999999999999 108.432 178.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -57.63 -27.51 62.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.903 0.705 . . . . 72.510000000000005 112.903 -178.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.442 ' H ' HG12 ' A' ' 78' ' ' VAL . 9.5 m -89.19 -2.61 58.57 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.049 -0.523 . . . . 60.049999999999997 111.273 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.525 HD11 ' CD2' ' A' ' 70' ' ' PHE . 46.0 tp -61.67 -56.99 27.59 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 119.041 -0.504 . . . . 75.239999999999995 111.794 -177.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.24 -38.67 94.64 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.437 1.425 . . . . 74.200000000000003 110.795 177.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.87 97.11 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.757 -0.656 . . . . 70.120000000000005 112.796 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.42 -41.27 80.61 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 117.212 0.506 . . . . 74.409999999999997 109.719 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.74 -35.59 81.06 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 116.026 -0.534 . . . . 64.349999999999994 110.754 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.6 m -67.24 -41.28 85.89 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 112.075 0.398 . . . . 72.329999999999998 112.075 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.02 -40.27 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 120.143 -0.623 . . . . 71.120000000000005 110.473 178.58 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 3.3 mm? -67.61 -36.07 80.15 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.623 -0.673 . . . . 63.240000000000002 112.285 175.05 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -63.54 -33.03 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.426 -0.583 . . . . 74.409999999999997 109.426 177.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 87' ' ' ILE . 18.5 t70 -63.18 -29.9 71.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.226 1.01 . . . . 73.049999999999997 109.847 178.244 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.4 -9.32 53.54 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.837 -0.62 . . . . 53.100000000000001 111.969 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.02 27.69 36.66 Favored Glycine 0 C--N 1.317 -0.483 0 O-C-N 122.769 -0.253 . . . . 23.239999999999998 113.442 178.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 76.6 m-85 -83.84 128.16 34.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.125 0.488 . . . . 63.310000000000002 112.055 -179.114 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 8.0 ptp180 -79.97 171.05 15.61 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.217 -0.901 . . . . 71.439999999999998 110.306 -179.509 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -54.35 -43.0 70.91 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.884 1.274 . . . . 72.230000000000004 111.667 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -60.03 -41.98 93.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 123.813 0.845 . . . . 63.32 110.502 -179.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -65.1 -39.71 93.53 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.828 -0.624 . . . . 71.530000000000001 110.055 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.0 mm -60.24 -47.52 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.244 -1.021 . . . . 63.340000000000003 108.244 -176.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.409 ' CE ' HG11 ' A' ' 58' ' ' VAL . 73.5 mtm -70.92 -26.38 63.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.982 -1.008 . . . . 71.5 112.725 -176.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -58.12 -66.17 0.52 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.885 0.698 . . . . 74.340000000000003 112.885 -179.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -68.24 -32.44 72.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.506 0.558 . . . . 65.329999999999998 112.506 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.568 ' HG ' HG22 ' A' ' 126' ' ' VAL . 32.3 tp -67.53 -40.38 85.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.826 -0.624 . . . . 61.340000000000003 111.519 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 26.7 m-85 -84.99 -3.05 58.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.422 0.527 . . . . 64.409999999999997 112.422 -179.025 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.9 m -86.99 109.85 28.05 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.367 -0.605 . . . . 65.120000000000005 109.367 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 103' ' ' PHE . 21.7 Cg_exo -65.87 139.67 57.93 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.637 2.225 . . . . 72.140000000000001 110.852 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.0 t70 -99.27 119.34 60.72 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.253 -1.017 . . . . 75.329999999999998 108.253 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.05 -24.87 78.14 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.259 2.64 . . . . 73.049999999999997 113.647 -176.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.8 p -106.25 8.38 31.88 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.258 0.466 . . . . 73.540000000000006 112.258 -176.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.45 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 56.4 tp -102.84 129.38 49.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 110.047 -0.353 . . . . 51.509999999999998 110.047 -178.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.5 m -112.12 112.72 24.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.451 -0.574 . . . . 60.439999999999998 109.451 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 C--N 1.3 -1.551 0 CA-C-N 115.902 -0.59 . . . . 72.219999999999999 109.461 -176.711 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.435 -1.184 0 N-CA-C 110.176 -0.305 . . . . 71.409999999999997 110.176 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 64.2 m -80.3 132.21 35.78 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.112 -1.069 . . . . 73.099999999999994 108.112 173.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.8 t30 75.38 72.97 0.09 Allowed 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.944 1.297 . . . . 75.319999999999993 108.274 -171.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.65 168.07 10.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.814 -1.085 . . . . 23.23 110.167 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -93.06 127.06 48.77 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 115.646 -0.706 . . . . 73.120000000000005 110.166 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.467 ' HB2' HD12 ' A' ' 102' ' ' LEU . 65.4 Cg_exo -55.73 -21.3 31.66 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.384 2.723 . . . . 75.430000000000007 113.469 178.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.568 HG22 ' HG ' ' A' ' 102' ' ' LEU . 43.0 t -60.35 -44.78 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.85 0.833 . . . . 72.219999999999999 109.73 178.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.7 -29.38 64.51 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.685 -1.143 . . . . 55.450000000000003 110.131 -176.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.52 -43.29 99.17 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.45 -0.796 . . . . 62.25 111.778 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -69.38 -34.98 75.35 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.638 -0.664 . . . . 65.040000000000006 109.779 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -66.65 -25.44 66.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.289 -1.323 . . . . 74.310000000000002 108.971 177.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.72 9.01 42.94 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.944 -1.025 . . . . 62.119999999999997 111.363 179.091 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.9 m80 65.25 28.23 12.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.322 1.049 . . . . 73.430000000000007 112.638 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.44 25.04 11.61 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.056 1.342 . . . . 63.409999999999997 107.74 176.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.57 -25.66 7.22 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 126.976 2.11 . . . . 72.430000000000007 112.767 -177.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 mmm-85 -54.19 -43.0 70.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.917 0.487 . . . . 74.430000000000007 110.286 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.3 -27.77 64.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.07 0.462 . . . . 53.43 111.323 179.16 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 129' ' ' LEU . 99.1 t -73.32 -49.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.543 -0.753 . . . . 60.439999999999998 109.762 178.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.493 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 79.2 t -59.08 -41.15 82.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.421 -0.809 . . . . 61.240000000000002 109.143 177.446 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.37 -46.72 79.91 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.246 -0.888 . . . . 74.299999999999997 110.157 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 144' ' ' MET . 43.9 mtp180 -67.92 -37.05 81.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.815 0.34 . . . . 72.510000000000005 111.864 176.503 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.28 99.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.648 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -59.64 -39.0 82.92 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 122.818 0.447 . . . . 73.219999999999999 110.404 176.116 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.46 66.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.316 -0.402 . . . . 74.450000000000003 110.978 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.6 mmm -82.68 -41.28 19.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.066 0.46 . . . . 72.109999999999999 110.526 179.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.74 -51.35 11.59 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.209 0.448 . . . . 72.329999999999998 112.209 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.511 -0.757 . . . . 74.530000000000001 109.023 -176.973 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.275 0 N-CA-C 106.15 -1.796 . . . . 73.129999999999995 106.15 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.17 -96.89 0.96 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 119.734 -1.222 . . . . 53.340000000000003 115.169 -175.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.1 119.94 37.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.17 0.509 . . . . 42.530000000000001 112.243 -169.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.45 109.77 2.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.996 -1.002 . . . . 54.25 110.421 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.19 -33.42 12.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.354 0.597 . . . . 75.040000000000006 110.158 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -78.44 173.78 11.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.012 -0.54 . . . . 75.549999999999997 110.135 176.075 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.88 129.98 42.31 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 107.985 -1.117 . . . . 72.409999999999997 107.985 176.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.63 -21.98 15.95 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.442 2.761 . . . . 64.030000000000001 115.061 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.46 -24.39 56.98 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.958 0.408 . . . . 71.439999999999998 110.484 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.71 157.19 87.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.724 -0.671 . . . . 73.430000000000007 111.844 -177.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -43.19 107.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 124.067 3.178 . . . . 74.450000000000003 113.601 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -135.05 164.04 28.53 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.107 -0.951 . . . . 73.230000000000004 110.426 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -127.37 160.7 30.59 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 125.623 1.569 . . . . 64.219999999999999 107.639 177.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.509 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.0 p30 -134.79 172.24 13.25 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 107.622 -1.251 . . . . 75.439999999999998 107.622 -178.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -46.04 -64.32 0.98 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 114.626 1.343 . . . . 75.140000000000001 114.626 -172.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.64 -27.59 69.11 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 121.569 1.513 . . . . 73.049999999999997 112.634 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.509 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 23.5 tpt180 -67.9 -48.29 66.44 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 110.179 -0.304 . . . . 65.519999999999996 110.179 178.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.84 -37.95 80.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.216 0.532 . . . . 74.239999999999995 109.915 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.47 -37.05 82.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.054 -0.976 . . . . 72.109999999999999 110.0 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.14 -44.96 71.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.2 -0.909 . . . . 71.510000000000005 109.885 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 97.2 mt -57.5 -41.98 81.82 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.354 -0.839 . . . . 74.400000000000006 111.962 -178.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.507 ' HB2' HG22 ' A' ' 41' ' ' VAL . 86.1 mt -94.29 -17.76 22.31 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.923 -0.58 . . . . 73.349999999999994 111.977 -177.178 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.86 61.55 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.37 -1.092 . . . . 63.520000000000003 110.37 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 39' ' ' LEU . 23.5 m -122.4 164.05 28.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.239 -0.652 . . . . 74.209999999999994 109.239 -178.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 39.6 Cg_endo -71.91 158.59 52.43 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.728 1.618 . . . . 73.430000000000007 111.341 173.434 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.28 -34.54 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.368 0.604 . . . . 73.310000000000002 110.012 178.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.7 t -62.25 -36.84 83.25 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.535 -0.757 . . . . 73.439999999999998 110.655 178.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 38.9 ttmt -69.77 -32.6 71.19 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 120.135 -0.626 . . . . 64.409999999999997 110.201 177.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.28 -42.25 92.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.653 -0.869 . . . . 52.530000000000001 108.653 175.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.08 82.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.888 -1.051 . . . . 23.309999999999999 110.438 176.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.2 mt-30 -66.82 -38.24 86.08 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.16 -0.473 . . . . 71.030000000000001 111.06 177.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.4 mm-40 -63.49 -41.29 98.56 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.998 -0.742 . . . . 71.120000000000005 108.998 177.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.55 -42.5 98.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.78 -1.1 . . . . 74.299999999999997 109.228 177.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -60.33 -32.67 71.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.277 1.031 . . . . 63.200000000000003 111.87 178.457 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -85.41 -9.91 56.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.937 0.399 . . . . 73.129999999999995 111.068 -177.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.18 33.1 54.96 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.6 -1.4 . . . . 53.329999999999998 109.6 -174.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.02 -16.91 20.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.475 -0.935 . . . . 72.540000000000006 108.475 178.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 tp -151.2 157.22 42.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.647 -1.242 . . . . 72.099999999999994 107.647 -179.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.14 147.63 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.82 -0.808 . . . . 65.129999999999995 108.82 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.58 161.78 34.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 123.208 0.603 . . . . 64.129999999999995 109.471 -178.084 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.21 166.59 28.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 123.612 0.765 . . . . 64.219999999999999 109.705 176.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 45.9 mtp180 -112.57 126.84 55.78 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.941 -0.304 . . . . 72.409999999999997 110.791 -177.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -129.8 122.68 29.23 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.002 -0.74 . . . . 71.319999999999993 109.002 176.66 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 26.14 15.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.716 0.806 . . . . 70.5 111.616 179.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 -7.26 77.17 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.987 -0.551 . . . . 61.119999999999997 112.237 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.82 149.4 19.29 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 121.302 -0.475 . . . . 64.540000000000006 111.942 -178.204 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.35 120.94 47.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.282 -1.377 . . . . 75.409999999999997 107.282 179.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.33 150.83 34.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.528 0.68 . . . . 73.439999999999998 110.961 -178.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.79 129.18 25.54 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 106.524 -1.658 . . . . 73.510000000000005 106.524 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.13 128.13 24.28 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 121.877 1.718 . . . . 71.530000000000001 111.273 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' ' 68' ' ' GLN . 5.9 tt0 -60.81 -26.77 67.54 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.198 0.523 . . . . 72.099999999999994 111.991 -178.746 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.11 -18.83 24.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.27 -0.877 . . . . 74.299999999999997 112.237 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.5 m-85 -73.74 -9.86 59.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.455 0.645 . . . . 74.510000000000005 110.657 177.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.04 161.94 17.08 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.522 -0.763 . . . . 61.299999999999997 109.455 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 p -83.55 176.1 9.28 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.405 -0.961 . . . . 63.240000000000002 108.405 175.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -61.79 -21.69 64.81 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.085 0.469 . . . . 70.349999999999994 110.961 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.9 t -80.79 -10.47 59.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.411 0.684 . . . . 73.329999999999998 110.298 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.2 24.78 53.82 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.641 -0.79 . . . . 74.430000000000007 111.773 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -112.89 152.15 29.63 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.142 -1.059 . . . . 63.119999999999997 108.142 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.478 HG13 HD23 ' A' ' 81' ' ' LEU . 41.9 t -62.87 135.31 27.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 120.595 0.236 . . . . 62.450000000000003 111.053 178.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 80' ' ' SER . 39.0 t -64.97 131.32 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.599 -0.889 . . . . 72.519999999999996 108.599 177.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -21.98 27.51 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.76 1.022 . . . . 61.130000000000003 113.76 -178.293 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.426 ' H ' HG12 ' A' ' 78' ' ' VAL . 17.9 t -94.58 -10.56 31.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.934 0.397 . . . . 62.210000000000001 110.456 -177.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 43.7 tp -60.18 -55.16 48.08 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 119.314 -0.374 . . . . 73.040000000000006 111.914 -177.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.34 -28.21 79.0 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.18 1.92 . . . . 63.140000000000001 111.716 178.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -45.66 60.44 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 121.103 -0.57 . . . . 73.049999999999997 111.935 -178.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.47 -40.31 81.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.42 0.628 . . . . 75.219999999999999 109.801 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 84.9 mt -62.18 -44.4 96.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.616 -0.72 . . . . 74.129999999999995 110.842 -178.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.4 m -70.39 -34.66 72.82 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 115.831 -0.622 . . . . 74.120000000000005 112.081 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -45.55 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 120.281 -0.567 . . . . 70.150000000000006 110.718 178.629 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 4.3 mm? -67.17 -35.81 80.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.1 0.407 . . . . 73.150000000000006 112.1 176.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.03 -37.36 79.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.273 -0.64 . . . . 65.200000000000003 109.273 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.38 -30.17 71.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 61.409999999999997 110.909 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.7 -2.31 84.63 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.965 -0.561 . . . . 74.439999999999998 112.182 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.19 39.44 11.35 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.479 -0.391 . . . . 73.310000000000002 112.591 178.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.451 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 68.9 m-85 -100.74 121.02 40.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.972 0.415 . . . . 71.230000000000004 111.694 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.623 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 38.1 ptt180 -71.0 171.61 10.53 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.112 0.965 . . . . 64.209999999999994 110.307 176.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -54.19 -44.97 72.02 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 125.24 1.416 . . . . 73.109999999999999 111.174 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.0 m -61.64 -41.4 97.45 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.94 -1.027 . . . . 75.310000000000002 110.625 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.623 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 41.6 mm-40 -67.31 -33.95 76.34 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.503 -0.317 . . . . 72.310000000000002 111.714 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.5 mm -61.16 -47.61 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.308 -0.997 . . . . 42.539999999999999 108.308 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.1 mtt -74.74 -18.77 60.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.775 -1.102 . . . . 74.340000000000003 112.074 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 77.8 ttt180 -55.97 -65.56 0.58 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.279 0.632 . . . . 70.420000000000002 110.371 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.51 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 53.3 p-90 -69.13 -32.06 71.16 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.528 -0.76 . . . . 72.530000000000001 112.623 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 125' ' ' PRO . 11.4 mt -64.99 -41.89 95.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.93 1.085 . . . . 63.109999999999999 113.93 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 124' ' ' ARG . 68.7 m-85 -89.5 -11.76 42.0 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 114.004 1.113 . . . . 71.209999999999994 114.004 -173.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.3 m -81.47 119.2 74.99 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.532 -0.544 . . . . 72.010000000000005 109.532 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.02 130.32 27.08 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.6 2.2 . . . . 61.340000000000003 111.21 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.5 t70 -99.86 125.24 41.0 Favored Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.45 -0.5 . . . . 74.129999999999995 110.358 -175.338 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 27.4 Cg_endo -60.86 -23.57 77.16 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.764 2.31 . . . . 64.430000000000007 113.645 -177.735 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.2 m -107.85 12.19 27.45 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.965 0.412 . . . . 73.349999999999994 110.848 -175.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.47 ' HG ' HG12 ' A' ' 111' ' ' ILE . 35.8 tp -108.37 124.92 51.1 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.193 -0.603 . . . . 44.32 110.793 -179.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 m -116.47 110.7 18.96 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.825 -0.806 . . . . 71.120000000000005 108.825 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.47 HG12 ' HG ' ' A' ' 109' ' ' LEU . 48.9 mm . . . . . 0 C--N 1.31 -1.119 0 C-N-CA 123.417 0.687 . . . . 74.420000000000002 110.013 -173.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.432 -1.33 0 N-CA-C 108.043 -1.095 . . . . 75.510000000000005 108.043 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -80.2 155.52 27.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.799 -0.815 . . . . 72.129999999999995 108.799 177.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.538 ' ND2' ' HA ' ' A' ' 107' ' ' PRO . 14.6 m120 67.7 37.17 3.35 Favored 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.808 0.692 . . . . 74.200000000000003 110.741 176.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.98 163.59 13.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.95 -0.389 . . . . 52.310000000000002 109.95 -179.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 103' ' ' PHE . 12.2 ptp85 -95.14 150.3 37.47 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.338 -0.615 . . . . 73.299999999999997 109.338 178.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.624 ' HB2' HD23 ' A' ' 102' ' ' LEU . 77.2 Cg_exo -54.89 -25.43 43.61 Favored 'Trans proline' 0 CA--C 1.555 1.533 0 C-N-CA 123.294 2.662 . . . . 62.539999999999999 114.028 178.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 102' ' ' LEU . 40.9 t -60.37 -43.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 120.858 0.361 . . . . 53.100000000000001 111.576 178.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.91 -32.79 74.66 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.611 -0.722 . . . . 72.109999999999999 109.885 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.53 75.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.4 -0.818 . . . . 72.299999999999997 111.961 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.478 ' HB3' HG21 ' A' ' 137' ' ' VAL . 4.1 pp -68.49 -37.39 80.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.525 -0.47 . . . . 70.400000000000006 111.277 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.82 -19.08 60.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.692 0.758 . . . . 74.439999999999998 109.493 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.09 7.79 45.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.338 -0.847 . . . . 60.329999999999998 111.157 177.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 64.3 27.88 13.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.445 1.117 . . . . 55.140000000000001 111.77 178.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.46 25.12 12.12 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.53 1.532 . . . . 75.120000000000005 108.425 179.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.8 3.88 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 128.204 2.601 . . . . 63.119999999999997 113.571 -176.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -53.97 -38.75 65.34 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 109.62 -0.511 . . . . 73.239999999999995 109.62 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -68.92 -27.64 65.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.453 0.644 . . . . 71.519999999999996 110.944 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 129' ' ' LEU . 61.9 t -73.46 -47.43 45.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.189 -0.914 . . . . 62.520000000000003 109.127 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.49 -41.8 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 64.219999999999999 109.188 176.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -56.93 -46.31 82.12 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.836 -1.074 . . . . 62.329999999999998 109.592 176.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -69.01 -36.44 77.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.147 -0.478 . . . . 72.099999999999994 110.734 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -58.72 -45.63 89.17 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.438 0.695 . . . . 54.130000000000003 110.516 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.87 -38.42 88.74 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.814 -0.63 . . . . 75.310000000000002 110.759 178.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.88 73.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.146 0.498 . . . . 73.099999999999994 110.594 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tpt -74.69 -47.11 33.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.699 -0.682 . . . . 73.450000000000003 110.907 -179.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.77 -32.9 46.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.992 0.738 . . . . 64.010000000000005 112.992 -176.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 108.892 -0.781 . . . . 61.240000000000002 108.892 -179.177 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 120.465 0.174 . . . . 55.539999999999999 110.702 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.3 -105.6 2.84 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 121.365 -0.445 . . . . 73.239999999999995 113.52 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -113.64 134.52 54.68 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.692 0.397 . . . . 65.319999999999993 110.489 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.18 127.6 33.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.668 0.747 . . . . 71.209999999999994 110.907 -179.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.07 -21.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.465 -0.789 . . . . 63.520000000000003 110.216 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -78.82 152.08 31.54 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 113.311 0.856 . . . . 71.430000000000007 113.311 -178.218 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.21 151.45 94.54 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 107.637 -1.245 . . . . 60.420000000000002 107.637 178.149 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.21 -25.0 76.54 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.769 1.646 . . . . 74.340000000000003 110.559 174.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -72.97 -13.81 61.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.145 -0.934 . . . . 73.340000000000003 111.209 177.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -83.61 131.41 52.43 Favored Pre-proline 0 N--CA 1.435 -1.175 0 N-CA-C 107.74 -1.207 . . . . 74.200000000000003 107.74 175.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.496 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 58.6 Cg_endo -69.2 146.34 63.31 Favored 'Trans proline' 0 C--O 1.256 1.4 0 C-N-CA 122.871 2.381 . . . . 72.5 113.204 -177.019 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -128.79 165.75 20.35 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.795 0.807 . . . . 74.349999999999994 112.165 -178.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.558 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 12.3 m-85 -130.34 161.45 31.26 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 125.927 1.691 . . . . 75.299999999999997 107.779 175.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 9.4 t70 -134.23 169.36 17.3 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 103.819 -2.659 . . . . 61.229999999999997 103.819 178.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HB3' HG13 ' A' ' 43' ' ' VAL . 6.2 mp -54.7 -51.99 74.08 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 114.262 1.208 . . . . 73.239999999999995 114.262 -171.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 15.8 Cg_endo -58.48 -36.12 97.84 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.157 1.904 . . . . 64.450000000000003 112.445 176.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 21.4 tpt180 -69.82 -39.34 76.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 122.912 0.485 . . . . 75.040000000000006 110.21 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.44 -38.84 77.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.318 0.58 . . . . 72.329999999999998 109.59 176.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -59.62 -36.14 75.75 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.201 -0.909 . . . . 75.540000000000006 109.881 177.1 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 37.8 tt0 -65.2 -43.77 90.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.575 -1.193 . . . . 75.049999999999997 109.963 178.165 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 83.9 mt -67.02 -50.24 62.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.799 -0.637 . . . . 64.340000000000003 111.285 -178.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.433 ' HB2' HG22 ' A' ' 41' ' ' VAL . 81.7 mt -81.06 -17.82 48.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.704 -0.68 . . . . 54.409999999999997 112.12 -173.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.71 63.08 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.682 -0.77 . . . . 42.549999999999997 111.619 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 39' ' ' LEU . 34.2 m -120.89 159.25 49.75 Favored Pre-proline 0 C--N 1.312 -1.052 0 N-CA-C 109.926 -0.398 . . . . 71.140000000000001 109.926 -177.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -61.32 154.12 60.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 122.269 1.979 . . . . 55.310000000000002 113.139 173.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 32' ' ' LEU . 90.3 t -57.88 -35.13 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.478 -1.237 . . . . 72.25 110.993 -179.367 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -64.55 -34.37 78.09 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 116.364 -0.38 . . . . 63.32 110.789 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 68.1 mttm -68.98 -35.78 77.12 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.905 -0.497 . . . . 75.540000000000006 110.225 176.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.21 -43.02 98.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.76 -0.655 . . . . 63.32 109.696 175.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.74 79.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.86 -0.609 . . . . 71.219999999999999 110.349 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 46.3 mt-30 -67.51 -35.2 78.65 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 115.954 -0.566 . . . . 63.439999999999998 111.848 177.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.9 mm-40 -58.26 -48.75 79.45 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.583 -0.895 . . . . 74.310000000000002 108.583 177.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -62.3 -42.69 99.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.844 -1.071 . . . . 64.120000000000005 110.27 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -70.13 -21.32 63.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.25 1.204 . . . . 71.439999999999998 114.25 -179.232 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 18.2 mm-40 -96.54 -4.85 40.6 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 119.749 -0.78 . . . . 74.530000000000001 110.758 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.56 36.49 37.99 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.105 -0.798 . . . . 41.020000000000003 111.105 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -106.68 -5.18 18.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.219 -1.03 . . . . 70.200000000000003 108.219 178.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -158.11 153.65 26.22 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.697 -1.594 . . . . 73.230000000000004 106.697 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.17 146.98 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.996 -0.742 . . . . 74.200000000000003 108.996 -176.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.56 153.28 51.03 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.297 -0.631 . . . . 72.329999999999998 109.297 -179.024 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.19 168.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 123.777 0.831 . . . . 61.420000000000002 109.726 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 59' ' ' ARG . 33.7 ttt180 -108.43 118.01 35.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.439 -0.949 . . . . 72.430000000000007 108.439 -176.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -123.9 123.47 40.49 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.089 -1.414 . . . . 74.409999999999997 109.473 -176.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.0 16.07 7.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.541 1.136 . . . . 52.439999999999998 112.034 177.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.46 -12.87 54.56 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.73 -0.668 . . . . 44.229999999999997 112.025 -178.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.15 156.9 17.96 Favored Glycine 0 CA--C 1.497 -1.093 0 C-N-CA 120.498 -0.858 . . . . 72.140000000000001 111.337 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.47 120.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.893 -1.151 . . . . 74.349999999999994 107.893 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.47 157.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.675 0.75 . . . . 62.350000000000001 111.451 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.9 mt -112.29 126.56 28.2 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 106.564 -1.643 . . . . 71.319999999999993 106.564 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.35 128.78 28.62 Favored 'Trans proline' 0 C--N 1.329 -0.471 0 C-N-CA 122.341 2.028 . . . . 63.549999999999997 112.697 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -66.31 -25.22 66.74 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 121.499 0.666 . . . . 75.040000000000006 110.937 179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.0 -8.1 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 115.181 -0.918 . . . . 72.109999999999999 112.44 178.028 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.6 -7.03 59.66 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.085 0.945 . . . . 71.430000000000007 109.424 173.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.35 164.12 13.61 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.645 -1.161 . . . . 74.219999999999999 108.501 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 p -93.59 173.92 7.45 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.841 -0.8 . . . . 75.200000000000003 108.841 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -66.33 -16.86 64.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.881 0.848 . . . . 71.420000000000002 109.571 178.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -79.72 -7.3 58.53 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.243 -0.889 . . . . 72.109999999999999 111.073 178.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.39 62.06 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.949 -0.644 . . . . 54.149999999999999 112.465 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -126.09 152.14 46.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.786 -0.82 . . . . 64.310000000000002 108.786 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.84 143.94 14.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 123.557 0.535 . . . . 73.540000000000006 109.683 -177.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.6 t -62.52 121.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.253 -1.018 . . . . 65.319999999999993 108.253 176.333 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -57.89 -39.69 78.51 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.471 0.708 . . . . 65.540000000000006 112.885 -173.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.9 t -93.07 3.18 56.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.206 0.447 . . . . 73.049999999999997 112.206 -176.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 8.4 tt -66.22 -45.07 60.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.026 1.121 . . . . 72.319999999999993 114.026 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.86 -21.62 34.03 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.123 2.549 . . . . 74.030000000000001 113.276 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.83 -41.3 99.13 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.171 -0.772 . . . . 51.539999999999999 111.171 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.15 -39.8 82.54 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.24 -0.652 . . . . 71.209999999999994 109.24 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.28 -43.85 98.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.367 -0.833 . . . . 62.240000000000002 109.903 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.3 m -57.76 -47.32 82.85 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.536 -0.756 . . . . 71.420000000000002 111.632 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -46.06 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.588 -0.278 . . . . 45.350000000000001 111.724 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.563 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -67.21 -37.99 84.55 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.571 0.952 . . . . 65.230000000000004 113.571 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -59.99 -44.99 94.16 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.004 0.43 . . . . 72.420000000000002 110.42 178.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.05 -27.34 63.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.064 -0.516 . . . . 73.120000000000005 110.987 178.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.96 -9.55 86.58 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.084 -0.507 . . . . 73.230000000000004 112.632 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.13 6.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.345 -0.455 . . . . 70.439999999999998 113.658 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -113.57 139.32 49.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.957 0.379 . . . . 74.409999999999997 111.331 177.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.497 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 14.3 ptp180 -89.93 172.07 9.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.604 -0.726 . . . . 75.239999999999995 110.716 -176.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.17 -45.4 72.1 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.429 1.491 . . . . 74.25 112.307 -176.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.0 m -64.63 -41.18 96.35 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.733 -0.667 . . . . 63.350000000000001 109.824 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.497 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 47.8 mt-10 -66.08 -38.75 89.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.602 -0.726 . . . . 64.129999999999995 111.058 -179.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 102' ' ' LEU . 30.0 mm -60.69 -47.24 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.689 -0.856 . . . . 74.129999999999995 108.689 -179.209 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.2 mtt -74.41 -18.42 60.66 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.836 -1.075 . . . . 63.219999999999999 113.095 -177.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -57.37 -64.33 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.24 0.543 . . . . 74.340000000000003 110.304 178.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.559 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 60.3 p-90 -69.62 -32.33 70.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 74.430000000000007 112.617 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.542 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.2 mt -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.572 0.953 . . . . 75.230000000000004 113.572 179.438 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.1 m-85 -98.61 10.76 40.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.303 0.482 . . . . 65.340000000000003 112.303 -177.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 101' ' ' TRP . 11.8 t -87.79 122.01 70.52 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 119.144 -1.022 . . . . 71.409999999999997 110.154 177.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.6 136.83 37.34 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.578 2.185 . . . . 71.510000000000005 110.956 177.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 14.7 t70 -106.93 112.7 63.21 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.79 -0.764 . . . . 73.150000000000006 109.472 178.101 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.09 -16.77 48.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.277 2.651 . . . . 61.530000000000001 114.596 -176.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -109.51 3.23 21.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.035 -0.416 . . . . 54.299999999999997 111.388 -177.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -102.62 125.27 49.29 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.43 0.633 . . . . 71.120000000000005 110.88 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.3 m -116.43 120.7 39.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.150000000000006 107.571 179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 123' ' ' ALA . 32.4 mt . . . . . 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 64.439999999999998 109.009 -173.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.435 -1.195 0 N-CA-C 107.946 -1.131 . . . . 75.129999999999995 107.946 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.8 p -86.92 141.14 28.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.202 -0.666 . . . . 63.130000000000003 109.202 177.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.2 t30 68.68 70.55 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.188 0.994 . . . . 55.0 110.315 -177.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.578 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -108.22 174.67 5.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.238 -0.892 . . . . 61.329999999999998 109.181 175.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.14 150.51 38.42 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 109.035 -0.728 . . . . 74.530000000000001 109.035 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.473 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.9 Cg_exo -52.7 -34.01 62.2 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.025 2.483 . . . . 64.099999999999994 112.544 173.296 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.3 t -64.08 -43.61 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 119.771 -0.772 . . . . 63.310000000000002 109.6 175.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.02 -30.8 70.13 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.886 -0.783 . . . . 71.010000000000005 108.886 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -66.02 -45.18 82.43 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.247 -0.888 . . . . 60.409999999999997 112.054 177.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.15 -33.48 73.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.161 0.505 . . . . 73.25 110.269 -179.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -66.33 -28.76 68.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.404 -0.961 . . . . 70.319999999999993 108.404 176.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.44 14.37 24.73 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.708 -1.133 . . . . 70.200000000000003 112.261 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 62.05 27.41 16.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.901 1.28 . . . . 63.520000000000003 111.885 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -110.64 24.69 12.64 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 123.772 1.749 . . . . 72.439999999999998 108.241 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.57 -26.31 12.97 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 111.389 -2.641 . . . . 70.140000000000001 113.495 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.52 -41.4 73.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.729 0.411 . . . . 72.299999999999997 110.875 -174.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.64 -35.6 77.5 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.454 0.645 . . . . 74.299999999999997 110.249 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.2 t -66.07 -42.42 91.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.053 -0.976 . . . . 74.519999999999996 109.754 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 98.6 t -61.49 -46.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 65.209999999999994 109.471 177.608 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -63.86 -38.96 93.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.117 0.484 . . . . 72.019999999999996 111.001 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -36.36 81.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.328 -0.99 . . . . 71.400000000000006 108.328 178.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.563 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -67.69 -46.37 72.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.559 0.744 . . . . 75.230000000000004 110.437 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 87.2 mt-30 -57.62 -49.5 76.24 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.046 -0.525 . . . . 73.340000000000003 109.851 178.359 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.71 -27.26 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.417 -0.811 . . . . 63.329999999999998 111.422 -178.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.559 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 14.9 tpt -77.45 -29.3 52.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.119 0.485 . . . . 72.239999999999995 110.171 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.21 -48.12 7.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.489 0.551 . . . . 54.240000000000002 112.489 -177.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 119.164 -0.446 . . . . 75.209999999999994 109.944 -176.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 108.155 -1.054 . . . . 70.0 108.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.89 100.46 1.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.738 1.625 . . . . 63.420000000000002 109.897 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.98 96.38 0.17 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.467 -0.873 . . . . 72.319999999999993 112.035 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.29 144.49 44.55 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.697 0.284 . . . . 72.430000000000007 110.78 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.43 122.72 58.67 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 109.363 -0.606 . . . . 61.310000000000002 109.363 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.84 41.92 1.0 Allowed 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.644 2.896 . . . . 74.030000000000001 112.242 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.28 64.38 0.43 Allowed Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 109.828 -1.309 . . . . 71.120000000000005 109.828 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.5 p -83.25 -34.6 25.78 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.648 0.737 . . . . 63.119999999999997 111.13 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.6 m -119.02 120.28 36.77 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.525 -0.761 . . . . 73.040000000000006 110.145 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -79.55 148.91 31.59 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.505 -0.771 . . . . 55.539999999999999 109.89 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.33 93.05 9.4 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.047 -0.723 . . . . 74.420000000000002 109.047 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -106.2 15.32 26.42 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.122 -0.945 . . . . 61.549999999999997 110.777 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.66 137.25 53.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.684 -1.144 . . . . 70.049999999999997 108.161 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.12 -162.77 30.5 Favored Glycine 0 N--CA 1.402 -3.584 0 N-CA-C 108.634 -1.787 . . . . 52.340000000000003 108.634 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.0 m -96.26 102.86 14.71 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 109.22 -0.659 . . . . 71.329999999999998 109.22 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.29 121.35 76.83 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 107.828 -1.175 . . . . 75.129999999999995 107.828 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.76 165.92 29.27 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.883 2.388 . . . . 73.200000000000003 112.802 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.95 123.81 29.69 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 106.974 -1.491 . . . . 73.120000000000005 106.974 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.11 -109.77 0.83 Allowed Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 119.675 -1.25 . . . . 24.109999999999999 114.395 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.56 121.35 29.88 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 121.319 0.58 . . . . 70.049999999999997 112.539 -168.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -60.03 120.22 9.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.489 -1.232 . . . . 71.209999999999994 110.993 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.8 t -88.84 -40.22 13.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.663 -0.699 . . . . 73.319999999999993 111.049 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.66 157.21 37.01 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 119.957 -0.697 . . . . 73.319999999999993 110.965 177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.14 141.55 70.92 Favored Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 73.439999999999998 108.346 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.95 -21.73 16.47 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.111 2.541 . . . . 65.239999999999995 115.011 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -79.79 -13.41 59.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.984 0.421 . . . . 73.340000000000003 110.823 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -75.3 137.18 71.78 Favored Pre-proline 0 C--O 1.238 0.474 0 N-CA-C 109.296 -0.631 . . . . 71.019999999999996 109.296 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.36 131.83 37.65 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 123.938 3.092 . . . . 62.210000000000001 113.841 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -137.87 158.83 43.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.595 -0.73 . . . . 72.140000000000001 111.832 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 6.2 m-85 -109.5 160.15 16.47 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.339 1.855 . . . . 73.430000000000007 107.596 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -135.18 162.48 32.41 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 105.728 -1.953 . . . . 72.450000000000003 105.728 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.3 mt -51.26 -54.34 39.43 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 113.239 0.829 . . . . 75.409999999999997 113.239 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.02 -36.7 96.15 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 121.807 1.671 . . . . 75.030000000000001 111.864 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 2.9 mpt_? -70.41 -37.61 74.47 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 116.373 -0.376 . . . . 71.120000000000005 111.856 -177.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.1 t -70.35 -37.59 71.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 120.17 -0.612 . . . . 72.439999999999998 109.845 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.13 -41.7 84.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.662 -0.866 . . . . 63.420000000000002 108.662 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 37.0 mt-10 -63.12 -45.69 90.78 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.884 -1.053 . . . . 65.299999999999997 111.99 175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.482 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 60.2 tp -61.49 -50.19 73.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.617 0.767 . . . . 54.420000000000002 112.153 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 41' ' ' VAL . 91.5 mt -89.09 -12.65 40.57 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.094 0.405 . . . . 65.030000000000001 112.094 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.17 27.75 65.57 Favored Glycine 0 C--N 1.316 -0.549 0 N-CA-C 111.212 -0.755 . . . . 75.439999999999998 111.212 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 39' ' ' LEU . 32.7 m -118.63 160.78 38.78 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.531 -0.544 . . . . 65.439999999999998 109.531 -176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD2' ' HD3' ' A' ' 45' ' ' LYS . 37.5 Cg_endo -68.7 160.29 50.14 Favored 'Trans proline' 0 C--O 1.252 1.189 0 C-N-CA 122.138 1.892 . . . . 55.25 111.723 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.51 -34.5 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 123.563 0.745 . . . . 65.340000000000003 110.492 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.4 m -61.27 -39.0 88.77 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.292 -0.867 . . . . 62.43 111.695 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD3' ' HD2' ' A' ' 42' ' ' PRO . 26.3 mtpp -69.82 -33.92 72.98 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.815 -0.354 . . . . 72.030000000000001 111.258 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.47 -44.43 98.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.852 -0.795 . . . . 74.140000000000001 108.852 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -63.01 -36.41 83.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.239 -0.892 . . . . 64.439999999999998 110.433 177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 15.4 mm100 -62.01 -40.77 96.8 Favored 'General case' 0 C--O 1.207 -1.169 0 CA-C-N 117.002 -0.09 . . . . 64.230000000000004 111.064 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -58.73 -44.49 90.47 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.464 0.649 . . . . 53.409999999999997 109.815 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.2 tp -62.5 -38.94 91.86 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.598 -1.183 . . . . 64.109999999999999 110.394 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 47' ' ' ALA . 20.0 mmm180 -71.32 -26.56 62.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.374 -0.375 . . . . 70.129999999999995 111.673 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 74.7 mm-40 -89.72 -2.64 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.596 -0.275 . . . . 74.120000000000005 111.119 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 35.86 54.14 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.776 -0.726 . . . . 63.240000000000002 111.907 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -99.81 -17.68 17.55 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 120.63 0.252 . . . . 74.200000000000003 111.01 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.9 tp -152.71 160.98 43.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.217 -1.031 . . . . 63.43 108.217 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -131.65 147.32 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.553 -0.906 . . . . 62.119999999999997 108.553 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.48 150.93 51.72 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.228 -0.656 . . . . 61.020000000000003 109.228 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 m -129.85 166.21 28.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 123.03 0.532 . . . . 73.219999999999999 110.034 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 37.2 ttt180 -114.61 123.11 48.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.879 -0.415 . . . . 74.299999999999997 109.879 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 62' ' ' GLY . 8.8 ptm180 -116.64 114.07 23.56 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.723 -0.844 . . . . 72.099999999999994 108.723 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.03 -16.81 0.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.138 1.375 . . . . 73.510000000000005 113.369 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 60' ' ' ARG . . . 147.0 -18.93 1.58 Allowed Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.713 -0.955 . . . . 41.539999999999999 110.713 -177.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -91.1 146.28 18.25 Favored Glycine 0 CA--C 1.499 -0.91 0 N-CA-C 112.346 -0.302 . . . . 73.129999999999995 112.346 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.56 121.69 48.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.869 -0.789 . . . . 60.43 108.869 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.11 157.88 43.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.471 0.653 . . . . 51.0 111.659 -177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 85.2 mt -126.52 122.22 23.7 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 107.144 -1.428 . . . . 70.329999999999998 107.144 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.54 132.36 50.04 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.152 1.901 . . . . 53.030000000000001 113.08 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -48.8 -38.52 22.27 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.818 0.847 . . . . 75.340000000000003 111.375 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.462 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 27.0 m -65.66 -11.1 11.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 114.592 1.33 . . . . 51.520000000000003 114.592 -174.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.597 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.6 m-85 -77.78 -12.87 60.02 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.699 0.761 . . . . 62.219999999999999 110.292 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.79 145.12 38.7 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 108.141 -1.059 . . . . 74.310000000000002 108.141 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.0 p -75.42 175.58 8.32 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 123.076 0.55 . . . . 73.329999999999998 110.421 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -65.85 -17.21 64.49 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 122.19 0.995 . . . . 71.129999999999995 109.863 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -90.15 -0.55 57.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.281 -0.872 . . . . 72.120000000000005 111.524 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.48 26.55 67.54 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.499 -0.382 . . . . 43.109999999999999 112.712 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -113.82 157.72 21.94 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.989 -1.115 . . . . 75.219999999999999 107.989 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.6 t -73.44 140.9 17.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.075 -1.083 . . . . 74.230000000000004 108.075 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 46.7 t -64.08 128.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.52 -0.919 . . . . 72.349999999999994 108.52 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -58.16 -43.9 87.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.342 0.867 . . . . 74.430000000000007 113.342 -173.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.0 t -89.74 1.71 55.76 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 121.01 -0.276 . . . . 61.210000000000001 111.502 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.651 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 7.9 tt -65.99 -50.24 53.29 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 119.513 -0.279 . . . . 73.030000000000001 111.511 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.64 -24.58 75.92 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.464 1.443 . . . . 60.329999999999998 110.512 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.48 -42.95 88.25 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.353 -0.84 . . . . 72.230000000000004 111.574 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -66.46 -39.78 89.01 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 108.021 -1.103 . . . . 62.43 108.021 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.52 -35.78 78.68 Favored 'General case' 0 C--O 1.202 -1.422 0 CA-C-N 115.44 -0.8 . . . . 72.310000000000002 110.652 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.4 m -59.46 -50.98 71.83 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.422 0.451 . . . . 72.120000000000005 111.263 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -42.97 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 116.268 -0.424 . . . . 72.439999999999998 111.36 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.468 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.3 mm? -66.72 -35.23 79.64 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.15 0.426 . . . . 64.049999999999997 112.15 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -64.37 -40.96 96.85 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.404 -0.591 . . . . 74.340000000000003 109.404 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.11 -30.14 68.35 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.665 -0.698 . . . . 74.329999999999998 110.067 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.88 -6.31 89.08 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.538 -0.755 . . . . 64.319999999999993 112.336 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.22 57.19 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 114.003 0.361 . . . . 70.120000000000005 114.003 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -90.87 129.11 36.95 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 122.168 -0.607 . . . . 75.439999999999998 112.099 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.406 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 8.0 ptp180 -78.02 171.8 14.46 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.159 -0.928 . . . . 75.209999999999994 110.802 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -54.26 -45.28 72.38 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.279 1.432 . . . . 61.119999999999997 111.848 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 23.9 m -61.8 -40.9 96.86 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.281 -0.872 . . . . 70.219999999999999 109.88 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 8.1 mm-40 -66.24 -39.37 89.48 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.766 -0.652 . . . . 74.510000000000005 110.713 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.9 mm -60.96 -48.63 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.367 0.603 . . . . 71.010000000000005 109.578 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.2 mtt -74.86 -21.33 59.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.346 -0.843 . . . . 53.229999999999997 111.941 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -55.59 -64.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.121 0.568 . . . . 61.109999999999999 110.954 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -68.89 -32.52 72.22 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.03 0.443 . . . . 71.329999999999998 112.102 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -67.39 -37.83 83.76 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.584 -0.734 . . . . 52.549999999999997 112.429 -174.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -93.39 -1.4 55.88 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 112.779 0.659 . . . . 74.239999999999995 112.779 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -87.29 116.96 67.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.575 -0.528 . . . . 72.340000000000003 109.575 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.64 128.72 22.96 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.81 1.673 . . . . 72.400000000000006 109.383 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 33.4 t70 -100.43 125.81 38.03 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 120.271 -0.572 . . . . 74.319999999999993 111.04 -174.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.56 -30.43 90.62 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.111 2.541 . . . . 64.129999999999995 113.164 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 p -92.0 5.49 49.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.289 0.566 . . . . 71.439999999999998 111.48 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.3 tp -102.79 126.07 49.78 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.205 -0.665 . . . . 73.540000000000006 109.205 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.3 m -131.72 110.53 10.95 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.542 -1.281 . . . . 74.209999999999994 107.542 176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 pt -134.24 164.97 32.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 CA-C-N 115.292 -0.867 . . . . 63.350000000000001 109.922 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.0 t -87.31 140.69 29.28 Favored 'General case' 0 N--CA 1.407 -2.625 0 N-CA-C 107.097 -1.446 . . . . 72.530000000000001 107.097 174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -73.15 136.33 44.78 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.981 -1.118 . . . . 64.540000000000006 107.981 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.54 126.35 27.23 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.169 0.509 . . . . 72.219999999999999 110.861 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.35 -18.08 55.92 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 111.044 -0.822 . . . . 72.530000000000001 111.044 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -111.96 -176.82 3.02 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-O 121.173 0.511 . . . . 53.299999999999997 109.769 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -115.07 -23.2 9.14 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 124.442 1.097 . . . . 72.319999999999993 108.69 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -80.05 156.45 27.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.869 -1.059 . . . . 73.25 112.132 -171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -99.2 140.54 33.2 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.16 -0.927 . . . . 72.329999999999998 110.605 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.01 119.92 57.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.918 -0.771 . . . . 63.340000000000003 108.918 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.6 t -86.51 139.04 31.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 106.441 -1.689 . . . . 73.140000000000001 106.441 173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.6 t30 67.1 68.63 0.4 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.073 0.94 . . . . 74.0 109.146 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -122.77 162.81 21.36 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.648 -1.16 . . . . 53.310000000000002 109.581 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -75.4 130.83 78.9 Favored Pre-proline 0 C--N 1.314 -0.97 0 O-C-N 123.592 0.557 . . . . 72.099999999999994 110.161 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 50.5 Cg_exo -55.49 -17.24 16.18 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 123.836 3.024 . . . . 74.209999999999994 113.351 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 65.8 t -59.73 -43.03 90.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 109.891 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.58 -29.88 69.35 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 116.112 -0.495 . . . . 74.430000000000007 111.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.18 -52.64 57.95 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.943 -0.571 . . . . 72.209999999999994 109.541 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -68.02 -34.11 75.87 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 111.735 0.272 . . . . 74.030000000000001 111.735 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -69.61 -24.06 63.61 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.688 0.756 . . . . 70.439999999999998 109.196 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.423 ' HB3' HE21 ' A' ' 133' ' ' GLN . . . -104.45 16.47 26.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.965 -1.016 . . . . 71.030000000000001 110.833 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.5 m80 64.05 28.33 14.27 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.35 1.06 . . . . 71.420000000000002 113.344 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 131' ' ' ALA . 39.8 mt-30 -99.73 23.11 10.04 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 105.796 -1.928 . . . . 70.049999999999997 105.796 174.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.31 -27.84 25.21 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 127.08 2.152 . . . . 62.310000000000002 114.658 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -56.49 -36.9 69.67 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.218 0.451 . . . . 75.140000000000001 112.218 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -67.76 -33.09 74.16 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.721 0.772 . . . . 72.430000000000007 109.664 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.1 t -72.01 -40.55 67.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.387 -0.824 . . . . 63.119999999999997 108.831 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.85 -44.22 98.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.086 -0.709 . . . . 73.329999999999998 109.086 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -57.87 -47.13 83.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.65 -0.705 . . . . 72.150000000000006 110.495 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -65.82 -34.29 77.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.726 -0.67 . . . . 73.030000000000001 109.787 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -66.57 -46.29 76.5 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.474 -0.784 . . . . 73.140000000000001 109.61 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.78 -48.19 82.67 Favored 'General case' 0 C--O 1.214 -0.79 0 CA-C-N 115.292 -0.867 . . . . 72.329999999999998 110.483 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.12 -29.8 71.08 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.286 0.366 . . . . 43.109999999999999 111.59 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.23 -34.07 70.45 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.286 -0.416 . . . . 65.209999999999994 110.925 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.9 -58.75 1.93 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 113.938 1.088 . . . . 72.409999999999997 113.938 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--N 1.314 -0.941 0 CA-C-O 119.072 -0.49 . . . . 65.049999999999997 110.743 -174.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 C--O 1.238 0.464 0 N-CA-C 110.22 -0.289 . . . . 74.319999999999993 110.22 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.32 -9.09 7.25 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.488 2.125 . . . . 51.549999999999997 112.16 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.45 -114.09 3.64 Favored Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 111.163 -0.775 . . . . 44.439999999999998 111.163 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -68.73 142.65 54.92 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-O 120.949 0.404 . . . . 71.150000000000006 111.15 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.0 149.45 11.69 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.6 -0.889 . . . . 62.340000000000003 108.6 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.86 -171.94 0.87 Allowed 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 122.23 1.953 . . . . 71.209999999999994 111.337 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.71 130.23 2.18 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 119.784 -1.198 . . . . 71.129999999999995 111.93 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m -75.31 119.45 19.44 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.992 -1.484 . . . . 74.209999999999994 106.992 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -81.23 174.26 11.71 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.859 0.361 . . . . 60.219999999999999 111.162 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.3 mt -88.14 154.23 20.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.985 -0.552 . . . . 74.319999999999993 110.791 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.13 104.61 10.61 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.026 0.441 . . . . 71.299999999999997 110.351 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -87.11 95.03 9.81 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.539 0.685 . . . . 73.519999999999996 111.817 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.0 m -111.72 82.87 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 122.395 1.093 . . . . 71.239999999999995 110.061 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.47 61.61 1.22 Allowed Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 114.894 -1.048 . . . . 75.430000000000007 111.21 -175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 2.4 p -73.78 125.1 27.37 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-O 121.197 0.522 . . . . 74.239999999999995 111.528 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.9 121.4 68.09 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 107.24 -1.393 . . . . 72.140000000000001 107.24 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.31 150.23 81.36 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 122.501 2.134 . . . . 73.420000000000002 110.885 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.03 132.83 35.12 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.366 -0.605 . . . . 72.140000000000001 109.366 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.4 -120.93 4.62 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 115.998 -0.546 . . . . 61.299999999999997 112.847 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -119.91 142.2 48.92 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.8 0.333 . . . . 73.230000000000004 110.495 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -69.92 137.65 51.75 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.991 -0.549 . . . . 74.430000000000007 111.305 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.608 HG11 ' HA ' ' A' ' 100' ' ' ARG . 21.8 t -115.45 -13.69 11.1 Favored 'Isoleucine or valine' 0 C--O 1.248 0.978 0 CA-C-O 122.195 0.997 . . . . 61.229999999999997 109.866 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -78.36 175.97 9.77 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.804 -1.184 . . . . 64.040000000000006 107.804 172.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 12.4 t70 -86.01 129.52 53.81 Favored Pre-proline 0 C--N 1.288 -2.079 0 C-N-CA 117.309 -1.756 . . . . 63.509999999999998 106.355 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -50.64 -21.19 7.51 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.215 2.61 . . . . 73.530000000000001 113.972 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -79.34 -21.19 46.17 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.032 0.382 . . . . 72.310000000000002 112.032 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.422 ' HG3' ' HB3' ' A' ' 24' ' ' ASP . 38.9 mt-10 -66.1 153.61 91.6 Favored Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 122.244 -0.285 . . . . 74.540000000000006 110.799 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.52 113.67 1.33 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.353 2.702 . . . . 61.020000000000003 113.666 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.7 p -126.4 -179.97 5.01 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 115.504 -0.771 . . . . 25.210000000000001 110.236 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' CE2' HD22 ' A' ' 38' ' ' LEU . 40.8 m-85 -130.33 161.03 32.2 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 106.648 -1.612 . . . . 70.049999999999997 106.648 170.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.7 m-20 -133.01 162.88 30.51 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 103.662 -2.718 . . . . 65.340000000000003 103.662 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -43.28 -56.04 7.23 Favored Pre-proline 0 N--CA 1.483 1.205 0 N-CA-C 114.501 1.297 . . . . 71.219999999999999 114.501 -175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.67 -36.54 51.93 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 121.381 1.387 . . . . 64.319999999999993 111.857 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 1.4 tpt180 -70.54 -34.4 72.21 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.053 -0.521 . . . . 71.400000000000006 110.951 -176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 31' ' ' ASP . 60.7 t -69.24 -41.75 81.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 N-CA-C 108.867 -0.79 . . . . 62.450000000000003 108.867 177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.31 83.19 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.661 -1.154 . . . . 70.409999999999997 109.385 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -64.09 -46.35 84.65 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.315 -0.857 . . . . 72.319999999999993 110.627 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 30' ' ' TYR . 29.3 tp -65.33 -47.26 77.14 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.425 -0.807 . . . . 65.409999999999997 111.268 -175.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 41' ' ' VAL . 96.6 mt -81.56 -17.46 48.3 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.965 -0.561 . . . . 72.239999999999995 111.688 -177.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.16 29.47 60.39 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.873 -0.891 . . . . 62.119999999999997 110.873 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 39' ' ' LEU . 32.7 m -121.68 164.14 26.65 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.541 -0.54 . . . . 70.120000000000005 109.541 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.27 165.47 27.72 Favored 'Trans proline' 0 C--O 1.264 1.821 0 C-N-CA 121.512 1.475 . . . . 75.409999999999997 110.875 172.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.49 -32.51 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.259 0.624 . . . . 73.230000000000004 110.408 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.8 t -57.06 -43.68 82.29 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 115.965 -0.561 . . . . 42.200000000000003 110.823 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 29.7 mtpp -69.49 -32.47 71.36 Favored 'General case' 0 C--O 1.21 -0.989 0 C-N-CA 120.041 -0.664 . . . . 72.099999999999994 111.039 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.0 t -61.41 -42.05 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.31 -0.626 . . . . 75.340000000000003 109.31 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -62.63 -37.23 85.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.696 . . . . 54.229999999999997 109.787 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -66.7 -35.93 81.29 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 116.074 -0.512 . . . . 33.109999999999999 111.64 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.6 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.4 mm100 -58.42 -46.25 86.86 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 108.086 -1.079 . . . . 75.530000000000001 108.086 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 15' ' ' SER . 4.4 mm? -62.67 -38.92 92.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.135 -1.393 . . . . 64.530000000000001 110.979 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' A' ' 15' ' ' SER . 97.9 mtt180 -71.05 -22.0 62.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.129 0.572 . . . . 72.549999999999997 112.289 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -85.11 -13.42 50.3 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.418 -0.513 . . . . 75.120000000000005 109.708 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 67.94 26.32 73.99 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.781 -1.328 . . . . 52.32 109.781 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -98.38 -9.13 25.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.551 0.691 . . . . 75.420000000000002 109.244 -173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.1 tp -158.21 152.55 24.4 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.932 -1.877 . . . . 53.149999999999999 105.932 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.27 158.03 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 120.213 -0.595 . . . . 72.400000000000006 109.49 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.0 162.04 29.59 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 122.71 0.404 . . . . 52.329999999999998 110.008 -176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 99' ' ' MET . 13.4 m -132.63 167.53 26.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 124.121 0.968 . . . . 74.200000000000003 109.141 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 75.4 mtm180 -109.9 139.27 45.18 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.683 -0.488 . . . . 74.420000000000002 109.683 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' NE ' HG11 ' A' ' 65' ' ' VAL . 36.7 ptt180 -128.41 120.05 26.17 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.509 -1.293 . . . . 71.349999999999994 107.509 173.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.1 16.9 8.66 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.864 0.866 . . . . 60.229999999999997 111.877 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.26 -7.31 54.2 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.991 -0.55 . . . . 52.219999999999999 112.55 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -95.61 151.83 20.13 Favored Glycine 0 CA--C 1.493 -1.31 0 N-CA-C 111.624 -0.591 . . . . 74.140000000000001 111.624 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.2 t -96.46 120.91 46.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 108.357 -0.979 . . . . 73.219999999999999 108.357 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.446 HG11 ' NE ' ' A' ' 60' ' ' ARG . 15.3 m -134.45 160.45 41.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.255 -0.884 . . . . 64.299999999999997 111.452 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.33 128.87 23.99 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 106.935 -1.505 . . . . 74.319999999999993 106.935 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.21 133.99 56.38 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.03 1.82 . . . . 62.240000000000002 111.622 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 68' ' ' GLN . 5.8 tt0 -63.05 -25.27 68.3 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 121.709 0.766 . . . . 45.439999999999998 111.312 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.31 -5.29 5.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.836 -1.075 . . . . 75.5 112.076 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.63 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.6 m-85 -87.7 -3.85 58.94 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 121.7 0.762 . . . . 71.109999999999999 110.211 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -120.16 148.54 43.51 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.395 -0.821 . . . . 75.200000000000003 109.179 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.4 p -83.64 174.98 10.06 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.884 -0.598 . . . . 74.140000000000001 109.602 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -67.66 -17.94 64.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.674 0.75 . . . . 70.040000000000006 109.171 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -79.52 -7.11 58.25 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.267 -0.879 . . . . 54.100000000000001 110.597 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.52 27.54 59.09 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.085 -0.578 . . . . 73.129999999999995 111.697 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -123.03 166.03 15.79 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.384 -0.599 . . . . 72.420000000000002 109.384 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.0 t -75.92 142.16 14.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.156 -1.053 . . . . 73.030000000000001 108.156 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 25.8 t -62.62 130.79 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 N-CA-C 107.914 -1.143 . . . . 75.430000000000007 107.914 176.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -65.29 -24.5 67.31 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.066 1.135 . . . . 75.120000000000005 114.066 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.6 p -92.84 -2.05 56.23 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.206 0.526 . . . . 72.310000000000002 111.967 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.63 HD11 ' CD2' ' A' ' 70' ' ' PHE . 7.8 tt -65.42 -50.37 58.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 CA-C-N 115.786 -0.643 . . . . 73.150000000000006 112.115 -177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.78 -29.52 86.17 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 121.34 1.36 . . . . 53.299999999999997 111.358 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.89 -44.33 94.77 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.954 -0.567 . . . . 63.030000000000001 111.946 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.01 -40.03 87.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.445 -0.576 . . . . 73.120000000000005 109.445 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.6 -37.9 89.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.933 -0.576 . . . . 70.340000000000003 110.527 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.8 m -67.39 -43.34 81.59 Favored 'General case' 0 C--O 1.254 1.336 0 CA-C-N 115.844 -0.616 . . . . 72.049999999999997 111.831 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -42.0 84.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 120.903 -0.319 . . . . 73.120000000000005 110.663 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.414 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.4 mm? -66.7 -34.57 78.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 112.167 0.432 . . . . 65.510000000000005 112.167 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -59.67 -35.15 73.86 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.021 -0.733 . . . . 72.329999999999998 109.021 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -66.04 -31.34 72.16 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.293 0.568 . . . . 74.230000000000004 110.371 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -9.26 75.91 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.623 -0.717 . . . . 74.25 112.34 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.17 35.24 34.72 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 121.296 -0.478 . . . . 72.340000000000003 112.401 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -97.16 132.8 42.57 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.928 0.394 . . . . 73.409999999999997 110.983 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -83.35 171.54 13.41 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.507 -0.77 . . . . 71.420000000000002 109.629 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 99' ' ' MET . 9.1 p-10 -53.95 -40.99 67.29 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.687 1.595 . . . . 71.129999999999995 112.107 -176.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -61.86 -41.25 97.61 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 123.238 0.615 . . . . 74.200000000000003 110.365 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 6.7 mm-40 -66.38 -36.5 83.01 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.152 -0.476 . . . . 72.109999999999999 109.897 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.7 mm -62.07 -47.77 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.842 -0.799 . . . . 71.150000000000006 108.842 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 23.9 mmt -69.15 -23.61 63.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.832 -1.077 . . . . 75.400000000000006 110.412 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.608 ' HA ' HG11 ' A' ' 22' ' ' VAL . 80.4 ttt180 -58.9 -63.43 1.3 Allowed 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.618 -0.719 . . . . 52.340000000000003 110.773 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.504 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.5 p-90 -69.65 -35.34 75.1 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 113.069 0.766 . . . . 63.43 113.069 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 126' ' ' VAL . 11.2 mt -57.77 -41.39 81.93 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.889 1.07 . . . . 52.539999999999999 113.889 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 96.8 m-85 -97.45 -6.04 34.75 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 113.311 0.856 . . . . 75.310000000000002 113.311 -174.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.8 m -87.29 121.24 71.41 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.208 0.317 . . . . 74.209999999999994 110.219 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.462 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 33.8 Cg_exo -63.99 128.91 23.0 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.737 1.625 . . . . 54.450000000000003 108.931 174.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 26.3 t70 -105.45 120.45 49.44 Favored Pre-proline 0 C--N 1.298 -1.636 0 C-N-CA 120.209 -0.596 . . . . 74.140000000000001 110.735 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.8 -22.72 74.6 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 123.332 2.688 . . . . 70.299999999999997 113.445 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.4 m -97.65 2.9 50.32 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.17 0.509 . . . . 72.129999999999995 110.109 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HG ' HG12 ' A' ' 111' ' ' ILE . 48.4 tp -109.77 128.69 55.46 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.109 -0.7 . . . . 72.0 109.109 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.487 HG22 ' HB1' ' A' ' 119' ' ' ALA . 30.9 m -130.61 113.17 13.87 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.188 -1.041 . . . . 72.25 108.188 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.4 HG12 ' HG ' ' A' ' 109' ' ' LEU . 36.9 mm -119.47 148.78 22.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.993 -0.549 . . . . 72.140000000000001 110.75 -172.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 19.1 p -89.79 132.62 35.14 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.106 -1.072 . . . . 62.399999999999999 108.106 177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -82.41 152.06 26.34 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.528 -0.469 . . . . 74.019999999999996 109.785 -174.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.14 115.45 4.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.327 -0.397 . . . . 64.140000000000001 110.204 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.53 19.7 47.74 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 111.441 -0.663 . . . . 51.219999999999999 111.441 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.9 m -143.1 131.71 22.47 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 109.368 -0.605 . . . . 71.040000000000006 109.368 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -84.01 -22.23 31.4 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 120.873 0.368 . . . . 71.510000000000005 110.636 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -75.62 148.81 38.48 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 115.575 -0.739 . . . . 71.329999999999998 110.229 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.487 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -107.48 141.72 38.47 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.881 -0.6 . . . . 45.020000000000003 111.017 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 50.0 t -107.19 126.59 63.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.418 -0.956 . . . . 74.310000000000002 108.418 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -82.27 154.82 25.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.755 -1.572 . . . . 72.450000000000003 106.755 176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 16.2 m120 69.26 36.02 2.47 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.434 0.694 . . . . 52.520000000000003 110.354 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.11 152.12 29.45 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.211 -1.033 . . . . 74.129999999999995 108.211 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -87.71 142.14 32.41 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 105.34 -2.096 . . . . 73.230000000000004 105.34 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.503 ' HB2' HD23 ' A' ' 102' ' ' LEU . 92.8 Cg_exo -51.72 -27.35 26.21 Favored 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 122.273 1.982 . . . . 64.409999999999997 111.695 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.641 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 93.8 t -62.82 -43.06 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.814 -0.63 . . . . 72.239999999999995 110.73 174.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -60.04 -37.85 81.01 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.433 0.635 . . . . 64.400000000000006 109.461 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.78 82.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.285 -1.325 . . . . 62.409999999999997 112.194 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -69.23 -38.69 78.63 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.168 -0.613 . . . . 63.350000000000001 111.234 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -69.36 -23.41 63.75 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.614 0.721 . . . . 75.209999999999994 109.716 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.55 7.05 44.94 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.289 -0.869 . . . . 74.530000000000001 111.075 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.3 m80 59.51 28.81 18.29 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 122.144 0.973 . . . . 61.329999999999998 112.578 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -96.13 22.98 6.94 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.253 -1.388 . . . . 74.239999999999995 107.253 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.43 -28.81 32.04 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.738 1.615 . . . . 65.540000000000006 112.712 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -56.26 -43.14 78.43 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 109.373 -0.603 . . . . 74.239999999999995 109.373 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -73.67 -30.55 62.97 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.328 -0.851 . . . . 71.129999999999995 110.608 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 80.6 t -63.77 -45.25 97.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.838 -0.801 . . . . 75.510000000000005 108.838 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.1 t -62.99 -42.12 95.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.953 -0.567 . . . . 70.019999999999996 109.7 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.17 -45.6 83.53 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.023 -0.535 . . . . 71.140000000000001 110.025 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 144' ' ' MET . 13.2 mmt85 -68.86 -37.06 78.83 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.044 -0.525 . . . . 73.140000000000001 111.362 177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.47 -44.04 93.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.083 0.553 . . . . 73.409999999999997 109.903 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -64.7 -38.4 90.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 72.340000000000003 110.323 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.86 -17.77 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.0 -0.546 . . . . 54.100000000000001 111.664 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 94.1 mmm -87.6 -29.81 20.95 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.22 0.533 . . . . 74.400000000000006 110.253 176.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.96 -44.56 14.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 111.042 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 108.075 -1.083 . . . . 63.43 108.075 -178.745 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.7 mmm . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 107.89 -1.152 . . . . 70.030000000000001 107.89 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.79 119.93 6.88 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.691 1.594 . . . . 44.240000000000002 109.754 174.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.97 57.46 3.56 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.431 -0.414 . . . . 53.240000000000002 113.487 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -74.83 144.72 43.32 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.555 0.742 . . . . 75.140000000000001 110.169 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.87 95.19 36.72 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 107.943 -1.132 . . . . 63.409999999999997 107.943 173.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.63 107.11 0.47 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.2 2.6 . . . . 74.239999999999995 114.219 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -117.14 21.44 10.94 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 108.025 -2.03 . . . . 71.430000000000007 108.025 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -58.76 113.87 2.25 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 113.415 -1.392 . . . . 70.310000000000002 110.247 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 m -116.92 140.78 49.05 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.197 -1.779 . . . . 62.240000000000002 106.197 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.87 96.5 1.28 Allowed 'General case' 0 C--O 1.249 1.052 0 CA-C-O 121.801 0.81 . . . . 61.020000000000003 111.159 -173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.3 143.82 29.12 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.063 -1.426 . . . . 74.430000000000007 109.225 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -84.63 89.02 7.38 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 122.282 1.039 . . . . 70.530000000000001 110.176 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.8 p -144.66 25.33 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 123.218 1.485 . . . . 71.510000000000005 108.239 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.47 48.1 3.71 Favored Glycine 0 C--N 1.309 -0.967 0 CA-C-N 114.276 -1.329 . . . . 73.019999999999996 112.508 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 25.3 m -88.8 51.32 2.14 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.608 0.718 . . . . 73.129999999999995 110.753 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mm -121.6 133.81 24.37 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 106.205 -1.776 . . . . 75.209999999999994 106.205 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.33 133.95 36.99 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 120.989 1.126 . . . . 72.049999999999997 110.59 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.93 145.5 50.96 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.894 -0.594 . . . . 43.229999999999997 109.958 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.38 -128.15 5.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.41 -0.9 . . . . 71.329999999999998 112.377 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 96' ' ' THR . 29.9 t70 -109.68 146.41 34.89 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.121 -0.696 . . . . 73.310000000000002 109.121 -174.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -86.06 125.37 33.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.449 0.642 . . . . 75.109999999999999 112.259 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.3 t -97.2 -31.17 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.33 -0.395 . . . . 75.530000000000001 111.457 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.494 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -69.77 171.72 8.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.011 0.745 . . . . 74.019999999999996 113.011 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.504 ' HB3' ' HG3' ' A' ' 27' ' ' GLU . 10.0 t70 -85.32 139.81 36.33 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 116.508 -0.314 . . . . 63.32 110.495 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.9 -24.6 14.02 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.066 3.177 . . . . 75.140000000000001 115.217 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -84.84 -25.18 28.24 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.134 -0.354 . . . . 74.409999999999997 111.568 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 24' ' ' ASP . 45.9 mt-10 -62.78 132.81 94.87 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 116.523 -0.308 . . . . 64.310000000000002 110.994 -176.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 38.3 Cg_endo -63.93 141.47 77.74 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 123.175 2.583 . . . . 75.109999999999999 113.137 -175.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.6 p -136.68 173.95 11.15 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.019 -0.991 . . . . 72.200000000000003 110.697 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -124.83 159.26 31.45 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.711 -1.589 . . . . 74.140000000000001 106.711 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 6.9 p-10 -137.04 173.84 11.26 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.334 -1.728 . . . . 74.230000000000004 106.334 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -37.32 -60.95 0.77 Allowed Pre-proline 0 CA--C 1.563 1.478 0 N-CA-C 115.45 1.648 . . . . 73.019999999999996 115.45 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.82 -33.81 32.77 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 121.216 1.277 . . . . 72.319999999999993 112.888 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 9.5 tpt180 -70.25 -35.12 73.59 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.627 0.251 . . . . 65.230000000000004 110.916 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 31' ' ' ASP . 62.0 t -69.2 -41.26 81.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.959 -0.756 . . . . 54.200000000000003 108.959 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.88 88.28 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 114.905 -1.043 . . . . 63.240000000000002 109.679 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.86 -45.49 92.34 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.131 1.372 . . . . 73.340000000000003 109.742 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.75 -50.1 39.68 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.608 -0.724 . . . . 64.049999999999997 112.382 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.04 -18.89 41.64 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.308 -0.406 . . . . 75.299999999999997 111.953 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.95 27.88 57.58 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 111.099 -0.801 . . . . 73.430000000000007 111.099 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -121.41 159.7 49.08 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 108.505 -0.924 . . . . 74.129999999999995 108.505 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.77 156.01 64.41 Favored 'Trans proline' 0 C--O 1.251 1.164 0 C-N-CA 121.523 1.482 . . . . 74.409999999999997 112.819 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -58.42 -37.4 63.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.467 -0.788 . . . . 74.030000000000001 111.181 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.1 t -62.19 -35.92 80.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.13 -0.486 . . . . 71.400000000000006 110.509 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 53.7 tttp -65.75 -40.64 92.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 108.133 -1.062 . . . . 71.25 108.133 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -60.76 -41.26 87.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.404 -0.816 . . . . 75.519999999999996 110.333 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.93 -41.86 88.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.902 -0.59 . . . . 12.41 110.243 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 1.4 mp0 -68.45 -41.61 79.99 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.764 -0.653 . . . . 73.129999999999995 112.051 177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.717 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.2 mm100 -58.09 -46.06 86.12 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.848 -0.797 . . . . 74.019999999999996 108.848 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD23 ' HG ' ' A' ' 55' ' ' LEU . 76.9 mt -61.93 -44.23 97.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.99 -1.005 . . . . 54.549999999999997 111.447 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -70.95 -21.62 62.31 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 112.672 0.619 . . . . 75.239999999999995 112.672 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 52.5 mt-10 -87.64 -6.62 58.18 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 120.654 -0.418 . . . . 62.520000000000003 110.898 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.86 39.09 21.69 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 120.594 -0.812 . . . . 51.439999999999998 111.107 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -86.3 -30.0 22.62 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.862 -1.162 . . . . 74.319999999999993 107.862 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.444 ' HG ' HD23 ' A' ' 50' ' ' LEU . 1.6 pt? -160.82 167.62 26.38 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.667 -1.605 . . . . 75.209999999999994 106.667 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.42 161.46 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 118.758 0.708 . . . . 61.399999999999999 112.084 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.05 51.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.332 -0.849 . . . . 41.32 110.242 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.42 HG11 ' SD ' ' A' ' 99' ' ' MET . 18.0 m -130.79 162.55 38.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 O-C-N 123.528 0.517 . . . . 71.349999999999994 109.82 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -110.42 118.02 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.859 -0.423 . . . . 34.539999999999999 109.859 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -124.56 123.83 40.93 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.891 -0.411 . . . . 54.399999999999999 109.891 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.89 16.77 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.032 0.933 . . . . 64.030000000000001 110.656 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.43 -15.5 62.83 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.602 -0.726 . . . . 65.109999999999999 113.05 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.22 137.85 13.83 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.021 -0.831 . . . . 64.310000000000002 111.021 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.79 120.77 46.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-O 121.55 0.69 . . . . 75.239999999999995 109.169 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.06 159.32 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 115.069 -0.969 . . . . 60.439999999999998 112.172 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.3 mm -111.1 132.02 21.9 Favored Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 125.937 1.695 . . . . 74.420000000000002 106.803 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -66.69 119.31 6.33 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 121.981 1.787 . . . . 74.5 111.672 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' A' ' 28' ' ' PRO . 6.2 tt0 -62.95 -25.48 68.37 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.572 0.701 . . . . 74.329999999999998 111.556 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.0 m -70.81 -5.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.413 -0.812 . . . . 73.549999999999997 112.451 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -86.13 -4.12 59.1 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.859 0.837 . . . . 65.409999999999997 109.653 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -111.12 160.14 17.18 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.037 -0.983 . . . . 63.140000000000001 108.397 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 p -84.06 166.27 17.85 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.247 -1.019 . . . . 73.109999999999999 108.247 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -67.53 -16.55 64.26 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.935 0.874 . . . . 74.319999999999993 109.609 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.6 m -78.76 -11.38 59.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.503 -0.771 . . . . 54.219999999999999 111.063 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.47 11.05 62.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.572 -0.823 . . . . 72.430000000000007 112.536 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -104.98 147.87 27.33 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.015 -0.365 . . . . 64.450000000000003 110.015 178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.5 t -63.12 136.05 26.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.457 -0.942 . . . . 74.409999999999997 108.457 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.92 133.19 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.737 -0.468 . . . . 64.129999999999995 109.737 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -54.61 -26.29 31.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.393 1.257 . . . . 53.509999999999998 114.393 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.7 t -114.62 19.37 16.1 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.342 -0.543 . . . . 53.229999999999997 110.849 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 17.6 tp -63.95 -55.69 30.69 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 116.44 -0.346 . . . . 74.319999999999993 111.326 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.21 -28.55 87.14 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.887 1.725 . . . . 73.129999999999995 111.75 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.82 -44.81 94.19 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.889 -0.596 . . . . 71.530000000000001 112.2 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.18 -40.53 82.21 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 109.395 -0.594 . . . . 73.030000000000001 109.395 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.5 mt -61.37 -44.51 97.03 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 115.718 -0.674 . . . . 74.239999999999995 110.634 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.7 m -61.41 -37.02 81.98 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.706 1.002 . . . . 52.140000000000001 113.706 -176.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.469 HG23 HD22 ' A' ' 88' ' ' LEU 0.25 0.0 OUTLIER -68.17 -45.04 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 C-N-CA 119.567 -0.853 . . . . 75.329999999999998 110.755 179.485 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 87' ' ' ILE . 3.2 mm? -67.75 -35.56 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.008 0.433 . . . . 73.420000000000002 111.189 175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -60.4 -39.54 87.7 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.744 0.818 . . . . 74.5 109.28 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -67.65 -30.6 70.19 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.728 0.775 . . . . 71.329999999999998 109.928 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.4 -3.05 89.9 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.065 -0.971 . . . . 54.130000000000003 112.053 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.89 22.46 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.895 -0.193 . . . . 54.450000000000003 113.155 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 93.7 m-85 -87.16 136.57 32.88 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 122.37 -0.488 . . . . 72.409999999999997 111.07 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 37.4 ptt180 -78.06 170.57 16.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.791 -0.641 . . . . 72.310000000000002 110.655 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -54.27 -41.01 68.36 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.946 1.298 . . . . 61.140000000000001 111.822 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' ASP . 23.4 m -61.74 -42.57 99.14 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.282 -0.872 . . . . 62.409999999999997 111.02 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.577 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 9.1 mm-40 -67.05 -33.49 75.63 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 116.141 -0.481 . . . . 74.239999999999995 110.965 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.2 mm -61.65 -49.05 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 108.211 -1.033 . . . . 70.329999999999998 108.211 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.592 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 10.9 ptp -74.84 -14.14 60.64 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.387 -0.824 . . . . 62.43 112.935 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 71.7 ttt180 -58.83 -65.62 0.63 Allowed 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.616 0.572 . . . . 72.209999999999994 109.944 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.535 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 46.0 p-90 -69.12 -32.92 72.65 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.236 0.458 . . . . 73.420000000000002 112.236 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 11.0 mt -58.93 -40.48 84.73 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.517 0.932 . . . . 75.019999999999996 113.517 -178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 73.0 m-85 -93.22 -2.5 55.09 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.406 0.521 . . . . 73.209999999999994 112.406 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.4 m -88.51 117.51 68.43 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 109.07 -0.715 . . . . 54.130000000000003 109.07 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.33 139.96 51.47 Favored 'Trans proline' 0 C--O 1.249 1.065 0 C-N-CA 122.305 2.003 . . . . 75.409999999999997 113.208 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 17.5 t70 -98.26 119.9 60.79 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 108.645 -0.872 . . . . 61.140000000000001 108.645 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.08 -22.91 71.57 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 123.149 2.566 . . . . 73.200000000000003 114.016 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 p -104.0 5.63 35.57 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 112.036 0.384 . . . . 50.509999999999998 112.036 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.3 tp -105.12 135.28 46.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.053 -0.351 . . . . 61.0 110.053 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.6 m -118.53 116.9 27.62 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.286 -1.005 . . . . 74.040000000000006 108.286 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 58.5 mt -125.37 150.12 30.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.128 -0.693 . . . . 71.340000000000003 109.128 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.8 p -105.84 126.29 51.99 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.576 -1.639 . . . . 34.509999999999998 106.576 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -80.72 123.61 28.34 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.63 -1.228 . . . . 73.209999999999994 109.371 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 25.3 t70 -57.71 124.76 20.24 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.212 -0.904 . . . . 75.019999999999996 112.355 -172.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 117.29 -25.97 8.44 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 108.546 -1.822 . . . . 54.43 108.546 -174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.1 t -120.17 140.75 50.65 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 107.49 -1.3 . . . . 44.439999999999998 107.49 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -91.61 -4.88 54.79 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.648 -0.821 . . . . 73.329999999999998 109.667 176.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -74.04 134.79 43.03 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.039 -0.982 . . . . 75.040000000000006 109.955 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.53 144.13 25.84 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.125 -0.943 . . . . 62.450000000000003 111.773 -173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.7 t -116.53 118.56 59.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.937 -1.135 . . . . 72.439999999999998 107.937 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.3 m -89.85 131.34 35.83 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.357 -1.72 . . . . 53.210000000000001 106.357 174.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.0 t30 75.46 69.06 0.08 Allowed 'General case' 0 C--N 1.321 -0.672 0 O-C-N 124.564 1.165 . . . . 73.409999999999997 108.235 -172.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.49 163.72 15.98 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 114.696 -1.138 . . . . 65.230000000000004 109.539 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 39.5 ptt180 -88.08 141.1 30.97 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 115.568 -0.742 . . . . 74.099999999999994 109.672 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB2' HD23 ' A' ' 102' ' ' LEU . 50.7 Cg_exo -55.17 -18.11 16.97 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 123.083 2.522 . . . . 75.219999999999999 114.228 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.609 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -61.03 -42.85 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 CA-C-O 121.444 0.64 . . . . 64.329999999999998 109.493 173.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.61 -30.75 71.77 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.276 -0.874 . . . . 71.400000000000006 109.619 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.72 -50.34 65.18 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.734 -0.667 . . . . 73.120000000000005 110.556 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -63.99 -36.76 85.05 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 121.017 0.437 . . . . 60.240000000000002 110.871 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -68.68 -24.7 64.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.38 -0.827 . . . . 63.409999999999997 109.54 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -102.53 12.78 35.96 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.406 -0.816 . . . . 75.349999999999994 112.85 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 70.02 27.87 4.26 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 122.638 1.209 . . . . 73.5 110.866 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -105.56 23.96 12.98 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.967 0.907 . . . . 63.43 109.028 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.12 -29.06 28.77 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.479 1.511 . . . . 63.299999999999997 113.817 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -56.7 -40.14 75.09 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 120.806 0.336 . . . . 71.450000000000003 110.752 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -73.12 -24.82 60.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.981 0.419 . . . . 74.319999999999993 110.967 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 129' ' ' LEU . 57.7 t -70.84 -42.0 77.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.478 -0.934 . . . . 62.520000000000003 108.478 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.7 t -63.27 -42.23 95.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.44 -0.578 . . . . 70.310000000000002 109.44 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -59.5 -47.09 86.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.619 -0.719 . . . . 74.319999999999993 109.697 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.559 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.4 tpp180 -64.6 -39.65 94.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.371 -0.831 . . . . 73.019999999999996 110.005 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.62 87.36 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.564 0.746 . . . . 72.140000000000001 110.832 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.98 -39.02 93.19 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.238 -0.437 . . . . 74.120000000000005 110.281 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -21.25 66.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.18 -0.464 . . . . 70.540000000000006 111.333 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 85.4 mmm -92.71 -22.49 19.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.022 0.439 . . . . 53.200000000000003 110.986 177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.83 -27.68 19.79 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.976 0.417 . . . . 64.200000000000003 111.062 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 . . . . . 0 C--O 1.255 1.36 0 N-CA-C 108.022 -1.103 . . . . 73.109999999999999 108.022 178.024 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 ttm . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 109.296 -0.631 . . . . 73.540000000000006 109.296 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -82.17 130.17 6.29 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.469 1.446 . . . . 52.240000000000002 111.269 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.95 98.56 0.98 Allowed Glycine 0 CA--C 1.504 -0.607 0 N-CA-C 109.339 -1.504 . . . . 74.099999999999994 109.339 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -73.5 143.77 46.44 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 113.349 0.87 . . . . 75.150000000000006 113.349 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.57 89.31 3.84 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 106.559 -1.645 . . . . 73.400000000000006 106.559 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.42 97.81 0.32 Allowed 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 122.707 2.271 . . . . 71.209999999999994 112.071 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.8 113.16 2.57 Favored Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 115.202 -0.908 . . . . 63.439999999999998 111.73 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 t -76.32 97.51 4.24 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.391 -1.337 . . . . 61.299999999999997 107.391 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -74.82 148.28 40.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.478 -0.783 . . . . 72.019999999999996 111.845 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 79.8 mt -111.97 177.87 4.5 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.181 -1.044 . . . . 74.120000000000005 108.181 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.39 109.41 19.53 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.171 0.51 . . . . 61.509999999999998 109.762 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.79 97.66 10.57 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.493 0.663 . . . . 75.409999999999997 110.543 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.46 146.9 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 107.671 -1.233 . . . . 63.240000000000002 107.671 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.05 -64.79 1.45 Allowed Glycine 0 C--N 1.286 -2.223 0 N-CA-C 110.015 -1.234 . . . . 53.539999999999999 110.015 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.7 t 178.33 159.31 0.52 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 104.721 -2.326 . . . . 52.43 104.721 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.405 HG21 HG12 ' A' ' 56' ' ' VAL . 1.9 mp -88.31 121.05 70.59 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 106.678 -1.601 . . . . 72.239999999999995 106.678 173.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.21 165.54 29.33 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.858 2.372 . . . . 71.310000000000002 112.875 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.24 124.24 47.48 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.052 -1.092 . . . . 64.319999999999993 108.052 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.15 -110.27 3.45 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.684 -0.769 . . . . 70.129999999999995 113.411 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -110.76 133.56 53.24 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 112.043 0.386 . . . . 72.010000000000005 112.043 -173.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.1 114.97 13.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.313 -0.995 . . . . 64.140000000000001 108.313 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.64 -8.61 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 N-CA-C 112.409 0.522 . . . . 73.200000000000003 112.409 -174.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 -173.11 2.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.772 -1.205 . . . . 74.310000000000002 113.936 -175.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -96.5 132.47 26.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 107.843 -1.169 . . . . 73.310000000000002 107.843 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.16 -20.73 32.34 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.452 2.768 . . . . 64.150000000000006 111.8 175.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.334 -0.848 . . . . 61.109999999999999 109.823 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -68.0 134.09 91.85 Favored Pre-proline 0 C--O 1.244 0.796 0 N-CA-C 109.365 -0.605 . . . . 65.0 109.365 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.22 128.1 27.35 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.57 2.18 . . . . 74.129999999999995 111.257 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.3 m -130.16 158.52 39.46 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.47 -0.567 . . . . 61.520000000000003 109.47 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -116.48 162.4 17.63 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.521 1.129 . . . . 72.0 109.965 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -134.06 167.25 20.97 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.381 -2.451 . . . . 62.329999999999998 104.381 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -48.45 -55.03 21.01 Favored Pre-proline 0 N--CA 1.475 0.782 0 N-CA-C 114.712 1.375 . . . . 72.329999999999998 114.712 -172.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.44 -46.39 33.79 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.118 1.879 . . . . 73.530000000000001 112.11 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 28.0 tpt180 -65.29 -39.04 92.04 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 112.485 0.55 . . . . 71.129999999999995 112.485 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.41 HG21 HD12 ' A' ' 66' ' ' ILE . 77.7 t -69.12 -40.53 80.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 120.164 -0.614 . . . . 72.439999999999998 110.239 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.03 -39.52 92.6 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.206 -0.906 . . . . 70.530000000000001 108.978 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.59 -44.95 85.06 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.494 -1.23 . . . . 74.140000000000001 111.105 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 95.6 mt -62.25 -47.45 84.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.482 0.658 . . . . 70.430000000000007 111.572 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.439 ' HB2' HG22 ' A' ' 41' ' ' VAL . 88.2 mt -82.77 -18.44 40.64 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.744 -0.662 . . . . 61.310000000000002 111.972 -175.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.84 27.36 60.78 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 110.592 -1.003 . . . . 74.519999999999996 110.592 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 39' ' ' LEU . 25.5 m -118.31 159.38 43.7 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 108.564 -0.902 . . . . 74.299999999999997 108.564 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.78 161.75 38.74 Favored 'Trans proline' 0 C--O 1.262 1.719 0 C-N-CA 121.149 1.232 . . . . 60.25 110.744 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.7 -33.85 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 115.88 -0.6 . . . . 72.109999999999999 109.92 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.6 m -57.66 -41.27 81.14 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 115.093 -0.958 . . . . 74.230000000000004 111.73 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 26.5 mtpp -69.77 -32.59 71.17 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 120.27 -0.572 . . . . 70.120000000000005 110.929 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.49 ' HA ' HE21 ' A' ' 49' ' ' GLN . 61.0 t -62.27 -42.27 94.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.165 -0.68 . . . . 72.040000000000006 109.165 174.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.96 83.58 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.83 -0.623 . . . . 60.25 110.311 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -66.36 -37.32 85.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.24 -0.437 . . . . 55.219999999999999 110.67 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.49 HE21 ' HA ' ' A' ' 46' ' ' VAL . 46.2 mt-30 -63.19 -46.4 87.25 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 109.938 -0.393 . . . . 73.150000000000006 109.938 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 93.8 mt -61.67 -38.43 87.72 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.54 -1.209 . . . . 54.0 110.03 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -61.63 -44.41 97.04 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.164 0.986 . . . . 55.039999999999999 112.507 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -92.59 -11.8 33.38 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.419 -0.512 . . . . 70.120000000000005 112.364 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.92 35.53 18.41 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.34 -0.933 . . . . 44.329999999999998 111.049 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -92.5 -18.55 23.03 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.154 -1.054 . . . . 75.310000000000002 108.154 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.0 tp -159.88 152.45 21.19 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 105.751 -1.944 . . . . 72.129999999999995 105.751 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.405 HG12 HG21 ' A' ' 16' ' ' ILE . 35.5 m -129.86 161.67 39.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.568 -0.53 . . . . 74.209999999999994 109.568 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.22 161.66 35.58 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.119 -0.697 . . . . 74.450000000000003 109.119 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.55 166.16 30.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 109.397 -0.594 . . . . 75.109999999999999 109.397 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 45.0 ttt180 -121.49 130.48 53.58 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 120.383 -0.527 . . . . 70.129999999999995 110.068 -175.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -125.56 117.31 23.31 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.602 -0.888 . . . . 63.219999999999999 108.602 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 20.47 8.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.597 0.759 . . . . 63.219999999999999 112.748 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.73 -17.14 30.64 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 121.068 -0.587 . . . . 74.239999999999995 112.976 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.34 140.75 15.22 Favored Glycine 0 CA--C 1.488 -1.61 0 C-N-CA 121.23 -0.51 . . . . 51.140000000000001 111.829 -177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -97.24 120.91 47.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 108.254 -1.017 . . . . 74.540000000000006 108.254 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.3 154.6 40.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 CA-C-N 115.826 -0.624 . . . . 63.109999999999999 110.916 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.41 HD12 HG21 ' A' ' 35' ' ' VAL . 64.3 mt -126.28 114.43 23.59 Favored Pre-proline 0 C--N 1.301 -1.519 0 N-CA-C 107.872 -1.158 . . . . 73.219999999999999 107.872 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.41 133.56 58.81 Favored 'Trans proline' 0 N--CA 1.479 0.664 0 C-N-CA 123.323 2.682 . . . . 75.239999999999995 113.102 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -57.12 -25.53 58.98 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 112.948 0.722 . . . . 72.540000000000006 112.948 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 21.9 m -60.28 -15.34 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 N-CA-C 113.361 0.875 . . . . 72.099999999999994 113.361 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' CD2' HD11 ' A' ' 81' ' ' LEU . 13.9 m-85 -82.28 -6.15 59.04 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.519 0.676 . . . . 75.299999999999997 111.001 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -121.06 162.36 20.13 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.553 -0.748 . . . . 61.43 109.126 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.0 p -88.14 175.53 7.67 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.713 -0.476 . . . . 72.010000000000005 109.713 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -61.25 -16.98 50.99 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.239 0.616 . . . . 72.310000000000002 111.176 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -97.21 3.43 51.46 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.312 0.486 . . . . 73.030000000000001 112.312 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.8 31.76 57.87 Favored Glycine 0 C--O 1.235 0.166 0 C-N-CA 120.465 -0.874 . . . . 23.420000000000002 111.94 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -112.55 146.23 38.9 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.634 -0.876 . . . . 75.540000000000006 108.634 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.3 t -66.9 130.39 32.24 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.546 -0.538 . . . . 40.32 109.546 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 80' ' ' SER . 60.5 t -56.14 130.55 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.798 -0.637 . . . . 73.25 109.459 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -57.32 -23.8 50.98 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.64 1.348 . . . . 62.329999999999998 114.64 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.401 ' H ' HG12 ' A' ' 78' ' ' VAL . 23.2 t -105.31 10.63 33.48 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.987 -0.446 . . . . 73.030000000000001 110.91 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 36.2 tp -66.02 -57.68 12.84 Favored Pre-proline 0 CA--C 1.558 1.262 0 N-CA-C 113.39 0.885 . . . . 74.329999999999998 113.39 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.63 -33.86 97.26 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 121.864 1.709 . . . . 73.519999999999996 112.944 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -61.94 -44.98 97.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.406 -0.426 . . . . 72.129999999999995 112.65 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.57 -40.32 80.64 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-O 121.289 0.566 . . . . 71.299999999999997 109.987 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.77 -42.25 95.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.51 -0.768 . . . . 74.530000000000001 111.144 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 64.1 m -64.41 -45.15 88.82 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.04 -0.527 . . . . 72.109999999999999 111.906 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -66.06 -43.85 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.973 0.416 . . . . 61.509999999999998 111.017 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.675 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 38.1 mt -66.61 -38.33 86.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.286 -0.416 . . . . 74.510000000000005 111.77 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -63.27 -42.57 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.842 -0.429 . . . . 71.140000000000001 109.842 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.94 -28.63 65.73 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.12 -0.491 . . . . 74.25 110.737 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.89 -1.56 84.78 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.59 -0.732 . . . . 63.329999999999998 112.77 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.88 23.26 30.79 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.867 -0.682 . . . . 73.010000000000005 113.087 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -102.84 144.53 31.05 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 122.485 -0.42 . . . . 63.229999999999997 110.784 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.532 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 31.2 ptt180 -97.01 172.3 7.94 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.232 -0.894 . . . . 71.010000000000005 109.156 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -53.55 -43.18 68.22 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.791 1.636 . . . . 51.0 111.593 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.4 m -62.5 -41.04 98.55 Favored 'General case' 0 N--CA 1.415 -2.194 0 C-N-CA 123.854 0.862 . . . . 73.319999999999993 110.164 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.532 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 28.9 mm-40 -67.04 -33.36 75.36 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.43 -0.35 . . . . 73.400000000000006 110.649 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.483 HD12 HD13 ' A' ' 88' ' ' LEU . 18.7 mm -61.3 -49.62 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 107.993 -1.114 . . . . 61.109999999999999 107.993 -176.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 17.2 ptp -76.08 -17.89 59.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.289 -0.869 . . . . 60.329999999999998 112.8 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -56.47 -67.53 0.29 Allowed 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 122.998 0.519 . . . . 72.109999999999999 110.66 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.675 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 52.5 p-90 -69.47 -32.13 70.85 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.277 0.473 . . . . 72.319999999999993 112.277 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.526 HD23 ' HB2' ' A' ' 125' ' ' PRO . 8.7 mt -60.09 -39.97 87.97 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.155 0.798 . . . . 74.109999999999999 113.155 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -85.08 -4.8 59.29 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 112.178 0.436 . . . . 63.340000000000003 112.178 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 74.6 m -87.17 120.2 71.28 Favored Pre-proline 0 N--CA 1.435 -1.189 0 N-CA-C 109.193 -0.669 . . . . 62.409999999999997 109.193 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.83 129.62 31.39 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 122.251 1.968 . . . . 74.450000000000003 110.788 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 35.4 t70 -96.33 124.25 51.94 Favored Pre-proline 0 C--N 1.307 -1.243 0 CA-C-N 116.182 -0.463 . . . . 53.549999999999997 110.807 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.38 -35.43 96.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.324 2.683 . . . . 73.219999999999999 113.057 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 p -90.04 2.98 54.59 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.802 0.667 . . . . 72.109999999999999 112.802 -176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.9 tp -102.69 129.51 49.33 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-O 121.291 0.567 . . . . 65.209999999999994 110.21 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.4 m -131.35 115.34 16.13 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.42 -1.696 . . . . 71.409999999999997 106.42 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.467 HG22 ' OE1' ' A' ' 133' ' ' GLN . 13.3 pt -132.45 142.61 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.238 0 N-CA-C 112.812 0.671 . . . . 64.420000000000002 112.812 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -92.65 136.51 33.17 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.883 -1.053 . . . . 73.109999999999999 109.032 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -82.51 153.09 25.75 Favored 'General case' 0 CA--C 1.48 -1.712 0 CA-C-O 121.549 0.69 . . . . 74.329999999999998 111.415 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -83.82 140.8 31.81 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.974 -1.121 . . . . 52.109999999999999 107.974 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.75 8.05 77.27 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 110.101 -1.2 . . . . 75.329999999999998 110.101 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.9 t -151.11 -173.32 4.46 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.611 -1.626 . . . . 63.219999999999999 106.611 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -133.76 -24.38 1.73 Allowed 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.547 0.573 . . . . 72.549999999999997 112.547 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.76 141.16 51.48 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.212 0.529 . . . . 75.340000000000003 111.836 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.42 128.85 41.23 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.035 -0.984 . . . . 32.420000000000002 110.248 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.1 t -93.92 118.9 40.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.991 -0.744 . . . . 71.230000000000004 108.991 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.2 m -84.67 134.8 34.35 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.58 -1.267 . . . . 74.510000000000005 107.58 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.4 t30 66.71 64.72 0.47 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.534 1.159 . . . . 74.230000000000004 108.908 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.97 163.71 15.5 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.263 -1.335 . . . . 53.420000000000002 108.887 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 39.6 ptt180 -82.39 136.18 46.27 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.545 -0.539 . . . . 71.530000000000001 109.545 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.526 ' HB2' HD23 ' A' ' 102' ' ' LEU . 31.0 Cg_exo -56.78 -17.08 21.89 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.244 2.63 . . . . 71.430000000000007 114.07 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.618 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.1 t -59.9 -40.58 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.454 0.645 . . . . 62.039999999999999 109.9 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.2 -30.29 67.35 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.19 -0.459 . . . . 64.150000000000006 111.051 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.09 -39.1 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.903 -0.59 . . . . 61.409999999999997 111.375 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.45 -33.9 75.01 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.028 -0.269 . . . . 74.239999999999995 111.401 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -75.25 -24.68 57.68 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.781 0.8 . . . . 62.229999999999997 108.907 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.81 7.29 24.41 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.774 -1.103 . . . . 72.439999999999998 111.179 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 54.6 m80 64.39 28.22 13.65 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.528 1.131 . . . . 52.240000000000002 111.512 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.467 ' OE1' HG22 ' A' ' 111' ' ' ILE . 72.7 mt-30 -111.23 23.84 13.58 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.345 -1.354 . . . . 74.140000000000001 107.345 176.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.26 -27.87 24.68 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 113.306 -1.77 . . . . 63.32 113.111 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -56.16 -36.21 68.07 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.935 0.494 . . . . 73.099999999999994 109.926 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.33 -38.58 87.98 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.405 0.621 . . . . 73.420000000000002 109.737 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.7 -46.51 74.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.078 -0.964 . . . . 70.219999999999999 109.597 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.435 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 93.0 t -61.22 -47.8 91.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.506 -0.77 . . . . 74.129999999999995 110.484 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -63.52 -37.93 89.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.123 -0.631 . . . . 64.409999999999997 110.915 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -63.71 -41.64 98.06 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.229 -0.656 . . . . 71.25 109.229 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.94 96.3 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.921 -0.581 . . . . 61.350000000000001 110.072 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -63.98 -38.66 91.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.414 -0.812 . . . . 72.299999999999997 111.411 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.91 -33.03 70.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.147 0.499 . . . . 74.409999999999997 110.441 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.1 tpt -69.71 -32.01 70.35 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.342 -0.844 . . . . 73.400000000000006 110.719 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -93.27 -58.91 2.16 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.803 0.668 . . . . 61.149999999999999 112.803 -177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.31 -1.126 0 CA-C-O 118.303 -0.856 . . . . 74.200000000000003 110.624 -175.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 CA--C 1.519 -0.225 0 N-CA-C 108.331 -0.988 . . . . 74.019999999999996 108.331 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -91.81 -178.18 1.06 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.665 2.243 . . . . 74.329999999999998 113.057 -174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.46 -143.71 14.62 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 111.353 -0.699 . . . . 45.25 111.353 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -73.75 133.81 43.37 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.716 -0.846 . . . . 64.109999999999999 108.716 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 144.2 51.84 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 110.09 -0.337 . . . . 72.340000000000003 110.09 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -85.21 -166.68 0.36 Allowed 'Trans proline' 0 C--O 1.247 0.959 0 C-N-CA 122.652 2.235 . . . . 43.130000000000003 111.94 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.1 -144.49 4.19 Favored Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 110.227 -1.149 . . . . 53.32 110.227 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -81.21 98.24 7.99 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.174 -0.676 . . . . 65.099999999999994 109.174 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.3 m -82.18 156.09 24.62 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.572 -0.899 . . . . 73.409999999999997 108.572 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.88 119.72 6.71 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 122.812 0.445 . . . . 63.350000000000001 110.408 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.75 135.22 50.91 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.961 -1.018 . . . . 61.030000000000001 110.045 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.409 ' HA ' ' HE ' ' A' ' 12' ' ' ARG . 1.9 mmp_? -106.62 77.53 1.2 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.669 0.747 . . . . 72.239999999999995 110.302 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 52' ' ' GLU . 95.3 t -90.76 -39.04 11.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 CA-C-N 114.398 -1.274 . . . . 72.129999999999995 108.61 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.94 169.26 27.21 Favored Glycine 0 N--CA 1.406 -3.306 0 CA-C-N 113.563 -1.653 . . . . 73.239999999999995 110.722 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -144.56 99.03 3.29 Favored 'General case' 0 C--N 1.27 -2.868 0 N-CA-C 106.099 -1.815 . . . . 74.319999999999993 106.099 174.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -106.04 127.8 27.64 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.718 -0.673 . . . . 64.409999999999997 109.25 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.5 165.28 30.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.334 2.023 . . . . 72.430000000000007 110.491 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.36 135.19 33.99 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.922 -0.399 . . . . 73.120000000000005 109.922 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.67 -78.79 0.62 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.559 -0.829 . . . . 75.140000000000001 113.994 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -135.73 129.97 33.44 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 122.262 -0.552 . . . . 53.340000000000003 110.631 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.568 ' OD2' ' HD2' ' A' ' 60' ' ' ARG . 13.3 t0 -69.22 139.46 54.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.165 -0.471 . . . . 65.420000000000002 111.697 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 100' ' ' ARG . 58.1 t -106.56 -18.52 7.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.661 -0.7 . . . . 43.420000000000002 110.991 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.285 1.0 OUTLIER -89.7 179.37 6.03 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.379 -1.328 . . . . 64.340000000000003 112.21 -179.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -98.03 152.21 37.93 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 109.085 -0.709 . . . . 71.519999999999996 109.085 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.89 -22.92 32.01 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.005 2.47 . . . . 65.409999999999997 113.035 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.74 -24.98 56.17 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.295 -0.253 . . . . 64.299999999999997 111.582 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 20.1 mm-40 -72.34 137.21 81.18 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 109.973 -0.38 . . . . 75.530000000000001 109.973 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 28.9 Cg_exo -63.02 136.72 58.1 Favored 'Trans proline' 0 C--O 1.256 1.408 0 C-N-CA 123.105 2.537 . . . . 53.229999999999997 112.774 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.9 p -130.6 169.81 15.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.283 0.563 . . . . 74.030000000000001 111.37 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 20.4 m-85 -130.33 160.2 34.68 Favored 'General case' 0 N--CA 1.425 -1.678 0 C-N-CA 124.808 1.243 . . . . 53.119999999999997 108.05 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.14 163.97 28.4 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 103.459 -2.793 . . . . 72.140000000000001 103.459 -178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' HB3' HG13 ' A' ' 43' ' ' VAL . 82.9 mt -49.93 -52.27 53.86 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 114.812 1.412 . . . . 75.25 114.812 -171.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.91 -38.61 68.16 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 121.6 1.534 . . . . 71.140000000000001 111.762 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.438 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.8 tpt180 -70.05 -33.98 72.63 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 116.566 -0.288 . . . . 73.230000000000004 111.309 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.1 -42.06 84.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.951 -0.759 . . . . 70.420000000000002 108.951 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.07 84.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.406 -0.815 . . . . 63.439999999999998 109.597 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 7.5 tp10 -61.68 -44.94 95.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.672 -1.149 . . . . 55.240000000000002 109.552 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.449 HD22 ' CE2' ' A' ' 30' ' ' TYR . 27.0 tp -69.63 -46.33 66.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.195 -0.911 . . . . 72.230000000000004 111.724 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 75' ' ' GLY . 96.7 mt -81.36 -18.44 45.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.189 -0.46 . . . . 64.030000000000001 111.606 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.3 28.2 62.36 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.058 -0.817 . . . . 70.129999999999995 111.058 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 39' ' ' LEU . 21.5 m -125.61 163.48 38.54 Favored Pre-proline 0 C--N 1.307 -1.246 0 N-CA-C 108.333 -0.988 . . . . 73.120000000000005 108.333 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 46.2 Cg_endo -70.87 157.83 57.15 Favored 'Trans proline' 0 C--O 1.254 1.311 0 C-N-CA 121.352 1.368 . . . . 50.450000000000003 111.232 174.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' A' ' 32' ' ' LEU . 61.2 t -57.9 -34.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.658 0.783 . . . . 74.150000000000006 109.786 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 47.1 m -57.66 -42.89 84.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.155 -0.929 . . . . 41.329999999999998 111.331 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.611 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.8 mtpt -69.27 -33.48 73.3 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.409 -0.516 . . . . 75.140000000000001 111.204 177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.8 t -62.23 -44.94 99.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.164 -0.68 . . . . 73.329999999999998 109.164 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.05 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.39 -0.823 . . . . 70.540000000000006 110.427 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.0 mt-30 -63.49 -39.79 95.37 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 116.241 -0.436 . . . . 61.140000000000001 110.397 176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.611 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 72.2 mt-30 -64.1 -42.4 96.93 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.418 0.628 . . . . 65.430000000000007 109.699 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.9 tp -62.17 -40.77 97.14 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.892 -1.049 . . . . 71.040000000000006 109.281 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -68.83 -22.27 64.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.508 -0.769 . . . . 62.039999999999999 112.89 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 49.9 mt-10 -93.04 -12.87 29.53 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.313 -0.555 . . . . 74.209999999999994 111.337 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.38 28.96 31.62 Favored Glycine 0 C--N 1.319 -0.41 0 N-CA-C 111.222 -0.751 . . . . 73.420000000000002 111.222 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -87.72 -28.38 21.8 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.31 -0.996 . . . . 73.349999999999994 108.31 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -145.95 158.6 43.86 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 107.429 -1.323 . . . . 65.540000000000006 107.429 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.71 157.55 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 108.464 -0.939 . . . . 41.140000000000001 108.464 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.4 162.87 32.47 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 123.122 0.569 . . . . 71.140000000000001 110.004 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 m -125.91 166.09 22.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.277 0.56 . . . . 64.319999999999993 111.701 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -110.23 124.73 52.14 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.203 -0.908 . . . . 74.129999999999995 108.783 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.568 ' HD2' ' OD2' ' A' ' 21' ' ' ASP . 8.9 ptm180 -151.3 138.37 19.17 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-N 115.573 -0.739 . . . . 74.409999999999997 110.123 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.63 -59.16 0.54 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.205 1.802 . . . . 74.219999999999999 110.515 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 173.48 24.77 0.02 OUTLIER Glycine 0 C--N 1.28 -2.573 0 CA-C-N 114.766 -1.106 . . . . 51.329999999999998 110.825 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 160.81 27.81 Favored Glycine 0 N--CA 1.427 -1.907 0 C-N-CA 120.395 -0.907 . . . . 65.019999999999996 111.893 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 80.2 t -101.88 119.88 50.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 106.931 -1.507 . . . . 64.409999999999997 106.931 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.8 158.6 39.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 120.926 0.394 . . . . 42.420000000000002 110.867 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.07 126.92 27.07 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.497 -1.297 . . . . 52.450000000000003 107.497 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.31 132.29 51.38 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.384 2.056 . . . . 55.310000000000002 111.539 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.6 tt0 -62.17 -25.8 67.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.38 0.609 . . . . 70.099999999999994 112.353 -177.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.461 ' HB ' HG11 ' A' ' 126' ' ' VAL . 31.2 m -71.81 -4.37 4.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.144 -0.934 . . . . 54.140000000000001 112.38 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.632 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.8 m-85 -82.85 -6.18 59.32 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.956 0.884 . . . . 73.439999999999998 110.239 175.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.65 160.87 20.59 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.579 -0.737 . . . . 74.319999999999993 110.52 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.412 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 47.3 p -92.84 168.53 11.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.065 -1.087 . . . . 71.129999999999995 108.065 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -68.93 -15.33 63.46 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.424 0.631 . . . . 74.219999999999999 111.661 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.0 m -78.64 -9.86 59.53 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.739 -0.664 . . . . 61.329999999999998 109.335 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 39' ' ' LEU . . . 81.16 25.8 54.2 Favored Glycine 0 C--O 1.212 -1.264 0 N-CA-C 111.0 -0.84 . . . . 72.099999999999994 111.0 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -114.52 147.34 39.54 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.092 -1.077 . . . . 75.019999999999996 108.092 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -70.58 137.73 23.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.847 -1.538 . . . . 62.200000000000003 106.847 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 15.8 t -60.87 127.28 20.2 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 108.666 -0.865 . . . . 70.230000000000004 108.666 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -55.3 -32.14 62.19 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 114.095 1.146 . . . . 73.019999999999996 114.095 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 m -85.16 -6.4 59.29 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.088 0.471 . . . . 44.240000000000002 111.457 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD11 ' CD2' ' A' ' 70' ' ' PHE . 7.0 tt -66.18 -50.09 52.13 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 112.616 0.598 . . . . 73.109999999999999 112.616 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -56.28 -31.39 84.28 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.552 1.502 . . . . 62.549999999999997 111.337 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -42.93 99.73 Favored Glycine 0 C--O 1.25 1.102 0 CA-C-N 115.872 -0.604 . . . . 53.43 112.682 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -67.86 -39.81 83.72 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.32 -0.622 . . . . 74.450000000000003 109.32 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.63 -36.33 83.46 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 115.719 -0.673 . . . . 73.140000000000001 110.542 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.7 m -59.5 -50.26 74.61 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.022 -0.536 . . . . 61.43 110.372 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -44.16 83.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 116.143 -0.48 . . . . 63.43 111.485 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.427 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.36 -36.35 81.21 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.98 0.733 . . . . 71.200000000000003 112.98 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -70.64 -33.72 71.3 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 74.409999999999997 109.285 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.05 -31.7 72.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.674 -0.694 . . . . 74.230000000000004 109.389 175.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.17 -9.37 80.18 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.408 -0.814 . . . . 65.329999999999998 112.676 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.5 33.48 25.14 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 121.174 -0.536 . . . . 71.439999999999998 113.295 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.403 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 68.9 m-85 -99.79 136.89 39.02 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.595 -0.356 . . . . 61.210000000000001 110.884 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -88.58 174.04 8.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.922 -0.581 . . . . 71.209999999999994 112.144 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.85 -42.59 65.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.355 1.862 . . . . 64.430000000000007 111.871 -174.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -64.2 -41.73 96.94 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.782 -0.644 . . . . 63.530000000000001 110.142 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -66.61 -37.27 84.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.171 -0.468 . . . . 75.430000000000007 110.369 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -61.27 -48.97 86.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.777 0.799 . . . . 74.400000000000006 109.337 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.2 mtt -75.41 -19.28 59.61 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.036 -0.984 . . . . 65.150000000000006 112.215 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HA ' HG11 ' A' ' 22' ' ' VAL . 79.0 ttt180 -56.88 -62.79 1.5 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.356 0.662 . . . . 62.140000000000001 111.05 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -69.05 -32.65 72.28 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.2 0.524 . . . . 63.219999999999999 111.829 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 125' ' ' PRO . 19.2 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.13 0.972 . . . . 64.25 112.436 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -93.52 -2.6 54.16 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 113.261 0.837 . . . . 75.510000000000005 113.261 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.6 m -86.02 113.49 52.07 Favored Pre-proline 0 C--N 1.309 -1.159 0 O-C-N 123.135 0.272 . . . . 71.299999999999997 111.224 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 38.4 Cg_endo -68.02 141.11 52.02 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.448 2.099 . . . . 41.350000000000001 110.856 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.9 t0 -112.53 126.94 27.52 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 120.371 -0.532 . . . . 53.310000000000002 109.693 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 122' ' ' ASN . 32.6 Cg_exo -58.55 -28.24 85.09 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 123.645 2.896 . . . . 70.200000000000003 112.961 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -96.13 7.18 47.08 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.05 -0.523 . . . . 53.539999999999999 110.504 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.414 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.8 tp -113.89 123.83 50.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.554 0.693 . . . . 63.43 109.891 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.47 HG22 ' HB1' ' A' ' 119' ' ' ALA . 12.8 m -120.26 120.57 36.49 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.547 -1.279 . . . . 60.310000000000002 107.547 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 62.0 mt -127.48 148.59 32.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.896 -1.15 . . . . 73.209999999999994 107.896 -174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.4 t -118.73 148.41 42.82 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 106.704 -1.591 . . . . 73.439999999999998 106.704 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -143.44 174.46 10.73 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.486 -0.561 . . . . 74.420000000000002 109.486 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.91 126.87 29.29 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.729 0.643 . . . . 72.310000000000002 110.221 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.68 -2.77 58.82 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.694 -0.765 . . . . 33.530000000000001 111.259 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.6 m -121.38 116.12 24.19 Favored 'General case' 0 N--CA 1.426 -1.665 0 O-C-N 122.555 -0.379 . . . . 64.349999999999994 110.011 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HD3' ' H ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -79.16 -40.73 30.18 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 104.723 -2.325 . . . . 71.349999999999994 104.723 174.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.27 -177.12 3.89 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 111.402 -2.635 . . . . 75.430000000000007 109.089 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.47 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -109.88 148.28 31.82 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 109.071 -0.715 . . . . 65.109999999999999 109.071 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.0 t -100.09 118.22 46.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 107.58 -1.267 . . . . 62.32 107.58 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.429 ' C ' HD22 ' A' ' 122' ' ' ASN . 19.3 m -83.46 154.0 24.17 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.262 -1.385 . . . . 63.409999999999997 107.262 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 106' ' ' ASP 0.393 0.1 OUTLIER 46.7 62.94 2.11 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.722 1.209 . . . . 63.140000000000001 113.244 -176.668 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 105' ' ' PRO . . . -104.51 172.62 6.7 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.37 -1.344 . . . . 74.209999999999994 107.37 177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -103.89 151.43 38.88 Favored Pre-proline 0 C--N 1.288 -2.075 0 N-CA-C 109.137 -0.69 . . . . 74.140000000000001 109.137 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.459 ' HB2' HD12 ' A' ' 102' ' ' LEU . 71.1 Cg_exo -50.9 -22.08 9.56 Favored 'Trans proline' 0 CA--C 1.549 1.229 0 C-N-CA 123.06 2.507 . . . . 73.329999999999998 113.453 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.461 HG11 ' HB ' ' A' ' 69' ' ' VAL . 94.4 t -60.05 -41.62 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.082 -0.34 . . . . 34.219999999999999 110.082 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.07 -40.11 94.69 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.752 -0.658 . . . . 74.219999999999999 109.719 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.37 -45.45 69.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.979 -1.01 . . . . 73.230000000000004 109.995 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.1 tp -59.75 -44.18 93.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.576 0.751 . . . . 75.409999999999997 112.144 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.412 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 16.8 t60 -70.26 -23.58 62.92 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.441 0.638 . . . . 74.409999999999997 109.887 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -100.54 10.92 40.53 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.375 -0.83 . . . . 62.340000000000003 112.289 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 65.79 27.55 11.09 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 122.754 1.264 . . . . 72.319999999999993 111.018 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -102.86 24.76 10.18 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.3 -1.741 . . . . 72.420000000000002 106.3 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.23 -27.25 14.12 Favored 'General case' 0 C--O 1.211 -0.972 0 C-N-CA 127.044 2.137 . . . . 14.300000000000001 115.381 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -56.5 -34.41 66.95 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.557 1.318 . . . . 71.129999999999995 114.557 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.437 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 0.9 OUTLIER -67.39 -34.77 77.96 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.767 0.794 . . . . 50.509999999999998 109.338 175.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.62 -48.44 65.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.922 -1.035 . . . . 72.510000000000005 108.958 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.77 -43.94 99.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-N 115.529 -0.76 . . . . 74.25 109.55 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.437 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 26.1 ttt180 -57.74 -47.2 83.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.449 -0.341 . . . . 72.439999999999998 110.916 177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 -65.92 -33.7 76.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.684 0.278 . . . . 74.349999999999994 111.468 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.427 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -65.17 -46.72 79.66 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.47 -0.567 . . . . 74.319999999999993 109.47 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -62.42 -48.01 81.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.106 -0.952 . . . . 75.439999999999998 110.509 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.75 -19.42 65.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.703 -0.681 . . . . 71.349999999999994 112.335 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.7 tpt -79.83 -45.84 17.99 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.209 0.528 . . . . 61.200000000000003 109.793 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.403 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.71 -44.26 17.33 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.539 0.57 . . . . 71.230000000000004 112.539 -177.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 108.836 -0.802 . . . . 73.209999999999994 108.836 -178.303 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 CA--C 1.509 -0.61 0 N-CA-C 107.474 -1.306 . . . . 64.400000000000006 107.474 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.21 143.15 82.86 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 122.268 1.979 . . . . 72.409999999999997 112.41 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.2 -174.18 46.77 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 109.28 -1.528 . . . . 75.129999999999995 109.28 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 135.03 48.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 118.162 0.981 . . . . 72.120000000000005 110.755 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.44 131.82 22.58 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 108.85 -0.796 . . . . 55.530000000000001 108.85 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.69 127.02 24.19 Favored 'Trans proline' 0 C--O 1.25 1.108 0 C-N-CA 122.84 2.36 . . . . 73.0 110.929 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -122.79 118.37 3.58 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 111.313 -0.715 . . . . 52.520000000000003 111.313 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -70.4 -33.99 72.01 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.665 -0.865 . . . . 65.519999999999996 108.665 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 m -99.48 128.03 45.58 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.414 -0.812 . . . . 71.420000000000002 109.476 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.98 162.55 13.51 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.439 -0.948 . . . . 71.329999999999998 108.439 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.34 79.04 9.53 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.571 -1.27 . . . . 72.439999999999998 107.571 173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.492 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -93.83 128.88 40.33 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 115.517 -0.765 . . . . 71.540000000000006 109.674 -176.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -116.84 153.38 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.82 0 N-CA-C 108.074 -1.084 . . . . 70.030000000000001 108.074 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.81 -175.64 14.02 Favored Glycine 0 N--CA 1.396 -3.986 0 N-CA-C 110.083 -1.207 . . . . 72.030000000000001 110.083 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.3 t -155.06 -177.7 6.72 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 106.592 -1.633 . . . . 72.519999999999996 106.592 -176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 94' ' ' ARG . 39.6 mm -85.03 133.77 42.45 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 107.515 -1.291 . . . . 71.409999999999997 107.515 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -62.51 162.64 23.53 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.896 1.731 . . . . 70.25 110.638 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.67 124.38 29.53 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.025 -0.731 . . . . 71.019999999999996 109.025 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' HH12 ' A' ' 94' ' ' ARG . . . -97.67 -87.12 1.85 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 116.17 -0.468 . . . . 72.319999999999993 113.717 -176.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -123.94 141.46 52.02 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.468 -0.493 . . . . 72.099999999999994 111.965 -173.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -81.5 133.98 35.46 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.504 -0.771 . . . . 61.329999999999998 110.481 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.38 -15.75 9.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.602 -0.727 . . . . 71.0 111.025 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 103' ' ' PHE 0.279 0.9 OUTLIER -82.56 -176.88 6.47 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 118.751 -1.18 . . . . 73.319999999999993 112.566 -178.348 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -86.93 136.0 34.69 Favored Pre-proline 0 C--N 1.299 -1.595 0 CA-C-N 116.286 -0.415 . . . . 75.340000000000003 110.263 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.58 -25.44 33.02 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 123.616 2.877 . . . . 73.099999999999994 113.814 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.45 -30.18 70.47 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.102 0.477 . . . . 75.349999999999994 110.234 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 43.6 mt-10 -76.35 123.58 87.89 Favored Pre-proline 0 C--O 1.254 1.308 0 CA-C-N 115.457 -0.792 . . . . 74.439999999999998 109.935 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.2 Cg_exo -73.69 175.99 9.98 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.318 2.012 . . . . 74.450000000000003 110.019 177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.432 ' HB ' ' HB ' ' A' ' 65' ' ' VAL . 12.9 p -139.97 177.93 7.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 121.579 0.704 . . . . 61.229999999999997 112.062 -178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 43.0 m-85 -109.17 160.81 15.79 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 125.919 1.688 . . . . 74.019999999999996 107.905 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 13.3 t0 -135.66 166.86 22.25 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 104.091 -2.559 . . . . 53.299999999999997 104.091 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 mp -55.21 -53.29 63.37 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 113.065 0.765 . . . . 65.450000000000003 113.065 -174.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 14.8 Cg_endo -58.3 -35.71 98.43 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.11 1.873 . . . . 55.310000000000002 112.66 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.435 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 23.9 tpt180 -67.38 -38.44 84.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.345 0.658 . . . . 75.120000000000005 110.284 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.4 t -69.2 -40.37 80.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 109.406 -0.591 . . . . 75.340000000000003 109.406 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -59.35 -39.49 83.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.822 -1.081 . . . . 73.140000000000001 109.646 177.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.18 -34.72 78.68 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 125.375 1.47 . . . . 73.530000000000001 110.469 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.454 HD11 ' CE1' ' A' ' 30' ' ' TYR . 97.1 mt -77.24 -47.5 19.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.284 0.564 . . . . 64.230000000000004 111.625 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.2 mt -85.02 -18.5 34.22 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 113.315 0.857 . . . . 74.5 113.315 -172.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.39 48.6 Favored Glycine 0 C--N 1.307 -1.038 0 C-N-CA 119.77 -1.205 . . . . 31.210000000000001 110.178 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 34.3 m -117.91 157.75 47.58 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.007 -1.108 . . . . 75.299999999999997 108.007 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.462 ' HD2' ' HD2' ' A' ' 45' ' ' LYS . 44.3 Cg_endo -72.04 164.53 35.38 Favored 'Trans proline' 0 C--O 1.259 1.558 0 C-N-CA 121.117 1.211 . . . . 53.140000000000001 110.958 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.89 -33.37 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 121.54 0.686 . . . . 75.150000000000006 109.269 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -57.45 -41.79 81.25 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 114.674 -1.148 . . . . 71.450000000000003 110.685 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 54.3 mttm -69.38 -36.93 77.28 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.625 -0.43 . . . . 73.420000000000002 111.658 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.64 -44.69 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 109.401 -0.592 . . . . 55.049999999999997 109.401 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.32 -36.92 79.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.439 -0.801 . . . . 55.439999999999998 110.157 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 96.2 mt-30 -67.38 -43.32 81.69 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 116.079 -0.51 . . . . 70.150000000000006 111.491 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 92.7 mt-30 -58.32 -46.1 86.81 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.486 0.66 . . . . 62.130000000000003 110.052 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 96.3 mt -61.42 -45.7 93.22 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.352 -1.295 . . . . 51.109999999999999 110.16 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -70.85 -22.09 62.35 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.118 0.785 . . . . 64.439999999999998 113.118 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 57.5 mt-10 -94.48 -1.16 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.891 -0.505 . . . . 72.329999999999998 110.913 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.4 35.04 63.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.882 -0.675 . . . . 55.210000000000001 111.979 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -102.17 -16.94 16.2 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.808 -1.182 . . . . 72.329999999999998 107.808 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 54.9 tp -151.26 152.72 33.62 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 106.054 -1.832 . . . . 63.329999999999998 106.054 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.48 161.53 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 109.262 -0.644 . . . . 64.430000000000007 109.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.65 164.15 28.91 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.291 0.636 . . . . 54.229999999999997 110.902 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.8 m -125.24 165.94 21.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 123.826 0.85 . . . . 75.109999999999999 108.96 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -123.98 131.74 53.61 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.882 -0.784 . . . . 70.109999999999999 108.882 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -152.24 138.71 18.59 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.117 -0.697 . . . . 72.430000000000007 109.117 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.93 9.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.278 1.031 . . . . 62.030000000000001 112.335 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.21 9.7 67.01 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 121.181 -0.533 . . . . 74.239999999999995 112.843 -178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.47 142.0 15.55 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 120.596 -0.811 . . . . 55.329999999999998 111.168 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.78 120.3 46.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.084 -1.45 . . . . 33.310000000000002 107.084 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 12.1 m -137.16 164.37 29.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 116.25 -0.432 . . . . 64.329999999999998 111.312 -174.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.7 mt -121.81 130.61 24.68 Favored Pre-proline 0 C--N 1.299 -1.621 0 N-CA-C 108.67 -0.863 . . . . 75.430000000000007 108.67 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -55.71 141.82 83.67 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 123.086 2.524 . . . . 72.299999999999997 113.941 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.472 ' HA ' ' CE2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -55.2 -39.82 70.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.786 1.234 . . . . 73.120000000000005 110.399 177.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.98 -4.91 4.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 114.129 1.159 . . . . 70.25 114.129 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.561 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.7 m-85 -83.49 -5.46 59.17 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.856 0.836 . . . . 74.239999999999995 110.836 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -124.34 149.03 47.07 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.691 -1.14 . . . . 72.349999999999994 108.644 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.1 p -76.17 169.0 19.04 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.807 -0.812 . . . . 73.120000000000005 108.807 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -61.6 -19.15 61.9 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.091 0.472 . . . . 70.129999999999995 110.953 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.6 m -80.08 -10.1 59.74 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 116.109 -0.496 . . . . 74.519999999999996 110.936 178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.62 14.06 66.25 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.004 -0.617 . . . . 62.140000000000001 111.887 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -105.06 148.22 27.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 122.819 -0.224 . . . . 71.409999999999997 110.744 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.97 138.65 22.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 O-C-N 123.811 0.694 . . . . 72.349999999999994 109.627 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 80' ' ' SER . 57.0 t -61.94 127.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.264 -1.013 . . . . 62.020000000000003 108.264 176.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -63.14 -24.02 67.7 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.454 0.645 . . . . 75.239999999999995 112.589 -176.452 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.421 ' H ' HG12 ' A' ' 78' ' ' VAL . 8.6 m -92.09 2.42 56.59 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.073 -0.512 . . . . 51.140000000000001 110.748 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 70' ' ' PHE . 11.8 tp -65.05 -55.62 25.78 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 116.433 -0.349 . . . . 41.219999999999999 111.454 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.88 -28.46 86.41 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 121.815 1.677 . . . . 72.120000000000005 111.218 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.7 -45.46 65.78 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.489 -0.778 . . . . 44.299999999999997 111.967 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.22 -40.81 81.99 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-O 120.985 0.422 . . . . 72.209999999999994 110.118 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.43 -39.27 92.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.148 -0.478 . . . . 75.409999999999997 111.006 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.1 m -71.36 -41.23 70.01 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.899 -0.592 . . . . 65.299999999999997 112.224 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -68.11 -39.84 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.32 -0.552 . . . . 61.340000000000003 109.535 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 4.4 mm? -66.18 -35.67 81.07 Favored 'General case' 0 CA--C 1.511 -0.521 0 O-C-N 122.257 -0.277 . . . . 63.240000000000002 111.399 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.34 -37.94 89.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.72 -0.474 . . . . 75.420000000000002 109.72 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.47 -24.94 65.66 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.741 0.781 . . . . 75.349999999999994 109.976 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.49 -2.93 84.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.665 -0.698 . . . . 73.409999999999997 111.795 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.29 20.95 50.88 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.784 -0.246 . . . . 62.200000000000003 113.058 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 9.1 m-85 -86.75 152.8 22.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.109 0.781 . . . . 72.400000000000006 113.109 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.448 HH12 ' HA3' ' A' ' 19' ' ' GLY . 11.1 ptt180 -123.24 175.96 6.38 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.82 -1.082 . . . . 60.229999999999997 110.063 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 99' ' ' MET . 11.1 p-10 -52.18 -47.06 65.72 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.851 1.66 . . . . 74.329999999999998 113.49 -171.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.1 m -67.93 -40.0 83.41 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-O 121.471 0.653 . . . . 74.209999999999994 109.348 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 29.7 mm-40 -66.29 -34.62 78.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.338 -0.847 . . . . 75.239999999999995 111.383 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 94' ' ' ARG . 33.4 mm -61.49 -47.19 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 121.87 0.843 . . . . 61.219999999999999 108.819 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 23.0 mmt -70.41 -23.22 62.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.347 -1.297 . . . . 73.340000000000003 110.773 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 68.9 ttt180 -55.09 -67.23 0.29 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.474 0.71 . . . . 63.210000000000001 110.888 -177.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.588 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 57.3 p-90 -68.93 -32.12 71.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.607 0.595 . . . . 72.349999999999994 112.607 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.588 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.2 mt -63.55 -40.6 97.43 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.328 0.862 . . . . 70.310000000000002 113.328 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 96.3 m-85 -98.33 -9.46 25.36 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 113.582 0.956 . . . . 63.329999999999998 113.582 -176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 27.4 m -88.35 110.97 40.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.815 -1.18 . . . . 42.140000000000001 107.815 174.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.26 129.9 37.27 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.65 2.233 . . . . 75.420000000000002 111.514 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.3 t70 -89.59 118.8 69.35 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 109.489 -0.559 . . . . 60.229999999999997 109.489 -176.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.1 -26.83 83.38 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.143 2.562 . . . . 75.010000000000005 112.213 -177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -94.84 10.05 36.77 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.685 -0.689 . . . . 65.230000000000004 111.431 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.9 tp -105.25 125.81 51.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 109.13 -0.693 . . . . 62.229999999999997 109.13 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 120' ' ' VAL . 52.1 m -132.04 110.68 10.89 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.352 -0.981 . . . . 61.109999999999999 108.352 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.84 160.99 42.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 115.878 -0.601 . . . . 70.5 110.508 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.442 HG23 HE22 ' A' ' 133' ' ' GLN . 1.6 t -88.85 126.03 35.18 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 105.0 -2.222 . . . . 62.229999999999997 105.0 172.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 116' ' ' SER . 57.2 mtp180 -84.45 169.07 14.9 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 114.498 1.296 . . . . 72.450000000000003 114.498 -169.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -57.01 101.0 0.05 Allowed 'General case' 0 C--O 1.242 0.688 0 CA-C-N 114.316 -1.311 . . . . 64.5 109.76 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.79 42.43 61.33 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.576 -0.738 . . . . 53.25 111.29 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 113' ' ' ARG . 17.4 m -142.47 106.28 4.69 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.174 -0.676 . . . . 72.219999999999999 109.174 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -60.17 -27.97 67.54 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.362 0.504 . . . . 73.519999999999996 112.362 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -84.56 144.21 28.8 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.897 -0.592 . . . . 65.230000000000004 110.802 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.99 127.59 35.68 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.546 -0.752 . . . . 74.540000000000006 109.175 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 110' ' ' THR . 44.4 t -104.56 122.8 57.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 116.164 -0.471 . . . . 63.140000000000001 110.177 -176.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.7 m -83.17 139.35 33.21 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.07 -1.456 . . . . 75.340000000000003 107.07 173.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.5 t30 69.36 69.33 0.26 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.386 1.089 . . . . 62.329999999999998 108.779 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.43 159.94 21.98 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.698 -1.137 . . . . 75.299999999999997 109.931 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -75.46 125.23 88.99 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 108.796 -0.816 . . . . 62.119999999999997 108.796 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 72.3 Cg_exo -53.89 -23.92 29.46 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 123.269 2.646 . . . . 75.340000000000003 112.958 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.723 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 84.6 t -60.31 -42.16 89.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.642 -0.708 . . . . 73.430000000000007 111.553 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.18 -30.71 71.64 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.358 0.599 . . . . 71.530000000000001 110.471 -172.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.9 84.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.008 -0.996 . . . . 61.32 111.786 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.723 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -70.41 -36.82 74.26 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.82 -0.55 . . . . 44.439999999999998 111.671 -177.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -76.09 -22.62 55.39 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 108.588 -0.893 . . . . 75.340000000000003 108.588 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.16 43.74 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.715 -1.129 . . . . 62.450000000000003 111.413 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.8 m80 65.52 28.44 11.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.111 0.964 . . . . 72.129999999999995 112.127 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.442 HE22 HG23 ' A' ' 112' ' ' THR . 72.7 mt-30 -108.64 25.23 11.97 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 125.146 1.378 . . . . 75.219999999999999 107.607 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.41 -26.37 7.82 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.89 2.076 . . . . 74.209999999999994 113.268 -175.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.415 ' O ' ' HG3' ' A' ' 139' ' ' ARG . 39.2 ttp180 -54.37 -41.26 68.97 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.933 -0.395 . . . . 75.430000000000007 109.933 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.504 ' HA ' ' HG3' ' A' ' 139' ' ' ARG . 56.6 mm-40 -67.35 -28.51 68.02 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 116.549 -0.296 . . . . 52.119999999999997 111.653 179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.07 -45.5 54.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.4 -0.963 . . . . 60.32 108.4 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.66 -49.2 84.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 CA-C-N 116.036 -0.529 . . . . 72.319999999999993 110.338 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 136' ' ' GLU 0.318 0.0 OUTLIER -63.64 -37.43 87.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.187 0.81 . . . . 74.219999999999999 113.187 178.379 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 144' ' ' MET . 1.6 mpt_? -63.6 -40.1 96.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.484 -0.561 . . . . 72.439999999999998 109.484 174.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.424 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -61.5 -42.78 99.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 52.420000000000002 110.614 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -56.89 -49.52 75.29 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.339 0.656 . . . . 73.5 109.88 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.56 -33.12 74.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.172 -0.922 . . . . 73.329999999999998 111.892 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.441 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 92.6 mmm -77.01 -47.2 21.33 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.835 -0.346 . . . . 63.009999999999998 111.093 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.88 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.857 -0.61 . . . . 60.420000000000002 112.065 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 . . . . . 0 N--CA 1.427 -1.576 0 C-N-CA 120.655 -0.418 . . . . 74.230000000000004 110.47 -178.61 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.107 0.48 . . . . 70.150000000000006 110.532 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -86.16 100.9 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.364 2.042 . . . . 54.229999999999997 110.842 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.15 45.47 1.93 Allowed Glycine 0 C--N 1.311 -0.851 0 C-N-CA 121.213 -0.518 . . . . 61.340000000000003 113.268 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -74.1 133.0 42.82 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.508 -0.553 . . . . 54.130000000000003 109.508 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.29 88.96 20.19 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 108.685 -0.857 . . . . 64.439999999999998 108.685 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -92.17 -174.96 0.58 Allowed 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 122.709 2.273 . . . . 70.439999999999998 111.922 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.0 28.23 59.01 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-N 116.011 -0.541 . . . . 75.109999999999999 112.359 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 p -72.94 112.35 8.89 Favored 'General case' 0 N--CA 1.423 -1.778 0 CA-C-O 121.624 0.726 . . . . 74.219999999999999 110.154 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -85.21 129.64 34.76 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.429 -0.805 . . . . 73.25 109.741 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.9 mt -67.94 157.54 34.76 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 109.948 -0.39 . . . . 71.329999999999998 109.948 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.86 93.19 3.07 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 120.963 0.411 . . . . 75.200000000000003 110.087 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -115.53 7.07 14.81 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.68 0.752 . . . . 62.439999999999998 111.094 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.83 101.64 12.39 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 106.784 -1.561 . . . . 54.350000000000001 106.784 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 51' ' ' ARG . . . -75.05 89.8 0.79 Allowed Glycine 0 N--CA 1.423 -2.203 0 CA-C-N 114.955 -1.02 . . . . 71.239999999999995 112.712 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.8 t -88.77 79.56 7.41 Favored 'General case' 0 N--CA 1.411 -2.378 0 N-CA-C 106.331 -1.729 . . . . 71.430000000000007 106.331 174.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -75.13 119.85 78.88 Favored Pre-proline 0 N--CA 1.441 -0.879 0 CA-C-N 115.442 -0.799 . . . . 73.25 109.738 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -75.98 137.54 19.73 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.006 1.804 . . . . 75.530000000000001 107.541 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.5 124.12 30.41 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.664 -0.814 . . . . 64.219999999999999 109.758 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.35 -104.28 2.72 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 121.07 -0.586 . . . . 73.409999999999997 112.351 -175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -117.06 137.28 52.36 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.392 -0.523 . . . . 74.340000000000003 111.539 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.58 143.1 35.08 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.346 -0.843 . . . . 75.010000000000005 110.937 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.63 -15.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 116.055 -0.52 . . . . 75.340000000000003 110.932 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.266 1.0 OUTLIER -86.09 175.55 8.48 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 118.314 -1.354 . . . . 74.239999999999995 111.631 179.02 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.446 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 20.3 t70 -82.21 141.1 46.02 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 109.172 -0.677 . . . . 73.209999999999994 109.172 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.413 ' HA ' ' NH1' ' A' ' 60' ' ' ARG . 71.1 Cg_exo -50.4 -32.06 32.59 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.003 2.469 . . . . 72.430000000000007 114.388 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.54 -10.02 59.55 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.942 1.09 . . . . 60.329999999999998 113.942 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 9.9 mm-40 -66.3 136.32 95.15 Favored Pre-proline 0 C--O 1.245 0.849 0 N-CA-C 107.787 -1.19 . . . . 75.030000000000001 107.787 175.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.8 133.71 51.74 Favored 'Trans proline' 0 C--O 1.247 0.943 0 C-N-CA 123.171 2.581 . . . . 72.430000000000007 112.629 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.7 p -132.84 168.55 18.19 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.057 -0.519 . . . . 63.399999999999999 111.092 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.469 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 24.6 m-85 -130.83 161.5 31.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 125.23 1.412 . . . . 73.349999999999994 108.464 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -134.67 166.57 22.62 Favored 'General case' 0 C--N 1.281 -2.37 0 N-CA-C 106.343 -1.725 . . . . 62.119999999999997 106.343 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -43.37 -61.54 1.8 Allowed Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 116.018 1.859 . . . . 63.119999999999997 116.018 -169.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.07 -29.37 74.86 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.448 1.432 . . . . 63.299999999999997 112.352 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 7.9 tpt180 -70.86 -36.22 72.75 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.081 0.467 . . . . 73.420000000000002 110.041 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -69.81 -37.9 74.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.628 -0.508 . . . . 74.430000000000007 109.628 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.15 81.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.458 -0.792 . . . . 74.129999999999995 109.393 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 35.9 tt0 -63.9 -45.78 87.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.716 -1.129 . . . . 54.340000000000003 110.724 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.466 HD22 ' CE2' ' A' ' 30' ' ' TYR . 39.6 tp -64.81 -46.93 79.94 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.194 -0.912 . . . . 64.230000000000004 111.534 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.65 -18.29 35.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.86 0.689 . . . . 64.109999999999999 112.86 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.81 53.07 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.07 -1.062 . . . . 53.219999999999999 111.448 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.05 158.71 74.39 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.131 -0.692 . . . . 54.039999999999999 109.131 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -65.78 159.84 46.66 Favored 'Trans proline' 0 C--O 1.25 1.089 0 C-N-CA 121.856 1.704 . . . . 62.009999999999998 112.192 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.2 -33.61 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.247 1.019 . . . . 63.43 111.252 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 p -57.87 -42.46 84.6 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.617 -0.72 . . . . 71.140000000000001 110.946 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.683 ' HA ' ' HG3' ' A' ' 48' ' ' GLN . 68.2 mttm -70.06 -34.82 73.68 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.006 -0.543 . . . . 74.530000000000001 112.007 177.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.36 -41.63 90.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.287 -0.635 . . . . 64.329999999999998 109.287 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.37 96.34 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.203 -0.908 . . . . 72.5 110.589 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.683 ' HG3' ' HA ' ' A' ' 45' ' ' LYS 0.308 0.0 OUTLIER -70.72 -35.03 72.52 Favored 'General case' 0 C--O 1.201 -1.483 0 C-N-CA 120.216 -0.594 . . . . 70.420000000000002 112.241 178.632 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 84.5 mm-40 -58.09 -43.14 86.93 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.482 0.658 . . . . 73.049999999999997 109.229 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -60.67 -46.09 91.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.687 -1.142 . . . . 74.239999999999995 108.933 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 94.2 mtt180 -70.68 -21.41 62.59 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.058 -0.974 . . . . 75.329999999999998 113.383 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -84.48 -7.39 59.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.904 0.383 . . . . 72.549999999999997 110.429 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.53 22.69 58.0 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.482 -0.647 . . . . 71.340000000000003 111.482 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.6 m170 -91.42 -17.95 24.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.058 0.456 . . . . 73.219999999999999 109.971 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 tp -151.42 155.37 38.47 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.43 -0.952 . . . . 72.120000000000005 108.43 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 68.5 t -137.47 147.11 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.028 -1.101 . . . . 70.340000000000003 108.028 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.14 156.15 44.36 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.3 -0.63 . . . . 64.209999999999994 109.3 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.3 m -127.48 166.03 25.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 O-C-N 123.595 0.559 . . . . 60.009999999999998 109.928 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -122.48 137.74 54.78 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.068 -0.716 . . . . 74.019999999999996 109.068 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' NH1' ' HA ' ' A' ' 25' ' ' PRO . 39.2 ptt180 -153.34 138.22 17.14 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.918 -1.142 . . . . 75.319999999999993 107.918 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.93 16.28 10.43 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.955 0.902 . . . . 74.319999999999993 110.875 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.3 -7.06 78.42 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 115.614 -0.721 . . . . 71.409999999999997 112.133 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.76 143.61 15.68 Favored Glycine 0 CA--C 1.488 -1.607 0 N-CA-C 111.312 -0.715 . . . . 54.049999999999997 111.312 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 p -97.73 123.27 50.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.777 0.799 . . . . 73.409999999999997 109.426 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -130.61 151.21 35.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.963 -1.017 . . . . 63.240000000000002 110.534 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.9 mp -105.35 126.67 30.33 Favored Pre-proline 0 C--N 1.28 -2.43 0 N-CA-C 107.517 -1.29 . . . . 64.120000000000005 107.517 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.36 118.03 4.91 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.091 1.86 . . . . 63.409999999999997 110.435 175.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.469 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 tt0 -60.95 -24.56 66.15 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 123.184 0.594 . . . . 75.340000000000003 111.667 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.0 m -67.83 -5.79 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.271 0 CA-C-N 115.265 -0.88 . . . . 53.119999999999997 112.436 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.42 ' CZ ' ' HE1' ' A' ' 99' ' ' MET . 3.2 m-85 -80.42 -14.39 58.35 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 122.009 0.909 . . . . 72.239999999999995 109.637 173.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -108.3 151.39 26.05 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.127 -1.064 . . . . 70.329999999999998 108.127 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.4 p -76.23 175.24 9.21 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.574 -0.528 . . . . 75.150000000000006 109.574 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.82 -17.75 63.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.7 0.762 . . . . 52.530000000000001 109.994 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 m -83.3 -4.14 58.15 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.075 -0.511 . . . . 71.25 111.186 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.79 26.3 60.9 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.039 -0.601 . . . . 51.240000000000002 112.822 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -124.58 154.88 39.99 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.716 -0.846 . . . . 72.0 108.716 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.57 135.07 27.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.536 -0.542 . . . . 74.150000000000006 109.536 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 12.7 t -61.94 141.61 17.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 107.064 -1.458 . . . . 73.239999999999995 107.064 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -54.32 -44.94 72.47 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 114.459 1.281 . . . . 62.299999999999997 114.459 -169.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 64.6 m -109.31 21.72 16.73 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.543 -0.863 . . . . 72.200000000000003 112.246 -176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.478 ' HB3' ' HD3' ' A' ' 82' ' ' PRO . 17.7 tp -58.04 -48.65 96.71 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 115.041 -0.981 . . . . 70.430000000000007 110.799 174.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 50.1 Cg_exo -58.96 -27.47 84.88 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.907 1.738 . . . . 70.530000000000001 111.396 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 87' ' ' ILE . . . -62.81 -45.53 95.52 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 115.949 -0.569 . . . . 63.140000000000001 112.388 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.56 -39.9 80.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.699 0.762 . . . . 74.219999999999999 109.329 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.55 -44.52 90.51 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.906 -1.043 . . . . 65.040000000000006 110.492 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.7 m -67.14 -45.84 75.9 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.764 -0.653 . . . . 41.219999999999999 111.657 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.508 HG22 ' O ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -61.58 -45.27 99.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-O 120.542 0.211 . . . . 64.109999999999999 111.403 -178.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD13 ' HB2' ' A' ' 145' ' ' ALA . 4.5 mm? -67.23 -42.45 84.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.65 0.611 . . . . 55.509999999999998 112.65 177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -64.56 -44.46 90.67 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.824 -0.436 . . . . 61.439999999999998 109.824 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -68.18 -26.77 65.91 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.852 -0.613 . . . . 72.519999999999996 109.51 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.48 -9.36 86.98 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.416 -0.811 . . . . 42.450000000000003 113.313 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.2 53.39 2.19 Favored Glycine 0 C--O 1.242 0.64 0 C-N-CA 121.03 -0.605 . . . . 65.310000000000002 113.009 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.539 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 84.1 m-85 -129.8 136.95 50.19 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 120.968 0.413 . . . . 64.310000000000002 111.46 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.657 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 24.1 ptt180 -81.23 169.97 16.68 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.114 -0.948 . . . . 75.040000000000006 110.807 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.42 ' O ' ' HG2' ' A' ' 99' ' ' MET . 12.3 p-10 -55.13 -45.2 75.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.217 1.407 . . . . 75.340000000000003 111.624 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -61.8 -40.38 95.04 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.596 -0.729 . . . . 73.040000000000006 111.084 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.657 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 45.1 mm-40 -66.13 -34.64 78.5 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 120.723 -0.391 . . . . 72.420000000000002 111.247 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 mm -63.17 -47.59 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.352 -0.981 . . . . 63.039999999999999 108.352 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.42 ' HE1' ' CZ ' ' A' ' 70' ' ' PHE . 22.3 mmt -69.77 -22.1 63.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.201 -1.363 . . . . 73.540000000000006 110.543 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -58.2 -67.1 0.38 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.265 0.626 . . . . 70.340000000000003 109.734 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.484 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.5 p-90 -69.18 -31.9 70.84 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 112.734 0.642 . . . . 74.230000000000004 112.734 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.484 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 mt -61.59 -39.93 92.96 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.828 0.677 . . . . 73.439999999999998 112.828 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 95.6 m-85 -98.69 -9.77 24.16 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 113.235 0.828 . . . . 72.349999999999994 113.235 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.9 m -86.0 116.04 64.18 Favored Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.552 -0.907 . . . . 72.140000000000001 108.552 175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -66.99 154.68 73.86 Favored 'Trans proline' 0 C--O 1.244 0.822 0 C-N-CA 122.753 2.302 . . . . 75.230000000000004 112.953 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.3 t70 -99.71 120.45 57.35 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 108.173 -1.047 . . . . 72.549999999999997 108.173 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.23 -27.32 84.64 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.267 2.645 . . . . 72.200000000000003 113.519 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.3 p -100.03 4.3 44.65 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.442 0.639 . . . . 62.109999999999999 112.215 -175.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 45.5 tp -102.16 139.33 37.92 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.408 -0.59 . . . . 75.549999999999997 109.408 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.2 m -129.82 118.49 21.85 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.278 -0.638 . . . . 74.239999999999995 109.278 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm -128.38 153.96 38.51 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 108.262 -1.014 . . . . 64.239999999999995 108.262 -174.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.9 p -89.51 126.16 35.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 105.997 -1.853 . . . . 54.509999999999998 105.997 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.496 ' HD3' ' N ' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -98.57 127.23 44.41 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.797 -0.761 . . . . 72.319999999999993 109.755 -172.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.496 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 15.7 m-20 -50.21 120.89 4.88 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 124.248 0.967 . . . . 74.0 111.356 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 134.36 -29.45 3.03 Favored Glycine 0 C--N 1.287 -2.159 0 N-CA-C 107.946 -2.061 . . . . 70.0 107.946 -173.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -145.61 170.51 16.3 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 106.479 -1.674 . . . . 60.210000000000001 106.479 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.69 6.56 32.03 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 122.065 0.936 . . . . 73.319999999999993 108.644 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -74.33 145.17 44.11 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.135 -1.393 . . . . 63.420000000000002 111.622 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.94 124.21 33.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.065 -0.971 . . . . 62.219999999999999 109.619 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.8 t -112.73 120.5 62.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 108.986 -0.746 . . . . 75.109999999999999 108.986 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.1 m -81.81 138.75 35.07 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.051 -1.092 . . . . 62.109999999999999 108.051 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 10.3 t30 72.4 69.33 0.14 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.293 1.044 . . . . 71.510000000000005 110.09 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.9 167.22 10.41 Favored 'General case' 0 C--O 1.25 1.102 0 CA-C-N 114.636 -1.165 . . . . 65.530000000000001 108.494 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.581 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 6.2 ptp180 -94.18 149.32 36.61 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.024 -0.732 . . . . 74.400000000000006 109.024 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.428 ' HB2' HD23 ' A' ' 102' ' ' LEU . 97.9 Cg_exo -50.8 -27.54 20.6 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.168 2.579 . . . . 62.329999999999998 113.306 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 48.3 t -60.97 -36.78 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.242 0.544 . . . . 74.349999999999994 110.375 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.581 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 66.4 m-20 -69.04 -36.87 78.2 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.037 -0.727 . . . . 62.43 109.037 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.79 -40.16 79.79 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.269 -0.878 . . . . 75.230000000000004 111.589 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -66.73 -38.85 87.51 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.766 -0.374 . . . . 74.109999999999999 111.931 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.413 ' N ' HD12 ' A' ' 129' ' ' LEU . 47.6 t-80 -75.97 -17.17 59.82 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.91 0.862 . . . . 75.230000000000004 109.239 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.76 4.5 36.57 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.131 -0.941 . . . . 72.109999999999999 110.055 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 67.88 28.3 7.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.561 1.144 . . . . 75.239999999999995 111.763 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -103.93 24.11 11.83 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 124.581 1.152 . . . . 64.420000000000002 108.746 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.49 -27.51 16.61 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 125.126 1.371 . . . . 73.420000000000002 112.72 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -55.53 -43.86 76.15 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.825 0.85 . . . . 73.049999999999997 110.974 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 139' ' ' ARG . 2.3 tm-20 -73.2 -32.13 64.6 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.969 -0.752 . . . . 72.299999999999997 108.969 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.64 -42.5 89.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 116.015 -0.539 . . . . 62.340000000000003 110.013 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 134' ' ' ALA . 92.6 t -59.23 -41.65 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 115.956 -0.565 . . . . 71.209999999999994 109.523 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 136' ' ' GLU . 43.0 ttt180 -56.88 -47.12 81.2 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 115.01 -0.996 . . . . 73.030000000000001 110.016 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -68.96 -35.58 76.93 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.044 -0.526 . . . . 71.310000000000002 111.858 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.2 -43.44 98.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.841 0.353 . . . . 71.439999999999998 110.227 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -60.19 -45.86 91.69 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.803 -0.635 . . . . 71.420000000000002 110.178 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.32 -36.4 84.01 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.196 -0.911 . . . . 31.52 112.075 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.57 -27.84 51.57 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.119 -0.492 . . . . 53.229999999999997 111.856 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -82.83 -63.6 1.33 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.182 0.808 . . . . 53.030000000000001 113.182 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 . . . . . 0 C--N 1.298 -1.665 0 CA-C-O 118.183 -0.913 . . . . 71.329999999999998 111.743 -170.863 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptp . . . . . 0 C--O 1.236 0.365 0 N-CA-C 109.682 -0.488 . . . . 62.130000000000003 109.682 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -85.94 136.35 5.07 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.134 1.89 . . . . 74.400000000000006 110.042 170.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.459 ' HA3' ' OE1' ' A' ' 97' ' ' GLU . . . -85.34 -46.64 5.47 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 109.777 -1.329 . . . . 32.420000000000002 109.777 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -74.09 132.46 42.31 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.299 -1.001 . . . . 72.219999999999999 108.299 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -172.24 102.94 0.35 Allowed Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 120.572 0.225 . . . . 72.439999999999998 111.221 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.77 116.16 3.15 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.345 2.03 . . . . 71.140000000000001 109.364 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.61 -127.74 2.37 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.407 -0.901 . . . . 71.340000000000003 112.947 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 m -69.88 106.38 3.14 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 123.35 0.66 . . . . 63.109999999999999 112.057 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.9 m -98.43 133.78 42.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.17 -0.678 . . . . 63.420000000000002 109.17 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.36 170.34 12.11 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.485 -0.561 . . . . 65.129999999999995 109.485 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.09 108.73 7.07 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.616 -1.624 . . . . 54.509999999999998 106.616 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -80.39 86.3 5.75 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 114.36 1.245 . . . . 63.549999999999997 114.36 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.57 79.49 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.162 -1.792 . . . . 75.030000000000001 106.162 173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.31 74.92 Favored Glycine 0 C--N 1.307 -1.034 0 N-CA-C 110.422 -1.071 . . . . 44.25 110.422 -175.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.3 m -97.46 129.84 44.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.822 -0.807 . . . . 72.310000000000002 108.822 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 16' ' ' ILE . 3.4 mp -96.91 126.55 42.22 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 107.273 -1.38 . . . . 73.409999999999997 107.273 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -68.69 134.66 30.94 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.191 1.261 . . . . 70.109999999999999 111.139 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.11 139.36 49.83 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.924 -1.51 . . . . 62.340000000000003 106.924 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.24 -129.17 3.52 Favored Glycine 0 N--CA 1.422 -2.254 0 C-N-CA 120.556 -0.83 . . . . 62.200000000000003 111.849 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -109.97 146.75 34.72 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.614 -0.513 . . . . 55.340000000000003 109.614 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.619 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 19.1 t0 -78.44 125.24 29.08 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.349 0.595 . . . . 72.420000000000002 111.456 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.2 t -90.67 -15.09 8.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.922 -1.036 . . . . 70.439999999999998 109.059 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.656 HD21 ' CE1' ' A' ' 103' ' ' PHE . 24.0 mt -85.84 174.4 9.33 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 115.084 1.512 . . . . 63.509999999999998 115.084 -175.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -105.34 141.98 23.75 Favored Pre-proline 0 N--CA 1.423 -1.825 0 CA-C-N 112.379 -2.192 . . . . 74.510000000000005 106.636 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -55.38 -27.05 56.24 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.943 2.429 . . . . 65.219999999999999 114.412 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -91.55 -13.59 31.79 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.389 0.614 . . . . 73.329999999999998 110.755 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.607 ' HG2' HD22 ' A' ' 23' ' ' LEU . 9.0 tp10 -77.85 129.37 76.46 Favored Pre-proline 0 C--O 1.242 0.683 0 N-CA-C 105.562 -2.014 . . . . 73.200000000000003 105.562 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HD2' ' OE2' ' A' ' 27' ' ' GLU . 17.7 Cg_exo -31.08 106.91 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.171 0 C-N-CA 125.204 3.936 . . . . 35.409999999999997 115.381 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.88 155.85 48.27 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.689 -0.687 . . . . 41.32 112.385 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.481 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 22.6 m-85 -129.45 161.38 30.51 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 125.552 1.541 . . . . 74.430000000000007 108.077 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.597 ' OD1' ' HD3' ' A' ' 34' ' ' ARG . 5.5 p-10 -135.13 172.1 13.49 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 106.38 -1.711 . . . . 71.540000000000006 106.38 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -42.98 -61.13 1.89 Allowed Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 115.844 1.794 . . . . 63.140000000000001 115.844 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.1 -34.97 99.06 Favored 'Trans proline' 0 C--N 1.368 1.553 0 C-N-CA 121.915 1.743 . . . . 60.310000000000002 112.764 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.597 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 5.2 mpt_? -70.15 -36.09 74.48 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.88 0.326 . . . . 73.420000000000002 111.88 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.538 HG21 HD12 ' A' ' 66' ' ' ILE . 79.8 t -69.69 -41.78 80.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.661 -0.496 . . . . 74.239999999999995 109.661 177.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.52 91.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.334 -0.848 . . . . 71.150000000000006 109.771 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -62.85 -46.11 89.41 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.838 1.255 . . . . 71.099999999999994 109.791 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.415 HD22 ' CE2' ' A' ' 30' ' ' TYR . 28.2 tp -70.52 -46.03 64.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.787 -1.097 . . . . 73.409999999999997 111.516 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HB2' HG22 ' A' ' 41' ' ' VAL . 98.0 mt -84.51 -18.97 34.06 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.42 0.526 . . . . 72.219999999999999 112.42 -176.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.79 29.57 59.09 Favored Glycine 0 C--O 1.243 0.681 0 N-CA-C 110.81 -0.916 . . . . 51.119999999999997 110.81 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 39' ' ' LEU . 19.4 m -126.51 164.25 35.52 Favored Pre-proline 0 C--N 1.317 -0.847 0 N-CA-C 109.405 -0.591 . . . . 74.140000000000001 109.405 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.99 164.48 27.33 Favored 'Trans proline' 0 C--O 1.252 1.182 0 C-N-CA 121.673 1.582 . . . . 73.329999999999998 111.446 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.54 -34.55 65.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.546 -0.752 . . . . 75.319999999999993 109.422 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.2 m -58.73 -38.9 79.37 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.59 -0.732 . . . . 52.130000000000003 111.851 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 24.3 ttmm -69.49 -37.5 77.27 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.481 -0.488 . . . . 70.239999999999995 110.285 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 59.7 t -63.84 -42.11 94.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.945 -0.761 . . . . 54.130000000000003 108.945 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.71 -36.62 74.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.331 -0.85 . . . . 72.329999999999998 110.556 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -66.8 -46.38 75.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.26 -0.427 . . . . 63.030000000000001 110.577 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 68.3 mt-30 -59.08 -45.95 89.52 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.213 0.53 . . . . 55.149999999999999 110.131 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 96.9 mt -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.627 -1.17 . . . . 52.549999999999997 110.305 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -70.3 -31.24 68.49 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.811 1.041 . . . . 74.209999999999994 113.811 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.71 -11.76 35.94 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.165 -0.614 . . . . 73.349999999999994 112.234 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.71 36.44 6.85 Favored Glycine 0 N--CA 1.434 -1.483 0 C-N-CA 120.318 -0.944 . . . . 73.200000000000003 111.965 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -99.11 -22.37 15.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.444 -0.947 . . . . 62.219999999999999 108.444 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 46.7 tp -157.13 155.26 30.72 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.773 -1.565 . . . . 73.230000000000004 106.773 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.83 161.64 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 118.159 0.436 . . . . 73.439999999999998 110.434 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.37 158.67 43.83 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.281 0.363 . . . . 50.140000000000001 110.21 -175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 m -127.83 165.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 123.343 0.657 . . . . 53.219999999999999 110.142 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -121.57 128.55 52.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.76 0.314 . . . . 61.240000000000002 111.161 -176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.619 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 20.9 ptt180 -136.2 124.2 22.84 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.394 -0.595 . . . . 74.099999999999994 109.394 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.72 14.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.192 0.997 . . . . 63.530000000000001 111.729 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.93 -3.41 84.69 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.933 -0.576 . . . . 60.130000000000003 112.303 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.19 138.09 13.74 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 111.056 -0.818 . . . . 54.409999999999997 111.056 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.6 123.45 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 107.874 -1.158 . . . . 65.239999999999995 107.874 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.2 m -131.22 151.23 35.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 121.345 0.593 . . . . 72.230000000000004 110.936 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.538 HD12 HG21 ' A' ' 35' ' ' VAL . 76.0 mt -124.45 125.5 25.6 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 107.437 -1.32 . . . . 74.129999999999995 107.437 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.415 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 54.4 Cg_exo -56.87 128.98 32.17 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.769 2.313 . . . . 63.439999999999998 112.607 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -64.54 -24.79 67.72 Favored 'General case' 0 C--O 1.212 -0.919 0 C-N-CA 123.421 0.688 . . . . 72.430000000000007 111.206 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.5 m -71.83 -3.67 4.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 115.569 -0.741 . . . . 74.040000000000006 112.425 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.415 ' CD1' ' HB2' ' A' ' 67' ' ' PRO . 5.1 m-85 -87.15 -4.1 59.1 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 122.428 1.109 . . . . 73.530000000000001 108.752 173.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -117.35 150.43 38.85 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 113.979 -1.464 . . . . 75.540000000000006 107.398 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.1 p -83.01 173.03 12.14 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.629 -0.878 . . . . 53.0 108.629 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -65.28 -17.27 64.37 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.411 0.624 . . . . 74.120000000000005 110.62 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -81.27 -3.91 53.92 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.692 -0.686 . . . . 63.219999999999999 111.478 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.95 23.84 58.85 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.77 -0.729 . . . . 41.310000000000002 112.976 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -127.12 154.76 44.33 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.285 -1.005 . . . . 74.329999999999998 108.285 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.8 t -62.6 142.75 16.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 O-C-N 123.62 0.575 . . . . 65.099999999999994 109.635 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.31 135.08 15.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 O-C-N 123.974 0.796 . . . . 63.329999999999998 109.346 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -54.91 -43.66 73.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.852 -0.613 . . . . 54.450000000000003 112.295 -174.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.0 p -98.67 18.35 17.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.904 0.705 . . . . 62.439999999999998 112.904 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -60.6 -52.08 75.27 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-N 116.595 -0.275 . . . . 65.530000000000001 110.803 178.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 19.3 Cg_endo -59.85 -27.92 86.03 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 121.881 1.721 . . . . 70.129999999999995 111.796 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.58 92.93 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 116.098 -0.501 . . . . 50.43 112.084 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.6 pp -68.22 -39.98 82.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.285 0.564 . . . . 65.129999999999995 109.482 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.29 -36.27 83.57 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.785 -0.643 . . . . 62.509999999999998 110.73 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 93.2 m -61.0 -47.8 84.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.358 -0.383 . . . . 73.040000000000006 111.999 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -42.56 86.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 120.67 -0.412 . . . . 71.25 110.607 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.04 -35.62 80.29 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.499 0.555 . . . . 73.540000000000006 112.499 177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -63.9 -33.45 75.74 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 110.026 -0.361 . . . . 73.530000000000001 110.026 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.58 -31.18 71.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.075 -0.511 . . . . 73.109999999999999 110.222 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.97 -9.19 81.17 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.715 -0.675 . . . . 43.340000000000003 111.473 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.12 55.76 3.96 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 112.402 -0.279 . . . . 64.299999999999997 112.402 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 88.7 m-85 -113.77 137.83 51.1 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 112.236 0.458 . . . . 74.540000000000006 112.236 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' O ' HG12 ' A' ' 98' ' ' ILE . 15.4 ptp180 -88.03 172.23 9.7 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.462 -0.79 . . . . 63.310000000000002 111.176 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -53.59 -45.06 69.88 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.267 1.427 . . . . 71.430000000000007 112.425 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.1 m -60.13 -41.57 92.94 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.208 0.603 . . . . 73.010000000000005 110.059 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 5.7 mm-40 -63.21 -43.85 96.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.992 -0.549 . . . . 73.549999999999997 110.412 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.7 mm -61.15 -48.13 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.587 0.708 . . . . 72.230000000000004 109.3 -176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.437 ' O ' ' HD2' ' A' ' 103' ' ' PHE . 53.8 mtt -74.65 -20.97 59.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.138 -0.937 . . . . 71.120000000000005 111.638 -176.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 64.3 ttt180 -57.2 -65.88 0.55 Allowed 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.025 0.53 . . . . 74.209999999999994 110.576 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.486 ' CD1' ' HG3' ' A' ' 144' ' ' MET . 41.0 p-90 -69.02 -33.1 73.1 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.968 0.729 . . . . 72.120000000000005 112.968 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.47 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.1 mt -57.24 -40.5 77.71 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.976 0.732 . . . . 71.25 112.976 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.656 ' CE1' HD21 ' A' ' 23' ' ' LEU . 97.1 m-85 -98.65 3.48 47.82 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.544 0.572 . . . . 72.109999999999999 112.544 -177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 53.3 m -87.44 119.58 70.83 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 109.985 -0.376 . . . . 45.509999999999998 109.985 177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 32.2 Cg_exo -62.74 128.84 24.37 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.616 1.544 . . . . 43.240000000000002 108.348 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . 30.1 t70 -99.99 122.57 50.21 Favored Pre-proline 0 C--N 1.288 -2.069 0 C-N-CA 120.301 -0.56 . . . . 72.430000000000007 110.209 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.4 -19.53 59.08 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.411 2.741 . . . . 65.140000000000001 113.7 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.5 p -107.6 3.86 25.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 111.919 0.34 . . . . 64.030000000000001 111.919 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.4 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 53.5 tp -102.64 130.6 49.59 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.74 0.781 . . . . 71.310000000000002 110.979 -177.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.538 HG22 ' HB1' ' A' ' 119' ' ' ALA . 29.9 m -131.28 118.65 20.66 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.476 -1.305 . . . . 41.43 107.476 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.1 163.6 33.86 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 N-CA-C 113.156 0.799 . . . . 65.420000000000002 113.156 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 60.9 p -109.4 159.95 16.58 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.306 -0.861 . . . . 75.209999999999994 109.198 -174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.02 -173.53 3.17 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.024 -1.102 . . . . 75.200000000000003 108.024 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -89.2 150.03 22.85 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.426 -0.583 . . . . 75.239999999999995 109.426 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.19 -69.22 3.06 Favored Glycine 0 C--N 1.312 -0.782 0 N-CA-C 109.271 -1.532 . . . . 43.340000000000003 109.271 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 53.2 p -98.1 101.61 13.13 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.102 -1.444 . . . . 74.299999999999997 107.102 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.536 ' HD3' ' H ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -89.72 3.68 51.99 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.872 -0.604 . . . . 74.510000000000005 112.326 -172.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -73.61 142.17 46.55 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.063 -1.088 . . . . 74.430000000000007 108.063 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -81.95 123.65 29.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.272 0.558 . . . . 74.319999999999993 111.307 -177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.2 t -96.59 128.73 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 C-N-CA 124.441 1.096 . . . . 75.450000000000003 109.065 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 p -83.21 154.46 24.22 Favored 'General case' 0 C--N 1.285 -2.226 0 CA-C-N 115.059 -0.973 . . . . 70.230000000000004 111.337 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 78.8 m-20 62.44 40.81 10.56 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.481 1.112 . . . . 74.120000000000005 110.949 176.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.71 174.41 6.07 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.16 -0.473 . . . . 62.109999999999999 110.858 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -102.69 143.74 27.21 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 116.379 -0.373 . . . . 75.340000000000003 111.077 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.5 Cg_exo -53.36 -24.32 27.07 Favored 'Trans proline' 0 CA--C 1.556 1.612 0 C-N-CA 123.847 3.031 . . . . 70.409999999999997 114.595 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.63 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 71.2 t -60.4 -39.83 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-O 122.158 0.98 . . . . 65.109999999999999 110.405 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.18 -30.47 67.6 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.052 -0.976 . . . . 74.209999999999994 110.381 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.17 77.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.704 -0.68 . . . . 71.340000000000003 111.422 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.71 -36.27 82.11 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.932 -0.307 . . . . 64.439999999999998 111.599 -177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -66.57 -29.13 69.12 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.68 0.752 . . . . 73.120000000000005 109.963 176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.89 0.38 53.24 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.883 -1.053 . . . . 44.43 111.608 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.7 t60 64.55 28.7 13.34 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-O 122.868 1.318 . . . . 51.420000000000002 109.572 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -95.02 25.13 4.35 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.788 1.28 . . . . 73.120000000000005 108.282 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -53.89 -29.39 41.55 Favored 'General case' 0 C--O 1.213 -0.838 0 CA-C-N 113.508 -1.678 . . . . 54.439999999999998 113.491 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -63.61 -37.55 87.75 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.931 -0.766 . . . . 71.140000000000001 108.931 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -63.18 -42.56 99.38 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.231 -0.895 . . . . 70.129999999999995 109.173 175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.3 t -64.43 -47.93 87.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.585 -0.734 . . . . 71.299999999999997 110.342 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 134' ' ' ALA . 99.1 t -59.38 -44.77 93.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 CA-C-N 116.434 -0.348 . . . . 73.299999999999997 111.416 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -63.68 -38.4 90.96 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 119.944 -0.702 . . . . 74.140000000000001 111.361 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 46.6 mmm-85 -69.0 -36.52 77.91 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.829 -0.434 . . . . 72.109999999999999 109.829 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.37 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.717 -0.674 . . . . 73.099999999999994 109.877 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -59.74 -42.88 94.18 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 115.939 -0.573 . . . . 52.450000000000003 111.015 176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.68 -25.96 65.95 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.23 0.538 . . . . 52.119999999999997 111.486 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.486 ' HG3' ' CD1' ' A' ' 101' ' ' TRP . 0.5 OUTLIER -82.18 -39.75 22.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.449 0.642 . . . . 61.109999999999999 109.421 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -81.54 -40.75 22.66 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.782 0.66 . . . . 75.420000000000002 112.782 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--N 1.301 -1.529 0 N-CA-C 109.453 -0.573 . . . . 74.239999999999995 109.453 -177.873 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 108.824 -0.806 . . . . 62.039999999999999 108.824 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -68.98 115.7 4.11 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 121.847 1.698 . . . . 71.209999999999994 110.72 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.61 133.7 5.7 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.97 -0.633 . . . . 43.399999999999999 111.695 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -73.34 144.23 46.58 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 110.124 -0.324 . . . . 71.530000000000001 110.124 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.29 137.49 48.88 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.712 -0.847 . . . . 72.049999999999997 108.712 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -52.63 153.91 13.26 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 123.218 2.612 . . . . 54.140000000000001 112.483 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.62 82.29 0.29 Allowed Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.915 -0.584 . . . . 41.43 113.38 -176.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.5 m -144.55 158.87 43.57 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.523 -1.288 . . . . 74.230000000000004 107.523 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -162.84 -161.13 0.68 Allowed 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.194 -1.41 . . . . 72.140000000000001 107.194 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.5 mt -73.61 145.02 45.73 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.288 -0.634 . . . . 73.310000000000002 109.288 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.04 11.38 37.78 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.5 0.666 . . . . 73.209999999999994 111.462 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -88.5 107.84 19.09 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.446 -0.797 . . . . 64.010000000000005 109.229 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.94 116.74 53.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 108.024 -1.102 . . . . 54.219999999999999 108.024 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.8 -165.97 23.34 Favored Glycine 0 N--CA 1.412 -2.933 0 CA-C-N 115.5 -0.773 . . . . 74.209999999999994 111.781 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 51' ' ' ARG . 6.9 m -65.57 108.52 2.06 Favored 'General case' 0 C--N 1.272 -2.8 0 C-N-CA 124.166 0.986 . . . . 74.230000000000004 112.87 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.66 124.06 89.95 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 107.27 -1.382 . . . . 50.210000000000001 107.27 170.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.04 166.26 30.03 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.084 2.523 . . . . 74.319999999999993 113.021 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -116.85 123.23 46.55 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.361 -1.718 . . . . 73.040000000000006 106.361 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.6 -110.96 2.97 Favored Glycine 0 N--CA 1.413 -2.893 0 C-N-CA 120.581 -0.819 . . . . 71.030000000000001 113.327 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.36 123.18 38.75 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.256 0.55 . . . . 75.129999999999995 111.879 -171.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 23' ' ' LEU . 3.5 t70 -61.29 131.94 51.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.285 -0.871 . . . . 71.209999999999994 111.75 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.06 -4.78 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 122.07 0.938 . . . . 72.109999999999999 109.29 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HB2' ' OD1' ' A' ' 21' ' ' ASP . 17.6 mt -74.98 165.15 25.71 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.618 1.199 . . . . 72.319999999999993 113.941 -175.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 8.3 t70 -94.26 134.66 25.37 Favored Pre-proline 0 C--N 1.291 -1.962 0 N-CA-C 105.314 -2.106 . . . . 72.129999999999995 105.314 172.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.84 -21.75 27.14 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 123.406 2.738 . . . . 52.520000000000003 114.572 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -87.86 -23.85 23.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.208 0.447 . . . . 54.43 112.208 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 23.2 mm-40 -65.87 139.22 96.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 121.07 -0.252 . . . . 65.530000000000001 111.676 -176.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.1 128.0 28.36 Favored 'Trans proline' 0 C--O 1.251 1.173 0 C-N-CA 123.351 2.701 . . . . 71.129999999999995 113.102 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.5 p -122.94 170.07 10.5 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-O 121.629 0.728 . . . . 73.319999999999993 111.484 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 24.9 m-85 -130.36 161.21 31.83 Favored 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 126.401 1.88 . . . . 71.299999999999997 107.851 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 66.3 t0 -135.03 161.74 34.44 Favored 'General case' 0 C--N 1.271 -2.839 0 N-CA-C 103.346 -2.835 . . . . 73.150000000000006 103.346 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.5 mt -53.12 -51.44 75.05 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 112.672 0.619 . . . . 72.409999999999997 112.672 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.31 -35.37 98.77 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.161 1.907 . . . . 55.509999999999998 112.2 174.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 13.5 tpt180 -70.78 -38.54 73.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.48 -0.327 . . . . 73.430000000000007 110.697 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG21 HD12 ' A' ' 66' ' ' ILE . 59.5 t -68.15 -37.46 78.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 109.602 -0.518 . . . . 53.210000000000001 109.602 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.89 81.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.289 -0.869 . . . . 64.439999999999998 109.68 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.8 -45.96 80.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.203 -0.908 . . . . 45.240000000000002 109.68 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.417 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 49.7 tp -62.31 -50.66 70.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.906 -1.043 . . . . 71.340000000000003 112.3 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.43 -13.92 41.94 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 112.469 0.544 . . . . 73.120000000000005 112.469 -175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.44 31.5 56.72 Favored Glycine 0 C--N 1.311 -0.85 0 N-CA-C 110.947 -0.861 . . . . 73.319999999999993 110.947 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.6 m -121.98 161.26 43.38 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 108.529 -0.915 . . . . 75.239999999999995 108.529 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.07 163.47 35.13 Favored 'Trans proline' 0 C--O 1.262 1.681 0 C-N-CA 121.393 1.395 . . . . 63.119999999999997 111.673 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.19 -33.21 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.82 0.848 . . . . 70.420000000000002 109.526 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 13.4 m -57.03 -44.38 82.86 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.728 -1.124 . . . . 63.399999999999999 110.617 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 51.8 mtpt -69.4 -32.04 70.79 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 122.101 -0.374 . . . . 71.420000000000002 111.425 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.485 ' HA ' HE21 ' A' ' 49' ' ' GLN . 47.2 t -62.43 -44.38 99.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 109.593 -0.521 . . . . 74.219999999999999 109.593 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.4 -36.83 81.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.761 -0.654 . . . . 64.519999999999996 109.996 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 44' ' ' SER . 25.7 mt-30 -64.51 -41.43 96.43 Favored 'General case' 0 C--O 1.208 -1.086 0 CA-C-N 116.275 -0.42 . . . . 74.319999999999993 111.543 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.485 HE21 ' HA ' ' A' ' 46' ' ' VAL . 43.7 mt-30 -61.04 -42.14 97.92 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.802 0.81 . . . . 74.319999999999993 109.961 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -62.24 -41.19 98.2 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.074 -1.421 . . . . 72.530000000000001 109.696 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 15' ' ' SER . 97.0 mtt180 -71.57 -21.97 61.81 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.77 -0.65 . . . . 74.019999999999996 112.291 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 50.9 mt-10 -81.71 -12.68 58.53 Favored 'General case' 0 C--N 1.319 -0.735 0 O-C-N 122.103 -0.373 . . . . 61.109999999999999 110.64 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.2 23.35 77.73 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.52 -1.032 . . . . 74.310000000000002 110.52 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -109.26 5.54 23.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.394 0.616 . . . . 74.450000000000003 110.523 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.5 tp -153.6 151.57 29.88 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.279 -1.749 . . . . 75.510000000000005 106.279 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 78.1 t -138.01 148.76 24.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.317 -0.623 . . . . 73.109999999999999 109.317 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB2' HG12 ' A' ' 66' ' ' ILE . . . -141.62 161.8 37.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.972 -0.751 . . . . 44.420000000000002 108.972 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.63 160.31 41.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 123.343 0.402 . . . . 60.420000000000002 110.445 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 40.2 ttm180 -115.34 117.84 31.58 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 121.393 0.616 . . . . 75.040000000000006 111.698 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 26.2 ptt180 -127.96 130.07 47.81 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.077 -0.712 . . . . 75.0 109.077 177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.05 21.63 12.65 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.945 0.898 . . . . 74.049999999999997 110.384 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.14 -15.06 64.02 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.841 -0.618 . . . . 42.240000000000002 112.731 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.45 143.1 16.52 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.02 -0.61 . . . . 32.420000000000002 112.244 -177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.14 121.41 47.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 109.366 -0.605 . . . . 72.219999999999999 109.366 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.8 m -131.43 152.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 115.605 -0.725 . . . . 74.230000000000004 110.892 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 57' ' ' ALA . 78.9 mt -115.1 133.48 22.67 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.283 -1.006 . . . . 72.239999999999995 108.283 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.12 130.33 19.92 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.755 1.637 . . . . 72.510000000000005 111.156 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.432 HE21 ' HB2' ' A' ' 68' ' ' GLN . 7.2 tt0 -62.59 -24.56 67.62 Favored 'General case' 0 C--O 1.215 -0.749 0 CA-C-O 121.164 0.507 . . . . 73.019999999999996 111.181 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 m -67.38 -6.97 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.684 -0.689 . . . . 63.340000000000003 112.707 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.571 ' CD2' HD11 ' A' ' 81' ' ' LEU . 5.2 m-85 -81.56 -11.24 59.23 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.217 1.008 . . . . 65.310000000000002 109.24 173.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -113.06 164.2 13.77 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.676 -1.147 . . . . 73.340000000000003 108.291 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.49 ' HA ' ' CD2' ' A' ' 130' ' ' HIS . 37.5 p -82.34 165.97 19.87 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.131 -0.692 . . . . 74.120000000000005 109.131 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -64.71 -19.14 65.59 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.047 -0.524 . . . . 72.209999999999994 109.627 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.6 m -79.51 -19.9 48.51 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.576 -0.738 . . . . 71.310000000000002 110.229 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.46 -5.96 38.47 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.436 -0.888 . . . . 70.530000000000001 113.75 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.84 166.2 11.74 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 122.086 -0.655 . . . . 74.129999999999995 109.489 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.05 139.91 20.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.757 -0.831 . . . . 64.150000000000006 108.757 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.76 136.74 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.231 -1.026 . . . . 75.400000000000006 108.231 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -54.77 -36.56 64.98 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 112.535 0.569 . . . . 52.219999999999999 112.535 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.6 p -88.11 -0.76 57.46 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 112.638 0.607 . . . . 64.439999999999998 112.638 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 70' ' ' PHE . 20.3 tp -65.36 -53.64 37.55 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 119.37 -0.348 . . . . 64.409999999999997 111.809 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 38.6 Cg_exo -60.28 -30.9 92.12 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.694 1.596 . . . . 73.329999999999998 111.304 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.44 -45.49 90.01 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.864 -0.607 . . . . 71.040000000000006 112.838 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 pp -68.39 -40.5 81.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.394 0.616 . . . . 72.430000000000007 109.355 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -63.34 -41.28 98.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.591 -0.731 . . . . 60.310000000000002 110.833 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -57.77 -47.72 81.74 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.477 -0.329 . . . . 71.400000000000006 111.795 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -42.11 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 120.812 -0.355 . . . . 65.430000000000007 111.345 -177.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.36 -37.17 82.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.467 0.543 . . . . 75.319999999999993 112.467 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -66.83 -32.29 73.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.664 -0.244 . . . . 74.349999999999994 111.08 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.19 -29.91 71.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.294 0.569 . . . . 63.25 109.778 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.77 6.42 64.71 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.556 -0.747 . . . . 54.409999999999997 112.394 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.31 33.43 84.98 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.465 0.546 . . . . 73.150000000000006 114.465 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 57.8 m-85 -85.85 131.63 34.27 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 117.626 0.713 . . . . 75.329999999999998 112.344 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.566 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 21.8 ptt180 -73.32 170.45 15.01 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-N 115.345 -0.843 . . . . 75.450000000000003 111.215 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -55.02 -44.84 74.98 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 125.899 1.679 . . . . 54.310000000000002 112.013 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.9 m -62.64 -42.1 99.41 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.085 -0.961 . . . . 72.540000000000006 110.628 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.566 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 61.7 mm-40 -66.6 -34.74 78.56 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.108 -0.496 . . . . 61.310000000000002 110.328 -177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.46 -48.42 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.741 0.781 . . . . 74.340000000000003 108.93 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 55.1 mtt -75.13 -18.43 60.22 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.91 -1.041 . . . . 73.150000000000006 111.894 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -60.73 -63.46 1.29 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.989 -0.55 . . . . 72.129999999999995 110.574 -174.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.514 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 31.3 p-90 -69.32 -32.82 72.19 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 112.129 0.418 . . . . 73.430000000000007 112.129 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 12.2 mt -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.95 1.093 . . . . 74.340000000000003 113.95 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.402 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 84.0 m-85 -95.75 -2.95 46.75 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 113.008 0.744 . . . . 72.430000000000007 113.008 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.2 m -88.57 109.79 32.0 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 110.193 -0.299 . . . . 60.200000000000003 110.193 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.451 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 42.9 Cg_exo -60.09 144.66 99.46 Favored 'Trans proline' 0 C--O 1.246 0.914 0 C-N-CA 122.892 2.395 . . . . 75.049999999999997 111.626 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 11.0 t70 -107.47 124.0 36.37 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 109.626 -0.509 . . . . 71.319999999999993 109.626 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.526 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 28.3 Cg_endo -60.62 -25.83 81.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.658 2.905 . . . . 65.340000000000003 114.513 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.6 m -102.41 1.49 35.43 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 120.984 0.421 . . . . 74.209999999999994 110.247 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.493 ' HG ' HG12 ' A' ' 111' ' ' ILE . 43.0 tp -101.66 130.58 48.04 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 109.601 -0.518 . . . . 63.509999999999998 109.601 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.524 HG22 ' HB1' ' A' ' 119' ' ' ALA . 25.3 m -128.04 110.54 12.59 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.802 -0.814 . . . . 63.520000000000003 108.802 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.493 HG12 ' HG ' ' A' ' 109' ' ' LEU . 39.9 mm -122.88 149.51 26.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.288 -0.869 . . . . 74.239999999999995 109.88 -172.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -102.61 153.1 20.43 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.897 -1.519 . . . . 62.439999999999998 106.897 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.617 ' HD3' ' N ' ' A' ' 114' ' ' ASP . 2.7 tmt_? -134.89 152.48 51.78 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.56 -0.856 . . . . 72.209999999999994 110.32 -171.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.617 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 10.8 m-20 -63.66 99.37 0.22 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.483 -0.932 . . . . 71.310000000000002 108.483 174.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 130.77 -37.68 2.07 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 110.037 -1.225 . . . . 74.409999999999997 110.037 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.0 m -122.09 96.55 5.1 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.752 -0.832 . . . . 71.120000000000005 108.752 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -69.8 -33.9 72.99 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.228 0.537 . . . . 75.109999999999999 109.863 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.2 133.04 55.73 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.224 -1.353 . . . . 74.340000000000003 107.747 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.524 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -67.07 135.08 53.09 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.968 0.413 . . . . 65.319999999999993 110.696 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 58.6 t -106.78 118.71 55.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 109.342 -0.614 . . . . 73.400000000000006 109.342 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.9 t -83.04 148.87 27.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.746 -1.575 . . . . 61.149999999999999 106.746 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.542 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 34.2 m-80 66.99 41.37 2.7 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 123.828 0.851 . . . . 75.310000000000002 109.08 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.63 150.38 26.86 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.463 -0.495 . . . . 63.350000000000001 110.754 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -80.36 128.1 73.96 Favored Pre-proline 0 C--N 1.312 -1.056 0 N-CA-C 108.629 -0.878 . . . . 75.349999999999994 108.629 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -49.53 -24.1 8.7 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.063 3.175 . . . . 75.439999999999998 115.11 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.6 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.1 t -60.62 -39.1 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.267 0.556 . . . . 74.120000000000005 110.419 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -69.95 -30.27 67.61 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.187 -0.461 . . . . 74.209999999999994 111.149 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.89 -46.36 82.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.699 -0.682 . . . . 73.109999999999999 111.17 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -63.95 -37.68 88.31 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.501 0.191 . . . . 74.200000000000003 111.307 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.49 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 61.1 t-80 -68.7 -36.79 78.92 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 115.741 -0.663 . . . . 73.319999999999993 109.301 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.14 21.2 5.25 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.342 -0.845 . . . . 74.129999999999995 112.773 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.8 t60 64.69 27.64 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.77 1.228 . . . . 70.400000000000006 111.361 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -110.53 24.42 12.99 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.965 1.364 . . . . 62.240000000000002 107.635 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.62 -25.91 12.07 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 112.416 -2.174 . . . . 74.319999999999993 112.627 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -54.78 -39.33 68.28 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.54 0.736 . . . . 54.340000000000003 110.75 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -68.35 -33.71 74.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.383 0.611 . . . . 73.420000000000002 111.072 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 129' ' ' LEU . 49.7 t -72.59 -41.96 63.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.48 -0.782 . . . . 75.239999999999995 109.651 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.7 -48.06 89.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 116.234 -0.439 . . . . 71.540000000000006 110.264 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -63.59 -37.85 88.88 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.746 -0.382 . . . . 70.349999999999994 111.428 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -65.02 -41.58 95.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.644 -0.873 . . . . 71.239999999999995 108.644 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.47 -45.08 88.95 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.103 -0.953 . . . . 74.230000000000004 110.262 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -62.13 -38.62 89.65 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 115.844 -0.616 . . . . 74.340000000000003 111.248 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.45 -38.21 84.14 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.05 0.453 . . . . 71.329999999999998 110.51 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.8 tpt -69.64 -39.28 77.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.809 -0.632 . . . . 61.020000000000003 110.736 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.94 -53.79 5.08 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.353 0.872 . . . . 62.25 113.353 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 118.691 -0.671 . . . . 73.109999999999999 109.426 -176.189 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 109.437 -0.579 . . . . 72.439999999999998 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.31 122.69 6.22 Favored 'Trans proline' 0 C--O 1.246 0.906 0 C-N-CA 122.219 1.946 . . . . 73.519999999999996 110.214 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -167.1 126.25 1.42 Allowed Glycine 0 N--CA 1.419 -2.473 0 N-CA-C 110.65 -0.98 . . . . 53.229999999999997 110.65 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -73.97 139.15 44.64 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.066 -0.716 . . . . 75.109999999999999 109.066 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.88 121.08 77.34 Favored Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 109.122 -0.696 . . . . 43.039999999999999 109.122 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -67.66 119.37 6.39 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.754 1.636 . . . . 64.200000000000003 110.815 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.56 -43.5 36.53 Favored Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 111.129 -0.788 . . . . 71.040000000000006 111.129 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m -69.98 99.91 1.51 Allowed 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.219 0.533 . . . . 72.140000000000001 109.746 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.6 m -120.97 138.88 53.93 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.618 -1.253 . . . . 72.200000000000003 107.618 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.0 mt -79.89 145.97 32.41 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 109.764 -0.458 . . . . 72.510000000000005 109.764 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.23 146.45 27.07 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 116.085 -0.507 . . . . 51.109999999999999 109.701 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.12 107.87 16.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.529 -0.915 . . . . 64.019999999999996 108.529 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.3 m -130.88 109.33 16.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 108.863 -0.792 . . . . 71.109999999999999 108.863 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.27 99.38 0.2 Allowed Glycine 0 N--CA 1.418 -2.526 0 C-N-CA 120.271 -0.966 . . . . 64.319999999999993 111.238 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.0 p -72.66 95.24 1.84 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.179 -0.675 . . . . 53.119999999999997 109.179 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.69 120.95 76.03 Favored Pre-proline 0 N--CA 1.437 -1.084 0 CA-C-N 115.484 -0.78 . . . . 73.209999999999994 109.918 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.72 165.07 29.34 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.467 2.112 . . . . 75.109999999999999 110.718 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.75 123.92 42.18 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.963 -1.125 . . . . 65.230000000000004 107.963 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -105.4 -86.72 1.94 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.336 -0.935 . . . . 65.519999999999996 112.796 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -127.53 143.54 51.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.832 0.349 . . . . 74.230000000000004 111.123 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -75.82 139.07 41.55 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.553 0.692 . . . . 72.409999999999997 112.369 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 67.9 t -112.12 -14.9 10.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.295 -0.866 . . . . 74.109999999999999 110.894 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.485 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -96.09 -179.63 4.74 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 118.922 -1.111 . . . . 65.099999999999994 111.657 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -106.64 137.08 19.36 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 108.05 -1.093 . . . . 73.519999999999996 108.05 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.88 -21.35 15.22 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.571 2.848 . . . . 62.549999999999997 114.191 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.05 -19.52 61.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.085 0.469 . . . . 64.129999999999995 111.51 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -88.5 154.68 51.16 Favored Pre-proline 0 C--N 1.308 -1.206 0 CA-C-O 119.296 -0.383 . . . . 75.319999999999993 110.017 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 4.0 Cg_endo -46.24 110.13 0.25 Allowed 'Trans proline' 0 CA--C 1.553 1.455 0 C-N-CA 123.984 3.123 . . . . 54.299999999999997 114.992 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.0 p -125.0 167.34 14.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.794 0.838 . . . . 75.409999999999997 110.686 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.499 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 13.0 m-85 -131.4 158.2 41.39 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.307 1.043 . . . . 72.209999999999994 108.193 169.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' VAL . 9.5 t70 -136.95 168.82 18.85 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 104.281 -2.488 . . . . 62.32 104.281 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -50.6 -56.61 17.65 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 113.964 1.098 . . . . 61.43 113.964 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 14.6 Cg_endo -57.74 -39.8 84.53 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.205 1.936 . . . . 72.549999999999997 112.346 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -70.38 -37.54 74.55 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 111.972 0.36 . . . . 65.420000000000002 111.972 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 31' ' ' ASP . 46.1 t -69.3 -37.64 76.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.061 -0.718 . . . . 72.030000000000001 109.061 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.14 83.89 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.889 -1.051 . . . . 52.409999999999997 109.704 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.7 -45.94 84.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.875 0.87 . . . . 73.109999999999999 110.061 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.8 tp -62.07 -43.33 99.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.84 -1.073 . . . . 53.409999999999997 111.903 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.547 ' HB2' HG22 ' A' ' 41' ' ' VAL . 83.5 mt -97.31 -12.56 22.72 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.939 -0.573 . . . . 72.010000000000005 112.097 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.3 17.15 80.18 Favored Glycine 0 C--O 1.236 0.271 0 N-CA-C 111.538 -0.625 . . . . 71.109999999999999 111.538 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' A' ' 39' ' ' LEU . 25.8 m -112.48 159.45 34.05 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 108.73 -0.841 . . . . 71.329999999999998 108.73 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.4 170.01 20.16 Favored 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 121.208 1.272 . . . . 72.010000000000005 111.246 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -57.08 -33.16 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.387 0.675 . . . . 71.140000000000001 110.484 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.8 m -56.35 -46.33 80.03 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 114.916 -1.038 . . . . 75.420000000000002 110.197 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 92.5 mttt -69.97 -35.27 74.32 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.032 0.382 . . . . 75.140000000000001 112.032 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -61.15 -43.72 96.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.145 0 N-CA-C 109.548 -0.538 . . . . 73.510000000000005 109.548 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' O ' ' HD3' ' A' ' 51' ' ' ARG . . . -61.04 -38.88 87.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.423 -0.808 . . . . 74.530000000000001 109.833 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.566 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 13.3 mm100 -66.84 -36.35 82.13 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 112.91 0.707 . . . . 74.129999999999995 112.91 178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.0 mm100 -57.87 -42.8 85.3 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.726 -0.842 . . . . 74.0 108.726 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.53 -40.61 97.33 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.4 -1.273 . . . . 64.030000000000001 110.662 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 47' ' ' ALA . 10.2 mpt_? -71.21 -20.87 62.21 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.228 0.825 . . . . 75.209999999999994 113.228 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 44.5 mm-40 -76.66 -11.87 59.92 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 120.525 -0.47 . . . . 75.010000000000005 109.824 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.72 72.15 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 110.944 -0.863 . . . . 61.340000000000003 110.944 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -105.46 4.28 30.45 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.119 -0.541 . . . . 74.109999999999999 110.206 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD21 HD13 ' A' ' 66' ' ' ILE . 32.2 tp -161.12 157.51 26.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.612 -0.884 . . . . 41.409999999999997 108.612 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 93.9 t -132.82 147.07 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.362 -0.977 . . . . 53.140000000000001 108.362 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.72 157.85 43.85 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.886 -0.783 . . . . 73.0 108.886 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 m -130.46 166.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 122.92 0.488 . . . . 74.439999999999998 110.21 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 43.8 ttp180 -121.07 125.68 47.91 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 116.59 -0.277 . . . . 62.130000000000003 110.801 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.486 ' NH1' HG13 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -116.62 117.09 28.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.69 -0.855 . . . . 70.420000000000002 108.69 177.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.96 -48.06 0.68 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 126.083 1.753 . . . . 44.439999999999998 111.583 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 63' ' ' GLY . . . -176.23 -12.07 0.02 OUTLIER Glycine 0 C--N 1.291 -1.966 0 CA-C-N 114.738 -1.119 . . . . 53.130000000000003 112.287 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 62' ' ' GLY . . . -103.53 146.06 16.35 Favored Glycine 0 CA--C 1.493 -1.339 0 C-N-CA 120.634 -0.793 . . . . 71.329999999999998 112.122 -176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -96.49 128.8 47.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.203 0.525 . . . . 72.219999999999999 109.771 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG13 ' NH1' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -131.54 158.75 43.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.698 1.199 . . . . 72.25 110.107 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.414 HD13 HD21 ' A' ' 55' ' ' LEU . 65.2 mt -124.77 121.93 25.64 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.114 -1.439 . . . . 63.130000000000003 107.114 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.67 126.67 22.54 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.057 1.838 . . . . 73.030000000000001 111.192 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.499 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.7 tt0 -62.22 -24.65 67.36 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-O 121.261 0.553 . . . . 74.430000000000007 111.447 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.68 -4.54 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.28 0 CA-C-N 115.092 -0.958 . . . . 54.310000000000002 112.665 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.1 m-85 -86.29 -7.64 58.34 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.073 0.939 . . . . 74.430000000000007 109.848 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -117.11 159.98 21.73 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.119 . . . . 74.129999999999995 107.994 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.0 p -88.02 163.37 16.32 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.823 -1.177 . . . . 62.509999999999998 107.823 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -66.26 -16.45 64.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.305 0.574 . . . . 72.430000000000007 110.382 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.2 m -79.72 -9.5 59.66 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 115.777 -0.647 . . . . 74.219999999999999 110.898 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.86 -2.43 66.54 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.304 -0.474 . . . . 51.420000000000002 113.164 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -90.37 152.84 20.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.505 -0.554 . . . . 71.109999999999999 109.505 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -72.53 136.19 26.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.259 -1.386 . . . . 72.310000000000002 107.259 171.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG21 HD13 ' A' ' 129' ' ' LEU . 23.8 t -61.25 129.06 23.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.443 -0.947 . . . . 45.520000000000003 108.443 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.41 -22.33 66.08 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.751 0.648 . . . . 72.0 112.751 -177.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.441 ' H ' HG12 ' A' ' 78' ' ' VAL . 7.1 m -87.75 -8.21 56.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.963 -0.562 . . . . 64.239999999999995 110.777 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 18.0 tp -63.45 -56.44 26.77 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 119.015 -0.517 . . . . 54.119999999999997 111.248 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.0 Cg_exo -62.83 -25.2 74.51 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.331 1.354 . . . . 72.329999999999998 110.706 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -45.36 64.57 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.602 -0.726 . . . . 45.439999999999998 111.721 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 pp -68.81 -40.43 79.54 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.996 -0.742 . . . . 73.239999999999995 108.996 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 74.0 mt -59.91 -39.17 84.48 Favored 'General case' 0 C--O 1.217 -0.634 0 CA-C-N 115.766 -0.652 . . . . 65.420000000000002 110.802 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 95.2 m -61.47 -48.36 81.48 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.054 -0.521 . . . . 71.340000000000003 111.399 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -44.41 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 111.862 0.319 . . . . 74.319999999999993 111.862 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.27 -35.79 80.24 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 120.177 -0.609 . . . . 62.350000000000001 112.225 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -64.27 -41.48 96.9 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.616 -0.883 . . . . 70.040000000000006 108.616 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.19 -31.2 72.25 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 114.96 -1.018 . . . . 74.530000000000001 110.58 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.38 -9.45 81.77 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.64 -0.709 . . . . 60.450000000000003 112.893 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.9 46.09 7.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 121.088 -0.577 . . . . 72.329999999999998 113.723 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.439 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 96.6 m-85 -111.0 142.92 42.48 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.895 -0.409 . . . . 74.019999999999996 109.895 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.476 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 16.9 ptp180 -87.94 171.03 10.63 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.558 -0.292 . . . . 74.310000000000002 111.141 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -55.05 -45.79 75.31 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.856 1.262 . . . . 65.0 111.87 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.8 m -64.5 -39.99 94.82 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.188 -0.915 . . . . 72.5 110.41 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.476 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 45.3 mt-10 -65.82 -35.1 79.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.079 -0.51 . . . . 74.209999999999994 111.615 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.28 -46.97 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 107.855 -1.165 . . . . 74.409999999999997 107.855 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 23.1 mmt -66.33 -28.64 68.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.028 -1.442 . . . . 64.120000000000005 111.029 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -54.0 -67.33 0.27 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 122.877 0.471 . . . . 75.310000000000002 111.037 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.457 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 43.3 p-90 -69.05 -32.1 71.35 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.89 0.7 . . . . 75.420000000000002 112.89 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 126' ' ' VAL . 13.6 mt -61.22 -40.78 95.3 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 113.097 0.777 . . . . 72.420000000000002 113.097 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.5 m-85 -91.46 -5.4 54.35 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.803 0.668 . . . . 74.25 112.803 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 92.4 m -78.15 119.94 79.29 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 108.963 -0.754 . . . . 71.329999999999998 108.963 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.14 129.5 20.68 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.579 1.519 . . . . 74.400000000000006 109.426 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.604 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 34.4 t70 -105.41 116.59 60.0 Favored Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 116.388 -0.369 . . . . 74.150000000000006 111.012 -175.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -61.19 -25.26 80.56 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.728 2.286 . . . . 70.209999999999994 112.084 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -17.72 59.63 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.931 -0.577 . . . . 62.420000000000002 110.511 -177.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.3 tp -101.96 125.63 48.69 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 121.766 0.793 . . . . 65.299999999999997 110.828 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 m -131.28 110.87 11.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.365 -1.346 . . . . 64.209999999999994 107.365 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.4 pt -136.64 163.31 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.872 0 N-CA-C 112.739 0.644 . . . . 64.120000000000005 112.739 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.0 p -90.45 127.57 36.25 Favored 'General case' 0 N--CA 1.407 -2.623 0 CA-C-N 114.825 -1.08 . . . . 70.239999999999995 108.089 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.542 ' HD3' ' N ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -80.54 130.49 35.16 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.697 -0.401 . . . . 73.519999999999996 110.475 -172.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.542 ' N ' ' HD3' ' A' ' 113' ' ' ARG . 22.5 t70 -58.31 119.76 7.49 Favored 'General case' 0 C--O 1.246 0.907 0 C-N-CA 123.649 0.779 . . . . 71.530000000000001 111.033 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.45 -12.56 47.44 Favored Glycine 0 N--CA 1.434 -1.485 0 N-CA-C 110.506 -1.038 . . . . 70.349999999999994 110.506 -178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.9 m -125.42 161.34 27.28 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 109.27 -0.641 . . . . 73.239999999999995 109.27 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -96.74 -22.12 17.16 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 109.153 -0.684 . . . . 74.439999999999998 109.153 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -66.56 151.34 47.48 Favored 'General case' 0 C--O 1.248 0.99 0 CA-C-N 114.235 -1.348 . . . . 72.420000000000002 113.317 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.16 131.08 46.31 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.608 -1.178 . . . . 61.130000000000003 108.26 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.78 121.59 62.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.097 -0.705 . . . . 72.239999999999995 109.097 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 m -90.1 138.66 31.33 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.775 -1.194 . . . . 73.439999999999998 107.775 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 44.6 t-20 69.39 59.23 0.32 Allowed 'General case' 0 C--O 1.245 0.831 0 CA-C-O 122.34 1.067 . . . . 70.510000000000005 109.134 176.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.66 164.09 11.84 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 114.689 -1.141 . . . . 74.219999999999999 109.9 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -87.55 145.85 38.17 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.464 -0.569 . . . . 70.109999999999999 109.464 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.402 ' HB2' HD23 ' A' ' 102' ' ' LEU . 79.7 Cg_exo -52.53 -28.84 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.403 2.735 . . . . 75.329999999999998 113.708 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.654 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 95.8 t -60.34 -41.99 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.242 0.544 . . . . 73.310000000000002 110.146 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.415 ' OD2' ' HG2' ' A' ' 113' ' ' ARG . 3.9 t70 -65.01 -30.04 70.99 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.601 0.715 . . . . 72.530000000000001 109.796 -172.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.23 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.222 -0.899 . . . . 63.149999999999999 112.316 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 3.9 pp -68.14 -34.29 76.07 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 120.464 -0.494 . . . . 71.25 110.333 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -65.38 -31.85 73.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.722 -0.844 . . . . 73.230000000000004 108.722 177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.74 8.28 20.4 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.785 -1.098 . . . . 72.420000000000002 111.961 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 64.06 28.32 14.26 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 123.011 1.386 . . . . 73.209999999999994 109.716 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -111.57 25.59 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.652 -1.158 . . . . 51.5 108.956 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.93 14.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.434 1.494 . . . . 74.120000000000005 112.212 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -56.44 -31.95 64.45 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.316 0.246 . . . . 72.319999999999993 111.659 174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -73.42 -26.87 61.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.091 0.472 . . . . 74.439999999999998 110.773 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.46 -45.6 78.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.562 -1.273 . . . . 44.450000000000003 107.562 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.48 HG12 HE21 ' A' ' 142' ' ' GLN . 58.7 t -62.26 -42.41 95.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.564 -1.198 . . . . 65.109999999999999 109.692 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -58.78 -45.31 90.11 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.44 0.696 . . . . 54.210000000000001 110.354 178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.505 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.1 tpp180 -66.16 -41.28 90.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.161 -0.681 . . . . 74.340000000000003 109.161 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.16 -46.58 88.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.591 -0.732 . . . . 55.340000000000003 111.118 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.48 HE21 HG12 ' A' ' 138' ' ' VAL . 79.3 mt-30 -62.16 -41.58 98.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.416 -0.356 . . . . 72.200000000000003 110.536 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.67 -27.45 67.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 70.230000000000004 112.113 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 93.8 mmm -86.0 -32.03 21.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.209 0.528 . . . . 73.219999999999999 110.347 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.439 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.5 -60.1 2.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.322 -0.399 . . . . 73.540000000000006 112.062 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 109.249 -0.649 . . . . 72.310000000000002 109.249 -176.28 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 CA--C 1.512 -0.508 0 N-CA-C 110.16 -0.311 . . . . 52.329999999999998 110.16 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -77.42 105.8 2.11 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.141 1.894 . . . . 72.230000000000004 110.436 174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.81 97.9 1.78 Allowed Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.762 -0.732 . . . . 72.519999999999996 112.912 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -75.39 133.63 41.14 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.746 0.308 . . . . 71.129999999999995 110.99 172.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.92 128.14 9.26 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.542 -1.281 . . . . 72.120000000000005 107.542 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.07 106.41 2.02 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.342 1.361 . . . . 75.519999999999996 109.982 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.62 -170.6 16.69 Favored Glycine 0 N--CA 1.407 -3.298 0 C-N-CA 120.458 -0.877 . . . . 73.540000000000006 111.452 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.2 t -161.04 164.57 30.78 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 106.404 -1.702 . . . . 62.310000000000002 106.404 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.1 m -75.59 119.57 19.81 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.749 -0.834 . . . . 73.540000000000006 108.749 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.43 152.87 42.88 Favored 'General case' 0 C--O 1.255 1.347 0 CA-C-N 115.59 -0.732 . . . . 73.310000000000002 111.705 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.78 152.89 34.58 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.511 -0.768 . . . . 73.540000000000006 110.055 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -58.38 97.73 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.523 1.305 . . . . 74.150000000000006 114.523 -175.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -127.96 18.07 3.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 122.517 1.151 . . . . 72.109999999999999 108.155 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.84 32.74 2.37 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 109.104 -1.598 . . . . 73.340000000000003 109.104 -172.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 m -65.89 153.51 41.82 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.469 1.107 . . . . 72.349999999999994 111.005 -175.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.436 HD12 ' N ' ' A' ' 16' ' ' ILE . 3.4 mp -120.27 133.66 24.01 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 106.777 -1.564 . . . . 65.25 106.777 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.16 136.22 59.15 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.151 1.234 . . . . 74.319999999999993 109.443 173.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -106.01 141.34 37.57 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.503 -0.925 . . . . 53.229999999999997 108.503 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.01 -156.85 12.87 Favored Glycine 0 N--CA 1.43 -1.763 0 C-N-CA 120.456 -0.878 . . . . 70.129999999999995 113.542 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -96.08 136.19 36.86 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.915 -0.642 . . . . 75.040000000000006 109.415 -176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.5 101.55 0.19 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.617 0.723 . . . . 74.319999999999993 111.761 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.95 -40.4 83.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 115.311 -0.859 . . . . 74.219999999999999 110.951 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.17 173.16 10.63 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.98 -0.554 . . . . 73.219999999999999 109.916 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.31 138.44 52.13 Favored Pre-proline 0 C--N 1.291 -1.957 0 N-CA-C 108.463 -0.94 . . . . 75.5 108.463 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.63 -21.71 8.27 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 123.344 2.696 . . . . 71.340000000000003 115.676 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -94.52 4.99 53.15 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.378 0.51 . . . . 75.040000000000006 112.378 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -84.53 158.18 60.45 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 110.03 -0.359 . . . . 72.109999999999999 110.03 176.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.406 ' C ' ' HG3' ' A' ' 68' ' ' GLN . 61.6 Cg_exo -42.85 106.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 124.177 3.251 . . . . 62.219999999999999 113.879 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.42 ' N ' ' HG3' ' A' ' 68' ' ' GLN . 0.9 OUTLIER -135.41 148.58 49.38 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 113.073 0.768 . . . . 71.409999999999997 113.073 -176.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.45 ' CD2' ' HG2' ' A' ' 68' ' ' GLN . 30.2 m-85 -116.32 162.22 17.85 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 126.34 1.856 . . . . 64.530000000000001 106.997 173.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.1 m-20 -132.1 161.76 32.49 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 104.81 -2.293 . . . . 71.109999999999999 104.81 -174.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.1 mt -45.28 -56.06 10.23 Favored Pre-proline 0 CA--C 1.556 1.206 0 N-CA-C 113.384 0.883 . . . . 70.409999999999997 113.384 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.28 -35.2 85.8 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 121.444 1.43 . . . . 70.340000000000003 112.158 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 4.3 tpt180 -70.28 -36.19 74.22 Favored 'General case' 0 C--O 1.214 -0.77 0 CA-C-O 121.022 0.439 . . . . 73.150000000000006 110.226 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.86 -37.89 74.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.847 0.356 . . . . 63.43 110.047 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.86 76.9 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.266 -0.642 . . . . 63.299999999999997 109.266 175.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 8.9 mm-40 -63.41 -45.23 91.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.936 -1.029 . . . . 65.310000000000002 111.697 173.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 91.1 mt -64.14 -50.13 69.43 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.082 0.468 . . . . 73.430000000000007 111.234 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.1 mt -81.59 -18.87 43.27 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.474 -0.784 . . . . 74.140000000000001 112.231 -174.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.16 31.83 69.15 Favored Glycine 0 C--O 1.239 0.447 0 N-CA-C 111.301 -0.719 . . . . 63.229999999999997 111.301 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 39' ' ' LEU . 24.4 m -127.84 161.55 54.9 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 109.177 -0.675 . . . . 73.049999999999997 109.177 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 27.8 Cg_endo -64.83 153.93 75.45 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 121.795 1.663 . . . . 72.140000000000001 112.069 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.89 -36.75 63.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.619 -0.719 . . . . 52.219999999999999 110.685 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 32.5 t -63.22 -33.93 76.55 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.144 -0.48 . . . . 73.030000000000001 110.961 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 62.3 tttp -69.53 -35.04 75.1 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.51 -0.552 . . . . 75.010000000000005 109.51 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 61.1 t -63.35 -41.94 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.837 -0.801 . . . . 63.210000000000001 108.837 174.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.426 ' O ' HD11 ' A' ' 16' ' ' ILE . . . -60.99 -36.98 80.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.784 -0.643 . . . . 61.520000000000003 110.425 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 44' ' ' SER . 27.8 mm-40 -69.19 -35.88 76.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.714 0.292 . . . . 73.430000000000007 110.266 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.8 mt-30 -64.05 -43.18 96.29 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.617 0.723 . . . . 73.150000000000006 109.608 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.3 mt -61.92 -40.59 95.99 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.452 -1.249 . . . . 71.329999999999998 109.412 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -61.52 -31.75 71.77 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.184 0.593 . . . . 71.439999999999998 111.781 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -85.27 -12.05 53.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.177 0.436 . . . . 74.530000000000001 112.177 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.9 58.57 Favored Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 109.967 -1.253 . . . . 73.340000000000003 109.967 -174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -82.77 -23.38 33.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.787 -1.19 . . . . 63.32 107.787 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -156.76 159.28 38.16 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.113 -1.81 . . . . 62.420000000000002 106.113 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.34 158.72 41.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.818 -0.438 . . . . 73.099999999999994 109.818 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.02 156.19 44.79 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.278 0.561 . . . . 71.239999999999995 111.969 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.41 165.81 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 C-N-CA 123.671 0.789 . . . . 73.129999999999995 110.52 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 50.7 ttp180 -114.65 125.98 54.36 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.024 0.379 . . . . 60.310000000000002 112.024 -174.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.518 ' NE ' HG11 ' A' ' 65' ' ' VAL . 30.9 ptt180 -116.25 113.63 23.29 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.813 -0.81 . . . . 75.109999999999999 108.813 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.11 9.55 0.68 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.326 1.05 . . . . 53.25 113.361 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 128.86 -28.95 4.06 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 121.346 -0.454 . . . . 64.140000000000001 111.988 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -84.12 141.34 19.91 Favored Glycine 0 CA--C 1.491 -1.439 0 C-N-CA 121.337 -0.459 . . . . 74.420000000000002 112.367 -175.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.9 t -97.24 120.54 46.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.775 -1.195 . . . . 71.129999999999995 107.775 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.518 HG11 ' NE ' ' A' ' 60' ' ' ARG . 18.8 m -133.39 159.77 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 115.035 -0.984 . . . . 72.239999999999995 112.974 -171.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.83 126.11 22.42 Favored Pre-proline 0 N--CA 1.434 -1.25 0 N-CA-C 106.75 -1.574 . . . . 73.310000000000002 106.75 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.32 130.49 36.18 Favored 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 122.632 2.221 . . . . 64.209999999999994 112.721 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HG2' ' CD2' ' A' ' 30' ' ' TYR . 71.2 mt-30 -53.94 -25.22 19.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.13 0.789 . . . . 51.210000000000001 113.13 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.83 -11.48 13.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.945 -0.57 . . . . 31.52 112.299 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.8 m-85 -85.31 -5.23 59.33 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 123.593 0.757 . . . . 73.140000000000001 110.367 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.41 155.11 29.1 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.6 -0.727 . . . . 72.219999999999999 110.056 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.6 p -75.78 175.89 8.28 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 115.002 -0.999 . . . . 74.120000000000005 109.516 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -59.48 -19.38 47.43 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.224 0.61 . . . . 74.219999999999999 111.212 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t -87.43 -8.57 56.36 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.159 0.584 . . . . 73.140000000000001 110.667 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.54 25.92 55.54 Favored Glycine 0 C--O 1.213 -1.179 0 N-CA-C 111.351 -0.7 . . . . 74.109999999999999 111.351 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -115.76 157.7 23.95 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.108 -0.701 . . . . 74.019999999999996 109.108 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.28 128.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.385 -0.598 . . . . 74.010000000000005 109.385 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 25.0 t -61.25 121.41 9.23 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.617 0 N-CA-C 108.039 -1.097 . . . . 65.010000000000005 108.039 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -59.96 -22.28 62.3 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 113.826 1.047 . . . . 74.450000000000003 113.826 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.5 m -87.68 -15.93 35.79 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.258 0.552 . . . . 54.210000000000001 110.987 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.546 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.6 tt -66.46 -45.91 58.85 Favored Pre-proline 0 CA--C 1.565 1.534 0 N-CA-C 115.157 1.54 . . . . 60.450000000000003 115.157 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.35 -28.43 62.97 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.401 2.067 . . . . 74.530000000000001 112.045 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.58 -42.93 98.68 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.65 -0.705 . . . . 73.230000000000004 112.265 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.53 -40.58 80.67 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.542 -0.54 . . . . 74.329999999999998 109.542 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.61 -37.67 87.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.126 -0.488 . . . . 64.329999999999998 110.777 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 69.3 m -68.55 -40.05 80.84 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.75 -0.659 . . . . 74.219999999999999 112.138 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -42.81 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 119.935 -0.706 . . . . 65.349999999999994 110.5 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.489 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.4 mm? -67.31 -36.44 81.5 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.291 -0.564 . . . . 73.450000000000003 112.191 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -65.14 -36.99 85.99 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.145 -0.687 . . . . 73.040000000000006 109.145 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -67.56 -30.81 70.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.415 0.626 . . . . 75.239999999999995 110.146 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.18 -9.45 86.59 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.284 -0.871 . . . . 61.509999999999998 112.332 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.35 24.0 32.6 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 121.25 -0.5 . . . . 52.43 113.129 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -99.59 133.45 43.89 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 122.532 -0.393 . . . . 72.420000000000002 110.425 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -88.12 173.4 8.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.582 0.23 . . . . 74.209999999999994 111.304 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.8 -45.74 63.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.057 1.343 . . . . 71.430000000000007 113.701 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.3 m -62.69 -41.57 99.18 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 123.607 0.763 . . . . 74.5 110.42 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.56 -38.37 89.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.415 -0.811 . . . . 74.209999999999994 110.585 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.416 HD12 ' CB ' ' A' ' 88' ' ' LEU . 7.1 mm -61.3 -47.3 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.742 -1.207 . . . . 73.549999999999997 107.742 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.62 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 76.2 mtm -74.17 -15.48 61.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.311 -1.313 . . . . 61.130000000000003 113.649 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -56.98 -65.77 0.56 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.879 -0.415 . . . . 75.420000000000002 109.879 177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.422 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.4 p-90 -69.07 -32.81 72.54 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.68 0.622 . . . . 75.430000000000007 112.68 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.736 HD23 ' HB2' ' A' ' 125' ' ' PRO . 13.4 mt -60.79 -40.8 93.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.177 0.806 . . . . 74.200000000000003 113.177 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -87.76 -9.38 54.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 112.561 0.578 . . . . 62.509999999999998 112.561 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 44.2 m -88.04 122.9 69.72 Favored Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 108.781 -0.822 . . . . 75.209999999999994 108.781 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.76 129.55 35.61 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.639 1.559 . . . . 73.340000000000003 108.98 174.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 9.8 t70 -90.21 121.08 69.02 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.386 -0.598 . . . . 54.329999999999998 109.386 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.55 -16.67 49.46 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.282 2.654 . . . . 71.340000000000003 113.74 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.4 m -110.98 6.79 21.29 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 121.949 -0.469 . . . . 51.32 111.076 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 38.0 tp -102.87 126.06 49.86 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 119.727 -0.789 . . . . 74.340000000000003 111.209 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 32.7 m -126.3 118.23 24.67 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 105.652 -1.981 . . . . 75.540000000000006 105.652 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 128' ' ' ALA . 16.8 pt -136.09 163.25 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.729 0 O-C-N 123.34 0.4 . . . . 72.099999999999994 111.678 -174.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 71.3 p -91.06 125.14 35.76 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 104.949 -2.241 . . . . 74.530000000000001 104.949 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -137.83 172.49 12.86 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 117.751 -1.58 . . . . 73.209999999999994 113.179 -171.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.1 t70 47.02 70.87 0.36 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.563 1.945 . . . . 72.019999999999996 110.718 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 92.9 -10.82 73.32 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.502 -1.226 . . . . 41.340000000000003 110.503 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m 67.52 25.72 8.35 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.604 1.561 . . . . 44.140000000000001 111.528 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -65.24 -27.55 68.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.061 -0.972 . . . . 64.140000000000001 112.741 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 112' ' ' THR . 23.9 t0 -162.99 165.22 25.18 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.032 -0.729 . . . . 64.140000000000001 109.032 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.31 138.2 31.65 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 124.032 0.832 . . . . 73.120000000000005 110.742 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.07 133.07 69.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.774 -1.195 . . . . 72.400000000000006 107.774 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 p -87.85 146.64 25.49 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 123.455 0.472 . . . . 75.25 110.3 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 2.9 m-20 61.81 68.32 0.7 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.576 1.15 . . . . 72.219999999999999 111.377 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -119.52 170.5 9.11 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.948 -1.024 . . . . 63.039999999999999 110.965 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -78.03 134.22 64.2 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 116.001 -0.545 . . . . 74.109999999999999 109.745 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.736 ' HB2' HD23 ' A' ' 102' ' ' LEU . 73.7 Cg_exo -56.34 -28.48 72.44 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.171 1.914 . . . . 72.420000000000002 111.488 172.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.576 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 51.4 t -66.2 -34.43 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.623 0.725 . . . . 73.219999999999999 109.622 176.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -69.93 -32.37 70.62 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.69 -0.856 . . . . 74.439999999999998 108.69 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.522 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -69.6 -35.5 75.36 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 114.942 -1.027 . . . . 64.439999999999998 112.519 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -68.83 -36.58 78.38 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.139 -0.624 . . . . 74.519999999999996 111.49 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.4 ' N ' HD12 ' A' ' 129' ' ' LEU . 9.4 t-160 -77.71 -15.58 59.05 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.732 0.777 . . . . 73.209999999999994 108.939 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -87.78 4.68 43.42 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.224 -0.898 . . . . 35.039999999999999 110.139 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.5 m80 63.7 27.72 14.82 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.594 1.158 . . . . 74.409999999999997 111.307 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -106.71 26.19 10.31 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.267 -1.333 . . . . 61.439999999999998 110.886 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -51.51 -28.56 13.9 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 114.156 -1.383 . . . . 73.430000000000007 113.665 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.14 -39.44 86.32 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.029 0.831 . . . . 73.420000000000002 111.82 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.421 ' HG3' ' NH2' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -63.98 -32.88 74.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.383 0.611 . . . . 74.430000000000007 110.087 177.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.97 -48.11 51.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.331 -0.849 . . . . 73.219999999999999 109.311 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 134' ' ' ALA . 86.6 t -60.47 -44.5 96.49 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 CA-C-N 115.715 -0.675 . . . . 64.150000000000006 110.994 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.421 ' NH2' ' HG3' ' A' ' 136' ' ' GLU . 14.8 ptt180 -63.84 -37.99 89.44 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.336 -0.546 . . . . 63.299999999999997 112.247 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -64.27 -39.81 94.7 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.76 -0.376 . . . . 75.400000000000006 110.35 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -61.46 -46.5 89.79 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.696 -0.684 . . . . 74.439999999999998 110.379 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -60.99 -45.45 94.75 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.706 -0.679 . . . . 74.239999999999995 110.757 178.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.93 65.24 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.136 0.494 . . . . 54.439999999999998 111.687 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 53.3 tpp -83.33 -41.25 18.46 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.346 0.594 . . . . 72.409999999999997 110.021 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.4 -52.18 7.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.098 -0.501 . . . . 71.329999999999998 112.314 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 C--N 1.307 -1.24 0 CA-C-N 116.648 -0.251 . . . . 72.519999999999996 110.333 -175.933 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 CA--C 1.503 -0.844 0 N-CA-C 109.304 -0.628 . . . . 72.230000000000004 109.304 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.429 ' HG2' ' CZ ' ' A' ' 4' ' ' ARG . 14.6 Cg_endo -65.74 119.36 6.37 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 121.572 1.515 . . . . 62.119999999999997 109.353 173.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.12 101.11 2.29 Favored Glycine 0 N--CA 1.426 -2.015 0 C-N-CA 120.833 -0.699 . . . . 41.409999999999997 112.352 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.467 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 6.5 mpt_? -73.32 144.32 46.59 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.283 -1.006 . . . . 73.109999999999999 108.283 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.04 107.6 44.93 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 123.25 0.344 . . . . 71.140000000000001 110.51 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 4' ' ' ARG . 2.6 Cg_exo -79.2 178.73 7.14 Favored 'Trans proline' 0 C--O 1.244 0.802 0 C-N-CA 122.845 2.363 . . . . 50.130000000000003 109.456 174.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.08 136.96 5.05 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 119.678 -1.249 . . . . 54.0 112.657 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.6 m -102.46 108.94 20.42 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.388 -0.967 . . . . 73.310000000000002 108.388 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.8 m -89.3 138.64 31.26 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.964 -0.384 . . . . 61.509999999999998 109.964 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.86 149.99 20.76 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.271 0.558 . . . . 74.439999999999998 111.004 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.78 104.9 16.82 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.621 -0.881 . . . . 64.120000000000005 108.621 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -76.54 83.38 3.22 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.18 0.807 . . . . 54.439999999999998 113.18 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -124.66 117.87 51.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 104.495 -2.409 . . . . 43.149999999999999 104.495 174.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.2 -151.95 6.56 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 119.642 -1.266 . . . . 42.420000000000002 113.73 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' A' ' 51' ' ' ARG . 23.8 m -82.73 126.99 33.0 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 123.736 0.814 . . . . 52.409999999999997 113.041 -174.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.78 120.57 58.51 Favored Pre-proline 0 N--CA 1.434 -1.256 0 N-CA-C 105.759 -1.941 . . . . 72.540000000000006 105.759 171.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -72.12 149.56 52.41 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.169 1.913 . . . . 73.409999999999997 112.239 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.34 133.48 34.95 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 115.904 -0.589 . . . . 75.450000000000003 110.092 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.58 -88.97 1.08 Allowed Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 115.937 -0.574 . . . . 73.109999999999999 112.671 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -121.37 126.07 48.51 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.805 0.336 . . . . 65.310000000000002 111.172 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 23' ' ' LEU . 12.5 t0 -80.4 142.14 34.65 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.548 -0.751 . . . . 74.409999999999997 111.361 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.42 -9.56 10.78 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 C-N-CA 123.679 0.792 . . . . 61.229999999999997 110.155 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.437 HD13 ' CG2' ' A' ' 29' ' ' THR . 40.2 mt -64.66 159.69 21.49 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 122.43 1.109 . . . . 75.450000000000003 113.663 -178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.6 t70 -80.23 138.16 52.48 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 105.799 -1.926 . . . . 72.439999999999998 105.799 170.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.68 -28.75 17.92 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.274 2.649 . . . . 73.409999999999997 115.452 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.18 23.17 11.09 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.161 0.8 . . . . 75.319999999999993 113.161 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 4.5 tp10 -73.83 143.43 81.38 Favored Pre-proline 0 N--CA 1.444 -0.741 0 N-CA-C 105.191 -2.152 . . . . 73.549999999999997 105.191 173.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HD2' ' OE1' ' A' ' 27' ' ' GLU . 6.0 Cg_exo -39.68 107.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.453 0 C-N-CA 123.945 3.097 . . . . 44.509999999999998 112.373 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.437 ' CG2' HD13 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -129.72 167.14 18.5 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 115.612 -0.722 . . . . 52.310000000000002 112.7 -174.256 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 26.0 m-85 -130.9 160.28 34.94 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.286 -1.376 . . . . 74.019999999999996 107.286 172.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.541 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 7.2 m-20 -134.91 159.73 40.49 Favored 'General case' 0 C--N 1.264 -3.121 0 N-CA-C 102.978 -2.971 . . . . 72.5 102.978 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.0 mt -48.47 -56.61 13.74 Favored Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 114.556 1.317 . . . . 64.010000000000005 114.556 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.89 -30.97 67.82 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 121.525 1.483 . . . . 60.229999999999997 112.284 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.541 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 17.7 tpt180 -70.41 -34.9 73.06 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.037 0.535 . . . . 75.420000000000002 109.69 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 31' ' ' ASP . 57.8 t -69.31 -39.81 79.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 N-CA-C 109.067 -0.716 . . . . 72.230000000000004 109.067 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.72 82.39 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.719 -1.128 . . . . 62.140000000000001 109.374 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.38 -45.67 79.29 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 124.37 1.068 . . . . 71.219999999999999 110.54 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 30' ' ' TYR . 38.2 tp -60.76 -49.03 79.13 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.577 -0.738 . . . . 75.439999999999998 111.693 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HB2' HG22 ' A' ' 41' ' ' VAL . 66.4 mt -88.89 -18.05 28.35 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.788 -0.642 . . . . 64.129999999999995 111.448 -174.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.27 16.13 76.99 Favored Glycine 0 C--N 1.315 -0.609 0 N-CA-C 111.229 -0.748 . . . . 71.030000000000001 111.229 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.452 HG22 ' HB2' ' A' ' 39' ' ' LEU . 23.8 m -104.14 162.12 20.86 Favored Pre-proline 0 C--N 1.31 -1.149 0 N-CA-C 108.417 -0.957 . . . . 73.019999999999996 108.417 -176.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.6 160.13 38.49 Favored 'Trans proline' 0 C--O 1.262 1.698 0 C-N-CA 120.931 1.088 . . . . 61.43 111.249 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.71 -32.85 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.747 0.784 . . . . 55.119999999999997 109.84 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 7.8 p -59.04 -37.68 77.53 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 114.933 -1.03 . . . . 52.530000000000001 111.758 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 19.4 ttmm -69.93 -32.89 71.41 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.408 -0.517 . . . . 73.549999999999997 110.553 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.41 -42.04 92.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.536 -0.913 . . . . 73.25 108.536 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -62.18 -36.53 82.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.582 -0.735 . . . . 65.519999999999996 110.399 175.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.1 mt-30 -64.94 -36.29 83.91 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.433 0.293 . . . . 61.030000000000001 110.973 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.1 mm-40 -60.46 -46.61 89.46 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.102 -1.073 . . . . 71.510000000000005 108.102 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.31 -38.59 89.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.55 -1.205 . . . . 74.150000000000006 110.36 176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.568 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 14.6 mmm180 -65.61 -28.81 69.39 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.696 0.628 . . . . 74.319999999999993 112.696 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.67 -1.48 30.04 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.604 0.594 . . . . 62.5 112.604 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.69 36.6 83.14 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 110.672 -0.971 . . . . 74.25 110.672 -177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -96.32 -20.19 18.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.396 -0.594 . . . . 72.129999999999995 109.396 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 42.1 tp -159.84 153.38 22.5 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.252 -1.388 . . . . 25.0 107.252 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.31 161.67 38.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 O-C-N 123.253 0.346 . . . . 64.109999999999999 110.572 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -133.96 159.71 39.89 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.538 -0.756 . . . . 52.299999999999997 109.084 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.5 HG11 ' HG3' ' A' ' 99' ' ' MET . 6.7 m -130.68 166.96 26.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 123.972 0.909 . . . . 74.129999999999995 109.746 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 52.2 ttp180 -114.02 115.81 28.2 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 121.119 -0.232 . . . . 72.340000000000003 111.608 -176.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.54 ' NE ' HG11 ' A' ' 65' ' ' VAL . 36.6 ptt180 -120.65 136.36 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.928 -1.138 . . . . 75.150000000000006 107.928 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 49.36 30.3 3.2 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.421 1.088 . . . . 65.109999999999999 113.826 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.3 22.96 57.91 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.288 -0.482 . . . . 73.140000000000001 113.023 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -133.2 152.04 20.26 Favored Glycine 0 CA--C 1.496 -1.134 0 N-CA-C 111.28 -0.728 . . . . 51.509999999999998 111.28 177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.7 t -97.62 120.38 46.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 107.369 -1.345 . . . . 72.510000000000005 107.369 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG11 ' NE ' ' A' ' 60' ' ' ARG . 24.2 m -134.81 164.33 34.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.816 -0.629 . . . . 63.549999999999997 111.373 -171.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 35' ' ' VAL . 62.6 mt -132.48 131.41 22.23 Favored Pre-proline 0 C--N 1.291 -1.951 0 N-CA-C 106.541 -1.651 . . . . 63.32 106.541 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 70' ' ' PHE . 23.4 Cg_exo -60.73 135.66 61.56 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 121.619 1.546 . . . . 25.120000000000001 111.221 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -68.66 -31.19 70.13 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-O 121.77 0.795 . . . . 74.209999999999994 109.353 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.435 HG23 HG11 ' A' ' 126' ' ' VAL . 23.5 m -68.44 -3.67 2.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 114.201 -1.363 . . . . 74.430000000000007 111.881 177.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -86.17 -11.01 53.7 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.942 0.877 . . . . 63.049999999999997 109.032 177.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.53 161.39 14.65 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 114.917 -1.038 . . . . 55.5 108.204 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.7 p -75.8 161.03 29.36 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.189 -0.671 . . . . 71.230000000000004 109.189 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -59.63 -17.36 32.87 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.324 0.49 . . . . 72.340000000000003 112.324 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.3 m -94.63 -0.94 54.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 116.068 -0.515 . . . . 73.150000000000006 111.86 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.09 4.08 69.32 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.855 -0.688 . . . . 52.310000000000002 114.204 176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.02 156.86 16.38 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.556 -0.905 . . . . 74.109999999999999 108.556 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.1 t -74.56 138.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 107.47 -1.307 . . . . 74.329999999999998 107.47 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 92.9 t -62.56 131.52 27.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.138 -0.689 . . . . 75.230000000000004 109.138 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 112.626 0.602 . . . . 52.020000000000003 112.626 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.2 t -88.15 12.15 14.46 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.391 -0.523 . . . . 62.409999999999997 111.417 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.3 tt -65.93 -54.83 25.31 Favored Pre-proline 0 CA--C 1.553 1.065 0 N-CA-C 109.519 -0.548 . . . . 75.299999999999997 109.519 177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.93 -31.78 90.58 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.766 1.644 . . . . 75.25 110.924 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -63.11 -44.59 97.01 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.444 -0.798 . . . . 53.140000000000001 112.294 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.12 -40.38 82.51 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.851 -0.796 . . . . 62.119999999999997 108.851 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.02 -36.7 77.81 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 115.927 -0.578 . . . . 75.239999999999995 110.66 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 49.0 m -60.59 -49.72 76.41 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.864 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -45.35 91.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-N 116.457 -0.338 . . . . 73.25 111.906 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.634 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.0 mm? -67.42 -38.56 84.77 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.348 0.87 . . . . 74.109999999999999 113.348 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -66.19 -35.14 79.67 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.538 -0.541 . . . . 53.509999999999998 109.538 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.91 -30.71 64.12 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.973 -0.558 . . . . 72.420000000000002 110.396 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.55 -9.33 83.48 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 112.09 -0.404 . . . . 54.43 112.09 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.97 39.97 12.4 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 121.809 -0.234 . . . . 51.43 113.196 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -108.59 126.39 52.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.915 0.388 . . . . 74.319999999999993 110.749 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 98' ' ' ILE . 12.0 ptm180 -85.39 173.86 9.97 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.656 . . . . 73.319999999999993 111.686 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -52.63 -44.01 65.79 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.355 1.862 . . . . 75.310000000000002 111.744 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -61.43 -41.02 96.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 123.859 0.864 . . . . 72.310000000000002 110.567 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -64.64 -44.55 90.09 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.152 -0.931 . . . . 74.230000000000004 108.938 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 94' ' ' ARG . 16.4 mm -60.61 -48.41 88.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 115.431 -0.804 . . . . 71.129999999999995 109.262 -174.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.5 ' HG3' HG11 ' A' ' 58' ' ' VAL . 24.6 mmt -68.06 -27.19 66.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 70.299999999999997 111.731 -176.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -58.88 -64.95 0.75 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 111.609 0.226 . . . . 61.229999999999997 111.609 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.426 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 33.2 p-90 -68.45 -32.01 71.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.298 0.481 . . . . 64.219999999999999 112.298 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.628 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . 11.5 mt -60.46 -40.14 90.14 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 113.014 0.746 . . . . 75.540000000000006 113.014 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.52 ' CE1' HG21 ' A' ' 126' ' ' VAL . 70.9 m-85 -95.63 -1.39 50.33 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.175 0.806 . . . . 75.420000000000002 113.175 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.5 m -88.2 116.0 64.88 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.971 -0.752 . . . . 73.450000000000003 108.971 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 124' ' ' ARG . 86.9 Cg_exo -52.85 129.55 33.37 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.817 2.345 . . . . 72.430000000000007 111.572 178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.39 125.7 58.99 Favored Pre-proline 0 C--N 1.304 -1.386 0 CA-C-N 115.908 -0.587 . . . . 73.010000000000005 110.702 -174.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.487 ' HA ' HD22 ' A' ' 122' ' ' ASN . 22.9 Cg_endo -60.75 -27.96 85.69 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.295 2.663 . . . . 42.109999999999999 113.591 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.4 m -99.84 6.86 45.31 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 120.807 0.337 . . . . 70.040000000000006 111.088 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.3 tp -102.47 120.09 39.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.924 0.868 . . . . 75.129999999999995 111.568 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.7 m -132.14 110.88 10.99 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 105.548 -2.019 . . . . 75.430000000000007 105.548 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 11.7 pt -134.43 163.52 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.025 0 N-CA-C 114.026 1.121 . . . . 71.219999999999999 114.026 -173.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 118' ' ' ASP . 45.2 p -89.99 126.71 35.84 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 106.665 -1.606 . . . . 72.420000000000002 106.665 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -94.91 136.21 35.5 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.107 -0.637 . . . . 75.430000000000007 110.752 -172.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 54.28 25.31 5.75 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.658 1.183 . . . . 72.310000000000002 113.653 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.77 15.75 81.1 Favored Glycine 0 C--N 1.309 -0.961 0 C-N-CA 120.64 -0.791 . . . . 73.430000000000007 112.855 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.6 t -83.46 172.24 12.63 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 107.905 -1.146 . . . . 63.219999999999999 107.905 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.499 ' HD3' ' H ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -86.12 -10.38 54.95 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-N 115.702 -0.681 . . . . 75.109999999999999 109.679 178.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 112' ' ' THR . 30.9 t70 -72.13 137.0 46.71 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 115.764 -0.653 . . . . 71.329999999999998 110.481 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.25 126.97 53.87 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.103 -0.953 . . . . 71.239999999999995 110.17 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.56 118.62 56.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.372 -0.973 . . . . 61.219999999999999 108.372 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.8 m -90.8 138.12 31.83 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.904 -0.589 . . . . 74.329999999999998 109.901 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.487 HD22 ' HA ' ' A' ' 107' ' ' PRO . 23.7 t-20 64.11 59.09 1.1 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 122.482 1.134 . . . . 72.129999999999995 110.032 176.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.23 161.64 13.6 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.493 -1.231 . . . . 62.140000000000001 108.739 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 105' ' ' PRO . 8.8 ptp180 -87.07 139.92 32.58 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 107.438 -1.319 . . . . 74.129999999999995 107.438 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.592 ' HB2' HD23 ' A' ' 102' ' ' LEU . 93.2 Cg_exo -49.66 -29.85 20.62 Favored 'Trans proline' 0 CA--C 1.553 1.46 0 C-N-CA 123.319 2.679 . . . . 55.329999999999998 114.812 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.628 ' CG2' ' HB3' ' A' ' 102' ' ' LEU . 24.8 t -67.37 -36.55 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 O-C-N 121.438 -0.789 . . . . 75.0 110.562 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.07 -30.67 67.98 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.888 -1.153 . . . . 73.409999999999997 107.888 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.34 83.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.426 -1.261 . . . . 55.130000000000003 111.097 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.5 pp -68.26 -33.39 74.27 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 121.939 -0.475 . . . . 65.010000000000005 110.806 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -63.86 -34.38 77.8 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 108.155 -1.054 . . . . 75.129999999999995 108.155 175.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.13 10.46 21.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.351 -1.295 . . . . 71.239999999999995 111.999 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 68.2 27.97 6.6 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.325 1.05 . . . . 62.109999999999999 112.536 177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -106.43 24.17 12.99 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.054 -1.091 . . . . 63.119999999999997 108.054 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -53.17 -30.58 38.13 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.685 1.194 . . . . 53.219999999999999 113.911 -173.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -59.01 -38.51 79.42 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 120.815 0.34 . . . . 75.239999999999995 111.187 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.24 -30.32 69.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.521 0.677 . . . . 72.099999999999994 109.508 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -71.39 -44.93 71.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.917 -1.038 . . . . 52.130000000000003 110.025 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 47.4 t -61.3 -42.98 95.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.604 0.716 . . . . 74.109999999999999 109.402 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -60.38 -38.78 85.01 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.068 -0.969 . . . . 71.140000000000001 111.611 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.41 -37.93 83.84 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.251 -1.018 . . . . 71.109999999999999 108.251 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.634 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -63.7 -42.45 97.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.424 -0.807 . . . . 43.350000000000001 111.05 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 74.4 mt-30 -59.03 -41.86 88.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 62.130000000000003 110.31 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.89 81.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.88 -0.6 . . . . 62.210000000000001 111.604 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.404 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 43.8 tpp -76.14 -27.56 57.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.647 0.737 . . . . 72.219999999999999 111.014 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.0 -47.24 11.93 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.745 -0.597 . . . . 54.420000000000002 111.747 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 C--N 1.31 -1.109 0 N-CA-C 109.209 -0.663 . . . . 75.519999999999996 109.209 -177.707 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 108.826 -0.805 . . . . 71.209999999999994 108.826 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.44 52.52 2.0 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 123.451 2.767 . . . . 72.310000000000002 112.314 176.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.34 96.86 0.24 Allowed Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 110.545 -1.022 . . . . 74.239999999999995 110.545 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.14 145.73 50.02 Favored 'General case' 0 C--O 1.251 1.16 0 N-CA-C 109.35 -0.611 . . . . 74.239999999999995 109.35 176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -36.99 118.05 0.76 Allowed Pre-proline 0 N--CA 1.477 0.908 0 C-N-CA 124.743 1.217 . . . . 72.450000000000003 111.558 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.75 114.29 2.08 Favored 'Trans proline' 0 C--O 1.25 1.086 0 C-N-CA 122.964 2.443 . . . . 70.540000000000006 113.91 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.33 114.87 2.98 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 108.082 -2.007 . . . . 51.109999999999999 108.082 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.0 m -146.0 138.92 25.77 Favored 'General case' 0 C--N 1.289 -2.048 0 O-C-N 122.535 -0.391 . . . . 75.209999999999994 110.162 -178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.404 HG23 HD22 ' A' ' 10' ' ' LEU . 13.8 t -101.2 -11.72 19.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 123.017 1.389 . . . . 45.299999999999997 108.908 176.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.404 HD22 HG23 ' A' ' 9' ' ' THR . 4.0 mm? -94.71 -160.58 0.79 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.253 -1.794 . . . . 45.020000000000003 106.165 170.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 126.05 27.68 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.824 -0.806 . . . . 41.240000000000002 108.824 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 90' ' ' ASP . 12.0 ttp180 -75.41 125.01 28.14 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-O 121.557 0.694 . . . . 74.25 110.299 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.6 m -108.3 161.34 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.115 0 N-CA-C 107.743 -1.206 . . . . 71.109999999999999 107.743 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -142.22 151.47 22.94 Favored Glycine 0 N--CA 1.401 -3.659 0 CA-C-O 121.689 0.605 . . . . 64.099999999999994 112.975 -174.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.3 t -104.38 110.6 22.91 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 105.241 -2.133 . . . . 71.349999999999994 105.241 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.1 mm -113.78 124.59 30.84 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 120.561 -0.455 . . . . 73.010000000000005 110.891 -173.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.67 167.31 27.39 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.309 2.673 . . . . 63.039999999999999 110.099 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.37 124.62 30.18 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 121.903 -0.498 . . . . 64.329999999999998 110.415 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA3' ' NH2' ' A' ' 94' ' ' ARG . . . -109.7 -115.81 3.76 Favored Glycine 0 N--CA 1.426 -1.992 0 C-N-CA 120.593 -0.813 . . . . 52.119999999999997 114.376 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -94.22 128.29 40.58 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 112.463 0.542 . . . . 72.409999999999997 112.463 -171.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.483 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 7.3 t70 -65.23 120.11 12.13 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.872 -1.058 . . . . 65.319999999999993 111.239 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.58 -32.05 3.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 112.661 0.615 . . . . 62.32 112.661 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -82.96 159.96 22.14 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 114.199 1.185 . . . . 62.509999999999998 114.199 -174.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 3.0 t70 -60.45 146.62 84.41 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 114.699 -1.137 . . . . 72.340000000000003 110.797 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -49.49 -36.73 40.35 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 123.568 2.845 . . . . 74.310000000000002 115.898 -177.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.9 11.43 39.3 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 114.433 1.272 . . . . 65.310000000000002 114.433 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 7.7 mm-40 -68.18 144.57 96.94 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 109.324 -0.621 . . . . 63.119999999999997 109.324 173.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.91 128.85 28.1 Favored 'Trans proline' 0 C--O 1.253 1.257 0 C-N-CA 122.822 2.348 . . . . 71.420000000000002 112.544 -178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 20.7 p -130.23 166.17 20.87 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.056 -0.52 . . . . 73.109999999999999 111.313 -176.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -131.45 160.19 35.87 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 125.55 1.54 . . . . 62.210000000000001 108.422 173.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.5 p-10 -135.6 159.38 41.8 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 106.121 -1.807 . . . . 64.400000000000006 106.121 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.0 mt -46.68 -56.87 10.15 Favored Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 114.738 1.385 . . . . 74.439999999999998 114.738 -171.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -59.31 -35.76 96.14 Favored 'Trans proline' 0 C--N 1.366 1.476 0 CA-C-N 120.465 1.202 . . . . 73.239999999999995 112.67 177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -69.56 -37.5 77.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.924 -0.398 . . . . 72.319999999999993 109.924 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 31' ' ' ASP . 60.8 t -69.8 -40.37 78.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.212 -0.449 . . . . 75.310000000000002 110.519 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.69 80.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.135 0.969 . . . . 73.409999999999997 109.167 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.17 -45.53 73.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.985 -1.462 . . . . 61.43 109.985 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.5 tp -65.26 -44.1 89.16 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 63.409999999999997 111.551 -176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.2 mt -84.38 -19.01 34.29 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 111.901 0.334 . . . . 65.310000000000002 111.901 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.28 65.31 Favored Glycine 0 C--N 1.317 -0.521 0 C-N-CA 120.54 -0.838 . . . . 70.25 111.989 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.0 152.15 77.0 Favored Pre-proline 0 C--N 1.315 -0.908 0 N-CA-C 108.73 -0.841 . . . . 75.219999999999999 108.73 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.98 163.25 29.16 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 122.304 2.003 . . . . 74.219999999999999 112.927 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.3 t -56.34 -33.38 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.189 0.996 . . . . 72.420000000000002 111.371 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.417 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 10.7 p -58.39 -46.15 86.93 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.465 -0.789 . . . . 72.010000000000005 111.493 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 60.1 mttp -68.93 -36.36 77.9 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.664 -0.244 . . . . 72.239999999999995 111.636 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.76 -48.14 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 O-C-N 123.595 0.559 . . . . 71.439999999999998 109.537 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.754 -0.657 . . . . 64.040000000000006 110.463 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 44' ' ' SER . 15.7 mm100 -62.42 -36.44 82.37 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.292 0.479 . . . . 73.519999999999996 112.292 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 91.8 mt-30 -63.34 -50.72 68.86 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.676 0.75 . . . . 63.520000000000003 108.995 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.35 -41.4 98.57 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.233 -1.349 . . . . 62.420000000000002 111.684 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -63.59 -27.48 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.788 0.292 . . . . 65.450000000000003 111.788 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -92.1 -0.36 57.45 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.762 0.315 . . . . 75.219999999999999 111.596 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.16 38.31 63.39 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 115.798 -0.637 . . . . 52.109999999999999 112.501 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -95.06 -15.36 23.5 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.07 -0.715 . . . . 75.219999999999999 109.07 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 56' ' ' VAL . 1.1 tt -157.74 152.91 25.76 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.106 -2.183 . . . . 74.129999999999995 105.106 -177.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.41 ' H ' HD23 ' A' ' 55' ' ' LEU . 17.8 m -132.1 161.6 41.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 122.609 0.364 . . . . 44.149999999999999 110.175 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.32 163.36 32.99 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.061 0.545 . . . . 74.540000000000006 109.6 -175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -126.71 160.48 34.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 O-C-N 123.427 0.455 . . . . 62.119999999999997 110.47 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -113.9 120.92 42.36 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.494 0.664 . . . . 70.129999999999995 111.256 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.483 ' HD2' ' OD1' ' A' ' 21' ' ' ASP . 12.3 ptm180 -142.69 134.95 27.5 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.931 -1.031 . . . . 65.129999999999995 108.939 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.65 23.67 13.93 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.909 0.883 . . . . 44.340000000000003 111.406 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.71 5.71 89.64 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.156 -0.545 . . . . 63.200000000000003 112.207 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.17 143.64 18.03 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 111.355 -0.698 . . . . 65.349999999999994 111.355 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.27 120.49 46.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.921 -1.14 . . . . 72.400000000000006 107.921 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.78 158.48 41.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.968 -0.56 . . . . 63.119999999999997 110.754 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.428 HD12 HG21 ' A' ' 35' ' ' VAL . 71.3 mt -114.86 132.06 23.15 Favored Pre-proline 0 C--N 1.289 -2.062 0 N-CA-C 108.106 -1.072 . . . . 73.239999999999995 108.106 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.98 126.12 20.15 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.877 1.718 . . . . 71.219999999999999 110.477 173.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.565 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.8 tt0 -60.58 -25.21 66.04 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 123.315 0.646 . . . . 72.329999999999998 112.467 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.82 -2.77 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 CA-C-N 115.681 -0.691 . . . . 71.140000000000001 112.65 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.623 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.38 -2.62 58.59 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.95 0.881 . . . . 72.430000000000007 110.026 174.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -119.61 163.9 16.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.119 -0.946 . . . . 70.299999999999997 109.089 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 130' ' ' HIS . 63.1 p -94.78 162.25 13.84 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.588 -0.893 . . . . 65.150000000000006 108.588 177.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -65.22 -16.55 63.65 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.335 0.588 . . . . 73.230000000000004 110.488 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.1 m -79.73 -8.32 59.17 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.699 -0.682 . . . . 44.329999999999998 110.487 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.59 12.72 64.2 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.851 -0.69 . . . . 60.450000000000003 112.23 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -108.6 154.01 22.58 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.438 -0.578 . . . . 74.120000000000005 109.438 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -71.34 140.53 18.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.793 -1.188 . . . . 73.340000000000003 107.793 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 80' ' ' SER . 44.7 t -64.02 129.22 27.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 107.934 -1.135 . . . . 63.32 107.934 177.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -63.69 -28.99 70.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.145 0.424 . . . . 71.219999999999999 112.145 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.417 ' H ' HG12 ' A' ' 78' ' ' VAL . 4.1 m -77.77 -6.51 54.3 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.939 -0.573 . . . . 75.299999999999997 110.886 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.623 HD11 ' CD2' ' A' ' 70' ' ' PHE . 9.7 tp -64.91 -57.25 16.56 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-N 116.384 -0.371 . . . . 73.150000000000006 111.882 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.29 -29.03 79.43 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.181 1.254 . . . . 71.230000000000004 111.244 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.15 -44.59 93.8 Favored Glycine 0 C--O 1.245 0.832 0 CA-C-N 115.964 -0.562 . . . . 65.239999999999995 112.598 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -67.96 -40.53 83.18 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 109.38 -0.6 . . . . 71.209999999999994 109.38 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 95.9 mt -62.32 -37.57 86.1 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 74.019999999999996 110.659 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 84.9 m -57.45 -47.51 81.63 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 116.239 -0.437 . . . . 63.030000000000001 111.582 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.471 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -67.95 -41.96 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 120.386 -0.525 . . . . 73.129999999999995 111.556 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.471 HD22 HG23 ' A' ' 87' ' ' ILE . 3.5 mm? -67.51 -39.32 85.15 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.804 0.668 . . . . 75.329999999999998 112.804 178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.401 ' CE1' ' HB3' ' A' ' 85' ' ' LEU . 62.1 m170 -66.5 -33.76 76.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.052 0.453 . . . . 75.319999999999993 110.085 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 12' ' ' ARG . 32.6 t70 -67.92 -26.2 65.86 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.537 -0.756 . . . . 72.310000000000002 110.142 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.91 -3.36 73.7 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.829 -0.623 . . . . 51.140000000000001 112.016 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.42 33.45 25.46 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.197 -0.525 . . . . 71.319999999999993 113.123 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 8.9 m-85 -90.75 159.38 16.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.882 0.372 . . . . 74.120000000000005 111.497 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.47 ' NH2' ' HA3' ' A' ' 19' ' ' GLY . 12.0 ptm180 -111.85 171.14 7.67 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.924 -0.58 . . . . 73.340000000000003 109.832 175.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -53.94 -45.87 71.38 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.442 1.897 . . . . 73.140000000000001 112.46 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.6 m -61.88 -41.67 98.16 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.275 -0.875 . . . . 70.230000000000004 110.418 -178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.06 -36.15 81.39 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.587 -0.733 . . . . 71.329999999999998 111.494 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.2 mm -61.24 -47.66 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 N-CA-C 108.121 -1.066 . . . . 72.099999999999994 108.121 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.47 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 56.3 mtt -73.35 -21.5 60.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.596 -1.183 . . . . 63.399999999999999 111.779 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -57.69 -63.37 1.26 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.031 0.443 . . . . 73.120000000000005 110.315 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -69.99 -32.38 70.56 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.02 0.748 . . . . 64.040000000000006 113.02 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.3 mt -59.0 -40.73 85.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.585 0.957 . . . . 73.209999999999994 113.585 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE2' HD23 ' A' ' 23' ' ' LEU . 50.5 m-85 -89.14 -16.83 30.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.958 0.725 . . . . 75.5 112.958 -176.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 30.9 m -87.51 118.28 69.63 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 116.435 -0.348 . . . . 74.549999999999997 110.243 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -55.65 129.78 36.91 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.857 2.371 . . . . 33.109999999999999 111.359 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.2 t70 -96.73 127.12 40.52 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 109.866 -0.42 . . . . 72.409999999999997 109.866 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 -20.25 61.94 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.554 2.836 . . . . 53.32 114.423 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.1 p -111.53 6.94 20.45 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.107 0.48 . . . . 72.010000000000005 112.122 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.1 tp -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.23 0.538 . . . . 74.120000000000005 110.107 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.5 m -118.95 122.56 42.51 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.885 -0.783 . . . . 75.510000000000005 108.885 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.419 HD12 ' HB3' ' A' ' 123' ' ' ALA . 61.1 mt -130.81 154.97 41.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 109.432 -0.581 . . . . 70.400000000000006 109.432 -174.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 53.6 m -122.62 126.82 48.45 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.929 -1.508 . . . . 72.140000000000001 106.929 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -131.03 137.0 48.97 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.214 0.321 . . . . 74.420000000000002 111.243 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.9 t70 49.88 88.87 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 126.001 1.72 . . . . 64.319999999999993 113.557 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.52 131.39 2.58 Favored Glycine 0 N--CA 1.4 -3.703 0 N-CA-C 110.161 -1.176 . . . . 73.209999999999994 110.161 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.0 m -72.3 82.6 1.03 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-O 121.605 0.716 . . . . 64.409999999999997 109.399 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -81.61 -51.63 8.03 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.101 -1.444 . . . . 72.430000000000007 107.101 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 t70 171.77 -175.6 0.05 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 102.975 -2.972 . . . . 73.150000000000006 102.975 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.33 140.12 30.08 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.274 -1.01 . . . . 71.150000000000006 108.274 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 51.3 t -110.98 118.83 58.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.368 -0.604 . . . . 63.329999999999998 109.368 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -87.28 141.42 28.66 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.767 -0.827 . . . . 72.140000000000001 108.767 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.3 t30 68.22 70.3 0.32 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.937 0.875 . . . . 64.409999999999997 110.806 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -124.39 173.64 8.28 Favored 'General case' 0 C--O 1.249 1.069 0 N-CA-C 107.762 -1.199 . . . . 63.119999999999997 107.762 174.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 3.5 ptp180 -91.59 137.25 25.86 Favored Pre-proline 0 C--N 1.316 -0.875 0 C-N-CA 120.309 -0.557 . . . . 70.430000000000007 109.758 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.64 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.1 Cg_exo -49.75 -22.44 6.98 Favored 'Trans proline' 0 CA--C 1.549 1.228 0 C-N-CA 123.71 2.94 . . . . 70.239999999999995 114.552 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.578 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.7 t -60.43 -39.0 79.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 120.87 0.367 . . . . 75.129999999999995 110.297 177.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -63.31 -37.12 86.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.315 0.579 . . . . 64.25 109.695 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.46 -40.69 76.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.237 -0.892 . . . . 65.209999999999994 112.063 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.44 -35.58 80.65 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.644 -0.422 . . . . 63.420000000000002 111.408 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.405 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 42.0 t-80 -76.02 -20.8 57.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.391 0.615 . . . . 52.350000000000001 109.455 178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.85 4.61 51.59 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.335 0.865 . . . . 74.019999999999996 113.335 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.31 38.74 4.34 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 123.581 1.658 . . . . 75.450000000000003 109.283 -178.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -120.36 23.89 10.66 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.75 -1.574 . . . . 73.5 106.75 176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.62 -28.05 30.45 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 112.648 -2.069 . . . . 63.32 112.756 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -55.43 -40.38 71.43 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.801 0.334 . . . . 72.239999999999995 110.915 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -71.33 -27.98 63.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.171 0.51 . . . . 70.200000000000003 110.919 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.72 -48.58 45.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 108.375 -0.972 . . . . 73.239999999999995 108.375 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 63.5 t -59.2 -41.54 84.12 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 CA-C-N 115.007 -0.997 . . . . 72.25 109.176 177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -57.15 -45.89 83.2 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.609 0.764 . . . . 73.040000000000006 111.264 177.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 144' ' ' MET . 3.8 tpp180 -65.89 -39.31 90.51 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.723 -0.473 . . . . 73.450000000000003 109.723 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.99 94.15 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.999 -0.546 . . . . 43.25 110.525 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 83.6 mm-40 -57.46 -46.61 83.45 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 123.353 0.661 . . . . 72.430000000000007 110.032 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.9 82.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.55 -0.75 . . . . 64.25 111.551 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.526 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.2 mmm -78.48 -37.39 43.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.353 -0.385 . . . . 74.120000000000005 111.407 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.8 19.59 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 112.789 0.663 . . . . 63.539999999999999 112.789 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 C--N 1.308 -1.239 0 CA-C-O 118.418 -0.801 . . . . 72.219999999999999 109.646 -176.498 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.237 0.396 0 N-CA-C 110.36 -0.237 . . . . 73.510000000000005 110.36 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.6 146.15 21.21 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.403 2.069 . . . . 74.420000000000002 112.232 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -113.68 -98.09 2.28 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 109.287 -1.525 . . . . 52.009999999999998 109.287 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -73.48 133.21 43.6 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 107.164 -1.421 . . . . 70.340000000000003 107.164 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.84 119.08 75.98 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-O 120.774 0.321 . . . . 74.319999999999993 110.925 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -87.0 33.03 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.002 2.468 . . . . 64.340000000000003 109.829 177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -95.0 3.59 67.19 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.261 -0.881 . . . . 75.310000000000002 112.375 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.3 p -116.55 157.76 24.74 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.827 -0.805 . . . . 74.219999999999999 108.827 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -76.14 130.13 37.81 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.547 -0.909 . . . . 63.219999999999999 108.547 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.3 mt -73.16 147.62 44.62 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.448 -0.945 . . . . 73.230000000000004 108.448 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.89 122.9 41.24 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 113.681 0.993 . . . . 64.0 113.681 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -104.75 122.11 45.03 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 104.548 -2.39 . . . . 72.510000000000005 104.548 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.74 135.52 4.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 C-N-CA 119.367 -0.933 . . . . 71.099999999999994 111.782 -173.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -97.61 -123.71 4.72 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 109.532 -1.427 . . . . 55.219999999999999 109.532 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.7 p -82.2 141.58 32.9 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.701 -0.4 . . . . 72.0 109.927 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.47 131.27 53.21 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 107.575 -1.269 . . . . 73.510000000000005 107.575 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.02 143.21 99.59 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.147 1.898 . . . . 64.299999999999997 110.637 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 124.35 30.35 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 120.895 0.379 . . . . 74.010000000000005 110.084 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' O ' ' HD3' ' A' ' 59' ' ' ARG . . . -94.76 -85.15 1.66 Allowed Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 115.726 -0.67 . . . . 73.310000000000002 111.64 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -137.62 150.09 47.14 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 120.877 0.37 . . . . 75.430000000000007 110.321 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.69 161.94 18.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.931 -0.766 . . . . 72.340000000000003 108.931 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 22' ' ' VAL . 23.9 t -121.29 13.79 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 123.345 1.545 . . . . 72.219999999999999 109.662 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.89 -172.41 2.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.26 -0.882 . . . . 72.010000000000005 110.69 178.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -100.26 138.01 20.13 Favored Pre-proline 0 C--N 1.292 -1.901 0 N-CA-C 105.25 -2.13 . . . . 74.219999999999999 105.25 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.16 -21.61 22.82 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.658 2.238 . . . . 50.5 114.448 -176.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.57 -16.05 57.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.076 0.398 . . . . 70.129999999999995 112.076 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -61.93 141.8 95.36 Favored Pre-proline 0 C--O 1.251 1.134 0 O-C-N 122.089 -0.382 . . . . 75.5 110.31 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.55 117.66 4.21 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.843 2.362 . . . . 73.5 111.1 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 67' ' ' PRO . 0.5 OUTLIER -133.37 161.94 33.18 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 115.369 -0.832 . . . . 60.140000000000001 111.519 -176.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -112.89 159.94 18.54 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.611 -1.177 . . . . 73.299999999999997 109.058 178.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.583 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 5.0 m-20 -134.74 169.16 17.77 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.004 -2.221 . . . . 71.549999999999997 105.004 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.87 -55.73 35.39 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 113.489 0.922 . . . . 74.329999999999998 113.489 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -61.26 -32.71 90.47 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.881 1.721 . . . . 73.510000000000005 112.381 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.583 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 20.7 tpt180 -68.53 -40.79 80.59 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.973 0.509 . . . . 74.150000000000006 110.683 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' ASP . 77.1 t -69.0 -37.71 77.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 109.498 -0.556 . . . . 74.109999999999999 109.498 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.84 85.8 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.327 -0.851 . . . . 73.040000000000006 109.659 176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -67.37 -46.7 72.56 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.181 -0.918 . . . . 65.439999999999998 109.52 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.4 tp -66.79 -50.32 63.05 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.051 -0.977 . . . . 64.319999999999993 112.269 -175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.51 ' HB2' HG22 ' A' ' 41' ' ' VAL . 91.9 mt -82.85 -18.61 39.77 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 120.495 -0.482 . . . . 73.209999999999994 111.357 -176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.66 30.1 58.56 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 110.677 -0.969 . . . . 53.009999999999998 110.677 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 39' ' ' LEU . 28.0 m -120.94 159.04 50.71 Favored Pre-proline 0 C--N 1.312 -1.025 0 N-CA-C 109.543 -0.54 . . . . 72.549999999999997 109.543 -177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.54 163.16 39.93 Favored 'Trans proline' 0 C--O 1.256 1.404 0 C-N-CA 122.011 1.807 . . . . 74.25 111.543 174.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.24 -32.37 48.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.419 0.688 . . . . 54.200000000000003 110.359 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.578 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 33.1 t -57.32 -43.12 83.02 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.751 -0.659 . . . . 74.310000000000002 110.4 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -69.25 -32.77 72.2 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 111.742 0.275 . . . . 75.540000000000006 111.742 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.77 -45.39 97.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.056 -0.72 . . . . 72.239999999999995 109.056 175.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.98 78.2 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.464 -0.789 . . . . 72.219999999999999 110.777 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 44' ' ' SER . 93.0 mt-30 -61.68 -43.47 98.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.262 -0.426 . . . . 73.109999999999999 111.334 178.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -60.12 -49.63 76.89 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 121.901 0.857 . . . . 71.530000000000001 109.043 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.23 -42.46 99.34 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.078 -1.419 . . . . 74.400000000000006 111.278 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -71.15 -22.33 62.07 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.109 0.781 . . . . 74.310000000000002 113.109 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -102.09 5.0 40.22 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.112 -1.035 . . . . 75.0 111.396 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.59 37.31 68.14 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 115.423 -0.808 . . . . 52.210000000000001 112.243 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -95.67 -13.81 23.96 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.546 0.689 . . . . 75.530000000000001 109.36 176.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.9 tp -160.66 152.77 20.19 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.693 -1.965 . . . . 74.329999999999998 105.693 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 p -133.58 151.38 33.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.204 -0.665 . . . . 70.209999999999994 109.204 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -121.87 154.94 36.42 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 123.518 0.511 . . . . 64.510000000000005 109.737 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.62 169.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 123.711 0.804 . . . . 75.319999999999993 111.165 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 19' ' ' GLY . 24.3 ttt-85 -107.3 121.34 44.37 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.135 -0.691 . . . . 73.420000000000002 109.135 -176.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' CZ ' HG11 ' A' ' 65' ' ' VAL . 49.3 ttp180 -115.4 112.81 22.89 Favored 'General case' 0 CA--C 1.482 -1.667 0 CA-C-N 114.225 -1.352 . . . . 74.230000000000004 107.61 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.58 -51.68 0.23 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.92 1.688 . . . . 61.439999999999998 112.473 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.54 15.15 0.03 OUTLIER Glycine 0 C--N 1.29 -2.01 0 CA-C-N 114.931 -1.031 . . . . 74.239999999999995 112.147 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.35 154.96 19.74 Favored Glycine 0 CA--C 1.497 -1.077 0 N-CA-C 110.691 -0.963 . . . . 74.219999999999999 110.691 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -96.89 120.12 45.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.781 -1.192 . . . . 63.219999999999999 107.781 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.433 HG11 ' CZ ' ' A' ' 60' ' ' ARG . 16.9 m -137.21 164.05 30.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 115.745 -0.661 . . . . 73.209999999999994 111.82 -172.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.61 123.98 26.28 Favored Pre-proline 0 C--N 1.307 -1.251 0 N-CA-C 107.011 -1.478 . . . . 50.32 107.011 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HA ' HG22 ' A' ' 29' ' ' THR . 37.3 Cg_exo -62.84 143.44 91.68 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.43 2.086 . . . . 70.239999999999995 114.063 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -48.81 -41.99 34.55 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.313 1.045 . . . . 63.130000000000003 111.196 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.4 m -65.54 -7.52 4.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.48 -1.236 . . . . 65.239999999999995 113.911 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.646 ' CD2' HD11 ' A' ' 81' ' ' LEU . 7.3 m-85 -88.5 -5.02 58.48 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.873 0.844 . . . . 73.5 110.515 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -117.41 159.29 23.02 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.028 -0.987 . . . . 71.219999999999999 108.611 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 47.1 p -86.88 175.69 8.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.829 -0.804 . . . . 64.129999999999995 108.829 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -63.3 -22.08 66.65 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.333 0.587 . . . . 75.329999999999998 110.623 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.3 t -79.52 -10.51 59.81 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 116.299 -0.409 . . . . 72.219999999999999 110.615 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.62 29.64 38.85 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.572 -0.823 . . . . 64.219999999999999 111.215 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.07 151.63 37.14 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.597 -1.26 . . . . 73.530000000000001 107.597 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -71.46 131.47 34.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.731 -0.84 . . . . 72.219999999999999 108.731 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 44.4 t -57.78 125.96 14.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.323 -0.621 . . . . 74.219999999999999 109.323 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 61.1 tttp -61.5 -36.44 80.52 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.285 0.564 . . . . 72.150000000000006 112.281 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.6 t -85.19 -5.16 59.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 116.307 -0.406 . . . . 73.010000000000005 111.734 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD11 ' CD2' ' A' ' 70' ' ' PHE . 8.1 tt -66.09 -48.16 60.53 Favored Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 112.894 0.701 . . . . 71.510000000000005 112.894 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 79' ' ' LYS . 74.1 Cg_exo -54.09 -30.57 60.82 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.047 1.831 . . . . 54.219999999999999 111.511 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.6 -41.46 99.81 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.473 -0.785 . . . . 72.530000000000001 112.207 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.37 -40.45 81.43 Favored 'General case' 0 C--O 1.22 -0.465 0 N-CA-C 109.081 -0.711 . . . . 74.400000000000006 109.081 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.52 -39.96 92.9 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 115.907 -0.588 . . . . 65.549999999999997 110.339 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.2 m -57.77 -47.5 82.34 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 116.144 -0.48 . . . . 72.450000000000003 111.662 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -42.93 83.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 120.943 -0.303 . . . . 73.25 111.697 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -66.64 -37.44 84.82 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 112.465 0.543 . . . . 74.200000000000003 112.465 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -65.74 -32.86 74.64 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.893 0.377 . . . . 71.420000000000002 110.344 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.86 -30.23 69.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.231 0.539 . . . . 64.540000000000006 110.272 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.5 -9.33 75.77 Favored Glycine 0 C--O 1.242 0.655 0 CA-C-N 115.579 -0.737 . . . . 52.530000000000001 113.039 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.97 33.05 11.37 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 121.539 -0.363 . . . . 73.209999999999994 112.971 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -98.74 129.8 45.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 122.471 -0.429 . . . . 75.409999999999997 111.42 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -87.24 174.24 8.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.702 -0.681 . . . . 70.530000000000001 110.881 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -52.67 -45.9 66.96 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.925 1.69 . . . . 63.409999999999997 112.208 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.595 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 29.3 m -64.92 -41.28 95.69 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 116.031 -0.531 . . . . 55.119999999999997 109.589 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -61.72 -42.28 98.74 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.025 -0.989 . . . . 65.340000000000003 111.077 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.471 HG22 HD12 ' A' ' 102' ' ' LEU . 19.9 mm -60.95 -47.6 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 108.626 -0.879 . . . . 74.120000000000005 108.626 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.429 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 51.2 mtt -74.34 -17.56 60.81 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 113.736 1.013 . . . . 65.340000000000003 113.736 -176.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 96' ' ' THR . 83.8 mtp180 -55.84 -65.0 0.67 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 120.877 0.37 . . . . 64.209999999999994 111.353 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.52 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 p-90 -68.75 -31.93 71.32 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 112.358 0.503 . . . . 64.010000000000005 112.358 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.52 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.4 mt -66.34 -39.87 89.48 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.126 1.158 . . . . 65.349999999999994 114.126 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -90.62 -12.03 38.15 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 114.596 1.332 . . . . 51.140000000000001 114.596 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -74.67 114.15 31.41 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 123.817 0.698 . . . . 65.219999999999999 109.731 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.94 132.56 35.1 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.713 2.276 . . . . 75.400000000000006 110.551 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 16.5 t0 -118.61 117.99 33.87 Favored Pre-proline 0 C--N 1.294 -1.835 0 CA-C-N 116.299 -0.41 . . . . 43.409999999999997 111.298 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.53 -24.92 79.49 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.225 2.616 . . . . 70.340000000000003 111.889 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.3 m -78.58 -10.06 59.59 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.555 -0.748 . . . . 64.340000000000003 110.143 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.9 tp -110.29 129.22 55.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 121.429 0.633 . . . . 74.340000000000003 110.609 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 86.1 m -119.02 125.04 48.43 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.31 -0.996 . . . . 74.530000000000001 108.31 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 123' ' ' ALA . 46.8 mt -131.0 156.84 43.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.994 -0.548 . . . . 70.0 110.227 -172.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 p -135.39 135.53 40.73 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.445 1.098 . . . . 75.439999999999998 109.226 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -106.83 165.51 11.27 Favored 'General case' 0 CA--C 1.506 -0.726 0 O-C-N 122.188 -0.32 . . . . 75.129999999999995 110.52 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.09 105.42 3.35 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.739 -0.837 . . . . 70.150000000000006 108.739 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.9 7.21 Favored Glycine 0 N--CA 1.44 -1.069 0 N-CA-C 110.331 -1.108 . . . . 72.439999999999998 110.331 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 46.7 m -130.37 92.85 3.34 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.726 -0.842 . . . . 75.129999999999995 108.726 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -76.52 -17.1 59.44 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.043 -0.526 . . . . 73.040000000000006 111.833 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.96 140.08 47.15 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.441 -0.578 . . . . 74.010000000000005 109.441 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.11 124.01 27.2 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.832 -0.622 . . . . 71.200000000000003 110.758 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.33 117.68 52.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.183 -0.673 . . . . 70.129999999999995 109.183 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 55.4 m -90.28 142.95 27.22 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.71 -0.848 . . . . 60.119999999999997 108.71 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.2 t30 74.36 72.26 0.11 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 124.272 0.982 . . . . 72.439999999999998 110.381 -176.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.439 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -123.44 172.82 8.42 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 106.625 -1.62 . . . . 63.149999999999999 106.625 171.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.504 ' HG2' ' OD2' ' A' ' 127' ' ' ASP . 8.0 ptp180 -92.82 143.79 27.51 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 107.111 -1.44 . . . . 73.340000000000003 107.111 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 90.2 Cg_exo -49.28 -25.6 10.09 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.313 2.675 . . . . 72.450000000000003 114.897 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.564 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.8 t -63.96 -32.33 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 120.331 -0.548 . . . . 45.130000000000003 110.113 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.504 ' OD2' ' HG2' ' A' ' 124' ' ' ARG . 10.5 m-20 -60.45 -30.84 69.92 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 116.254 -0.43 . . . . 64.230000000000004 110.415 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.5 -43.88 72.19 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.883 -0.599 . . . . 60.409999999999997 111.092 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -70.18 -33.98 72.41 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.932 -0.48 . . . . 74.430000000000007 111.099 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -67.53 -19.53 65.31 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 122.15 0.976 . . . . 73.140000000000001 109.238 176.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.94 9.44 32.66 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.924 -1.034 . . . . 60.32 111.838 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 74.9 m80 61.77 28.47 17.5 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.911 0.862 . . . . 52.340000000000003 112.249 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -106.3 25.11 11.47 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.827 1.651 . . . . 72.540000000000006 107.512 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.2 -26.87 12.7 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 126.926 2.09 . . . . 74.209999999999994 114.237 -174.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -55.69 -37.18 68.01 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.194 0.813 . . . . 64.530000000000001 113.194 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -67.54 -32.36 73.08 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.291 0.567 . . . . 71.129999999999995 110.59 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.48 -49.14 68.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.615 -0.883 . . . . 74.420000000000002 108.615 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.569 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 67.8 t -58.07 -42.85 83.93 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.804 0 CA-C-N 115.404 -0.817 . . . . 74.120000000000005 109.58 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -57.0 -47.47 80.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.72 -0.673 . . . . 65.219999999999999 110.822 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -68.79 -34.1 74.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 73.329999999999998 111.045 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.416 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -67.53 -46.71 72.01 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.106 -0.497 . . . . 75.530000000000001 110.941 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 15.9 mm100 -59.66 -40.11 86.68 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.028 0.531 . . . . 71.430000000000007 110.04 178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 -31.02 68.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.424 -0.807 . . . . 42.109999999999999 111.257 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.1 tpp -78.04 -47.9 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.904 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.5 -29.29 37.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.543 0.942 . . . . 72.400000000000006 113.543 -173.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 C--N 1.312 -1.059 0 CA-C-O 117.989 -1.005 . . . . 55.240000000000002 110.038 -179.574 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.511 -0.526 0 N-CA-C 109.621 -0.511 . . . . 72.0 109.621 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.84 95.53 1.02 Allowed 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.519 1.48 . . . . 65.329999999999998 110.382 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.32 95.27 1.55 Allowed Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 110.901 -0.88 . . . . 73.040000000000006 110.901 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -72.86 136.66 45.35 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.754 0.312 . . . . 62.310000000000002 110.737 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.16 122.92 73.92 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 107.489 -1.3 . . . . 71.140000000000001 107.489 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.42 148.87 68.24 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.911 1.74 . . . . 73.010000000000005 111.408 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.91 50.35 4.38 Favored Glycine 0 C--N 1.316 -0.561 0 N-CA-C 111.904 -0.479 . . . . 73.430000000000007 111.904 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.9 t 177.68 134.92 0.07 Allowed 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 106.385 -1.709 . . . . 60.109999999999999 106.385 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.5 m -67.47 130.75 44.05 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.342 -1.355 . . . . 74.420000000000002 107.342 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.85 144.93 51.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.138 0.494 . . . . 74.439999999999998 111.559 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.09 145.14 25.65 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.434 -0.95 . . . . 72.310000000000002 108.434 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -105.76 93.23 4.54 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.729 0.776 . . . . 74.219999999999999 110.709 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 t -101.09 80.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.514 -1.291 . . . . 73.030000000000001 107.514 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.35 -162.05 10.9 Favored Glycine 0 N--CA 1.412 -2.907 0 N-CA-C 110.38 -1.088 . . . . 65.349999999999994 110.38 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 16.3 m -54.44 118.03 3.81 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.822 0.849 . . . . 52.299999999999997 112.552 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.9 mp -73.28 134.06 80.43 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 107.748 -1.204 . . . . 72.040000000000006 107.748 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.21 165.11 33.46 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.379 2.053 . . . . 44.119999999999997 112.528 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.33 123.72 44.88 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.632 -1.618 . . . . 74.510000000000005 106.632 173.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.88 -118.17 3.11 Favored Glycine 0 N--CA 1.423 -2.232 0 C-N-CA 120.257 -0.973 . . . . 55.240000000000002 113.801 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.11 107.1 18.85 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 112.884 0.698 . . . . 72.349999999999994 112.884 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' OD1' ' HD2' ' A' ' 60' ' ' ARG . 11.2 t70 -44.69 113.02 0.49 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 126.108 1.763 . . . . 53.119999999999997 113.108 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.67 -33.96 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.558 -0.747 . . . . 70.439999999999998 111.645 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' A' ' 103' ' ' PHE 0.406 0.4 OUTLIER -67.18 140.8 57.49 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.283 1.586 . . . . 74.340000000000003 115.283 -176.024 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.36 146.41 84.39 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 113.222 -1.808 . . . . 41.130000000000003 110.993 -177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HA ' HH22 ' A' ' 60' ' ' ARG . 89.9 Cg_exo -50.52 -22.43 9.09 Favored 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 123.409 2.739 . . . . 70.030000000000001 115.601 178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -97.71 3.53 50.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.942 0.719 . . . . 52.140000000000001 112.942 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -79.42 128.14 76.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 108.906 -0.776 . . . . 63.43 108.906 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.48 147.09 70.24 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.554 2.169 . . . . 70.120000000000005 112.685 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.4 p -133.45 173.69 11.21 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.497 0.665 . . . . 75.420000000000002 111.645 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 23.2 m-85 -130.25 161.09 31.99 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 126.299 1.84 . . . . 64.109999999999999 106.626 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.416 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.4 t0 -134.08 167.42 20.68 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 104.802 -2.296 . . . . 73.530000000000001 104.802 -176.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -49.79 -57.0 13.62 Favored Pre-proline 0 C--N 1.31 -1.146 0 C-N-CA 123.839 0.856 . . . . 72.519999999999996 112.999 -172.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.7 -32.25 47.58 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 121.152 1.234 . . . . 71.120000000000005 112.14 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 34' ' ' ARG . 19.4 tpt180 -70.34 -37.74 74.72 Favored 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 112.187 0.44 . . . . 74.25 112.187 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 31' ' ' ASP . 58.5 t -67.23 -39.12 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.738 -0.838 . . . . 74.129999999999995 108.738 177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.72 -47.89 83.87 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 114.66 -1.154 . . . . 70.030000000000001 110.032 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.04 -43.1 99.59 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.941 0.896 . . . . 72.150000000000006 109.814 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.0 tp -62.16 -50.06 73.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.404 -0.817 . . . . 73.519999999999996 111.396 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -86.76 -18.53 30.9 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.038 0.755 . . . . 73.140000000000001 113.038 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.32 28.01 53.91 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.436 -0.887 . . . . 63.240000000000002 110.961 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.09 161.18 46.21 Favored Pre-proline 0 C--N 1.31 -1.112 0 N-CA-C 107.611 -1.255 . . . . 61.350000000000001 107.611 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.63 163.26 31.99 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 121.253 1.302 . . . . 64.340000000000003 111.409 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.9 t -58.79 -32.64 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.6 0.714 . . . . 74.230000000000004 109.35 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.587 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.1 m -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 114.723 -1.126 . . . . 74.109999999999999 110.606 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 49.6 mttp -68.94 -32.92 72.87 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.678 -0.409 . . . . 74.299999999999997 111.253 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.473 ' HA ' HE21 ' A' ' 49' ' ' GLN . 61.3 t -62.16 -46.23 96.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.466 -0.568 . . . . 53.229999999999997 109.466 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.25 81.29 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.423 -0.808 . . . . 51.420000000000002 110.759 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 44' ' ' SER . 29.3 mm-40 -64.35 -37.94 89.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 62.530000000000001 110.772 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 38.6 mt-30 -68.31 -45.05 74.05 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.896 0.855 . . . . 75.540000000000006 109.163 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.86 -45.29 94.43 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.789 -1.551 . . . . 72.200000000000003 109.797 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 25.9 ptt180 -66.12 -22.28 66.38 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 113.138 0.792 . . . . 64.019999999999996 113.138 -175.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -102.66 11.78 37.24 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.216 -0.994 . . . . 71.109999999999999 112.49 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.58 57.48 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.976 -0.63 . . . . 53.409999999999997 113.02 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -96.13 -5.74 40.01 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.265 0.555 . . . . 74.129999999999995 109.866 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.1 tp -163.42 157.65 20.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.399 -1.704 . . . . 74.140000000000001 106.399 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.54 147.05 27.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 118.393 0.542 . . . . 75.430000000000007 109.586 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.59 162.69 19.21 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 123.346 0.659 . . . . 74.219999999999999 110.473 -176.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.44 157.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 123.001 0.521 . . . . 62.219999999999999 110.226 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -110.86 119.07 37.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.204 -0.665 . . . . 60.509999999999998 109.204 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.566 HH22 ' HA ' ' A' ' 25' ' ' PRO . 11.4 ptm180 -149.24 130.61 14.71 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.367 -0.378 . . . . 75.439999999999998 111.187 -178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.63 26.58 16.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.995 0.918 . . . . 72.439999999999998 112.121 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.13 8.1 82.36 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 116.039 -0.528 . . . . 63.340000000000003 112.341 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.01 141.0 12.76 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 111.424 -0.67 . . . . 62.5 111.424 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.52 119.91 48.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.263 -1.384 . . . . 73.319999999999993 107.263 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.47 162.29 39.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.861 -0.609 . . . . 52.100000000000001 110.13 -175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.7 128.01 26.02 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 108.089 -1.078 . . . . 53.509999999999998 108.089 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.28 122.01 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.787 2.324 . . . . 61.43 112.037 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.521 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.5 tt0 -65.74 -24.59 66.99 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.136 0.493 . . . . 62.350000000000001 111.699 -178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.5 -8.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 115.637 -0.711 . . . . 72.230000000000004 112.373 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -86.73 -2.47 58.56 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.388 0.613 . . . . 71.420000000000002 110.95 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -116.83 148.51 41.18 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 73.430000000000007 109.248 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.4 p -82.74 175.47 10.1 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.571 -0.9 . . . . 63.539999999999999 108.571 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -64.42 -17.21 63.58 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.931 0.396 . . . . 63.210000000000001 111.729 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 m -79.78 -9.14 59.62 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.348 0.595 . . . . 65.409999999999997 109.778 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.29 22.44 62.85 Favored Glycine 0 C--O 1.215 -1.081 0 N-CA-C 110.73 -0.948 . . . . 70.209999999999994 110.73 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -108.06 143.82 36.26 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 108.759 -0.83 . . . . 75.129999999999995 108.759 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.0 t -62.98 134.46 28.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 108.134 -1.062 . . . . 61.409999999999997 108.134 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 58.7 t -57.04 128.19 17.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 N-CA-C 108.185 -1.043 . . . . 71.530000000000001 108.185 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -23.07 65.86 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.741 0.645 . . . . 73.5 112.741 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 78' ' ' VAL . 17.5 m -88.22 -1.93 58.31 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 120.998 0.428 . . . . 75.010000000000005 111.169 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.0 tt -65.58 -54.24 31.69 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.386 0.513 . . . . 61.210000000000001 112.386 -177.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 39.5 Cg_exo -60.76 -29.77 88.95 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 121.265 1.31 . . . . 75.310000000000002 110.979 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.17 -42.15 99.7 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-N 115.319 -0.855 . . . . 55.020000000000003 112.216 178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.9 pp -68.92 -42.01 77.36 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.587 -0.523 . . . . 73.219999999999999 109.587 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.33 -37.34 85.25 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 116.243 -0.435 . . . . 71.209999999999994 110.645 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 99.6 m -58.69 -48.04 82.47 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.837 -0.619 . . . . 60.240000000000002 111.89 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.427 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -68.27 -42.15 84.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 120.607 -0.437 . . . . 75.420000000000002 111.045 -177.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.427 HD22 HG23 ' A' ' 87' ' ' ILE . 3.2 mm? -67.07 -35.29 79.51 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.112 -0.635 . . . . 72.140000000000001 111.874 176.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -62.94 -33.4 75.27 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.484 -0.562 . . . . 75.010000000000005 109.484 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -67.97 -31.4 71.1 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.017 -0.538 . . . . 53.119999999999997 110.148 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.72 -3.96 63.99 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.569 -0.741 . . . . 51.43 111.756 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.22 37.07 55.33 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 113.708 0.243 . . . . 75.439999999999998 113.708 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 52.1 m-85 -92.06 126.19 37.05 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 117.55 0.675 . . . . 75.239999999999995 111.18 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.57 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 26.8 ptt180 -70.43 169.21 14.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.901 . . . . 75.299999999999997 111.276 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 99' ' ' MET . 7.7 p-10 -54.87 -44.5 74.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.052 1.341 . . . . 74.340000000000003 111.816 -176.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.4 m -62.06 -41.02 97.71 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.332 -0.849 . . . . 52.439999999999998 110.835 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.57 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 49.8 mm-40 -66.38 -37.92 86.36 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 120.747 -0.381 . . . . 74.420000000000002 110.482 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.2 -50.07 82.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.751 0 N-CA-C 109.112 -0.699 . . . . 62.439999999999998 109.112 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.9 ptt? -74.67 -17.49 60.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.334 -0.848 . . . . 70.450000000000003 112.948 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.31 -65.26 0.72 Allowed 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.47 0.481 . . . . 72.230000000000004 110.099 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -70.38 -32.26 69.84 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.245 0.831 . . . . 74.030000000000001 113.245 177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 125' ' ' PRO . 40.8 tp -68.33 -40.46 81.61 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.038 0.755 . . . . 72.420000000000002 113.038 -173.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CE2' HD23 ' A' ' 23' ' ' LEU . 26.6 m-85 -87.16 -18.3 30.7 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.367 0.877 . . . . 73.510000000000005 113.367 -175.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 63.2 m -81.03 127.37 74.68 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 112.194 0.442 . . . . 52.229999999999997 112.194 -174.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 104' ' ' THR . 23.4 Cg_exo -66.47 132.31 28.84 Favored 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 122.664 2.243 . . . . 44.25 111.31 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -118.19 121.45 31.29 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.465 -0.334 . . . . 62.32 111.839 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.98 -26.43 82.38 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.585 2.856 . . . . 73.439999999999998 112.205 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.0 m -85.96 -0.21 54.88 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.213 0.53 . . . . 53.43 111.239 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.4 tp -107.63 126.89 53.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.207 -0.664 . . . . 73.319999999999993 109.207 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 27.2 m -131.28 114.34 14.91 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.206 -1.035 . . . . 73.400000000000006 108.206 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.45 HD13 ' HB2' ' A' ' 128' ' ' ALA . 11.5 pt -136.51 163.06 34.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 116.45 -0.341 . . . . 71.129999999999995 110.759 -175.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -101.36 126.64 48.15 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 107.969 -1.123 . . . . 54.409999999999997 107.969 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -103.14 162.96 12.53 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 114.257 1.206 . . . . 73.219999999999999 114.257 -171.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -64.96 116.85 6.82 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.43 -1.714 . . . . 63.020000000000003 108.636 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.85 -2.54 38.67 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.7 -0.762 . . . . 62.350000000000001 112.094 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.7 t -131.32 156.49 45.4 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 107.559 -1.274 . . . . 71.430000000000007 107.559 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -99.71 -27.93 13.42 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 121.086 0.47 . . . . 74.340000000000003 111.231 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -102.66 -169.92 1.73 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.092 -0.707 . . . . 54.539999999999999 109.092 -172.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -103.94 132.79 49.85 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.005 0.431 . . . . 65.219999999999999 110.039 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.2 t -107.83 126.15 64.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.292 -1.003 . . . . 62.020000000000003 108.292 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 6.0 t -89.13 162.02 16.18 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.964 -1.124 . . . . 65.329999999999998 107.964 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.7 t30 67.57 44.67 1.66 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 122.647 1.213 . . . . 70.549999999999997 108.521 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.86 16.74 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.963 -1.017 . . . . 71.430000000000007 110.763 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -95.43 137.97 21.96 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.11 -0.7 . . . . 63.310000000000002 109.11 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.602 ' HB2' HD12 ' A' ' 102' ' ' LEU . 87.6 Cg_exo -50.0 -26.24 14.04 Favored 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.638 2.892 . . . . 74.129999999999995 114.755 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 94.7 t -60.58 -39.74 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-O 121.529 0.68 . . . . 73.349999999999994 110.283 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.01 -33.26 75.39 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.257 -0.883 . . . . 64.329999999999998 109.659 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.45 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -69.48 -47.92 62.35 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.245 -0.889 . . . . 52.020000000000003 111.45 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -65.81 -34.57 78.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.021 0.439 . . . . 70.530000000000001 110.438 -177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -66.43 -32.26 73.52 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.229 -0.896 . . . . 71.030000000000001 108.945 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.91 13.16 19.32 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.094 -0.957 . . . . 65.319999999999993 111.445 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 64.76 28.05 12.98 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.524 1.13 . . . . 74.120000000000005 110.693 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -109.43 23.85 13.9 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.586 1.184 . . . . 74.329999999999998 108.99 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.94 -25.4 11.77 Favored 'General case' 0 C--O 1.21 -0.985 0 CA-C-N 112.913 -1.949 . . . . 75.010000000000005 112.151 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -54.51 -39.69 67.84 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.95 0.5 . . . . 60.119999999999997 111.286 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -73.0 -28.63 62.49 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.236 0.541 . . . . 74.209999999999994 110.432 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.75 -48.94 68.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 108.829 -0.804 . . . . 61.240000000000002 108.829 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 89.2 t -60.07 -41.17 85.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 123.559 0.744 . . . . 61.409999999999997 109.792 176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -56.97 -46.45 82.17 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.562 -0.744 . . . . 73.430000000000007 109.598 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -69.04 -36.48 77.76 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 116.316 -0.402 . . . . 75.109999999999999 111.848 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.7 89.59 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.06 -0.518 . . . . 53.210000000000001 109.621 177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.2 mt-30 -62.88 -37.53 87.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.708 -0.678 . . . . 74.420000000000002 110.442 177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.5 76.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.257 0.551 . . . . 70.010000000000005 111.017 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.58 -36.89 57.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.146 -0.479 . . . . 73.409999999999997 110.598 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.549 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -76.74 -49.62 15.55 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.613 0.968 . . . . 61.210000000000001 113.613 -176.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--O 1.255 1.346 0 CA-C-O 118.975 -0.536 . . . . 72.349999999999994 111.218 -174.639 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.509 -0.599 0 N-CA-C 108.821 -0.807 . . . . 52.329999999999998 108.821 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.31 113.02 1.22 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.155 1.904 . . . . 73.219999999999999 110.046 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.16 -160.98 35.89 Favored Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 115.699 -0.682 . . . . 54.229999999999997 113.297 -176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -66.99 133.58 50.24 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 123.605 0.762 . . . . 43.5 111.693 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.35 126.33 27.28 Favored Pre-proline 0 C--N 1.303 -1.441 0 CA-C-N 115.377 -0.829 . . . . 44.149999999999999 109.688 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.93 -169.25 0.72 Allowed 'Trans proline' 0 C--O 1.253 1.252 0 C-N-CA 122.521 2.147 . . . . 70.530000000000001 111.455 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.67 -119.23 1.37 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 110.869 -0.892 . . . . 63.399999999999999 110.869 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 t -157.78 156.71 32.03 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.146 -1.427 . . . . 74.230000000000004 107.146 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.4 m -89.24 143.93 26.47 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.468 -0.938 . . . . 72.010000000000005 108.468 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.78 169.81 9.89 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.752 0.31 . . . . 71.030000000000001 111.418 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.22 -177.85 5.76 Favored 'General case' 0 C--O 1.252 1.207 0 N-CA-C 109.544 -0.539 . . . . 62.509999999999998 109.544 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 12' ' ' ARG . 20.0 mmt180 -79.55 80.38 5.94 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 113.775 1.028 . . . . 71.140000000000001 113.775 177.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -114.28 80.99 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 105.361 -2.088 . . . . 70.409999999999997 105.361 171.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 51' ' ' ARG . . . -151.17 -120.23 0.92 Allowed Glycine 0 N--CA 1.415 -2.766 0 CA-C-N 115.068 -0.969 . . . . 70.219999999999999 112.439 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.3 p -88.26 137.81 31.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-O 121.236 0.541 . . . . 75.129999999999995 110.404 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.415 HG21 ' HB2' ' A' ' 94' ' ' ARG . 3.4 mp -91.98 127.95 47.55 Favored Pre-proline 0 C--N 1.285 -2.217 0 N-CA-C 106.404 -1.702 . . . . 75.420000000000002 106.404 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.03 137.46 79.29 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.173 1.915 . . . . 70.140000000000001 110.708 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.63 123.99 29.17 Favored 'General case' 0 C--O 1.249 1.066 0 N-CA-C 108.626 -0.879 . . . . 35.310000000000002 108.626 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.82 -101.37 2.71 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 115.576 -0.738 . . . . 34.219999999999999 113.88 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -98.97 120.78 40.0 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.099 0.476 . . . . 73.319999999999993 111.537 -173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.59 146.29 50.18 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.148 -0.933 . . . . 63.350000000000001 110.12 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.35 -12.08 11.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 116.529 -0.305 . . . . 61.409999999999997 111.147 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 103' ' ' PHE 0.282 0.8 OUTLIER -89.16 169.55 11.38 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 114.702 1.371 . . . . 71.420000000000002 114.702 -177.435 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -101.48 148.15 34.81 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 107.346 -1.353 . . . . 61.43 107.346 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.64 -22.6 9.65 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.892 2.395 . . . . 61.140000000000001 113.699 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.6 -32.19 73.73 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.86 -0.422 . . . . 73.030000000000001 109.86 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.64 126.26 90.85 Favored Pre-proline 0 N--CA 1.444 -0.747 0 N-CA-C 108.595 -0.891 . . . . 74.099999999999994 108.595 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.32 154.87 61.13 Favored 'Trans proline' 0 C--O 1.256 1.416 0 C-N-CA 122.181 1.921 . . . . 70.140000000000001 111.047 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 p -136.05 169.57 17.39 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.968 0.89 . . . . 74.310000000000002 112.71 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -119.83 160.95 21.65 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 127.09 2.156 . . . . 73.299999999999997 106.127 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.467 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 7.1 t70 -134.49 156.91 47.78 Favored 'General case' 0 C--N 1.26 -3.308 0 N-CA-C 102.982 -2.97 . . . . 72.439999999999998 102.982 -175.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.51 -51.77 75.43 Favored Pre-proline 0 C--N 1.313 -0.987 0 N-CA-C 113.605 0.965 . . . . 72.310000000000002 113.605 -173.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 13.4 Cg_endo -60.23 -31.57 93.2 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.792 1.661 . . . . 62.439999999999998 112.255 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.467 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 19.9 tpt180 -70.79 -37.57 73.32 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.886 0.374 . . . . 75.540000000000006 110.368 178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.5 t -69.03 -37.87 77.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.665 -0.865 . . . . 61.200000000000003 108.665 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.77 -37.06 78.0 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.944 -1.026 . . . . 71.340000000000003 110.035 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.63 -46.67 68.61 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.627 0.771 . . . . 70.299999999999997 109.504 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.77 -46.38 82.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.688 -1.142 . . . . 72.519999999999996 111.617 -176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.54 -18.41 29.85 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 120.552 -0.459 . . . . 75.219999999999999 111.842 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.02 61.55 Favored Glycine 0 C--N 1.314 -0.644 0 C-N-CA 120.965 -0.636 . . . . 64.329999999999998 111.554 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.99 161.1 48.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 109.324 -0.621 . . . . 73.510000000000005 109.324 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.87 158.63 56.17 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 121.908 1.739 . . . . 73.010000000000005 112.051 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -60.2 -33.33 53.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.868 0.867 . . . . 75.299999999999997 110.854 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.0 p -60.34 -40.43 90.63 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.686 -0.688 . . . . 73.109999999999999 111.445 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 65.0 tttm -69.33 -34.12 74.16 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.069 -0.715 . . . . 71.049999999999997 109.069 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.487 ' HA ' HE21 ' A' ' 49' ' ' GLN . 64.0 t -63.51 -44.1 98.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 115.742 -0.663 . . . . 63.420000000000002 109.615 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.62 -36.5 82.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.109 -0.95 . . . . 52.240000000000002 110.357 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -65.82 -35.09 79.72 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.064 0.394 . . . . 75.319999999999993 112.064 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 46' ' ' VAL . 37.8 mt-30 -62.56 -42.51 99.59 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.87 0.843 . . . . 71.450000000000003 108.838 175.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.56 -34.84 78.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.552 -1.204 . . . . 75.129999999999995 109.451 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.468 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 13.2 mmt85 -67.16 -29.38 69.07 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.928 0.891 . . . . 74.439999999999998 112.33 177.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.43 6.13 39.99 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.334 -0.546 . . . . 74.140000000000001 111.902 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 43.22 76.02 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.12 -0.562 . . . . 62.030000000000001 112.173 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -104.73 -17.0 14.78 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.112 -0.699 . . . . 74.409999999999997 109.112 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.3 tp -149.35 158.39 44.13 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.675 -1.231 . . . . 62.229999999999997 107.675 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 85.7 t -136.23 147.22 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.0 -0.741 . . . . 40.229999999999997 109.0 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.84 161.54 28.0 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.111 0.565 . . . . 71.349999999999994 110.113 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.426 HG11 ' HG3' ' A' ' 99' ' ' MET . 6.7 m -136.68 165.61 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 123.928 0.891 . . . . 60.229999999999997 109.093 176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -117.03 115.88 26.28 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.659 -0.497 . . . . 43.539999999999999 109.659 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -116.81 124.44 49.57 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.016 -0.735 . . . . 63.140000000000001 109.016 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.74 22.59 5.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.835 0.854 . . . . 65.120000000000005 112.712 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.13 -24.02 21.92 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.396 -0.906 . . . . 64.239999999999995 113.24 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.29 143.55 16.73 Favored Glycine 0 CA--C 1.496 -1.146 0 C-N-CA 120.811 -0.709 . . . . 74.510000000000005 112.252 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.3 124.11 48.87 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 109.128 -0.694 . . . . 71.140000000000001 109.128 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.44 168.56 22.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.751 -1.113 . . . . 61.030000000000001 111.286 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.0 mm -118.64 135.92 23.9 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 105.875 -1.898 . . . . 74.549999999999997 105.875 178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -68.92 139.7 43.92 Favored 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 121.606 1.537 . . . . 65.409999999999997 112.638 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -54.15 -36.37 63.27 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.655 0.782 . . . . 64.439999999999998 110.141 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.418 ' CG2' HG11 ' A' ' 126' ' ' VAL . 20.0 m -70.17 -3.18 2.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.405 -1.271 . . . . 63.210000000000001 113.92 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -88.4 -5.93 57.99 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.085 0.945 . . . . 72.239999999999995 109.64 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -124.13 155.54 38.25 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.491 -1.231 . . . . 74.230000000000004 108.395 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.8 p -83.21 165.0 19.8 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.39 -1.337 . . . . 74.439999999999998 107.39 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -67.1 -16.02 64.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.361 0.6 . . . . 75.120000000000005 110.996 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -79.47 -3.67 47.71 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.301 -0.863 . . . . 70.340000000000003 111.02 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.63 21.71 55.44 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.009 -0.615 . . . . 51.43 112.694 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -114.58 161.38 18.13 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 120.607 0.241 . . . . 74.140000000000001 110.505 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.72 138.23 21.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.107 -1.071 . . . . 71.340000000000003 108.107 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.82 129.52 24.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.036 -1.098 . . . . 74.230000000000004 108.036 176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.87 -26.39 62.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.348 0.87 . . . . 75.319999999999993 113.348 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.8 m -99.02 6.91 46.43 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.411 -0.359 . . . . 71.030000000000001 111.645 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 70' ' ' PHE . 19.2 tp -61.12 -54.93 49.09 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 111.98 0.363 . . . . 64.430000000000007 111.98 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.99 -22.14 73.62 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 121.749 1.632 . . . . 75.120000000000005 111.73 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.43 -44.46 90.28 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.754 -0.657 . . . . 34.109999999999999 112.221 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.07 -39.12 86.78 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.7 -0.852 . . . . 72.049999999999997 108.7 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.77 -36.86 84.44 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.694 -1.139 . . . . 71.409999999999997 111.294 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 m -57.54 -49.21 77.11 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 120.611 0.243 . . . . 73.319999999999993 111.333 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -43.95 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 120.928 0.394 . . . . 74.239999999999995 111.353 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.654 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 83.4 mt -66.69 -39.92 88.3 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.36 0.504 . . . . 64.099999999999994 112.36 -178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -68.29 -35.64 78.15 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.117 -0.492 . . . . 73.420000000000002 110.496 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -67.38 -31.67 72.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.597 -0.52 . . . . 72.439999999999998 109.597 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.79 -0.77 89.91 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.502 -0.772 . . . . 45.009999999999998 112.798 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 34.21 55.29 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.309 -0.472 . . . . 62.340000000000003 113.278 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -94.72 123.79 38.38 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.357 0.598 . . . . 61.299999999999997 112.271 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.415 ' HB2' HG21 ' A' ' 16' ' ' ILE . 14.2 ptm180 -73.87 173.71 9.54 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.781 -1.1 . . . . 72.530000000000001 112.076 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -53.02 -45.32 67.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.061 1.745 . . . . 54.439999999999998 111.238 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 61.3 m -64.24 -40.77 96.71 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 123.842 0.857 . . . . 74.200000000000003 110.092 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.406 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 25.1 mm-40 -66.81 -37.49 84.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.975 -0.557 . . . . 74.319999999999993 111.601 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.547 HD12 HD13 ' A' ' 88' ' ' LEU . 20.7 mm -60.85 -48.11 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.126 -1.064 . . . . 72.219999999999999 108.126 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.435 ' SD ' ' HE1' ' A' ' 103' ' ' PHE . 21.8 mmt -74.2 -22.35 59.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.648 -1.16 . . . . 52.0 111.229 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 77.9 ttt180 -54.3 -69.32 0.13 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.868 0.867 . . . . 72.549999999999997 111.653 -174.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.654 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 55.2 p-90 -70.35 -32.15 69.72 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.214 0.449 . . . . 74.519999999999996 112.214 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.588 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 9.3 mt -61.34 -39.81 91.95 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 114.689 1.366 . . . . 64.310000000000002 114.689 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 56.8 m-85 -94.79 -12.17 27.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 113.599 0.963 . . . . 62.439999999999998 113.599 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.1 m -83.17 129.52 60.66 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 108.741 -0.837 . . . . 62.399999999999999 108.741 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.12 128.97 29.61 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.033 1.822 . . . . 61.539999999999999 109.626 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -95.8 118.36 65.96 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.63 -0.878 . . . . 73.5 108.63 -176.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 23.3 Cg_endo -61.11 -20.25 66.97 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.959 2.44 . . . . 64.5 113.667 -177.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.2 m -101.21 4.83 42.27 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 116.479 -0.328 . . . . 73.430000000000007 110.353 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.2 tp -107.67 123.28 48.27 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.828 0.823 . . . . 74.109999999999999 111.155 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.3 m -131.2 113.0 13.32 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.87 -1.53 . . . . 74.109999999999999 106.87 175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.0 pt -130.67 163.83 35.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 112.372 0.508 . . . . 72.420000000000002 112.372 -172.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.9 t -96.64 159.27 15.02 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.938 -1.875 . . . . 73.450000000000003 105.938 173.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 116' ' ' SER . 41.5 ttm180 -128.82 162.03 28.41 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 110.625 -0.139 . . . . 74.409999999999997 110.625 -174.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.91 112.05 1.21 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.087 0.555 . . . . 64.129999999999995 110.327 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.38 -1.34 87.39 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.212 -0.518 . . . . 71.230000000000004 112.575 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 113' ' ' ARG . 50.8 m -126.34 100.79 6.43 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.712 -0.477 . . . . 71.540000000000006 109.712 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -81.53 -11.11 59.3 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 122.157 0.979 . . . . 62.310000000000002 109.006 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -72.59 140.73 48.22 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 113.361 -1.745 . . . . 65.150000000000006 108.131 172.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.94 136.24 33.7 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 116.133 -0.485 . . . . 55.539999999999999 111.133 -175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 45.4 t -106.67 119.7 56.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.395 -0.965 . . . . 63.5 108.395 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 m -90.23 151.62 21.45 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.537 -0.912 . . . . 72.120000000000005 108.537 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 50.1 m-80 54.37 63.66 2.09 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.306 0.642 . . . . 64.010000000000005 111.634 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.59 156.38 24.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.259 -0.645 . . . . 43.149999999999999 109.259 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.588 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -72.8 135.93 80.51 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 120.348 -0.541 . . . . 74.450000000000003 109.907 175.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.505 ' HB2' HD23 ' A' ' 102' ' ' LEU . 47.0 Cg_exo -56.06 -21.22 33.7 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.946 2.431 . . . . 62.0 114.47 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.635 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.8 t -61.53 -36.64 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.909 0.861 . . . . 62.329999999999998 109.55 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.0 -31.83 72.95 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.767 -1.106 . . . . 71.299999999999997 109.201 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.97 71.08 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.665 -1.152 . . . . 52.299999999999997 111.478 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -68.49 -33.02 73.42 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 122.304 -0.247 . . . . 72.230000000000004 111.367 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -64.91 -29.7 70.65 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.013 0.911 . . . . 71.420000000000002 108.55 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HB3' HE21 ' A' ' 133' ' ' GLN . . . -98.55 15.95 23.4 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.49 -1.232 . . . . 64.409999999999997 110.584 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.1 m80 58.23 34.2 23.88 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.814 1.413 . . . . 72.140000000000001 114.814 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 131' ' ' ALA . 46.7 mt-30 -104.07 23.53 12.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.682 -1.599 . . . . 74.319999999999993 106.682 172.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.96 -28.35 23.3 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 126.883 2.073 . . . . 75.5 113.772 -175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -55.3 -40.18 70.78 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.966 0.412 . . . . 70.519999999999996 111.541 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.37 -27.73 61.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.568 0.699 . . . . 61.100000000000001 109.746 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -71.55 -40.9 72.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.29 -0.868 . . . . 72.329999999999998 108.903 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.477 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 63.3 t -58.73 -46.72 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 N-CA-C 108.599 -0.889 . . . . 74.420000000000002 108.599 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.93 -1.032 . . . . 75.420000000000002 112.301 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -64.97 -36.12 83.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 120.876 -0.33 . . . . 64.340000000000003 110.166 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.14 -43.27 98.83 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.872 -0.418 . . . . 61.530000000000001 109.872 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -59.51 -44.23 93.18 Favored 'General case' 0 C--O 1.206 -1.192 0 CA-C-N 115.577 -0.738 . . . . 74.329999999999998 109.688 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.3 -26.58 68.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 60.0 111.867 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.5 tpt -81.61 -34.26 31.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.026 0.441 . . . . 72.140000000000001 110.608 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.61 -43.45 15.62 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.075 0.464 . . . . 62.32 111.49 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 . . . . . 0 C--O 1.261 1.669 0 CA-C-N 115.73 -0.668 . . . . 73.219999999999999 109.264 -177.22 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 CA--C 1.51 -0.572 0 N-CA-C 109.141 -0.688 . . . . 54.229999999999997 109.141 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.56 103.58 1.15 Allowed 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 122.341 2.028 . . . . 74.239999999999995 112.677 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.85 25.6 0.02 OUTLIER Glycine 0 C--N 1.311 -0.83 0 C-N-CA 120.009 -1.091 . . . . 72.450000000000003 113.813 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -73.9 133.41 43.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.467 -0.568 . . . . 73.25 109.467 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.38 135.66 22.25 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 110.34 -0.244 . . . . 61.219999999999999 110.34 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.18 143.33 48.5 Favored 'Trans proline' 0 C--O 1.242 0.713 0 C-N-CA 122.664 2.243 . . . . 74.310000000000002 111.645 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.22 90.51 1.21 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 115.916 -0.584 . . . . 73.209999999999994 112.6 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 m -96.38 105.06 17.07 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.672 -0.492 . . . . 75.239999999999995 109.672 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 m -86.8 144.61 26.97 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.098 -0.704 . . . . 73.430000000000007 109.098 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -84.71 158.24 20.84 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.663 -0.495 . . . . 71.409999999999997 109.663 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.11 146.77 41.13 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.178 -0.465 . . . . 35.299999999999997 109.889 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.56 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -91.55 86.78 6.13 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.574 1.178 . . . . 71.120000000000005 108.626 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.1 m -111.88 130.24 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 CA-C-N 114.453 -1.249 . . . . 51.229999999999997 110.286 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.67 44.4 0.69 Allowed Glycine 0 C--N 1.269 -3.174 0 N-CA-C 107.765 -2.134 . . . . 71.319999999999993 107.765 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 14.0 m -74.95 100.0 4.0 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.582 -0.809 . . . . 73.420000000000002 110.992 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.5 mm -114.0 121.38 36.88 Favored Pre-proline 0 C--N 1.289 -2.052 0 N-CA-C 107.42 -1.326 . . . . 71.329999999999998 107.42 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.52 166.38 17.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.692 2.261 . . . . 55.009999999999998 110.565 176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.92 124.28 29.59 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.002 -0.679 . . . . 62.409999999999997 109.987 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.02 -121.06 3.54 Favored Glycine 0 N--CA 1.428 -1.869 0 CA-C-N 115.841 -0.618 . . . . 75.25 113.946 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -109.22 129.79 55.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.546 0.212 . . . . 74.409999999999997 111.315 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -65.96 109.48 2.55 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.706 -0.679 . . . . 74.010000000000005 111.267 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -86.56 -30.93 6.08 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 N-CA-C 113.205 0.816 . . . . 64.340000000000003 113.205 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.484 HD23 ' CE2' ' A' ' 103' ' ' PHE 0.273 0.5 OUTLIER -82.86 171.99 13.31 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 118.88 -1.128 . . . . 63.439999999999998 112.294 -178.493 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.19 137.41 75.46 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 109.233 -0.655 . . . . 52.119999999999997 109.233 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.71 -21.61 32.84 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.254 2.636 . . . . 74.239999999999995 113.852 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -73.98 -22.55 59.57 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 120.687 0.279 . . . . 63.329999999999998 111.72 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.48 138.4 97.35 Favored Pre-proline 0 C--O 1.239 0.519 0 CA-C-N 116.168 -0.469 . . . . 64.420000000000002 110.109 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.655 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 34.5 Cg_endo -67.41 104.81 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.484 2.122 . . . . 43.210000000000001 110.425 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.2 p -102.59 170.08 8.25 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 121.431 0.634 . . . . 70.400000000000006 112.044 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -109.24 158.67 17.62 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 107.712 -1.218 . . . . 70.319999999999993 107.712 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.565 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 13.3 t0 -136.53 164.15 28.84 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 103.528 -2.767 . . . . 63.439999999999998 103.528 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.501 ' HB3' HG13 ' A' ' 43' ' ' VAL . 93.5 mt -56.56 -53.76 60.84 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.327 0.862 . . . . 71.420000000000002 113.327 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.565 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 12.0 Cg_endo -58.06 -35.83 98.45 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 121.83 1.686 . . . . 72.239999999999995 112.012 175.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 26.9 tpt180 -67.35 -39.95 85.79 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.9 0.381 . . . . 73.140000000000001 111.068 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -70.08 -36.77 69.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 120.789 -0.364 . . . . 74.109999999999999 110.386 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.82 68.36 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.002 -0.74 . . . . 42.409999999999997 109.002 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 33' ' ' PRO . 42.0 mt-10 -68.48 -45.08 73.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 114.769 -1.105 . . . . 71.109999999999999 111.844 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.5 tp -64.5 -46.55 82.48 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.489 -0.778 . . . . 75.549999999999997 112.033 -176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.419 ' HB2' HG22 ' A' ' 41' ' ' VAL . 97.5 mt -93.94 -10.22 34.47 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.608 0.595 . . . . 73.099999999999994 112.608 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.05 30.12 72.17 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 111.262 -0.735 . . . . 51.539999999999999 111.262 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.419 HG22 ' HB2' ' A' ' 39' ' ' LEU . 20.4 m -124.65 156.61 67.8 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 108.765 -0.828 . . . . 64.120000000000005 108.765 -177.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.35 156.39 66.4 Favored 'Trans proline' 0 C--O 1.254 1.3 0 C-N-CA 121.391 1.394 . . . . 54.0 111.639 176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' A' ' 32' ' ' LEU . 74.5 t -57.02 -33.32 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.937 -0.574 . . . . 52.240000000000002 110.371 178.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 28.3 t -57.48 -40.85 79.47 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 115.639 -0.71 . . . . 74.430000000000007 110.812 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 62.4 tttp -70.47 -35.99 73.62 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 120.861 0.362 . . . . 72.109999999999999 110.202 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.31 -44.51 98.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.221 -0.659 . . . . 55.310000000000002 109.221 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.05 -36.61 80.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.047 -0.979 . . . . 43.200000000000003 110.21 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.623 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 54.7 mt-30 -63.18 -43.44 98.22 Favored 'General case' 0 C--O 1.197 -1.693 0 CA-C-N 116.055 -0.521 . . . . 75.140000000000001 111.133 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.7 mm-40 -58.38 -41.25 84.43 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.326 0.584 . . . . 74.510000000000005 110.317 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 tp -61.67 -43.34 99.03 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.627 -1.169 . . . . 72.109999999999999 109.116 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 29.3 mtp180 -71.26 -23.95 62.08 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.531 -0.759 . . . . 64.099999999999994 112.512 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 10.4 mm-40 -82.97 -12.87 56.94 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.571 -0.529 . . . . 74.310000000000002 109.571 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.4 33.16 44.71 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.034 -0.826 . . . . 74.109999999999999 111.034 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.1 m170 -99.13 -15.72 18.87 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 120.771 0.319 . . . . 74.430000000000007 110.228 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 43.3 tp -161.41 156.95 24.44 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.488 -1.301 . . . . 65.299999999999997 107.488 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.5 m -129.28 157.37 42.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.387 -0.597 . . . . 72.310000000000002 109.387 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.8 36.86 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.422 -0.584 . . . . 71.120000000000005 109.422 -176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.8 m -128.62 166.68 25.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 123.463 0.477 . . . . 73.200000000000003 111.044 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.476 ' NE ' ' HA2' ' A' ' 62' ' ' GLY . 19.4 ttt180 -109.63 121.04 44.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.428 0.632 . . . . 75.129999999999995 110.537 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -123.0 114.67 20.72 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.673 -1.149 . . . . 71.310000000000002 109.063 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.89 19.07 11.3 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.817 0.847 . . . . 54.109999999999999 111.023 178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.476 ' HA2' ' NE ' ' A' ' 59' ' ' ARG . . . 99.7 -14.11 60.61 Favored Glycine 0 N--CA 1.428 -1.839 0 CA-C-N 115.664 -0.698 . . . . 32.520000000000003 112.112 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -89.31 151.33 21.91 Favored Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.744 -0.942 . . . . 73.140000000000001 110.744 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.78 119.79 45.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 106.648 -1.612 . . . . 75.120000000000005 106.648 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -130.86 153.75 39.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 115.618 -0.719 . . . . 72.400000000000006 110.486 -174.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 63.9 mt -126.45 131.84 24.08 Favored Pre-proline 0 C--N 1.293 -1.858 0 N-CA-C 108.189 -1.041 . . . . 71.540000000000006 108.189 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.39 141.38 86.9 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.238 1.959 . . . . 43.310000000000002 112.857 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.655 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.2 tp-100 -48.84 -42.39 36.16 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 125.213 1.405 . . . . 73.310000000000002 110.984 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.74 4.33 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 114.133 -1.394 . . . . 43.229999999999997 114.498 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.573 ' CD2' HD11 ' A' ' 81' ' ' LEU . 12.8 m-85 -91.96 -6.23 51.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.168 0.985 . . . . 53.340000000000003 109.501 173.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.51 144.58 47.96 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.405 -1.27 . . . . 74.140000000000001 108.683 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 p -75.85 172.95 11.81 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.253 -1.017 . . . . 71.420000000000002 108.253 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -69.73 -17.3 63.45 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.895 0.855 . . . . 64.420000000000002 109.261 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m -79.87 -6.86 58.21 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.191 -0.913 . . . . 74.219999999999999 110.552 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.92 -13.88 66.33 Favored Glycine 0 C--O 1.219 -0.827 0 C-N-CA 121.294 -0.479 . . . . 33.130000000000003 113.523 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -95.38 155.04 16.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 112.228 0.455 . . . . 62.299999999999997 112.228 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.9 t -63.37 141.8 17.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.408 -0.814 . . . . 73.120000000000005 108.812 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 26.4 t -59.91 134.16 25.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.3 -0.63 . . . . 60.149999999999999 109.3 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -55.78 -43.54 76.86 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.445 0.906 . . . . 75.109999999999999 113.445 -173.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.9 t -91.68 3.41 55.13 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 120.859 -0.336 . . . . 74.230000000000004 111.774 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.647 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 8.2 tt -66.46 -49.9 50.23 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 112.671 0.619 . . . . 73.430000000000007 112.671 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.06 -30.06 85.38 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.583 1.522 . . . . 54.439999999999998 111.028 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.25 -42.48 96.24 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.631 -0.713 . . . . 74.420000000000002 111.925 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -67.99 -40.16 83.12 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 109.055 -0.72 . . . . 75.530000000000001 109.055 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -61.53 -35.78 78.71 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 115.978 -0.556 . . . . 74.400000000000006 110.402 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.2 m -61.46 -49.09 78.18 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.947 -0.57 . . . . 62.100000000000001 111.677 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.412 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -64.53 -43.37 96.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.635 0.255 . . . . 71.019999999999996 111.226 -178.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.565 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.8 mm? -67.49 -36.08 80.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.541 0.571 . . . . 74.409999999999997 112.541 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -61.13 -45.24 95.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.264 0.554 . . . . 72.439999999999998 109.866 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -72.6 -25.7 61.42 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.716 -0.674 . . . . 71.510000000000005 110.445 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.11 86.97 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.6 -0.727 . . . . 74.209999999999994 112.559 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.44 30.6 24.24 Favored Glycine 0 C--O 1.243 0.695 0 C-N-CA 121.425 -0.417 . . . . 42.020000000000003 113.786 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -106.1 147.73 28.62 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 117.128 0.464 . . . . 71.549999999999997 111.537 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.407 ' O ' HG12 ' A' ' 98' ' ' ILE . 16.2 ptp180 -99.62 171.39 7.94 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.672 0.789 . . . . 71.150000000000006 110.724 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -54.02 -45.51 71.56 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.537 1.535 . . . . 70.239999999999995 112.418 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.8 m -64.23 -41.02 97.19 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.636 -0.711 . . . . 54.229999999999997 110.16 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 47.7 mt-10 -66.12 -37.42 85.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.86 -0.609 . . . . 75.310000000000002 110.352 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 94' ' ' ARG . 14.5 mm -61.53 -49.52 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.831 -0.803 . . . . 60.219999999999999 108.831 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.567 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.7 ptp -75.29 -15.92 60.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.187 -0.915 . . . . 52.329999999999998 113.251 -177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.71 -62.94 1.5 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.26 -0.644 . . . . 72.140000000000001 109.26 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -69.98 -32.98 71.47 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.479 0.918 . . . . 74.109999999999999 113.479 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.583 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.0 mt -58.96 -40.32 84.36 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.212 0.819 . . . . 75.109999999999999 113.212 -178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.484 ' CE2' HD23 ' A' ' 23' ' ' LEU . 39.0 m-85 -86.14 -11.13 53.45 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 112.602 0.594 . . . . 70.530000000000001 112.602 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.3 m -87.51 121.14 71.26 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 108.902 -0.777 . . . . 65.219999999999999 108.902 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.49 130.12 35.83 Favored 'Trans proline' 0 C--O 1.241 0.67 0 C-N-CA 122.568 2.178 . . . . 60.310000000000002 111.846 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 8.1 t70 -79.71 122.81 83.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 N-CA-C 108.189 -1.041 . . . . 74.409999999999997 108.189 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.568 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 31.3 Cg_endo -60.78 -16.88 46.82 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 123.573 2.849 . . . . 71.219999999999999 114.6 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.6 t -119.1 5.74 11.29 Favored 'General case' 0 N--CA 1.421 -1.898 0 O-C-N 122.077 -0.39 . . . . 63.530000000000001 110.883 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -100.77 130.63 46.83 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.314 0.578 . . . . 64.510000000000005 110.261 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.561 HG22 ' HB1' ' A' ' 119' ' ' ALA . 48.7 m -131.56 114.81 15.32 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.984 -1.117 . . . . 74.420000000000002 107.984 178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.73 158.65 43.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 113.883 1.068 . . . . 73.519999999999996 113.883 -174.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.424 ' O ' ' HB1' ' A' ' 131' ' ' ALA . 1.4 t -116.86 127.03 53.89 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.763 -1.569 . . . . 75.540000000000006 106.763 174.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 116' ' ' SER . 12.1 ptp85 -108.77 169.49 8.63 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.763 -0.653 . . . . 74.409999999999997 110.559 -172.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -73.38 99.95 3.07 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.604 -1.628 . . . . 74.010000000000005 106.604 172.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 133.11 -16.94 4.63 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 111.264 -0.734 . . . . 63.240000000000002 111.264 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.401 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 14.9 m -145.84 107.97 4.38 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.729 -0.841 . . . . 61.509999999999998 108.729 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -74.43 -20.93 59.86 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.965 0.412 . . . . 73.329999999999998 111.076 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -77.58 143.83 38.01 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.043 -0.725 . . . . 65.239999999999995 109.043 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.561 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -85.95 124.39 32.36 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.065 0.46 . . . . 75.510000000000005 110.615 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 110' ' ' THR . 48.1 t -97.23 124.65 50.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.933 -0.766 . . . . 54.420000000000002 108.933 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.5 m -88.15 146.97 25.12 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.77 -0.65 . . . . 63.530000000000001 110.162 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.568 ' ND2' ' HA ' ' A' ' 107' ' ' PRO . 17.3 m120 64.72 57.57 1.06 Allowed 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.277 1.031 . . . . 73.129999999999995 109.211 -178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 159.9 15.68 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 114.737 -1.119 . . . . 72.329999999999998 109.696 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -81.03 147.88 62.65 Favored Pre-proline 0 C--N 1.299 -1.604 0 N-CA-C 108.325 -0.991 . . . . 72.329999999999998 108.325 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.583 ' HB2' HD23 ' A' ' 102' ' ' LEU . 52.1 Cg_exo -56.99 -28.15 76.91 Favored 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 121.892 1.728 . . . . 72.109999999999999 111.387 174.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 62.0 t -63.68 -35.42 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.609 0.719 . . . . 73.519999999999996 110.409 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -69.81 -41.57 74.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.68 -1.23 . . . . 60.229999999999997 107.68 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.09 -34.86 79.0 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.485 -1.234 . . . . 63.020000000000003 113.173 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.77 -32.96 71.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.584 -0.698 . . . . 72.420000000000002 111.263 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -76.74 -13.61 60.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.885 0.85 . . . . 73.349999999999994 109.907 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 112' ' ' THR . . . -89.91 3.85 51.78 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.802 -1.09 . . . . 75.310000000000002 110.421 177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.9 t60 64.14 27.17 14.03 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.211 1.482 . . . . 73.219999999999999 109.689 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -114.13 24.86 11.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.0 -1.455 . . . . 74.450000000000003 108.139 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.73 -27.85 19.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.602 -1.635 . . . . 75.519999999999996 112.43 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -56.37 -42.84 78.51 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.468 -0.567 . . . . 52.399999999999999 109.468 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 22.6 mm-40 -65.64 -39.63 91.65 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 115.361 -0.836 . . . . 72.420000000000002 109.481 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.64 -47.0 94.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.4 -0.818 . . . . 62.119999999999997 109.786 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 57.9 t -60.83 -41.79 89.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.816 -0.629 . . . . 52.109999999999999 109.805 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -63.42 -40.4 97.07 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 120.923 0.392 . . . . 73.319999999999993 111.2 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 14.3 mmt85 -66.22 -35.49 80.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.864 -0.791 . . . . 70.099999999999994 108.864 177.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.565 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.46 -41.26 98.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.491 -0.777 . . . . 63.109999999999999 109.888 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.6 mt-30 -61.7 -38.62 88.51 Favored 'General case' 0 C--O 1.208 -1.092 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 109.887 176.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.96 -22.78 65.01 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.963 0.411 . . . . 53.119999999999997 111.366 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 24.1 mmt -89.07 -29.66 19.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.348 0.594 . . . . 64.540000000000006 110.013 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.32 -45.17 13.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.077 -0.511 . . . . 74.019999999999996 111.8 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 107.785 -1.191 . . . . 70.329999999999998 107.785 -178.954 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 CA--C 1.505 -0.775 0 N-CA-C 107.914 -1.143 . . . . 74.310000000000002 107.914 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.0 83.53 2.22 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 121.532 1.488 . . . . 60.210000000000001 109.586 173.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.44 68.18 3.57 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 110.504 -1.039 . . . . 41.030000000000001 110.504 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.14 132.58 49.53 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.303 0.573 . . . . 74.530000000000001 111.093 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -105.3 151.47 39.64 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 106.478 -1.675 . . . . 74.540000000000006 106.478 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.09 86.19 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.049 1.833 . . . . 62.549999999999997 111.973 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.01 -36.31 2.77 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 109.384 -1.486 . . . . 71.230000000000004 109.384 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 m -95.31 -177.24 4.04 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 109.001 -0.74 . . . . 74.099999999999994 109.001 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.0 m -146.74 149.89 34.28 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.036 -1.098 . . . . 74.150000000000006 108.036 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.1 mt -66.34 144.86 56.3 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.447 0.642 . . . . 73.329999999999998 111.281 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.8 167.7 10.77 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.95 -1.023 . . . . 74.400000000000006 110.739 -175.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 51' ' ' ARG . 52.2 ttt85 -76.08 95.66 3.68 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-O 121.454 0.645 . . . . 74.040000000000006 110.494 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.02 -3.77 9.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.38 -1.282 . . . . 64.319999999999993 109.857 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.08 67.97 0.45 Allowed Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 109.325 -1.51 . . . . 64.439999999999998 109.325 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.497 ' OG ' ' HG2' ' A' ' 12' ' ' ARG . 39.3 m -83.17 77.56 9.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 112.531 0.567 . . . . 52.299999999999997 112.531 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.64 119.78 66.82 Favored Pre-proline 0 N--CA 1.438 -1.071 0 N-CA-C 105.923 -1.88 . . . . 62.32 105.923 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.34 146.45 31.48 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.335 2.023 . . . . 75.030000000000001 112.192 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.92 129.3 34.93 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.798 -0.815 . . . . 63.32 108.798 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -119.93 -107.77 2.19 Favored Glycine 0 N--CA 1.413 -2.879 0 N-CA-C 110.842 -0.903 . . . . 52.039999999999999 110.842 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -118.17 141.88 48.03 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.703 -0.481 . . . . 61.109999999999999 109.703 -176.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -74.09 158.09 34.87 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.997 0.903 . . . . 73.150000000000006 111.696 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 22' ' ' VAL . 38.9 t -121.23 32.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 124.172 1.939 . . . . 74.340000000000003 106.262 175.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.458 HD13 HG21 ' A' ' 29' ' ' THR . 40.4 mt -104.49 178.93 4.42 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 113.239 -1.8 . . . . 43.399999999999999 111.266 -175.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 15.3 t70 -90.79 136.05 28.23 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 105.704 -1.961 . . . . 61.25 105.704 169.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.65 -25.47 14.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.393 2.728 . . . . 75.219999999999999 115.193 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.52 33.68 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.524 -0.87 . . . . 74.439999999999998 110.973 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 25.3 tp10 -72.57 129.46 87.06 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 105.726 -1.953 . . . . 71.420000000000002 105.726 172.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 52.4 Cg_exo -55.27 98.39 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.66 2.24 . . . . 74.340000000000003 111.681 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.458 HG21 HD13 ' A' ' 23' ' ' LEU . 6.1 p -107.16 -177.66 3.42 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 115.732 -0.667 . . . . 73.310000000000002 112.197 -176.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.445 ' CZ ' HD22 ' A' ' 38' ' ' LEU . 52.3 m-85 -111.48 159.78 17.75 Favored 'General case' 0 N--CA 1.404 -2.773 0 CA-C-N 114.999 -1.001 . . . . 71.120000000000005 109.445 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.3 m-20 -136.52 162.46 33.03 Favored 'General case' 0 C--N 1.266 -3.064 0 N-CA-C 101.84 -3.392 . . . . 73.230000000000004 101.84 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.3 mt -50.94 -51.55 66.18 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-N 119.028 0.831 . . . . 72.120000000000005 112.447 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.87 -35.95 85.94 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.021 1.814 . . . . 65.040000000000006 112.553 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.515 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 7.7 tpt180 -70.27 -36.99 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.864 0.364 . . . . 73.519999999999996 110.181 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 31' ' ' ASP . 66.0 t -69.1 -39.03 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.475 -0.565 . . . . 71.329999999999998 109.475 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.45 -39.75 84.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.465 -0.789 . . . . 63.039999999999999 109.52 176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.2 -36.69 79.96 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.592 -1.186 . . . . 73.510000000000005 110.247 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 56.9 tp -72.55 -45.46 59.12 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.54 -0.755 . . . . 70.310000000000002 111.335 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 41' ' ' VAL . 94.0 mt -85.71 -18.44 33.09 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.637 0.606 . . . . 54.409999999999997 112.637 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.56 28.04 60.18 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.796 -0.922 . . . . 34.43 110.796 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.479 HG22 ' HB2' ' A' ' 39' ' ' LEU . 31.6 m -123.01 159.09 55.52 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.319 -0.993 . . . . 75.430000000000007 108.319 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -67.23 155.25 71.4 Favored 'Trans proline' 0 C--O 1.26 1.597 0 C-N-CA 121.057 1.171 . . . . 75.099999999999994 111.644 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.46 -33.5 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.428 0.691 . . . . 73.25 110.424 178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 36.8 t -57.33 -45.62 84.07 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.954 -0.566 . . . . 71.030000000000001 110.787 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 64.7 mttm -64.72 -36.74 85.25 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.392 -0.523 . . . . 64.5 110.88 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.9 t -63.33 -45.17 98.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 109.496 -0.557 . . . . 60.549999999999997 109.496 177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.56 -36.45 80.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.581 -0.736 . . . . 72.549999999999997 110.552 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.641 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 97.2 mt-30 -61.73 -46.77 88.21 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.802 -0.444 . . . . 54.310000000000002 109.802 176.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 77.6 mt-30 -59.39 -42.55 91.95 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.706 0.765 . . . . 64.329999999999998 110.556 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.1 tp -62.2 -38.33 88.74 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.437 -1.256 . . . . 74.420000000000002 109.427 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 12' ' ' ARG . 59.9 mtm180 -71.25 -29.13 64.73 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.185 0.439 . . . . 75.109999999999999 112.185 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.641 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 56.0 mt-10 -76.55 -12.26 60.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.737 0.303 . . . . 74.540000000000006 110.375 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.44 22.47 64.76 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.545 -1.022 . . . . 62.229999999999997 110.545 -177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -94.62 -0.32 54.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.103 0.478 . . . . 70.340000000000003 111.049 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.7 tp -163.23 152.79 15.18 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.403 -1.702 . . . . 74.530000000000001 106.403 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.9 p -132.09 148.13 32.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.013 -0.736 . . . . 71.329999999999998 109.013 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.23 154.3 37.7 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 123.567 0.542 . . . . 75.319999999999993 110.01 -177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.576 HG12 ' OD2' ' A' ' 95' ' ' ASP . 19.6 m -128.39 166.63 25.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 124.302 1.041 . . . . 75.150000000000006 109.116 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 53.4 mtm180 -110.91 129.37 55.9 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.743 -0.466 . . . . 71.129999999999995 109.743 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -125.34 123.84 40.26 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.648 -1.612 . . . . 70.129999999999995 106.648 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.04 -15.78 0.32 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.418 1.087 . . . . 60.030000000000001 112.8 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.01 -13.83 4.67 Favored Glycine 0 N--CA 1.432 -1.575 0 N-CA-C 110.927 -0.869 . . . . 63.32 110.927 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -92.7 152.52 21.12 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 110.804 -0.918 . . . . 63.149999999999999 110.804 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.9 t -96.8 120.78 46.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.835 -1.172 . . . . 71.519999999999996 107.835 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -135.39 160.29 40.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.479 -0.782 . . . . 63.310000000000002 111.218 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 74.6 mt -123.06 125.7 26.19 Favored Pre-proline 0 C--N 1.286 -2.176 0 N-CA-C 106.978 -1.49 . . . . 74.439999999999998 106.978 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HA ' HG22 ' A' ' 29' ' ' THR . 51.3 Cg_exo -56.43 139.22 86.6 Favored 'Trans proline' 0 CA--C 1.533 0.475 0 C-N-CA 122.745 2.296 . . . . 75.239999999999995 113.625 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.541 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.9 tp-100 -53.81 -37.26 63.36 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.286 1.034 . . . . 70.25 110.165 178.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.459 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 34.3 m -72.18 2.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 113.574 -1.648 . . . . 74.450000000000003 113.95 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.3 m-85 -95.49 -1.68 50.24 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.935 0.874 . . . . 74.430000000000007 109.497 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -121.46 139.32 53.63 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 114.656 -1.156 . . . . 73.510000000000005 109.719 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 51.7 p -79.51 168.94 18.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.016 -0.993 . . . . 70.040000000000006 109.519 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -57.56 -23.41 50.46 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.068 0.547 . . . . 73.340000000000003 111.35 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 21.8 t -79.96 -8.13 59.17 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 116.191 -0.459 . . . . 73.299999999999997 110.345 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.17 18.33 65.03 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.998 -0.62 . . . . 65.329999999999998 112.719 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -119.13 161.84 19.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.046 -0.724 . . . . 72.439999999999998 109.046 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.27 144.86 11.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.332 -0.988 . . . . 72.329999999999998 108.332 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.8 t -64.02 124.64 19.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 108.406 -0.961 . . . . 73.230000000000004 108.406 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -55.26 -44.72 75.84 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.584 1.327 . . . . 62.219999999999999 114.584 -174.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.9 m -96.55 9.82 40.29 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 112.758 0.651 . . . . 65.420000000000002 112.758 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 7.1 tt -65.64 -45.34 67.11 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 116.368 -0.378 . . . . 72.430000000000007 111.864 176.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.88 -25.76 54.33 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 121.924 1.749 . . . . 75.319999999999993 111.658 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.9 -38.66 96.93 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 115.658 -0.701 . . . . 33.0 111.658 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -68.98 -41.06 78.4 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 108.971 -0.751 . . . . 63.299999999999997 108.971 177.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.43 -34.39 75.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.108 -0.496 . . . . 72.299999999999997 110.355 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 51.0 m -61.65 -49.02 78.22 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.486 -0.779 . . . . 64.239999999999995 110.791 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.35 -41.81 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 111.642 0.238 . . . . 71.420000000000002 111.642 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.409 HD21 ' HB1' ' A' ' 141' ' ' ALA . 2.9 mm? -66.75 -35.19 79.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.029 -0.668 . . . . 74.140000000000001 112.511 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -63.72 -35.95 82.27 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.131 -0.692 . . . . 75.0 109.131 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.09 -31.22 67.54 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.481 -0.781 . . . . 71.25 110.002 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.62 -8.63 70.05 Favored Glycine 0 C--O 1.219 -0.819 0 CA-C-N 115.625 -0.716 . . . . 72.049999999999997 112.8 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.04 49.61 5.9 Favored Glycine 0 C--N 1.318 -0.423 0 C-N-CA 121.338 -0.458 . . . . 62.329999999999998 113.669 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -115.94 139.8 49.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 122.259 -0.553 . . . . 71.109999999999999 111.865 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -85.09 170.03 13.33 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.351 -0.84 . . . . 74.400000000000006 110.3 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.576 ' OD2' HG12 ' A' ' 58' ' ' VAL . 19.1 p-10 -55.28 -42.69 73.91 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.506 1.522 . . . . 74.209999999999994 111.945 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.2 m -61.32 -42.24 98.35 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.098 -0.955 . . . . 73.549999999999997 110.012 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.73 -37.12 84.02 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.141 -0.482 . . . . 75.540000000000006 110.928 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.4 mm -61.09 -48.9 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.844 0.831 . . . . 75.049999999999997 108.813 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.489 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 59.0 mtt -75.48 -20.87 58.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.784 -1.098 . . . . 73.209999999999994 112.227 -177.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -57.97 -61.13 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.511 0.507 . . . . 72.340000000000003 109.736 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.419 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 29.1 p-90 -69.46 -32.53 71.52 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.19 0.811 . . . . 64.049999999999997 113.19 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 126' ' ' VAL . 17.0 mt -60.12 -41.45 92.68 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.812 0.671 . . . . 75.329999999999998 112.812 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -85.02 -14.72 46.48 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 120.605 -0.438 . . . . 70.510000000000005 112.081 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 60.5 m -87.05 118.59 70.25 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.788 -0.449 . . . . 74.310000000000002 109.788 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.93 131.07 40.71 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.903 2.402 . . . . 74.319999999999993 111.217 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.6 t70 -90.47 122.84 66.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 116.26 -0.427 . . . . 61.119999999999997 110.966 -174.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.91 -16.31 44.04 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 123.935 3.09 . . . . 50.25 114.56 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.5 t -118.03 10.54 13.08 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.798 -0.564 . . . . 55.340000000000003 110.4 -176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.32 131.3 49.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.488 0.661 . . . . 71.129999999999995 111.917 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 m -125.99 120.28 29.89 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.867 -1.531 . . . . 62.0 106.867 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.464 HG22 ' NE2' ' A' ' 133' ' ' GLN . 28.1 pt -130.86 165.01 32.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 120.429 0.156 . . . . 72.439999999999998 111.285 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.522 HG22 ' OE1' ' A' ' 133' ' ' GLN . 15.1 t -89.05 159.48 17.55 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.221 -1.029 . . . . 61.340000000000003 108.221 175.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 2.1 tpm_? -127.71 166.17 18.63 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 110.071 -0.344 . . . . 71.120000000000005 110.071 -174.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.403 ' H ' ' NE ' ' A' ' 113' ' ' ARG . 5.9 m-20 -87.88 140.27 29.67 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 122.786 0.434 . . . . 73.5 110.435 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.38 -71.35 2.68 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 109.0 -1.64 . . . . 74.329999999999998 109.0 -178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 113' ' ' ARG . 3.4 p -88.8 78.98 7.53 Favored 'General case' 0 N--CA 1.403 -2.798 0 N-CA-C 106.96 -1.496 . . . . 64.510000000000005 106.96 174.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -68.51 16.94 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.828 1.651 . . . . 65.439999999999998 114.602 -173.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -76.87 178.13 7.12 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 123.239 0.616 . . . . 72.030000000000001 110.018 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.48 125.23 35.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.602 -0.518 . . . . 73.519999999999996 109.602 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.15 118.82 54.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.82 -0.627 . . . . 63.439999999999998 109.393 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 39.8 m -90.17 139.9 30.19 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.842 -0.617 . . . . 52.520000000000003 109.55 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 29.0 t-20 59.81 67.79 0.84 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-O 122.746 1.26 . . . . 72.150000000000006 110.619 -177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -113.1 179.23 4.02 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.288 -1.324 . . . . 52.32 109.877 177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.451 ' HD3' ' N ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -87.12 138.35 32.6 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 109.014 -0.736 . . . . 63.109999999999999 109.014 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.505 ' HB2' HD23 ' A' ' 102' ' ' LEU . 71.4 Cg_exo -56.27 -29.93 78.3 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.198 1.932 . . . . 61.140000000000001 110.122 170.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.633 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 70.5 t -61.82 -42.8 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 121.345 0.593 . . . . 74.129999999999995 110.37 173.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -67.98 -34.76 77.15 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 120.07 -0.652 . . . . 72.209999999999994 109.305 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.79 85.07 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 114.915 -1.039 . . . . 63.219999999999999 112.853 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.65 -32.51 71.21 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.029 -0.42 . . . . 71.400000000000006 110.917 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -71.74 -23.41 61.61 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.686 0.755 . . . . 70.430000000000007 109.767 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.38 -0.26 54.28 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.851 -1.068 . . . . 61.310000000000002 110.423 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 69.7 m80 64.03 28.24 14.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.59 1.156 . . . . 71.310000000000002 110.256 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.522 ' OE1' HG22 ' A' ' 112' ' ' THR . 12.7 mt-30 -102.61 25.07 9.56 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.956 -1.475 . . . . 72.129999999999995 107.414 176.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.49 -28.31 19.86 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 113.914 -1.494 . . . . 73.409999999999997 112.675 -178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 44.3 mtp180 -56.77 -41.15 77.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.81 0.338 . . . . 71.409999999999997 110.707 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.51 -34.18 77.65 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.909 -0.587 . . . . 63.329999999999998 110.165 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.24 -44.87 83.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.685 -0.688 . . . . 52.229999999999997 109.144 177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 134' ' ' ALA . 64.2 t -61.1 -42.33 92.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 109.458 -0.571 . . . . 61.549999999999997 109.458 176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -58.11 -43.44 87.15 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.977 -0.556 . . . . 72.209999999999994 110.403 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 144' ' ' MET . 73.2 mmt-85 -65.84 -39.0 90.37 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 116.618 -0.265 . . . . 71.329999999999998 111.126 176.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.409 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -58.87 -45.1 90.96 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.365 0.416 . . . . 23.399999999999999 110.272 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -43.02 99.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.585 -0.734 . . . . 72.340000000000003 109.993 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.07 -19.83 63.25 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.401 -0.818 . . . . 51.399999999999999 112.632 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 91.3 mmm -88.4 -21.49 24.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.313 0.577 . . . . 65.409999999999997 109.799 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.37 -61.0 2.01 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.328 -0.619 . . . . 74.510000000000005 109.328 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 C--N 1.302 -1.457 0 CA-C-O 118.304 -0.855 . . . . 65.439999999999998 109.52 -178.847 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.8 mmm . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 109.781 -0.452 . . . . 72.329999999999998 109.781 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.62 156.45 44.74 Favored 'Trans proline' 0 C--O 1.244 0.779 0 C-N-CA 122.242 1.961 . . . . 60.439999999999998 111.003 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.86 -59.91 0.05 OUTLIER Glycine 0 C--N 1.307 -1.036 0 N-CA-C 110.795 -0.922 . . . . 64.129999999999995 110.795 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -69.09 145.07 53.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.928 -0.397 . . . . 73.299999999999997 109.928 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -82.71 112.05 34.24 Favored Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 107.831 -1.174 . . . . 72.510000000000005 107.831 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HG2' ' O ' ' A' ' 29' ' ' THR . 27.7 Cg_exo -67.83 -178.63 1.7 Allowed 'Trans proline' 0 C--O 1.253 1.23 0 C-N-CA 122.944 2.43 . . . . 54.039999999999999 113.003 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.92 40.67 2.82 Favored Glycine 0 N--CA 1.419 -2.487 0 N-CA-C 106.363 -2.695 . . . . 71.019999999999996 106.363 -170.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 m -65.28 -48.29 73.69 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.886 -1.157 . . . . 75.450000000000003 108.326 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.3 m -144.05 129.36 18.84 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.227 -1.398 . . . . 63.130000000000003 107.227 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.0 mt -76.18 143.56 41.03 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.253 -0.647 . . . . 73.5 109.253 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.36 95.55 9.7 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 112.914 0.709 . . . . 53.030000000000001 112.914 -173.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -104.29 75.68 1.27 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.589 -0.732 . . . . 72.420000000000002 109.71 173.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.5 m -141.46 150.42 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 106.582 -1.636 . . . . 74.310000000000002 106.582 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.92 37.29 3.61 Favored Glycine 0 C--N 1.287 -2.167 0 C-N-CA 121.002 -0.618 . . . . 53.119999999999997 114.344 -173.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.437 ' HA ' ' NH2' ' A' ' 51' ' ' ARG . 18.3 m -121.24 14.06 11.24 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.565 0.698 . . . . 71.409999999999997 110.483 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.456 HG23 HD13 ' A' ' 50' ' ' LEU . 73.4 mt -120.69 121.8 28.86 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 115.27 -0.877 . . . . 65.540000000000006 110.765 -175.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.45 134.04 13.61 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 121.393 1.395 . . . . 74.530000000000001 108.939 166.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . -132.24 150.24 52.2 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 122.094 -0.379 . . . . 72.030000000000001 111.388 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.04 -171.53 18.77 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.268 -1.133 . . . . 31.239999999999998 110.268 175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -87.68 138.28 31.61 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.022 -0.733 . . . . 73.120000000000005 109.022 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.08 111.45 7.33 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 122.118 0.961 . . . . 73.439999999999998 112.421 -173.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 100' ' ' ARG . 25.9 t -96.83 45.14 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 106.525 -1.657 . . . . 74.549999999999997 106.525 171.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.473 HD23 ' CE2' ' A' ' 103' ' ' PHE . 57.0 mt -107.97 161.01 15.32 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 114.315 -1.311 . . . . 74.25 110.645 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.589 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 4.5 t70 -97.4 143.27 25.87 Favored Pre-proline 0 C--N 1.289 -2.037 0 N-CA-C 105.504 -2.035 . . . . 74.319999999999993 105.504 171.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.37 -24.67 12.38 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.318 2.679 . . . . 45.350000000000001 114.539 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -96.43 2.59 52.72 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 113.759 1.022 . . . . 62.509999999999998 113.759 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.589 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 41.2 mm-40 -78.15 127.57 81.01 Favored Pre-proline 0 C--O 1.249 1.079 0 N-CA-C 109.139 -0.689 . . . . 74.150000000000006 109.139 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.13 142.11 60.03 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.878 2.385 . . . . 75.200000000000003 112.802 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.576 ' O ' ' HG2' ' A' ' 6' ' ' PRO . 3.3 p -123.06 -174.65 2.99 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 115.286 -0.87 . . . . 71.450000000000003 110.552 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -133.15 161.84 33.36 Favored 'General case' 0 C--N 1.276 -2.62 0 C-N-CA 127.344 2.258 . . . . 64.239999999999995 107.059 172.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.9 p30 -133.41 156.41 47.73 Favored 'General case' 0 C--N 1.256 -3.482 0 N-CA-C 104.132 -2.544 . . . . 73.519999999999996 104.132 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.311 4.5 mm? -51.7 -52.61 58.99 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 116.126 1.898 . . . . 75.420000000000002 116.126 -172.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.15 -33.74 97.78 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 120.371 1.168 . . . . 74.150000000000006 111.935 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -69.35 -41.23 76.87 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.057 -0.349 . . . . 74.109999999999999 110.057 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG21 HD12 ' A' ' 66' ' ' ILE . 62.4 t -67.65 -39.64 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 116.306 -0.406 . . . . 72.019999999999996 109.972 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 -40.89 91.66 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.428 -0.806 . . . . 71.120000000000005 109.612 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -68.69 -41.01 79.79 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.841 -1.072 . . . . 54.210000000000001 110.351 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.4 tp -69.06 -44.44 72.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.345 -0.843 . . . . 61.350000000000001 111.516 -176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.0 mt -88.0 -13.95 40.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.32 -0.4 . . . . 72.549999999999997 112.046 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.7 23.77 71.75 Favored Glycine 0 C--O 1.243 0.673 0 C-N-CA 120.888 -0.672 . . . . 61.329999999999998 112.339 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.05 143.71 50.12 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.652 -0.87 . . . . 63.399999999999999 108.652 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.53 155.18 43.32 Favored 'Trans proline' 0 C--O 1.257 1.444 0 C-N-CA 122.432 2.088 . . . . 75.430000000000007 113.064 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.8 t -50.8 -35.76 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.338 1.055 . . . . 62.149999999999999 111.722 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 t -57.68 -42.98 84.7 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 122.72 0.408 . . . . 71.010000000000005 110.867 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -69.69 -36.01 75.59 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.806 0.336 . . . . 52.130000000000003 110.957 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.3 t -65.12 -40.54 89.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.5 -0.555 . . . . 72.230000000000004 109.5 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.46 75.36 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.666 -0.697 . . . . 74.549999999999997 111.049 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 48' ' ' GLN . 12.4 mm-40 -65.7 -39.99 91.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.997 0.427 . . . . 71.019999999999996 110.679 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.08 -44.65 95.19 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.0 0.905 . . . . 74.439999999999998 109.213 176.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.456 HD13 HG23 ' A' ' 16' ' ' ILE . 92.3 mt -62.17 -35.16 77.96 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.103 -1.408 . . . . 64.519999999999996 110.505 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.437 ' NH2' ' HA ' ' A' ' 15' ' ' SER . 33.2 mmt180 -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.229 0.455 . . . . 73.129999999999995 112.229 176.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -84.75 -12.19 54.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.119 -0.632 . . . . 70.340000000000003 111.403 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.64 34.47 25.05 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 110.491 -1.044 . . . . 72.209999999999994 110.491 -176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.408 ' O ' HD23 ' A' ' 81' ' ' LEU . 36.9 t-80 -82.12 -21.52 36.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.772 -0.825 . . . . 71.219999999999999 108.772 177.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.5 tp -152.32 157.97 42.08 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.989 -1.856 . . . . 74.0 105.989 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 65.6 t -128.46 146.01 34.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.554 -0.906 . . . . 73.150000000000006 108.554 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -118.61 158.68 25.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.246 -1.02 . . . . 74.439999999999998 108.246 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.2 m -132.56 162.37 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 121.396 0.617 . . . . 74.030000000000001 111.204 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -110.55 115.48 29.69 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.591 -1.263 . . . . 61.020000000000003 107.591 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -130.38 129.9 43.69 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 106.935 -1.506 . . . . 73.439999999999998 106.935 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.33 9.71 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.797 0.839 . . . . 75.219999999999999 110.879 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.93 -14.32 65.53 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.786 -0.643 . . . . 63.119999999999997 112.358 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.29 146.52 18.23 Favored Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 121.186 -0.53 . . . . 71.430000000000007 111.955 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.51 121.78 48.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 109.454 -0.573 . . . . 75.239999999999995 109.454 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.29 167.28 18.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 C-N-CA 125.264 1.426 . . . . 63.399999999999999 108.48 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.438 HD12 HG21 ' A' ' 35' ' ' VAL . 74.7 mt -115.47 131.49 23.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.397 -0.964 . . . . 73.329999999999998 108.397 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.68 126.71 17.27 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 121.861 1.707 . . . . 64.519999999999996 112.616 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.41 ' HB2' HE21 ' A' ' 68' ' ' GLN . 6.5 tt0 -64.03 -23.98 67.54 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 122.951 0.501 . . . . 73.450000000000003 111.603 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.7 m -67.87 -6.81 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 N-CA-C 112.332 0.493 . . . . 61.229999999999997 112.332 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.8 m-85 -89.37 -3.24 58.53 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 122.037 0.922 . . . . 73.439999999999998 109.847 174.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -117.86 152.35 35.55 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.666 -1.152 . . . . 74.0 108.162 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 66.0 p -82.65 175.28 10.28 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 123.441 0.463 . . . . 72.140000000000001 110.034 178.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.04 -33.68 69.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.549 0.74 . . . . 72.340000000000003 110.718 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.1 m -79.54 -3.57 47.48 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.961 -0.563 . . . . 65.25 112.511 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.9 35.59 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.309 -0.948 . . . . 73.200000000000003 111.398 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.57 145.51 37.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.272 -1.01 . . . . 74.239999999999995 108.272 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.435 HG13 HD22 ' A' ' 81' ' ' LEU . 55.2 t -68.99 133.43 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.228 -1.027 . . . . 74.310000000000002 108.228 174.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -56.84 127.87 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.37 -0.974 . . . . 72.109999999999999 108.37 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -68.81 -25.46 64.69 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 121.891 -0.506 . . . . 70.510000000000005 112.188 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 56.7 m -90.25 6.92 40.81 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.493 -0.321 . . . . 60.240000000000002 111.439 176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 13.0 tp -61.23 -53.19 65.35 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 119.235 -0.412 . . . . 71.409999999999997 111.029 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 27.3 Cg_exo -63.12 -29.84 74.79 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 121.359 1.373 . . . . 74.140000000000001 110.984 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.14 91.99 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.721 -0.672 . . . . 41.119999999999997 111.923 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.2 pp -68.04 -40.19 82.89 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.292 0.567 . . . . 71.209999999999994 109.493 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.54 -45.96 88.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.645 -0.707 . . . . 52.350000000000001 110.437 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.5 m -62.56 -43.79 97.94 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.748 0.647 . . . . 72.219999999999999 112.748 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.503 HG23 HD22 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -61.94 -47.7 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 118.128 0.422 . . . . 71.129999999999995 111.537 -178.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.586 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -67.28 -42.79 83.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.965 0.412 . . . . 74.430000000000007 112.06 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -64.35 -35.33 80.51 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.164 -0.68 . . . . 52.229999999999997 109.164 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -71.07 -30.2 66.28 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.433 0.635 . . . . 52.140000000000001 110.595 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.19 -9.22 86.84 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.918 -0.583 . . . . 50.009999999999998 112.673 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.62 39.95 4.28 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 120.775 -0.726 . . . . 73.109999999999999 112.999 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 65.7 m-85 -119.62 136.82 54.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.251 -0.648 . . . . 65.450000000000003 109.251 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.587 ' HG2' ' OE1' ' A' ' 97' ' ' GLU . 7.8 ptp85 -84.61 171.07 12.74 Favored 'General case' 0 C--N 1.31 -1.113 0 O-C-N 123.251 0.345 . . . . 75.209999999999994 110.697 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -53.38 -45.29 69.19 Favored 'General case' 0 C--O 1.256 1.429 0 C-N-CA 124.601 1.161 . . . . 62.43 112.969 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.0 m -62.04 -40.65 96.47 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.627 -0.715 . . . . 73.510000000000005 109.95 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.587 ' OE1' ' HG2' ' A' ' 94' ' ' ARG . 44.7 mt-10 -65.87 -33.83 76.75 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.941 -0.572 . . . . 62.119999999999997 111.798 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.414 HD12 ' CB ' ' A' ' 88' ' ' LEU . 9.4 mm -62.53 -49.4 83.97 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 N-CA-C 108.296 -1.002 . . . . 64.140000000000001 108.296 -177.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.493 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 14.9 ptm -75.44 -16.32 60.34 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.243 -0.89 . . . . 54.119999999999997 112.634 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.454 ' HA ' HG11 ' A' ' 22' ' ' VAL . 68.4 ttt180 -58.59 -64.42 0.93 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.351 0.66 . . . . 71.230000000000004 110.364 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.486 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 44.0 p-90 -68.84 -31.67 70.8 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.192 -0.458 . . . . 72.129999999999995 112.145 178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 11.9 mt -57.71 -39.56 77.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.007 0.743 . . . . 70.420000000000002 113.007 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CE2' HD23 ' A' ' 23' ' ' LEU . 30.0 m-85 -86.49 -3.14 58.96 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.241 0.46 . . . . 71.540000000000006 112.241 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.5 m -86.2 125.43 68.09 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 107.606 -1.257 . . . . 63.439999999999998 107.606 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.56 133.84 59.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.649 2.233 . . . . 64.540000000000006 110.94 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 13.7 t70 -91.45 121.37 67.56 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 109.428 -0.582 . . . . 72.109999999999999 109.428 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.78 -16.38 43.73 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.693 2.929 . . . . 72.430000000000007 114.779 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.9 m -123.46 16.02 9.66 Favored 'General case' 0 N--CA 1.436 -1.127 0 O-C-N 122.01 -0.431 . . . . 72.400000000000006 111.108 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 28.9 tp -104.28 115.18 29.93 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.726 -0.79 . . . . 65.430000000000007 111.231 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 58.2 m -122.37 110.68 15.95 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.901 -1.518 . . . . 75.019999999999996 106.901 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.8 pt -139.38 164.45 24.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 112.37 0.507 . . . . 72.420000000000002 112.37 -171.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -88.86 152.9 21.47 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 104.773 -2.306 . . . . 65.129999999999995 104.773 169.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -117.17 173.93 6.4 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 108.207 -1.034 . . . . 72.140000000000001 108.207 -171.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -85.79 94.09 9.05 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.389 -1.337 . . . . 74.540000000000006 107.389 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.88 -58.18 0.69 Allowed Glycine 0 C--N 1.296 -1.647 0 N-CA-C 109.134 -1.586 . . . . 45.0 109.134 -176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.0 m -79.8 99.69 7.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 107.075 -1.454 . . . . 74.329999999999998 107.075 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -75.33 -28.26 59.57 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.218 -0.446 . . . . 75.409999999999997 110.991 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.67 152.94 35.6 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.551 -0.75 . . . . 61.240000000000002 109.247 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.85 125.85 27.98 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.156 0.503 . . . . 72.219999999999999 111.81 -175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.2 t -107.71 122.74 62.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.392 -0.822 . . . . 54.140000000000001 108.806 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.1 m -87.46 149.33 24.49 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 123.059 0.544 . . . . 72.540000000000006 109.892 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 4.8 m-20 56.42 43.47 26.03 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.309 1.044 . . . . 41.140000000000001 111.138 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.61 175.66 9.1 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.111 -0.949 . . . . 71.25 111.988 -176.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -86.74 124.67 68.89 Favored Pre-proline 0 C--N 1.313 -0.996 0 CA-C-N 115.33 -0.85 . . . . 75.439999999999998 110.41 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.469 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.6 Cg_exo -51.96 -28.08 30.54 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 124.068 3.179 . . . . 72.109999999999999 114.443 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.653 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.9 t -60.39 -39.1 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 121.515 0.674 . . . . 65.129999999999995 109.879 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.13 -30.07 68.25 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.567 -0.742 . . . . 62.539999999999999 111.176 -178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.22 87.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.295 -0.411 . . . . 62.140000000000001 110.213 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.2 pp -70.2 -34.05 72.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.88 -0.415 . . . . 62.219999999999999 109.88 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -68.65 -25.28 64.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.44 -0.8 . . . . 73.510000000000005 109.241 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.47 7.03 46.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.15 -0.932 . . . . 71.230000000000004 111.071 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.9 m80 69.35 32.79 3.41 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.931 0.872 . . . . 70.120000000000005 112.873 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -112.01 24.69 12.36 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.82 -1.178 . . . . 72.239999999999995 107.82 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.93 -29.74 30.45 Favored 'General case' 0 C--O 1.217 -0.622 0 C-N-CA 125.22 1.408 . . . . 55.329999999999998 113.657 -173.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -57.77 -35.44 70.76 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.835 0.35 . . . . 74.319999999999993 111.476 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.57 -32.37 68.01 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.476 0.655 . . . . 73.010000000000005 109.845 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.4 t -70.97 -42.83 77.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.964 -1.016 . . . . 63.340000000000003 108.523 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.544 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 90.2 t -59.46 -42.64 88.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-N 115.428 -0.806 . . . . 73.040000000000006 109.874 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -60.71 -47.18 87.44 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.658 -0.246 . . . . 71.420000000000002 111.255 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -61.14 -39.21 89.22 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.354 -0.61 . . . . 75.230000000000004 109.354 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.586 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -59.87 -46.74 88.33 Favored 'General case' 0 C--O 1.212 -0.904 0 CA-C-N 115.271 -0.877 . . . . 63.130000000000003 110.87 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.3 mt-30 -58.57 -41.18 85.12 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.2 0.6 . . . . 61.25 111.529 178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.03 -35.24 79.46 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.9 -0.591 . . . . 42.130000000000003 111.221 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.1 tpt -80.34 -35.44 35.56 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.889 -0.596 . . . . 71.450000000000003 110.697 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 88' ' ' LEU . . . -71.89 -49.87 34.24 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 113.294 0.85 . . . . 71.510000000000005 113.294 -176.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 . . . . . 0 C--N 1.307 -1.276 0 CA-C-O 118.628 -0.701 . . . . 71.109999999999999 109.575 -175.411 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 110.13 -0.322 . . . . 52.329999999999998 110.13 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -73.43 103.46 1.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.769 1.646 . . . . 72.120000000000005 110.084 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.57 119.95 2.19 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.195 -1.002 . . . . 61.030000000000001 112.653 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.04 139.5 46.61 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.236 -1.024 . . . . 72.120000000000005 108.236 176.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.46 92.19 45.82 Favored Pre-proline 0 C--N 1.305 -1.366 0 C-N-CA 120.388 -0.525 . . . . 52.310000000000002 111.694 -176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -74.32 118.04 5.21 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.47 2.114 . . . . 63.039999999999999 110.445 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.21 -127.46 1.63 Allowed Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 109.835 -1.306 . . . . 73.099999999999994 109.835 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.2 t -164.57 124.34 1.95 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.462 -0.94 . . . . 45.210000000000001 108.462 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.3 m -65.08 147.32 53.68 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.257 -1.016 . . . . 70.439999999999998 108.257 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.0 -174.55 0.79 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 110.599 -0.149 . . . . 71.340000000000003 110.599 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.42 104.98 0.56 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.143 0.497 . . . . 73.420000000000002 110.677 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.508 ' HB2' ' HB2' ' A' ' 15' ' ' SER . 18.0 ptt180 -107.84 125.3 51.28 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 115.974 -0.557 . . . . 73.019999999999996 110.702 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.6 m -115.15 107.87 23.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.244 0.545 . . . . 74.439999999999998 110.009 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 51' ' ' ARG . . . 69.03 18.72 73.09 Favored Glycine 0 C--O 1.22 -0.738 0 CA-C-N 115.541 -0.754 . . . . 72.540000000000006 112.844 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' A' ' 12' ' ' ARG . 7.9 m -105.43 114.55 28.79 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.411 -1.329 . . . . 74.019999999999996 107.411 -175.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.3 mt -116.82 121.73 32.44 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 115.943 -0.571 . . . . 62.439999999999998 110.896 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.61 166.5 13.41 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.117 2.545 . . . . 72.310000000000002 109.837 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB1' ' C ' ' A' ' 58' ' ' VAL . . . -81.83 132.92 35.29 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.96 -0.696 . . . . 74.409999999999997 110.317 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.491 ' HA3' ' OD1' ' A' ' 95' ' ' ASP . . . -83.94 -164.8 37.71 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.173 -0.922 . . . . 73.010000000000005 115.06 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.12 112.89 20.22 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 114.342 -0.929 . . . . 63.420000000000002 111.224 -173.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -46.23 111.85 0.42 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.92 1.288 . . . . 54.009999999999998 113.846 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 100' ' ' ARG . 91.8 t -86.67 -37.7 11.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 107.92 -1.141 . . . . 72.209999999999994 107.92 172.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HB3' ' CD2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -73.63 164.67 26.33 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.955 -1.02 . . . . 74.019999999999996 111.238 177.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.37 150.07 97.43 Favored Pre-proline 0 C--N 1.313 -0.994 0 N-CA-C 109.757 -0.46 . . . . 64.150000000000006 109.757 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 59.3 Cg_exo -51.28 -41.0 60.57 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.646 2.231 . . . . 73.310000000000002 113.2 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.14 26.74 8.42 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.119 0.785 . . . . 63.229999999999997 113.119 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.66 138.39 90.86 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 105.832 -1.914 . . . . 75.310000000000002 105.832 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -36.46 110.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 124.463 3.442 . . . . 74.209999999999994 113.496 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.89 174.98 10.02 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.353 0.597 . . . . 74.540000000000006 112.271 -176.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.494 ' CE2' HD22 ' A' ' 38' ' ' LEU . 35.0 m-85 -130.33 161.52 31.1 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 125.418 1.487 . . . . 75.310000000000002 107.828 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 35' ' ' VAL . 11.6 t0 -133.28 166.74 21.8 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 103.344 -2.836 . . . . 72.25 103.344 -176.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -46.62 -56.0 12.73 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 113.706 1.002 . . . . 72.5 113.706 -170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.32 -40.9 78.5 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 121.794 1.663 . . . . 44.329999999999998 112.004 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.43 ' N ' ' HD2' ' A' ' 34' ' ' ARG . 1.9 mpt_? -70.77 -34.69 72.07 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 113.055 0.761 . . . . 73.299999999999997 113.055 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 31' ' ' ASP . 45.5 t -69.86 -43.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.979 -0.748 . . . . 74.510000000000005 108.979 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.71 80.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.911 -1.04 . . . . 72.239999999999995 109.475 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.5 -45.45 75.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.279 -0.873 . . . . 63.240000000000002 110.436 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.494 HD22 ' CE2' ' A' ' 30' ' ' TYR . 30.2 tp -65.76 -50.12 65.9 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 71.010000000000005 111.096 -175.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.501 ' HB2' HG22 ' A' ' 41' ' ' VAL . 93.6 mt -83.1 -18.37 39.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.795 -0.639 . . . . 71.450000000000003 112.217 -176.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.18 28.85 63.38 Favored Glycine 0 C--N 1.323 -0.159 0 N-CA-C 111.056 -0.818 . . . . 73.230000000000004 111.056 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 39' ' ' LEU . 21.1 m -124.28 165.05 26.37 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 108.835 -0.802 . . . . 74.239999999999995 108.835 -177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -79.45 163.57 24.4 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.205 1.27 . . . . 63.210000000000001 110.709 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.48 -34.14 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.452 0.701 . . . . 61.32 111.25 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 11.6 p -61.25 -40.85 95.58 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.601 -0.727 . . . . 75.040000000000006 111.837 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 83.0 tttt -69.54 -32.21 70.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.898 0.38 . . . . 71.140000000000001 110.289 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.16 -42.17 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.239 -0.652 . . . . 73.209999999999994 109.239 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.25 74.88 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.542 -0.754 . . . . 61.420000000000002 110.212 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 44' ' ' SER . 73.9 mm-40 -66.39 -35.45 80.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.5 -0.318 . . . . 75.140000000000001 111.038 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 76.6 mm-40 -64.34 -47.22 80.21 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.417 -0.957 . . . . 70.030000000000001 108.417 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.81 -45.0 95.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.086 -1.415 . . . . 65.129999999999995 110.017 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 25.1 mtp85 -65.39 -23.6 67.01 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 114.187 1.18 . . . . 62.32 114.187 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -102.27 3.14 37.86 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.028 -1.069 . . . . 65.409999999999997 111.366 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.97 41.25 41.29 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.591 -0.731 . . . . 54.039999999999999 112.297 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -101.12 -12.26 18.93 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.938 -0.393 . . . . 73.420000000000002 109.938 176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.3 tp -156.77 161.38 39.78 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.57 -0.9 . . . . 60.340000000000003 108.57 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 77.1 t -129.23 146.82 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.89 -0.782 . . . . 61.549999999999997 108.89 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.39 148.31 43.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 63.409999999999997 109.024 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.486 ' C ' ' HB1' ' A' ' 18' ' ' ALA . 17.7 m -127.06 155.07 37.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 120.862 0.363 . . . . 54.210000000000001 110.877 -176.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -110.41 115.12 29.09 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.7 -0.852 . . . . 71.310000000000002 108.7 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -126.82 123.74 38.03 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.206 -0.664 . . . . 61.219999999999999 109.206 -179.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 63.93 14.75 8.64 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.375 1.07 . . . . 71.140000000000001 111.378 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.92 4.31 60.25 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 115.656 -0.702 . . . . 41.439999999999998 112.362 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.51 145.68 16.13 Favored Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 110.563 -1.015 . . . . 74.439999999999998 110.563 177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' A' ' 18' ' ' ALA . 95.4 t -97.15 120.03 45.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.591 -0.892 . . . . 74.340000000000003 108.591 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.26 169.53 20.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.212 -0.904 . . . . 72.099999999999994 109.228 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.433 HD12 HG21 ' A' ' 35' ' ' VAL . 57.0 mt -119.75 129.19 25.49 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 108.455 -0.943 . . . . 74.129999999999995 108.455 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.11 122.23 11.41 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.956 2.438 . . . . 74.540000000000006 112.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.486 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.5 tt0 -64.66 -25.6 68.02 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 111.921 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 32.8 m -72.2 -4.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 120.969 0.414 . . . . 73.349999999999994 112.108 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.606 ' CD2' HD11 ' A' ' 81' ' ' LEU . 6.0 m-85 -86.86 -4.94 59.23 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.018 0.914 . . . . 65.430000000000007 109.718 175.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -117.04 151.29 37.09 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.835 -1.172 . . . . 65.230000000000004 107.835 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.5 p -83.06 166.87 18.39 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.86 -16.48 64.33 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.534 0.683 . . . . 72.239999999999995 110.112 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.1 m -79.96 -1.82 41.18 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.976 -0.556 . . . . 75.109999999999999 111.906 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.15 28.1 56.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.311 -0.947 . . . . 55.420000000000002 111.883 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -124.5 143.04 50.88 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.081 -1.081 . . . . 74.219999999999999 108.081 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.15 141.12 18.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 108.059 -1.089 . . . . 60.539999999999999 108.059 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.631 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.4 t -57.81 122.34 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 108.38 -0.971 . . . . 53.049999999999997 108.38 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -67.33 -27.61 67.29 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.437 0.902 . . . . 74.129999999999995 113.437 -172.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 m -89.92 -6.77 55.38 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.161 0.505 . . . . 72.140000000000001 111.086 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.631 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 9.1 tt -65.91 -47.51 63.98 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 113.646 0.98 . . . . 63.240000000000002 113.646 -175.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.5 Cg_endo -55.72 -28.89 68.74 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.654 1.569 . . . . 64.140000000000001 111.186 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -40.23 93.67 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.663 -0.699 . . . . 74.540000000000006 111.987 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.5 pp -67.97 -40.13 83.21 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 109.077 -0.712 . . . . 73.430000000000007 109.077 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.69 -39.34 93.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.647 -0.706 . . . . 63.520000000000003 109.966 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.6 m -58.81 -50.03 75.49 Favored 'General case' 0 C--O 1.248 1.019 0 CA-C-N 115.674 -0.694 . . . . 61.43 111.524 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -41.62 87.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.634 -0.257 . . . . 71.439999999999998 111.516 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.487 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.6 mm? -66.8 -36.31 82.1 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 112.077 0.399 . . . . 73.319999999999993 112.077 178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -65.92 -32.81 74.52 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.486 0.184 . . . . 72.430000000000007 110.973 176.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.75 -30.64 71.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.163 0.506 . . . . 62.039999999999999 110.199 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.86 -2.68 88.43 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.861 -0.608 . . . . 63.350000000000001 111.672 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.79 35.91 38.58 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.752 -0.224 . . . . 70.329999999999998 113.09 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 99.4 m-85 -97.67 145.66 26.1 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 122.412 -0.464 . . . . 73.349999999999994 111.04 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -95.6 171.43 8.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.594 -0.73 . . . . 75.239999999999995 110.205 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.491 ' OD1' ' HA3' ' A' ' 19' ' ' GLY . 2.0 p30 -53.65 -45.69 70.31 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.522 1.129 . . . . 74.120000000000005 113.092 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 51.3 m -62.4 -40.74 97.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 122.807 0.443 . . . . 71.430000000000007 111.239 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.75 -37.58 86.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.986 -0.552 . . . . 72.219999999999999 110.407 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.18 -49.06 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 121.869 0.842 . . . . 74.25 109.644 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 13.0 ptt? -74.77 -13.52 60.6 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.864 -1.062 . . . . 74.349999999999994 113.356 -177.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.511 ' HA ' HG11 ' A' ' 22' ' ' VAL . 77.3 ttt180 -57.43 -66.24 0.49 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.93 -0.308 . . . . 75.230000000000004 110.87 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.482 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 32.0 p-90 -67.61 -32.13 72.65 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 112.393 0.516 . . . . 72.310000000000002 112.393 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.482 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 13.9 mt -58.49 -40.82 83.82 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.6 0.593 . . . . 63.350000000000001 112.6 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.406 ' CD2' ' HB3' ' A' ' 23' ' ' LEU . 82.3 m-85 -95.23 -4.19 46.27 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 112.952 0.723 . . . . 73.430000000000007 112.952 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 93.9 m -87.34 120.09 71.11 Favored Pre-proline 0 C--N 1.293 -1.859 0 N-CA-C 109.035 -0.728 . . . . 75.319999999999993 109.035 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.96 129.1 23.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.551 1.501 . . . . 63.329999999999998 108.788 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 12.3 t70 -80.68 125.13 81.17 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.665 -0.494 . . . . 65.299999999999997 109.665 -176.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.595 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 26.9 Cg_endo -60.41 -22.25 70.73 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.518 2.812 . . . . 72.439999999999998 114.065 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -109.4 -1.48 18.39 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.128 -0.629 . . . . 73.230000000000004 111.542 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 23.7 tp -102.57 128.9 49.04 Favored 'General case' 0 N--CA 1.424 -1.769 0 C-N-CA 119.435 -0.906 . . . . 71.519999999999996 111.509 -174.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.3 m -116.56 122.14 43.78 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.078 -1.823 . . . . 73.239999999999995 106.078 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 128' ' ' ALA . 40.1 mt -127.42 144.44 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 120.498 -0.481 . . . . 71.430000000000007 110.261 -174.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 p -98.7 126.09 44.2 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 105.569 -2.012 . . . . 71.340000000000003 105.569 174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -121.9 -173.9 2.76 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.981 -1.087 . . . . 75.030000000000001 112.915 -173.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -91.69 130.28 37.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.048 -0.523 . . . . 72.099999999999994 109.759 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.98 -69.59 0.21 Allowed Glycine 0 C--N 1.302 -1.322 0 N-CA-C 107.851 -2.1 . . . . 62.200000000000003 107.851 -175.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.6 m -102.5 100.42 10.52 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 106.354 -1.721 . . . . 64.519999999999996 106.354 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -77.15 0.35 22.01 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.816 1.043 . . . . 72.430000000000007 113.816 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -83.23 163.9 20.46 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.962 -0.563 . . . . 64.329999999999998 110.781 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.44 123.81 22.22 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.745 -0.661 . . . . 71.209999999999994 110.781 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.87 119.73 58.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 107.423 -1.325 . . . . 70.530000000000001 107.423 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.0 p -81.62 137.95 35.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.315 -0.402 . . . . 54.32 110.23 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.595 ' OD1' ' HA ' ' A' ' 107' ' ' PRO . 33.5 m-80 68.12 66.44 0.35 Allowed 'General case' 0 CA--C 1.51 -0.575 0 C-N-CA 124.235 1.014 . . . . 63.210000000000001 110.299 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.429 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -109.45 169.4 8.72 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.055 -0.658 . . . . 73.329999999999998 109.824 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -89.37 157.59 47.24 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.555 -0.293 . . . . 72.030000000000001 110.443 -176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.88 -25.61 79.9 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.054 1.836 . . . . 64.530000000000001 109.848 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.483 ' CG1' ' HB ' ' A' ' 69' ' ' VAL . 84.9 t -62.56 -38.71 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.22 -0.9 . . . . 61.109999999999999 109.716 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -68.98 -42.28 76.76 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.276 -0.639 . . . . 71.040000000000006 109.276 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -59.53 -41.0 89.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 64.439999999999998 112.857 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.6 pp -64.69 -40.5 95.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.061 0.393 . . . . 64.219999999999999 112.061 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -77.6 -14.27 59.69 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.381 0.61 . . . . 73.340000000000003 111.058 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.53 5.9 50.43 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.317 -0.856 . . . . 12.4 111.575 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.0 m80 66.97 28.43 8.52 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.678 0.791 . . . . 64.519999999999996 112.028 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -115.3 23.19 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.077 0.941 . . . . 64.099999999999994 108.969 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.03 -28.66 39.72 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.018 1.727 . . . . 54.210000000000001 112.426 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -56.07 -38.44 70.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.366 -0.379 . . . . 74.109999999999999 110.62 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.98 -29.67 63.23 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 116.459 -0.337 . . . . 72.319999999999993 111.231 177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.62 -49.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.118 -0.697 . . . . 60.130000000000003 109.118 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 57.6 t -62.53 -47.35 93.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.66 -0.7 . . . . 74.319999999999993 110.03 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.36 -46.59 83.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.8 -0.637 . . . . 73.530000000000001 111.121 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 140' ' ' ARG . 7.0 ttm180 -69.0 -33.41 73.62 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 63.520000000000003 110.5 -177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.487 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -64.96 -43.89 91.21 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.693 -0.484 . . . . 74.019999999999996 109.693 175.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.537 ' HG2' ' O ' ' A' ' 138' ' ' VAL . 14.7 mm100 -57.6 -44.55 85.52 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.345 0.593 . . . . 74.409999999999997 109.747 175.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.28 79.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.508 -0.769 . . . . 61.130000000000003 111.817 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -72.18 -38.59 69.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.323 0.582 . . . . 75.5 109.794 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -74.93 -51.77 12.93 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.915 -0.584 . . . . 60.0 112.567 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--O 1.255 1.391 0 N-CA-C 109.666 -0.494 . . . . 64.120000000000005 109.666 -176.149 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.468 0.444 0 N-CA-C 110.005 -0.369 . . . . 75.439999999999998 110.005 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -90.37 -178.96 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.591 2.194 . . . . 62.310000000000002 110.859 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 109.89 -21.96 24.35 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 119.839 -1.172 . . . . 53.310000000000002 112.816 175.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -73.1 133.4 44.14 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.746 -0.464 . . . . 72.040000000000006 109.746 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.25 103.78 46.82 Favored Pre-proline 0 C--N 1.307 -1.282 0 CA-C-N 116.271 -0.422 . . . . 73.340000000000003 110.239 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.38 160.65 44.44 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 122.776 2.317 . . . . 60.109999999999999 111.492 178.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.84 55.51 4.23 Favored Glycine 0 C--N 1.319 -0.383 0 CA-C-O 121.347 0.415 . . . . 72.019999999999996 112.395 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -120.4 103.23 9.03 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 107.604 -1.258 . . . . 70.310000000000002 107.604 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -139.89 11.5 2.44 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.748 -0.834 . . . . 64.319999999999993 108.748 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 71.0 mt -110.07 143.63 39.83 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.291 -0.868 . . . . 65.140000000000001 111.85 -173.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.73 93.92 4.6 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.402 -1.333 . . . . 60.329999999999998 107.402 176.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -88.68 25.32 1.76 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.503 -0.772 . . . . 75.540000000000006 110.944 -174.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.3 p -84.69 -15.99 10.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-O 121.913 0.863 . . . . 53.219999999999999 110.076 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -92.63 55.91 2.67 Favored Glycine 0 C--N 1.302 -1.356 0 CA-C-N 114.682 -1.144 . . . . 34.240000000000002 110.768 -179.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.0 m -92.92 105.84 17.9 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.827 -0.805 . . . . 72.140000000000001 108.827 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mp -104.93 121.04 47.98 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 108.591 -0.892 . . . . 63.25 108.591 179.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -67.05 141.93 59.7 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.062 1.841 . . . . 65.439999999999998 111.25 177.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.01 125.56 32.82 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 110.02 -0.363 . . . . 54.509999999999998 110.02 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -117.13 -99.49 2.07 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 121.38 -0.438 . . . . 61.409999999999997 112.305 179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.71 135.18 51.05 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 122.327 -0.514 . . . . 60.439999999999998 112.238 -174.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 25.1 t0 -77.84 146.77 35.51 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.076 -0.965 . . . . 62.439999999999998 109.544 175.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.2 t -114.25 -15.85 9.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.396 -0.365 . . . . 65.439999999999998 111.342 -174.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 1.6 pp -90.61 179.25 5.87 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.32 -0.952 . . . . 71.540000000000006 111.442 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -105.58 137.11 19.21 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 106.927 -1.508 . . . . 73.409999999999997 106.927 173.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -53.32 -20.94 16.21 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 122.812 2.341 . . . . 74.099999999999994 114.376 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.45 -24.69 61.24 Favored 'General case' 0 C--O 1.241 0.622 0 O-C-N 122.083 -0.385 . . . . 72.209999999999994 110.432 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.83 152.31 84.77 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 74.340000000000003 108.203 177.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -55.99 111.81 0.88 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 122.668 2.245 . . . . 74.340000000000003 113.085 -178.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.407 ' HA ' ' H ' ' A' ' 68' ' ' GLN . 1.7 m -124.59 169.35 12.01 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 108.787 -0.819 . . . . 61.329999999999998 108.787 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 15.7 m-85 -128.91 160.98 30.95 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.021 -1.474 . . . . 74.439999999999998 107.021 172.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.587 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 10.9 t70 -134.66 168.59 18.72 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 104.429 -2.434 . . . . 75.230000000000004 104.429 -173.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.5 mt -52.01 -57.19 15.91 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 112.983 0.734 . . . . 54.140000000000001 112.983 -173.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.587 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 21.7 Cg_endo -62.61 -31.6 79.54 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.778 1.652 . . . . 75.439999999999998 111.756 176.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.505 ' HB2' ' H ' ' A' ' 31' ' ' ASP . 2.4 mpt_? -70.63 -36.83 73.65 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.428 0.529 . . . . 72.540000000000006 112.428 -178.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.59 -41.95 80.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 N-CA-C 109.195 -0.669 . . . . 75.25 109.195 177.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.82 91.63 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.789 -1.096 . . . . 73.150000000000006 109.422 176.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.2 -45.8 83.3 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.833 1.253 . . . . 73.400000000000006 110.445 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD22 ' CE2' ' A' ' 30' ' ' TYR . 38.8 tp -65.64 -50.28 65.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.477 -0.783 . . . . 73.099999999999994 111.604 -177.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.59 -9.54 58.21 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.531 0.567 . . . . 71.530000000000001 112.531 -174.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.41 29.26 71.79 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 111.672 -0.571 . . . . 63.219999999999999 111.672 179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.23 160.28 48.44 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.544 -0.91 . . . . 74.219999999999999 108.544 -178.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.68 160.08 38.27 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.564 1.51 . . . . 75.209999999999994 111.219 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.1 t -57.6 -32.84 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.349 0.659 . . . . 72.439999999999998 110.419 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.6 t -57.44 -42.84 83.21 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 116.185 -0.461 . . . . 64.450000000000003 110.495 177.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -70.16 -32.43 70.4 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.949 0.404 . . . . 73.420000000000002 110.603 178.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.509 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 77.7 t -62.28 -44.0 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 N-CA-C 109.116 -0.698 . . . . 72.219999999999999 109.116 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -59.36 -36.94 76.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.27 -0.423 . . . . 52.210000000000001 110.299 177.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 83.6 mm-40 -69.63 -40.41 76.57 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.637 0.606 . . . . 73.349999999999994 112.637 179.234 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.548 ' O ' ' HB3' ' A' ' 54' ' ' HIS . 3.2 pt20 -68.69 -33.71 74.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.929 -0.708 . . . . 73.239999999999995 109.854 178.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 95.8 mt -62.47 -39.72 94.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.971 -0.752 . . . . 65.129999999999995 108.971 174.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 70.2 mtt-85 -70.78 -21.43 62.49 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.979 0.733 . . . . 72.120000000000005 112.979 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 44.4 mt-10 -76.77 -12.11 59.93 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 121.161 -0.216 . . . . 71.310000000000002 110.63 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.81 30.55 65.84 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 107.991 -2.043 . . . . 64.530000000000001 107.991 -169.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 49' ' ' GLN . 11.9 t-160 -97.23 -32.21 12.04 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 125.139 1.376 . . . . 71.140000000000001 108.625 -176.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 41.6 tp -152.61 153.19 32.86 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.1 -1.444 . . . . 73.209999999999994 107.1 -179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.75 161.48 39.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 117.9 0.318 . . . . 13.449999999999999 110.467 177.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.34 154.05 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.152 -0.685 . . . . 75.219999999999999 109.152 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.43 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 123.449 0.699 . . . . 61.329999999999998 110.548 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 98.8 mtt180 -117.24 134.76 54.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.767 -0.197 . . . . 64.319999999999993 110.607 -177.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -139.98 127.36 21.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.864 -1.161 . . . . 75.099999999999994 107.864 170.845 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 57.97 21.52 7.83 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.898 1.279 . . . . 63.109999999999999 111.882 -177.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.02 -0.88 67.18 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.378 -0.439 . . . . 71.200000000000003 112.681 -179.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -98.48 135.77 12.34 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.064 -0.814 . . . . 63.310000000000002 111.064 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.1 t -97.19 120.78 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.024 -1.102 . . . . 65.150000000000006 108.024 -179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.83 161.61 39.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.48 0.657 . . . . 64.510000000000005 111.878 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.88 120.75 25.55 Favored Pre-proline 0 C--N 1.295 -1.775 0 N-CA-C 106.384 -1.71 . . . . 73.140000000000001 106.384 178.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.02 124.61 16.36 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.409 2.073 . . . . 65.019999999999996 112.705 178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.509 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -64.77 -25.3 67.86 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.887 0.851 . . . . 75.540000000000006 111.015 -179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 m -66.53 -12.24 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 114.562 -1.199 . . . . 74.329999999999998 112.208 177.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.1 m-85 -78.55 -11.35 59.96 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.889 0.852 . . . . 64.209999999999994 110.299 175.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -106.83 149.53 27.3 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 107.61 -1.255 . . . . 75.230000000000004 107.61 178.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.0 p -76.04 175.64 8.7 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.498 -0.556 . . . . 75.239999999999995 109.498 178.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.56 -22.84 66.65 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.208 0.527 . . . . 54.149999999999999 110.079 176.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.4 m -84.05 1.01 45.96 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.755 -0.657 . . . . 65.329999999999998 112.298 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.67 66.82 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.351 -0.452 . . . . 75.5 112.71 179.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -113.97 152.77 30.4 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.651 -0.87 . . . . 71.510000000000005 108.651 177.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -70.79 135.64 27.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.831 -1.174 . . . . 65.299999999999997 107.831 175.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.437 HG12 ' H ' ' A' ' 80' ' ' SER . 58.0 t -59.55 135.21 24.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.335 -0.617 . . . . 74.239999999999995 109.335 178.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -59.09 -31.56 69.01 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.862 0.69 . . . . 64.329999999999998 112.862 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.437 ' H ' HG12 ' A' ' 78' ' ' VAL . 33.0 m -89.38 3.05 53.5 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.081 -0.509 . . . . 72.230000000000004 111.78 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.549 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.19 -54.12 48.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.989 -0.374 . . . . 73.140000000000001 109.989 179.393 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 32.2 Cg_exo -62.81 -30.87 78.18 Favored 'Trans proline' 0 C--N 1.383 2.35 0 C-N-CA 121.134 1.222 . . . . 64.120000000000005 110.598 177.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.12 93.94 Favored Glycine 0 N--CA 1.445 -0.767 0 CA-C-N 115.713 -0.676 . . . . 73.400000000000006 112.221 -178.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.4 pp -67.64 -40.02 84.61 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 121.17 0.509 . . . . 54.350000000000001 109.827 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.86 -46.55 87.35 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.799 -0.637 . . . . 74.140000000000001 110.264 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.8 m -60.71 -41.49 95.34 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.952 -0.567 . . . . 52.119999999999997 112.529 -177.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -47.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 121.103 -0.239 . . . . 54.200000000000003 110.885 -178.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.498 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -68.01 -35.74 78.8 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.97 0.73 . . . . 74.129999999999995 112.97 176.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -59.39 -42.59 92.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.507 0.723 . . . . 72.129999999999995 110.338 -177.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.4 -30.37 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.299 0.571 . . . . 61.399999999999999 110.572 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.99 -9.47 86.65 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.683 -0.69 . . . . 64.299999999999997 112.582 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.31 24.2 54.93 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 121.713 -0.28 . . . . 52.109999999999999 113.146 177.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 145' ' ' ALA . 94.5 m-85 -89.61 132.98 34.85 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.576 -0.367 . . . . 73.519999999999996 111.123 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -78.88 169.88 17.53 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.597 0.713 . . . . 74.329999999999998 112.858 -175.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -54.39 -45.34 72.84 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.395 1.878 . . . . 52.109999999999999 112.003 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.0 m -64.56 -40.39 95.48 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 115.568 -0.742 . . . . 52.130000000000003 110.204 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -65.96 -36.79 84.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.612 -0.267 . . . . 64.219999999999999 111.273 179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.1 mm -61.42 -49.0 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 108.415 -0.957 . . . . 71.420000000000002 108.415 -178.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.52 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 57.4 mtt -74.96 -17.72 60.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.799 -1.092 . . . . 75.439999999999998 112.391 -178.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -59.4 -65.05 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.626 -0.509 . . . . 75.420000000000002 109.626 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.4 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 36.0 p-90 -68.94 -32.56 72.25 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 112.749 0.648 . . . . 72.230000000000004 112.749 177.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 125' ' ' PRO . 13.1 mt -58.59 -40.84 84.31 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 112.477 0.547 . . . . 62.350000000000001 112.477 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 54.9 m-85 -92.49 -11.57 34.29 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 112.345 0.498 . . . . 75.319999999999993 112.345 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 94.6 m -86.62 125.36 67.47 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 109.654 -0.499 . . . . 71.329999999999998 109.654 177.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.604 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.6 Cg_exo -56.16 129.91 37.37 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.592 2.195 . . . . 74.200000000000003 110.693 175.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -90.53 123.41 65.41 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 108.525 -0.917 . . . . 74.319999999999993 108.525 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.21 -24.55 77.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.027 2.485 . . . . 71.430000000000007 113.6 -176.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.5 m -102.98 3.56 36.42 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.722 0.296 . . . . 72.140000000000001 111.367 -175.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.62 124.0 46.56 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.562 0.696 . . . . 54.509999999999998 111.016 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.41 HG22 ' HB1' ' A' ' 119' ' ' ALA . 37.7 m -131.35 110.48 11.1 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.866 -1.161 . . . . 75.230000000000004 107.866 177.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 128' ' ' ALA . 23.2 pt -136.29 157.91 37.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 120.924 0.392 . . . . 63.399999999999999 111.871 -174.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 t -89.35 136.28 33.11 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 105.66 -1.978 . . . . 62.450000000000003 105.66 169.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.486 ' HB2' ' OD1' ' A' ' 127' ' ' ASP . 6.0 ptp180 -102.1 166.95 10.33 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.559 -0.856 . . . . 74.310000000000002 109.973 -174.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 33.9 t70 -78.03 84.96 4.27 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.599 -0.889 . . . . 65.450000000000003 108.599 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.85 -4.25 2.39 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.243 -0.89 . . . . 72.200000000000003 111.607 -176.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.424 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 17.0 m -149.71 112.58 4.83 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.634 -0.876 . . . . 75.329999999999998 108.634 177.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -68.48 -22.31 64.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.102 0.477 . . . . 75.219999999999999 110.976 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.98 159.19 34.22 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.499 -0.773 . . . . 62.020000000000003 110.232 175.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.41 ' HB1' HG22 ' A' ' 110' ' ' THR . . . -96.47 124.87 40.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.879 -0.601 . . . . 52.009999999999998 110.791 -176.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.6 120.82 46.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.163 -1.051 . . . . 71.230000000000004 108.163 178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.0 t -90.22 148.44 22.93 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.311 -1.366 . . . . 71.430000000000007 107.311 178.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 65.6 t30 65.85 44.79 2.71 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.497 -1.297 . . . . 65.200000000000003 107.497 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.82 160.79 17.08 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.335 -0.848 . . . . 73.109999999999999 110.423 -178.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -97.27 132.3 25.79 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.444 -0.576 . . . . 75.340000000000003 109.444 -177.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.556 ' HB2' HD23 ' A' ' 102' ' ' LEU . 80.9 Cg_exo -50.01 -29.53 21.84 Favored 'Trans proline' 0 CA--C 1.551 1.372 0 C-N-CA 124.061 3.174 . . . . 65.010000000000005 115.543 -178.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.538 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 90.3 t -61.69 -42.72 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 118.519 0.599 . . . . 75.530000000000001 110.274 176.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.486 ' OD1' ' HB2' ' A' ' 113' ' ' ARG . 12.5 t70 -67.67 -33.64 75.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.278 -1.008 . . . . 52.539999999999999 108.278 -176.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -62.75 -50.2 72.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.723 -1.126 . . . . 62.409999999999997 111.386 177.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -65.7 -34.26 77.8 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.036 0.446 . . . . 74.400000000000006 110.946 -179.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -68.58 -23.63 64.5 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 75.319999999999993 109.157 178.04 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -96.66 7.7 45.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.815 -1.084 . . . . 74.409999999999997 110.982 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.1 m80 66.27 29.43 9.58 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.612 0.72 . . . . 75.409999999999997 111.773 -179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -101.36 22.69 12.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.033 -1.469 . . . . 73.230000000000004 107.033 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.31 -30.23 59.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.848 -1.524 . . . . 75.409999999999997 114.595 -173.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -56.75 -43.29 80.58 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.028 0.442 . . . . 54.229999999999997 111.524 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -73.31 -26.21 60.97 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.737 -0.665 . . . . 73.430000000000007 110.818 -179.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 81.7 t -69.05 -42.13 81.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.653 -0.869 . . . . 75.239999999999995 108.653 175.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 86.1 t -60.03 -41.92 87.94 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.675 0 CA-C-N 115.323 -0.853 . . . . 73.129999999999995 109.913 176.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -60.91 -40.28 92.56 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 121.341 0.591 . . . . 74.409999999999997 110.157 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.49 -41.04 93.67 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 108.457 -0.942 . . . . 74.439999999999998 108.457 178.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.498 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -62.21 -45.12 94.78 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.967 -1.015 . . . . 73.219999999999999 110.549 177.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.6 mt-30 -57.3 -36.18 70.75 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.462 0.705 . . . . 73.319999999999993 110.574 176.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.4 -34.49 78.43 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.943 -0.571 . . . . 65.310000000000002 111.152 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 29.5 ttm -80.78 -45.39 17.07 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.724 -0.79 . . . . 74.209999999999994 112.618 175.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' HA ' ' CE2' ' A' ' 93' ' ' TYR . . . -69.72 -34.84 74.43 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 114.031 1.123 . . . . 74.120000000000005 114.031 -174.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 C--N 1.305 -1.366 0 N-CA-C 109.24 -0.652 . . . . 70.549999999999997 109.24 -178.664 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 110.096 -0.335 . . . . 61.210000000000001 110.096 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.17 113.98 3.26 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 122.727 2.284 . . . . 74.310000000000002 111.892 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.54 -164.57 29.42 Favored Glycine 0 C--N 1.302 -1.358 0 N-CA-C 111.133 -0.787 . . . . 75.129999999999995 111.133 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 31.8 mmm180 -73.58 133.58 43.56 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.205 -1.035 . . . . 71.349999999999994 108.205 177.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.81 105.34 44.43 Favored Pre-proline 0 C--N 1.294 -1.816 0 N-CA-C 109.657 -0.497 . . . . 52.32 109.657 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 4' ' ' ARG . 15.7 Cg_exo -70.79 143.46 45.93 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 122.262 1.974 . . . . 62.299999999999997 110.73 177.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.33 -175.3 49.69 Favored Glycine 0 N--CA 1.398 -3.862 0 N-CA-C 110.28 -1.128 . . . . 72.430000000000007 110.28 -179.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -96.57 -174.26 2.98 Favored 'General case' 0 C--N 1.257 -3.42 0 CA-C-N 115.33 -0.435 . . . . 52.539999999999999 109.838 -177.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.0 m -61.69 152.33 31.29 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.81 -0.811 . . . . 44.109999999999999 108.81 174.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -63.85 103.3 0.56 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 108.915 -0.772 . . . . 71.129999999999995 108.915 177.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.31 124.77 33.72 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.032 -0.985 . . . . 72.299999999999997 109.637 -178.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -79.86 96.66 6.4 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.443 -0.947 . . . . 74.400000000000006 108.443 178.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.5 m -96.59 136.16 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 115.041 -0.981 . . . . 72.319999999999993 110.373 -176.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.85 1.02 49.03 Favored Glycine 0 C--N 1.277 -2.722 0 CA-C-N 114.027 -1.442 . . . . 75.010000000000005 109.988 -177.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.3 m -91.53 91.11 7.92 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.506 0.669 . . . . 74.409999999999997 110.683 -178.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.62 120.15 50.26 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 107.641 -1.244 . . . . 62.130000000000003 107.641 175.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -74.07 165.17 32.66 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.38 2.053 . . . . 55.210000000000001 110.172 176.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.23 133.79 33.62 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 120.571 0.224 . . . . 61.229999999999997 110.579 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.74 -87.17 1.99 Allowed Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.561 -1.016 . . . . 61.329999999999998 110.561 178.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -141.12 159.95 41.13 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.604 -0.351 . . . . 73.150000000000006 110.848 176.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 9.6 t0 -93.75 137.67 32.76 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.636 -0.711 . . . . 45.32 112.647 -173.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 100' ' ' ARG . 86.1 t -100.01 -26.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.692 -0.685 . . . . 72.239999999999995 111.8 -175.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.555 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -80.45 -178.9 6.89 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 118.663 -1.215 . . . . 74.349999999999994 110.655 -179.912 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -100.79 147.94 34.34 Favored Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 107.868 -1.16 . . . . 73.049999999999997 107.868 -178.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.08 -21.27 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.992 2.462 . . . . 71.150000000000006 113.576 175.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.78 -27.24 68.14 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 122.903 0.481 . . . . 72.239999999999995 110.548 176.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.15 125.24 85.44 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 107.756 -1.201 . . . . 64.299999999999997 107.756 171.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 16.6 Cg_exo -65.31 139.73 61.14 Favored 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 122.218 1.946 . . . . 61.439999999999998 112.898 -177.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 65' ' ' VAL . 6.3 p -118.22 156.97 27.86 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.252 0.834 . . . . 72.400000000000006 113.252 -179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 28.0 m-85 -109.78 161.89 15.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 125.452 1.501 . . . . 74.209999999999994 108.858 176.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.569 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 4.3 m-20 -134.56 165.77 24.43 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 104.623 -2.362 . . . . 72.430000000000007 104.623 -178.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -50.04 -56.37 18.15 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 114.415 1.265 . . . . 70.230000000000004 114.415 -175.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HA ' HG22 ' A' ' 43' ' ' VAL . 28.7 Cg_endo -63.05 -31.62 76.05 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 121.915 1.744 . . . . 75.439999999999998 112.424 178.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.569 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 14.8 tpt180 -70.42 -39.37 74.47 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.736 0.814 . . . . 72.030000000000001 110.221 -178.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 31' ' ' ASP . 59.3 t -69.2 -38.58 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.372 -0.603 . . . . 71.420000000000002 109.372 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.11 91.13 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.441 -0.799 . . . . 54.420000000000002 109.626 177.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.57 -44.98 94.98 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.016 -1.447 . . . . 71.200000000000003 110.06 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.4 tp -65.62 -47.48 75.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.921 -1.036 . . . . 73.019999999999996 111.339 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -82.7 -18.54 40.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.865 0.691 . . . . 54.439999999999998 112.865 -174.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.67 29.45 55.13 Favored Glycine 0 C--N 1.311 -0.827 0 N-CA-C 111.017 -0.833 . . . . 30.129999999999999 111.017 -179.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 20.4 m -124.22 161.83 45.23 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.148 -1.056 . . . . 70.150000000000006 108.148 179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 36.1 Cg_endo -67.94 156.23 66.7 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 121.362 1.374 . . . . 64.439999999999998 112.603 178.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 33' ' ' PRO . 42.9 t -60.45 -37.87 76.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 51.030000000000001 110.256 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 23.0 t -60.69 -34.78 74.86 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.534 -0.757 . . . . 45.119999999999997 110.653 179.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 60.8 tttp -69.33 -39.02 78.44 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.837 -0.431 . . . . 71.299999999999997 109.837 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.2 t -61.34 -41.16 88.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.249 0.547 . . . . 65.109999999999999 109.56 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -36.81 81.84 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.41 -0.814 . . . . 73.530000000000001 110.498 176.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 44' ' ' SER . 55.2 mt-30 -65.36 -44.0 89.03 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.359 -0.382 . . . . 74.209999999999994 110.308 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.9 mm-40 -61.86 -43.17 99.38 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.791 0.682 . . . . 74.299999999999997 110.226 -178.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.8 tp -61.97 -40.81 96.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.589 -1.187 . . . . 73.329999999999998 110.343 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.47 -21.49 61.94 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.201 0.815 . . . . 75.129999999999995 113.201 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -88.14 -11.88 45.63 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 120.406 0.146 . . . . 70.209999999999994 111.272 178.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.98 32.45 49.28 Favored Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 110.234 -1.146 . . . . 33.43 110.234 -175.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -93.74 -13.74 27.08 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.31 -1.367 . . . . 74.099999999999994 107.31 178.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.4 tp -157.08 152.86 26.96 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.193 -2.151 . . . . 75.510000000000005 105.193 179.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.6 p -135.6 152.05 30.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.162 -0.681 . . . . 65.109999999999999 109.162 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -127.26 162.14 26.91 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.086 -0.506 . . . . 64.319999999999993 110.575 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.433 HG11 ' HG3' ' A' ' 99' ' ' MET . 5.2 m -126.64 166.2 23.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 123.397 0.679 . . . . 74.099999999999994 109.467 178.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -120.5 131.65 54.83 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 120.879 -0.328 . . . . 72.430000000000007 110.649 -176.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 30.1 ptt180 -147.51 138.32 23.46 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.582 -0.895 . . . . 71.329999999999998 108.582 175.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.35 17.71 9.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.004 0.922 . . . . 72.040000000000006 111.612 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.85 -4.02 74.78 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.976 -0.556 . . . . 42.009999999999998 112.245 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -105.24 144.38 15.77 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.836 -0.697 . . . . 74.209999999999994 111.593 -178.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.44 120.12 46.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.04 -1.467 . . . . 65.219999999999999 107.04 178.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 29' ' ' THR . 14.8 m -133.68 154.42 38.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-O 121.36 0.6 . . . . 72.209999999999994 111.796 -173.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.4 mp -113.53 120.75 38.98 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 107.497 -1.298 . . . . 65.319999999999993 107.497 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.439 ' HB3' HD21 ' A' ' 23' ' ' LEU . 88.0 Cg_exo -53.74 128.39 29.38 Favored 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 122.698 2.265 . . . . 73.109999999999999 112.179 177.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.45 ' NE2' ' HB2' ' A' ' 28' ' ' PRO . 6.1 tt0 -57.34 -25.53 59.53 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.36 0.504 . . . . 65.0 112.36 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -70.95 -4.24 4.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.782 -0.645 . . . . 73.310000000000002 112.446 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.526 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.8 m-85 -83.84 -4.66 58.85 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 122.248 1.023 . . . . 74.439999999999998 109.913 174.539 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -122.16 158.84 28.47 Favored 'General case' 0 N--CA 1.41 -2.457 0 N-CA-C 106.801 -1.555 . . . . 72.430000000000007 106.801 177.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.2 p -91.57 163.87 13.98 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 108.69 -0.856 . . . . 45.200000000000003 108.69 179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.73 -16.29 62.73 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.336 0.588 . . . . 74.120000000000005 110.147 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.6 m -79.47 -0.67 34.09 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.238 0.615 . . . . 52.149999999999999 111.187 -178.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.7 24.38 60.48 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 120.851 -0.69 . . . . 23.140000000000001 112.005 178.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -125.9 145.95 50.04 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.607 -1.257 . . . . 43.140000000000001 107.607 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.17 155.48 7.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 107.967 -1.123 . . . . 63.130000000000003 107.967 176.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 48.4 t -69.82 112.03 4.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.498 -0.927 . . . . 70.230000000000004 108.498 177.483 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.7 pttt -56.18 -35.11 66.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.467 1.284 . . . . 54.299999999999997 114.467 -175.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.5 m -90.69 -4.25 56.89 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.223 0.535 . . . . 74.329999999999998 111.536 -178.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 8.6 tt -65.83 -47.48 64.85 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.51 0.929 . . . . 73.439999999999998 113.51 -176.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 9.6 Cg_endo -54.24 -28.73 53.6 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 121.743 1.628 . . . . 73.209999999999994 111.514 176.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.15 -38.2 95.61 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.709 -0.678 . . . . 42.409999999999997 112.048 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -68.17 -40.15 82.37 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 108.767 -0.827 . . . . 75.209999999999994 108.767 178.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -61.88 -32.69 73.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.756 -0.656 . . . . 74.099999999999994 110.233 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.1 m -62.76 -50.18 72.08 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.66 -0.7 . . . . 54.310000000000002 110.289 179.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.73 -40.25 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.465 -0.334 . . . . 52.109999999999999 111.439 -179.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.542 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.7 mm? -66.88 -35.36 79.84 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 112.58 0.585 . . . . 71.400000000000006 112.58 176.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -61.68 -40.54 95.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 60.25 109.343 176.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -65.63 -31.87 73.13 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.791 -0.64 . . . . 70.310000000000002 110.854 178.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -88.53 -9.95 68.46 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.962 -0.637 . . . . 75.120000000000005 112.495 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.48 48.98 8.54 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 114.004 0.361 . . . . 41.109999999999999 114.004 177.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 88.4 m-85 -110.17 139.44 45.32 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 117.408 0.604 . . . . 72.340000000000003 111.447 178.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -81.91 171.79 14.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 72.420000000000002 111.851 -179.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 99' ' ' MET . 13.0 p-10 -54.64 -45.51 73.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.894 1.678 . . . . 72.540000000000006 111.83 -177.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 m -62.38 -40.62 97.07 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 123.364 0.666 . . . . 73.420000000000002 110.052 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -63.65 -38.74 92.28 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.624 -0.717 . . . . 74.049999999999997 111.229 179.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.2 mm -61.26 -47.5 93.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.334 -0.987 . . . . 65.430000000000007 108.334 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 22.8 mmt -67.99 -26.07 65.73 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.677 -1.147 . . . . 75.519999999999996 111.656 -176.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.413 ' HA ' HG11 ' A' ' 22' ' ' VAL . 45.3 ttp85 -52.56 -71.26 0.07 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.694 0.627 . . . . 75.120000000000005 112.694 -176.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -68.58 -31.46 70.67 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.166 0.432 . . . . 75.409999999999997 112.166 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.7 mt -56.55 -40.64 75.49 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 112.131 0.419 . . . . 71.219999999999999 112.131 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 96.5 m-85 -102.02 2.01 37.21 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 112.956 0.724 . . . . 70.129999999999995 112.956 -176.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 85.1 m -89.08 112.13 49.17 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 109.712 -0.477 . . . . 71.430000000000007 109.712 173.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -65.1 128.76 21.3 Favored 'Trans proline' 0 C--O 1.251 1.145 0 N-CA-C 108.434 -1.41 . . . . 64.040000000000006 108.434 173.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 23.6 t70 -96.85 126.29 43.34 Favored Pre-proline 0 C--N 1.303 -1.455 0 C-N-CA 120.698 -0.401 . . . . 60.539999999999999 111.501 -173.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.66 -16.9 46.18 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.22 2.613 . . . . 61.229999999999997 114.277 -178.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.4 t -114.53 8.99 16.57 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-O 121.163 0.506 . . . . 63.200000000000003 109.924 -178.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 51.6 tp -106.94 118.68 37.33 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.729 0.776 . . . . 73.040000000000006 112.328 -178.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.0 m -118.2 117.19 28.46 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 108.191 -1.04 . . . . 71.409999999999997 108.191 178.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.41 HG12 ' HG ' ' A' ' 109' ' ' LEU . 29.3 mm -117.45 148.88 19.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 115.118 -0.946 . . . . 73.549999999999997 109.826 -175.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.4 p -97.87 126.06 43.06 Favored 'General case' 0 C--N 1.263 -3.184 0 N-CA-C 108.46 -0.941 . . . . 64.409999999999997 108.46 175.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -82.23 167.39 18.7 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 120.451 -0.5 . . . . 71.430000000000007 111.86 -178.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.26 112.44 2.14 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 124.308 1.005 . . . . 73.010000000000005 109.596 -178.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.37 64.92 0.83 Allowed Glycine 0 N--CA 1.426 -1.986 0 N-CA-C 106.934 -2.466 . . . . 61.100000000000001 106.934 -170.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.5 m -67.19 87.31 0.16 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.837 1.051 . . . . 75.510000000000005 113.837 -172.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -100.94 -25.54 14.05 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.325 -1.307 . . . . 75.5 109.369 175.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -163.58 157.82 19.94 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 107.567 -1.272 . . . . 74.329999999999998 107.567 -174.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.31 139.08 36.5 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.502 -0.555 . . . . 73.120000000000005 109.502 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.6 t -103.73 117.9 49.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.05 -0.722 . . . . 64.099999999999994 109.05 -176.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.9 m -84.0 149.83 26.03 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.268 -0.641 . . . . 70.129999999999995 109.268 179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 22.8 t-20 70.1 40.42 1.22 Allowed 'General case' 0 C--O 1.22 -0.475 0 C-N-CA 124.219 1.008 . . . . 73.310000000000002 109.798 178.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.55 156.65 22.68 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 121.734 -0.604 . . . . 43.229999999999997 110.348 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.578 ' HD3' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -102.95 143.65 27.03 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 108.711 -0.848 . . . . 73.420000000000002 108.711 175.821 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' HB2' HD23 ' A' ' 102' ' ' LEU . 82.1 Cg_exo -49.73 -34.08 34.36 Favored 'Trans proline' 0 CA--C 1.549 1.252 0 C-N-CA 123.655 2.904 . . . . 61.420000000000002 114.856 -177.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 98.5 t -62.95 -40.46 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.466 0.651 . . . . 54.229999999999997 110.782 177.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.23 -37.79 88.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.347 -0.982 . . . . 74.439999999999998 108.347 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.94 78.66 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.484 -1.235 . . . . 54.32 112.023 179.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -66.41 -36.22 82.29 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 122.013 -0.429 . . . . 74.540000000000006 112.114 -177.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.419 ' N ' HD12 ' A' ' 129' ' ' LEU . 16.6 t-80 -73.27 -16.16 61.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.216 1.007 . . . . 74.219999999999999 108.975 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.83 5.25 51.75 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.019 -0.991 . . . . 64.230000000000004 110.465 177.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.0 m80 65.22 28.99 11.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.416 1.086 . . . . 63.530000000000001 112.296 -179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -103.83 23.71 12.39 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.653 -1.24 . . . . 73.439999999999998 107.653 176.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.38 -26.83 13.48 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.549 1.94 . . . . 51.310000000000002 112.74 -176.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -54.39 -38.2 65.9 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.881 0.472 . . . . 74.430000000000007 111.773 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.43 ' HG2' HD11 ' A' ' 109' ' ' LEU . 13.9 tp10 -73.5 -32.2 64.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 109.696 -0.483 . . . . 73.140000000000001 109.696 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.52 -48.31 77.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.501 -0.772 . . . . 75.450000000000003 109.586 -178.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.503 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 59.6 t -62.37 -42.79 96.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 N-CA-C 109.279 -0.638 . . . . 73.349999999999994 109.279 177.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -62.61 -39.45 93.83 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.711 -0.677 . . . . 73.140000000000001 111.188 178.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.417 ' NH2' HD13 ' A' ' 109' ' ' LEU . 2.7 tpp180 -64.73 -38.84 92.35 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.077 -0.712 . . . . 73.340000000000003 109.077 178.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.542 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -68.85 -38.66 79.91 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.831 -1.077 . . . . 75.530000000000001 110.613 178.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 98.0 mt-30 -58.87 -49.51 77.47 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.591 -0.277 . . . . 74.120000000000005 110.288 176.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -23.82 67.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 72.549999999999997 111.141 178.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 2.5 tpt -83.39 -30.94 26.98 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.346 0.593 . . . . 72.400000000000006 110.191 178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.452 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -84.21 -54.07 5.07 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 111.638 -177.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 C--N 1.309 -1.174 0 N-CA-C 108.676 -0.861 . . . . 74.519999999999996 108.676 -177.45 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 CA--C 1.516 -0.35 0 N-CA-C 109.897 -0.409 . . . . 60.240000000000002 109.897 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.82 -41.61 10.24 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.463 2.109 . . . . 53.399999999999999 112.679 -177.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.79 105.67 2.56 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 111.621 -0.591 . . . . 15.43 111.621 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -68.24 138.37 55.5 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.529 -0.545 . . . . 64.340000000000003 109.529 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.34 112.04 53.34 Favored Pre-proline 0 C--N 1.305 -1.361 0 N-CA-C 109.656 -0.498 . . . . 53.539999999999999 109.656 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -79.39 -162.47 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.718 2.279 . . . . 43.219999999999999 110.728 175.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.42 -65.87 1.6 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 111.079 -0.809 . . . . 63.329999999999998 111.079 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -90.45 77.98 6.44 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 122.323 1.059 . . . . 62.539999999999999 112.429 -178.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.5 m -155.61 148.68 24.53 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.985 -1.857 . . . . 64.420000000000002 105.985 175.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 98.1 mt -123.5 167.24 14.15 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.514 -0.55 . . . . 74.219999999999999 109.514 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.64 87.13 6.3 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.832 -1.173 . . . . 74.140000000000001 107.832 174.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -75.83 100.29 4.72 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 113.836 -1.529 . . . . 73.329999999999998 110.102 -177.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.39 83.22 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.644 0.735 . . . . 52.130000000000003 111.201 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -92.12 53.92 2.88 Favored Glycine 0 C--N 1.303 -1.255 0 N-CA-C 108.087 -2.005 . . . . 53.229999999999997 108.087 173.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 51' ' ' ARG . 35.1 t -145.88 155.94 43.21 Favored 'General case' 0 N--CA 1.409 -2.513 0 N-CA-C 107.841 -1.17 . . . . 74.409999999999997 107.841 -172.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.74 125.05 32.57 Favored Pre-proline 0 N--CA 1.422 -1.873 0 N-CA-C 107.08 -1.452 . . . . 52.149999999999999 107.08 176.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.77 166.21 14.38 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.036 2.49 . . . . 70.430000000000007 110.955 174.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.58 125.55 31.29 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.306 -0.627 . . . . 64.239999999999995 109.306 -178.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -106.17 -133.99 7.63 Favored Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 121.144 -0.55 . . . . 64.420000000000002 112.314 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.28 124.39 46.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.533 -0.543 . . . . 71.25 109.533 -174.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.69 130.78 44.87 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.25 0.548 . . . . 62.020000000000003 111.048 -176.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.519 HG23 ' HE3' ' A' ' 99' ' ' MET . 22.3 t -111.44 27.27 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 CA-C-O 123.294 1.521 . . . . 74.430000000000007 109.5 -178.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.4 OUTLIER -118.68 172.94 7.15 Favored 'General case' 0 C--N 1.275 -2.648 0 CA-C-N 114.994 -1.003 . . . . 63.439999999999998 110.098 175.6 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.449 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 14.3 t70 -86.5 137.06 34.47 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 107.724 -1.213 . . . . 63.100000000000001 107.724 175.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -50.78 -21.96 9.06 Favored 'Trans proline' 0 CA--C 1.557 1.67 0 C-N-CA 123.149 2.566 . . . . 72.200000000000003 115.242 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.91 -1.46 56.7 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 113.509 0.929 . . . . 72.140000000000001 113.509 178.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 27.1 mm-40 -67.42 151.76 96.84 Favored Pre-proline 0 C--O 1.248 0.979 0 N-CA-C 109.268 -0.642 . . . . 73.109999999999999 109.268 176.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.3 119.01 5.46 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.712 2.275 . . . . 64.540000000000006 111.371 176.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 54.1 m -136.29 162.11 33.92 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.679 -0.86 . . . . 62.229999999999997 108.679 -174.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 21.8 m-85 -126.72 160.11 31.77 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 108.379 -0.971 . . . . 74.439999999999998 108.379 174.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' VAL . 10.3 t0 -134.69 157.92 45.42 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 103.883 -2.636 . . . . 71.150000000000006 103.883 -178.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -46.83 -54.22 21.17 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 114.443 1.275 . . . . 71.129999999999995 114.443 -169.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.23 -39.19 86.97 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.833 1.689 . . . . 55.240000000000002 112.188 177.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -71.01 -34.74 71.63 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.614 -0.266 . . . . 71.540000000000006 110.476 -177.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 31' ' ' ASP . 27.3 t -69.12 -42.3 81.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.71 -0.478 . . . . 63.020000000000003 109.71 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.9 82.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.273 -0.876 . . . . 61.229999999999997 109.516 178.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.63 -46.02 70.32 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.36 -1.291 . . . . 52.109999999999999 110.467 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 30' ' ' TYR . 26.8 tp -64.26 -50.06 69.43 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.118 0.967 . . . . 63.020000000000003 112.177 -176.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.435 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.6 mt -86.07 -18.24 32.95 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.739 -0.664 . . . . 65.430000000000007 111.614 -175.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.21 63.58 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.704 -0.958 . . . . 71.230000000000004 110.704 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 39' ' ' LEU . 11.7 m -121.91 159.61 50.61 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 108.814 -0.81 . . . . 74.349999999999994 108.814 -176.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.74 157.93 51.23 Favored 'Trans proline' 0 C--O 1.252 1.217 0 C-N-CA 121.425 1.417 . . . . 64.450000000000003 111.846 176.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.11 -33.0 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.765 -0.652 . . . . 74.409999999999997 110.642 178.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.6 t -57.67 -42.65 84.02 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.036 -0.529 . . . . 72.299999999999997 110.615 177.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 88.2 tttt -69.51 -34.34 74.14 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.948 0.404 . . . . 72.409999999999997 110.127 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.92 -45.07 99.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 CA-C-N 115.847 -0.615 . . . . 72.540000000000006 109.432 177.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 51' ' ' ARG . . . -61.91 -37.28 84.04 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.348 -0.842 . . . . 74.239999999999995 110.35 178.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 15.7 mm100 -62.84 -40.1 96.4 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 116.277 -0.42 . . . . 73.230000000000004 111.542 178.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 80.9 mm-40 -59.75 -44.24 93.92 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.577 0.703 . . . . 60.119999999999997 109.459 178.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.7 tp -62.21 -43.95 97.67 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.828 -1.078 . . . . 74.230000000000004 109.886 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.506 ' HE ' ' HA ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -66.1 -21.61 66.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.979 -0.555 . . . . 74.310000000000002 112.379 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 48' ' ' GLN . 43.2 mt-10 -98.91 -7.89 26.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.423 -0.511 . . . . 72.450000000000003 111.798 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.04 27.9 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.482 -0.866 . . . . 61.340000000000003 111.615 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.65 -8.92 14.55 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.815 -0.809 . . . . 75.439999999999998 108.815 177.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.4 tp -155.22 154.15 31.76 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.715 -1.587 . . . . 64.450000000000003 106.715 179.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.2 146.59 33.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.818 -0.808 . . . . 74.329999999999998 108.818 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 66' ' ' ILE . . . -126.09 151.17 47.57 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 107.63 -1.248 . . . . 50.310000000000002 107.63 178.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.523 HG11 ' SD ' ' A' ' 99' ' ' MET . 34.4 m -129.85 166.03 28.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 123.437 0.695 . . . . 53.039999999999999 109.856 -176.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -110.27 121.45 45.32 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.763 -0.828 . . . . 73.140000000000001 108.763 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -117.09 113.8 22.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 109.012 -0.736 . . . . 64.420000000000002 109.012 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 70.96 -53.19 0.68 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.268 1.827 . . . . 64.530000000000001 111.191 -179.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.97 0.44 0.03 OUTLIER Glycine 0 C--N 1.286 -2.208 0 CA-C-N 114.913 -1.039 . . . . 61.009999999999998 113.0 179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.92 149.38 17.02 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.39 -0.91 . . . . 43.520000000000003 111.061 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.6 t -97.6 120.6 47.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.535 -1.283 . . . . 73.129999999999995 107.535 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.39 171.63 15.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 124.509 1.124 . . . . 53.130000000000003 108.312 -175.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.419 HG22 ' CB ' ' A' ' 57' ' ' ALA . 40.6 pt -127.68 144.06 49.77 Favored Pre-proline 0 C--N 1.295 -1.798 0 N-CA-C 108.938 -0.764 . . . . 43.109999999999999 108.938 178.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -67.57 118.31 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.612 1.541 . . . . 72.420000000000002 110.799 176.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.4 tt0 -61.44 -24.88 66.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.365 0.666 . . . . 74.0 111.811 -178.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' HB ' ' CG1' ' A' ' 126' ' ' VAL . 35.0 m -63.67 -9.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.133 0 CA-C-N 115.422 -0.808 . . . . 74.239999999999995 112.631 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.557 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.2 m-85 -78.77 -6.83 56.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.826 0.822 . . . . 71.439999999999998 109.948 175.043 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -117.0 161.29 19.62 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.937 -1.135 . . . . 75.409999999999997 107.937 175.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.458 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 63.1 p -90.54 168.22 11.99 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.501 -1.296 . . . . 71.230000000000004 107.501 176.096 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -66.59 -17.49 64.85 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.656 0.613 . . . . 61.340000000000003 112.656 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.8 m -80.1 -9.09 59.68 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.376 -0.375 . . . . 72.409999999999997 111.311 178.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.68 9.9 62.27 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 120.532 -0.842 . . . . 51.200000000000003 112.509 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -97.34 140.2 32.15 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 106.59 -1.633 . . . . 72.019999999999996 106.59 177.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.59 152.4 7.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.135 -1.061 . . . . 74.310000000000002 108.135 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.52 126.55 22.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.423 -0.584 . . . . 74.200000000000003 109.423 178.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.19 -34.17 77.74 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 113.288 0.847 . . . . 73.129999999999995 113.288 -175.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 t -91.93 8.11 38.98 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.369 0.604 . . . . 32.509999999999998 110.281 -177.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 70' ' ' PHE . 14.5 tp -58.83 -54.01 60.68 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.748 -0.66 . . . . 73.420000000000002 112.048 -177.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.75 -25.24 74.81 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 121.53 1.487 . . . . 73.319999999999993 111.846 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.79 -44.95 78.43 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 116.135 -0.484 . . . . 72.109999999999999 111.905 -178.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.8 pp -67.38 -39.51 85.63 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.116 -0.698 . . . . 62.439999999999998 109.116 179.425 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.06 -40.07 95.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.368 -0.833 . . . . 71.329999999999998 111.068 179.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 97.4 m -62.28 -47.35 84.69 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-N 116.437 -0.347 . . . . 64.519999999999996 111.558 -178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -43.79 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 CA-C-N 116.471 -0.331 . . . . 62.439999999999998 111.344 -177.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' CD2' ' HB1' ' A' ' 141' ' ' ALA . 4.4 mm? -66.91 -35.79 80.8 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.901 -0.5 . . . . 75.409999999999997 112.257 177.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -64.93 -33.14 75.32 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.528 -0.545 . . . . 75.109999999999999 109.528 177.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.25 -31.25 70.6 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.143 0.497 . . . . 63.149999999999999 110.81 176.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.76 -9.3 78.31 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.762 -0.654 . . . . 74.439999999999998 112.036 178.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.73 48.1 6.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 121.386 -0.435 . . . . 51.200000000000003 112.487 178.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 80.0 m-85 -110.8 138.15 47.56 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 120.787 0.327 . . . . 74.25 111.335 179.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.557 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 28.5 ptt180 -86.28 170.9 11.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 75.349999999999994 109.818 177.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -55.05 -41.27 71.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.511 1.524 . . . . 44.219999999999999 111.233 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 m -61.67 -41.26 97.3 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.496 -0.774 . . . . 71.510000000000005 110.608 -179.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 8.8 mm-40 -66.02 -38.06 87.5 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.897 -0.779 . . . . 63.119999999999997 108.897 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 94' ' ' ARG . 24.9 mm -61.12 -48.0 90.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.651 -0.87 . . . . 61.210000000000001 108.651 -177.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.523 ' SD ' HG11 ' A' ' 58' ' ' VAL . 76.0 mtm -71.49 -22.36 61.81 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.249 -0.887 . . . . 71.329999999999998 112.194 -177.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -56.01 -65.31 0.62 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.798 -0.816 . . . . 75.019999999999996 108.798 -179.655 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.577 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 53.2 p-90 -69.78 -33.86 72.98 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.787 0.662 . . . . 71.349999999999994 112.787 179.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 125' ' ' PRO . 19.4 tp -66.76 -39.06 87.75 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.714 0.806 . . . . 72.329999999999998 112.941 -173.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 47.6 m-85 -92.63 7.88 41.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.632 0.605 . . . . 75.409999999999997 112.632 -178.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 88.1 m -86.94 116.51 66.32 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 109.562 -0.533 . . . . 73.230000000000004 109.562 177.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.7 129.22 19.42 Favored 'Trans proline' 0 C--O 1.249 1.075 0 C-N-CA 121.516 1.478 . . . . 62.229999999999997 108.26 172.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 25.7 t70 -115.71 119.75 37.05 Favored Pre-proline 0 C--N 1.295 -1.774 0 C-N-CA 120.637 -0.425 . . . . 75.439999999999998 110.791 -175.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.42 -28.95 87.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.021 2.48 . . . . 63.149999999999999 112.815 -177.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.5 p -90.88 2.05 56.48 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.487 0.551 . . . . 55.299999999999997 112.487 -177.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.9 tp -102.17 125.13 48.78 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 107.869 -1.16 . . . . 74.329999999999998 107.869 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.1 m -118.5 113.35 21.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.07 -1.085 . . . . 64.140000000000001 108.07 -177.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 37.9 mm -131.19 148.73 32.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-N 116.116 -0.493 . . . . 74.209999999999994 109.7 -173.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -112.95 126.71 55.79 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 106.001 -1.852 . . . . 74.420000000000002 106.001 171.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.429 ' HA ' ' HB2' ' A' ' 131' ' ' ALA . 15.9 ttp180 -110.21 167.93 9.82 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.762 -0.654 . . . . 62.539999999999999 109.856 -172.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -57.84 135.66 56.87 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.737 0.815 . . . . 64.120000000000005 110.168 178.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.73 -21.61 42.42 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-N 115.806 -0.634 . . . . 71.140000000000001 111.67 -177.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.8 m -109.39 143.37 39.04 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 108.661 -0.866 . . . . 65.329999999999998 108.661 -178.06 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -96.17 -27.26 15.13 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.358 0.599 . . . . 73.409999999999997 111.728 179.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -105.5 167.8 9.51 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.821 -0.627 . . . . 62.340000000000003 110.842 -176.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -91.59 136.55 33.05 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.044 -0.525 . . . . 62.200000000000003 110.339 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.82 129.42 64.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.502 -0.925 . . . . 71.439999999999998 108.502 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.9 m -82.84 138.84 33.79 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.204 -1.406 . . . . 64.150000000000006 107.204 175.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 42.7 t30 78.3 69.0 0.04 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 124.056 0.942 . . . . 72.530000000000001 110.947 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.54 173.1 6.71 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.213 -1.032 . . . . 65.519999999999996 108.213 172.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -96.19 156.94 36.43 Favored Pre-proline 0 C--N 1.304 -1.376 0 N-CA-C 106.391 -1.707 . . . . 75.400000000000006 106.391 177.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 102' ' ' LEU . 27.7 Cg_exo -61.75 -20.08 67.75 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 121.39 1.394 . . . . 73.549999999999997 110.518 173.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 102' ' ' LEU . 74.3 t -60.67 -43.41 94.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.304 0 N-CA-C 109.131 -0.692 . . . . 71.230000000000004 109.131 173.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -64.47 -39.29 93.52 Favored 'General case' 0 CA--C 1.492 -1.253 0 CA-C-N 115.68 -0.691 . . . . 43.219999999999999 109.43 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.46 66.37 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.468 -0.787 . . . . 44.43 112.002 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 130' ' ' HIS . 4.6 pp -66.81 -35.52 80.25 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.993 0.425 . . . . 51.119999999999997 111.598 -177.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.458 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 13.8 t60 -70.81 -24.85 62.63 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.852 0.834 . . . . 75.120000000000005 108.939 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 113' ' ' ARG . . . -99.05 11.49 38.86 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.16 -0.927 . . . . 73.420000000000002 112.24 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 66.7 27.54 9.32 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 122.348 1.071 . . . . 71.329999999999998 110.889 177.095 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -109.68 25.09 12.19 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.586 -1.264 . . . . 73.219999999999999 107.586 177.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 138' ' ' VAL . . . -52.56 -26.49 13.46 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 126.366 1.866 . . . . 71.409999999999997 113.196 -175.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -54.65 -35.91 63.99 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.657 0.208 . . . . 75.140000000000001 110.559 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.17 -28.08 62.01 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.659 0.742 . . . . 73.219999999999999 110.735 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.3 -44.99 54.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 108.639 -0.875 . . . . 44.32 108.639 177.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 61.3 t -61.1 -44.25 97.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-N 115.541 -0.754 . . . . 54.020000000000003 110.634 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.11 -38.69 89.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 120.457 -0.497 . . . . 73.420000000000002 110.824 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 68.0 mtt180 -69.12 -38.01 78.64 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 120.83 0.348 . . . . 74.450000000000003 110.998 175.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.447 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -59.01 -43.32 91.52 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.743 -0.662 . . . . 62.520000000000003 110.256 178.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 93.8 mt-30 -63.06 -45.47 92.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.851 -0.613 . . . . 73.540000000000006 110.167 177.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.18 -39.91 94.99 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.639 -0.709 . . . . 42.109999999999999 111.112 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.577 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 17.0 tpt -70.34 -32.82 70.7 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.757 -0.656 . . . . 74.239999999999995 111.031 -179.166 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -81.3 -54.51 5.43 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.013 -0.54 . . . . 70.409999999999997 111.538 -178.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 118.567 -0.73 . . . . 75.019999999999996 109.115 -175.842 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 C--O 1.239 0.542 0 N-CA-C 109.179 -0.674 . . . . 75.040000000000006 109.179 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.3 107.73 2.03 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.836 1.69 . . . . 63.43 109.076 174.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.83 103.64 1.86 Allowed Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 108.729 -1.749 . . . . 64.329999999999998 108.729 -172.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -73.09 134.0 44.37 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 120.438 0.161 . . . . 65.409999999999997 110.806 -177.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.06 83.18 0.2 Allowed Pre-proline 0 C--N 1.322 -0.625 0 C-N-CA 124.871 1.268 . . . . 35.039999999999999 111.762 -178.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.3 143.57 28.29 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.685 2.257 . . . . 70.239999999999995 110.083 176.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.41 116.02 3.82 Favored Glycine 0 N--CA 1.411 -2.978 0 C-N-CA 120.325 -0.94 . . . . 71.340000000000003 110.992 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 p -75.14 -24.49 57.99 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.397 1.094 . . . . 74.129999999999995 108.288 176.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 m -159.4 155.44 26.68 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.746 -2.316 . . . . 52.43 104.746 175.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.4 mt -65.2 150.38 48.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 118.399 0.545 . . . . 73.340000000000003 110.397 177.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.23 141.42 37.14 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.903 -0.589 . . . . 53.240000000000002 111.95 -174.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.505 ' HA ' ' CE1' ' A' ' 89' ' ' HIS . 28.6 ptt180 -144.81 112.0 6.0 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.538 0.685 . . . . 53.020000000000003 110.455 176.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.5 t -127.38 121.67 57.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 107.417 -1.327 . . . . 64.019999999999996 107.417 -178.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.77 -32.82 58.71 Favored Glycine 0 C--N 1.317 -0.491 0 C-N-CA 121.04 -0.6 . . . . 73.400000000000006 111.768 -177.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -102.18 89.1 3.49 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.571 -0.529 . . . . 72.049999999999997 109.571 178.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mp -67.99 121.89 81.69 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.841 -0.618 . . . . 64.0 109.436 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.52 155.14 40.5 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.523 2.148 . . . . 73.129999999999995 113.561 -179.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.77 132.98 53.45 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.441 -1.689 . . . . 64.200000000000003 106.441 173.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.94 -106.19 2.77 Favored Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.884 -0.674 . . . . 72.150000000000006 112.408 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.25 121.56 35.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 120.931 0.396 . . . . 75.209999999999994 110.452 -175.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -61.39 119.17 8.0 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.977 -1.01 . . . . 75.329999999999998 110.81 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' HE3' ' A' ' 99' ' ' MET . 93.4 t -77.07 -25.28 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.447 0.641 . . . . 53.43 111.234 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.6 148.44 28.0 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 119.407 -0.917 . . . . 54.009999999999998 111.9 176.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.32 145.19 99.1 Favored Pre-proline 0 C--N 1.302 -1.468 0 CA-C-N 114.988 -1.006 . . . . 60.240000000000002 110.782 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.44 -27.07 30.38 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.347 2.698 . . . . 62.030000000000001 114.058 177.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -74.8 -23.35 58.48 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.734 0.272 . . . . 73.019999999999996 111.734 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -65.09 126.63 91.66 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 108.903 -0.777 . . . . 70.299999999999997 108.903 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -56.64 106.53 0.22 Allowed 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.876 2.384 . . . . 72.230000000000004 111.387 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.5 p -106.67 172.05 7.03 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.833 -0.621 . . . . 73.209999999999994 110.829 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 38' ' ' LEU . 16.6 m-85 -109.63 161.5 15.32 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.581 -0.896 . . . . 73.140000000000001 108.581 177.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -133.14 166.24 22.91 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 103.606 -2.739 . . . . 74.349999999999994 103.606 -173.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.5 mt -52.79 -51.13 76.88 Favored Pre-proline 0 C--N 1.309 -1.188 0 O-C-N 123.881 0.738 . . . . 53.210000000000001 112.004 -179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.528 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 10.9 Cg_endo -57.53 -39.71 86.39 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.794 1.663 . . . . 65.200000000000003 112.352 175.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.501 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 3.9 mpt_? -70.35 -36.2 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.979 0.733 . . . . 73.140000000000001 112.979 -177.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 66' ' ' ILE . 73.4 t -70.81 -37.4 68.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.971 -0.692 . . . . 52.530000000000001 109.764 175.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.01 73.59 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.157 -0.929 . . . . 75.329999999999998 109.055 174.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 33' ' ' PRO . 19.3 mm-40 -65.52 -45.49 83.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.254 -0.884 . . . . 72.109999999999999 112.092 175.25 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 30' ' ' TYR . 89.1 mt -62.73 -50.74 69.89 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.339 -0.391 . . . . 71.349999999999994 111.623 -176.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.505 ' HB2' HG22 ' A' ' 41' ' ' VAL . 90.9 mt -88.01 -15.38 36.57 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.799 -0.637 . . . . 74.099999999999994 112.137 -174.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.47 32.6 67.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.39 -1.084 . . . . 64.209999999999994 110.39 -177.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 39' ' ' LEU . 20.8 m -122.21 164.61 24.79 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 108.671 -0.862 . . . . 61.530000000000001 108.671 -177.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -82.87 167.05 14.72 Favored 'Trans proline' 0 C--O 1.254 1.296 0 C-N-CA 121.44 1.427 . . . . 71.319999999999993 111.638 174.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.5 t -59.02 -33.09 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.579 0.751 . . . . 64.450000000000003 110.644 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 24.6 p -57.58 -43.58 84.67 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.455 -0.793 . . . . 72.540000000000006 111.201 179.454 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.585 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 56.9 mtpt -69.33 -33.61 73.39 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 116.761 -0.199 . . . . 74.5 111.091 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.403 ' O ' HD13 ' A' ' 50' ' ' LEU . 57.5 t -62.5 -43.7 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.626 -0.509 . . . . 52.299999999999997 109.626 177.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.47 78.71 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.885 -0.598 . . . . 62.340000000000003 110.479 177.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 44' ' ' SER . 97.9 mt-30 -65.43 -36.54 84.22 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.958 -0.564 . . . . 62.530000000000001 111.495 178.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm100 -63.28 -43.21 98.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.384 -0.969 . . . . 72.230000000000004 108.384 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 9.3 mp -61.75 -46.64 88.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.515 -1.22 . . . . 75.019999999999996 110.154 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -60.47 -25.72 66.24 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.676 0.991 . . . . 65.129999999999995 113.676 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 54' ' ' HIS . 7.6 pt-20 -102.55 2.77 36.65 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.425 -0.91 . . . . 63.43 111.625 -177.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.32 38.88 71.15 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.507 -0.854 . . . . 54.219999999999999 111.476 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.564 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 3.4 t60 -96.28 -28.9 14.29 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.853 -1.166 . . . . 74.25 107.853 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 55.9 tp -159.73 156.02 26.97 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.418 -2.068 . . . . 63.32 105.418 -178.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.9 p -133.48 152.29 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.123 -0.695 . . . . 72.510000000000005 109.123 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.7 161.82 19.45 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 123.489 0.493 . . . . 73.530000000000001 109.747 -179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.52 HG11 ' SD ' ' A' ' 99' ' ' MET . 22.2 m -126.54 166.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.01 -0.737 . . . . 31.140000000000001 109.01 -177.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -116.58 134.84 54.36 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.56 -0.533 . . . . 72.400000000000006 109.56 -174.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -148.21 125.96 11.87 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.76 -0.83 . . . . 72.540000000000006 108.76 171.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 60.17 22.89 12.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.075 0.95 . . . . 65.239999999999995 112.017 178.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.57 -14.78 64.39 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.847 -0.615 . . . . 72.209999999999994 112.495 -178.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.41 150.0 20.53 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 121.306 -0.473 . . . . 60.149999999999999 112.426 -174.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.7 t -97.75 120.57 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.592 -1.262 . . . . 74.129999999999995 107.592 177.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -135.3 160.8 40.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.604 -0.725 . . . . 73.540000000000006 109.697 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 35' ' ' VAL . 70.7 mt -130.69 129.08 22.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 108.286 -1.005 . . . . 62.43 108.286 -179.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.4 131.63 47.37 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.566 2.177 . . . . 62.329999999999998 111.425 176.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.427 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 5.8 tt0 -65.27 -25.48 67.67 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 120.836 0.351 . . . . 72.299999999999997 111.227 -179.139 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.29 -2.25 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.519 -0.764 . . . . 72.120000000000005 112.636 178.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.657 ' CD2' HD11 ' A' ' 81' ' ' LEU . 5.6 m-85 -86.38 -8.21 57.85 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 122.374 1.083 . . . . 70.329999999999998 109.359 173.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.6 m-85 -115.86 155.63 27.58 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 106.53 -1.656 . . . . 74.510000000000005 106.53 176.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 65.7 p -80.89 173.73 12.32 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.434 -0.951 . . . . 65.109999999999999 108.434 177.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -58.29 -20.57 43.88 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 113.029 0.752 . . . . 75.409999999999997 113.029 -177.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 t -89.04 -2.52 58.61 Favored 'General case' 0 CA--C 1.562 1.42 0 O-C-N 121.9 -0.5 . . . . 74.5 111.488 179.048 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.39 15.21 58.99 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.087 -0.578 . . . . 62.329999999999998 113.509 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -113.08 142.06 46.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.88 -0.785 . . . . 64.230000000000004 108.88 178.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 71' ' ' PHE . 11.8 p -62.01 144.18 14.39 Favored 'Isoleucine or valine' 0 C--O 1.249 1.032 0 O-C-N 123.715 0.635 . . . . 62.240000000000002 110.869 -175.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 35.2 t -65.46 131.82 31.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.979 -0.749 . . . . 44.439999999999998 108.979 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -61.87 -34.04 75.28 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.523 0.935 . . . . 72.510000000000005 113.523 -176.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.0 m -86.2 -6.29 59.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.041 0.448 . . . . 65.099999999999994 111.069 -177.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.657 HD11 ' CD2' ' A' ' 70' ' ' PHE . 10.2 tt -66.3 -49.19 55.27 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 114.134 1.161 . . . . 53.119999999999997 114.134 -175.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -53.88 -33.84 73.42 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 121.961 1.774 . . . . 64.439999999999998 111.413 176.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.48 95.9 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.212 -0.904 . . . . 64.409999999999997 112.725 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.7 pp -67.34 -40.49 85.86 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.57 -0.53 . . . . 65.519999999999996 109.57 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.45 -34.61 77.13 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 116.263 -0.426 . . . . 73.120000000000005 110.662 -179.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.2 m -62.34 -48.08 81.4 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-N 115.821 -0.627 . . . . 62.520000000000003 112.041 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -40.98 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 111.72 0.267 . . . . 65.340000000000003 111.72 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.562 HD21 ' HB1' ' A' ' 141' ' ' ALA . 3.4 mm? -66.67 -35.04 79.21 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.552 -0.459 . . . . 73.109999999999999 111.66 176.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.505 ' CE1' ' HA ' ' A' ' 12' ' ' ARG . 26.4 t-80 -58.7 -43.15 89.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.254 -0.647 . . . . 73.430000000000007 109.254 176.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -65.03 -31.03 72.06 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 124.015 0.822 . . . . 64.049999999999997 110.842 178.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.87 -9.1 81.53 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.986 -0.552 . . . . 71.140000000000001 112.643 -177.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 33.55 28.2 Favored Glycine 0 N--CA 1.44 -1.085 0 C-N-CA 120.871 -0.68 . . . . 74.510000000000005 112.275 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -102.12 125.52 48.84 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.94 0.4 . . . . 73.209999999999994 111.037 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 37.2 ptt180 -75.67 171.79 13.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.663 -0.698 . . . . 73.129999999999995 111.157 178.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -54.2 -40.62 67.77 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.234 1.413 . . . . 74.209999999999994 110.866 -178.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.7 m -61.52 -42.32 98.63 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.858 -1.065 . . . . 73.219999999999999 110.67 -178.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 12.4 mm-40 -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.128 -0.487 . . . . 74.140000000000001 110.228 -179.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.4 mm -60.99 -47.92 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 108.486 -0.931 . . . . 63.210000000000001 108.486 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.52 ' SD ' HG11 ' A' ' 58' ' ' VAL . 70.7 mtm -71.82 -25.04 61.83 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.85 -1.068 . . . . 71.140000000000001 111.415 -178.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -64.18 0.98 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.112 -0.699 . . . . 60.509999999999998 109.112 -176.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 34.5 p-90 -69.44 -32.78 71.95 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 112.947 0.721 . . . . 71.109999999999999 112.947 178.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 125' ' ' PRO . 14.8 mt -61.22 -40.64 94.77 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.905 0.706 . . . . 61.32 112.905 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -93.15 -1.21 56.59 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.427 0.529 . . . . 65.299999999999997 112.427 -177.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.1 m -87.99 127.1 58.88 Favored Pre-proline 0 C--N 1.31 -1.135 0 N-CA-C 109.236 -0.653 . . . . 74.010000000000005 109.236 175.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.434 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 44.0 Cg_exo -61.26 129.19 27.46 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 121.903 1.736 . . . . 64.219999999999999 110.105 174.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 10.6 t70 -85.91 126.31 66.07 Favored Pre-proline 0 C--N 1.311 -1.102 0 N-CA-C 108.812 -0.81 . . . . 61.229999999999997 108.812 -177.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.95 -17.39 51.08 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.296 2.664 . . . . 52.43 114.017 -177.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.3 m -122.49 15.68 10.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.892 -0.505 . . . . 73.239999999999995 111.443 -176.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 53.2 tp -108.47 126.4 52.86 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.738 0.644 . . . . 53.25 112.738 -176.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.4 m -119.72 133.64 55.54 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 105.354 -2.091 . . . . 73.219999999999999 105.354 174.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.82 160.77 15.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.111 -1.036 . . . . 74.109999999999999 113.791 -175.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.404 HG22 ' OE1' ' A' ' 133' ' ' GLN . 11.2 t -92.71 160.09 15.13 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.396 -1.274 . . . . 74.329999999999998 109.604 -177.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' HD3' ' O ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER -54.84 120.5 6.93 Favored 'General case' 0 C--O 1.253 1.259 0 O-C-N 123.529 0.518 . . . . 74.129999999999995 112.352 178.372 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.547 ' HB3' ' HA ' ' A' ' 131' ' ' ALA . 4.9 t70 161.78 120.33 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 127.403 2.281 . . . . 74.349999999999994 104.975 172.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.65 -53.81 4.86 Favored Glycine 0 C--N 1.308 -1.026 0 N-CA-C 108.807 -1.717 . . . . 72.530000000000001 108.807 -173.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.6 m -103.94 123.12 46.58 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 106.102 -1.814 . . . . 65.140000000000001 106.102 171.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -62.04 -24.25 66.95 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.188 0.995 . . . . 72.010000000000005 112.304 -176.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -136.92 178.59 6.96 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 116.199 -0.455 . . . . 73.329999999999998 109.786 -174.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.4 131.23 40.06 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 123.577 0.548 . . . . 74.400000000000006 110.904 -177.092 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.19 122.19 64.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.678 -0.692 . . . . 72.430000000000007 109.394 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.8 p -88.32 150.2 23.35 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.055 -1.091 . . . . 61.520000000000003 108.055 173.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 12.7 m120 61.09 42.28 12.65 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 122.31 1.053 . . . . 73.420000000000002 108.405 -173.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.6 163.92 26.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.098 -1.41 . . . . 60.32 111.752 -176.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -97.11 133.02 24.61 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.769 -1.105 . . . . 72.120000000000005 109.279 -178.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.489 ' HB2' HD23 ' A' ' 102' ' ' LEU . 86.3 Cg_exo -52.16 -31.09 44.03 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.635 2.89 . . . . 74.530000000000001 114.423 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.588 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 67.8 t -60.83 -42.21 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 121.257 0.551 . . . . 73.400000000000006 110.709 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.2 -40.38 82.18 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.096 -0.705 . . . . 74.120000000000005 109.096 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.95 83.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.123 -0.944 . . . . 75.019999999999996 112.091 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.7 pp -68.52 -34.62 76.19 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.58 -0.448 . . . . 74.430000000000007 111.778 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -77.34 -24.13 50.79 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 107.745 -1.206 . . . . 73.099999999999994 107.745 179.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 114' ' ' ASP . . . -85.18 12.45 7.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 114.622 -1.172 . . . . 71.310000000000002 111.583 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.0 m80 66.85 28.17 8.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.061 0.945 . . . . 71.349999999999994 110.927 176.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.404 ' OE1' HG22 ' A' ' 112' ' ' THR . 53.6 mt-30 -112.28 23.22 13.9 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.049 -1.093 . . . . 75.540000000000006 108.049 176.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.52 -31.48 46.42 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 114.262 -1.335 . . . . 63.350000000000001 113.318 -176.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -65.18 -35.12 80.08 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 120.978 -0.289 . . . . 73.340000000000003 111.719 179.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -69.83 -28.56 65.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.679 0.752 . . . . 62.109999999999999 109.688 177.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.0 -45.7 53.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.957 -0.757 . . . . 61.219999999999999 108.957 176.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.449 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 82.7 t -59.87 -41.65 86.55 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.724 0 N-CA-C 109.11 -0.7 . . . . 65.109999999999999 109.11 175.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.797 0.839 . . . . 63.409999999999997 110.945 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -63.11 -37.25 86.48 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.572 -0.529 . . . . 75.239999999999995 109.572 177.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.562 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -65.14 -44.24 89.26 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.428 -0.806 . . . . 45.5 110.833 178.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 92.2 mt-30 -67.46 -36.35 80.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.473 -0.331 . . . . 73.349999999999994 110.198 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.15 -18.84 62.48 Favored 'General case' 0 C--O 1.208 -1.085 0 CA-C-N 116.153 -0.476 . . . . 54.200000000000003 110.662 176.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 44.0 tpp -78.89 -30.85 45.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.389 0.614 . . . . 73.5 109.422 177.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.79 -41.69 13.1 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.861 -0.609 . . . . 53.009999999999998 111.366 178.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.607 -0.711 . . . . 63.299999999999997 110.106 -178.683 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 106.478 -1.675 . . . . 64.120000000000005 106.478 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.35 122.35 11.4 Favored 'Trans proline' 0 C--O 1.246 0.907 0 C-N-CA 122.848 2.365 . . . . 75.129999999999995 112.731 -177.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.41 47.41 1.02 Allowed Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.775 -0.93 . . . . 53.340000000000003 110.775 -178.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.598 ' HD3' ' H ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -62.0 141.37 58.1 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 123.117 0.567 . . . . 74.420000000000002 110.199 177.819 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.15 103.91 46.89 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 110.03 -0.359 . . . . 70.319999999999993 110.03 -178.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.19 126.31 11.63 Favored 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 122.174 1.916 . . . . 73.420000000000002 111.226 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.66 97.26 1.42 Allowed Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 120.872 -0.68 . . . . 64.420000000000002 111.468 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -68.13 -37.2 80.85 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.681 0.753 . . . . 73.439999999999998 109.915 178.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.6 m -133.96 140.84 47.01 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.273 -1.38 . . . . 53.409999999999997 107.273 178.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.2 mt -79.05 154.46 29.42 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.167 0.508 . . . . 63.130000000000003 111.264 -175.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.46 105.1 11.34 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.94 -0.763 . . . . 74.409999999999997 108.94 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.95 91.93 6.67 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.203 -0.665 . . . . 63.329999999999998 109.203 -178.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 m -128.8 117.37 44.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.722 -0.672 . . . . 65.120000000000005 111.423 -179.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -96.8 4.12 63.19 Favored Glycine 0 C--N 1.306 -1.086 0 N-CA-C 109.645 -1.382 . . . . 64.340000000000003 109.645 176.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.525 ' CB ' ' HA ' ' A' ' 51' ' ' ARG . 0.7 OUTLIER -86.02 108.06 18.06 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-N 114.716 -0.742 . . . . 72.120000000000005 112.549 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.04 129.24 56.87 Favored Pre-proline 0 C--N 1.287 -2.125 0 N-CA-C 103.874 -2.639 . . . . 73.450000000000003 103.874 168.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.54 158.26 16.52 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.941 1.76 . . . . 53.420000000000002 110.944 179.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.35 124.18 29.76 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 120.092 -0.643 . . . . 74.420000000000002 109.765 -176.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.72 -110.19 2.48 Favored Glycine 0 N--CA 1.427 -1.92 0 CA-C-N 115.961 -0.563 . . . . 64.120000000000005 113.552 -176.363 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -129.16 123.92 33.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.678 0.275 . . . . 72.230000000000004 110.422 -172.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.491 ' OD2' ' HD3' ' A' ' 60' ' ' ARG . 17.5 t0 -61.84 130.99 48.33 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.777 1.029 . . . . 71.299999999999997 113.777 -175.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.87 -23.5 4.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.422 -0.808 . . . . 60.399999999999999 112.352 -175.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD23 ' CE2' ' A' ' 103' ' ' PHE . 0.7 OUTLIER -89.51 -172.43 3.59 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 119.075 -1.05 . . . . 64.519999999999996 112.173 -178.086 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -90.2 137.01 28.03 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 109.304 -0.628 . . . . 74.310000000000002 109.304 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.54 -21.92 70.3 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.54 2.16 . . . . 64.530000000000001 111.939 177.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -68.61 -25.15 64.71 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 115.89 -0.595 . . . . 70.099999999999994 111.464 179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 29' ' ' THR . 5.6 mm-40 -73.76 117.39 60.58 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 107.857 -1.164 . . . . 74.010000000000005 107.857 177.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 37.0 Cg_exo -60.88 99.91 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.831 2.354 . . . . 62.420000000000002 112.041 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 66' ' ' ILE . 42.0 p -98.86 -162.11 0.93 Allowed 'General case' 0 N--CA 1.408 -2.533 0 CA-C-N 115.019 -0.992 . . . . 53.539999999999999 109.131 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -109.27 159.33 17.04 Favored 'General case' 0 N--CA 1.391 -3.392 0 N-CA-C 107.723 -1.214 . . . . 64.409999999999997 107.723 174.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 35' ' ' VAL . 5.2 m-20 -135.11 161.24 35.89 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 103.583 -2.747 . . . . 73.340000000000003 103.583 -176.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.6 tp -48.66 -54.83 23.38 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 113.742 1.015 . . . . 63.229999999999997 113.742 -173.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.2 -34.1 46.75 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 121.47 1.447 . . . . 54.140000000000001 111.889 177.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 22.7 tpt180 -67.02 -34.98 78.9 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.418 -0.355 . . . . 64.140000000000001 110.965 -179.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 31' ' ' ASP . 56.7 t -69.33 -40.8 80.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.16 -0.681 . . . . 73.400000000000006 109.16 178.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.3 -35.81 78.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.196 -0.911 . . . . 61.409999999999997 109.5 176.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -69.0 -45.32 70.85 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.284 -0.871 . . . . 74.209999999999994 110.868 178.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.28 -45.06 81.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.978 -0.555 . . . . 63.509999999999998 111.532 -177.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.9 mt -81.8 -12.34 58.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.299 -0.41 . . . . 52.149999999999999 111.86 -177.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.67 30.67 74.92 Favored Glycine 0 CA--C 1.505 -0.541 0 CA-C-N 115.914 -0.585 . . . . 75.319999999999993 111.965 179.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.28 155.6 80.69 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 109.84 -0.43 . . . . 71.219999999999999 109.84 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.17 166.81 19.9 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.109 1.873 . . . . 73.099999999999994 112.001 177.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.4 t -56.3 -37.43 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.806 0.843 . . . . 70.340000000000003 110.909 -177.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.7 m -57.73 -41.53 82.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 115.365 -0.834 . . . . 72.340000000000003 111.479 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.658 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 45.4 mtpt -70.06 -36.83 75.26 Favored 'General case' 0 C--O 1.2 -1.545 0 C-N-CA 119.268 -0.973 . . . . 75.129999999999995 111.266 178.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.5 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.482 -0.562 . . . . 75.010000000000005 109.482 177.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -58.9 -43.37 91.02 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.693 -0.685 . . . . 74.409999999999997 110.247 177.086 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 3.5 pt20 -70.53 -34.2 72.01 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 116.522 -0.308 . . . . 75.030000000000001 111.499 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.658 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.2 mm100 -57.53 -46.59 83.66 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.3 -1.0 . . . . 61.549999999999997 108.3 177.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.8 mt -62.1 -43.52 98.65 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.378 -1.283 . . . . 74.129999999999995 109.762 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.525 ' HA ' ' CB ' ' A' ' 15' ' ' SER . 19.7 mtp180 -63.44 -26.17 68.61 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 112.71 0.633 . . . . 63.039999999999999 112.71 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.13 7.21 45.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.941 0.401 . . . . 73.329999999999998 111.51 -178.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.78 36.15 81.65 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.774 -0.648 . . . . 54.350000000000001 113.602 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -85.19 -31.51 23.17 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.783 -0.367 . . . . 73.349999999999994 111.0 178.695 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -161.61 171.26 18.3 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.642 -0.874 . . . . 70.010000000000005 108.642 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.22 161.6 38.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.536 -0.542 . . . . 71.239999999999995 109.536 179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.89 161.69 33.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.578 -0.897 . . . . 64.409999999999997 108.578 -177.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 m -131.77 166.18 29.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 123.511 0.507 . . . . 62.439999999999998 110.021 179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 17.7 mtp180 -122.75 142.66 50.47 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.054 0.454 . . . . 75.409999999999997 111.846 -178.628 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.491 ' HD3' ' OD2' ' A' ' 21' ' ' ASP . 13.5 ptt180 -149.27 127.21 11.88 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.774 -1.195 . . . . 64.439999999999998 107.774 175.474 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.83 17.88 11.21 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.549 1.14 . . . . 51.409999999999997 110.566 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.52 80.79 Favored Glycine 0 C--O 1.22 -0.719 0 CA-C-N 115.509 -0.769 . . . . 74.329999999999998 112.023 -177.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -88.4 142.52 17.36 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 111.688 -0.565 . . . . 71.439999999999998 111.688 -179.222 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.19 119.7 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 107.476 -1.305 . . . . 73.329999999999998 107.476 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 m -133.67 157.74 42.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.45 -0.795 . . . . 72.109999999999999 110.29 -175.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.438 ' O ' ' HB ' ' A' ' 29' ' ' THR . 55.0 mt -128.41 125.18 23.17 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.037 -1.097 . . . . 75.150000000000006 108.037 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 29' ' ' THR . 72.6 Cg_exo -53.45 133.95 55.44 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.782 2.322 . . . . 33.229999999999997 112.59 177.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 7.3 tp-100 -48.97 -42.2 36.75 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.681 1.192 . . . . 64.129999999999995 111.477 -177.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.409 ' CG2' HG11 ' A' ' 126' ' ' VAL . 16.0 m -69.22 -7.18 7.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 115.351 1.611 . . . . 44.329999999999998 115.351 -174.377 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -78.75 -14.53 59.23 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 122.243 1.02 . . . . 62.210000000000001 109.587 174.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.99 156.75 19.37 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.315 -1.365 . . . . 73.030000000000001 107.315 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.503 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 66.3 p -86.14 172.54 10.48 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 109.91 -0.404 . . . . 75.219999999999999 109.91 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -68.81 -17.26 63.99 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.335 0.588 . . . . 55.020000000000003 110.241 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.3 m -88.71 2.98 52.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 116.234 -0.439 . . . . 52.32 111.072 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 20.1 68.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.98 -0.629 . . . . 71.329999999999998 113.294 176.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -111.21 166.26 11.24 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.313 -1.365 . . . . 65.200000000000003 107.313 178.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.73 3.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.394 -1.322 . . . . 64.340000000000003 107.524 178.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 47.0 t -64.77 137.69 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-O 120.892 0.377 . . . . 71.549999999999997 110.679 -178.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 58.2 tttp -64.71 -40.44 95.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.219 0.533 . . . . 75.140000000000001 112.208 -179.121 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -84.44 -0.35 52.5 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.318 0.58 . . . . 63.310000000000002 110.615 -175.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 60.1 tp -65.53 -54.35 31.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 113.005 0.742 . . . . 64.329999999999998 113.005 -178.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 51.9 Cg_exo -58.09 -33.26 97.15 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 121.475 1.45 . . . . 73.030000000000001 111.158 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.81 -44.99 87.88 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.669 -0.696 . . . . 72.299999999999997 112.293 -179.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.3 pp -65.66 -40.01 91.99 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.343 0.592 . . . . 75.099999999999994 109.878 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.57 -34.46 77.85 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.903 -0.589 . . . . 70.319999999999993 110.762 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.5 m -70.49 -42.06 71.86 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 116.126 -0.488 . . . . 63.100000000000001 111.873 -178.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -42.06 85.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.786 0.327 . . . . 65.450000000000003 110.732 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.515 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.3 mm? -66.26 -35.1 79.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 122.255 -0.278 . . . . 75.409999999999997 111.378 176.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -59.64 -35.85 75.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.039 -0.528 . . . . 75.310000000000002 110.159 176.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -69.44 -30.77 68.77 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.319 0.581 . . . . 65.400000000000006 110.683 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.94 -9.14 83.1 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.633 -0.712 . . . . 71.299999999999997 111.441 178.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.17 47.36 11.15 Favored Glycine 0 N--CA 1.437 -1.256 0 CA-C-N 115.592 -0.304 . . . . 73.230000000000004 113.154 177.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.16 129.51 55.49 Favored 'General case' 0 C--N 1.31 -1.15 0 O-C-N 122.673 -0.31 . . . . 74.400000000000006 111.049 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.61 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 36.1 ptt180 -74.9 170.78 15.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.709 -0.678 . . . . 72.230000000000004 110.676 -179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -54.41 -44.85 72.73 Favored 'General case' 0 C--O 1.25 1.122 0 C-N-CA 126.552 1.941 . . . . 74.439999999999998 111.547 -175.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.1 m -63.93 -41.91 97.5 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.869 -1.06 . . . . 62.420000000000002 110.375 -177.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.61 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 16.4 mm-40 -67.52 -34.04 76.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.071 -0.513 . . . . 72.219999999999999 111.148 -178.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 15.6 mm -61.54 -49.45 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 108.578 -0.897 . . . . 75.219999999999999 108.578 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.55 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 21.4 ptp -75.68 -14.85 60.36 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.077 -0.965 . . . . 50.130000000000003 113.055 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.49 -62.18 2.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.636 0.374 . . . . 74.120000000000005 110.411 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.471 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 42.0 p-90 -69.19 -31.84 70.72 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.603 0.594 . . . . 72.019999999999996 112.603 176.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 99' ' ' MET . 12.2 mt -62.34 -40.26 95.81 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.931 1.086 . . . . 72.299999999999997 113.931 -179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.468 ' CE2' HD23 ' A' ' 23' ' ' LEU . 33.5 m-85 -85.32 -16.65 39.31 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.538 0.94 . . . . 74.420000000000002 113.538 -177.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.8 p -84.36 124.09 74.15 Favored Pre-proline 0 N--CA 1.42 -1.935 0 N-CA-C 109.338 -0.615 . . . . 34.25 109.338 175.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -52.68 134.91 55.25 Favored 'Trans proline' 0 C--O 1.249 1.055 0 C-N-CA 122.743 2.295 . . . . 53.450000000000003 111.766 178.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 20.0 t70 -93.35 121.33 65.41 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 115.868 -0.605 . . . . 73.0 110.255 -177.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -60.71 -23.62 76.66 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.211 2.608 . . . . 71.239999999999995 113.708 -177.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.9 m -98.48 0.79 45.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 120.958 0.408 . . . . 55.439999999999998 110.757 -176.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 42.3 tp -101.89 124.86 48.24 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-O 121.675 0.75 . . . . 53.340000000000003 110.744 -177.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.9 m -132.45 116.5 16.87 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 106.685 -1.598 . . . . 74.310000000000002 106.685 175.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.2 pt -139.15 163.22 26.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.16 0.505 . . . . 72.150000000000006 112.201 -175.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.7 t -97.77 130.4 44.72 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.488 -1.301 . . . . 61.439999999999998 107.488 171.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.512 ' HG3' ' OD1' ' A' ' 127' ' ' ASP . 32.7 ttt180 -95.05 154.17 17.3 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.21 -0.663 . . . . 75.420000000000002 109.21 -175.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.43 104.55 2.33 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 109.345 -0.613 . . . . 63.43 109.345 178.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.95 1.2 24.04 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-N 115.296 -0.866 . . . . 71.420000000000002 110.955 -176.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.444 ' HB3' ' OD1' ' A' ' 118' ' ' ASP . 54.9 m -140.55 103.64 4.58 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 123.039 0.536 . . . . 52.409999999999997 109.634 178.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -72.27 -17.92 61.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.03 -0.532 . . . . 70.299999999999997 111.04 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 116' ' ' SER . 9.6 p-10 -74.51 150.13 39.95 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.143 -0.935 . . . . 74.010000000000005 109.725 178.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.48 124.07 32.4 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.088 -0.708 . . . . 74.400000000000006 109.088 -178.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.5 t -98.48 118.07 44.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.565 -0.902 . . . . 73.239999999999995 108.565 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -90.84 137.45 32.35 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.687 -0.688 . . . . 70.450000000000003 109.399 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 57.8 t30 65.63 62.98 0.63 Allowed 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.13 0.894 . . . . 60.439999999999998 109.43 178.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.47 162.14 13.98 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.975 -1.011 . . . . 53.200000000000003 109.918 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.6 127.97 76.35 Favored Pre-proline 0 C--O 1.243 0.743 0 C-N-CA 119.944 -0.702 . . . . 74.549999999999997 110.545 179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.538 ' HB2' HD23 ' A' ' 102' ' ' LEU . 76.6 Cg_exo -52.59 -21.7 15.06 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.025 3.15 . . . . 73.219999999999999 114.989 -178.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 21.6 t -63.75 -39.83 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 120.183 -0.607 . . . . 73.109999999999999 110.371 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.512 ' OD1' ' HG3' ' A' ' 113' ' ' ARG . 14.2 t70 -69.86 -33.77 72.71 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.446 -0.946 . . . . 63.409999999999997 108.446 -178.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.65 68.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.91 -1.041 . . . . 55.329999999999998 111.122 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.3 pp -64.44 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.981 0.419 . . . . 71.349999999999994 110.771 -179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.503 ' CE1' ' HA ' ' A' ' 72' ' ' THR . 7.4 t60 -67.62 -36.49 80.9 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.584 -0.895 . . . . 75.219999999999999 108.584 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.16 9.45 28.34 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.092 -0.958 . . . . 45.399999999999999 112.006 -178.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 67.5 27.77 7.84 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-O 122.882 1.325 . . . . 73.400000000000006 111.395 178.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -96.94 23.61 7.02 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.178 -1.786 . . . . 70.239999999999995 106.178 173.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.78 -26.76 15.26 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 127.172 2.189 . . . . 72.349999999999994 114.643 -173.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.572 ' HD2' ' H ' ' A' ' 135' ' ' ARG . 3.4 mpt_? -55.74 -47.58 76.7 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.057 0.223 . . . . 74.420000000000002 111.254 -174.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.469 ' OE2' ' HD3' ' A' ' 139' ' ' ARG . 9.8 mm-40 -66.64 -32.39 73.68 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.187 0.439 . . . . 73.340000000000003 112.187 176.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.2 t -69.09 -49.29 63.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.353 -0.385 . . . . 62.420000000000002 110.158 -177.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.73 -42.45 96.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.909 -0.587 . . . . 75.409999999999997 109.597 179.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.469 ' HD3' ' OE2' ' A' ' 136' ' ' GLU . 57.8 ttt180 -59.12 -46.92 87.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.854 -0.612 . . . . 74.549999999999997 111.05 178.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.63 -38.31 90.58 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.898 -0.779 . . . . 52.109999999999999 108.898 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.515 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -64.15 -46.64 83.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.694 -0.684 . . . . 32.119999999999997 110.413 178.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -62.32 -36.59 82.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.847 0.356 . . . . 63.32 111.283 178.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.99 83.91 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.196 0.522 . . . . 72.310000000000002 110.58 178.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.1 tpt -69.8 -45.11 68.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.48 -0.782 . . . . 51.0 111.408 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.34 -31.06 62.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 113.017 0.747 . . . . 63.530000000000001 113.017 -176.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 C--N 1.312 -1.047 0 C-N-CA 120.621 -0.432 . . . . 71.299999999999997 110.539 -178.517 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 107.886 -1.154 . . . . 75.450000000000003 107.886 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.93 121.13 9.22 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.411 2.074 . . . . 74.25 112.618 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.79 102.75 1.53 Allowed Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 110.39 -1.084 . . . . 62.450000000000003 110.39 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.0 ttm105 -72.98 132.63 43.67 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.823 -0.436 . . . . 52.329999999999998 109.823 -179.095 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . . . -88.87 152.78 49.09 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 116.077 -0.511 . . . . 24.34 111.085 -174.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 5' ' ' ALA . 5.2 Cg_endo -87.45 85.22 0.79 Allowed 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 122.626 2.218 . . . . 71.140000000000001 111.601 176.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.98 93.73 1.78 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.257 -1.137 . . . . 75.230000000000004 110.257 177.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.3 t -123.98 166.55 15.52 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.925 -0.768 . . . . 72.420000000000002 108.925 -178.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -73.46 136.85 44.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 122.984 0.514 . . . . 62.509999999999998 110.143 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -84.8 -175.6 5.85 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.717 -0.475 . . . . 72.230000000000004 109.717 177.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.9 123.03 18.35 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.882 -0.414 . . . . 62.509999999999998 109.882 178.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -77.68 115.33 17.35 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 115.878 -0.601 . . . . 70.519999999999996 111.246 -175.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.8 m -112.81 96.68 4.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 122.047 0.927 . . . . 71.299999999999997 110.091 174.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.61 -50.85 4.54 Favored Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 109.643 -1.383 . . . . 70.450000000000003 109.643 177.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 t 174.24 163.89 0.2 Allowed 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.138 -1.43 . . . . 73.450000000000003 107.138 174.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.24 120.87 43.16 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 106.337 -1.727 . . . . 74.329999999999998 106.337 176.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -73.1 144.36 37.57 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.118 1.878 . . . . 73.049999999999997 110.746 178.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.88 128.14 34.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.836 -0.431 . . . . 64.129999999999995 109.836 -178.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -114.98 -112.13 2.89 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.907 -0.663 . . . . 63.420000000000002 112.878 -178.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -95.1 128.05 41.63 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.702 0.286 . . . . 73.310000000000002 110.797 -174.335 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -70.2 138.73 52.0 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.311 -0.858 . . . . 73.140000000000001 111.441 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -98.16 -11.35 8.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 115.232 -0.895 . . . . 70.200000000000003 109.811 -176.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.96 -169.82 2.67 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.799 0.809 . . . . 70.150000000000006 109.539 176.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.434 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 29.2 t70 -105.75 138.29 19.58 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 105.837 -1.912 . . . . 71.409999999999997 105.837 169.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.68 -26.04 16.35 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.978 2.452 . . . . 72.430000000000007 115.042 -176.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.74 -3.8 58.94 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.206 0.447 . . . . 74.120000000000005 112.206 -177.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 24' ' ' ASP . 26.6 mm-40 -74.61 145.57 82.22 Favored Pre-proline 0 C--O 1.25 1.126 0 O-C-N 121.552 -0.717 . . . . 64.510000000000005 110.941 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.49 ' HB2' ' HG3' ' A' ' 68' ' ' GLN . 12.2 Cg_endo -54.65 123.72 14.39 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 123.214 2.61 . . . . 74.140000000000001 111.524 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.7 p -140.47 168.93 18.64 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.568 -0.742 . . . . 53.399999999999999 111.812 -174.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.479 ' CE2' ' HA ' ' A' ' 68' ' ' GLN . 36.4 m-85 -109.77 160.38 16.38 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 125.377 1.471 . . . . 75.340000000000003 109.325 176.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -135.73 161.13 36.42 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.229 -2.878 . . . . 41.549999999999997 103.229 178.051 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.25 -52.25 70.52 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 113.804 1.039 . . . . 72.25 113.804 -173.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.08 -36.06 96.93 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 121.826 1.684 . . . . 73.430000000000007 112.66 176.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.85 -37.86 85.27 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.883 -0.414 . . . . 74.439999999999998 109.883 177.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.75 -40.97 79.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.18 -0.464 . . . . 72.209999999999994 110.354 176.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.43 -43.36 83.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.29 -0.868 . . . . 60.32 109.076 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.09 -45.29 92.78 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.361 -1.291 . . . . 74.129999999999995 110.254 178.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.6 -40.75 96.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.965 -1.016 . . . . 74.439999999999998 111.49 -176.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.4 mt -93.76 -18.31 22.21 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.408 -0.36 . . . . 55.530000000000001 111.437 -177.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.37 62.08 Favored Glycine 0 C--N 1.315 -0.608 0 N-CA-C 111.395 -0.682 . . . . 54.409999999999997 111.395 -178.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.4 m -113.38 161.89 24.94 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 108.941 -0.763 . . . . 64.519999999999996 108.941 -177.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -68.54 155.81 67.73 Favored 'Trans proline' 0 C--O 1.251 1.154 0 C-N-CA 121.703 1.602 . . . . 75.540000000000006 111.963 174.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.72 -35.46 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 123.375 0.67 . . . . 71.049999999999997 109.686 179.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 23.3 t -59.58 -38.52 81.4 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.518 -0.765 . . . . 73.030000000000001 110.33 178.243 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 52.4 mttp -69.15 -32.78 72.36 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.932 -0.48 . . . . 75.040000000000006 111.94 177.106 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.8 t -62.53 -42.8 97.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.814 -0.81 . . . . 65.129999999999995 108.814 174.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.77 83.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.727 -0.67 . . . . 74.329999999999998 110.278 176.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 44' ' ' SER . 16.3 mm100 -66.89 -36.05 81.41 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 115.992 -0.549 . . . . 73.349999999999994 110.978 177.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 76.6 mt-30 -61.55 -43.29 99.13 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.456 0.646 . . . . 73.030000000000001 109.697 176.155 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.8 -34.69 76.36 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.448 -1.251 . . . . 61.450000000000003 110.473 176.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -71.66 -32.89 68.37 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.541 -0.754 . . . . 73.549999999999997 112.748 175.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -92.04 -11.75 35.03 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.13 0.49 . . . . 72.299999999999997 112.225 -176.027 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.27 35.99 28.45 Favored Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.929 -1.129 . . . . 75.349999999999994 110.716 -177.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -92.82 -27.42 17.17 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.113 -1.069 . . . . 63.520000000000003 108.113 176.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 46.6 tp -147.92 152.57 37.78 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.847 -1.538 . . . . 42.219999999999999 106.847 -175.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.07 154.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 108.766 -0.827 . . . . 60.340000000000003 108.766 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.6 162.02 33.89 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 123.306 0.379 . . . . 75.329999999999998 110.264 -174.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.1 m -132.03 166.67 28.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 123.883 0.873 . . . . 62.25 109.471 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 83.3 mtm180 -110.95 131.29 55.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.886 0.699 . . . . 75.439999999999998 112.886 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 33.0 ptt180 -116.12 116.07 27.18 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 106.901 -1.518 . . . . 74.129999999999995 106.901 176.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.66 14.16 6.94 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.667 0.746 . . . . 62.32 111.019 -177.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 106.09 -20.89 34.78 Favored Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 115.821 -0.627 . . . . 70.430000000000007 112.697 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -78.57 145.7 29.29 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 110.585 -1.006 . . . . 60.219999999999999 110.585 -179.037 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.2 t -95.97 120.23 45.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.962 -0.755 . . . . 43.109999999999999 108.962 -175.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.23 163.82 34.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.643 -0.708 . . . . 73.219999999999999 111.51 -177.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 69.7 mt -128.97 125.2 22.79 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.967 -1.123 . . . . 70.349999999999994 107.967 -179.105 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.1 139.24 85.04 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.575 2.183 . . . . 73.239999999999995 113.235 178.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HG3' ' HB2' ' A' ' 28' ' ' PRO . 73.8 mm-40 -48.72 -34.88 12.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.271 1.028 . . . . 71.439999999999998 112.485 177.011 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -71.13 -3.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 113.883 1.068 . . . . 42.020000000000003 113.883 -174.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 81' ' ' LEU . 8.0 m-85 -86.68 -5.84 59.01 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 122.066 0.936 . . . . 75.120000000000005 110.141 175.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -134.42 164.5 27.29 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.799 -1.091 . . . . 62.109999999999999 108.104 178.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.6 p -94.6 158.46 15.52 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 107.204 -1.406 . . . . 63.409999999999997 107.204 176.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -69.78 -15.79 63.19 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.208 0.528 . . . . 74.310000000000002 110.647 176.339 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.7 m -79.05 -5.56 54.27 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.563 -0.744 . . . . 71.25 111.71 -178.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.24 -7.41 40.41 Favored Glycine 0 CA--C 1.508 -0.344 0 C-N-CA 119.641 -1.266 . . . . 71.349999999999994 114.312 174.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -106.05 162.86 13.24 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.681 -0.808 . . . . 71.329999999999998 110.238 179.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.79 156.19 5.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 106.86 -1.533 . . . . 73.230000000000004 106.86 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.92 125.07 22.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 108.427 -0.953 . . . . 65.329999999999998 108.427 177.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.95 -22.21 65.44 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.93 1.085 . . . . 74.25 113.93 -173.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 t -103.41 11.81 36.06 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.887 0.375 . . . . 73.140000000000001 110.203 -179.063 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 70' ' ' PHE . 12.9 tp -63.41 -51.47 67.55 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-O 119.305 -0.378 . . . . 65.120000000000005 111.762 -178.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 31.4 Cg_exo -61.68 -29.59 83.98 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 121.363 1.376 . . . . 64.049999999999997 111.78 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.49 -45.04 97.01 Favored Glycine 0 C--O 1.24 0.489 0 O-C-N 123.377 0.423 . . . . 72.5 113.082 -178.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.5 pp -68.4 -40.36 81.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.316 0.579 . . . . 71.340000000000003 109.463 179.271 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 96.4 mt -64.02 -42.47 97.11 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.504 -0.771 . . . . 72.219999999999999 111.233 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.0 m -57.54 -46.87 83.36 Favored 'General case' 0 C--O 1.249 1.054 0 N-CA-C 112.044 0.387 . . . . 73.329999999999998 112.044 -177.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -41.96 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.013 0.435 . . . . 73.109999999999999 110.83 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.684 HD11 ' HZ2' ' A' ' 101' ' ' TRP . 55.8 mt -67.08 -35.86 80.73 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.359 0.503 . . . . 72.019999999999996 112.359 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.422 ' CE1' ' HB3' ' A' ' 85' ' ' LEU . 58.3 m170 -65.23 -33.2 75.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 116.553 -0.294 . . . . 53.100000000000001 110.73 177.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.59 -31.64 72.86 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.357 0.411 . . . . 74.349999999999994 110.332 178.248 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -92.04 -3.2 68.09 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.768 -0.651 . . . . 70.420000000000002 112.281 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.49 42.69 55.22 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 121.502 -0.38 . . . . 74.209999999999994 112.903 179.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 145' ' ' ALA . 56.0 m-85 -93.26 130.61 38.92 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 122.453 -0.439 . . . . 72.109999999999999 111.962 178.528 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 18.7 ptp180 -81.1 171.77 14.52 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.09 -0.959 . . . . 62.409999999999997 111.459 -176.841 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -54.33 -45.96 72.79 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.725 1.61 . . . . 73.230000000000004 112.551 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.4 m -61.65 -40.99 96.88 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.291 -0.413 . . . . 73.25 110.414 178.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 17.9 mm-40 -65.94 -39.39 90.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.446 -0.343 . . . . 73.420000000000002 111.587 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 88' ' ' LEU . 24.4 mm -61.1 -49.48 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.749 -0.834 . . . . 60.439999999999998 108.749 -177.104 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.5 mtt -76.1 -18.53 59.14 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.738 -1.119 . . . . 75.230000000000004 112.336 -177.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -56.81 -67.26 0.33 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 123.378 0.671 . . . . 65.019999999999996 110.935 -175.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.684 ' HZ2' HD11 ' A' ' 88' ' ' LEU . 52.7 p-90 -68.9 -32.75 72.61 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.363 0.505 . . . . 75.239999999999995 112.363 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.56 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 9.4 mt -60.35 -40.13 89.59 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.201 0.815 . . . . 74.209999999999994 113.201 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.19 -0.5 55.14 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.083 0.771 . . . . 74.450000000000003 113.083 -178.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.2 m -87.51 120.32 71.08 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.367 -0.605 . . . . 71.120000000000005 109.367 178.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.28 129.75 21.06 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.227 1.951 . . . . 74.400000000000006 110.751 177.316 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.6 t70 -102.5 124.16 40.29 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 120.264 -0.575 . . . . 62.210000000000001 109.519 -179.078 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.35 -23.92 76.01 Favored 'Trans proline' 0 N--CA 1.476 0.479 0 C-N-CA 123.603 2.869 . . . . 71.400000000000006 113.556 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -104.44 10.27 35.32 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.429 0.633 . . . . 62.240000000000002 110.966 -177.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 50.1 tp -103.84 123.16 46.6 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.585 -0.894 . . . . 72.219999999999999 108.585 174.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 49.0 m -131.2 111.34 11.84 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.665 -1.235 . . . . 63.399999999999999 107.665 179.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.2 pt -127.15 145.8 34.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.792 0.664 . . . . 72.400000000000006 112.792 -172.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 10.0 t -89.42 152.63 21.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.688 -1.227 . . . . 71.099999999999994 107.688 177.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -141.58 136.12 30.74 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.367 -0.975 . . . . 72.450000000000003 108.367 -173.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.19 129.46 31.39 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.373 0.669 . . . . 73.299999999999997 112.391 -177.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 124.41 -23.33 6.43 Favored Glycine 0 C--N 1.307 -1.035 0 N-CA-C 110.0 -1.24 . . . . 74.450000000000003 110.0 -177.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 m -152.55 150.4 29.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.275 -1.38 . . . . 54.310000000000002 107.275 178.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -9.07 53.39 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.381 -0.927 . . . . 75.120000000000005 111.318 179.181 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.04 151.09 38.74 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.858 -1.064 . . . . 74.310000000000002 110.936 -179.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 112' ' ' THR . . . -102.45 146.63 27.82 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.561 -0.745 . . . . 30.120000000000001 111.267 -178.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 61.5 t -102.92 121.3 53.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.799 -1.186 . . . . 64.319999999999993 107.799 177.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.7 t -90.58 148.26 22.8 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 107.957 -1.127 . . . . 52.439999999999998 107.957 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 7.9 t30 65.26 63.58 0.65 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.439 1.114 . . . . 71.239999999999995 108.923 -178.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -123.71 164.71 18.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.686 -1.143 . . . . 72.310000000000002 109.728 -178.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 36.7 ptt180 -87.34 142.94 33.69 Favored Pre-proline 0 C--N 1.299 -1.62 0 CA-C-N 115.863 -0.608 . . . . 61.409999999999997 109.756 179.005 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HB2' HD23 ' A' ' 102' ' ' LEU . 48.7 Cg_exo -57.16 -18.34 29.09 Favored 'Trans proline' 0 CA--C 1.552 1.389 0 C-N-CA 123.264 2.642 . . . . 54.530000000000001 114.336 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.529 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 97.8 t -60.62 -41.96 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-O 121.237 0.542 . . . . 64.430000000000007 110.351 178.087 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.36 -32.54 73.34 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.88 -0.6 . . . . 70.420000000000002 111.224 -179.18 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.04 -36.1 74.79 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.38 -0.827 . . . . 55.130000000000003 110.176 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 126' ' ' VAL . 17.0 tp -60.1 -43.65 95.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 123.478 0.711 . . . . 74.209999999999994 112.246 -177.067 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -71.84 -15.67 62.14 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.55 0.691 . . . . 75.530000000000001 110.697 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -101.58 13.38 35.14 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.289 -0.869 . . . . 44.229999999999997 111.373 -175.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 65.93 27.32 10.86 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 123.122 1.439 . . . . 63.439999999999998 110.225 179.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -106.29 23.49 14.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.079 -1.452 . . . . 64.409999999999997 107.079 176.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.05 -26.84 17.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.317 -2.22 . . . . 74.040000000000006 111.868 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -56.18 -39.19 72.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.288 -0.415 . . . . 71.010000000000005 111.405 178.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.4 mm-40 -69.27 -33.68 73.6 Favored 'General case' 0 C--O 1.209 -1.04 0 C-N-CA 120.77 -0.372 . . . . 72.310000000000002 110.887 175.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.457 HG21 ' HB2' ' A' ' 129' ' ' LEU . 60.0 t -62.19 -43.65 98.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 108.872 -0.788 . . . . 72.450000000000003 108.872 177.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.54 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 66.1 t -61.58 -49.11 85.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 CA-C-N 115.673 -0.694 . . . . 75.140000000000001 109.41 176.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.416 ' HA ' ' OE1' ' A' ' 142' ' ' GLN . 0.7 OUTLIER -57.86 -41.8 83.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.076 -0.511 . . . . 71.140000000000001 111.452 179.886 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 16.6 mmt180 -68.42 -37.78 80.63 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.978 -0.378 . . . . 75.549999999999997 109.978 178.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.4 -43.86 96.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.163 -0.471 . . . . 71.219999999999999 110.228 177.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 91.3 mt-30 -58.52 -49.16 78.39 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.469 0.708 . . . . 65.310000000000002 110.016 178.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.12 71.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.568 -0.742 . . . . 74.319999999999993 111.774 -178.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 96.6 mmm -84.6 -36.8 21.8 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.568 -0.453 . . . . 64.150000000000006 111.208 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.583 ' HA ' ' CE1' ' A' ' 93' ' ' TYR . . . -77.44 -42.82 34.61 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 113.291 0.848 . . . . 53.539999999999999 113.291 -176.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 119.164 -0.446 . . . . 65.129999999999995 110.507 -175.86 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.27 0 N-CA-C 108.007 -1.108 . . . . 71.310000000000002 108.007 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.96 99.69 1.31 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.466 1.444 . . . . 71.420000000000002 110.935 175.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.42 55.91 0.19 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 119.722 -1.228 . . . . 64.030000000000001 112.705 -179.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.426 ' HD2' ' H ' ' A' ' 4' ' ' ARG . 0.7 OUTLIER -73.79 144.11 45.71 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.007 -0.738 . . . . 72.510000000000005 109.007 175.992 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.12 128.23 5.85 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 110.489 -0.189 . . . . 75.319999999999993 110.489 -179.301 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.74 106.78 2.33 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.595 1.53 . . . . 74.319999999999993 108.907 172.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.19 -148.32 11.62 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 120.73 -0.748 . . . . 43.340000000000003 113.851 -175.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 m -60.62 119.82 8.83 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 124.116 0.966 . . . . 64.109999999999999 112.594 -175.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.7 m -119.77 146.49 45.62 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.864 -1.532 . . . . 73.040000000000006 106.864 178.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.0 mt -81.12 151.16 28.42 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 112.952 0.723 . . . . 51.409999999999997 112.952 -175.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.9 146.87 52.45 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.283 -1.006 . . . . 74.450000000000003 108.283 177.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -153.82 133.95 13.28 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.825 0.345 . . . . 72.239999999999995 111.013 -177.344 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.4 p -155.82 99.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.208 1.004 . . . . 60.039999999999999 109.657 175.537 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.09 -85.62 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.082 -0.963 . . . . 74.319999999999993 112.025 -178.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.2 p -71.09 117.01 12.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.328 0.492 . . . . 63.5 112.328 -176.531 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.418 ' H ' HD12 ' A' ' 16' ' ' ILE . 3.9 mp -85.68 122.08 73.21 Favored Pre-proline 0 N--CA 1.443 -0.806 0 N-CA-C 108.037 -1.098 . . . . 63.219999999999999 108.037 178.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -69.35 158.81 56.11 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 121.947 1.764 . . . . 75.519999999999996 110.016 174.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.62 135.87 33.18 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 110.382 -0.229 . . . . 75.319999999999993 110.382 -177.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.14 -96.95 2.11 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 121.34 -0.457 . . . . 71.420000000000002 113.912 -177.268 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -104.97 131.99 51.78 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-O 121.212 0.529 . . . . 75.319999999999993 111.757 -175.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -75.03 94.36 2.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.294 -0.866 . . . . 43.119999999999997 110.329 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.57 -45.96 96.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 CA-C-N 114.875 -1.057 . . . . 72.099999999999994 111.035 -179.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.88 150.97 46.21 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.444 0.64 . . . . 64.150000000000006 112.583 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.81 151.16 93.21 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.181 -0.918 . . . . 73.400000000000006 109.058 178.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.75 -25.51 61.07 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.771 2.314 . . . . 74.209999999999994 112.826 178.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.66 -28.4 66.84 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.895 -0.322 . . . . 61.049999999999997 110.899 178.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.53 118.16 65.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 106.993 -1.484 . . . . 73.099999999999994 106.993 178.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.84 147.46 89.48 Favored 'Trans proline' 0 C--O 1.255 1.329 0 C-N-CA 122.474 2.116 . . . . 72.340000000000003 113.917 -173.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.1 p -129.93 172.73 11.4 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.683 -0.69 . . . . 53.549999999999997 112.155 -177.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.447 ' CZ ' HD11 ' A' ' 38' ' ' LEU . 10.6 m-85 -117.33 160.68 20.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 126.597 1.959 . . . . 74.099999999999994 108.184 173.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -133.19 163.75 28.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.31 -2.107 . . . . 74.510000000000005 105.31 179.225 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.433 ' H ' HD22 ' A' ' 32' ' ' LEU . 3.2 mm? -42.35 -54.84 7.39 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.426 1.639 . . . . 72.420000000000002 115.426 -174.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.99 -41.1 65.03 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.074 1.849 . . . . 45.310000000000002 113.006 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -71.45 -34.8 70.57 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 120.986 0.422 . . . . 74.109999999999999 110.688 -178.654 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 66' ' ' ILE . 76.0 t -69.15 -41.34 81.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 CA-C-O 121.349 0.595 . . . . 64.150000000000006 109.547 177.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -60.2 -36.08 76.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.857 -1.065 . . . . 65.129999999999995 109.766 176.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 38.0 tt0 -64.12 -45.06 90.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.569 1.148 . . . . 72.209999999999994 110.493 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.447 HD11 ' CZ ' ' A' ' 30' ' ' TYR . 97.0 mt -60.9 -45.6 93.98 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.476 -0.784 . . . . 75.140000000000001 111.19 -178.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 41' ' ' VAL . 84.8 mt -84.98 -18.35 34.78 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.209 -0.905 . . . . 54.530000000000001 111.395 -176.493 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.0 31.05 69.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 111.35 -0.7 . . . . 73.319999999999993 111.35 -178.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 39' ' ' LEU . 28.4 m -129.24 158.78 71.97 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 109.583 -0.525 . . . . 74.430000000000007 109.583 -178.196 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -65.46 160.89 40.66 Favored 'Trans proline' 0 C--O 1.256 1.42 0 C-N-CA 122.225 1.95 . . . . 75.120000000000005 112.136 174.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -59.09 -33.02 49.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 123.923 0.889 . . . . 61.509999999999998 111.752 -177.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.4 p -60.1 -40.22 88.87 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.225 -0.443 . . . . 65.349999999999994 111.226 178.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -69.75 -32.52 71.08 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.89 0.376 . . . . 65.230000000000004 111.384 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.8 t -64.5 -40.66 89.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.962 -0.755 . . . . 71.030000000000001 108.962 174.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . -61.82 -36.06 80.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.455 -0.793 . . . . 62.229999999999997 110.382 176.118 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 44' ' ' SER . 25.5 mt-30 -61.67 -39.32 90.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.348 -0.387 . . . . 73.099999999999994 110.342 178.452 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -58.66 -46.21 87.68 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.812 -0.81 . . . . 60.210000000000001 108.812 177.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.8 tp -62.23 -39.81 94.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.928 -1.033 . . . . 71.319999999999993 110.638 179.338 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 47' ' ' ALA . 89.1 mtt180 -68.71 -26.9 65.51 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.921 179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.95 -8.19 37.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.587 -0.278 . . . . 74.530000000000001 111.398 -176.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.47 25.73 45.95 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.555 -0.831 . . . . 41.340000000000003 111.883 -178.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -96.55 -5.54 39.05 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.486 -0.191 . . . . 63.350000000000001 110.486 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.4 tp -163.12 153.94 16.68 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.223 -1.029 . . . . 74.409999999999997 108.223 -176.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.83 161.42 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.471 -1.307 . . . . 74.519999999999996 107.471 176.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.31 162.66 35.86 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.915 -0.402 . . . . 75.340000000000003 109.915 -175.218 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.418 HG13 ' HE1' ' A' ' 99' ' ' MET . 6.4 m -126.04 164.86 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 O-C-N 123.79 0.681 . . . . 71.209999999999994 109.709 177.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 32.9 ttp180 -110.83 132.38 54.25 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 116.222 -0.444 . . . . 70.099999999999994 110.48 -174.599 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.559 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -136.29 124.4 23.0 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.614 -0.513 . . . . 72.430000000000007 109.614 175.888 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.84 30.57 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.945 0.898 . . . . 63.420000000000002 112.127 176.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.05 -4.33 71.06 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.821 -0.627 . . . . 61.240000000000002 113.342 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -107.57 146.35 16.22 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 121.127 -0.559 . . . . 62.409999999999997 112.816 -178.178 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.15 120.85 47.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.361 -1.348 . . . . 64.319999999999993 107.361 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.79 159.93 41.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.878 -0.601 . . . . 71.230000000000004 111.124 -174.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 35' ' ' VAL . 56.0 mt -124.32 128.39 25.02 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.217 -1.031 . . . . 71.129999999999995 108.217 179.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.14 138.62 86.2 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.62 2.213 . . . . 74.209999999999994 113.099 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -52.55 -35.58 53.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.333 1.053 . . . . 74.219999999999999 111.712 178.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -69.01 -9.2 11.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.898 -1.046 . . . . 50.310000000000002 113.641 -175.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -80.23 -15.72 56.37 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 121.745 0.783 . . . . 73.030000000000001 110.345 176.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -111.79 162.35 15.35 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 115.167 -0.924 . . . . 75.019999999999996 109.528 -178.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 55.7 p -85.87 165.78 16.54 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 107.353 -1.351 . . . . 61.43 107.353 175.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.82 -21.57 66.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.891 0.853 . . . . 74.400000000000006 109.506 177.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m -80.23 -1.89 42.57 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-N 115.108 -0.951 . . . . 55.409999999999997 112.092 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.47 -16.91 59.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.391 -0.909 . . . . 72.340000000000003 114.941 173.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -92.16 164.87 13.41 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 118.178 0.989 . . . . 73.340000000000003 109.612 179.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 p -83.84 155.71 3.7 Favored 'Isoleucine or valine' 0 C--O 1.258 1.546 0 N-CA-C 108.34 -0.985 . . . . 62.149999999999999 108.34 -179.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 80' ' ' SER . 42.6 t -65.97 126.11 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.041 -0.725 . . . . 72.120000000000005 109.041 178.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -26.6 67.92 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 112.626 0.602 . . . . 64.310000000000002 112.626 -178.231 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.475 ' H ' HG12 ' A' ' 78' ' ' VAL . 13.6 m -84.33 -0.56 52.99 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.884 -0.598 . . . . 73.200000000000003 111.899 -179.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.515 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 57.1 tp -60.79 -55.1 48.1 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 113.01 0.745 . . . . 62.409999999999997 113.01 -179.217 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -58.29 -28.98 86.47 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.087 1.858 . . . . 64.230000000000004 112.594 -178.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.13 -45.29 96.37 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.057 -0.592 . . . . 53.340000000000003 111.941 -179.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.1 pp -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.452 0.644 . . . . 60.130000000000003 110.308 178.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.4 -42.72 95.95 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.576 -0.738 . . . . 62.340000000000003 111.845 -177.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -62.49 -45.43 93.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.136 -0.484 . . . . 71.230000000000004 112.205 -176.325 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -43.29 95.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 120.829 -0.349 . . . . 72.239999999999995 110.687 -179.15 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.443 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.5 mm? -67.61 -35.8 79.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.395 0.517 . . . . 60.119999999999997 112.395 176.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -62.29 -42.45 99.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.677 -0.49 . . . . 74.25 109.677 179.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -64.18 -30.51 71.56 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.859 -0.609 . . . . 60.109999999999999 110.723 176.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -82.26 -9.29 85.23 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.479 -0.782 . . . . 63.030000000000001 112.104 177.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.37 23.1 55.3 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.577 -0.344 . . . . 71.109999999999999 113.837 177.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -87.47 129.6 35.0 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.163 0.506 . . . . 75.140000000000001 111.539 -178.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.462 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 16.6 ptp180 -78.49 172.67 13.32 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.006 0.922 . . . . 74.230000000000004 110.897 -177.049 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -53.64 -45.08 70.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.583 1.553 . . . . 73.120000000000005 111.035 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.607 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 31.2 m -63.46 -42.12 98.62 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 115.121 -0.945 . . . . 64.409999999999997 110.269 -179.405 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.462 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 41.8 mt-10 -65.41 -39.91 92.73 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.983 -0.553 . . . . 62.420000000000002 110.27 -177.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 94' ' ' ARG . 21.5 mm -61.35 -48.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.773 0.796 . . . . 74.409999999999997 109.575 -178.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.423 ' HA ' ' HB2' ' A' ' 102' ' ' LEU . 51.9 mtt -74.58 -15.98 60.82 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 113.55 0.945 . . . . 74.450000000000003 113.55 -175.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.607 ' HG3' ' O ' ' A' ' 96' ' ' THR . 84.2 mtt180 -55.77 -65.26 0.63 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.935 0.398 . . . . 72.25 111.028 178.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.476 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 41.7 p-90 -68.68 -32.03 71.56 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.707 0.632 . . . . 72.340000000000003 112.707 -179.616 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 125' ' ' PRO . 15.7 mt -62.3 -40.84 97.6 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.516 0.932 . . . . 71.340000000000003 113.516 -179.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -92.91 -16.03 25.67 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 112.554 0.576 . . . . 73.409999999999997 112.554 -177.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 59.0 m -87.32 124.09 68.74 Favored Pre-proline 0 C--N 1.296 -1.761 0 N-CA-C 109.31 -0.626 . . . . 75.310000000000002 109.31 179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.519 ' HB3' ' O ' ' A' ' 122' ' ' ASN . 74.3 Cg_exo -54.13 129.64 35.46 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.823 2.349 . . . . 64.439999999999998 111.938 178.556 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . 8.9 t70 -80.5 126.26 78.96 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 108.209 -1.034 . . . . 73.340000000000003 108.209 178.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HA ' ' OD1' ' A' ' 122' ' ' ASN . 24.9 Cg_endo -60.52 -20.39 63.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.039 2.493 . . . . 74.239999999999995 114.401 -176.523 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.7 m -115.98 4.8 13.83 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.953 -0.467 . . . . 71.329999999999998 111.887 -176.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 106' ' ' ASP . 39.9 tp -102.34 119.83 39.47 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 122.023 0.916 . . . . 51.340000000000003 111.812 -176.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.2 m -120.11 131.1 54.93 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.699 -1.593 . . . . 75.439999999999998 106.699 178.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' ALA . 14.5 pt -115.68 155.69 16.91 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 120.265 -0.574 . . . . 61.329999999999998 112.301 -177.765 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.7 p -89.32 159.23 17.48 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.406 -1.27 . . . . 74.439999999999998 112.629 -172.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.434 ' HG2' ' N ' ' A' ' 114' ' ' ASP . 56.2 ttp180 -68.6 171.65 7.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.548 1.139 . . . . 71.510000000000005 109.007 179.252 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.434 ' N ' ' HG2' ' A' ' 113' ' ' ARG . 17.5 m-20 74.81 14.02 3.37 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 122.436 1.112 . . . . 73.019999999999996 110.746 176.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.75 -40.87 0.04 OUTLIER Glycine 0 C--N 1.291 -1.918 0 N-CA-C 107.173 -2.371 . . . . 61.009999999999998 107.173 177.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 p -113.76 -177.06 3.04 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 106.9 -1.519 . . . . 73.030000000000001 106.9 172.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.82 -26.75 66.22 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 114.089 1.144 . . . . 74.140000000000001 114.089 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -175.34 -172.95 0.61 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.413 -2.81 . . . . 71.209999999999994 103.413 179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' ILE . . . -70.83 123.94 23.15 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 119.588 1.086 . . . . 63.420000000000002 108.382 178.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.4 t -112.76 118.58 58.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.874 -0.417 . . . . 71.230000000000004 109.874 -176.012 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.5 m -88.93 140.08 29.8 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.81 -1.552 . . . . 74.129999999999995 106.81 176.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 105' ' ' PRO . 44.9 m-80 63.29 55.92 1.78 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.847 0.832 . . . . 71.530000000000001 109.566 -175.489 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' HB2' HG12 ' A' ' 111' ' ' ILE . . . -84.8 144.83 28.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.405 -0.816 . . . . 54.420000000000002 110.548 179.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -76.94 139.44 65.86 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 107.174 -1.417 . . . . 63.439999999999998 107.174 174.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.521 ' HB2' HD23 ' A' ' 102' ' ' LEU . 95.8 Cg_exo -49.55 -30.46 21.61 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.376 2.717 . . . . 72.219999999999999 114.403 -179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.573 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 96.3 t -60.78 -43.25 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.443 0.639 . . . . 72.219999999999999 110.782 178.212 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -70.34 -31.02 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.94 -0.573 . . . . 73.239999999999995 110.783 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.71 76.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.887 -0.597 . . . . 31.329999999999998 111.45 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -66.81 -35.77 80.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.719 0.295 . . . . 61.240000000000002 111.01 -179.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -72.32 -24.66 61.34 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.86 0.838 . . . . 71.109999999999999 109.048 179.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -93.21 21.4 5.99 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.116 -0.947 . . . . 63.520000000000003 111.568 -179.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.73 27.29 16.04 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.148 1.379 . . . . 73.430000000000007 112.15 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -115.0 23.73 12.3 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.408 1.099 . . . . 65.109999999999999 109.236 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -53.37 -27.17 22.41 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 113.041 -1.89 . . . . 74.450000000000003 111.682 177.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -54.75 -46.89 74.39 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.016 0.526 . . . . 71.200000000000003 109.687 178.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 47.2 mm-40 -71.83 -29.2 64.15 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 116.239 -0.437 . . . . 73.239999999999995 111.464 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.18 -47.74 72.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 116.301 -0.409 . . . . 73.099999999999994 110.354 -179.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.527 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 62.8 t -63.92 -42.66 96.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 N-CA-C 109.303 -0.629 . . . . 73.530000000000001 109.303 177.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -58.67 -44.3 90.15 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.435 0.694 . . . . 73.150000000000006 109.942 178.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 2.4 tpp85 -64.92 -38.2 90.19 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.117 -0.947 . . . . 61.219999999999999 109.213 -178.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -66.4 -44.15 83.82 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.655 0.782 . . . . 73.450000000000003 110.564 179.146 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 96.1 mt-30 -60.48 -49.94 75.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.935 -0.575 . . . . 72.439999999999998 109.822 178.768 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 -17.54 63.47 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.86 -1.064 . . . . 61.119999999999997 111.957 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 49.7 tpp -82.27 -40.59 21.33 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.025 0.441 . . . . 72.430000000000007 110.035 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.53 -48.74 8.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 61.229999999999997 111.716 -177.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 118.085 -0.959 . . . . 71.299999999999997 109.615 -177.354 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 107.733 -1.21 . . . . 64.120000000000005 107.733 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.7 155.66 67.96 Favored 'Trans proline' 0 C--O 1.248 0.991 0 C-N-CA 122.055 1.837 . . . . 64.299999999999997 111.998 -179.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.87 113.46 0.57 Allowed Glycine 0 N--CA 1.423 -2.194 0 N-CA-C 108.389 -1.884 . . . . 42.409999999999997 108.389 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.416 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 52.0 mtp180 -71.93 142.86 49.45 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 120.953 0.406 . . . . 60.039999999999999 111.952 -176.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.35 103.45 9.66 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 106.833 -1.543 . . . . 71.340000000000003 106.833 173.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 4' ' ' ARG . 17.1 Cg_exo -68.19 132.86 27.03 Favored 'Trans proline' 0 C--O 1.247 0.957 0 C-N-CA 122.628 2.219 . . . . 73.230000000000004 112.151 -176.304 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.84 -116.51 1.23 Allowed Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.247 -1.141 . . . . 74.420000000000002 110.247 178.104 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 t -156.73 160.76 39.6 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 105.854 -1.906 . . . . 74.129999999999995 105.854 176.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 m -66.55 126.88 30.29 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.299 -1.0 . . . . 62.439999999999998 108.299 177.017 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.76 148.47 46.69 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.662 0.744 . . . . 73.099999999999994 112.624 -176.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.62 129.71 34.75 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.502 -1.295 . . . . 72.200000000000003 107.502 177.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -113.86 138.12 50.73 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 120.924 0.392 . . . . 72.200000000000003 109.955 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.97 128.11 68.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-N 115.069 -0.969 . . . . 74.109999999999999 109.348 178.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.43 97.91 1.45 Allowed Glycine 0 C--N 1.284 -2.306 0 CA-C-N 115.049 -0.978 . . . . 43.219999999999999 114.22 -174.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.5 p -102.51 154.23 19.31 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.425 -1.324 . . . . 75.310000000000002 107.425 172.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 mm -86.94 120.82 71.77 Favored Pre-proline 0 C--N 1.31 -1.113 0 C-N-CA 119.464 -0.894 . . . . 70.400000000000006 110.941 -175.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -76.71 165.39 28.82 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.542 2.161 . . . . 74.219999999999999 110.632 173.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 57' ' ' ALA . . . -85.88 137.09 33.0 Favored 'General case' 0 C--O 1.25 1.088 0 N-CA-C 109.508 -0.553 . . . . 52.009999999999998 109.508 177.362 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.23 -137.43 7.34 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 120.595 -0.812 . . . . 75.219999999999999 114.369 -177.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -97.51 123.39 41.36 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.418 0.687 . . . . 70.540000000000006 111.812 -173.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -70.45 126.07 28.6 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-N 115.078 -0.965 . . . . 51.219999999999999 109.633 -178.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.6 t -100.36 -19.83 5.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.813 -0.631 . . . . 73.109999999999999 111.584 -175.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -98.68 176.0 5.79 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.602 -0.839 . . . . 61.240000000000002 111.8 -177.867 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' ' HG2' ' A' ' 27' ' ' GLU . 20.7 m-20 -82.8 151.36 64.2 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.901 -0.407 . . . . 71.530000000000001 109.901 179.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 60' ' ' ARG . 32.5 Cg_exo -61.86 -22.11 73.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.596 2.197 . . . . 75.049999999999997 112.383 178.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -84.05 -8.28 59.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.866 -0.606 . . . . 54.149999999999999 110.72 -179.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 24' ' ' ASP . 16.2 mm-40 -76.37 154.94 84.09 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.533 -0.543 . . . . 74.310000000000002 109.533 177.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 68' ' ' GLN . 28.3 Cg_endo -58.82 111.2 0.82 Allowed 'Trans proline' 0 C--O 1.251 1.16 0 C-N-CA 122.877 2.385 . . . . 63.439999999999998 112.814 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 p -133.32 167.49 20.3 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.801 -0.636 . . . . 74.409999999999997 111.497 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 19.8 m-85 -128.66 161.69 29.09 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 125.08 1.352 . . . . 75.200000000000003 108.774 178.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.8 m-20 -133.9 161.01 35.95 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 104.365 -2.457 . . . . 73.430000000000007 104.365 -174.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.4 mt -47.08 -56.66 11.35 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.84 1.052 . . . . 62.240000000000002 113.84 -174.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.56 -29.68 43.92 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 121.242 1.295 . . . . 75.510000000000005 112.195 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.462 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 9.7 tpt180 -70.84 -37.83 73.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.8 0.334 . . . . 75.239999999999995 110.534 -178.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 31' ' ' ASP . 47.3 t -69.11 -40.83 81.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.79 -0.819 . . . . 74.540000000000006 108.79 178.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.49 81.5 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.909 -1.042 . . . . 54.130000000000003 109.46 177.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.36 -45.54 72.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.026 -0.988 . . . . 61.310000000000002 110.103 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.21 -50.66 69.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.254 -0.884 . . . . 72.329999999999998 111.437 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.432 ' HB2' HG22 ' A' ' 41' ' ' VAL . 97.5 mt -84.07 -16.93 41.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.829 -0.623 . . . . 64.209999999999994 112.653 -175.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.13 30.84 62.41 Favored Glycine 0 C--N 1.316 -0.546 0 C-N-CA 120.303 -0.951 . . . . 70.219999999999999 110.756 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 39' ' ' LEU . 18.6 m -126.99 160.83 57.26 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 107.754 -1.202 . . . . 73.310000000000002 107.754 -178.379 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.89 159.38 52.75 Favored 'Trans proline' 0 C--O 1.25 1.124 0 C-N-CA 121.738 1.625 . . . . 54.310000000000002 111.563 176.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.04 -32.84 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 108.751 -0.833 . . . . 70.25 108.751 178.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 8.6 m -57.16 -41.35 79.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.644 -1.162 . . . . 53.039999999999999 110.73 177.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 57.3 tttm -70.11 -36.25 74.71 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 121.283 0.563 . . . . 75.219999999999999 109.521 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.83 -40.9 90.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.753 0.787 . . . . 71.209999999999994 109.096 176.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.42 -35.49 80.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.952 -1.022 . . . . 64.519999999999996 110.652 177.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 44' ' ' SER . 80.3 mm-40 -61.24 -41.24 96.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.252 -0.647 . . . . 73.530000000000001 109.252 178.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 12.9 mm-40 -58.98 -47.23 85.91 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.477 -0.783 . . . . 74.120000000000005 109.142 179.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -63.92 -34.06 77.1 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.252 -0.886 . . . . 55.350000000000001 110.853 -179.231 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -67.2 -34.47 77.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 116.203 -0.453 . . . . 72.0 111.963 176.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 19.6 mm-40 -88.21 -11.73 45.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.03 0.443 . . . . 74.540000000000006 110.432 -176.634 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.95 28.52 49.94 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.662 -0.975 . . . . 73.510000000000005 110.662 -176.504 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -88.98 -10.55 47.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.669 -0.863 . . . . 72.340000000000003 108.669 -178.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.5 tp -158.3 158.09 33.71 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.339 -1.726 . . . . 70.430000000000007 106.339 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.87 155.48 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.723 -0.843 . . . . 74.510000000000005 108.723 177.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 18' ' ' ALA . . . -126.54 157.43 38.81 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.938 -0.764 . . . . 55.210000000000001 108.938 -176.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG11 ' CE ' ' A' ' 99' ' ' MET . 35.1 m -131.75 164.44 34.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 109.671 -0.492 . . . . 64.530000000000001 109.671 178.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -122.34 122.35 38.85 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 110.008 -0.368 . . . . 73.329999999999998 110.008 -176.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 25' ' ' PRO . 5.8 ptp180 -117.06 113.73 22.74 Favored 'General case' 0 C--O 1.253 1.244 0 CA-C-N 115.926 -0.579 . . . . 72.219999999999999 109.477 177.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.68 -40.8 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.372 1.869 . . . . 61.32 112.012 178.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 174.18 -13.03 0.04 OUTLIER Glycine 0 C--N 1.29 -2.011 0 CA-C-N 114.949 -1.023 . . . . 55.140000000000001 111.969 -177.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.62 145.35 17.7 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 120.855 -0.688 . . . . 63.340000000000003 111.921 -178.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.8 120.92 46.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.581 -1.266 . . . . 70.310000000000002 107.581 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.46 164.94 33.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.04 -0.982 . . . . 64.310000000000002 110.708 -174.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 40.8 mm -121.32 132.31 24.25 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 107.404 -1.332 . . . . 74.430000000000007 107.404 -179.02 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -67.1 119.45 6.47 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 121.685 1.59 . . . . 74.340000000000003 111.029 175.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.0 tt0 -62.99 -25.01 68.18 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.547 0.739 . . . . 74.409999999999997 112.091 -177.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.0 m -65.27 -9.64 7.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.482 -0.781 . . . . 72.319999999999993 112.605 177.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.525 ' CD2' HD11 ' A' ' 81' ' ' LEU . 3.8 m-85 -81.55 -6.16 58.7 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.743 0.782 . . . . 75.239999999999995 110.159 175.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -110.86 154.35 24.14 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 115.163 -0.926 . . . . 70.219999999999999 108.991 179.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.1 p -76.83 175.96 8.98 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 123.659 0.784 . . . . 73.340000000000003 110.573 179.091 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -56.31 -31.86 64.08 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.466 0.707 . . . . 74.140000000000001 110.214 174.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.1 m -80.17 -2.58 45.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.626 -0.716 . . . . 71.340000000000003 111.74 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.53 32.46 59.61 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.103 -0.57 . . . . 61.219999999999999 111.977 179.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -115.7 157.78 23.76 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.343 -0.614 . . . . 75.510000000000005 109.343 177.47 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.418 HG13 HD23 ' A' ' 81' ' ' LEU . 43.9 t -66.23 130.32 31.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.226 -0.657 . . . . 74.430000000000007 109.226 175.708 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 80' ' ' SER . 42.0 t -63.16 132.34 28.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.432 -0.951 . . . . 55.219999999999999 108.432 178.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -57.63 -27.51 62.85 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.903 0.705 . . . . 72.510000000000005 112.903 -178.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.442 ' H ' HG12 ' A' ' 78' ' ' VAL . 9.5 m -89.19 -2.61 58.57 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.049 -0.523 . . . . 60.049999999999997 111.273 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.525 HD11 ' CD2' ' A' ' 70' ' ' PHE . 46.0 tp -61.67 -56.99 27.59 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 119.041 -0.504 . . . . 75.239999999999995 111.794 -177.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -56.24 -38.67 94.64 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 121.437 1.425 . . . . 74.200000000000003 110.795 177.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -62.18 -44.87 97.11 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.757 -0.656 . . . . 70.120000000000005 112.796 -179.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 2.4 pp -68.42 -41.27 80.61 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 117.212 0.506 . . . . 74.409999999999997 109.719 178.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.74 -35.59 81.06 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 116.026 -0.534 . . . . 64.349999999999994 110.754 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.6 m -67.24 -41.28 85.89 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 112.075 0.398 . . . . 72.329999999999998 112.075 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.02 -40.27 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 120.143 -0.623 . . . . 71.120000000000005 110.473 178.58 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 3.3 mm? -67.61 -36.07 80.15 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.623 -0.673 . . . . 63.240000000000002 112.285 175.05 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -63.54 -33.03 74.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.426 -0.583 . . . . 74.409999999999997 109.426 177.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 87' ' ' ILE . 18.5 t70 -63.18 -29.9 71.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.226 1.01 . . . . 73.049999999999997 109.847 178.244 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.4 -9.32 53.54 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 115.837 -0.62 . . . . 53.100000000000001 111.969 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.02 27.69 36.66 Favored Glycine 0 C--N 1.317 -0.483 0 O-C-N 122.769 -0.253 . . . . 23.239999999999998 113.442 178.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 76.6 m-85 -83.84 128.16 34.34 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.125 0.488 . . . . 63.310000000000002 112.055 -179.114 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 8.0 ptp180 -79.97 171.05 15.61 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.217 -0.901 . . . . 71.439999999999998 110.306 -179.509 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -54.35 -43.0 70.91 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.884 1.274 . . . . 72.230000000000004 111.667 -178.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -60.03 -41.98 93.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 123.813 0.845 . . . . 63.32 110.502 -179.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 14.6 mm-40 -65.1 -39.71 93.53 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 115.828 -0.624 . . . . 71.530000000000001 110.055 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 94' ' ' ARG . 25.0 mm -60.24 -47.52 91.86 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.244 -1.021 . . . . 63.340000000000003 108.244 -176.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.409 ' CE ' HG11 ' A' ' 58' ' ' VAL . 73.5 mtm -70.92 -26.38 63.18 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.982 -1.008 . . . . 71.5 112.725 -176.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -58.12 -66.17 0.52 Allowed 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.885 0.698 . . . . 74.340000000000003 112.885 -179.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -68.24 -32.44 72.63 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.506 0.558 . . . . 65.329999999999998 112.506 -179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.568 ' HG ' HG22 ' A' ' 126' ' ' VAL . 32.3 tp -67.53 -40.38 85.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.826 -0.624 . . . . 61.340000000000003 111.519 -176.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.443 ' CZ ' HD23 ' A' ' 23' ' ' LEU . 26.7 m-85 -84.99 -3.05 58.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.422 0.527 . . . . 64.409999999999997 112.422 -179.025 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 73.9 m -86.99 109.85 28.05 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 109.367 -0.605 . . . . 65.120000000000005 109.367 177.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 103' ' ' PHE . 21.7 Cg_exo -65.87 139.67 57.93 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.637 2.225 . . . . 72.140000000000001 110.852 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 12.0 t70 -99.27 119.34 60.72 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.253 -1.017 . . . . 75.329999999999998 108.253 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -60.05 -24.87 78.14 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.259 2.64 . . . . 73.049999999999997 113.647 -176.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.8 p -106.25 8.38 31.88 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.258 0.466 . . . . 73.540000000000006 112.258 -176.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.45 ' CB ' ' HB3' ' A' ' 106' ' ' ASP . 56.4 tp -102.84 129.38 49.5 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 110.047 -0.353 . . . . 51.509999999999998 110.047 -178.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.5 m -112.12 112.72 24.54 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.451 -0.574 . . . . 60.439999999999998 109.451 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.1 mm -116.84 146.93 20.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.902 -0.59 . . . . 72.219999999999999 109.461 -176.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.6 t -113.69 145.01 41.99 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 106.35 -1.722 . . . . 61.229999999999997 106.35 176.382 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 42.6 ttt-85 -97.23 146.76 24.79 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 119.269 -0.972 . . . . 73.209999999999994 111.996 -173.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 24.3 t70 -68.05 127.13 31.73 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.902 -0.59 . . . . 61.549999999999997 109.991 177.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.43 14.19 54.1 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.282 -1.127 . . . . 31.120000000000001 110.282 -176.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.4 t -147.27 171.52 15.28 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 108.499 -0.926 . . . . 71.25 108.499 -178.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.93 -1.84 8.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.54 -0.754 . . . . 74.299999999999997 110.9 175.605 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -80.91 133.63 35.59 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 115.921 -0.582 . . . . 64.510000000000005 110.606 -178.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -104.69 129.25 52.9 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.114 -0.948 . . . . 74.430000000000007 108.596 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.3 t -115.25 118.99 60.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 116.353 -0.385 . . . . 71.409999999999997 110.176 -177.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 64.2 m -80.3 132.21 35.78 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.112 -1.069 . . . . 73.099999999999994 108.112 173.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 8.8 t30 75.38 72.97 0.09 Allowed 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 124.944 1.297 . . . . 75.319999999999993 108.274 -171.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -117.65 168.07 10.77 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 114.814 -1.085 . . . . 23.23 110.167 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -93.06 127.06 48.77 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 115.646 -0.706 . . . . 73.120000000000005 110.166 -178.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.467 ' HB2' HD12 ' A' ' 102' ' ' LEU . 65.4 Cg_exo -55.73 -21.3 31.66 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.384 2.723 . . . . 75.430000000000007 113.469 178.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.568 HG22 ' HG ' ' A' ' 102' ' ' LEU . 43.0 t -60.35 -44.78 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.85 0.833 . . . . 72.219999999999999 109.73 178.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.7 -29.38 64.51 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.685 -1.143 . . . . 55.450000000000003 110.131 -176.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.52 -43.29 99.17 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.45 -0.796 . . . . 62.25 111.778 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.4 pp -69.38 -34.98 75.35 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.638 -0.664 . . . . 65.040000000000006 109.779 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -66.65 -25.44 66.58 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.289 -1.323 . . . . 74.310000000000002 108.971 177.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -96.72 9.01 42.94 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.944 -1.025 . . . . 62.119999999999997 111.363 179.091 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.9 m80 65.25 28.23 12.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.322 1.049 . . . . 73.430000000000007 112.638 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -106.44 25.04 11.61 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 125.056 1.342 . . . . 63.409999999999997 107.74 176.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -51.57 -25.66 7.22 Favored 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 126.976 2.11 . . . . 72.430000000000007 112.767 -177.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 32.4 mmm-85 -54.19 -43.0 70.33 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.917 0.487 . . . . 74.430000000000007 110.286 179.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -70.3 -27.77 64.66 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.07 0.462 . . . . 53.43 111.323 179.16 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 129' ' ' LEU . 99.1 t -73.32 -49.49 37.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.543 -0.753 . . . . 60.439999999999998 109.762 178.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.493 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 79.2 t -59.08 -41.15 82.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.811 0 CA-C-N 115.421 -0.809 . . . . 61.240000000000002 109.143 177.446 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.37 -46.72 79.91 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.246 -0.888 . . . . 74.299999999999997 110.157 178.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 144' ' ' MET . 43.9 mtp180 -67.92 -37.05 81.19 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.815 0.34 . . . . 72.510000000000005 111.864 176.503 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.28 99.15 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.648 178.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 97.1 mt-30 -59.64 -39.0 82.92 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 122.818 0.447 . . . . 73.219999999999999 110.404 176.116 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.67 -27.46 66.0 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.316 -0.402 . . . . 74.450000000000003 110.978 178.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 140' ' ' ARG . 89.6 mmm -82.68 -41.28 19.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.066 0.46 . . . . 72.109999999999999 110.526 179.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.74 -51.35 11.59 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.209 0.448 . . . . 72.329999999999998 112.209 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 C--N 1.311 -1.068 0 CA-C-O 118.511 -0.757 . . . . 74.530000000000001 109.023 -176.973 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 109.791 -0.448 . . . . 52.329999999999998 109.791 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -78.92 125.84 6.84 Favored 'Trans proline' 0 C--O 1.242 0.711 0 C-N-CA 122.432 2.088 . . . . 73.540000000000006 111.651 178.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.23 7.69 58.6 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 120.999 -0.62 . . . . 72.230000000000004 113.294 -178.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 133.34 41.74 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.14 -0.624 . . . . 73.329999999999998 109.42 176.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 63.63 98.36 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 124.636 1.174 . . . . 52.350000000000001 112.053 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -86.6 25.65 0.67 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.25 2.633 . . . . 72.420000000000002 111.797 179.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.37 70.29 1.34 Allowed Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.311 -1.515 . . . . 60.119999999999997 109.311 -175.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 p -140.38 154.5 46.73 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 109.632 -0.507 . . . . 65.239999999999995 109.632 -176.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -110.45 144.51 39.14 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.319 -0.622 . . . . 73.450000000000003 109.319 179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.9 mt -104.46 178.63 4.51 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.055 0.455 . . . . 63.409999999999997 110.505 -178.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.68 -172.99 2.18 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.415 -1.328 . . . . 54.219999999999999 107.415 174.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.535 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -140.71 114.4 8.87 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 114.427 1.269 . . . . 74.549999999999997 114.427 -177.883 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 p -142.46 106.29 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 114.794 -1.094 . . . . 72.310000000000002 108.78 177.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.432 ' O ' ' HG3' ' A' ' 51' ' ' ARG . . . 67.75 37.34 88.69 Favored Glycine 0 C--O 1.222 -0.651 0 N-CA-C 109.557 -1.417 . . . . 53.240000000000002 109.557 -175.099 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.535 ' OG ' ' HB2' ' A' ' 12' ' ' ARG . 36.7 p -91.83 101.37 13.96 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 113.041 0.756 . . . . 74.349999999999994 113.041 -171.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.83 121.77 85.71 Favored Pre-proline 0 C--N 1.301 -1.538 0 N-CA-C 106.415 -1.698 . . . . 75.129999999999995 106.415 170.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.77 165.14 32.15 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.367 2.045 . . . . 73.030000000000001 113.528 -176.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.26 123.89 31.14 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 106.15 -1.796 . . . . 73.129999999999995 106.15 174.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.17 -96.89 0.96 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 119.734 -1.222 . . . . 53.340000000000003 115.169 -175.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -98.1 119.94 37.62 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.17 0.509 . . . . 42.530000000000001 112.243 -169.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.45 109.77 2.87 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.996 -1.002 . . . . 54.25 110.421 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.19 -33.42 12.82 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 CA-C-O 121.354 0.597 . . . . 75.040000000000006 110.158 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -78.44 173.78 11.99 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.012 -0.54 . . . . 75.549999999999997 110.135 176.075 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.88 129.98 42.31 Favored Pre-proline 0 C--N 1.29 -1.998 0 N-CA-C 107.985 -1.117 . . . . 72.409999999999997 107.985 176.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -52.63 -21.98 15.95 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.442 2.761 . . . . 64.030000000000001 115.061 -178.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.46 -24.39 56.98 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.958 0.408 . . . . 71.439999999999998 110.484 -179.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.71 157.19 87.1 Favored Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.724 -0.671 . . . . 73.430000000000007 111.844 -177.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -43.19 107.63 0.09 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 124.067 3.178 . . . . 74.450000000000003 113.601 179.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -135.05 164.04 28.53 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.107 -0.951 . . . . 73.230000000000004 110.426 -178.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -127.37 160.7 30.59 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 125.623 1.569 . . . . 64.219999999999999 107.639 177.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.509 ' H ' ' HB3' ' A' ' 34' ' ' ARG . 3.0 p30 -134.79 172.24 13.25 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 107.622 -1.251 . . . . 75.439999999999998 107.622 -178.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.0 mt -46.04 -64.32 0.98 Allowed Pre-proline 0 CA--C 1.563 1.454 0 N-CA-C 114.626 1.343 . . . . 75.140000000000001 114.626 -172.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.64 -27.59 69.11 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 121.569 1.513 . . . . 73.049999999999997 112.634 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.509 ' HB3' ' H ' ' A' ' 31' ' ' ASP . 23.5 tpt180 -67.9 -48.29 66.44 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 110.179 -0.304 . . . . 65.519999999999996 110.179 178.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.84 -37.95 80.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.216 0.532 . . . . 74.239999999999995 109.915 -179.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.47 -37.05 82.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.054 -0.976 . . . . 72.109999999999999 110.0 179.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.14 -44.96 71.28 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.2 -0.909 . . . . 71.510000000000005 109.885 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 97.2 mt -57.5 -41.98 81.82 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.354 -0.839 . . . . 74.400000000000006 111.962 -178.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.507 ' HB2' HG22 ' A' ' 41' ' ' VAL . 86.1 mt -94.29 -17.76 22.31 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.923 -0.58 . . . . 73.349999999999994 111.977 -177.178 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.23 33.86 61.55 Favored Glycine 0 C--N 1.315 -0.594 0 N-CA-C 110.37 -1.092 . . . . 63.520000000000003 110.37 -177.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 39' ' ' LEU . 23.5 m -122.4 164.05 28.54 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.239 -0.652 . . . . 74.209999999999994 109.239 -178.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 39.6 Cg_endo -71.91 158.59 52.43 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 121.728 1.618 . . . . 73.430000000000007 111.341 173.434 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.4 t -59.28 -34.54 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.368 0.604 . . . . 73.310000000000002 110.012 178.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 48' ' ' GLN . 21.7 t -62.25 -36.84 83.25 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.535 -0.757 . . . . 73.439999999999998 110.655 178.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 38.9 ttmt -69.77 -32.6 71.19 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 120.135 -0.626 . . . . 64.409999999999997 110.201 177.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.6 t -61.28 -42.25 92.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.653 -0.869 . . . . 52.530000000000001 108.653 175.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.08 82.5 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.888 -1.051 . . . . 23.309999999999999 110.438 176.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.499 ' HG3' ' O ' ' A' ' 44' ' ' SER . 54.2 mt-30 -66.82 -38.24 86.08 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 116.16 -0.473 . . . . 71.030000000000001 111.06 177.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.4 mm-40 -63.49 -41.29 98.56 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.998 -0.742 . . . . 71.120000000000005 108.998 177.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.3 tp -61.55 -42.5 98.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.78 -1.1 . . . . 74.299999999999997 109.228 177.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 14' ' ' GLY . 70.0 ttt180 -60.33 -32.67 71.46 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.277 1.031 . . . . 63.200000000000003 111.87 178.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -85.41 -9.91 56.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.937 0.399 . . . . 73.129999999999995 111.068 -177.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.18 33.1 54.96 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.6 -1.4 . . . . 53.329999999999998 109.6 -174.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -97.02 -16.91 20.34 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.475 -0.935 . . . . 72.540000000000006 108.475 178.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 37.9 tp -151.2 157.22 42.37 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.647 -1.242 . . . . 72.099999999999994 107.647 -179.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.14 147.63 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.82 -0.808 . . . . 65.129999999999995 108.82 178.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.58 161.78 34.12 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 123.208 0.603 . . . . 64.129999999999995 109.471 -178.084 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 m -133.21 166.59 28.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 123.612 0.765 . . . . 64.219999999999999 109.705 176.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 63' ' ' GLY . 45.9 mtp180 -112.57 126.84 55.78 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.941 -0.304 . . . . 72.409999999999997 110.791 -177.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -129.8 122.68 29.23 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.002 -0.74 . . . . 71.319999999999993 109.002 176.66 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 59.53 26.14 15.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.716 0.806 . . . . 70.5 111.616 179.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 -7.26 77.17 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.987 -0.551 . . . . 61.119999999999997 112.237 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 59' ' ' ARG . . . -96.82 149.4 19.29 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 121.302 -0.475 . . . . 64.540000000000006 111.942 -178.204 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -97.35 120.94 47.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.282 -1.377 . . . . 75.409999999999997 107.282 179.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -131.33 150.83 34.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-O 121.528 0.68 . . . . 73.439999999999998 110.961 -178.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.79 129.18 25.54 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 106.524 -1.658 . . . . 73.510000000000005 106.524 179.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.13 128.13 24.28 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 121.877 1.718 . . . . 71.530000000000001 111.273 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' ' 68' ' ' GLN . 5.9 tt0 -60.81 -26.77 67.54 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 121.198 0.523 . . . . 72.099999999999994 111.991 -178.746 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -65.11 -18.83 24.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.27 -0.877 . . . . 74.299999999999997 112.237 179.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 81' ' ' LEU . 4.5 m-85 -73.74 -9.86 59.09 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.455 0.645 . . . . 74.510000000000005 110.657 177.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.04 161.94 17.08 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 115.522 -0.763 . . . . 61.299999999999997 109.455 179.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 56.9 p -83.55 176.1 9.28 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.405 -0.961 . . . . 63.240000000000002 108.405 175.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -61.79 -21.69 64.81 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.085 0.469 . . . . 70.349999999999994 110.961 179.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 27.9 t -80.79 -10.47 59.72 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.411 0.684 . . . . 73.329999999999998 110.298 179.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.2 24.78 53.82 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.641 -0.79 . . . . 74.430000000000007 111.773 -179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -112.89 152.15 29.63 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.142 -1.059 . . . . 63.119999999999997 108.142 178.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.478 HG13 HD23 ' A' ' 81' ' ' LEU . 41.9 t -62.87 135.31 27.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 120.595 0.236 . . . . 62.450000000000003 111.053 178.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 80' ' ' SER . 39.0 t -64.97 131.32 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.599 -0.889 . . . . 72.519999999999996 108.599 177.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -21.98 27.51 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.76 1.022 . . . . 61.130000000000003 113.76 -178.293 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.426 ' H ' HG12 ' A' ' 78' ' ' VAL . 17.9 t -94.58 -10.56 31.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 120.934 0.397 . . . . 62.210000000000001 110.456 -177.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 43.7 tp -60.18 -55.16 48.08 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-O 119.314 -0.374 . . . . 73.040000000000006 111.914 -177.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -57.34 -28.21 79.0 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.18 1.92 . . . . 63.140000000000001 111.716 178.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.25 -45.66 60.44 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 121.103 -0.57 . . . . 73.049999999999997 111.935 -178.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.47 -40.31 81.05 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.42 0.628 . . . . 75.219999999999999 109.801 179.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 84.9 mt -62.18 -44.4 96.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.616 -0.72 . . . . 74.129999999999995 110.842 -178.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.4 m -70.39 -34.66 72.82 Favored 'General case' 0 CA--C 1.557 1.227 0 CA-C-N 115.831 -0.622 . . . . 74.120000000000005 112.081 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -45.55 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 120.281 -0.567 . . . . 70.150000000000006 110.718 178.629 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 93' ' ' TYR . 4.3 mm? -67.17 -35.81 80.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.1 0.407 . . . . 73.150000000000006 112.1 176.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -60.03 -37.36 79.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.273 -0.64 . . . . 65.200000000000003 109.273 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.38 -30.17 71.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.03 -0.532 . . . . 61.409999999999997 110.909 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.7 -2.31 84.63 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.965 -0.561 . . . . 74.439999999999998 112.182 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.19 39.44 11.35 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.479 -0.391 . . . . 73.310000000000002 112.591 178.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.451 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 68.9 m-85 -100.74 121.02 40.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.972 0.415 . . . . 71.230000000000004 111.694 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.623 ' HG2' ' HG2' ' A' ' 97' ' ' GLU . 38.1 ptt180 -71.0 171.61 10.53 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.112 0.965 . . . . 64.209999999999994 110.307 176.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -54.19 -44.97 72.02 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 125.24 1.416 . . . . 73.109999999999999 111.174 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.0 m -61.64 -41.4 97.45 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.94 -1.027 . . . . 75.310000000000002 110.625 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.623 ' HG2' ' HG2' ' A' ' 94' ' ' ARG . 41.6 mm-40 -67.31 -33.95 76.34 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.503 -0.317 . . . . 72.310000000000002 111.714 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.5 mm -61.16 -47.61 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.308 -0.997 . . . . 42.539999999999999 108.308 -179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.1 mtt -74.74 -18.77 60.44 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.775 -1.102 . . . . 74.340000000000003 112.074 -178.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 97' ' ' GLU . 77.8 ttt180 -55.97 -65.56 0.58 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.279 0.632 . . . . 70.420000000000002 110.371 -179.385 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.51 ' CZ3' ' HG ' ' A' ' 102' ' ' LEU . 53.3 p-90 -69.13 -32.06 71.16 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.528 -0.76 . . . . 72.530000000000001 112.623 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 125' ' ' PRO . 11.4 mt -64.99 -41.89 95.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.93 1.085 . . . . 63.109999999999999 113.93 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 124' ' ' ARG . 68.7 m-85 -89.5 -11.76 42.0 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 114.004 1.113 . . . . 71.209999999999994 114.004 -173.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.3 m -81.47 119.2 74.99 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 109.532 -0.544 . . . . 72.010000000000005 109.532 -179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.02 130.32 27.08 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 122.6 2.2 . . . . 61.340000000000003 111.21 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 15.5 t70 -99.86 125.24 41.0 Favored Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.45 -0.5 . . . . 74.129999999999995 110.358 -175.338 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.538 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 27.4 Cg_endo -60.86 -23.57 77.16 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.764 2.31 . . . . 64.430000000000007 113.645 -177.735 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 15.2 m -107.85 12.19 27.45 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 120.965 0.412 . . . . 73.349999999999994 110.848 -175.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.47 ' HG ' HG12 ' A' ' 111' ' ' ILE . 35.8 tp -108.37 124.92 51.1 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.193 -0.603 . . . . 44.32 110.793 -179.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.6 m -116.47 110.7 18.96 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.825 -0.806 . . . . 71.120000000000005 108.825 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.47 HG12 ' HG ' ' A' ' 109' ' ' LEU . 48.9 mm -123.33 155.49 29.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 123.417 0.687 . . . . 74.420000000000002 110.013 -173.46 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.479 HG23 HE22 ' A' ' 133' ' ' GLN . 9.8 t -131.6 159.39 38.38 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.515 -1.291 . . . . 72.0 107.515 179.137 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -123.13 171.79 9.05 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 118.264 0.483 . . . . 71.019999999999996 110.686 -178.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -64.95 126.84 29.26 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.199 -1.038 . . . . 62.100000000000001 108.199 177.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.79 34.93 7.04 Favored Glycine 0 C--N 1.301 -1.41 0 N-CA-C 110.778 -0.929 . . . . 72.530000000000001 110.778 -178.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.9 m -147.74 138.51 23.29 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.982 -0.747 . . . . 73.349999999999994 108.982 177.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -97.3 -19.2 18.7 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.332 0.587 . . . . 74.120000000000005 110.509 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -117.78 173.41 6.76 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.546 -0.752 . . . . 60.539999999999999 111.123 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.74 157.46 18.1 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.316 0.579 . . . . 54.420000000000002 111.591 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.42 120.75 58.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.043 -1.095 . . . . 75.510000000000005 108.043 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.4 m -80.2 155.52 27.35 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.799 -0.815 . . . . 72.129999999999995 108.799 177.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.538 ' ND2' ' HA ' ' A' ' 107' ' ' PRO . 14.6 m120 67.7 37.17 3.35 Favored 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.808 0.692 . . . . 74.200000000000003 110.741 176.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.98 163.59 13.61 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.95 -0.389 . . . . 52.310000000000002 109.95 -179.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 103' ' ' PHE . 12.2 ptp85 -95.14 150.3 37.47 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.338 -0.615 . . . . 73.299999999999997 109.338 178.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.624 ' HB2' HD23 ' A' ' 102' ' ' LEU . 77.2 Cg_exo -54.89 -25.43 43.61 Favored 'Trans proline' 0 CA--C 1.555 1.533 0 C-N-CA 123.294 2.662 . . . . 62.539999999999999 114.028 178.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 102' ' ' LEU . 40.9 t -60.37 -43.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 120.858 0.361 . . . . 53.100000000000001 111.576 178.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.91 -32.79 74.66 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.611 -0.722 . . . . 72.109999999999999 109.885 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.53 75.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.4 -0.818 . . . . 72.299999999999997 111.961 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.478 ' HB3' HG21 ' A' ' 137' ' ' VAL . 4.1 pp -68.49 -37.39 80.07 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.525 -0.47 . . . . 70.400000000000006 111.277 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -73.82 -19.08 60.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.692 0.758 . . . . 74.439999999999998 109.493 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.09 7.79 45.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.338 -0.847 . . . . 60.329999999999998 111.157 177.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m80 64.3 27.88 13.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.445 1.117 . . . . 55.140000000000001 111.77 178.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.479 HE22 HG23 ' A' ' 112' ' ' THR . 76.9 mt-30 -110.46 25.12 12.12 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.53 1.532 . . . . 75.120000000000005 108.425 179.567 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.91 -24.8 3.88 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 128.204 2.601 . . . . 63.119999999999997 113.571 -176.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -53.97 -38.75 65.34 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 109.62 -0.511 . . . . 73.239999999999995 109.62 -179.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -68.92 -27.64 65.94 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.453 0.644 . . . . 71.519999999999996 110.944 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 129' ' ' LEU . 61.9 t -73.46 -47.43 45.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.189 -0.914 . . . . 62.520000000000003 109.127 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.49 -41.8 91.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.679 -0.691 . . . . 64.219999999999999 109.188 176.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -56.93 -46.31 82.12 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.836 -1.074 . . . . 62.329999999999998 109.592 176.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -69.01 -36.44 77.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.147 -0.478 . . . . 72.099999999999994 110.734 178.558 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.404 ' HB1' ' CD2' ' A' ' 88' ' ' LEU . . . -58.72 -45.63 89.17 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.438 0.695 . . . . 54.130000000000003 110.516 179.31 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.87 -38.42 88.74 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.814 -0.63 . . . . 75.310000000000002 110.759 178.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.02 -32.88 73.56 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.146 0.498 . . . . 73.099999999999994 110.594 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tpt -74.69 -47.11 33.5 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.699 -0.682 . . . . 73.450000000000003 110.907 -179.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.77 -32.9 46.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.992 0.738 . . . . 64.010000000000005 112.992 -176.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 108.892 -0.781 . . . . 61.240000000000002 108.892 -179.177 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 15.7 tpt . . . . . 0 CA--C 1.553 1.064 0 N-CA-C 113.726 1.01 . . . . 72.319999999999993 113.726 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 57.3 Cg_endo -77.41 150.87 28.9 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 121.686 1.591 . . . . 73.540000000000006 112.579 -178.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.82 59.75 4.92 Favored Glycine 0 C--N 1.314 -0.646 0 N-CA-C 110.689 -0.964 . . . . 74.099999999999994 110.689 178.088 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.6 ttm180 -73.06 131.93 42.72 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 123.06 0.544 . . . . 72.230000000000004 110.188 -177.064 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 159.7 127.8 0.0 OUTLIER Pre-proline 0 C--O 1.24 0.6 0 C-N-CA 126.851 2.06 . . . . 63.439999999999998 106.992 -179.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.29 79.93 3.03 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.706 1.604 . . . . 53.329999999999998 109.129 174.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.8 106.04 2.83 Favored Glycine 0 N--CA 1.423 -2.174 0 N-CA-C 108.48 -1.848 . . . . 44.329999999999998 108.48 -172.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 p -69.69 -24.92 63.66 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 114.285 1.217 . . . . 71.319999999999993 114.285 -173.479 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 m -114.16 144.7 42.75 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.824 -0.436 . . . . 64.209999999999994 109.824 -178.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.18 152.48 39.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.993 -0.373 . . . . 72.040000000000006 109.993 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.14 139.59 51.88 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.23 -0.656 . . . . 64.450000000000003 109.23 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -85.78 92.14 8.52 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-O 121.275 0.56 . . . . 65.400000000000006 110.19 -179.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.46 117.56 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 CA-C-O 122.037 0.922 . . . . 63.229999999999997 109.861 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.24 -47.61 2.64 Favored Glycine 0 C--N 1.286 -2.223 0 CA-C-N 114.383 -1.28 . . . . 74.310000000000002 111.144 -179.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.6 t -71.62 99.23 2.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.477 0.656 . . . . 63.329999999999998 109.814 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 mm -100.94 122.93 47.1 Favored Pre-proline 0 C--N 1.301 -1.515 0 N-CA-C 108.306 -0.998 . . . . 64.150000000000006 108.306 179.181 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -73.06 155.23 52.63 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.459 1.439 . . . . 64.219999999999999 110.239 174.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.11 124.88 30.91 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.406 0.282 . . . . 55.539999999999999 110.702 -176.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.3 -105.6 2.84 Favored Glycine 0 N--CA 1.434 -1.452 0 C-N-CA 121.365 -0.445 . . . . 73.239999999999995 113.52 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -113.64 134.52 54.68 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 122.692 0.397 . . . . 65.319999999999993 110.489 -175.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -75.18 127.6 33.56 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.668 0.747 . . . . 71.209999999999994 110.907 -179.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.7 t -97.07 -21.46 5.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.465 -0.789 . . . . 63.520000000000003 110.216 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -78.82 152.08 31.54 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 113.311 0.856 . . . . 71.430000000000007 113.311 -178.218 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.21 151.45 94.54 Favored Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 107.637 -1.245 . . . . 60.420000000000002 107.637 178.149 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.21 -25.0 76.54 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.769 1.646 . . . . 74.340000000000003 110.559 174.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -72.97 -13.81 61.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.145 -0.934 . . . . 73.340000000000003 111.209 177.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -83.61 131.41 52.43 Favored Pre-proline 0 N--CA 1.435 -1.175 0 N-CA-C 107.74 -1.207 . . . . 74.200000000000003 107.74 175.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.496 ' HB2' ' NE2' ' A' ' 68' ' ' GLN . 58.6 Cg_endo -69.2 146.34 63.31 Favored 'Trans proline' 0 C--O 1.256 1.4 0 C-N-CA 122.871 2.381 . . . . 72.5 113.204 -177.019 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -128.79 165.75 20.35 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.795 0.807 . . . . 74.349999999999994 112.165 -178.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.558 ' CE2' ' HG3' ' A' ' 68' ' ' GLN . 12.3 m-85 -130.34 161.45 31.26 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 125.927 1.691 . . . . 75.299999999999997 107.779 175.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 33' ' ' PRO . 9.4 t70 -134.23 169.36 17.3 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 103.819 -2.659 . . . . 61.229999999999997 103.819 178.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HB3' HG13 ' A' ' 43' ' ' VAL . 6.2 mp -54.7 -51.99 74.08 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 114.262 1.208 . . . . 73.239999999999995 114.262 -171.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 15.8 Cg_endo -58.48 -36.12 97.84 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.157 1.904 . . . . 64.450000000000003 112.445 176.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 21.4 tpt180 -69.82 -39.34 76.55 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 122.912 0.485 . . . . 75.040000000000006 110.21 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.44 -38.84 77.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.318 0.58 . . . . 72.329999999999998 109.59 176.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 41' ' ' VAL . . . -59.62 -36.14 75.75 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.201 -0.909 . . . . 75.540000000000006 109.881 177.1 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 37.8 tt0 -65.2 -43.77 90.52 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.575 -1.193 . . . . 75.049999999999997 109.963 178.165 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 34' ' ' ARG . 83.9 mt -67.02 -50.24 62.71 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.799 -0.637 . . . . 64.340000000000003 111.285 -178.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.433 ' HB2' HG22 ' A' ' 41' ' ' VAL . 81.7 mt -81.06 -17.82 48.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.704 -0.68 . . . . 54.409999999999997 112.12 -173.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.07 23.71 63.08 Favored Glycine 0 C--N 1.312 -0.802 0 C-N-CA 120.682 -0.77 . . . . 42.549999999999997 111.619 178.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 39' ' ' LEU . 34.2 m -120.89 159.25 49.75 Favored Pre-proline 0 C--N 1.312 -1.052 0 N-CA-C 109.926 -0.398 . . . . 71.140000000000001 109.926 -177.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -61.32 154.12 60.72 Favored 'Trans proline' 0 C--O 1.26 1.599 0 C-N-CA 122.269 1.979 . . . . 55.310000000000002 113.139 173.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 32' ' ' LEU . 90.3 t -57.88 -35.13 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.478 -1.237 . . . . 72.25 110.993 -179.367 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -64.55 -34.37 78.09 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 116.364 -0.38 . . . . 63.32 110.789 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 49' ' ' GLN . 68.1 mttm -68.98 -35.78 77.12 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 121.905 -0.497 . . . . 75.540000000000006 110.225 176.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.21 -43.02 98.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-N 115.76 -0.655 . . . . 63.32 109.696 175.705 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.59 -36.74 79.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.86 -0.609 . . . . 71.219999999999999 110.349 177.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 46.3 mt-30 -67.51 -35.2 78.65 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-N 115.954 -0.566 . . . . 63.439999999999998 111.848 177.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 15.9 mm-40 -58.26 -48.75 79.45 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.583 -0.895 . . . . 74.310000000000002 108.583 177.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.3 tp -62.3 -42.69 99.58 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.844 -1.071 . . . . 64.120000000000005 110.27 178.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -70.13 -21.32 63.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 114.25 1.204 . . . . 71.439999999999998 114.25 -179.232 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 18.2 mm-40 -96.54 -4.85 40.6 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 119.749 -0.78 . . . . 74.530000000000001 110.758 179.148 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.56 36.49 37.99 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.105 -0.798 . . . . 41.020000000000003 111.105 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -106.68 -5.18 18.76 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.219 -1.03 . . . . 70.200000000000003 108.219 178.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.8 tp -158.11 153.65 26.22 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.697 -1.594 . . . . 73.230000000000004 106.697 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.17 146.98 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.996 -0.742 . . . . 74.200000000000003 108.996 -176.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.56 153.28 51.03 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 109.297 -0.631 . . . . 72.329999999999998 109.297 -179.024 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 m -129.19 168.0 23.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 123.777 0.831 . . . . 61.420000000000002 109.726 179.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 59' ' ' ARG . 33.7 ttt180 -108.43 118.01 35.67 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.439 -0.949 . . . . 72.430000000000007 108.439 -176.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -123.9 123.47 40.49 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.089 -1.414 . . . . 74.409999999999997 109.473 -176.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 62.0 16.07 7.83 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.541 1.136 . . . . 52.439999999999998 112.034 177.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.46 -12.87 54.56 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.73 -0.668 . . . . 44.229999999999997 112.025 -178.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.15 156.9 17.96 Favored Glycine 0 CA--C 1.497 -1.093 0 C-N-CA 120.498 -0.858 . . . . 72.140000000000001 111.337 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.47 120.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.893 -1.151 . . . . 74.349999999999994 107.893 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.47 157.32 42.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.675 0.75 . . . . 62.350000000000001 111.451 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 71.9 mt -112.29 126.56 28.2 Favored Pre-proline 0 C--N 1.283 -2.31 0 N-CA-C 106.564 -1.643 . . . . 71.319999999999993 106.564 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.35 128.78 28.62 Favored 'Trans proline' 0 C--N 1.329 -0.471 0 C-N-CA 122.341 2.028 . . . . 63.549999999999997 112.697 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.558 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 6.6 tt0 -66.31 -25.22 66.74 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 121.499 0.666 . . . . 75.040000000000006 110.937 179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -69.0 -8.1 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 115.181 -0.918 . . . . 72.109999999999999 112.44 178.028 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -82.6 -7.03 59.66 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 122.085 0.945 . . . . 71.430000000000007 109.424 173.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -112.35 164.12 13.61 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 114.645 -1.161 . . . . 74.219999999999999 108.501 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.3 p -93.59 173.92 7.45 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.841 -0.8 . . . . 75.200000000000003 108.841 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -66.33 -16.86 64.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.881 0.848 . . . . 71.420000000000002 109.571 178.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -79.72 -7.3 58.53 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.243 -0.889 . . . . 72.109999999999999 111.073 178.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.39 62.06 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.949 -0.644 . . . . 54.149999999999999 112.465 178.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -126.09 152.14 46.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.786 -0.82 . . . . 64.310000000000002 108.786 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.84 143.94 14.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 123.557 0.535 . . . . 73.540000000000006 109.683 -177.371 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 59.6 t -62.52 121.07 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 108.253 -1.018 . . . . 65.319999999999993 108.253 176.333 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -57.89 -39.69 78.51 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 123.471 0.708 . . . . 65.540000000000006 112.885 -173.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.9 t -93.07 3.18 56.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.206 0.447 . . . . 73.049999999999997 112.206 -176.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 8.4 tt -66.22 -45.07 60.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 N-CA-C 114.026 1.121 . . . . 72.319999999999993 114.026 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.86 -21.62 34.03 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 123.123 2.549 . . . . 74.030000000000001 113.276 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -60.83 -41.3 99.13 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.171 -0.772 . . . . 51.539999999999999 111.171 177.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.15 -39.8 82.54 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.24 -0.652 . . . . 71.209999999999994 109.24 -179.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -61.28 -43.85 98.2 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.367 -0.833 . . . . 62.240000000000002 109.903 -178.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 55.3 m -57.76 -47.32 82.85 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.536 -0.756 . . . . 71.420000000000002 111.632 -176.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -46.06 82.32 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.588 -0.278 . . . . 45.350000000000001 111.724 -179.839 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.563 HD21 ' HB1' ' A' ' 141' ' ' ALA . 4.1 mm? -67.21 -37.99 84.55 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.571 0.952 . . . . 65.230000000000004 113.571 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -59.99 -44.99 94.16 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.004 0.43 . . . . 72.420000000000002 110.42 178.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.05 -27.34 63.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.064 -0.516 . . . . 73.120000000000005 110.987 178.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.96 -9.55 86.58 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.084 -0.507 . . . . 73.230000000000004 112.632 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.13 6.87 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.345 -0.455 . . . . 70.439999999999998 113.658 176.162 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -113.57 139.32 49.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.957 0.379 . . . . 74.409999999999997 111.331 177.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.497 ' HG2' ' HG3' ' A' ' 97' ' ' GLU . 14.3 ptp180 -89.93 172.07 9.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.604 -0.726 . . . . 75.239999999999995 110.716 -176.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -54.17 -45.4 72.1 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 125.429 1.491 . . . . 74.25 112.307 -176.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.0 m -64.63 -41.18 96.35 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 115.733 -0.667 . . . . 63.350000000000001 109.824 -178.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.497 ' HG3' ' HG2' ' A' ' 94' ' ' ARG . 47.8 mt-10 -66.08 -38.75 89.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.602 -0.726 . . . . 64.129999999999995 111.058 -179.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 102' ' ' LEU . 30.0 mm -60.69 -47.24 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.689 -0.856 . . . . 74.129999999999995 108.689 -179.209 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 53.2 mtt -74.41 -18.42 60.66 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.836 -1.075 . . . . 63.219999999999999 113.095 -177.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -57.37 -64.33 0.93 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.24 0.543 . . . . 74.340000000000003 110.304 178.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.559 ' CD1' ' HG2' ' A' ' 144' ' ' MET . 60.3 p-90 -69.62 -32.33 70.97 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 74.430000000000007 112.617 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.542 ' HG ' ' CZ3' ' A' ' 101' ' ' TRP . 11.2 mt -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.572 0.953 . . . . 75.230000000000004 113.572 179.438 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.606 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 57.1 m-85 -98.61 10.76 40.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.303 0.482 . . . . 65.340000000000003 112.303 -177.729 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 101' ' ' TRP . 11.8 t -87.79 122.01 70.52 Favored Pre-proline 0 N--CA 1.434 -1.274 0 C-N-CA 119.144 -1.022 . . . . 71.409999999999997 110.154 177.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -68.6 136.83 37.34 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 122.578 2.185 . . . . 71.510000000000005 110.956 177.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 14.7 t70 -106.93 112.7 63.21 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 119.79 -0.764 . . . . 73.150000000000006 109.472 178.101 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.09 -16.77 48.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.277 2.651 . . . . 61.530000000000001 114.596 -176.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.4 m -109.51 3.23 21.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.035 -0.416 . . . . 54.299999999999997 111.388 -177.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 tp -102.62 125.27 49.29 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.43 0.633 . . . . 71.120000000000005 110.88 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 57.3 m -116.43 120.7 39.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.571 -1.27 . . . . 75.150000000000006 107.571 179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 123' ' ' ALA . 32.4 mt -126.37 150.6 32.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.009 -0.737 . . . . 64.439999999999998 109.009 -173.281 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 23.6 p -89.48 126.4 35.56 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.886 -1.524 . . . . 71.019999999999996 106.886 175.049 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -88.48 149.49 23.62 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.576 -0.85 . . . . 74.120000000000005 111.431 -171.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 131' ' ' ALA . 29.5 t70 -77.04 153.69 34.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.369 -0.604 . . . . 72.349999999999994 109.369 179.081 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.57 -54.02 3.08 Favored Glycine 0 CA--C 1.492 -1.388 0 N-CA-C 108.983 -1.647 . . . . 63.200000000000003 108.983 -175.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.9 p -95.0 -169.24 1.96 Allowed 'General case' 0 N--CA 1.39 -3.462 0 N-CA-C 108.078 -1.082 . . . . 75.010000000000005 108.078 175.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 117' ' ' ARG . 0.0 OUTLIER -135.24 9.05 3.46 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.626 -0.879 . . . . 61.340000000000003 108.626 177.573 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -92.37 147.69 22.71 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.365 -1.289 . . . . 63.420000000000002 110.579 -173.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' THR . . . -87.99 128.57 35.39 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.553 -0.748 . . . . 73.239999999999995 109.789 177.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.5 t -115.24 127.59 72.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 107.946 -1.131 . . . . 75.129999999999995 107.946 -179.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 14.8 p -86.92 141.14 28.95 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.202 -0.666 . . . . 63.130000000000003 109.202 177.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 106' ' ' ASP . 9.2 t30 68.68 70.55 0.29 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.188 0.994 . . . . 55.0 110.315 -177.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.578 ' HB3' HD12 ' A' ' 111' ' ' ILE . . . -108.22 174.67 5.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.238 -0.892 . . . . 61.329999999999998 109.181 175.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.14 150.51 38.42 Favored Pre-proline 0 C--N 1.317 -0.838 0 N-CA-C 109.035 -0.728 . . . . 74.530000000000001 109.035 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.473 ' HB2' HD23 ' A' ' 102' ' ' LEU . 84.9 Cg_exo -52.7 -34.01 62.2 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.025 2.483 . . . . 64.099999999999994 112.544 173.296 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 61.3 t -64.08 -43.61 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 119.771 -0.772 . . . . 63.310000000000002 109.6 175.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.02 -30.8 70.13 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.886 -0.783 . . . . 71.010000000000005 108.886 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -66.02 -45.18 82.43 Favored 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 115.247 -0.888 . . . . 60.409999999999997 112.054 177.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 126' ' ' VAL . 4.6 pp -69.15 -33.48 73.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.161 0.505 . . . . 73.25 110.269 -179.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -66.33 -28.76 68.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.404 -0.961 . . . . 70.319999999999993 108.404 176.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' A' ' 114' ' ' ASP . . . -96.44 14.37 24.73 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.708 -1.133 . . . . 70.200000000000003 112.261 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 62.05 27.41 16.56 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.901 1.28 . . . . 63.520000000000003 111.885 176.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -110.64 24.69 12.64 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-O 123.772 1.749 . . . . 72.439999999999998 108.241 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.57 -26.31 12.97 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 111.389 -2.641 . . . . 70.140000000000001 113.495 179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -55.52 -41.4 73.09 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.729 0.411 . . . . 72.299999999999997 110.875 -174.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.64 -35.6 77.5 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 121.454 0.645 . . . . 74.299999999999997 110.249 178.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.2 t -66.07 -42.42 91.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 115.053 -0.976 . . . . 74.519999999999996 109.754 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 142' ' ' GLN . 98.6 t -61.49 -46.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 65.209999999999994 109.471 177.608 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -63.86 -38.96 93.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.117 0.484 . . . . 72.019999999999996 111.001 178.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -36.36 81.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 108.328 -0.99 . . . . 71.400000000000006 108.328 178.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.563 ' HB1' HD21 ' A' ' 88' ' ' LEU . . . -67.69 -46.37 72.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.559 0.744 . . . . 75.230000000000004 110.437 178.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 138' ' ' VAL . 87.2 mt-30 -57.62 -49.5 76.24 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.046 -0.525 . . . . 73.340000000000003 109.851 178.359 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.71 -27.26 66.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.417 -0.811 . . . . 63.329999999999998 111.422 -178.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.559 ' HG2' ' CD1' ' A' ' 101' ' ' TRP . 14.9 tpt -77.45 -29.3 52.76 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.119 0.485 . . . . 72.239999999999995 110.171 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.21 -48.12 7.12 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.489 0.551 . . . . 54.240000000000002 112.489 -177.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 119.164 -0.446 . . . . 75.209999999999994 109.944 -176.499 . . . . . . . . 0 0 . 1 stop_ save_